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O001 | Preserved neuron reactivity dynamics
during prolonged wakefulness is linked to
cognitive fitness in aging, independently of tau
and amyloid beta burden
M. Van Egroo1; J. Narbutas1,2; G. Besson1; V. Muto1;
D. Chylinski1; P. Villar-Gonzalez1; G. Gaggioni1;
P. Ghaemmaghami1; X. Pepin1; M. Cerasuolo3; M. Blanpain1;
E. Tezel1; C. Le Goff4; E. Cavalier4; E. Lambot1; S. Laloux1;
C. Hagelstein1; A. Luxen1; C. Degueldre1; M.A. Bahri1;
P. Maquet1,5; E. Salmon1,2,5; C. Schmidt1,2; C. Phillips1,6;
C. Bastin1,2; F. Collette1,2; G. Vandewalle1
1GIGA‐CRC In Vivo Imaging, 2Psychology and Cognitive Neuroscience
Research Unit, Université de Liège, Liège, Belgium, 3Department of
Psychology, University of Campania, Caserta, Italy, 4Department of
Clinical Chemistry, Université de Liège, Liège, 5Department of
Neurology, Université de Liège, Liege, 6GIGA‐In Silico Medicine,
Université de Liège, Liège, Belgium
Objectives/Introduction: Aging is associated with important mod-
ifications in sleep homeostasis and circadian rhythmicity. Whether
these changes influence cognition beyond the age‐related decline in
brain integrity remains unclear, however. Here, we investigated
whether the dynamics of neuron reactivity, a basic aspect of brain
function influenced by sleep homeostasis and circadian processes, is
related to performance across different cognitive domains in healthy
aging. We further asked whether the link between neuron reactivity
and cognition was independent from abnormal brain protein accumu-
lations central to the pathophysiology of Alzheimer's disease (AD).
Methods: We used transcranial magnetic stimulation combined
with electroencephalography (TMS‐EEG) to assess the temporal
dynamics of frontal cortical neuron reactivity in 47 healthy older
individuals (aged 51–69 years, mean = 59.3 ± 5.2; 30 females) during
20 hr of wake extension in strictly‐controlled constant routine condi-
tions. A comprehensive battery of neuropsychological tasks measur-
ing memory, attentional, and executive functions was administered
to all participants while well‐rested. Performance was Z‐scored to
create composite scores for memory, attentional, and executive abili-
ties. Participants also underwent two Positron Emission Tomography
(PET) scans to quantify tau and amyloid beta protein burden using,
respectively, 18F‐THK5351 and 18F‐flutemetamol radioligands.
Results: Generalized linear mixed models analyses reveal that fron-
tal neuron reactivity dynamics during prolonged wakefulness is
strongly associated with the executive performance (p = 0.004), but
not with memory (p = 0.9) or attentional (p = 0.16) functions (con-
trolling for age, sex, and education). Importantly, those individuals
retaining young‐like dynamics in brain reactivity showed better exec-
utive performance. Critically, this domain‐specific association remains
significant after controlling for tau and amyloid beta burden in brain
regions underlying executive functions (p = 0.01).
Conclusions: Our data show that older individuals exhibiting pre-
served sleep‐wake regulation of frontal cortical neuron reactivity
have better executive performance. Furthermore, this association
appears independent of tau and amyloid beta protein accumulations
which take place during normal aging and decades before the onset
of AD cognitive symptoms. These original results provide strong sup-
port for a key role of sleep homeostasis and circadian rhythmicity in
determining age‐related cognitive decline apart from the age‐related
deterioration in brain structures.
Disclosure: Support: FNRS, ULiège, ARC17/21‐09, FEDER, WBI,
Clerdent Foundation.
O002 | Discovering the role of miR‐709 in the
sleep homeostatic process
K. Kompotis; G. Mang; S. Jimenez; Y. Emmennegger;
P. Franken
Centre for Integrative Genomics, University of Lausanne, Lausanne,
Switzerland
Objectives/Instruction: MicroRNAs are small non‐coding RNAs
occupying a key role in various biological processes, including sleep.
We previously performed a microRNA‐array analysis to determine
which microRNAs are affected by sleep loss in the mouse brain and
found the expression of miR‐709, an activity‐dependent microRNA,
to be increased in the forebrain after 6 hr of sleep deprivation (SD).
The current study aims to decipher the functional involvement of
miR‐709 in sleep homeostasis.
Methods: In vivo knockdown of miR‐709 was performed using
locked nucleic acid (LNA) inhibitors (Exiqon, Denmark). Cannulated
mice, equipped with electroencephalography (EEG) and electromyog-
raphy (EMG) electrodes, were injected intracerebroventricularly (ICV)
with either (a) specific miRNA‐709 inhibitors (imiR‐709, n = 7), (b)
non‐functional “scrambled” inhibitors (scr, n = 6), or (c) artificial cere-
brospinal fluid (aCSF, n = 5) as vehicle control. The response to a
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6 hr SD relative to baseline was compared among the three groups.
To identify pathways affected by miR‐709 inhibition, we used pri-
mary cortical cultures from mouse embryos, treated with either (a)
imiR‐709, (b) scr, or (c) vehicle (n = 6/condition), and performed
mRNA sequencing (RNA‐seq) on the extracted RNA. Affected path-
ways were identified by enrichment analysis using the PANTHER
Overrepresentation Test (released 2017‐12‐05) and the Gene Ontol-
ogy (GO) database (released 2018‐02‐02).
Results: In vivo inhibition of miR‐709 in murine brains resulted in a
higher increase in the spectral composition of the EEG during NREM
sleep after periods of prolonged wakefulness, as compared to the
controls. This higher increase was specific to the slow delta fre-
quency band (0.75–2.25 Hz). In vitro inhibition of miR‐709 resulted
in an up‐ or downregulation in the expression levels of 111 genes
with known contributions in ion‐channel activity (i.e. Cacna1i,
Kcnip4), synaptic remodelling (i.e. Nlgn1, Akap12), and glutamatergic
signalling (i.e. Grip1, Grin1), as compared to the control groups.
Conclusions: Our findings delineate miR‐709 as a fine tuner of
neuronal activity and synaptic plasticity in the mouse brain. In previ-
ous studies, miR‐709 has been found to be upregulated after activa-
tion of metabotropic glutamate receptors, which are directly
implicated in sleep homeostasis. miR‐709 might therefore function-
ally link neuronal excitation during extended wakefulness to the
recovery process occurring during sleep.
Disclosure: Nothing to disclose.
O003 | Symptom‐based clinical subtypes of
obstructive sleep apnoea show differences in
spectral power and immediate post‐arousal
dynamics
D. Mazzotti1; B. Keenan1; J. Kim1; M. Younes2; A. Pack1
1University of Pennsylvania, Philadelphia, PA, United States, 2University
of Manitoba, Winnipeg, MB, Canada
Objectives/Introduction: There is an emerging concept that dis-
tinct symptom subtypes exist in obstructive sleep apnoea (OSA),
which relate to treatment responses and outcomes. However, the
physiology of these subtypes has not been comprehensively charac-
terized. Spectral analysis and recent electroencephalographic (EEG)
markers of sleep, including the odds‐ratio product (ORP), have suc-
cessfully quantified sleep depth and response to arousal. This study
identifies OSA symptom subtypes in a cohort from the U.S. and
examines whether specific EEG physiological markers characterize
these subtypes.
Methods: We used polysomnographic and symptom questionnaire
data from 654 individuals with moderate‐severe OSA [apnoea‐
hypopnoea index (AHI) ≥15; 65.4 ± 10.5 years‐old; 32% female] in
the Sleep Heart Health Study, a multi‐centre, population‐based longi-
tudinal study. Symptom subtypes were identified using latent class
analysis. We compared several EEG markers of sleep and
conventional polysomnographic sleep parameters (e.g. AHI, sleep
stage percentages, arousals and stage shifts) among identified sub-
types using linear regression with and without adjusting for age, gen-
der and body mass index.
Results: Analyses identified 4 subtypes as the optimal solution:
‘moderate sleepiness only’ (38.1%), ‘minimally symptomatic’ (32.7%),
‘excessively sleepy’ (16.5%) and ‘disturbed sleep’ (12.7%). There
were statistically significant (p = 0.003), but clinically small differ-
ences in AHI; average AHI ranged from 27.2 to 34.2 events/hr.
While no other conventional polysomnographic measures differed,
symptom subtypes were associated (p < 0.05; 5% false discovery
rate adjusted) with overall normalized EEG power, delta, sigma, beta‐
1 and gamma power, average wake ORP, and number of arousals
with max‐baseline ORP difference >0.5. After covariate adjustment,
the ‘moderate sleepiness only’ group had lower delta [β (95% CI) =
−7.3 (−12.0, −2.7); p = 0.002] and gamma power [−0.12 (−0.21,
−0.04) μV2/Hz; p = 0.002] and the ‘excessively sleepy’ group had a
higher number of arousals with max‐baseline ORP difference >0.5
[23.2 (6.6, 39.9); p = 0.006] compared to the ‘disturbed sleep’
group.
Conclusions: We show for the first time that EEG markers of
sleep can explain differences in OSA symptom subtypes. The higher
delta and gamma power in the ‘disturbed sleep’ group might indicate
physiological responses to the insomnia‐related symptoms in these
patients. Similarly, the higher number of arousals with large ORP dif-
ferences in the ‘excessively sleepy’ group might reflect more frag-
mented sleep, explaining their daytime symptoms.
Disclosure: Nothing to disclose.
O004 | The impact of treating insomnia upon
functional health, psychological wellbeing and
sleep‐related quality of life: a randomised
controlled trial with mediation analysis
A.I. Luik1,2; R. Emsley3; S.D. Kyle1; C. Gordon4,5; C.L. Drake6;
A. Marsden7; C.A. Espie1,8
1Sleep & Circadian Neuroscience Institute (SCNi) Nuffield Department of
Clinical Neurosciences University of Oxford, Oxford, United Kingdom,
2Department of Epidemiology, Erasmus MC University Medical Center,
Rotterdam, the Netherlands, 3King's College London, Biostatistics &
Health Informatics Department, Institute of Psychiatry, Psychology &
Neuroscience, London, United Kingdom, 4Sydney Nursing School,
University of Sydney, 5CIRUS Centre for Integrated Research and
Understanding of Sleep, Woolcock Institute of Medical Research,
University of Sydney, Sydney, NSW, Australia, 6Department of Sleep
Disorders and Research Center, Henry Ford Health System, Detroit, MI,
United States, 7Centre for Biostatistics, School of Health Sciences,
University of Manchester, Manchester, 8Big Health Ltd., London, United
Kingdom
Objectives/Instruction: Digital Cognitive Behavioural Therapy
(dCBT) is a scalable and effective intervention for treating the ubiq-
uitous problem of insomnia. However, the majority of people with
insomnia seek help because of the daytime consequences of
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insomnia, and not the night‐time effects per se. We investigated the
impact of dCBT for insomnia upon functional health, psychological
well‐being and sleep‐related quality of life (QoL), and whether a
reduction in insomnia was a mediating factor.
Methods: This online, two‐arm parallel group randomised trial with
waitlist control included 1711 adults with complaints of insomnia
(ISRCTN 60530898). Participants were randomized to dCBT (Slee-
pio™) or sleep hygiene education (SHE). Online assessments took
place at 0 (baseline), 4 (mid‐treatment), 8 (post‐treatment), and 24
(follow‐up) weeks. At week 25 participants allocated to SHE were
offered dCBT. Primary outcomes were functional health (Patient
Reported Outcome Measurement Information System: Global Health
scale), psychological well‐being (Warwick‐Edinburgh Mental Wellbe-
ing Scale) and sleep‐related QoL (Glasgow Sleep Impact Index). Sec-
ondary outcomes comprised mood, fatigue, sleepiness, cognitive
failures, work productivity and relationship satisfaction. Insomnia
was assessed with the Sleep Condition Indicator. All analyses were
intention‐to‐treat.
Results: In the dCBT group 681 participants (81%) logged on for at
least one dCBT session and 491 participants (57.6%) completed at
least 4 sessions. At weeks 4, 8 and 24, dCBT was associated with a
small improvement in functional health (Cohen's d: 0.16, 0.31, 0.31
respectively) and psychological well‐being (Cohen's d: 0.13, 0.35,
0.38), and a large improvement in sleep‐related QoL (Cohen's d:
−0.69, −1.38, −1.46) compared with SHE (all p < 0.01). Improve-
ment in insomnia mediated these outcomes (range percent mediated
45.5–84.0%). Symptoms of depression, anxiety, sleepiness, fatigue,
cognitive failures and work productivity all demonstrated significant
differences in favour of dCBT.
Conclusions: dCBT is effective in improving insomnia, functional
health, psychological well‐being and sleep‐related QoL in people
screening positive for insomnia disorder. Targeting insomnia com-
plaints could therefore be a therapeutic pathway for addressing self‐
reported health, well‐being and quality of life. In addition, these
results confirm that dCBT improves both daytime and night‐time
aspects of insomnia strengthening existing recommendations of CBT
as the treatment‐of‐choice for insomnia.
Disclosure: AIL held a position at the University of Oxford during
the conduct of the study that was funded by Big Health Ltd, the
company which developed the dCBT for insomnia program (Sleepio).
CAE is co‐founder and Chief Medical Officer of Big Health Ltd.
UNRAVELING THE NEUROBIOLOGY OF
SLEEP IN NORMAL AGEING AND IN
NEURODEGENERATION
5 | Sleep oscillations and the pathogenesis of
Alzheimer′s disease
R.S. Osorio1; A.W. Varga2
1Psychiatry, NYU School of Medicine, 2Pulmonology, Icahn School of
Medicine at Mount Sinai, New York, NY, United States
With 10% of adults over the age of 65 suffering from dementia and
this number projected to double by 2050, understanding the factors
responsible for cognitive impairment is of critical importance. Amy-
loid beta (Aβ) plaques and neurofibrillary tangles (NFT) are two key
pathological processes that lead to cognitive deterioration in Alzhei-
mer's disease (AD). Cerebrospinal fluid (CSF) Aβ and tau concentra-
tions have been used extensively as biomarkers of AD pathology
and found to correlate with amyloid plaques and NFT at post‐mor-
tem. Emerging evidence suggests that the sleep‐wake cycle directly
influences their levels. Specifically, low NREM stage 3 (NREM3) slow
wave activity (SWA) is associated, in normal elderly, with high cere-
brospinal fluid (CSF) Aβ, while active disruption of slow wave sleep
(SWS) results in increases in CSF Aβ peptides within‐subjects. Unlike
Aβ, associations between poor SWS and tau have not been observed
suggesting that disruption in other sleep oscillations could be linked
to tau pathology. In a cross‐sectional study with one‐night in‐lab
nocturnal polysomnography (NPSG) and morning‐to early afternoon
CSF collection that was conducted on 50 community‐dwelling, cog-
nitively normal healthy subjects, with normal or mild obstructive
sleep apnea (OSA) defined as an apnea‐hypopnea index with 4%
desaturation (AHI4%) <15, we found that spindles during NREM
stage 2 (NREM2) sleep were negatively correlated with CSF T‐tau
levels and to a lesser degree to CSF P‐tau. Spindle‐duration count
and fast spindle density were also negatively correlated with T‐tau
levels. Sleep duration and other measures of sleep quality were not
correlated with spindle characteristics and did not modify the associ-
ations when included in the models. While reductions in NREM
sleep oscillations, including SWS and sleep spindles, or the more
recently reported reductions in REM sleep percentage from the
Sleep Heart Health Study, may reflect a preclinical AD state, it
remains unclear just how these attenuated oscillations are mechanis-
tically linked to cellular processes regulating Aβ and tau. Candidate
mechanisms would include patterned activity‐driven synthesis or
degradation of such molecules or the coupling of such oscillations to
neuroimmune function. Longitudinal and interventional studies to
assess changes in sleep oscillations as well as AD biomarkers are
needed.
Disclosure: Consulting with Eisai.
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6 | Orexin and Alzheimer′s disease
C. Liguori
University of Rome ‘Tor Vergata’, Rome, Italy
In the recent years, orexinergic system dysregulation has been
described in Alzheimer's Disease (AD) neurodegenerative process. In
human studies, it has been demonstrated that both patients affected
by moderate‐severe AD and patients affected by mild cognitive
impairment (MCI) due to AD pathology show increased CSF orexin
levels compared to controls. These findings suggested that the orexin-
ergic neurotransmitter system may be dysregulated in the early as well
as in the advanced stages of the AD neurodegenerative processes. It is
well known that the role of the orexinergic system is not limited to the
control of diurnal wake, but also influences nocturnal sleep. In physio-
logic condition, higher orexin brain levels seems to reduce primarily
REM and slow wave sleep and increase wakefulness during nocturnal
sleep; whereas during the day the higher orexinergic tone promotes
daytime wakefulness. The finding that CSF orexin levels are higher in
AD and MCI patients and correlate with sleep dysregulation proposed
that orexinergic signaling dysregulation coupled with nocturnal sleep
alteration can be responsible for circadian rhythm disruption in AD
patients. Animal model studies supported this finding by demonstrat-
ing that modulation of orexin and its effects on sleep appear to induce
β‐amyloid pathology in the brain. Taking into account that Alzheimer′s
pathology interferes with sleep physiology, orexinergic system dysreg-
ulation may play a significant role in altering sleep in AD patients and
promoting AD pathology by inducing β‐amyloid neurodegeneration.
Hence, we will show the recent evidence about the relationship
among orexinergic signaling overexpression, the disruption of the
sleep‐wake cycle and AD pathology.
Disclosure: Nothing to disclose.
7 | Isolated RBD, an early stage of
α‐synucleinopathy
B. Högl
Medical University of Innsbruck, Department of Neurology, MUI,
Innsbruck, Austria
The isolated form of REM sleep behaviour disorder (RBD) has been
recognized during the last years as the prodromal stage of an α‐
synucleinopathy. Several long‐term follow‐up studies of patients with
isolated RBD from different centers demonstrated independently a
very high risk (>90%) of developing α‐synucleinopathies, such as
Parkinson disease, dementia with Lewy bodies or multiple system
atrophy.
Biomarkers of α‐synucleinopathies have been extensively investi-
gated in iRBD. Some biomarkers, like DAT‐SCAN, olfactory function
and subtle motor signs, are indicative of proximity to conversion to
overt α‐synucleinopathy. DAT‐SCAN can be useful also in monitoring
disease progression. Other biomarkers including different imaging
techniques, tests of autonomic function, neuropsychological and EEG
finding, tissue analysis, genetic, speech analysis and color vision need
to be further investigated to clarify their potential usefulness in iden-
tifying patients at risk of short‐term conversion or in monitoring dis-
ease progression. A long‐term (>10 years) follow‐up study by the
Sleep Innsbruck Barcelona (SINBAR) group showed that biomarkers
of prodromal PD are ubiquitous in patients with isolated RBD, pro-
viding evidence that even these patients are affected by an underly-
ing neurodegenerative process.
The term ‘prodromal RBD’ (in analogy to prodromal Parkinson disease)
has been proposed to define recognizable precursory disease states
before the full diagnostic criteria for isolated RBD are met. In fact, evi-
dence is accumulating that a prodromal stage of RBD exists. Patients
with isolated REM sleep without atonia (RWA) or REM‐sleep‐related
behavioural events (RBE) who do not fulfil the diagnostic criteria for
RBD show a gradual increase in EMG activity or jerks captured on video
during REM sleep over time. These observations suggest that RBD has
an insidious onset until clinically manifest RBD develops. Thus, early
screening using video‐polysomnography could identify patients at risk
of neurodegeneration even before isolated RBD becomes manifest.
Giving the outstandingly high specificity and very long interval
between the onset of idiopathic RBD and the clinical manifestations
of α‐synucleinopathies, the prodromal phase of this disorder repre-
sents a unique opportunity for potentially disease‐modifying inter-
vention, allowing an even earlier detection of individuals at risk of
neurodegeneration.
Disclosure: Honoraria for speaking and/or advisory board or con-
sulting from Otsuka, Mundipharma, UCB, Janssen Cilag, Lündbeck,
AbbVie, Lilly, Axovant, Benevolent Bio.
8 | Is OSA associated with pathological aging?
A neuropsychological and neuroimaging
perspective
N. Gosselin
University of Montreal, Montreal, QC, Canada
There is accumulating evidence that obstructive sleep apnea (OSA)
may impact brain structure and function. Recent cohort studies sug-
gest that OSA is a risk factor for stroke, mild cognitive impairment
and Alzheimer's disease. Because prevention through treatment of
risk factors is currently the main intervention for reducing the inci-
dence of dementia, how OSA affects brain health and whether its
treatment can slow neurodegeneration are relevant questions. This
presentation will addressthe most recent findings on the neurocogni-
tive consequences of OSAin the elderly. We will discuss neuropsy-
chological results obtained in large cohort studies and the specific
cognitive profile observed in older OSA adults. Regarding neuroimag-
ing, most studies on OSA have been performed in young and mid-
dle‐aged adults. Whether these findings can be generalized to an
aged brain is unclear, as neuroimaging studies with older adults have
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only just emerged. We will therefore review the most recent results
from structural (e.g. voxel‐based morphometry, cortical thickness and
diffusion tensor imaging) and functional neuroimaging (e.g. cerebral
blood flow, metabolism). Given the complexity of changes that can
occur in response to OSA (e.g. cellular death, edema, increase in
brain water content, neuroinflammation, changes in cerebral perfu-
sion, increase in Aβ deposition), heterogeneous results can be
obtained depending on participants’ age, severity of intermittent
hypoxia and sleep fragmentation, clinical stages of dementia, etc. It
is therefore important to investigate the effect of OSA by combining
multiple neuroimaging techniques. We will present how findings
from neuropsychology and neuroimaging could impact future OSA
management in older individuals. Finally, we will discuss the effect
of OSA treatment, which may slow, stop or reverse neurodegenera-
tive processes accentuated by OSA, even in individuals already
affected by a neurodegenerative disease.
Disclosure: Nothing to disclose.
THE BIG SLEEP: UNRAVELING INSOMNIA
USING BIG DATA
9 | Epidemiology, genetic models and
epigenetics of insomnia
T. Paunio1,2
1Department of Psychiatry, University of Helsinki and Helsinki
University Hospital, 2National Institute for Health and Welfare, Helsinki,
Finland
Clinically significant, persistent insomnia is a common problem in
health, associated to increasing age and female gender. According to
twin and family studies, the heritability estimates for self‐reported
symptoms of insomnia are modest but tend to be higher for women
than for men. Despite challenges in revealing specific genetic factors
for sleep traits – most likely reflecting the multifactorial nature of
these traits ‐ such factors are emerging, thanks to combined efforts
of basic sleep research, studies on experimental settings and on sam-
ples enriched for extreme phenotypes, and, recently, by making use
of the very large genetic screenings. The strong positive correlation
between the polygenic risk for insomnia symptoms and anxiety dis-
order is in line with previous analysis on twins showing completely
shared additive genetic influences on insomnia and generalized anxi-
ety disorders. The slightly lower genetic correlation between insom-
nia and depression symptoms is likely to be etiologically more
complicated, as evidenced by twin studies showing only modest
shared genetic influences between symptoms for insomnia and
depression in cross‐sectional and longitudinal settings.
Sleep is highly adaptive to the environment so that the propensity
of sleep to react to external influences is built within its basic physi-
ology. There are a few concrete examples revealing a modifying
effect of a genetic variation for liability to disturbed sleep under a
specific environmental influence, such as caffeine or shift work. At
level of chromatin activity, the environment is considered to exert
its effect via epigenetic mechanisms, including DNA methylation.
Understanding the mechanisms involved in gene‐environment inter-
actions for disturbed sleep will be, by no doubt, of primary interest
in order to fully understanding the risk at level of an individual and,
eventually, bring important insight into risk prediction and develop-
ment of therapeutic strategies.
Disclosure: Nothing to disclose.
10 | Trait and life history profiles reveal stable
insomnia subtypes
T.F. Blanken1,2; J.S. Benjamins3; D. Borsboom4;
J.K. Vermunt5; C. Paquola1,6; J. Ramautar1; K. Dekker1;
D. Stoffers1,7; Y. Wei1; E.J.W. Van Someren1,2
1Department of Sleep and Cognition, Netherlands Institute for
Neuroscience, 2Integrative Neurophysiology and Psychiatry, VU
University Medical Center, Amsterdam, 3Department of Social, Health
and Organizational Psychology, Experimental Psychology Section,
Utrecht University, Utrecht, 4Department of Psychological Methods,
University of Amsterdam, Amsterdam, 5Department of Methodology and
Statistics, Tilburg University, Tilburg, the Netherlands, 6Brain and Mind
Centre, University of Sydney, Sydney, NSW, Australia, 7Spinoza Centre
for Neuroimaging, Amsterdam, the Netherlands
Objectives: Insomnia Disorder (ID) is the second‐most prevalent
disorder and a primary risk factor for depression. Despite its heri-
tability, and recently identified risk‐genes, it has proven difficult to
pinpoint consistent biomarkers of ID. These inconsistencies have
stalled progress in our understanding of mechanisms and flag possi-
ble heterogeneity. Previously proposed subtypes were predominantly
defined by sleep‐related characteristics. This method of subtyping
unfortunately has limited reliability and validity. The present large‐
scale study investigated whether traits and life history profiles could
reveal previously unrecognized subtypes with better reliability and
relevance for treatment response and biomarkers.
Methods: N = 4322 volunteers of the Netherlands Sleep Registry
completed up to 34 questionnaires on traits relevant to insomnia
(Benjamins et al. Sleep Med Rev 2017:36:71‐81). Latent class analy-
sis on N = 2224 participants who fulfilled diagnostic criteria for ID
allowed for data‐driven identification of subtypes. Classification
accuracy was evaluated in N = 1046 who completed at least 10
questionnaires. The subtypes were validated in an independent sam-
ple and using longitudinal follow‐up. Clinical relevance of ID sub-
types was assessed with respect to risk of comorbid depression, and
using preliminary data on subtype development, biomarker, and
treatment response differences.
Results: Five ID subtypes were identified that were distinguished
by their multivariate profile of life history, affect and personality
rather than their specific sleep complaints. The five‐class solution
performed equally well in an independent sample, and follow‐up
4.8 ± 1.6 years later demonstrated high subtype stability. Lifetime
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and comorbid depression differed significantly across subtypes.
Moreover, preliminary analyses revealed differences between sub-
types in the developmental trajectories of sleep complaints, brain
function as indicated by an EEG biomarker, and treatment effect.
Conclusions: This large‐scale study identified robust and clinically
relevant ID subtypes, defined by traits and life history rather than
sleep complaints. The demonstrated stability of the ID subtypes
paves the way for studies to target homogeneous subtype samples,
resolve inconsistencies, personalize treatments and select those with
the highest risk of depression for preventive interventions. Feasibility
of this approach was confirmed using preliminary data. A derived
concise questionnaire for subtyping is freely available upon request.
Disclosure: Nothing to disclose.
11 | Genome‐wide analysis of insomnia in UK
Biobank and 23andMe identifies novel loci and
functional pathways
P. Jansen1,2; K. Watanabe1; S. Stringer1; N. Skene3;
J. Bryois3; J. Benjamins4; A. Munoz-Manchado3; J. Tung5;
D. Hinds5; V. Vacic5; P. Sullivan6; T. Polderman1; A. Smit7;
J. Hjerling-Leffler8; E. van Someren9,10; D. Posthuma1,11
1Complex Trait Genetics, VU University Amsterdam, Amsterdam,
2Erasmus Medical Center, Rotterdam, the Netherlands, 3Karolinska
Institutet, Stockholm, Sweden, 4Social Health and Organizational
Psychology and Experimental Psychology, Utrecht University, Utrecht,
the Netherlands, 523andMe, Inc., Mountain View, CA, United States,
6Medical Epidemiology and Biostatistics, Karolinska Institutet,
Stockholm, Sweden, 7Molecular and Celullar Neurobiology, VU
University Amsterdam, Amsterdam, the Netherlands, 8Laboratory of
Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden,
9Integrative Neuropsychologyand Psychiatry InGeest, VU University
Medical Center, 10Sleep and Cognition, Netherlands Institute for
Neuroscience, 11Clinical Genetics, VU University Medical Center,
Amsterdam, the Netherlands
Insomnia is the second‐most prevalent mental disorder, with no suf-
ficient treatment available. Despite a substantial role of genetic fac-
tors, only a handful of genes have been implicated and insight into
the associated neurobiological pathways remains limited. Here, we
perform large‐scale genome‐wide analysis (GWAS) in UK Biobank
and combine results in a meta‐analysis with a GWAS in 23andMe to
allow detection of a substantial number of genetic variants and gain
insight into biological functions, cell types and tissues involved in
insomnia. Moreover, we investigate six additional sleep‐related phe-
notypes through GWAS in UK Biobank.
We perform genome‐wide analysis (GWAS) of insomnia in UK Bio-
bank (N = 386,533), and subsequent meta‐analysis with GWAS
results from 23andMe (N = 944,477) to increase statistical power
(total N = 1,331,010). Next, we perform extensive follow‐up analysis,
including functional annotation using the online FUMA platform
developed by our group, and analysis of gene‐sets and tissue and
single neuron gene‐expression. The results are compared with
GWAS of six‐sleep related traits in UK Biobank.
We identify 202 genome‐wide significant loci implicating 956 genes
through positional, eQTL and chromatin interaction mapping. We
show involvement of the axonal part of neurons, of specific cortical
and subcortical tissues, and several specific cell‐types in insomnia:
striatal medium spiny neurons, pyramidal neurons in the claustrum
and hypothalamic neurons. These cell‐types have been implicated
previously in the regulation of reward processing, sleep and arousal
in animal studies, but have never been genetically linked to insomnia
in humans. We found weak genetic correlations with other sleep‐
related traits, but strong genetic correlations with psychiatric and
metabolic traits. Mendelian randomization identified causal effects of
insomnia on specific psychiatric and metabolic traits. In addition, we
observe many new genomic loci for sleep‐related traits, including
being a morning person and sleep duration.
Our findings reveal key brain areas and cells implicated in the neuro-
biology of insomnia and its related disorders, and provide novel tar-
gets for treatment. These results illustrate how big data approaches
using large‐scale datasets such as UK Biobank are accelerating novel
breakthroughs and transform the field of human genetics.
Disclosure: Nothing to disclose.
12 | Modelling sleep disorders in mice
V. Tucci
Genetics and Epigenetics of Behaviour Laboratory, Neuroscience and
Brain Technologies, Istituto Italiano di Tecnologia, Genova, Italy
The combination of large‐scale approaches to both human and
mouse genetics offers tremendous opportunities into the investiga-
tion of the biological mechanisms of sleep defects. Moreover, the
development of precise preclinical models allow the development of
novel intervention that can eventually be transferred to clinics. Over
last decade in our lab we developed a series of novel preclinical
mouse models that describes the modulations of important sleep
phenotypes. In particular, we concentrated out attention towards: (i)
the interaction between circadian clock and sleep homeostasis; (ii)
the epigenetic control of sleep; (iii) the interplay between thermoreg-
ulation and sleep defects. Here I will describe an advanced platform
for phenotyping sleep in mice that offers the possibility to cover
large‐scale datasets and to decipher the heterogeneous nature of
sleep. In addition, focusing on the sleep defects associated with Pra-
der‐Willi syndrome (PWS), I will present our understanding of the
genetic and epigenetic elements of the sleep abnormalities in PWS.
Moreover, by using a preclinical mouse model of PWS we tested
pharmacological interventions that ameliorates the REM sleep defi-
cits and the alteration of temperature.
Disclosure: Nothing to disclose.
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CIRCADIAN MODULATION OF EEG BRAIN
ACTIVITY AND COGNITION, AND THE
IMPACT OF LIGHT ON SLEEP
13 | The role of light in regulating alertness
and performance in mice
S. Peirson
Sleep and Circadian Neuroscience Institute, University of Oxford,
Oxford, United Kingdom
Light exerts a profound effects on physiology and behaviour. As well
as circadian entrainment, light modulates autonomic and neuroen-
docrine responses as well as regulating cognitive processes such as
attention, arousal and performance. The retinal photoreceptors medi-
ating these non‐image forming responses to light include the rods
and cones as well as a subset of melanopsin‐expressing photosensi-
tive retinal ganglion cells (pRGCs). Despite major advances in this
field, our understanding of the mechanisms by which light influences
alertness and performance are limited, including both the photore-
ceptors and the central neural pathways underlying these responses.
In humans, the effects of light on alertness have been primarily
investigated via four different approaches:
(1) measures of subjective sleepiness;
(2) measures of cognitive performance;
(3) electroencephalography (EEG) and
(4) brain imaging.
These studies have provided a wealth of data on the effects of light
stimuli on different aspects of alertness and cognitive performance,
providing a critical basis for improved lighting design. By contrast,
surprisingly few studies have been conducted on rodent models,
which has limited our understanding of the fundamental mechanisms
underlying these responses. Studies in mice have shown that mela-
nopsin regulates alerting/arousing responses, associated with
increased plasma corticosterone levels. As in humans, these
responses are wavelength‐dependent. Furthermore, recognition
memory performance is acutely regulated by light. For the first time,
we demonstrate that light exerts dose‐dependent effects on recogni-
tion performance, and that these changes are paralleled by changes
in EEG power in the theta and gamma range. Our preliminary data
show that these effects on performance and EEG power also appear
to be wavelength‐dependent. Together, these data demonstrate that
paralleling the approaches used in human studies, mice show a light‐
dependent regulation of alertness and performance, providing the
basis for future studies on the role of specific photoreceptors and
neural pathways in these responses.
Disclosure: Nothing to disclose.
14 | Effects of the circadian system and
circadian misalignment on cognition in non‐shift
workers and chronic shift workers
S.L. Chellappa1; C.J. Morris2; F.A.J.L. Scheer2
1Harvard Medical School, 2Brigham and Women's Hospital, Harvard
Medical School, Boston, MA, United States
Shift work increases the risk for human errors with extraordinary
socio‐economical costs. Overnight operations pose a challenge
because our endogenous circadian system inhibits cognitive perfor-
mance at night. Importantly, as task‐specific cognitive brain regions
have different 24‐hr circadian dynamics, circadian misalignment,
which corresponds to the misalignment between the circadian pace-
maker and behavioral/environmental cycles, may impact cognition
task‐dependently. Furthermore, how the circadian system modulates
cognition over multiple days, and its relevance for chronic shift
workers remain to be established. Using a randomized, cross‐over
design mimicking night shift work, we show that circadian misalign-
ment increases cognitive vulnerability on sustained attention, cogni-
tive throughput, information processing and visual‐motor
performance over multiple days, as compared to circadian alignment
(day shifts). Circadian misalignment effects are task‐dependent: while
they acutely impair sustained attention with recovery after 3‐days,
they progressively hinder daily learning. Individuals felt sleepier dur-
ing circadian misalignment, but they did not rate their performance
as worse. Furthermore, circadian misalignment effects on sustained
attention depended on prior sleep history (sleep efficiency). Shift
workers frequently undergo circadian misalignment, which has been
proposed as a biological mechanism that may explain why they
experience decrements in their perceived levels of alertness and cog-
nitive efficiency. However, it remains uncertain whether chronic shift
workers may, to some extent, adapt to circadian misalignment and
thus show no adverse effects on cognitive function. Therefore, we
investigated whether the task‐dependent cognitive effects of circa-
dian misalignment can be translated to chronic shift workers.
Chronic shift workers had more cognitive vulnerability on sustained
attention, information processing and visual‐motor performance
under circadian misalignment as compared to when the same individ-
uals were under circadian alignment, particularly after more than
10 hr of wakefulness. Furthermore, their subjective perception of
sleepiness and their prior sleep history significantly predicted perfor-
mance variability on sustained attention and visual‐motor perfor-
mance. These data suggest that when chronic shift workers are
under circadian misalignment their performance may dramatically
deteriorate if exposed to longer durations of wakefulness, while their
performance across the wake episode remains fairly stable under cir-
cadian alignment. Collectively, circadian misalignment may provide
an important biological framework for developing countermeasures
against adverse cognitive effects in shift workers.
Disclosure: Nothing to disclose.
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15 | Relationship between daytime light
exposure and EEG sleep architecture, slow‐wave
activity, and sleep quality in young healthy office
workers
M. Gordijn1,2; M. Geerdink1,2; E. Wams2; T. Woelders2;
R. Hut2
1Chrono@Work BV, 2University of Groningen, Groningen,
the Netherlands
Introduction: Light is the primary signal for the circadian organiza-
tion of the sleep‐wake cycle. A possible role of daytime light on
sleep characteristics and sleep quality, other than timing alone, has
become more likely since the discovery of direct projections of pho-
tosensitive retinal ganglion cells to brain areas involved in sleep reg-
ulation. In addition, studies in mice have shown the involvement of
melanopsin in homeostatic sleep regulation. Recently, two studies
were carried out that supported the effect of daytime light on night-
time sleep quality in humans.
Study 1: In a field study with ambulatory polysomnography and a
light sensor at the wrist (n = 20), we found a clear correlation
between the amount of daytime light and sleep architecture during
the subsequent night; high daytime light exposure significantly corre-
lated with a lower percentage of REM sleep (p < 0.001) and a larger
and faster accumulation of slow‐wave sleep (p < 0.05).
Study 2: A laboratory experiment supported the idea of high day-
time light levels improving sleep. In a within study design, 12 partici-
pants completed two conditions: 1900 lux of bright white light (BL)
or 130 lux of low light (LL) from 9 a.m. to 5 p.m. Sleep‐EEG analysis
of the subsequent night showed a significant (p < 0.05) increase in
percentage of REM sleep (LL: 19.7%; BL: 23.3%), decrease in per-
centage wake after sleep onset (LL: 5.8%; BL: 2.5%) and increased
sleep efficiency (LL: 92.1%; BL: 95.8%). The accumulation of slow‐
wave‐activity (1–4 Hz) during non‐REM sleep was significantly faster
in the BL condition compared to the LL condition (p < 0.001). Sub-
jective ratings of sleepiness the next morning supported the
improved sleep quality: early morning sleepiness as measured with
the Karolinska Sleepiness Scale was significantly lower after a night
in the BL condition compared to the day before (p < 0.001), while
this was not found in the LL condition (p = 0.12).
Conclusion: In general, these findings support the idea that higher
daytime light levels improve sleep quality during the night. Whether
this is explained by an alerting effect of light during the day, or
reflects a direct effect on sleep homeostasis at night will be dis-
cussed.
Disclosure: Marijke Gordijn works as a consultant for Philips
Healthy Sleep Solutions.
16 | Impact of different light exposures in the
evening on EEG slow‐wave activity and REM
sleep
M. Münch1,2,3; F. Bes1,2; A. Papakonstantinou1,2;
C. Nowozin1,2; J. Regente4; A. Wahnschaffe1,2; S. Hädel1;
G. Gruber5; D. Kunz1,2,6
1Institute of Physiology, Group Sleep Research and Clinical
Chronobiology, Charité ‐ Universitätsmedizin Berlin, corporate member
of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin
Institute of Health, 2Clinic for Sleep‐ and Chronomedicine,
St. Hedwig‐Krankenhaus, 3Institute of Medical Immunology; Group
Chronobiology, 4Department for Psychiatry and Psychotheraphy,
Charité ‐ Universitätsmedizin Berlin, corporate member of Freie
Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of
Health, Berlin, Germany, 5Siesta Group, Vienna, Austria, 6Intellux GmbH,
Berlin, Germany
Objectives: Quality and quantity of evening light exposure has
been shown to impact on sleep architecture, slow‐wave activity and
REM sleep. We aimed at testing the effects of three different light
conditions in the evening on EEG sleep spectra during NREM and
REM sleep.
Methods: A total of 18 young participants (mean age
23.2 ± 3.3 years; 12f and 6 m) were exposed to different light con-
ditions on three subsequent evenings (for 30 min): blue‐enriched
polychromatic light, bright orange light, or dim light. In the morn-
ings they received either blue‐enriched polychromatic or control
light (=incandescent bulb) for 3 consecutive days, in a balanced
cross‐over design. EEG recordings from all nights were visually
scored according to standard criteria and subjected to spectral anal-
ysis (Fast Fourier Transformation). NREM/REM sleep cycles were
expressed as percentiles. Artifact free REM sleep cycles were also
subjected to semi‐automated microstate analysis (Siesta Group,
Vienna, Austria). Statistical analyses were performed with mixed lin-
ear regression models.
Results: EEG slow‐wave/theta activity in the frequency range
between 1.5–5.25 Hz (from a central derivation) was significantly
higher after orange light in sleep cycle 2 when compared to blue‐
enriched light (sleep cycle x evening light; p < 0.05). The REM sleep
atonia index was larger after orange lighting in the evening than
after dim light (main effect of evening light; p < 0.05). For morning
light conditions, EEG activity in the sigma range (14–16.25 Hz) and
beta range (17.25–23 Hz) was significantly lower after the blue‐
enriched morning light compared to control light exposure (main
effect of morning light; p < 0.05), without statistically significant
interactions with evening light conditions.
Conclusions: Our results confirm and expand previous findings
such that orange light in the evening increases SWA during NREM
sleep compared to blue‐enriched light and led to lower EMG ampli-
tudes during REM sleep. Blue‐enriched morning light seems to lower
EEG beta activity the following night. It remains to be tested
whether orange light exposure in the evening may have beneficial
effects in patients with different sleep disorders.
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Disclosure: G. Gruber is working for the Siesta Group and D. Kunz
is the shareholder of Intellux GmbH, Germany.
SLEEP AND DRIVING
O017 | Maintenance of Wakefulness Test, real
and simulated driving in narcolepsy/hypersomnia
patients
P. Sagaspe1,2; J.-A. Micoulaud-Franchi1,2; O. Coste3;
D. Léger4; S. Espié5; D. Davenne6; R. Lopez7; Y. Dauvilliers7;
P. Philip1,2
1CHU Bordeaux, 2USR CNRS 3413 SANPSY, Université de Bordeaux,
3Centre Hypersomnies Rares, CHU Bordeaux, Bordeaux, 4Centre
Hypersomnies Rares, Université Paris Descartes, APHP, Hôtel Dieu de
Paris, Centre du Sommeil et de la Vigilance, 5TS2/SIMU&MOTO,
IFSTTAR, Paris, 6UMR 1075, INSERM, Université de Caen, Caen,
7Reference National Center for Narcolepsy, Sleep Unit, CHU
Montpellier, Montpellier, France
Objectives/Introduction: Sleepiness at the wheel is a major risk
factor for highway traffic accidents. Narcolepsy and idiopathic hyper-
somnia (IH) are rare central disorders that induce severe daytime
sleepiness. The objective of this study is to assess the relationship
between real and simulated driving performance and the objective
level of alertness as measured by the Maintenance of Wakefulness
Test (MWT) in patients suffering from narcolepsy or idiopathic
hypersomnia.
Methods: 27 patients (10 patients with narcolepsy, type 1 (n = 7)
and type 2 (n = 3), and 17 patients with idiopathic hypersomnia,
mean age = 33.8 ± 11.1 years, range = 18–65 years; 4 males) were
recruited in a randomized, crossover, double‐blind placebo‐controlled
trial and compared to 27 matched healthy controls.
Patients were randomly assigned to receive modafinil (400 mg) or
placebo before the driving test (2 hr of real and 2 hr of simulated
highway driving for each patient). Standard Deviation of Lateral Posi-
tion (SDLP) of the vehicle in real and simulated driving and mean
sleep latency in a 4 × 40 min MWT were assessed.
Results: Untreated patients presented shorter sleep latencies on the
MWT (20.8 (IQ range 16.1–32.9) vs. 34.9 min (IQ range 28.1–40.0))
and worse simulated driving performance (p < 0.001) than treated
patients. Nevertheless, treated patients still exhibited shorter mean
sleep latencies on the MWT than controls (34.9 (IQ range 28.1–40.0)
vs. 40 min (IQ range 37.1–40.0), p < 0.05) but driving performance
was identical in both groups. The SDLP of the vehicle in real driving
conditions and the MWT score correlated with the SDLP in simulated
driving (respectively, r = 0.34, p < 0.05 and r = −0.56, p < 0.001).
Conclusions: In patients with narcolepsy/idiopathic hypersomnia,
simulated driving and MWT explore different dimensions of fitness‐to‐
drive and could be used complementarily to better evaluate sleep‐
related driving impairment. The use of validated simulators among the
sleep community would be a reasonable goal to harmonize evaluation
of the ability to drive in patients suffering from central hypersomnia.
Disclosure: Nothing to disclose.
O018 | To predict sleep related accidental risk
of patients with obstructive sleep apnea
syndrome: self reported sleepiness at the wheel
versus Apnea Hypopnea Index
P. Philip1; S. Bailly2; M. Benmerad3; J.-A. Micoulaud Franchi1;
Y. Grillet4; M. Sapene5; R. Tamisier6; J.-L. Pepin6; OSFP
1SANPSY‐USR 3413, SANPSY‐CNRS, Bordeaux, 2AME UMR 1137
Inserm Université Paris Diderot, CHU de Grenoble, 3Hypoxia‐
Pathophysiology Laboratory – INSERM U 1042, Grenoble Alps
University Hospital, Université Grenoble Alpes, CHU de Grenoble,
Grenoble, 4Pneumologist, Private Clinic Wyss, Valence, 5Pneumologist,
Private Clinic, Bordeaux, 6University Grenoble Alpes, HP2, Inserm, U
1042, CHU de Grenoble, Grenoble, France
Objectives/Introduction: Sleep related accidents are a major con-
cern for patients suffering from obstructive sleep apnea syndrome
(OSAS) and recommendation about fitness to drive are a key issue
for both patients and physicians. Up to now articles in the literature
do not always discriminate patients suffering from nocturnal breath-
ing disorders (AHI < 10) from patients complaining of sleepiness at
the wheel with an AHI > 10. We conducted a new study to identify
factors associated to sleep related accidents (SRA) among patients
suspected of OSAS.
Methods: We analyzed through the French Sleep Observatory of
the federation of pneumology 58,815 sleep recordings and question-
naires collected on patients suspected of suffering from OSAS. All
patients had to complete questionnaires on their level of daytime
sleepiness (i.e. Epworth Sleepiness Scale), self reported sleepiness at
the wheel, symptoms of OSAS and socio demographic variables.
Multivariate logistic regression was performed to identify associated
factors.
Results: 2.4% of patients presented an AHI ≥10 (n = 42,617). 35%
of these patients reported suffering in the last year of episodes of
sleepiness at the wheel. 2% of the patients included in the databasis
(1,316) reported a sleep related accident in the past year, Patients
suffering from an AHI ≥ 10 without sleepiness at the wheel in the
past year (n = 27,634) did not have an increased risk of SRA com-
pared to subjects having an AHI < 10 and without sleepiness at the
wheel (n = 10,829). Patient reporting sleepiness at the wheel inde-
pendently of the AHI value presented a significant higher risk of
SRA (adjusted p value <0.01) compared to patients not reporting
sleepiness at the wheel.
Conclusions: Fitness to drive should be evaluated on self reported
sleepiness at the wheel and AHI alone should not be a single criteria
used to evaluate driving risk in patients suffering from OSAS.
Disclosure: Nothing to disclose.
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O019 | Diagnostic patterns of sleep‐ and
vigilance tests in distinct causes of excessive
daytime sleepiness
J. Mathis1; D. Andres2; A. Mathis2; W. Schmitt3;
C.L. Bassetti2; D.R. Schreier2
1Department of Neurology, University of Bern, 2Department of
Neurology, University Hospital Bern, 3Psychiatric University Services,
UPD Bern, Bern, Switzerland
Objectives/Introduction: After excluding the most frequent
causes of excessive daytime sleepiness, (EDS) such as internistic and
neurological disorders as well as sleep apnoea syndrome, a few
ambiguous diagnoses remain, presenting a challenging differential
diagnosis. Sleep and vigilance tests (SVT) are often used as support-
ive tools in the further diagnostic process. The aim of this study was
to evaluate in EDS patients the extent to which SVTs, namely the
Epworth Sleepiness Scale (ESS), polysomnography based sleep effi-
ciency (PSG), Multiple Sleep Latency Test (MSLT), Maintenance of
Wakefulness Test (MWT), actigraphy based inactivity index (ACTI),
Psychomotor Vigilance Task (PVT), Steer Clear Test (SCT) and pupil-
lography (PUI) can help to differentiate between fatigue syndromes
(FS), insufficient sleep syndrome (ISS), narcolepsy with cataplexy
(NC), narcolepsy without cataplexy (N), idiopathic hypersomnia (IH)
and non‐organic hypersomnia (NOH).
Methods: The Bern sleep database (1997–2016) contains >17,000
SVTs. We retrospectively analysed those 167 FS, 106 ISS, 102 NC,
63°N, 86 IH and 155 NOH patients who underwent ≥1 MSLT and
≥1 additional SVT. Comparisons (Kruskal‐Wallis, Dunn‐Bonferroni;
p < 0.05) between patient groups (=15 pairs) were performed for
each SVT and sensitivity and specificity of each SVT for each diag-
nosis was analysed by comparing the area under the curve of Recei-
ver Operating Characteristic (ROC) curves (CI 95%, p < 0.05).
Results: Mean values differed significantly in most diagnoses‐pairs
(11/15) for both the MWT and MSLT, in many pairs for ESS (10/15),
SCT (9/15) and PVT (7/15), but less frequent for PUI (5/15), ACTI (2/
15) and PSG (2/15). We found a “fair” to “good” diagnostic power in
the MSLT for NC (0.834), N (0.747) and FS (0.897), and also in the
MWT for NC (0.834), N (0.801) and FS (0.754), while all other power
values ranged from “poor” to invalid”.
Conclusions: MWT and MSLT are the most valuable diagnostic
tests to differentiate between ambiguous disorders of EDS. Over all
diagnoses, single SVTs have a rather poor differentiating power and
combining multiple tests together with a careful clinical judgement is
mandatory to accurately diagnose patients suffering from EDS.
Disclosure: Nothing to disclose.
O020 | Moderate and severe OSA in males
impair psychomotor reaction times assessed by
CRD‐series testing
I. Pavlinac Dodig1; R. Pecotic1; M. Valic1; L. Lusic1; Z. Dogas2
1University of Split School of Medicine, 2Department of Neuroscience,
Split Sleep Medicine Center, University of Split, School of Medicine,
Split, Croatia
Objectives/Introduction: Obstructive sleep apnoea (OSA) is char-
acterized by repetitive transient obstructions of the upper airway,
which result in cessations of the airflow and consequently lead to
hypoxemia and hypercapnia. Most obstructive events in apnoeic
patients are accompanied by (micro) arousals from sleep, resulting in
chronic sleep fragmentation, sleep deprivation and consequent
excessive daytime sleepiness (EDS). All those factors may be mecha-
nisms underlying psychomotor impairment in OSA patients, mostly in
areas of general psychomotor functioning, memory, attention and
vigilance, perception and alertness. We hypothesize that moderate
and severe OSA have adverse effects on reaction times to visual
stimuli, simple arithmetic tasks, and complex psychomotor limbs
coordination assessed by the computer‐based psychomotor CRD‐ser-
ies tests.
Methods: The study was conducted on 206 male subjects; 103 of
them had moderate or severe OSA (Apnea Hypopnea Index, AHI >
15) diagnosed by whole‐night polysomnography/polygraphy. Control
subjects (N = 103), matched with OSA patients by age and BMI, had
no recorded OSA in their medical history, no increased risks for OSA
measured by STOP and STOP‐BANG questionnaires and EDS mea-
sured by Epworth Sleepiness Scale (ESS) score. All subjects solved
three multiple task tests, which measured speed of visual perception
(CRD311), convergent thinking during solving simple arithmetic oper-
ations (CRD11), and operative thinking during tasks that required
complex psychomotor limbs coordination (CRD411). In each test,
total test solving time (TTST), minimum (best) single task solving time
(MinT), and median time for task solving (MedT) were recorded.
Results: OSA patients had worse results compared to control sub-
jects on all CRD tests: MinT was 3.0 ± 0.9 s vs. 2.6 ± 0.6 s,
p < 0.001 on CRD11; 0.49 ± 0.1 s vs. 0.46 ± 0.1 s, p = 0.089 on
CRD311; and 0.69 ± 0.2 s vs. 0.61 ± 0.1 s, p = 0.007, respectively.
No significant correlation was found between ESS score and CRD11
and CRD311 results, and negative correlation was found between
ESS score and CRD411 results in OSA group (r = −0.213, p = 0.03
for MedT).
Conclusions: Moderate and severe OSA increased psychomotor
reaction times in male patients, in which there was no positive corre-
lation of EDS and poorer results on psychomotor testing. The results
may suggest that working or driving performance in those patients
could be impaired independent of excessive daytime somnolence.
Disclosure: Nothing to disclose.
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O021 | A pre‐drive ocular assessment predicts
subsequent driving impairment: a naturalistic
driving study in shift workers
M.D. Mulhall1,2; J. Cori3; J. Kuo4,5; M. Magee1,2; A. Collins3;
C. Anderson1,2; T. Sletten1,2; M.G. Lenné4,5;
S.M.W. Rajaratnam1,2; M.E. Howard1,2,3
1Monash University, Monash Institute of Cognitive and Clinical
Neurosciences, 2Cooperative Research Centre for Alertness, Safety and
Productivity, 3Institute for Breathing and Sleep, Austin Health,
Melbourne, VIC, 41/11 Lonsdale St, Seeing Machines Ltd, Braddon, ACT,
5Monash University, Monash University Accident Research Centre,
Melbourne, VIC, Australia
Objectives/Instruction: Sleep‐related motor vehicle accidents
account for approximately 20% of all crashes, with shift workers at
higher risk than the general population. Predicting sleep‐related driv-
ing impairment before a drive allows for timely intervention. We
assessed whether pre‐drive ocular variables predicted subsequent
driving impairment, and objective alertness measured by ocular vari-
ables during the drive.
Methods: Shift workers (n = 20, Males = 7) were recruited from a
metropolitan Melbourne hospital (nurses = 13, doctors = 7). Partici-
pants completed driving diaries and drove an instrumented vehicle
over 2 weeks, while working day and/or evening shifts and a mini-
mum of 2 night shifts, as determined by their work roster. The
instrumented vehicle was fitted with the Seeing Machines Driver
Monitoring System, comprising a driver‐facing camera utilising real‐
time algorithms to detect driver features, including ocular parameters
(mean blink duration (MBD), the Percentage of time with Eyes
Closed (PERCLOS), and average long eye closures >300 ms). A road‐
facing camera (MobilEye) was used to detect lane departures as a
measure of driver impairment. A 4‐min assessment (N = 131) was
completed immediately prior to each drive to measure ocular param-
eters. A 5‐min Psychomotor Vigilance Task (PVT, N = 55) was com-
pleted at the end of 3 shifts, prior to driving home. We examined
whether pre‐drive ocular variables, mean RT and PVT lapses pre-
dicted driving impairment (ROC curve analyses) and whether pre‐
drive PVT parameters predicted objective measures of alertness dur-
ing the drive (Linear regression).
Results: MBD during the pre‐drive assessment significantly pre-
dicted the occurrence of lane departures (AUC = 0.68, p = 0.009).
While PVT Lapses also approached significance (AUC = 0.72,
p = 0.052), PERCLOS, long eye closures and mean RT did not signifi-
cantly predict lane departures (p = 0.94, 0.65 and 0.29, respectively).
Mean RT (R2=0.13, p = 0.01), RT variability (R2=0.14, p = 0.007), the
slowest 10% of RT (R2=0.22, p = 0.001) and PVT lapses (R2=0.19,
p = 0.001) significantly predicted PERCLOS during the drive. No sig-
nificant predictors of MBD or long eye closures were found.
Conclusions: We demonstrated that pre‐drive ocular parameters
and PVT show promise for predicting subsequent driving impairment
in a naturalistic setting. Further analysis will incorporate multiple fac-
tors into the prediction model and examine prediction of micro‐
sleeps.
Disclosure: This research was supported by the CRC for Alertness,
Safety and Productivity, Melbourne, Australia, and partially funded
by Seeing Machines Ltd, Braddon, Australia. Megan Mulhall and Jen-
nifer Cori have nothing to disclose. Jonny Kuo is employed by See-
ing Machines Ltd, a part‐funder of this research. Michelle Magee and
Allison Collins have nothing to disclose. Clare Anderson is a Theme
Leader within the CRC for Alertness, Safety and Productivity. Tracey
Sletten is a Project Leader within the CRC for Alertness, Safety and
Productivity. Michael Lenné is employed by Seeing Machines Ltd, a
part‐funder of this research. Shantha Rajaratnam serves as a Program
Leader and Consultant to the CRC for Alertness, Safety and Produc-
tivity. Mark Howard serves as a Theme Leader for the CRC for
Alertness, Safety and Productivity.
NEW METHODS IN BASIC AND CLINICAL
SLEEP RESEARCH
O022 | Environmental influence on the
behaviorally defined sleep (rest) in a wild
nocturnal primate Nycticebus javanicus
K. Reinhardt1,2; V. Vyazovskiy3; K.A.I. Nekaris1,2
1Oxford Brookes University, Oxford, United Kingdom, 2Little Fireface
Project, Garut, Indonesia, 3University of Oxford/Sleep and Circadian
Neuroscience Institute, Oxford, United Kingdom
Objectives/Introduction: Growing evidence suggests that envi-
ronmental variables, including temperature and light, have a major
influence on sleep and activity patterns of animals and humans.
While research on these influences in primates has increased over
the last decade, only a few species have been systematically studied
in the natural habitat, and the knowledge on sleep‐wake patterns in
wild nocturnal primates is essentially lacking.
Methods: We monitored a wild population of Javan slow lorises
Nycticebus javanicus in West Java, Indonesia between 2014 and
2017, to test the influence of environmental factors on their daily
activity patterns. We fitted 12 Javan slow lorises with accelerometer
devices to record locomotor activity, which was stored at 1‐min
intervals. Each recording was performed on average over
34.8 ± 13.5 days. We used actigraphy and linear mixed‐effect mod-
els to test the relationship between slow loris activity, climatic varia-
tion (ambient temperature, humidity, rainfall) and solar phases.
Results: We quantified the amount and distribution of activity and
behavioural sleep (rest) across 24 hr. All animals displayed prolonged
periods of consolidated rest during the light period patterns, entering
a sleeping site shortly before sunrise and emerging soon after sun-
set. All individuals displayed a striking synchronization of onset and
end of activity in relation to sunrise and sunset, spending
10:53:04 ± 02:46:08 (hh:mm:ss) immobile. Notably, all lorises dis-
played longest consolidated rest periods with least locomotor activ-
ity at the beginning of the light phase, with fragmentation increasing
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during the second half of the day. We also observed a relationship
between rest fragmentation and the levels of ambient temperatures,
suggesting a strong influence of environmental variables on sleep.
Conclusions: In conclusion, here we for the first time characterized
the daily activity patterns in a wild nocturnal primate Nycticebus
javanicus. We observed a major influence of lighting conditions on
rest and activity, suggesting that the levels of illumination are an
important determinant of the circadian rhythm in behaviour in these
animals. Increased consolidation of rest at the beginning of their
habitual sleep period may reflect increased sleep ‘intensity’, although
the environmental influence cannot be excluded.
Disclosure: Nothing to disclose.
O023 | Two million nights to characterize
sleep heterogeneity: what objective and self
report big data tell us
A. Volkov; H.M. Rus; S. Danoff-Burg; J. Kim; D. Albrecht;
Z. Bennett; R.J.E.M. Raymann
SleepScore Labs, Carlsbad, CA, United States
Objectives/Introduction: Demographic, health, and lifestyle fac-
tors all affect sleep. However, little is known about how heterogene-
ity among such factors relates to sleep outcomes, and most studies
use a single self‐report sleep measure. We used big data – both
objective and self‐report – to identify distinct sleep profiles.
Methods: We analyzed 1,920,457 nights of objective sleep data
collected between 7‐13‐14 and 1‐8‐18 via S+ by ResMed sleep
tracking technology, complemented with self‐report data. We per-
formed Multiple Correspondence Analysis and hierarchical profiling
on 20 self‐report categorical variables reflecting demographic,
health, and lifestyle factors (e.g., age, BMI, smoking, exercise,
blood pressure, stress) to reveal distinct clusters of sleepers. We
set the number of clusters to 8 based on the inertia gain criterion
and visual inspection of the dendrogram. Each cluster was then
profiled using objective sleep data, including TST, SOL, Number of
Awakenings, and Sleep Stage durations (Wake, Light, Deep, and
REM).
Results: Analysis of the self‐report data revealed 8 clusters. Profil-
ing those clusters with objective sleep data revealed between‐cluster
heterogeneity:
(1) Active and healthy (n = 2,679);
(2) Older, with healthy lifestyle (n = 1,857);
(3) Stressed, tired but active patients without sleep issues
(n = 1,379);
(4) Active and healthy but with restless sleep and sleep breath-
ing issues (n = 1,955);
(5) Otherwise healthy with sleep disorders (n = 1,420);
(6) Stressed smokers (n = 640);
(7) Overweight and older with health issues and restless sleep
(n = 1,811); and
(8) Overweight older patients with health issues and sleep disor-
ders (n = 1,120).
Interestingly, the two clusters with the poorest sleep included the
most smokers and the most people whose BMI indicated obesity,
showing an important association between sleep and lifestyle fac-
tors.
Conclusions: This study is the first to identify sleep profiles using
both self‐report and objective big data collected in the home envi-
ronment. Uncovering heterogeneity among sleep profiles can help us
better understand relations between sleep and demographic, health,
and lifestyle factors. Findings can inform the development of behav-
ior change guidelines that might aid in achieving better sleep and
new interventions to improve sleep.
Disclosure: This study was conducted by SleepScore Labs. All
authors are affiliated employees of SleepScore Labs. ResMed
launched S+ by ResMed in 2014.
O024 | Studying the temporal dynamics of
human sleep in real life and large numbers
E. Winnebeck1; D. Fischer2; T. Leise3; T. Roenneberg1
1Institute of Medical Psychology, Ludwig Maximilian University Munich,
Munich, Germany, 2Brigham and Women's Hospital, Harvard Medical
School, Boston, 3Department of Mathematics and Statistics, Amherst
College, Amherst, MA, United States
Objectives/Introduction: The temporal dynamics of sleep are
complex. First of all, each sleep episode itself is highly structured in
time, on a scale of seconds to hours (sleep architecture, cycles, frag-
mentation). These ultradian dynamics of sleep are then embedded
and influenced by factors on a longer timescale, that is the circadian
timing of the sleep episode as well as the timing and structure of
prior sleep and wakefulness (sleep history). Studying these temporal
dynamics and their clinical relevance has been difficult since the
monitoring of ultradian sleep dynamics relies heavily on polysomnog-
raphy, which is impractical for recordings over longer circadian and
infradian timescales such as days and weeks.
Methods: To enable combined analyses of sleep from ultradian to
infradian timescales, we developed a method to probe ultradian
sleep dynamics from simple wrist activity recordings (actimetry/actig-
raphy): a non‐linear transformation of locomotor activity to “Loco-
motor Inactivity During Sleep” (LIDS). To test its suitability for large
scale field studies, LIDS was not only assessed in standard laboratory
polysomnography (20 nights) but also in 16,441 sleep bouts from
longitudinal recordings of 573 people in real life. Using mixed model
regressions, we analyzed influences of age, sex, sleep duration, work
schedules and mental health status on ultradian LIDS dynamics.
Results: Our analyses show that the ultradian structure of sleep is
directly reflected in Locomotor Inactivity During Sleep ‐ despite the
expectedly lower resolution than polysomnography. LIDS oscillates
in synchrony with sleep cycles, showing a median period of 110 min.
LIDS also declines gradually during sleep in its levels, reminiscent of
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sleep homeostatic markers. LIDS‐derived sleep dynamics did not dif-
fer between women and men (despite differences in absolute levels),
but were strongly altered with age and also shift work. Altered were
particularly the decline rates and rhythm amplitudes, while period
and phase were remarkably stable. Circadian and homeostatic influ-
ences are currently under investigation.
Conclusions: Our actimetry‐based method makes sleep dynamics
easily quantifiable in everyday contexts and in huge numbers of
nights and people. This enables large‐scale field studies bridging the
time scales necessary to investigate the complex temporal dynamics
of sleep.
Disclosure: Parts of this study were supported by a grant from the
Friedrich‐Baur‐Stiftung (grant number 11/13) to EW. EW, DF and TL
declare that they have no conflicts of interest. TR is founder of
Chronsulting UGmbh and consultant to Condor Instruments LTDA,
Vanda Pharmaceuticals, jetlite GmbH, HiPP‐Werk Georg Hipp OHG,
and Reset Therapeutics, Inc.
O025 | Scoring sleep with artificial intelligence
enables quantification of sleep stage ambiguity
P. Anderer1,2; M. Ross1; A. Cerny1; A. Moreau1
1Sleep and Respiratory Care, Home Healthcare Solutions, Philips Austria
GmbH, 2Department of Psychiatry and Psychotherapy, Medical
University of Vienna, Vienna, Austria
Objectives/Instruction: In the last few years machine learning
approaches have made significant advancements and offer now
powerful tools for classification problems such as sleep scoring. The
objectives of the study was to evaluate the performance of a bidi-
rectional long short‐term memory (LSTM) recurrent neural network
(RNN) classifier based on sleep‐wake related features and to explore
the possible value of the sleep stage probability distribution (“hypn-
odensity”) obtained at the RNN output.
Methods: Supervised deep learning for sleep scoring was trained
with 472 and tested in 116 polysomnographies (PSGs), all scored
independently by 2 experts and by a consensus scorer. In total,
556.797 soft targets were available to predict sleep stage probabili-
ties. The trained RNN outputs hypnodensities, which are used to
determine sleep stages and their ambiguities. The validation data
consisted of 97 PSGs scored by 4 human experts, with 10 PSGs hav-
ing been scored in addition by 8 experts. Epoch‐by‐epoch Cohen's
kappa agreement was determined as compared to a consensus scor-
ing without the assessed scorer included in the consensus.
Results: The kappa coefficients between manual and consensus
scoring ranged between 0.61 and 0.77 (mean ± SD: 0.71 ± 0.04) for
the 10 studies with 12 manual scorings and between 0.70 and 0.79
(mean ± SD: 0.74 ± 0.04) for the 97 studies with 4 manual scorings.
The kappa coefficients between auto and consensus scoring were
0.79 for both the 10 and the 97 PSGs. By exploiting available
options of the Somnolyzer system to vary sensitivity settings for
NREM sub‐classification, the kappa values for autoscoring increased
to 0.86. The RNN‐derived hypnodensities correlated significantly
with the sleep stage distribution derived from the 12 human scorings
(r = 0.92, 0.75, 0.89, 0.91 and 0.97 for W, N1, N2, N3 and R).
Exploring the hypnodensities revealed ambiguities of sleep onset by
5 to 10 min in 21% and by more than 10 min in 40% of the studies.
Ambiguous REM periods were identified in 21% of the 97 studies.
Conclusions: Autoscoring based on the RNN classifier was equal
to the best human expert scorer and even outperformed all human
expert scorers after adjusting the sensitivity settings accordingly.
Moreover, the RNN‐derived hypnodensity is a sensitive measure for
sleep stage ambiguity.
Disclosure: All authors are employees of Philips Austria GmbH.
O026 | New spectral analysis method to
identify trait‐like features in NREM sleep power
spectra
G. Hammad1; V. Muto1; G. Gaggioni1; M. Jaspar1; C. Meyer1;
P. Maquet1,2; C. Schmidt1,3; C. Phillips1,4; D. Coppieters ‘t
Wallant1,4
1GIGA ‐ CRC In Vivo Imaging, Université de Liège, 2Département de
Neurologie, Centre Hospitalier Universitaire de Liège, 3Unité de
Recherche Psychologie et Neuroscience Cognitive, 4Département
d’Électricité, Électronique et Informatique, Université de Liège, Liège,
Belgium
Objectives/Introduction: Variability among individuals in sleep/
wake biology and behaviour is pervasive. Sleep/wake‐related variabil-
ity involves individual trait‐like features (ITLF). In order to study ITLF,
we developed an advanced spectral analysis method (ASAM) to com-
pare, in a systematic and reproducible way, 3 features of NREM
power spectra (PS). As sleep spindles (SS) have been reported sev-
eral times to be an important ITLF, we focused on a broad range of
sigma activity (10–18 Hz).
Methods: The ASAM is composed of three main steps. First, EEG
sleep recording is preprocessed and the NREM PS is computed for
each channel of interest. Second, three characteristic features from
the NREM PS related to sigma peak activity are extracted: magni-
tude, peak location and standard deviation. Third, the intra‐individual
stability and the inter‐individual variability of these features, as well
as the influence of sleep perturbations, are statistically tested using
the Intra‐Class Correlation (ICC) coefficient and the Wald Z‐test. The
performance of the ASAM was assessed using different polysomnog-
raphy‐derived sleep recordings from 16 healthy young male subjects
(18–30 years). For each subject, these recordings were acquired in 5
different “sleep contexts”: the acquisition was varied from 4 to
12 hr and was performed at different circadian phases.
Results: All three features of sigma activity (magnitude, peak loca-
tion and its standard deviation) were recognized as important ITLFs
(ICC = 0.74, 0.94 and 0.63 respectively). Furthermore, the inter‐
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individual variability of these three features was significant different
from zero (Wald Z‐test ps < 0.05).
Conclusions: Three aspects of NREM PS sigma activity are recog-
nized as important ITLFs. It is also showed that even though these
features changed according to sleep context, they remained specific
to the individuals. Establishing the trait‐specific nature of variability
in sleep/wake parameters could elucidate genetic mechanisms.
Disclosure: The authors do not disclose a potential conflict of
interest. Sources of funding: Belgian Fund for Scientific Research
(FNRS), European Research Council (ERC‐Starting Grant). Actions de
Recherche Concertée of the Wallonia‐Brussels Federation, University
of Liège research funds, Fondation Médicale Reine Elisabeth, Fonda-
tion Simone et Pierre Clerdent.
O027 | Cognitive functioning following sleep
deprivation is moderated by time‐of‐day: results
from the Karolinska WakeApp
B.C. Holding1; T. Sundelin1,2; J. Axelsson1,3
1Department of Clinical Neuroscience, K8, Psychology, Karolinska
Institutet, Stockholm, Sweden, 2Psychology, New York University, New
York, NY, United States, 3Stress Research Institute, Stockholm
University, Stockholm, Sweden
Objectives/Introduction: Cognitive functioning is known to be
impaired following sleep deprivation. Similarly, the effect of sleep
deprivation has been shown to fluctuate depending on time‐of‐day.
However, it is less understood the extent to which the effects of
time‐of‐day and sleep loss interact. This study aims to investigate
the interaction between sleep deprivation and changes in perfor-
mance on five cognitive tasks over one day. This study also intro-
duces the ‘Karolinska WakeApp’ – an extremely brief mobile
application for cognitive testing.
Methods: 176 participants (101 female, ages 18–45) participated in
a sleep‐deprivation experiment. After two nights of normal sleep (7–
9 hr), participants were randomised to either one night of sleep
deprivation or a third night of normal sleep. Participants completed a
battery of cognitive tests using the Karolinska WakeApp. Cognitive
tests included psychomotor vigilance (PVT), working memory (WM),
episodic memory (EM), mathematical ability (MA) and impulse inhibi-
tion (Stroop). Each test being 2 min. A baseline measurement was
completed at 22:00, and three further measurements were taken the
following day (post sleep‐deprivation) at approximately 08:00, 12:30
and 16:30.
Results: Growth curve modelling revealed that sleep deprivation
led to a linear decrease in performance over time in all tasks
(p < 0.05), highlighting that brief 2‐min tests are sensitive at detect-
ing the impairments in both higher and lower cognitive functions
after sleep loss. Additionally, PVT, EM and MA showed a significant
interaction between sleep deprivation and orthogonal time polyno-
mials (time2 and time3, p < 0.001). This suggests that sleep depriva-
tion leads to a stronger influence of time‐of‐day compared to control
participants, even after accounting for a general linear decrease in
performance.
Conclusions: Sleep deprivation causes significant performance
impairments in five cognitive tasks ‐ and several cognitive domains
including executive functions ‐ as measured through the Karolinska
WakeApp. This establishes the use of brief 2‐min tasks to assess
cognitive functioning following sleep loss. Additionally, we find that
the cognitive performance following sleep deprivation is not only
impacted by time‐of‐day, but also moderated by it. Therefore, this
study highlights the importance of scheduling tasks following sleep
deprivation in order to best preserve cognitive ability.
Disclosure: Nothing to disclose.
O028 | A computer algorithm to quantify REM
sleep without atonia
A. Papakonstantinou1,2; J. Klemming1; F. Bes1,2; D. Kunz1,2
1Charitè ‐ Universitätsmedizin Berlin, Corporate Member of Freien
Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Insitute of
Health, Institute of Physiology, Sleep Research & Clinical Chronobiology,
2Clinic for Sleep & Chronomedicine, St. Hedwig‐Krankenhaus, Berlin,
Germany
Objectives/Instruction: REM sleep behaviour disorder (RBD) is
characterized by intermittent loss of muscle atonia during REM
sleep, causing elaborated motor activities associated with dream
mentation. Several methods have been proposed to visually quantify
this REM sleep without atonia (RWA), using the electromyographic
(EMG) channels of a polysomnography (PSG). Visual scoring however
is time consuming and subjective to a human scorer's judgement.
We developed a computer algorithm that follows the criteria of the
visual RWA‐scoring used in our clinic, using only the chin EMG, but
that also can be used to consider additional EMG channels as e.g.
with the SINBAR method.
Methods: Preassumption is that PSG recordings were scored on
sleep stages and epochs with artefacts were excluded. Our algo-
rithm then evaluates the chin EMG on a second to second base,
without differentiating between phasic and tonic activity. It brings
to zero EMG amplitudes exceeding 500 μV, dismisses REM epi-
sodes as artefacted if the EMG threshold value is higher than
5 μV and removes electrocardiographic (ECG) crosstalk. In addition,
the algorithm returns a signal quality report, providing information
about number of samples exceeding a 500 μV reference value,
correlation of the EMG with the ECG signal and ECG‐corrected
epochs, and EMG threshold value of each REM episode. This indi-
cates possible limitations of the computation due to technical
problems.
With the algorithm we analyzed 60 PSGs (20 RBD patients, 20
healthy controls and 20 PLMS patients as controls with another type
of nocturnal motor disability) and also visually scored on RWA.
Results: The automatically generated RWA scores showed highly
significant correlations with the visual analysis for all subjects
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(R = 0.95, p < 0.01), as well as for the RBD subgroup (R = 0.92,
p < 0.01).
Conclusions: Our algorithm reliably detects loss of atonia during
REM.
Disclosure: Nothing to disclose.
O029 | Evaluation of night‐to‐night variability
of sleep apnea in home polysomnography
L.C. Rohling; R. Tijdens; K.W. van Kralingen
Sleep Medicine, Stichting Epilepsie Instellingen Nederland (SEIN), Zwolle,
the Netherlands
Objectives/Introduction: Clinical polysomnography (PSG, type 1)
is the golden standard for investigating sleep disorders. An alternative
for a complete polysomnography investigation is the home
polysomnography (H‐PSG, type 2). Sleep apnea is diagnosed and
graded by conventional thresholds of apneas and hypopneas per hour
of sleep, and treatment is usually initiated in the presence of symp-
toms. This study assessed the night‐to‐night variability of the apnea
hypopnea index (AHI) during two consecutive nights of H‐PSG.
Methods: In our tertiary sleep center we were accustomed to per-
form two consecutive 24 hr H‐PSGs. A retrospective study was per-
formed on the data of 262 patients of which 51 patients (72.5%
male, 53.9 ± 12.1 years, BMI:2 9.4 ± 6.5 kg/m2) were diagnosed as
having a Sleep Related Breathing Disorder (SRBD) diagnosis based
on history and the combined data of 1st and 2nd night. We com-
pared the apnea hypopnea index (AHI) of the second night to the
first night to assess if a second night of PSG affects diagnosis and
classification of SRB severity. The sleep apnea was categorized
according to conventional thresholds using the AHI (no sleep apnea:
<5; mild: 5–14; moderate: 15–30; and severe: >30).
Results: Twenty‐one percent of the 51 the SRBD patients had a
nightly H‐PSG AHI variability of greater than 10. Seventeen percent
of all patients had a significantly higher AHI on the first night, and
7.8% had a significantly higher AHI on the second night. The sleep
apnea severity category shifts in 35.3% of the patients. Only four
patients (7.8%) have in the second night such a higher AHI that they
shift to a more severe diagnostic group. One patient went from the
group no diagnosis to a mild sleep apnea.
Conclusions: Only a slight percentage of the patients shift to a
more severe diagnostic category. Therefore, a second H‐PSG will not
effect the treatment strategy of the majority of the SRBD patient.
The Clinical Practice Guideline for Diagnostic Testing for Adult
Obstructive Sleep Apnea of the AASM (Kapur et al. 2017) recom-
mends to do a second PSG if the first one isn't conclusive. Our data
suggest that doing a second night H‐PSG hardly alters the treatment
strategy.
Disclosure: Nothing to disclose.
O030 | Accuracy of detecting sleep apnea
using machine‐held submental ultrasonography
P.-L. Lee1,2; C.-C. Shu2; E.C.H. Liu3; Y.-C. Tsai3; C.-W. Hsu3;
H.-C. Wang2; A. Chen4; C.-N. Chen5
1Center of Sleep Disorder, 2Internal Medicine, National Taiwan
University Hospital, 3AmCad BioMed Corporation, 4Institute of
Industrial Engineerin, National Taiwan University, 5Surgery, National
Taiwan University Hospital, Taipei, Taiwan
Objectives/Introduction: We previously reported that manually‐
operated submental ultrasonography (US) could be used to identify
patients with severe obstructive sleep apnea (OSA). The present
study aimed to test the accuracy of machine‐held submental US to
identify patients with moderate‐severe OSA.
Methods: 13 heathy volunteers [apnea‐hypopnea index (AHI) < 5/
hr] and 40 OSA patients (AHI > 5/hr) were enrolled. The pharynx
was scanned for 4 s through hypoid bone to mandibular plane with
5‐MHz convex transducers (Terason T3000, USA) while the partici-
pants were awake and at supine position. Total 84 frames of US
image were obtained for each 4‐s scan. The transverse diameter of
pharyngeal aerospace was measured for three times at both of the
tidal breathing and Müller′s Maneuver (MM) where the median coef-
ficient of variance of measurement as 4.9% in the volunteers. The
dynamic change was defined as percentage of pharyngeal diameters
shortening from the diameters upon expiration during tidal breathing
to that during MM. Multivariate logistic regression was applied to
identify independent predictors for moderate‐severe OSA (AHI ≥
15). Thereafter, these independent predictors were used to estimate
the probability of moderate‐severe OSA, which was tested using the
area under the receiver operating characteristic (AUROC) curve for
diagnosing moderate‐severe OSA.
Results: Among 53 participants, 69.8% male, the median age was
46 y/o [interquartile range (IQR), 18] and body mass index (BMI) was
27.2 Kg/m2 (6.7). The AHI was 0.4/hr (0.5) and 22/hr (34.7) in volun-
teers and OSA patients, respectively. The age (r = 0.45, p < 0.001),
BMI (r = 0.65, p < 0.001), median pharyngeal diameter at MM
(r = 0.4, p = 0.003) and dynamic change (r = 0.51, p < 0.001) were
correlated with AHI. The Stepwise logistic analysis identified the
BMI [odds ratio (OR) 1.242, 95% CI 1.026–1.505, p = 0.026] and
median dynamic change (OR 1.062, 95% CI 1.010–1.117, p = 0.018)
as independent predictor for moderate‐severe OSA. The AUROC of
BMI and median diameters for identifying the moderate‐severe OSA
was 0.866 (95% CI 0.772–0.961, p < 0.001).
Conclusions: Using BMI and median dynamic change of pharyn-
geal diameter as the indicators, the machine‐held submental US
could be applied to identify patients with moderate‐severe OSA with
good accuracy.
Disclosure: This research was funded by National Taiwan Univer-
sity (106‐S‐C12). Edward C.H. Liu, Yuan‐Chun Tsai, Chin‐Wei Hsu
are employees to AmCad BioMed Corporation.
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O031 | Cerebral free‐water imaging with
obstructive sleep apnea severity
A.-A. Baril1,2; K. Gagnon2,3; M. Descoteaux4,5; S. Chami1,2;
J. Montplaisir1,2; E. Sanchez1,2; L. De Beaumont1,2;
R. Osorio6; J. Carrier1,2; N. Gosselin1,2
1Hôpital du Sacré‐Coeur de Montréal, 2Université de Montréal, 3Hôpital
Rivière‐des‐Prairies, Montreal, 4Centre Hospitalier Universitaire de
Sherbrooke, 5Université de Sherbrooke, Sherbrooke, QC, Canada, 6NYU
Langone Medical Center, New York, NY, United States
Objectives/Instruction: Obstructive sleep apnea (OSA) is increas-
ingly recognized as a risk factor for dementia, and thus, characterizing
its effect on the aging brain is key to understanding its role in neu-
rodegeneration. A novel diffusion‐weighted imaging technique quanti-
fies in vivo the cerebral free‐water fraction (extracellular) and
restricted‐water (intracellular). Pathological processes modify the
extracellular/intracellular water: increased intracellular water is
observed in cytotoxic oedema, inflammatory cellular recruitment and
reactive gliosis, while increased extracellular water is observed in
vasogenic oedema, neuroinflammation and cellular loss. Measuring the
cerebral free‐water fraction in OSA can clarify the nature of cerebral
tissue alterations. The objective of this study was to investigate free‐
water fraction in untreated older individuals with different severity of
OSA. We hypothesized that different OSA severity levels will feature
different free‐water patterns, suggesting a biphasic presentation of
pathological processes similarly to preclinical neurodegeneration.
Methods: Sixty‐three subjects (16F; age: 64.8; 55–82) were divided
in three groups (no, mild and moderate‐severe) according to various
indices of OSA severity: apnea‐hypopnea index (OSA; cut‐off: 5 and
15 events/hr); sleep time with oxygen saturation <90% (hypoxemia;
cut‐off: 0 and 1.7 min); micro‐arousal index (sleep fragmentation; cut‐
off: 10 and 18 events/hr). ANCOVA was used for cerebral free‐water
fraction between groups adjusted for cerebrospinal fluid volume.
Results: The mild OSA/hypoxemia groups had lower free‐water
fraction compared to the no OSA/hypoxemia and moderate‐severe
OSA/hypoxemia groups (p between 0.017 and 0.049). No group dif-
ference was observed between the sleep fragmentation groups.
Conclusions: Mild OSA and hypoxemia is associated with
decreased free‐water fraction representing increased intracellular
water, which could be caused by cytotoxic oedema, inflammatory
cellular recruitment and reactive gliosis. The U‐shape relationship
between OSA severity and free‐water fraction suggest a biphasic
pattern of pathological processes. More severe OSA and hypoxemia
may be characterized by the reversal of pathological processes, or by
an apparent normalization of the free‐water fraction caused by com-
peting processes that yield both increased intracellular and extracel-
lular water.
Disclosure: This study was funded by the Canadian Institutes of
Health Research (Gosselin, Baril, De Beaumont, Carrier, Montplaisir);
the Fonds de la recherche du Québec en Santé (Gosselin, Sanchez,
De Beaumont); and the Canadian Sleep and Circadian Network
(Baril).
SLEEP, – OMICS AND NOVEL CELLULAR
AND MOLECULAR MECHANICS
O032 | Predicted gene expression in the brain
is associated with sleep macrostructure in
healthy young individuals
P. Ghaemmaghami1; V. Muto1,2; M. Jaspar1,2,3; C. Meyer1,2;
M. Elansary4; M. Van Egroo1; C. Berthomier5; E. Lambot1,2;
J. Devillers1,2; M. Brandewinder5; A. Luxen1; C. Degueldre1;
E. Salmon1,3,6; F. Collette1,3; S.N. Archer7; C. Phillips1,8;
D.-J. Dijk7; M. Georges4; P. Maquet1,2,6; G. Vandewalle1,2
1GIGA‐Cyclotron Research Centre‐In Vivo Imaging, University of Liege,
2Walloon Excellence in Life Sciences and Biotechnology (WELBIO),
3Psychology and Cognitive Neuroscience Research Unit, 4GIGA‐Medical
Genomics, University of Liege, Liege, Belgium, 5PHYSIP SA, Paris,
France, 6Department of Neurology, University Hospital of Liège, Liege,
Belgium, 7Surrey Sleep Research Centre, University of Surrey, Guildford,
United Kingdom, 8GIGA‐In Silico Medicine, University of Liege, Liege,
Belgium
Objectives/Introduction: Uncovering the genetics of sleep is a
very difficult challenge. Many genes have been associated with dif-
ferent sleep features in animal models and in humans. The brain is
obviously implicated in sleep and several key brain regions have
been identified. How the expression of “sleep genes” in different
parts of the brain may be related to sleep regulation is unknown,
however. Here, we took advantage of a novel genetic tool to predict
gene expression in different tissues to assess the association
between regional sleep genes brain expression and sleep in young
adults.
Methods: Sleep electroencephalography was recorded during an
8 hr baseline sleep in 200 healthy young male volunteers devoid of
any sleep disorders (aged 18–31 years, mean = 22.07 ± 2.71). Blood
sample were collected in all participants to assess common Single
Nucleotides Polymorphisms (SNPs) over the entire genome. PrediX-
can (http://predictdb.org/) was employed to predict the expression
of 101 sleep genes, selected based on the literature, in 9 different
human brain tissues based on these common SNPs.
Results: Generalized linear mixed model revealed significant associa-
tions between sleep metrics and the predicted expression of sleep
genes in 2 different brain regions: the cerebral cortex and the anterior
cingulate cortex. Predicted sleep gene expression in the anterior cin-
gulate cortex was associated with the sleep onset latency (p < 0.001).
Moreover, predicted sleep gene expression in brain cortex was signifi-
cantly linked to the percentage of the REM sleep (p = 0.01). These
associations remain significant after adjusting for age.
Conclusions: These original preliminary results show that one can
use whole genome information to assess the association between
predicted gene expression in different parts of the brain and sleep.
They further suggest that where in the brain genes are expressed
matter for variability in sleep.
Disclosure: FNRS, ULiège, ARC, FEDER, Welbio, FMRE, Clerdent
Foundation.
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O033 | The cortical synaptic transcriptome is
organized by clocks, but its proteome is driven
by sleep
S. Noya
University of Zurich, Zurich, Switzerland
Objectives/Introduction: Circadian oscillations occur at the level
of transcription and post‐transcription to modulate levels of RNAs,
proteins and their activity. Complicating matters still further, rhythms
in RNA levels can also be driven by temporally consolidated behav-
iors. As an example, in the cortex, sleep‐wake cycles play a major
role (Maret et al., 2005). Neurons present a special case. They have
developed elaborated mechanisms to traffic RNA and proteins into
distant synapses to facilitate changes in their composition and allow
rapid synaptic responses. However, the control of these processes
across the day remains unstudied.
Here we will use a multi‐omic approach to provide novel mechanistic
insights into the combined regulation of synaptic RNA and proteins
by the clockwork and sleep.
Methods: Taking a biochemical approach to isolate synaptosomes
from mouse forebrain, we analyzed the transcriptome and proteome
of these neuronal compartments.
Results: We show that forebrain synaptic transcript accumulation is
overwhelmingly circadian ‐ with 70% of synaptic transcripts showing
time‐of‐day‐dependent abundance to anticipate dawn or dusk ‐ but
independent of oscillations in the soma. Transcripts preceding dawn
relate to metabolism and translation, whereas those anticipating dusk,
to synaptic transmission. Comprehensive characterization of the
synaptic proteome around the clock demonstrates the functional rele-
vance of temporal gating for synaptic processes and energy homeosta-
sis. Surprisingly, however, simple sleep deprivation completely abolished
proteomic but not transcriptomic oscillations. (n = 3, p < 0.05).
Conclusions: Altogether, the emerging picture is one of circadian
anticipation of mRNA needs in the synapse only followed by transla-
tion as demanded by rest‐activity cycles. (124 words)
Disclosure: Nothing to disclose.
O034 | mGluR5‐dependent nuclear speckle
assembly drives sleep‐wake transcriptomics
A. Spinnler1; K. Seignette1; D. Colameo1; M. Znidaric1;
G. Bosshard1; T. Gschwind1; M. Zaichuk1; W. Elgrawani1;
F. Brüning2; M. Tafti3; S. Nakagawa4; T. Hirose5;
M.S. Robles6; J.-M. Fritschy1; S.K. Tyagarajan1; S.A. Brown1
1Institute of Pharmacology and Toxicology, University of Zürich, Zürich,
Switzerland, 2Department of Proteomics and Signal Transduction, Max
Planck Institute of Biochemistry, Martinsried, Germany, 3Department of
Physiology, Faculty of Biology and Medicine, University of Lausanne,
Lausanne, Switzerland, 4RNA Biology Laboratory, Faculty of Biology and
Medicine, Hokkaido University, 5Institute for Genetic Medicine,
Hokkaido University, Sapporo, Japan, 6Institute of Medical Psychology,
Ludwig‐Maximilians‐University, Munich, Germany
Objectives/Introduction: The nucleus has been shown to be
heavily compartmentalized to regulate gene expression, but the
extent of its plasticity during normal daily sleep‐wake rhythms still
remains elusive. Here we show the importance of structural rear-
rangement upon neuronal activity by the example of the RNA bind-
ing Drosophila Behavior Human Splicing (DBHS) protein family,
consisting of NONO, PSPC1 and SFPQ.
Methods: C57Bl6 and DBHS knockout mice were analyzed for
nuclear morphology, sleep phenotype and gene expression variations
using immunofluorescence, omics techniques and cortical EEG
recording.
Results: We show that DBHS proteins form a new type of hetero-
geneous clusters in neurons in vivo and in vitro, and expression levels
are increased concurrent to neuronal firing (in vivo: n = 4, p < 0.05,
in vitro: n = 9–10, p < 0.01). These clusters rearrange upon neuronal
activity which is signaled via glutamatergic pathways, mainly via
mGluR5 (in vivo: n = 4–6, p < 0.05, in vitro: n = 30, p < 0.05) and its
downstream target PKC (in vivo: n = 3–4, p < 0.05, in vitro: n = 8,
p < 0.001). We also show that DBHS proteins are important for
sleep gene expression and homeostatic response to sleep deprivation
(n = 4–9, p < 0.01).
Conclusions: Our results identify DBHS protein clusters as plastic,
intra‐nuclear structures important for regulation of synaptic transmis-
sion during sleep and wake and give an insight into possible down-
stream mechanisms of mGluR5.
Disclosure: Nothing to disclose.
O035 | RNA‐Seq analysis of the impact of
sleep deprivation in medial prefrontal cortex of
young and old mice
X. Guo1; B.T. Keenan1; D. Sarantopoulou2; G.R. Grant2;
A.I. Pack1
1Center for Sleep and Circadian Neurobiology, 2Institute for
Translational Medicine and Therapeutics, University of Pennsylvania,
Philadelphia, PA, United States
Objectives/Instruction: Sleep deprivation (SD) negatively affects
cognitive functions, particularly learning and memory. Sleep and
memory loss are both significant problems associated with aging.
Behavioral studies on interactions of SD and aging show inconsistent
results. Here, we aimed to understand the age‐related differences in
the molecular consequences of SD in medial prefrontal cortex
(mPFC) of young and old mice using next generation RNA‐sequen-
cing.
Methods: Fifty‐four young (3‐month) and 54 old (18‐month) male
C57/B6 mice were separated into 9 groups (n = 6 per condition) cor-
responding to baseline (Z0; lights‐on), sleep for 3, 6, 9, and 12 hr
and SD for 3, 6, 9, and 12 hr. Libraries were made using TruSeq
Stranded mRNA kit, and sequencing was done using Hi‐Seq 4000.
Differentially expressed genes (DEGs) between SD and sleep at any
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of the four time‐points were determined within young and old ani-
mals, separately, using the F‐test in the LimmaVoom package. We
also compared the SD‐related changes between young and old at
each time‐point to evaluate which genes showed age‐specific
responses.
Results: Using a false‐discovery rate of 5% (FDR < 0.05), we found
7,330 DEGs in young and 5,157 DEGs in old animals, representing
8,412 unique genes. Approximately 50% of DEGs were common
between young and old mice, whereas 3,255 were unique in young
and 1,078 unique in old. Using interaction tests, 35 genes met statis-
tical criteria for differential responses based on age. Reln, a synapse
gene affecting learning and memory, was down‐regulated by SD in
the young mice, but not in the old. Slc22a3, an organic cation trans-
porter linked with brain function and cognition, and Cacna1b, an N‐
type Ca2+ channel protein affecting long‐term memory and potentia-
tion, showed similar effects. Insulin growth factor 2 (Igf2) was down‐
regulated by SD in the old mice, but not the young.
Conclusions: Sleep deprivation affected more genes in the mPFC
of young mice than in the old. Thirty‐five genes showed significantly
different sleep/wake responses between ages; many related to
synapse and memory. Results help to understand potential molecular
mechanisms of age differences in sleep/wake responses.
Disclosure: Nothing to disclose.
Funding source: NIA PPG: P01 AG017628.
O036 | The effects of insufficient sleep on
microglial morphology and functional state
H.-K. Wigren1; S. Steffens1; S. Piirainen2; L. Tian2; T. Porkka-
Heiskanen1
1Faculty of Medicine/Medicum/Physiology, 2Neuroscience Center,
University of Helsinki, Helsinki, Finland
Objectives/Introduction: Insufficient sleep activates the innate
immune response and many of the molecular immune mediators are
crucially involved in sleep regulation. However, less is known how
microglia, the brain resident immune cell, is affected. The steady‐
state microglia maintain tissue homeostasis in highly branched mor-
phology whereas upon challenge they transform into reactive from
with distinct morphological and functional changes. We investigated
how acute sleep deprivation (SD) or chronic sleep fragmentation (SF)
affected microglial morphology and functional state in mice.
Methods: Acute 9 hr SD was performed with the gentle handling
method while the 14d SF by housing the mice (B57) in the Sleep
Fragmentation Chamber, in which sleep was automatically inter-
rupted in 2 min intervals during the 12 hr lights‐on period. In vivo,
microglial morphology was investigated by repeated two‐photon flu-
orescent imaging of cortical microglia in freely behaving microglia
reporter mice throughout the experiments. Parallel brain samples
from the somatosensory cortex (sCX), the hippocampus (HC) and the
basal forebrain (BF) were collected, immunohistochemically stained
for detection of microglia (IBa1) and analyzed for microglial morphol-
ogy by confocal microscopy. Morphometric analyses of the fluores-
cent images were performed using Fiji's Simple Neurite Tracer. For
analysis of microglial functional state, cell suspensions from brain
samples were stained with flow cytometric markers of microglia
(CD11b+) as well as with markers for microglial activation (MHCII
and/or CD206), and the number of reactive microglia were counted.
Results: In vivo the microglia soma size in the sCX consistently
decreased during the acute SD as compared to baseline (BL) day
while during the recovery day soma size was slightly increased
(Ncells = 91, p = 0.003, Nmice = 4). When cortical microglial morphol-
ogy was assessed from the brain sections, SF simultaneously
decreased the number of processes while increasing their length
(Ncells = 10, p < 0.005, Nmice = 4). Neither of the treatments signifi-
cantly affected microglial functional state assessed by flow cytome-
try but the number of reactive microglia was in general consistently
higher (Nmice = 46, p < 0.005) in the BF as in other brain areas.
Conclusions: Even relatively short periods of SD dynamically mod-
ify the microglial phenotype but the effect is not uniform across
brain areas.
Disclosure: Nothing to disclose.
PRECLINICAL SYSTEMATIC REVIEWS AND
META ‐ANALYSIS IN SLEEP RESEARCH
37 | Introduction to systematic review and
meta‐analysis of preclinical animal studies
R. de Vries
SYRCLE, Department for Health Evidence, Radboudumc, Nijmegen, the
Netherlands
While systematic reviews and meta‐analyses are frequent and well‐
established in clinical research, they are still uncommon in animal
experimentation. However, recent publications have highlighted
important features of systematic reviews of animal studies from
experimental, translational and ethical perspectives. Animal system-
atic reviews are an effective methodological tool to gather all rele-
vant data on a given animal experimentation topic, providing
comprehensive analyses and conclusions and, last but not least, lead-
ing to a more reasonable usage of animal resources. In this introduc-
tion, the key features of systematic reviews will be explained and
the aspects in which they differ from classical reviews highlighted.
Moreover, the advantages of these reviews for preclinical research
in general and for sleep research in particular will be illustrated.
Disclosure: Nothing to disclose.
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38 | Meta‐analysis on the relationship between
sleep deprivation and anxiety in rodents
G.N. Pires; A.G. Bezerra; S. Tufik; M.L. Andersen
Department of Psychobiology, Universidade Federal de São Paulo
(UNIFESP), São Paulo, Brazil
Increased anxiety is a common behavioral comorbidity of sleep
deprivation in humans. Due to the relevance of this relationship, sev-
eral preclinical studies have tried to replicate this condition using
animal models. However, despite the consistency in clinical data, ani-
mal studies (mainly rodents) have failed to replicate the increased
state anxiety caused by lack of sleep in clinical settings. While some
of these studies report anxiogenesis as a consequence of sleep
deprivation, others presented anxiolysis as a final result. Taking these
discrepancies into account, this work aimed to explore the effects of
preclinical sleep deprivation the effect of sleep deprivation on anxi-
ety‐like behavior in preclinical research, by means of a systematic
review and meta‐analyses. Fifty articles were in accordance with our
inclusion criteria, among which 30 were conducted in mice, 19 on
rats and a single one used Zebrafish models. Our results demon-
strate that lack of sleep leads to a decreased in anxiety‐like behavior
in animal models, which is conflicting with the increase anxiety
observed in clinical studies. These findings were supported by strati-
fied analysis having species, sleep deprivation method and anxiety
measurement techniques as control variables. In conclusion, the use
of preclinical models of lacks translational applicability when trying
to access the relationship between sleep deprivation and anxiety.
New experimental should be considered or developed, in order to
provide more reliable methodological tools for the research on the
field of sleep deprivation and anxiety in experimentation animals.
Disclosure: Nothing to disclose.
39 | Adenosine and sleep: a systematic review
and meta‐analyses of the preclinical literature
C.H.C. Leenaars1,2,3; S.A. Savelyev4; S. Van der Mierden3;
R.B.M. De Vries1
1SYRCLE, Radboud University Medical Center, Nijmegen, 2DWM,
Utrecht University, Utrecht, the Netherlands, 3ZTL, Hannover Medical
School, Hannover, Germany, 4Medical Biological Research &
Development Centre ‘Cytomed’, St. Petersburg, Russian Federation
The neuroregulator adenosine is, amongst others, involved in sleep‐wake
control. It can be measured with microdialysis, a diffusion‐based method
to study the extracellular space in vivo. Basal forebrain (BF) adenosine
levels have long been known to increase during sleep deprivation. Only
few studies addressed the effect of sleep deprivation on adenosine con-
centrations in other brain regions. Because cortical functioning appears
to decrease after sleep deprivation, it would be interesting to know what
happens to adenosine levels in various cortical regions.
A systematic literature review (SR) was performed, the protocol was
posted to the SYRCLE website on 25 January 2016. A
comprehensive search for studies measuring intracerebral adenosine
in animals by means of Microdialysis in Embase, Pubmed and Web of
Science retrieved 981 unique references; we included 133 in the final
review. 124 of these described baseline adenosine levels, nine
described one or more sleep deprivation experiments. Sleep depriva-
tion data were available for the following brain regions: BF, brain-
stem, several cortical regions, hypothalamus, nucleus accumbens and
thalamus. These studies mainly used the gentle handling technique,
only one study used intermittent forced locomotion. Rats were stud-
ied in eight papers, cats in one.
Meta‐analyses (MAs) were performed to analyse global effects of
sleep deprivation on adenosine levels in the BF and the cortex. Ade-
nosine concentrations in the brainstem, hypothalamus, nucleus accum-
bens and thalamus were only reported in one paper and not further
analysed. Our MA reflects BF dialysate adenosine concentrations
increasing during sleep deprivation, with on average 74.7% (95% CI:
54.1–95.3%) over baseline. Cortex dialysate adenosine concentrations
during sleep deprivation were only reported by 2 publications. The
evidence for cortical adenosine levels is still inconclusive (BF com-
pared to cortex: on average 35.28% more increase; 95% CI: −16.03
to 86.60, MA for difference in change scores: p = 0.18).
The increase in adenosine during sleep deprivation may be specific
to the BF. The evidence for adenosine levels in other brain regions
is so far scarce, and insufficient for making generalised conclusions.
At this stage, further primary studies are still warranted.
Disclosure: This work was funded by The Netherlands Organisa-
tion for Health Research and Development (ZonMW; 114024101).
Cathalijn H.C. Leenaars has no conflicts of interest. Sergey A. Save-
lyev has no conflicts of interest. Stevie van der Mierden has no con-
flicts of interest. Rob B.M. de Vries has no conflicts of interest.
40 | Systematic review on the relationship
between monoamines and sleep
J.M.L. Menon1; R.B.M. de Vries1; W.H.I.M. Drinkenburg2;
C.H.C. Leenaars1,3,4
1SYRCLE, Department for Health Evidence (Section HTA), Radboud
University Medical Center, Nijmegen, the Netherlands, 2Department of
Neuroscience Discovery, Janssen Research & Development, a Division of
Janssen Pharmaceutica N.V., Beerse, Belgium, 3Department of Animals
in Science and Society ‐ Human‐Animal Relationship, Utrecht University,
Utrecht, the Netherlands, 4Institute for Laboratory Animal Science,
Hannover Medical School, Hannover, Germany
Background: Sleep is a complex process involving a network of
exogenous and endogenous regulators including monoamines. Mono-
amine disruption, e.g. by sleep deprivation (SD), seems to promote
certain diseases. Assessment of monoamine levels during the light
and dark phase, sleep stages and SD is instrumental to understand
the molecular dynamics during and after SD and their consequences.
Methods: A comprehensive search was performed in PubMed and
EMBASE. Two independent reviewers screened 2662 retrieved pub-
lications, resulting in 96 inclusions. Information on the used study
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design, animal model, measurement characteristics and outcomes,
was extracted and tabulated by experiment type and monoamine (i.e.
dopamine, serotonin, noradrenalin, adrenaline, 5‐hydroxyindoleacetic
acid (5‐HIAA) and 3,4‐dihydroxyphenylacetic acid (DOPAC)). Results
were described qualitatively. Network‐meta analyses (NMAs) were
performed to compare noradrenalin and serotonin concentrations
between naturally occurring sleep‐wake stages.
Results: Dopamine and DOPAC levels generally seemed to increase
during the dark phase and decrease during the light phase. Serotonin
and 5‐HIAA levels generally peaked at or after dark phase onset.
Noradrenalin and adrenaline levels did not show an overall consis-
tent pattern. Monoamine levels were generally higher during wake-
fulness while lower during sleep; except for dopamine levels in
amygdala and locus coeruleus, which were stable. These qualitative
observations were supported by the NMAs: monoamine levels
decreased from wakefulness to slow wave sleep (serotonin: stan-
dardized mean difference (SMD): −0.16, 95% Confidence interval
(CI) [ −0.21; −0.12]; Noradrenalin: SMD: −1.01, 95% CI [−1.55;
−0.47]), and decreased further during Rapid Eye Movement sleep
(serotonin: SMD: −0.24, 95% CI [−0.29; −0.19]; Noradrenalin: SMD:
−2.30; 95% CI [−2.98; −1.63]). In contrast, monoamine levels gener-
ally increased during SD, and sometimes remained high even during
subsequent recovery. Decreases during or after SD were only
reported for serotonin levels.
Conclusion: This systematic literature review indicates that mono-
amine levels show systematic variation over the light‐dark cycle and
between sleep stages. Sleep deprivation modifies these naturally
occurring patterns, with effects sometimes extending beyond the
sleep deprivation duration.
Disclosure: Nothing to disclose.
LACK OF SLEEP: EFFECTS ON PERIPHERY
AND THE BRAIN
O041 | Effects of sleep restriction on glucose
tolerance in adolescents
J. Gooley; D. Twan; S. Karamchedu; J. Lo; M. Chee
Centre for Cognitive Neuroscience, Neuroscience and Behavioural
Disorders Programme, Duke‐NUS Medical School, Singapore, Singapore
Objectives/Instruction: Many adolescents are exposed to chronic
partial sleep deprivation. Short sleep duration has been hypothesized
to contribute to elevated blood glucose and increased risk of type 2
diabetes. Here, we examined effects of sleep restriction on glucose
tolerance in adolescents whose sleep was scheduled as a single bout
during the night versus a split‐sleep schedule with a shorter night
segment and a mid‐afternoon nap.
Methods: Adolescents aged 15–19 years underwent 2 cycles of
sleep restriction (6.5 hr of time in bed) and recovery (9 hr of time in
bed) that simulated sleep behaviour over 2 school weeks. During
sleep restriction, participants were given 6.5 hr of time in bed (TIB)
at night (n = 29), or 5 hr of TIB at night plus a 1.5‐hr nap opportu-
nity (n = 29). A 75‐g oral glucose tolerance test was administered on
mornings following baseline sleep, sleep restriction, recovery sleep,
and re‐exposure to sleep restriction. The finger‐prick method was
used to measure the change in capillary blood glucose from the fast-
ing state to 2 hr after the glucose load.
Results: The split‐sleep group with shorter night sleep (5.0 hr TIB
plus 1.5‐hr nap) exhibited significantly elevated blood glucose during
both cycles of sleep restriction compared with their baseline glucose
response after 9 hr of TIB (p < 0.05 for both comparisons). In con-
trast, glucose responses in the consolidated sleep group (6.5 hr TIB)
did not differ between sleep restriction and baseline sleep.
Conclusions: In adolescents exposed to moderate sleep restric-
tion (6.5 hr of TIB per day), the split‐sleep schedule with shorter
night sleep was associated with reduced glucose tolerance com-
pared with consolidated night sleep. Our results indicate that the
distribution of TIB in sleep‐restricted adolescents has considerable
impact on glucose responses. Adolescents who take naps to com-
pensate for short night sleep may exhibit reduced morning insulin
sensitivity.
Disclosure: This work was supported by the National Medical
Research Council, Singapore (NMRC/STaR/015/2013), the National
Research Foundation, Singapore (NRF2016_SOL002), and the Far
East Organization.
O042 | The relationship between adolescents’
sleep spindles and cognitive performance
following experimental sleep restriction
C.M. Reynolds; M. Gradisar; M.A. Short
College of Education, Psychology and Social Work, Flinders University,
Adelaide, SA, Australia
Objectives/Instruction: Sleep spindles have shown associations
with cognitive performance in adults and increasingly in adolescents,
however it is unclear whether sleep loss has an impact on this rela-
tionship. Adolescents typically restrict their sleep during weekdays
and experience detriments to academic achievement. An analysis of
sleep spindle activity and cognitive performance in the context of
experimental sleep restriction may elucidate a mechanism through
which this occurs.
Methods: 34 adolescents participated in a 10‐day laboratory study
where they firstly received one adaptation and one baseline night of
10 hr time in bed. Adolescents were allocated to one of three sleep
‘doses’: 5 hr (n = 12), 7.5 hr (n = 10) or 10 hr (control condition;
n = 12) of time in bed. Two recovery nights of 10 hr time in bed fol-
lowed. Cognitive variables examined were: working memory (opera-
tion span task), fluid intelligence (letter sets and number series tasks)
and attention (psychomotor vigilance task).
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Results: At baseline for the full sample, fluid intelligence was posi-
tively correlated with fast spindle density (r = 0.36, p = 0.04) and
trended toward significance with fast spindle duration (r = 0.26,
p = 0.13) and slow spindle amplitude (r = 0.28, p = 0.11). Working
memory and attention did not show significant relationships with
spindle characteristics at baseline. The change in spindle parameters
across the experimental phase was associated with several changes
in cognitive performance, however a clear dose‐response effect was
not evident. Although correlations did not reach significance
(p > 0.05), there were consistent small relationships between work-
ing memory improvements and increased density of fast spindles in
all conditions (5 hr: r = 0.29; 7.5 hr: r = 0.19; 10 hr: r = 0.40). During
moderate sleep restriction (7.5 hr), increases in fast spindle duration
were consistently associated with worse cognitive performance
(working memory: r = −0.50, p = 0.15; fluid IQ: r = −0.69, p = 0.03
(letter sets), r = −0.45, p = 0.19 (number series); attention: r = −0.51,
p = 0.14). Such consistent patterns were not seen for severe sleep
restriction or the control condition.
Conclusions: Sleep spindles show both static and dynamic associa-
tions with some measures of cognitive performance in adolescents.
Adolescents whose fast sleep spindles became longer across moder-
ate sleep restriction experienced more deficits in cognitive perfor-
mance.
Disclosure: This work was supported by the Australasian Sleep
Association Rob Pierce Grant in Aid. There are no conflicts of inter-
est to disclose for any of the authors.
O043 | Association between individual
impairments in glucose metabolism and cognitive
performance in response to sleep restriction
E.-M. Elmenhorst1,2; D. Elmenhorst3,4; E. Hennecke1;
D. Lange1; J. Fronczek3; A. Bauer3,5; D. Aeschbach1,6,7
1Sleep and Human Factors Research, Institute of Aerospace Medicine,
German Aerospace Center, Cologne, 2Institute for Occupational and
Social Medicine, Medical Faculty, RWTH Aachen University, Aachen,
3Institute of Neuroscience and Medicine (INM‐2), Research Center
Jülich, Jülich, 4Department of Psychiatry and Psychotherapy, Rheinische
Friedrich‐Wilhelms‐University Bonn, Bonn, 5Neurological Department,
Medical Faculty, Heinrich‐Heine‐University, Düsseldorf, Düsseldorf,
Germany, 6Division of Sleep and Circadian Disorders, Brigham and
Women's Hospital, 7Division of Sleep Medicine, Harvard Medical School,
Boston, MA, United States
Objectives/Introduction: Short sleep durations have been associ-
ated with impaired glucose metabolism as well as with trait‐like
impairments in cognitive functions. We examined whether this trait
vulnerability of cognitive performance to sleep loss extends also to
glucose tolerance and insulin sensitivity.
Methods: Thirty‐six healthy volunteers underwent a 12‐day sleep
lab study. In a sequential design, they completed one adaptation
night and two baseline nights with 8 hr time in bed (TIB), 5 nights
with 5 hr TIB (21 participants of the sleep restriction group, 9
female, mean ± SD, age 26 ± 4 years, BMI 23.1 ± 1.9) or 5 nights
with 8 hr TIB (control group, data not shown here), followed by one
8 hr TIB recovery night, 38 hr of sleep deprivation, and a final night
with 10 hr TIB. Oral glucose tolerance was tested in the morning
immediately after lights on (>10 hr fasting) on the second baseline
day, after 5 nights with 5 or 8 hr TIB, after the recovery night, and
after 24 hr of sustained wakefulness. Fasting glucose and insulin
levels, as well as those 30, 60, 90, and 120 min after glucose intake
were analyzed in blood samples. Averaged daytime results of a 3‐
hourly performed psychomotor vigilance task (10‐min PVT) were cal-
culated. Pearson correlations between impairments (differences to
baseline) in glucose metabolism and performance were calculated.
Results: Mixed ANOVAs showed that in comparison to baseline
areas under the curve (AUC) of glucose, insulin, and the homeostasis
model assessment (HOMA) were increased after sleep restriction (all
p = 0.0003), stayed elevated after one night of recovery sleep (all
p < 0.02), but returned to baseline levels after 24 hr of sleep depri-
vation (all p > 0.6). Impairments after 5 nights of sleep restriction
showed significant correlations between mean speed/10th percentile
of speed and glucose at 90 min (r = −0.51/r = −0.52), insulin at
30 min (r = −0.55/r = −0.59), 90 min (r = −0.61/−0.61), and at
120 min (r = −0.51/trend r = −0.49) after exposure.
Conclusions: Sleep restriction, but not acute sleep deprivation,
impaired glucose tolerance and insulin sensitivity. Individuals under
sleep restriction appeared to be likewise either vulnerable or resilient
regarding both glucose metabolism and cognitive performance.
Disclosure: Nothing to disclose.
O044 | Investigation of the neural substrates
underlying the homeostatic sleep response in the
basal forebrain
H. Bouaouda1; C. Shukla1; J. McKenna1; J. McNally1;
S. Winston1; A. Kalinchuk1; S. Thankachan1; R. Strecker1;
K. Deisseroth2; R. Brown1; R. Basheer1
1Psychiatry, Harvard Medical School‐VA Boston Healthcare System,
West Roxbury, MA, 2Stanford University, Stanford, CA, United States
Objectives/Introduction: Optogenetic stimulation of Cholinergic
(ChAT+), vesicular glutamate transporter2‐expressing glutamatergic
(vGluT2+) or parvalbumin‐expressing GABAergic (PV+) neurons in
the basal forebrain (BF) cause arousal responses. However, little is
known about their role in the homeostatic sleep response (HSR).
ChAT+ are thought to play a privileged role in this response since
selective lesions of these neurons abolish the HSR. Here, we explore
the interactive roles of the three neurotransmitter systems in BF.
Methods: C57BL/6 (WT) mice were sleep deprived (SD) 6 hr with
and without microdialysis of cholinergic antagonists, α‐amino‐3‐
hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid (AMPA) or N‐methyl‐D‐
aspartate (NMDA) glutamate receptors antagonists into BF to exam-
ine the effect of pharmacological blockade of the cholinergic and
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glutamatergic receptors on recovery sleep and delta activity (0.5–
4.5 Hz), the markers of HSR. We transduced AAV‐ChR2‐EYFP in BF
of ChAT‐Cre, vGluT‐Cre and PV‐Cre mice and examined the effect
of 6 hr laser illuminations (5 s/min, 10 ms pulses, 10 Hz for ChAT+,
20 Hz vGluT2+ and 40 Hz for PV+) on HSR, during the 2 hr post‐
stimulation period and compared it with time matched sham stimula-
tion. In ChAT‐Cre mice we performed optodialysis of cholinergic
antagonists during 6 hr optical stimulation and examined the post
stimulation HSR.
Results: In WT mice (n = 4) microdialysis of cholinergic antagonists
did not prevent HSR as evaluated by an increase in time spent in
sleep (+36.74%±5.65) and the delta power (+13.82%±3.62). Micro-
dialysis of AMPA or NMDA receptor antagonists in another set of
WT mice (n = 3) showed a tendency towards attenuated recovery
sleep by −5.06%±7.35 and −11.72%±4.05, respectively. Optogenetic
stimulation of ChAT+ (n = 3) led to increase in sleep‐time (BL
52.6 ± 0.56 vs. Post‐stim 57 ± 2.88) and delta by 24% during the
2 hr Post‐stimulation. Acetylcholine antagonist administrations during
ChAT+ stimulations failed to block HSR. Optogenetic stimulation of
vGluT2+ (n = 3) led to HSR. GABAPV+ stimulation did not provoke
HSR.
Conclusions: Our preliminary results suggest that ChAT+ and
vGluT2+ but not PV+ neurons, are involved in HSR. Local effects of
acetylcholine on nonChAT+ neurons are not required for HSR.
Moreover, microdialysis of glutamate receptor antagonists attenuates
vGluT2+ stimulation‐induced HSR.
Disclosure: VA‐I01BX001404, I01BX001356, I01BX002774,
IK2BX002130; NIH‐NS079866, MH039683, HL095491, MH099180.
JTM received partial salary/funding from Merck MISP, no conflict of
interest with this work.
O045 | ′Waking at a lower cost′: running
wheel access reduces sleep propensity
L. Milinski1; S.P. Fisher1; G. Ang2; D.M. Bannerman2;
V.V. Vyazovskiy1
1Department of Physiology, Anatomy and Genetics, University of Oxford /
Sleep and Circadian Neuroscience Institute, 2Department of Experimental
Psychology, University of Oxford, Oxford, United Kingdom
Objectives/Introduction: Sleep need increases during waking and
dissipates during subsequent sleep. The nature of the process that
keeps track of the time spent awake is unknown. We hypothesize
that waking behaviour affects the capacity to sustain continuous
wakefulness and may affect accumulation of sleep pressure. We pro-
pose that stereotypical behaviour reduces build‐up of sleep pressure
compared to more demanding, goal‐directed behaviour.
Methods: To test this hypothesis, continuous EEG/EMG recordings
were performed in adult male C57BL/6 mice (n = 6–8/group), well
habituated to wheel running, and subjected to 3‐hr sleep deprivation
(SD) by providing novel objects during the last 3 hr of the light
phase. Subsequently, starting from dark onset the animals were kept
awake for an additional 3 hr, either by novel objects to elicit pre-
dominantly exploratory behaviour (exploratory wakefulness, EW), or
by providing access to the wheels, which the animals used exten-
sively (RW). Subsequently, the animals were left undisturbed without
wheel access.
Results: We found that the animals from the EW group had a sig-
nificantly shorter sleep latency, defined as the time until the first
consolidated sleep period >5 min (EW: 62.9 ± 30.0 min, RW:
116.0 ± 41.2 min, p < 0.05), and the total amount of waking during
the first hour after the animals were left undisturbed was lower in
the EW group compared to RW animals (EW: 38.8 ± 5.0 min, RW:
53.1 ± 3.1 min, p < 0.05). The total time spent awake from the
beginning of SD procedure until sleep onset following the SD+EW/
RW interval was ~50 min longer in the RW as compared to EW con-
dition (p = 0.08). However, the total amount of sleep during the first
1‐hr interval starting from sleep onset was strikingly similar between
the groups (EW: 37.6 ± 3.8 min, RW: 37.4 ± 4.8 min, p = 0.95), and
the levels of NREM EEG slow wave activity during this interval were
nearly identical (EW: 166.9 ± 11.1%, RW: 166 ± 20.5% of mean
before SD).
Conclusions: Our preliminary results suggest that waking beha-
viour affects the capacity to sustain consolidated wakefulness. The
excess wakefulness dominated by stereotypical wheel running
appears to have little effect on the level of sleep need. We conclude
that certain types of wakefulness, which are associated with a low
cognitive/attentional demand, correspond to a ‘waking at a lower
cost’.
Disclosure: The study was supported by MRC (MR/L003635/1),
Wellcome Trust (098461/Z/12/Z) and ESA (4000114025/15/NL/LF/
as).
PULSE WAVE ANALYSIS DURING SLEEP – A
MEANINGFUL TOOL FOR IMPROVED
PHENOTYPING IN SLEEP DISORDERS?
46 | Pulse wave analysis during sleep ‐
physiology and methodology
T. Penzel; N. Laharnar; M. Glos; C. Schöbel; I. Fietze
Interdisziplinäres Schlafmedizinisches Zentrum, Charité –
Universitätsmedizin Berlin, Berlin, Germany
Introduction: Many sleep disorders pose a stress on the cardiovas-
cular system. According to the AASM rules for the recording of
polysomnography for cardiac signals only ECG recording is manda-
tory. If available, the pulse wave can be recorded as well. However,
there are no recommendations to record of monitor blood pressure.
To assess blood pressure or ultimately the cardiovascular risk for a
particular patient during sleep is desirable for many sleep disorders.
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Method: The pulse wave signal is monitored as finger photo-
plethysmography by pulse oximetry at two wavelengths and may be
stored with polysomnography if hardware and software settings
allow this. Regularly only the final calculated oximetry signal is
recorded and stored with the polysomnography data. Sometimes
one photoplethysmographic signal is recorded as well. Some add‐on
devices provide pulse wave signals as raw signals, which can be
recorded in parallel to polysomnography. Based on these it is possi-
ble to derive a surrogate for blood pressure from finger photo-
plethysmography under the assumption that other modifiers stay
constant during sleep. The pulse wave reflects sympathetic tone and
parasympathetic activity as vascular signals.
Results: This has been exploited by peripheral arterial tonometry
recorded by external devices. Photoplethysmography allows to esti-
mate blood pressure non‐invasively up to some degree and allows to
estimate cardiovascular risk by using additional algorithms for the
processing of the signal. If the photoplethysmographic signal is stabi-
lized and standardized, it can be used for diagnosing sleep stages
and sleep disordered breathing. This had been exploited by periph-
eral arterial tonometry regularly recorded by external devices.
Discussion: The recording of pulse wave and an advanced analysis
of the pulse wave allows assessment of sympathetic activity during
sleep. Amplitude changes, pulse rate changes, and pulse wave char-
acteristics are the three targets for analysis. Advanced signal pro-
cessing and advanced classification rules allow to derive sleep
stages, some sleep disorders, and finally provide a cardiovascular risk
assessment.
Disclosure: TP has received institutional grants by Cidelec, Itamar,
Heinen+Löwenstein, Philips, Resmed for research studies on the
diagnosis of sleep disorders.
47 | Pulse wave analysis during sleep in
insomnia
N. Laharnar1; L. Grote2; D. Zou2; J. Hedner2;
D. Sommermeyer2; A. Marciniak3; C. Straßberger3;
S. Potzka1; M. Glos1; S. Zimmermann1; I. Fietze1; T. Penzel1
1Interdisciplinary Center of Sleep Medicine, Charite‐Universitätsmedizin
Berlin, Berlin, Germany, 2Center for Sleep and Vigilance Disorders,
Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden,
3Institute of Biomedical Engineering, University of Karlsruhe, Karlsruhe,
Germany
Introduction: Cardiovascular (CV) diseases account for about 30%
of all deaths worldwide making CV risk assessment highly important.
Sleep disorders and especially short sleep duration may increase CV
risk due to hyperarousal state. Photoplethysmography is a non‐inva-
sive method to measure pulse rate and blood circulation with a fin-
ger pulse oximeter. By conducting a pulse wave analysis, CV risk can
be assessed.The aim of our study was to detect autonomic and car-
diovascular differences in insomnia and non‐insomnia participants
with pulse wave analysis.
Method: We examined 52 participants (26 men, median age = 32.5
years, median BMI = 23.2 kg/m2) with 26 insomnia patients and 26
non‐insomnia participants. We additionally divided the insomnia
patients into 12 with objectively measured high sleep efficiency
(SE > 80%) and 14 with low sleep efficiency (SE ≤ 80%). All partici-
pants underwent laboratory‐based overnight polysomnography
including advanced analysis of the pulse wave signal derived from
finger pulse oximetry.
Results: While the insomnia and non‐insomnia group were compa-
rable for gender distribution, age, BMI, alcohol consumption, smok-
ing, and apnea‐hypopnea index, both insomnia groups showed
significantly lower subjective sleep quality than the non‐insomnia
group. Also, average heart rate and arousal index were increased in
insomnia patients compared to non‐insomnia participants. Pulse
wave analysis revealed differences regarding single parameters (pulse
rate, pulse propagation time (PPT)) and composite variables (cardiac
risk index). Pulse rate was significant higher for both insomnia
groups compared to the non‐insomnia group (p < 0.01). Vascular
stiffness was highest in insomniacs with low SE (median PPT = 169
ms) and differed significantly from both, the high SE insomnia
(237 ms) and the non‐insomnia group (244 ms; p < 0.01). Addition-
ally, the composite cardiac risk index was higher in insomnia subjects
with low SE (p = 0.054).
Discussion: The polysomnography and pulse wave analysis support
the assumption of a physiological hyperarousal evidenced by cardio-
vascular and autonomous activity during sleep in subjects with
insomnia. Especially pulse rate and vascular stiffness were increased
indicating rigid and atherosclerotic vessels and a higher CV risk in
insomnia patients with low SE. Overnight pulse wave analysis
appeared to be a useful tool for continuous assessment of relevant
cardiovascular parameters during sleep. To be more conclusive, we
recommend further investigations including different insomnia phe-
notypes.
Disclosure: Nothing to disclose.
JOINT SYMPOSIUM ESRS ‐ EAN ‐ DISORDER
OF AROUSALS (DOA): AN UPDATE
48 | Local aspect of sleep and wakefulness:
implications for DOA
F. Siclari
Center for Investigation and Research on Sleep, University of Lausanne,
Lausanne, Switzerland
Disorders of arousals (confusional arousals, sleepwalking, sleep ter-
ror) are a group of Non Rapid Eye Movement Sleep parasomnias, in
which features of sleep and wakefulness are thought to be simulta-
neously present in different brain areas. In addition, the normally
integrated aspects of consciousness and environmental connection
can become selectively impaired in these conditions, providing a
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valuable opportunity to study these features in isolation. Case
reports and clinical observations suggest that affected patients can
either be fully conscious and perceive their surroundings during
parasomnia episodes (consciousness without sensory disconnection),
be conscious but disconnected and only interact with imaginary peo-
ple or objects (consciousness with sensory disconnection), or behave
in an almost entirely automatic way without awareness (uncon-
sciousness or minimal consciousness). In the present talk I will pre-
sent a study in which we systematically assessed consciousness and
environmental disconnection during episodes of disorders of arousal,
with the aim of studying how these features relate to local patterns
of sleep and wakefulness. Subjects with frequent parasomnia epi-
sodes underwent two high‐density EEG sleep recordings (baseline
and recovery sleep after sleep deprivation). In order to increase the
frequency and complexity of episodes, serial awakenings were per-
formed during recovery sleep. Subjects were systematically inter-
viewed about their mental activity after each behavioral episode. I
will present a detailed description of the conscious experiences
reported by the patients and will show some preliminary high‐den-
sity EEG findings.
Disclosure: Nothing to disclose.
49 | Clinical and PSG features distinguishing
DOA from sleep related hypermotor epilepsy‐
SHE
P. Proserpio1; L. Nobili1,2
1Center of Sleep Medicine, Department of Neuroscience, Niguarda
Hospital, Milano, 2Department of Neuroscience (DINOGMI), Gaslini
Institute, University of Genoa, Genoa, Italy
The differential diagnosis between Sleep Related Hypermotor Epi-
lepsy (SHE) and Disorder of Arousal (DOA) can be challenging. A
definitive diagnosis is paramount to establish a correct management
of these disorders. Different anamnestic key features have been rec-
ognized as discriminant in the differential diagnosis between SHE
and DOA and clinical scales have been developed, though limited by
contradictory diagnostic accuracy. Therefore, Video‐Polysomnogra-
phy represents the “gold‐standard” test for diagnosing paroxysmal
sleep‐related events. Considering that interictal and even ictal scalp
EEG can be uninformative in many SHE patients, a careful semiologi-
cal analysis of manifestations is considered the most useful tool to
differentiate epileptic versus parasomnic events. However, some
clinical characteristics do not allow to make a definite diagnosis and
brief arousals of epileptic and non‐epileptic origin are frequently
indistinguishable. Moreover, the analysis of clinical patterns implies a
part of subjectivity and depends on the clinician experience. The
stage from which nocturnal events emerge and event timing relative
to sleep onset are considered as discriminant features between epi-
lepsy and DOA. Generally DOA, arise more frequently from deep
NREM sleep, in the first third of the night while sleep‐related sei-
zures occur mostly during light NREM sleep anytime during the sleep
period. However, systematic studies analyzing and comparing these
aspects in parasomnic and epileptic patients are scanty and some-
times discordant. In a recent retrospective study we reviewed video‐
polysomnography recordings of 89 patients with a definite diagnosis
of DOA or SHE analyzing the stage and the relative time of occur-
rence of every major or minor event. We found that episodes
occurred mostly during N3 and N2 in DOA and SHE patients respec-
tively. Indeed, the occurrence of at least one major event outside
N3 was highly suggestive for SHE while the occurrence of at least
one minor event during N3 was highly suggestive for DOA. More-
over, DOA episodes tended to occur more frequently during the first
part of the night with respect to epileptic events. Thus, our work
confirms that the stage and the relative time of occurrence of minor
and major complex motor manifestation during sleep represent a
useful tool to discriminate DOA from SHE episodes.
Disclosure: Nothing to disclose.
50 | Parasomnia overlap disorders
P. Bargiotas
Sleep Wake Epilepsy Center and Department of Neurology, University
Hospital and University of Bern, Bern, Switzerland
Parasomnia overlap disorder (POD) is a condition with clinical fea-
tures of both non‐REM and REM parasomnias. POD is currently clas-
sified as a subtype of REM parasomnias.
However, increasing evidence suggests that POD is a distinct type
of parasomnia. There is a number of reports on symptomatic and
idiopathic cases of POD, however, incomplete understanding of the
etiology, the pathological basis and the clinical spectrum of POD
continue to impede the final classification and the correct diagnosis
of the disorder.
Is POD just the result of co‐occurring parasomnias or it might repre-
sent a dyscontrol of sleep‐related motor behavior that progressively
affects the different sleep stages? Are the REM‐ or the NREM‐
related behaviors more prominent in POD? Are there any distinctive
features in POD compared to REM‐ and NREM‐Parasomnias? How
does POD evolve?
In this talk, we present an update on the clinical features and the
spectrum of conditions associated with POD, and we discuss avail-
able data on electrophysiological characteristics and possible neuro-
biological mechanism of this disorder.
Disclosure: Nothing to disclose.
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ASYMPTOMATIC SLEEP DISORDERED
BREATHING: WHO SHOULD BE TREATED?
51 | Predictors and biomarkers of negative
outcomes in obstructive sleep apnea
R. Heinzer
University Hospital of Lausanne, Center for Investigation and Research
in Sleep (CIRS), Lausanne, Switzerland
Obstructive sleep apnea (OSA) is associated with incident cardiovas-
cular, metabolic or psychiatric diseases. While some untreated OSA
patients will develop these negative outcomes, many others will not.
It is unfortunately unclear how to differentiate these two popula-
tions since they may show the same level of apnea hypopnea index
(AHI).
Considering the high prevalence of OSA in the general population
and the cost of OSA treatment, providing preventive treatment to all
asymptomatic OSA patients would be irrealistic and ethically ques-
tionable. It is thus crucial to find predictors and biomarkers other
than AHI to determine which OSA patients are at risk for developing
negative outcomes and should be treated. These predictors could be
demographic, genetic, inflammatory, clinical (sleepiness) or associated
with specific physiological sleep parameters. Among these, auto-
nomic nervous system activations following respiratory events has
raised interest in the last years. The hypothesis is that OSA patients
with strong sympathetic activations following respiratory events may
be at higher risk of devolping cardiovascular, cerebrovascular and
metabolic disorders than OSA patients with only mild sympathetic
activations.
HypnoLaus is a population‐based sleep cohort in which 2162 middle
to older age participants underwent full polysomnography at home,
answered questionnaires regarding their sleep habits and complaints,
and had a full clinical assessment. Pulse wave amplitude variations,
as a marker of sympathetic activation during sleep, was also anal-
ysed. At 5 years follow‐up of this cohort, incident hypertension, dia-
betes, metabolic syndrome, and depression were assessed. Each
cardiovascular or cerebrovascular events were also adjudicated by a
pannel of experts. Preliminary analysis of the follow‐up data of Hyp-
noLaus cohort revealed that the duration of the pulse wave ampli-
tude drops was independently associated with incident hypertension
(OR: 2.08; CI: 1.06–4.11, p = 0.034) after adjustment for age, sex,
BMI and baseline blood pressure, while AHI was not (OR: 1.00; CI
0.88–1.13; p = 0.535). This suggests that autonomic activations dur-
ing sleep may be one of the biomarkers of incident cariovascular
outcomes in OSA patients.
Disclosure: R. Heinzer is member of the medical advisor bords of
nightbalance and rythm companies.
52 | Plasma miRNAs as predictor of CPAP
response in resistant hypertension
M. Sánchez-de-la-Torre
IRB Lleida, CIBERES, Lleida, Spain
In patients with resistant hypertension (RH) and obstructive sleep
apnea (OSA), the blood pressure response to continuous positive air-
way pressure (CPAP) treatment is highly variable even when adher-
ent use of CPAP is documented, with some patients exhibiting major
reductions in blood pressure (>10 mm Hg) and others showing
either unchanged or even worsening of blood pressure levels. In fact,
25–30% of patients who use CPAP treatment for >4 hr/night do not
experience a positive effect on blood pressure. The underlying
causes of patient variability in response to continuous adherent use
of CPAP are unknown. No clinical or anthropometrical variable has
been identified to date that enables clinicians to identify those
patients who will respond favorably to CPAP treatment (i.e. reduced
blood pressure levels). It has been explored cardiovascular system‐
focused circulating miRNA expression in responders and nonrespon-
ders to CPAP treatment on blood pressure. So, a recent study
reported a singular cluster of circulating miRNAs that predicts blood
pressure responses to CPAP treatment in patients with resistant
hypertension and OSA. This specific expression profile gives a quan-
titative score parameter (the HIPARCO score), which identifies those
patients with resistant hypertension and OSA who will exhibit a
favorable blood pressure response to CPAP. This approach repre-
sents the first validated precision medicine tool for resistant hyper-
tension management in OSA patients. Interestingly, this study also
reported that effective use of CPAP treatment in patients who
respond to CPAP treatment by lowering their blood pressure is
accompanied by concurrent changes in cardiovascular system‐related
miRNAs that may potentially influence the risk for cardiovascular
disease among patients with OSA and resistant hypertension.
The features of OSA heterogeneity and their determinants have not
yet been characterized, and this issue constitutes one of the main
challenges for OSA management. Improved phenotyping of OSA
patients should improve prognosis prediction and guide therapeutic
strategies. Moreover, the application of technologies for the predic-
tion of the clinical response to CPAP treatment, is urgently needed.
Disclosure: Nothing to disclose.
53 | Breath analysis in OSA patients, new
biomarkers?
M. Kohler
Department of Pulmonology, University Hospital of Zurich, Zurich,
Switzerland
Introduction: Obstructive sleep apnoea (OSA) is a highly prevalent
disorder and is associated with metabolic changes. OSA is usually
diagnosed by overnight polysomnography which is time‐consuming
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and provides few information on the patient′s individual phenotype
thus limiting a personalised treatment approach. Exhaled breath con-
tains extensive information on metabolism that can be analysed by
diverse techniques including mass spectrometry.
Objectives: The objective of the presented studies was to identify
a breath profile in patients with OSA by the use of secondary‐elec-
trospray‐ionization‐mass spectrometry (SESI‐MS).
Aims: Breath profiles specific for OSA characterise an individual′s
metabolic response and make a comprehensible phenotyping of OSA
possible. This can be of use to diagnose OSA and monitor treatment
effects.
Methods: Daytime, real‐time exhaled breath analysis by untargeted
SESI‐MS was performed in patients with OSA.
Results: A panel of discriminating mass‐spectral features was found
and allowed differentiation between treated and untreated OSA.
Conclusions: Exhaled breath analysis by SESI‐MS allows rapid
and accurate detection of OSA. The technique makes it possible
to characterise an individual′s metabolic response to OSA and
thus has the potential to become a comprehensible tool for phe-
notyping.
Disclosure: Malcolm Kohler received advisory fees from Bayer.
TEMPORAL CONSTRAINTS ON SLEEP AND
COGNITION: IMPORTANCE FOR BRAIN
HEALTH DURING AGEING
54 | The translational potential of sleep and
circadian rhythm disturbances as a biomarker of
Alzheimer's disease
B.A. Kent1; M.M. Michalik2; M. Shafiee1; M.S. Mirian1;
H.H. Feldman3; J. Valerio1; M.J. McKeown1;
R.E. Mistlberger2; H.B. Nygaard1
1Division of Neurology, Department of Medicine, University of British
Columbia, Vancouver, 2Department of Psychology, Simon Fraser
University, Burnaby, BC, Canada, 3Department of Neurosciences,
University of California San Diego, La Jolla, CA, United States
Introduction: Sleep disturbances have long been known to be
associated with Alzheimer's disease (AD), and there is now growing
interest in how these disturbances might impact AD pathophysiol-
ogy. It is hypothesized that interventions modulating sleep may have
therapeutic potential in AD, but the precise sleep disturbances to
target are not well understood.
Objectives: To address this important gap in knowledge, we char-
acterized daily sleep‐wake rhythms and sleep architecture in 4 trans-
genic mouse models of AD and in patients diagnosed with AD.
Methods: In mice, we used continuous recording of locomotion
using infrared motion sensors to assess sleep‐wake rhythmicity and
cranial implants of EEG electrodes to evaluate sleep architecture. In
patients diagnosed with mild‐moderate AD, we used actigraphy to
assess sleep‐wake rhythmicity and a portable EEG headband to
assess sleep architecture in the home environment.
Results: The mouse models of AD exhibit spectral EEG shifts,
such that there is a reduction in the slow‐wave frequencies. Data
collection in the human patients is ongoing, but preliminary valida-
tion of the portable EEG headbands against polysomnography sug-
gests that high quality ambulatory assessment of deep sleep is
feasible.
Conclusions: Our findings in preclinical AD models are consistent
with EEG data from certain studies in patients with Mild Cognitive
Impairment, suggesting an evolution of EEG abnormalities across the
AD spectrum. Ongoing studies in human AD will attempt to validate
these preclinical findings, and determine to what extent EEG power
spectral signatures and sleep quality can be used for diagnostic pur-
poses and outcome measures in clinical trials.
Funding: The authors gratefully acknowledge grant funding from
MSFHR (B.A.K., H.B.N.), Killam Trusts (B.A.K.), CIHR Banting (B.A.K.),
AFTD (H.B.N.), and NSERC (R.E.M., M.M.).
Disclosure: Nothing to disclose.
55 | Brain molecular, histopathological and
structural measures linking sleep, circadian
rhythms, and dementia in community‐dwelling
older adults
A. Lim1,2
1Neurology, University of Toronto, 2Neurology, Sunnybrook Health
Sciences Centre, Toronto, ON, Canada
Work in model organisms suggests that sleep and circadian rhythm
disruption may be a contributor to and/or a consequence of Alz-
heimer's disease related brain pathophysiological processes. To
investigate this, we studied older community‐dwelling adults partic-
ipating in the Rush Memory and Aging Project. We quantified
sleep and diurnal rhythms by actigraphy, assessed cognition annu-
ally with a battery of neuropsychological tests, obtained brain MR
imaging, performed a structured autopsy in decedents, and
assessed the neocortical transcriptome and epigenome. We found
that sleep fragmentation is associated with the risk of incident
dementia, the rate of cognitive decline, local grey matter volumes,
several dementia‐related neuropathologies, and changes in the neo-
cortical transcriptome. We also found that normal diurnal and sea-
sonal rhythms in the neocortical transcriptome and epigenome are
disrupted in the context of Alzheimer′s disease pathology. These
data support the hypothesis that sleep and circadian disruption
may be a marker of or contributor to dementia‐related brain
changes in community‐dwelling older adults and invite further
investigations of sleep and circadian targeted interventions to delay
or prevent dementia.
Dr. Lim receives funding from the Canadian Institutes of Health
Research (MSH136642 and MOP336806), National Institute on
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Aging (R01AG052488 and R01AG051175), Ontario Ministry of
Research and Innovation (ER‐16‐12‐034), and Fondation Leducq.
Disclosure: Nothing to disclose.
56 | Age‐related changes in circadian sleep‐
wake regulation: impact on cognitive
performance and cerebral correlates
C. Schmidt1,2; C. Reichert3; M. Maire4; G. Gaggioni1;
M. Deantoni1; M. Reyt1; G. Vandewalle1; F. Collette1;
V. Muto1; G. Hammad1; C. Cajochen3
1GIGA‐CRC in Vivo Imaging, 2Psychology and Neurosciences of
Cognition, University of Liège, Liège, Belgium, 3Center for Chronobiology,
University of Basel, Basel, 4University of Bern, Bern, Switzerland
The ageing process is variably associated with cognitive decline.
Temporal organization of sleep‐wake states is fundamental to brain
function and prone to disruption by the ageing process. The two‐
process model of circadian and homeostatic sleep‐wake regulation
has not only been established as a powerful tool for the prediction
of sleep timing and structure, but also accounts for human sleepiness
and neurobehavioural performance modulation over day and night.
We will first show results providing further functional significance of
sleep‐wake regulation onto cognition and its underlying cerebral cor-
relates. In a next step, the impact of the ageing process on those
modulations will be discussed. There is evidence that performance
of older adults is less impaired by sleep deprivation compared to
young adults. We will present data indicating that such reduced age‐
related responsiveness to sleep loss and circadian phase are also
detectable at the cerebral level, both by probing task‐dependent
brain activity using functional magnetic resonance imaging and corti-
cal excitability using transcranial magnetic stimulation coupled to
high density electroencephalography. Finally, we will address more
specifically the putative role of the temporal framework of sleep‐
wake regulation on cognitive and brain fitness in the aged. First data
reveal large variability in circadian sleep‐wake modulation over the
24‐hr day. They further suggest that this variability is linked to cog-
nitive performance in the aged such that a more distinctive alloca-
tion of sleep to night‐time and wakefulness to daytime is indicative
for better working memory performance. In the same vain, prelimi-
nary results suggest an association between circadian integrity and
MRI‐derived brain volume and surface measures in healthy older par-
ticipants. Overall, the data suggest that both sleep fragmentation
during night‐time and wake fragmentation during daytime should be
taken into account when assessing a putative link between sleep
and cognition in the aged.
Disclosure: Nothing to disclose.
57 | Dynamic LED lighting: finding the right
light at the right time for severely demented
residents
K. Wulff
Oxford University, Oxford, United Kingdom
Light has potent effects on us beyond vision, light adjust our body
clock, stimulates attention and modulates our mood and mental
effort as confirmed in numerous laboratory studies. With the emer-
gence of light‐emitting diodes (LED) technology, the lighting industry
has devoted designs to adapt lighting to the benefit of people's
health. Such a tuneable lighting system has been installed in a
dementia care home at the Ceres Centre in Horsens, Denmark,
which is home for 16 individuals with severe dementia. Here every
room has been fitted with colour temperature adjusted lighting to
account for morning, daytime and evening exposure, which sets this
installation apart from communal room only fittings. In order to
assess the impact of the new dynamic lighting on the residents, indi-
viduals were studied for patterns of activity and rest, including sev-
eral sleep parameters derived from actigraphy, as well as for changes
in affective and behavioural abilities derived from observational rat-
ings of the staff. The presentation includes data collected at three
time points during the year over 3 weeks each: before installation in
spring (April), and again after installation in summer (July) and in win-
ter (November). The repeated measurement design has the potential
to estimate the variability and trends within each session to evaluate
the sustainability within and between sessions. Observational ratings
of staff showed an improved Quality of Life and ratings on hallucina-
tions and delusions were lower after changing the lighting. In terms
of number of naps during the day no significant change occurred.
No shifts towards timing of morning awakening, no worsening in
sleep fragmentation and no decrease in sleep efficiency was found.
The spread of habitual get‐up time became smaller and this was sus-
tained. Overall, high inter‐individual variability in time patterns
revealed small positive changes and improvements were seen in
observational ratings.
Disclosure: Nothing to disclose.
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ELECTROPHYSIOLOGY OF SLEEP
O058 | Sharpening the paradox of REM sleep:
cortical oscillations, synchronization and
topographical aspects during phasic and tonic
REM microstates
P. Simor1; G. van der Wijk2; F. Gombos3; I. Kovács3
1Department of Affective Psychology, Eötvös Loránd University,
2Cognitive Science Department, Budapest University of Technology and
Economics, 3Department of General Psychology, Pázmány Péter
Catholic University, Budapest, Hungary
Objectives/Instruction: Rapid Eye Movement (REM) sleep is
viewed as a homogeneous state characterized by high cortical
activity, low muscle tone, and the occurrence of eye movements.
REM sleep is composed of two markedly different neural states,
termed as phasic and tonic microstates. These states differ in
awakening thresholds, sensory processing, oscillatory activity, and
cortical synchronization. Previous findings indicate that the tonic
state is characterized by synchronized alpha and beta oscillatory
activity resembling resting wakefulness, whereas the phasic state
exhibits increased gamma power arising from more local networks.
These findings however, are based on low density EEG, therefore,
our aim was to explore phasic and tonic REM states using
high density EEG, and to examine the topographical aspects and
global synchronization of cortical oscillations during these micro-
states.
Methods: We analyzed the EEG data of healthy, young adults
(N = 18) that spent an undisturbed second night in our laboratory.
Segments of phasic and tonic REM were selected based on the pres-
ence or absence of eye movements, respectively. Independent Com-
ponent Analyses and surface Laplacian transformation were applied
to attenuate the confounding effects of artefacts, volume conduc-
tion, common reference, and microsaccades. We calculated the aver-
age spectral power and the global field synchronization within a
frequency range between 2 and 48 Hz for phasic and tonic REM
periods.
Results: Tonic periods were characterized by increased central
high‐alpha (p < 0.01) and frontocentral beta (p < 0.001) power,
whereas phasic periods showed globally increased gamma activity.
Interestingly, the phasic state was characterized by relatively higher
global synchronization in the delta (p < 0.001) and theta (p < 0.001)
ranges, while global beta synchronization was prominent (p < 0.001)
during the tonic state. Global synchronization in the gamma range
was not statistically different across phasic and tonic states.
Conclusions: Phasic and tonic REM states are different in terms of
oscillatory activity and cortical synchronization. Widespread and syn-
chronized activity in high alpha and fast frequency beta oscillations
during tonic REM might reflect the reinstated activity of frontopari-
etal attentional networks. Increased, but globally desynchronized
gamma oscillations might indicate sensorimotor activity,
superimposed on synchronized low frequency oscillations that mini-
mize external processing during phasic sates.
Disclosure: Nothing to disclose.
O059 | Bidirectional interactions between slow
waves and synaptic plasticity
M.C. Kahn1; A. Langfelder1; P. Antonoudiou1; Y. Huang1;
M. Lohse1; L. Upton1; V. Vyazovskiy1,2; E. Mann1,3
1Department of Physiology, Anatomy and Genetics, University of
Oxford, 2Nuffield Department of Clinical Neurosciences, University of
Oxford/Sleep & Circadian Neuroscience Institute, 3Oxford Ion Channel
Initiative, University of Oxford, Oxford, United Kingdom
Objectives/Introduction: Sleep has been proposed to serve a key
function in reducing the net strength of synaptic connections in the
brain, and thereby relieve sleep pressure. Sleep pressure is com-
monly quantified as slow wave activity (SWA), the signal power in
the range of 0.5–4 Hz. Importantly, SWA is enhanced in a local and
use‐dependent fashion and dissipates across the course of sleep.
While considerable evidence supports the occurrence of net synaptic
weakening during sleep, it is unknown whether this is necessary
and/or sufficient for the modulation of SWA. This is, in part, because
the mechanisms of synaptic weakening during sleep remain unclear.
We and others have recently shown that cortical slow oscillations
can induce synaptic weakening. Here, we explore whether slow
wave‐induced synaptic weakening is sufficient to induce local
changes in SWA.
Methods: We recorded the local field potential (LFP) and multi‐unit
activity (MUA) in the barrel cortex of anesthetised mice using an
eight by eight channel array. We quantified responses to whisker
deflections and assessed SWA in part of the interstimulus interval.
Following a forty‐minute baseline, we paired whisker deflections
with either the UP‐phase or DOWN‐phase of the cortical slow oscil-
lation, analogous to the plasticity protocol we used in our previous
work. Subsequently, we continued monitoring whisker‐evoked
responses for sixty minutes.
Results: Pairing whisker deflections with UP but not DOWN states
led to a lasting decrease in the whisker‐evoked response both in the
LFP and the MUA (p < 0.05 for time*group; mixed ANOVA, n = 6
per group). Concurrently with plasticity in the sensory response,
there was a significant decrease in slow wave activity (p < 0.05 for
time*group; mixed ANOVA, n = 6 per group). This decrease was not
equal across all channels but was local and dependent on the extent
of plasticity in a given channel.
Conclusions: We confirm that cortical UP states can facilitate
synaptic weakening in vivo and find that synaptic weakening can
locally reduce cortical slow wave activity in a dose‐dependent man-
ner. To our knowledge, this is the first experimental test of this
important prediction of the synaptic homeostasis hypothesis of
sleep.
Disclosure: Nothing to disclose.
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O060 | Orexin‐independent decreases in sleep
propensity mark the onset of spontaneous
torpor bouts in calorically‐restricted mice
G. Zoccoli1; S. Alvente1; R. Amici1; S. Bastianini1;
C. Berteotti1; M. Cerri1; V. Lo Martire1; A. Silvani1;
S. Swoap2; A. Valli1
1Department of Biomedical and Neuromotor Sciences, University of
Bologna, Bologna, Italy, 2Bronfman Science Center, Williams College,
Williamstown, MA, United States
Objectives/Introduction: In conditions of reduced food intake
and ambient temperature, mice enter into torpor, a state of beha-
vioural quiescence and controlled body temperature reduction. Sleep
also entails quiescence and temperature reduction. Orexin neuropep-
tides control sleep, body temperature, and food intake. However, it
is still unclear whether orexins mediate the relationship between tor-
por and sleep in mice. Here, we investigated whether
i) sleep alterations mark the onset of torpor in mice
ii) these alterations are orexin-dependent.
Methods: female orexin knock‐out mice (n = 6) and congenic wild‐
type controls (C57Bl6/J, n = 5) were implanted with a thermistor to
measure brain cortical temperature, a telemetric transducer
(TA11PA‐C10, DSI) to measure arterial pressure, and electrodes to
record the electroencephalogram (EEG) and the neck muscle elec-
tromyogram (EMG). After recovery, signals were recorded together
with oxygen consumption rate (VO2, indirect calorimetry) in freely‐
behaving mice calorically‐restricted and exposed to a 20°C ambient
temperature. Sleep was scored manually on 4‐s epochs based on
EEG and EMG signals. Slow‐wave activity (SWA) in non‐rapid‐eye‐
movement (non‐REM) sleep was computed based on EEG spectral
power at 0.5–4 Hz. Torpor onset was defined as the 20‐min window
centred on the start of a monotonic decrease in brain temperature
>5°C. Baseline values were computed as averages over a 20‐min
window ending 30 min before torpor onset. Torpor onset was com-
pared with baseline in orexin knock‐out and wild‐type mice employ-
ing analysis of variance (ANOVA) with significance at p < 0.05.
Results: compared with baseline, torpor onset entailed more time
in wakefulness, higher EMG tone and VO2, less time in non‐REM
and REM sleep, and lower SWA in non‐REM sleep (p < 0.05 for all).
None of these effects showed a significant interaction with orexin
deficiency (p > 0.16).
Conclusions: Data suggest that an orexin‐independent decrease in
sleep propensity marks the onset of spontaneous torpor bouts in
mice. The resulting increase in VO2 may play a role in triggering tor-
por. Better knowledge of mouse torpor may help in developing syn-
thetic torpor‐like states to address problems of targeted temperature
management and long‐term space flight in humans.
Disclosure: Nothing to disclose.
O061 | Electrophysiological correlates of sleep
and wakefulness in Aplysia californica
A. Vorster1,2; N. Niethardt3; H. Chiel4; J. Born3,5
1Med. Psychology and Behav. Neurobiol, University of Tübingen,
2International Max Planck Research School (IMPRS) at the University of
Tübingen, Graduate Training Centre of Neuroscience (GTC), 3Med.
Psychology and Behavioral Neurobiology, University of Tübingen,
Tübingen, Germany, 4Department of Biology, Case Western Reserve
University, Cleveland, OH, United States, 5Center for Integrative
Neuroscience CIN, University of Tübingen, Tübingen, Germany
Objectives/Introduction: Sleep in invertebrates resembles mam-
malian sleep as it is characterized by a heightened arousal threshold
and a homeostatic sleep rebound after sleep deprivation. A long
standing question is whether electrophysiological signatures of sleep
and wakefulness can be found in invertebrates and whether these
signatures relate to those seen in mammals. Characterizing neuronal
activity during sleep in invertebrates might thus help to elucidate the
mechanisms of sleep and also shed light into putative functions of
sleep, like the processing and consolidation of memory during sleep.
Here we studied the mollusk Aplysia that served as a pioneer model
for invertebrate electrophysiology equipped with only 20.000 neu-
rons, distributed in five pairs of ganglia. This allowed us to record
the crosstalk between these neuronal nodes during wakefulness and
sleep.
Methods: Aplysia californica (N = 10) were used for in vivo elec-
trophysiological recording for up to 72 hr. We implanted up to six
pairs of differential electrodes and recorded from the following gan-
glia connectives: Cerebro‐Buccal Connective, Cerebro‐Pedal Connec-
tive, Cerebro‐Pleural Connective and Pleural‐Abdominal Connective.
Results: Our analysis focused on the oscillatory nature of neuronal
activity that is typically used to discriminate sleep and wake states
in the mammalian brain.During sleep episodes we detected an oscil-
lation in neuronal activity in the range of 0.2–0.5 Hz.
Conclusions: We found electrophysiological correlates of sleep
and wake states in the invertebrate Aplysia californica that may help
to elucidate the evolutionary basis of sleep.
Disclosure: Nothing to disclose.
O062 | Intranasal leptin treats sleep disordered
breathing in obese mice
V.Y. Polotsky; S. Berger; H. Pho; T. Fleury Curado;
A. Schwartz
Johns Hopkins University School of Medicine, Baltimore, MD, United
States
Objectives/Instruction: Sleep‐Disordered Breathing (SDB) is char-
acterized by recurrent upper airway obstruction and/or hypoventila-
tion during sleep. Leptin acts in the brain to regulate energy balance
and stimulate breathing. Obesity in humans and mice is associated
with leptin resistance, due to limited blood‐brain barrier (BBB)
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permeability. We hypothesized that intranasal (IN) leptin will over-
come leptin resistance in mice with diet‐induced obesity (DIO) at the
BBB level and treat SDB acting at specific central nervous system
sites.
Methods: Male C57BL/6J DIO mice, 26 weeks of age, 45.5 ± 0.9 g
of weight, were treated with a single dose of IN (n = 9) or intraperi-
toneal (IP, n = 8) leptin at 0.4 mg/kg in 1% bovine serum albumin
(BSA) versus vehicle (BSA only) followed by polysomnography using
barometric plethysmography. Upper airway obstruction was detected
based on inspiratory flow limitation (IFL) defined as a plateau in mid‐
inspiratory flow. Minute ventilation (VE) was normalized per body
weight. Effective delivery of leptin to the brain was confirmed by
immunofluorescence of phosphorylated STAT3 (pSTAT3), a transcrip-
tion factor activated by leptin signalling.
Results: Leptin administered by both routes did not affect the per-
centage of IFL, which was detected in 11.1 ± 2.8% of breaths in
NREM sleep and 32.0 ± 3.3% of breaths in REM sleep. IN leptin
increased VE in non‐REM sleep (from 0.74 ± 0.08 ml/g/min to
0.91 ± 0.10 ml/g/min, p < 0.01) and in REM sleep (from 0.69 ± 0.07
to 1.0 ± 0.09 ml/g/min, respectively, p < 0.01). In contrast, IP leptin
had no effect on breathing. IN leptin did not raise plasma leptin,
whereas IP leptin increased plasma leptin from 48.7 ± 8.5 ng/ml to a
peak of 374 ± 53 ng/ml (p < 0.01) 1 hr after treatment. IN leptin
activated the pSTAT3 in the hypothalamus and respiratory nuclei of
medulla, including the nucleus of the solitary tract and the ventral
respiratory group. pSTAT3 was not observed after vehicle treatment
or after IP leptin administration.
Conclusions: Similar to humans, DIO in mice is associated with
SDB. Leptin did not affect upper airway obstruction. IP leptin did
not affect breathing, despite high plasma concentrations. IN leptin
bypassed the BBB and acted as a potent respiratory stimulant.
Disclosure: Nothing to disclose.
SLEEP PROBLEMS IN EARLY CHILDHOOD –
PERSPECTIVES INTO EPIDEMIOLOGY AND
TREATMENT
63 | Disturbed sleep during early infancy:
findings from the CHILD‐SLEEP cohort
E.J. Paavonen1,2; I. Morales-Munoz1; A. Kylliäinen3;
P. Pölkki4; T. Porkka-Heiskanen5; T. Paunio5; O. Saarenpää-
Heikkilä3
1National Institute of Health and Welfare, 2University of Helsinki and
Helsinki University Central Hospital, Helsinki, 3University of Tampere,
Tampere, 4University of Eastern Finland, Kuopio, 5University of Helsinki,
Helsinki, Finland
Objective: Sleeping problems are reported to be common in early
childhood, but only a few longitudinal studies describe the develop-
ment of sleep quality in early childhood. In this study, we studied
the prevalence of infant sleeping problems as reported by the par-
ents.
Methods: Altogether 1667 families from Pirkanmaa Hospital Dis-
trict, Finland, participated in the CHILD‐SLEEP birth cohort study.
The data collection started during pregnancy approximately at 32nd
week and infant sleep quality was measured at the ages of three,
eight, 18 and 24 months. We studied sleep quality and quantity as
well as development of circadian rhythm. In addition, we aimed to
recognize some environmental factors related to persistence of
sleeping difficulties in early childhood (e.g. gender, family structure).
Results: Average sleep duration was 14.1 hr (Standard deviation,
SD 2.1) at the age of 3 months, 13.3 hr (SD 1.0) at 8 months,
12.3 hr (SD 0.9) at 18 months and 11.9 hr (SD 0.9) at 24 months.
Proportion of daytime sleep decreased from 34.6% (SD 4.3) at the
age of 3 months to 25.7% (SD 5.0) at 8 months, 16.9% (SD 3.0) at
18 months and 15.7% (SD 3.2) at 24 months. At these four mea-
surement points, prolonged sleep onset latency (≥30 min) was
reported in 24.9%, 9.7%, 9.9% and 18.3% of the infants while fre-
quent night wakings (≥3) decreased clearly during the follow up (the
prevalence being 18.4%, 14.1%, 10.0% and 5.3% at 3, 8, 18 and
24 months, respectively). Approximately 20% of infants had persis-
tent difficulties in self‐soothing. Overall, mild, moderate or severe
sleeping problems were reported by 22.5%, 39.8%, 24.8% and
21.9% of the parents. We also evaluated gender differences and fac-
tors related to persistence of sleeping difficulties.
Conclusion: Infant sleep quality is highly variable in early childhood
and many sleeping difficulties are highly prevalent and persistent in
early childhood. Many of them may warrant treatment in clinical set-
tings.
Disclosure: Nothing to disclose.
64 | Developmental trajectories of sleep
problems in toddlers and later emotional and
behavioral problems
B. Sivertsen1,2,3; A.G. Harvey4; T. Reichborn-Kjennerud5;
E. Ystrom5; M. Hysing6
1Division of Mental and Physical Health, Norwegian Institute of Public
Health, Bergen, 2Department of Mental Health, Norwegian University of
Science and Technology, Trondheim, 3Department of Research and
Innovation, Helse‐Fonna HF, Haugesund, Norway, 4Department of
Psychology, University of California, Berkeley, CA, United States,
5Division of Mental and Physical Health, Norwegian Institute of Public
Health, Oslo, 6Department of Psychosocial Science, University of
Bergen, Bergen, Norway
Introduction: Sleep and depression are interlinked throughout the
lifespan, nut very few studies have examined the directionality of
the sleep‐depression link in children.
Objective and aim: To examine the bidirectional association
between sleep problems and internalizing problems/depressive symp-
toms in toddlers and children aged 1.5 and 8 years.
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Methods: A large population‐based longitudinal study was con-
ducted in January 2018 using data from the Norwegian Mother and
Child Cohort Study conducted at the Norwegian Institute of Public
Health from October 1999 to July 2009. A total of 28,725 children
were included. Sleep duration, nocturnal awakenings, and internaliz-
ing problems (1.5 years) was provided by the mothers. Internalizing
problems were measured with items from the Child Behavior Check-
list and operationalized according to recommended clinical cutoffs,
corresponding to T scores of greater than 65 (93rd percentile). Infor-
mation on sleep duration and depressive symptoms at 8 years was
provided by the mothers. Symptoms of depression were assessed
using the short version of the Mood and Feelings Questionnaire
(SMFQ). Risk ratios (RRs) were calculated using negative binomial
regression.
Results: After accounting for previous internalizing problems, short
sleep duration (≤10 hr) and frequent (≥3) nightly awakenings at
1.5 years predicted the development of depressive symptoms at
8 years of age (RR = 1.41; 95% confidence interval [CI] 1.15–1.72,
and RR = 1.36; 95% CI 1.15–1.62, respectively). Also, internalizing
problems at 1.5 years predicted onset of later short sleep duration
(RR = 1.72, 95% CI 1.13–2.59) after accounting for early sleep prob-
lems.
Conclusions: This study demonstrated a bidirectional association
between sleep and depressive symptoms from toddlerhood to later
in childhood. Intervention studies are needed to examine whether
targeting either of these problems at this early age may prevent
onset of the other.
Disclosure: Nothing to disclose.
65 | Clinically oriented subtyping of chronic
insomnia of childhood
O. Bruni1; S. Sette1; M. Angriman2; E. Baumgartner1;
L. Selvaggini1; C. Belli1; R. Ferri3
1Department Developmental and Social Psychology, Sapienza Università
di Roma, Rome, 2Department of Pediatrics, Child Neurology and
Neurorehabilitation Unit, Hospital of Bolzano, Bolzano, 3Sleep Research
Centre, Department of Neurology I.C, Oasi Institute, Troina, Italy
Introduction: Subtypes of insomnia have been proposed in the
major classification systems; however, the reliability and validity of
the different nosological entities included was so poor that they did
not improve diagnostic accuracy suggesting that alternate diagnostic
paradigms for insomnia classification should be considered.
Objectives and aims: Our aim was to identify different figures of
chronic insomnia of childhood, based on the common descriptors
used by parents and on the clinical pictures (nocturnal awakenings,
difficulty in falling asleep, nocturnal restlessness, early morning
awakenings).
Methods: A structured parent interview was conducted in 338
children (mean age 21.29, SD 10.56) referred by pediatricians
because of insomnia resistant to behavioral approaches and common
drug treatments. A latent class analysis (LCA) was run to identify
profiles of insomnia. We then associated the profiles derived from
the LCA to the history of the child and to the family sleep‐related
history. Analysis of variance and the chi‐square test were used to
examine differences between profiles.
Results: A three‐class model was built by LCA: 17% (n = 58) of
children constituted the first class characterized by difficulties in fall-
ing asleep with restlessness, nocturnal restlessness, and awakenings
during the night; the second class, characterized by early morning
awakenings comprised 21% (n = 71) of children; 62% (n = 209) of
children fell within the third class because of their high frequency of
nocturnal awakenings and difficulties in falling asleep. The first class
reported longer sleep latency and the presence of restless legs syn-
drome and anemia in the family history; depression and/or mood dis-
orders were more frequent in class 2 and allergies and/or food
intolerance were more frequent in class 3.
Conclusions: In this study, we identified three different pheno-
types based on the common presentations of insomnia in children,
based on clinical, personal, and familiar data. These different pheno-
types might underlie different pathophysiological mechanisms and
might help optimizing the assessment and treatment of insomnia in
young children.
Disclosure: Nothing to disclose.
66 | What have we learnt in the last 5 years of
pharmacological treatments for children with
sleep problem?
P. Gringras
Paediatric Sleep, Evelina Children's Hospital, Kings College University,
Kings College London, London, United Kingdom
Even after well conducted sleep behavioural interventions a percent-
age of children will still have significant sleep onset and maintenance
problems. This is particularly relevant to children with neurodevelop-
mental disorders such as autism. Professor Gringras leads the Sleep
Medicine Department at the Evelina London Children's Hospital and
over the last 5 years has led large randomised‐controlled trials of
pharmacological and non‐pharmacological interventions for children
with neurodevelopmental disorders and sleep problems. He is deter-
mined that we think more about core objective and subjective out-
come data sets, based on consensus between both professionals
parents and their children. He published the MENDS immediate
release melatonin study in 2012 and in 2017 a paper on a novel
Paediatric Prolonged‐Release Melatonin with important new out-
comes and a longer follow‐up period than any previous study.
Although the evidence is greatest around melatonin there are other
medications that deserve more careful evaluation with more ran-
domised controlled studies and this presentation will touch on future
opportunities.
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Disclosure: I received funding from Neurim for my time as CI
on the Neurim PR melatonin study. I do not have shares or any
other COI
KEYNOTE LECTURE – CHARALAMBOS P.
KYRIACOU
67 | Molecular analysis of biological clocks:
beyond circadian rhythms
C. Kyriacou
Genetics & Genome Biology, University of Leicester, Leicester, United
Kingdom
The molecular analysis of circadian rhythms has provided a mile-
stone for how genes can determine complex behavioural pheno-
types, underscored by the award of the 2017 Nobel Prize for
Medicine or Physiology to Jeffrey Hall, Michael Rosbash and Mike
Young for their pioneering work on the Drosophila clock. I shall
outline a brief history of the major developments that led to this
remarkable achievement and embroider the margins of the fly story
with some recent findings from my own laboratory. I will then
extend the discussion to the role of the circadian clock and the
canonical clock genes in the determination of other timing‐related
phenomena.
Disclosure: Nothing to disclose.
SLEEP AND COGNITION
O068 | Selective tracking of relevant speech
during human sleep
T. Andrillon1,2; L. Guillaume2,3; M. Koroma2; S. Kouider2
1Monash University, Melbourne, VIC, Australia, 2Department of
Cognitive Studies, Ecole Normale Supérieure, Paris, France,
3Neuroscience Center, University of Geneva, Geneva, Switzerland
Objectives/Introduction: Falling asleep leads to a disconnection
that renders organisms vulnerable. Yet, despite the absence of beha-
vioural responses, the brain remains sensitive to external stimuli.
Here, we hypothesised that sleepers enter a ‘standby mode’ in
which they continue to track relevant signals, allowing them to
awake when necessary.
Methods: We used scalp electroencephalography in 24 healthy
participants to reconstruct competing auditory streams in a multi‐
talker environment. Participants were exposed to concomitant audi-
tory streams (one in each ear) during wakefulness and daytime naps
(Non‐Rapid Eye‐Movement sleep). Auditory streams were made of
either real speech or meaningless pseudo‐speech. The
pseudo‐speech was identical to the real speech in terms of basic
sensory properties (same phonemes and prosody as real speech) but
was deprived on any meaning as it was composed of made‐up
words.
Results: Real‐speech was better reconstructed, from brain activity,
than its pseudo‐speech counterpart in 60% of trials in wakefulness
(signed rank test against chance level = 50%; p = 1.02.10−4) and
52% of trials in NREM sleep (stage 2 and 3; p = 2.84.10−2). Since
real and pseudo‐speech share common phonological properties and
differ only by the presence or absence of meaning, we demonstrate
here that the sleeping brain amplifies meaningful speech compared
to irrelevant signals. However, although sensory encoding remained
constant, attention allocation was transient. It was stronger during
light sleep (stage 2: real‐speech>pseudo‐speech in 56% of trials) and
vanished during deep sleep (stage 3). The impact of sleep depth
reflected the promotion of attention by K‐complexes in light‐sleep
and the active suppression of relevant signals by slow‐waves in
deep‐sleep. Sleep spindles marginally modulated both stimulus
encoding and attentional amplification, putting their role in sensory
decoupling into question.
Conclusions: Thus, attentional mechanisms continue to operate
during sleep, but are strongly modulated by sleep depth and specific
brain rhythms. Our work highlights the role of sleep′s micro‐struc-
ture in the filtering and processing of external stimuli during sleep.
Disclosure: Nothing to disclose.
O069 | Maintaining vigilance with limited sleep
opportunity: is it better to consolidate or split
sleep?
J. Lo; X.K. Lee; E. van Rijn; J.L. Ong; J. Gooley; M. Chee
Centre for Cognitive Neuroscience, Duke‐NUS Medical School, Outram,
Singapore
Objectives/Instruction: Adolescents are often faced with situa-
tions where they curtail their sleep across multiple school nights.
Here, we examined whether among adolescents exposed to chronic
sleep restriction, sustained attention was less impaired when sleep
was scheduled during one consolidated session, as compared with a
split sleep schedule with a shorter night time segment and a mid‐
afternoon nap.
Methods: Participants (age: 15–19 years) underwent two cycles of
sleep restriction (TIB = 6.5 hr per 24‐hr period) and recovery (TIB =
9 hr) that simulated sleep opportunities over two school weeks.
During the sleep restriction periods, participants had either a 6.5‐hr
TIB at night (consolidated sleep group: n = 29), or a 5‐hr nocturnal
TIB plus a 1.5‐hr afternoon nap opportunity (split sleep group:
n = 29). Sustained attention was assessed by the number of lapses
in the Psychomotor Vigilance Task (PVT).
Results: During the first cycle of sleep restriction, the split sleep
group had fewer PVT lapses than the consolidated sleep group in
the morning (6 hr before naps; p < 0.003), afternoon (1 hr after
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naps; p < 0.02), and evening (4.75 hr after naps; p < 0.04). Conso-
nant with our previous work, vigilance decline was greater in the
second cycle of sleep restriction for both groups (p < 0.03), revealing
carry‐over effects from the previous week of sleep loss. The group
difference in vigilance performance favouring the split sleep group
was accentuated in the second week for PVTs taken after nap
opportunities (p < 0.001).
Conclusions: In adolescents with total sleep opportunity limited to
6.5 hr per 24 hr, sustained attention was better maintained with a
split sleep schedule relative to a consolidated nocturnal sleep sched-
ule. These findings raise the possibility that a split sleep schedule
may serve to minimize cumulative negative effects of recurrent sleep
restriction. It should be emphasized, however, that vigilance in the
split sleep group was worse compared with adolescents given 9 hr
of TIB in our prior studies, indicating that the split sleep schedule
did not adequately replace healthy nocturnal sleep.
Disclosure: This work was supported by the National Medical
Research Council, Singapore (NMRC/STaR/0004/2008 and NMRC/
STaR/015/2013), the National Research Foundation, Singapore
(NRF2016_SOL002), and the Far East Organization.
O070 | Effect of total sleep deprivation on the
recall of active avoidance response in rats
T. Oniani; T. Shetekauri; M. Tsaava; N. Khmiadashvili;
T. Charekishvili; N. Oniani
Tengiz Oniani Laboratory of Sleep‐Wakefulness Cycle Studies, Ilia State
University, Tbilisi, Georgia
Objectives/Introduction: Kamin's classical experiments, showed
that 1 hr retention interval between learning and relearning sessions
impairs two‐way active avoidance response recall (Kamin effect). Our
objective was to examine the effect of total sleep deprivation (TSD)
on Kamin effect and its influence on memory recall of incompletely
learned active avoidance task.
Methods: 80 inbred albino adult laboratory rats, both male and
female, were randomly divided into 3 experimental groups. Learning
task was 25 trials of standard active avoidance procedure, with CS‐
US interval of 5 s and time interval between trials with 1 min. All
groups were given learning and two relearning sessions of active
avoidance procedure. To measure learning level we counted the
mean number of correct responses in each active avoidance session.
In control group (n = 55) the retention interval between sessions
was 0 hr. In first (n = 12) and second (n = 13) exp. groups the reten-
tion intervals between sessions were 1 hr, during which rats were
placed back in their home cages. First exp. group during retention
intervals stayed in home cages without any experimental manipula-
tions while second exp. group underwent TSD, using gentle handling
method.
Results: Control group's first and second relearning session values
(18.2 ± 0.8 and 20.4 ± 0.7) was significantly higher than learning
session value (8.9 ± 0.6; p < 0.001). During 1 hr retention intervals,
animals of the first exp. group slept 20.8 ± 6.9 min and
26.1 ± 6.7 min, with sleep onset latency of 35.5 ± 6.2 min and
30.2 ± 6.7 min, respectively. First and second relearning session val-
ues (13.2 ± 1.0 and 14.2 ± 1.6), of this exp. group, was less than
control group's corresponding session values (p < 0.03 and
p < 0.001). When during 1 hr retention interval, animals underwent
1 hr TSD (second exp. group), first and second relearning session
values (18.2 ± 0.9 and 21.8 ± 0.7) did not differ from control group's
corresponding session values (p < 0.9 and p < 0.4).
Conclusions: Our data indicate that keeping animals in the waking
state during retention intervals interferes with the development of
Kamin effect and promotes the memory consolidation of active
avoidance, while sleep bouts result in the Kamin effect manifestation
and impairment of memory recall in relearning sessions.
Disclosure: Nothing to disclose.
O071 | The sleeping brain not only monitors
the environment, but also detects relevant
information
M. Wislowska1,2; C. Blume1,2; A. Michalak1; N. Weisz1,2;
M. Schabus1,2
1University of Salzburg, 2Center for Cognitive Neuroscience (CCNS),
Salzburg, Austria
Objectives/Introduction: During sleep our consciousness fades
away, we become behaviorally unresponsive, and oscillatory activity
of our brain changes entirely. The sleeping brain engages into
“housekeeping” activities, like memory reorganization or removal of
neurotoxic waste. Nevertheless recent research suggests that also
during sleep the brain can process incoming stimuli, especially that
of a potential relevance. “Cocktail party” phenomenon and studies
with unaware participants showed that subject's own name (SON)
has a very strong bottom‐up drive, even during states of reduced
consciousness, making it a good candidate for stimulus that could be
processed during sleep. Therefore in the current study we investi-
gated brain responses induced by names during different sleep
stages.
Methods: Twenty‐one young (mean age = 25 ± 2 years), healthy,
and partially sleep‐deprived subjects listened to auditory stimuli,
while their brain activity was simultaneously recorded with EEG and
MEG. After 20 min of wakefulness, participants were given an
opportunity to sleep for 2 hr. During that time all of the subjects
reached N1, 19 subjects reached N2, and 10 subjects reached SWS.
Over the entire course of the experiment participants were pre-
sented with a stream of auditory stimuli that consisted of SON and
other unfamiliar names, which were additionally spoken either by a
close relative/friend or by a stranger. The event‐related brain
responses were analyzed by means of oscillatory power of magnetic
fields. Statistical testing was done on clusters of brain activity
ABSTRACTS | 33 of 433
(adjacent in space‐time‐frequency), with cluster‐based permutation
statistics as implemented in FieldTrip software.
Results: During wakefulness, brain responses significantly differed
depending on which type of voice (p = 0.11) and which type of
name (p < 0.001) was presented. Interestingly, after falling asleep,
SON kept inducing stronger oscillatory response than unfamiliar
names, over a similar topography and frequency band as during
wakefulness (N1: p < 001; N2: p = 0.002). During SWS however, it
was the unfamiliar name that induced a stronger oscillatory brain
response than SON (p = 0.016).
Conclusions: The sleeping brain not only continuous to monitor
the environment, but also discerns relevant information. Even though
a complete “shielding” of the environment during sleep seems bene-
ficial, the brain's preserved capacity for processing external stimuli
could have potential relevance for health and even survival.
Disclosure: Nothing to disclose.
O072 | Neural correlates of human cognitive
abilities during sleep: an EEG‐fMRI study
Z. Fang1,2; L. Ray2,3; A.M. Owen2; S. Fogel2,3,4
1University of Ottawa Brain & Mind Research Institute, Ottawa, 2Brain
& Mind Institute, Western University, London, 3The Royal's Institute for
Mental Health Research, 4School of Psychology, University of Ottawa,
Ottawa, ON, Canada
Objectives/Introduction: Spindles are one of the only known
electrophysiological oscillations identified as a biological marker of
cognitive abilities typically assessed by intelligence tests. Spindles
are highly correlated to trait‐like “Reasoning”, but not “Verbal” abili-
ties. Simultaneous electroencephalography and functional magnetic
resonance imaging (EEG‐fMRI) have revealed brain activations which
occur during spindles, including thalami, paralimbic, striatal and
motor cortical areas. Interestingly, these regions are known to sup-
port Reasoning abilities. However, the neural correlates of the rela-
tionship between spindles and cognitive abilities are unknown. EEG‐
fMRI was employs to identify, for the first time, the neural activation
patterns time‐locked to spindles that are related to cognitive abili-
ties. This will provide insight into the neural basis of the functional
significance of spindles.
Methods: A total of 29 healthy adults (17 females; age = 24 ± 3.9)
completed the Cambridge Brain Sciences (CBS) Trials online prior to
the experimental session (21 h00–23 h00) where simultaneous EEG‐
fMRI was recorded while subjects slept in the MRI scanner. CBS Tri-
als yields:
(1) a Reasoning subscale (i.e., “fluid intelligence”),
(2) a Verbal subscale (i.e., “crystalized intelligence”), and
(3) a Short Term Memory subscale (STM).
Results:
(1) Similar to previous studies, spindles detected at Cz (11–
16 Hz) in non-rapid eye movement sleep were related to
Reasoning (p = 0.03) but not Verbal (p = 0.70) or STM
(p = 0.53) abilities, and
(2) activations time-locked to spindles were observed in the tha-
lamus, bilateral striatum, middle cingulate cortex, and cerebel-
lum (p < 0.05, FWE).
(3) Importantly, Reasoning abilities were correlated with spindle-
related activation in a subset of these regions including the
thalamus, bilateral striatum, medial frontal gyrus, middle cin-
gulate cortex, and precuneus (p < 0.05, FWE). Importantly,
No spindle-related activations were correlated to Verbal abili-
ties or STM.
Conclusions: Our results show for the first time, that brain areas
activated time‐locked to spindles, and were related to interindivid-
ual differences in Reasoning but not Verbal, or STM. These results
may help elucidate the physiological mechanisms which support
the function of sleep for the capacity for reasoning. This may ulti-
mately help to understand the significance sleep to a variety of
normal and abnormal cognitive functioning in healthy individuals
and in neurological conditions where spindle activity is abnormal
or deficient.
Disclosure: Nothing to disclose.
O073 | Effect of interictal epileptic spikes on
sleep spindles in medial temporal regions during
NREM sleep: are there consequences on
memory long‐term consolidation? A SEEG study
I. Lambert1; E. Tramoni-Negre2; N. Roehri2; S. Lagarde2;
B. Giusiano2; O. Felician2; C. Benar2; F. Bartolomei2
1Sleep Unit, Clinical Neurophysiology, 2Aix Marseille University, Timone
Hospital, Marseille, France
Objectives/Instruction: The hippocampal‐neocortical transfer of
memories is supposed to occur during non‐REM (NREM) sleep
(Rasch and Born, 2013). Specific brain oscillations or activities, such
as sleep spindles, ripples or slow waves, probably play a key role in
this process.
Some epileptic patients ‐generally with a medial temporal lobe epi-
lepsy‐ suffer from a specific impairment of long‐term memory con-
solidation, called accelerated long‐term forgetting (ALF). In this
impairment, patients perform normally to memory tests with stan-
dard delay of recall or recognition (30 min) but forget more than
controls when tested with one to few weeks delay.
As epileptic activities are activated during NREM sleep, we aimed to
study the effect of epileptic activities on physiological sleep activities
in the hippocampus, such as sleep spindles, and the consequences
on long‐term memory consolidation with intracranial EEG recordings.
Methods: We prospectively studied patients with drug‐resistant
focal epilepsy hospitalized for a presurgical investigation with stereo-
electroencephalography (SEEG), with at least one electrode localized
in hippocampus.
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Each patient had memory tests 48–72 hr after electrodes implanta-
tion, with immediate and delayed (30 min) recall and recognition,
and a second test 1 week later to test specifically long‐term consoli-
dation processes.
We studied spike frequency and spindle frequency on contacts local-
ized in hippocampus during the first cycle of NREM sleep of the
night following the first tests.
Results: We included 13 patients and 13 matched‐controls. We
studied spike frequency and spindle frequency during NREM sleep in
20 hippocampi. There was a non‐linear negative correlation between
spike frequency and spindle frequency (−0.49, p < 0.05). We found
an accelerated long‐term forgetting in our group of patients com-
pared to controls: there was no significant difference between
patients and controls at immediate recall and 30 min‐delay recall, but
there was a significant impairment at 1 week‐delay (p < 0.05). We
found significant a negative correlation between spike frequency
during sleep and test at 1 week, and between the number of sei-
zures and performance at 1 week.
Conclusions: These results suggest that spike and spindle fre-
quency in hippocampus during NREM sleep play a role in long‐term
memory consolidation.
Disclosure: Nothing to disclose.
O074 | Bad sleepers’ night sleep quality
improves after pre‐sleep cognitive training
M. Cerasuolo1; F. Conte1; F. Borriello1; I. Di Iorio2;
G. Fusco1; S. Malloggi2; F. Giganti2; G. Ficca1
1Department of Psychology, University of Campania, Caserta,
2NEUROFARBA, University of Florence, Florence, Italy
Objectives/Introduction: Recently, we have reported that a com-
plex ecological learning task (requiring the simultaneous activation of
several cognitive functions), intensively administered at bedtime,
improves daytime sleep continuity and stability, possibly as a result
of ongoing memory processes1. Here, our aim is to extend these
results to night time sleep in a sample of young adults with subjec-
tive sleep complaints.
Methods: The sleep of 18 subjects (27.9 ± 8.0 years), identified as
bad sleepers (PSQI global score ≤5) was recorded in three experi-
mental conditions: (1) baseline undisturbed sleep (BL); (2) post “ac-
tive‐control” sleep (AC), i.e. a sleep episode preceded by a non‐
learning control task, (tablet‐based, similar to the Psychomotor Vigi-
lance Task); (3) post “training” sleep (TR), preceded by a complex
learning task, i.e. a modified version of the word‐game Ruzzle, in
which subjects have 1.5 min to form (by touching an iPad screen) as
many words as possible with the 16 letters available on a 4 × 4 grid.
At morning awakening from TR, subjects were retested at the cogni-
tive task.
Results: Post‐training sleep showed significantly decreased fre-
quencies of arousals (F = 3.54, p = 0.04; BL>TR), state transitions
(F = 5.05, p = 0.01; BL>TR and AC) and functional uncertainty
(FU) periods (F = 6.24, p = 0.005; BL>TR and AC) as well as sig-
nificantly less time spent in FU periods (F = 5.22, p = 0.01; BL>TR
and AC). Awakening frequency was also reduced in TR relative to
BL (total awakenings: F = 3.1; p = 0.05; BL>TR; short awakenings:
F = 3.63, p = 0.04; BL>TR and AC). Finally, TR showed an
increase in the number and mean duration of NREM‐REM cycles
(respectively F = 9.25, p = 0.001; TR>BL and AC; F = 5.99,
p = 0.006; TR>BL and AC), and longer time spent in cycles
(F = 9.84, p < 0.001; TR>BL and AC). In TR, retest score at awak-
ening was significantly higher than pre‐sleep score (t = 5.048,
p < 0.001).
Conclusions: In our sample of bad sleepers, night sleep in TR was
notably more continuous, stable and organized than baseline sleep,
confirming previous results obtained on a daytime nap1.
These findings challenge the assumption that pre‐sleep cognitive
activity impairs sleep quality and suggest to further explore cognitive
training as a strategy to improve sleep in sleep‐disordered individu-
als.
References: 1. Arzilli C. et al. Behav Sleep Med (2018) 25:1–9.
Disclosure: Nothing to disclose.
REM SLEEP FRAGMENTATION AND
EMOTIONAL DYSREGULATION: EVIDENCE
FOR A NEW MECHANISM LINKING SLEEP
AND AFFECT?
75 | Restless REM sleep impedes overnight
emotional resolution in insomnia
R. Wassing1; O. Kamal1; J. Ramautar1; D. Stoffers2;
J.S. Benjamins3; K. Spiegelhalder4; B. Feige4; D. Riemann4;
S. Van Der Sluis5; L.M. Talamini6; M.P. Walker7;
F. Schalkwijk8; E.J.W. Van Someren1,9,10
1Department of Sleep and Cognition, Netherlands Institute for
Neuroscience, 2Spinoza Centre for Neuroimaging, Amsterdam,
3Department of Social, Health and Organizational Psychology, Utrecht
University, Utrecht, the Netherlands, 4Department of Clinical Psychology
and Psychophysiology, University Medical Center Freiburg, Freiburg,
Germany, 5Department of Clinical and Complex Trait Genetics, VU
University Medical Center, 6Department of Psychology, University of
Amsterdam, Amsterdam, the Netherlands, 7Department of Psychology,
University of California, Berkeley, CA, United States, 8Institute for
Psychotherapy, 9Department of Medical Psychology, Vrije Universiteit
Medical Center, 10Department of Integrative Neurophysiology,
Neuroscience Campus, Amsterdam, the Netherlands
Introduction: Insomnia disorder (ID) is the second‐most common
mental disorder. A prominent characteristic is fragmented REM
sleep. Given the role of REM sleep in the adaptation of emotional
memories, restless REM sleep might perturb specifically the over-
night dissipation of emotional distress and underlying functional
reorganization of emotional salience circuits.
ABSTRACTS | 35 of 433
Objectives:
(1) To uncover the direct and mediating associations between
restless REM sleep, duration of emotional distress and hyper-
arousal in a large community sample.
(2) To evaluate the time-course of distress dissipation across
periods of wakefulness and sleep in normal sleepers (NS) and
ID.
(3) Finally, to study differences in the functional reorganization
of emotional salience circuits underlying distress dissipation
between NS and ID.
Methods:
(1) A survey on nocturnal mentation was validated to indicate
restless REM sleep and was subsequently queried in
N = 1,199 participants along with surveys on emotional dis-
tress and hyperarousal. Structural equation and mediation
models evaluated directionality of associations.
(2) Self-conscious emotions were experimentally induced in peo-
ple with ID (N = 26) and NS (N = 46) by exposing them to
their out-of-tune solo singing. Mixed-effect models evaluated
the dissipation of shame (experiential shame scale, ESS)
across four intervals of wakefulness or sleep.
(3) In N = 57, fMRI was used to evaluate long-term effects of
failing distress dissipation in ID on the functional reorganiza-
tion of emotional salience circuits by comparing the reliving
of past distress with novel emotional experiences.
Results:
(1) Structural equation and mediation models indicate that rest-
less REM sleep specifically impedes overnight distress dissi-
pation and leads to hyperarousal.
(2) Scores on the ESS showed selective overnight distress dissi-
pation in NS that failed in ID.
(3) Participants suffering from ID showed similar neuronal net-
work activity elicited by a novel emotional experience as by
reliving distress from the distant past. While relived distress
didn′t activate the anterior cingulate cortex (ACC) anymore
in NS, it continued to activate the ACC as if it was a new
experience in ID.
Conclusions: ID is characterized by insufficient overnight distress
dissipation, which accumulates into hyperarousal. People with
chronic insomnia and restless REM sleep may never fully accomplish
functional reorganization of emotional salience circuits underlying
overnight distress dissipation.
Disclosure: Nothing to disclose.
76 | Awakening thresholds and (REM) sleep
perception in insomnia patients and good
sleeper controls
B. Feige1; C. Baglioni1; D. Riemann1
1Department of Clinical Psychology and Psychophysiology, Medical
Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany
Introduction: Insomnia disorder (ID) is a frequent sleep disorder
coupled with increased risks for somatic and mental illness. While
subjective complaints are severe, polysomnography (PSG) parameters
show only modest differences between groups. In previous studies
we have postulated that REM (rapid eye movement) sleep may be
especially vulnerable to be perceived as wake. To assess this issue
more directly, we determined auditory waking thresholds and sleep
perception in ID patients and healthy control subjects (GSC) in N2
and REM sleep.
Materials and Methods: Twenty‐seven ID patients and 27 age‐
and gender‐ matched controls were included. Four consecutive nights
were assessed in the sleep laboratory, with nights 3 and 4 each con-
taining three awakenings either from stable N2 or REM sleep.
Results: With subjective sleep of course strongly impaired, PSG
data of the 1st and 2nd night showed the commonly observed rela-
tively weak group differences. Awakening thresholds in ID patients
did not differ from GSC, but decreased over the course of the night.
ID patients indicated significantly more frequently than GSC having
been awake when woken from REM sleep but not from N2 and
were less sure when indicating they had been asleep. Additionally,
ID subjects rated their REM sleep mentation as more emotionally
negative compared to GSC.
Conclusions: This study presents direct evidence that the subjec-
tive experience of insomnia might be specifically coupled to the
REM sleep state. Assuming chronic hyperarousal as a central patho-
physiologically relevant pathway for insomnia, this might become
especially evident during REM sleep, thus reflecting a “hybrid” sleep
state in insomnia being coupled with altered sleep perception.
Disclosure: The study was funded by the DFG (Deutsche
Forschungsgemeinschaft; RI 565/13–1).
77 | REM sleep fragmentation and depressive
symptoms in late adolescence: evidence from a
community cohort
A.-K. Pesonen1; M. Gradisar2; L. Kuula3; I. Merikanto3;
S. Tuominen3; R. Tark3; K. Räikkönen3; J. Lahti3
1Department of Logopedics and Psychology, University of Helsinki, HY,
Finland, 2The University of Adelaide, Adelaide, SA, Australia, 3University
of Helsinki, Helsinki, Finland
Introduction: The discontinuity of REM sleep has been associated
with insomnia severity. Fragmented REM sleep also may also
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contribute negatively to the overnight resolution of distress, where
REM sleep plays a significant role. In the long run, this may reflect
negatively on emotion regulation and mood. Alternatively, both frag-
mented REM and depressive symptoms may share a common
genetic origin.
Objectives: We explored the associations between the continuity
of REM sleep, depressive symptoms, and a polygenetic risk score
(PRS) for depression based on a prior genome‐wide analysis.
Aims: To increase understanding of fragmented REM in relation to
mood and genetics.
Methods: 160 adolescents belonging to a consecutive birth cohort
born in 1998 participated in the study at the mean age of 16.9
(SD = 0.1) years. They underwent a sleep EEG at home and self‐
reported their depressive symptoms with Beck Depression Inven-
tory‐II (BDI), and sleep quality with the Pittsburgh Sleep Quality
Index (PSQI). Based on a recent genome‐wide association study, we
calculated PRS for depression across whole genome. We used Illu-
mina OmniExpress Exome 1.2 bead chip in genotyping. REM frag-
mentation was manually calculated from all REM epochs by counting
short (<3 s) and long (>=3 and <15 s) arousals, thus below threshold
to be scored as awake epoch. The percent duration of fragmented
REM in relation to entire REM duration was calculated.
Results: A higher level of self‐reported depressive symptoms was
associated with an increased number of arousals and with an
increased fragmentation percent in relation to total time in REM,
adjusting for age, and sex (β = 0.20; p < 0.005). When split accord-
ing to fragmentation duration, this concerned only long arousals
(>=3 s). PRS for depression was not associated with either BDI‐II
scores or REM arousals (p‐values >0.11). Adjusting further for PRS
did not change the significant associations. Subjectively assessed
sleep quality as measured with PSQI was not associated with either
PRS for depression or REM fragmentation (p‐values >0.33).
Conclusions: Depressive symptoms are associated with more frag-
mented REM sleep. The association was not explained by a genetic
risk for depression.
Disclosure: Nothing to disclose.
78 | Does school‐aged children′s anxiety
reduce after sleep restriction therapy via REM
sleep consolidation?
M. Gradisar1; E. Hunt1; C. Reynolds1; N. Cain1; M. Heath1;
K. Bartel1; C. Richardson1; M. Short1
1Psychology, Flinders University, Adelaide, SA, Australia
Objectives: Sleep disturbance and anxiety are highly co‐morbid
during middle childhood. Some studies show sleep treatments can
confer secondary benefits to children's anxiety. Several mechanisms
have been proposed, including the recent REM sleep fragmentation
hypothesis. The objectives of the present study were to
(1) examine an association between REM sleep fragmentation
and anxiety in school-aged children experiencing insomnia,
and
(2) whether REM sleep consolidation in response to sleep
restriction therapy accounts for changes in anxiety.
Method: 13 children (mean age = 10.0 ± 1.6 yrs, 6f) diagnosed
with chronic insomnia disorder and reporting anxiety were ran-
domised to receive either sleep restriction therapy (SRT; N = 5) or a
control treatment (bedtime regularisation, BR; N = 8) over a 2‐week
period. SRT involved providing 30‐min less time in bed relative to
their pre‐treatment total sleep time. BR involved providing the same
amount of time in bed, as per their average pre‐treatment time in
bed, yet specifying consistent bedtimes and rise times. Children com-
pleted sleep diaries, the Spence Children's Anxiety Scale, and under-
went home‐recorded polysomnography during pre‐ and post‐
treatment. Total micro‐ (<3 s) and macro‐arousal (<15 s) were scored
within REM sleep by two sleep technicians.
Results: Significant large correlations were found between pre‐
treatment self‐reported anxiety and both the number of micro‐
(r = 0.63, p = 0.02) and macro‐arousals (r = 0.60, p = 0.03) during
REM sleep. A significant group*time interaction for total sleep time
(TST) occurred (p = 0.02), with a greater decrease in TST for the SRT
group; however, no significant interaction was found for REM sleep
(p = 0.74). From pre‐treatment to post‐treatment there was no sig-
nificant interaction in self‐reported anxiety scores (SRT: Pre = 28.0,
Post = 24.0 vs. Control: Pre = 39.0, Post = 35.0), p = 0.14. No signif-
icant interaction was found for REM micro‐arousals between the
SRT (Pre = 8.50, Post = 13.00) and control group (Pre = 11.63,
Post = 11.13), p = 0.43, nor REM macro‐arousals (SRT: Pre = 11.00,
Post = 10.50 vs. Control: Pre = 12.25, Post = 13.50), p = 0.89.
Discussion: There was some evidence for an association between
REM sleep fragmentation and self‐reported anxiety scores in school‐
aged children. Despite total sleep time decreasing for children under-
going sleep restriction therapy, less sleep did not translate to less
REM sleep minutes, nor fewer micro‐ or macro‐arousals (i.e., REM
sleep consolidation). No significant decreases in anxiety occurred
due to sleep restriction therapy.
Disclosure: This study was supported by a Flinders University Fac-
ulty Research Grant.
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INFORMATION PROCESSING DURING
SLEEP: RECENT DEVELOPMENTS AND
FUTURE PERSPECTIVES
79 | Associative learning during human sleep:
an interplay between behavior, sleep stages and
brain activity
A. Arzi
Department of Psychology, University of Cambridge, Cambridge, United
Kingdom
Recent finding suggests that humans can learn novel information dur-
ing sleep, and that this information can modulate behavior during
wakefulness in a sleep stage‐dependent manner. Specifically, new
associations learned during non rapid eye movement sleep (NREM)
had larger and longer lasting influence on behavior than associations
learned during rapid eye movement (REM) sleep. NREM sleep, unlike
REM sleep, is rich in slow waves and these slow waves promote mem-
ory consolidation of information previously learned during wakeful-
ness. We set out to test whether slow waves in delta frequency range
(0.5–4 Hz) are also part of the mechanism underlying associative
learning during sleep. We recorded electroencephalogram (EEG) dur-
ing partial‐reinforcement conditioning during NREM and REM sleep.
On reinforced trials (two‐thirds of trials), the conditioned stimulus was
paired with an unconditioned stimulus (odor). On non‐reinforced trials
(one‐third of trials), the conditioned stimulus was presented without
an ensuing odor, which enabled us to measure learning without the
interference of the unconditioned stimulus. We found an increase in
delta power in non‐reinforced trials during NREM sleep, but not dur-
ing REM sleep. Moreover, during NREM the increase in delta power
was significantly larger when the conditioned stimulus was previously
paired with an unpleasant odor than when it was paired with a pleas-
ant odor. This difference was not evident during REM sleep. Finally,
we found a significant correlation between learning‐related delta
power in NREM sleep and retrieval up on awake. Our results demon-
strate that new associations learned during natural human sleep mod-
ulates delta power in a sleep stage dependent manner, and that this
modulation in linked to ability to learn during sleep. Altogether, these
findings suggest that slow waves are involve in the process of sleep
stage‐dependent associative learning during sleep.
Disclosure: Nothing to disclose.
80 | The MemoSleep‐Hypothesis: how does
cognition influence sleep?
B. Rasch
Departement of Psychology, Cognitive Biopsychology and Methods,
University of Fribourg, Fribourg, Switzerland
Sleep is critical for optimal cognitive functioning and health. Sleep
disturbances are highly frequent in our society and strongly
influenced by cognitive factors, e.g. rumination, expectations and
thoughts. However, the mechanism of how cognition influences
sleep architecture is not yet understood. To explain how cognition
influences sleep, I propose the “Memories‐of‐Sleep” (MemoSleep)‐
Hypothesis. Based on the theory of embodied cognition and evi-
dence that memories are reactivated during sleep, the MemoSleep‐
Hypothesis makes the following assumptions: (1) Cognitions related
to sleep/wake states encompass not only their semantic meaning,
but also their sensorimotor body representation. Thus, the mental
representation of the word ‘wake’ is directly linked to our body sen-
sation of wakefulness. (2) If embodied sleep/wake memories are acti-
vated before sleep, they will have a higher probability of being
reactivated during sleep. (3) During sleep, increased reactivation of
embodied sleep/wake memories activates associated body responses
and thereby affects sleep architecture. Thus, increased reactivation
of the mental representation of ‘wake’ will activate wake‐related
physiological responses and disrupt sleep. In my talk, I will explain
the rational of the MemoSleep‐Hypothesis, present and discuss
empirical findings related to the hypothesis as well as alternative
accounts.
Disclosure: Nothing to disclose.
81 | What can be learned during sleep?
Neurophysiological evidence for limitations and
boundary conditions
P. Peigneux
UR2NF ‐ Neuropsychology and Functional Neuroimaging Research Unit
at CRCN, Université Libre de Bruxelles (ULB), Bruxelles, Belgium
Introduction: Hypnopedia, or the capacity to learn during sleep, is
debatable. De novo acquisition of reflex stimulus‐response associa-
tions was shown possible both in man and animal. Whether sleep
allows more sophisticated forms of learning remains unclear.
Objectives: To probe the possibility to learn disjoint, probabilistic
relationships between auditory elements during NREM sleep.
Methods: We recorded during diurnal Non‐Rapid Eye Movement
(NREM) sleep auditory magnetoencephalographic (MEG) frequency‐
tagged responses mirroring ongoing statistical learning. While in
NREM sleep, participants were exposed at non‐awakenings thresh-
olds to fast auditory streams of pure tones, either randomly orga-
nized or structured in such a way that the stream statistically
segmented in sets of 3 elements (tritones).
Results: During NREM sleep, only tone‐related frequency‐tagged
MEG responses were observed, evidencing successful perception of
individual tones. No participant showed tritone‐related frequency‐
tagged responses, suggesting lack of segmentation. In the ensuing
wake period however, all participants exhibited robust tritone‐related
responses during exposure to statistical (but not random) streams.
Conclusions: Our data suggest that associations embedded in sta-
tistical regularities remain undetected during NREM sleep, although
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implicitly learned during subsequent wakefulness. These results sug-
gest intrinsic limitations in de novo learning during NREM sleep that
might confine the NREM sleeping brain′s learning capabilities to sim-
ple, elementary associations. It remains to be ascertained whether it
similarly applies to REM sleep.In this talk, we will also discuss the
neurophysiological and protective conditions that may make high‐
level learning difficult to achieve during sleep.
Disclosure: The study was funded by T.109.13 grant of the Bel-
gian National Fund for Scientific Research (FRS‐FNRS). The author(s)
declare no competing financial or non‐financial interests.
RECENT ADVANCES IN FATIGUE RISK
MANAGEMENT: FROM FATIGUE
COUNTERMEASURE STRATEGIES TO SLEEP
SCIENCE ‐BASED POLICY MAKING
82 | Basic and clinical sleep and circadian
science as a foundation for fatigue risk
management in occupational settings
H. Van Dongen
Sleep and Performance Research Center, Washington State University
Spokane, Spokane, WA, United States
Around‐the‐clock operations are common in large parts of the indus-
trialized world. Many operational settings, including transportation,
health care, emergency response, law enforcement, manufacturing,
information technology, resource extraction, energy production, and
the military, involve night or shift work and/or extended or irregular
work hours. In such settings, there is a high prevalence of occupa-
tional sleepiness ‐ or “fatigue” as it is typically called in the opera-
tional environment. Fatigue has the potential to adversely affect
safety, productivity, profitability, health, and well‐being, and
increases the risk of errors, incidents, and accidents. Basic and clini-
cal sleep and circadian science provides a foundation for contempo-
rary approaches to managing these fatigue‐related risks. As
instantiated in the two‐process model of sleep regulation, fatigue
levels are a function of two primary biological mechanisms: the circa-
dian and homeostatic processes. These two processes and their
effects on fatigue interact with situational factors in the workplace,
such as hours of service regulations, workload, caffeine use, and
workplace napping policies. They also interact with situational fac-
tors outside the workplace, such as caregiver duties, home sleeping
environment, light exposure, and lifestyle. Additionally, sleep disor-
ders and other medical conditions may interfere with the recupera-
tive potential of sleep, and thereby increase fatigue levels.
Fatigue is associated with instability in waking brain function, leading
to an increase in attentional lapses, and degradation of attentional
control mechanisms, leading to reduced cognitive flexibility. These
effects have important implications for productivity and safety in the
workplace. In addition, chronic exposure to dysregulation of the
circadian and homeostatic processes causes metabolic disturbances
and other physiological challenges, which may ultimately lead to
poor long‐term health outcomes.
A direct link between fatigue and adverse outcomes is typically diffi-
cult to demonstrate, because many other factors – both personal
(e.g., genetic vulnerability) and circumstantial (e.g., hazard exposure)
– are involved. Approaches to managing fatigue‐related risk seek to
remove factors causally involved in producing adverse outcomes
and/or add layers of defense by introducing mitigation factors. Con-
crete examples include flexible work hours, sanctioned workplace
napping, company‐sponsored sleep disorder screening and treatment
programs, fatigue education programs, and use of biomathematical
modeling to develop fatigue‐minimized work schedules.
Disclosure: Nothing to disclose.
83 | Fatigue risk management for the offshore
oil and gas industry
V. Riethmeister1; S. Brouwer1; M. de Boer2; U. Bültmann1
1Department of Health Sciences, Community and Occupational
Medicine, University of Groningen / University Medical Center,
Groningen, 2Department of Health Sciences, Faculty of Earth and Life
Sciences, Vrije Universiteit Amsterdam/Public Health Institute,
Amsterdam, the Netherlands
Introduction: Fatigue risk management (FRM) is an important risk
mitigation strategy for managing the risk associated with offshore
shift work scenarios (e.g. 2–4 weeks of successive 12‐hr shifts) and
offshore sleeping arrangements (e.g. noise disturbances). Yet, there is
a lack of knowledge on the time courses and predictors of sleep and
fatigue parameters during offshore shift rotations hampering cus-
tomization and successful implementation of offshore FRM pro-
grams.
Objectives: A collection of studies will be presented that aimed to
better understand sleep and fatigue parameters during offshore shift
rotations to ultimately improve existing FRM programs and systems.
Methods: A longitudinal repeated measures study using both
objective (e.g. actigraphy, PVT‐B, saliva samples) and subjective mea-
sures (e.g. questionnaires and sleep diaries) was conducted among
N = 60 offshore workers for the duration of one 28‐day offshore
rotation. Pre‐offshore (1 week), offshore (2 weeks) and post‐offshore
(1 week) work periods were examined and compared.
Results: Pre‐offshore work periods were identified as preparation
periods in which sleep efficiency scores decreased. Post‐offshore
work periods were identified as recovery periods in which evening
sleepiness scores were high and declined rapidly. During offshore
work periods, sleep durations, perceived sleep quality and level of
rest after awakening decreased and sleep loss and post‐shift sleepi-
ness scores accumulated over the 14‐day period. The accumulation
of post‐shift fatigue scores was significantly related to successive
days on shift and chronic sleep loss. On average, 1 in 6 offshore
workers reported severe sleepiness (KSS>6) each day offshore.
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Indications of a third-quarter-phenomenon were found in which post‐
shift fatigue scores peaked on day 10/11 of a 14‐day offshore work
period after which they slowly declined. Pre‐offshore sleepiness
levels, age, chronotype, smoking status and physical/mental health
were predictors of individual sleepiness time courses during offshore
work periods. BMI predicted pre‐shift severe sleepiness scores.
Conclusions: Our results suggest that FRM programs should not
only focus on the offshore work period, but should also include pre‐
and post‐offshore work periods. Furthermore, prolonging offshore
shifts will likely result in elevated fatigue/sleepiness risk. Findings
from our studies should be incorporated in existing offshore FRM
programs to aid the optimization of FRM programs and systems.
Disclosure: Presented studies were funded by the Nederlandse
Aardolie Maatschappij B.V. and Royal Dutch Shell. The authors
declare no conflict of interest.
84 | Alertness management strategies among
long‐haul truck drivers and airline pilots
M. Sallinen1,2
1Finnish Institute of Occupational Health, Helsinki, 2University of
Jyväskylä, Jyväskylä, Finland
Long‐haul airline pilots and truck drivers are similarly exposed to fati-
gue factors at work, but only pilots work under well‐defined fatigue
risk management (FRM) regulations and procedures. Four studies
among these occupational groups will be presented. The main
emphasis will be put on the results that may help to further develop
FRM in the transport sector. All results are based on field measure-
ments (diary, actigraphy, nine‐step Karolinska Sleepiness Scale (KSS))
among commercial pilots (n = 86, 2‐month measurement period) and
truck drivers (n = 54, 2×2‐week measurement period). The first two
studies addressed personal fatigue management strategies (FMS).
Caffeine and alertness‐enhancing activity (e.g., slight body move-
ments) were prevalent especially on night duties in both truck dri-
vers (70% and 38% of night duties, respectively) and pilots (65% and
60%), whereas nap breaks were prevalent only among pilots (88%).
26% of night duties involved reduced alertness among truck drivers
(KSS peak ≥7). For pilots, the corresponding proportion was similar
(21%) even though a more stringent criterion for reduced alertness
was applied (KSS peak ≥8). The third study (randomised controlled
trial) examined whether a feasible fatigue management training actu-
ally improves FMS and on‐duty alertness among truck drivers. Inter-
vention‐related improvements were observed in none of the
outcomes. The fourth study investigated whether possible individual
differences in on‐duty alertness are associated with personal FMS.
KSS ratings given during Helsinki‐Asia‐Helsinki flights showed that
one‐fourth rated a reduced alertness level (KSS 7–9) on each flight,
whereas another one‐fourth never rated correspondingly. The only
clear difference in FMS between these groups was the length of
prior sleep that was an hour longer for more alert pilots. Our studies
show that reduced alertness levels are prevalent in nighttime long‐
haul transport operations, even if FRM regulations and procedures
were in place. Second, FM training does not seem to be a sufficient
measure to improve alertness. Third, there is a need for paying
attention to individual differences in fatigue proneness and manage-
ment strategies. In all, our findings emphasis the need for organisa-
tional, data‐driven FRM policy. Otherwise it may be difficult to
develop employees’ own behaviors and operational demands to sup-
port on‐duty alertness.
Disclosure: Nothing to disclose.
85 | Fatigue proofing: the next generation of
fatigue risk management
D. Dawson
Appleton, HMAS, CQUniversity, Wayville, SA, Australia
Traditionally, fatigue management has focussed on interventions that
reduce the likelihood of fatigue by altering the working time arrange-
ment (WTA). While potentially useful, changes to the WTA are often
difficult. Operational constraints, labour contracts and employee
expectations around overtime and income make changes politically
challenging. From a risk‐based perspective, risk can be reduced by
either decreasing the likelihood of fatigue or by decreasing the con-
sequence of a fatigue‐related error. What we have labelled as ‘fa-
tigue‐proofing’. In this paper we present a series of case studies
describing informal protective behaviours that have evolved within
workplaces to reduce the consequence of a fatigue‐related error.
Adopting Helmreich's principles of threat and error management, we
demonstrate a novel methodology for eliciting common fatigue‐
related errors and re‐proceduralising the task environment to pre-
vent or attenuate adverse outcomes. This approach holds consider-
able promise for reducing fatigue‐related risk in operational
environments where fatigue is unavoidable including defence, emer-
gency services, disaster relief, medical and health care services.
Disclosure: Nothing to disclose.
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CARDIOVASCULAR AND OTHER
CONSEQUENCES AND SLEEP APNEA
O086 | Risk factors for increased daytime
sleepiness in sleep apnea – results from the
National Swedish Sleep Apnea Registry
L. Grote1,2; D. Zou2; C. Wartenberg3; S. Franzen3;
J. Hedner2,4
1Department of Pulmonary Medicine, Sahlgrenska University Hospital
and Sahlgrenska Academy, 2Center for Sleep and Wake Disorders,
Sahlgrenska Academy, University of Gothenburg, 3SESAR Registry,
Registercentrum Väst, 4Pulmnary Medicine, Sleep Disorders Center,
Sahlgrenska University Hospital, Gothenburg, Sweden
Objectives/Introduction: Excessive daytime sleepiness (EDS) is
one of the key daytime symptoms considered in patients with
obstructive sleep apnea (OSA). However, recent research in popula-
tion based samples has identified OSA phenotypes without EDS,
suggesting a referral bias in clinical cohorts. This study aimed to ana-
lyze the risk factors for EDS in a national OSA patient cohort.
Methods: Data from an unselected group of 7,008 patients (Swed-
ish Sleep Apnea Registry (SESAR), 20 sleep centers) was used to
explore the Epworth Sleepiness Scale (ESS) Score in subgroups of
patients defined by OSA measures (apnea hypopnea index (AHI)),
anthropometrics, and comorbidities by means of general linear mod-
elling. In a second model, EDS was defined as ESS≥11 and predic-
tors of EDS were determined by logistic regression analysis.
Results: Mean ESS score was 9.5 (95% CI 9.2–9.8) in non‐apneic
OSA (AHI < 5 n/h) and 10.3 (95% CI 10.1–10.5) in severe OSA
(AHI ≥ 30 n/h) (p < 0.001). Female gender, AHI, comorbid depres-
sion and diabetes were significantly associated with a higher ESS
score. In contrast, hypertension and age were associated with lower
ESS score (all p < 0.001). EDS criteria were fulfilled by 41.9% of
OSA patients and independent risk factors included female gender
(risk increase +26%), depression (+22%), and severe OSA defined by
AHI > 30 n/h (+49%). A hypertension diagnosis (risk −17%) and
higher age (risk −17% per 10 years) reduced the probability of a high
EDS.
Conclusions: In this national patient cohort, OSA measures,
anthropometrics and comorbidities strongly predicted ESS ratings.
The ESS score was almost identical in those with and without OSA
but severe OSA (AHI ≥ 30 events/h) remained as a risk factor for
EDS. Phenotypic criteria suggestive of a lower ESS score were iden-
tified. The use of the ESS to identify OSA‐related sleepiness may be
insufficient, particularly in patients with mild to moderate OSA.
Disclosure: Ludger Grote: Speakers Bureau and/or scientific sup-
port from Resmed, Philips, Itamar, and Weinmann.
O087 | Differences in arousal probability and
duration after apnea and hypopnea events in
adult obstructive sleep apnea patients
T. Leppänen1,2; A. Kulkas2,3; A. Oksenberg4; B. Duce5,6;
E. Mervaala1,7; J. Töyräs1,2
1Diagnostic Imaging Center, Kuopio University Hospital, 2Department of
Applied Physics, University of Eastern Finland, Kuopio, 3Department of
Clinical Neurophysiology, Seinäjoki Central Hospital, Seinäjoki, Finland,
4Sleep Disorders Unit, Loewenstein Hospital ‐ Rehabilitation Center,
Raanana, Israel, 5Department of Respiratory & Sleep Medicine, Princess
Alexandra Hospital, 6Institute of Health and Biomedical Innovation,
Queensland University of Technology, Brisbane, QLD, Australia,
7Department of Clinical Neurophysiology, Institute of Clinical Medicine,
Faculty of Health Sciences, University of Eastern Finland, Kuopio,
Finland
Objectives/Introduction: In obstructive sleep apnea (OSA)
breathing cessations are often followed by arousals leading into
sleep fragmentation and thus, impaired sleep quality and efficiency.
Arousals and fragmented sleep are also related to detrimental cardio-
vascular events. The key index for OSA diagnosis is apnea‐hypopnea
index (AHI). AHI attributes equal diagnostic value to both apneas
and hypopneas despite the physiological stress they induce may be
very different. In this study, we investigate whether the probability
and duration of apnea‐ and hypopnea‐related arousals differ and
whether the difference in severity of desaturations following apneas
and hypopneas is dependent on sleep stage.
Methods: Polysomnographic recordings of 348 OSA patients were
included for analysis. Duration of arousals and duration, depth, and
area of desaturations related to hypopneas within different sleep
stages were compared to those related to apneas. The probabilities
of apnea‐ and hypopnea‐related arousals and proportional time spent
in different sleep stages were evaluated within different OSA sever-
ity categories.
Results: Apneas caused arousals less frequently than hypopneas in
N1, N2, and N3 sleep in all OSA severity categories. However, in
N1, N2, and REM sleep after adjustment for respiratory event dura-
tions, arousals caused by apneas were longer (p ≤ 0.004) and desat-
urations related to apneas deeper, longer, and greater in area
(p ≤ 0.001) compared to those related to hypopneas. Also in N3
sleep desaturations related to apneas were deeper and greater in
area (p < 0.001) compared to desaturations related to hypopneas.
Conclusions: Desaturations and arousals related to apneas are
more severe compared to those related to hypopneas albeit hypop-
neas are more often followed by an arousal (except in REM sleep).
Therefore, it would be beneficial to give different diagnostic signifi-
cance for apneas and hypopneas in general but also while consider-
ing whether they are followed by arousal, by desaturation, or by
both arousal and desaturation. This could enhance the estimation of
true severity of OSA and risk of related severe health consequences.
Disclosure: Study was financially supported by the Academy of
Finland (decision number 313697); the Research Foundation of the
Pulmonary Diseases; Kuopio University Hospital, the Research
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O088 | Analysing morphine‐induced respiratory
depression in obstructive sleep apnoea patients
using new technologies: a randomised double‐
blind placebo‐controlled study
D. Wang1; J. Wu1; L. Rowsell1; K. Wong1; R. Thomas2;
B. Yee1; R. Grunstein1
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Objectives/Introduction: The effect of morphine on breathing
during sleep has been rarely studied, while the gold standard mea-
surement of polysomnography (PSG) is difficult to access and costly.
In addition, a commonly used clinical dose of morphine may not
cause significant respiratory depression. This study aims to detect
and quantify opioid‐induced subtle respiratory depression during
sleep in obstructive sleep apnoea (OSA) patients using new tech-
nologies. Secondly, we aim to test correlations between the new
technologies and PSG respiratory depression measures.
Methods: Under a randomised double‐blind placebo‐controlled
crossover design, 60 male OSA patients attended 2 visits to the hospi-
tal sleep laboratory, at least 1‐week apart. Either a 40 mg controlled‐
release oral morphine or placebo was administered. Breathing during
sleep was measured using standard in‐lab PSG. Besides conventional
PSG analyses, we performed quantitative respiratory flow analyses‐
inter‐breath interval (IBI) to quantify breathing irregularity. In addition,
cardiorespiratory coupling (CPC) was analysed from PSG ECG channel.
Results: Following the consumption of morphine, the 60 OSA
patients had significantly less number of breaths (p = 0.0006), longer
breath interval (mean IBI 4.34 ± 0.52 s vs. 5.02 ± 0.57 s,
p < 0.0001), and more irregular breaths with significantly increased
IBI coefficient of variation (CV) (0.23 ± 0.09 vs. 0.29 ± 0.15,
p = 0.0015) compared to the placebo night. We tested correlations
of the key parameters of the new techniques with six key PSG respi-
ratory depression parameters: apnoea‐hypopnoea index, arousal
index, oxygen desaturation index, pressure of transcutaneous CO2
(PtcCO2), SpO2 nadir and sleep time spent below SpO2 < 90%. The
change of IBI CV significantly correlated with the change of all the
six key PSG parameters (all p < 0.05). The change of CPC parame-
ters of sleep quality index and two individual band measures also
significantly correlated with the change of 5 out of 6 PSG measures
(except from PtcCO2) (all p < 0.05).
Conclusions: The 40 mg controlled‐release morphine resulted in
mild respiratory depression with longer breathing cycle and
increased breathing irregularity. The significant links between the IBI
and CPC techniques and a range of PSG respiratory depression
parameters may show clinical potentials for the new techniques as
surrogate overnight cardiorespiratory measurements, since both res-
piratory flow and ECG can be measured by small portable devices.
Disclosure: Nothing to disclose.
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St. Ann′s University Hospital, Brno, 2Internal Cardiology Department,
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Objectives/Instruction: Sleep apnea (SA) has a high prevalence in
patients after myocardial infarction (MI). While SA might be a modifi-
able risk factor, recent data suggest that SA is severely underdiag-
nosed in patients after MI. There is also limited evidence about long‐
term prognosis of patients after MI according to SA categories.
Therefore we sought to determine the relationship between SA and
long‐term prognosis among patients presenting with MI.
Methods: We prospectively studied 782 consecutive patients
admitted to the hospital with the diagnosis of acute MI. The study
was conducted in two tertiary care institutions, where primary per-
cutaneous coronary intervention (PCI) is the standard of care in the
treatment of acute MI. All subjects underwent sleep evaluations
using a portable diagnostic device after at least 48 h post‐admission,
provided they were in stable condition. Patients were followed for
median follow‐up of 66 months.
Results: Almost all patients (98%) underwent urgent coronary
angiography and 91% of patients underwent primary PCI. 175
(22.4%) patients had technically inadequate limited sleep studies (less
than 4 h recording time or inability to score study due to excessive
artifact). We therefore analyzed the data from 607 patients who had
good quality sleep study records. Using a threshold of AHI ≥ 5
events/h, SA was present in 65.7% of patients after acute myocardial
infarction. Mild SA was present in 32.6%, moderate in 20.4% and
severe in 12.7%. There was a relation between the severity of SA
and long‐term prognosis. Patients after MI with increasing severity
of SA had higher total mortality (p = 0.002, log‐rank test). The
Kaplan‐Meier survival curves are presented. There was also a higher
total mortality in reduced than in preserved left ventricular ejection
fraction patients after MI (21.7% vs. 10.6%) in the group of moder-
ate to severe SA (p = 0.033).
Conclusions: Mortality of patients after MI significantly increased
with increasing severity of SA. Whether treatment of SA after MI
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will significantly improve outcomes in these patients remains to be
determined.
Disclosure: Nothing to disclose.
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Objectives/Introduction: Obstructive sleep apnoea syndrome
(OSAS), especially moderate‐severe disorder, predisposes to nonfatal
and fatal cardiovascular disease (CVD) events. The data regarding the
impact of continuous positive airway pressure (CPAP) treatment on risk
reduction are inconsistent, possibly due to variance in the CPAP compli-
ance. We evaluated whether CPAP reduces the risk of nonfatal and fatal
CVD events in CPAP‐treated in comparison to OSAS patients who had
discontinued the CPAP treatment despite of the doctor's advice.
Methods: Retrospective observational cohort consisted of CPAP‐
treated and control OSAS patients matched for gender, age and
apnoea‐hypopnoea index (AHI). Prevalence of CVD and other com-
mon cardiovascular risk factors were determined for both groups at
baseline. The study endpoint was a composite of nonfatal (primary
or secondary) and fatal CVD events. Cox regression model was used
to determine the association between CPAP treatment and event‐
free survival. The model was adjusted to known CVD risk factors.
Results: A total of 2060 patients (75.8% male, mean age
56.0 ± 10.5 years), of which 76.4% had moderate‐severe OSAS
(AHI ≥ 15 per h), were included. In the CPAP‐treated group
(N = 1,030), the median use of CPAP was 6.4 h/day during a median
follow‐up of 8.7 years. The control group (N = 1,030) was followed
for a median of 6.2 years after the CPAP treatment had ended (prior
use of CPAP 0.7 h/day for 4.0 months on average). The study end-
point occurred in 14.4% (N = 148) of the CPAP‐treated and in
18.8% (N = 194) of the control patients (p = 0.006 for the trend).
Using the Cox regression model adjusted for gender, age, AHI, body
mass index and the history of CVD, hypertension, type 2 diabetes or
chronic obstructive pulmonary disease at baseline, CPAP treatment
protected against nonfatal and fatal CVD events (hazard ratio 0.64,
confidence interval 95% 0.5–0.8, p < 0.001).
Conclusions: CPAP treatment associated with a decreased risk of
nonfatal and fatal CVD events. The association was demonstrated
independent from common cardiovascular risk factors.
Disclosure: Nothing to disclose.
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Objectives/Introduction: Cardiac arrhythmias are presumed to be
a common problem in patients with OSA, although their true preva-
lence and gender related differences remain to be determined. The
aim of our study was to estimate the prevalence and risk factors for
arrhythmias in a large cohort of patients in the context of European
Sleep Apnoea Database (ESADA).
Methods: A multi‐centric cohort of 22,169 patients in the ESADA
network was evaluated. We estimated the prevalence of cardiac
arrhythmias in the whole cohort and separately in four groups: no
OSA (AHI < 5), mild (AHI = 5–14), moderate (AHI = 15–29) or severe
OSA (AHI ≥ 30). We compared clinical and sleep study variables
among the groups.
Results: The prevalence of arrhythmias in the whole cohort was
3.4%, 3.6% among males, 2.8% among females. Patients with
arrhythmias were older (61 vs. 52 years), with a similar BMI as com-
pared to the patients without arrhythmias (31.8 vs. 31.5 kg/m2).
Prevalence of arrhythmias was 1.9%, 3.5%, 3.8% and 3.7% (χ2: p‐
value <0.001) in patients with no OSA, mild, moderate or severe
OSA, respectively. Additionally, the strongest association between
arrhythmias and OSA severity was observed in patients under
65 years of age. Interestingly we found peculiar gender differences
with a significantly lower prevalence of arrhythmias in females
(2.9%) as compared to males (4.2%) in group with moderate OSA
(p = 0.032), in particular after 65 years (5.1% vs. 9.0%, p = 0.026).
ABSTRACTS | 43 of 433
Conclusions: Arrhythmias were common in the ESADA cohort,
and an increased severity of OSA was related to an increased risk of
arrhythmias, especially in younger individuals. Moreover, female gen-
der seems to play a protective role towards arrhythmias in particular
in moderate OSA. These results confirm that arrhythmias must be
considered in the cardiovascular risk assessment of OSA patients
and gender related differences can play a significant role in this asso-
ciation.
Disclosure: Nothing to disclose.
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Objectives/Instruction: Cardiovascular (CVD) consequences of
obstructive sleep apnea (OSA) may result from sympathetic over‐
activity related to hypoxia and arousals. OSA during rapid eye move-
ment (REM) sleep has been associated with the development of
hypertension. Heart rate variability (HRV), a measure of influence of
the autonomic nervous system on the heart is also associated with
CVD. This study aimed to examine any interaction of HRV with OSA
in the association with hypertension, in a population‐based sample
of men.
Methods: The population‐based Men Androgen Inflammation Life-
style Environment and Stress (MAILES) Study of men ≥40 years con-
ducted home‐based full polysomnography (n = 837, Embletta X100).
HRV measures (SDNN, standard deviation of normal‐to‐normal RR‐
intervals; RMSSD, root mean‐square of successive differences of N‐
N intervals) were calculated during periods free from scored respira-
tory events or arousals during non‐REM (n = 761) and REM sleep
(n = 671). Cases with atrial fibrillation (AF) or frequent ectopic beats
were excluded. Multivariable logistic regression models determined
associations of hypertension (>140/90 mmHg/medication) with OSA
and lowest quartile (Q1) of SDNN or RMSSD [vs. quartiles 2–4,
entered in separate models] adjusted for usual factors. Odds ratios
(OR) and 95% confidence intervals (CI) are presented.
Results: Hypertension prevalence was 53% (n = 403) and was
associated with low non‐REM HRV (e.g. RMSSD: 67.4% vs. 50.5%
Q2–4; p < 0.001) and low REM HRV (RMSSD: 60.8% vs. 49.9% Q2–
4; p = 0.017) and increasing total, non‐REM and REM OSA severity
(p < 0.001). In adjusted analyses during REM sleep, hypertension
was significantly associated with moderate severe REM OSA (OR:
2.2, 1.4–3.1) but not with REM HRV (SDNN Q1: 1.3, 0.9–2.1;
RMSSD Q1: 1.3, 0.8–1.9). During non‐REM sleep, hypertension was
significantly associated with non‐REM RMSSD (Q1: 1.7, 1.2–2.6) but
not SDNN (Q1: 1.0, 0.7–1.5) and was not associated with moderate‐
severe non‐REM OSA (1.4, 0.95–2.2). Interaction terms in the mod-
els were non‐significant indicating that HRV did not modify the asso-
ciation of OSA with hypertension.
Conclusions: In REM sleep, REM AHI severity but not HRV was
associated with hypertension. However, in non‐REM sleep, hyperten-
sion was associated with HRV (RMSSD) independently of OSA in
men without AF. This may reflect differential effects of OSA across
sleep stages on cardiac sympathetic and vagal activity.
Disclosure: Nothing to disclose.
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Objectives/Introduction: Unstable ventilatory control (high loop
gain, LG) is an important physiological trait that contributes to
obstructive sleep apnea (OSA). A high LG means relatively high ven-
tilatory response to a given blood gas disturbance, which will persis-
tently destabilize breathing while upper airway mechanical load was
partially or entirely eliminated by positive airway pressure therapy.
We hypothesized that measures of high loop gain could predict the
short‐term efficacy of positive airway pressure therapy.
Methods: 42 adult patients with OSA (M/F = 39/9, aged
40 ± 8 years, apnea‐hypopnea index, ahi were 68.2 [42.9, 81.0]
events/h) were studied. The stability of the ventilatory control sys-
tem (LG) was quantified by fitting a simplified mathematical model
to the spontaneous ventilatory pattern obtained via polysomnogra-
phy. LG, pulmonary function test results, and other PSG parameters
were analyzed in patients who had post‐treatment AHI > 10 events/
h (non‐responders) using auto‐positive airway pressure therapy.
Results: Nine patients (34.6%) had post‐treatment AHI > 10
events/h (non‐responders). Twenty patients (47.6%) had residual
AHI < 5 events/h. Loop gain and pre‐treatment mixed apnea index
were higher in the non‐responders versus responders (0.74 [0.62,
0.82] vs. 0.49 [0.37, 0.77], p = 0.035) and (11.0 [4.3, 22.9] vs. 2.0
[0.2, 5.3], p = 0.004). In the 26 patients with LG>0.6, nine (34.9%)
had post‐treatment 5 < AHI < 10 events/h. And all of the non‐
responders had LG (n = 9, 34.9%). The difference were significant
between the LG > 0.6 and LG < 0.6 group (p = 0.007).
Conclusions: Loop gain and mixed apnea index was higher in
patients with residual AHI>10 events/hr after short‐term auto‐PAP
therapy. Ventilatory control stability evaluation might have predictive
value for PAP treatment efficacy in OSA patients.
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Objectives/Instruction: Depression is more prevalent among
sleep apnea patients than normal population and obstructive sleep
apnea has been shown to increase the risk of mood disorders. Rev-
ersed causality has also been suggested, but no evidence seems to
exist. We aimed to examine psychological distress and self‐reported
diagnosed depression as predictors of sleep apnea.
Methods: The data were drawn from the longitudinal Finnish Pub-
lic Sector study. The sample comprised of 47,867 current or former
public sector employees aged 19–78 years (83% women), who
responded to survey questionnaires in 2008–2009 (Time 1) and
2012–2013 (Time 2). At Time 1, Psychological distress was measured
with the 12‐item version of General Health Questionnaire and
depression with self‐report of having ever been diagnosed with
depression by a doctor. The outcome was self‐reported doctor diag-
nosed sleep apnea between Time 1 and Time 2. The data were ana-
lyzed using logistic regression analysis, and the analyses were
adjusted for sex, age, socioeconomic status, employment status,
chronic somatic diseases, and health behaviors.
Results: During the 4‐year follow‐up, 743 (1.6%) of the 47,867 par-
ticipants were diagnosed with sleep apnea. Of all participants, 22%
reported psychological distress, 13% depression, and 6% reported
both. After full adjustments, psychological distress was associated
with 1.40‐fold [95% confidence interval (CI) 1.19–1.66, p < 0.001]
compared with those without psychological distress. The odds ratio
for depression was 1.99 (95% CI 1.67–2.37, p < 0.0001) compared
with those without depression. Participants with both psychological
distress and doctor diagnosed depression had a 2.27‐fold (95% CI
1.78–2.89, p < 0.0001) risk of sleep apnea compared with partici-
pants without either.
Conclusions: Results from the current study support the hypothe-
sis that depression may precede sleep apnea. Thus, based on the
current and previous findings the association between depression
and sleep apnea seems to be bidirectional. However, difficulties in
differential diagnosis between depression and sleep apnea limit con-
clusions on direction of causality.
Disclosure: Nothing to disclose.
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Objectives/Introduction: In obstructive sleep apnea (OSA),
obstructed upper respiratory airways cause breathing cessation and
daytime sleepiness. The prevalence of OSA (apnea‐hypopnea index
≥5) reaches 38% in the adult population and increases with older
age. Recent evidence shows that OSA presence and severity con-
tribute to age‐related impairments in cognitive function. The STOP‐
BANG is a validated 8‐item questionnaire used to screen OSA
patients. It includes questions on sleep habits and other risk factors
for OSA. This study determined whether risk factors for OSA, based
on the STOP‐BANG, are associated with lower cognitive functioning
in a large Canadian population‐based cohort.
Methods: 30,097 participants aged 45–86 years old included in the
Canadian Longitudinal Study on Aging (CLSA) completed health
questionnaires, physical examinations and cognitive tests. Partici-
pants were included in the analyses if the dataset necessary to com-
pute the STOP subscore (snoring; tiredness; observed apnea; high
blood pressure‐HBP) was completed. Multivariate linear regressions
were used to determine the association between the STOP subscore
and cognitive performance, and were adjusted for age, sex, educa-
tion, depression and body mass index (BMI). Two models were
developed for each test: model 1 included the STOP items individu-
ally, and model 2 included the STOP subscore (0–4). Significant
threshold was set at p < 0.05 and a Bonferonni correction was
applied.
Results: The STOP subscore was available for 25,563 participants,
where 26.0% (N = 6,671) scored ≥2, predicting higher risk for OSA.
Regression models showed that the STOP subscore, along with
increasing age, increasing BMI, being a male, lower education and
depression were associated with worse executive function (STROOP
Inhibition condition: all p‐values< 10−3; adjusted model R2=0.205).
When included individually, only the STOP tiredness and HBP items
were associated with worse cognitive abilities. Individual STOP items
were also associated with impaired performance on memory and
verbal fluency tests (Rey Audio Verbal Learning and Animal Naming
Tests).
Conclusions: The presence of OSA risk factors is related to poorer
cognitive functioning. The next step is to identify moderating factors,
e.g. cardiovascular diseases, psychiatric comorbidities and lifestyle,
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that impact the association between OSA risk factors and cognitive
decline over time.
Disclosure: Nothing to disclose.
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Introduction: To elucidate the complexity of sleep and wakeful-
ness, it is necessary to take into account not only the neuronal net-
works and their neurotransmission systems, but also their cellular,
genetic and metabolic context. Recently, the “omics” technologies,
monitoring the expression of almost every gene and protein within a
tissue, have been applied to vigilance states in whole brain or in
specific cell types. These strategies have provided a more integrated
view of the physiology of the sleep‐wake states and have revealed
unexpected molecular and cellular pathways, in cell types that
extend beyond neurons, such as glial cells.
Objectives: The majority of gene profiling studies so far have
focused on temporally limited sleep disruption. While this strategy
has many merits, it may miss mechanisms that are associated with
chronic sleep disorders, which result in the reorganization of brain
networks, particularly when it is associated with neuronal damage
such as in narcolepsy, sleep apnea or neurodegeneration. Thus we
focused on identifying cellular factors potentially involved in chronic
sleep disruption.
Methods: We used gene profiling and transcriptomics in Drosophila
and mouse models, combined with Drosophila molecular genetics for
functional gene studies. In Drosophila, a short term memory assay
was used to assess sensitivity to sleep loss.
Results: We conducted gene profiling studies in mutant flies as
well as in wild type flies selected individually for traits revealing life‐
long resilience or vulnerability to sleep loss. The function of candi-
date genes showing differential expression in those conditions was
investigated by inhibiting or activating them in specific cell types
using Drosophila molecular genetics. This strategy led us to identify
unexpected neuronal and glial factors that can modulate sleep/wake
regulation as well as vulnerability to sleep loss. These factors are
involved in innate immunity, ubiquitination, and Notch signalling.
Gene profiling studies in a mouse model of narcolepsy allowed us to
reveal a sleep/wake regulatory role for amino‐acid transport in
dopaminergic transmission.
Conclusion: These studies identify key molecular and cellular play-
ers influencing sleep/wake regulation and vulnerability to sleep loss.
Such mechanisms could be involved in the maintenance of vigilance
states in chronic sleep disruption.
Disclosure: Nothing to disclose.
RESTLESS LEGS SYNDROME AND
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Objectives/Introduction: The association between restless leg
syndrome (RLS) and cardiovascular diseases (CVD) or hypertension
remain controversial. Periodic leg movements during sleep (PLMS)
found in 80% of RLS patients, are often associated with micro‐arou-
sals (PLMA) and repeated night‐time increase in blood pressure (BP)
and heart rate (HR). Only two studies assessed the relationship
between RLS and the non‐dipping BP pattern using a 24‐h ambula-
tory BP monitoring (ABPM) with controversial results. The aim of
the present study is to assess the 24‐h HR and BP profile and
endothelial function in patients with primary RLS and controls.
Methods: Eighty‐four drug‐free patients with primary RLS (53
females, mean age 55.1 ± 12.3 y.o.) and 76 controls (47 females,
mean age 52.2 ± 15.3 y.o.) underwent semi structured evaluation,
polysomnographic recording, endothelial function assessment and
24‐h ABPM. Logistic regression models were used to compare char-
acteristics between the two groups. Mixed models regression were
performed to study the evolution of BP and HR over 24 h and the
two groups.
Results: Mean age at RLS onset was 40.6 y.o. (±15.8). Moderate
and severe to very severe RLS symptoms were reported in 52% and
36% of patients respectively. Controls and patients did not differ for
clinicobiological features although a tendency for hyperlipidemia in
patients was found (p = 0.06). Increased PLMS, PLMA, and sleep
fragmentation were found in patients compared to controls. An
increased frequency of systolic and mean BP non‐dipping pattern
(i.e. <10% drop in BP during sleep) were found in patients with RLS
compared to controls (p = 0.04). Mixed models showed global
changes on BP between the different periods, with interactions
found between groups and periods for systolic (p = 0.002) and dias-
tolic BP (p = 0.003), indicating differences in response profiles
between groups. However, no between‐group differences were
found for 24‐h, daytime or night‐time BP or HR values, or for hyper-
tension according to ABPM or endothelial function in unadjusted
and adjusted models.
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Conclusions: Patients with primary RLS exhibit a 24‐h BP dysregu-
lation with an increased frequency of systolic BP non‐dipping than
controls. This association may have major clinical consequences
related to the increased risk for CVD morbidity and mortality, further
requiring both precocious diagnosis and early optimal management.
Disclosure: Invitation to congress UCB pharma, Laidet.
O098 | Stroke‐related restless legs syndrome:
an anatomo‐clinical entity with clues to
pathophysiology
E. Ruppert1; A. Hacquard1; L. Tatu2; I.J. Namer3; U. Kilic-
Huck1; H. Comtet1; O. Lagha-Boukbiza4; V. Wolff5;
M. Bataillard1; P. Bourgin1,6
1Department of Neurology, Sleep and Electrophysiology Clinic,
University Hospital of Strasbourg – CIRCSom, Strasbourg, 2Department
of Anatomy, FR Sciences Médicales et Pharmaceutiques, University of
Franche‐Comté, Besançon, 3Department of Biophysics and Nuclear
Medicine, Hôpitaux Universitaires de Strasbourg, 4Department of
Neurology, Center for Movements Disorders, University Hospital of
Strasbourg, 5Department of Neurology, Stroke Unit, University Hospital
of Strasbourg, 6CNRS, University of Strasbourg, INCI, Strasbourg, France
Objectives/Introduction: Restless legs syndrome (RLS) symp-
tomatic of well‐defined lesions, such as observed in stroke‐related
situations is a promising way to further improve our understanding
of its pathophysiology.
Methods: Sixteen patients with stroke‐related RLS were included
in this monocentric observational study. Structural imaging using
brain MRI was performed in all patients for neuroanatomical analysis.
In 11 patients stroke‐induced metabolic modifications were assessed
by isotopic explorations of both glucose consumption using 18F‐FDG
PET and nigrostriatal dopamine terminal functioning. PET with 18F‐
FDOPA evaluated the functional integrity of the presynaptic
dopaminergic synthesis and dopamine reuptake was explored using
123I‐FP‐CIT SPECT.
Results: Eight patients presented RLS symptomatic of a lenticulos-
triate infarct. The body of the caudate nucleus was the common
anatomical structure affected in 6 of them. In all patients with lentic-
ulostriate infarct, isotopic explorations showed increased 18F‐FDOPA
uptake in the ipsilateral putamen associated with decreased dopa-
mine transporter binding. Seven patients had stroke‐related RLS due
to brainstem infarction affecting the anterior part of the pons in 6
and the medulla oblongata in one. Metabolic imaging for dopamine
was performed in two of them, none showed any abnormalities.
Solely one patient presented stroke involving the vermis of the cere-
bellum and the left occipital lobe. Isotopic explorations regarding his
dopaminergic system were normal. Unilateral or asymmetric RLS
contralateral to the lesion was found in 3 patients, all other patients
had bilateral and symmetric RLS symptoms. In 12 patients RLS
appeared de novo and 4 had clear exacerbation of RLS present prior
to stroke. Post‐stroke RLS was most common; nevertheless RLS pre-
ceded stroke symptoms in two patients with a clear temporal
relationship. Therefore, we suggest that the term of stroke‐related
RLS is more accurate than that of post‐stroke RLS.
Conclusions: Stroke‐related RLS seems to affect mainly patients
with infarction in the territories of the middle cerebral artery and
the perforating branches of the basilar artery. Further prospective
studies with a systematic stroke‐related RLS screening are needed to
better determine predisposing factors and frequency. Given its poor
literature, stroke‐related RLS is a probably underdiagnosed anatomo‐
clinical entity. Clinicians should be aware of this condition, especially
as efficient treatments are available.
Disclosure: Nothing to disclose.
O099 | Sleep‐wake fragmentation is linked to
amyloid beta brain deposition in healthy ageing
J. Narbutas1,2; M. Van Egroo1; D. Chylinski1; P. Villar
González1; G. Borraita-Amador1; V. Muto1; G. Hammad1;
G. Besson1; E. Lambot1; S. Laloux1; C. Hagelstein1;
P. Ghaemmaghami1; C. Degueldre1; C. Schmidt1,2;
P. Maquet1,3; E. Salmon1,2,3; C. Phillips1,4; M.A. Bahri1;
C. Bastin1,2; F. Collette1,2; G. Vandewalle1
1GIGA‐CRC In Vivo Imaging, 2Psychology and Cognitive Neuroscience
Research Unit, University of Liège, 3Department of Neurology,
University Hospital of Liège, 4GIGA‐In Silico Medicine, University of
Liège, Liège, Belgium
Objectives/Introduction: Animal and human studies reported that
Alzheimer's disease (AD) pathophysiology and sleep‐wake regulation
are strongly associated. The extent of this link remains to be fully
characterized. For instance, the fragmentation of sleep and wakeful-
ness states has been related to the risk of developing AD. The objec-
tive of the present study was to explore whether sleep‐wake
fragmentation is associated with Amyloid β (Aβ) and Tau brain burden,
two key proteins for AD, in healthy ageing. We also investigated how
these AD biomarkers are related to subjective sleep quality.
Methods: Thirty‐seven healthy and cognitively normal late middle‐
aged participants (51–69 y.o.; mean 59 ± 5; 13 males) were included
in our study. Intradaily variability was calculated using data obtained
from 14 days wrist actigraphy. Subjective sleep quality was evalu-
ated using the Pittsburgh Sleep Quality Index (PSQI). Aβ total brain
deposition was assessed using 18F‐flutemetamol radiotracer Positron
Emission Tomography (PET) scan. Total brain Tau level was assessed
using 18F‐THK‐5351 radiotracer PET scan.
Results: General linear mixed models, controlling for sex and age,
revealed that intradaily variability is significantly associated with the
interaction between whole brain Aβ burden and education (p = 0.04)
and with whole brain Aβ burden (p = 0.02) and education (p = 0.04)
alone, but not with whole brain Tau level (p = 0.54). Further analy-
ses, controlling for sex and age, showed that PSQI scores were sig-
nificantly associated both with whole brain 18F‐flutemetamol uptake
(p = 0.01), and with whole brain 18F‐THK‐5351 uptake (p = 0.01),
both in interaction with education (p < 0.01).
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Conclusions: These preliminary results confirm that sleep‐wake
fragmentation is associated with AD pathophysiology. They show
that it is related to Aβ brain accumulation, one of the hallmarks of
AD pathophysiology. In addition, subjective perception of sleep qual-
ity appears to be associated with both Aβ and Tau burden. This war-
rants further investigations of the respective roles of both Aβ and
Tau proteins in age‐related changes in sleep‐wake regulation.
Disclosure: Support: FNRS, ULiège, ARC17/21‐09, FEDER, WBI,
Clerdent Foundation.
O100 | EEG functional connectivity during
REM sleep: a marker of cognitive status?
A. Lafrenière1,2; P. Brayet2,3; J.-M. Lina2; D. Petit2;
J.-F. Gagnon2,3; J. Montplaisir1,2; N. Gosselin1,2; J. Carrier1,2
1Université de Montréal, 2Center for Advanced Research in Sleep
Medicine, Hôpital du Sacré‐Coeur de Montréal, 3Université du Québec à
Montréal, Montréal, QC, Canada
Objectives/Introduction: Changes in the basal forebrain choliner-
gic system (BFCS) represent the most salient and earliest biochemical
changes in Alzheimer′s disease, and can be seen even in patients
with mild cognitive impairment (MCI). During wakefulness, decreased
EEG coherence in the alpha frequency band (Co‐alpha) was reported
to be related to the extent of cholinergic deficits in MCI patients.
Cortical activation during Rapid‐Eye‐Movement (REM) sleep relies
upon the BFCS to a far greater extent than activation during wake-
fulness. Accordingly, we compared Co‐alpha during wakefulness and
REM sleep in patients with MCI and in cognitively healthy controls
(HC).
Methods: Thirty‐two subjects with MCI (22 M; mean age
64 ± 6.1 years) and thirty‐two HC (22 M; mean age 63.7 ± 6.6 years)
underwent a neuropsychological assessment, a night of polysomnogra-
phy and a resting‐state EEG recording with 14 EEG electrodes. EEG
Co‐alpha was assessed using imaginary coherence computed on manu-
ally selected artefact‐free epochs in both REM sleep and resting wake-
fulness. Differences in connectivity between REM sleep and
wakefulness were assessed with a Welch′s t‐stat. A non‐parametric
test on the max‐stat and a permutation resampling allowed to account
for multiple comparisons (between pairs of electrodes) in a false dis-
covery rate like thresholding (p < 0.04).
Results: During wakefulness, MCI patients showed lower Co‐alpha
on the frontal interhemispheric axis, compared to HC (p < 0.04).
During REM sleep, both groups showed a global Co‐alpha decrease
compared to wakefulness (p < 0.04), but this reduction was less
prominent in MCI patients. Hence, MCI patients showed higher Co‐
alpha on the left antero‐posterior and interhemispheric axes during
REM sleep than did HC (p < 0.04).
Conclusions: Our results corroborate previous reports of lower
Co‐alpha in MCI patients relative to HC during wakefulness. Com-
pared to HC, MCI patients show a reduced capability to decrease
functional connectivity in the alpha frequencies during REM sleep
with respect to wakefulness. Insofar as the cholinergic projections
from the BFCS to the cerebral cortex constitute an important sub-
stratum of alpha rhythms, observed changes within this band during
REM sleep might mirror neurodegenerative process. Future research
is required to further characterize the relationship between EEG
functional connectivity and cholinergic denervation during REM
sleep.
Disclosure: Nothing to disclose.
O101 | Serotine melatonin timing secretion in
real life conditions in Alzheimer patients of mild
to moderate severity
R. Manni; R. Cremascoli; C. Perretti; M. Terzaghi; S. Cerri;
R. De Icco; M. Picascia; E. Sinforiani
IRCCS C. Mondino, Pavia, Italy
Objectives/Instruction: The study focused on serotine melatonin
secretion with calculation of dim light melatonin onset (DLMO) and
AUC after DLMO in AD patients.
Methods: Twenty‐one patients (11 males; 74.14 ± 5.4 years) with
a diagnosis of AD according to McKhann criteria (2011), mean dis-
ease duration of 3.4 ± 1.6 years, were consecutively enrolled.
Twenty‐one healthy subjects comparable for age and sex served as
controls (HC). Subjective sleep parameters were calculated. DLMO
(set at 3 pg/ml) and quantitative aspects of the initial nocturnal mela-
tonin secretion were calculated by means of a five‐ point melatonin
salivary test. The sample size was determined using the “Open
Source Epidemiologic Statistics for Public Health”. Categorical vari-
ables were submitted to cross‐tabulation and statistical significance
was evaluated using the chi‐square test or Fisher′s exact test. Con-
tinuous variables were expressed as mean values ± sd. Differences
between groups were tested with ANOVA (analysis of variance) fol-
lowed by a post hoc Bonferroni test. The level of significance was
set at 0.05.
Results: The percentage of PSQI score above 5 did not differ
between patients and controls (AD: 38.1%, HC: 29.4%, p = 0.57) and
neither did the mean PSQI score (AD: 6.24 ± 5.4, HC: 4.47 ± 3.0,
p = 0.24).The mean MEQ score was comparable in the AD patients
and HC (p = 0.12). Mid sleep values fell within the normal range of
values of same age Caucasian general population, in both AD and
HC. The mean DLMO time in AD patients occurred significantly later
respect to controls (55 min; p = 0.028). Melatonin secretion after
DLMO as measured by AUC was significantly lower in AD patients
(p < 0.001). The linear regression analysis showed that DLMO pat-
terns of secretion are independent from age and sex, while they are
statistically related to AD diagnosis (p = 0.038).
Conclusions: Our data show that DLMO delay and decreased
melatonin secretion may occur early in AD patients who have not
developed overt sleep disorders yet.
Disclosure: Nothing to disclose.
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RHYTHMS OF (UN)HEALTHY SLEEP:
UNDERSTANDING AND MODULATION OF
MULTI ‐SYSTEM OSCILLATIONS
102 | EEG correlates of multi‐system
oscillations: from visual identification to the
analysis of complexity
R. Ferri
Oasi Research Insitute IRCCS, Troina, Italy
Since the first polysomnographic sleep recordings in the ‘60s and
‘70s, it appeared clear that during sleep, and especially during non-
REM sleep, the EEG tends to show an oscillatory pattern with an
alternation between higher and lower amplitudes, involving, in par-
ticular, slow waves (approximately 0.5–2.5 Hz) and higher frequen-
cies, in the alpha and beta range. This oscillatory pattern is
synchronized with oscillations in a variety of other recordable activi-
ties, including physiological (heart rate) and pathological phenomena
(periodic leg movements, bruxism, sleep apnea). Interestingly, topo-
graphic mapping of the slow wave activity during these oscillations
shows a mostly anterior (frontal) origin while faster activities (alpha)
are generated over the parietal‐occipital areas. Taken all together,
these data show the importance of connectivity for the complex
synchronization between the different underlying structures, which
was shown to be characterized by nonlinear dynamics, rather than
by simple oscillatory phenomena. This implies that these oscillations
arise as the results of the complex nonlinear interaction between the
different generators, which are able to oscillate by themselves even
when pharmacologically or anatomically disconnected from each
other, but also tend to synchronize when connected together. The
analysis of the complexity of these oscillations has shown that dur-
ing sleep high‐amplitude slow‐wave transients, the EEG signals tends
to assume a low‐complexity state, in conjunction with a functional
connectivity organization carrying the signatures of the so‐called
“small‐world networks”.
Disclosure: Nothing to disclose.
103 | Autonomic background of multi‐system
oscillations: from humans to model organisms
A. Silvani
Department of Biomedical and Neuromotor Sciences, University of
Bologna, Bologna, Italy
The power spectrum of the electroencephalogram (EEG) in different
frequency bands, the occurrence of arousals, limb movements,
epileptic discharges, and apneas have a loosely periodic structure
and tend to synchronize together with oscillations of the autonomic
nervous system during sleep. As a result, multi‐system oscillations
during sleep impact on heart rate and arterial blood pressure, with a
potential role as a risk factor for cardiovascular disease. The mecha-
nisms of this autonomic background of multi‐system oscillations at
system, organ, and cellular levels are still insufficiently understood
despite their potential practical relevance. Greater mechanistic
understanding is being provided by technical advancements that
make it feasible to record multiple polysomnographic signals during
sleep in freely‐behaving small animals such as mice. These signals
include: multiple EEG derivations and the electromyogram (EMG) of
proximal (neck) and distal (e.g., tibialis anterior) muscles recorded
with implantable miniature electrodes; breathing recorded with
whole‐body plethysmography; and heart rate and blood pressure
recorded with implanted telemetric devices. The main challenges are
to co‐record multiple polysomnographic signals without perturbing
sleep in small animals, to develop mathematical tools balancing com-
plexity and interpretability for the analysis of complex autonomic‐
somatic interactions, and to explicitly test the translation of results
from clinical studies to basic research and back.
Disclosure: Nothing to disclose.
104 | The interplay between sleep bruxism,
arousals and breathing or period movement
related events
G. Lavigne
Faculty of Dental Medicine, Universite de Montreal, Montreal, QC,
Canada
Sleep bruxism (SB), characterized by tooth grinding and sustained
jaw muscle activity, is a repetitive motor activity. It presence during
sleep is estimated by a biomarker, rhythmic masticatory muscle
activity (RMMA). The role of such natural activity is debated from a
physiological reactivity to autonomic cardiac and respiratory adjust-
ments. SB‐RMMA are highly prevalent in child; incidence drop with
age. During sleep of young and healthy subject, most RMMA are
associated with sleep arousals, with the A3 arousal phase of the
Cyclic Alternating Pattern (CAP). Clonidine, an alpha 2 adrenergic
agonist, reduce the autonomic activation and the frequency of
RMMA. The occurrence of SB is dominant in light sleep and in the
minutes before REM sleep. In some individuals, RMMA may be asso-
ciated with some breathing events, either preceding or following
RMMA. Then the putative association of RMMA to apnea is debate,
i.e., probably coincidental and not a cause of SB. Furthermore, the
timing of RMMA and period limb movement (PLM) is frequent with
sleep arousals but its prevalence is also age dependent. SB and
RMMA frequent in young subjects and PLM is more dominant with
aging.
Disclosure: Nothing to disclose.
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PARASOMNIAS
O105 | Negative stress coping is associated
with structural integrity of posterior cingulate
cortex in sleep walking
M. Ramm1; A. Urbanek1; P. Young1; C. Scherfler2;
A. Heidbreder1
1Institute of Sleep Medicine and Neuromuscular Disorders,
Universitätsklinikum Münster, Münster, Germany, 2Department of
Neurology, Medical University of Innsbruck, Innsbruck, Austria
Objectives/Introduction: Subjects with mood or anxiety disorders
are thought to be at higher risk for a non‐rapid eye movement
(NREM) parasomnia. Studies that investigated the psychological fea-
tures below the threshold of a psychiatric disorder are rare. More-
over, the neurobiological underpinnings of this disorder remain
largely unknown. Recently, gray matter abnormalities in the left pos-
terior midcingulate (MCC) and dorsal posterior cingulate cortex
(dPCC) have been suggested as a neuroanatomical substrate of
NREM parasomnia. Aim of the current study was to further investi-
gate personality structure and, more specifically, stress coping skills
in relation to posterior cingulate structural integrity in patients with
NREM parasomnia.
Methods: Standardized questionnaires of personality and stress
coping skills were administered in 15 drug‐free and polysomnogra-
phy‐confirmed adult patients with NREM parasomnia and 15 age
and gender matched healthy controls. 3 Tesla T1‐weighted magnetic
resonance imaging data of the patients were analyzed with voxel‐
based morphometry.
Results: In the Freiburg Personality Inventory FPI‐R patients with
NREM parasomnia showed significant higher extraversion (p = 0.03)
and neuroticism (p < 0.01) compared to controls. Moreover, higher
behavioral inhibition trait (p < 0.04) as assessed by the Reinforce-
ment Sensitivity Theory of Personality Questionnaire and higher
negative stress coping trait (p < 0.01) using the Stress Coping Ques-
tionnaire SVF 120 were found. Increased adjusted posterior cingu-
late volume predicted pronounced negative stress coping tendencies
(r = 0.67; p < 0.01).
Conclusions: Results indicate a personality structure with emotion-
ality, avoidance tendency and negative stress coping in patients with
NREM parasomnia that is partly related to an increased PCC volume.
This is congruent to the assumption in Gray's influential personality
theory that the PCC is part of the brain's behavioral inhibition sys-
tem. The findings add support to the idea that NREM parasomnia,
PCC gray matter abnormality and negative coping strategies such as
flight, resignation and social withdrawal are all part of a common
pathophysiology.
Disclosure: MR, AU, PY, CS and AH claim that there is no conflict
of interest concerning the contents of this abstract.
O106 | Topographical spectral power changes
associated with NREM parasomnia episodes – a
high‐density EEG study
J. Cataldi1; S. Lecci1; G. Bernardi1,2; F. Siclari1
1University Hospital of Lausanne, Lausanne, Switzerland, 2IMT School
for Advanced Studies, Lucca, Italy
Objectives/Introduction: Arousal disorders are NREM parasom-
nias characterized by incomplete awakenings from slow wave sleep
(SWS) and abnormal behavior. Previous work suggested that para-
somnia episodes (PE) display features of both sleep and wake in dif-
ferent brain areas. However, these observations are based on single
episodes/patients and techniques that are not widely available
(SPECT, intracranial recordings). Here we asked whether we could
identify consistent changes in brain activity associated with PE using
high‐density (hd)‐EEG
Methods: Six subjects (4F, age 24.3 ± 5.3, 18–33) presenting
NREM parasomnia episodes (sleepwalking, confusional arousals or
night terrors) at least 1×/week underwent a baseline and a second
sleep recording after 24 h total sleep deprivation (hd‐EEG with 256
electrodes). During the latter, acoustic stimulations were adminis-
tered to provoke PE. Selected EEG segments corresponding to PE
were cleaned from artifacts using independent component analysis.
Channels with artifacts were removed and interpolated. Topographi-
cal spectral power (2–35 Hz) of PE was compared with SWS (60 s
preceding each episode) and daytime wakefulness (20 s with eyes
open) using paired t‐tests. A cluster‐ and probability based correction
for multiple comparisons was applied.
Results: 26 clear‐cut PE in 6 subjects were recorded (confusional
arousals and night terrors). Compared to SWS, PE were character-
ized by significantly lower delta (2–4 Hz) and higher beta power (18–
30 Hz) in a centro‐frontal region (p < 0.05). With respect to wakeful-
ness, this area showed significantly increased delta activity during PE
(p < 0.05). Alpha power was also significantly increased in temporal
regions (p < 0.05) during PE. No significant differences were found
for other frequency bands.
Conclusions: Our results suggest that it is possible to use hd‐EEG
recordings to study regional brain activity during behavioral epi-
sodes. EEG during episodes displays both features of wake (in-
creased high‐frequency activity with respect to sleep) and sleep
(increased low‐frequency activity with respect to wake). The most
consistent changes were restricted to a circumscribed fronto‐central
brain region, which is known to receive major projections from arou-
sal related structures.
Disclosure: Nothing to disclose.
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O107 | Regional patterns of neuronal activity
in REM sleep behavior disorder using high‐
density EEG
A. Valomon1; B.A. Riedner1,2; S.G. Jones1,2;
R.L. Goodpaster3,4; G. Tononi1; D.T. Plante1,2,3; R.M. Benca5;
M. Boly1,6
1Department of Psychiatry, 2School of Medicine and Public Health,
3UW Health, 4Wisconsin Sleep, University of Madison Wisconsin,
Madison, WI, 5Department of Psychiatry and Human Behavior,
University of California, Irvine, CA, 6Department of Neurology,
University of Madison Wisconsin, Madison, WI, United States
Objectives/Introduction: Rapid eye movement (REM) sleep
behavior disorder (RBD) is a sleep disorder characterized by REM
sleep abnormalities, such as loss of muscle atonia and enactments of
complex motor behaviors emerging from phasic REM sleep. To verify
the hypothesis that regional distribution of neuronal activity is
impaired in RBD, we performed quantitative analyses of sleep and
wake, using high‐density electroencephalography (hdEEG).
Methods: HdEEG recordings (256 channels), coupled with tradi-
tional sleep polysomnography, were obtained in 9 idiopathic RBD
patients and 9 age‐ and gender‐matched healthy subjects
(50 ± 10 years old, 66.7% male). Epochs of steady stage of N2/N3
sleep, REM sleep and wake were extracted. EEG data was filtered
from 1–40 Hz and average‐referenced. Tonic REM sleep was sepa-
rated from phasic REM sleep based on the absence/presence of REMs.
Independent component analysis was applied to remove physiological
noise. Absolute and subject‐normalized (Z scores) power densities for
each frequency bands (delta/theta/alpha/low beta/beta/gamma) were
compared using unpaired two‐sample t‐tests between the two popula-
tions and in each state. Tests were thresholded at corrected p < 0.05
using nonparametric threshold‐free cluster enhancement.
Results: In wake, RBD patients displayed reduced normalized delta
activity in frontal regions compared to controls. In NREM sleep,
compared to controls, RBD patients showed decreased absolute
theta power over centro‐parietal regions as well as reduced normal-
ized gamma and alpha activity in centro‐occipital regions. In REM
sleep, compared to controls, RBD patients showed a trend for
reduced global theta power and low beta activity in centro‐occipital
regions. Compared to tonic REM, phasic REM was characterized by
increased delta/theta power in frontal and central regions and
decreased alpha power in occipital regions, with greater visible dif-
ference in controls compared to patients.
Conclusions: Our findings suggest that decreased theta power dur-
ing N2/N3 sleep in scalp regions overlaying motor cortex, and conceiv-
ably blunted differentiation between tonic and phasic REM sleep,
might predispose RBD patients to motor behaviors during sleep. We
also confirmed previously described reduction in absolute alpha ‐ beta
power in RBD patients during both wake and REM sleep. Future analy-
ses using source localization reconstruction may help to identify corti-
cal origins that are the sources of observed differences.
Disclosure: Nothing to disclose.
O108 | Actigraphic differences in the rapid eye
movement sleep behavior disorder patients
D. Kemlink; P. Perinova; P. Dusek; E. Ruzicka; K. Sonka
General University Hospital, Department of Neurology, Charles
University in Prague, Praha, Czech Republic
Objectives/Instruction: The patients suffering of the rapid eye
movement sleep behavior disorder (RBD) are in high risk of develop-
ing a neurodegenerative disorder, most frequently from the group of
alpha‐synucleinopathies, such as Parkinson′s disease (PD) or multiple
system atrophy (MSA). The definitive diagnosis of RBD is based on
polysomnographic investigation. Actigraphy is much easier to per-
form adn reflects condition in patients home environment. The aim
of this study was to find suitable biomarkers for RBD, which can be
detectable by actigraphic recording.
Methods: High resolution actigraphic recording (MotionWatch,
CamNtech ltd.) for all four extremities were performed along with
polysomnographic recording in 37 RBD patients and 46 patients
with other sleep diagnoses. Each individual file was analysed be soft-
ware testing for amount of sleep (MotionWare 1.1.20) and secondly
for periodic motor activity (PLMS analysis 1.0.16). The 10‐item
patient self‐rating questionnaire (maximum total score 13 points)
translated to Czech language was also used for screening purposes.
We used an RBDSQ score of five points as a positive test result as
suggested by the original publication of the scale.
Results: When using the actigraphic sleep detection, we found sig-
nificant differences related to sleep fragmentation, more prominent
in the recording from the non‐dominant hand. Most notable was
increased percentage of immobile bouts (45.3% vs. 28.4%,
p < 0.00001), increased fragmentation index (69.1 vs. 41.6,
p < 0.00001) and decreased sleep efficiency (75.6% vs. 86.3%,
p = 0.0004). When analysing periodic motor activity, we also found
more movements on upper extremities in RBD patients (p = 0.006)
and surprisingly also more periodic hand movements (p = 0.0006).
On the other hand, differences on lower extremities using either
measurement were not significant. The discrimination function based
on RBDSQ and short immobile bouts could allocated correctly the
RBD status in 75.0% of cases with Wilks Lambda 0.71 and
p = 0.0002.
Conclusions: Actigraphic recording from upper extremities show
consistently more prominent sleep fragmentation in RBD patients
compared to other sleep diagnoses. We suggest also usefulness of
actigraphy in broader screening for RBD.
Disclosure: Supported by Grant of the Czech ministry of Health ‐
AZV 16‐28914A.
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O109 | Efficacy of prolonged release melatonin
for REM sleep behaviour disorder in Parkinson's
disease: a double blind, randomised, placebo‐
controlled trial
M. Gilat1,2; N. Marshall1,2; D. Hammond2; A. Coeytaux
Jackson1,3; A. Mullins1,2; J. Hall2; R. Grunstein1,2; S. Lewis1,2
1Woolcock Institute, University of Sydney, Camperdown, 2University of
Sydney, Sydney, NSW, Australia, 3Centre de Médecine du Sommeil et de
l’Éveil, Geneva, Switzerland
Objectives/Instruction: Half of all Parkinson's disease (PD)
patients experience REM behaviour disorder (RBD) with dream
enactment, which can be frequently injurious. Currently, melatonin
and clonazepam are the most recommended treatments for RBD.
However, current recommendations are based on poor evidence
from case‐reports and small case series. Thus, there is a need for
high quality evidence from randomized clinical trials to inform the
guidelines. We aimed to test the efficacy of prolonged‐released
melatonin for RBD in Parkinson's disease.
Methods: A phase‐II, randomised, double blind, placebo‐controlled,
parallel group trial with an 8‐week intervention period and 4 weeks
of observation before and after the intervention. 30 PD patients
with RBD were randomized into one of two arms (1:1) to receive
4 mg prolonged released melatonin (Circadin) or matched placebo
(lactose monohydrate) ingested orally once daily within 1 h of bed-
time. The efficacy of melatonin was assessed as the difference in
the mean total number of RBD events as captured by the “weekly
CIRUS‐RBD questionnaire”, which measures the frequency and
severity of RBD symptoms using daily entries. The primary outcome
was the aggregate of all incidents measured within weeks 5 to 8 of
treatment compared to the 4 weeks prior to treatment.
Results: One participant dropped out after moving overseas and
one participant with idiopathic RBD was mistakenly randomized as
being diagnosed with PD at study inclusion. All data obtained were
included in the mixed model analysis of variance (SAS 9.4). Adverse
events were mild and included headaches, mild fatigue and morning
sleepiness, (n = 4 in treatment and n = 5 on placebo). The dosage of
one participant in the treatment arm had to be reduced to 2 mg
daily for 4 weeks during treatment due to light‐headedness and fati-
gue in the morning, as per protocol. The primary outcome analysis
revealed no significant reduction in RBD events per week between
groups within weeks 5 to 8 of the protocol (3.6 events in the mela-
tonin group vs. 3.4 in the placebo group; difference 0.2 events/week;
95% CI = −3.2 to 3.6 events; p = 0.91).
Conclusions: Eight weeks of prolonged released melatonin did not
alleviate self‐reported RBD event rates in patients with RBD+Parkin-
son's disease.
Disclosure: Investigational product and matched placebo were pro-
vided to the investigators free of charge by the manufacturer for this
trial
JOINT SYMPOSIUM ESRS – ERS
INTERACTION BETWEEN SLEEP AND
OBSTRUCTIVE AIRWAY DISEASE: A
COCKTAIL PARTY
110 | Sleep disorders in COPD: etiology and
consequences
W. McNicholas
University College Dublin, Dublin, Ireland
Sleep quality is typically poor in COPD with diminished amounts of
rapid‐eye‐movement (REM) and slow‐wave sleep, which may con-
tribute to the daytime fatigue frequently reported by these patients,
and may also contribute to reduced survival. Sleep impairment in
COPD is linked to worse pulmonary function and lower daytime
activity levels and lung hyperinflation also appears to relate to poor
sleep quality in COPD patients. Furthermore, normal physiological
respiratory adaptations that occur during sleep are frequently ampli-
fied in COPD patients, resulting in clinically significant disturbances
in gas exchange, especially during REM sleep. These adaptations
include diminished respiratory drive, reduced skeletal muscle activity
that is particularly relevant to accessory muscle contraction, and
changes in lung mechanics such as reduced functional residual
capacity that adversely affect ventilation‐perfusion relationships.
These physiological adaptations do not produce clinically significant
changes in gas exchange in normal subjects but may result in major
oxygen desaturation in patients with COPD, which may result in
serious clinical consequences including an increased risk of death at
night during acute exacerbations, especially in hypercapnic patients.
Disclosure: Nothing to disclose.
THE DIFFERENT ENIGMATIC FACES OF REM
SLEEP BEHAVIOR DISORDER
111 | Does isolated REM sleep behavior
disorder exist? Lesson learned from the
longstanding non‐convertors
A. Stefani
Department of Neurology, Medical University of Innsbruck, Innsbruck,
Austria
An important proportion of individuals initially diagnosed with the
isolated form of RBD (iRBD) eventually develop an overt neurode-
generative disease, particularly the α‐synucleinopathies Parkinson
disease (PD), dementia with Lewy bodies, and less frequently multi-
ple system atrophy. Thus, it has become clear that iRBD represents
a prodromal stage of the α‐synucleinopathies in most, if not all,
cases. However, some patients do not develop an α‐synucleinopathy
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10 years or more after the diagnosis of iRBD (longstanding non‐con-
vertor). It can be hypothesized, that these subgroup of patients is
not at risk of developing an α‐synucleinopathy. A recent study by
the Sleep Innsbruck Barcelona (SINBAR) group investigated 20 long-
standing non‐cnvertors (mean follow‐up 12.1 ± 2.6 years) and 32
matched controls, showing that objective smell loss, constipation,
and mild parkinsonian signs were more frequent in iRBD patients
than controls. Interestingly, dopamine transporter imaging showed
decreased striatal uptake in 82.4% of the patients. All 20 patients
showed clinical, neuroimaging, or histologic markers of PD, suggest-
ing that they are affected by an underlying neurodegenerative pro-
cess. These results have been later on confirmed in a cohort of
eleven iRBD patients by the Montreal group. In this cohort, differ-
ences in progression speed, i.e. the annual increase in prodromal PD
probability, have been reported. Patients with IRBD are obvious can-
didates for future disease‐modifying trials. Some markers, like smell
function and DAT‐SCAN, have been reported to predict short‐term
conversion to overt α‐synucleinopathy. However, an important pro-
portion of longstanding iRBD patients presents these markers of
short‐term conversion. It can be speculated that iRBD patients who
remain disease‐free after a long period of follow‐up might constitute
a separate disease subtype, maybe associated with specific environ-
mental or genetic factors. This needs to be defined and character-
ized in further studies. Studies on long‐term non‐convertors showed
that the isolated form of RBD probably does not exist, and that all
these patients are in a prodromal stage of PD. These data emphasize
the difficulty in defining the ideal IRBD group to be recruited for dis-
ease modification trials. Identifying the modulators of latency to phe-
noconversion and exploring mechanisms for variable progression
rates in IRBD is a critical research priority.
Disclosure: Ambra Stefani received research funding and honoraria
for consulting from Axovant, travel support from Habel Medizintech-
nik and UCB.
112 | How to design a neuroprotective trial for
idiopathic rem sleep behavior disorder
A. Iranzo
Hospital Clinic de Barcelona, Barcelona, Spain
REM sleep behavior disorder (RBD) is characterized by abnormal
motor behaviors and vocalizations (e.g., jerking, kicking, shouting,
crying, laughing) and nightmares (e.g., being attacked or chased by
people or animals) linked to REM sleep without atonia. The idio-
pathic for of RBD (IRBD) is neither associated with cognitive com-
plains nor parkinsonism. IRBD is the most specific predictor of the
prodromal stage of Parkinson disease (PD) because (1) longitudinal
studies conducted in sleep centers have shown that most patients
diagnosed with IRBD eventually develop PD or related synucle-
inopathies (dementia with Lewy bodies and much less frequently
multiple system atrophy), (2) IRBD patients show clinical and
subclinical abnormalities that are characteristic of PD including sub-
tle parkinsonian signs, asymptomatic cognitive deficits, hyposmia,
constipation, depression and abnormal neuroimaging of the nigrostri-
atal system (e.g, hyperechogenicity of the substantia nigra, decreased
dopamine transporter uptake in the putamen), and (3) in vivo exami-
nation of subjects with IRBD demonstrates alpha‐synuclein aggre-
gates in peripheral tissues such as the colon, the submandibular
gland, the parotid gland, the minor salivary glands of the lips and the
skin. This indicates that IRBD may be a good candidate to test dis-
ease‐modifying interventions to stop the ongoing neurodegenerative
process in prodromal PD. This talk will address how to design a clini-
cal trial in patients with IRBD taking into account aspects such as
1) the duration of the trial,
2) the sample size,
3) the need for a placebo control,
4) the primary end point,
5) the secondary end point, and
6) the selection of the drug.
Disclosure: Nothing to disclose.
113 | Why do not all patients with Parkinson
disease have RBD?
F. Provini1,2; L. Baldelli2; G. Calandra-Buonaura1,2;
L. Sambati1; A. Cecere2; F. Mignani2; P. Cortelli1,2
1Department of Biomedical and NeuroMotor Sciences, University of
Bologna, 2IRCCS, Institute of Neurological Sciences of Bologna, Bologna,
Italy
Parkinson's disease (PD) is a widely heterogeneous disorder charac-
terized by a variety of motor and nonmotor manifestations including
REM sleep behaviour disorder (RBD). RBD is considered a harbinger
of an evolving α‐synucleinopathy, up to 81% of the patients converts
to an overt neurodegenerative disease over 16 years. However, RBD
prevalence in PD patients hardly reaches 40%, with many of them
developing RBD after motor symptoms onset. This intriguing associ-
ation can be discussed from both clinical and pathological points of
view. Tremor‐dominant PD patients show a lower prevalence of
RBD, while RBD is frequently associated with an akinetic/rigid motor
subtype. It has been observed that RBD is accompanied by more
severe autonomic dysfunction and cognitive impairment. RBD pres-
ence in PD seems to affect also the prognosis, as recently confirmed
by a prospective cluster analysis. RBD alongside two other nonmotor
features of PD (mild cognitive impairment and orthostatic hypoten-
sion) is one of the main determinants of a “diffuse malignant” sub-
type of PD. In contrast, the “mainly motor‐slow progression”
subtype is usually spared by RBD. Braak's pathological staging model
of PD progression suggests that RBD should appear as early as in
stage 2 of the disease. However, some patients reach the advanced
stages of PD without having never experienced RBD. Spreading
models, although conceptually true, could be interpreted in the light
of different spreading patterns, rather than different times of
ABSTRACTS | 53 of 433
progression. In fact, patients without RBD present with less density
and range of synuclein aggregation at brain autopsy. This could
explain the differences in clinical subtypes and prognosis. In conclu-
sion, evidence has slowly been moving researchers’ attention from
“why do PD patients have RBD?” to “why does not everyone with
PD have RBD?” correlating RBD absence with a better prognosis.
The answers to these questions can only be investigated into a
broader prospective considering not only the presence or absence of
sleep disorders, but also the whole clinical, instrumental and patho-
logical spectrum characterising PD.
Disclosure: Nothing to disclose.




Institute for Sleep Medicine and Neuromuscular Disorders, UKM
University Hospital Muenster, Muenster, Germany
The evidence that REM sleep behaviour disorder (RBD) plays a key
role in the development of alpha synucleinopathies is scientifically
undisputed. Isolated RBD's actuating variable is accordingly an early
marker of neurodegeneration. This is reflected in the high risk
(>80%) of RBD to convert into Parkinson's disease (PD), Dementia
with Lewy Bodies (DLB) or Multiple System Atrophy (MSA) within a
decade or longer. Beside this, RBD is occasionally applied as symp-
tom in the diagnosis of diseases such as immune mediated sleep dis-
orders. Different autoantibodies including paraneoplastic antibodies
are associated to these. RBD was described in encephalitis with anti-
bodies against CASPR2, Ma2 and LGI1 but also in anti‐IgLON‐5 dis-
ease. The anti‐IgLON‐5 disease is an antibody associated novel
neurological disorder. It was first characterized in 8 patients in 2014
by Sabater et al. This newly discovered disorder recaps a complex
neurological disorder with sleep, movement, neuroimmunological and
neurodegenerative aspects. It is characterised by parasomnia involv-
ing NREM and REM sleep, insomnia, and hypersomnolence. Beside
this, sleep disordered breathing with stridor is often observed. Other
neurological symptoms involving gait instability, bulbar, oculomotor
and autonomic symptoms, and cognitive impairment can be present.
Till today 4 different syndromes according to the predominant symp-
tom of Anti‐IgLON5 disease are described:
1 Sleep Disorder,
2 Bulbar Syndrome,
3 PSP like Syndrome,
4 Cognitive Impairment.
It is associated with IgG4 antibodies to IgLON5, a neuronal surface
cell adhesion molecule. Neuropathological examination showed neu-
ronal loss and gliosis associated with an atypical tauopathy mainly
involving the tegmentum of brainstem and hypothalamus. REM sleep
behaviour disorder was found in the majority of the described
patients and tended to be mild.This presentation gives an overview
of the current knowledge of the anti‐IgLON‐5 disease and the role
of REM‐ behaviour disorder in this recently described complex neu-
rological disorder.
Disclosure: Anna Heidbreder received honoraria for lecturing from
UCB, Bioprojet, Servier, and Vanda.
INSOMNIA DISORDER
O115 | Feeling awake while asleep: a high‐
density EEG assessment of sleep perception
S. Lecci1; J. Cataldi1; G. Bernardi1,2; J. Haba-Rubio1;
R. Heinzer1; G. Tononi3; F. Siclari1
1Lausanne University Hospital, Lausanne, Switzerland, 2MoMiLab Unit,
IMT School for Advanced Studies, Lucca, Italy, 3Department of
Psychiatry, University of Wisconsin‐Madison, Madison, WI, United
States
Objectives/Introduction: The impression of being awake despite
polysomnographically documented sleep is sometimes observed in
healthy individuals and to an extreme degree in patients with para-
doxical insomnia. The mechanisms underlying the subjective percep-
tion of sleep are not well understood. Here we asked whether high‐
density (hd)‐EEG, a technique with a refined spatial resolution, could
identify local patterns of brain activity related to the subjective per-
ception of sleep.
Methods: 14 healthy subjects (age 33.6 ± 8.5 years, 10 females)
underwent a serial awakening paradigm in the sleep lab while
recorded with hd‐EEG (256 electrodes). 969 awakenings were per-
formed across all sleep stages. At each awakening, subjects were
asked to describe what was going through their mind and to esti-
mate if immediately prior to the awakening they had been asleep or
awake.
Results: 10 of 14 subjects presented at least one instance in which
they reported feeling awake (FAW) during sleep (15.92 ± 8.76%
times per subject, total of n = 99 times). 70.83% of FAW instances
occurred in N1, 18.77% in N3, 9.79% in N2 and 3.57% in REM
sleep. Only stages N2 and N3 were further considered for analysis.
Compared to when subjects reported feeling asleep (FAS), FAW
instances occurred earlier in the night (147 ± 79 min after lights off
vs 231 ± 25 min; p = 0.0038). The presence of conscious experi-
ences during sleep did not distinguish FAW from FAS, but experi-
ences associated with FAW tended to be more thought‐like and less
perceptual compared to FAS (Score: 0.52 ± 1.17 for FAS;
−1.00 ± 1.84 for FAW; p = 0.076). FAW was associated with
increased alpha (8–12 Hz) and sigma power (12–16 Hz) in central
and posterior brain regions in the 20 s before the awakening. No
significant differences were observed for other frequency bands.
Conclusions: The preferential occurrence of FAW early in the
night (N3 > N2), its quasi‐absence during REM sleep and its
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association with increased alpha power in posterior (sensory) brain
regions may indicate that the subjective perception of sleep depends
on the degree of sleep‐related environmental disconnection.
Disclosure: Nothing to disclose.
O116 | Insomnia with objective short sleep
duration is associated with cardiometabolic,
cardiovascular and cerebrovascular disease risk
J. Fernandez-Mendoza1; F. He1; S. Calhoun1; D. Liao1;
E. Bixler1; A. Vgontzas1
1Penn State College of Medicine, Penn State College of Medicine,
Hershey, PA, United States
Objectives/Introduction: Insomnia with objective short sleep
duration has been previously associated with cardiometabolic risk
factors (CMR); however, there is a key gap on data regarding the
presence of an increased risk of cardiovascular (CVD) or cerebrovas-
cular (CBVD) disease in insomnia with objective short sleep duration.
Methods: We examined this question in the Penn State Adult
Cohort (N = 1,741, 52.2% women, 48.8 ± 13.6 years). The presence
of CVD was defined as a history of heart disease (n = 219) and that
of CBVD as a history of stroke (n = 40), while the presence of CMR
was defined as a history of hypertension and/or type 2 diabetes
(n = 877). The presence of sleep difficulty was defined based on 3‐
levels of severity of normal sleep (n = 1022), poor sleep (n = 520)
and chronic insomnia (n = 199). Given the small number of CBVD
cases and similar distribution of CVD among poor sleep and chronic
insomnia, our primary outcome was the presence of CVD/CBVD
(n = 259) and our primary exposure the presence of poor sleep or
chronic insomnia (n = 719). Objective short sleep duration was
defined as <6 h based on in‐lab polysomnography.
Results: A significant interaction indicated that objective short
sleep duration modified the association of insomnia with CMR and
CVD/CBVD (p < 0.05). Insomnia with short sleep duration was asso-
ciated with a significant increased risk of CVD/CBVD (OR = 1.85,
95% CI = 1.10–3.10) and CMR (OR = 42.37, 95% CI = 1.62–3.45),
while insomnia with normal sleep duration was not (CVD/CBVD:
OR = 1.33, 95% CI = 0.78–2.26; CMR: OR = 0.98, 95% CI = 0.66–
1.45).
Conclusions: Insomnia with objective short sleep duration is asso-
ciated with an increased prevalence of CMR and CVD/CBVD. These
data further support that the insomnia with short sleep duration
phenotype is a more biologically severe form of the disorder, whose
underlying pathophysiologic mechanisms and treatment needs
require further investigation.
Disclosure: This study was funded by the American Heart Associa-
tion (14SDG19830018; PI: Fernandez‐Mendoza) and the National
Heart Lung and Blood Institute (R01 HL51931, R01 HL40916; PI:
Bixler).
O117 | Bedtime social media use and insomnia
in adults
S. Hyvämäki1; P. Salo1,2
1Department of Psychology, University of Turku, 2Finnish Institute of
Occupational Health, Turku, Finland
Objectives/Instruction: Insomnia prevalence has increased during
the last decades. At the same time use of electronic media, espe-
cially social media, has increased. Social media is associated with
sleep disturbances among adolescents and young adults, especially
prebedtime use. In this study on adults, we distinguished speed mes-
saging, the more interactive part of social media use, from overall
social media use. Also watching television, as a more passive media
type, in bed was analyzed for comparison.
Methods: Two separate adult samples (aged 18–69) were com-
bined for analyzes. Participants (n = 587) were asked about volume
and frequency of their electronic media use in bed, insomnia symp-
toms and background information. Association between social media
use and insomnia was analyzed with logistic regression analysis,
where sex, age, relationship status, depression, self‐reported health
and sampling method were adjusted.
Results: Association between insomnia and volume and frequency
of social media was observed. More than one hour use of speed
messaging in bed was associated with 3.16‐fold (95% CI 1.28–7.81,
p = 0.013) risk for insomnia in fully adjusted model, comparing with
those who did not use speed messages in bed. Regarding social
media, 30–60 min use in bed was associated with 2.02‐fold (95% CI
1.00–4.05, p = 0.049) and >60 min use with 2.62‐fold (95% CI 1.05–
6.50, p = 0.038) risk for insomnia compared with non‐users. Fre-
quency of use was associated only with speed messaging with odds
ratio of 1.93 (95% CI 1.13–3.31, p = 0.017) for risk of insomnia
when speed messages were used in bed every night, compared with
non‐users. As a comparison, duration or frequent use of TV in bed
was not associated with insomnia.
Conclusions: Frequent or long lasting use of social media in bed
before bedtime was associated with higher risk for insomnia in
adults. The effect of speed messaging, which is more socially and
emotionally interactive, was slightly stronger than the other use of
social media. There was no association between passive media use
and insomnia. That may indicate the underlying mechanism of social
interaction in this context. Further research using more objective
measures and exploring direction of causality is needed.
Disclosure: Nothing to disclose.
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O118 | Treatment response of insomnia
disorder phenotypes and subtypes to
standardised digital cognitive behavioural
therapy
C. Gordon1,2; C. Miller3; N. Lovato4; M. Comas2,5;
N. Marshall1,2; D. Bartlett2,5; R. Grunstein2,5
1Sydney Nursing School, The University of Sydney, 2CIRUS Centre for
Sleep and Chronobiology, Woolcock Institute of Medical Research,
Sydney, NSW, Australia, 3Big Health Ltd., London, United Kingdom,
4Flinders University, Adelaide, SA, 5Central Clinical School, University of
Sydney, Sydney, NSW, Australia
Objectives/Instruction: Sleep duration phenotypes and clinical
subtypes are used to classify symptom and physiological differences
between patients with Insomnia Disorder. Whilst emerging evidence
suggests that phenotypic response to treatment may be different
between these groups, these results have been derived from post
hoc analyses of clinical trials. We aimed to evaluate treatment
response for phenotypes and subtypes of insomnia to standardised
digital cognitive behavioural therapy.
Methods: Participants were screened and diagnosed with Insomnia
Disorder (DSM‐5) and sleep physicians determined clinical subtypes
(sleep onset, maintenance, early morning awakening, mixed). Patients
attended two consecutive nights in a sleep laboratory for measure-
ment of: (i) objective (PSG) sleep duration; and, (ii) circadian measure
(dim light melatonin onset). All patients were enrolled in 16 weeks
of digital Cognitive Behavioural Therapy for insomnia (dCBTi:
SHUTi). Insomnia phenotypes were classified as short and normal
sleep duration using cluster analysis of sleep onset latency, wake
after sleep onset, total sleep time and circadian delayed (DLMO after
22:00). Primary outcome was Insomnia Severity Index (ISI) measured
at baseline, weekly (×6) during dCBTi and follow‐up. (ACTRN
12615000751572).
Results: 130 insomnia patients (47.2 (14.8) years; 69% female)
entered the study with 29 lost to follow‐up. 78 (60%) of patients com-
pleted at least 4/6 modules. Across all patients, there was a significant
decrease in ISI (19.9 [4.1] to 11.7 [5.8]; p < 0.001). Insomnia clinical
subtypes did not differ in treatment response (p > 0.05). Objective
short‐sleep duration (n = 62; TST 295.8; SOL 27.7; WASO 116.4) and
normal‐sleep duration insomnia (n = 67; TST 390.1; SOL 15.6; WASO
54.6) treatment response was not different (delta ISI: 7.7 (6.2) vs. 7.4
(6.0); p = 0.806). Similarly, the ISI treatment response of circadian‐
delayed insomnia phenotypes (n = 32; DLMO clock time 23:03 h;
post‐treatment ISI 10.4) were not different from non‐delayed (n = 79;
DLMO 20:33 h; post‐treatment ISI 12.3; p = 0.150).
Conclusions: This is the first a priori study showing dCBTi does
not have different efficacy in insomnia sleep‐duration and circadian
phenotypes. Despite short‐sleep duration insomnia phenotype with
heightened physiological hyperarousal having been posited to exhibit
treatment resistance to CBTi, their response rates were similar to
their normal‐sleep duration counterpart. The severity of physiological
derangement may not preclude treatment response.
Disclosure: CBM is a Research lead at Big Health (Sleepio) Ltd.
CJG, DB, RG were provided support from the Alertness, Productivity
and Safety CRC.
O119 | How best to sequence cognitive
behavioural therapy and medication when
treating chronic insomnia with and without
psychiatric comorbidity?
C. Morin1; J. Edinger2; A. Krystal3; H. Ivers1; S. Bonneau-
Beaulieu1; B. Guay1; A. Cartwright2; A. Solanoa2
1Laval University, Quebec, QC, Canada, 2National Jewish Health,
Denver, CO, 3Pscyhiatry, University of California, San Francisco, CA,
United States
Objectives/Instruction: There is little information on how best to
combine or sequence medication and cognitive/behavioural therapies
for insomnia to optimize outcomes. This paper reports findings from
a two‐site randomized clinical trial examining the efficacy of these
therapies, when used individually and in various sequences.
Methods: Patients were 211 adults (132 women; M age = 45.6 ±
14.9 years old) with an insomnia disorder, including 72 with a
comorbid psychiatric disorder. They were randomly assigned to first‐
stage 6‐week therapy involving either behavioural therapy (BT,
n = 104) or zolpidem (n = 107). Individuals not achieving remission
were randomized to a second treatment involving either pharma-
cotherapy (zolpidem or trazodone) or psychological therapy (BT or
cognitive therapy‐CT). The primary end points reported in this paper
was based on the Insomnia Severity Index and included treatment
response (ISI change score ≥8 point) and remission (ISI total score
<8).
Results: Intent‐to‐treat analyses showed that there were similar
proportions of treatment responders (44% vs. 43%) after initial
treatment with BT or zolpidem, but a larger proportion of remitters
in BT (33% vs. 26%). For those who did not remit with BT, the
addition of zolpidem or cognitive therapy yielded equivalent
response rates after 12 weeks (52% and 56%, respectively), but lar-
ger remission rates when there was a switch of treatment modality
(BT to zolpidem; 33%) than when patients remained within the
same modality (BT to CT; 22%). For those who did not remit with
zolpidem, the addition of BT or trazodone yielded similar response
rates after 12 weeks (44 vs. 48%) and identical remission rates
(22%). Although response/remission rates were generally lower
among patients with psychiatric comorbidity, treatment sequences
that involved BT followed by CT or zolpidem followed by tra-
zodone led to better outcomes for comorbid insomnia than for
insomnia without comorbidity.
Conclusions: These findings suggest that sequential therapy is an
effective strategy to optimize insomnia management. Adding a sec-
ond treatment modality produces an added value for those who fail
to respond to initial therapies. Patients with comorbid insomnia may
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also benefit from therapies (cognitive therapy, antidepressant) that
target mood in addition to sleep.
Disclosure: CM has served as speaker for Merck and as consultant
on an advisory board for Phillips.
LOCAL NETWORK SLEEP IN VIVO AND
IN VITRO
120 | The slow oscillation in vitro: a model for
sleep regulation
M. Tafti; S. Saberi-Moghadam
Department of Physiology, University of Lausanne, Lausanne,
Switzerland
Cortical networks in mature cortical cultures show a slow oscillation
characterized by a synchronized burst‐pause activity. When cortical
cultures grown on microelectrode arrays are stimulated with a cock-
tail of waking neuromodulators, a tonic network activity appears but
the slow‐oscillation returns after 24 h. The recovery from stimulation
results in a dose‐dependent homeostatic response with decreasing
inter‐burst intervals and increasing burst duration. Additionally, the
network shows higher cross‐correlation and strong phasic synchro-
nized burst activity. Spectral power below <1 Hz significantly
increases and the increase is due to steeper slopes of bursts. This
in vitro synchronized and sleep‐like activity seems to be generated
by cortical neurons only. Thalamic cultures, for instance, show a con-
tinuous tonic activity, while thalamo‐cortical co‐cultures show mixed
tonic and synchronized burst activity. Thus, we propose that this
simple in vitro model can be used for dissecting network mechanisms
of sleep homeostasis.
Disclosure: Nothing to disclose.
121 | Neuronal network dynamics of sleep and
wakefulness in C. elegans
M. Zimmer
Research Institute of Molecular Pathology (IMP), Vienna, Austria
How are global brain states like sleep and wakefulness reversibly
generated and maintained? The nematode worm C. elegans is a tract-
able model system to address this question. It has a stereotypic ner-
vous system of just 302 neurons. We recently developed a Ca2+‐
imaging approach to record the activity of nearly all neurons in the
brain, in real time and at single cell resolution. We applied this
approach to investigate how the brain switches between sleep and
wakefulness. Our previous work in awake animals discovered brain‐
wide neuronal population activity that involve a large fraction of the
animal's interneurons and motorneurons. This brain‐wide network
activity exhibits properties of a dynamic limit cycle attractor, which
corresponds to a neuronal representation of an action commend
sequence. Sleep is the pervasive brain state during specific episodes
of development, termed lethargus, when animals transit to the next
larval stage. We developed a sensory arousal paradigm that enabled
us to rapidly control the brain state of lethargus animals: aversive
atmospheric O2 concentrations, sensed by dedicated O2 sensory cir-
cuits, evoke a sustained state of arousal, while preferred intermedi-
ate O2 levels permit sleep. We found that when these animals are
left unaroused, neuronal population dynamics converge sponta-
neously towards a fixed‐point attractor. At this fixed point, most
neurons that are active during wakefulness are systemically down-
regulated, with the exemption of a few sleep‐active GABAergic
motor‐ and interneurons, which retain sustained activity. During
wakefulness, these sleep active neurons also participate in network
dynamics. However, activity of the sleep promoting interneuron class
RIS is elevated when the sleep pressure of the system is high, like
during lethargus. In summary, we show that sleep in C. elegans exhi-
bits a specific signature in brain‐wide network activity. Our data sup-
port a view of sleep as a default convergent state of the brain, from
which it must be aroused during wakefulness. In this model, the role
of sleep promoting neuronal circuits is to modulate the bias of the
network to approach the fixed‐point attractor. We propose that this
attractor state mechanism could be a means of switching effectively
between drastically different global states of the brain.
Disclosure: Nothing to disclose.
122 | Local origin of slow EEG waves during
sleep
I. Timofeev
CERVO Brain Research Center, Université Laval, Québec, QC, Canada
Neuronal activity mediating EEG slow waves consists of synchronous
alternation of intracellular active and silent states. Recent data
demonstrate that each active state of a sleep slow wave originates
in a particular cortical location and propagate to involve other corti-
cal areas. Preferential site of origin of these waves is the frontal cor-
tex in adult humans, and some animal species. At the site of origin
of these slow waves any neuron can initiate a particular cycle, how-
ever there are neuronal groups with high likelihood of triggering a
particular cycle. In epileptic patients, these neurons are mostly
located in superficial layers, but in healthy experimental animals,
populations of intrinsically bursting neurons with a high probability
of triggering spontaneous active states have been found in deeper
cortical layers. I will present data showing that each slow wave starts
in some set of neurons and from there, it propagates, occasionally
involving the whole cortical regions.
Supported by CIHR, NSERC and FRQNT.
Disclosure: Nothing to disclose.
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123 | Gene‐dependent state oscillations in vivo
and in vitro
J. Krueger1; J. Nguyen1; P. Taishi1; K. Jewett1; M. Xue2;
S. Roy2
1Washington State University, Spokane, 2Washington State University,
Pullman, WA, United States
We posit sleep is an activity‐dependent property of local brain net-
works based on;
(a) after all brain lesions, surviving subjects sleep;
(b) slow EEG waves wax and wane within isolated cortical
islands;
(c) marine mammals exhibit unilateral cortical EEG slow waves
during sleep; and
(d) human dissociated states within individuals suggest awake
and sleep can occur simultaneously.
Our hypothesis predicts that any neuronal/glial small network e.g.
cortical columns in vivo and co‐cultures in vitro, will oscillate between
sleep‐ and wake‐like states. Rector described individual cortical col-
umns oscillating between sleep‐ and wake‐like states in vivo. The
cortical column sleep‐like state is dependent on its prior activity, and
manifests sleep homeostasis. Small network sleep was extended to
in vitro cell‐cultures, by Corner who described their sleep‐like default
state. Independently, Tafti and Krueger extended those observations.
Culture state is changed by electrical or chemical stimulation and the
sleep‐like state in culture has homeostatic properties. Briefly, our
group showed that sleep regulatory substances, e.g. TNF, induce a
deeper sleep‐like state in vitro as evidenced by enhanced delta wave
power and that prolonged cell culture electrical stimulation promotes
the wake‐like state, which is followed the next day by a sleep‐like
state rebound. Cells lacking both TNF receptors have lower sponta-
neous delta wave power suggesting they are in a more wake‐like
state than wild type (WT) cells. Further, WT cells and cells lacking
the TNF receptors have reduced delta wave power after treatment
with a soluble TNF receptor, suggesting that reverse TNF signaling,
i.e. soluble TNF receptors binding to transmembrane TNF, wakes up
cultures. In contrast, soluble TNF binding to transmembrane recep-
tors promotes sleep. Cells derived from mice lacking a neuron‐speci-
fic interleukin‐1 receptor accessory protein, (AcPb), develop sleep
linked emergent network properties more slowly than WT cells. Fur-
ther, electrical stimulation of cells lacking AcPb is less effective as a
waking stimulus than in WT cells. Mice lacking AcPb, lack a homeo-
static sleep rebound after sleep deprivation. We conclude that small
neuronal/glial cultures manifest sleep‐defining emergent network
properties which are dependent upon sleep regulatory genes. Sup-
ported by NIH (USA) NINDS grant #'s NS025378 and NS096250A.
Disclosure: Nothing to disclose.
SHOULD WE BANK OUR SLEEP AND
CLOCKS? HOW AND WHY CREATING LARGE
MULTIMODAL DATABASES
124 | Regulations and ethics in biobanking
G. Vandewalle
GIGA‐Cyclotron Research Centre‐In Vivo Imaging, University of Liege,
Liege, Belgium
Science has entered the big data era. Multiple initiatives have
demonstrated the power of large reference databases including tens
of thousands of individual data to uncover the physiology and genet-
ics of complex diseases and their biomarkers (e.g. Alzheimer's,
Parkinson's, autism, diabetes, etc.). These initiatives imply multicenter
international consortia and require a lot of standardization for acqui-
sition, storage and analysis. They also raise interoperability concerns
about the Web diffusion of anonymized data. Perhaps most impor-
tantly, researchers are beginning to realize the potential of sharing
their data, encouraged by funding agencies and journals increasingly
requiring data to be openly available (e.g. FAIR principle). Several
sleep and chronobiology research have successful banked large
amount of data to gain insight notably in narcolepsy, chronotype,
insomnia and sleep duration. These examples remain however far
from being the norm, probably because sleep and wakefulness regu-
lation is such a rich phenomenon requiring multimodal and multilevel
detailed phenotyping (omics, electrophysiology, behavior, etc.). This
symposium will bring together three important actors of the
biobanking world. This first presentation will breifly set up the stage
for the other three speakers of the round table with an overview of
the legal and ethic issues that need to be taken into account in
biobanking initiatives.
Disclosure: Nothing to disclose.
125 | The Canadian Sleep Research Biobank
S. Warby
Hôpital du Sacré‐Coeur (Sommeil), Université de Montréal, Montreal,
QC, Canada
The Canadian Sleep Research Biobank has two primary goals: i)
assist individual researchers to with the collection of biological mate-
rials such as blood, cells and DNA to enable genetic, biochemical
and biomarker studies for sleep and circadian research, and ii) enable
larger scale collaborative projects that would not be possible other-
wise. Since many sleep/circadian traits and disorders are known to
have a strong genetic component, there is tremendous interest in
performing genetic studies, although not all investigators currently
have the facilities and capabilities to perform these studies. The Bio-
bank is an integral part of the Canadian Sleep and Circadian Net-
work, and can assist researchers in any of the steps in the process
of consenting patients, collecting and storing samples, producing
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blood marker or genotype data, and analyzing results. In addition to
the biological samples, the biobank stores phenotypic information
such as questionnaires or metadata from polysomnography studies.
The biobank provides a unified framework to standardize the collec-
tion of biological samples and information to maximize the useful-
ness of the data in the future. Investigators involved in biobanking
retain control over the decision of where and when to share the
samples they have collected, and the biobank facilitates the sharing
of the samples and information when appropriate. One specific focus
of the biobank is the overlap between sleep/circadian disorders and
their relationship with cognitive decline, psychiatric disorders and
neurodegenerative disease. The identification of genes and blood
markers involved in this relationship will help develop therapies to
treat these conditions.
Disclosure: Funding for this work was provided by the Chaire Pfi-
zer, Bristol‐Myers Squibb, SmithKline Beecham, Eli Lilly en psy-
chopharmacologie de l′ Université de Montréal, the Canadian Sleep
and Circadian Network (CSCN; https://www.cscnweb.ca/), and a
CIHR‐ICRH Community Development Program Grant.
CHRONOBIOLOGY
O127 | Objective sleepiness is reduced by
daytime polychromatic white light exposures
depending on melanopic lux
J. de Zeeuw1,2; A. Papakonstantinou1,3; C. Nowozin1,3;
S. Wisniewski1,3; M. Zaleska2; T. Fox2; S. Hädel1; F. Bes1,3;
D. Kunz1,2,3; M. Münch1,3,4
1Institute of Physiology, Sleep Research & Clinical Chronobiology,
Charité – Universitätsmedizin Berlin, Corporate Member of Freie
Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of
Health, 2Intellux GmbH, 3Clinic for Sleep & Chronomedicine, St. Hedwig‐
Krankenhaus, 4Institute of Medical Immunology, Charité –
Universitätsmedizin Berlin, Corporate Member of Freie Universität
Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health,
Berlin, Germany
Objectives/Instruction: The aim of this study was to determine
the impact of daytime light exposure on objective and subjective
sleepiness, by using polychromatic white light conditions which dif-
fered in peak wavelength of the blue light spectrum and/or light
intensity.
Methods: Seventy‐two healthy participants visited the laboratory
four times, arriving 1 hr after habitual wake‐up times while wearing
dark goggles (48 female; 24.4 ± 2.7 years; mean ± SD; within‐
between‐subject design). Starting ~3 hr after wake‐up, they were
exposed for 3 hr to polychromatic white light which differed in the
peak wavelength of the blue portion of the light spectrum but had
similar CCT (=3,500 K; blue light peak at 435 nm or at 480 nm), or
differed in illuminance (100, 200, 600, 1,200 lx; randomized order),
or a dim light (DL) condition. Subjective sleepiness assessed by visual
analogue scales and objective sleepiness in the electroencephalogram
(EEG; Karolinska drowsiness tests of 5 min closed and open eyes)
were measured hourly.
Results: During 3 hr of light exposure, objective sleepiness (as
determined by the EEG alpha attenuation index) was at 100 lx signif-
icantly reduced by light with a spectral peak at 480 nm compared to
435 nm or DL. We also found a trend for a reduction of objective
sleepiness by higher light intensities, which was greatest at 1,200 lx.
In addition, there were significant differences between the lighting
conditions in the EEG delta, theta, sigma and beta ranges depending
on the peak wavelength and light intensity. Subjective sleepiness
showed a significant and acute reduction in the first hour of expo-
sure to light with a spectral peak at 480 nm, when compared to
435 nm or DL.
Conclusions: The impact of the different spectral compositions of
light on the waking EEG was most pronounced at low light intensi-
ties (at 100 photopic lux), with higher melanopic lux (i.e. greater blue
portion at 480 nm) showing stronger alerting effects during daytime
in well‐rested participants. At higher light intensities the alerting
effects were mixed and interacted with spectral compositions, and
thus were less obvious.
Disclosure: Funding: This study was funded by the German Fed-
eral Ministry of Education and Research (OLIVE project) and Intellux
GmbH (Berlin), Germany Disclosures: none
O128 | Influence of habitual caffeine intake
and its withdrawal on circadian phase and nap
sleep in the evening
J. Weibel1,2; Y.-S. Lin1,2,3; H.-P. Landolt4,5; C. Garbazza1,2;
M. Meyer1,2,6; H. Slawik1,2,6; S. Borgwardt3; C. Cajochen1,2;
C. Reichert1,2
1Centre for Chronobiology, Psychiatric Hospital of the University of
Basel, 2Transfaculty Research Platform Molecular and Cognitive
Neurosciences, University of Basel, 3Neuropsychiatry and Brain Imaging,
Psychiatric Hospital of the University of Basel, Basel, 4Institute of
Pharmacology and Toxicology, University of Zurich, 5Zurich Center for
Interdisciplinary Sleep Research, University of Zurich, Zurich, 6Clinical
Sleep Laboratory, Psychiatric Hospital of the University of Basel, Basel,
Switzerland
Objectives/Introduction: Acute caffeine intake is well‐known for
its interference with the sleep homeostatic process and there is also
evidence that caffeine shifts circadian phase. Usually these effects
have been investigated in low caffeine consumers who were previ-
ously withdrawn from caffeine. Thus, our aim was to examine the
influence of habitual caffeine intake and its withdrawal on circadian
phase and on a nap sleep episode scheduled to a time of high circa-
dian wake‐promotion.
Methods: Seventeen male volunteers (age 25.9 ± 4.1 years, habit-
ual daily caffeine consumption 480.9 ± 110.0 mg) participated in a
double‐blind, balanced, crossover study comprising a caffeine
(3 × 150 mg caffeine for 11 days), a placebo (3 × placebo for
11 days), and a withdrawal condition (3 × 150 mg caffeine for
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9 days followed by 2 days placebo). Salivary melatonin was regularly
collected on days 10 and 11 of treatment under constant routine
conditions. Sleep electroencephalography was assessed in the eve-
ning during a 1‐hr nap episode scheduled 14.5 hr after habitual wake
time.
Results: Dim light melatonin onset did not reveal any significant dif-
ferences among the three conditions (p > 0.1). During nap sleep,
latency to sleep stage 2 was shorter (p < 0.05) and sleep efficiency
enhanced (p < 0.05) during withdrawal compared to caffeine and pla-
cebo condition. In addition, during withdrawal, slow‐wave sleep (stage
3 + 4) was prolonged (p < 0.05) and delta activity (0.75–4.5 Hz)
increased (p < 0.05) compared to caffeine condition. However, in the
caffeine condition, sleep latency, sleep structure and spectral power
density did not significantly differ from placebo (p > 0.1).
Conclusions: Our results corroborate that the acute challenge of
withdrawal from caffeine is associated with a higher sleep pressure as
mirrored in an increased sleep propensity and enhanced sleep intensity
compared to placebo and caffeine condition even at a time of high cir-
cadian wake‐promotion. Furthermore, our data indicate that habitual
caffeine intake does neither result in a clear circadian phase shift nor in
a stronger wake‐promotion in the evening. This might be related to
adaptive processes to the regular consumption of the stimulant.
Disclosure: Nothing to disclose.
O129 | Entrainment of circadian system and
sleep to extremely long photoperiods in modern
life and nature
J.R. Guzzetti1; T. Sundelin2,3; B.C. Holding4; P. Solsjö4;
A. Jemstedt5; K. te Paske4; Y. Altuzarra4; D. Skene6;
K.P. WrightJr7; J. Axelsson1,3
1Stress Research Institute, Stockholm University, Stockholm, Sweden,
2Psychology, New York University, New York, NY, United States,
3Clinical Neuroscience, Karolinska Instititute, 4Clinical Neuroscience,
Karolinska Institute, 5Psychology, Stockholm University, Stockholm,
Sweden, 6Health and Medical Science, University of Surrey, Guildford,
United Kingdom, 7Integrative Physiology, University of Colorado at
Boulder, Boulder, CO, United States
Objectives/Introduction: Light influences physiological processes
in humans, chiefly through synchronizing the internal circadian clock.
We have previously demonstrated that the human circadian clock syn-
chronizes to solar phase following exposure to only natural light, more-
over, the human clock adapts to seasonal changes in the natural light‐
dark cycles at ~40°N. In addition, living in natural environments with-
out artificial lights leads to a longer biological night during the winter,
predominantly driven by a large advance in melatonin onset timing
with no change in melatonin offset. Herein we aimed to elucidate a cir-
cadian response to extremely long natural photoperiods, measuring
melatonin timing before and after 1 week of camping in nature.
Methods: Participants wore Actiwatch Spectrums for assessment
of sleep, activity, and light exposure during 1 week of urban living in
Stockholm, Sweden (~59°N) and 1 week of camping in nature at
Sweden's High Coast (~63°N; 20 hr 40 min: 3 hr 20 m in natural
light‐dark cycle), within 2 weeks of the summer solstice. Salivary
melatonin levels were assessed from hourly samples taken during
two in‐laboratory 24‐hr dim‐light melatonin onset (DLMO) circadian
phase assessments conducted immediately before and after camping.
Results: On average, participants’ (n = 10) melatonin onset was not
different between environments (p = 0.45). Melatonin midpoint and
offset occurred ~0.7 and ~1.3 hr earlier, respectively (p < 0.01).
Melatonin offset occurred ~2.2 hr following the average sleep offset
prior to camping, and ~0.4 hr following sleep offset after camping.
Participants’ actigraphy‐estimated sleep onset, offset and duration
were similar etween environments (p ≥ 10).
Conclusions: Exposure to an extremely long summer photoperiod
in nature phase advanced the timing of the melatonin offset result-
ing in the biological night ending closer to wake time than when
compared to the urban environment. The latter is consistent with
prior findings and demonstrates that the end of the biological night
occurs closer to wake time even in extreme natural photoperiods as
compared to urban environments.
Disclosure: Kenneth P. Wright Jr., PhD serves on the Sleep Disor-
ders Research Advisory Board—National Heart Lung and Blood Insti-
tute, the Board of Directors of the Sleep Research Society, the
Scientific Advisory Board of CurAegis Technologies, as a consultant
for Circadian Therapeutics, has research support from, CurAegis
Technologies, Philips Inc., Somalogics, NIH, Office of Naval Research,
the PAC‐12. The other authors have no conflicts of interest to dis-
close.
O130 | Greater sleep inertia in young adults in
early biological morning
K.-M. Zitting1,2; M.Y. Münch1,2; S.W. Cain1,2; W. Wang1,2;
C.A. Czeisler1,2; J.F. Duffy1,2
1Division of Sleep and Circadian Disorders, Departments of Medicine
and Neurology, Brigham Health, 2Division of Sleep Medicine, Harvard
Medical School, Boston, MA, United States
Objectives/Introduction: Alertness is often impaired immediately
upon waking due to sleep inertia (SI), and this effect is magnified
under chronic sleep deficiency. Aging is associated with weaker cir-
cadian sleep‐promoting signal in the early biological morning, but
whether there is an age difference in the severity of SI after waking
up has not been extensively studied.
Methods: 12 healthy young (18–27; 6f) and 12 older adults (55–
70; 6f) participated in a 39‐day inpatient study. The study consisted
of 3 baseline days (time‐in‐bed (TIB) 10 hr/24 hr), followed by
3 weeks of chronic sleep restriction (CSR‐6.5 hr time TIB/28 hr,
equivalent to 5.6 hr/24 hr) in a forced desynchrony protocol. The
effect of SI during CSR was assessed by Karolinska Sleepiness Scale
(KSS, administered every 5 min) and the number of Slow Eye
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Movements (SEM, 30 s epochs) during the first hour of scheduled
waking. Mixed‐Model ANOVA was used for statistics.
Results: Subjective and objective alertness were most impaired
when waking from sleep at circadian phases 300, 0, and 60 (corre-
sponding to the biological night) and improved with time awake.
Young adults reported higher levels of sleepiness and had more
SEMs than older adults when waking up at circadian phase 60
(p = 0.009 for KSS; p = 0.002 for SEM), which corresponds to late
biological night/early biological morning. Young adults also spent less
time awake during the last hour of their 6.5 hr sleep opportunity
(2.2% vs. 27.0%, p < 0.001) and were more likely to have their final
awakening from REM than from NREM sleep than older adults
(p = 0.009).
Conclusions: These results support a weakened circadian sleep‐
promoting signal in the early biological morning with aging, and have
important implications for the scheduling of work in occupational
settings which require alertness immediately upon awakening.
Disclosure: Nothing to disclose.
O131 | Subjective sleepiness and waketime are
related to light perception
R. Lasauskaite1,2; C. Cajochen1,2
1Centre for Chronobiology, Psychiatric Hospital of the University of
Basel, 2Transfaculty Research Platform Molecular and Cognitive
Neurosciences, University of Basel, Basel, Switzerland
Objectives/Introduction: We aimed at identifying possible rela-
tionships between sleep‐related measures (sleep duration in the
night prior to the experiment, time awake, and subjective sleepiness)
and light ratings.
Methods: We pooled self‐report data from four psychophysiologi-
cal studies in which participants, after 10‐min baseline (2,800 K
light), spent 15 min in one of the experimental light conditions, fol-
lowed by a 5‐min cognitive task. Participants filled in Karolinska
Sleepiness Scale (KSS) upon the arrival to the lab and after the light
exposure episode. Light ratings (sense of color temperature as cool
to warm and preference of color temperature as rather cooler or
warmer, both on a scale from 1 to 7) were filled in at the end of the
experimental session. Two of four experiments included two experi-
mental blocks. For the present analysis, only KSS ratings concerning
the first block were considered. All designs were between‐subject.
We selected only experimental lighting conditions of 2,800 and
6,500 K to have a comparable number of participants for each con-
dition (total N = 197; 140 women). Physiological data were not con-
sidered for this analysis.
Results: The results revealed that lighting color temperature per-
ception and preference are related to subjective sleepiness and
waketime. KSS ratings were significantly correlated to lighting color
preference, r = 0.157, p = 0.028: the sleepier a person felt upon arri-
val to the lab, the warmer the light they have preferred
(independently of experimental lighting condition). The results also
revealed that the light was perceived as cooler the longer the wake-
time, r = 0.188, p = 0.008. Other correlations between sleep mea-
sures and light ratings were not significant (ps > 0.192).
Experimental lighting did not affect the change in subjective sleepi-
ness nor color temperature ratings (ps > 0.165).
Conclusions: Subjective sleepiness and wake time are related to
light perception. It is possible that higher subjective sleepiness leads
to preference of warmer, i.e. less activating, light because this way
the environment would better match the subjective state. Similarly,
wake time possibly modulates the perception of lighting color tem-
perature as a function of sensitivity to light.
Disclosure: This research was supported by the Swiss National
Science Foundation (No. PMPDP1_164478/1) and the Biäsch Stif-
tung (No. 2016/37), both awarded to the first author.
SLEEP IN REAL LIFE
O132 | Sleep, fatigue and cognitive
performance on different types of fishing vessels
A. á Høvdanum1; P. Weihe1; W. van Leeuwen2; F. Debes1
1Department of Occupational Medicine and Public Health, Faroese
University, Tórshavn, Faroe Islands, 2Stress Research Institute,
Stockholm University, Stockholm, Sweden
Objectives/Introduction: Trawlers, netting vessels, and long liners
are the main vessels on which Faroese fishermen work. Longliners
typically have a regular working schedule, whereas trawlers and net-
ting vessels have more irregular shifts (6–16 hr in a row), respec-
tively. This study compares sleep, fatigue and cognitive performance
on these three types of vessels and investigates how these parame-
ters are affected during the length of a fishing trip.
Methods: Crew of trawlers (n = 15), netting vessels (n = 32), and
longliners (n = 79) participated during their 3‐day, 4‐day, and 14‐day
fishing trips respectively. During these periods, sleep diaries were
filled in and sleepiness was rated every second hour or more, using
the Karolinska Sleepiness Scale (KSS). Moreover, a cognitive test bat-
tery was performed at the start and end of each fishing trip.
Results: Although reaction times of crew of all types of vessels
were slower at the end of the trip (trawers from 428 to 455 ms;
netting vessels from 426 to 1206 ms; longliners from 471 to
761 ms), no statistical significance was reached. Even working mem-
ory remained stable (varying from 77 to 80% correct) on all types of
vessels. Severe sleepiness (KSS > 7) was significantly more prevalent
on trawlers (26%) and netting vessels (23%) as compared to longlin-
ers (14%; chi squares respectively 15, 77, p = 0.0001 and 27, 51,
p < 0.0001). Crew of netting vessels had significantly longer sleep
periods than that of longliners and trawlers (p < 0.001). Sleep dairies
showed that working patterns on‐board netting vessels allowed for
the longest consecutive sleep periods (average of 347 min), but with
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only one period per day, while the work patterns on‐board trawlers
allowed for the shortest consecutive sleep periods (average of
228 min), but usually divided over 3 periods per day. Longliners
were the vessels that had a fixed shift system. Their consecutive
sleep period was 266 min twice a day.
Conclusions: Although cognitive performance did not differ
between different vessel types, levels of severe sleepiness were con-
siderably higher on‐board trawlers and netting vessels, despite the
fact that crew on netting vessels had the possibility to obtain the
longest sleep periods.
Disclosure: Nothing to disclose.
O133 | Do rats avoid a radiofrequency
exposed environment to sleep?
F. Del Vecchio1,2; A. Bosquillon de Jenlis1; C. Person3; R. de
Seze4; S. Delanaud1; V. Bach1; A. Pelletier1
1Laboratory PériTox, University of Picardie Jules Verne, AMIENS, 2Unité
Risques Technologiques Emergents, Institut de Recherche Biomédicale
des Armées, Brétigny sur Orge, 3IMT Atlantique, Brest, 4Laboratory
PériTox, INERIS, Verneuil‐en‐Halatte, France
Objectives/Introduction: Some people living near a base station
antenna reported sleep disturbances and discomfort but whether
there is any causal link with radiofrequency (RF) exposure remains
questionable. In a previous study, we demonstrated physiological
(tail vasoconstriction) and hypnic (fragmentation of REMS, prefer-
ence to sleep at higher ambient temperature) modifications when
rats were continuously exposed to radiofrequency electromagnetic
fields (RF‐EMF), suggesting a thermal discomfort (Pelletier A. et al.,
2013, 2014). This study assesses whether rats discriminate RF‐
EMF constraint and if hypnic impairment appears when they are
free to choose between a shielded and a RF‐EMF exposed envi-
ronment.
Methods: Three weeks‐old male Wistar rats (n = 17) have been
chronically exposed during 5 weeks to low RF‐EMF (900 MHz,
2 V/m, whole‐body SAR = 30 mW/kg). During the 5th week of expo-
sure, the RF‐EMF preference was assessed during four consecutive
days with an experimental chamber made of 2 interconnected com-
partments. Each day, alternatively, one compartment was exposed to
RF‐EMF (more than 2 V/m) and the other control compartment was
less exposed (less than 1 V/m). Wakefulness, NREM and REM sleep
were recorded continuously with a telemetric system to allow free
moving of rats. The time spent in each compartment, the total dura-
tions of sleep stages, the mean durations of episodes and their fre-
quencies were tested using analysis of variance. The results are
expressed in mean ± SD.
Results: During the 11‐hr light‐rest period, rats spent more time in
the control compartment with respect to the RF‐EMF exposed one
(+82.6 min, p < 0.01). In contrast, during the 12‐hr dark period,
there is no statistical preference (344.6 ± 103.9 min vs.
375.4 ± 103.9 min). There is no difference in sleep parameters
whether the rat sleeps in the control or in the RF‐EMF exposed
compartments.
Conclusions: Our results point out for the first time that rats
“feel” RF‐EMF exposure since they partially avoid the more exposed
RF‐EMF compartment during the daytime‐sleep period. This strategy
prevents them from sleep disturbances observed in our previous
studies. This result could explain some discrepancies in the epidemi-
ological studies regarding sleep disturbances and RF‐EMF.
Disclosure: Nothing to disclose.
O134 | Exercise effects on the circadian
rhythm of adolescents with extreme evening‐
type circadian preference: a novel treatment to
improve sleep health
C. Lang1,2; C. Richardson3; M. Short3; M. Gradisar3
1Department of Sport, Exercise, and Health, University of Basel, Basel,
Switzerland, 2College of Education, Psychology and Social Work,
3Flinders University, Adelaide, SA, Australia
Objectives/Introduction: Over the course of adolescence, biologi-
cal sleep patterns shift to later sleeping and waking times, leading to
a greater gap between sleep duration on every night of the week.
Delayed sleep pattern seem to be a normal part of adolescent devel-
opment. However a severe form of eveningness has been identified
as delayed sleep‐wake phase disorder (DSWPD). The delay in falling
asleep can be a hindrance to academic achievement. In contrast,
morning exercise before school may be a novel intervention that can
be easily incorporated into adolescents’ weekly routine, with benefi-
cial effects on sleep. Therefore, the main goal was to measure short‐
term effects of morning exercise on phase of melatonin rhythm in
adolescents with an extreme eveningness preference.
Methods: 18 male adolescents aged 15–18 participated in this ran-
domised controlled trial, with exercise as the between‐subjects fac-
tor. The primary outcome variable is timing of dim light melatonin
(DLMO) and core body temperature. Secondary outcomes include
daytime sleepiness, sleep, and mood. Data assessment took place
during school holidays, allowing participants to spend six consecutive
nights at the sleep laboratory. Morning procedure included either
45 min walking on a treadmill (IG) or sedentary activities (CG) in dim
light (<10 lux). Saliva DLMO, core body temperature and mood were
assessed during the first and last night of laboratory attendance. The
treatment protocol for morning exercise is based on the bright light
approach described by Bjorvatn & Pallesen (2009). Sleep and physi-
cal activity pattern were controlled in the week prior and throughout
study assessment subjectively and objectively.
Results: Individuals in the control group had delayed their circadian
timing (M = −22 min, SD = ±37 min), while the exercise group has
slightly advanced (M = +5 min, SD = 22). In other words, 5 days of
morning exercise appeared to have a preventive effect of a negative
circadian shift by 27 min (p < 0.07).
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Conclusions: Given the dearth of knowledge on adolescent sleep,
this study adds to our current understanding about exercise‐induced
phase advances on human melatonin rhythm. Research in this area
will add to the identification and current treatment procedures of
young patients with a DSWPD.
Disclosure: Nothing to disclose.
O135 | Chronotype, social jetlag and work
performance in a sample of Japanese workers
Y. Komada1; I. Okajima2; S. Kitamura3; Y. Inoue4
1Liberal arts, Psychology, Meiji Pharmaceutical University, 2Department
of Psychological Counseling, Faculty of Humanities, Tokyo Kasei
University, 3Department of Sleep‐Wake Disorders, National Institute of
Mental Health, National Center of Neurology and Psychiatry,
4Department of Somnology, Tokyo Medical University, Tokyo, Japan
Objectives/Instruction: Several studies have suggested that social
jetlag have negative effects on daytime function, such as academic
performance, daytime sleepiness. Individual chronotype has been
also associated with a range of health behaviors, depressive symp-
toms. The shift‐work research reported significantly slower reaction
times during morning shifts, as compared to night shifts, in a sample
of late chronotype. The aim of this study was to investigate the rela-
tionship between self‐reported work performance, chronotype, and
social jetlag.
Methods: A web‐based cross‐sectional survey was conducted
among registered monitors of a survey company in Japan. A total of
10,000 monitors who were matched in age, sex and resident area to
a Japanese representative sample, were randomly invited to partici-
pate in the survey. We excluded those who provided invalid answers
(n = 198), who has not worked (n = 3,966) or engaged in shift work
(n = 1,232), and who reported sleep times on free days with use of
alarm clocks, a requirement for determining chronotype (n = 2,389).
The final sample comprised 3,708 participants (57.8% male, average
age: 44.2 [13.5] years old). This study was approved by the ethics
committee of Tokyo Medical University. Questionnaires consisted of
demographic variables, Munich Chronotype Questionnaire (MCTQ),
and Japanese version of the Work Limitations Questionnaire (WLQ).
The WLQ is a self‐administered questionnaire measuring the degree
to which health problems affect job performance (on‐the‐job work
disability) and the work productivity impact of these work limitations
in the previous 2 weeks.
Using MCTQ, we calculated mid‐sleep (the mid‐point between sleep
onset and sleep end) on free (MSF) and work days (MSW). To deter-
mine individual chronotype, mid‐sleep on free days was calculated,
corrected for accumulated sleep debt on work days (MSFsc). Social
jetlag (SJL) is computed by the absolute difference between MSF
and MSW.
Results: There was no significant difference in workplace perfor-
mance between SJL >= 1 hr and SJL < 1 hr in early chronotype. The
groups of SJL >= 1 hr/late and intermediate chronotype showed
larger productivity loss (F (5, 3464) = 9.39, p < 0.01), whereas work-
place performance outcomes (presenteeism, mental interpersonal
demands) were kept in the groups of SJL < 1 hr/late and intermedi-
ate chronotype.
Conclusions: Our results suggested that circadian misalignment,
but not chronotype per se, may be critical for work performance.
Disclosure: This work was supported in part by a Grant‐in‐Aid for
Scientific Research from the Japan Society for the Promotion of
Science (JSPS KAKENHI Grant Number 16K07545). Komada has
received grant support from Otsuka Pharmaceutical Co., Ltd., Eisai
Co., Ltd., and MSD K.K.
O136 | Dreaming of Mars: inter‐individual
differences in sleep, sleepiness and performance
during a year‐long stay in Antarctica
O. Mairesse1,2,3; D. Neu4; E. Macdonald-Nethercott5;
N. Pattyn2,6
1Experimental and Applied Psychology, Vrije Universiteit Brussel, 2Royal
Military Academy (R.M.A.), 3CHU Brugmann, 4Sleep Laboratory and
Unit for Chronobiology, CHU Brugmann, Brussels, Belgium, 5Princess
Alexandra Hospital, Essex, United Kingdom, 6Vrije Universiteit Brussel,
Brussels, Belgium
Objectives/Introduction: Manned spaceflights from Earth to Mars
will likely become reality within the next decades. Humans will be
exposed to prolonged isolation and confinement and altered pho-
toperiods in artificial atmospheric conditions, with potential adverse
effects on sleep and performance. On Earth, polar environments
serve as space‐analogues to study human adaptation, yet few studies
include polysomnography (PSG) due to operational constraints.
Methods: Polysomnography, subjective sleep, sleepiness and fati-
gue and psychomotor vigilance tested every 6 weeks in 13 males
(Hivernauts) during a winter‐over campaign at Concordia (Antarctica;
corrected altitude = 3,800 m) and compared to controls (n = 13; 2
females) in normobaric normoxia. Stability and robustness of inter‐
individual differences are examined by means of intra‐class correla-
tions (ICCs).
Results: Hivernauts present with periodic breathing (p < 0.001),
increased sleep onset latency (p < 0.001), reduced sleep efficiency
(p < 0.05) and increased sleep fragmentation (p < 0.001). Latency to
REMS appeared to be shorter (p < 0.005), REMS duration (p < 0.05)
increased and light sleep decreased (p < 0.001). Reaction speed is
reduced in Hivernauts (p < 0.005) and lapsing is increased
(p < 0.05). Situational sleepiness is moderate in Hivernauts, but
higher than controls (p < 0.05). Hivernauts with fixed work sched-
ules went significantly earlier to bed and rose earlier than partici-
pants with variable schedules, especially during the polar winter
season (p < 0.01). Subjectively reported sleep onset latencies are
shorter for crewmembers with variable sleep/wake schedules
(p < 0.001), but no significant differences are observed in PSG
parameters. Over time, all polysomnographic, chronometric and
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questionnaire variables showed significant inter‐individual variability
(between‐subject effects; all p's < 0.001) and were eligible for mean-
ingful ICC calculations. Individual differences in respiratory variables
show the highest degree of stability and robustness (>60% of
explained variance), followed by fatigue and situational sleepiness,
sleep fragmentation and cognitive speed (40 to 60% explained vari-
ance), suggesting moderate to substantial trait‐like characteristics.
Conclusions: Under prolonged exposure to extreme conditions,
the initial individual variability of sleep‐related responses to the envi-
ronment play a major role in how humans will adapt to it. Hence,
specific in‐depth, but not necessarily extended simulations are war-
ranted for selecting eligible candidates for extra‐terrestrial sojourns.
Disclosure: Nothing to disclose.
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137 | Sex and gender differences in sleep
apnea: a window into understanding disease
susceptibility
S. Redline
Medicine, Brigham and Women's Hospital, Boston, MA, United States
Obstructive sleep apnea is an explemar of a complex, chronic disease
that displays sexual dimorphisms in regards to symptom presenta-
tion, polysomnographic attributes, associated co‐morbidity, and clini-
cal impact. Women tend to report a higher frequency of insomnia
symptoms, have shorter hypopneas, and have a higher prevalence of
REM‐predominant sleep apnea. While early data suggested that
women may be at lower risk of cardiovascular complications, more
recent data with longer term follow‐up show that older women with
sleep apnea may be at greater risk for experiencing cardiac dysfunc-
tion, heart failure or death, compared to men with sleep apnea.
Emerging data also indicate that the association between physiologi-
cal endotypes as well as genetic variants with sleep apnea vary in
men and women. These data indicate that women have a higher
loop gain, lower arousal threshold and less airway collapsibility com-
pared to men. Differences in presentation and polysomnographic
findings likely have contributed to under‐recognition of sleep apnea
in women compared to men. Sleep apnea also varies in prevalence
across the lifespan, increasing both during pregnancy and after
menopause. This talk will review the key features that distinguish
sleep apnea in men and women with the goals of improving recogni-
tion and treatment of sleep apnea in women, and advancing the sci-
entific understanding of this complex disorder.
Disclosure: Received grants from the National Institutes of Health,
Jazz Pharma, and Beckman Coulter. Received consulting fees from
Jazz Pharma.
KEYNOTE LECTURE – WENBIAO GAN
138 | Learning and sleep‐dependent dendritic
spine plasticity and maintenance
W. Gan
Department of Neuroscience and Physiology and Skirball Institute, New
York University School of Medicine, New York, NY, United States
Dendritic spines are the postsynaptic sites of most excitatory
synapses in the mammalian brain. In vivo imaging of dendritic spines
in the mouse cerebral cortex indicates that spines are highly plastic
during development and become remarkably stable in adulthood. In
my presentation, I will discuss how learning experiences and subse-
quent sleep regulate the plasticity and maintenance of dendritic
spines. Because dendritic spines are the key elements for informa-
tion acquisition and retention, understanding how they are regulated
by sleep in the living brain provides important insights into the func-
tions of sleep in learning and memory.
Disclosure: Nothing to disclose.
HEADACHE AND SLEEP
139 | Headache and sleep
P. Jennum
Danish Center for Sleep Medicine, Department of Clinical
Neurophysiology, Rigshospitalet, Glostrup, Denmark
There is strong association between sleep and headache which both
show significant comorbidity in either children or adults. This comor-
bidity is linked to common neurophysiological and neuroanatomical
substrates. Several types of headache show correlation to sleep or
chronobiology. One of the strongest association are noted for hypnic
headaches. There is evidence in favor of an association between epi-
sodic cluster headache and sleep and circadian factors. However
other types of headaches including migraine also show relation to
sleep‐wake pattern. Headache also show association to specific sleep
disorders like parasomnias, restless legs syndrome, sleep apnea, peri-
odic limb movements during sleep, and narcolepsy. The assessment
of children and adults with headache should always include an accu-
rate anamnesis for the presence of sleep problems. Management of
headache should furthermore include relevant sleep diagnosis and
potential treatment.
Disclosure: Nothing to disclose.
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140 | Cluster headache & the clock
R. Fronczek1,2
1Department of Neurology, Leiden University Medical Centre, Leiden,
2Sleep‐Wake Center Stichting Epilepsie Instellingen Nederland (SEIN),
Heemstede, the Netherlands
Cluster headache is one of the most painful disorders known, with daily
up to 8 attacks of headache so excruciating that is it often referred to as
‘suicide headache’. The disease affects 0.1% of the population. An
extraordinary feature of cluster headache is its episodic nature: daily
attacks occur in clusters of weeks to months, alternating with periods of
months without pain attacks. Furthermore, attacks have a daily
rhythmicity.
In a recent study of our group, 82% of patients reported attacks to exhibit
a predictable, daily rhythmicity, with most attacks between 00:00 and
04:00 hr. Clusters of attacks occur in certain, with an intriguing relation
with the solstices and equinoxes. In cluster headache, alterations of secre-
tion patterns have been described for melatonin, cortisol, testosterone,
gonadotrophins, prolactin, growth hormone and thyrotropin. Our biologi-
cal clock resides in the suprachiasmatic nucleus of the hypothalamus. This
is a brain structure which contains the biological clock and regulates
essential bodily functions, such as sleep. A higher activation during attacks
was found in the ipsilateral posterior inferior hypothalamus using func-
tional magnetic resonance imaging (fMRI). At the end of cluster periods,
patients show decreased functional connectivity between the hypothala-
mus and pain networks using resting state fMRI. Recent work of our
group shows that the anterior part of the hypothalamus (the location of
the biological clock) is enlarged in cluster headache.
Cluster headache attacks are often linked to sleep. In a recent study of
our group, the most common headache trigger was sleep (80%). Attacks
often occur around 1.5 hr after sleep onset, suggesting a link with REM‐
sleep. In clinical anecdotes, patients can have a fear of going to bed,
actively postpone sleep or use voluntary sleep deprivation to avoid an
attack. The exact nature of the link between cluster headache and (REM)‐
sleep has never been fully elucidated, with contrasting results in the few
studies that have looked into this topic.
The episodic and circadian nature, the association with sleep as well as
neuroimaging data suggest a role for the hypothalamus and its biological
clock.
Disclosure: Nothing to disclose.
141 | Hypnic headache – the undesired
alarmer
C. Schankin
Department of Neurology, Inselspital, Bern University Hospital,
University of Bern, Bern, Switzerland
Background: Hypnic headache is a rare headache disorder that is
strongly connected with sleep. It occurs typically in elderly patients
and wakes them up at the same time at night. Caffeine can have a
paradoxical beneficial effect.
Objective and aims: To give an overview and update about hyp-
nic headache with a focus on headache‐sleep‐interaction. Clinical
presentation, differential diagnosis, pathophysiological background
and treatment options will be discussed.
Methods and results: Review of the literature on the clinical
description of the syndrome and on pathophysiological mechanisms
that have been investigated using brain imaging as well as sleep,
electrophysiological and hormonal studies.
Conclusion: Hypnic headache and sleep are closely related. The
exact mechanism remains unclear, but hypothalamic involvement is
possible.
Disclosure: Nothing to disclose.
142 | Hypothalamic pathways in headache &
sleep
P. Holland
King's College London, London, United Kingdom
Primary headache disorders represent a group of diverse neurologi-
cal disorders that present with varying intensity, duration, frequency
and associated symptoms. Despite these underlying differences the
hypothalamus has emerged as a critical component of several attack
forms, including migraine and cluster headache. Migraine is com-
monly associated with sleep disruption, shows a circadian pattern of
attack onset and is associated with abnormal fatigue during the earli-
est premonitory phase. Similarly, cluster headache often occurs dur-
ing sleep and attacks show clear circadian and circannual periodicity.
As such, there is a clear clinical association between sleep and head-
ache, with several lines of evidence pointing to hypothalamic
involvement.
Of particular interest the hypothalamic orexinergic system has
emerged as a key regulator of migraine‐related nociceptive process-
ing and targeted modulation of orexin receptors remains a valid ther-
apeutic target for primary headaches. In conjunction recent genetic
data has highlighted a key role for disruption of casein kinase 1‐delta
in the generation of familial advanced sleep phase system and
comorbid migraine with aura.
The hypothalamus is thus a key regulator of homeostatic mecha-
nisms including sleep‐wake cycles under circadian regulation. It has
emerged as a key structure for the regulation of primary headaches
and sleep and recent evidence points towards shared anatomical,
physiological and genetic points of convergence in hypothalamic net-
works.
Disclosure: PRH reveals no actual or perceived conflicts of inter-
est. Funding was received by the Medical Research Council.
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BIOMARKERS FOR SLEEP DISRUPTION AND
SLEEP DISORDERS
143 | Computational approaches to identify
and validate blood transcriptome biomarkers for
sleep and circadian health
E. Laing; C. Moller-Levet; N. Santhi; S. Archer; D.-J. Dijk
Faculty of Health and Medical Sciences, University of Surrey, Guildford,
United Kingdom
Blood is an easily accessible tissue, enabling the repeated and longi-
tudinal assessment of an individual. Technologically, transcriptomics
has been shown to be less error prone than other ‐omics and pro-
vides the opportunity to assess all transcripts. We and others have
shown that the whole‐blood transcriptome provides more informa-
tion than just the response of blood cells and can be used as an ′ac-
cessible window′ to the status of the human system. Blood
transcriptome biomarkers are therefore a viable solution on which to
base objective clinical assessments of circadian and/or sleep pertur-
bations. The development of objective assessments is important for
treatment and diagnosis, with applications in many real world situa-
tions e.g. suspected sleepy (drowsy) driver accidents, assessing ‘fit-
ness for duty’, interpretation and diagnosis of circadian rhythm and/
or sleep‐wake disorders, and evaluation of therapeutic interventions.
Here we present computational approaches to identify and validate
panels of transcriptome biomarkers for predicting the circadian (me-
latonin) phase and sleep debt status (experience of acute and chronic
sleep loss) of an individual from just one or two blood transcriptome
samples. For each target variable we were able to identify a panel of
biomarkers with >89% accuracy when applied to independent vali-
dation sets. Use of a priori knowledge did not produce top perform-
ing panels for the majority of variables. Biomarker panels for sleep
debt status showed little overlap with biomarkers for circadian
phase.
Our novel analyses demonstrate the feasibility of the human blood
transcriptome as a reservoir of biomarker panels related to sleep and
circadian processes, and highlight important methodological consid-
erations for future research.
Disclosure: Nothing to disclose.
144 | Systems genetics of sleep loss in the
mouse
M. Jan1; S. Diessler2; Y. Emmenegger2; N. Guex1;
B. Middleton3; D.J. Skene3; M. Pagni1; M. Ibberson1;
F. Burdet1; L. Götz1; M. Sankar1; R. Liechti1; C.N. Hor2;
I. Xenarios1; P. Franken2
1Vital‐IT Systems Biology Division, SIB Swiss Institute of Bioinformatics,
2Center for Integrative Genomics, Lausanne, Switzerland, 3Faculty of
Health and Medical Sciences, University of Surrey, Guildford, United
Kingdom
Sleep is an essential state to maintain optimal brain functioning.
Chronic disruption of sleep results however has negative impact on
health well beyond the central nervous system, with an increased
risk of metabolic disorders such as diabetes. To gain insight into rela-
tionship between sleep‐wake behavior and metabolism, and identify
possible novel biological substrates involved in the sleep regulatory
process, we assembled an extensive multi‐scaled dataset in mouse
using systems genetics. This approach allows to interrogate such
dataset at the genetic level and how genetic factors interact with
environmental factors such as a sleep deprivation. Furthermore, the
use of machine learning algorithms and high‐throughput sequencing
technology permit to appraise the plethora of physiological and
molecular phenotypes that constitute sleep at many systems levels.
This dataset is composed of 33 mouse recombinant inbred lines (RIL)
from the BXD panel that were interrogated under sleep deprivation
and undisturbed conditions for 341 sleep‐wake related physiological
phenotypes, 124 blood plasma metabolites, and cortical and liver
transcriptomes. First analyses pointed out the pervasive effects of
short sleep deprivation, which reshaped the systems genetics land-
scape by altering the mouse cortex and liver transcriptomes, and
blood metabolome. The strong genetic contribution could be mea-
sured at all phenotypic levels and could also drives the response to
sleep deprivation. Our findings led to the discovery of a bidirectional
relationship between fatty acid turnover and sleep homeostasis but
also between brain slow‐waves activity and ionotropic glutamate
receptor transport. The addition of supplementary data like chro-
matin accessibility may further complete this dataset for better com-
prehension of the molecular mechanisms involved. Using cloud‐
based technologies, we aimed at transforming this powerful hypoth-
esis‐building resource into a digital research object that can be data‐
mine by the sleep community.
Disclosure: Nothing to disclose.
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145 | DNA methylation in blood leukocytes as
putative biomarkers for insufficient sleep
A. Lahtinen1,2; S. Puttonen3; T. Paunio1,2
1Department of Health, Genomics and Biomarkers Unit, National
Institute for Health and Welfare, 2Department of Psychiatry, University
of Helsinki and Helsinki University Central Hospital, 3Work Ability and
Working Career, Finnish Institute of Occupational Health, Helsinki,
Finland
Sufficient sleep is essential for our health. Lack of sleep affects basic
physiological processes, including systemic inflammatory reaction,
and leads to an increased risk for various psychiatric and somatic
disorders. The identification of key players of molecular processes
associated with curtailed sleep could improve the assessment and
early prevention of the long‐term health risks. Though sleep is pre-
cisely regulated, the detailed mechanisms of the brain processes dur-
ing sleep remain unclear. As DNA methylation plays crucial role in
the regulation of cell gene expression, the study of differentially
methylated positions (DMPs) might enhance our understanding of
the molecular mechanisms underlying insomnia. We performed epi-
genome‐wide association studies for two independent cohorts of
males to identify DMPs in whole blood samples of individuals suffer-
ing from insufficient sleep (a population‐based sample) or diagnosed
with shift‐work disorder (an occupational cohort of shift workers).
Genes corresponding to DMPs common for both cohorts were ana-
lyzed by various tools to investigate affected biological pathways in
individuals lacking sleep. The data analysis showed that processes
related to neuronal plasticity and neurodegeneration were compro-
mised in people lacking sleep, as well as there is an enrichment of
genes involved in visual processing and regulation of circadian
rhythm. The majority of these DMPs were hypomethylated in cases
in both cohorts, as compared to controls, suggesting that insufficient
sleep may be associated with loss of DNA methylation. The results
give evidence for the importance of the epigenetic regulation in
mediating both brain‐specific and systemic stress caused by compro-
mised sleep and diurnal rhythm.
Disclosure: Nothing to disclose.
PHARMACOLOGICAL THERAPY OF
OBSTRUCTIVE SLEEP APNEA. NOVEL TOOLS
AND PRINCIPLES
146 | The challenge of designing trials in OSA
J. Verbraecken
Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital
and University of Antwerp, Edegem, Belgium
Before implementing a study, careful consideration should be given
to the appropriateness of the proposed study design, especially in
terms of practical feasibility, study information to be obtained,
expected duration of the study and resources. Apart from the type
of study choosen, the following problems can be encountered: sam-
ple size, access to patients, the time available to investigate a
research problem and measure change or stability over time (short‐
term versus long‐term risk and effect of treatment), selection bias,
use of gold standard techniques (polysomnography versus polygra-
phy; esophageal pressure cathethers versus noninvasive markers;
inhospital versus ambulatory techniques), scoring rules for EEG and
respiratory events, subclassification of respiratory events into
obstructive, central, mixed apneas and hypopneas, pathophysiological
phenotype, clinical phenotype (symptomatic versus asymptomatic
subjects, comorbidities or not (comorbidities may produce changes in
symptoms that are similar to OSA symptoms), concommittant sleep
disorders, level of obesity), intensity of follow‐up, application of tele-
monitoring, use of medications that cause side effects or that pro-
voke respiratory events, compliance for treatment or intervention.
Lifestyle characteristics such as socioeconomic and cultural back-
ground, health status, smoking, alcohol habits, and exercise are con-
founding but unmeasurable factors. Finally, an important problem is
the occurrence of missing data for participants in a clinical trial (lost
to follow‐up, withdrawal due to adverse effects of an intervention).
Use of an intention‐to‐treat approach (patients to be included even
if they did not fully adhere to the protocol should still be kept in the
analysis) versus a per‐protocol analysis (only patients who complete
the entire clinical trial according to the protocol are counted towards
the final results). A per‐protocol analysis will lead to an overestima-
tion of the treatment effect. Clinicians and researchers should care-
fully consider this potential spectrum bias in study designs and data
analyses.
Disclosure: Nothing to disclose.
147 | Pathophysiological phenotyping as a
rational for drug development
D.J. Eckert
Neuroscience Research Australia (NeuRA) and The University of New
South Wales, Randwick, Sydney, NSW, Australia
Existing therapies for obstructive sleep apnoea (OSA) such as contin-
uous positive airway pressure (CPAP), mandibular advancement
splints (MAS) and upper airway surgery focus on alleviating the
upper airway anatomical predisposition to OSA. CPAP is highly effi-
cacious although poorly tolerated with adherence rates of 50% or
less. Second‐line therapies, including MAS and upper airway surgery
have variable and unpredictable efficacy. Thus, given the burden of
disease, the shortcomings of existing therapies, and the major health
and safety consequences of untreated OSA, development of new
therapies for OSA is a priority. In recent years there have been
major advances in our understanding of sleep apnoea pathogenesis.
The concept of pathophysiological phenotyping has emerged. In
addition to varying degrees of impairment in upper airway anatomy,
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this body of work has identified three key non‐anatomical contribu-
tors to OSA:
1) impaired upper airway dilator muscle function,
2) a low respiratory arousal threshold and
3) unstable respiratory control [high loop gain].
Identification of these non‐anatomical phenotypes, one or more of
which are present in ~70% of OSA patients, has unlocked new tar-
gets for therapy including pharmacotherapies. Indeed, proof of con-
cept physiology studies that deliver pharmacotherapies to improve
impairment in each of the three non‐anatomical causes of OSA (in
isolation or in combination) using a targeted phenotypic approach
have been shown to reduce OSA severity. Inadequate consideration
of the heterogeneity of OSA pathogenesis combined with incom-
plete understanding of the neurobiology for pharmacological targets
likely explain why substantial previous attempts to develop pharma-
cotherapies for OSA in unselected patients have largely failed. This
presentation will highlight the latest knowledge in sleep apnoea phe-
notyping and its crucial role in the development of targeted pharma-
cotherapies to treat OSA for which there is considerable promise.
Disclosure: DJE is supported by a National Health and Medical
Research Council (NHMRC) of Australia Senior Research Fellowship
(1116942). His research is funded by the NHMRC and Cooperative
Research Centre (CRC) funding programs, a collaboration between
the Australian Government, Academia and Industry (Industry partner:
Oventus Medical). He serves as a consultant for Bayer.
148 | Cannabinoid receptor modulation in
sleep apnea
D. Carley
Biobehavioral Health Science and Medicine, University of Illinois at
Chicago, Chicago, IL, United States
Sleep related breathing disorders (SRBD), especially obstructive sleep
apnoea (OSA), represent an important worldwide health problem,
conferring substantial cognitive/behavioral symptoms and increased
risk of motor vehicle accident, hypertension, myocardial infarction,
stroke, diabetes and death on at least 3% of the population. Identify-
ing novel treatments for OSA is of great public health significance,
because fully effective and acceptable treatments are lacking.
Despite basic research advances regarding the pathogenesis of OSA
and numerous clinical trials, generally effective drug treatments have
not been identified. Over the past two decades a range a basic and
clinical studies have supported the hypothesis that increased activity
of vagal afferent sensory pathways may importantly increase apnoea
propensity during sleep due to both disruption of respiratory rhythm
generation and inhibition of motor outputs to upper airway dilator
muscles. If correct, this view suggests novel pharmacotherapeutic
targets in OSA. For example, vagal sensory neurons express both
excitatory serotonin type‐3 and inhibitory cannabinoid type 1 and 2
receptors. Studies in an animal model of spontaneous sleep related
central apnoea showed that intraperitoneal injection of serotonin
dramatically increased apnoea frequency ‐ an effect that could be
abolished by pretreatment with dronabinol, a cannabinoid receptor
agonist. Further, dronabinol alone suppressed spontaneous apnoeas
in a dose‐dependent fashion. Moreover, direct injection of dronabi-
nol into the vagal afferent cells of the nodose ganglia yielded a dra-
matic increase of upper airway dilator muscle activity. The concept
of cannabimimetic therapy for OSA has now been translated to clini-
cal proof of concept. Most recently, dronabinol was tested in a
phase II randomized, placebo‐controlled, fully blinded, parallel groups
design in 78 adults with moderate or severe OSA. Again, dronabinol
treatment was associated with a clinically significant dose‐dependent
reduction of apnoea/hypopnea index. Collectively, these findings
support the view that cannabimimetic modulation of vagal afferent
signaling may prove effective in the treatment of at least some indi-
viduals with OSA. Larger pivotal clinical studies will be required to
demonstrate the best potential approach(es) to cannabinoid based
therapy of OSA.
Disclosure: DWC is an inventor on patents and patent applications
related to cannabinoid‐based treatment of sleep apnea. These
patents and applications have been assigned to the University of Illi-
nois at Chicago which has licensed relevant intellectual property
rights to RespireRx Inc. None of the work to be presented or dis-
cussed has been sponsored by RespireRx. Within the past year,
DWC has served as a consultant to RespireRx and to Jazz Pharma-
ceutical, Inc.
149 | Carbonic anhydrase activity modulation
in sleep apnea
E. Hoff; Z. Ding; G. Ludger; K. Stenlöf; J. Hedner
Department of Internal Medicine, Respiratory Medicine, Sahlgrenska
Academy, University of Gothenburg, Gothenburg, Sweden
Current therapy in obstructive sleep apnea (OSA) is mainly mechani-
cal by e.g. positive airway pressure or an oral appliance. Several
attempts to identify a pharmacological remedy targeting respiratory
drive (directly or indirectly) or upper airway collapsibility have been
made but there is yet no clinically documented drug available. Fur-
ther along these lines, a recent Cochrane review of drug treatment
in OSA (2013) stated that there is no currently evaluated substance
could be recommended for clinical use. Recent developments in the
area of precision medicine and the proposal of specific physiological
subtypes of OSA have sparked a renewed interest in the area and
lead to initiation of new trials. This presentation will deal with novel
insights into the effect of drugs with carbonic anhydrase (CA) inhibi-
tory properties in OSA. Experimental studies suggest that CA activity
may be increased in OSA in relation to the severity of the condition.
Such elevated activity has also been linked to hypertension in OSA.
In line with this data our recent studies suggests that CA inhibitors,
which have been used for treatment of high altitude illness and glau-
coma, may reduce the number of obstructive respiratory events dur-
ing sleep and reduce an elevated blood pressure in patients with
68 of 433 | ABSTRACTS
OSA and hypertension. Several CA inhibitors have also been shown
to possess other potentially beneficial effects in OSA such as drug‐
induced weight loss. Besides reviewing these specific effects of CA
inhibitors, this presentation will address aspects of trial design, defi-
nition of efficacy and the potential of future strategies for pharma-
cological treatment of OSA.
Disclosure: Hoff Erik, Ding Zou: none. Hedner Jan, Grote Ludger,
Stenlöf Kaj: 2 patent applications related to the topic
HYPERSOMNIA
O150 | Kleine‐Levin syndrome is associated
with LMOD3 variants
A. BaHammam1,2; S. Alshareef3; S. Basit4; S. Li5; C. Pfister6,7;
S. Pradervand8; M. Lecendreux9; G. Mayer10; Y. Dauvilliers11;
V. Salpietro12; H. Houlden12; M. Tafti6,7,13
1University Sleep Disorders Center, King Saud University, 2The Strategic
Technologies Program of the National Plan for Sciences and Technology
and Innovation, 3Al Imam Mohammad Ibn Saud Islamic University,
Riyadh, 4Taibah University, AlMadinah, Saudi Arabia, 5Department of
Physiology, Faculty of Biology and Medicine, Lausanne University
Hospital, 6Department of Physiology, Faculty of Biology and Medicine,
7Center for Integrative Genomics, Faculty of Biology and Medicine,
8Genomic Technologies Facility, Faculty of Biology and Medicine,
University of Lausanne, Lausanne, Switzerland, 9AP‐HP, Pediatric Sleep
Center and National Reference Center for Orphan Diseases, Narcolepsy,
Idiopathic Hypersomnia and Kleine‐Levin Syndrome, Robert‐Debré
Hospital, Paris, France, 10Hephata Klinik, Scwalmstadt and Philipps
University of Marburg, Marburg, Germany, 11Reference National Center
for Narcolepsy, Department of Neurology, Gui‐de‐Chauliac Hospital,
Montpellier, France, 12Department of Molecular Neuroscience, Institute
of Neurology, University College of London, London, United Kingdom,
13Center for Investigation and Research in Sleep, Lausanne University
Hospital, Lausanne, Switzerland
Objectives/Introduction: Kleine‐Levin syndrome (KLS) is a rare
periodic hypersomnia with associated behavioral abnormalities but
with often favorable prognosis. There is excess risk of KLS in first‐
degree relatives, suggesting a strong genetic contribution. So far, no
mutation is identified in KLS and comprehensive genetic analysis of
affected individuals is lacking.
Methods: We performed whole genome SNP genotyping and
exome sequencing in a large family with seven affected members.
The identified gene with a mutation was resequenced in 38 sporadic
KLS patients and the expression of the gene product was mapped in
the mouse brain.
Results: Linkage analysis mapped the disease locus to chromosome
3 and exome analysis identified a heterozygous missense variant in
LMOD3 (p.E142D) in the linkage interval. The variant was found to
segregate in all affected and one presumably unaffected member of
the family. Resequencing LMOD3 in 38 other KLS patients and their
families revealed three other low frequency or rare missense variants
in 7 cases that were inherited with incomplete penetrance. LMOD3
is expressed in the brain and co‐localized with major structures
involved in the regulation of vigilance states. LMOD proteins are
structural proteins and seem to be developmentally regulated.
Conclusions: Our findings suggest that KLS might be a structural/
neurodevelopmental brain disease.
Disclosure: Nothing to disclose.
O151 | ADHD symptoms in H1N1‐vaccinated
youths with narcolepsy type 1
B.H. Hansen1,2,3; S. Knudsen2
1Psychiatric Department, University of Oslo/Institute of Clinical
Medicine, 2Norwegian Centre of Expertise for Neurodevelopmental
Disorders and Hypersomnias, Oslo University Hospital, Oslo, 3Division of
Mental Health, Akershus University Hospital, Lorenskog, Norway
Objectives/Introduction: Narcolepsy pathophysiology may
include ADHD like symptoms, and high occurrence of ADHD symp-
toms have been described in narcolepsy. Previous studies have
mainly reported from medicated patients, possibly causing underre-
porting as narcolepsy treatment (stimulants) also target core ADHD
symptoms. Norwegian Centre of Expertise for Neurodevelopment
Disorders and Hypersomnia (NevSom) has since 2010 followed up
patients who developed narcolepsy after 2009 H1N1‐vaccinations.
This study report preliminary ADHD findings from youths (n = 44
age range 7–20, 63.6% girls) with narcolepsy type 1(NT1).
Methods: Patients were all medication free in a fourteen day per-
iod previous to clinical sleep evaluation. ADHD symptoms, as they
occurred in the medication free period, were rated by parents on
the ADHD Rating Scale. ADHD Rating Scale sum scores were com-
pared with age and gender adjusted population norms. An item
scored as occurring either “often” or “very often” were considered
an ADHD symptom.
Results: A total of 22/44 youths (50.0%) had ADHD symptoms in a
clinical range; 8/16 (50%) of boys and 14/28 (50%) of girls. In all but
2 cases ADHD manifested after onset of narcolepsy. Ten youths
(22.7%) had combined type; nine (20.5%) had predominantly inatten-
tive, while three (2.3%) had predominantly hyperactive/impulsive
type. A total of 34/44 (77.3%) of youths had at least one ADHD
symptom. The most frequently reported inattentive symptoms were
“failure to sustain attention” (n = 28, 63.7%), followed by “forgetful-
ness” (n = 43.2%), and “not follow though” (n = 18, 40.9%). The
most frequently reported hyperactive/impulsive symptoms were “fid-
gets/squirms”, “talks excessively”, “blurts out “, and “difficulties wait-
ing turn” all n = 12, 27.3%.
Conclusions: Medication free youths with NC1 have high occur-
rence of ADHD symptoms, especially inattention symptoms, occur-
ring mostly after onset of narcolepsy. This may reflect true
comorbidity, symptom overlap between ADHD and narcolepsy, or
symptom misinterpretation such as daytime consequences of
impaired sleep mimicking ADHD symptoms.
Disclosure: Nothing to disclose.
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O152 | Repeated measures of hypocretin‐1
level in individuals with narcolepsy type 1 and
clinical controls
E.W. Torstensen1; B.R. Kornum2; B. Wanscher1;
P.J. Jennum1
1Rigshospitalet, Glostrup, Danish Center for Sleep Medicine,
Copenhagen University Hospital, Rigshospitalet‐Glostrup, Glostrup,
2Copenhagen University, Health Faculty, Copenhagen, Denmark
Objectives/Introduction: Hypocretin‐1 (Hcrt‐1) regulates several
important homeostatic functions including sleep/wake cycle and
arousals. It is a small neuropeptide produced in the lateral hypothala-
mus. The hcrt‐1 level is rather stable in healthy individuals but may
variate with seasonal changes. Further, hcrt‐1 deficiency causes nar-
kolepsi type 1 (NC1) and measuring hcrt‐1 in the cerebrospinal fluid
(CSV) is a highly specific and sensitive test in diagnosing NC1. How-
ever, it is still not clarified how Hcrt‐1 level changes within the indi-
vidual over time. Therefor we evaluated the changes in hcrt‐1 over
time in patients diagnosed with NC1 and in clinical controls.
Methods: Individuals previously evaluated for narcolepsy were
recruited in a clinical study to validate the diagnosis of narcolepsy
including repeating hcrt‐1 evaluation. Further, individuals who previ-
ously underwent lumbar puncture twice were identified in a register
study. All the hcrt‐1 results were normalized using the Stanford ref-
erence.
Results: We have repeated measures of hypocretin level in 26
patents and clinical controls. Hereof 12 individuals from the clinical
study and 14 individuals from the register study. The first measure-
ment (T1): Of the total 26 individuals 8 patients had NC1 with a
hypocretin level below 200 pg/ml at T1: 6 had low hcrt‐1 level
(<110 pg/ml); 2 had intermedia Hcrt‐1 level (110 pg/ml< hcrt‐
1 < 200 pg 7 ml). They all had cataplexy. Thus 18 individuals had a
normal hcrt‐1 level (>200 pg/ml) at T1. They were grouped as fol-
lowed: 4 had narcolepsy type 2; 4 had idiopathic hypersomni; 1 had
Klein Levin diseases; 1 had sleep apnoea; 5 with normal sleep exami-
nations; 3 without access to further record. The second measure-
ment (T2): One NC1 patient with intermedia hcrt‐1 level dropped to
low hcrt‐1 level (131→31 pg/ml). This patient experienced a worsen-
ing of cataplexy, sleepiness and a more fragmented sleep. Two NC1
patients increased in hcrt‐1 level (10→131 pg/ml and 10→pg/ml,
respectively). In both patints the symptoms were reduced. All indi-
viduals with normal hcrt‐1 level at T1 had normal hcrt‐1 level at T2
(>200 pg/ml).
Conclusions: We found that hcrt‐1 level at T1 is fairly stable in
clinical controls with normal hcrt‐1 level. We forund changes in tree
NC1 patients which all were correlated to clinical changes.
Disclosure: Nothing to disclose.
O153 | Sustained attention to response task
(SART) shows impaired vigilance versatility in
narcolepsy type 1: a simultaneous EEG‐fMRI
study
J.K. Gool1,2,3; R. Fronczek2,3; G.J. Lammers2,3; Y.D. van der
Werf1
1Department of Anatomy and Neurosciences, VU University Medical
Center, Amsterdam, 2Sleep‐Wake Center SEIN, Heemstede,
3Department of Neurology, Leiden University Medical Center, Leiden,
the Netherlands
Objectives/Introduction: Narcolepsy type 1 patients suffer from
reduced vigilance levels, severely impairing their daytime perfor-
mance and quality of life. As hypocretin is known to normally project
towards neural attention regulation areas, we assessed the capacity
of patients to adapt to changes in vigilance demand using a modified
Sustained Attention to Response Task (SART), while simultaneously
acquiring EEG‐fMRI to identify the functional neural correlates
underlying patient's vigilance deficits.
Methods: Twelve drug‐naïve ICSD‐3‐diagnosed narcolepsy type 1
patients and 12 one‐on‐one age‐ and gender‐matched controls com-
pleted the SART while simultaneous EEG‐fMRI measurements were
recorded. During the SART participants were asked to refrain from
pressing keys to one in nine stimuli in two difficulty levels, which
differed in stimulus duration. Between‐group and repeated‐measures
analyses (to evaluate the effect of increasing vigilance demand) were
performed. Outcome measures were average reaction speed of cor-
rect presses, percentage of mistakes and d‐prime score as a
weighted performance indicator correcting the hit‐rate for the false
alarm‐rate.
Results: By switching from medium to high vigilance demand,
patients ‐ but not controls ‐ made significantly more mistakes
(p = 0.018) and had a lower d‐prime score (p = 0.013). Patients
reacted significantly slower than controls in the more difficult level
(p = 0.048). No significant differences between groups in test perfor-
mance and within‐group average reaction speed between difficulty
levels were found.
Conclusions: We conclude that narcolepsy patients tend to react
more slowly than healthy controls, explained by their intrinsically
reduced reaction speed and as a coping mechanism to improve pre-
cision. When vigilance demand increases, patients are unable to fur-
ther utilise this speed‐accuracy trade‐off mechanism, indicating that
narcolepsy type 1 patients suffer from impaired regulation of vigi-
lance. The modified SART is a reliable vigilance test in an MRI envi-
ronment. The behavioural results will be presented in the light of
EEG/fMRI brain imaging findings.
Disclosure: Nothing to disclose.
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O154 | Alternative MSLT cutoffs for diagnosis
of pediatric narcolepsy type 1
F. Pizza1,2; L. Barateau3; S. Vandi1,2; E. Mignot4; I. Jaussent5;
R. Lopez3,5; E. Antelmi1,2; G. Plazzi1,2; Y. Dauvilliers3,5;
MonBo Study Group (G. Plazzi, F. Pizza, E. Antelmi, M.
Filardi, M. Moresco, S. Vandi, M. Iloti, G. Neccia, A. Mazzoni,
F. Ingravallo, U. Pagotto, Y. Dauvilliers, I. Jaussent, R. Lopez,
L. Barateau, S. Chenini, E. Evangelista, S. Scholz, C. Pesenti,
B. Carlander)
1Department of Biomedical and Neuromotor Sciences, Università di
Bologna ‐ Alma Mater Studiorum, 2IRCCS Institute of the Neurological
Sciences, AUSL di Bologna, Bologna, Italy, 3Sleep Disorders Center,
Department of Neurology, Gui‐de‐Chauliac Hospital, National Reference
Centre for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia and
Kleine‐Levin Syndrome, Montpellier, France, 4Stanford Center for Sleep
Sciences and Medicine, Stanford University Sleep Medicine Center, Palo
Alto, CA, United States, 5Inserm, U 1061, Montpellier, Italy
Objectives/Introduction: Central disorders of hypersomnolence
diagnosis strongly relies on the characterization of daytime sleepi-
ness by MSLT mean sleep latency and number of sleep onset REM
periods (SOREMP), while only narcolepsy type 1 (NT1) has an exclu-
sive biological marker (cerebrospinal hypocretin deficiency). Scarce
data are available on MSLT in pediatric patients, thus we aimed at
validating MSLT in a large population of patients below 18 years old.
Methods: Clinical, neurophysiological (nocturnal polysomnography ‐
PSG, and MSLT), and available biological data (HLA DQB1*0602
positivity, hypocretin levels) of 377 consecutive subjects below
18 years of age evaluated at the Centers for Narcolepsy of Bologna
and of Montpellier were collected together with final diagnosis
according to the third International Classification of Sleep Disorders
criteria (122 subjective hypersomnolence ‐ sEDS, 13 idiopathic
hypersomnia, 19 narcolepsy type 2, 9 secondary narcolepsy/hyper-
somnia, 214 NT1). Best MSLT cut offs were obtained by ROC curve
analysis by contrasting among patients with available hypocretin
assay (n = 229) those with and without hypocretin deficiency and
applied to the whole population.
Results: Hypocretin deficiency was best indentified by a mean
sleep latency ≤ 8.6 minutes and 2 SOREMPs at the MSLT (area
under the ROC curve of 0.950 ± 0.018, p < 0.00001). When consid-
ering patients’ age, the combination of two SOREMPs best identified
hypocretin deficiency combined with a mean sleep latency of 10 and
of 8.6 min in patients’ subgroups with age up to and above 12 years
old respectively (area under the ROC curve of 0.959 ± 0.017,
p < 0.00001). These cut off well identified NT1 in patients without
hypocretin assay as well as in the whole dataset.
Conclusions: A mean MSLT sleep latency ≤8.6 min in teenagers or
10 min in patients up to 12 years old combined with 2 SOREMPs is
a reliable neurophysiological marker for NT1 in pediatric patients.
Disclosure: Nothing to disclose related to the presented work.
ACUTE OR CHRONIC CAFFEINE
CONSUMPTION: WHAT KEEPS YOU
AWAKE?
155 | Mechanisms of caffeine′s effect on sleep
T. Porkka-Heiskanen
University of Helsinki, Helsinki, Finland
Adenosine is an inhibitory neuromodulator that, through pre‐and
post‐synaptic mechanisms, promotes sleep, while caffeine promotes
wakefulness. Caffeine is a non‐specific adenosine receptor antago-
nist, preventing thus the sleep‐promoting actions of adenosine. Of
the four known adenosine receptors (A1, A2A, A2B and A3), the
effects on sleep are mediated through A1 and A2A receptors. A1
receptor is inhibitory while A2A receptor is excitatory. Increasing
brain levels of adenosine, or administration of adenosine A1 receptor
agonists promotes sleep in many species. During sleep deprivation,
adenosine levels increase in the cholinergic basal forebrain area, pro-
moting sleep through A1 receptors. However, while caffeine admin-
istration to A1 receptor knock‐out mice reduced their sleep,
administration to A2A knock‐out mice had no effect (Huang et al.
2005). This implies that the effects of caffeine are mediated via the
excitatory A2A receptors. These receptors have been found on
VLPOA neurons, which are sleep promoting, offering an explanation
for the finding. This view is supported by the finding that a polymor-
phism in the A2A receptor gene (ADORA2A) modulates individual
sensitivity to caffeine (Retey et al. 2007). Fly studies have suggested
non‐adenosine receptor‐mediated mechanisms for caffeine's effects.
Chronic administration of caffeine reduced and fragmented sleep in
fruit flies, but mutants lacking fly adenosine receptor had both nor-
mal sleep and normal response to caffeine, implying that adenosine
receptor is not mediating the sleep effects in flies (Wu et al. 2009).
Dopamine is required for the wake‐promoting effect of caffeine in
the fly, and caffeine likely acts presynaptically to increase dopamine
signaling (Nall et al. 2016). Whether such mechanism are limited to
non‐mammalian species is presently unclear. Huang ZL et al. Adeno-
sine A2A, but not A1, receptors mediate the arousal effect of caf-
feine. Nat Neurosci. 2005 Nall AH et al. Caffeine promotes
wakefulness via dopamine signaling in Drosophila. Sci Rep. 2016.
Rétey JV et al. A genetic variation in the adenosine A2A receptor
gene (ADORA2A) contributes to individual sensitivity to caffeine
effects on sleep. Clin Pharmacol Ther. 2007. Wu MN et al. The
effects of caffeine on sleep in Drosophila require PKA activity, but
not the adenosine receptor. J Neurosci. 2009.
Disclosure: Nothing to disclose.
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156 | Deeper sleep during chronic caffeine
consumption in mice
T. DeBoer
Department of Cell and Chemical Biology, Leiden University Medical
Center, Leiden, the Netherlands
Caffeine has a well‐known impact on sleep and circadian physiology
and is one of the most widely consumed psychostimulants. Most
laboratory studies available investigated the acute effect of caffeine
on sleep. However, in society caffeine is generally consumed chroni-
cally on a daily basis. We therefore investigated the acute and
chronic effect of caffeinated drinking water on sleep and the elec-
troencephalogram (EEG) in mice. We recorded the EEG and elec-
tromyogram on a control day, on the first day of caffeine
consumption (acute), and following 2 weeks of continuous caffeine
consumption (chronic). In the latter condition, a 6‐hr sleep depriva-
tion was conducted during the light period. For extra comparison, an
additional control group of mice provided with normal drinking water
was also recorded and sleep deprived. We found that caffeine
induced contrasting effects following acute and chronic consump-
tion. Over 24 h, waking increased in the acute condition, at the
expense of non‐rapid eye‐movement (NREM) sleep, whereas no
changes over 24‐hr were found in the chronic condition. In the acute
condition EEG slow‐wave activity (SWA), a well‐known marker for
sleep pressure, was significantly reduced. The light‐dark amplitude of
vigilance states increased in both acute and chronic conditions, with
the highest amplitude in the chronic condition, showing an increase
in sleep during the light period and an increase in waking during the
dark. Furthermore, EEG SWA in NREM sleep was significantly
increased during the first half of the light period of the chronic con-
dition, compared to both controls. The sleep deprivation was more
challenging and less successful under chronic caffeine. Together with
the increased SWA results, this indicates an increased sleep pressure
in the chronic condition. In contrast to the traditional conception of
the impact of caffeine consumption on sleep, chronic caffeine intake
seems to enhance circadian amplitude, improve daily sleep‐wake
cycles and increase sleep depth. The results will be discussed in the
context of chronic daily caffeine consumption in society.
Disclosure: Nothing to disclose.
157 | Acute and chronic caffeine intake and
human sleep
H.-P. Landolt
Zürich Center of interdisciplinary Sleep Research, University of Zürich,
Zürich, Switzerland
There is general consensus that caffeine can interfere with the qual-
ity of sleep. Indeed, the available literature of epidemiological studies
and placebo‐controlled trials supports the notion that caffeine pro-
longs sleep latency, reduces total sleep time and sleep efficiency,
lowers EEG markers of sleep intensity, and worsens perceived sleep
quality (Clark & Landolt, Sleep Med Rev, 2017). The studies, however,
suggest possible evidence of a dose‐response relationship between
caffeine intake and sleep quality, and individuals typically respond
differently to caffeine based on factors including their age, habitual
consumption, and genetic factors contributing to individual sensitiv-
ity to sleep disruption by caffeine. Based on this evidence mainly
derived from studies investigating acute caffeine effects on sleep,
the expected consumption of caffeine in society appears sufficient
to interfere with sleep. Nevertheless, insights into the effects of pro-
longed, chronic caffeine intake and its repercussions on sleep need
to be obtained, to fully disentangle the complex relationships
between caffeine and sleep. This research is currently very scarce. In
this presentation, the present knowledge of acute and chronic caf-
feine use in humans and its influence on sleep will be summarized,
actual research topics and issues will be addressed, and some pro-
spects for future research will be outlined.
Disclosure: The author's research on caffeine is supported by the
Swiss National Science Foundation, the University of Zürich, and the
Institute for Scientific Information on Coffee (ISIC).
158 | Effects of chronic caffeine consumption
and caffeine withdrawal on human waking
performance, sleep and brain structure
C.F. Reichert1,2; J. Weibel1,2; Y.-S. Lin1,2,3; C. Garbazza1,2;
M. Meyer1,2,4; H. Slawik4; H.-P. Landolt5,6; S. Borgwardt3;
C. Cajochen1,2
1Centre for Chronobiology, Psychiatric Hospital of the University of
Basel, 2Transfaculty Research Platform Molecular and Cognitive
Neurosciences, University of Basel, 3Neuropsychiatry and Brain Imaging,
4Clinical Sleep Laboratory, Psychiatric Hospital of the University of
Basel, Basel, 5Institute of Pharmacology and Toxicology, 6Zürich Center
of Interdisciplinary Sleep Research, University of Zürich, Zürich,
Switzerland
Caffeine is the most widely used psychoactive substance worldwide,
often consumed on a daily basis. The stimulating properties of caf-
feine have often been confirmed in so‐called caffeine‐naïve individu-
als, particularly during extended wakefulness. However, only little is
known about whether the alerting effects of caffeine persist under
habitual chronic intake. In our double‐blind placebo‐controlled cross‐
over laboratory study, volunteers consuming 450 mg caffeine daily
(i.e., around 5 cups of coffee) did neither feel more alert nor did they
perform better in a vigilance task after a 9‐day caffeine‐treatment
compared to 9 days of placebo. Furthermore, in cerebral blood flow
during resting, assessed six hours after caffeine ingestion after
9 days of treatment, we did not observe the prominent reductions,
which have been reported after acute caffeine consumption in low‐
or non‐consumers. In contrast, we have first evidence from voxel‐
based morphometric whole‐brain analyses that grey matter in the
superior and middle frontal gyrus is reduced after a 9‐day caffeine
treatment compared to 9 days of placebo. Similar to what has been
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reported for slow‐wave sleep after a long‐term caffeine‐treatment,
EEG delta activity (0.75–4.5 Hz) during an evening nap did not sig-
nificantly differ between caffeine and placebo when measured after
9 days of treatment. Interestingly, the effects of withdrawal from a
9‐day caffeine consumption period were clearly detectable as
indexed by significantly higher sleepiness, worse vigilance perfor-
mance, increased thalamic cerebral blood flow, higher parietal grey
matter density, and higher EEG delta activity during nap sleep com-
pared to placebo. Taken together these data indicate that differ-
ences in sleepiness, performance, and sleep delta activity due to
chronic daily caffeine consumption are much less pronounced than
the negative effects associated with its cessation. Thus, in these
variables, daily intake of high doses of caffeine may lead to a pro-
gressive reduction in responsiveness to the drug. Furthermore, the
observed caffeine‐induced differences in frontal grey matter suggest
that brain morphology might be changed under conditions of con-
stant long‐term caffeine consumption. Importantly, these caffeine‐
induced grey matter changes seem to be reversible within the range
of several days once consumption is discontinued.
Disclosure: Nothing to disclose.
SLEEP IN PSYCHIATRIC DISORDERS
O159 | The role of sleep spindles in procedural
memory consolidation in depression
L. Bovy1; M. Dresler1,2; F.D. Weber1; A. Steiger2
1Donders Centre for Neuroscience, HB Nijmegen, the Netherlands,
2Research Group Sleep Endocrinology, Max Planck Institute of
Psychiatry, Munich, Germany
Objectives/Instruction: There is robust evidence that sleep facili-
tates the consolidation of procedural memory. In depressed patients,
however, sleep‐related procedural memory consolidation is impaired.
Sleep spindles have been shown to be involved in the off‐line pro-
cessing of simple motor procedural memory during sleep. Neural
mechanisms of off‐line components of procedural memory in affec-
tive disorders, however, remain unclear so far. We investigated the
specific influence of sleep spindles on overnight consolidation of a
procedural memory task in patients with depression and in healthy
controls.
Methods: All participants were trained on a sequential finger‐tap-
ping task. Finger tapping performance was estimated by the number
of correctly tapped sequences per 30‐s trial. The percent increase in
mean performance between the last three trials during training on
the first day and the first three retest trials on the second day was
the measure of overnight consolidation. We examined the influence
of spindle activity during the total night and depression on overnight
consolidation. Spindles were analyzed automatically using the Spi-
SOP toolbox (Weber, 2013) over two central channels. Participants
included 40 depressed patients (Hamilton Depression Scale >17, 22
female, age: M = 50.1, SD = 8.6) and 40 healthy volunteers (19
female, age: M = 46.8, SD = 10.7) matched for age and gender as
control group. All patients were medicated with antidepressants.
Results: Patients showed worse performance on the finger tapping
task at the start of the task (F (1, 78) = 11.441, p = 0.001), com-
pared to healthy controls. They did not show, however, any differ-
ence in online training effect of the task (F (1, 78) = 0.002,
p = 0.963). In contrast, patients showed worse procedural overnight
memory consolidation (F (1, 78) = 28.052, p < 0.000) than healthy
controls. Interestingly, an interaction between spindle density and
group on offline overnight memory consolidation approached signifi-
cance (b = 0.15, SE b = 0.09, β = 3.73, p = 0.09), suggesting that
overnight consolidation depends more on the density of sleep spin-
dles in depressed patients as their relation of spindles and consolida-
tion appeared stronger.
Conclusions: Our results suggest that, despite disturbed sleep pat-
tern and general performance and overnight consolidation impair-
ments, depressed patients show a surprisingly strong relation
between overnight memory consolidation and sleep spindle activity.
Disclosure: Nothing to disclose.
O160 | Poor sleep and its relation to
impulsivity in forensic psychiatric patients with
antisocial or borderline personality disorders
M. Van Veen1; J. Karsten1,2; M. Lancel1,2
1Forensic Psychiatry, GGZ Drenthe Mental Health Institute, Assen,
2Clinical Psychology, Groningen University, Faculty of Behavioural and
Social Sciences, Groningen, the Netherlands
Objectives/Instruction: Studies investigating sleep and personality
disorders consistently demonstrate a relation between personality
disorders characterized by behavioural disinhibition and/or emotional
dysregulation (traditionally termed cluster B personality disorders)
and poor sleep. This finding is in line with previous studies associat-
ing insomnia with impulsive behaviour, since this is a core character-
istic of both antisocial and borderline personality disorder. Both
sleep problems and antisocial or borderline personality disorders are
highly prevalent in forensic psychiatry. However, studies on the
prevalence of sleep disturbances and its relation to impulsive beha-
viour in forensic psychiatric patients are scarce.
Methods: This cross‐sectional study investigates a group of foren-
sic psychiatric inpatients with antisocial or borderline personality dis-
order or traits thereof. Data will be drawn from an ongoing
prospective observational study, monitoring treatment outcomes at
the Forensic Psychiatric Hospital in Assen, the Netherlands. Subjec-
tive sleep characteristics and impulsivity were assessed with the
Pittsburgh Sleep Quality Index (PSQI), the Sleep Diagnosis List (SDL)
and the Barratt Impulsiveness Scale (BIS‐11), respectively. Poor sleep
quality was defined as having a PSQI score >5, whereas chronic
insomnia was defined as having a SDL insomnia subscale score >3.
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Results: A total of 112 patients was included in the analyses. More
than half of the patients (53.6%) report poor sleep quality and
22.3% appears to suffer from severe chronic insomnia. Both poor
sleep quality (B = 0.74, p < 0.01) and chronic insomnia (B = 5.22,
p < 0.001) are associated with self‐reported impulsivity, in particular
with attentional impulsiveness (F (21, 109) = 2.54, p < 0.001 for
sleep quality; F (44, 67) = 2.03, p < 0.01 for insomnia). These associ-
ations were not moderated by comorbid psychiatric disorders.
Conclusions: Poor sleep is highly prevalent in forensic psychiatric
patients and significantly related to self‐reported levels of impulsiv-
ity. Actively treating sleep problems in these patients may not only
improve sleep quality, mental health and physical wellbeing, but may
also have impact on impulsivity‐related behaviour by increasing self‐
control.
Disclosure: Nothing to disclose.
O161 | The influence of genetic variants on
sleep and health improvement in adolescents
with an eveningness chronotype
M. Dolsen; A. Harvey
Department of Psychology, University of California, Berkeley, Berkeley,
CA, United States
Objectives/Instruction: Genetic variants have been proposed to
moderate the effect of both positive and negative environments on
mental health outcomes. This may have important implications for
identifying predictors of treatment response to psychological inter-
ventions. In this study we tested if a cumulative genetic score (CGS)
composed of sleep and circadian gene variants moderates the effects
of a psychological intervention that targets sleep, circadian dysfunc-
tion, and health.
Methods: Adolescents with an eveningness chronotype were ran-
domized to either the Transdiagnostic Sleep and Circadian Interven-
tion for Youth (TranS‐C; n = 87) or Psychoeducation (PE; n = 86).
Sleep and circadian measures included weekday total sleep time
(TST) and bedtime assessed via sleep diary, the Children's Morning-
ness‐Eveningness Preferences scale, and dim‐light melatonin onset
(DLMO). Emotional, cognitive, behavioral, social, and physical health
composite risk scores were derived from self‐report measures. The
CGS was created based on gene variants for PER1, PER2, PER3,
ARNTL, AANAT, and CLOCK.
Results: At post‐treatment, a higher CGS was associated with less
social risk at the trend level (z = −1.93, p = 0.054) whereas a lower
CGS was related to more social risk (z = 2.27, p = 0.023) controlling
for treatment condition. For participants with a higher CGS, an ear-
lier DLMO was associated with reduced emotional risk (z = 2.03,
p = 0.042) and social risk (z = 2.05, p = 0.040) during treatment con-
trolling for treatment condition. Similar findings were obtained for
bedtime such that an earlier bedtime was associated with reduced
social risk during treatment (z = 2.32, p = 0.020).
Conclusions: The present study provides preliminary evidence that
a higher CGS is associated with reduced social risk during treatment.
Furthermore, an earlier shift in a marker of the endogenous circadian
rhythm was associated with improved emotional and social risk, but
only for participants with a higher CGS. Replication is needed, and
future research should further examine if genetic variants influence
treatment response among adolescents.
Disclosure: Nothing to disclose.
O162 | Synaptic mechanisms of therapeutic
sleep deprivation in major depression
C. Nissen1,2; M. Kuhn2; B. Feige2; S. Maiwald2; M. Michel2;
J.G. Maier1; S. Klöppel1; D. Riemann2
1University Psychiatric Services, Bern, Switzerland, 2University Medical
Centre, Freiburg, Freiburg, Germany
Objectives/Introduction: Major depressive disorder (MDD) is the
leading cause for reduced quality of life due to illness worldwide.
Therapeutic sleep deprivation presents a unique paradigm to study
the neurobiology of MDD. Yet up to now, the neurobiological basis
of the rapid antidepressant effect, which is most likely different from
today′s slow first‐line treatments, remains to be determined. We
recently integrated two prominent hypotheses of MDD and sleep,
the synaptic plasticity hypothesis of MDD and the synaptic home-
ostasis hypothesis of sleep‐wake regulation, into a synaptic plasticity
model of therapeutic sleep deprivation in MDD. We further tested
this model positing that homeostatically enhancing net synaptic
strength through sleep deprivation shifts the initially deficient
inducibility of associative synaptic long‐term potentiation (LTP)‐like
plasticity in patients with MDD into a more favorable window of
associative plasticity.
Methods: We used paired associative stimulation (PAS), a transcra-
nial magnetic stimulation protocol (TMS), to induce synaptic LTP‐like
plasticity after one night of therapeutic sleep deprivation in the pri-
mary motor cortex of 28 patients with MDD according to DSM‐IV
criteria (14 men, 14 women, age 40.3 ± 13.0 years).
Results: Consistent with the concept of significantly enhanced
LTP‐like plasticity in SD responders, we observed an increased
inducibility of LTP‐like plasticity in clinical responders (>50%
improvement on the 6‐item Hamilton‐Rating‐Scale‐for‐Depression,
n = 13) compared to non‐responders (n = 15). Specifically, a rm‐
ANOVA showed a significant effect for the factor Group, no signif-
icant effect for the factor Time and a significant Group × Time
interaction. Post‐hoc t‐tests yielded similar MEP amplitudes at
baseline and post 1, but significantly higher MEP amplitudes in SD‐
responders at post 2 (t26 = 2.9, p = 0.008) and post 3 (t26 = 2.8,
p = 0.009).
Conclusions: The results are consistent with the notion that sleep
deprivation might act via shifts into a more favorable window of
associative LTP‐like plasticity in MDD. Further determining the
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mechanisms of action of therapeutic sleep deprivation might help to
identify novel rapid pathways to treatment for MDD.
Disclosure: Nothing to disclose.
O163 | Let there be (blue‐depleted) light in
psychiatry
D. Vethe1,2; K. Langsrud2; J. Scott3; M. Engstrøm4,5;
A. Olsen6; Ø. Salvesen7; B. Mathusiak8; T. Sand4,5;
G. Morken1,2; H. Kallestad1,2
1Department of Mental Health, Norwegian University of Science and
Technology, 2Department of Østmarka, St. Olavs University Hospital,
Trondheim, Norway, 3Institute of Neuroscience, University of Newcastle,
Newcastle, United Kingdom, 4Department of Neuroscience, Norwegian
University of Science and Technology, 5Department of Clinical
Neurophysiology, St. Olavs University Hospital, 6Department of
Psychology, 7Section for Applied Clinical Research, 8Faculty of
Architecture and Design, Norwegian University of Science and
Technology, Trondheim, Norway
Objectives/Introduction: Sleep‐wake cycle and circadian dys-
rhythmias are shared features of an acute episode in major mental
disorders, and restoration of rhythmicity is associated with recovery.
This has stimulated the development of a new psychiatric intensive
care unit in Trondheim, Norway, that aims to optimize circadian
rhythms in acutely admitted psychiatric patients by using a tunable
light system. All light sources in half the unit are depleted of blue
light between 18:30 and 07:00 h, whilst the other half has normal
lighting at all times. The primary aim of the current study was to test
the effect of the blue‐depleted light environment on circadian
rhythms/melatonin. Secondary aims were to test its effect on sleep,
arousal, and to assess the acceptability of the blue‐depleted environ-
ment. Findings in both aims will be presented.
Methods: In a randomized crossover trial, 12 healthy participants
were admitted for 5 days in each light environment, with 1 day
break between admissions. Melatonin was assessed using hourly sal-
iva samples collected from 19:00 to 23:00 h, in dim light on day 0, 6
and 12, and in the respective light environments on day 5 and 11.
Phase shift of melatonin onset and melatonin suppression in each
light condition was estimated from these assessments. The effect of
′condition′ on phase‐shift and suppression was estimated using a lin-
ear mixed model. Sleep was assessed with polysomnography, actigra-
phy, and a novel radar technology. Arousal was assessed with
neuropsychological testing, motor activity, subjective reports, and
resting‐state electroencephalography. Acceptability was assessed
with questionnaires and a color‐perception test.
Results: Relative to dim light, melatonin levels were less sup-
pressed in the blue‐depleted environment compared to the normal
environment 15% versus 45% (p = 0.007). Dim light melatonin onset
showed a greater phase advance after the blue‐depleted environ-
ment (1:45 h versus 0:35 h, p < 0.001). Analyses are currently being
finalized on secondary outcomes including sleep, arousal and accept-
ability and will be presented.
Conclusions: This proof‐of‐principle study demonstrates that it is
possible to create a hospital environment that has a meaningful
impact on the circadian system, and so far we have not identified
any discernable adverse effects.
Disclosure: Nothing to disclose.
EPIDEMOLOGY OF SLEEP
O164 | Sleep duration and mortality‐does
weekend sleep matter?
T. Åkerstedt1,2; F. Ghilotti1,3; A. Grotta4; H. Zhao5;
H.-O. Adami6; Y. Trolle-Lagerros7,8; R. Bellocco6,9
1Clinical Neuroscience, Karolinska Institute, 2Stress Research Institute,
Stockholm University, Stockholm, Sweden, 3Statistics and Quantitative
Methods, University of Milano‐Bicohcca, Milan, Italy, 4Center for Health
Equity Studies, Stockholm University and Karolinska institute,
Stockholm, Sweden, 5Epidemiology and Biostatistics, Texas A&M
University, College Station, TX, United States, 6Medical Epidemiology
and Biostatistics, 7Department of Medicine, Karolinska Institute,
8Department of Medicine, Karolinska University Hospital Huddinge,
Stockholm, 9Statistics and Quantitative Methods, University of Milano‐
Bicocca, Milan, Sweden
Objectives/Instruction: Previous studies of weekday sleep dura-
tion found a U‐shaped relationship with mortality. These studies
have mainly focused on weekday sleep, but it is possible that week-
end sleep may also be of relevance. We here address the association
of combined weekday and weekend sleep duration with overall mor-
tality.
Methods: A cohort of 43,880 subjects was followed for 13 years
through record‐linkages. Cox proportional hazards regression models
with attained age as time‐scale were fitted to estimate multivariable‐
adjusted hazard ratios (HR) and 95% confidence intervals (95% CI)
for mortality. Additional stratified analyses on age (below and above
age 65) were conducted.
Results: Among individuals <65 years, short sleep (£5 hr) during
weekends at baseline was associated with a 52% higher mortality
rate (HR 1.52; 95% CI 1.15–2.02) compared to the reference group
(7 hr), while no association was observed for long (9 or longer)
weekend sleep at baseline. When weekday and weekend sleep dura-
tions were combined, we observed a detrimental association with
consistently sleeping 5 h or less (HR 1.65; 95% CI 1.22–2.23) or 8 h
or longer (HR 1.25; 95% CI 1.05–1.50), compared to consistently
sleeping 6–7 hr per day (reference group). The mortality rate among
participants with short sleep during weekdays, but long sleep during
weekends, did not differ from the rate of the reference group.
Conclusions: It was concluded that short, but not long, weekend
sleep was associated with an increased mortality in subjects below
the age of 65 and that individuals <65 years with short sleep on
both weekdays and weekend have an increased mortality, as do indi-
viduals <65 years with long sleep on both weekday and weekend.
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We suggest that long weekend sleep may reduce the association of
short weekday sleep with mortality.
Disclosure: Nothing to disclose.
O165 | Sleep fragmentation in sleep disordered
breathing based on a large database (ESADA)
T. Penzel1; M. Wächter1; M.R. Bonsignore2; I. Bouloukaki3;
P. Escourrou4; I. Fietze1; J.W. Kantelhardt5; C. Lombardi6;
O. Marrone7; I. Paranicova8; A. Pataka9; S. Ryan10;
S. Schiza3; P. Sliwinski11; P. Steiropoulos12; J. Verbraecken13;
L. Grote14; ESADA Study Group
1Schlafmedizinisches Zentrum, Charité ‐ Universitätsmedizin Berlin,
Berlin, Germany, 2University of Palermo, Palermo, Italy, 3Medical School,
University of Crete, Heraklion, Greece, 4Hopital Antoine Beclere, Paris,
France, 5Institute of Physics, Martin‐Luther‐Universität Halle‐
Wittenberg, Halle, Germany, 6Istituto Auxologico Italiano, IRCCS ‐
Milano Bicocca University, Milano, 7National Research Council IBIM,
Palermo, Italy, 8University Hospital Kosice, Kosice, Slovakia, 9Aristotle
University of Thessaloniki, Thessaloniki, Greece, 10University College
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12Medical School, Democritus University of Thrace, University Hospital
of Alexandroupolis, Alexandroupolis, Greece, 13Antwerp University
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Objectives/Introduction: Sleep disordered breathing is accompa-
nied by fragmented sleep. Sleep fragmentation can be analyzed by
non‐linear analysis of sleep stage duration and sleep stage transi-
tions. Both methods require large datasets to systematically address
the effects of apnea severity (AHI) and potential confounders like
age and gender. It is hypothesized that sleep apnea severity signifi-
cantly increase sleep stage transition pattern independent of con-
founders.
Methods: The European Sleep Apnea Database (ESADA) collects
data from patients with sleep disordered breathing across Europe.
For the purpose of this study sleep scoring data on an epoch‐by‐
epoch basis from standard overnight polysomnography had been
assembled (1,118 hypnograms from 11 sleep centers). Subjects were
analyzed in groups separated by age (<40, 40–59, >59 years) and by
AHI groups (5–14, 15–30, >30 events/hr). Sleep stage transitions
were analyzed according to sequences of three epochs.
Results: The duration of wake stages follows power laws and the
duration of sleep stages follows exponential laws. Older people had
more N1‐W‐N1 (<40: 4.16%; 40–59: 4.90%; >59: 8.16%) and W‐
N1‐W (<40: 4.64%; 40–59: 5.21%; >59: 35%) sleep stage transitions
than the other age groups. Younger people had a more continuous
sleep with less transitions from and to wake state which was inde-
pendent of AHI. Severe AHI had more transitions within light sleep
(N2‐N1‐N2 and N1‐N2‐N1). Conventional sleep parameters showed
less N3 and REM sleep with increasing AHI (e.g. REM for AHI 5–15:
21.2; for AHI>30: 17.9; p < 0.001). The pattern of sleep stage tran-
sitions varied significantly between sleep centers independent of age
and AHI (p < 0.05).
Conclusions: Our results in a large scale clinical OSA patient popu-
lation show that sleep regulation is systematically affected by the
degree of sleep apnea, but even more by age. The analysis of sleep
stage transitions showed very stable pattern mostly affected by age
and center specific sleep scoring practice. It is very important to ana-
lyze further the differences in scoring habits between sleep centers.
Genetic traits reflected by regional differences or center specific
scoring differences may account for these findings and further sys-
tematic analysis of this question is required.
Disclosure: The ESADA group has received grants from Wein-
mann, ERS, University Gothenburg to support the data hosting and
consortium meetings.
O166 | Sleep disturbances associated with
increased risk of mortality: UK Biobank Study
M. von Schantz1; J. Ong2; K. Knutson2
1Chronobiology Section, University of Surrey, Guildford, United Kingdom,
2Feinberg School of Medicine, Northwestern University, Chicago, IL,
United States
Objectives/Introduction: Inadequate sleep has been associated
with increased prevalence and incidence of a variety of diseases,
including diabetes, cardiovascular disease and cancer. Some charac-
teristics of sleep, such as sleep duration, have also been associated
with increased mortality risk. The objective of this analysis was to
determine whether sleep disturbances were associated with mortal-
ity in a large cohort study in the United Kingdom.
Methods: The UK Biobank is a prospective, population‐based
cohort study designed to investigate risk factors for major diseases
of middle and older age. It enrolled 502,642 participants aged 37–
73 years (53% women) from across the UK. Mean follow‐up time
was 6.5 years. Primary outcomes were all‐cause, cancer, and cardio-
vascular disease (CVD) mortality. Primary exposure was “sleep dis-
turbances”, based on the question (asked at the time of enrollment),
“Do you have trouble falling asleep at night or do you wake up in
the middle of the night”. Responses were “never/rarely”, “some-
times”, or “usually”. Cox proportional hazard models were used
adjusting for age, sex, smoking, body mass index and depression.
Results: The frequency of sleep disturbances was “never/rarely” for
24.1%, “sometimes” for 47.7% and “usually” for 28.2% of the sam-
ple. Compared to those who never/rarely had sleep disturbances, risk
of all‐cause mortality was significantly higher in those who some-
times (HR 1.07, 95% CI 1.02–1.12) or usually (HR 1.27, 95% CI
1.21–1.34) had sleep disturbances. Risk of cancer mortality was also
higher in those who sometimes (HR 1.09, 95% CI 1.02–1.15) or usu-
ally (HR 1.24, 95% CI 1.16–1.33) had sleep disturbances. Those who
usually had sleep disturbances were also at increased risk of CVD
mortality (HR 1.17, 95% CI 1.05–1.30).
Conclusions: Sleep disturbances were common in this middle‐aged
and ageing cohort; only one‐quarter of participants reported never/
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rarely having sleep disturbances. Age‐adjusted mortality risk was sig-
nificantly higher in those who reported sleep disturbances. Our find-
ings reinforce the hypothesis that sleep disturbances could have a
significant public health impact.
Disclosure: Nothing to disclose.
O167 | Sleep in major psychiatric disorders:
results from nationwide SUPER Finland study
E. Cederlöf1; M. Torniainen-Holm2; T. Paunio1; J. Suvisaari2;
A. Palotie3; Super Study Group
1University of Helsinki, 2National Institute for Health and Welfare,
3Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland
Objectives/Introduction: Persons with major psychiatric disorders
have an increased frequency of sleep disturbances. These distur-
bances include changes in total sleep time, increased sleep onset
latency and increased wake time after sleep onset. This study's goal
was to describe the sleep disturbances among the different diagnos-
tic, gender and age groups, and to investigate the relationship
between sleep disturbances and subjective health among persons
with psychotic disorders.
Methods: Altogether, 5,046 persons with a major psychiatric dis-
order (schizophrenia: 2972, schizoaffective disorder: 640, bipolar
disorder: 1097 and psychotic depression: 330) and aged 18–80
participated in a nationwide Super project. The Finnish SUPER
(Finnish acronym for “Finnish study on genetic mechanisms of psy-
chotic disorders”) study is a part of the international Stanley Glo-
bal Neuropsychiatric Genomics Initiative. The results were
compared with a representative general population sample of 8018
adults (Health 2000). Sleep was evaluated in a self‐report question-
naire. The following questions were included: Total sleep time,
tiredness (defined as feeling more tired than other people of the
same age during day time at least weekly, yes/no), difficulties in
falling asleep without sleep medication often or almost every night
(yes/no) and early awakenings either often or almost every night
(yes/no).
Results: Long sleep (≥10 hr per day) was the most frequent finding
compared to the general population (p < 0.001 in every diagnostic
and age group), especially among young people with schizophrenia
and schizoaffective syndrome. Tiredness was the most common
sleep‐related symptom, with over 40% prevalence in every diagnos-
tic group. Difficulty in falling asleep and increased frequency of
awakenings was more prevalent in every psychiatric disorder in
patients below 60 years of age (p < 0.001), especially among per-
sons with psychotic depression and bipolar disorder. Schizoaffective
disorder was in every sleep variable found between schizophrenia
and affective disorders.
Conclusions: Sleep disturbances seem to be common in persons
with major psychiatric disorders. Tiredness was widely reported in all
diagnostic groups. Long sleep was most common in schizophrenia
and schizoaffective syndrome and difficulties in falling asleep and
early morning or night awakenings in affective psychoses. More
research is needed on factors affecting and possibilities to treat
sleep disturbances in major psychiatric disorders.
Disclosure: Nothing to disclose.
O168 | Seasonal differences in obstructive
sleep apnea severity. Results from the European
Sleep Apnea Database (ESADA)
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Gothenburg University, Gothenburg, Sweden, 3Department of Pulmonary
Diseases, Turku University Hospital, Turku, Finland, 4Department of
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Medicine, Royal Infirmary Edinburgh, Edinburgh, United Kingdom,
7National Research Council, Institute of Biomedicine and Molecular
Immunology, Palermo, Palermo, Italy, 8Department of Respiratory
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Medical School University of Crete, Crete, Greece, 11Biomedical
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Centre, Antwerp University Hospital and University of Antwerp,
Antwerp, Belgium
Objectives/Introduction: Several internal and external factors,
including sleep stage, body position, anthropometrics, comorbidities
and ambient temperature, are suggested to produce ultradian or cir-
cadian changes in obstructive sleep apnea (OSA) severity. The cur-
rent analysis addressed the possibility of circannual OSA severity
changes in the large ESADA study cohort derived from more than
30 sleep laboratories across Europe.
Methods: We included 20,996 patients (age 52.6 ± 13, BMI
31.4 ± 7, apnea/hypopnea index (AHI) 27.8 ± 25, oxygen desatura-
tion index (ODI) 24.3 ± 25, mean SaO2 93.1 ± 3) from the ESADA
cohort. Data was adjusted for recording month and the Koeppen‐
Geiger climate classification (http://koeppen-geiger.vu-wien.ac.at) for
the geographical location (Bsk, Cfa, Cfb, Csa, Dfa and Dfb) of the
study sites (n = 28). Variations of AHI and ODI across month of the
year were tested by ANOVA. Means for AHI and ODI according to
month were calculated with general linear models (GLMs) adjusting
for age, BMI, gender and climate zone.
Results: The mean AHI and ODI varied significantly according to
month of the year (p = 0.004 and p = 0.009, respectively, ANOVA).
The mean number of patients per month ranged from 1483 (July) to
1914 (January). The factor ‘month of the year’ independently pre-
dicted AHI and ODI (p = 0.009 and p = 0.012, respectively, GLM).
The mean adjusted AHI extremes were 26.5 n/hr (September) and
29.1 n/hr (December) corresponding to a 10% difference. The
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corresponding numbers for ODI were 26.8 n/hr (August) and 24.1 n/
hr (September), 11%.
Conclusions: The severity of sleep disordered breathing showed a
circannual variation which was independent of important confound-
ing factors including climate zone. Our data suggest that traditional
sleep apnea risk factors as well as environmental factors influence
the degree of sleep disordered breathing across the year. A further
in‐depth analysis of such factors is warranted.
Disclosure: The first author receives travelling grants from Vita-
lAire and Linde‐Healthcare.
RLS
169 | Brain iron metabolism and its effects on
brain neurocircuitry in RLS
R. Allen
Neurology, Johns Hopkins Univ., Baltimore, MD, United States
Brain iron deficiency (BID) is the best‐established biological abnormal-
ity in RLS with 11 imaging studies, two ultra‐sound studies, two cere-
brospinal fluid studies and several clinical studies showing iron
treatment benefit for all RLS with or without peripheral iron defi-
ciency. Only two of the research studies failed to find brain iron defi-
ciency, possibly type 2 errors related to sample size or methods. BID
produces several significant CNS effects, e.g. Dopamine receptor bal-
ance change favouring D1, hypoxic pathway activation, decreased
myelination and hypoadenosinergic, hyperglutamatergic and hyper-
dopaminergic states. BID increase of striatal dopaminergic activity is
particularly surprising given the treatment benefits of dopamine ago-
nists, but this BID effect occurs in animals and is documented in CSF
and imaging studies of RLS patients. The BID increase in hypoxic‐
inducible factor‐1 (HIF‐1) relates to increase in striatal tyrosine
hydroxylase (TH) and dopamine production. The dopamine receptor
and transporter changes also support dopamine increase. BID not only
increases striatal dopamine but also exaggerates the normal dopamine
circadian pattern. These BID dopaminergic changes provide a biologi-
cal basis for the circadian pattern of RLS symptoms and for the major
clinical problem of RLS augmentation. BID has a complicated impact
on Adenosine receptors that overall decreases brain adenosine activ-
ity significantly affecting sleep patterns. The BID in substantia nigra
relates specifically to the periodic limb movements of sleep, the motor
sign of RLS. This may impact pathways involving the thalamus, cortex
and spine. BID also produces decreased myelination particularly for
the corpus callosum, anterior cingulum and prefrontal gyrus possibly
related to some of the RLS cognitive deficits. Overall, BID accounts
for four major features of RLS: dopamine responsive, circadian pat-
tern, sleep disturbances and periodic limb movements. BID also pro-
vides a basis for development of iron treatments for RLS. IV iron
appears needed to increase peripheral levels enough to alter brain
iron. Pre‐clinical studies showed IV iron increased brain iron in regions
with iron deficiency without increasing iron where there was no defi-
cit thus producing no iron overload. This supports both utility and
safety of IV iron for treating RLS.
Disclosure: I have consulting services and clinical research funding
from Luitpold pharmaceutical and research funding from AMAG
pharmaceuticals.
170 | Balance‐shift of spinal dopamine
receptors during long‐term treatment. A possible
mechanism for augmentation
S. Clemens; M.-L. Dinkins; P. Lallemand
Physiology, East Carolina University, Greenville, NC, United States
Restless Legs Syndrome (RLS) is a highly prevalent chronic sensorimo-
tor disorder that severely disrupts sleep, affects quality of life, and
usually requires lifelong treatment. It is identified by patient‐subjective
sensory features (“urge to move”), but clinical outcome measurements
usually assess more readily quantifiable motor functions associated
with RLS (periodic leg movements during sleep, PLMS). Dopamine
receptor agonists, in particular those targeting the inhibitory
(Gi‐coupled) dopamine (DA) D3 receptor subtype (D3R), have shown
fast and significant relief from RLS and PLMS symptoms in the clinic
and decrease spinal reflex amplitudes and increase thermal pain with-
drawal latencies in the animal model. However, over time these pro-
longed D3R agonist treatment therapies cause a worsening of the
symptoms (augmentation). We have mimicked this outcome in mice,
and we found that blockade of excitatory (Gs‐coupled) D1 receptor
(D1R) function in such “augmented” animals restored the favourable
effects of the prolonged D3R agonist treatment. Our data indicate that
the mechanisms leading to augmentation in RLS patients after long‐
term use of the currently used dopamine receptor agonists may be
related to a D3R‐induced upregulation of the D1R system. As such,
our model can be used to assess the interactions between D3R and
D1R and unravel the mechanisms that lead to augmentation and serve
as a platform for the development of new pharmacological strategies
for the treatment of both RLS and augmentation.
Disclosure: Nothing to disclose.
171 | Hypoadenosinergic state as a driving
force leading to hyperdopaminergic and
hyperglutamatergic states in RLS
S. Ferre
National Institutes of Health, Integrative Neurobiology Section, National
Institute on Drug Abuse, Intramural Research Program, Baltimore, MD,
United States
Restless legs syndrome (RLS) is a common sensorimotor disorder,
whose basic components include a sensory experience, akathisia,
78 of 433 | ABSTRACTS
and a sleep‐related motor sign, periodic leg movements during sleep
(PLMS), both associated with an enhancement of the individual's
arousal state. The present review attempts to integrate the major
clinical and experimental neurobiological findings into a heuristic
pathogenetic model. The model also integrates the recent findings
on RLS genetics indicating that RLS has aspects of a genetically‐
moderated neurodevelopmental disorder involving mainly the cor-
tico‐striatal‐thalamic‐cortical circuits. Brain iron deficiency (BID)
remains the key initial pathobiological factor and relates to alter-
ations of iron acquisition by the brain, also moderated by genetic
factors. Experimental evidence indicates that BID leads to a hyper-
dopaminergic and hyperglutamatergic states that determine the dys-
function of cortico‐striatal‐thalamic‐cortical circuits in genetically
vulnerable individuals. However, the enhanced arousal mechanisms
critical to RLS are better explained by functional changes of the
ascending arousal systems. Recent experimental and clinical studies
suggest that a BID-induced hypoadenosinergic stateprovides the link
for a putative unified pathophysiological mechanism for sensorimotor
signs of RLS and the enhanced arousal state. Downregulation of ade-
nosine A1 receptors determines the hypoadenosinergic state, that
can lead to the hyperglutamatergic and hyperdopaminergic states
involved in PLMS and akathisia and the mechanism of activation of
the arousal systems. In fact, we have previously shown that adeno-
sine receptors localized in the cortico‐striatal terminals play a very
significant role in the modulation of striatal glutamate and indirectly
dopamine release. Inhibitors of adenosine transporters, such as
dipyridamole, counteract the hyperglutamatergic and hyperdopamin-
ergic states and preliminary data indicate that they can provide a
new therapeutic approach for RLS.
Disclosure: Nothing to disclose.
172 | The search for new therapeutic targets
D. Garcia-Borreguero
Sleep Research Institute, Madrid, Spain
Although dopamine agonists are effective agents for the short‐term
treatment of restless legs syndrome//Willis‐Ekbom disease (RLS/
WED), their main long‐term complication is augmentation of RLS
symptoms, that is, an overall increase in symptom severity. If not
stopped, augmentation can become a serious complication, as it will
eventually progress and can lead to discontinuation of treatment.
Studies show that after a treatment period of approximately
10 years, the prevalence of augmentation nears 50%. Furthermore,
given that RLS is frequently a chronic disease it is likely that with
protracted treatment, the risk of augmentation will increase even
further. In light of this, there is a clinical need for treatment alterna-
tives to dopaminergic drugs.
Brain iron deficiency (BID) is considered a main initial pathophysio-
logical mechanism in the development of RLS. Recent studies have
shown that BID in rodents is associated with a hypoadenosinergic
state, with down‐regulation of adenosine A1receptors (A1R) in the
striatum. Furthermore, down‐regulation of A1R could explain the
other two main alterations found in the pathophysiology of RLS,
which are the presynaptic hyperdopaminergic and hyperglutamater-
gic states. So far, the main therapeutic alternative to dopaminergic
medication have been alpha‐2 delta ligands (gabapentin, pregabalina).
These drugs probably exert their therapeutic effects by reduction of
glutamatergic release. Furthermore, our group has shown that per-
ampanel, an antagonist of glutamatergic AMPA receptors, also
improves RLS symptoms.
Given the presumed A1R down‐regulation in RLS patients, it could
be hypothesized that an increase in adenosinergic function might
help to alleviate symptoms. However, a direct targeting of A1R by
means of A1R agonists does not seem a therapeutic option at pre-
sent since they cause significant peripheral cardiovascular effects.
On the other hand, equilibrative nucleoside transporters (ENT1) con-
stitute an alternative therapeutic target, since, under normal condi-
tions, they promote the uptake of adenosine from the extracellular
space, thus keeping a relative low endogenous tone of adenosine.
Hence dipyridamol, which blocks reuptake of extracellular adenosine
by ENT, has shown promising therapeutic effects in a recent study.
In light of the existing interconnections between adenosine, gluta-
mate and dopamine in corticostriatal pathways, we will discuss addi-
tional future therapeutic targets.
Disclosure: Dr. G‐B has received research grants from MSD and
Xenoport.
TRANSCUTANEOUS CARBON DIOXIDE
DURING SLEEP IN SLEEP ‐DISORDERED
BREATHING: THE REVERSE SIDE OF THE
COIN
173 | Transcutaneous carbon dioxide during
sleep‐disordered breathing
V. Rimpilä1,2
1Faculty of Medicine and Life Sciences, University of Tampere, 2Unesta
Research Center, Tampere, Finland
Primary stimulus for eupneic breathing during sleep comes from
pCO2 while pO2 is relevant mainly during hypoxia. Development of
obstructive sleep‐disordered breathing is a gradual process, which
usually begins with minor upper airway flow‐limitation and later
develops into full obstruction. Despite the fact that CO2 is major
respiratory controller, the number of studies on sleep‐disordered
breathing (SDB) reporting pCO2 values is relatively limited. During
sleep it is useful to determine the eupneic pCO2 level as that will be
the target for ventilation. It is also common to determine the apneic
threshold for pCO2 and pCO2 level that triggers arousal may also be
found above eupneic levels. We were interested to see how the
transcutaneous carbon dioxide (tcpCO2) measurement would
ABSTRACTS | 79 of 433
perform during different SDB types. In terms of inspiratory flow‐lim-
itation the tcpCO2 levels increase as the level of obstruction wors-
ens. If the flow‐limitation stabilizes, the tcpCO2 assumes level that is
above eupneic pCO2. If so happens that inspiratory flow‐limitation
occurs below eupneic CO2 levels, these events are not characterized
with increased efforts whereas flow‐limitation occurring above the
eupneic level is, along with the appearance of snoring due to
increased efforts to keep the airway open. Central apneas are char-
acterized with the loss of effort that comes from crossing the apneic
threshold, whereas during the obstructive apnea and hypopnea the
effort remains throughout the event. As expected, with tcpCO2 the
central apneas are characterized with lowest values relative to wake-
fulness or eupneic breathing during sleep. Hypopnea and obstructive
sleep apnea assume tcpCO2 values that are (on average) at eupneic
levels or slightly below. Since the tcpCO2 measurement has an
inherent delay, these results were calculated from a sequence of
events. In conclusion, SDB events are characterized with different
levels of tcpCO2, information which could be useful when different
treatment options are considered. Elevated levels of pCO2 associ-
ated with inspiratory flow‐limitation and increased effort are not cur-
rently detected as the disease severity is determined mainly with
apnea‐hypopnea‐index (AHI) and oxygen desaturation index (ODI).
Disclosure: Nothing to disclose.
THE RELATIONSHIP BETWEEN BRAIN
OSCILLATIONS DURING SLEEP,
NEUROPLASTICITY AND STROKE
174 | Perilesional induction of sleep slow
waves improves motor recovery after ischemic
stroke
L. Facchin1; C. Schöne1; M. Bandarabadi1,2; K. Schindler2;
A. Adamantidis1,2; C. Bassetti1,2
1Experimental Neurology, 2Neurology Department, University Hospital
Inselspital, Bern, Switzerland
Introduction: Sleep‐wake disturbances are frequent after stroke
and are associated with poorer rehabilitation and long‐term out-
comes. Clinical and experimental studies suggest a favourable effect
of sleep on post‐stroke neuroplasticity and functional recovery.
Here, we investigate the role of sleep Slow Wave (SW)‐like oscilla-
tions on motor recovery following ischemic stroke using optogenetic
and in vivo electrophysiology techniques in mice.
Methods: Ischemic stroke was induced in wild type mice via mid-
dle cerebral artery occlusion (MCAO). Different optogenetic opsins
were targeted to pyramidal neurons using local infusion of CamkII‐
ChR2‐EYFP (ChR2) CamkII‐ArchT‐EYFP (ArchT) and CamkII‐mCherry
(control) adeno‐associated viruses (AAV) within the peri‐lesional pri-
mary somatosensory forelimb (S1FL) cortex. Optical stimulations
were designed to mimic SW‐like bistability during sleep during the
recovery period. Optogenetic SW‐like were delivered daily (2 hr/day,
at ZT 09:00) starting on post‐stroke day 5 until day 15. Behavioural
tests were conducted on post‐stroke days 4, 7, 10 and 15 to assess
the effect of optogenetically‐evoked SW on motor outcomes.
Results: We showed that MCAO induced an increased amount of
NREM sleep (n = 5, t‐test, p < 0.05) following ischemic stroke,
where ipsilesional SW where longer in duration compared to control
animals (n = 5, t‐test, p < 0.05) We showed that both optogenetic
activation (ChR2, n = 7) and silencing (ArchT, n = 7) of pyramidal
neurons within the per‐lesional S1FL cortex successfully induced
SW‐like bistability in ipsilesional and contralesional cortical elec-
troencephalography (EEG) recordings. Next, we showed that chronic
optogenetic induction of SW‐like bistability, predominantly during
NREM sleep, significantly improved the recovery of fine motor
movements (two‐way ANOVA, p < 0.05) as compared to control
mice (n = 7). Interestingly, the induction of SW‐like bistability post‐
stroke did not affect strength or symmetry of movements.
Conclusion: Our findings showed that optogenetically‐induced
SW‐like bistability through manipulation of peri‐lesional pyramidal
neurons activity significantly improves functional outcomes after
stroke. In line with the literature, our results suggest a positive role
of sleep in motor recovery following ischemic stroke.
Disclosure: Nothing to disclose.
NARCOLEPSY
175 | Is cataplexy a dissociated state of
paradoxical (REM) sleep? Role of glutamatergic
neurons of the sublaterodorsal nucleus in a
mouse model of narcolepsy type 1
A. Roman1; M. Villalba1; P.-A. Libourel1; C. Peyron2
1University of Lyon1, CNRS UMR5292, INSERM U1028, 2CRNL | CNRS
UMR5292, INSERM U1028, CRNL, CNRS UMR5292, INSERM U1028,
Université‐lyon1, Lyon, France
Narcolepsy type 1 is a chronic neurologic disorder characterized by
an excessive daytime sleepiness and episodes of cataplexy. Cata-
plexy is characterized by a bilateral loss of muscle tone during wake-
fulness, and triggered by a strong and generally positive emotion,
without loss of conciousness. This symptom has long been described
as a REM sleep dissociated state because the muscle atonia pheno-
type observed during cataplexy resembles the characteristic muscle
atonia of REM sleep. This supposes that a common neuronal net-
work underlies REM sleep and cataplexy muscle atonia, however it
has never been demonstrated.
To test this hypothesis, we abolished the glutamatergic transmission
in the sublaterodorsal tegmentum nucleus (SLD) ‐responsible for
REM Sleep atonia (Garcia Valencia et al, 2016)‐ in narcoleptic Orex‐
KO mice, using short‐hairpin RNA method (shRNA) directed against
the vesicular transporter 2 of glutamate. Mice were injected with
80 of 433 | ABSTRACTS
the experimental (shGlut; n = 9) or control (shCtrl; n = 6) AAV,
locally in the SLD. After 8 weeks necessary for an efficient expres-
sion, mice underwent 48 hr of baseline recordings followed by a
protocol of cataplexy induction with chocolate.
As expected, blockage of the SLD glutamate transmission induced
episodes of REM sleep without atonia in shGlut mice. However, cat-
aplexy was not reduced in its total amount or bouts number, in shG-
lut mice compare to shCtrl, and this during Baseline condition or
after cataplexy‐induced protocols (Mann Whitney, p = 0.82).
To conclude, these data altogether suggest that cataplexy does not
rely on the activation of glutamate SLD neurons, and that cataplexy
is not a dissociated state of REM sleep into wakefulness. Uncovering
the neuronal network supporting cataplexy phenotype is thus of
great importance for the development of future innovative treat-
ments.
Disclosure: Nothing to disclose.
MOLECULAR AND CELLULAR MECHANISM
OF SLEEP HOMEOSTASIS
176 | Ca2+‐dependent hyperpolarization
pathway in sleep homeostasis
S. Shi1,2,3; K. Yoshida1; H.R. Ueda1,2,3
1Department of Systems Pharmacology, 2International Research Center
for Neurointelligence (WPI‐IRCN), University of Tokyo, Tokyo,
3Laboratory for Synthetic Biology, RIKEN Center for Biosystems
Dynamics Research, Osaka, Japan
A primary goal of sleep research is to understand the molecular basis
of sleep. To address this challenge, we combined mathematical anal-
ysis and comprehensive KO study. We constructed a simple compu-
tational model of an averaged neuron, which recapitulates the
electrophysiological characteristics of the slow‐wave sleep and
awake states. Comprehensive bifurcation analysis of an ensemble of
more than 1,000 models predicted that a Ca2+‐dependent hyperpo-
larization pathway may play a role in slow‐wave sleep and hence in
sleep‐time regulation. To experimentally validate the prediction, we
performed a comprehensive KO study and succeeded in identifying
eight genes playing a role in sleep‐duration regulation (Kcnn2, Kcn-
n3, Atp2b3, Cacna1g, Cacna1h, Camk2a, Camk2b, and Nr3a), which
suggests that the Ca2+‐dependent hyperpolarization pathway may
play a role in sleep‐duration regulation. In addition, we further sim-
plified our computational model and obtain a model with five chan-
nels and a pump. By combining a comprehensive bifurcation against
this simplified model and KO study, we found that impairment of
the leak K+ channel (Kcnk9) decreased sleep duration. Based on
these results, we hypothesize that the Ca2+‐dependent hyperpolar-
ization pathway and leak K+ channels cooperatively regulate sleep
duration in mammals.
Disclosure: Nothing to disclose.
177 | Long‐ and short‐term molecular
consequences of sleep loss in mice
C.N. Hor1; J. Yeung2; M. Jan1,3; Y. Emmenegger1;
J. Hubbard1; F. Naef2; P. Franken1
1University of Lausanne, 2EPFL, 3SIB ‐ Swiss Institute of Bioinformatics,
Lausanne, Switzerland
Numerous studies in a variety of species, including humans and mice,
have investigated the effects of sleep loss on gene expression under a
variety of experimental protocols. With few exceptions, the effects of
this intervention on the transcriptome has been assessed immediately
after a period of enforced wakefulness and were then contrasted to
the matching time‐of‐day under undisturbed ad lib sleep conditions,
precluding the assessment of the dynamic changes during the sleep
deprivation (SD) and the longer term repercussions during recovery
sleep and how these dynamics compare to those observed under
undisturbed conditions. Here we present data on an extensive RNA‐
seq (gene expression) and ATAC‐seq (chromatin accessibility) study in
C57BL/6J male mice for which we sampled cortex and liver tissue over
a 72 hr period during baseline (ZT0, −3, −6, −12, and −18), during a
6 hr SD deprivation (ZT0, 3‐, and −6), during 48 hr recovery (ZT12,
−18, −0, −6, −12, −18, −0, −6), and, finally, 2 time points 1 week after
SD (ZT0 and −6; a total 18 time points, n = 3/time point). Transcrip-
tome dynamics were classified according to 5 models including a
strictly circadian model (with and without SD effect on amplitude), a
strictly homeostatic model (sleep‐wake driven; based on EEG data
obtained in a separate cohort of mice), and 2 combinations thereof.
The study confirmed the earlier reported immediate‐early gene path-
ways being up‐regulated immediately after SD which we show to
quickly revert to basal levels. We also found evidence of pathways
affected by SD with much slower dynamics outlasting the SD effects
on sleep and the EEG. Moreover, the amplitude of several components
of the core clock machine machinery were markedly blunted during
recovery sleep. The ATAC‐seq results revealed numerous genomic
sites, mostly concerning intronic or intergenic regions, for which chro-
matin accessibility was changed immediately by SD; i.e., 3 and 6 hr into
the SD, but these changes reverted to basal level within 12 hr of recov-
ery. Analyses of the motives under the affected chromatin regions for
transcription factor binding sites pointed to key transcription factors
important for driving the expression of the rapidly induced transcripts.
Disclosure: Nothing to disclose.
178 | The gating of sleep by motivated
behavior
M. Lazarus
International Institute for Integrative Sleep Medicine (IIIS), University of
Tsukuba, Tsukuba, Japan
As humans, we often defy sleepiness and stay awake when atten-
tion is necessary, but also experience an inescapable desire to
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sleep in boring situations. The brain mechanisms governing the
regulation of sleep by cognitive and emotional factors are not well
understood. We recently reported that a part of the brain that is
associated with motivation and pleasure ‐ the nucleus accumbens
(NAc) ‐ also can produce sleep (Oishi et al., Nat Commun, 2017).
We used chemo‐genetic and optical techniques to remotely control
the activities of NAc neurons that express adenosine A2Areceptors
(A2AR), also known as indirect pathway neurons. As a result, we
discovered that NAc A2AR neurons projecting to the ventral pal-
lidum have an extremely strong ability to induce sleep that is
indistinguishable from the major component of natural sleep,
known as slow‐wave sleep, when activated. Inhibition of these
neurons prevents the sleep induction but does not affect the
homoeostatic sleep rebound. Interestingly, motivational stimuli inhi-
bit the activity of ventral pallidum‐projecting NAc A2AR neurons
and suppress sleep. Our findings may explain why we have the
tendency to fall asleep in the absence of motivating stimuli, i.e.,
when bored. Caffeine, the most widely consumed psychostimulant
in the world, produces its arousal effect also in the NAc by block-
ing A2AR. Therefore, the classic somnogen adenosine is a strong
candidate for evoking the sleep effect in the NAc.
Disclosure: Nothing to disclose.
SLEEP IN CHILDREN AND ADOLESCENTS
O179 | Sleep mediates the association
between school pressure, physical activity,
screen‐time and psychological distress in
adolescents
K. Dhondt1; A. Vandendriessche2; A. Ghekiere2; J. Van
Cauwenberg2; B. De Clercq2; A. Desmet2; M. Verlogne2;
D. Benedicte2
1Child & Adolescent Psychiatry, Ghent University Hospital, 2Ghent
University, Ghent, Belgium
Objectives/Instruction: This study examines the mediating role of
sleep duration and sleep difficulties on the association between
screen‐time, school pressure, physical activity and psychological dis-
tress in adolescents.
Methods: Data were retrieved from 49,403 children
(13.7 ± 1.6 years old, 48.1% boys) from 12 countries participating in
the WHO ‘Health Behaviour in School‐aged Children’ study con-
ducted in 2013/2014. Psychological distress (feeling low, irritability or
bad temper, feeling nervous), school pressure, physical activity (num-
ber of days/week 60 min moderate‐to‐vigorous), screen‐time behav-
iors (TV, gaming, other purposes), sleep duration on week‐ and
weekend days and sleep difficulties (perceived difficulties in getting
asleep) were assessed using a validated self‐reported questionnaire.
Multilevel mediation analyses were conducted using the statistical
program R.
Results: School pressure (ref. ‘none’; ‘some’ B = 0.40, p = 0.01;
‘a lot’ B = 0.86, p = 0.01) and screen‐time (B = 0.04, p = 0.001)
were positively associated with psychological distress, while physi-
cal activity (B = −0.02, p = 0.002) was negatively associated.
Except for sleep duration in the association between physical
activity and psychological distress, all associations were significantly
mediated by sleep duration on week‐ and weekend days and
sleeping difficulties. Percentages mediated ranged from 2.84% to
21.16% for sleep duration on weekdays, from 0.66% to 4.49% for
sleep duration on weekend days and from 24.60% to 34.13% for
sleeping difficulties.
Conclusions: These results explain partly how school pressure,
screen‐time and physical activity is related to mental wellbeing. Future
interventions improving adolescents’ mental wellbeing could target
schoolwork, physical activity and screen‐time, as these behaviours are
directly and indirectly (through sleep) related to psychological distress.
Disclosure: Nothing to disclose.
O180 | Tracking infant development: Links
between sleep‐wake behavior and gut bacteria
beta‐diversity
S.F. Schoch1,2,3; J.L. Castro-Mejía4; B. Leng4; W. Kot5;
Ł. Krych4; D.S. Nielsen4; S. Kurth1,2,3
1Department of Pulmonology, University Hospital Zurich, 2Clinical
Research Priority Program Sleep and Health, University of Zurich,
3University Children's Hospital Zurich, Zurich, Switzerland, 4Department
of Food Science, University of Copenhagen, Copenhagen, 5Department
of Environmental Science, Aarhus University, Roskilde, Denmark
Objectives/Instruction: In the first year of life infants’ sleep regu-
lation undergoes rapid maturation towards more consolidated, noc-
turnal sleep. Simultaneously, the community of gut bacteria (GB)
inhabiting the digestive tract increases in diversity and complexity.
Increasing evidence from animal and human adult research suggests
a bi‐directional relationship between sleep regulation and GB compo-
sition. However, little is known about this relationship in the devel-
opmental period of early human life.
Methods: Sleep behavior was assessed longitudinally in healthy
infants using ankle actigraphy (Geneactiv) and 24‐hr sleep‐wake dia-
ries (n = 83.3 months, n = 76.6 months, n = 36.12 months). Total
Sleep Duration (per 24 hr), Fragmentation (of night time sleep/h), Bed-
time variability and % Night Sleep (of total sleep duration) were quan-
tified based on 7.0 ± 2.1 (M ± SD) days by adapting a previously
published algorithm (Sadeh et al., 1995) and integrating 24‐hr diaries.
Fecal samples were collected from which total genomic DNA was
extracted and subjected to high throughput 16S rRNA gene (V3
region) amplicon sequencing. Operational Taxonomic Units were
constructed with UPARSE pipeline using the Greengenes (13.8) 16S
rRNA gene collection as reference. Behavioral developmental status
was quantified using the parent‐reported Ages and Stages Question-
naire (composite score).
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Results: Sleep and GB composition were not related at 3 mo, yet a
significant relationship was found at 6 mo between % Night Sleep
and GB beta‐diversity (p = 0.04), partially explained by Bifidobac-
terium prevalence. At 12 months, Fragmentation was linked to GB
beta‐diversity (p = 0.03), revealing a positive association with Bac-
teroides and a negative association with Lachnospiraceae prevalence.
Interestingly, at the same age, the sleep variable Fragmentation was
also linked to behavioural developmental status (r = −0.32, p = 0.06).
In addition, Bedtime Variability was associated with GB beta‐diversity
(p = 0.02) specifically showing a positive association with Bifidobac-
terium longum (p < 0.001), yet a negative association with other Bifi-
dobacterium species (p = 0.008).
Conclusions: These findings uncover an interplay between infant
sleep and GB, throughout the maturational period of the first year of
life, specifically with the genera Bifidobacterium and Bacteroides. We
propose a simultaneous maturation of sleep regulation and GB com-
position, but future studies should examine the directionality of this
link.
Disclosure: Nothing to disclose.
O181 | Sleep in infancy and its relation to the
symptoms of attention‐deficit and hyperactivity
disorder at age 5 years: a longitudinal study
H. Huhdanpää1,2; I. Morales Muñoz1; A. Kylliäinen3;
O. Saarenpää-Heikkilä4; E. Aronen2; E.J. Paavonen1,2
1Department of Health, National Institute for Health and Welfare,
2Child Psychiatry, University of Helsinki and Helsinki University
Hospital, Helsinki, 3Psychology, School of Social Sciences and
Humanities, University of Tampere, 4Pediatric Clinics, Tampere
University Hospital, Tampere, Finland
Objectives/Introduction: There are cross‐sectional population‐
based studies and meta‐analysis indicating that sleep difficulties are
associated with cognitive and behavioral problems. It is not well
studied, however, how the early sleep in infancy is related to later
development. The aim of this study was to identify whether parent
reported short sleep duration, night awakenings and sleeping difficul-
ties during the first years are associated with ADHD‐related symp-
toms at age 5.
Methods: The study is based on a longitudinal CHILD‐SLEEP birth
cohort comprising altogether >1,600 families from the Pirkanmaa
area, Finland, with several measurement points. For this study, we
used the information regarding maternal questionnaires during preg-
nancy and two sleep questionnaires, the Brief Infant Sleep Question-
naire (BISQ) and the Infant Sleep Questionnaire (ISQ) filled out by
the parents when the child aged 3, 8, 24 months and 5 years.
ADHD‐related symptoms at age 5 were assessed using the Strengths
and Difficulties Questionnaire (SDQ) and Five‐to‐Fifteen (Viivi) ques-
tionnaires. The final sample included 605 children with measure-
ments at all time points.
Results: In order to examine the effects of sleep problems on
ADHD‐related symptoms, logistic regression analysis was conducted.
Infant′s age, gender, mother′s educational level and number of chil-
dren were included as covariates. Our main results showed that
short sleep at 3 months of age predicted inattentiveness at age 5
(p < 0.01). Further, short sleep and sleep difficulties at age of
24 months increased the risk for having inattentive symptoms at age
5 (p < 0.05; and p < 0.001, respectively). Moreover, 5‐year‐old chil-
dren with current sleep difficulties had increased risk for hyperactiv-
ity (p < 0.001) and inattentiveness (p < 0.001). Number of night
awakenings were also associated with hyperactivity (p < 0.01) and
inattentiveness (p < 0.01) at that age.
Conclusions: Sleep problems at early childhood were associated
with later occurring ADHD‐related problems. More specifically, short
sleep at age 3 months was associated with inattentiveness at 5 years
old. Short sleep and sleep difficulties at 24 months increased the risk
for having inattentive symptoms at age 5 years. Our findings indi-
cated that altered developmental pathway of sleep quality occurs
early in infancy among the children who would later have ADHD‐
related difficulties.
Disclosure: Nothing to disclose.
O182 | Later school start times alleviate sleep
deprivation and social jetlag in adolescent high
school students
A.M. Biller; C. Molenda; M. Vuori; T. Roenneberg;
E. Winnebeck
Institute of Medical Psychology, Munich, Germany
Objectives/Introduction: School starts between 7 and 8 am in
many countries. While this early start is in line with the normally
early circadian phase of younger students, it clashes with the often
late circadian phase and thus extremely late bedtimes of adolescent
students. Consequently, adolescents accumulate a substantial
amount of sleep loss over the school week and suffer from „social
jetlag”. This can impair their health, cognitive performance and
career prospects. Nonetheless, early school start times for adoles-
cents are largely maintained ‐ for a scarce body of evidence that
delaying them alleviates the problem.
Methods: We therefore monitored changes in sleep, circadian
rhythms and grades, when in February 2016 a high school near
Aachen (Germany) introduced “flexi time”, allowing senior students
to choose daily between an 8‐ or 9‐am‐start. Using actimetry and
sleep diaries, we followed 93 students aged 15–19 for 3 weeks
before and 6 weeks into the flexi‐system, obtaining high‐quality data
from 39 and 65 students, respectively. In February 2017, we con-
ducted a 1‐year‐follow‐up in which 106 students aged 15–21 kept a
sleep diary for 6 weeks (overlap with 2016: 41). 2016‐data (pre-
sented below) were analysed using paired t‐tests, Wilcoxon Signed‐
Rank Test and Cohen's d at a significance level of .05.
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Results: In our 2016‐study, nearly all participants benefited from a
9‐am‐start compared to an 8‐am‐start according to both subjective
and objective sleep measures. Independent of chronotype, partici-
pants slept on average one hour longer on 9‐am‐days since sleep
onset remained unchanged but sleep offset became significantly
later. We also observed that students with short sleep duration at
baseline benefited more compared to students with longer sleep
duration. On 9‐am‐days, participants reported to use the alarm clock
less often, to feel more concentrated and motivated, and to sleep
and learn better. Social jetlag was significantly reduced in the flexible
system because weekend sleep timing was advanced.
Preliminary results from our follow‐up study corroborate these find-
ings. A longitudinal analysis of grades will shed light on whether this
translates to a change in academic performance.
Conclusions: Based on our findings and feedback from teachers
and students we recommend later school start times for adolescents.
Disclosure: TR is founder of Chronsulting UGmbh, consultant to
Condor Instruments LTDA, Consultant to Vanda Pharmaceuticals,
Consultant to jetlite GmbH, consultant to HiPP‐Werk Georg Hipp
OHG, consultant to Reset Therapeutics, Inc.
O183 | Sleep‐dependent memory consolidation
in children with high‐functioning autism
spectrum disorder
K. Zinke1; E.-M. Kurz2; A. Conzelmann2; G.M. Barth2;
L. Ebbeler2; D.K. Schenk2; T.J. Renner2; J. Born1
1Institute of Medical Psychology and Behavioral Neurobiology,
University of Tübingen, 2Paediatric and Juvenile Psychiatry,
Psychosomatic and Psychotherapy, University Hospital Tübingen,
Tübingen, Germany
Objectives/Introduction: Sleep supports memory consolidation in
both adults and children. Disturbed sleep during childhood may cru-
cially alter cognitive development. Autism spectrum disorder (ASD) is
accompanied by alterations in both cognition and sleep and prelimi-
nary evidence suggests that deficits in sleep‐dependent memory
consolidation due to sleep disturbances may underlie some of the
cognitive deficits. Thus, the current study aimed to investigate if
sleep is altered in children with ASD and if these alterations are
linked to impairments in sleep‐dependent memory consolidation.
Methods: In a counterbalanced within‐subjects design we tested
memory retention across a nocturnal sleep and a daytime wake
interval in twenty‐one children with ASD and twenty age (9–
12 years) and IQ matched typically developing (TD) controls. Three
different memory tasks were used that focus on abstraction of infor-
mation: gist‐based false memories, emotional memories, explicit
knowledge of an implicitly learned serial reaction time task. Sleep
was assessed using standard polysomnography.
Results: Contrary to our predictions, children with ASD did not
show any specific impairment in sleep‐dependent memory
consolidation. They generally performed worse (independent of
retention interval) than the TD children in the recognition of emo-
tional memories (Group main effect: p < 0.001), the correct recall of
words in the false memory task (p = 0.014), and trend wise in the
explicit sequence knowledge in a serial reaction time task
(p = 0.080). Interestingly, children with ASD showed a sleep‐depen-
dent benefit for recalling gist‐based false memories that was not
observed in the TD children (Group × Condition: p = 0.012).
Although parents reported more sleep disturbances in children with
ASD compared to children without ASD (p < 0.001) none of the
objectively assessed sleep parameters differed significantly between
groups.
Conclusions: Thus, even though, we confirmed a general deficit in
memory performance in children with ASD, sleep‐dependent mem-
ory consolidation and abstraction processes seem to be preserved.
We propose that sleep might have a compensating function in chil-
dren with ASD.
Disclosure: Nothing to disclose.
O185 | Sleep‐dependent memory consolidation
enhancement from childhood to adolescence is
related to developmental changes in sleep
spindles and slow oscillations
M. Hahn1; A.-K. Joechner1; D. Heib1; G. Gruber2;
M. Schabus1; K. Hoedlmoser1
1Laboratory for Sleep, Cognition and Consciousness Research,
Department of Psychology, Centre for Cognitive Neuroscience (CCNS),
University of Salzburg, Salzburg, 2Department of Psychiatry and
Psychotherapy, Medical University of Vienna, Vienna, Austria
Objectives/Introduction: The precise interplay between slow
oscillations and sleep spindles is supposed to orchestrate sleep‐
dependent memory consolidation. This interplay during which sleep
spindles are nested within the slow oscillations up‐states deterio-
rates from young adulthood to old age. The period with the most
rapid and drastic changes to sleep spindles and slow oscillations
however, is during puberty. Here we investigated the development
of sleep spindles and slow oscillations from childhood to adolescence
and whether these changes benefit sleep‐dependent memory consol-
idation.
Methods: Our longitudinal, within‐subject design comprised four
ambulatory full‐night polysomnographies recorded in 36 healthy par-
ticipants (24 female). We recorded the first two nights during child-
hood (age range 8–11 years) and the second two nights during
adolescence (age range 14–18 years). At both times, participants had
to recall previously learned word pairs before and after sleep. Slow
oscillations and sleep spindles were automatically detected at central
electrodes during non‐rapid eye movement sleep.
Results: We found that both, slow oscillation up‐state duration
(t (32) = −2.65, p = 0.012, d = −0.68) and fast spindle density
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(t (32) = −10.71, p < 0.001, d = −1.22) increased from childhood to
adolescence. Furthermore, Spearman correlations (corrected for age
difference) revealed that not only the developmental extension of
the slow oscillation up‐state (rs (30) = 0.40, p = 0.022), but also the
developmental increase in fast spindle density (rs (30) = 0.55,
p = 0.001) correlated positively with enhanced sleep‐dependent
memory consolidation.
Conclusions: Our results suggest that brain development from
childhood to adolescence lead to prolonged slow oscillation up‐
states and increased fast spindle density. These developmental
changes were found to be related to enhanced sleep‐dependent
declarative memory consolidation. The prolonged up‐state could pro-
vide a wider timeframe in which memories can be potentiated by
fast spindles during sleep. Not only do these results support the key
role of slow oscillations and sleep spindles for memory consolidation
from a developmental perspective, but they also hint at a qualitative
change of slow oscillation‐spindle‐coupling during puberty, which we
are currently investigating.
Disclosure: Nothing to disclose.
O186 | During day and night: childhood
psychotic‐like experiences and nightmares
M.E. Koopman-Verhoeff1; K. Bolhuis1; C.A.M. Cecil1,2;
D. Kocevska3; F.C. Verhulst3; M.P.C.M. Luijk3,4;
H. Tiemeier1,5
1Child and Adolescent Psychiatry ‐ Generation R, Erasmus Medical
Center, Rotterdam, the Netherlands, 2Institute of Psychiatry, Psychology
and Neuroscience, Kings College London, London, United Kingdom,
3Child and Adolescent Psychiatry, Erasmus Medical Center, 4Psychology,
Erasmus University Rotterdam, Rotterdam, the Netherlands, 5Social and
Behavioral Science, Harvard TH Chan School of Public Health, Boston,
MA, United States
Objectives/Instruction: Psychotic‐like experiences are auditory
and visual perceptive phenomena, such as hearing or seeing things
that are not there or delusional thoughts, in the absence of a psy-
chotic disorder. Psychotic‐like experiences commonly occur in the
general pediatric population and predict the onset of severe mental
illness. They have been associated with sleep problems, but studies
with objective sleep measures are lacking. This study assessed
whether psychotic‐like experiences were associated with actigraphic
sleep measures, symptoms of dyssomnia, nightmares, or other para-
somnias.
Methods: This cross‐sectional population‐based study was embed-
ded in the Generation R Study. Sleep was assessed using a tri‐axial
wrist accelerometer in N = 814 children, who wore the accelerome-
ter for five consecutive school days. At age 10 years, psychotic‐like
experiences were assessed by self‐report, dyssomnia and parasomnia
symptoms were reported by both child and mother. The analyses
were adjusted for age, sex, ethnicity, gestational age, maternal edu-
cational attainment and psychiatric problems, and additional for
child's concurrent psychopathology.
Results: Self‐reported psychotic‐like experiences and hallucinatory
phenomena were not associated with objective sleep duration, sleep
efficiency, or arousal. However, psychotic‐like experiences and hallu-
cinatory phenomena were associated with self‐reported dyssomnia
(respectively, B = 1.22, 95% CI: 0.77–1.67, p < 0.01; B = 1.25, 95%
CI: 0.61–1.89, p < 0.01) and mother‐reported parasomnia, specifi-
cally nightmares (respectively, ORadjusted = 5.30, 95% CI 2.91–9.66,
ORadjusted = 2.99, 95% CI 1.37–6.55).
Conclusions: Childhood psychotic‐like experiences hallucinatory
phenomena were not associated with objective sleep measures. In
contrast, psychotic‐like experiences were associated with nightmares,
which are a known risk‐indicator of psychopathology in preadoles-
cence. More research is needed to shed light on the potential etio-
logic or diagnostic role of nightmares in the development of
psychotic phenomena.
Disclosure: The funders had no role in the study design, data col-
lection, analysis, interpretation of the data, or writing of the report.
F.C.V. is the contributing editor of the Achenbach System of
Empirically Based Assessment, from which he receives remunera-
tion. For the other authors, no competing financial interest were
reported.
O187 | Slow wave activity topography predicts
development of brain myelin in children
M. Le Bourgeois1; S. Deoni2; D. Dean3; S. Kurth4
1Integrative Physiology, University of Colorado Boulder, Boulder, CO,
2School of Engineering, Brown University, Providence, RI, 3Waisman
Laboratory for Brain Imaging and Behavior, University of Wisconsin,
Wisconsin, WI, United States, 4University Hospital Zurich, Zurich,
Switzerland
Objectives/Introduction: Sleep is an essential contributor to neu-
rodevelopmental processes: insufficient sleep results in behavioral
malfunction in cats, rodents and flies. While epidemiological research
in humans reveals negative cognitive, emotional and psychosocial
consequences of poor sleep in early life, pediatric longitudinal stud-
ies are lacking that quantify the physiological underpinning of these
observations, i.e. sleep neurophysiology and structural brain matura-
tion. We investigated correlational relationships between matura-
tional markers in sleep EEG topography at preschool‐age and brain
myelin content 3.5 years later.
Methods: 9 healthy children underwent all‐night sleep hdEEG at
T1 (age 2.4–8.0 years, mean 4.7 years) and again at T2 (age 6.0–
12.2 years, mean 8.8 years). The maturational status of slow wave
activity topography was quantified as Frontal/Occipital (F/O) ratio of
slow wave activity (1–4.5 Hz) in predefined clusters of 2*5 elec-
trodes in the first 60 min of NREM sleep. mcDESPOT‐MRI was
obtained at T2 to quantify white matter myelin microstructure (mye-
lin water fraction, MWF).
Results: F/O‐ratio at T1 predicted whole‐brain MWF at T2
(R = 0.89, p = 0.001, partial correlation with factor “age” R = 0.75,
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p = 0.03). At T2, F/O‐ratio was only linked to whole‐brain MWF
when corrected for age, showing a negative relationship (R = 0.18,
p = ns, partial R = −0.84, p = 0.008). In other regions of interest,
F/O‐ratio was only a weak (at T1, Superior Longitudinal Fasciculus,
R = 0.8, p = 0.1, partial R = 0.64, p = 0.08; at T2, p = ns, partial
R = −0.86, p = 0.006) or else no correlative predictor for MWF (Cor-
pus Callosum, Optic Radiation, p = ns).
Conclusions: The topographical distribution of slow wave activity
(F/O ratio) in children is an early marker for whole brain myelin
development. This preliminary finding supports the concept that
sleep not only reflects, but also predicts brain myelin maturation.
These findings make two important contributions, in (1) unraveling
possible factors shaping the brain connectome, and (2) informing
about longitudinal associations of sleep and myelin in childhood,
which is relevant for translational avenues of mental health.
Disclosure: Nothing to disclose.
O188 | Beneficial effects of a lifestyle
intervention program on C‐reactive protein:
impact of cardiorespiratory fitness in obese
adolescents with sleep‐related disorders
J. Roche1,2,3; L. Isacco1,2; F. Perret4; G. Dumoulin5; V. Gillet3;
F. Mougin2,6
1Research unit EA 3920, Prognostic Markers and Regulatory Factors
of Cardiovascular Diseases, and Exercise Performance, Health,
Innovation Platform, 2Sports Sciences Faculty, University of Bourgogne
Franche Comté, Besançon, 3Sleep Medicine Center ‘Ellipse’, Franois,
4UGECAM Bourgogne Franche‐Comté, Specialized Residential Nursing
Institution La Beline, Salins Les Bains, 5Medical Biochemistry,
University Hospital, 6Research unit EA 3920 Prognostic Markers and
Regulatory Factors of Cardiovascular Diseases, and Exercise
Performance, Health, Innovation Platform, University of Bourgogne
Franche Comté, Besançon, France
Objectives/Introduction: Lifestyle modification is an adjunct ther-
apy for obstructive sleep apnea (OSA) in obese youths but its effects
on inflammation are not well understood. This study assessed the
relationship between inflammation and OSA and whether the life-
style program (LIP) effects on inflammatory markers are mediated by
changes in anthropometric parameters, cardiorespiratory fitness,
sleep duration and sleep‐related breathing disorders in severe obese
adolescents.
Methods: Participants were aged of 14.6 ± 1.2 years, with a body
mass index (BMI) of 40.2 ± 6.5 kg/m2. Sleep, investigated by ambula-
tory polysomnography, anthropometric parameters, glucose metabo-
lism, inflammatory profile and cardiorespiratory fitness were
assessed at admission and at the end of a 9‐month LIP. V˙O2peak
was expressed relative to the body weight; V˙O2peakBW (ml/min/kg),
and to the fat‐free mass; V˙O2peakFFM (ml/min/kgFFM). Associations
between C‐reactive protein (CRP) concentrations and BMI, sex, oxy-
gen desaturation index (ODI), sleep fragmentation, total sleep time
(TST) and V˙O2peak were assessed via ANCOVA.
Results: Twenty‐three subjects completed the study. OSA‐subjects
(n = 13) exhibited higher CRP concentrations and a trend for higher
BMI than N‐OSA (p = 0.09) at admission. Post‐intervention, obstruc-
tive apnea‐hypopnea index did not change but CRP and leptin levels
significantly decreased while adiponectin concentrations increased in
the OSA‐group and overall population. OSA was normalized in 6 sub-
jects (46%). At admission, BMI adjusted for sex, arousal index, ODI,
TST and V˙O2peakBW was associated with CRP levels (adjusted
r2 = 0.32, p < 0.05). Decrease in CRP concentrations post‐interven-
tion was explained by enhanced V˙O2peakFFM adjusted for sex, weight
loss and changed sleep parameters (adjusted r2 = 0.75, p < 0.05).
Conclusions: Despite higher amounts of CRP in OSA‐subjects,
obesity overpasses the pro‐inflammatory effects of sleep‐related dis-
orders and low cardiorespiratory fitness and explains systemic
inflammation at admission of a LIP. Although the program did not
normalize OSA in every subject, levels of CRP and adipokines were
improved in overall population although these concentrations remain
alarming. Finally, the decrease of inflammation is mediated by
enhanced cardiorespiratory fitness related to fat‐free mass, after
controlling for sex, weight loss and changes in sleep parameters. In
view of the long‐term health implications of obesity and OSA, fur-
ther studies are needed to better explore the relationship between
fitness and inflammation in obese adolescents with sleep‐related
breathing disorders.
Disclosure: Nothing to disclose.
O188a | The impact of a teacher‐led,
classroombased, sleep education programme on
adolescent sleep in UK schools: the Teensleep
study
R. Sharman; G. Illingworth; R. Foster; C. Espie;
C.-J. Harvey
Sleep and Circadian Neuroscience Institute, Nuffield Department of
Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
Objectives/Instruction: Insufficient sleep during adolescence
associates with poorer physical and emotional health. The National
Sleep Foundation (NSF) recommend a healthy sleep duration of 8–
10 hr yet weeknight sleep duration in adolescents around the world
has shown a steady decline over the past century. Numerous move-
ments are championing the delay of school start times to increase
weekday sleep durations. However, UK schools start around 9 am,
significantly later than other countries. Sleep education is a promis-
ing alternative mechanism for change. Therefore, the Oxford Teen-
sleep project sought to evaluate if adolescent sleep could be
improved through a teacher‐led sleep education programme.
Methods: The Teensleep programme was taught to Year 10 (14–
15 years) students in ten UK schools over one term. The 10‐lesson
programme consisted of teacher and student workbooks supported
by PowerPoints. Teachers received a half‐day training session on the
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materials. Lessons were designed to be interactive and discursive
covering sleep science, sleep hygiene, and stress management. Stu-
dents were asked to complete the Sleep Condition Indicator (SCI;
n = 694), Munich Chronotype Questionnaire (MCTQ; n = 347) and a
sleep knowledge quiz (n = 779). A subgroup of students completed
2‐weeks’ sleep monitoring (actigraphy: n = 84; diary: n = 77). All
measures were completed before and after the intervention.
Results: Sleep knowledge (p < 0.001) and sleep quality (SCI)
(p < 0.001) improved. Students classified as having probable insom-
nia (SCI) at baseline (n = 113) showed a significant improvement in
sleep quality (p < 0.001) with 52% moving out of this classification
post‐intervention. Subgroup weekday sleep duration did not signifi-
cantly change following the intervention (diary = 7:51 hr, actigra-
phy = 7:02 hr) but survey sleep duration (MCTQ) improved
(07:41 hr) (p = 0.026). Notably, sleep duration remained below NSF
guidelines. Subgroup diary weekday sleep onset (p = 0.018) and
wake after sleep onset (p = 0.018) significantly improved. There was
no change in chronotype or degree of social jetlag.
Conclusions: This was the first sleep education study in the UK
and the largest to use both pseudo‐objective and subjective mea-
sures. This study highlights how teacher‐led sleep education alone
may be sufficient to improve sleep in those with insomnia symp-
toms. However, additional interventions to address the biological
delay may be required to increase sleep duration to NSF recommen-
dations for all students.
Disclosure: Nothing to disclose.
SLEEP IN AGING AND DEMENTIA
O189 | Association of circadian sleep‐wake
regulation and brain structure in older adults: a
multi‐modal approach
M. Deantoni1; G. Hammad1; M. Maire2,3,4; M. Ali Bahri1;
C. Berthomier5; C. Cajochen2,3; C. Reichert2,3; C. Schmidt1,6
1GIGA‐CRC in Vivo Imaging, Université de Liège, Liège, Belgium, 2Centre
for Chronobiology, Psychiatric Hospital, 3Transfaculty Research Platform
Molecular and Cognitive Neurosciences, University of Basel, Basel,
4Institute of Primary Health Care (BIHAM), University of Bern, Bern,
Switzerland, 5PHYSIP, Paris, France, 6Psychology and Neurosciences of
Cognition (PsyNCog), Université of Liège, Liège, Belgium
Objectives/Introduction: The temporal organization of sleep and
wakefulness evolves throughout the lifespan, leading to an increased
sleep‐wake fragmentation with ageing. However, how circadian
aspects of sleep‐wake regulation relate to brain structure during age-
ing is not known. We aimed at exploring whether grey matter vol-
ume and surface measures are associated to an electrophysiology‐
derived index of circadian sleep‐wake regulation.
Methods: Eleven older participants (55–75 years; 7 men) under-
went a 40‐hr multiple nap protocol encompassing 10 nap periods.
Nap sleep efficiency over the circadian cycle was obtained with
polysomnography and used as an index of circadian sleep‐wake pro-
motion. The difference between the sleep ability during the night
and day sleep, here called circadian sleep amplitude (CSA) was taken
as an indicator of circadian integrity. T1‐weighted brain scans were
analysed with two complementary approaches: Voxel‐Based Mor-
phometry (VBM) to extract total grey matter volume, and Surface‐
Based Morphometry to extract total cortical thickness.
Results: Contrary to our hypothesis, a correlation analysis revealed
that grey matter volume was negatively associated with CSA
(r2 = 0.385, p = 0.042), while cortical thickness was not significantly
correlated. Remarkably, grey matter volume was also negatively
associated with cortical thickness (r2 = 0.454, p = 0.023). Since VBM
fails to properly detect folding structures inside the brain, we calcu-
lated the local gyrification index for each participant using a surface‐
based morphometry approach. We observed that the mean of local
gyrification indices across the brain showed a trend for a positive
correlation with CSA (r2 = 0.324, p = 0.067).
Conclusions: Despite the small sample size, our data suggest that
a less folded brain has more “visible” grey matter detectable with
the VBM approach, explaining the negative link between grey matter
volume and cortical thickness but also with CSA. The results high-
light the necessity of analysing surface indices in addition to volume-
try. Within this context, our data suggest that a more “folded” brain,
an index of brain fitness at older age, is associated with circadian
integrity and should be considered in models linking sleep‐wake reg-
ulation to brain ageing. Future region‐based analyses of brain surface
indices will be performed.
Disclosure: C. Berthomier have ownership and directorship in Phy-
sip, and is employee of Physip. Sources of funding: AXA Research
Foundation, Swiss National Foundation (SNF), Belgian Fund for Sci-
entific Research (FNRS), European Research Council (ERC‐Starting
Grant).
O190 | Impact of intraocular cataract lens
replacement on circadian rhythms and sleep in
older adults
S. Chellappa1; V. Bromundt2; S. Frey3; A. Steinemann4;
C. Schmidt5; T. Schlote6; D. Goldblum4; C. Cajochen3
1Harvard Medical School, Boston, MA, United States, 2University
Hospital Bern, Bern, 3University of Basel, 4University Eye Clinic Basel,
Basel, Switzerland, 5University of Liege, Liege, Belgium, 6Augenarztpraxis
Klingentalstrasse, Basel, Switzerland
Objectives/Introduction: Aging is associated with a progressive
decline in light transmission due to the clouding and yellowing of
the natural crystalline lens, particularly for shorter blue‐light wave-
length. The downstream effects of aging lens include reduced photic
input to the circadian clock, with subsequent long‐term disruption of
the circadian system and sleep regulation. Importantly, these
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age‐related circadian and sleep effects are exacerbated in clinical
ocular pathologies, particularly in cataract patients. Here, we investi-
gated whether lens replacement (intra‐ocular blue‐blocking, BB, or
UV‐only blocking) in older cataract patients increases the effects of
light on the circadian system and improves sleep.
Methods: Sixteen healthy older participants and thirteen post‐cat-
aract surgery patients (eight with BB lens, five with UV lens),
matched by age and sex (55–75 years; 8 women per group), under-
went a randomized within‐subject crossover design with 3 in‐labora-
tory protocols. Each protocol was 1‐week apart, and comprised
1.5 hr of dim light, 1.5 hr of dark adaptation, followed by 2 hr of
evening light exposure to polychromatic light at 6,500 K (blue‐
enriched) or 2,500 K or 3,000 K (both non‐blue enriched).
Results: In comparison to healthy older individuals, cataract
patients with lens replacement had significantly greater melatonin
suppression during light exposure (BB and UV lens) and immediately
after (UV lens), a hallmark of circadian photosensitivity (interaction
“time” vs. “group”: F = 4.7; p < 0.001). With respect to sleep regula-
tion, UV patients had increased all‐night non‐rapid eye movement
(NREM) slow‐wave sleep (“group”: F = 4.5; p = 0.02) and more
NREM sleep slow‐wave activity (SWA: 0.75–4.5 Hz) (“group”:
F = 3.1; p = 0.03) following light exposure. Furthermore, SWA
dynamics, a functional index of homeostatic sleep pressure, was sig-
nificantly higher during the first NREM‐REM sleep cycle in UV
patients as compared to BB patients and healthy older individuals
(interaction “time” vs. “group”: F = 1.3; p = 0.02).
Conclusions: Our data indicate that lens replacement, particularly
UV‐only blocking intra‐ocular lens, in older cataract patients may
increase the effects of light on the circadian system, with greater
melatonin suppression, and improve sleep, as indexed by more SWS
and NREM SWA. Ultimately, optimizing the spectral lens transmis-
sion of photic signals to the circadian clock and sleep regulatory
mechanisms may minimize the adverse circadian and sleep effects
associated with aging lens.
Disclosure: Nothing to disclose.
O191 | Pain, depression, dementia and their
association with sleep in nursing home patients ‐
a cross‐sectional study
K.M. Blytt1,2,3; E. Flo4; A. Erdal5,6; B. Bjorvatn3,5;
B. Husebo5,6
1Department of Global Public Health and Primary Care, University of
Bergen, Norway, 2Centre for Elderly and Nursing Home Medicine,
University of Bergen, Norway, University of Bergen, 3Norwegian
Competence Center for Sleep Disorders, Haukeland University Hospital,
4Faculty of Psychology, 5Department of Global Public Health and
Primary Care, 6Centre for Elderly and Nursing Home Medicine,
University of Bergen, Bergen, Norway
Objectives/Introduction: Previous research suggests a positive
association between pain, depression and sleep. In this study, we
aim to investigate how sleep correlates with varying levels of pain,
depression and dementia in nursing home (NH) patients.
Methods: Cross‐sectional study based on sleep‐related data (as
measured with actigraphy for seven consecutive days), derived
from two independent multicenter studies conducted in Norway;
the COSMOS trial (n = 83) and DEP.PAIN.DEM trial (n = 106). The
following inclusion criteria applied for the COSMOS trial: NH
patients ≥65 years of age, with life expectancy >6 months, not
diagnosed with schizophrenia. In short, the following inclusion cri-
teria applied for the DEP.PAIN.DEM trial: dementia according to
the Mini Mental State Examination (MMSE ≤ 20) and depression
according to the Cornell Scale for Depression in Dementia (CSDD ≥
8). In both studies, pain was measured with Mobilization-Observa-
tion-Behavior-Intensity-Dementia-2 Pain Scale (MOBID-2), depression
with CSDD and various levels of cognitive function with MMSE.
We investigate the following sleep parameters: sleep onset latency
(SOL), wake after sleep onset (WASO), early morning awakening
(EMA), total sleep time (TST), sleep efficiency (SE), and daytime
total sleep time (DTS).
Results: The linear regression predicting SE showed that being in
pain was associated with increased SE (p < 0.01) Furthermore, being
in pain and degree of dementia were both associated with reduced
WASO (p < 0.01 and p < 0.05, respectively) and increased TST
(p < 0.01 and p < 0.05, respectively). Severe dementia was associ-
ated with reduced TST (p < 0.05). Being in pain was associated with
more DTS (p < 0.01). No statistical significant associations were
found regarding depression and the measured sleep parameters.
Conclusions: We found that being in pain was associated with
increased SE, TST and reduced WASO. Pain was also associated with
increased DTS. Furthermore, our results showed that more severe
dementia was associated with reduced TST. This implies that being
in pain was associated with better sleep, as measured with actigra-
phy. This may be attributed to inactivity because of pain, which in
turn may be registered as sleep with actigraphy. However, the
underlying mechanisms remain unclear, and future research should
explore this further.
Disclosure: Nothing to disclose.
O192 | Sleep, orexin and β‐amyloid metabolism
in obstructive sleep apnea syndrome and
Alzheimer's disease
C. Liguori; N.B. Mercuri; F. Izzi; M. Nuccetelli; A. Cordella;
S. Bernardini; F. Placidi
University of Rome ‘Tor Vergata’, Rome, Italy
Objectives/Introduction: Alzheimer's Disease (AD) is featured by
cerebral β‐amyloid plaques deposition; orexin has been demonstrated
interfering with β‐amyloid metabolism in AD pathology. Obstructive
Sleep Apnea Syndrome (OSAS) is associated with pathological
changes of cerebral β‐amyloid dynamics. This study aimed at
88 of 433 | ABSTRACTS
investigating CSF β‐amyloid and orexin levels in OSAS patients com-
pared to AD patients and controls.
Methods: In this observational study, OSAS and AD patients were
included and compared to a group of controls. All patients and con-
trols underwent lumbar puncture for assessing CSF levels of β‐amy-
loid40 (Aβ40) and β‐amyloid42 (Aβ42), tau proteins and orexin, and
polysomnography (PG) to evaluate nocturnal sleep architecture.
Results: We included 20 OSAS, 10 AD, and 10 controls. OSAS
patients showed higher CSF orexin levels than AD and controls
(p < 0.05), and AD patients showed higher CSF orexin levels than
controls (p < 0.05). Moreover, OSAS patients showed lower CSF
Aβ40 levels than AD and controls (p < 0.05), and AD patients
showed lower CSF Aβ42 levels than OSAS (p < 0.01), who in turn
showed lower CSF Aβ42 levels than controls (p < 0.05). Sleep
macrostructure was similarly altered in OSAS and AD patients; in
particular, the alteration of sleep quality, efficiency, and continuity
was evident in both OSAS and AD patients compared to controls.
Considering the correlation analysis, CSF β‐amyloid levels correlated
with apnea‐hypopnea index in OSAS patients (R = −0.46, p < 0.05),
while CSF orexin levels correlated with CSF AD biomarkers and
sleep architecture changes in AD patients.
Conclusions: This study documented the alteration of CSF orexin
levels and β‐amyloid metabolism in OSAS patients. Sleep apneas cor-
related with the alteration of CSF β‐amyloid metabolism in OSAS
patients. We suppose that orexinergic system dysregulation and β‐
amyloid pathology may be present in OSAS patients and related to
sleep dysregulation and intermittent hypoxia. This evidence further
supports the current hypothesis that OSAS may possibly start AD
neurodegeneration.
Disclosure: Nothing to disclose.
O193 | Arousals during sleep are associated
with brain tau and amyloid‐β burden in healthy
older adults
D. Chylinski1; F. Rudzik2; D. Coppieters ‘t Wallant3;
M. Van Egroo1; V. Muto1; J. Narbutas1,4; P. Villar González1;
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P. Berthomier5; M. Brandewinder5; C. Schmidt1,4;
P. Maquet1,6; E. Salmon1,4,6; C. Philips1,7; M.A. Bahri1;
C. Bastin1,4; F. Collette1,4; G. Vandewalle1
1GIGA ‐ In Vivo Imaging, University of Liège, Cyclotron Research Centre,
Liège, Belgium, 2Centre for Chronobiology, Psychiatric Hospital of the
University of Basel, Basel, Switzerland, 3Department of Electrical
Engineering and Computer Science, University of Liège, 4Psychology and
Cognitive Neuroscience Research Unit, University of Liège, Liège,
Belgium, 5PHYSIP SA, Paris, France, 6Department of Neurology,
University Hospital of Liège, 7GIGA‐In Silico Medicine, University of
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Objectives/Introduction: Arousal during sleep are deemed to
reflect poorer sleep quality. Their impact on brain function and brain
structure is however not established. In addition, accumulating evi-
dence support a strong link between sleep‐wake dysfunction and the
pathogenesis of Alzheimer's disease (AD), including the abnormal
accumulation of amyloid‐β (Aβ) and tau protein in the brain. Here we
investigated whether arousals during sleep are associated with Aβ
and Tau burden in healthy aging. We also addressed whether these
arousals are related to specific cognitive impairments.
Methods: Forty‐one healthy and cognitively normal older individu-
als (aged 51–69; mean 59 ± 5; 30 females) were included in the pro-
tocol. We recorded their night time sleep in the laboratory under
EEG and assessed Aβ and tau protein burden during two Positron
Emission Tomography (PET) scans, respectively with 18F‐flutemeta-
mol and 18F‐THK 5351 radiotracers. Validated automatic arousal
detection was computed on all EEG recordings. All participants com-
pleted an extensive cognitive battery of neuropsychological tasks to
assess memory, attentional, and executive functioning while well‐
rested.
Results: Generalized linear mixed models analyses revealed that
the total number of arousals detected during sleep was significantly
associated with whole‐brain tau burden (p = 0.018), and with whole‐
brain Aβ burden (p = 0.02), even when correcting for age, sex and
education. Further analyses showed that sleep macrostructure
parameters such as sleep onset latency, wake after sleep onset, sleep
efficiency or percentage of each stages were not significantly associ-
ated to whole‐brain F18‐THK 5351 or F18‐flutemetamol intake val-
ues. Interestingly, memory performance showed a trend (p = 0.07)
for an association with total number of arousals.
Conclusions: These findings suggest that arousals during sleep are
strongly linked to whole‐brain AD pathophysiology. They suggest
that sleep arousals are key correlate of Tau and Aβ brain burden in
healthy aging. Additionally, more arousals could be associated with
lower memory performance, an essential feature of AD. The possibil-
ity will be verified after the inclusion of additional subjects. These
results cast new light on the association between sleep and AD
pathophysiology.
Disclosure: Support: FNRS,ULiège,ARC17/21‐09,FEDER,WBI,Cler-
dent Foundation C. Berthomier, P. Berthomier and M. Brandewinder
have ownership and directorship in Physip, and are employees of
Physip.
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O194 | Sleep efficiency and
electroencephalographic patterns in midlife are
associated with cognitive change over the adult
life course
M. Waser1,2,3; M.J. Lauritzen4,5; B. Fagerlund6,7; M. Osler8,9;
E.L. Mortensen4,9; H.B.D. Sørensen1; P. Jennum2,4
1Biomedical Engineering – Department of Electrical Engineering,
Technical University of Denmark, Kgs. Lyngby, 2Danish Center for Sleep
Medicine ‐ Dep. of Clinical Neurophysiology, Rigshospitalet Glostrup,
Glostrup, Denmark, 3AIT Austrian Institute of Technology GmbH,
Vienna, Austria, 4Center for Healthy Aging and Department of
Neuroscience, University of Copenhagen, Copenhagen, 5Department of
Clinical Neurophysiology, Rigshospitalet Glostrup, 6Clinical Intervention
and Neuropsychiatric Schizophrenia Research/Center for
Neuropsychiatric Schizophrenia Research, Psychiatric Center Glostrup,
Glostrup, 7Department of Psychology, University of Copenhagen,
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Objectives/Introduction: Disrupted sleep is a contributing factor
to cognitive aging, while also being associated with major neurode-
generative disorders. Little is known, however, about the relation of
sleep and the gradual positive or negative cognitive changes over
the adult life course. Patterns in the sleep electroencephalogram
(EEG) are potential markers of the cognitive progress.
Methods: To test this hypothesis, we assessed the sleep architecture
and sleep EEG of 167 men born in the Copenhagen Metropolitan Area
in 1953, who – based on individual cognitive testing from early
(~18 years) to late adulthood (~58 years) – were divided in 85 subjects
with negative and 82 with positive cognitive change over their adult
age span. As part of a Center for Healthy Aging (University of Copen-
hagen) study, participants underwent standard polysomnography
including manual sleep scoring between 2009 and 2013. Features of
sleep stage distribution were combined with a number of EEG features
to distinguish between the two groups: EEG rhythmicity was assessed
by spectral power analysis in frontal, central and occipital scalp sites.
Functional connectivity was measured by inter‐hemispheric EEG
coherence. Group‐differences were assessed by analysis of covariance
(p < 0.05) including completed level of formal education as covariate.
Significant features were combined in a machine learning approach to
estimate their discriminative usability.
Results: Subjects with cognitive decline exhibited lower sleep effi-
ciency, reduced inter‐hemispheric functional connectivity during
rapid eye movement (REM) sleep, and slower EEG rhythms during
stage 2 non‐REM sleep. While none of these measures passed as
stand‐alone features, the combined effects discriminated the two
groups with an accuracy of 72% (sensitivity 75%, specificity 67%).
Conclusions: In conclusion, the study demonstrates the potential
of combined sleep and electrophysiological measures as signs of cog-
nitive changes. Ongoing medical screenings of the cohort are
required to identify subjects progressing from cognitive decline to
severe neurological disorders. These future investigations will need
to confirm the demonstrated potential of sleep disruptions as strong
indicators of a possible later development of a neurodegenerative
disorder.
Disclosure: Nothing to disclose.
O195 | A polysomnographic sleep and resting
state fMRI connectivity study in the general
population
T.S. Lysen1; H.I. Zonneveld2; R.L. Muetzel2,3; M.A. Ikram2,4;
M.W. Vernooij2,5; H. Tiemeier2
1Erasmus MC, 2Epidemiology, 3Child and Adolescent Psychiatry/
Psychology, 4Neurology, 5Radiology and Nuclear Medicine, Erasmus MC,
Rotterdam, the Netherlands
Objectives/Introduction: With aging, sleep patterns change and
sleep problems become more common in elderly persons. There is
increasing evidence that impaired sleep is associated with structural
brain characteristics, but less is known about the link with functional
brain connectivity. We investigated the association of sleep with
functional connectivity of the brain in an observational setting.
Methods: In 630 participants from the population‐based Rotterdam
Study we investigated cross‐sectional associations of polysomno-
graphic and subjective sleep aspects with resting‐state functional
connectivity during daytime. We investigated both resting‐state cor-
relations and BOLD‐signal amplitude, on a global, network, and nodal
level, defined by ICA. Analyses were adjusted for age, sex and other
potential confounders.
Results: Longer total sleep time (TST) was associated with lower
mean signal amplitude on a global brain level (Beta = −0.023, 95%
CI −0.041; −0.004, PFWE-corrected = 0.01). Regionally, this effect was
driven by multiple resting‐state networks and remained significant in
the ventral attention network after correcting for multiple testing
(Beta = −0.049, 95% CI −0.075; −0.023, PFWE-corrected = 0.001). The
effect of TST was mainly accounted for by shorter duration of rapid
eye movement (REM) and N2 stages, but not stage N3. Moreover,
this relation between longer TST and lower amplitude seemed par-
ticularly apparent in persons with good subjective sleep quality. We
found no associations of sleep and resting‐state correlations
between and within networks, or between nodes.
Conclusions: In this cross‐sectional, population‐based study, longer
TST was related to a lower amplitude of low‐frequency fluctuations
in BOLD‐signal during daytime, in multiple resting‐state networks.
This relation is driven by stages N2 and REM, and extends beyond
homeostatic, night‐to‐day effects. Sleep may facilitate the repertoire
of low‐frequency fluctuations during daytime, or, vice versa, daytime
brain activity in the low‐frequency range may influence (a need for)
sleep.
Disclosure: Nothing to disclose.
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O196 | Changes in slow waves density: a
matter of aging and sex or an inaccurate
detection?
T. Rosinvil1,2,3; J. Bouvier1,2; J. Dubé1,2,3; M. Bouchard1,2,3;
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J.-M. Lina1,5
1Center for Advanced Research in Sleep Medicine, Hôpital du Sacré‐
Coeur de Montréal, 2Department of Psychology, University of Montreal,
3Research Center, Institut Universitaire Gériatrique de Montréal,
4Department of Psychiatry, University of Montreal, 5Department of
Electric Engineering, École de Technologie Supérieure, Montréal, QC,
Canada
Objectives/Introduction: Starting at the age of 40, reduced slow
wave density (number SW/min in NREM) and amplitude are com-
monly observed. Considering the amplitude criterion to detect SW
(peak‐to‐peak amplitude [Ap] >75 μV; negative amplitude [An]
>40 μV), the age‐related decrease in SW density could be due to a
reduction in SW amplitude and not to a decline in the capacity to
generate SW per se. Moreover, women show higher SWS and delta
power across age groups, but it remains a matter of debate whether
the aging process differentially influences men and women. There-
fore, we developed a data‐driven approach to derive age‐ and sex‐
specific SW amplitude criteria, enabling more valid comparisons
between age and sex groups.
Methods: Two‐hundred seven healthy adults, young (N = 97, 52
women, 23.8 years old) and middle‐aged (N = 110, 61 women, 57.5
years old), participated in one night of sleep recording. An algorithm
was used to detect SW in central derivations (C3–C4) during NREMs
sleep on artefact‐free, filtered (−3 dB at 0.3 and 4.0 Hz) signal. SW
were detected using very low criteria (Ap > 9 μV; An > 5 μV). From
the young adults, a signal‐to‐noise ratio (SNR) was computed using
the “signal” (SW with Ap ˃ 75 μV and An ˃ 40 μV) and “noise” (spu-
rious SW with Ap ˂ 75 μV or An ˂ 40 μV) for men (SNR = 0.07) and
women (SNR = 0.08). Combined to this SNR, a ratio between Ap
and An (75:40) was used to determine the final criterion for middle‐
aged men (Ap = 61.5 μV; An = 32.5 μV) and women (Ap = 68.5 μV;
An = 36.5 μV). ANOVAs were performed to assess age and sex
effects with standard SW detection or SW SNR‐detection.
Results: When applying the standard SW detection, middle‐aged adults
showed lower SW density compared to young adults (main age effect:
F(1,203) = 70.851, p < 0.0001) and women had a higher SW density than
men (main sex effect: F(1,203) = 13.836, p < 0.0001). Similar results were
obtained with the SW SNR‐detection, e.g., main age (F(1,203) = 15.216,
p < 0.0001) and sex effects (F(1,203) = 5.831, p = 0.017).
Conclusions: Using a data driven SW detection, age‐ and sex‐
related differences remain despite a lower amplitude SW detection
criterion in the middle‐aged participants. Our results are in favor of
age‐ and sex‐related decline in SW generation capacity rather than
an artefact of the detection amplitude criteria.
Disclosure: Nothing to disclose.
O197 | Change in sleep duration at retirement:
a longitudinal study using objective assessments
J. Garefelt; S. Gershagen; L. Platts; H. Westerlund;
G. Kecklund
Stress Research Institute, Stockholm University, Stockholm, Sweden
Objectives/Introduction: Retirement is an important life event,
but relatively little is known about how sleep changes during the
retirement transition. Previous studies have reported longer sleep
duration following retirement, and gender differences in the change,
but measure sleep duration using self‐reports. In contrast, the cur-
rent study uses day‐to‐day wrist actigraphy to investigate changes in
sleep duration during the retirement transition, with a particular
focus on week day and weekend sleep patterns.
Methods: In this ongoing study, 117 participants aged 60–70 years
have been recruited from the Swedish Longitudinal Survey of Health
(SLOSH) while still in paid work. During one week – approximately
6 months before their planned retirement date – the participants
wore a wrist actigraph and filled out daily sleep and wake diaries.
After 12 months, the participants were followed up for a second
week using the same procedure. Using actigraphy, complemented by
information from the sleep diaries, average total sleep duration per
night, averaged over 7 days, was calculated. Sleep durations were
also calculated for weekdays and at the weekend (nights prior to
Saturday and Sunday) separately. Changes in sleep duration before
and following retirement were calculated. Data from all participants
who have so far completed both baseline and follow‐up (n = 58)
were analysed with regression analysis.
Results: Mean sleep duration per average night increased by
23 min (p < 0.001, 95% CI: 17–30). Following retirement, sleep dura-
tion during the week increased by 31 min (p < 0.001, 95% CI: 22–
40), but the increase at the weekend was not significant at the 95%
significance level (8 min, p = 0.121, 95% CI: −2 to 19). Differences
between males and females were not significant at the 95% signifi-
cance level.
Conclusions: This study suggests that after retiring from work,
sleep duration increases, particularly on weekdays. To our knowl-
edge, this study is the first to use a longitudinal design and apply
actigraphy to measure changes in sleep duration before and after
retirement. The findings support prior results using subjective sleep
measures which show increased sleep duration after retirement.
Disclosure: Nothing to disclose.
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O198 | Objectively measured sleep
disturbances are associated with reduced
microstructural integrity of white matter. A
prospective cohort study in middle‐aged and
older persons
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Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands,
3Department of Social and Behavioral Science, Harvard TH Chan School
of Public Health, Boston, MA, United States, 4Department of Radiology
and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the
Netherlands, 5Nuffield Department of Clinical Neurosciences, Sleep and
Circadian Neuroscience Institute, Oxford, United Kingdom, 6Department
of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
Objectives/Introduction: Poor sleep affects cognition; moreover,
sleep loss may destabilize axonal integrity and deteriorate white mat-
ter. In particular, older adults are at risk for both sleep problems and
structural brain changes, but the temporal relation between these
two processes is poorly understood. Previous neuroimaging studies
of sleep have been small, cross‐sectional, and mostly based on self‐
reported sleep. Therefore, we investigated the associations between
actigraphically measured sleep and repeatedly measured white mat-
ter microstructural integrity.
Methods: We studied 1201 middle‐aged and older adults
(57.5 ± 6.8 years, 55% women) from a population‐based prospective
cohort study. Total sleep time (TST, hr), sleep onset latency (SOL,
min), wake after sleep onset (WASO, min), and sleep efficiency (SE,
%) were measured at baseline using a wrist‐worn actigraph. White
matter microstructural integrity was measured twice (average inter-
val of 5.8 years (3.9–10.8)) with diffusion tensor magnetic resonance
imaging to quantify global and tract‐specific fractional anisotropy
(FA) and mean diffusivity (MD). Longitudinal associations were
explored with linear mixed models adjusted for mental and physical
health parameters.
Results: Higher WASO was prospectively associated with
decreased global FA (Bmin = −0.003, 95% CI: −0.005, −0.001) and
increased global MD (Bmin = 0.002, 95% CI: 0.0004, 0.004). Corre-
spondingly, higher SE was associated with increased global FA
(B% = 0.01, 95% CI: 0.002, 0.01) and decreased MD (B% = −0.01,
95% CI: −0.01, −0.0004) values across follow‐up. Longer TST was
associated with increased global FA (Bhr = 0.06, 95% CI: 0.01, 0.12),
but not with MD. SOL was not associated with white matter
microstructural integrity. Global findings were driven by lower FA
and/or higher MD in the cingulum, anterior forceps of corpus callo-
sum, and several projection and association tracts.
Conclusions: This is the first study showing a temporal relation
between objective sleep indices and white matter microstructure in
middle‐aged and older adults. Longer periods of wake after sleep
onset and a corresponding lower sleep efficiency, are prospectively
associated with reduced white matter microstructural integrity in
middle‐aged and older persons. Tracts projecting to the orbitofrontal
cortex, cingulum, corticospinal, thalamocortical and interhemispheric
connections seem most sensitive to sleep disturbances. Sleep distur-
bances may thus be a potentially modifiable risk factor for
microstructural changes of white matter in the aging brain.
Disclosure: Nothing to disclose.
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199 | Dreaming and consciousness
F. Siclari
Center for Investigation and Research on Sleep, University of Lausanne,
Lausanne, Switzerland
Dreaming is a form of consciousness that occurs during sleep, while
we are functionally disconnected from the environment. Traditionally,
dreaming has been linked to REM sleep, a behavioral state character-
ized by fast, desynchronized electroencephalographic activity similar
to wakefulness. In recent years however, it has become clear that
dreaming can also occur in NREM sleep, in which EEG activity is
dominated by slow waves and spindles. This has challenged the
understanding of the neural correlates of conscious experiences in
sleep. In the present talk I will present a series of studies in which we
investigated the neural correlates of dreaming using a serial awaken-
ing paradigm and high‐density EEG recordings. We found that dream-
ing, irrespective of sleep stage, is associated with a local reduction of
low‐frequencyactivity in posterior cortical régions in both REM and
NREM sleep. By monitoring brain activity in these regions in real
time, we were able to predict the presence or absence of dreaming in
NREM sleep with a high accuracy. This local EEG correlate may thus
account for the presence of conscious experiences in two behavioral
states (REM and NREM sleep) with radically different global EEG sig-
natures. In addition, we found that specific dream contents were
associated with localized high‐frequency increases within these pos-
terior cortical areas. Finally, dream recall seems to be heralded by the
presence of arousal‐related EEG changes. Taken together, these
results provide noninvasive measures that could represent a useful
tool to infer the state of consciousness during sleep.
Disclosure: Nothing to disclose.
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200 | Sleep biomarkers in insomnia and
depression
T. Mikoteit1,2; M. Hatzinger1; A. Steiger2; M. Pawlowski2,3
1Psychiatric Services Solothurn and University of Basel, Solothurn,
Switzerland, 2Max Planck Institute of Psychiatry, Munich, 3Centre of
Mental Health, Klinikum Ingolstadt, Ingolstadt, Germany
Objectives: Sleep may serve as a window to brain functions and
as a source of biomarkers for mental disorders. Accordingly, heart
rate variability (HRV) correlates very well with sleep EEG stages and
may indicate nocturnal brain activity.
Aims: To examine biomarker properties of sleep EEG related HRV
concerning (1) insomnia, (2) major depressive disorder (MDD) inde-
pendently from antidepressant (AD) effects, and (3) treatment
response in MDD.
Methods: We examined two controlled clinical samples by
polysomnography: (1) Ten women (mean age: 50 ± 8 years) with pri-
mary insomnia without any other physical or mental illness. (2) Thirty‐
four out‐patients with MDD without AD treatment (age:
32 ± 11 years; 52.9% females) and again one week under AD treat-
ment. HRV frequency domain measures (i.e. very low frequency power
(VLF), low frequency power (LF) and high frequency power (HF)) of
REM, N2 and N3 sleep were compared between patients vs. controls
and responders vs. non‐responders. Response was defined as ≥50%
reduction of baseline Hamilton depression rating score at week 4.
Results: (1) In contrast to conventional sleep‐EEG variables sup-
pressed sleep‐EEG related HRV discriminated primary insomnia from
normal sleep with large effect sizes (Cohen′s d > 1.3). In REM sleep
there was a specific difference of less relative HF‐power and
increased VLF‐power (p < 0.05). (2) In antidepressant‐free MDD
patients the pattern of HRV results was similar. (3) After one week
of treatment, AD had exerted an additional suppressing effect on
HRV, most prominently on absolute VLF‐ and LF‐power in REM‐
sleep (Cohen′s d = 1.90 and 1.01). The AD related change of REM
sleep related relative VLF‐power at week 1 separated between
responders and non‐responders at week 4 again with large effect
size (F(1, 32) = 6.42, p = 0.016, η2 = 0.167).
Conclusions: Our findings of suppressed HRV measures in insom-
nia support the hypothesis of hyperarousal. Concerning MDD, sleep‐
EEG stage related HRV seems to be a reliable, AD independent mar-
ker of depression at baseline. Under treatment, the dynamic of REM
sleep related HRV shows early changes during the first week and
may provide a promising biomarker of treatment outcome.
Disclosure: Nothing to disclose.
POSTER SESSION 1
CELLULAR, MOLECULAR BIOLOGY &
GENETICS
P001 | Insulin resistance and leptin levels in
patients with obstructive sleep apnea
K. Sadeghniiat-Haghighi; M.R. Mohajeri-Tehrani; A. Khajeh-
Mehrizi; Z.B. Alemohammad; A. Rahimi-Golkhandan;
S. Hafizi; B. Larijani
Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
Objectives/Instruction: Obstructive sleep apnea (OSA) has been
associated with metabolic syndrome, diabetes mellitus and cardiovas-
cular disease. Insulin resistance and increased leptin levels could
explain the impaired metabolic condition in patients with OSA. This
study aimed to assess the association of OSA severity with insulin
resistance and leptin levels in a cohort of subjects referred to sleep
disorders clinic.
Methods: Ninety‐one patients with OSA and 17controlswere
included in this study. All subjects underwent full night polysomnog-
raphy (PSG) and blood samples were collected in the morning after
PSG. The insulin resistance index was estimated by homeostasis
model assessment (HOMA).
Results: HOMA values were not significantly different between
groups. Significant difference in leptin level was found between
patients with severe OSA and mild OSA. Leptin level was signifi-
cantly correlated with age (r = 33, p = 0.02), apnea‐hypopnea index
(r = 0.41, p = 0.004), and oxygen desaturation index (r = 46,
p = 0.03). HOMA were in significant positive correlation only with
TG level (p = 0.01). Stepwise multiple regression analysis showed
that apnea‐hypopnea index, body mass index and gender were
determinant factors for leptin levels but no determinant variable was
found for predicting HOMA.
Conclusions: Our findings suggest that leptin levels might be inde-
pendently associated with severity of OSA. Other factors except
insulin resistance should be considered for increasing vascular dis-
eases in OSA patients.
Disclosure: Nothing to disclose.
P002 | Genetic risk factors for schizophrenia
associate with sleep spindle activity in healthy
adolescents
I. Merikanto
Psychology and Logopedics, University of Helsinki, Helsinki, Finland
Objectives/Instruction: Schizophrenia has been associated with
disturbed sleep, even before the onset of the disorder, and also in
ABSTRACTS | 93 of 433
non‐schizophrenic first‐order relatives. This may point to an underly-
ing genetic influence. Here we examine whether weighted polygenic
risk scores (PRS) for schizophrenia are associated with sleep spindle
activity in healthy adolescents.
Methods: Our sample comes from a community‐based cohort of
157 non‐schizophrenic adolescents (57% girls) having both genetic
data and an overnight sleep EEG measurement available. Based on a
recent genome‐wide association study, we calculated PRS for
schizophrenia across whole genome. We also calculated PRS for CAC-
NA1l gene region, which has been associated with both schizophrenia
and sleep spindle formation. We performed an overnight sleep EEG at
the homes of the participants. Stage 2 sleep spindles were detected
using an automated algorithm. Sleep spindle amplitude, duration,
intensity and density were measured separately for central and frontal
derivations and for fast (13–16 Hz) and slow (10–13 Hz) spindles.
Results: PRS for schizophrenia associated with higher fast spindle
amplitude (p = 0.04), density (p = 0.006) and intensity (p = 0.04) at
central derivation, and PRS in CACNA1l region associated with higher
slow spindle amplitude (p = 0.01), duration (p = 0.03) and intensity
(p = 0.002) at central derivation.
Conclusions: A positive association between genetic variants for
schizophrenia and sleep spindle activity among healthy adolescents
support a view that sleep spindles and schizophrenia share similar
genetic pathways. This study suggests that altered sleep spindle
activity might serve as an endophenotype of schizophrenia.
Disclosure: Nothing to disclose.
P003 | Neuron‐specific interleukin‐1 receptor
accessory protein is required for the maturation
of small network emergent sleep‐like
electrophysiological properties
J. Nguyen1; P. Taishi1; K. Jewett2; R. Sandip3; M. Xue3;
J. Krueger1
1Integrative Physiology and Neuroscience, 2Biomedical Science,
Washington State University, Spokane, 3Electrical Engineering and
Computer Science, Washington State University, Pullman, WA, United
States
Objectives/Instruction: Small neuronal/glial networks oscillate
between sleep‐ and wake‐like states in vivo, e.g. cortical columns
(Brain Res. 1047:45), and in vitro, e.g. co‐cultured neurons and glia
(Eur. J. Neurosci. 42:2078). Sleep regulatory substance interleukin‐1β
(IL1) signals via its type I receptor and a receptor associated protein
(AcP). AcP has an isoform that is neuron‐specific called AcPb. Mice
lacking AcPb lack sleep rebound after sleep deprivation (Brain Behav.
Immunity 47:35). Herein we determined whether AcP and AcPb alter
network emergent properties in cultured neurons/glia.
Methods: AcP knockout (KO), AcPbKO, and wild type (WT) mice
were obtained from Amgen Inc. Cortical cells from 1‐day‐old pups
from each strain were cultured separately on multi‐electrode arrays.
Recordings were taken from days in vitro (DIV) 4–14 for 1 hr each
day. Synchrony (SYN) and delta wave power (DWP) were calculated
from filtered recordings and fast Fourier analyses. A total of 4 inde-
pendent preparations from each strain were used and recordings
from 297 electrodes (WT and AcPKO cells) and 162 electrodes
(AcPbKO cells) were analyzed. Two‐way analyses of variance were
used.
Results: Both SYN and DWP exhibited main time and strain effects
(SYN: genotype x time F(20,15979) = 37.77, p < 0.001; DWP: geno-
type × time F(20,6873) = 26.12, p < 0.001). Post‐hoc Student's t‐tests
indicated that SYN was higher in AcPKO cells from DIV 5–14 com-
pared to WT and AcPbKO cells. WT SYN was greater than SYN in
AcPbKO cells from DIV 6–14. Compared to SYN emergence, the
development of DWP was slower in onset in AcPKO and WT cells.
In contrast, DWP in AcPbKO cells was first significantly above their
baseline values on DIV 11 whereas SYN was not until DIV 13. From
DIV 9–14 DWP was highest in AcPKO cells, followed by WT cells,
and lowest in AcPbKO cells.
Conclusions: The lack of AcP accelerates the maturation of net-
work properties compared to those occurring in WT cells. In con-
trast, the lack of AcPb delays network emergence of sleep‐linked
electrophysiological properties. IL1 signaling has a critical role in
emergent sleep‐linked network behavior.
Disclosure: Nothing to disclose.
P004 | Effect of cyclical intermittent hypoxia
on mouse model of Ad5CMVCre induced solitary
lung cancer progression and spontaneous
metastases in KrasG12D+; p53fl/fl; myristolated
p110fl/fl ROSA‐gfp
X. Guo1; Y. Liu2; J. Kim1; E. Kim1; E. Kim1; A. Jansen1; K. Li1;
M. Chan1; A. Pack3; J. Conejo-Garcia4; D. Lim3
1Center for Sleep and Circadian Neurobiology, University of
Pennsylvania, Philadelphia, PA, United States, 2Department of
Otolaryngology Head and Neck Surgery, Jilin University, Changchun,
China, 3Medicine, University of Pennsylvania, Philadelphia, PA, 4MOFFIT
Cancer Center, University of South Florida, Tampa, FL, United States
Objectives/Instruction: Epidemiological data suggests that
obstructive sleep apnea is associated with increased cancer incidence
and mortality. Here we investigate the effects of cyclical intermittent
hypoxia (CIH), akin to the underlying pathophysiology of obstructive
sleep apnea, on lung cancer progression and metastatic profile in a
genetically engineered mouse (GEM) KrasG12D+/−; p53 fl/fl; myristo-
lated‐p110αfl/fl‐ROSA‐gfp activated by intrathoracic injection of
Ad5CMVCre virus.
Methods: With the goal to develop a translatable pre‐clinical
model, we combine several techniques into one model: (1) intratho-
racic injection of Ad5CMVCre virus to produce a solitary lung carci-
noma with validation of injection technique; (2) serial micro CT scans
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with respiratory gating (no contrast) and freely available software
(ITK‐SNAP) to manually segment lung tumors on consecutive slices;
(3) use of RT‐PCR to detect spontaneous metastases in distant
organs with validation using H&E stain and flow cytometry; (4) effect
of CIH on mice with intrathoracic injection of Ad5CMVCre to induce
lung tumors.
Results: This mouse model of lung cancer consistently provides a
solitary lung cancer that spontaneously metastasizes. (1) 3.12×107/
3 μL of Ad5CMVCre virus was injected into the left lung and a Taq-
Man real‐time PCR assay targeting the CMV promoter region
revealed a recovery rate of 88% of the injected virus from the dis-
sected lung tissue and a CV of 8.4%; (2) Serial micro CT demon-
strates that male mice exposed to CIH have a significant increase in
tumor volume compared to control (room air) on Day 19 (p = 0.02),
26 (p = 0.008) and 33 (p = 0.02) post injection; (3) Tumor volume
variability measured using interquartile range (IQR) increases as
tumor progress and CIH increases IQR by 2 to 4‐fold between
Day19 to Day40 post injection; (4) RT‐PCR using 3 different probes‐
gfp, SPC and CC10, positively detects metastases most frequently in
diaphragm (100%), right lung (86%), mediastinal lymph nodes (59%),
ribs (46%) and axillary lymph nodes (40%).
Conclusions: We describe a new model of using intrathoracic
injections of Ad5CMVCre virus into the GEM KrasG12D+/−; p53 fl/fl;
myristolated‐p110αfl/fl‐ROSA‐gfp that spontaneously metastasizes to
distal organs within 40 days. We also report that male mice with
solitary lung cancer have increase variability and tumor growth when
exposed to cyclical intermittent hypoxia.
Disclosure: JCG: External Advisory Boards: KSQ Therapeutics,
ITUS, Compass Therapeutics; Sponsored research: Compass Thera-
peutics, ITUS.
P005 | Key elements in biology and physiology
of Hcrt and Mch cells affecting normal sleep
A. Seifinejad1; S. Li1; S. Pradervand2; Y. Arribat1; F. Amati1;
M. Tafti1
1Department of Physiology, 2CIG, University of Lausanne, lausanne,
Switzerland
Objectives/Instruction: Hcrt/Orexin and mlenain concentrating
hormone (Mch) neurons are located in the lateral hypothalamus.
They have established roles in the regulation of normal vigilance
states and also feeding behavior, addiction, reward and stress. The
expression of Hcrt is dysregulated in the brain of narcoleptic
patients, which results in the loss of these cells causing excessive
daytime sleepiness and cataplexy. How these neurons are involved
in multiple functions and how they act as physiological integrators
remain unknown.
Methods: The hypothalami of E18 pups were dissected and FACS
sorted by a method developed in the lab which amplifies the repor-
ter mCherry only in the Hcrt cells and EGFP in Mch cells. RNA
sequencing was performed to compare the transcriptome of Hcrt
cells with the rest of the hypothalamus. Immunostaining, in situ
hybridization and qPCR were used for data validation and in depth
analysis.
Results: We have identified 340 genes significantly differentially
expressed in Hcrt cells and more than 2000 genes in Mch cells com-
pared to the rest of hypothalamic cells with fold changes from 2 to
100. We identified two gene sets distinguishing these neuronal cell
types from each other and other cell types of the hypothalamus. We
identified transcription factors enriched in both cell types. Knock-
down of them in zebrafish identified critical ones for the expression
of Hcrt and Mch. Knocked down of a paternally expressed gene by
morpholinos totally abolished the expression of Hcrt and Mch indi-
cating a critical role of this gene in the physiology of these neu-
ropeptides. Morphant larvae exhibited significantly less locomotor
activity mainly during daytime (wt = 42.6 vs. morphants = 21.1;
p < 0.01), which is the active period of zebrafish larvae. This reduc-
tion in activity is accompanied with increased sleep time during the
day (wt = 24.2 vs. morphants = 45.2; p < 0.0001, t‐test).
Conclusions: We, for the first time, purified intact Hcrt and Mch
cells and performed RNA sequencing. This led to the identification
of molecules involved in the biology and physiology of Hcrt and
Mch cells and also sleep and wakefulness.
Disclosure: Nothing to disclose.
P006 | Oxidative stress in Caucasian and Asian
menopausal women with sleep disorders
N. Semenova; I. Madaeva; L. Kolesnikova
Federal State Public Scientific Institution «Scientific Centre for Family
Health and Human Reproduction Problems», Irkutsk, Russian Federation
Objectives/Introduction: 35–60% of menopausal women com-
plain about certain problems with sleep. It is well known, that sleep
loss may cause oxidative stress. The aim of this work was assess-
ment of the lipid peroxidation and antioxidant protection system
parameters in Caucasian and Asian menopausal women with sleep
disorders.
Methods: 255 menopausal women divided into Caucasian
(n = 123) and Asian (n = 132) groups were examined. All women
underwent clinico‐anamnestic examination. Polysomnography and
specialized questionnaires for the assessment of sleep disorders
were used. Each ethnic group was divided into control (without
sleep disorders) and main groups (insomnia and insomnia with
obstructive sleep apnea syndrome (OSAS)). Lipid peroxidation and
antioxidant system parameters (conjugated dienes (CDs), malonyl
dialdehyde (MDA), α‐tocopherol, retinol, superoxide dismutase activ-
ity, reduced and oxidized glutathione, total antioxidant activity) by
spectrophotometric and fluorometric methods were determined. Sta-
tistical analysis was performed by non‐parametric tests. A study was
supported by a grant MК‐3615.2017.4.
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Results: In Caucasian patients compared to control was observed
accumulation of lipid peroxidation products both in perimenopause
with insomnia (CDs by 25% (p < 0.05)) and in postmenopause with
insomnia (CDs, MDA by 42% and 21% respectively (p < 0.05)) and
insomnia with OSAS (MDA by 25% (p < 0.05)). Total antioxidant
activity level decreased by 20% (p < 0.05) in Caucasian women with
insomnia and OSAS. In Asian patients both in insomnia and insomnia
with OSAS revealed a higher content of CDs in perimenopause (by
37% and 63% respectively (p < 0.05)) and MDA in postmenopause
(by 51% and 28% respectively (p < 0.05)) compared to control. The
decreasing of α‐tocopherol level by 19% (p < 0.05) was observed in
Asian perimenopausal women with insomnia and superoxide dismu-
tase activity by 9% (p < 0.05) both insomnia and insomnia with
OSAS compared to control. Also, the decreasing of the total antioxi-
dant activity level by 21% (p < 0.05) in Asian postmenopausal
women with insomnia and OSAS and the increasing of reduced glu-
tathione level by 18% and 17% respectively (p < 0.05) in patients
with insomnia and insomnia with OSAS was found.
Conclusions: Our results demonstrate the development of oxida-
tive stress in patients with insomnia and insomnia with OSAS in both
Caucasian and Asian menopausal women.
Disclosure: Nothing to disclose.
P007 | Melatonin receptor type 1A gene linked
to intolerance to shift work and Alzheimer's
disease in old age
S. Sulkava1,2; P. Muggalla3; R. Sulkava4; H.M. Ollila5;
T. Peuralinna3; L. Myllykangas3; S. Helisalmi4; H. Soininen4;
T. Polvikoski6; M. Hiltunen4; P.J. Tienari3; H.J. Huttunen3;
T. Paunio7,8
1Genomics and Biomarkers, National Institute for Health and welfare,
2Psychiatry, 3University of Helsinki, Helsinki, 4University of Eastern
Finland, Kuopio, Finland, 5Stanford Center for Sleep Sciences and
Medicine, Palo Alto, CA, United States, 6Newcastle University,
Newcastle, United Kingdom, 7Genomics and Biomarkers, National
Institute for Health and Welfare, 8Psychiatry, University of Helsinki and
Helsinki University Hospital, Helsinki, Finland
Objectives/Introduction: Disruption of the circadian rhythms is a
well‐known consequence of shift work and a frequent preclinical and
clinical manifestation of Alzheimer's disease. In a recent study, we
demonstrated association of the variant rs12506228 near melatonin
receptor 1A gene (MTNR1A) with shift work intolerance (Sulkava
et al. Sleep 2016, PMID 28364478). Here, we tested association of
the same variant with clinical and pathological Alzheimer's disease.
Methods: We genotyped the variant in two Finnish population‐
based cohorts of very elderly individuals, Vantaa 85+ and Kuopio
75+, and in a younger Finnish case‐control sample. Vantaa 85+
included post‐mortem neuropathological examination for half of the
cohort. We studied also the effects of RNAi‐mediated silencing or
overexpression of MTNR1A on amyloid precursor protein (APP) pro-
cessing using APP‐overexpressing N2A cell line in vitro.
Results: The risk variant of intolerance to shift work was associ-
ated with clinical Alzheimer's disease in Vantaa 85+ (p < 0.0001,
OR=2.1, n = 357) and the association was replicated in Kuopio 75+
(p < 0.05, OR=1.5, n = 490) but not in the younger case‐control
sample (n = 651 + 669). The risk variant also associated with higher
amounts of neurofibrillary tangles and amyloid plaques (p < 0.005),
the neuropathological hallmarks of Alzheimer's disease, in the Vantaa
85+ cohort. Lower level of MTNR1A gene expression in the brain
was detected in the carriers of risk variant according to NIAGADS
database. In vitro, Silencing of MTNR1A increased, and overexpres-
sion decreased amyloidogenic processing of APP. (Sulkava et al.
Sleep, in press).
Conclusions: We suggest the MTNR1A variant as a common
genetic risk factor for shift work intolerance and Alzheimer's disease
among the very elderly. Differences in MTNR1A expression which
modulate APP metabolism, are likely to mediate the association with
Alzheimer's disease.
Disclosure: SS has an immediate family member who is an
employee and shareholder of Amialife Ltd, which is not related to
this study. RS is an employee and shareholder of Amialife Ltd, which
is not related to this study. HMO is consulting for Jazz Pharmaceuti-
cals Plc on topics unrelated to the work described in this manuscript.
HJH is an employee and shareholder of Herantis Pharma Plc, which
is not related to this study. The other authors report no conflicts of
interest.
P008 | The impact of insufficient sleep on
microglia morphology
S. Steffens; H.-K. Wigren; T. Stenberg; Sleep Team Helsinki
Faculty of Medicine/Medicum/Physiology, University of Helsinki,
Helsinki, Finland
Objectives/Introduction: Sleep deficient in duration and quality is
a common problem in the modern society. Studies have shown that
sleep is beneficial for the retention of the brain homeostasis and
that chronic insufficient sleep leads to low grade inflammation. How-
ever only little is known about the effects of insufficient sleep on
microglia, the brain resident macrophages.
Our main hypothesis is that sleep is crucial for microglial functions.
If sleep is restricted, microglial physiological functions are impaired.
As microglial morphology changes with their functional state, the
impact of acute sleep deprivation (SD) and chronic sleep fragmenta-
tion (SF) was studied via the characterization of microglia morphol-
ogy by confocal microscopy.
Methods: SD (9 h; gentle handling) and SF (14d; Sleep Fragmenta-
tion Chamber (Lafayette, USA)) were performed in mice. After the
treatments the animals were sacrificed and perfused. The brain tis-
sue was sliced, immunostained for microglia (anti‐IBA1 and Alex-
afluor 568, Synaptic Systems) and imaged with a confocal
microscope (Leica TCS SPX, Germany). Morphometric analysis of the
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fluorescent images (Z‐stacks: 55–85 × 0.2 μm) from the somatosen-
sory cortex was accomplished using Fiji (ImageJ, NIH) Simple Neurite
Tracer.
Results: A statistically significant (Ncells=40; Nmice=8; p ≤ 0.01)
increase in the average branch length and decrease in the number of
branches was found between SF and the control group in the
somatosensory cortex. This response was significantly different com-
pared to the LPS induced microglial activation (Ncells=20; Nmice=4;
p ≤ 0.01).
Conclusions: Microglial morphology is affected by insufficient
sleep. But interestingly microglial reactivity after SF was not identical
to LPS induced activation.
Disclosure: Nothing to disclose.
P009 | Epigenetic age and sleep quality in
adolescence
L. Kuula; A. Suarez; J. Lahti; A.-K. Pesonen; K. Räikkönen
University of Helsinki, Helsinki, Finland
Objectives/Introduction: Sleep problems and insomnia are com-
monly associated with health‐related symptoms and several detri-
mental outcomes. One of the most recent biomarkers of aging are
those based on DNA methylation (DNAm). Epigenetic age accelera-
tion, or a DNAm age which is higher than chronological age, has
been associated with an increased risk of all‐cause mortality. How-
ever, no previous study has addressed the association between sleep
and epigenetic age in adolescence, even though risks related to
accelerated aging are likely to accumulate over several decades. We
studied adolescent sleep behaviour and problems in order to investi-
gate whether the risks of accelerated aging are already present at a
young age.
Methods: The participants came from a healthy birth cohort. We
calculated a total sleep problem score at age 12.3 years (SD=0.5)
(n = 223; 119 girls) from The Sleep Disturbance Scale for Children,
and derived sleep duration and latency from actigraphy (Actiwatch
7). The Pittsburgh Sleep Quality Index was administered at age 17
(n = 105; 65 girls), resulting in a total sum score. We used the Hor-
vath method to calculate the DNAm predicted age, and used linear
regressions to study the associations between sleep and DNAm age.
We adjusted all analyses for sex and pubertal development scores
derived from the Pubertal Development Scale.
Results: Sleep duration and latency at age 12 years were not sig-
nificantly associated with DNAm age (p > 0.2). Higher total sleep
problem score at age 12 years was associated with accelerated age
(p = 0.005). Similarly, at age 17 years, poorer sleep quality as mea-
sured by the Pittsburgh Sleep Quality Index score was associated
with higher DNAm age (p = 0.015).
Conclusions: As epigenetic aging is likely to be a longitudinal pro-
cess, it is expected that persistent insomnia symptoms from an
earlier age are associated with accelerated aging. Our study is the
first to detect this association already in early adolescence.
Disclosure: Nothing to disclose.
P011 | GABAA receptors of the thalamic
reticular nucleus regulate NREM delta
oscillations: an in vivo investigation by CRISPR‐
Cas9 genetic abscission
D.S. Uygun; C. Yang; H. Miwa; J.T. McKenna; F. Katsuki;
J.M. McNally; R.E. Strecker; R.E. Brown; R. Basheer
VABHS/Havard Medical School, Dept of Psychiatry., West Roxbury, MA,
United States
Objectives/Introduction: Understanding the cellular/molecular
mechanisms which regulate non‐rapid‐eye‐movement sleep (NREM)
delta oscillations (1–4 Hz) is of considerable importance due to their
association with synaptic homeostasis, cellular energy regulation and
clearance of toxic metabolites. Cortical delta‐oscillations are gener-
ated by intrinsic delta‐frequency burst discharge of thalamocortical
(TC) neurons whose main inhibitory input is from GABAergic thalamic
reticular nucleus (TRN) neurons, the majority of which contain the cal-
cium‐binding protein, parvalbumin (PV). TRN‐neurons themselves are
regulated by extrinsic GABAergic inputs from wake‐active neurons
acting on alpha3‐subunit containing GABAA receptors (GABAAR).
Based on this model, and findings that tonic optogenetic stimulation
of TRN‐neurons promotes delta‐power, we hypothesize that knock-
down of alpha3‐GABAAR on TRN‐neurons increases NREM‐delta.
Methods: We used clustered‐regularly‐interspersed‐short‐palindro-
mic‐repeats (CRISPR) gene‐editing to selectively knock‐down (KD)
alpha‐3 GABAARs in a region‐specific (TRN) and cell‐type specific
(GABA‐PV) manner in vivo. An adeno‐associated viral (AAV) vector
encoding three single‐guide‐RNAs targeting the alpha‐3 subunit was
injected into TRN of PV‐Cre/Cas9 transgenic mice, to disrupt local
expression of synaptic GABAARs, in TRN‐PV neurons. We measured
electroencephalography (EEG) and electromyography to determine
NREM, REM and wakefulness in freely moving mice before and after
AAV induced CRISPR‐Cas9 mediated KD of alpha‐3 subunits locally
in TRN. We validated the effectiveness of the KD by in vitro record-
ings of inhibitory post synaptic currents.
Results: During the light period, NREM time was increased
(9.9 ± 1.7%, p = 0.001) with longer bout durations (22%±8.7,
p = 0.02) in mice (N = 5) after alpha‐3 KD in TRN‐PV neurons. Nor-
malized delta‐power was higher (light‐period:43.9 ± 31.01%,
p = 0.05, dark‐period:38.7 ± 17, p = 0.02) after alpha‐3 KD in TRN‐
PV neurons. sIPSCs frequency was reduced in alpha‐3 KD TRN‐PV‐
neurons (1.01 ± 0.53, N = 5) vs. control PV‐tdTomato‐neurons
(3.47 ± 0.75, N = 6, p = 0.03).
Conclusions: This is the first use of cell‐type and brain‐region
localized CRISPR‐Cas9 technology to study sleep or EEG in vivo. Our
data suggests that in the absence of alpha‐3‐GABAARs the TRN‐PV
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neuronal activity is upregulated, leading to the potentiation of NREM
sleep and delta activity. This might explain how hypnotics which
potentiate alpha‐3‐GABAARs suppress delta‐oscillations while pro-
moting sleep.
Disclosure: VA‐I01BX001404, I01BX001356, I01BX002774,
IK2BX002130; NIH‐NS079866, MH039683, HL095491, MH099180.
JTM received partial salary/funding from Merck MISP, no conflict of
interest with this work.
P012 | CLOCK gene polymorphism
(rs1801260) in menopausal women of two
ethnic groups with insomnia
N. Semenova; I. Madaeva; T. Bairova; L. Kolesnikova
Federal State Public Scientific Institution, Scientific Centre for Family
Health and Human Reproduction Problems, Irkutsk, Russian Federation
Objectives/Introduction: One of the genes that determine circa-
dian rhythms is the Clock gene. The relationship of pathological
states with Clock gene polymorphisms depends on the population
under study. The aim of study is to determine an association of
Clock gene polymorphism (rs1801260) and insomnia in Caucasian
and Asian menopausal women.
Methods: 403 menopausal women aged 45–60 years divided into
Caucasian (without insomnia (n = 68) and with insomnia (n = 146))
and Asian (without insomnia (n = 61) and with insomnia (n = 128))
groups were examined. The program of the study included the fol-
lowing methods: clinical‐anamnestic (specialized questionnaires for
the assessment of sleep disorders, polysomnographic monitoring,
gynecological examination) and statistical. Genotyping by Clock gene
polymorphic marker rs1801260 was carried out in women.
Results: Both in Caucasian and Asian women, the T‐allele and the
TT‐genotype was more prevalent (T ‐ 0.70, TT ‐ 51.4%, TC ‐ 36.4%,
CC ‐ 12.2% and T ‐ 0.81, TT ‐ 69.3%, TC ‐ 22.8%, CC ‐ 7.9%, respec-
tively (p < 0.05)). The frequency of the TC‐genotype was signifi-
cantly larger in Caucasian women (p < 0.05) and the frequency of
TT‐genotype was less (p < 0.05). The C‐allele was more frequent in
Caucasian women (30.4% vs. 19.3%, p < 0.05). The distribution of
the genotypes in ethnic groups with/without insomnia corresponded
to the Hardy‐Weinberg distribution law (p > 0.05). Differences in
the distribution of the Clock gene polymorphism genotypes were
found only between groups of the Caucasian women. TT-genotype is
more incident in women with insomnia compared to control (55.5%
and 42.6%, respectively (p < 0.05)). T-allele was fairly more frequent
in group with insomnia compared to control (73.6% and 61%,
respectively (p < 0.05)). The odds ratio for the risk of insomnia real-
ization in Caucasian women was 1.78 (95% CI: 1.16–2.75).
Conclusions: T-allele of rs1801260 Clock gene polymorphism is
prognostic sign for the formation of insomnia only in Caucasian
women.
Disclosure: Nothing to disclose.
P013 | The role of melanin concentrating
hormone and orexin/hypocretin neurons in the
Prader‐Willi syndrome
M. Pace; M. Falappa; E. Balzani; V. Tucci
Istituto Italiano di Tecnologia, Genova, Italy
Objectives/Introduction: Prader‐Willi syndrome (PWS) is pater-
nally imprinted disorderthat leads to sleep and feeding alterations. It
is characterized by hypothalamic dysfunction. Melanin concentrating
hormone (MCH) and orexin/hypocretin (OX) neurons, located in the
lateral hypothalamus (LH), are strongly implicated in the regulation
of sleep‐wake cycle and feeding behavior. To this, we postulate that
MCH and OX may represent a key component in the pathophysiol-
ogy of PWS.
Methods: Two groups of mice were used: a) PWS mice with pater-
nally inherited Snord116 deletions (PWS mice) b) wild type litter-
mate control (WT mice). The gene expression of MCH (Precursor of
MCH (Pmch) and its receptor MCH receptor 1 (MchR1)) and OX
(prepro‐Orexin (Ppox) and receptors OX receptor 1 (OxR1) and OX
receptor 2 (OxR2)) systems were performed by qRT‐PCR at three
time points: at the baseline (T0), after a sleep deprivation (T1) and
after 2 hr of sleep deprivation (T2) in different brain regions:
hypothalamus (Hy); parietal cortex (PC) and frontal cortex (FC). The
neuronal activity of the LH was recorded by using tetrode‐based
in vivo recording technique, during BLsuaand during the last hour of
SD (T1sua)and the following first hour after SD (T2sua). Simultane-
ously, EEG/EMG electrodes were implanted to assess sleep‐wake
cycle.
Results: Gene expression: MCH system, both the neuropeptide and
its receptor, was found increased only at T2 in PWS mice,in the Hy
(p = 0.012). OX system was increased at T0(p = 0.04) and at T2
(p = 0.045) in the Hy, FC and PC, in PWS micerelative to WT mice.
Using tetrode‐based in vivo recording technique, we identified vari-
ous firing patterns of the LH that accurately respond to specific
sleep‐wake stages across conditions (i.e. BLsua, T1sua, T1sua).
Conclusions: These preliminary results suggest that MCH and OX
systems are altered in PWS. Furthermore, a different neuronal activ-
ity in the LH coordinated with sleep‐wake stages was observed.
Although these are very preliminary results we can conclude that
MCH and OX neurons may be involved in the pathophysiology of
PWS representing new treatment options for PWS.
Disclosure: Nothing to disclose.
98 of 433 | ABSTRACTS
P014 | Characterization of sleep architecture
and oscillations in a mouse model with reticular
thalamic nuclear dysfunction
P. Stuellet1; M. Bandarabadi2; A. Adamantidis2,3; K. Q. Do1;
C. Gutierrez Herrera2,3
1Department of Psychiatry, Center for Psychiatric Neuroscience,
Lausanne University Hospital, Lausanne, 2Department of Neurology,
Centre for Experimental Neurology, Inselspital University Hospital,
University of Bern, 3Department for BioMedical Research (DBMR),
University of Bern, Bern, Switzerland
Objectives/Introduction: In mammals, during non‐rapid eye
movement (NREM) sleep, the electroencephalogram (EEG) activity
shows typical signs of brain activity that include a predominant slow
wave (< 1 Hz) associated with delta (1–4 Hz) and spindles (9–16 Hz)
macroscopic oscillatory events. These oscillations are modulated by
subcortical inputs to the thalamus network. We had previously
demonstrated that TRN cells integrate subcortical arousal inputs
selectively during NREM sleep and may participate in sleep intensity
and consciousness (Herrera CG, et al. Nat. Neurosci., 2016). Interest-
ingly, recent investigations have suggested alterations in the thala-
mo‐cortical system in patients with schizophrenia (SZ) bipolar
disorders (BD), where TRN neuroanatomy and functionality is signifi-
cantly altered.
Methods: We use LFP/EEEG/EMG electrodes to characterised
sleep architecture and oscillations in a mouse model of schizophrenia
(Gclm KO) (Steullet et al. Molecular Psychiatry 2018). We recorded
knock out (KO) and wild type litter mates (WT) for 24 h. Sleep
homeostatic processes were induced by 4 hr sleep deprivation start-
ing at the onset of the light period and followed by recordings of
the recovery sleep (RS) for 6 h.
Results: We found that KO vs. WT sleep‐wake cycles were not sig-
nificantly different. However, KO mice show no increase of NREM
duration (61±6.9 WT, 38±5.1 KO) and delta power (O.07 ± 9 e10−4
WT, 2 e 10−3 ± 1.01 e10−6 KO) during SR, characteristic of homeo-
static sleep regulation. Finally, the rate of spindles during NREM
were decreased ~26% in baseline sleep in KO when compared to
WT mice; however, during sleep recovery spindle rate increased only
in KO ~36%, resulting in values comparable to baseline NREM sleep
spindle rate in WT. Data are presented as mean +/SEM. p < 0.005,
2way ANOVA.
Conclusions: The combination of sleep, spindles disruption and
attention deficits have been shown in SZ as well in BD and autistic
patients, and it has been proposed that the TRN deficits may be a
common mechanism. In agreement, our findings provide a functional
insight underlying network dysfunction relevant for schizophrenia;
and it renders the possibility of a combinatorial approach that will be
indeed invaluable to determine the extent of TRN involvement in
these disorders.
Disclosure: Nothing to disclose.
P015 | CDK5‐mediated phosphorylation of
PER2 regulates circadian clock
A. Brenna; U. Albrecht
Biochemistry, Biology, University of Fribourg, Fribourg, Switzerland
Objectives/Introduction: Defects in circadian rhythmicity
influences sleep, mood, and neurodegenerative disorders. The
Cyclin‐dependent Kinase 5 (CDK5) is a proline‐directed serine/thre-
onine kinase related to the Cdc2/Cdk1 family, which has been shown
to be directly involved in some of the above‐mentioned disorders.
The clock component Per2 has also been shown to be involved in
these disorders and its protein is highly phosphorylated by various
kinases.
Methods: We used protein analyis methods, shRNA techiques, cell
culture experiments and in vivo mouse behavior analysis to investi-
gate CDK5 influence on the clock component PER2.
Results: We find that CDK5 phosphorylates PER2 protein at a
unique highly conserved Serine residue, not yet characterized. In the
Suprachiasmatic nuclei (SCN), CDK5 kinase activity per se is circadian
and the protein itself undergoes rhythmic interaction with PER2
around the clock. PER2 phosphorylation at S392 facilitates the inter-
action with CRY and allows the PER2: CRY complex to enter the
nucleus. When PER2 is not phosphorylated it is quickly degraded via
the proteosome, and the leftover protein is located only in the cyto-
plasm. CDK5 down regulation lengthens circadian period, because
Cry stays longer is the cytoplasm due to reduced presence of phos-
phorylated PER2. This leads to a delayed arrival of CRY in the
nucleus to act as suppressor of the BMAL1/CLOCK complex.
Conclusions: CDK5 is a novel circadian kinase that phosphorylates
PER2. This phosphorylation is critical for the period of the molecular
circadian cycle. Our results close the gap of knowledge, on the ques-
tion which kinase drives the nuclear entry of PER2.
Disclosure: Nothing to disclose.
P016 | Sleep‐wake and thermoregulatory
changes in Panx1−/− mice
V. Kovalzon1,2; A. Latyshkova1,3; A. Komarova1,3;
Y. Panchin1,4
1Kharkevich Inst Information Transmission, Russian Academy Sciences,
2Severtsov Inst Ecology/Evolution, Russian Academy Sciences, 3Dept
Higher Nervous Activity, Lomonosov Moscow State University, Biological
Faculty, 4Lomonosov Moscow State University, Belozersky Inst. Physical‐
Chemical Biology, Moscow, Russian Federation
Objectives/Introduction: Recently a 17‐years old female patient
has been described carrying out a homozygous point mutation in
the Panx1 gene (an exchange of guanine to adenine at the position
650) which leads to the substitute of Arg for His at the position
217 in the expressed protein. This patient demonstrates
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multisystem disfunction including intellectual disability, sensorineural
hearing loss, skeletal defects, and primary ovarian failure [Shao
et al., J. Biol. Chem. 2016, 291(24):12432–43]. It was proposed that
the primary origin of this global pathology is a disfunction of the
Panx1 protein discovered in 2000 [Panchin et al., Curr. Biol. 10:
R473–4]. The ability to form ATP permeable membrane channels is
regarded as one of the main functions of this protein. ATP mole-
cules can exit the cell cytoplasm and enter the interstitial space
through these channels and take part in the paracrine regulation
[Esseltine, Laird, Trends Cell Biol. 2016, 26(12):944–55]. Extracellular
ATP, in its turn, is the source of adenosine, the main regulator of
the sleep‐wake cycle [Holst, Landolt, Curr. Sleep Med. Rep. 2015, 1
(1):27–37]. So we proposed that the Panx1 gene mutation could
also play an important role in sleep‐wake disorders [Shestopalov
et al., Front. Cell. Neurosci. 2017, 11:210].
Methods: Continuous EEG recordings plus implanted thermo-
probes. in mice.
Results: Our experiments in Panx−/− mice demonstrated an
increase in motor activity and wake percentage and correspondent
decrease in SWS especially expressed during the dark (active) period
as compared to WT animals [Kovalzon et al., Behav. Brain Res. 2017,
318:24–27]. The following studies revealed a decreased level of the
basal body temperature and decreased response to pyrogene admin-
istration as well as an increased tendency to spontaneous falling into
torpor within the room temperature in Panx−/− vs. WT mice
(p < 0.05; N = 8; U-test).
Conclusions: Thus, both clinical and experimental data are in favor
of the important role of Panx1 in the regulation of various physio-
logical functions including the sleep‐wake cycle and thermoregula-
tory processes. Supported by the Russian Science Foundation №17-15-
01433.
Disclosure: Nothing to disclose.
DREAMING
P017 | The degree of lucidity experienced in
dreaming could reflect the capacity of conflict
resolution in cognitive control
M.-R. Loo; S.-K. Cheng
Institute of Cognitive Neuroscience, National Central University,
Taoyuan, Taiwan
Objectives/Instruction: A lucid dream refers to the condition that
a dreaming individual is aware that he or she is dreaming. Some pre-
vious studies found that the dorsal lateral prefrontal cortex, which
has been linked to executive functions, yielded greater activations
during lucid dreams than non‐lucid ones. It has also been suggested
that the tendency of an individual to experience lucid dreams is
related to the performance of executive functions. However, it is far
from clear how and why lucid dreaming is related to the various
components of executive functions.
Methods: To address this issue, the current study recruited 77 par-
ticipants to record the degree of lucidity of the dreams they experi-
enced for 7 consecutive days. These participants then visited our lab
twice to complete a various kinds of executive function tasks, includ-
ing task switching, attentional network (ANT), operation‐span, and
the majority function task.
Results: Our data shows that there is a significant correlation
(p = 0.012) between trait lucidity and the conflict score obtained in
the ANT task while the alerting effect is positive.
Conclusions: This result suggesting that people who are more “lu-
cid” in their dreams tend to have better capacity for conflict resolu-
tion in cognitive control.
Disclosure: Nothing to disclose.
P018 | A technique for inducing high levels of
signal‐verified lucid dreams in a laboratory
morning nap
M. Carr1; K. Konkoly2; R. Mallett3; C. Edwards1; K. Appel4;
M. Blagrove1
1Swansea University, Swansea, United Kingdom, 2Northwestern
University, Evanston, IL, 3University of Texas at Austin, Austin, TX,
United States, 4Osnabruck University, Osnabruck, Germany
Objectives/Introduction: Lucid dreams occur when the sleeper is
aware that they are dreaming while asleep. We attempted to induce
lucid dreams in a laboratory setting using pre‐sleep training and
audio/visual cues during sleep.
Methods: Participants underwent 25 min of training in bed in the
sleep lab. First, participants practiced how to signal a lucid dream
with eye movements (look left‐right 4 times). Then, we played audio
and visual cues (beeping or flashing LED lights) at approximate 1‐min
intervals and instructed participants to become lucid (i.e. self‐aware,
mindful) each time they observed a cue. Participants then had a 90‐
min sleep period with PSG recording.
38 participants were randomly assigned to one of 3 conditions: 7:30
am nap with cues (n = 14, age=20.86 ± 2.71), 11:00 am nap with
cues (n = 13, age=21.77 ± 4.38), 11:00 am nap without cues
(n = 11, age=24.64 ± 6.27). The audio/visual cues were presented
during REM sleep. Participants were awakened to report dreams and
complete the LuCiD Scale, which measures dream insight, control,
memory, among others.
Results: In the 7:30 am cued condition, 9 participants reported a
lucid dream, 7 were signal‐verified. In the 11:00 am cued condition,
8 participants reported a lucid dream (7 signal‐verified). The two
cued conditions did not differ in signal‐verified lucid dream count (χ2
p = 0.84). Within the 7:30 am cued condition, lucid dream reporters
had longer sleep duration the previous night (4.1 vs. 6.0 h, p = 0.03)
than non‐lucid dream reporters.
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In the 11:00 am non‐cued condition, 4 participants reported a lucid
dream (2 signal‐verified); the 11:00 am cued condition had marginally
more signal‐verified lucid dreams (χ2 p = 0.07), higher insight
(p = 0.004) and memory (p = 0.02) scores than the non‐cued condi-
tion.
Importantly, in the cued conditions, signal‐verified lucid dreams
occurred in 4 of 6 participants who had never before experienced a
lucid dream. Of methodological interest, 2 participants did eye sig-
nals but did not report lucid dreams.
Conclusions: Overall, findings suggest that lucid dreams can be
efficiently elicited by a combination of training and audio/visual cues
during sleep, and elicited even in previous non‐lucid dreamers. That
2 non‐lucid dream reporters did eye movement signals highlights the
potential to influence dream content through training even without
intervening lucidity.
Disclosure: MCarr, Funding Source: Dream Science Foundation/
International Association for the Study of Dreams Research Grant.
KKonkoly, nothing to disclose. RMallett, nothing to disclose. CEd-
wards, nothing to disclose. KAppel, nothing to disclose. MBlagrove,
nothing to disclose.
P019 | Electrophysiological response to
emotional voices during sleep and wakefulness
as a function of stimulus‐reactivity
M. Moyne1; J. Domínguez-Borràs1; G. Legendre1; L. Arnal1;
V. Sterpenich1; D. Grandjean1; M. Seeck2; S. Schwartz1;
P. Vuilleumier1
1University of Geneva, 2Geneva University Hospitals, Geneva,
Switzerland
Objectives/Introduction: As compared to neutral sounds, emo-
tional sounds elicit enhanced cortical responses during wakefulness.
Whether this effect is similarly present during sleep remains unre-
solved. On one hand, evidence shows that the sleeping brain is not
fully disconnected from its acoustic environment. On the other hand,
compared to wakefulness, sleep is characterized by an over‐activa-
tion of limbic regions related to emotion processing. Moreover, a
recent study suggested that individual differences in brain reactivity
associated to dream recall frequency determine brain responses to
external stimuli during sleep (Vallat et al., 2017). Here we hypothe-
sized that elevated emotional arousal during sleep enhances brain
reactivity to affectively‐loaded information.
Methods: We examined event‐related potential (ERP) responses to
angry and neutral voices (Grandjean et al., 2005) in 13 healthy par-
ticipants (age: 21.69 ± 1.6) both during wakefulness and sleep. We
also included an extra set of control stimuli, with the same envelope
as the experimental angry and neutral voices, but filled with white
noise. Stimuli were 750 ms binaural meaningless word‐like vocal
utterances pronounced with either angry or neutral prosody, deliv-
ered every 8 (±3) seconds. During sleep, the stimulation started dur-
ing the first stable N3 sleep episode.
Results: We observed enhanced auditory responses to angry com-
pared to neutral voices, both during wakefulness and NREM sleep.
The effect observed during NREM sleep predominated in high dream
recallers (n = 5), characterized by high reactivity to external stimuli,
and was not significant when only considering low dream recallers
(n = 8). Moreover, the number of arousals during NREM sleep after
presentation of angry voices was greater than for neutral voices, an
effect that, again, only occurred in high dream recallers. Importantly,
the control stimuli did not elicit differential responses to angry‐ or
neutral‐related stimuli, thus confirming that the emotional effects
observed with the original voices were driven by affective stimulus
attributes.
Conclusions: We show that emotion encoding of external stimuli
may be preserved even in conditions of deep sleep, and that this
effect depends on individual brain reactivity during NREM.
Disclosure: Nothing to disclose.
P021 | Relationship between EEG frontal alpha
asymmetry and dream affect
P. Sikka1,2; V. Noreika3,4; A. Revonsuo1,2; K. Valli1,2
1Turku Brain and Mind Center, Department of Psychology, University of
Turku, Turku, Finland, 2Department of Cognitive Neuroscience and
Philosophy, University of Skövde, Skövde, Sweden, 3Department of
Psychology, University of Cambridge, 4Medical Research Council
Cognition and Brain Sciences Unit, Cambridge, United Kingdom
Objectives/Introduction: Establishing the neurophysiological cor-
relates of dream phenomenology, including dream affect, has
remained challenging. Frontal alpha asymmetry (FAA) is considered a
marker of affective and motivational states and traits as well as
affect regulation in the waking state. Our aim was to explore
whether FAA during rapid eye movement (REM) sleep is associated
with corresponding dream affect, and whether FAA during evening
resting wakefulness predicts dream affect in REM sleep dreams.
Methods: Electroencephalography (EEG) recordings were obtained
from seventeen (7 male, 10 female) young adults (mean age = 25.76
± 4.93) who spent two non‐consecutive nights in the sleep labora-
tory. Participants were awakened 5 min after the onset of every
REM stage, after which they gave an oral dream report (N = 115,
M = 6.76 ± 3.05) and rated their dream affect using the modified
Differential Emotions Scale. Two‐minute EEG samples from each
REM sleep stage that resulted in a dream report were analysed.
Additionally, 8 min of evening pre‐sleep and morning post‐sleep EEG
was recorded during resting wakefulness. Mean spectral power in
the alpha frequency band (8–13 Hz) and corresponding FAA was cal-
culated over the mid‐frontal (F4/3 electrodes) and subsequently over
all the other homologous electrode pairs.
Results: Linear regression analyses showed that FAA over mid‐
frontal regions (F4/3) during REM sleep (N = 17, β = 0.690,
p = 0.002), as well as during evening resting wakefulness (N = 17,
β = 0.728, p = 0.001), predicted ratings of dream anger. Moreover,
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Pearson correlations showed that FAA over the F4/3 electrode pair
was positively correlated across different states of consciousness
(evening wakefulness, REM sleep, and morning wakefulness) (N = 17,
r = 0.637 — 0.720, p < 0.01).
Conclusions: These results suggest that FAA may serve as a neural
correlate of state and trait affect regulation (i.e., inhibitory control of
affective processing) not only in the waking but also in the sleeping
state.
Disclosure: Nothing to disclose.
P022 | Increase of both bottom‐up and top‐
down attentional processes in high dream
recallers
P. Ruby; B. Chatard; L. Bottemanne; R. Vallat; A. Bidet-Caulet
CRNL DYCOG Team, Bron Cedex, France
Objectives/Instruction: Evoked potentials associated with the
automatic orientation of attention towards an unexpected sound (bot-
tom‐up processes) are of larger amplitude in high dream recallers (HR)
than in low dream recallers (LR) (Eichenlaub et al. 2014a). Such result
suggests different attentional processes or strategies in the two
groups.
Methods: To further investigate this issue, we measured bottom‐
up and top‐down attentional performance and their cerebral corre-
lates with EEG in HR and LR using a paradigm in the auditory
modality (Bidet‐Caulet et al. 2014). EEG was recorded in 18 HR (7
men, age = 22.7 ± 4.1 years, dream recall frequency = 5.3 ± 1.3 days
with a dream recall per week) and 19 LR (9 men, age = 22.3, DRF =
0.2 ± 0.2) while they had to detect a target sound (played either in
the right or the left ear) preceded either by an uninformative or
informative visual cue (indicating the ear in which the sound will be
played). In 25% of the trials a distracting sound was presented
between the cue and the target.
Results: Significant between group differences were found in event
related potentials (ERPs to cue, target and distractor) but not in
behavioral responses. The results confirm that HR present a larger
P2/earlyP3a complex to distracting sounds than LR, suggesting
enhanced bottom‐up attentional processes in HR. HR also presented
a greater contingent negative variation (CNV) during target expec-
tancy and a larger P3b response to the target sound than LR, speak-
ing for an enhanced top‐down control of attention in HR. These
results demonstrate that both bottom‐up and top‐down attentional
related mechanisms are exacerbated in HR compared to LR.
Conclusions: This general increase leads to a apparently preserved
balance between bottom‐up and top‐down processes since similar
performance were observed in the two groups. These results show
that different neurophysiological profiles allow to achieve similar
cognitive performance, with some profiles possibly more costly in
term of resource/energy consumption.
Disclosure: Nothing to disclose.
P023 | PTSD‐like symptoms, morning affect
and intrusive memories in nightmare disorder
B. Blaskovich1; R. Reichardt1; V. Reicher1; G. van der Wijk1;
A. Király2; Á. Szegőfi2; P. Simor2
1Department of Cognitive Science, Budapest University of Technology
and Economics, 2Eötvös Loránd University, Budapest, Hungary
Objectives/Introduction: Nightmare disorder is characterized by
frequent, intense and highly unpleasant mental experiences (night-
mares), usually appearing during late‐night Rapid Eye Movement
(REM) sleep. Frequent nightmares are related to impaired subjective
sleep quality, altered sleep architecture and sleep fragmentation.
According to Levin and Nielsen's (2007) model, nightmare disorder is
characterized by impaired emotional regulation during sleep. The aim
of the following experiment was to investigate the relationship
between emotional information processing, sleep and affect in a
group of nightmare sufferers and healthy controls.
Methods: 22 Nightmare sufferers, and 22 age and gender matched
controls participated in our experiment. Participants spent two nights
of sleep in the sleep laboratory (“habituation” night, “experimental”
night) monitored by electroencephalography (EEG). During the
experimental night IAPS (Nneutral = 20, Nnegative = 20) pictures were
presented. The same picture set was presented in the next morning.
Upon awakening, participants completed a dream questionnaire.
Affective states were monitored during the experiment by standard-
ized scales (PANAS). In addition, they were asked to keep a “Flash-
back diary” for the following week about their intrusive, image‐like
memories concerning the presented IAPS pictures.
Results: Preliminary analyses showed significant Group (Nightmare,
Control) x Time (PANASpre-test, PANASpost-test, PANASmorning) interac-
tion (F2,42 = 3.7, p = 0.027), mainly due to increased negative affect
in the nightmare group in the morning (p = 0.005). Questionnaire
based measures significantly differed between the two groups
(PTSD‐like symptoms: t(34.79) = −3.56, p = 0.003; Insomniac com-
plaints: t(27.749) = −3.806; p < 0.001). The Nightmare group experi-
enced significantly more intrusive images (p = 0.022), and these
images were more negative (p = 0.043) compared to the Control
group. Furthermore, Nightmare group participants reported higher
rate of negative emotions in their dreams (p = 0.004) compared to
the Control group. Negative dream affect was significantly correlated
with PTSD scores in both groups (rhoNM = 0.459, p = 0.036;
rhoCTL = 0.509, p = 0.006).
Conclusions: Idiopathic nightmare sufferers seem to show
increased PTSD‐like symptomatology and insomniac complaints, that
might affect their everyday mood, emotional reactivity, and dream
affect. Negative affect in the morning might reflect the impairment
of the mood regulatory function of sleep.
Disclosure: Nothing to disclose.
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P024 | Testing the empathy theory of
dreaming: the relationship between trait
empathy and positive attitude towards dreams
and the frequencies of listening to and telling
dreams
M. Blagrove1; S. Hale1; J. Lockheart2; M. Carr1; A. Jones1
1Psychology, Swansea University, 2University of Wales Trinity St Davids,
Swansea, United Kingdom
Objectives/Introduction: In the empathy theory of dreaming the
sharing of dreams is proposed to have an empathic effect on the
dreamer and on significant others who hear and engage with the tell-
ing of the dream. In this theory, dreaming is a simulation of waking
life (Revonsuo et al., 2015), and with a mixture of characters, motiva-
tions, scenarios, positive and negative emotions, and almost entirely
fictional plot, is proposed to have been selected for in evolution, and
in particular in sexual selection, as part of the selection for emotional
intelligence and empathy (cf Smith et al., 2017). This study tests three
correlations that are predicted by the theory, that trait empathy will
be correlated with dream telling frequency, frequency of listening to
others’ dreams, and with positive attitude towards dreams.
Methods: 160 participants (120 females, 40 males; mean age =
21.30, SD = 4.70) completed the Toronto Empathy Questionnaire
and the Mannheim Dream Questionnaire online.
Results: Pearson partial correlations were conducted, with age and
sex partialled out, dfs = 156, and with one‐tailed ps. Trait empathy
was found to be significantly associated with frequency of listening
to the dreams of others (r = 0.14, p = 0.045), frequency of telling
one's own dreams to others (r = 0.32, p < 0.001), and positive atti-
tude towards dreams (r = 0.29, p < 0.001).
Conclusions: The hypotheses were confirmed. A proposed mecha-
nism is that the dream acts as a piece of fiction, that is explored by
the dreamer and others and that, like literary fiction (Matthijs Bal &
Veltkamp, 2013), can induce empathy about the life circumstances
of the dreamer. Future studies should investigate the effect on state
empathy of experimental alterations in frequency of telling and lis-
tening to dreams.
References:
Matthijs Bal, P., & Veltkamp, M. (2013). How does fiction reading
influence empathy? An experimental investigation on the role of
emotional transportation. PLOS ONE, 8, e55341.
Revonsuo, A., Tuominen, J. & Valli, K. (2015). The avatars in the
machine ‐ Dreaming as a simulation of social reality. In T. Metzinger
& J. M. Windt (Eds). Open MIND: 32(T). Frankfurt am Main: MIND
Group.
Smith, D. et al. (2017). Cooperation and the evolution of hunter‐
gatherer storytelling. Nature Communications, 8, 1853.
Disclosure: Nothing to disclose.
P025 | Emotions in dreams correlate with
coping style
A. Coppola; B. Albinni; M. Cerasuolo; F. Conte; G. Ficca
Department of Psychology, University of Campania, Caserta, Italy
Objectives/Introduction: Modern dream research has shown
interesting relationships between some cognitive‐behavioural trait
variables and dream content (Malinowski, 2015). Aim of this study is
to analyse the role played by behavioural activation systems and
coping strategies in determining interindividual differences in dream
emotional content. Specifically, continuity between waking cognitive/
emotional strategies and dream emotions was expected.
Methods: Ten adult subjects were administered: a) the Behavioural
Inhibition and Activation Scale (BIS/BAS Scale, Italian version, Leone
et al., 2002), addressing interindividual differences in inhibition/acti-
vation through the following subscales: “Behavioural Inhibition
System”, “Reward Responsiveness”, “Drive”, “Fun Seeking”, “Beha-
vioural Activation System”; b) the Coping Orientation to Problems
Experienced ‐ New Italian Version (COPE‐NVI, Sica et al., 2008),
evaluating the frequency of different coping strategies through the
subscales: “Social Support”, “Avoidance”, “Positive Attitude”, “Prob-
lem‐focused Coping”, “Religious Coping”. Dream reports were col-
lected for 38 consecutive days. The central 8 days were analysed for
the following dream features: number of dreams, dream length (in
temporal units), number of total emotions, number of positive emo-
tions, number of negative emotions, number of somatic sensations,
dream bizarreness (subjectively reported on a 5‐point scale). These
variables were then correlated to all BIS/BAS and COPE‐NVI sub-
scales.
Results: Significant Spearman correlations were found between
emotion type and two types of coping strategies: the number of
positive emotions positively correlates with “Problem‐focused Cop-
ing” (rho = 0.247, p ≤ 0.01) and negatively correlates with “Avoid-
ance” (rho = 0.300, p ≤ 0.05). No significant associations emerged
with BIS/BAS subscales.
Pearson analysis of correlation between BIS/BAS and COPE‐NVI rat-
ings on one hand and number of words, number of dreams and
dream bizarreness on the other hand, showed no significant results.
Conclusions: Our results point to a continuity of emotional pro-
cessing from waking to the sleep state. The positive correlation
between positive emotionality in dreams and active coping is consis-
tent with existent data on waking emotional processing reporting
associations between positive affect and active coping strategies
(Khosla & Hangal, 2004) Similarly, the negative correlation of dream
positive emotions with avoidance coping frequency confirms previ-
ous literature on the waking state (Piira et al., 2002). Future research
should address the direction of this association.
Disclosure: Nothing to disclose.
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P026 | Dreams of children with
neurodevelopmental disorders: autism spectrum
and attention deficit/hyperactivity
K. Nguyen1; É. Soucy-Savard1; M. Chicoine1; R. Godbout1,2
1Sleep Laboratory & Clinic, Hôpital Rivière‐des‐Prairies, CIUSSS‐NIM,
2Department of Psychiatry, Université de Montréal, Montreal, QC,
Canada
Objectives/Introduction: The Autism Spectrum disorder (ASD)
and the Attention Deficit/Hyperactivity (ADHD) disorder are two
highly comorbid neurodevelopmental disorders (NDDs) with atypical
cognitive functioning, including emotional processing. The study of
dreams in these two groups of children could constitute an opportu-
nity to better understand the physiopathology of NDDs.
Methods: 18 children diagnosed with ASD (11.7 ± 3.7 years) and
18 children diagnosed with ADHD (11.8 ± 3.3 years) filled a dream
content self‐report. Groups were compared on easiness to recall
content (1 = never, 5 = easy), cloudiness of recall (1 = vivid, 5 = very
cloudy) and the frequency of four emotions in their dreams (joy, fear,
sadness and anger; 1 = never, 5 = always). Results were compared
with t‐tests. We expected that recall, clarity and emotions would be
decreased in the ASD group.
Results: The ASD group recalled less their dreams than the ADD
group (means ± s.d.: 2.0 ± 1.0 vs. 2.7 ± 0.9; t(29)=2.04, p < 0.05), the
content was more cloudy (3,9 ± 1,1 vs. 3.0 ± 1.4; t(29)=2.02, p < 0.05)
but there were no differences on the frequency of emotional items, both
groups reporting rarely or seldom joy, fear, sadness or anger.
Conclusions: Dream recall is less easy and less clear in children
with an ASD compared to ADHD but groups did not differ on the
frequency of emotional items. Comparable results on recall were
published in ASD adults compared to a group of neurotypical indi-
viduals (Daoust et al., 2008). The two groups of children do not dif-
fer on the frequency of emotional items, both displaying low scores.
This possibly reflects an altered processing of emotional load in
dreams of children with NDDs.
Disclosure: Nothing to disclose.
P027 | Efficacy of cognitive behavioral therapy
for insomnia on nightmares in veterans with
PTSD
H. Barilla1,2; P. Gehrman1,2; E. Phelps3; E. Medvedeva2;
J. Brownlow1,2; J. Prigge2; W. Rehman2; C. Roberts2;
S. Kuna1,2
1University of Pennsylvania, 2Corporal Michael J Crescenz Veterans
Affairs Medical Center, Philadelphia, 3Coatesville Veterans Affairs
Medical Center, Coatesville, PA, United States
Objectives/Introduction: Insomnia and nightmares are two of the
diagnostic criteria for Posttraumatic Stress Disorder (PTSD). Cogni-
tive behavioral therapy for insomnia (CBT‐I) is considered the gold
standard in treatment for insomnia however little is known about
impact CBT‐I has on the frequency of nightmares in a Veteran popu-
lation. Here we report results of a randomized trial in Veterans with
PTSD and chronic insomnia comparing delivery of CBT‐I by video
teleconference vs. in‐person delivery.
Methods: Veterans with current PTSD on the Clinician Adminis-
tered PTSD Scale and Insomnia Severity Index (ISI) score ≥ 15 were
randomized to receive CBT‐I in person or via video telehealth equip-
ment. Nightmares were assessed using the Nightmare Frequency
Questionnaire (NFQ), and Nightmare Distress Questionnaire (NDQ).
Relationships were examined using paired t‐tests comparing baseline
and 3‐month follow‐up measures within each group.
Results: Subjects who received CBT‐I in person (n = 46) reported
experiencing a total of 2.2 nightmares on 2.1 days a week while
Veterans who received CBT‐I via telemedicine (n = 49) reported a
number of 2.3 nightmares on an average of 2.2 days a week. At the
3‐month follow‐up Veterans in the in‐person CBT‐I group averaged
2.5 nightmares on 2.5 days a week and those in the telemedicine
group reported 3.2 nightmares on 3.1 days per week. On the NDQ,
subjects who received in‐person CBT‐I scored a 26.82 ± 8.08 prior
to treatment and a 28.81 ± 7.70 at the 3‐month follow‐up while
Veterans who received CBT‐I via telemedicine scored a 26.73 ± 7.74
at baseline and 25.46 ± 7.95. These improvements were not statisti-
cally significant. Baseline ISI scores significantly improved when com-
pared to scores at the 3‐month follow‐up (p < 0.01).
Conclusions: Nightmares continue to be a staple symptom in
Veterans with PTSD. Overall, sleep improved in both groups how-
ever the frequency of nightmares was not found to be significantly
impacted from treatment. This could be an indication that CBT‐I
alone does not aid in the improvement of nightmares in Veterans
with PTSD. Further research is needed in this area to determine the
factors driving nightmares in this population.
Disclosure: Nothing to disclose.
P028 | Emotions in REM dream reports in
healthy women
J. Pires1; T. Paiva2
1Lisbon School of Health Technology, Amadora, 2CENC ‐ Sleep Medicine
Center, Lisbon, Portugal
Objectives/Introduction: To evaluate and compare two methods
of analysing the emotional content of REM dreams′ recall: self‐rating
and with the Hall and Van Castle scale/
Emotions are an important aspect of dreams. Negative emotions
(NE) tend to predominate in the case of explicitly mentioned emo-
tions, whereas in the case of self‐ratings, the affective tone is bal-
anced. (Schredl et al., 1998).
Methods: 20 adult healthy women were recorded for 2 PSG con-
secutive nights. REM awakenings dreams were collected after 10
continuous minutes of REM.
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Dream emotional content analysis was measure with:
(1) A scale for dreamers’ self-ratings their dreams′ reports: six
emotion categories (1-fear/anxiety, 2-anger, 3-sadness, 4-
shame, 5-joy/elation, 6-affection/erotic) on a scale of 1–5
(5 = highest intensity).
(2) Evaluated by the Hall and Van de Castle method; this system
scores all explicitly mentioned emotions in five categories:
anger, apprehension, happiness, sadness, and confusion. A
dream report was considered
(a) positive, when the number of PE were predominant;
(b) negative, when the number of NE exceeded that of PE;
(c) balanced (BT), when the number of PE and NE was equal and
(d) with no emotions (NE), when no emotions were explicitly
mentioned.
Results: 20 women were admitted in our study with mean age of
27,7 (min 20; max 36).
127 REM awakenings were performed (mean= 4,86; SD= 2,74), with
82,9% recall rate; 105 dreams were evaluated (5.25 per subject, min
2; max 9; mean=1,38; SD= 1,90).
With the self‐rating analysis we obtain 35 with NE (33.3%), 61 with
PE (58.1%), 1 with BT (1%) and 8 with NE (7,6%) and with the Hall
and Van Castle evaluation, 27 with NE (25,8%), 8 with PE (7,6%), 2
with BT (1,9%) and 68 with NE (64,8%).
With the two methods the resulting difference between PE and NE
was not significant (ANOVA with Bonferroni correction p < 0,05.)
The two content analysis were different: Self‐rating analysis
1.83 ± 0.790 and Hall and Van Castle 3.06 ± 1.329, (Mann‐Whitney
test Z = −7,189 p < 0,001).
Conclusions: PE and NE were similar in the two evaluations.The
two analyses were different, probably associated with the low rate
of explicitly mentioned emotions in the dreams reports.
Disclosure: Nothing to disclose.
P029 | Sleep inertia and functional
connectivity between brain regions at awakening
in high and low dream recallers: an EEG‐fMRI
study
P. Ruby; D. Meunier; A. Nicolas; R. Vallat
CRNL - DYCOG, Bron Cedex, France
Objectives/Introduction: Sleep inertia is a transitional state of
lowered arousal occurring immediately after awakening from sleep
and producing a temporary (typically 30 min) decrement in subse-
quent performances in various kind of tasks. Designing this study,
our aims were to test a possible role for sleep inertia in dream recall
frequency variations measuring its behavioral effects and cerebral
correlates at awakening in high and low dream recallers (HR, LR).
Our hypothesis was that a stronger sleep inertia in LR than in HR
may prevent the short‐term memory trace of the dream from surviv-
ing the sleep‐wakefulness transition.
Methods: Participants (n = 55, 28 males, age=22.5 ± 2.4) were
selected as either high (HR, n = 28, DRF=6.6 ± 0.7 days per week
with a dream recall) and low dream recallers (LR, n = 27, DRF=0.2 ±
0.1). After a partial sleep deprivation (sleep slot : from 5 to 8 am),
participants were equipped with fMRI compatible EEG and installed
in the scanner at approximately 1 pm. After reference measures,
they were instructed that they could sleep (max 45 min). They were
awakened in NREM sleep and asked about their dreams. Measures
of sleep inertia (2 min of the descending subtraction task) and func-
tional connectivity (eyes open resting state scans) were done before
the nap, 1–2 min and 25 min after awakening.
Results:
(1) replicated previous ones showing an alteration of the DST
performance 5 min after awakening,
(2) showed that this effect tended to be stronger in LR than in
HR, and
(3) that it was associated with a significant decrement of the
functional connectivity of the DMN in LR as compared to
HR.
Between‐group contrasts of the functional connectivity at 5 min
post‐awakening revealed a pattern of enhanced connectivity in HR
vs. LR within the default mode network and regions involved in
memory retrieval (i.e. medial prefrontal cortex, precuneus, left medial
temporal lobe, left dorsolateral prefrontal cortex).
Conclusions: These results show that
(1) HR and LR cerebral functioning is different,
(2) designate sleep inertia as a good candidate to explain some
of the dream recall frequency variations, and
(3) provide some cerebral correlates of the functional state
favoring dream recall at awakening.
Disclosure: Nothing to disclose.
SLEEP PHYSIOLOGY 1
P030 | Sleep EEG topography as an
endophenotype: insights from an adolescent
twin study
A. Markovic1; P. Achermann2,3,4; T. Rusterholz1,2;
L. Tarokh1,2,5
1University Hospital of Child and Adolescent Psychiatry and
Psychotherapy, University of Bern, Bern, 2Institute of Pharmacology and
Toxicology, University of Zurich, 3Neuroscience Center Zurich, University
of Zurich and ETH Zurich, 4Zurich Center for Interdisciplinary Sleep
Research, University of Zurich, Zurich, Switzerland, 5Department of
Psychiatry and Human Behavior, Alpert Medical School of Brown
University, Providence, RI, United States
Objectives/Instruction: Twin studies can disentangle the genetic
and environmental contributors to a given phenotype. These studies
are based on the assumption that greater similarity between MZ
twins as compared to DZ twins can be attributed to the larger
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proportion of shared genes. Low‐density EEG studies in adult twins
showed that the spectral composition of the sleep EEG is genetically
determined. This study examined the degree to which genes con-
tribute to sleep EEG topography during adolescence, a period of
rapid changes in brain structure and organization.
Methods: High‐density (58 derivations) sleep EEG was recorded
in 14 monozygotic (MZ) and 12 dizygotic (DZ) adolescent twin
pairs (mean age = 13.2; SD = 1.1; 20 females). The topographic dis-
tribution of power was examined for delta (1–4.6 Hz), theta (4.8–
7.8 Hz), alpha (8–10.8 Hz), sigma (11–16 Hz), beta 1 (16.2–20 Hz),
beta 2 (20.2–24 Hz), gamma 1 (24.2–34 Hz) and gamma 2 (34.2–
44 Hz) bands during rapid eye movement (REM) and non‐REM
(NREM) sleep. Because we were interested in the spatial distribu-
tion of power across the scalp, absolute power at each derivation
was normalized with mean power across derivations resulting in a
vector of 58 values per individual. This vector was then correlated
within a twin pair, resulting in one correlation coefficient (r) per
twin pair. An ANOVA was used to evaluate the differences in the
correlation coefficients between MZ (rMZ) and DZ (rDZ) twins. Fur-
thermore, a heritability coefficient, h2, defined as 2(rMZ‐rDZ) was
calculated.
Results: The observed correlation coefficients were significantly
higher in MZ as compared to DZ twin pairs for NREM sleep across
all bands except theta and gamma 2. For REM sleep rMZ was signifi-
cantly higher than rDZ in the beta 1 to gamma 1 bands. We found
highest heritability in the beta bands (0.44 ≤ h2 ≤ 0.57), while heri-
tability was modest in the delta to sigma bands (0.01 ≤ h2 ≤ 0.26).
Conclusions: EEG topography is not only a representation of brain
anatomy, but also reflects functional networks. Our results indicate
that sleep EEG topography at higher frequencies is highly heritable
suggesting that such topography may be a rich metric of brain func-
tion and a potential endophenotype for psychiatric disorders.
Disclosure: Nothing to disclose.
P031 | Event‐related analysis of awakenings
due to road traffic noise at night: a
polysomnographic field study
S. Sanok1; M. Berger2; F. Mendolia1; U. Müller1;
S. Weidenfeld1; E.-M. Elmenhorst1; D. Aeschbach1
1Sleep and Human Factors Research, Institute of Aerospace Medicine,
German Aerospace Center, Cologne, 2Department of Medical Biometry,
Informatics and Epidemiology, University of Bonn, Bonn, Germany
Objectives/Instruction: Nocturnal traffic noise causes sleep dis-
turbances in residents. Thus, knowledge about noise effects is
important to help protect residents’ sleep and maintain health, well‐
being, and performance. In recent years, DLR has established expo-
sure‐response curves regarding the effects of aircraft and railway
noise on the awakening probability of residents. However, such a
curve has not yet been established for road traffic noise.
Methods: We conducted a field study in residential areas where
road traffic was the dominant noise source and noises were attributa-
ble to separate events. Forty healthy participants (mean age = 29.1,
SD = 11.7; 26 females) that were free of sleep disorders were
polysomnographically examined for five consecutive nights. Acoustic
measurements were undertaken at the sleepers’ ear. The synchronous
collection of electrophysiological and acoustic data allowed for an
event‐related analysis of noise events and associated awakenings.
Results: The present analysis included 152 nocturnal recordings with
a total of 11265 road traffic noise events within the participants’ sleep
period. Participants were exposed to a median of 107 road traffic
noise events per night. A random effects logistic regression model,
including acoustic, sleep‐related and participant‐related (e.g. age) vari-
ables, revealed a significant increase in the awakening probability with
increasing maximum sound pressure level of a noise event (p < 0.001).
When holding all confounding variables constant at their respective
sample median, the awakening probability per single noise event ran-
ged from 0.5% at 24.2 dB(A) to 3.8% at 70 dB(A) maximum sound
pressure level. Assuming an exposure of 107 noise events per night
with maximum sound pressure level of 39.4 dB(A) (median) the model
estimates on average one noise‐induced awakening per night.
Conclusions: The present study is of high ecological validity and
provides for the first time an exposure‐response curve regarding the
effect of separate road traffic noise events on the awakening proba-
bility. Our study focussed on residential areas with moderate traffic
density at night. Further investigations of urban areas with dense
traffic are still needed, which, however, will require a novel method-
ological approach as an event‐related analysis is no longer feasible.
The ultimate goal will be to establish physiologically based noise pro-
tection measures.
Disclosure: Nothing to disclose.
P032 | Light‐induced sleep is homeostatically
regulated in mice
S. Hasan1; A. Ramkisoensing1; S.N. Peirson1; R.G. Foster1;
V.V. Vyazovskiy2
1Nuffield Department of Clinical Neurosciences, 2Department of
Physiology, Anatomy and Genetics, University of Oxford/Sleep and
Circadian Neuroscience Institute, Oxford, United Kingdom
Objectives/Instruction: Prolonged wakefulness leads to longer
and more intense sleep. Light exposure during the dark period reli-
ably triggers sleep in mice, but it is unknown whether sleep‐wake
history affects light‐induced sleep, and, conversely, whether light‐
induced sleep contributes to sleep pressure dissipation. The aim of
this study was to determine whether light‐induced sleep is homeo-
statically regulated in mice.
Methods: EEG recordings from the frontal and occipital cortex
were performed in adult male C57BL/6J mice (n = 11) during sponta-
neous and light‐induced sleep. Mice were subjected to one‐hour
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white light pulses (~150 lux) either two (ZT14) or six (ZT18) hours
after dark onset.
Results: At ZT14, the light pulse induced NREM sleep within min-
utes (2.1 ± 0.6 min), and the total amount of NREM sleep during the
1‐h light pulse was higher than during the corresponding interval of
baseline (41.5 ± 2.2 vs. 15.3 ± 3.5 min, p < 0.01). The light pulse
induced more NREM sleep at ZT14 as compared to ZT18, when only
25.9 ± 6.2 of NREM sleep occurred during the light exposure
(p < 0.05). The total 12‐h amount of NREM sleep only was not dif-
ferent between baseline and the night when the light pulse was
delivered. The amount of NREM during the light pulse at ZT14 and
ZT18 was negatively correlated with the amount of NREM during
the 2‐h intervals prior to the light pulse (p < 0.0001). Furthermore,
the amount of sleep during the 2‐h interval following the light expo-
sure was negatively correlated with the amount of sleep during the
light pulse (p = 0.0101). Finally, the light‐induced sleep was charac-
terised by elevated EEG power density in slow frequencies, which
significantly exceeded baseline values by 70% in the frontal deriva-
tion between 0.5 and 1 Hz at ZT18, and by 43.1% in the fronto‐
occipital derivation between 0.75 and 1.5 Hz at ZT14 (p < 0.01).
EEG spectra in the occipital derivation did not differ significantly
between light‐induced and spontaneous sleep.
Conclusions: Light exposure during the dark period reliably
induces sleep in mice especially in the conditions of elevated physio-
logical sleep pressure. Furthermore, light‐induced sleep effectively
dissipates sleep pressure, as manifested in reduced sleep following
the light pulse. These data suggest that light‐induced sleep is homeo-
statically regulated.
Disclosure: Supported by Wellcome Trust (106174/Z/14/Z &
098461/Z/12/Z).
P033 | Wanderlust ‐ travelling and stationary
sleep oscillations
L. Himmer1; M. Schönauer1; Z. Bürger1; J. Maschke1;
L. Wagner1; C. Braun2; S. Gais1
1Institute of Medical Psychology and Behavioral Neurobiology,
2University Hospital Tübingen MEG Center, University of Tübingen,
Tübingen, Germany
Objectives/Instruction: Slow waves and sleep spindles represent
exclusive hallmarks of the sleeping brain's activity. Various conflicting
theories about their physiology and emergence across the cortex
exist. Here, we aim to elucidate their patterns of distribution and
their spatio‐temporal propagation across the brain.
Methods: We acquired high‐density 268‐channel MEG with addi-
tional EEG polysomnography of 10 participants. Each participant
spent four 6‐h nights in the MEG, enabling us to compare nights
within and across participants. Slow waves and sleep spindles were
automatically detected and clustered into contiguous events across
sensors using a nearest‐neighbour algorithm.
Results: The distribution of slow‐wave events across the head
showed a large diversity in their characteristics both in the temporal
(stationary vs. travelling) and in the spatial domain (local vs. global).
Travelling waves wandered for up to ~2s, covering distances of up
to ~40 cm. Slow waves originated uniformly from locations across
the entire head surface and showed little preferred travel directions.
Sleep spindles also showed travelling properties, but to a lesser
extent (up to ~1s and ~15 cm). They had a more local appearance,
but could occur in multiple synchronous but distinct bursts. Spindles
often originated simultaneously in distant, analogous bilateral
regions. Spindles were preferentially detected in clusters of central
and occipital‐parietal sensors.
Conclusions: The higher spatial resolution of MEG in combination
with advanced clustering techniques revealed some unexpected
characteristics of sleep oscillations, in particular their local origination
and the spatial distinctness of simultaneous events. The distinct
characteristics of slow waves and spindles imply divergent physiol-
ogy and might also point to functional differences.
Disclosure: Nothing to disclose.
P034 | Alteration of sleep and wake triggered
by chronic social defeat stress in mice
F. Henderson; V. Vialou; S. El Mestikawy; V. Fabre
Neuroscience Paris Seine, Sorbonne Universités, Paris, France
Objectives/Instruction: Stress plays a key role in the develop-
ment of psychiatric disorders and has a strong impact on sleep. In
mice, chronic social defeat (SD) stress is an ethologically valid model
of stress‐related disorders but little is known about its effects on
sleep regulation.
Aims: Here, we investigate the acute and long term effects of a
chronic SD stress on vigilance states in mice.
Methods: C57Bl/6J mice were implanted with electrodes for poly-
graphic recordings. After 2 weeks of recovery, implanted mice were
subjected to ten consecutive days of SD, during which they were
confronted to an aggressive CD1 mouse. Then, we identified suscep-
tible mice, i.e. mice that develop long‐lasting social avoidance. Sleep‐
wake stages were monitored by polygraphic recordings at baseline,
following each stress session and 5 days after the end of SD proto-
col. Vigilance states, including rapid eye movement (REM) sleep, non
REM (NREM) sleep and wake, and electroencephalogram (EEG)
power density were analyzed. Statistical significance was ascertained
by repeated measures ANOVA.
Results: SD produces biphasic changes in sleep‐wake pattern that
are preserved across the different SD sessions. For several hours
after the SD session, wake is enhanced while REM sleep is strongly
decreased (n = 9, p = 0.0014 and p < 0.0001 respectively). Concomi-
tantly, slow wave activity is increased during NREM sleep (n = 7,
p = 0.001); this might correspond to recovery or consolidation. Then,
SD produces a delayed increase in REM and NREM sleep amounts
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(n = 9, p < 0.0001 and p = 0.0008 respectively). On the 5th day of
recovery following the 10‐day stress, these modifications disappear.
However, reduced delta activity and enhanced power in higher fre-
quency bands emerged within NREM sleep (n = 7, p = 0.0003), a
feature reminiscent of sleep in insomniacs.
Conclusions: Chronic SD stress induces strong adaptations of the
sleep‐wake pattern in mice. Altogether, our study might provide
valuable insights into the pathophysiological mechanisms triggered
by chronic psychological stress.
Disclosure: Nothing to disclose.
P035 | Cold‐Inducible RNA Binding Protein
contributes to quality of waking, REM sleep
homeostasis, and modulates the cortical
molecular response to sleep deprivation
M. Hoekstra; Y. Emmenegger; P. Franken
University of Lausanne, Lausanne, Switzerland
Objectives/Instruction: The sleep‐wake distribution is orches-
trated by interacting homeostatic and circadian processes. Clock‐
genes are involved in sleep homeostasis, as sleep deprivation [SD]
changes clock‐gene expression. How does sleep pressure affect clock
gene expression? We propose a role for Cold‐Inducible RNA Binding
Protein (CIRBP) because (i) its expression is sleep‐wake driven, likely
through sleep‐wake dependent changes in cortical temperature (Tcx),
and (ii) CIRBP is necessary for high‐amplitude clock‐gene expression
in vitro. Therefore, we predict that sleep‐wake dependent changes in
clock‐gene expression are attenuated in CIRBP knock‐out (KO) mice,
thereby altering the sleep homeostat.
Methods: We assessed EEG activity, sleep‐wake distribution, and
locomotor activity in male KO mice (n = 17) and their wild‐type (WT)
(n = 20) littermates, as well as Tcx in a sub‐cohort of the WT mice
(n = 6), during two baseline days [BL], a 6 h SD starting at light onset
(ZT0) and two recovery days. In a separate cohort, cortical gene
expression was quantified at ZT0 and 6 h later with (SD‐ZT6) or with-
out (NSD‐ZT6) sleep deprivation (n = 5 per genotype per condition.
Results: Tcx correlated well with sleep‐wake state (R2=0.76,
p < 0.0001, n = 6, 96 values per mouse) and SD sustained high Tcx
(t(5)=−35.8, p < 0.0001). KO mice were more active (t(31)=−2.56,
p = 0.015), displaying faster theta activity in the EEG during active
waking (t(35)=2.03; p = 0.0506). Furthermore, KO mice demon-
strated an altered sleep‐wake distribution (F(1,34)=6.02, p = 0.0194)
resulting in higher NREM sleep EEG delta power (0.75–4 Hz) (F
(1,34)=4.65, p = 0.038). KO mice recovered less REM sleep after SD
(t(35)=2.99, p = 0.0005). In the cortex, a genotype dependent effect
of SD was demonstrated in the clock genes RevErba and Clock
(p = 0.02 and 0.01, resp.) but not Per2 (p = 0.80).
Conclusions: Our findings confirm that also in the mouse the
sleep‐wake distribution drives changes in Tcx under the conditions
studied. Furthermore, CIRBP contributes to the sleep‐wake distribu-
tion, suppresses activity and accompanying speed of theta activity
during the dark phase, and REM sleep homeostasis. Reverba's
response to SD is amplified by CIRBP, whereas Clock’ response is
attenuated. Overall, the relative contribution of CIRBP to SD‐
induced changes in (clock) gene expression and its interaction with
other sleep‐wake driven pathways remain to be elucidated.
Disclosure: Nothing to disclose.
P036 | Does chronic exposure to
electromagnetic fields combined with noise has
effects on sleep and homeostasis in juvenile
rats?
A. Bosquillon de Jenlis1; F. Del Vecchio2; S. Delanaud1;
V. Bach1; A. Pelletier1
1PeriTox Laboratory, Université de Picardie Jules Verne, Amiens, 2IRBA,
Bretigny sur Orge, France
Objectives/Instruction: The electrosensitive population, estimated
to 1.5 to 5% of Europeans, attributes symptoms (sleep perturbation,
weight lost…) to radiofrequency‐electromagnetic‐fields (RF‐EMF).
The effects of RF‐EMF are controversial maybe because simple
exposure to RF‐EMF would induce non‐significant effects. To verify
this hypothesis, we exposed juvenile rats to RF‐EMF with another
environmental factor frequently encountered in everyday life: noise.
The aim of this study is to see the chronic effects of a low‐level RF‐
EMF exposure combined with a high‐level noise exposure in juvenile
rats on sleep and homeostasis parameters.
Methods: 48 3‐weeks‐old male Wistar rats: 12 controls (noise level
< 65 dB, RF‐EMF < 0.25 V.m−1), 12 RF‐EMF animals (23 h/24,
900 MHz, 1,8 V.m−1 and SAR=0,3 mW.kg−1), 12 Noise animals
(87.5 dB, 50–20.000 Hz, mixing environmental and artificial noises,
12 h/24 during the light‐rest period) and 12 co‐exposed RF‐EMF
Noise animals. After 3 weeks of exposure, rats were surged to dis-
pose polysomnographic telemetric implants (EEGs and EMG) and 24‐
h polysomnography was performed at 5th week of exposure. Food
intake and body weight were recorded. The data were expressed in
Mean±SD. Significance at p < 0.05 (two‐way ANOVA or Mann‐
Whitney according to Normality).
Results: The weight of RF‐EMF or noise animals but not of co‐
exposed animals increased compared to controls (p < 0.05).
Noise animals ate more compared to controls (p < 0.001) and RF‐
EMF animals presented food intake pattern (p < 0.001). Co‐exposed
animals ate more (p < 0.001) even if the number of meals decreased
(p < 0.001).
Noise sleep effects consisted in diminution of Quiet Wakefulness
and NREM episodes (p < 0.05) and increased of mean duration of
NREM episodes (p = 0.058). RF‐EMF decreased frequency and mean
duration of Wake episodes (p = 0.038 and p = 0.044), without modi-
fication of Wake total duration. The mean duration of NREM
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episodes increased only in non‐noise exposed animals (p = 0.048). In
contrast to single exposures, there are no effects of the co‐exposure
on sleep parameters.
Conclusions: Both chronic noise exposure and RF‐EMF exposure
induced modification of sleep microstructure without modification of
sleep macrostructure. Noise exposure induced weight gain associ-
ated with hyperphagia whereas RF‐EMF exposure induced weight
gain with modification of food pattern. the expected synergy effect
was not observed for co‐exposed animals.
Disclosure: Nothing to disclose.
P037 | The dynamic of consciousness loss
when falling asleep
M. Strauss1; F. Raimondo2; J. Sitt2; L. Naccache2;
S. Dehaene1
1Cognitive Neuroimaging Unit, CEA DSV/I2BM, INSERM, Université
Paris‐Sud, Université Paris‐Saclay, NeuroSpin Center, Gif/Yvette, 2Picnic
Lab, Institut du Cerveau et de la Moelle Épinière, INSERM UMRS 975,
Paris, France
Objectives/Introduction: Falling asleep is a dynamical process
lasting several minutes, during which the brain changes from rapid
wakefulness rhythms to slower activities specific to sleep. Yet, the
precise time course of consciousness fading during sleep onset
remains unclear.
We aimed at better define the falling asleep process, analyzing the
precise dynamic of the cognitive and consciousness modifications
that take place during the transition between wakefulness and sleep.
Methods: We presented 31 awake and falling asleep subjects with
the auditory ‘local‐global’ paradigm, a variant of the classical oddball
that enables to dissociate two hierarchical prediction error signals
when detecting auditory novelty: the mismatch negativity (MMN)
and the P300. Subjects were asked to give a motor response to glo-
bal deviant sounds, as soon as they were conscious of, and were
recorded in electro‐ and magneto‐encephalography (MEEG). Only
subjects who did well apply the detection task and who presented
enough sleep onset periods to extract a clear auditory event‐related
field were kept for analysis (N = 14). We analyzed behavioral and
MEEG data using the detailed classification of the falling asleep pro-
cess (Hori et al., 1994), which describes 9 stages from wakefulness
to the occurrence of the first sleep spindle, using epochs of 5 sec.
Results: Behaviourally, response rate decreased and reaction times
increased along sleep onset stages. The MMN progressively
decreased and was not significant anymore from the occurrence of
theta waves. The P300 was present only when subjects were aware
of deviant sounds, almost exclusively before alpha suppression.
Using permutation entropy, we showed that while theta power
increased with sleep onset stages, the information embedded in this
theta decreased, meaning that this theta did not support complex
information usually associated with consciousness.
Conclusions: We showed that the falling asleep process, within the
first stage of sleep (NREM1), embeds multiple cognitive and conscious
states. Subjects are mostly conscious (motor responses, P300) and
keep predictive coding capabilities (MMN and P300) before the occur-
rence of theta waves. After that, most of the subjects are unconscious
(no behavior, no P300, decreased entropy) and may detect auditory
novelty only through bottom‐up sensory adaptation mechanisms.
Disclosure: Nothing to disclose.
P038 | Effects of selective silencing of layer 5
pyramidal neurons on sleep‐wake distribution
and local cortical EEG activity
L. Krone1,2; T. Yamagata2; A. Hoerder-Suabedissen1;
Z. Molnár1; V. Vyazovskiy1,2
1Department of Physiology, Anatomy and Genetics, 2Sleep and
Circadian Neuroscience Institute, University of Oxford, Oxford, United
Kingdom
Objectives/Introduction: Layer 5 pyramidal neurons are a key
population in the generation and propagation of cortical slow oscilla-
tions. Slow oscillations represent an electroencephalographic hall-
mark of non‐rapid eye movement (NREM) sleep, might be
functionally relevant for neuronal recovery during sleep, and their
spectral power (slow wave activity, SWA) is a marker of sleep pres-
sure. Considering the relevance of layer 5 pyramidal neurons for
slow oscillations, we postulate that this cell population is additionally
involved in the initiation and maintenance of slow wave sleep.
Specifically, we hypothesise that chronic silencing of layer 5 pyrami-
dal neurons affects sleep‐wake regulation and the homeostatic
response to sleep deprivation.
Methods: We investigated a transgenic mouse model in which
~15–30% of pyramidal cells in layer 5 are functionally silenced by
removal of the t‐SNARE protein SNAP25 (Rbp4‐Cre; Ai14; Snap25fl/fl).
Male adult mice (10–17 weeks, four homozygous, one heterozygous
and one wild type control) were housed on a 12 h/12 h light/dark
cycle. We recorded frontal and occipital EEG as well as local field
potentials (LFPs) and neuronal activity in the primary motor cortex
with a 16‐channel laminar probe. On one occasion, 6 h sleep depriva-
tion (SD) was performed starting at light onset.
Results: During the light period, all animals demonstrated a similar
distribution of vigilance states regardless of genotype (13.8–
20.4 min/h awake, 32.0–36.4 min/h NREM, 4.9–7.6 min/h rapid eye
movement (REM) sleep). During the dark period, layer 5 silenced ani-
mals showed extensive wakefulness (48.9 and 56.3 min/h awake)
whereas the heterozygous control was awake for 40.0 min/h and the
wild type control for 31.3 min/h. In response to sleep deprivation
transgenic mice had a numerically lower increase of SWA relative to
individual baseline averages compared to control animals. Transgen-
ics also presented recurrent episodes of behavioural arrest accompa-
nied by high‐voltage spindles during waking and REM sleep.
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Conclusions: We tentatively interpret this data as preliminary evi-
dence for altered sleep regulation by disruption of layer 5 pyramidal
cell function. We postulate that this neuronal population might rep-
resent a core element in a circuit, which tracks the homeostatic cor-
tical need for sleep and translates it into sleep pressure.
Disclosure: Nothing to disclose.
P039 | Sleep and cardio‐metabolic risk in
regional dwelling individuals
S. Yiallourou1; P. Zimmet2; M. Carrington1
1Baker Heart and Diabetes Institute, 2Monash University, Melbourne,
VIC, Australia
Objectives/Instruction: In Australia, individuals living in regional
communities (areas that lie beyond the major capital cities) have a
higher prevalence of chronic disease risk factors compared to those
living in urban communities. Poor sleep is thought to negatively
impact cardio‐metabolic risk factors, however sleep is not a well
acknowledged modifiable lifestyle factor for risk prevention. Accord-
ingly, in an effort to determine the association between sleep and
cardio‐metabolic risk, we aimed to assess the effects of sleep, physi-
cal activity and diet on cardio‐metabolic risk measures (i.e, blood
pressure, body weight and blood lipid and glucose levels) in regional
dwelling adults.
Methods: In 204 adults (76M/128F, aged 58 ± 8 years), screened
for high cardio‐metabolic risk, 7 day actigraphy was performed.
Mean values for WASO (min), TST (min), SE (%) were assessed and
percentage of time spent in levels of physical activity (light and mod-
erate‐vigorous) were calculated. To assess cardio‐metabolic profile,
HbA1c, total, low density and high density lipoprotein cholesterol
and triglyceride levels were measured using blood collected via fin-
ger prick (Alere Afinion™). Standard anthropometric measurements
were recorded as well as blood pressure (Omron™). Diet was
assessed using the Dietary Questionnaire for Epidemiological Studies
(DQES v2) and macro/miro‐nutrient intake examined. Multiple step-
wise linear regression was performed to determine predictors (sleep,
diet and physical activity measures) of cardio‐metabolic risk factors.
Data were adjusted for gender, age, smoking status and family his-
tory of cardiovascular disease and diabetes. Level of significance was
p < 0.05. Data are presented as mean±SD.
Results: Of a sample size of 204, average TST was 897 min/night ±
50 min, SE 97% ± 2%, WASO 12 ± 9 min. Body weight was inde-
pendently associated with SE (β=‐1.93, p = 0.003), monounsaturated
fat intake (β=2.3, p = 0.005), moderate‐and vigorous physical activity
(β=‐1.5, p = 0.008) and TST (β=‐0.47, p = 0.049); (r2=0.24, p > 001).
Diastolic blood pressure was predicted by SE (β = ‐0.86, p = 0.02)
(r2=0.05, p = 0.005). No other risk factors were independently asso-
ciated with sleep, physical activity or diet.
Conclusions: People with poorer lifestyle behaviours and worse
sleep quality are more likely to have elevated risk factors,
highlighting the need for improvement of sleep and diet and lifestyle
modification for prevention of cardio‐metabolic disease.
Disclosure: Nothing to disclose.
P040 | Hypocretin in footshock stimulation‐
induced REM sleep suppression
P.-L. Yi1; Y. Lo2; F.-C. Chang2
1Department of Sport Management, Aletheia University, New Taipei
City, 2Department of Veterinary Medicine, National Taiwan University,
Taipei, Taiwan
Objectives/Introduction: To elucidate the involvement of
hypocretin (hcrt), projected from the lateral hypothalamic area (LHA)
to locus coeruleus (LC) and dorsal raphe nucleus (DRN), in sleep
alterations when rats received an inescapable footshock stimulation
(IFS).
Methods: Male Sprague‐Dawley rats (250–300 g; BioLASCO, Tai-
wan) were used in present study. The IFS consisted of twelve times
of electrical stimuli (5.0 mA, 133 V, and 50 ms of duration for each
stimulation), which were randomly given within 10‐min period at the
beginning of the light period. The sleep‐wake activity was recorded
for 24 hours. To clarify the involvement of hcrt in stress‐induced
sleep alterations, a high dose (2.5 μg) and a low dose (1.25 μg) of
hypocretin receptor (hcrtR) antagonist, TCS‐1102, were directly
microinjected into the DRN and LC. In the other groups of rats, the
brain tissues were collected at three different zeitgeber times (ZT),
ZT0, ZT1, and ZT2 after rats received the IFS, and the expression of
prepro hypocretin (prepro‐hcrt), hypocretin 1 (hcrt‐1), and c‐fos at
LHA were determined after the IFS.
Results: The IFS suppressed rapid eye movement (REM) sleep dur-
ing the first 6 hours of the light period; however, a compensatory
REM sleep enhancement appeared during the subsequent dark per-
iod. Administration of hcrtR antagonist TCS‐1102 into the LC and
DRN blocked the IFS‐induced REM sleep alterations. Immunoreac-
tive cells of prepro‐hcrt and hcrt‐1 were increased in the LHA after
the IFS. Cells expressing both prepro‐hcrt and hcrt‐1 were increased
from 12,003 to 13,640 at ZT0; from 11,049 to 11,932 at ZT1; and
from 12,929 to 16,323 at ZT2. We also found that the IFS increased
c‐fos expression in the LHA; however, there are more c‐fos express-
ing neurons beyond the hcrt‐1 expressing neurons.
Conclusions: Our results indicate that the IFS activated the neu-
rons in the LHA, increased the expression of prepro‐hcrt, and
increased the cleavage of prepro‐hcrt to hcrt‐1. The IFS suppressed
REM sleep and this REM sleep suppression was blocked when hcrtR
antagonist was administered into the LC or DRN, suggesting the
involvement of hcrt projections from LHA to LC and DRN in the
stress‐induced REM suppression.
Disclosure: Nothing to disclos.
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P041 | Analysis of day and night‐time stress
markers after sleeping with nocturnal traffic
noise
L. Thiesse1; F. Rudzik1; R. Pieren2; J.M. Wunderli2;
K. Spiegel3; R. Leproult4; M. Brink5; N. Probst-Hensch6;
M. Röösli6; C. Cajochen1
1Centre for Chronobiology, Psychiatric Hospital of the University of
Basel, Basel, 2Empa‐ Swiss Federal Laboratories for Materials Science
and Technology, Duebendorf, Switzerland, 3WAKING Team, Lyon
Neuroscience Research Center (CRNL) ‐ INSERM U 1028, CNRS UMR
5292, University Claude Bernard Lyon 1, Lyon, France, 4Université Libre
de Bruxelles (ULB), Bruxelles, Belgium, 5Swiss Federal Office for the
Environment, Bern, 6Swiss Tropical and Public Health Institute, Basel,
Switzerland
Objectives/Introduction: Exposure to traffic noise is associated
with increased stress markers which on the long term can lead to
cardiovascular diseases. Traffic noise at night is also known to impair
sleep, a vital function that helps to regulate the stress pathways.
However, the importance of sleep in this association remains to be
investigated.
Methods: Eighteen young volunteers (age: 19‐33 y) participated in
a laboratory study starting with a noise‐free baseline night (BL) fol-
lowed with four randomly presented noise scenarios: a 4‐lane high-
way (scenario_A), a 2‐lane country road (scenario_B), a 1‐lane urban
road (scenario_C), and a railway noise situation (scenario_D). All
noise scenarios had an hourly Leq of 45 dB(A) at the ear of the slee-
per and differed according to intermittency ratio (IR), an acoustical
descriptor for the eventfulness of noise exposure. Salivary cortisol
was sampled at regular interval throughout the day and urinary cate-
cholamine (adrenaline and noradrenaline) was collected during the
night. Sleep was recorded by polysomnography and subjective sleep
quality was assessed each morning with the LEEDS questionnaire.
Results: Morning cortisol tended to increase after sleeping with a
high intermittent road noise (scenario_C: IR=0.8) compared to BL
(p = 0.1) and the railway noise (scenario_D: IR=0.9, p = 0.08),
whereas no differences were reported with scenario_A (IR=0.3) and
scenario_B (IR=0.7) (F4,64=2.35, p = 0.06). Evening cortisol increased
after sleeping with scenario_C compared to BL (p = 0.03) and sce-
nario_D (p = 0.02); here also no differences were seen compared to
scenario_A and scenario_B (F4,68=3.16, p = 0.02). Nocturnal cate-
cholamine levels did not significantly change in presence of traffic
noise. None of the objective and subjective all‐night sleep variables
differed significantly between the noise scenarios.
Conclusions: These preliminary results suggest that at a same
LAeq and a similar IR, road traffic noise is more stressful (higher cor-
tisol secretion) than railway noise. However, nocturnal catecholamine
levels, another stress marker, did not differ in presence of nocturnal
traffic noise with an hourly Leq of 45 dB(A). Moreover, we did not
observe significant changes in sleep variables between the different
traffic noise scenarios, suggesting that sleep alterations were not
involved in the detrimental effect of traffic noise on cortisol levels.
Disclosure: Nothing to disclose.
P042 | Subjective sleepiness: its relationship to
actual sleep tendency and neurophysiological
changes
M. Matsuo; Y. Sumi; H. Kadotani
Shiga University of Medical Science, Otsu, Japan
Objectives/Introduction: Although subjective sleepiness is a pri-
mary complainant in sleep disorders and a major treatment outcome,
it is not well studied how these subjective experiences are correlated
to physiological consequence. In addition, the mechanism how such
subjective experiences are intervened is poorly understood. To phys-
iologically examine the actual consequences of subjective sleepiness,
we conducted a survey and additional neurophysiological measure-
ments, during multiple sleep latency test (MSLT) and polysomonogra-
phy (PSG) at preceding night.
Methods: Nineteen male and 11 female with average age of
29.47 ± 11.63 (mean ± standard deviation) years old were partici-
pated in this study. They were asked to participated to conduct
tasks and fulfill the questionnaire just before the PSG and every
MSLT sessions, as following:
To record subjective sleepiness, we used two independent scale;
Stanford Sleep Scale (SSS) and Visual Analogue Scale (VAS). Along
with the questionnaire, subjects were asked to participate in a
~20 min of attention required task, during which electro‐encephalo-
graphy (EEG) was recorded. The task was attention network test,
which requires continuous attention so that participants response
quickly and correctly to the presented stimuli. The spectral analysis
of the EEG was conducted to obtain alpha, beta, and theta activity
power.
Results: To examine the validity of ‘subjective sleepiness’, correla-
tion between VAS and SSS were analyzed. As expected, VAS scores
and SSS scores were significantly correlated on every occasion
including PSG, MSLT‐Nap1, MSLT‐Nap2, MSLT‐Nap3 and MSLT‐
Nap4 (linear fit model; R2= 0.66, 0.46, 0.72, 0.30, 0.24 respectively,
with p < 0.01 in all occasions). However, both measures were not
correlated with sleep latencies in any occasions (p > 0.05). Correla-
tion analysis between EEG activity with VAS or sleep latency
showed similar results, with no significant correlation in most cases.
In some occasions, such as beta activity at MSLT‐Nap3 and Nap4
showed significant correlation with sleep latencies, although the lin-
ear fitting was not clear (R2=0.39 and 0.16, respectively).
Conclusions: Current study showed elusive nature of subjective
sleepiness. However, significant correlations in some occasions, such
as between beta activity and sleep latency in afternoon, could be a
result of time dependent correlations.
Disclosure: This study protocol was approved by the ethics com-
mittee of the Shiga University of Medical Science. There are no con-
flicts of interest. This study was supported by JSPS KAKENHI Grant
Numbers 17H00872 and 15K16565.
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P043 | Japanese sake yeast improves human
sleep quality and daytime fatigue: a double‐blind
randomised placebo‐controlled clinical trial
Y. Nagamori1; K. Hirao1; K. Oka1; N. Monoi1; Y. Urade2
1Lion Corp, Odawara, 2WPI‐IIIS, University of Tsukuba, Tsukuba, Japan
Objectives/Instruction: We have shown that Japanese sake yeast
ingestion enhances human slow wave sleep and improves sleep qual-
ity via Adenosine A2a receptors (Monoi N. et al. J Sleep Res. 2016.
Nakamura Y. et al., J Sleep Res. 2016). Although, sleep quality is clo-
sely associated with daytime feelings, it remains unclear whether this
sake yeast‐mediated sleep improvement ameliorates daytime feel-
ings. In this study, we investigated whether sake yeast intake
improves daytime fatigue and vitality.
Methods: In a double‐blind, placebo‐controlled cross‐over clinical
study, 36 healthy adults with low sleep quality were selected by the
Pittsburgh Sleep Quality Index score, which is equal to or higher
than 5 points. They were instructed to ingest tablets containing
300 mg of sake yeast or placebo tablets an hour before going to
bed for 4 days. The effects of Japanese sake yeast were evaluated
using a visual analog scale for daytime fatigue, SF‐8 health survey
for vitality and a subjective sleep quality questionnaire (MA version
of the Oguri‐Shirakawa‐Azumi sleep questionnaire). The effects of
Japanese sake yeast and placebo were compared by Student's paired
t‐test. Correlations between fatigue, vitality and sleep quality were
analysed by Pearson's correlation analysis.
Results: Compared with placebo, daytime fatigue (n = 35, p < 0.01)
and vitality (n = 35, p < 0.05) were significantly improved by sake
yeast ingestion. In a sleep quality questionnaire, sleepiness (n = 35,
p < 0.05) and fatigue (n = 35, p < 0.05) in the morning were also
improved. Correlation analyses showed amount of improvement in
daytime fatigue or vitality and subjective sleep quality were signifi-
cantly correlated (n = 35, p < 0.05).
Conclusions: Sleep improvement mediated by Japanese sake yeast
intake improves daytime subjective fatigue and increases vitality.
Disclosure: Nothing to disclose.
P044 | Effects of Japanese sake yeast
supplementation on human skin quality and
analysis of its mechanism
K. Oka1; T. Sano1; Y. Nakamura1,2; Y. Nagamori1; N. Monoi1;
A. Uchiyama1; Y. Urade2
1Lion Corp, Tokyo, 2WPI‐IIIS Univ. of Tsukuba, Ibaraki, Japan
Objectives/Instruction: We have demonstrated that Japanese
sake yeast enhances slow‐wave sleep and increases amount of
growth hormone secretion during sleep (Monoi N, et al. J Sleep Res.
2016). Recent studies suggest that insomnia exacerbates skin condi-
tion, and GH increases the skin thickness and elasticity. We
hypothesized that improvement of sleep quality and up‐regulation of
GH secretion by Japanese sake yeast ameliorate skin condition.
Thus, in the present study, we examined the effects of Japanese
sake yeast on skin quality and analysed the mechanism involved in
the skin quality improvement.
Methods: 1) Clinical trial: We performed a double‐blind placebo‐
controlled parallel‐group comparison study. Twenty participants
[twelve males and eight females; age, 34.5 ± 9.1 years, Pittsburgh
Sleep Quality Index ≥ 5] intaked tablets containing 300 mg of Japa-
nese sake yeast or placebo tablets an hour before bedtime for
5 weeks. We evaluated the subjective sleep quality and the skin
elasticity and collagen density in the cheeks using the Oguri‐Shira-
kawa‐Azumi sleep questionnaire and cutometer and ultrasonic imag-
ing, respectively.
2) In vitro study: Human dermal fibroblasts were treated with GH or
insulin like growth factor (IGF‐1; GH‐dependent secreted hormone)
for 24‐48 h. After the treatment, cells and culture supernatant were
harvested for RNA and protein analysis. We measured the skin elas-
ticity‐related factors using quantitative real‐time reverse transcription
PCR and enzyme‐linked immunosorbent assay.
Results: 1) Clinical trial: Japanese sake yeast increased the skin
elasticity and the density of collagen in the cheeks and reduced
sleepiness in the morning compared with placebo (student t‐test,
p < 0.05).
2) In vitro study: GH and IGF‐1 treatment upregulated gene expres-
sion of HAS‐2, whereas IGF‐1 treatment upregulated gene expres-
sion of COL1A1, COL3A1 and downregulated gene expression of
MMPs (student t‐test, p < 0.05). IGF‐1 also augmented the amount
of type I collagen protein and attenuated the amount of MMP‐1 pro-
tein in the culture supernatant (student t‐test, p < 0.05).
Conclusions: Japanese sake yeast enhances skin elasticity as well
as improves sleep quality in humans, and GH and IGF‐1 promote
skin elasticity by regulating the production of factor for skin elastic-
ity in vitro.
Disclosure: Nothing to disclose.
P045 | The role of self‐reported feelings of
getting sufficient rest on the relationship
between quick returns and health complaints
A. Harris1; S. Pallesen1,2; S. Waage2,3; B. Bjorvatn2,3;
Ø. vedaa1,4
1Faculty of Psychology, Department of Psychosocial Science, University
of Bergen, 2Norwegian Competence Center for Sleep Disorders,
Haukeland University Hospital, 3Faculty of Medicine, Department of
Global Public Health and Primary Care, University of Bergen,
4Helsefremmende Arbied, Folkehelseinstituttet, Bergen, Norway
Objectives/Instruction: Research has showed an association
between quick returns (QRs: < 11 hours of rest between two shifts)
and negative health outcomes like shortened sleep, and sick leave.
However, not all workers report negative consequences of QRs. We
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examined if subjective reports of getting sufficient rest between
shifts could moderate the association between exposure to numbers
of QRs over 12 months on subjectively reported health complaints
(SHC) the following month.
Methods: Health care workers (n = 937) completed a questionnaire
about relevant background variables, prevalence of SHC, and a ques-
tion about feelings of sufficient rest; “How often do you get insuffi-
cient rest between two shifts”, answered on a five‐point scale
ranging from almost never to very often”. This information was
linked to objective records of shift work exposure retrieved from the
employers’ record. The PROCESS macro SPSS supplement was used
to analyze whether sufficient rest moderated the prospective rela-
tionship between exposure to QRs and SHC. Age, shift work experi-
ence, diurnal preferences, languidity and flexibility were included as
control variables in the analyses.
Results: The QRs‐SHC relationship was moderated by subjective
reports of getting sufficient rest between shifts. The model explained
18.6% of the variance in SHC, (F (11, 852) 17.99, p < 0.001). The QRs‐
SHC relationship was only significant for those answering “almost
never”/”seldom” on obtaining insufficient rest (B = ‐0.07, SE=0.03,
t = ‐2.81, p ≤ 0.01), as opposed to those who answered “sometimes”
(B = ‐0.03, SE=0.02, t = 1.61, p = 0.11) or “often”/”very often”
(B = 0.05, SE=0.03, t = 1.59, p = 0.11). These results may suggest a
protective effect of having a higher number of QRs for some workers.
Conclusions: A single question about getting sufficient rest
between shifts may contribute in identifying workers who have ben-
eficial effects of a work plan that includes a higher number of QRs.
We propose such questions should be asked more routinely and
taken into consideration in the planning of work schedules.
Disclosure: Nothing to disclose.
P046 | Abrupt shift to slower frequencies after
arousal in healthy young adults during sleep
Y. Suzuki1; F. Kawana1,2; Y. Hirozane3; S. Zhang3; H. Osumi3;
I. Park1; T. Abe1; K. Tokuyama3; M. Satoh1
1IIIS, University of Tsukuba, Tsukuba, 2Juntendo University, Bunkyoku,
3University of Tsukuba, Tsukuba, Japan
Objectives/Introduction: The American Academy of Sleep Medi-
cine criteria for scoring arousal are used to quantify certain types of
sleep disturbances that abrupt shifts in electroencephalographic
activity can occur in the alpha and theta bands, and frequencies
above 16 Hz (without spindles), however, they do not address atypi-
cal arousals. Younger patients with obstructive sleep and disordered
breathing often exhibit abrupt shifts to slower frequencies in arou-
sal‐related responses, appearing as slow wave clusters. Here, we
observed arousal responses with slow wave bursts in healthy young
adults, examining the prevalence of atypical arousal responses.
Methods: Eleven healthy young adults underwent polysomnogra-
phy (two females, 22.4 ± 2.8 years [mean ± standard deviation]).
Written informed consent was obtained from all subjects. The Regis-
tered Polysomnographic Technologist and a technologist counted
the number of participants showing arousal responses shifting to a
slower frequency for between several and several tens of seconds
(post arousal synchronous activity). We counted the number of post
arousal synchronous events per night. We examined the sleep stage
and number of sleep cycles in which post arousal synchronous activ-
ity appeared, and whether post arousal synchronous activity
occurred in the former or latter stage of sleep, which was divided
into two total sleep periods. We conducted chi‐square tests. We
used an alpha level of 0.05.
Results: All subjects exhibited post arousal synchronous activity
(5.5 ± 6.0 times per night). Post arousal synchronous activity
appeared most frequently during N2, followed by N1 and N3. Post
arousal delta bursts increased significantly in sleep stage N2 com-
pared with N3 (p = 0.004, w = 0.44). Post arousal synchronous activ-
ity was significantly intensified in the former compared with the
latter sleep period (p = 0.01, w = 0.40), and was augmented in the
first sleep cycle.
Conclusions: Post arousal synchronous activity is relatively com-
mon in healthy young subjects. Post arousal synchronous activity dif-
fers from the smooth arousal reactions associated with normal
arousal. We found that post arousal synchronous activity increased
in light sleep, former sleep and the first sleep cycle, which contained
a high degree of slow wave sleep. In future studies, we will examine
the propagation of post arousal delta bursts in children and elderly
people.
Disclosure: Nothing to disclose.
P047 | Red ears while sleepy: relation between
ear skin temperature and sleepiness
M. Schinkelshoek1,2; K. de Wit3; I. Smolders1; E. Bakker1;
V. Hoogslag1; M. Tannemaat1,3; R. Fronczek1,2;
G.J. Lammers1,2
1Neurology, Leiden University Medical Center, Leiden, 2Sleep‐Wake
Centre, Stichting Epilepsie Instellingen Nederland, Heemstede, 3Clinical
Neurophysiology, Leiden University Medical Center, Leiden, The
Netherlands
Objectives/Introduction: Red ears in sleepy children is a com-
monly described phenomenon. This ear discolouration could repre-
sent increased blood flow in the skin of the ear, consistent with an
increased distal skin temperature observed before sleep onset in
adults. We hypothesise that ear skin temperature is associated with
objective and subjective sleepiness in subjects without sleeping dis-
orders.
Methods: Distal, proximal and ear skin temperature were measured
in two groups of patients undergoing diagnostic EEG examination
for suspected epilepsy: one group was sleep‐deprived (n = 7), one
group was not (n = 20). Prior to, during and after the EEG examina-
tion, ear skin temperature was measured using different methods:
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thermographic imaging, ear surface and wireless skin temperature
measurement. Objective and subjective sleepiness were assessed by
sleep‐onset latency during the EEG examination and the Stanford
Sleepiness Scale, respectively.
Results: We found no association between pre‐ and post‐EEG ear
skin temperature and either objective (Spearman's ρ = 0.036;
p = 0.885) or subjective sleepiness (Spearman's ρ = 0.218;
p = 0.285). However, the sleep‐deprived group showed a trend of a
stronger increase in ear skin temperature during the EEG examina-
tion compared with the group that was not sleep‐deprived
(1.89 ± 0.84°C vs. 0.48 ± 0.33°C; p = 0.067). Higher objective
(1.93 ± 0.71°C vs. 0.39 ± 0.34°C; p = 0.035) and subjective
(1.27 ± 0.39°C vs. ‐0.16 ± 0.55°C; p = 0.051) sleepiness were both
associated with an increase in ear skin temperature during EEG
examination.
Conclusions: Objective and subjective sleepiness are associated
with an increase in ear skin temperature during EEG examination in
patients without sleeping disorders. This may reflect ear skin temper-
ature changes preceding sleep onset. Intervention studies are
needed to elucidate the relationship between sleepiness and ear skin
temperature and explain the physiological mechanism behind sleepy
children's red ears.
Disclosure: Nothing to disclose.
CHRONOBIOLOGY 1
P049 | Later chronotype associates with higher
alcohol consumption and more adverse
childhood experiences in young healthy women
E. Hug1; K. Winzeler2; M.C. Pfaltz3; C. Cajochen4; K. Bader1
1Centre for Specific Psychotherapy, CBT Unit, 2Psychiatric Hospital of
the University of Basel, Basel, 3Department of Consultation‐Liaison
Psychiatry and Psychosomatic Medicine, University Hospital Zurich,
Zurich, 4Centre for Chronobiology, Psychiatric Hospital of the University
of Basel, Basel, Switzerland
Objectives/Instruction: This study aimed at examining potential
associations between self‐selected sleep timing and stimulant use,
depressive symptoms, and BMI in a sample of healthy young
women. Furthermore, it was explored whether there is a relationship
between sleep‐wake‐behaviour as indexed by chronotype and social
jetlag and adverse childhood experiences (ACEs).
Methods: 146 healthy young women (mean age 21.7 ± 1.7 years)
took part in a 2‐week ambulatory assessment on daily consumption
of alcohol and caffeine. They completed standardized questionnaires
on ACEs, chronotype, subjective sleep quality as well as symptoms
of depression. Two‐tailed Pearson correlations and Chi‐Square tests
of independence were calculated to assess the relationships between
the assessed variables.
Results: Later chronotype and higher social jetlag were both associ-
ated with higher average alcohol intake (r = 0.226, p = 0.006;
r = 0.216, p = 0.009). No correlations were observed between
chronotype or social jetlag and caffeine intake, depressive symptoms,
and BMI. Participants of the above median ACE group were more
likely to be late chronotypes compared to participants of the below
median ACE group (X2 (2) = 6.595, p = 0.037).
Conclusions: Our findings are of clinical relevance since they show
that in a sample of healthy, young women an association between
late chronotype and higher alcohol consumption is evident. Further-
more, they suggest a relationship between environmental factors,
namely ACEs, and chronotype. Therefore, considering self‐selected
sleep timing as one factor in reducing the risk of health conse-
quences in later chronotypes is important.
Disclosure: Nothing to disclose.
P050 | Evening light exposure, sleepiness,
sleep timing and duration in college students: an
ecological investigation
T. Shochat1; N. Santhi2; P. Herer1; D.-J. Dijk2
1Cheryl Spencer Department of Nursing, University of Haifa, Haifa,
Israel, 2Surrey Sleep Research Center, University of Surrey, Guildford,
United Kingdom
Objectives/Instruction: Laboratory studies have shown that eve-
ning light exposure (ELE) suppresses evening sleepiness and delays
sleep timing; whereas field studies have demonstrated that later
bedtime is associated with lower and later daytime light exposure.
Associations between ELE, evening sleepiness, sleep timing and
duration have scarcely been assessed in the ecological setting, and
are the focus of this study. Specifically we examined in undergradu-
ate students: (1) Repeated assessments of ELE and sleepiness 4‐h
before bedtime, comparing individuals with early, intermediate and
late bedtimes; (2) Associations between magnitudes of changes in
ELE and evening sleepiness and subsequent sleep timing and dura-
tion.
Methods: Twenty three healthy men and women ages 18‐21 were
recruited by advertisements. Data of nineteen students who com-
pleted the protocol were used for analysis. The within‐subjects
repeated measures study took place in early winter (November ‐
December, standard time) and in spring (April‐May, summer time).
Each assessment period included 3 weeks of actigraphy monitoring
(Actiwatch, CamNtech Ltd) of activity and light illuminance (lux), half
hourly ratings of sleepiness (Karolinska Sleepiness Scale ‐ KSS) 4‐h
before bedtime, and sleep timing and duration, derived from sleep
diaries and actigraphy. Differences in bedtime were categorically
divided by tertiles (BTcat) as early, intermediate and late. Mixed
model analyses were performed for ELE and evening sleepiness by
BTcat, and for sleep measures by changes in ELE and sleepiness
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(computed as differences between levels on first and last 4‐h record-
ings), controlling for season and day type (weekday/weekend).
Results: Over the 4‐h before bedtime, ELE decreased and evening
sleepiness (KSS) increased, with a less steep ELE decline for late
compared to early (F(2,5765)=20.09, p < 0.001), and a less steep KSS
increase for late compared to early and intermediate (F(2,5855)=54.32,
p < 0.001) BTcat. Steeper decrease in ELE was associated with ear-
lier bedtime (F(1,585)=4.94, p = 0.027). Steeper increase in KSS was
associated with earlier bedtime (F(1,585)=37.43, p < 0.001) and longer
sleep duration (F(1,569)=12.25, p < 0.001).
Conclusions: The data suggest that differences in bedtime are
associated with differences in the time courses of both evening light
exposure and sleepiness.
Disclosure: Nothing to disclose.
P052 | Association between social jetlag and
eating duration in Brazilian undergraduate
students
G. Teixeira; M.C. Mota; C. Crispim
Federal University of Uberlândia, Uberlândia, Brazil
Objectives/Introduction: Current studies have demonstrated that
social jetlag ‐ a behavioral indicator of circadian misalignment ‐ may
influence eating behavior of individuals, predisposing to obesity, type
2 diabetes and depressive symptoms. Additionally, recent studies
have demonstrated that restricting the time of caloric intake to a
window of 8‐12 hours ‐ without modifying the quantity or quality of
diet ‐ can provide physiological benefits. However, the relationship
between social jetlag and eating duration ‐ defined as the interval
between first meal and last meal in the waking period ‐ is little
explored by studies. Therefore, the aim of this study was to investi-
gate the association between social jetlag and eating duration in
undergraduate students.
Methods: The study included 721 undergraduate students from a
Brazilian public university. Dietary intake and meal times were
assessed by a 24‐hour food recall. Social jetlag was calculated based
on the absolute difference between mid‐sleep time on weekdays
and weekends. Multiple linear regression modeling analyses adjusted
for confounders were used to assess the association between social
jetlag and eating duration.
Results: Eating duration were negatively associated with the break-
fast time (coefficient=‐0.33; p =< 0.001) and lunch time (coeffi-
cient=‐0.10; p =< 0.001); and positively associated with dinner time
(coefficient=0.27; p < 0.001). Also, social jetlag was positive associ-
ated with eating duration (coefficient=0.08; p = 0.03).
Conclusions: Our results suggest a greater “window to eat” among
individuals with higher levels of social jetlag. These data join the
emerging body of evidence they suggest individuals with circadian
misalignment are prone to food consumption at an inappropriate cir-
cadian time. Future studies are needed to confirm these findings.
Disclosure: Nothing to disclose.
P053 | Circadian regulation of breath alcohol
concentration
A. Jos; S.C. Yeo; A.V. Rukmini; J. Gooley
Centre for Cognitive Neuroscience, Neuroscience and Behavioural
Disorders Programme, Duke-NUS Medical School, Singapore, Singapore
Objectives/Instruction: The circadian system plays an important
role in drug metabolism. Previous studies have shown that alcohol
toxicity and liver enzymes involved in alcohol metabolism are circa-
dian‐regulated. Here, our goal was to evaluate the degree to which
the circadian system regulates breath alcohol responses in humans.
Methods: Twenty healthy adults aged 21‐30 years took part in a
4‐day laboratory study. Participants underwent a 40‐h constant rou-
tine procedure to assess circadian rhythms. Every 4 h, participants
were given a fixed oral dose of alcohol, calculated to result in a peak
breath alcohol concentration (BrAC) of 0.030 g/210L based on each
person's estimated total body water volume. Breathalyzer measure-
ments were taken every 5 min to assess the time‐course of BrAC
across different circadian phases. We determined the peak BrAC for
each oral dose of alcohol, and cosinor analysis was performed to
examine group‐level circadian rhythmicity.
Results: Peak BrAC values exhibited a circadian rhythm (Cosinor
amplitude, p < 0.05), in which the range of values across the circa-
dian cycle varied by about 10% relative to the mean. Peak BrAC val-
ues were lowest in the biological evening, near the peak of the core
body temperature rhythm and the nadir of the salivary cortisol
rhythm. Peak BrAC values increased during the biological night and
reached their highest levels near the middle of the biological day.
Conclusions: The circadian system modulates physiologic
responses to alcohol. Taking the same oral dose of alcohol at differ-
ent points of the circadian cycle can result in different BrAC
responses. The increase in peak BrAC during the biological night
could have implications for alcohol‐induced impairment of driving
performance, as well as alcohol toxicity.
Disclosure: This work was supported by the Ministry of Education,
Singapore (MOE2015‐T2‐2‐077), and the Defence Science & Tech-
nology Agency, Singapore (PA/9016104043).
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P054 | Dynamics of daytime light exposure in
a naturalistic setting impacts on sleep
architecture
C. Nowozin1,2; A. Wahnschaffe1,2; J. de Zeeuw1;
A. Papakonstaninou1,2; F. Bes1,2; M. Münch1,2,3; D. Kunz1,2
1Institute of Physiology, Sleep Research & Clinical Chronobiology,
Charité ‐ Universitätsmedizin Berlin, Corporate Member of Freie
Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of
Health, 2Clinic for Sleep and Chronomedicine, St. Hedwig Hospital,
3Institute of Medical Immunology, Charité ‐ Universitätsmedizin Berlin,
Corporate Member of Freie Universität Berlin, Humboldt‐Universität zu
Berlin, and Berlin Institute of Health, Berlin, Germany
Objectives/Introduction: While rapid eye movement (REM) sleep
is predominantly circadian driven, slow wave sleep (SWS) is homeo-
statically driven. There is also evidence that light during daytime has
an impact on subsequent sleep. A recent study by Wams et al. in
2017 found an association between the timing and amount of (natu-
ral) light exposure during daytime, REM sleep and SWS accumulation
during ambulatory polysomnographically (PSG) recorded sleep epi-
sodes. The aim of the current evaluation was to replicate and
expand these findings using the data from an older study performed
in a semi‐natural setting.
Methods: Eleven healthy adults participated in the study 2008.
Individual illuminance was continuously recorded at the eye level
between 8am and 7 pm (Luxblick, TU Ilmenau, Prof. C. Schierz). Four
hours before habitual bedtime participants came to the laboratory
and remained in dim light (< 5 lx). Their sleep episode was recorded
with PSG. All PSG recordings (available from 9 participants) were
visually scored according to standard criteria and illuminance record-
ings were collapsed into hourly bins. For analysis non‐parametric
tests were applied.
Results: Participants spent 59% of their days with illuminance
levels lower than 50 lx and 90% below 200 lx. Participants had more
SWS during the night when they had a later time of maximum light
exposure (min; Rho=0.733; p = 0.025) and were exposed to more
light between 2 and 3 pm (Rho= 0.70; p = 0.036). Accordingly, a
later maximum light exposure was associated with less stage 2 sleep
(min; Rho=‐0.683; p = 0.042). The fitted slopes from accumulated
SWS were significantly steeper and associated with higher illumi-
nance between 4 and 5 pm (Rho=0.683; p = 0.042). Regarding REM
sleep accumulation, less steep slopes were associated with greater
illuminance between 11 and ‐12 am (Rho=0.683, p = 0.042). Finally,
longer REM sleep latency was significantly related to higher illumi-
nance levels between 11 and 12 am (Rho =. 90; p = 0.001). Shorter
REM sleep latency was associated with more light between 4 and
5 pm (Rho=‐0.700; p = 0.036).
Conclusions: Our results support earlier work showing an associa-
tion of natural daylight exposure and sleep architecture during the
subsequent night. Based on the explorative analysis in this small
sample we hypothesize a differential impact of light at different
times of day on different sleep stages.
Disclosure: Funded by the BMBF, German Ministery of Education
and Research FKZ: 13N8973.
P055 | Sleep and fatigue in commercial
aviation ‐ a field study
W. van Leeuwen1; G. Öztürk1; C. Ullvetter2; G. Kecklund1
1Stress Research Institute, Stockholm University, Stockholm, 2Civil
Aviation and Maritime Department, Swedish Transport Agency,
Norrköping, Sweden
Objectives/Instruction: New EASA FTL (European Aviation Safety
Agency flight time limitations) came into force early 2016 with the
purpose of protecting pilots against fatigue. The present field study
evaluates sleep and fatigue in Swedish commercial airline pilots since
the implementation of these new EASA FTL.
Methods: 32 randomly selected Swedish commercial airline pilots
participated in the field study. During a period of 13 days all pilots
wore an actiwatch and completed work and sleep diaries that con-
tained questions about sleep quality and quantity, working condi-
tions as well as Karolinska Sleepiness Scale (KSS) ratings during pre‐
defined stages of flight (i.e., blocks off, top of climb, top of descent,
blocks on). Linear mixed models were used for statistical analyses.
Results: On working days, actigraphy based sleep duration was
longer at home than in a hotel (455 versus 425 min, p = 0.043),
sleep efficiency was higher (95,3% versus 93,9%, p = 0.002), and
KSS sleepiness levels at wake up were lower (5,8 versus 6,5,
p = 0.015). Minutes of wake after sleep onset (WASO) did not differ
between home and hotel sleep. Sleep duration was also longer dur-
ing days off as compared to working days (489 versus 439 min,
p < 0.001) although sleep efficiency and WASO did not differ.
Sleep duration was shorter preceding days with early (0400‐0659)
check‐in (382 min.) compared to daytime (0700‐1659) check‐in
(469 min.; p < 0.001) and evening/night (1700‐0359) check‐in
(479 min.; p < 0.001).
A significant main effect of flight stage on pilot sleepiness was
observed (p = 0.01), with increasing sleepiness as time in flight pro-
ceeds (0,2 KSS increase per flight). Moreover, an interaction
between flights and flight stage was observed (p = 0.001), with the
increase of sleepiness during flight becoming more pronounced as
more flights are executed within a duty period.
Conclusions: Hotel sleep is of worse quantity and quality than
sleep at home. Pilots do experience sleepiness levels to increase dur-
ing the course of each flight, an effect getting worse the more flights
are flown within a duty period. Moreover, early morning check‐ins
are associated with a strongly reduced amount of sleep.
Disclosure: Nothing to disclose.
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P056 | Different chronotype profiles impact on
children habits before and during sleep
J.M. Serra-Negra1; L. Abreu2; K. Simon2; I. Prado2;
F. Provini3; S.M. Auad2
1Universidade Federal de Minas Gerais, 2Department of Paediatric
Dentistry and Orthodontics, Universidade Federal de Minas Gerais, Belo
Horizonte, Brazil, 3Neuroscience, Università di Bologna, Bologna, Italy
Objectives/Instruction: The objective of this study was to analyse
the association between chronotype profiles, sleep bruxism and
sleep characteristics among 12‐year‐old Brazilian children.
Methods: A cross‐sectional study with 240 children and their par-
ents was conducted in public and private's schools from Brumadinho,
southeast Brazil. Parents answered a questionnaire regarding chil-
dren's sleep characteristics (hours of sleep per night, sleep position,
drooling and snoring) and history of sleep bruxism. Chronotype pro-
file was assessed by means of the Portuguese version of the Puberty
and Phase Preference Scale (PPPS), answered by the children in the
classroom. Weight and high of all children were measured by a single
researcher in a separate room at school. Body mass index (BMI) was
calculated and categorized according to the recommendations of
World Health Organization as follows: underweight, normal, over-
weight and obese. Statistical analysis was calculated using chi‐square
test and binary logistic regression. Statistical significance was set at
p < 0.05%. This study was approved by the institutional ethics com-
mittee of the Federal Brazilian University (protocol
#54989816.3.0000.5142).
Results: Most participants were girls (55.7%). Eveningness profile
prevalence was 52.1% and morningness was 47.9%. Among the 240
participants, 105 drooled on the pillow (43.7%). The prevalence of
sleep bruxism was 17.9%. The normal BMI was observed among 151
participants (63%). Among the 24 obese individuals, 62.5% had
eveningness profile and 37.1% were morningness. Chi‐square test
showed a statistically significant association between eveningness
profile and girls (p = 0.038), children who eat sugar before bedtime
(p = 0.035) and children who drool on the pillow (p < 0.001). Those
three variables were included in the logistic regression model along
with the variable ‘sleep duration per night’ (p < 0.20) and the vari-
able ‘Obesity ‐ BMI’. The final model showed that children with
eveningness profile were more likely to drool on the pillow (Preva-
lence Ratio [PR] = 2.96; 95% Confidence Interval [CI] = 1.56–5.61)
and to eat sugar before bedtime (PR=2.03; 95% CI =1.08–3.81)
when compared to morningness profile individuals.
Conclusions: The eveningness profile children were more likely to
drool on the pillow and to eat sugar before bedtime when compared
to their morningness peers. Educational policies should be encour-
aged.
Disclosure: Nothing to disclose.
P057 | Treatment outcome of non‐24‐hour
sleep‐wake rhythm disorder: a retrospective
study of 24 consecutive cases in a sleep clinic
M. Hirose; C. Arakawa; A. Watanabe; Y. Esaki; R. Kawai;
N. Iwata; T. Kitajima
Department of Psychiatry, Fujita Health University School of Medicine,
Toyoake, Japan
Objectives/Introduction: Reports on the treatment outcome of
non‐24‐hour sleep‐wake rhythm disorder (N24SWD) are limited
because of low prevalence. We retrospectively analyzed it using
stoppage of free‐run as the primary index.
Methods: We enrolled 24 consecutive patients who visited the
sleep clinic of the Department of Psychiatry of Fujita Health Univer-
sity Hospital and were diagnosed with N24SWD according to the
International Classification of Sleep Disorders, Third Edition. Data
were retrospectively collected from medical records. When a
stopped free‐run was identified in an individual during the treatment
period, the patient's clinical state was determined as one of four
defined categories based on the extent of the clinical improvement,
including “normalization” (i.e., normalized sleep‐phase for
>3 months). Chronobiological interventions (e.g., bright light therapy,
ramelteon administration, and hospitalization) that were considered
to have a temporal association with free‐run stoppage were also
examined.
Results: “Normalization” occurred in 12.5% (3/24 patients) and
free‐run stoppage occurred in 45.8% (11/24), whereas free‐run per-
sisted throughout the course in 45.8% (11/24). The drop‐out rate
during the treatment course was 54.2% (13/24 patients). No single
intervention achieved “normalization,” and patients with free‐run
stoppage tended to undergo multiple chronobiological interventions.
Conclusions: The very low “normalization” rate and the large num-
ber of patients with ongoing free‐run who dropped out suggest that
N24SWD is extremely refractory. The possibility of free‐run stop-
page using a combination of multiple chronobiological interventions
may be plausible, although we were unable to identify a specific
treatment that was effective. Further studies that include the analy-
sis of therapeutic interventions are required.
Disclosure: This is not an industry‐sponsored study. Dr. Hirose, Dr.
Arakawa, Dr. Watanabe, Dr. Esaki, and Dr. Kawai declares that there
is no conflict of interest. Dr. Iwata has received research grants from
Otsuka, GSK, Tanabe‐Mitsubishi, Dainippon‐Sumitomo, Eizai, Dai-
ichisankyo, and has received personal fees from EliLilly, Janssen,
Otsuka, Shionogi, GSK, Dainippon‐Sumitomo, Astellas, Yoshitomi,
Meiji,Novartis, and Pfizer. Dr. Kitajima has received research grants
from Eizai, Takeda, MSD, and has received personal fees from Eizai,
Tanabe‐Mitsubishi, Otsuka, Takeda, Eli Lilly, MSD, Meiji,Yoshito-
miyakuhin, Dainippon‐Suimitomo, Fukuda, Shionogi, and Novo Nor-
disk.
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P058 | Randomised controlled trial of bright
light therapy and morning activity for
adolescents and young adults with delayed
sleep‐wake phase disorder
C. Richardson; N. Cain; K. Bartel; G. Micic; B. Maddock;
M. Gradisar
Psychology, Flinders University, Adelaide, SA, Australia
Objectives/Instruction: A randomised controlled trial evaluated
bright light therapy and morning activity for the treatment of
Delayed Sleep‐Wake Phase Disorder (DSWPD) in young people.
Methods: 60 adolescents and young adults (range= 13‐24 years,
mean= 15.9 ± 2.2 y, 63% f) diagnosed with DSWPD were ran-
domised to receive 3 weeks of post‐awakening Green Bright Light
Therapy (~507 nm) and Sedentary Activity (sitting, watching TV),
Green Bright Light Therapy and Morning Activity (standing, playing
motion‐sensing videogame), Red Light Therapy (~643 nm) and
Sedentary Activity or Red Light Therapy and Morning Activity. Sleep
(i.e sleep onset time, wake up time, sleep onset latency, total sleep
time) and daytime functioning (i.e morning alertness, daytime sleepi-
ness, fatigue, functional impairment) were measured pre‐treatment,
post‐treatment and at one and 3 month follow‐up.
Results: Contrary to predictions, there were no significant differ-
ences in outcomes between treatment groups; interaction effects
between treatment group and time for all outcome variables were
not statistically significant (p > 0.05). However, adolescents and
young adults in the morning activity conditions did not meaningfully
increase their objective activity (i.e movement frequency). Overall,
adolescents reported significantly improved sleep timing (p = 0.007‐
0.04, d = 0.30‐0.46), sleep onset latency (p = 0.03, d = 0.32) and
daytime functioning (p ≤ 0.001, d = 0.45‐0.87) post‐treatment.
Improvements in sleep timing (p ≤ 0.001, d = 0.53‐0.61), sleep onset
latency (p = 0.008, d = 0.57), total sleep time (p = 0.02, d = 0.51),
and daytime functioning (p ≤ 0.001‐0.01, d = 0.52‐1.02) were main-
tained, or improved upon, at the 3 month follow‐up. However,
relapse of symptomology was common and 38% of adolescents and
young adults requested further treatment in addition to the 3 weeks
of light therapy.
Conclusions: Although there is convincing evidence for the short‐
term efficacy of chronobiological treatments for DSWPD, long‐term
treatment outcomes can be improved.
Disclosure: Michael Gradisar has previously received partial indus-
try funding from Re‐Time Pty Ltd. All other authors have no financial
disclosures pertinent to this manuscript.
P059 | To explore the impact depression and
anxiety has on shift work disorder risk amongst
healthcare shift workers
L. Booker1,2,3; T. Sletten2,3; P. Alvaro2; M. Barnes1,4;
A. Collins1; C.L. Chai-Coetzer5; S. Lockley2,3;
S. Rajaratnam2,3; M. Howard1,2,3
1Institute for Breathing and Sleep, Austin Health, Heidelberg, 2CRC for
Alterness, Safety and Productivity, Notting Hill, 3School of Psychological
Sciences, Monash University, Clayton, 4University of Melbourne,
Parkville, VIC, 5Flinders Univeristy, Flinders Drive, Bedford Park, SA,
Australia
Objectives/Instruction: Mental health disorders have been linked
to shift work and have been partly attributed to circadian misalign-
ment and sleep disturbances. Some shift workers experience chronic
sleep insufficiency, excessive sleepiness and/or insomnia due to their
work schedules, known as Shift Work Disorder (SWD). SWD is a cir-
cadian rhythm disorder resulting from the temporal misalignment
between the circadian clock and the sleep‐wake cycle and affects
20‐30% of shift workers. Individuals with SWD have been shown to
have higher rates of depression and anxiety. Research specifically
within the healthcare sector is needed due to the unique work and
environmental stressors healthcare shift workers are exposed to,
which makes them more vulnerable to depression and anxiety. The
aim of this study to investigate the relationship between depression,
anxiety and SWD in healthcare shift workers.
Methods: A cross‐sectional sample of healthcare shift workers was
collected from a larger clustered randomized controlled trial. Partici-
pants completed an online survey consisting of demographic infor-
mation, Shift Work Disorder Questionnaire (SWDQ), Patient Health
Questionnaire (PHQ‐9) to measure depression and General Anxiety
Disorder Questionnaire (GAD‐7) to measure anxiety. Participants
were categorized into high and low risk groups for SWD and com-
parisons explored.
Results: 202 participants were recruited. 97% were female, with an
average age of 35.28 (SD=12). Nearly one‐third, (29%, n = 59) were
at high risk of SWD. Of these, 23.7%, had moderate to severe symp-
toms of depression compared to only 3.5% of those at low risk
(x2=37.45, p < 0.001). Furthermore, 13.6% of high risk participants
had moderate to severe anxiety symptoms compared to only 2.8%
at low risk (x2=19.85, p < 0.001). This difference was significant,
with the high risk SWD group overall having higher depression
scores (M = 7.54, SD= 4.28 vs. M = 3.78, SD=3.24; p < 0.001) and
higher anxiety scores (M = 5.66, SD=3.82 vs. M = 2.83, SD=3.33,
p < 0.001) compared to the low risk group.
Conclusions: A substantial proportion of healthcare workers that
are at high risk of SWD also suffer from severe mental health
impairment. This highlights the necessity to screen and manage
SWD and help alleviate this mental health risk.
Disclosure: Nothing to disclose.
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P060 | Body rhythms in concert? Integrity of
circadian rhythms predicts consciousness levels
in severely brain‐injured patients
C. Blume1,2; M. Angerer1; M. Raml1; R. del Giudice1,2;
N. Santhi3; G. Pichler4; A. Kunz5; E. Trinka5; M. Schabus1,2
1Department of Psychology, Laboratory for Sleep, Cognition and
Consciousness Research, 2Centre for Cognitive Neuroscience, University
of Salzburg, Salzburg, Austria, 3Surrey Sleep Research Centre, Faculty of
Health and Medical Sciences, University of Surrey, Guildford, United
Kingdom, 4Albert Schweitzer Clinic, Apallic Care Unit, Geriatric Health
Centres of the City of Graz, Graz, 5Christian‐Doppler‐Klinik,
Universitätsklinik der Paracelsus Medizinischen Privatuniversität,
Salzburg, Austria
Objectives/Instruction: In healthy individuals, stability of the cir-
cadian sleep‐wake cycle results in consolidated periods of conscious
wakefulness and unconscious sleep. Therefore, circadian rhythms
have previously been suggested to also contribute to consciousness
levels in patient groups characterised by a relative instability
thereof such as patients with disorders of consciousness (DOC) fol-
lowing severe brain injury. Earlier studies have however only
looked at selected examples of circadian rhythms one at a time.
Therefore, this study aimed at adopting a systems‐level perspective
taking into account three different circadian indexes. Moreover, we
aimed at assessing whether the body temperature maximum could
help pre‐specify the optimal time point for neuropsychological
assessment.
Methods: Going beyond earlier studies, we investigated the joint
predictive value of circadian indexes of body temperature, mela-
tonin secretion and body activity for n = 20 DOC patients’ beha-
viourally assessed state using multilevel modelling. For behavioural
evaluation we used the Coma Recovery Scale‐Revised (CRS‐R; Kal-
mar & Giacino, 2005), a well‐established neuropsychological test
battery. For the assessment of circadian rhythmicity, we measured
variations in temperature and activity across 7 days and mela-
toninsulfate (aMT6s) levels during 48 h in two‐hourly intervals.
Additionally, we assessed in n = 16 whether patients’ performance
varies with time of day or the time offset from the body temper-
ature maximum, that is when cognitive performance is expected
to peak. Specifically, patients were assessed at five time points in
regularly spaced intervals around the temperature maximum on
two consecutive days. Effects denoted significant had a p < 0.05,
trends < 0.1.
Results: We find that a higher integrity of the circadian mela-
tonin and temperature rhythms predicts a better state of patients.
Moreover, higher CRS‐R scores are predicted by less deviation
from the pre‐specified time of occurrence of the body tempera-
ture maximum (median at 2:25 pm). Likewise, higher CRS‐R scores
are associated with later daytime, which overlaps with the occur-
rence of the temperature maximum (4 pm in the average healthy
person).
Conclusions: In conclusion, results suggest that therapeutic
approaches should aim at improving circadian rhythms in brain‐
injured patients and diagnostic procedures should preferentially be
scheduled around the pre‐assessed body temperature maximum.
Funding was by the Austrian Science Fund (W‐1223, Y‐777).
Disclosure: Nothing to disclose.
P061 | Effects of different light expositions on
wakefulness, mood, and attention in shift
workers: an ongoing field study in a morning and
evening shift system
A. Rodenbeck1,2; A. Wiater1; M. Neuwirth1; R. Özgüc3
1Pediatrics, Krankenhaus Porz am Rhein, Köln, 2Pneumology & Sleep
Laboratory, Evangelisches Krankenhaus Goettingen‐Weende gGmbH,
Goettingen, 3Photonik and Environment, Fraunhofer Institute for
Environmental, Safety, and Energy Technology, Oberhausen, Germany
Objectives/Introduction: Bright and/or blue light has been shown
to improve alertness in experimental settings. Field studies are lim-
ited and focus on night shifts. We therefore studied different light
expositions in blue collar workers working in a morning and evening
shift system.
Methods: In an ongoing study Insomnia Severity Index (ISI),
Epworth Sleepiness Scale (ESS), mood (non verbal face scale), subjec-
tive sleep time, actual wakefulness, light comfort, participants global
impression of change (PGI), objective attention (d2 test) and sleepi-
ness (pupillography) as well as sleep‐wake rhythm (fitness tracker)
were measured during the evening shifts after 2 weeks of the fol-
lowing light regimes: baseline (BL, 5000 K, 120 mlux), L1 (2700 K,
122 mlux), L2 (5000 K, 213 mlux), L3 (dynamic setting: 7000 K at
morning ‐ 2700 K in the evening), L4 (7000 K, 400 mlux). Light was
continuously given during morning and evening shifts, excepted the
dynamic L3 setting.
Results: 46 males and 4 females out of 79 workers completed the
conditions BL to L3 up to now. Preliminary results based on ANO-
VAs for repeated measures (n = 50) and correlations for single condi-
tions (n = 65). Mood (p < 0.05), PGI (p < 0.005), and attention
(p < 0.005) improve significantly following all light settings compared
to baseline. Light comfort differed significantly between the condi-
tions (p < 0.005) being lowest at L1 and highest at L2. Although
there are no changes in wakefulness over time, light comfort corre-
lates positively to acute wakefulness and mood at BL, L2, and L3 as
well as to PGI at L2 and L3 (p < 0.05 each); at L3 higher light com-
fort is also associated with a lower ISI. In contrast, light comfort
shows a weak but significant negative correlation to wakefulness at
L1. Objective attention increases continuously over time and doesn't
correlate to any other parameter.
Conclusions: Considering the same mlux (BL, L1) respectively the
same blue wavelength spectrum (L1, L2) the results indicate that
brightness, light colour and blue wavelength maximum influence light
content, mood, PGI, and wakefulness in evening shift workers in dif-
ferent ways and should be considered infurther field studies.
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P062 | Tasimelteon reentrains sleep period in a
patient with phase delay syndrome
A. Steiger
Research Group Sleep Endocrinology, Max Planck Institute of Psychiatry,
Munich, Germany
Objectives/Instruction: The phase delay syndrome is a rare incapac-
itating disorder of the circadian sleep‐wake rhythm. It results in sleep
period which is delayed related to the environment. No therapy is avail-
able so far. We report off label use of tasimelteon in an individual cura-
tive trial which aimed to treat this disorder. Tasimelteon is an agonist at
melatonin (MT) 1 and 2 receptors. The substance is approved to treat
non‐24‐h‐sleep‐wake‐disorder in totally blind patients.
Methods: In our trial the 62 years old patient reported a history of
this disorder since his youth. Furthermore he had a history of
adrenalectomy and cortisone substitution after Cushing′s syndrome
and of Whipple procedure due to pancreatic cancer. Before treat-
ment his sleep onset occurred between 06.00 and 08.00 h. He
awakened by 16.00 h. He received an oral dose of 20 mg tasimel-
teon daily one hour before bedtime.
Results: Already after some days treatment with tasimelteon the
patient′s sleep period was advanced by about four hours as docu-
mented by sleep diary and actigraphy. He reported improved quality
of life as his participation in daily living became possible. This effect
was stable so far for more than ten months. The patient reported
vivid dreaming including some unpleasant dreams. Before therapy
with tasimelteon he did not remember dreams. Beside these dreams
the substance was well tolerated.
Conclusions: Our findings suggest that tasimelteon is capable to
reentrain delayed sleep period in phase delay syndrome. Tasimelteon
appears to be suited to treat circadian sleep‐wake disorders also
beyond non‐24‐h sleep‐wake‐disorder.
Disclosure: Nothing to disclose.
P063 | Evening cronotypes mediate the
association between early life stress and
emotion dysregulation in Bipolar Disorder
L. Palagini; U. Moretto; D. Caruso; M. Novi; I. Masci;
B. Tripodi
Department of Clinical and Experimental Medicine, Psychiatric Unit,
University of Pisa, School of Medicine Pisa, Italy, University of Pisa,
Pisa, Italy
Objectives/Instruction: In Bipolar Disorder (BD), both rhythms
and emotion dysregulation play an important role by negatively
influencing its trajectory. Recent studies also documented an associ-
ation of negative life events and Bipolar Disorder onset and course.
The aim was to assess the possible association between early life
stress chronotype and of emotion regulation in subjects with BD.
Methods: One‐hundred patients (62 females, 13 males, mean age
of 48.2 ± 12.4 years) with a BD‐type II depressive episode with
mixed features, according to DSM‐5 and 20 healthy controls (16
females, 15 males, mean age of 47.7 ± 12 years) were recruited.
Subjects with BD were evaluated with the SCID‐DSM‐5 and the
Morningness Eveningness Questionnaire (MEQ), Difficulties in Emo-
tion Regulation Scale (DERS), Beck Depression Inventory (BDI‐II),
Mania Rating Scale (MRS) and Early Trauma Inventory‐Short Form
(ETISR‐SF). An a priori power analysis has been performed, and cor-
relations were studied with regression and mediation analyses.
Results: Twenty‐nine BD subjects (29.9%) 3 healthy controls (15%)
showed evening types (p < 0.01), the BDI‐II and MRS scores were
respectively 23.3 ± 11.1 and 9.1 ± 6.8 in BDs, 5.2 ± 1.2 and
3.0 ± 0.1 in healthy subjects (p < 0.001) and the ETISR‐SF score was
9.8 ± 04 and 2.1 ± 1 (p < 0.01). In bipolars greater early life stress
significantly correlated with greater MEQ scores (coeff= ‐0.49,
p = 0.03), MEQ evening types (coeff= 0,23 p < 0.001) and DERS
scores (coeff= 0.05, p = 0.009) while no correlations were found
with BDI‐II (coeff= 0.04, p = 0.22) and MRS (coeff= 0.07, p = 0.30).
In bipolars greater early life stress independently predicted the
greater emotion dysregulation (p = 0.0009) and evening types (co-
eff= 0.14, p = 0.04). Evening cronotypes mediate the association
between early life stress and emotion dysregulation (Z = 2.9,
p = 0.02).
Conclusions: Early life stress may impact on later psychopathology,
especially favoring sleep rhythms and emotion dysregulation. Particu-
larly, if evening chronotypes may contribute to the association
between early life stress and emotion dysregulation in bipolars, we
may hypothesized early life stress having negative consequences at
first on chronobiological rhythms. Further studies with longitudinal
design are required.
Disclosure: Nothing to disclose.
P064 | Obstructive sleep apnea as a predictive
factor of reduced heart rate variability
D. Urbanik1; R. Poręba1; M. Podgórski1; H. Martynowicz1;
G. Mazur1; M. Sobieszczańska2; P. Gać3
1Department of Internal Medicine, Occupational Diseases, Hypertension
and Clinical Oncology, 2Department and Clinic of Geriatrics,
3Department of Hygiene, Wroclaw Medical University, Wroclaw, Poland
Objectives/Introduction: Obstructive sleep apnea (OSA) is a
sleep disorder leading to obturation of respiratory tract, recurrent
hypoxia, arousals, pathological day time sleepiness. It causes sympa-
thetic hyperactivity, endothelial dysfunction, inflammation and oxida-
tive stress, hypercoagulability, insulin resistance and changes in
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intrathoracic pressure and leads to increase of cardiovascular risk.
OSA is strongly correlated with autonomic system dysfunction and
increased risk of cardiovascular diseases: hypertension, ischemic
heart disease, heart failure, stroke and arrhythmias. Dysregulation of
autonomic system can be diagnosed in ECG holter monitoring by
gathering the heart rate variability (HRV) indices. This study evalu-
ated the correlation of heart rate variability with different stages of
OSA.
Methods: The study included 104 subjects: 24 patients with mild
OSA, 31 with moderate OSA, 34 patients with severe OSA and 15
patients without apnea. Subjects were examined with in‐laboratory
polysomnography combined with ECG holter monitoring, laboratory
tests and surveys. HRV indices were obtained and calculated with
time and spectral analysis of different time periods: total recording,
daily activity, night rest and 15‐min fragments of daily activity and
stage N3 sleep.
Results: HRV analysis revealed lower SDNN, PNN50 and higher
LF/HF (p < 0,05) in OSA patient compared with patients without
OSA, suggesting sympathetic hyperactivity in OSA patients. There is
a positive, statistically significant, correlation between AHI and LF/
HF. More parasympathetic HRV indices (SDNN, rMSSD, SDSD,
PNN50) are reduced in moderate‐severe OSA group than in control
group (without OSA and mild OSA) and it is observed also during
daily activity.
Conclusions:
(1) Patients with OSA have reduced heart rate variability in time
and spectral analysis, due to sympathetic hyperactivity.
(2) HRV alterations are more relevant in moderate and severe
OSA.
(3) Autonomic impairment in OSA patient is permanent,
observed both at night rest and day-time activity.
Disclosure: Nothing to disclose.
P065 | Improvements in mood and subjective
sleep measures along the course of adjunctive
phototherapy: an open‐label study
A. Nixon1,2; M. Strike3; S. Thatte3; N. Glozier4; K.-L. Fields4;
J. De Koninck1,2; R. Robillard1,2
1University of Ottawa Institute of Mental Health Research, 2School of
Psychology, University of Ottawa, 3The Royal Ottawa Mental Health
Cemtre, Ottawa, ON, Canada, 4The University of Sydney, Sydney, NSW,
Australia
Objectives/Introduction: Bright light can have antidepressant
effects, which may notably operate via the restoration of sleep and
circadian disruptions. Since phototherapy trials in non‐seasonal
depression yielded inconsistent results, there is a need to identify
subgroups of individuals most likely to respond to phototherapy.
Youth with depression may be good candidates since they com-
monly have delayed sleep‐wake cycles and other sleep disruptions.
This study aimed to uncover parts of the antidepressant mechanisms
of phototherapy and identify predictors of treatment response.
Methods: This study included 27 individuals with depression
recruited from mental health services in Australia and Canada
(21.3 ± 5.0 years old; 22% males). During 4 weeks, morning pho-
totherapy was conducted adjunctively to standard clinical care using
green‐blue light‐emitting glasses. Seventeen participants were taking
psychotropic medications, and all of them maintained a stable
dosage for at least 4 weeks before study enrollment. Before, as well
as after two and 4 weeks of phototherapy, participants completed
the Beck Depression Inventory‐II (BDI‐II), Leeds Sleep Evaluation
Questionnaire (LSEQ), Functional Outcome of Sleep Questionnaire
(FOSQ), and Glasgow Content of Thoughts Inventory (GCTI).
Results: On average, BDI‐II scores did not change significantly after
2 weeks of phototherapy, but they significantly decreased after
4 weeks (n = 20, t(19)=3.1, p = 0.006). Improvements on the BDI‐II
after 2 weeks of phototherapy correlated with reductions in pre‐
sleep unhelpful thoughts (n = 25, r = 0.47, p = 0.018) and improve-
ments in the ease to fall asleep (n = 26, r = ‐0.48, p = 0.013). Subse-
quent improvements on the BDI‐II after 4 weeks correlated with
reductions in sleep‐related daytime dysfunctions (n = 17, r = ‐0.67,
p = 0.003). Stronger antidepressant responses were found in those
who initially had more frequent pre‐sleep unhelpful thoughts
(n = 19, r = 0.46, p = 0.050) and worse difficulties falling asleep
(n = 20, r = ‐0.51, p = 0.021).
Conclusions: These findings suggest that adjunctive phototherapy
can alleviate depressive symptoms in youth with depression, how-
ever, this needs to be replicated in randomized control trials. The
correlations between mood and sleep‐related changes support the
notion that the restoration of sleep, and subsequent improvements
in daytime functioning, may represent one of the mechanisms under-
lying the antidepressant effects of light. Initial sleep difficulties and
their daytime consequences may be useful predictors to identify
individuals most likely to respond to phototherapy.
Disclosure: Nothing to disclose.
P066 | Altered regional neuronal activity in
shift work associated with sleep and emotion:
resting state perfusion MRI study
Y.K. Park1; S.J. choi2; E.Y. Joo3
1Bundang Jesaeng General Hospital, Seongnam‐si, 2Department of
Clinical Nursing Science, Samsung Medical Center, 3Neuroscience
Center, Samsung Biomedical Research Institute, Samsung Medical
Center, Seoul, Republic of Korea
Objectives/Instruction: Shift work is known to disrupt workers’
normal circadian rhythms, and to be associated with increased health
problems. In contrast to the considerable literature regarding neu-
ropsychological function in shift work, evidence for the impact of
shift work on brain functional imaging is limited. The aim of this
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study is to compare regional cerebral flow (rCBF) between shift
workers and day workers using perfusion brain MRI(pMRI) and
investigate correlation among the altered rCBF with sleep status and
neuropsychological assessment.
Methods: 15 day workers (DW) and 15 rotational shift workers
(SW) were included into the study. Measures of habitual sleep were
obtained from 2 weeks of wrist actigraphy. We compared demo-
graphics, emotional states, insomnia severity, daytime sleepiness and
automated battery of psychometric measures between two groups.
Using pMRI, the differences of rCBF were measured in DW vs SW.
Results: Shift worker was associated with higher anxiety (HADS‐A
score, p = 0.029), depressive mood (HADS‐D score, p = 0.001), inat-
tention (CAARS‐K subscale; hyperacitivity/restless, p = 0.029) and
reported more severe insomnia (ISI score, p < 0.001) than day
worker. Resting state pMRI revealed decreased regional Cerebral
Blood Flow (rCBF) at right cuneus, cerebellum and fusiform gyrus in
shift workers. On the contrary, left inferior occipital gyrus showed
increased rCBF in shift workers compared to day workers. Although
sleep related measures (TST, SL, SE, WASO) and neurocognitive per-
formance showed no significant difference between two groups,
sleep onset and duration irregularity showed positive correlation
with the severity of anxiety and depressive mood.
Conclusions: The pMRI showed involvement of brain areas related
to depression in SW and disruption of the individuals’ circadian
rhythms resulting in anxiety and depressive mood, regardless of
sleep quality.
Disclosure: Nothing to disclose.
BEHAVIOR 1
P068 | Sleep coaching provides help for shift
workers: a field report
B. Holzinger1; K. Levec1; G. Klösch2; M.-M. Munzinger1
1Institute for Consciousness and Dream Research, 2Department of
Neurology, Medical University of Vienna, Vienna, Austria
Objectives/Instruction: To examine subjective ratings of sleep
quality and daytime sleepiness in shift workers employed in a railway
company (OEBB: Oesterreichische Bundesbahnen), and how shift‐
related complaints can be addressed during a 2 day sleep coaching
seminar.
Methods: Pre intervention questionnaire, containing items of the
PSQI and the ESS, questions about chronotype, personality factors
and possible burnout risk factors. In total, 182 employees (162 male;
age: 22‐58, M = 45.89, SD = 8.99) took part in the investigation.
Results: Shift workers reported poorer sleep quality, prolonged
sleep latencies, high sores of daytime sleepiness and a variety of
daytime dysfunction as well as higher body mass indices.
Conclusions: Sleep coaching by Holzinger & Kloesch™ is a new
approach for non‐pharmacologic treatment of non‐restorative sleep
and includes psychotherapeutic aspects, which enable clients to
improving their sleep quality as well as their quality of life, by devel-
oping one′s own coping strategies which can be implemented in
daily routine. The 2 day SC seminar is beneficial by exactly focusing
on the sleep problems related to shift workers.
More research with a greater sample and a longitudinal design is
needed to examine the long time effects of SC.
Disclosure: Nothing to disclose.
P069 | The association between outdoor
activity and insufficient sleep among children in
China
J. Luo; M. Cao; F. Sun; J. Jing
Department of Maternal and Child Health, Sun Yat-sen University,
Guangzhou, China
Objectives/Instruction: The relationship between outdoor activity
(OA) and insufficient sleep duration (ISD) remains unknown. We aim
to examine the relationship using a school based national survey
data among Chinese children.
Methods: The sample consisted of 62,517 children aged 6‐
17 years which were multi‐stage sampled from 7 representative
areas in China during September and November, 2013. In the struc-
tured questionnaire, children and their caregivers reported daily
sleep hours (< 7 h, 7‐9 h and > 9 h), daily outdoor activity time (less
than 1 h, 1‐2 h, and more than 2 h) and other behavior, demographic
information. ISD was defined as < 9 hours/day (aged 6‐13 years) and
< 7 hours/day (aged 14‐17 years). The relationship between insuffi-
cient sleep and outdoor activity were evaluated by logistic regression
and multi‐variable adjusted.
Results: A total of 46,639 children (50.9% boys) completed the
study. The prevalence of ISD was 62.8% (61.7% in boys and 63.9%
in girls). Stratified by age, comparing with < 1 h OA, the odds ratios
(ORs) for ISD were 0.652 (95% CI: 0.607‐0.701, aged 6‐13 years)
and 0.600 (0.522‐0.688, 14‐17 years) in >2 h OA group; 0.882
(0.830‐0.937, 6‐13 years) and 0.711 (0.641‐0.789, 14‐17 years) in 1‐
2 h OA group. Further stratified by gender, comparing with < 1 h
OA, ORs for ISD were 0.671 (0.607‐0.741, 6‐13 years) and 0.692
(0.567‐0.845, and 14‐17 years) in > 2 h OA boys, and 0.633 (0.570‐
0.702, 6‐13 years) and 0.522 (0.430‐0.634, and 14‐17 years) in >2 h
OA girls; 0.897 (0.824‐0.976, 6‐13 years) and 0.778 (0.664‐0.912,
14‐17 years) in 1‐2 h OA boys, 0.866 (0.794‐0.945, 6‐13 years) and
0.662 (0.575‐0.761, 14‐17 years)in 1‐2 h OA girls. All the ORs were
adjusted for age, gender, urban/rural area, geographical location,
father's education, mother's education, BMI, physical activity and
inactivity.
Conclusions: Outdoor activity time more than 1 h is associated
with decreased risks for insufficient sleep duration among children
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aged 6‐17 years. Further research is in need to explore the causal
relationship between outdoor activity and sleep duration.
Disclosure: Nothing to disclose.
P070 | Iron metabolism in epigenetics:
relationship between sleep, physical exercise and
movement disorders in an animal model
B. Franco; P. Daubian-Nosé; D. Mota; L. Cavallaro;
N. Rodrigues; L. Simino; R. Bezerra; F. Manchado-Gobatto;
A. Torsoni; A. Esteves
Faculdade de Ciências Aplicadas, Universidade Estadual de Campinas,
Limeira, Brazil
Objectives/Instruction: The objective of the current study was to
observe in the offspring of rats, treated with diet representing differ-
ent concentrations of iron, alterations caused in sleep, locomotor
activity, dopaminergic system and iron metabolism. In addition, the
impact of physical exercise on these variables analyzed in the off-
spring was evaluated.
Methods: For this, Wistar rats were distributed in groups that
received control, supplementation and iron restriction diets during
the pregnancy. After weaning, the offspring of each group were
divided into two groups: physical exercise and sedentary (n = 8/
group). Sleep assessments (Polysomnography), behavior (Open Field)
and gene expression (PCR) of the dopaminergic system (D2, DAT,
TH, MAP2K5‐ERK5) and hepicidina were performed after 8 weeks
of physical exercise (swimming).
Results: The offspring results showed that physical exercise and
iron supplementation of the mothers had an influence on the behav-
ior after the 8 weeks of intervention. In the Open Field test, the off-
spring from the mothers supplementation group showed a significant
increase in the Freezing when compared to all other groups most of
the time (Repeated measures ANOVA p < 0.05). Through
polysomnography, during the light period, the sedentary and physical
exercise offspring from the mothers supplementation showed a
higher % of Total Sleep Time and Slow Wave Sleep in relation to
mothers iron restriction offspring; and reduced awakening in relation
to the other groups (Factorial ANOVA p < 0.05). In the analysis of
gene expression, the offspring groups showed no differences in the
hepcidin, DAT and TH gene after 8 weeks of intervention. The
sedentary group receiving iron supplementation from the mothers
showed a greater expression of the D2 gene in relation to the con-
trol and the mothers iron restriction offspring with sedentary and
physical exercise (Factorial ANOVA p < 0.05).
Conclusions: In this context, we can suggest that iron diet during
pregnancy and physical exercise performed by offspring in adulthood
may present some changes in the behavior, sleep and gene expres-
sion in the offspring evaluated. However, the results suggest that
the presence of iron deficiency during pregnancy is not a
predisposing factor for the offspring to present movement disorders
in adult life.
FAPESP (2014‐19212‐0).
Disclosure: Nothing to disclose.
P071 | Comparison of sleep quality between
seafarers working for European and Chinese
shipping companies
Z. Zhao1,2; E. Zheng3; Y. Zhu1; W. van Leeuwen4
1Seafarers Development Research Centre, Dalian Maritime University,
Dalian, China, 2Centre of Maritime Health and Society, University of
Southern Denmark, Odense, Denmark, 3School of Science, Dalian
Maritime University, Dalian, China, 4Stress Research Institute,
Stockholm University, Stockholm, Sweden
Objectives/Introduction: This large questionnaire based study
compared sleep quality between seafarers employed by European
and Chinese shipping companies, aiming to provide more insight into
the possible cultural differences between European and Chinese
shipping industry.
Methods: 454 European and 483 Chinese employed seafarers
answered a revised version of the questionnaire designed in the Car-
diff Seafarers’ Fatigue Research program. Cross tabulation analysis
was carried out to investigate whether a significant relation between
pairs of variables existed in the form of joint frequencies. Pearson
chi‐square tests were used to examine whether the relation variables
were statistically independent.
Results: A significant proportion of Chinese companies’ seafarers
(28.3%) reported difficulty of falling asleep, 33.1% reported difficulty
of staying asleep, 37.7% reported to often wake up during sleep, and
38.4% reported restless sleep. These percentages were all consider-
ably higher than the proportions of European seafarers with these
problems, which were 18.4%, 14.3%, 20.3% and 15.1%, respectively.
The reported number of sleep periods (longer than 1.5 hours) in a
typical 24 hour period at sea also differs between the European and
Chinese companies’ seafarers. 88.5% of Chinese companies’ seafar-
ers had two or more sleep periods compared with 54.8% of European
seafarers. Considering the influences of Environmental factors, which
relate to noise, bad weather and ship motion, 29.3% and 19.4% of
European seafarers felt their sleep were disturbed by noise and ship
motion, respectively, while the percentages of Chinese companies’
seafarers with this view were as high as 47.6% and 58.6%. Without
exception, p ‐values were less than 0.001, which indicates that signifi-
cant relationships between pairs of variables existed.
Conclusions: This study indicates that seafarers employed by Chi-
nese shipping companies suffered more severely from poor sleep
quality and were significantly more likely to have interrupted and
disturbed sleep than seafarers that are employed by European ship-
ping companies.
Disclosure: Nothing to disclose.
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P072 | Factors related to seafarer fatigue and
their importance for different categories of
seafarers
Z. Zhao1,2; Y. Zhu1; W. van Leeuwen3
1Seafarers Development Research Centre, Dalian Maritime University,
Dalian, China, 2Centre of Maritime Health and Society, University of
Southern Denmark, Odense, Denmark, 3Stress Research Institute,
Stockholm University, Stockholm, Sweden
Objectives/Instruction: Fatigue has a negative impact on seafar-
ers’ health and performance and even poses a threat to their safety.
This study explores the fatigue related factors and their impact on
different groups of seafarers.
Methods: 454 European and 483 Chinese employed seafarers
answered a revised version of the questionnaire designed in the Car-
diff Seafarers’ Fatigue Research program. Five aspects of fatigue
were used to address the intensity and frequency of perceived phys-
ical and mental fatigue. Independent variables were those previously
indicated as factors associated with fatigue (categorical variables). An
optimal scaling regression model was used to analyze the factors
having greatest effect size on the degree of seafarers’ fatigue. Eta‐
squared was used to analyze the most important factors affecting
fatigue in different categories of seafarers.
Results: According to the optimal scaling regression model
(R2=0,400; p < 0,05), the three factors affecting seafares’ fatigue
most are.
(1) difficulties falling asleep,
(2) constant pressure due to heavy workload, and
(3) having restless/disturbed sleep.
Eta‐squared results show that fatigue in officers and in those work-
ing on deck is most significantly influenced by having restless/dis-
turbed sleep (η2 of 0,27 and 0,21 respectively). Fatigue in ratings (i.e.
those not being officers) is mostly influenced by difficulties falling
asleep (η2 of 0,18), whereas fatigue in those working in engineering
is most significantly affected by constant time pressure due to a
heavy workload (η2 of 0,26).
Conclusions: This study indicates that suboptimal sleep patterns
significantly contribute to seafarers’ fatigue. Moreover, different
groups of seafarers are faced with different kinds of sleep problems
associated with fatigue.
Disclosure: Nothing to disclose.
P073 | Cataplexy is reduced after modulation
of serotonin transmission
A. Seifinejad1; M.-L. Possovre1; S. Jimenez2; M. Tafti1
1Department of Physiology, 2CIG, University of Lausanne, Lausanne,
Switzerland
Objectives/Instruction: Cataplexy is a major symptom of nar-
colepsy and is defined as a sudden loss of muscle tone during
wakefulness while consciousness is preserved. It is a dynamic, multi‐
phased process which involves different brain regions before, during
and after its occurrence. Monoaminergic neuronal populations that
are important wake‐promoting systems play also an important role in
pathophysiology of narcolepsy with cataplexy. In this work we
sought to understand if the modulation of the serotonin transmission
can influence cataplexy occurrence in mice.
Methods: The mice were implanted with EEG electrodes and
EMBLA™ hardware was used for signal acquisition and Somnologica‐
3™ (Medcare) software for data analysis. High resolution camera also
was used to record animal behavior during different vigilance state.
Results: Our results showed that introducing a null 5‐HTT gene
(serotonin transporter) in the animal model of cataplexy (Hcrt KO
mice) greatly reduced cataplectic attacks but REM sleep amount
increased. The decrease in cataplexy was displayed both in episod
number and time in state and was even more pronounced after
sleep deprivation, with 4 fold decrease as compared to Hcrt KO
mice. Power spectral analysis showed that wake quality follows the
same pattern across the knockout and wild type animals.
Conclusions: This finding indicates that serotonergic system is a
major downstream hcrt pathway to regulate cataplexy onset and
duration supporting the serotonergic system as the therapeutic tar-
get for controlling cataplexy in narcolepsy patients.
Disclosure: Nothing to disclose.
P074 | Cabin crews’ views on managing
fatigue and the importance of sufficient rest and
company support: a qualitative study
M. van den Berg; T.L. Signal; P.H. Gander
Sleep/Wake Research Centre, Massey University, Wellington, New
Zealand
Objectives/Instruction: Considering the important role of Cabin
Crew in maintaining passenger and cabin safety, Cabin Crew fatigue
and its associated risk needs to be managed carefully. Because fati-
gue is a ‘whole‐of‐life’ issue, its management must be a shared
responsibility between the employer and employee. To be able to
reduce or mitigate fatigue, the causes and consequences of fatigue
need to be understood. However, Cabin Crews’ views on fatigue
and their strategies for mitigating it, have seldom been sought.
Methods: A qualitative study was conducted using semi‐structured
focus group discussions. Thematic analysis was undertaken with data
from 25 Cabin Crew using a 6‐phase iterative process. Taking a
pragmatist approach, the analysis was situated within the existing
knowledge of fatigue risk management and a safety system
approach.
Results: Participants indicated that the consequences of Cabin
Crew fatigue are twofold, affecting
(1) Cabin Crew health and wellbeing and
(2) safety (cabin, passenger and personal) and cabin service.
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Whereas the primary causes of fatigue were sleep loss and circadian
disruption, participants identified a range of other factors including:
insufficient time for rest, high workload, the work environment, a
lack of company support and limited fatigue management training.
They highlighted the importance of sufficient rest, not only for
obtaining adequate recovery sleep but also for achieving a work‐life
balance. They also highlighted the need for company support, in the
form of fatigue‐related provisions, effective communication and
management's engagement with Cabin Crew in general.
Conclusions: Whereas traditionally fatigue has been managed
through prescriptive limits on maximum duty duration and minimum
rest durations, the present findings demonstrate the need for a much
broader approach. Fatigue Risk Management Systems (FRMS) that
are based on scientific and operational knowledge about the causes
of fatigue and its management, and include fatigue management
training for all relevant personnel (including senior management) as
well as an effective fatigue reporting system, can ameliorate the
gaps identified and thus improve Cabin crews’ safety and service,
and health and well‐being.
Disclosure: This study was made possible by Wynand Serfontein
at South African Airways and it was funded by the Sleep/Wake
Research Centre, Massey University.
P075 | Night‐competition affects sleep quality
and perceived recovery in top‐level athletes
J.A. Vitale1; A. La Torre2,3; A. Galbiati4,5; L. Ferini-Strambi4,5;
G. Banfi2,4
1Chronobiology, Sports Medicine, & Physiology, 2IRCCS Galeazzi
Orthopedic Institute, 3Department of Biomedical Sciences for Health,
University of Milan, 4Vita‐Salute San Raffaele University, 5Department
of Clinical Neurosciences, Neurology ‐ Sleep Disorders Center, IRCCS
San Raffaele Scientific Institute, Milan, Italy
Objectives/Instruction: It is becoming increasingly evident that
sleep plays an essential role for athletes’ well‐being and recovery.
Several factors are able to negatively influence sleep and both the
kind and timing of physical activity significantly affect athletes’ sleep
quality. It has indeed been showed that high‐intensity acute exercise,
especially when performed late in the evening or close to bedtime,
may negatively affect sleep. Therefore, we investigated actigraphy‐
based sleep quality and perceived recovery before and after a night‐
game in top‐level athletes.
Methods: Sleep parameters were evaluated through actigraphy for
three consecutive nights with 24 elite volleyball players (12 males
and 12 females, mean age = 26.0 ± 3.4) during the competitive sea-
son 2016‐2017. One night before (PRE) and two nights after (POST
1 and POST 2) an official night‐match were studied and athletes’
subjective perception of recovery was evaluated by the Total Quality
Recovery scale (TQR). The following actigraphic parameters were
studied: Time in Bed (TB), Sleep Latency (SL), Sleep Efficiency (SE),
Wake After Sleep Onset (WASO), Total Sleep Time (TST), Immobility
Time (IT), Moving Time (MT), and Fragmentation Index (FI).
Results: Repeated‐measures analysis of variance (RM‐ANOVA) fol-
lowed by the Bonferroni post‐hoc test highlighted significant differ-
ences for all sleep variables. Partial eta squared (ήp2) was used to
determine the magnitude of the effect for significant outcomes in
RM‐ANOVA. Sleep quantity parameters were lower at POST 1 com-
pared to PRE (p < 0.05) and POST 2 (p < 0.001) (TST: p = 0.0001;
ήp2=0.66). Similarly, sleep quality parameters were worse immedi-
ately after the night‐competition compared to both pre‐match values
(p < 0.05) and the second night after competition (p < 0.001) (SE:
p = 0.0005; ήp2 = 0.44). The same differences among three nights
were observed in TQR values (p < 0.001; ήp2 = 0.54).
Conclusions: Actigraphy‐based sleep quality and perceived recov-
ery were significantly affected by night‐competition and more atten-
tion should be paid to the first night after night‐match. These
preliminary results can be utilized by team coaches to implement
behavioral strategies in top‐level athletes and to develop a greater
knowledge of how sleep differs during different phases of competi-
tion.
Disclosure: Nothing to disclose.
P076 | Actigraphic measurement of physical
activity changes due to sleep extension
intervention
J.K. Devine; T. Burke; L. Skeiky; J. Choynowski; T. Balkin;
V. Capaldi; A. Brager; G. Simonelli
Behavioral Biology, Walter Reed Army Institute of Research, Silver
Spring, MD, United States
Objectives/Instruction: Epidemiologic research suggests that both
short (< 7 h) and long sleep (>9 h) are associated with adverse health
outcomes. Evidence that supports a causal link between longer sleep
and adverse health outcomes is particularly unclear. One hypothesis is
that decreased physical activity due to oversleeping may affect health.
However, laboratory studies consistently show cardiometabolic and
cognitive benefits of sleep extension. The current study aims to deter-
mine whether, and the extent which, a week of sleep extension alters
activity levels across 24 hours as well as within the waking active per-
iod and sleep period to determine whether increased time in bed is
related to an increase in sedentary behavior.
Methods: Twenty‐seven healthy volunteers (24.37 ± 5.41 years
old, 16 males) wore wrist actigraphs (Actiwatch 2.0, Philips) for
6 days during their normal schedules and for 6 days during a sleep
extension intervention. During baseline conditions, participants main-
tained their normal activities and sleep practices at home. Partici-
pants then extended time in bed to 10 hours for the 6‐night sleep
extension period but maintained normal daily activities. Independent
students’ t tests compared the mean difference (MD) between
weekly average activity counts per minute (AC/min) for the active
period (AP), sleep period (SP) and 24 hour period (24P) for baseline
and sleep extension conditions.
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Results: Sleep duration for the sleep extension week was signifi-
cantly greater than during the baseline condition (MD):98 min,
t = 8.00, p < 0.001). There were no significant differences in weekly
activity for 24P (MD:10.00 AC/min; t = 0.90, p = 0.37), AP
(MD:12.00 AC/min; t = 0.66, p = 0.51) or SP (MD:0.88 AC/min,
t = 0.60, p = 0.55) between baseline and sleep extension conditions.
Conclusions: These findings suggest that extending time in bed for
1 week increases sleep without altering weekly average activity
levels in healthy individuals. An association between long sleep and
low activity may develop over time and therefore, may not be evi-
dent in short term sleep extension. It is also possible that the
observed association between long sleep duration, low levels of
physical activity and overall mortality in epidemiological populations
may be due to underlying lifestyle or health factors as opposed to
increased sedentary behavior due to time in bed.
Disclosure: Nothing to disclose.
P077 | Sleep is shortened prior to morning and
night shifts in Air Traffic Controllers
J.L. Zaslona; M. van den Berg; L.J. Wu; T.L. Signal
Sleep/Wake Research Centre, Massey University, Wellington, New
Zealand
Objectives/Instruction: There is evidence that shift timing
impacts the amount of sleep obtained prior to the shift, with early
starts curtailing sleep and night shifts displacing sleep. These analy-
ses aimed to investigate the effects of shift timing on the sleep of
Air Traffic Controllers (ATCs).
Methods: Thirteen ATCs (11 male, mean age 48 years) were moni-
tored using wrist actigraphy across four work patterns each 4 days
long (patterns 1–4) and one 7‐day work pattern (pattern 5). Shifts
were classified as ‘morning’, ‘afternoon’ or ‘night’ shifts. Pattern 5
included a 24‐h period free of duty prior to the first of two consecu-
tive night shifts, whereas in patterns 1 and 2 a single night shift
started on the day the morning shift ended. Total sleep time (TST)
was calculated as the amount of sleep occurring in the 24 h prior to
the start of each shift. Linear mixed models were conducted to
determine: 1) whether TST prior to a shift differed between morning,
afternoon and night shifts and 2) whether TST prior to a night shift
differed between shift patterns.
Results: ATCs obtained significantly less sleep prior to a morning
than an afternoon shift (p< 0.01, difference 50 min) and significantly
less sleep prior to a night shift than an afternoon shift (p< 0.01, 50‐
min difference). There was no significant difference in TST prior to a
morning compared to a night shift (p=0.98). ATCs obtained signifi-
cantly more sleep prior to the first night shift in pattern 5, following
24‐h off‐duty, relative to pattern 1 (p=0.03, 57‐min difference) but
not pattern 2 (p = 0.08, 45‐min difference). Prior to the second night
shift in pattern 5, they obtained less sleep than prior to the night
shift in patterns 1 and 2 (respectively p = 0.02, p< 0.01, 61‐ and 74‐
min difference) and the first night shift of pattern 5 (p< 0.01, 118‐
min difference).
Conclusions: Overall, the timing of a shift impacted the amount of
sleep obtained by ATCs prior to their shift with morning and night
shifts resulting in shortened sleep duration. However, it appears that
a 24‐h period free of duty prior to a night shift can mitigate this
effect.
Disclosure: This study was industry funded.
P078 | Subjective mood and the processing of
emotional stimuli following a brief, midday nap
J. Goldschmied1; P. Deldin2
1Center for Sleep and Circadian Neurobiology, University of
Pennsylvania, Philadelphia, PA, 2Department of Psychology, University
of Michigan, Ann Arbor, MI, United States
Objectives/Introduction: Napping is an effective intervention for
daytime fatigue and sleepiness and has also been shown to confer
additional benefits such as increasing frustration tolerance. This may
indicate that napping provides facilitation of emotion regulation,
more generally. The processing of emotional stimuli is an important
component process of emotion regulation and is widely believed to
be affected by continued wakefulness. Thus, the present study
aimed to examine the impact of a brief, midday nap on subjective
mood and the processing of emotional stimuli.
Methods: 40 participants between the ages of 18–50 were ran-
domized into a 60‐min nap or no‐nap condition. Mood was mea-
sured using visual analogue scales, both before and after the nap or
no‐nap period. A subset of 30 participants also completed a dot‐
probe task that assessed attentional bias to emotional stimuli, ana-
lyzed using a repeated measures ANOVA with condition (pre or
post‐nap) as a within‐subjects factor and group (nap or no‐nap) as a
between‐subjects factor.
Results: Results revealed that those in the no‐nap condition
demonstrated shorter reaction time to emotional images while those
in the nap group exhibited similar reaction times to emotional vs
neutral images, F(1, 28) = 4.52, p < 0.05. While those in the no‐nap
condition showed no change in mood, F(1, 38)=8.91, p < 0.01, those
in the nap condition showed a worsening of mood following the nap
which was not associated with level of sleepiness.
Conclusions: Our results indicate that over the course of the day,
continued wakefulness may be associated with an increase in
response bias toward emotional stimuli, even when subjective mood
is not affected. Napping may prevent these biases from occurring,
however may come at the cost of subjective mood impairments. As
sleepiness was not associated with mood ratings in the nap group,
further research will be needed to identify the mechanism responsi-
ble for mood impairments post‐nap.
Disclosure: Nothing to disclose.
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P079 | Relationship status, sleep patterns and
sleep quality ‐ how are they related?
K. Bosancic1; A. Koscec Bjelajac2
1Croatian Studies, Psychology, University of Zagreb, 2Occupational
Health and Environmental Medicine Unit, Institute for Medical Research
and Occupational Health, Zagreb, Croatia
Objectives/Introduction: Sharing a bed may affect usual sleep
patterns but sleeping with a partner seems to have a beneficial
impact. The aim of this study was to examine the differences in
sleep quality (SQ) and sleep patterns between people who slept with
their partners and those who slept alone. In addition, we wanted to
examine the predictive value of the relationship quality and relation-
ship duration for subjective SQ.
Methods: The study was conducted with 449 participants (79%
women, M = 32.3 years, SD = 11.37), where 56% were married or
living with partner, 23% were in relationship but not cohabiting, and
21% were single, divorced or widowed. A total of 225 reported reg-
ularly sharing bed with a partner and 176 reported sleeping alone.
Seventy percent of participants were highly educated, and 62.4%
employed full‐time. Online questionnaire comprised general ques-
tions, questions on sleep patterns on work‐days and weekends, nap-
ping, estimated sleep need and subjective SQ, and the Relationship
Assessment Scale.
Results: T‐tests showed significant differences between partici-
pants sleeping with or without a partner in several sleep characteris-
tics. Participants who shared bed with a partner estimated shorter
sleep latency (p = 0.005), had earlier bedtimes and wake‐up times on
workdays (p = 0.000), were napping less on work days (p = 0.000),
went to bed earlier, woke up earlier and slept shorter on weekends
(p = 0.000), and generally needed less sleep (p = 0.027). Regression
analysis showed that, irrespective of bed‐sharing, in those who were
in the relationship age, relationship quality, duration of relationship
and duration of cohabitation significantly explained only 4% of SQ
variance (p = 0.037). The only significant individual predictor was the
relationship quality (p = 0.001).
Conclusions: The results of our study indicate differences in sleep
patterns and other sleep characteristics indicative of SQ between
those who slept with their partners and those who slept alone,
although the groups did not differ in subjectively estimated SQ. The
results showed that sleeping with a partner could be considered a
protective factor for healthier sleep patterns, and that being in a
good relationship significantly contributes to better subjective SQ.
Disclosure: Nothing to disclose
P080 | Refraining from smartphone use for
30 min before bedtime prevents the extension
of the following sleep latency
M. Takahara
Fukushima University, Fukushima, Japan
Objectives/Introduction: The purpose of this study was to exam-
ine the effect of smartphone use through polysomnography (PSG)
recording, especially to examine until how many minutes before the
prescribed bedtime smartphone‐use would affect the following sleep
quality.
Methods: In our preliminary questionnaire survey on university
students’ information and communication technology (ICT) use at
nighttime and sleep habits (n = 160), it was found that the most
used ICT apparatus was smartphone, and the most frequent activity
was to search something on the internet. Pittsburgh Sleep Quality
Index (PSQI) score of the group that used smartphone until just
before their bedtime was worse than that of the group that
refrained from using smartphone before their bedtime for at least
30‐min or longer (ps < 0.05). Then, having controlled the time differ-
ence between the last smartphone use and prescribed bedtime, a
psychophysiological experiment was conducted using PSG. Partici-
pants were 6 male university students (mean age = 21.3 years). The
controlled times were, 60‐min, 30‐min, and 0‐min (just) before the
prescribed bedtime (0:00), and within‐subject comparisons were per-
formed. It was confirmed that they all had regular sleep habits
before the experiments.
Results: Sleep structures were not affected by the difference time;
however, the sleep latencies were significantly extended in the 0‐
min condition than the 30‐ or 60‐min before conditions (ps < 0.05).
Conclusions: It was experimentally indicated that when one used
smartphone until just before the bedtime, the sleep latency would
be longer, and that refraining from use 30 min until bedtime could
prevent the effect. Habitual delay of sleep onset time could be fol-
lowed by worse sleep health.
Disclosure: Nothing to disclose.
P081 | Social patterning of inadequate sleep
and behavioural sleep problems: findings from
the 2016 sleep health foundation Australia
survey
A. Reynolds1; S. Appleton2; T. Gill2; A. Taylor2;
R.D. McEvoy3; S. Ferguson4; R. Adams2
1Appleton Institute, CQUniversity, Wayville, 2University of Adelaide,
3Adelaide Institute of Sleep Health, 4CQUniversity, Adelaide, SA,
Australia
Objectives/Introduction: Inadequate sleep costs the Australian
community $66 billion annually. Given the pervasiveness of
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inadequate sleep and sleep problems in the population, there is a
need to identify specific social groups which may be most vulnerable
to inadequate sleep to facilitate development of targeted public
health interventions.
Methods: A 2016 online survey of a representative sample of
1,011 Australian adults included social patterning predictors of hous-
ing situation, income, educational attainment, work status/schedules,
financial savings/strain, neighbourhood index of relative socioeco-
nomic disadvantage, metro v rural status, domestic partnership, and
country of birth. Outcome variables were perceived habitual sleep
adequacy and symptoms of a sleep problem (including daytime
symptoms, sleep onset or maintenance problems, fatigue, irritability/
moodiness). Multivariable‐adjusted binary logistic regression analyses
were conducted for each significant social patterning predictor con-
trolling for age, sex and clinical sleep disorders (sleep apnea, insom-
nia, restless legs).
Results: Perceived Habitual Sleep Adequacy was significantly associ-
ated with income, financial savings status, work status and work
schedules (all p< 0.05). In adjusted models, only those working eve-
ning or night shift were less likely to report feeling they achieve ade-
quate sleep (OR = 0.56, CI = 0.34, 0.91, p = 0.021). Sleep Problems
were associated with sex, financial strain, financial savings status,
bed partner status, work status and work schedule (all p < 0.05).
Those married/defacto were less likely to report symptoms reflecting
a sleep problem (OR = 0.59, CI = 0.42, 0.84, p = 0.003). Work status
also remained significant in adjusted models indicating a reduced
odds of sleep problems in full time workers (OR = 0.33, CI = 0.15,
0.73, p = 0.006), part time workers (OR = 0.24, CI=0.10, 0.56,
p = 0.001) and retirees (OR = 0.37, CI = 0.14, 0.99, p = 0.049) com-
pared with students. No associations were seen with neighbour-
hood‐level disadvantage.
Conclusions: Associations of sleep adequacy and sleep problems
with financial strain or savings behavior were attenuated in multi-
variable models. However, occupational and educational stressors,
rather than socioeconomic disadvantage and living arrangements, are
predictive of poor sleep. Further research is needed in Australian
samples to determine whether additional social patterning factors
including neighbourhood characteristics (noise, violence and per-
ceived safety) and family status influence perceived habitual sleep
adequacy and prevalence of behavioural sleep problems.
Disclosure: This research was funded by the Sleep Health Founda-
tion in a grant awarded to CIA Adams.
P082 | A field‐study on the role of sleep in
stress resilience in rescue workers: preliminary
analyses of wrist‐actigraphy and home‐
polysomnography
I. Clark1; Y. Azza1,2,3; S. Müller4; P. Schwab5; W. Karlen5;
E. Seifritz2,6; B. Kleim1,2,3; H.-P. Landolt1,6,7
1Equal Contributions, Institute of Pharmacology and Toxicology,
University of Zurich, 2Department of Psychiatry, Psychotherapy and
Psychosomatics, University Hospital for Psychiatry, 3Department of
Experimental Psychopathology and Psychotherapy, University of Zurich,
4Schutz & Rettung Zürich, 5Institute of Robotics and Intelligent Systems,
D‐HEST, ETH Zurich, 6Zurich Center for interdisciplinary Sleep Research
(ZiS), 7Institute of Pharmacology and Toxicology, University of Zurich,
Zurich, Switzerland
Objectives/Introduction: Previous research suggested that good
quality sleep may benefit stress resilience and emotional regulation.
Here we aim at better understanding the role sleep plays in stress
resilience in rescue workers, an at‐risk group for stress disorders.
Methods: To date, we monitored a sample of 15 rescue workers
(male and female, 18–65 years) continuously over the course of
1 month. Data on psychological stress and sleep‐wake habits were
collected by post‐traumatic stress disorder checklist 5 (PCL‐5) and
continuous recordings of wrist‐actigraphy (ACT) and heart rate, vali-
dated by single‐night polysomnographic (PSG) sleep recordings at
home.
Results: Preliminary analyses of sleep latency and sleep efficiency
derived from ACT compared to home‐PSG revealed similar values
(n = 15; pall > 0.05), demonstrating the accuracy and reliability of
continuous real‐time wearable data collection over the one‐month
study period. Regression analysis indicated PCL‐5 scores as signifi-
cant predictor of sleep duration, such that those with higher stress
scores compared to lower stress scores slept longer (p = 0.013).
Conclusions: The preliminary findings of this ongoing study indi-
cate inter‐ and intrasubject variability in sleep profiles and stress
management, which warrant further investigation. Simultaneous
recording of long‐term estimates of sleep quality and heart rate and
smartphone/app assessed stress events in a larger study sample may
substantiate a distinct role for sleep in stress resilience in rescue
workers.
Disclosure: Nothing to disclose
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P083 | Making errors at work due to
sleepiness or sleep problems is not limited to
shift working populations: results of the 2016
Sleep Health Foundation survey
S. Ferguson1; S. Appleton2; A. Reynolds3; T. Gill4; A. Taylor2;
R.D. McEvoy5; R. Adams2
1Appleton Institute, CQUniversity Australia, Wayville, 2University of
Adelaide, 3Appleton Institute, CQUniversity, 4Univeristy of Adelaide,
5Adelaide Institute of Sleep Health, Adelaide, SA, Australia
Objectives/Introduction: As many as 30% of Australians report
making errors at work as a consequence of sleepiness or general
sleep issues. While fatigue risk management systems are intended to
reduce the risk of errors and accidents at work as a consequence of
work‐related fatigue, such systems are typically implemented in
workplaces with shift working operations. Long working hours and
commutes also impact day workers’ sleep behaviours and opportuni-
ties. Our aim was to determine the relationship between sleep dura-
tion and disorders, sleep health and hygiene factors, work related
factors and errors at work in Australian workers.
Methods: From a sample of 1011 Australian adults, age‐adjusted
binary logistic regression analyses were conducted in 512 workers
who provided responses to the question “Thinking about the past
3 months, how many days did you make errors at work because you
were too sleepy or you had a sleep problem?”
Results: A number of sleep behaviours and poor sleep hygiene fac-
tors were linked with work errors related to sleepiness or sleep
problems, with age‐adjusted odds of errors (confidence intervals) up
to 11.5 times higher (5.4–25.1, p < 0.001) in some sleep disorders,
7.7 (4.6–12.9) times higher in those who report multiple sleep prob-
lems (p< 0.001), 7.0 times higher (3.4–14.8) in short (≤5 h/night)
sleepers (p< 0.021), 6.1 times higher (2.9–12.7) in those staying up
later than planned most nights of the week (p< 0.001) and 2.4 times
higher (1.6–3.7) in those drinking alcohol ≥3 nights/week before bed
(p< 0.001). More than 40% of shiftworkers reported making errors
at work and they were more likely to be young (compared to the
main sample of workers) and more likely to engage in work activities
in the h before bed.
Conclusions: Sleep factors beyond clinical sleep disorders were
also associated with increased likelihood of sleep‐related work
errors. Both shift workers and non‐shift workers engage in work,
sleep and health behaviours that do not support good sleep health,
and these behaviours may be impacting safety and productivity in
the workplace through increased sleepiness‐related errors.
Disclosure: This work was funded by a grant from the Sleep
Health Foundation awarded to CI Adams.
P084 | Long‐term trends of sleep disturbances
related with attitude towards the health and
cardiovascular prevention in women 25–44 years
in Russia/Siberia
D. Panov; E. Gromova; E. Krymov; I. Gagulin; A. Gafarova;
V. Gafarov
Collaborative Laboratory of Cardiovascular Diseases Epidemiology,
Institute of Internal and Preventive Medicine - Branch of Institute of
Cytology and Genetics, Novosibirsk, Russian Federation
Objectives/Introduction: To determine the 23‐year dynamics
(1994–2017) of the relationship between sleep disorders (SD) and
attitude towards the health and cardiovascular prevention in female
population aged 25–44 years in Russia/Siberia.
Methods: Under the third screening of WHO program MONICA ‐
Psychosocial a random representative sample of women aged 25‐ 44
years in one of Novosibirsk district (n = 282) were examined in 1994
and it was done in 2017 (n = 668). The sleep assessment was per-
formed using the Jenkins Sleep Questionnaire. Attitude to their
health and the prevention of cardiovascular diseases were studied
using the “Knowledge and attitude to one′s health” scale proposed
by protocol “MONICA”.
Results: The prevalence of sleep disorders in the open population
among women aged 25–44 in the dynamics from 1994 to 2017
decreased from 59.6% to 47.3%. From 86.2% to 67.6% the propor-
tion of women with sleep disorders who consider themselves not
completely healthy or sick has decreased. The majority of women
with sleep disorders (57%) consider a high probability of getting a
serious illness in the next 5–10 years, but only 7% of women with
sleep disorders have regular preventive checks. By 2017 people with
sleep disorders have become more likely to seek medical help when
signs of heart disease appear and they prefer to conduct a more
thorough examination and obtain the opinion of outside specialists
during diagnostics. The share of those who were satisfied with medi-
cal care increased by 2017, but does not exceed 13%. In case of a
malaise, only 1 in 10 women apply to a doctor, as in 1994. The
intensity of work of young women with sleep disorders is higher
compared to a good sleep; they more often (more than 40%) do
additional work, have a higher responsibility. The growth of family
stress in women with SD by 2017y is due to frequent relatives’ ill-
ness or death or changes in their marital status.
Conclusions: We found decreasing in SD rates over two decades.
There is more careful attitude to their health in those with SD by
2017 but increased intensity and responsibilities at work and family
stress.
Disclosure: Nothing to disclose.
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P085 | ADHD symptoms are associated with
decreased activity of fast sleep spindles and
poorer procedural overnight learning during
adolescence
I. Merikanto
Department of Psychology and Logopedics, University of Helsinki,
Helsinki, Finland
Objectives/Instruction: ADHD and its subclinical symptoms have
been associated with both disturbed sleep and weakened memory
consolidation. As sleep spindle activity during NREM sleep plays a
key role in both sleep maintenance and memory consolidation, we
examined the association between ADHD characteristics and sleep
spindle activity. Furthermore, we hypothesized that sleep spindle
activity would mediate the effect of subclinical ADHD characteristics
on overnight learning in a procedural memory task.
Methods: We studied these questions in a community‐based
cohort of 170 adolescents (58% girls, mean age = 16.9, SD = 0.1
years), who filled in the Adult ADHD Self‐Report Scale (ASRS‐v1.1),
and underwent an overnight sleep EEG coupled with a mirror tracing
task before and after sleep.
Results: Elevated ADHD symptoms were associated with lower
fast spindle amplitude at frontal derivation (p = 0.04), shorter fast
spindle duration at both frontal (p = 0.005) and central (p = 0.04)
derivations, as well as weaker fast spindle intensity at both frontal
(p = 0.01) and central (p = 0.03) derivations. Elevated ADHD symp-
toms (p = 0.04) as well as lower sleep spindle amplitude (p = 0.03 at
central derivation and p = 0.04 at frontal derivation) and intensity
(p = 0.04 at both central and frontal derivations) were associated
with poorer overnight learning in the procedural memory test. How-
ever, sleep spindles, contrary to the hypothesis, did not mediate the
association between ADHD symptoms and overnight learning.
Conclusions: Our results show that a higher level of ADHD symp-
toms in adolescence is associated with similar alterations in sleep
spindle activity at frontal areas as observed in many neuropsychiatric
conditions.
Disclosure: Nothing to disclose.
P086 | Associations between brain oscillation
cross‐frequency coupling during sleep and
declarative learning in healthy older adults
O. Weiner1,2,3; J. O'Byrne2,3; D. Bolanis1,2; J. Giraud3,4;
L. Homer1,2,3; L. Tarelli1,2; V. Yue1,2; K. Walker2;
R. Tamaddon1; R. Carbone1,2; J. Lumia1,2; K. Eddebbarh1,2,3;
K. Chhuon1,2; D. Smith1,2,3; M. Mograss2,3; N. Cross2,3;
T.T. Dang-Vu2,3,4
1Psychology, Concordia University, 2Exercise Science, PERFORM Centre
(Concordia University), 3Institut Universitaire de Gériatrie de Montréal,
4Département de Neurosciences, Université de Montréal, Montreal, QC,
Canada
Objectives/Introduction: Learning and memory consolidation pro-
cesses may be mediated by a spontaneous synchronization of neu-
ronal oscillations known as cross‐frequency coupling (CFC). Coupling
of neuronal oscillations is observed in both awake and asleep elec-
troencephalogram (EEG) recordings. Associations between learning
and increased CFC during non‐rapid‐eye‐movement (NREM) and
rapid‐eye‐movement (REM) sleep have been observed in animals and
young adult humans. However, similar studies have rarely been con-
ducted in older adults. The current study with healthy older adults
tested a hypothesis that increases in CFC during sleep are positively
associated with better performance on a sleep‐dependent declarative
memory task.
Methods: Nineteen healthy, community‐dwelling older adults (M
(SD) age = 67.8 (5.12) years; 13 female) completed a baseline
polysomnography to rule‐out severe sleep apnea, followed by 7 days
of ambulatory monitoring using actigraphy and a daily sleep diary. A
second overnight polysomnography was performed at least 1 week
after the first and included a word‐pair associates task (40 word‐
pairs), with immediate (pre‐sleep) and delayed (post‐sleep) recall peri-
ods. Phase‐amplitude CFC was quantified using the modulation index
from frontal (Fz) and central (Cz or C3) EEG data between delta (1–
4Hz) and sigma (11–16Hz; adapted) bands during the first NREM
sleep cycle (NREM2, NREM3, NREM2/3), and between delta (1.5–
3Hz) [or theta (4–7Hz)] and gamma (50–100Hz) bands during total
REM sleep. Associations among relative changes in CFC between
overnight recordings (Night 2‐Night 1) and word‐pair memory perfor-
mance were examined using linear regression, controlling for age,
sex, education (years), and apnea‐hypopnea index.
Results: A greater relative increase in delta‐sigma CFC during
NREM2/3 was positively associated with better word‐pair recall per-
formance in both immediate (R2change = .281, β = .694, p = 0.008)
and delayed testing conditions (R2change = .299, β = .715, p=.003). A
greater relative increase in theta‐gamma CFC during REM sleep was
positively associated with greater word‐pair performance stability
between immediate and delayed recall conditions (R2change = .206,
β= .497, p = 0.047). Results were significant only on central EEG
channels.
Conclusions: Findings from this study further add to a growing
theory that CFC during sleep reflects a neural mechanism underlying
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offline memory consolidation for newly learned declarative material.
This study also provides novel evidence for relations between CFC
during sleep and declarative learning in healthy older adults.
Disclosure: Nothing to disclose.
P087 | Overnight production of false memories
in adolescents ‐ associations with sleep EEG and
spindles
L. Kuula1; J. Tamminen2; I. Merikanto1; T. Makkonen1;
A.-K. Pesonen1
1University of Helsinki, Helsinki, Finland, 2Department of Psychology,
Royal Holloway, University of London, Surrey, United Kingdom
Objectives/Introduction: The process of reorganizing and consoli-
dating memories is one of the central cognitive functions of sleep.
During sleep, the brain reorganizes newly encoded material, and
facilitates remembering. One likely mechanism is through sleep spin-
dles, the thalamocortical oscillations which occur during stage 2
sleep. The role of sleep in memory consolidation is not restricted to
the reorganization of veridical memory, but growing evidence
demonstrates that sleep also facilitates the extraction of semantic
regularities amongst the newly encoded memories, which may also
lead to increased false memories. We investigated the potential role
of sleep spindles and sleep stage proportions in the formation of
adolescents’ false memories.
Methods: Participants came from a healthy, full‐term birth cohort
and underwent ambulatory overnight polysomnography (PSG) (Som-
noScreen plus, SomnoMedics) at mean age 16.9 year (SD = 0.1). 196
adolescents participated (61% girls). We used the standard Deese,
Roediger & McDermott (DRM) procedure to induce false memories
with eight lists of 15 words (altogether 120 words) in the evening,
with free recall the following morning. Sleep was scored manually
into stages 1, 2, 3 and REM. Central and frontal region spindle num-
ber, frequency, density (number of spindles per 30‐s‐epoch), duration
(seconds), and amplitude (μV) were used as measures of general
spindle activity and individual spindles for slow (10–13 Hz) and fast
(13–16 Hz) ranges.
Results: Girls’ produced a higher number of correctly recalled stud-
ied words, critical lures (false memories), and intrusion words than
boys (all p ≤ 0.001). In linear regression analyses, girls’ longer sleep
duration was associated with more intrusion words, but not with
critical lures (p = 0.03). In girls, a lower amount of critical lures was
associated with higher spindle frequency (p ≤ 0.009), density
(p ≤ 0.009), amplitude (p = 0.029), and number (p ≤ 0.028). These
associations survived adjustment for age, pubertal status, and intelli-
gence. Regarding boys, no significant results emerged regarding
these associations.
Conclusions: We found that in adolescents girls higher spindle
activity was associated with fewer critical lures being falsely recalled
in the DRM paradigm. Unlike studies using adult participants, we did
not observe any association between stage 3 sleep and false mem-
ory formation.
Disclosure: Nothing to disclose.
P088 | Baseline cortical activity predicts
reactivity to nociceptive stimuli during sleep
H. Bastuji; A. Cadic-Melchior; L. Garcia-Larrea
CRNL Neuropain Team, LYON, France
Objectives/Instruction: Nociceptive stimuli are known to disrupt
sleep and this sleep disruption follows the apparition of a ‘cognitive’
wave, supposed to reflect the activation of a widespread cortical
network (Bastuji et al. 2008). The factors allowing the activation of
this network are unknown and remain to be identified. The aim of
the present study was to test if the characteristics of baseline corti-
cal activity can predict reactivity to these nociceptive stimuli. For
this purpose, intra‐cerebral electrophysiological signal before noci-
ceptive stimuli during sleep were analysed in the time‐frequency
domain.
Methods: Intracerebral recordings were obtained in 14 epileptic
patients receiving thermo‐nociceptive stimulations, calibrated slightly
above the individual pain threshold, during whole night sleep. Spec-
tral content of 5 s pre‐stimulus EEG signal and phase coherence
between posterior insula and 14 other brain areas were compared
according to presence or absence of arousal post‐stimulus, during
sleep N2 and paradoxical sleep (PS).
Results: Spectral power of delta activity pre‐stimulus was signifi-
cantly lower before arousal reaction as compared to that with no
arousal in N2 (p < 0.0001), and higher in PS (p < 0.001). Pre‐stimu-
lus phase coherence between posterior insula and other brain areas
was significantly higher before post‐stimulus arousal as compared to
no arousal, and this in N2 as well as in PS.
Conclusions: Arousal occurrence is related to a lighter sleep when
the nociceptive stimulus is delivered and a higher functional connec-
tivity between the sensory and other cortices. This greater connec-
tivity between sensory and association areas may facilitate
information propagation leading to conscious perception and physio-
logical response.
Disclosure: Nothing to disclose.
P089 | Sleep strengthens spontaneous retrieval
processes in prospective memory
R.L.F. Leong; J.C. Lo; M.W.L. Chee
Neuroscience and Behavioral Disorders Program, Duke-NUS Medical
School, Singapore, Singapore
Objectives/Instruction: Prospective memory (PM) is defined as
remembering to execute a future intention. Here, we investigated
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the effect of sleep on prospective memory as well as the relationship
between macrostructural features of sleep and prospective memory
consolidation.
Methods: Forty‐nine adults (mean age ± SD: 22.1 ± 1.71 years; 18
males) encoded intentions comprising 4 related (‘phone‐unplug ear-
phones’) and 4 unrelated (‘mirror‐close the book’) cue‐action pairs.
They were instructed to remember to perform these actions in
response to cue words presented during a semantic categorization
task performed 12‐h later. The interval was either across a period of
wakefulness (09:00–21:00; n = 24) or following overnight sleep that
was monitored with polysomnography (21:00–09:00; n = 25).
Results: We found a significant group x relatedness interaction for
prospective memory accuracy (F(1,47) = 8.35, p < 0.01). The sleep
group successfully executed a significantly higher percentage of
related intentions compared to the wake group (mean ± SEM: 94.00
± 2.61% vs. 66.67 ± 6.84%, p < 0.01).There was no significant group
difference in the percentage of unrelated intentions successfully exe-
cuted (82.00 ± 5.10% vs. 72.92 ± 6.88%, p = 0.29). Further, the ben-
efit for related intentions was associated with more post‐learning
slow wave sleep (p < 0.05).
Conclusions: Sleep may selectively strengthen spontaneous retrie-
val processes in prospective memory, promoting the execution of
intentions comprising intuitively linked cue‐action pairs.
Disclosure: Nothing to disclose.
P090 | Information processing during sleep is
linked to changes in sleep microstuctures
M. Ameen1; C. Blume1; D.P.-J. Heib1; R. Del Giudice2;
M. Schabus1
1Department of Psychology, Center for Cognitive Neuroscience,
University of Salzburg, Salzburg, Austria, 2Università degli Studi di
Milano‐Bicocca, Milan, Italy
Objectives/Introduction: While for a long time it was assumed
that the brain is ‘shielded’ from the environment during sleep, we
now know that processing of information continues even during the
deepest stages of sleep including REM sleep. However, brain
responses to salient stimuli change from wakefulness to sleep. In
particular, it has been proposed that such changes may reflect the
appearance of sleep‐specific microstructures such as arousal, K‐com-
plexes, sleep spindles and slow oscillations, which have been shown
to influence information processing. We investigated the changes in
sleep microstructures induced by auditory stimulation and the effect
of this change on information processing.
Methods: We employed nocturnal (8 h) 256‐channel EEG record-
ings to measure brain responses to salient stimuli during sleep in 17
healthy sleepers. More specifically, we presented participants with
their own name and unfamiliar names uttered by a familiar voice or
an unfamiliar voice. We assessed changes in sleep microstructures
namely; arousals, K‐complexes and fast spindles (13–15Hz), following
the presentation of auditory stimuli. Analyses were performed on 4 s
epochs starting with stimulus onset (evoked) and baseline corrected
to random 4 s epochs where no auditory stimuli were presented
(spontaneous). To identify the difference between the two groups,
non‐parametric tests were calculated. Effects p < 0.05 are denoted
significant.
Results: The incidence of auditory‐evoked arousals to occur was
significantly higher than that of spontaneous arousals (p < 0.01).
However, there was no difference between the duration of auditory‐
evoked and spontaneous arousals. Similarly, the amount of evoked
K‐complexes measured on both left and right hemispheres was sig-
nificantly higher than spontaneously generated K‐complexes (p< .01,
at C3 and C4). Interestingly, only on the left hemisphere the mean
amplitude of evoked K‐complexes was lower than that of sponta-
neous K‐complexes (p < .05 at C3). Finally, fast spindle activity
increased significantly following auditory stimulation (p < .05). Ongo-
ing analyses focus on the subtle alertness changes (evaluated by
Hori scale; Tanaka et al., 1996) evoked by different auditory stimuli.
Conclusions: Our results suggest that information processing is
ongoing even during the most “inhibitory” events in sleep. They also
propose a direct link between the activity of sleep microstructures
and information processing.
Disclosure: Nothing to disclose.
P091 | The consolidation of cognitive
strategies is enhanced by sleep, but not the
motor skills needed to acquire it
L.B. Ray1; N.H. van den Berg2; J. Al-Kuwatli2; J. Paulin3;
A.M. Owen3,4; S.M. Fogel1,2,4
1The Royal's Institute of Mental Health Research, 2School of
Psychology, University of Ottawa, Ottawa, 3The Brain and Mind
Institute, 4Department of Psychology, Western University, London, ON,
Canada
Objectives/Instruction: Sleep is beneficial for the consolidation of
both “cognitive procedural memory” (CPM) and “simple procedural
memory” (SPM). CPM involves the acquisition of a novel cognitive
strategy through the execution a series of motor movements. By
contrast, SPM involves motor skills learning of a cognitively simple
sequence of movements. Sleep has been implicated in the consolida-
tion of implicit CPM, whereas the role of sleep in implicit SPM
remains unclear. The present study directly compared the differential
benefit of sleep for CPM vs. implicit SPM consolidation.
Methods: To disentangle and directly compare SPM to CPM, sub-
jects were tested on: (1) the “classic” Tower of Hanoi task (ToH)
where the solution requires the use of both recursive elements (i.e.,
a repetitive series of movements, thus involving SPM) and non‐
recursive elements (i.e., a non‐repetitive series of movements that
can only be learned by acquiring the underlying cognitive strategy,
thus involving CPM); and (2) a “modified” version of the ToH, akin
to the serial reaction time (SRT) task, designed to prevent the
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acquisition of a cognitive strategy, thus isolating the SPM compo-
nent of the task. Participants (n = 57) were trained on either the
ToH or SRT, then retested on both the ToH and SRT. Half were
trained in the evening, retested after a night of sleep, and again after
a day of wake (PM‐AM‐PM). The other half were counterbalanced
(AM‐PM‐AM).
Results: The time taken to complete the ToH improved following
sleep vs. wake from training to retest (F(2, 52)=3.22, p = 0.048), but
not for the SRT (F(2,54) = 0.324,p = 0.725). Follow‐up tests revealed
that performance improved only for the ToH after sleep – and only
after sleep – either immediately after training, or 1 day later. More-
over, sleep significantly enhanced the non‐recursive elements but
not the recursive elements of the ToH, but not the SRT.
Conclusions: Sleep preferentially supported CPM, whereas implicit
SPM improved regardless of sleep or wake. These results suggest
that sleep benefits the cognitive aspects of procedural memory,
rather than strengthening the implicitly acquired motor sequences
involved in learning the strategy itself.
Disclosure: Nothing to disclose.
P092 | Dynamic of the hippocampus activity
during arousing reaction from sleep: an
intracranial EEG study
P. Ruby; M. Eskinazi; R. Bouet; R. Vallat; L. Peter-Derex
CRNL DYCOG Team, Bron Cedex, France
Objectives/Introduction: Short phasic activations during sleep are
considered as transient elevations of the level of vigilance and are
called arousals (3–15 s) or awakenings (more than 15 s). As predicted
by the arousal‐retrieval model (Koulack & Goodenough 1976), we
previously found that the average duration of intra‐sleep awakenings
was a good predictor of dream recall (2 min vs 1 min in average in
high vs low dream recallers, Vallat et al. 2017). Intracranial EEG stud-
ies have shown that cortical patterns of activation during short arou-
sals were inconsistent across time and heterogeneous according to
brain regions, but none of them had the chance to explore the hip-
pocampus (Peter‐Derex et al. 2015).
Methods: We investigated the hippocampus activity during sleep
and short arousing reactions lasting from 3 s to 2 min using intracra-
nial recordings (S‐EEG) in 4 drug‐resistant epileptic patients undergo-
ing pre‐surgical investigation. Sleep EEG recordings from the
thalamus and hippocampi free of epileptic activity were analysed.
The average power in S‐EEG hippocampal signal for frequency bands
of interest (between 0.5 and 140 Hz) was calculated in 4 time win-
dows: the 10 sec of sleep preceding the arousal, the first 3 sec of
the arousal, the end of the arousal, and 10 sec of evening wakeful-
ness.
Results: A total of 617 arousing reactions were analysed. Compar-
isons between hippocampal spectral power in the 4 time windows of
interest showed that 1) the power in several frequency bands during
the arousals was intermediate between the power during wakeful-
ness and the power in the preceding sleep, 2) the longer the arousal,
the more wake‐like the power in these frequency bands, 3) the
power in the gamma band was not significantly lower in N2 sleep
than in wakefulness, and 4) the power in the delta band was not sig-
nificantly different in REM sleep and wakefulness.
Conclusions: The results show that during short arousals/awaken-
ings
1 the hippocampus activity changes,
2 the reinstatement of the wakefulness hippocampus activity
takes several tens of seconds,
3 the timing of the hippocampus reactivation is coherent with
the timing of dream recall/forgetting and awareness of wake-
fulness reinstatement at awakening.
Disclosure: Nothing to disclose.
P093 | Influence of hypnotic suggestions on
spindles, slow oscillations and memory
consolidation during sleep
J. Beck; M.J. Cordi; B. Rasch
Cognitive Biopsychology and Methods, University of Fribourg, Fribourg,
Switzerland
Objectives/Instruction: Slow Oscillations (SO) and sleep spindles
are associated with memory consolidation during sleep (Mednick
et al., 2013; Ngo, Martinetz, Born, & Mölle, 2013; Rasch & Born,
2013). Moreover, fast spindles seem to mediate information process-
ing during sleep (Cairney, Guttesen, El Marj, & Staresina, 2017) in
association with SOs (Helfrich, Mander, Jagust, Knight, & Walker,
2018; Latchoumane, Ngo, Born, & Shin, 2017; Niknazar, Krishnan,
Bazhenov, & Mednick, 2015).
Two recent studies provided evidence that listening to a hypnotic
suggestion to “sleep deeper” prior to a nap or a night of sleep pro-
longs subsequent SWS (Cordi & Rasch, under revision; Cordi, Sch-
larb, & Rasch, 2014). This beneficial effect only occurred in
participants suggestible to hypnosis (HS) but not in low suggestible
(LS). Despite of the large inter‐individual differences in SWS
between the hypnosis and control night, no benefit of declarative
memory consolidation occurred. Here we examined whether a more
fine‐grained analysis of SO and sleep spindles would explain the lack
of memory consolidation effect during sleep.
Methods: We used the SpiSOP toolbox (Frederik D. Weber, 2013)
based on Matlab 2015a (Mathworks, Natick, USA) that utilizes Field-
trip (Oostenveld, Fries, Maris, & Schoffelen, 2011) to detect slow
and fast spindles and SO in the EEG Data. Healthy young partici-
pants listened either to a hypnosis a control tape before a nap (N =
30) or a full night of sleep (N = 48), in a within‐subject cross‐over
design.
Results: As expected, SO density was significantly increased (p <
.001) in the hypnosis vs. the control condition for HS, while the
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pattern was reversed in LS. However, spindle density did not signifi-
cantly follow this results pattern (p = .19). Pilot analysis suggested a
reduced synchrony between occurrence of spindles and slow oscilla-
tion in the hypnosis condition for high suggestible participants.
Conclusions: Hypnotic suggestion to sleep deeper might have a
larger effect on slow oscillations as compared to sleep spindles. This
differential effect on SO vs. sleep spindles might reduce the associa-
tion strength between SO and sleep spindles necessary for promot-
ing declarative memory consolidation during sleep.
Disclosure: This study was funded by a grant of the European
Research Council under the European Union's Horizon 2020
research and innovation program. The funders had no role in study
design, data collection and analysis, decision to publish, or prepara-
tion of a manuscript.
P094 | Evaluating short and long‐term effects
of full‐night sleep and heart rate variability on
procedural memory performance
F.J. van Schalkwijk1; T. Hauser1; K. Hoedlmoser1;
C. Sauter2,3; G. Klösch2; D. Moser2; G. Gruber4; P. Anderer4;
B. Saletu4; S. Parapatics4; J. Zeitlhofer2; M. Schabus1
1Laboratory for Sleep, Cognition and Consciousness Research, Centre for
Cognitive Neuroscience CCNS, University of Salzburg, Salzburg,
2Department of Neurology, Medical University of Vienna, Vienna,
Austria, 3Competence Center of Sleep Medicine, Charité, University
Medicine, Berlin, Germany, 4Department of Psychiatry and
Psychotherapy, Medical University of Vienna, Vienna, Austria
Objectives/Instruction: Sleep and memory studies primarily focus
on overnight rather than long‐term performance changes, and tradi-
tionally investigate associations with sleep architecture and sleep
spindles. Yet, heart rate variability (HRV) during wakefulness has
been positively associated with cognitive performance, and may
therefore be an additional variable of interest when studying over-
night performance changes. This study investigated overnight and
long‐term performance changes for procedural memory, and evalu-
ated potential associations with HRV (standard deviation of RR inter-
vals [SDNN]), sleep characteristics, and sleep spindle activity.
Methods: Participants (N = 20, Mage = 23.40 ± 2.78 years) were
trained on a procedural mirror‐tracing task for counterbalanced con-
trol (normal vision) and learning (mirrored vision) conditions. Perfor-
mance was evaluated after evening training (T1), a full‐night of sleep
(T2), and seven days (T3). Performance changes, HRV, sleep architec-
ture, and spindle activity were analyzed for both conditions.
Results: Overnight performance changes (T1–T2) resulted in fewer
errors (p = 0.002) and shorter error time (p = 0.039), whereas a long‐
term (T2–T3) improvement was observed for speed (p = 0.004).
Overnight performance change for speed was negatively associated
with SDNN during sleep stages NREM1 (p = 0.004) and REM
(p = 0.001); meaning that higher variability in RR intervals resulted in
lower performance the next day. Contrasting participants based on
performance change for speed showed that SDNN was higher for
non‐improvers compared with improvers during NREM1 (p = 0.002)
and REM (p = 0.022). No associations were found between over-
night performance changes, sleep architecture, or spindle characteris-
tics after correcting for multiple comparisons (all ps ≥ 0.021).
Contrasting participants based on a change in spindle activity from
control to learning conditions showed that only participants with
increased spindle activity had a significant overnight reduction in the
number of errors (p = 0.012) and long‐term improvement in speed
(p = 0.021).
Conclusions: This study demonstrated that long‐term performance
changes can occur following overnight changes. Furthermore, these
results indicate HRV should be considered as a variable of interest
when evaluating overnight memory consolidation, in addition to tra-
ditional sleep characteristics.
Disclosure: Research was funded by the Austrian Science Fund
FWF (FWF P‐15370; Doctoral College W1233‐G17.
P096 | Effectiveness of reappraisal and
distraction in regulating emotion across sleep
S. Dhaka1; N. Kashyap2
1Humanities and Social Sciences, National Institute of Technology
Rourkela, Odisha, 2Humanities and Social Sciences, Indian Institute of
Technology Guwahati, Guwahati, India
Objectives/Introduction: Sleep provides an ideal neurobiological
medium which depotentiate prior negative experiences and restores
optimal post‐sleep affective reactivity and cognitive functions
(Walker and van der Helm, 2009). The first and central factor in
order that predict the effectiveness of emotion regulation strategies
is the underlying operating mechanism and the cognitive resources
required for modulation. The present study compares the effective-
ness of two affect regulating strategies (distraction and cognitive
reappraisal) in reducing negative affect across sleep.
Methods: Seventeen healthy participants performed on visual emo-
tion regulation task after sleep deprivation or sleep‐filled nights. The
dependent variable was valance rating on Self‐Assessment Manikin
Scale. Subjects on experimental nights provided valence ratings on
the Self‐Assessment Manikin Scale (SAM) under both no‐regulation
(control) and regulation (distraction/appraisal) strategies. Statistical
analyses were carried out using Statistical Package for Social
Sciences (SPSS).
Results: Separate repeated measure ANOVA were performed on
valance rating across [session (sleep/deprivation) and strategy (con-
trol/regulate)] for both the regulation strategies. Self‐reported rating
of valance for group using distraction strategy varied significantly [(F
(1, 16) = 4.56, p < 0.05)] across sleep and deprivation sessions. Simi-
larly, distraction as compared to control lead to significant differences
on self‐reported valence score [F (1, 16) = 24.97, p < 0.05]. For cogni-
tive reappraisal strategy, no significant differences for valance rating
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across sleep and deprivation nights resulted. However, there was a
significant difference in valence rating across control and regulation
strategy [F(1, 16) = 66.49, p < 0.05]. Both the regulation strategy
caused significant changes in valence as compared to control strategy.
In addition only distraction strategy revealed significant changes in
valence ratings across sleep and deprivation sessions.
Conclusions: Regulation strategies successfully modulated valence
when compared to no regulation sessions. In addition, only appraisal
strategy was able to modulated valence across sleep deprivation
leading to similar valence ratings across both deprivation and sleep
nights. Possible reason behind these results could be the underlying
mechanism and use of cognitive resources in individual strategy.
Disclosure: Nothing to disclose.
P097 | The role of sleep spindle activity in
consolidating statistical learning in obstructive
sleep apnea patients
D. Stevens1; C. Leong2; H. Cheung2; J. Arciuli3; A. Vakulin1,4;
J. Leow4; R. Grunstein4,5,6; B. Saini2,4; A. D'Rozario4,6,7
1Adelaide Institute for Sleep Health, Flinders University, Daw Park, SA,
2Faculty of Pharmacy, 3Faculty of Health Sciences, University of
Sydney, 4CIRUS, Centre for Sleep and Chronobiology, Woolcock Institute
of Medical Research, Sydney, 5Department of Respiratory and Sleep
Medicine, Royal Prince Alfred Hospital, Camperdown, 6Sydney Medical
School, 7School of Psychology, Faculty of Science, Brain and Mind
Centre and Charles Perkins Centre, University of Sydney, Sydney, NSW,
Australia
Objectives/Introduction: Statistical learning (SL) is where statisti-
cal regularities, in either auditory and/or visual stimuli, are learnt
implicitly, as in with no conscious awareness. Studies in healthy
individuals show that increased spindle activity during sleep is asso-
ciated with improved SL. Although deficits in sleep spindle activity
have been reported in overnight electroencephalogram (EEG)
recordings of untreated patients with obstructive sleep apnea
(OSA), no study has examined the relationship between sleep spin-
dles and SL in this population. This study examined whether spindle
frequency activity in NREM sleep during overnight polysomnogra-
phy was associated with SL performance in moderate to severe
OSA patients.
Methods: Patients underwent overnight full polysomnography
(PSG) in the sleep laboratory. Power spectral analysis was performed
on the EEG signals to derive spindle frequency activity, specifically
very slow (9–11Hz), slow (11–13Hz) and fast (13–16Hz) activity in
NREM sleep. SL was assessed by exposing participants to a reaction
time ‘cover task’ at 7 pm before the sleep study. Cartoon alien pic-
tures would flash on the screen, and participants would be asked to
respond to a repeated picture. Unbeknownst to participants, the pic-
tures appeared in groupings of three. 24 h later participants were
asked to judge the triplets. Correlations between spindle activity
and SL performance were conducted using Spearman's correlation
coefficients.
Results: Forty seven participants were studied (age 49 ± 9, BMI
30.0 ± 4.2, AHI 35.5±22.9). Average SL performance was 55.4%,
which was significantly above 50% chance level (t46 = 2.45, p =
0.018). Very slow and slow spindle frequency activity at both frontal
(F3 and F4) and central (C3 and C4) brain regions were significantly
correlated with improved SL performance Furthermore, fast spindle
activity at F3 and C4 sites significantly correlated with improved SL
performance (e.g., F3: very slow spindle activity, rho = 0.39, p =
0.008; slow spindle activity, rho = 0.41, p = .006; fast spindle activ-
ity. rho = .353, p = 0.019).
Conclusions: This study demonstrates that those OSA patients
with increased cortical spindle activity during overnight sleep had
greater SL performance. This highlights the potential importance of
spindle activity as a marker of implicit learning encoding in untreated
OSA patients.
Disclosure: Study funded by NHMRC Project Grant (no.
APP1028624). Authors declare no conflicts of interest.
P098 | Remembering emotional information
over a week: does sleep play any role?
M. Mercurio1; M. Sarlo1,2; N. Cellini1
1Department of General Psychology, 2Padova Neuroscience Center,
University of Padova, Padova, Italy
Objectives/Introduction: Sleep seems to play a key role in con-
solidating emotional memories. Nevertheless, most of the studies
have been focused on a single sleep period, and whether sleep pref-
erentially facilitates the consolidation of negative memories over
time remains unclear. Here, we investigated the role of sleep in
remembering emotional information over a week.
Methods: Using an incidental learning paradigm, 31 healthy univer-
sity students (23F) were exposed to a first set of 40 neutral and 40
unpleasant pictures. Fifteen minutes later they performed an imme-
diate recognition test where they were presented again 40 of the
previous pictures intermixed with 40 novel stimuli. They had to
decide whether they had seen the picture before. Seven days later
they performed a delayed recognition task with the remaining 40
pictures presented at the encoding intermixed with 40 novel stimuli.
During each session participants also rated the subjective valence
and arousal evoked by image viewing. Sleep pattern during the week
between the two recognition tasks was monitored actigraphy.
Results: At the immediate recognition, participants showed a higher
memory recognition (d’) for neutral compared to unpleasant pictures
(p = 0.016). As expected, one‐week later participants showed a
reduced performance compared to the immediate test for both
unpleasant and neutral memories (p< 0.001), but this time the d’ did
not differ between picture types (p = 0.80), indicating a reduced
degree of forgetting for emotional memories. Subjective arousal level
only nominally decreased between the sessions for both stimuli
types, while valence rating remained stable across time. Wake time
ABSTRACTS | 135 of 433
was positively associated with changes in memory discrimination
(r = 0.42, p = 0.018) and negatively with false alarm rate (r = −.32,
p = 0.078) for the unpleasant stimuli, indicating that individuals who
spent more time awake were the ones who showed less forgetting
for emotional memories.
Conclusions: Our results showed that after 7‐days, emotional
memories exhibit a reduced degree of forgetting compared to neu-
tral ones. However, participants with worse sleep quality were the
one who remembered better emotional information. We suggest that
emotional memories are more resistant to forgetting than neutral
ones over a week, and poor sleep may induce a paradoxical effect,
turning these memories even more resilient.
Disclosure: Nothing to disclose.
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P099 | Can insomnia be a predictor of attrition
in longitudinal studies?
C. Latreille1; S. Desjardins1; A. Desgagné2
1Department of Psychology, Université du Québec à Trois‐Rivières,
Trois‐Rivières, 2Department of Mathematics, Université du Québec à
Montréal, Montréal, QC, Canada
Objectives/Instruction: Attrition in longitudinal studies can be
due to mortality, disability, ineligibility (the participant no longer
meet the study requirements), refusal (the participant drop out vol-
untarily by refusing to participate in later months), and loss of con-
tact. Age and sex can be related to some of these forms of attrition.
For example, participants who left due to mortality can be older on
average, and more likely to be male in comparison with those who
remained in a study. There may also be other factors that make par-
ticipants more likely to withdraw. Can insomnia be one of them?
Methods: Four hundred and fifty‐one participants (ages 18–82;
mean = 27.9; 21.3% male) took part in a longitudinal study we con-
ducted. Each participant filled in the Insomnia Severity Index (ISI)
online. The questionnaire was to be completed monthly for a year.
Results: A multiple regression was performed between the number
of months completed in the study as the dependent variable and ISI
total score in month one, age, and sex as independent variables. The
results of the regression indicated that the three predictors
explained 7% of the variance (R2 = 0.07, F(3,417), p < 0.001). Only
ISI total score (beta = −0.090, p = 0.006) and age (beta = 0.078,
p < 0.001) were statistically significant.
Conclusions: Although the magnitude of the results is relatively
small, this study suggests that insomnia can be a risk factor for attri-
tion. These findings may be important to inform future studies on
ways to lessen or prevent systematic loss of participants.
Disclosure: Nothing to disclose.
P100 | Concomitant actigraphy and
polysomnography at home in different sleep
disorders
A. Alakuijala1,2; T. Jokela1,2; J. Toppila1,2
1Dep. of Clinical Neurophysiology, HUS Medical Imaging Center, 2Dep.
of Neurological Sciences, University of Helsinki, Helsinki, Finland
Objectives/Introduction: Actigraphy (ACT) is a much cheaper and
less cumbersome method for measuring sleep than polysomnography
(PSG). We aimed to compare sleep parameters measured with ACT
and ambulatory PSG in clinical practice.
Methods: We included 290 clinical measurements to 281 subjects
(mean age 37.9 years, 182 female) in the study. Subjects were
referred to us with suspicion of some sleep disorder causing exces-
sive daytime sleepiness. Concomitant ambulatory PSG and ACT of
sleep laboratory patients were analysed to determine the agreement
between the two methods in subjects with obstructive sleep apnea,
narcolepsy, periodic leg movement disorder, hypersomnia, other rarer
disorder (circadian rhythm sleep‐wake disorder, REM sleep behaviour
disorder etc.) or no organic sleep disorder (usually suffering from
insufficient sleep syndrome).
Results: Actigraphy's estimation of sleep time showed excellent
and statistically highly significant correlation to total sleep time in
PSG in all diagnostic subgroups. The Spearman's rank correlation
coefficients in different sleep disorders varied from 0.691 to 0.918
(P ≤ 0.001 in all subgroups). Correlations for sleep efficiencies were
also good and statistically significant. The correlation coefficients
ranged from 0.371 to 0.665 (p < 0.001 to P = 0.047). The best cor-
relation coefficients were achieved in subgroups with no organic
sleep disorder and hypersomnia.
Conclusions: ACT is a useful tool for measuring sleep time and
sleep efficiency in situations when multiple nights are needed (pre-
ceding Multiple sleep latency test, for example) or PSG is not avail-
able. However, the effectiveness of ACT in determining sleep seems
to decrease in subjects with very low sleep efficiencies.
Disclosure: Nothing to disclose.
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P101 | Results from an on‐road driving
performance study in non‐elderly and elderly
healthy subjects with dual orexin receptor
antagonist lemborexant
A. Vermeeren1; E. Vuurman1; S. Jongen1; C. Van Leeuwen1;
A. Van Oers1; J. Ramaekers1; P. Murphy2; M. Moline2;
C. Perdomo2; K. Pinner3
1Faculty of Psychology and Neuroscience, Department of
Neuropsychology and Psychopharmacology, Maastricht University,
Maastricht, The Netherlands, 2Eisai Inc., Woodcliff Lake, NJ, United
States, 3Eisai Ltd, Hatfield, United Kingdom
Objectives/Introduction: Sedating CNS‐active drugs are typically
studied for the potential to impair next‐morning driving. Data from
an on‐road driving performance study are presented for lemborexant
(LEM), a dual orexin receptor antagonist under development for
insomnia disorder.
Methods: Randomized, double‐blind, 4‐period, incomplete cross-
over design. Healthy subjects (n = 24 non‐elderly, n = 24 elderly;
26M, 22F) received placebo (P), zopiclone 7.5mg (Z; positive control),
and 2 of 3 LEM doses (2.5/5/10 mg). P and LEM were taken for 8
consecutive nights; Z was dosed on Night 1 and Night 8 with P on
Nights 2–7. The standardized 1‐hr on‐road driving tests on Day 2
(D2) and Day 9 (D9) started ~9h post dose. Standard deviation of
lateral position (SDLP in cm) was the primary endpoint.
Results: All 48 subjects completed the study. Assay sensitivity was
demonstrated, as for Z vs P, the 95% CI upper bound was > 2.4 cm
(standard threshold for impairment) at both D2 and D9. Additionally,
mean SDLP for Z vs P and symmetry analyses of subjects with SDLP
difference in Z vs P > 2.4cm vs < ‐2.4cm were statistically signifi-
cant at D2 and D9 (P< 0.01). For each LEM dose vs P, the 95% CI
upper bound was < 2.4 cm. No mean SDLP for LEM vs P was signif-
icant for any dose on D2 (p > 0.05) or D9 (p > 0.05). Symmetry
analyses were not statistically significant for any LEM dose on D2 or
D9 (p > 0.05). Results were similar in age and sex subgroups. No
serious or severe adverse events (AEs) were reported. AEs of som-
nolence were reported more frequently after LEM 10 mg than LEM
2.5 and 5 mg administration.
Conclusions: As measured by SDLP and at the doses tested, lem-
borexant did not impair driving performance after either single (Day
2) or multiple (Day 9) dose administration. These results warrant
continued testing of the efficacy and safety of LEM for the treat-
ment of insomnia disorder.
Disclosure: This study was financially supported by Eisai, Inc. and
Purdue Pharma LP. AV, EV, SJ, CVL, AVO, JR have nothing to dis-
close. PM, MM, CP are employees of Eisai Inc. KP is an employee of
Eisai Ltd.
P102 | Custom‐built electronic referral system
for home oximetry studies
C. Kemp; A. Simpson
South Tees NHS Foundation Trust, Medical Physics, NHS,
Middlesbrough, United Kingdom
Objectives/Introduction: Pulse oximetry is often used as an
adjunct to clinical consultation in the diagnosis of obstructive sleep
apnoea (OSA). It is a low cost, simple diagnostic test carried out in
the patient's home, with a high sensitivity in the detection of OSA.
The Medical Physics Department at the James Cook University
Hospital receives over 50 referrals per week for oximetry studies
from clinicians throughout the region. Previously, referrals were
received via a number of routes; telephone requests, letters, faxes
and emails. This was inefficient and inaccurate; risking delays in
referrals reaching the department, incorrect/incomplete referral data
and the possible loss of referrals.
Create a paperless solution that reduces inefficiencies and improves
data quality in the referral pathway.
Methods: We have created a Home Oximetry Study E‐Referral
System (the system) that streamlines the patient referral process into
the Home Oximetry Service. The system has been custom designed
and integrated with an existing MS Access database, which stores
patient's overnight oximetry results electronically. Data are stored
securely and comply with all relevant data protection regulations.
The web front end is integrated with the existing MS Access Data-
base using a linked table, which allows the existing database to
access the actioned referrals from the referral system. The system
also utilises a MSSQL Database for admin authentication, system
logging/auditing and email alerting.
Results: Since the implementation of the system, over 400 stan-
dardised referrals have been created. These referrals contain all
essential data and are received electronically instantly, enabling a
fully paperless workflow.
The system enables patient waiting times to be accurately deter-
mined and allows audit of the entire patient pathway, from initial
referral to final report creation. The result is a reduction in delays in
the patient pathway and higher quality data throughout.
Conclusions: We have created a Home Oximetry Study E‐Referral
System that streamlines the patient referral process into the Home
Oximetry Service, enabling a paperless workflow, and ensuring that
all referrals are of a sufficiently high standard to be processed. The
system can be used to monitor patient delays and referral statistics,
improving both service quality and patient experience.
Disclosure: Nothing to disclose.
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P103 | Sleep prediction algorithm based on
machine learning technology
K. Park1; S. Lee2; S. Lee3; S. Wang4; S. kim4; E. lee5
1Psychiatry, 2Yonsei University College of Medicine, Seoul, 3Division of
information and computer science, Dankook University, Yongin, 4Future
Information & Network Architecture Lab, Korea University, 5Psychiatry,
Yonsei University College of Medicine/Institute of Behavioral Science in
Medicine, Seoul, Republic of Korea
Objectives/Instruction: Clinicians believe that maladaptive sleep‐
related factors such as inactivity during daytime, excessive time
spent in bed, poor exposure to light, and high stress level contribute
development of chronic insomnia. However, there's paucity of evi-
dences which factors are important to sleep. Moreover, traditional
assessment methods cannot integrate sleep outcome with sleep‐
related factors by itself. We want to find relationship of sleep out-
come with sleep‐related factors including daytime activity, exposure
to light, and stress‐related index. Also, we tried to develop algorithm
that can predict sleep quality by using machine learning technology.
Methods: Forty‐six healthy participants (mean age 31.5, 47.8%
male) were enrolled to our study. We measured their sleep and
sleep‐related factors by using actigraphy and heart rate sensor for
two weeks. We used metabolic equivalent of task (MET), and sorted
it as vigorous activity (MET≥6), moderate activity (3≤MET< 6), and
light activity (MET< 3). Exposure to light was divided into outside
light and inside light. For heart rate variability, we used pNN50.
Alcohol and caffeine consumption were assessed by sleep diary.
Daytime data was subdivided into 3 part: wake‐up to noon (period
1), noon to 18:00 (period 2), and 18:00 to bedtime (period 3). The
dependent variable of the analysis was sleep quality(sleep efficiency
≥90%). We performed logistic regression analysis which was opti-
mized to maximize accuracy. For machine learning, we used multi‐
input one‐dimensional convolutional neural network (1D‐CNN)
model.
Results: By ten times of optimized logistic regression, vigorous
activity during period 1, total activity during period 1 and 2, expo-
sure to light during period 1, and exposure to outside light during
period 2 showed significant correlations with sleep quality. The
effect of stress level on sleep quality was below significance level.
Logistic regression's accuracy rate was 71.5% Machine learning algo-
rithm acquired by 1D CNN model showed 73.2% of accuracy rate.
Conclusions: The results suggest that morning activity, especially
vigorous activity, and exposure to any light in morning, and outside
light during afternoon are important to sleep quality. The algorithm
made by 1D‐CNN model can predict sleep quality accurately which
is comparable to the traditional logistic regression.
Disclosure: Nothing to disclose.
P104 | Comparison of automated methods for
REM sleep without atonia detection
M. Cesari1,2; J.A.E. Christensen1,2; G. Mayer3; W.H. Oertel3;
F. Sixel-Döring4; C. Trenkwalder4; H.B.D. Sorensen1;
P. Jennum2
1Department of Electrical Engineering, Technical University of Denmark,
Kgs. Lyngby, 2Danish Center for Sleep Medicine, Department of Clinical
Neurophysiology, Rigshospitalet, Glostrup, Denmark, 3Department of
Neurology, Philipps University, Marburg, 4Paracelsus‐Elena Klinik, Kassel,
Germany
Objectives/Introduction: REM sleep without atonia (RSWA)
detection is a prerequisite for REM sleep behaviour disorder (RBD)
diagnosis. Since current visual methods for RSWA detection are sub-
jective and tedious, several automated methods have been proposed.
This study aims to compare their accuracies in identifying RSWA
and to analyse the influence of respiration and arousal‐related move-
ments in such accuracies.
Methods: In a cohort including 27 healthy control subjects (C), 25
Parkinson's disease (PD) patients without RBD (PD‐RBD), 29 PD
patients with RBD (PD+RBD), 29 idiopathic RBD patients and 36
patients with periodic limb movement disorder (PLMD), the following
indices were calculated: The REM atonia index (RAI), the supra‐
threshold‐REM‐activity metric (STREAM), the Frandsen index (FRI),
the short/long muscle activity indices (sMAI/lMAI) and the Kempfner
index (KEI). The indices were calculated in various cases: 1) consider-
ing all muscle activities; 2) excluding the ones related to arousals; 3)
excluding the ones during apnea events; 4) excluding the ones
before and after apnea events; 5) combining cases 2 and 3; and 6)
combining cases 2 and 4. In each case, each index was used to train
and test a logistic regression model with 10‐fold cross‐validation
scheme to calculate accuracies in the following comparisons:
1 (C, PD-RBD, PLMD) vs (PD+RBD, RBD);
2 C vs RBD;
3 PLMD vs RBD;
4 C vs PD-RBD;
5 C vs PLMD;
6 PD-RBD vs PD+RBD; and
7 C vs PLMD vs RBD.
Kruskal‐Wallis tests were used to assess whether the accuracies for
each index and comparison were varying significantly across the cases.
Results: The indices showed varying performances across cases
and comparisons, making it impossible to identify one index as sig-
nificantly better than the others. In all comparisons and cases, the
average test accuracy of each index was lower than 80%. Moreover,
apnea and arousal‐related movements did not influence significantly
the performance of the algorithms in group distinctions.
Conclusions: None of the automated method can be elected as
the optimal one for RSWA detection and the accuracies suggest the
need of improvements. Automated methods seem robust towards
respiration and arousal‐related movements.
Disclosure: Nothing to disclose.
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P105 | Validation of a new data‐driven method
for identification of muscular activity in REM
sleep behaviour disorder
M. Cesari1,2; J.A.E. Christensen1,2; G. Mayer3; W.H. Oertel3;
F. Sixel-Döring4; C. Trenkwalder4; H.B.D. Sorensen1;
P. Jennum2
1Department of Electrical Engineering, Technical University of Denmark,
Kgs. Lyngby, 2Danish Center for Sleep Medicine, Department of Clinical
Neurophysiology, Rigshospitalet, Glostrup, Denmark, 3Department of
Neurology, Philipps University, Marburg, 4Paracelsus‐Elena Klinik, Kassel,
Germany
Objectives/Introduction: REM sleep behaviour disorder (RBD) is
a parasomnia characterized by lack of atonia during REM sleep. Gold
standard methods for RBD diagnosis require manual REM sleep
without atonia (RSWA) scoring, which is time‐consuming and subjec-
tive. We propose and validate a new data‐driven algorithm and com-
pare it to other automatic methods based on RSWA detection for
identifying RBD patients.
Methods: We included 27 control subjects (C), 29 idiopathic RBD
patients and 36 patients with periodic limb movement disorder
(PLMD). After artefact removal, mean absolute amplitude values of
1‐s windows of chin, tibialis left and right EMG signals during REM
from 9 randomly selected controls were used to define a probabilis-
tic model delineating atonia. For the remaining subjects, each 1‐s
window was labelled as movement if its probability of being atonia
was lower than an optimized threshold. For each EMG signal, we
calculated the percentages of 1‐s windows with movements and the
median intra‐movement distance during REM and NREM. Using
these indices, a classification algorithm was trained and tested (5‐
fold cross‐validation) to distinguish the three subject groups. For
comparison, the REM atonia index (RAI), Frandsen index (FRI) and
Kempfner index (KEI) were calculated for the same cohort and an
analogous classification algorithm was applied to each of them. The
overall test accuracies, sensitivities and specificities for C, RBD and
PLMD were calculated for each method.
Results: The following test performances were achieved (mean and
standard deviation across the five folds in %): Overall accuracy:
79.58±9.16 (this work), 44.56±6.27 (RAI) 46.73±5.40 (FRI),
49.08±11.82 (KEI); RBD sensitivity: 81.67±17.08 (this work),
53.67±13.03 (RAI), 58.71±10.94 (FRI), 58.81±28.37 (KEI); RBD speci-
ficity: 83.98±5.09 (this method), 83.59±4.12 (RAI), 85.48±4.18 (FRI),
77.80±5.54 (KEI). Further, the proposed method achieved higher sen-
sitivity and specificity for identifying C and PLMD than the other ones.
Conclusions: The proposed data‐driven method outperforms other
automatic methods in distinguishing C, RBD and PLMD subjects and
is more sensitive for RBD detection. Compared to the other meth-
ods based only on RSWA detection, this method uses also NREM
muscular activity to characterize patients groups. The obtained high
performances thus confirm previous findings of increased NREM
muscular activity in RBD patients.
Disclosure: Nothing to disclose.
P106 | Sleep disorders in Praxeos medicae
universae praecepta by Joseph Frank
(1771 ‐ 1842)
E. Sakalauskaite-Juodeikiene; D. Jatuzis
Institute of Clinical medicine, Clinic of Neurology and Neurosurgery,
Vilnius University Faculty of Medicine, Vilnius, Lithuania
Objectives/Instruction: Joseph Frank (1771–1842) was a gradu-
ate of the University of Pavia, whose most famous teachers were
Antonio Scarpa (1752–1832), Alessandro Volta (1745–1827), and his
father Johann Peter Frank (1745–1821). J. Frank spent 20 years in
Vilnius (1803–1823): he was Professor of Special Therapy and Clini-
cal Medicine, an organiser, a reformer, a founder of clinics, institutes,
and medical societies.
Methods: We analyzed descriptions and clinical cases presented in
J. Frank's textbook Praxeos medicae universae praecepta… continens
doctrinam de morbis systematis nervosi in genere et de iis cerebri in
specie (“Practical Textbook of General Medicine… Containing Doc-
trine of Nervous System Diseases and the Special Diseases of Cere-
brum”), written in Vilnius in Latin and published in 1818 in Leipzig.
Results: J. Frank analyzed the phenomena of hypersomnia (cat-
aphora), insomnia (agrypnia), snoring (rhonchus), restlessness with or
without limb movements (jactatio), leg cramps, hot flushes (ardor),
night terrors (pavor in somno), nightmares (somnia terrifica), breath-
lessness with feeling pressure on the chest (incubus), somnambulism,
catalepsy and other diseases described in his chapter devoted for
the sleep disorders. The author analyzed the predisposing factors,
causes and symptoms of the diseases, prognosis (for example, stated
that snoring predisposes patients to apoplexy and headaches), and
also discussed about treatment options, mentioning the importance
of antiphlogistic methods (bloodletting, leeches, cupping therapy, lax-
atives, diuretics), stimulating drugs (camphor, aether), opium, animal
magnetism and proper sleep hygiene (recommended diet, safe envi-
ronment, gymnastics, fast walks, to avoid long sitting and sleeping
during daytime).
Conclusions: J. Frank presented the most important sleep disor-
ders in his textbook, devoted for nervous system diseases, and sug-
gested using antiphlogistic methods for the treatment, based on
humoral theories that were still very popular in the beginning of the
nineteenth century in Vilnus and other European universities and
clinics.
Disclosure: Nothing to disclose.
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P107 | Measurement of daily sleep behaviour
and symptomatology through self‐report
anamnesis questionnaire. A validation by means
of sleep diaries
M.-J. Kater1; A. Rodenbeck2
1Georg‐Elias‐Müller‐Institut for Psychology, Georg‐August‐University
Göttingen, Goettingen, 2Studienzentrum Wilhelmshöhe GmbH, Kassel,
Germany
Objectives/Instruction: Retrospective self‐report questionnaires
about sleep difficulties constitute a standard instrument for clinical
routine even in patients with suspected obstructive sleep apnea
(OSA). Nevertheless, the actual validity has been barely examined,
yet. In particular findings related to sleep breathing disorders are
rare, even though an increasing prevalence underlines the impor-
tance of a precise diagnostic. Furthermore, a sleep quality index
could be able to provide easy access to further specific anamnesis.
Hence, this study investigates whether a retrospective sleep anam-
nesis questionnaire and a sleep quality index are valid methods to
measure sleep behaviour.
Methods: 326 patients (219 men, mean age of 58.8 ± 12.5 years)
completed a sleep diary for fourteen days, followed by a retrospec-
tive sleep questionnaire. Stepwise multiple regression analyses were
conducted to test if the questionnaire predicted the average sleep
diary ratings: time in bed, sleep latency, restoration after sleep, day-
time tiredness and concentration. A sleep quality index (SQI), gener-
ated by questionnaire items, was added to analyses as both single
and additional predictor. Personal features like gender, age, body
mass index and comorbidities were adjusted and used as compara-
tive models. The significance threshold was set at .05, two‐sided.
Results: Questionnaire items significantly predicted sleep diary
measures (all p < 0.001). Together, these multivariable models
explained 35–47% of the variance, which is significant more than
the comparative models. The sleep quality was found to be a signifi-
cant predictor of subjective sleep quality and all sleep parameters
except time in bed (all p < 0.001). Furthermore, the additional SQI
predicted feeling rested, daytime tiredness and concentration better
than the given questionnaire items alone (all p < 0.05).
Conclusions: Results strongly indicate that sleep questionnaires
are a valid method to measure daily sleeping behaviour and symp-
tomatology. Therefore, an application by patients with OSA is well‐
funded. The SQI conveys deeper information about the patient′s
daily conditions and subsecently permits an appraisal of the suffers
as well as therapy′s urgency and necessary intensity.
Disclosure: Nothing to disclose.
P108 | Influence of daytime activity on
hormone secretion in saliva after awakening in
infants
M. Ohira; S. Masuda
Shiga University, Otsu, Japan
Objectives/Introduction: Appropriate sleeping time and ensuring
sleep quality are essential for the development of children. There-
fore, in this research, we aim to clarify the influence of daytime
activity on the quality of sleep and salivary hormone levels of
infants.
Methods: The subjects comprised 15 infants (3.4 ± 0.6 years of
age) whose parents provided us with consent. Data from daily activ-
ity recorded by MTN‐210. In addition, Heart rate (HR) during sleep
was examined using data obtained by non‐contact sheet sensor devi-
ce.This study was approved by the ethics committee of Shiga
University.
Results: HR during sleep gradually decreased with the passage of
sleeping time regardless of the amount of activity during the day.
However, HR in infants with high activity levels during the day (high
activity group) tended to increase before awakening. In contrast, in
infants with low activity levels (low activity group), no significant
fluctuation was observed in HR, even close to the wake‐up time.
Furthermore, when subjects were classified into two groups based
on differences in the amount of activity during the day, significantly
increased HR before awakening was observed in the high activity
group (p < 0.05). The salivary cortisol concentration tended to
increase in both groups from immediately after awakening to 30 min
after waking (p = 0.06). There was no significant difference in the
salivary dehydroepiandrosterone (DHEA) response upon awakening.
However, the DHEA response upon awakening was higher in the
high activity group than in the low activity group (p = 0.07). Interest-
ingly, it has been demonstrated that DHEA is related to the reactiv-
ity immediately after waking and quality of sleep in adults.
Conclusions: Adequate activity during the day leads to improved
sleep efficiency and ensures high‐quality sleep. This leads to a grad-
ual increase in sympathetic nerve activity near the time of waking
and a pleasant awakening. The present findings suggest that the
above series of events lead to a sense of ‘sleeping well’. In general,
it is known that ‘If you move frequently, you can sleep well’. How-
ever, the results of our study suggest that the aforementioned well‐
known axiom may even be applicable to infants.
Disclosure: Nothing to disclose.
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P110 | Nodding off but can′t disconnect:
development and validation of the iNOD index
of Nighttime Offline Distress
H. Scott; H.C. Woods; S.M. Biello
University of Glasgow, Glasgow, United Kingdom
Objectives/Instruction: Despite attracting widespread media and
public attention, the link between social media use and sleep out-
comes is based on evidence that relies heavily on single‐item mea-
sures assessing frequency and duration of social media use, rather
than understanding underlying emotional and cognitive drivers. How-
ever, recent research indicates that these factors – including emo-
tional connection to social media and fear of missing out – are in
fact stronger predictors of poor sleep outcomes than time spent
using social media. This study responds to the need for a rigorously
developed, validated measure that captures the extent of difficulty
disengaging from social media at night, arising from these underlying
cognitive and emotional drivers.
Methods: Using a data‐driven approach, 31 original candidate
items were developed based on thematic analysis of focus group
data on drivers for bedtime social media engagement. 220 partici-
pants (aged 16–62) rated each candidate item from “not at all true
of me” to “extremely true of me”, and completed measures of social
media engagement and sleep duration, timing and quality.
Results: Iterative exploratory factor analysis and reliability analyses
produced a final 12‐item measure (Cronbach′s alpha = 0.94), with 3
subscales: Arousal, Obligation and Fear of Exclusion (alpha = 0.87,
0.90, 0.91, respectively). Higher scores on this final measure – the
iNOD index of Nighttime Offline Distress ‐ were associated with
using social media for longer after intended bedtimes (rs = 0.50,
p< 0.001), poorer sleep quality (rs = −0.25, p < 0.05), longer Shut
Eye Latency (SEL; rs = 0.26, p < 0.05) and later sleep onset (rs = .35,
p < 0.001). The iNOD outperformed existing measures in models of
poor sleep quality, bedtime social media use and perceived sleep
impact. Further validation in adult and adolescent samples is cur-
rently ongoing.
Conclusions: This study provides a validated 12‐item self‐report
measure of difficulty disengaging from social media at night, which
has high validity with bedtime social media behaviours and related
sleep outcomes. This provides a data‐driven tool for today's sleep
researchers and practitioners wishing to move beyond simply mea-
suring duration of social media use, to instead examine and under-
stand core underlying issues.
Disclosure: Nothing to disclose.
P111 | Gentle rocking stimulation influences
the regulation of sleep in poor sleepers
A.A. Perrault1,2; S. Schwartz1,2; L. Bayer3
1Department of Neuroscience, University of Geneva, 2Swiss Center for
Affective Science, 3Center for Sleep Medicine, Geneva University
Hospitals, Geneva, Switzerland
Objectives/Introduction: We previously demonstrated that a
gentle rocking motion (0.25Hz) can beneficially affect sleep in
healthy volunteers (Bayer et al., 2011, Curr Biol 21, R461‐2). More
recently, we again showed that the same rocking stimulation admin-
istered continuously during a whole night shortened sleep latency
and increased spindle activity, while it also increased time spent in
deep sleep with fewer arousals, and improved declarative memory
performance (submitted manuscript). Given these effects on sleep in
good sleepers, here we asked whether a continuous rocking stimula-
tion may benefit sleep in a population complaining of sleep difficul-
ties.
Methods: We studied 12 poor sleepers (mean± SD age = 24.8 ±
3.7), i.e. with difficulties to fall asleep and/or maintain sleep at least
2 nights per week in the last 3 months (screened with question-
naires, actigraphy and clinical polysomnography). Each participant
slept during two experimental nights in the rocking bed, which either
remained in a stationary position or rocked gently at 0.25Hz. Whole
night polysomnography included EEG (24 scalp electrodes), EOG,
EMG, and ECG.
Results: There was a tendency for increased sleep efficiency
(p = 0.06) mediated by a decrease in time spent awake during rock-
ing night (p = 0.06). Participants also exhibited a tendency to better
sleep maintenance as suggested by lower sleep fragmentation score
(total number of awakenings and shifts to lighter stages/total sleep
time; p = 0.09) and decrease in arousal density, more specifically
during late NREM (i.e., second half of the night; p = 0.01). While
there was no overall difference in delta and sigma power, rocking
stimulation decreased EEG power within the high beta band (19‐30
Hz) during NREM and REM, suggesting reduced cortical arousal.
Conclusions: The present findings suggest that a continuous low‐
frequency rhythmic rocking stimulation applied during a whole night
of sleep beneficially influences the regulation of sleep in poor sleep-
ers, while moderating the “hyper‐aroused” state that characterizes
patients with insomnia.
Disclosure: Nothing to disclose.
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P112 | Bedside approach in the diagnosis
obstructive sleep apnea using postprandial
oximetry testing. Comparative study with
polisomnography
E. Saricam1; E. Yalcınkaya2; N. Basay3
1Cardiology, 2Ear Nose and Throat, 3Pulmonoloji, Medicana
International Ankara Hospital, Ankara, Turkey
Objectives/Introduction: Obstructive sleep apnea (OSA) is associ-
ated with important morbidity and mortality that includes cardiovas-
cular, metabolic, and neurocognitive impairment. Therefore, the early
diagnosis of OSA is important. Polysomnography (PSG) is gold stan-
dard for OSA diagnosis. However, PSG has many difficulties, including
access availability, requiring a specialized laboratory, and cost issues.
To avoid challenges from PSG, there is a need for simpler tests for an
initial assessment of the patients with suspected OSA, serving as a
gatekeeper for PSG. The patients with OSA according to the Berlin
questionnaire and Epworth sleepiness scale have been known to suf-
fer from somnolence after meal or driving. Taking this fact into
account, we introduced a bedside test in the patients with suspected
OSA by using postprandial oximetry testing (POT).
Methods: This single center prospective study included 42 patients
(32 patients with suspected OSA and 10 patients no symptom OSA).
In POT, after at least a 7–8 h of awake period, the patients were
admitted into PSG room. Then the patients ate lunch at 12.30 pm.
After lunch, all the patients were monitored for 1 h with pulse
oximetry and standard electroencephalographic system for sleeping
documentation. The desaturation events (SpO2 drops below 90%
and 90% in a postprandial oximetry recordings were accepted as
indicative of moderate‐to‐severe OSAS. Above 90% SpO2 level and
≥4% lowest oxygen level/initial oxygen percent was defined indica-
tive of mild OSA. Unaffected oxygen percent or < 4 lowest oxygen
level/initial oxygen percent was accepted as normal. Finally, all of the
patients were performed PSG testing for comparison. Exclusion cri-
teria included known diagnosed OSA, diabetes mellitus.
Results: The mean age of the patients was 40.50 ± 7.06 (37 male,
5 female). The patient body mass index was 30.15± 6.21 kg/m2.
Their average homeostatic model assessment of insulin resistance
(HOMA‐IR) was 1.68 ±0.74. Positive correlation was found between
POT and PSG‐derived AHI (Cramer correlation 0.712, p< 0.001). The
reliability for POT was 95%. Accuracy was 0.903 for POT.
Conclusions: POT may be useful as a bedside technique in the ini-
tial assessment of the patients with suspected OSA, serving as a
gatekeeper for PSG.
Disclosure: Nothing to disclose.
P113 | Simulating sleep homeostasis in mice:
effects of time of day and waking experience
M.C.C. Guillaumin1; L.E. McKillop1; N. Cui1; S.P. Fisher1;
R.G. Foster1; M. de Vos1; P.M. Nolan2; S.N. Peirson1;
P. Achermann3; V.V. Vyazovskiy1
1University of Oxford, Oxford, 2MRC Harwell, Harwell Campus, United
Kingdom, 3University of Zurich, Zurich, Switzerland
Objectives/Instruction: Sleep‐wake history, time and lighting con-
ditions influence sleep, but neither their relative contribution, nor
the underlying mechanisms are fully understood. To investigate the
impact of extrinsic factors on sleep homeostasis, we adapted for the
first time an ‘elaborated’ version of the two‐process model of sleep
to mouse data. This model describes the interaction between a
sleep/wake‐dependent ‘Process S’ and a circadian ‘Process C’, and is
used to predict electroencephalogram (EEG) slow‐wave activity
(SWA, 0.5–4Hz) during sleep. We hypothesised that the influence of
extrinsic factors – such as time of day or wake behaviour – on sleep
homeostasis would manifest in deviations between empirical SWA
and model predictions.
Methods: We used undisturbed 48‐h EEG recordings from adult
male C57BL/6J mice; vigilance states were annotated in 4‐s epochs.
EEG electrodes were implanted in the occipital and frontal regions
of the neocortex. To investigate the impact of waking behaviour on
the performance of the model, 3 conditions were used: access to a
regular‐wheel (RW, n = 7) or a complex‐wheel (CW, n=7) and
exploratory wakefulness (EW, n = 7).
Results: Simulated SWA matched empirical levels well across con-
ditions, throughout 24 h and within non‐rapid eye movement sleep
episodes. The model's performance was satisfactory across condi-
tions, with neither waking experience (p = 0.904) nor light phase
(p = 0.529) being found to have a significant influence on the fit
between data and simulation. However, Process S declined during
sleep consistently faster in the frontal than in the occipital deriva-
tion, as shown by decay rate values (Frontal: 9.6 ± 0.7 × 10−4
epoch−1, Occipital: 6.4±1.3 × 10−4 epoch−1, p = 0.031, mean±SEM).
The upper asymptote of Process S was also higher in the frontal
area (Frontal: 469±25% mean SWA, Occipital: 270 ± 22% mean
SWA, p = 0.016, mean ± SEM).
Conclusions: Our results support the notion of local sleep regula-
tion, with regional inhomogeneity in the dissipation and build‐up of
sleep pressure across brain areas. The model's robustness to specific
waking behaviours suggests that extrinsic factors do not strongly
influence sleep homeostasis, despite their major role in shaping daily
sleep‐wake architecture. Finally, this modelling approach is a valuable
tool to gain insights into sleep regulation in a novel mutant mouse
line with striking sleep‐wake and SWA patterns.
Disclosure: Nothing to disclose.
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P114 | Signatures of the sleep and wake drives
identified by comparison of
electroencephalographic spectra obtained for
different sleep and wake states and sub‐states
A. Putilov; O. Donskaya
Research Group for Math-Modeling of Biomedical Systems, Research
Institute for Molecular Biology and Biophysics, Novosibirak, Russian
Federation
Objectives/Instruction: Circadian rhythmicity of sleep and wake
states originates from the interaction between two competing regu-
latory processes, the sleep and wake drives. This interaction cannot
be traced by pure measuring slow wave activity that is viewed as an
electroencephalographic (EEG) indicator of only one of these drives.
We previously suggested that the contributions of the sleep and
wake drives to the EEG signal can be separated by scoring the 1st
and 2nd principal components of the EEG power spectrum, respec-
tively. Here we proposed another approach to calculation of a single
measure (SM) of each of the drives.
Methods: In four experimental studies with, in total, 80 partici-
pants the EEG signals were recorded during night sleep, multiple
naps, and sleep deprivation. Each differential spectrum (DS) was cal-
culated as a difference between the EEG spectra obtained for two
distinct sub‐states within the continuum of sleep and wake states
and sub‐states. Such a DS provided a set of weights that were used
to calculate one SM by summation of weighted spectral EEG power
densities constituting each initial EEG spectrum. Each such initial
EEG spectrum was replaced by the set of SM representing the corre-
sponding set of DS for alert vs. sleepy sub‐state of wake state, one
vs. another conventional sleep stage, initial vs. final interval of the
whole night sleep, higher vs. lower level of homeostatic sleep pres-
sure during wake state, higher vs. lower intensity of the sleep debt
payment process during sleep, etc. These sets of SM were subjected
to principal component analysis.
Results: A high loading (>0.7) was shown by each SM on either 1st
or 2nd principal component of variation in these measures. Such
result suggested possibility to reduce all kinds of DS to only two
general DS interpreted as the EEG signatures of the sleep and wake
drives, respectively.
Conclusions: Research on regulation and dysregulation of the
sleep‐wake cycle can be facilitated by implication of the suggested
approach to calculation of SM of the sleep and wake drives into
quantitative evaluations and model‐based simulations of the oppo-
nent regulatory processes underlying normal and abnormal alterna-
tions of sleep and wake states.
Disclosure: Nothing to disclose.
P115 | EEG connectivity measures wPLI and
wSMI identify distinctive differences in brain
functional interactions during wakefulness and
sleep
L. Imperatori1; M. Betta1; E. Ricciardi1; P. Pietrini1; F. Siclari2;
G. Bernardi1,2,3
1MoMiLab Unit, IMT School for Advanced Studies, Lucca, Italy, 2Center
for Investigation and Research on Sleep, Lausanne University Hospital,
Lausanne, Switzerland, 3University Hospital of Pisa, Pisa, Italy
Objectives/Introduction: Functional connectivity measures repre-
sent a powerful tool to investigate brain inter‐regional interactions in
distinct behavioural states. We recently demonstrated that the
weighted Phase Lag Index (wPLI) and the weighted Symbolic Mutual
Information (wSMI), two connectivity measures that are relatively
immune to volume‐conduction, present a different sensitivity for lin-
ear and non‐linear interaction dynamics, respectively. Here we inves-
tigated whether these two methods may unveil distinct functional
differences between wakefulness and sleep, as well as across the
distinct sleep stages.
Methods: Twelve healthy volunteers (25±4 years, 6F) participated
in the study. All subjects underwent hd‐EEG recordings (256 chan-
nels, 500Hz) during the night (11.30 PM‐7 AM) and while awake in
bed after sleep (8AM; 6 min, eyes‐closed). After pre‐processing, 70
2 s data segments (minimum common number across subjects and
stages) were extracted from wake data (W) and from the first sleep
epochs of stable N2, N3 and REM‐sleep. For each electrode, the
median connectivity between each pair of channels was computed in
delta, sigma and gamma bands. Friedman tests were used to investi-
gate stage‐related effects, while signed‐rank tests were used in post‐
hoc comparisons (p< 0.05, Bonferroni correction).
Results: Delta‐wPLI was significantly increased in all sleep stages
relative to W, whereas delta‐wSMI was decreased in REM‐sleep as
compared to W and N2 (p< 0.05; N = 12). In sigma‐band, wPLI was
significantly higher in N2 relative to W, while wSMI was significantly
higher in N2 and N3 relative to REM‐sleep. Finally, gamma‐wSMI
was significantly lower in REM‐sleep relative to N2 and N3, and in
W relative to N3. No significant stage‐effects were found for
gamma‐wPLI.
Conclusions: All sleep stages were characterized by a significant
increase in linear dynamics within the delta range, likely due to the
presence of travelling low‐frequency oscillations. Sleep spindles may
account for changes in sigma‐connectivity specific to NREM sleep,
while differences in high‐frequency activity are consistent with pre-
vious work reporting the occurrence of hypercorrelated gamma
activity in this stage. These results demonstrate that sleep is associ-
ated with both general and stage‐specific changes in linear and non‐
linear brain dynamics. Their combined study may offer a valuable
tool for assessing changes in level of consciousness under physiolog-
ical and pathological conditions.
Disclosure: Nothing to disclose.
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P116 | Quantitative modelling of the direct
alerting effects of light
T. Tekieh1; S. McCloskey1,2; S.W. Lockley2,3;
P.A. Robinson1,2,4; S. Postnova1,2,4
1School of Physics, University of Sydney, Sydney, NSW, 2Cooperative
Research Centre for Alertness, Safety and Productivity, 3School of
Psychological Sciences and Monash Institute of Cognitive and Clinical
Neurosciences, Monash University, Melbourne, VIC, 4Centre of
Excellence for Integrative Brain Function, University of Sydney, Sydney,
NSW, Australia
Objectives/Introduction: Light affects alertness in two distinct
ways: (i) via its effects on the circadian phase thus adjusting the daily
rhythm in alertness, and (ii) as a stimulant, by directly increasing
alertness during light exposure. Prediction of alertness would prove
highly useful, especially under shiftwork and jetlag conditions where
reduced alertness increases the risk of accidents. A number of mod-
els have succeeded in predicting the circadian rhythm of alertness.
To date, however, none have accounted for the direct alerting
effects of light. We have extended our model of arousal dynamics to
incorporate the direct alerting effect of light and tested those pre-
dictions against experimental data.
Methods: Our model of arousal dynamics simulates the flip‐flop
switch between the sleep‐ and wake‐active neuronal populations
under the effects of the homeostatic and circadian drives. The phase
of the circadian drive is adjusted by light according to the human
phase‐ and dose‐response curves. The model has been successful in
prediction of subjective sleepiness and objective performance under
acute sleep deprivation and forced desynchrony in dim light condi-
tions. It has been proposed that the direct effects of light on alert-
ness are regulated by the homeostatic rather than circadian
mechanisms. Here this theory is tested computationally and an
extended model is developed to incorporate the direct alerting
effects of light.
Results: The model is tested against published experimental data
from five laboratory studies investigating direct alerting effects of
light (with 39 to 14 subjects). The model successfully reproduces the
dose‐response of subjective sleepiness to light exposure at night as
well as the effects of bright vs. dim light exposure at different circa-
dian phases on subjective sleepiness and objective performance. The
model is further tested for compliance with previous results for sleep
propensity and for alertness dynamics in dim light conditions. It is
thus shown to perform well against data from twenty‐two studies
with protocols challenging prediction of alertness under different
conditions.
Conclusions: A modified model of arousal dynamics is successful
in reproducing the experimentally observed alerting effects of light
and allows for testing of potential mechanisms.
Disclosure: Svetlana Postnova (SP) serves as a Theme Leader, Ste-
ven W Lockley (SWL) as a Program Leader, and Peter A Robinson
(PAR) as a Chief Investigator in the Cooperative Research Center for
Alertness, Safety, and Productivity. TT, SM, SWL, PAR and SP have
no additional conflicts of interests related to the research or results
reported in this paper.
P117 | Relationship between sleep structure of
patients after ischemic stroke and daily
measures
Z. Roštáková; R. Rosipal
Department of Theoretical Methods, Institute of Measurement Science,
Slovak Academy of Sciences, Bratislava, Slovakia
Objectives/Introduction: We aim to identify specific sleep tem-
poral profiles reflecting important physiological aspects of sleep of
patients following an ischemic stroke.
Methods: We applied the developed probabilistic sleep model
(PSM) to the polysomnographic data from 24 patients following an
ischemic stroke. Subjects performed a battery of tests for assess-
ment of attention, concentration, working memory and fine‐motor
activity and questionnaires scoring their subjective level of drowsi-
ness, exhaustion and motivation before and after performing the
tests.
The PSM represents the sleep process by posterior probability val-
ues of a finite set of sleep microstates. This representation can in
turn be considered as a set of temporal curves and the methodology
of functional data analysis can be applied. In the present work func-
tional cluster analysis and time synchronization of curves is used for
detecting groups of subjects with similar curve ‐ profiles. Finally, the
Kruskal‐Wallis test is used for testing significant differences in daily
measures between the formed clusters.
Results: Relationship between clustering structure and daily mea-
sures was found for several sleep microstates. Subjects with deeper
sleep were observed to feel less drowsy or exhausted after perform-
ing the whole battery of tests and they were able to remember more
digits in backward order (p‐value 0.02) than their colleagues with
low probability values for the deep sleep. On the other hand they
showed higher reaction times (p‐value 0.02).
In the case of the Wake stage and related sleep microstates the
curves alignment led to inferior results in comparison to the cluster-
ing of original curves. Therefore, we hypothesize that the exact
occurrence of the wake periods during the night are important fac-
tors establishing a stronger relationship between sleep and the
investigated daily measures. Increased probability of sleep micro-
states similar to the S1 stage was observed to improve performance
in the Fine Motor Activity test (p‐value 0.02). However, increased
probability for sleep microstate laying on a border between stages
S1 and S2 led to opposite results.
Conclusions: This preliminary study shows statistically significant
relationships between the sleep structure of patients after stroke
and daily measures. The PSM and functional data analysis are
promising tools for the analysis of the sleep process.
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P118 | Soft cervical support in obstructive
sleep apnea: a pilot study
P. Bordier; A. Lataste; S. Orazio
Haut-Leveque Cardiology Hospital, Pessac, France
Objectives/Instruction: A soft cervical collar can limit antero‐pos-
terior flexion/extension of the head and backward motion of the
mandible. Prior to a randomized controlled trial of a soft cervical col-
lar to treat obstructive sleep apnea (OSA), our pilot study assessed
1) night tolerance of the soft cervical collar in patients with OSA; 2)
alteration of pharyngeal patency with this support in OSA; 3) trial
population size for conclusive results.
Methods: Among 78 consecutive subjects referred for suspicion of
sleep apnea, 21 patients with severe OSA according to baseline noc-
turnal polygraphy were randomly assigned to second polygraphy
either with no intervention (control group, n = 10) or wearing a soft
cervical collar (intervention group, n = 11). Polygraphy data were
compared and night collar tolerance was assessed with a question-
naire. Required trial population size was calculated using Cohen′s d
method.
Results: Fourteen men and seven women aged 53.9 ± 2.6,
33.8 ± 0.2 kg/m2, were studied. Questionnaire showed that the col-
lar was generally well tolerated by the patients. No polygraphy data
were significantly different between the baseline and second record-
ings in each group, e.g., apnea‐hypopnea index was 57.8 ± 5.5 vs.
52.4±7.2 (p = 0.40) in the control group and 54.2 ± 7.7 vs.
51.5 ± 7.6 (p = 0.47) in the intervention group. Data changes
between the two recordings were the same in both groups. For con-
clusive effects according to the study design, trial population size
was calculated at 246 patients equally distributed between both
groups.
Conclusions: In our small‐scale short‐term randomized pilot study,
a soft cervical collar was well tolerated and had no obvious effects
on pharyngeal patency in patients with OSA. A larger‐scale random-
ized controlled trial with conclusive results appeared feasible. On the
other hand, beneficial effects of combination of a soft cervical collar
with CPAP ventilation with a facial mask used to treat OSA in five
patients have been recently published. It could reinforce the interest
of further studies on cervical supports in patients with OSA.
Disclosure: Nothing to disclose.
P119 | Living obstructive, mixed and central
apneas in the same epoch: an interesting OSAS
case
S. Yilmaz; H. Selimoglu Sen; G. Kirbas; Sleep disorders
Department of Chest Diseases and Tuberculosis, Dicle University
Faculty of Medicine, Diyarbakir, Turkey
Objectives/Instruction: Sleep related breathing disorders consists
of several different disorders, like obstructive sleep apnea, central
sleep apnea and Cheyne‐Stokes respiration. An apnea is the near to
interruption or interruption of airflow for at least 10 second. Central
apnea, obstructive apnea and mixed apnea are respiratory events
used to diagnose sleep related respiratory disorders. An obstructive
apnea is associated with evidence of ongoing breathing efforts
throughout the event. However, the central apnea is associated with
the absence of breathing efforts and the mixed apneas are associ-
ated with the absence of respiratory effort at the beginning of the
event, followed by respiratory effort during the second part of the
event.
Methods: A 68‐year‐old male patient. He applied to our clinic with
complaints of snoring, witnessed apnea, excessive daytime sleepi-
ness, gasping and choking in the sleep. The patient was diagnosed as
having obstructive sleep apnea syndrome (OSAS) with electroen-
cephalography (EEG), electrooculography (EOG), electrocardiography
(ECG), chin and pretibial electromyography (EMG), oximeter, pulse
transit time (PTT), oro‐nasal airflow, snoring voice, pulse and body
position recordings were taken with all night polysomnography. Dur-
ing the recording, the sleep technician was ready for the whole
shooting.
Results: The duration of total recording was 392.3 minutes and
sleep efficiency was 80.4%. The REM stage was detected as 13.8%.
The duration of non‐REM stage‐1 sleep was 7.3%, stage‐2 was
65.2% and stage‐3 was 13.8%. 251 obstructive apnea, 50 mixed
apnea, 33 central apnea and 334 apnea in total were detected. How-
ever, 40 hypopneas were scored. Apnea index was calculated as
78.0 h and apnea hypopnea index (AHI) as 87.5 h. The lowest oxy-
gen desaturation value was measured as 64% and the oxygen desat-
uration index (ODI) was measured as 93.6 h. According to the
International classification of sleep disorders‐3 criteria, the patient
was diagnosed with severe obstructive sleep apnea syndrome.
Conclusions: The aim of this case is to determine in the same
epoch both obstructive, central and mixed apneas during the
polysomnographic respiration scoring (Figure 1). This situation has
made our case interesting. We hope that this screen will contribute
to literature as a education patient.
Disclosure: Nothing to disclose.
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P120 | Retinal vascular tortuosity in patients
with obstructive sleep apnea‐chronic obstructive
pulmonary disease overlap syndrome
M. Yousif1; R. Elwahsh1; A. Ibrahim2
1Chest Department, 2Ophthalmology Department, Menoufia University,
Shebin Elkom, Egypt
Objectives/Instruction: Obstructive sleep apnea (OSA) and
chronic obstructive pulmonary disease (COPD) are linked with
microvascular changes. Retinal microvasculature can be examined in
a direct noninvasive way.
The aim of this study was to evaluate tortuosity of the retinal ves-
sels in patients with COPD, OSA, and overlap syndrome.
Methods: A total of 60 participants were included:15 patients with
OSA,15 patients with COPD,15 patients with COPD‐OSA overlap
syndrome, and 15 matched controls. All participants underwent digi-
tal retinal photography, polysomnography, arterial blood gases,
spirometry, Epworth sleepiness scale, and STOP‐BANG question-
naire.
Results: Tortuosity of most retinal vessels was higher in all patient
groups when compared with the control group (p< 0.05), and tortu-
osity was more marked in the overlap syndrome group (p< 0.001).
There was a negative correlation (−1< r >0, p< 0.05) between tortu-
osity of retinal vessels and PO2, O2 saturation, and minimum O2
saturation, and a positive correlation (0 < r >1, p< 0.05) with PCO2,
apnea hypopnea index, O2 desaturation index, BMI, and smoking
index.
Conclusions: Retinal vascular tortuosity occurs in OSA, COPD, and
overlap syndrome. Retinal vascular tortuosity is correlated with arte-
rial blood gases parameters, polysomnographic findings, smoking
index, and BMI.
Disclosure: Nothing to disclose.
P121 | Associational analysis between sleep‐
related variables and sleep positional difference
of Apnea‐Hypopnea Index in obstructive sleep
apnea syndrome
D.-H. Park
Department of Psychiatry, Konkuk University Medical Center, Seoul,
Korea, Seoul, Republic of Korea
Objectives/Instruction: Obstructive sleep apneas are likely to
increase more in supine position. But, it is known that apnea‐hypop-
nea index (AHI) is not associated with sleep position time in obstruc-
tive sleep apnea syndrome (OSAS). This study investigated how
sleep‐related variables associate with positional difference of AHI in
patients with OSAS.
Methods: A total of 313 men with OSAS were enrolled. Sleep
positional difference of AHI (ΔAHI) was indicated that supine AHI
(during supine position, sAHI) minus AHI. ΔAHI were partially corre-
lated with the variables of demographic data, sleep structure, sleep
position, sleep apnea, age and body mass index (BMI). Sleep posi-
tion‐related variables included supine position time(SPT), non‐supine
position time(NSPT), index of SPT(%; 100xSPT/sleep position time,
ISPT) and transitional index (number of positional changes per hour).
Subjects were divided into two groups by score 5 of ΔAHI. A group
with a ΔAHI of 5 or more was Positional OSAS Group (PG‐OSAS;
N = 135), and a group with less than 5 was Non‐Positional OSAS
Group (NPG‐OSAS; N = 178). Two groups were compared with
above variables by independent‐T test.
Results: sAHI was higher than AHI (42.06 vs. 34.11, p< 0.001).
ΔAHI showed a very high correlation with sAHI (rp = 0.50, p<
0.001). ISPT was most highly correlated with ΔAHI (rp= −0.64, p<
0.001). Transition index showed a very high correlation with ΔAHI
(rp = 0.31, p< 0.001). PG‐OSAS showed lower ISPT (58.16 vs. 86.31,
p< 0.001), higher transitional index (3.27 vs. 1.82, p< 0.001), higher
sAHI (52.84 vs. 33.88, p< 0.001), non‐significant AHI (35.96 vs.
32.71, p = 0.21), lower snoring percentage (22.35 vs. 27.76,
p = 0.007), and lower difference of NREM‐REM sleep average oxy-
gen saturation (0.09 vs. 1.02, p = 0.000251).
Conclusions: Sleep positional difference was significantly corre-
lated with sAHI, but without AHI. It is suggested that both sAHI and
AHI should be considered when analyzing the degree of sleep apnea
in OSAS patients with larger portion of non‐supine position time.
The differences in NREM‐REM sleep average oxygen saturation and
ISPT were significantly greater than in the group with lower ΔAHI.
This may mean that the group with higher ΔAHI is more likely to
take a non‐supine position to prevent severe hypoxia during REM
sleep.
Disclosure: This study was supported by research fund of Seoul
Konkuk University Medical Center.
P122 | The distributions and importance of
respiratory events in the patients with severe
Obstructive Sleep Apnea (OSA)
E. Akman; B. Gulbay; T. Acican
Department of Pulmonary Diseases, Ankara University School of
Medicine, Ankara, Turkey
Objectives/Instruction: The apnea hypopnea index that means
predominantly obstructive respiratory events per hour of sleep dur-
ing a PSG in the diagnostic criteria of obstructive sleep apnea is
used. However, in this definition, the effects of the excess of the
patient′s apnea or hypopnea on the current OSA and OSA results
are unknown.
Methods: We retrospectively reviewed the files and polysomnog-
raphy records of 81 (70 M/11 F) severe OSA patients who under-
went polysomnography. Patients were divided into two groups as
the total apnea numbers> the total hypopnea numbers (group 1),
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the total hypopnea numbers > the numbers of total apnea (group 2).
We compared comorbidities, and polysomnographic findings of the
patients.
Results: There were 71 patients (10F/61 M) in group 1 and 10
patients (1F/9 M) in group 2. The mean age of the patients was
higher in group 2 (p = 0.031). There was no difference in gender dis-
tribution (p = 0.592). Although, there were no statistically significant
difference in terms of sleep architecture between two groups, the
sleep efficiency is lower in the group 2 (p = 0.01) and the WASO is
lower in the group 1 (p = 0.01). In the group 1, the total AHI
(p = 0.025) was higher. And, the mean apnea duration were higher
in NREM stages of the patients with group 1 (p = 0.012). While the
mean hypopnea number was higher in the group 2 (p< 0.01), there
were no difference in terms of the mean hypopnea duration both
NREM and REM sleep stages (p; 0.708 0.785, respectively) between
the two groups. The total ODI was higher in the group 1
(p = 0.029), there were no statistically significant difference in terms
of average oxygen saturation, minimum Sp02, and % of nocturnal
oxygen desaturation (p; 0.669, 0.272, 0.193, respectively) between
two groups. Despite the shortcomings in the file information, the
additional disease (15 patients) in the group 1 was significantly
higher than that in the group 2 (5 patients).
Conclusions: Our study showed that patients with apnea dominat
OSA had a heavier OSA and had more comorbidities at an earlier
age, although the distribution of patients was not equal.
Disclosure: Nothing to disclose.
P123 | Polysomnography and clinical
characteristics of patients presenting to a single
sleep referral clinic: a study on 1248 patients
over 6 years
M.S. Kanwar1; D.K. Thakur1; K. Nagpal2; S.K. Wangnoo3
1Pulmonary Critical Care and Sleep Medicine, 2ENT, 3Endocrinology,
Indraprastha Apollo Hospitals, New Delhi, India
Objectives/Instruction: Sleep disordered breathing (SDB) disor-
ders are a major cause of morbidity and mortality. We studied clini-
cal characteristics and Polysomnography (PSG) correlation of SDB in
patients referred to our sleep clinic. There has been no single very
large study in Asia correlating the clinical features with PSG findings
in patients of SDB. We also wanted to see if these characteristics
differed in our overseas patients from African continent who visit
our institution for medical reasons compared to our Indian patients.
Methods: 1248 patients analysed who presented to our referral
sleep clinic from June 2012 to March 2018. Mallampatti (MPT) and
Epworth Sleepiness Scale (ESS) were scored. PSG′s were scored
manually and revalidated by a single sleep specialist. Gender, BMI,
ESS, MPT, snoring pattern, AHI, oxygen desaturation, arousal index
and arrhythmias were recorded and analysed. Demographic and PSG
differences in Indian and African patients were also studied.
Results: 1248 patients were studied. Mean BMI was 31.62. Mean
ESS score was 11.38. Mean Arousal index was 49.26. Postural rela-
tion was present in 250 (20%) patients of OSA. Atrial fibrillation (AF)
was present in only 5 (0.5%) patients of OSA. 1021 (81.8%) patients
had OSA alone. 227 (18.1%) had upper airway resistance syndrome
(UARS) with OSA. Twenty six (2.0%) had UARS only. Three had nar-
colepsy. Six had complex sleep apnoea. Two had mixed apnoea. 6
had primary snoring. One (0.2%) patient had Idiopathic hypersomnia.
Four (0.3%) had sleep onset and maintenance insomnia without res-
piratory disturbance. Only 5 (0.4%) had normal study. AHI of > 30/
hr was found in 48% of Africans vs 58% of Indians. SWS was very
short to absent in 49% and protective in 23% of Africans vs 34%
and 29% of Indians respectively.
Conclusions: Almost 58% SDB patients had severe OSA and
almost 33.41% of all SDB patients had an AHI >60/hr. AF in our ser-
ies is very uncommon present in only 0.5% patients of SDB. Indians
had relatively higher OSA severity than African patients with
matched BMI. Also MPT and ESS were significantly higher among
Indians compared to their African counterparts.
Disclosure: Nothing to disclose.
P124 | Supine and non supine obstructive
sleep apnoea syndrome (OSAS): comparison
between gender, Body Mass Index (BMI), and
OSAS severity
M. Balicaco; A. O Brien; B. Casserly; M. Purcell; C. Falcao;
T. Nyaude; J. Stephenson
Respiratory and Sleep, University Hospital Limerick, Limerick, Ireland
Objectives/Instruction: In our sleep centre, we have noticed
increasing number of predominantly non supine OSA. This study
aims to determine the comparison between Supine and Non‐Supine
OSAS in relation to gender, BMI and Severity of OSA.
Methods: The polysomnography studies (PSGs) of patients referred
to our sleep centre, from 2016 up to the second quarter of 2017,
were retrospectively reviewed. All patients with AHI >/= 5 per hour
were included. All patients were investigated with full PSG. Respira-
tory events were defined as hypopnoea or apnoea. We classified
OSAS between Supine and Non Supine, gathered and compared
their gender, BMI and OSAS severity.
Results: 210 patients were included in the study. 148 patients
have supine OSAS while 62 patients have Non‐Supine OSAS. Of the
148 predominantly supine OSAS patients, 61% were male and 39%
were female. The average BMI of this group is 31.4, and 89% have a
BMI >25. In this group 46% were classified as severe OSAS. Of the
62 predominantly Non‐Supine OSAS patients, 63% were male and
37% were female. The average BMI of this group is 33.6, and 92%
have a BMI of >25. In this group 53% were classified as mild OSAS.
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Conclusions: Presently, we found no difference between gender
and BMI in both supine and non‐supine OSAS; there were however,
more severe cases of OSAS in the supine population than in non
supine population.
Disclosure: Nothing to disclose.
P125 | An indigenous device to detect lung
and sleep disorders using labview
S. Vijayakumar
Biomedical Engineering, Sri Ramakrishna Engineering College, Affiliated
to Anna University, Chennai, Coimbatore, India
Objectives/Instruction: The pressure of exhaled breath is
detected through a pressure sensor and the flow rate is calculated
from differential pressure using Bernoulli′s formula. Pulmonary disor-
ders directly affect the sleep of a patient because of variation in
oxygen circulation. This device also detects the various sleep modes
of the patient using the number of breaths taken per minute. Detec-
tion of sleep modes helps a physician to treat the snoring problems
faced by a patient. The design and implementation involved NI DAQ
6009 and LabVIEW 2016 software for processing.This is a low‐cost
respiratory monitor to address this issue.
Methods: The thermistor and pressure sensor are placed inside the
nebulizer mask.Temperature is detected by the thermistor in mill
volts and then converted into degree Celsius. The indication of
degree Celsius is connected to comparison blocks where tempera-
tures for various respiratory diseases are compared to check
whether any correlation occurs. Since the pressure sensor gives the
output in terms of differential pressure it can be used to find the
flow rate of exhaled air by Bernoulli's formula. The output is com-
pared with the values fed in the comparison block to find the pres-
ence of disease.
Results: The number of breaths calculated per minute in this loop
is used to detect whether the patient is in NREM sleep or in REM
sleep. It is also used to detect the presence of disease by compar-
ison with the values in the blocks.The output of the pressure sensor
is in a volt which is then converted into cmH2O. The obtained values
are fed into the comparison blocks to check whether the pressure
value correlates with any of the pressure values indicating the pres-
ence of disease.
Conclusions: This respiratory monitor can be useful for obtaining
respiratory rate and for detecting sleep abnormalities. With the
known fact that temperature, pressure and flow rate of exhaled air
increases or decreases with ailing respiratory system, this project is
done. From the values of the exhaled air it is also possible to detect
the presence or absence of other lung disorders, since those condi-
tions have increased exhaled air temperature, pressure and flow rate.
Disclosure: Nothing to disclose.
P126 | Comparing the efficacy of
Uvulopalatopharyngoplasty (UPPP) with
Modified Radiofrequency Tissue Ablation
(MRFTA) in mild to moderate Obstructive Sleep
Apnea
S. Rahavi-Ezabadi; A. Amali; M. Motiee-Langroudi; B. Saedi;
A. Karimian; B. Amirzargar
Otorhinolaryngology Head and Neck Surgery Department, Tehran
University of Medical Sciences, Tehran, Islamic Republic of Iran
Objectives/Instruction: The aim of this study was to compare the
efficacy of Modified Radiofrequency Tissue Ablation (MRFTA) with
Uvulopalatopharyngoplasty (UPPP) based on both subjective and
objective outcome measures in mild to moderate Obstructive Sleep
Apnea (OSA) patients.
Methods: Forty patients with mild to moderate OSA were ran-
domly divided into UPPP and MRFTA groups. Apnea Hypopnea
Index (AHI), Sleep Apnea Quality of Life Index (SAQLI) and Epworth
Sleepiness Scale (ESS), were evaluated immediately before the sur-
gery and 6 months postoperatively.
Results: The postoperative AHI scores were improved significantly
in both groups, although the postoperative AHI in UPPP group was
significantly lower than MRFTA group (p value = 0.02). The differ-
ence between success rates for moderate OSA in UPPP and MRFTA
was significant (77% vs. 30%, p value = 0.03) but there was no sig-
nificant difference between success rates for mild OSA in UPPP and
MRFTA groups (70% vs. 50%, p value = 0.36). Comparing postopera-
tive ESS scores in two groups showed no significant difference (p
value = 0.24). The post operative scores in social interaction, treat-
ment related symptoms domain and SAQLI total score were signifi-
cantly higher in MRFTA group.
Conclusions: MRFTA as well as UPPP can greatly improve daytime
sleepiness and AHI, especially in patients with mild OSA. MRFTA
proved to be more effective than UPPP to enhance quality of life of
patients with OSA. Further studies with longer follow‐up are
required to evaluate long‐term safety and efficacy of these proce-
dures.
Disclosure: Nothing to disclose.
P127 | Obesity hypoventilation syndrome and
neurocognitive function ‐ impact of positive
airway pressure therapy
S. Sivam; K. Wong; A. Piper; D. Wang; B. Yee; R. Grunstein
Royal Prince Alfred Hospital, Camperdown, NSW, Australia
Objectives/Instruction: We investigated neurocognitive function,
anxiety and depression in stable obesity hypoventilation syndrome
(OHS) patients compared with obstructive sleep apnoea (OSA)
patients, at baseline and after 3 months of positive airway pressure
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(PAP) therapy. It was hypothesised that there will be limited
improvements post PAP in the OHS cohort due to poorly reversible
brain injury.
Methods: OHS patients with a BMI >40 kg/m2 and spirometric
ratio > 0.7, and OSA patients with an AHI >20 events/hour were
recruited. Patients underwent a PAP titration and review study at
baseline and after 3 months of PAP therapy respectively, with neu-
rocognitive tests including psychomotor vigilance test (primary out-
come: PVT slowest 10% of the reciprocal reaction time) and Stroop
tests, depression and anxiety questionnaires, functional outcomes of
sleep questionnaires and Epworth sleepiness scale scores performed
in the evening of both sleep studies.
Results: Thirty‐six patients with OSA (mean partial pressure of car-
bon dioxide, PCO2 = 42mmHg, duration of oxygen saturation <
90%, TST< 90% = 140 mins, daytime oxygen saturation, SaO2=96%)
and 15 patients with OHS (mean PCO2 = 51 mmHg, TST< 90%
=308 mins, SaO2 = 92%) were recruited. Post‐PAP pCO2 was
43 mmHg in the OHS group. In the majority of neurocognitive tests,
including the primary outcome, there were no significant differences
within or between OSA and OHS groups, at baseline and post PAP
therapy, and neither group improved with PAP. Anxiety and depres-
sion scores and ESS improved in both groups post PAP therapy
(p < 0.05), but no differences were found between groups. A higher
% slow wave sleep was also observed at 3 month post PAP therapy
in the OHS cohort (31 vs. 22%; p < 0.05) compared with OSA
patients.
Conclusions: In summary, no significant neurocognitive function
differences were observed between groups after 3 months of PAP
therapy despite improvements in gas exchange, mood and sleepi-
ness.
Disclosure: Nothing to disclose.
P128 | Sleep apnea patients with high and low
sleepiness response: clinical and
polysomnographical differences
W. Moraes; L. Prado; G. Prado
Neurologia, Universidade Federal de Sao Paulo, São Paulo, Brazil
Objectives/Introduction: Sleepiness response is the intensity of
the daytime sleepiness associated to the severity of sleep apnea.
The objective of the present study is to determine clinical and
polysomnographic differences between patients with high and low
sleepiness response.
Methods: In order to measure sleepiness response, we used a ratio
between Epworth Sleepiness Scale scores and apnea/hypopnea
index. All patients were submitted to polysomnography and clinical
interview. Forty‐eight patients, 27 females and 21 males, aging 22‐
79 years with apnea/hypopnea index (AHI) ≥5 were included. A ratio
between Epworth Sleepiness Scale score and apnea/hypopnea index
(E/A ratio) was calculated for each patient in order to assess the
sleepiness response to the respiratory disturbance. The sample was
divided in two E/A ratio groups: Lower E/A ratio group, below 50th
percentile (< 0.32) and higher E/A ratio group, above 50th percentile
(≥ 0.32). Differences between both groups were assessed by t‐tests
for independent samples.
Results: The lower E/A ratio group presented shorter slow‐wave
sleep duration (p< 0.05) and lower slow‐wave sleep percentage (p<
0.01). Patients in the lower E/A ratio group were older (p< 0.05) and
had higher AHI (p< 0.01).
Conclusions: Lower sleepiness response was associated to older
age and shorter slow‐wave sleep duration. Lower sleepiness
response may be associated to a decreased homeostatic process in
older patients with sleep apnea syndrome.
Disclosure: Nothing to disclose.
P129 | Effects of a weight‐loss Mediterranean
lifestyle intervention on obstructive sleep apnea:
preliminary results of a randomized controlled
clinical trial
M. Georgoulis1; K. Labrou2; N. Yiannakouris1; I. Mourati1;
E. Vagiakis2; I. Kechribari1; A. Kokkinos3; M. Kontogianni1
1Department of Nutrition & Dietetics, School of Health Science & Education,
Harokopio University, 2Center of Sleep Disorders, First Department of
Critical Care, ‘Evaggelismos’ General Hospital, 3First Department of
Propaedeutic Internal Medicine, Medical School, National and Kapodistrian
University of Athens, ‘Laiko’ General Hospital, Athens, Greece
Objectives/Instruction: Continuous positive airway pressure
(CPAP) is currently the first‐line treatment for obstructive sleep
apnea (OSA) and is prescribed alone as standard care in the vast
majority of patients. Given that obesity is a well‐established risk fac-
tor for OSA, weight loss through lifestyle changes has also emerged
as an important therapeutic approach for overweight patients. The
aim of the present study was to explore whether a weight‐loss
Mediterranean lifestyle intervention (MLI) combined with CPAP is
superior in the management of OSA, compared to CPAP alone.
Methods: Participants were 108 adult overweight patients [79%
men, mean age: 47±10 years, mean body mass index (BMI): 35.9±6.2
kg/m2] with polysomnography‐diagnosed moderate‐to‐severe OSA
[mean apnea‐hypopnea index (AHI): 59.6±31.6 events/h]. Patients
were randomized to either a standard care group (SCG, n = 54) or a
MLI group (MLIG, n = 54). Patients in SCG received CPAP and general
written lifestyle advice, while those in MLIG participated in an inten-
sive 6‐month lifestyle intervention, in addition to CPAP, aiming at a 5–
10% weight loss and an increase in the level of adherence to the
Mediterranean lifestyle (compliance to the Mediterranean diet,
increased physical activity and optimal sleep habits). Patients were
evaluated pre‐ and post‐intervention with regard to polysomnographic
data, OSA symptomatology, anthropometric indices and lifestyle
habits. Per protocol analysis was implemented.
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Results: The two groups did not differ in anthropometric, lifestyle
or clinical parameters at baseline. Drop‐out rates were 24.1% for
MLIG and 31.5% for SCG. Following intervention, weight and BMI
were lower, while the level of adherence to the Mediterranean diet,
physical activity and daily sleep duration were higher in MLIG, com-
pared to SCG (all P_between_groups < 0.05). The AHI decreased by
3.7 events/h in SCG (P_within_group = 0.3) and by 31.2 events/h in
MLG (P_within_group < 0.001), and the difference between groups
was statistically significant even after adjusting for baseline AHI,
weight change and adherence to CPAP (P_between_groups = 0.003).
Both groups experienced significant reductions in daytime sleepiness
and degree of insomnia (P_within_groups < 0.05); however, reduc-
tions were greater in MLIG (P_between_groups < 0.001).
Conclusions: A weight‐loss MLI combined with CPAP offers signif-
icant additional improvements in OSA severity and symptomatology,
compared to CPAP alone.
Disclosure: Nothing to disclose.
P130 | Associations of obstructive sleep apnea
(OSA) and hypoxemia with heart rate variability
in a population‐based sample of men
S. Appleton1; M. Baumert2; S. Immanuel2; P. Catcheside3,4;
A. Vakulin3,4; G. Wittert2; S. Martin2; D. McEvoy3,4;
R. Adams1
1University of Adelaide, Woodville, 2The University of Adelaide,
Adelaide, 3Adelaide Institute of Sleep Health, Daw Park, 4Flinders
University, Bedford Park, SA, Australia
Objectives/Instruction: Autonomic dysfunction may result from
OSA‐related hypoxemia and arousals but population‐based studies
are scarce. The aim of this study was to determine the relationship
of a measure of autonomic function, nocturnal heart rate variability
(HRV), with OSA metrics, in a population‐based sample of men.
Methods: In the population‐based Men Androgen Inflammation
Lifestyle Environment and Stress (MAILES) Study of men ≥ 40 year,
HRV measures (SDNN, standard deviation of normal‐to‐normal RR‐
intervals; RMSSD, root mean‐square of successive differences of N‐
N intervals) were calculated from the ECG channel during periods
free from scored respiratory events or arousals from home‐based full
unattended polysomnography (Embletta ×100). To compute respira-
tory sinus arrhythmia (RSA), inspiratory onsets were automatically
detected from RIP signals to obtain the magnitude of phase‐aver-
aged RR modulation. Linear regression models determined associa-
tions of sleep metrics with HRV/HR adjusted for age, BMI, blood
pressure, smoking and insomnia. Unstandardised B coefficients (SE)
are presented.
Results: OSA was present in n = 443 (53%), with moderate OSA in
14% and severe in 12%. Valid HRV measures were available on 761
men during non‐rapid eye movement (NREM) sleep and 671 men
during REM sleep. In NREM sleep, apnea hypopnea index (AHI) was
significantly associated with increasing mean heart rate [HR: 0.05
(0.02), p = 0.036]. Oxygen desaturation index [‐0.14 (0.07),
p = 0.032] and percentage total sleep time with SaO2 < 90% [−0.2
(0.1), p = 0.014] were associated with decreasing SDNN and with
increasing mean HR (all p< 0.001). In REM sleep, AHI was signifi-
cantly associated with increasing mean RSA [0.1 (0.05) p = 0.036]
and hypoxemia metrics were associated with increasing mean HR
(p< 0.01). No associations were seen with RMSSD.
Conclusions: In a community dwelling sample of middle aged and
older men, during NREM sleep, AHI showed inconsistent associa-
tions with HRV. Direct measures of nocturnal hypoxemia were mod-
estly associated with lower overall HRV that may contribute to
increased cardiovascular risk in OSA. Increasing OSA severity by any
metric was generally associated with increasing heart rate across
both NREM and REM sleep.
Disclosure: Nothing to disclose.
P131 | Improved CPAP compliance with pillow
height change: a case report
H. Kim
Department of Neurology, Catholic Kwandong University/International
St.Mary's Hospital, Incheon, Republic of Korea
Objectives/Instruction: Continuous positive airway pressure
(CPAP) is the most effective treatment for the obstructive sleep
apnea (OSA). CPAP adherence is main issue of successful treatment.
The high CPAP is a major cause for patients to suffer from various
reasons and to reduce the rate of CPAP adherence
Methods: This patient was a 32‐year‐old female who had been rec-
ognized snoring since severe years ago. She had been diagnosed with
impaired glucose tolerance and hypertension for the past two years.
To manage medial problems, she decided to visit sleep clinic. Her BMI
was 46.02 Kg/m2. Apnea Hypopnea idex (AHI) was 60.5/hr that is sev-
ere OSA. She had CPAP treatment and optimal pressure for 2 weeks
was reported to 14 cmH2O. She appealed discomfort of air leak and
had trouble with high pressure phobia. In order to reduce the pressure,
we proposed to vary the pillow height. At the first step, the height of
the pillow was 11.5 cm, and the height of the cervical vertebral when
the pillow was 4.5 cm. At the first trial, residual AHI was 4.3/hr and
pressure of CPAP was 14 cmH2O. At the next step, the height of the
pillow was 8cm, and the height of the cervical vertebral when the pil-
low was 2 cm. At the second trial, residual AHI was 3.9/hr and pres-
sure of CPAP was 13 cmH2O. The pressure was reduced by only
1cmH2O, but she showed a better adaptation to the use of CPAP.
Results: Pillow is valuable factor to increasing CPAP adherence espe-
cially for with severe OSA. By lowering the height of the pillow, the
position of the head is changed to a form that broadens the airway.
Conclusions: If the patient have difficulty using CPAP, it is impor-
tant to consider the height of the pillow.
Disclosure: Nothing to disclose.
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P132 | The reconstruction of upper airway
after velopharyngeal surgery in obstructive sleep
apnea patients
J. Ye; J. Li; G. Yin; J. Xu; X. Cao
Department of Otolaryngology, Affiliated Beijing Tsinghua Changgung
Hospital, Tsinghua University, Beijing, China
Objectives/Instruction: To analyze the upper airway anatomical
changes and its influence factors after velopharyngeal surgery in
obstructive sleep apnea (OSA) patients, explore the relationships
between the reconstruction of upper airway and treatment out-
comes.
Methods: Forty‐seven OSA patients underwent velopharyngeal
surgery including revised uvulopalatopharyngoplasty with uvula
preservation and transpalatal advancement pharyngoplasty was
included. Pre‐ and postoperative upper airway 3‐dimensional com-
puted tomography and polysomnographical parameters were
obtained. We conducted an analysis on changes of upper airway
anatomical parameters and its influence factors.
Results: The overall apnea hypopnea index (AHI) decreased from
54.2±20.8times/h preoperatively to 21.4 ± 16.1 times/h postopera-
tively (p< 0.001). The VmCSA, VmLAT, GmCSA and GmLAT signifi-
cantly increased and mAP of the glossopharynx significantly
decrease after surgery. The LAT/AP ratio was significantly increased
after surgery, from 1.8 to 2.5 velopharynx (p = 0.004) and from 1.1
to 2.3 in glossopharynx (p<0.001), respectively. Preoperative AHI
(r = −0.390, p = 0.007), AHTI (r =−0.387, p = 0.008) and GmAP
(r = −0.529, p<0.001) have significant correlation with the change in
GmAP and only AHTI was independent predictor of the change in
GmAP (p =0.019, R2 = 0.123). Changes in mCSA of the velopharynx
(VmCSA) was the only significantly different anatomical parameters
between responders and nonresponders.
Conclusions: Velopharyngeal surgery can effectively change the
lumen dimensions not only in velopharynx but also in glossopharynx
and change the shape of upper airway in depth. The reconstruction
of upper airway was thought to make the upper airway tend to be
more stable.
Disclosure: Nothing to disclose.
P133 | Correlations between sleep parameters
and inflammatory and oxidative stress
biomarkers in patients with obstructive sleep
apnoea
I. Kechribari1; K. Lamprou2; R. Tenta1; E. Fragopoulou1;
I. Mourati1; M. Georgoulis1; E. Vagiakis2; M.D. Kontogianni1;
N. Yiannakouris1
1Department of Nutrition & Dietetics, School of Health Science &
Education, Harokopio University, Kallithea, 2Center of Sleep Disorders,
1st Department of Critical Care, ‘Evaggelismos’ General Hospital,
Athens, Greece
Objectives/Instruction: Obstructive sleep apnoea (OSA) not only
is considered a respiratory disorder, but also a significant cause of
morbidity and mortality due to its close relationship with obesity
and cardiometabolic complications. Inflammation and oxidative stress
may be involved in OSA pathogenesis. The aim of this study was to
investigate potential associations between sleep parameters and sev-
eral reliable inflammatory and oxidative stress biomarkers in patients
with OSA.
Methods: Participants were 199 adult Greek patients with OSA
(145 males, aged 25‐70 years, mean body mass index: 35.4 ± 6.4 kg/
m2). Polysomnography was performed to evaluate the presence and
the severity of OSA as indexed by the apnoea‐hypopnea index (AHI;
mean value: 53.1±33.0 events/h). Circulating adiponectin, tumor
necrosis factor‐a (TNF‐a), and high‐sensitivity C‐reactive protein
(hsCRP) levels were measured in fasting serum samples, while 8‐iso-
prostane (a marker for lipid peroxidation) and 8‐OH guanosine (a
marker of oxidative DNA damage) were measured in first morning
urine samples. Spearman correlation analysis was used to evaluate
the associations between biomarkers and sleep parameters. Mann‐
Whitney U test was used to test differences between patients with
severe and mild/moderate OSA.
Results: Serum adiponectin concentrations showed a statistically
significant negative correlation with AHI, (rho = −0.25, p < 0.001),
oxygen desaturation index (rho=−0.22, p = 0.004), AHI in REM sleep
(rho=−0.21, p = 0.02), and AHI in non‐REM sleep (rho = −0.26,
p = 0.001), while a positive correlation was observed between serum
hsCRP and the above sleep parameters (rho = 0.27, 0.32, 0.28 and
0.26, respectively, all p ≤ 0.001). Moreover, compared to patients
with mild/moderate OSA (5≤AHI < 30 events/h, n = 64), patients
with severe OSA (AHI≥30 events/h, n = 135) exhibited lower serum
adiponectin levels [median (IQR): 3.4 (2.2‐4.9) vs. 4.9 (2.6‐7.1) μg/mL,
p = 0.001) and higher hsCRP levels [3.4 (1.4‐5.9) vs. 2.1 (0.9‐3.8) mg/
dL, p = 0.003). In contrast, no significant differences between the
two groups were observed for serum TNF‐a [3.2 (2.3‐4.2) vs. 3.1
(1.9‐4.4) pg/mL, p = 0.54), and in creatinine corrected urinary 8‐iso-
prostane and 8‐OH guanosine levels [0.5 (0.3–1.2) vs. 0.4 (0.3–0.9)
ng/mg, p = 0.18 and 65 (43–104) vs. 66 (49–93) ng/mg, p = 0.63,
respectively).
ABSTRACTS | 151 of 433
Conclusions: Our findings confirm the involvement of inflamma-
tion in OSA pathogenesis and suggest that circulating adiponectin
and hsCRP levels may be predictive markers for disease severity.
Disclosure: Nothing to disclose.
P134 | Nicotine dependence in patients with
Obstructive Sleep Apnea Syndrome
A. Pataka; S. Kotoulas; G. Kalamaras; E. Chatzopoulos;
E. Panagiotidou; K. Fekete; P. Argyropoulou
Respiratory Failure Unit G.Papanikolaou Hospital, Aristotle University of
Thessaloniki, Thessaloniki, Greece
Objectives/Instruction: Smoking is highly prevalent in patients
with Obstructive Sleep Apnea Syndrome (OSAS) and may act as a
risk factor for developing OSAS. Studies have revealed that OSAS
might be responsible for nicotine addiction.
Objectives: To evaluate if there are differences in nicotine depen-
dence measured with Fagerstrom Test for Nicotine Dependence
(FTND) between different severity groups of OSAS (i.e. no, mild,
moderate, severe).
Methods: Patients visiting a Sleep Clinic were prospectively studied.
They completed FTND, Epworth Sleepiness Scale (ESS), Stop Bang
(SB) and Athens Insomnia Scale (AIS). Sleep studies were performed.
Results: SPSS version 17.0 was used for the statistical analysis.
Analysis of variance (ANOVA) was used for the analysis of the dif-
ferences between group means and Pearson correlation coefficient
(for normally distributed) and Spearman correlation (for non‐normally
distributed data) to evaluate significant correlations between differ-
ent variables. Tests were two‐tailed and p < 0.05 was accepted as
statistically significant. In the study, 383 smokers (mean age:
48.56±12 years, 69.2% male) were involved with FTND 5.23±2.83.
From them, 26.1% did not suffer from OSAS, 14.5% suffered from
mild, 21.6% from moderate and 37.8% from severe (mean
AHI:27.5 ± 26.2). The mean pack/years (p/y) was 35.4 ± 28.8 with
23.45±14.13 cigarettes/day. ESS was 8.99 ± 4.67, SB: 4.04 ± 1.45,
AIS: 8.4 ± 5.25. Neither the FTND nor each of the questions of the
FTND presented statistically significant differences between the dif-
ferent OSAS severity groups. The only significant difference found
was between p/y and cigarettes per day especially between no, mild
and severe OSAS (p < 0.05). There was a strong correlation between
AHI and p/y (p < 0.001), AHI and cigarettes per day (p < 0.001), ESS
and p/y (p < 0.001), ESS and cigarettes per day (p < 0.002), AIS and
FTND (p = 0.002).
Conclusions: Nicotine dependence measured by FTND did not dif-
fer between OSAS severity groups; significant correlations were
found between AHI and ESS with p/y and cigarettes per day.
Disclosure: Nothing to disclose.
P135 | High risk and low treatment response
in obstructive sleep apnea: a real‐world study in
office occupational population
Q. Ou; M. Pan; B. Chen
Sleep Center, Department of Respiratory, Guangdong Institute of
Geriatrics, Guangdong General Hospital, Guangdong Institute of Medical
Sciences, Guangzhou, China
Objectives/Introduction: To investigate the prevalence and the
treatment response of OSA among office occupational population to
provide the basis for medical management decision.
Methods: Using cluster sampling, we conducted a cross‐sectional
survey in office occupational population. The Berlin Questionnaire
was used to screening for high‐risk patients and home sleep test to
diagnose. For all diagnosed patients, we carry out an active interven-
tion by CPAP and regular follow‐up to determine their treatment
response.
Results: For all 1241 adults, a total of 1036 subjects completed
valid questionnaire and were included. The average age was
40.6 ± 0.3 years. 22.0% subjects with positive result of Berlin Ques-
tionnaire was regarded as high‐risk OSA. The related factors of high‐
risk OSA were age, BMI, neck circumference, waist circumference,
hip circumference, pharynx morphology, ESS score, insomnia, anxi-
ety, depression, smoking, and drinking (p all < 0.05). Among 228
high‐risk OSA subjects, 75 rejected home sleep test and there left
154 completed. Results showed an OSA morbidity of 65.6% in high‐
risk subjects. The related factors of OSA were gender, age, BMI,
neck circumference, waist circumference, pharynx morphology, mid-
dle‐age drinking (p all < 0.05). The prevalence of OSA was estimated
as 10.5%. The OSA awareness survey showed 99.1% of the high‐risk
population has never been diagnosed. In high‐risk population the
score of OSA patients in energy/fatigue (p = 0.021) and emotional
well‐being (p = 0.049) was higher than non‐OSA subjects. It may be
associated with an excessive exaggeration of their symptoms due to
mental problems in the screening of OSA, resulting in a positive
questionnaire. Free Auto‐CPAP treatment was given to all OSA
patients. Among them 46 subjects didn't receive initial treatment,
The primary reasons for rejection were self‐behavior intervention,
and self‐concept of non‐requirement. 54.4% patients received initial
treatment. After 1‐week, 32.7% patients gave up, the main reasons
for giving up were nasal discomfort, insomnia, and suffocating
feeling.
Conclusions: High risk, high prevalence, and low rate of diagnosis
and treatment for OSA were existed in office occupational popula-
tion. It should be emphasized to diagnose and manage OSA patients
in office occupational population.
Disclosure: Nothing to disclose.
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P136 | Derived arterial stiffness in OSAS with
persistent sleepiness on CPAP and periodic limb
movement
E. Dongol1; P. Drakatos2; A. Williams2
1Chest Disease Department, South Valley University, Qena, Egypt,
2Sleep Disorders Center, Guy's and St. Thomas NHS, London, United
Kingdom
Objectives/Introduction: Untreated obstructive sleep apnea
(OSAS) is associated with increased arterial stiffness and increased
cardiovascular risk. The effect of the CPAP in improving the derived
arterial stiffness, in sleep apnea patients is well documented.
We aimed in this work to assess the derived arterial stiffness in
patients who were still sleepy on CPAP and developed PLMs.
Methods: In a tertiary sleep disorders center at Guy′s and St Thomas
Hospital, patients who had OSAS diagnosed by polysomnography,
complained of persistent sleepiness on CPAP and developed increased
PLMs index on follow up polysomnography were included. Measure-
ment of the arterial stiffness index was done through the index of
large artery stiffness derived from the digital volume pulse (SIDVP).
SIDVP was derived from the raw data of photoplethysmography of
the nocturnal polysomnography. The measurement was averaged for
2 min prior to sleep initiation (baseline), on completion in the morning.
Results: 12 patients were included. 9(75%) of patients were males.
Average calculated CPAP use was 6.024 ± 1.335 hr/night. No signifi-
cant difference in the BMI, ESS pre‐ and post‐CPAP was found.
There was significant difference in the AHI pre‐ and post‐ CPAP. Sig-
nificant difference was found in the mean SIDVP in early night mea-
sure, as well as the minimum, maximum and mean of the SIDVP
measured in the early morning. SIDVP increased.
Conclusions: The derived arterial stiffness index increased in
patients with OSAS with persistent sleepiness on CPAP, who devel-
oped PLMs. This implies the incremental effect of periodic limb
movement on the arterial stiffness.
Disclosure: Nothing to disclose.
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P137 | Fat mass distribution measured by
Viscan as a risk factor for Obstuctive Sleep
Apnea Syndrome
A. Pataka1; T. Chainopoulou2; G. Basiliou2; S. Kotoulas1;
E. Daskalopoulou2; E. Vlachogiannis2
1Respiratory Failure Unit G.Papanikolaou Hospital, Aristotle University
of Thessaloniki, 2Sleep Laboratory, Saint Paul Hospital, Thessaloniki,
Greece
Objectives/Instruction: Obstuctive Sleep Apnea Syndrome
(OSAS) prevalence is increasing in modern society. The most
common predisposing factors for OSA include obesity, central fat
distribution, male sex, age, postmenopausal state and structural fac-
tors.
Objectives: To evaluate central fat mass distribution measured by
Viscan as a risk factor for OSAS.
Methods: Patients visiting a sleep clinic were prospectively studied.
Anthropometric values (age, gender, BMI, neck, waist, hip circumfer-
ence) were measured and Epworth Sleep Scale (ESS) was completed.
Viscan that uses Dual Frequency BIA technology was used for the
measurement of fat mass (trank, visceral). Sleep studies were per-
formed. Multivariate logistic regression analysis was used to assess
the association between OSAS and possible risk factors and
p < 0.05 was accepted as statistically significant.
Results: The study included 106 patients (84% male) aged
47.9±12.4 years, with BMI 30.6 ± 6.4 kg/m2, ESS: 7.9 ± 5.5 and
Apnea Hypopnea Index (AHI) : 34.4±26.15/h. From them, 9.4% did
not suffer from OSAS, 17.9% from mild, 22.6% from moderate and
50% from severe. Trunk fat percentage and visceral fat mass mea-
sured by the Viscan were 30.6±6.4% and 18.2±7.9 respectively. In
the univariate regression analysis, anthropometric risk factors for
OSAS involved: neck circumference (OR: 1.44, 95% Confidential
interval (CI) 1.19–1.73, p < 0.001), visceral fat (OR: 1.21, 95% CI
1.11–1.32, p < 0.001), BMI (OR: 1.14, CI 1.04–1.24, p = 0.003),waist
circumference (OR: 1.1, 95% CI 1.05–1.15, p < 0.001), trunk fat per-
centage (OR: 1.06, CI 95% 1.01–1.11, p = 0.018) and age (OR: 1.04,
95% CI: 1.002–1.08, p = 0.04). In multivariate logistic regression
analysis adjusted for gender and age, risk factors associated with
moderate‐severe OSAS included neck circumference (OR: 1.45, 95%
CI 1.18–1.78, p < 0.001), visceral fat (OR: 1.2, 95% CI 1.09‐1.32,
p < 0.001), BMI (OR: 1.14, CI 1.05–1.26, p = 0.003), waist circumfer-
ence (OR: 1.09, 95% CI 1.04–1.14, p< 0.001) and trunk fat percent-
age (OR: 1.09, CI 95% 1.03–1.15, p = 0.003). There was a strong
correlation (p < 0.001) between waist, neck circumference, BMI,
AHI, trunk fat percentage and visceral fat mass.
Conclusions: Fat mass distribution measured by Viscan was found
to be stronly associated with OSAS and correlated well with other
antropometric measures and AHI.
Disclosure: Nothing to disclose.
P138 | Obstructive sleep apnea as a risk factor
of insulin resistance in nondiabetic patients
H. Martynowicz1; M. Michalek1; R. Poręba1; R. Skomro2;
A. Wojakowska1; G. Mazur1
1Department of Internal Medicine, Occupational Diseases, Hypertension
and Clinical Oncology, Wroclaw Medical University, Wroclaw, Poland,
2Division of Respiratory Critical Care and Sleep Medicine, University of
Saskatchewan, Saskatoon, SK, Canada
Objectives/Instruction: Obstructive sleep apnea (OSA) is associ-
ated with increased prevalence of metabolic syndrome, type 2 dia-
betes mellitus (DM) and obesity however the association between
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OSA and prevalence of insulin resistance (IR) in nondiabetic patients
needs further studies.
This research provides the information about the association
between polysomnography (PSG) parameters, daytime sleepiness
scored with Epworth Sleepiness Scale (ESS) and IR.
Methods: Our study group estimated 102 nondiabetic individuals.
Sleep analysis included an overnight PSG examination. The HOMA
index was calculated on the basis of fasting plasma insulin and glu-
cose concentration.
Results: Among study sample (n = 102) 71 men and 31 women,
mean age 53.02 ± 12.37 suspected of having OSA, n = 85 (83.3%)
had OSA, 64 men (75.3%) and 21 (24.7%) women. The difference
between groups with and without OSA was not statistically signifi-
cant on existence of arterial hypertension, body mass index (BMI)
and age. After the study sample was divided according to apnea‐
hypopnea index values (AHI) we observed statistically significant
(p < 0.05) higher fasting plasma insulin concentration and HOMA‐
IR index values in patients with moderate to severe OSA (AHI
≥ 15) comparing with group with AHI < 15. The statistically rele-
vant difference (p< 0.01) in parameters of carbohydrate metabo-
lism was also present in group with severe OSA (AHI ≥ 30)
compared to patients with AHI< 30. There was not any correla-
tion between ESS rates and fasting plasma glucose/insulin concen-
tration. Higher percentage of desaturation time below 90% was
an independent risk factor for higher fasting glucose levels
(p < 0.05).
Conclusions: Individuals with moderate to severe OSA without
DM had higher HOMA‐ IR indexes than patients without or with
mild OSA. This study revealed that there is no evidence if the evalu-
ation of daytime sleepiness using ESS is a predicting factor of devel-
oping IR. Higher AHI and oxygen desaturation index (ODI) were
independent risk factors for higher fasting plasma insulin concentra-
tion and higher HOMA‐ IR index.
Disclosure: Nothing to disclose.
P139 | Adherence in positive airway pressure
in naïve obstructive sleep apnea patients: the
importance of the first month of treatment and
the impact of telemedicine monitoring
S. Marques1; A. Bento1; A. Gralho2; M. Duarte2;
S. Mayoralas3; C. Caneiras2
1Clinica Lusiadas Almada, Almada, 2Healthcare Department of Praxair,
Lisbon, Portugal, 3Healthcare Department of Praxair, Madrid, Spain
Objectives/Introduction: Long‐term conditions are associated
with poor adherence. Is especially prevalent in conditions where
symptoms may fluctuate or may be hidden like Obstructive Sleep
Apnea (OSA). Untreated OSA lead to high morbidity, such as
reduced cognitive function, depression, infertility, increased risk of
accidents, and it is associated with diseases such as hypertension,
diabetes, myocardial infarction, and stroke. Chronic multimorbidity is
a new challenge and must involve a change in the global organiza-
tion of care and follow‐up.
We prospectively assessed adherence using daily telemonitoring of
naïve Positive Airway Pressure (PAP) OSA patients′ data and associ-
ated clinical parameters of cardio‐metabolic risk during one year. The
ultimate goal of this trial will be to develop an effective, extensible
and cost‐effective system to promote improved adherence to CPAP
patients.
Methods: In a single center, 60 naïve PAP adult patients with
moderate to severe OSA were randomized in two groups: standard
care consisting in first, third and sixth month consultations and
those with daily telemonitoring information (i.e., adherence, air
leak, residual AHI) plus first and second week consultation and
standard care (first, third and sixth month consultations). Subjects
who used PAP for at least 5 hours per night for at least 90% of
the days monitored were regarded as adherent. We also analyzed
the correlation between adherence and cardio‐metabolic clinical
parameters.
Results: 52 patients were enrolled, 34 were randomized to teleme-
dicine and 18 to standard care. The mean age was 54,2 year, mean
AHI was 38,3 events/hr, and 56% of patients were male. Only after
1 month, mean PAP adherence was significantly greater in the tele-
medicine arm versus the standard arm. After 3 mo. PAP adherence
in the telemedicine arm was almost total sleep time (7h34) versus
3h47 in the standard arm.
Conclusions: PAP adherence should be improved with the use of
a web‐based telemedicine system at the beginning of the treatment.
This trial demonstrates that good PAP adherence occurs during the
first few days and can be predicted in first two consultations. Car-
dio‐metabolic clinical parameters significantly improved with total
sleep time PAP adherence associated with body mass control and
exercise.
Disclosure: Nothing to disclose.
P140 | The impact of a telemedicine
monitoring on positive airway pressure in naïve
obstructive sleep apnea patients’ outcomes: a
randomized controlled trial
S. Marques1; A. Bento1; A. Gralho2; M. Duarte2;
S. Mayoralas3; C. Caneiras2
1Clinica Lusiadas Almada, Almada, 2Healthcare Department, Praxair,
Lisbon, Portugal, 3Healthcare Department, Praxair, Madrid, Spain
Objectives/Introduction: Untreated Obstructive Sleep Apnea
(OSA) can lead to high morbidity, such as reduced cognitive function
and increased risk of accidents, and it is associated with diseases
such as systemic arterial hypertension, metabolic syndrome, acute
myocardial infarction, and stroke. Multimorbidity implies to change
organization of care and follow‐up. We prospectively assessed
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adherence using daily telemonitoring of naïve Positive Airway Pres-
sure (PAP) OSA patients′ data and other associated clinical parame-
ters of cardio‐metabolic risk during one year. The ultimate goal of
this pilot trial will be to develop an effective, extensible and cost‐
effective system to promote improved adherence to CPAP patients,
as well as monitor clinical parameters (HR, hypertension, glycaemia,
and oximetry) of frequently associated OSA co‐morbidities.
Methods: In a single center, 80 naïve PAP adult patients with mod-
erate to severe OSA were randomized in two groups: standard care
consisting in first week, first, third and sixth month consultations
and those with daily telemonitoring information (i.e., adherence, air
leak, residual AHI) plus standard care. Subjects who used PAP for at
least 5 h per night for at least 90% of the days monitored were
regarded as adherent. We also analyzed the correlation between
adherence and cardio‐metabolic clinical parameters.
Results: 73 patients were enrolled, 35 were randomized to teleme-
dicine and 38 to standard care. The mean age was 57.2 year, mean
AHI was 38,4 events/hr, and 59% of patients were male. After 1
month, mean PAP adherence was significantly greater in the teleme-
dicine arm versus the standard arm. But after 6 months mean PAP
adherence was almost total sleep time in both arms (6h34 vs 5h58).
Conclusions: PAP adherence can be motivated and faster with the
use of a web‐based telemedicine system at the beginning of the
treatment. This trial demonstrates that sustained long‐term PAP
adherence occurs during the first few days. Telemedicine monitoring
of naïve PAP OSA patients can be cost‐effective by reducing the
need of consultations. Also cardio‐metabolic clinical parameters sig-
nificantly improved with total sleep time PAP adherence associated
with body mass control and exercise.
Disclosure: Nothing to disclose.
P141 | CPAP mask usage time and its effect
on air leak
M. Seppänen1; H. Avellan-Hietanen2; A. Bachour3
1Heart and Lung Department, Sleep Unit, 2Heart and Lung Center,
Sleep Unit, 3Heart and Lung Center, Helsinki University Hospital,
Helsinki, Finland
Objectives/Instruction: Unintentional air leaks during CPAP ther-
apy is common. Such leaks may be related to mask leak or mouth
breathing. The silicon and strap characteristics may change over
time, leading to poorer mask fit. It is unknown how often masks
should be replaced. The purpose of this study is to evaluate modifi-
cations of air leaks over time.
Methods: All patients were followed for CPAP therapy. The hospi-
tal proposed one mask per year at no cost to the patient. Different
mask types and brands were used. We evaluated 89 consecutive
patients during their yearly visit for leak values obtained from the
ResScan program. Leak values during the first month of use were
compared to those at 12 months.
Results: Eighty‐nine patients used 89 masks for a mean period of
578 ± 379 days. Mean patient age was 58 years. There were 28
Female and 61 male patients. There were eight full‐face masks, six
of which were ResMed Quatro masks. Of the 64 nasal masks, 32
were Respironics Comfort Classic, 17 were Resmed Mirage Micro/
Ultra or Softgel, 18 were Fischer & Paykel Flexifit 406 or 407. Of
the 17 nasal‐pillow masks, 15 were ResMed Swift II or LT. Mean
leak values at 12 months were not higher than during the first
month of use (8.261 vs. 7.218 L/min, F [1, 134] = 0.370; P = 0.544).
Conclusions: Unintentional air leak did not increase after one year
of using the same CPAP mask. Our results indicate that CPAP masks
continue to fit well after one year of CPAP use.
Disclosure: Nothing to disclose.
P142 | Comparing the current classification of
obstructive sleep apnea severity with oxygen
saturation parameters
S. Wali1; B. Abalkhail2; I. Al Qassas3; F. Alhejaili1
1Sleep Medicine and Research Center, King Abdulaziz University
Hospital, 2Community Medicine Department, King Abdulaziz University,
3International Medical Center, Jeddah, Saudi Arabia
Objectives/Instruction: Current guidelines categorize Obstructive
Sleep Apnea (OSA) severity according to the Apnea Hypopnea Index
(AHI). However, there is a lack of clarity as to what best defines
OSA severity.
We aim to assess the correlation of American Academy of Sleep
Medicine (AASM) classification of OSA severity to various oxygen
saturation parameters.
Methods: This study followed a survey on the prevalence of OSA
among 2,682 middle‐aged people in Saudi Arabia. Among the 346
subjects who underwent PSG, 235 had OSA. OSA severity was
classfied according to the AASM criteria using AHI into (5–14) mild,
(15–30) moderate and (> 30) severe. This standard classification of
OSA severity was compared with different oxygen saturation as well
as PSG parameters. These include: Number of desaturations per
hour of sleep; minimal oxygen saturation; percent of sleep time with
desaturation; sleep time with oxygen saturation below 90%; average
duration of apnea and hypopnea; total arousal index and respiratory
arousal index; and duration of Rapid Eye Movement (REM) sleep.
The study was limited to PSG studies of at least 240 minutes dura-
tion with REM sleep.
Results: Of the 346 subjects whom underwnt PSG, 189 had PSG
of at least 240 min duration with REM sleep. Of these, 129 had
obstructive sleep apnea based on an AHI of > 5. There was signifi-
cant correlation between OSA severity based on AHI and different
oxygenation parameters: Number of desaturations per hour of sleep;
minimal oxygen saturation; percept of sleep time with desaturation;
sleep time with oxygen saturation below 90%; and average duration
of apnea had significant Spearman rank correlation coefficients with
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(p‐value < 0.001). Index of total arousals and of respiratory arousals
again correlated well with severity (p‐value < 0.001). The duration of
REM also was found to be assicated with OSA severity (p‐value
< 0.003). However, there was no significant correlation with the
duration of hypopnea (p‐value = 0.704).
Conclusions: This study revealed a significant correlation between
the current standard OSA severity classification based on AHI and
different variables of oxygenation and PSG parameters, which con-
firms its practicality to be used clinically.
Disclosure: Nothing to disclose.
P143 | Impacts of time of day and seasonal
light variation on cognitive performance in
patients with suspected Obstructive Sleep Apnea
M. Bowen1; P. Hanly2; N. Ayas3; M. Fenton1; J. Raneri2;
N. Fox3; E. Lynch2; J. Carrier4; E. Smith2; A. Beaudin2;
R. Skomro1
1University of Saskatchewan, Sasakatoon, SK, 2University of Calgary,
Calgary, AB, 3University of British Columbia, Vancouver, BC, 4University
of Montreal, Montreal, QC, Canada
Objectives/Instruction: Time of day (ToD) and seasonal light vari-
ation (SLV) are factors that may influence cognitive testing. Obstruc-
tive Sleep Apnea (OSA) may also be associated with mild cognitive
impairment (MCI). Little is known how ToD and SLV may affect cog-
nitive testing in OSA.
Methods: Adult patients (N = 391) with suspected OSA who
underwent in‐lab polysomnography were recruited into a multi‐cen-
ter observational cohort study (Canadian Sleep and Circadian
Rhythm Network) to determine the association between OSA and
MCI. Patients completed the Epworth Sleepiness Scale (ESS) and the
Montreal Cognitive Assessment Test (MoCA). ToD and SLV were
defined as the time of day and the time from sunrise to sunset when
the MoCA was completed. Patients were stratified into four cate-
gories using Apnea‐Hypopnea Index (AHI): no (AHI < 5), mild (AHI
5–15) moderate (AHI 15–30) and severe (AHI > 30) OSA. Multiple
linear regression and pairwise correlations were completed using
Stata 13.0.
Results: SLV, age, ToD, sex (female), AHI, ESS were significant pre-
dictors of performance on the MoCA (r2 = 0.16, p < 0.0005) in that
order (Betas: 0.23, −0.20, −0.17, 0.1, −0.1, −0.1). MoCA score wors-
ened during later ToD in participants with no, mild, and moderate
OSA (r = −0.37, p = 0.003; r = −0.19, p = 0.05; r = −0.25, p = 0.02
respectively), but those with severe OSA were not impacted
(p = 0.3). SLV affected all participants, except those with mild OSA
(r = 0.15, p = 0.1), (No OSA, r = 0.34, p = 0.002; Moderate, r = 0.39,
p < 0.0005; Severe, r = 0.20, p = 0.009). However, the impacts of
SLV were only present when individuals completed the MoCA in the
morning (r = 0.25, p < 0.0005) or evening (r = 0.33, p = 0.02), but
not in the afternoon (p = 0.7).
Conclusions: ToD may affect MoCA performance in those with no
or less severe OSA, while SLV may have impacts on most individuals
regardless of OSA severity. SLV and ToD may interact, suggesting
exposure to sunlight may affect cognition.
Disclosure: Funded by the Canadian Institute of Health Research
(CIHR) through the Canadian Sleep and Circadian Network (CSCN).
P144 | Effects of nocturnal ventilatory
treatment in cognitive functions in a cohort of
patients affected by OHS
P. Congiu1; G. Gioi1; M. Figorilli1; R. Lecca1; P. Pisanu1;
M.G. Mascia2; L. Tamburrino1; I. Laccu1; M.M.F. Puligheddu1
1University of Cagliari, Sleep Center, Monserrato, 2Neurorehabilitation
Unity ‐ SS Trinità Hospital, Cagliari, Italy
Objectives/Introduction: Obstructive sleep apnea syndrome
(OSAS) and obesity‐hypoventilation syndrome (OHS) are the most
frequent forms of sleep disordered breathing (SDB) associated to
obesity (BMI>30). OSAS and OHS are important negative factors in
management and prognosis in obese patients, and may have several
common complications, namely excessive daytime sleepiness, mood
disorders, increased risk of car accidents, hypertension, and cardio-
vascular events and stroke. OSAS and OHS may cause cognitive
impairment, such as attention/vigilance deficit, delayed verbal and
visual long‐term memory, visuospatial/constructional abilities, and
executive function, due to sleep fragmentation and nocturnal inter-
mittent hypoxia/hypoventilation. The greatest dysfunction is reported
to concern the executive functions, carried out by prefrontal cortex
(PFC). Damage of PFC may be due to sleep fragmentation, disruption
of circadian rhythm, cerebrovascular disease, and nocturnal intermit-
tent hypoxia/hypoventilation. Brain tissue damage, once occurred,
may be only partially reversed by regular treatment with CPAP/NIV.
Methods: Among the patients referred to the outpatient service of
Sleep disorders center of University of Cagliari, 30 consecutive
obese patients were selected. 26 patients underwent to a full‐night
complete polysomnography (PSG); arterial blood gas analysis was
performed in 19 subjects, 8 patients underwent to PAP titration and
neuropsychological assessment which was made both before starting
nocturnal ventilator treatment and after 6 months of treatment.
Diagnosis of OSAS/OHS was made according to AASM criteria.
Results: OSAS (AHI≥5) was diagnosed in 83% of subjects, and
OHS (BMI≥30 and PCO2>45mmHg) in 31%. Cognitive assessment
showed impairment in executive function, in particular a deficit in
attention (visual attention, attention flexibility, selective attention
and more). After 6 months of nocturnal treatment we found a signif-
icant improvement in “attention” (time interference effect at Stroop
test: p = 0.022; visual search: p = 0.017; trial making test‐A:
p = 0.019) and in logical thinking (Raven's progressive matrices:
p = 0.015).
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Conclusions: The prevalence of SDB in obese subjects is very
high. Early identification of any SDB in obese patients and set up of
adequate ventilator nocturnal treatment may improve nocturnal and
diurnal quality of life of these patients and may also prevent brain
tissue damage to develop, contrasting permanent cognitive
impairment.
Disclosure: Nothing to disclose.
P145 | The impact of arousal on sleep‐related
deglutition in patients with obstructive sleep
apnea hypopnea syndrome
Y. Li1,2; X. Ding1,2; C. Wang1,2; Q. Yang1,2; D. Han1,2
1Department of Otorhinolaryngology Head and Neck Surgery, Beijing
Tongren Hospital, Capital Medical University, 2Key Laboratory of
Otolaryngology Head and Neck Surgery Capital Medical University,
Ministry of Education, Beijing, China
Objectives/Instruction: Sleep‐related deglutition in patients with
obstructive sleep apnea‐hypopnea syndrome (OSAHS) and its corre-
lation with sleep stage and cortical arousals were investigated.
Methods: Simultaneous polysomnography and pharyngeal pressure
monitoring were performed in 23 adult patients with OSAHS, the
following parameters were analyzed: (1) the relationship between
arousal and deglutition; (2) the effect of sleep stage on deglutition;
(3) The relationship between the frequency of deglutition and the
severity of OSAHS.
Results: The study subjects aged 43±12 years, and the mean
apnea‐hypopnea index (AHI) was (49.2±27.7) times/hour. A total of
1382 deglutition were recorded during sleep, with a median of 9.2
[5.8, 13.8] times/person. There was a positive correlation between
deglutition frequency and AHI(r = 0.570, p = 0.005) and negatively
correlated with oxygen saturation (r = −0.639, p = 0.001). The
majority of the deglutition (73.7%) occurred after the respiratory
event and in association with respiratory arousal. Deglutition
occurred more in Non‐rapid eye movement sleep stage 1 (N1) than
N2, N3 and REM sleep (Z = −3.680, p < 0.001; Z = −2.746,
p = 0.006; Z = −3.490, p < 0.001).
Conclusions: The occurrence of deglutition in patients with
OSAHS is associated with cortical arousals. Deglutition frequency
increased with the severity of apnea; and affected by sleep staging.
Disclosure: This research was supported by National Key Research
& Development Program of China (2017YFC0112500) and Beijing
Municipal Administration of Hospitals’ Mission Plan (SML20150201).
P146 | Non‐rapid eye movement oscillatory
events in middle‐aged and older adults with
obstructive sleep apnea
S. Chami1,2; K. Gagnon2,3; M.-È. Martineau-Dussault2,4;
A.-A. Baril2,5; H. Blais2; J. Carrier2,4; J. Montplaisir2,5;
N. Gosselin2,4
1Neurosciences, Université de Montréal, 2Center for Advanced Research
in Sleep Medicine, 3Psychologie, Université de Québec à Montréal,
4Psychologie, 5Psychiatrie, Université de Montréal, Montreal, QC,
Canada
Objectives/Introduction: Obstructive sleep apnea (OSA) is a
sleep disorder characterized by cessations (apnea) or reductions (hy-
popnea) of airflow due to upper airway obstructions. These respira-
tory events cause sleep fragmentation and intermittent hypoxemia.
OSA was recently shown to increase the risk of dementia, but the
mechanisms linking OSA to dementia are not clear and need further
investigation. Considering that non‐rapid eye movement (NREM)
oscillatory events (i.e. sleep slow waves and spindles) are important
for memory consolidation and synaptic plasticity, the aim of the pre-
sent study was to test the hypothesis that OSA is associated with
altered sleep slow waves and spindles.
Methods: Our study included 103 middle‐aged and older subjects
(mean age = 64.2±6.6 years) with an OSA varying from absent to
severe (mean apnea‐hypopnea index = 20.4±17.8 events/h). They
were tested with one night of in‐laboratory polysomnography. Spin-
dles and slow waves were automatically detected during N2 and N3
sleep. Partial correlations that included age and sex were performed
between slow wave (amplitude, density, duration, slope), electroen-
cephalogram slow wave activity power (0.5 à 4.5 Hz), spindle charac-
teristics (amplitude, density, duration, frequency), N2 and N3 sleep
duration and markers of OSA severity (sleep time with oxygen satu-
ration < 90%, apnea‐hypopnea index and micro‐arousal index).
Results: We found that higher apnea‐hypopnea index and micro‐
arousal index were associated with decreased slow wave amplitude
and density (r varying from −0.260 to −0.315, p varying from 0.002
to 0.01). Moreover, increased apnea‐hypopnea index and micro‐arou-
sal index correlated with lower slow wave activity power (r varying
from −0.280 to −0.378, p varying from 0.000 to 0.005) and reduced
N2 and N3 sleep duration (r varying from −0.264 to −0.431, p vary-
ing from 0.000 to 0.008). No significant correlations were found
between spindle characteristics and OSA severity.
Conclusions: Overall, our findings suggest that OSA severity may
compromise the regular generation of sleep slow waves in middle‐
aged and older subjects. Further studies are required to examine
whether these changes in slow waves prevent optimal synaptic plas-
ticity and lead to cognitive dysfunctions.
Disclosure: Nothing to disclose.
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P147 | The effects of nasal decongestion on
obstructive sleep apnea: a detailed analysis
Y. An; D. Han
Department of Otolaryngology Head and Neck Surgery, Beijing Tongren
Hospital, Capital Medical University, Beijing, China
Objectives/Instruction: Many studies indicated associations
between nasal obstruction and sleep disorders. However, the precise
nature of the relationship between nasal patency and sleep apnea
remains unclear. In this study, we analyzed the specific effects of
nasal patency on the sleep quality in obstructive sleep apnea(OSA)
patients by applying nasal spray decongestant.
Methods: We perform a randomized, placebo‐controlled double
blind study on the effects of topical nasal decongestion on sleep
architecture, respiratory events, body position and subjective scores
in OSA patients with chronic nasal congestion and without obvious
pharyngeal narrowing. Ten eligible OSA patients (9 males, 38.5±10.5
years old) were recruited. All participants received specific physical
examinations, subjective scale assessments and a two‐night
polysomnography sduty (by randomly applying oxymetazoline for
one night and placebo for another.). Data collected after oxymetazo-
line or placebo treatments were compared. Results were presented
as means±SD or M(P25, P75). Differences between the paired sam-
ples were identified by paired t test or Wilcoxon rank test. p < 0.05
was considered to be statistically significant.
Results: Compared with placebo, oxymetazoline resulted in a signif-
icant reduction in apnea/hyponea index (AHI) (36.43±15.38 vs.
29.39±16.60), mainly affecting non‐rapid eye movement(NREM)
sleep period (34.34±16.84 vs. 28.35±16.38), rather than rapid eye
movement(REM) sleep period. In terms of respiratory events pat-
terns of sleep, the apnea index were significantly decreased
(30.74±17.38 vs.22.88±17.96) and the change of hypopnea index
did not meet statistical significance. Oxymetazoline was not associ-
ated with significant changes in respiratory event duration, mean
SpO2 or minimal SpO2 compared with placebo. However, the per-
centage of sleep time with SpO2 below 90% (TST90) was signifi-
cantly decreased [placebo 2.27%(0.13%,7.99%) vs. oxymetazoline
0.41%(0%,4.3%)]. After nasal decongestion, it was manifested great
improvements in the frequency of postural changes [placebo 2.33
(1.35, 4.12) vs. oxymetazoline 1.17(0.68, 3.34)], AHI in supine posi-
tion[placebo 56.15 (39.20, 63.2) vs. oxymetazoline 39.70(32.00,
51.10)], and arousal index(placebo 26.85±15.08 vs. oxymetazoline
16.69±13.00) in patients with OSA, whereas AHI in non‐supine posi-
tion did not significantly improved.
Conclusions: Nasal patency participates in the pathogenesis of
OSA by affecting the respiratory pattern of NREM sleep,especially in
supine position. Improvement of nasal patency can lead to an unin-
terrupted sleep and a reduced times of sleep‐turning.
Disclosure: Nothing to disclose.
P148 | Association of restless legs syndrome
with depression, anxiety, and insomnia in
patients with obstructive sleep apnea syndrome
K. Bae
Chonnam National University Medical School, Gwangju, Republic of
Korea
Objectives/Instruction: An association between obstructive sleep
apnea syndrome (OSAS) and restless legs syndrome (RLS) has long
been reported. Both syndromes are associated with depression, anxi-
ety, insomnia, and daytime sleepiness. However, these relationships
have not been studied extensively, and many questions remain unan-
swered. This study investigated the prevalence of RLS and its associ-
ation with depression, anxiety, insomnia, and daytime sleepiness in
OSAS patients in Korea.
Methods: The study enrolled 152 Korean OSAS patients Chonnam
National University Hospital. The International Restless Legs Syn-
drome Study Group criteria and International Restless Legs Scale
were used to determine the diagnosis and severity of RLS. To assess
depression, anxiety, and insomnia, all patients completed the Beck
Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Insomnia
Severity Index (ISI), and Epworth Sleepiness Scale (ESS).
Results: Overall, 65 (42.6%) patients met least one of the RLS diag-
nostic criteria, and 17 (11.1%) were diagnosed with RLS. The mean
BDI, BAI, and ISI scores were higher in subjects with RLS symptoms
compared with those without such symptoms. ESS scores were not
significantly associated with RLS symptoms. There were significant
positive correlations between RLS severity and BDI (rs = 0.341,
p < 0.001), BAI (rs = 0.322, p< 0.001), and ISI (rs=0.369, p< 0.001)
scores.
Conclusions: There were significant relationships between RLS
symptoms and depression, anxiety, and insomnia. We recommend
that patients with OSAS be evaluated for symptoms of RLS.
Disclosure: Nothing to disclose.
P149 | A composite screening method to
maximise pick up rate of obstructive sleep
apnoea in train drivers
L. Ogunyemi1; T. Stacey2; M. Sovani3
1Trinity Occupational & Public Health Solutions, Nottingham, 2East
Midlands Trains, Leicester, 3Nottingham University Hospitals NHS Trust,
Nottingham, United Kingdom
Objectives/Instruction: Undiagnosed OSA has been implicated in
a number of rail crashes and otherl incidents. (1,2) The majority of
the UK Occupational Medical services screen for OSA using ESS
which is subjective and grossly under‐reported (3). We used a combi-
nation of screening methods to maximise the pick up rye for OSA in
Train Drivers (TD).
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Methods: TD were screened and assigned as high risk if they were
positive for one of the following: their ESS >10, STOP‐Bang (SB)>3,
Adjusted Neck Circumference (ANC)>48 and Body Mass Index
based on Australian Road OSAS criteria (BMI >35 + risk factor or
BMI >40). Drivers were referred for a Home Limited Channel Polyg-
raphy (Type 3) study.
Results: Of the 292 drivers screened during the year, 7 had a pre‐
existing diagnosis of OSA.
Of the remaining 285, 40 met at least one criteria for the referral
for Home PG.
Baseline data for 285 drivers screened versus 40 drivers referred for
Home PG were : BMI 29 v 36), STOP‐Bang 2.4 v 4.7, Adjusted Neck
Circumference 42 v 48 and mean ESS of 3.4 v 4.5
From 40 TD who underwent home PG, 3 out of 3 with ESS >10
were diagnosed with OSA, another 14/23 with high STOP‐Bang had
OSA, 12/25 with ANC >48 and 13/25 with BMI criteria were posi-
tive for OSA.
Of the 40 who had Home PG, 12 had mild OSA, 7 moderate & 5
severe OSA. TOTAL with OSA = 24 New + 7 pre diagnosed= 31/
292. 6 result are awaited, and 10 drivers had negative Home PG.
This gives a prevalence of at least 10.6%.
24/40 or 60% had a positive sleep study.
Conclusions: ESS is inadequate as the only screening tool for
OSA. We recommend using a combination of screening tools
allowed us to maximise pick up rate of OSA in train drivers. With
60% pick up rate this approach was effective in our population.
Disclosure: Nothing to disclose.
P150 | Asociation between obstructive sleep
apnea hypopnea syndrome and neutrophyl‐to‐
lymphocyte ratio
J.M. Escobar-Montalvo1; E. Herráez Sánchez1; M.J. Aguilar-
Amat Prior2; M. Naranjo Castresana2; J. Oliva Navarro2;
E. Petrica1; M. Merino Andreu2
1Neurology Service, 2Sleep Disorder Unit ‐ Neurology Service, La Paz
University Hospital, Madrid, Spain
Objectives/Introduction: Currently the neutrophil-tolymphocyte
ratio (INL) is consider a cheaper and very accessible biomarker of
some inflammatory and non‐inflammatory diseases. The obstructive
sleep apnea‐hypopnea syndrome (OSAHS) is a serious public health
problem in which found accessible and valid biomarkers is very
important.
The aim is study the association between OSAHS and NRL value.
Methods: Retrospective study based on hospital data. Clinical
records were analyzed for variables such as demographic characteris-
tics, hematological (including NLR), C‐reactive protein levels, and
polysomnographic parameters. Statistical analyses were following:
descriptive analysis, median comparison (with Mann‐Withney U and
Kruskal‐Wallis tests) for association between INL and OSAHS
diagnosis/severity, and Receiver Operating Characteristic curve for
INL values and polysomnographyc diagnosis. One logistic regression
model was performed between OSAHS and INL values.The signifi-
cance level was 95%.
Results: Fifty‐six subjects were included. The 62.5% were diag-
nosed of OSAHS. Median of NLR levels were 1.40 (range: < 0.25;
6.0]>). Median differences between NLR levels of subjects with and
without OSAHS were statistically significant (Mann–Withney U test:
p< 0.0001, < 0.65; 1.16>). Severity of OSAHS were associated with
NLR levels (Kruskal‐Wallis: p< 0.00001). ROC curve determined a
NLR cut‐off >1.55 (sensitivity: 60%, specificity: 80%, and area under
curve (AUC) = 0.68: p< 0.012, < 0.54; 0.80>) to OSAHS diagnosis.
Unadjusted logistic regression model determined an OR = 2.48 (p =
0.237, < 1.13; 5.43>). However, this association was lost after being
adjusted by age.
Conclusions: The neutrophyl-to-lymphocyte ratio is associated to
polysomnographic diagnosis of OSAHS and Its severity. The NLR
cut-off calculated had low sensitivity and acceptable specificity. More
studies with prospective designs should be perform to confirm the
association between NLR and OSAHS.
Disclosure: Nothing to disclose.
P151 | Effect of obesity on upper airway
obstruction during drug‐induced sleep
endoscopy
H. Kim1; J.S. Lee2; S.J. Heo3; J.S. Kim3
1Otorhinolaryngology‐Head and Neck Surgery, Hallym University College
of Medicine/Dongtan Sacred Heart Hospital, Hwaseong,
2Otorhinolaryngology‐Head and Neck Surgery, Hallym University College
of Medicine/Hallym University Sacred Heart Hospital, Anyang,
3Otorhinolaryngology‐Head and Neck Surgery, Kyungpook National
University School of Medicine/Kyungpook National University Hospital,
Daegu, Republic of Korea
Objectives/Instruction: Through previous studies, relationship
between obesity and obstructive sleep apnea (OSA) has been well
known. In anatomical aspect, people have been thought that fat depo-
sition in the upper airway leads to pharyngeal airway narrowing, and it
causes to increase collapsibility of the upper airway. In our study, we
performed drug‐induced sleep endoscopy (DISE) to sleep apnea
patients, and analyzed the effect of obesity on airway obstruction.
Methods: Subjects included the OSA patients without surgery his-
tory and all patients perform the polysomnography (PSG) and DISE
for their OSA between April 2014 and July 2015. Demographics,
polysomnographic data, DISE results were collected prospectively.
The obstruction on DISE was classified as VOTE classification;
velum, oropharynx, tongue base, and epiglottis. The severity of
obstruction was classified as 0, no obstruction; 1, partial obstruction;
2, complete obstruction. Patients were divided into non‐obese and
obese group by BMI, and analyzed the factors associating obstruc-
tion findings on DISE.
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Results: Totally 113 patients were enrolled, male was 101 and
female was 12. Among them, non‐obese patients (BMI < 25) were
47, and obese (BMI≥25) patients were 66. There was no statistical
difference in age between two groups. When dividing patients with
totally obstruction of anatomy and patients with none or partially
obstruction groups, There is no difference in obstruction of tongue
base, and epiglottis between two groups. However, oropharynx total
obstruction was more frequently presented in obese patients with
statistical significance (p = 0.021). On the other hand, epiglottis par-
tial obstruction on DISE was identified in non‐obese group more fre-
quently with statistical significance (p = 0.026). When assessing their
tonsil by Friedman grading scale, there is no significant difference in
tonsil size between two groups. When using biological regression
model, obesity can affect obstruction of the epiglottis with statistical
significance (p = 0.005).
Conclusions: There are complex relationship between OSA and
obesity. Focusing anatomical aspect of upper airway, obesity can
affect the oropharynx area obstruction. On the other hand, non‐
obese patients show obstruction of the epiglottis more frequently
than obese patients. These results can be affect decision of treat-
ment modalities according to obesity, and further large study will be
expected.
Disclosure: Nothing to disclose.
P152 | Reliable sleep apnea characterization in
adults with suprasternal pressure
T. Penzel1,2; A.K. Sabil3; M. Glos1; A. Günther1; C. Schöbel1;
I. Fietze1
1Sleep Medicine Center, Charité ‐ Universitätsmedizin Berlin, Berlin,
Germany, 2International Clinical Research Center, St. Anne's University
Hospital Brno, Brno, Czech Republic, 3Research and Development at
CIDELEC, Sainte Gemmes, France
Objectives/Instruction: To determine if recording of suprasternal
pressure (SSP) can classify apneas as reliably as respiratory induc-
tance plethysmography (RIP) belts and compare the two methods to
classification with esophageal pressure (Pes), the reference method
for assessing respiratory effort.
Methods: In addition to polysomnographic recordings that included
Pes, SSP was recorded using the PneaVoX technology (CIDELEC,
France). 32 patients (25 males, mean age 66.7±15.3 years, and mean
BMI 30.1±4.5 kg/m²) were used to compare the classification of
detected apneas by 3 methods of respiratory effort evaluation (Pes,
RIP belts and SSP). Signals were analyzed randomly and indepen-
dently from each other by 2 scorers. All recordings were analyzed
according to AASM guidelines.
Results: Comparison of apnea characterized by SSP and by Pes
showed an agreement of 99.0% for obstructive, 94% for central and
92.1% for mixed apneas and 97.2%, 92.6% and 96.9%, by scorer 1
and scorer 2, respectively. Comparing RIP to Pes, agreement was
98.9% for obstructive, 92.5% for central and 80.5% for mixed
apneas and 97.8%, 87% and 83.4%, by scorer 1 and scorer 2,
respectively.
Conclusions: Compared to Pes, the golden standard method for
respiratory effort evaluation, the SSP method scored slightly better
than the RIP belt method. Thus, we conclude that sleep apnea char-
acterization in adults with suprasternal pressure is a reliable method.
Disclosure: The authors received a grant from Cidelec to support
the additional effort needed for this study.
P153 | Sleep apnea in Tibetans and Han
long‐term high altitude residents
L. Tan1,2; T. Li1; M. Furian2; X. Xue3; R. Ren1; J. Zhou1;
Y. Zhang1; J. He3; S. Ulrich2; K.E. Bloch2; X. Tang1
1Sleep Medicine Center, West China Hospital, Sichuan University,
Chengdu, China, 2Sleep Disorders Center, Dept. of Respiratory Medicine,
University Hospital Zurich, Zurich, Switzerland, 3Dept. of Cardiology,
Diqing Tibetan Autonomous Prefectural People's Hospital, Shangri‐La,
China
Objectives/Instruction: Obstructive sleep apnea (OSA) is associ-
ated with adverse health outcomes in lowlanders. The propensity to
OSA may be modified by ethnic and environmental influences. We
compared the prevalence of sleep apnea between Tibetans and Han
long‐term residents at high altitude.
Methods: 86 consecutive long‐term residents (>5 y) of Shangri‐La,
3200m, China, referred for evaluation of snoring or witnessed apnea
underwent clinical and questionnaire evaluation and polysomnogra-
phy (PSG) at the local hospital at 3200m.
Results: In 42 Tibetans, 38 men, median age 50 y, body mass index
(BMI) 25.1 kg/m2, forced expiratory volume in 1s (FEV1) 93%pred.,
the apnea/hypopnea index (AHI) was 55.3/h. In 44 Hans, 32 men,
age 47 y, BMI 24.4 kg/m2, FEV1 98%pred., the AHI was 25.8/h (p<
0.001 vs. Tibetans). In multiple regression analysis controlling for
age, sex, BMI, Epworth sleepiness score (ESS) and several other
known predictors of OSA, the AHI was positively correlated with
Tibetan vs. Han ethnicity (coefficient +19.8/h, 95%CI +8.4 to +31.3,
p = 0.001). Moreover, in 40 men, 20 Tibetans and 20 Hans, matched
for age, BMI and ESS, the AHI in Tibetans was higher than in Hans
(47.0 vs. 29.4/h, p = 0.028). In 36 men, 18 Tibetans and 18 Hans,
matched for age, BMI and AHI, ESS was similar (6.5 vs. 5.5,
p = 0.628). The mean nocturnal oxygen saturation (SpO2) was lower
[median 85% (quartiles 83; 88) vs. 89% (87; 90)] and the apnea dura-
tion longer [22sec (20; 24) vs. 18sec (17; 20) sec] in Tibetan vs. Han
(p< 0.0001, both instances).
Conclusions: Our data suggest that long‐term residents at high
altitude of Tibetan ethnicity have a greater prevalence of sleep
apnea than Han Chinese, possibly due to differences in control of
ventilation.
Disclosure: Nothing to disclose.
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P154 | Study on endogenous cannabinoid
receptors CB1 of bone metabolism in chronic
intermittent hypoxia rat model
W. Bei
Shanxi Medical University, Taiyuan, China
Objectives/Instruction: To investigate the mechanism of CB1R
during the bone damage caused by chronic intermittent hypoxia
(CIH).
Methods: 48 rats were randomly divided into six groups with 8
rats in each: two control groups (CG) [rats exposed to normal air for
four weeks (4W) (CG1) and for 6 weeks (6W) (CG2) respectively];
rats exposed to intermittent hypoxia (IH) for 4W (IH1group)and 6W
(IH2 group) respectively; rats exposed to the same IH enviroment
but received intraperitoneal injection of CB1 antagonist (rimonabant)
at the dosage of 1.5mg/kg/d prior to IH modeling (treatment group 1
and treatment group 2). To detect the activity of serum β‐CTX by
using enzyme‐linked immunosorbent method (ELISA) and CB1R by
immunohistochemistry. Morphological changes were observed by
hematoxylin‐eosin staining (HE).
Results: In CG1 and CG2 the bone cell morphology was normal
and the trabecular structure was complete. However, the bone cells
in IHG 1 displayed with mild edema and inflammatory cells infiltra-
tion as well as reduced trabecular bone quantity; while in IHG2 such
changes were more severe. Compared with CG1 and CG2, TRAP
and CB1R was gradually and significantly elevated from IH1 group to
IH2 group with a significant difference among groups (all p < 0.05).
Compared with IH group, β‐CTX in the HI group was statistically
lower at the same time point of treatment groups. (all p < 0.05).
Pearson correlation analysis showed that there was a positive corre-
lation between the CB1R and the TRAP activity.
Conclusions: IH could lead to the disorder of ECS, the bone meta-
bolic and bone structure abnormality. Such a bone damage could
became more severe with the extension of IH exposure time and
could be improved with the use of CB1R antagonist (rimonabant)
intervention.
Disclosure: Nothing to disclose.
P155 | Epworth sleepiness scale and
maintenance of wakefulness test in patients with
obstructive sleep apnoea
N. Plos; I. Kušar Stojakovič; G. Omejec; L. Dolenc Grošelj
Clinical Institute of Clinical Neurophysiology, University Medical Center
Ljubljana, Ljubljana, Slovenia
Objectives/Instruction: Excessive daytime sleepiness (EDS) is a
frequent symptom of patients with obstructive sleep apnoea (OSA).
EDS is a high‐risk factor for road accidents. In a clinical setting, OSA
patients require assessment for EDS. This is generally undertaken by
subjective questionnaire Epworth Sleepiness Scale (ESS). This
method of assessing sleepiness is susceptible to reporting bias, par-
ticularly by professional drivers who may seek to underestimate
severity. On the other hand objective testing is expensive, time con-
suming and not well suited to large scale evaluations. Probably the
most commonly performed objective test for assessing EDS is the
maintenance of wakefulness test (MWT), which in no respect repli-
cates real‐life driving situations.
The aim of the study was to evaluate objective and subjective
aspects of EDS in untreated patients with different levels of OSA
severity.
Methods: 106 untreated OSA patients with different levels of OSA
were studied regarding night sleep and EDS. The criterion for severity
was the apnea hypopnea index (AHI). Patients were classified as: nor-
mal (AHI < 5), mild (AHI 5‐15), moderate (AHI 15–30) and severe OSA
(AHI >30). Full night polisomnography was performed. Next day
patients underwent 20‐min MWT testing and completed the ESS.
Results: Based on the AHI, 17 patients were normal (median
Epworth and MWT values: 12 and 20), 22 had mild OSA (median
ESS and MWT values: 13 and 20), 19 had moderate OSA (median
ESS and MWT values: 11 and 20) and 48 patients had severe OSA
(median ESS and MWT values: 12.5 and 14). There was no correla-
tion between AHI and ESS in all of the groups. Weak correlation
existed between AHI and MWT in severe OSA patients (Spearman r:
−0.2806, p = 0.0534). There was weak correlation between ESS and
MWT in patients with mild (Spearman r: −0.3909, p = 0.0721) and
moderate OSA (Spearman r: −0.3974, p = 0.0920). However none of
the correlations were statistically significant.
Conclusions: All patients with untreated OSA had abnormal ESS,
while MWT was normal in all groups. However, we did not find sta-
tistically significant correlations between severity of OSA and subjec-
tive evaluation and objective measurements of EDS.
Disclosure: Nothing to disclose.
INSOMNIA 1
P156 | Sex‐difference in insomnia symptom in
a Korean nation‐wide population‐based sample
Y. La; W. Kim
Neurology, Gangnam Severance Hospital, Yonsei University College of
Medicine, Seoul, Democratic People`s Republic of Korea
Objectives/Instruction: Insomnia is the most common sleep disor-
der with significant psychiatric/physical comorbidities in the general
population. Sex, age, mood, lifestyle factors and medical conditions
are known predictors of insomnia. The aim of this study is to investi-
gate whether socioeconomic and demographic factors are associated
with sex differences in insomnia and insomnia subtypes in South
Korea.
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Methods: The present study used data from the Korean‐Headache
Sleep Study (KHSS), a nationwide, cross‐sectional study with a struc-
tured questionnaire on headache and sleep among all Koreans aged
19 to 69 years conducted by trained interviewers. The Insomnia
Severity Index (ISI) was used to diagnose and classify insomnia and
its subtypes (cutoff value: 10). Other questionnaires included the
Pittsburgh Sleep Quality Index (PSQI), Goldberg Anxiety Scale (GAS)
and Patient Health Questionnaire‐9 (PHQ‐9) to measure sleep qual-
ity, anxiety and depression.
Results: A total of 2695 participants completed the survey (50.1%
female; 49.9% male). 715 (26.5%) of the participants were classified
as suffering from poor sleep quality. The overall prevalence of
insomnia symptoms was 10.7%, including difficulty in initiating sleep
(DIS) (6.8%), difficulty in maintaining sleep (DMS) (6.5%) and early
morning awakening (EMA) (6.5%), and these symptoms were more
prevalent in women than in men. Multivariate analysis showed that
female sex, shorter sleep time and psychiatric complications such as
anxiety and depression were found to be independent predictors for
insomnia symptoms and subtypes. Lower education level and older
age were associated with higher risk of EMA. After adjusting for
covariates among these factors, female sex remained a significant
risk factor for insomnia symptoms and its subtypes.
Conclusions: Approximately one‐tenth of the sample from the
Korean general population had insomnia symptoms. The prevalence
of insomnia symptoms was higher in women than in men. Among
the subtypes of insomnia symptoms, DIS, DMS and EMA were more
prevalent in women than men. Sex is an independent factor for
insomnia symptoms.
Disclosure: Nothing to disclose.
P157 | The compliances of doxepin for the
treatment of insomnia in real world
S.C. Hong; S.M. Kim
Department of Psychiatry, St. Vincent's Hospital, The Catholic
University of Korea, Suwon, Republic of Korea
Objectives/Instruction: Doxepin is the only approved antidepres-
sant for the treatment of insomnia. Low‐dose doxepin acts as a
selective antagonist for histamine H1 receptor, which facilitates
sleep without the risk of dependence or abuse. However, to our
knowledge, there is no studies focusing on compliance of patients
treating with doxepin in real world. Therefore, we analyzed 2‐
months discontinuation rate of doxepin for treating insomnia,
according to the type of prescribing doxepin and the reasons of dis-
continuation for the establishment of prescribing strategies.
Methods: We reviewed medical records of 534 outpatients pre-
scribed low‐dose doxepin, with diagnosis of insomnia in St. Vincent's
hospital between June, 2016 and May, 2017. The medication history
of sedatives and the type of prescription, such as prescribing doxepin
initially, switching from other medications or adding doxepin on
previous sedatives, were collected and the data were available from
201 subjects. Then, Kruskal‐Wallis test was performed for comparing
the discontinuation rate of groups depending on the prescribing type
and chi‐square test was used through the comparison of reasons for
discontinuation between groups. All significance levels were set to
0.05.
Results: 64.2% among 201 subjects were taking sedatives. And
35.8% of samples have been prescribed doxepin as the initial treat-
ment and groups of switching to doxepin and adding doxepin on
prior medications were 8.5% and 55.7%, respectively. At 2 months
follow‐up, 113 subjects (56.2%) discontinued doxepin and the most
frequent reason of discontinuation were lost to follow up (36.3%).
The rate of discontinuation was highest in the sedatives‐naïve group
(69.4%), and different from those of sedatives‐switching group
(52.9%) and doxepin‐adding group (48.2%) with a p‐value of 0.018.
Lost to follow up was the main reason of discontinuation in seda-
tives‐naive group (48.0%) and sedatives‐switching group (33.3%) and
the main reason of discontinuation in doxepin‐adding group was lack
of efficacy (37.0%).
Conclusions: This study has shown the difference of discontinua-
tion rate and the reason of discontinuation depending on the type
of the type of prescribing doxepin in real world. Therefore, appropri-
ate strategies applying doxepin for the treatment of insomnia should
be needed for each groups.
Disclosure: Nothing to disclose.
P158 | Clinical trial, using chronobiological
sensors, from a chronoregulator and sleep
inducer supplement
C. Estivill-Domènech1; E. Estivill2; A. Pastor2; B. Rodríguez-
Morilla3
1Fundación Estivill Sueño, 2Estivill Sleep Clinic, Barcelona, 3Chronolab,
University of Murcia, Murcia, Spain
Objectives/Introduction: Primary insomnia (DSM‐IV‐TR) is caused
by stress or worries during the day. Consequences are difficulties in
falling asleep and sleep maintenance.
The diagnosis is traditionally done through anamnesis, but actigraphy
is an innovative and valuable tool that can provide objective data
about sleep over long periods of time.
The treatment with anxiolytic‐sedative phytotherapic ingredients and
other food supplements may be appropriate in primary insomnia,
which can help to reduce stress and sleep quality.
In this study, the use of a food supplement for treating patients suf-
fering from primary insomnia was evaluated. The supplement was a
multicomponent based on hypnotic‐sedative natural products (vale-
rian, passionflower, poppy) in a delayed release form, and melatonin
as a chronoregulator. Sleep monitoring was done by a novel multi-
channel and multivariable chronobiological sensor (actigraphy, as well
as position and endogenous temperature of the patient).
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Methods: We studied 18 patients (8 men‐10 women, mean
age=54 years), who met the inclusion criteria (ICD‐10‐CM‐code:
F51‐02).
The methodology of the study consisted in a first basal week study
of sleep, using chronobiological sensors (KW‐5, Kronowise) and a
battery of subjective questionnaires. Subsequently, the multicompo-
nent supplement was orally administered daily during a week, con-
trolling their sleep with the same sensors. At the end of the
treatment, the subjective assessment tests have also been adminis-
tered. The baseline and treatment results were compared by the
paired samples t-Student test.
Results: By means of the circadian records, we obtain sleep param-
eters before and after the treatment. We observed a statistically sig-
nificant variation of the latency (19.6–15.3; p = 0.019), awakenings
during the 7 nights (20.7–16.6; p = 0.002), sleep efficiency (86.6–
91.1, p = 0.02), and nocturnal distal temperature (34.6–34.9,
p = 0.046), as an endogen marker of sleep dept. Pittsburgh variation
(8.9–6.6, p = 0.005) and ISI test (12.7–9.6, p = 0.003) were signifi-
cant.
Conclusions: Therefore, mild‐moderate primary insomnia can be
treated effectively with a natural plant‐based treatment such as the
one presented in this study, in combination with healthy hygiene
routines. This treatment allows an improvement in the efficiency of
sleep, latency, number of awakenings and subjective perception of
sleep.
Disclosure: Nothing to disclose.
P159 | Predictors of effect for brief behavioral
therapy for chronic insomnia
P. Pchelina1; M. Poluektov1; A. Tabidze2
1I.M. Sechenov First Moscow State Medical University, 2Center
‘Psychotherapeutic Pedagogics’, Ministry of Education and Science of
the Russian Federation, Moscow, Russian Federation
Objectives/Instruction: A practical doctor still faces the problem
of choice of treatment method as between CBT‐I (cognitive‐beha-
vioral therapy of insomnia) that requires special training and notice-
able time expenditures and pharmacotherapy associated with
adverse effects and drug addiction. Although CBT‐I remains prefer-
able and most recommended method, it has low response rate (60%)
according to Morin (2009). In the meantime shortened and simplified
approaches have been developing in order to make CBT‐I more
accessible.
The objective of the present stude was to determine anthropomet-
ric, psychological and polysomnographic predictors of effectiveness
of brief behavioral therapy (BBT‐I).
Methods: 42 adults (14 males, 28 females, from 18 to 90 years,
mean age 54 ± 14.9) meeting International Classification of Sleep
Disorder‐3, criteria of chronic insomnia participated in the study.
Participants passed 2‐week courses of treatment by BBT‐I and
zopiclone assigned in different orders with 2‐week washout period
between the courses. Primary outcome measure was determined as
change of Insomnia Severity Index (ISI) between pre‐ and post treat-
ment for each treatment course. Criterion of response was defined
as the reduction of ISI score >7 points from baseline. Baseline mea-
sures administered to determine predictors of response were: clinical
examination, Beck Depression Inventory, State‐trait anxiety inven-
tory, Big Five Questionnaire, Dysfunctional beliefs about sleep scale,
Sleep hygiene index, 1‐night Polysomnography.
Results: After BBT‐I phase 32% of participants (n=13) met the
response criteria. After the zopiclon phase 5 participants (12%) met
the response criteria. Comparison of anthropometric variables of
responders and nonresponders for BBT‐I demonstrated that former
were younger (42.4±15.7 vs. 54.7±12.7 years, p = 0.01), had higher
ISI score (21.5 ± 2.4 vs 17.5 ± 4.9, p = 0.008), higher percentage of
1 stage NREM‐sleep (5.5 ± 4.8 vs 3.1 ± 1.8%, p = 0.02) and lower
levels of empathic ability (43.5±3.8 vs 47.7 ± 5.0, p = 0.01), self‐con-
trol of emotions (29.5 ± 5.4 vs 36.0±8.6, p = 0.02) and impulsivity
(33.1 ± 6.2 vs 40.0 ± 7.3, p = 0.005) than nonresponders. Anthropo-
metric, psychometric and polysomnographic variables of responders
on zopiclone showed no statistically significant difference with non-
responders.
Conclusions: Response rate was low both for BBT‐I and for zopi-
clone. Supposed factors of BBT‐I effectiveness such as younger age
and higher ISI score provide clinicians easily identifiable predictors of
behavioral treatment success.
Disclosure: Nothing to disclose.
P160 | Risk of common cold in patients with
nonapnea sleep disorders: a retrospective cohort
study
C.-L. Lin1; Y.-S. Chen2; C.-H. Kao3; C.-L. Lin3; C.-S. Chen3;
H.-M. Cheng3; T.-Y. Yang3
1Department of Nursing, Chang Gung University of Science and
Technology, Taoyuan, 2China Medical University Hospital, 3China
Medical University, Taichung, Taiwan
Objectives/Instruction: Evidence describing the associaton among
nonapnea sleep disorders (NSDs), hypnotic (benzodiazepines [BZDs]
or zolpidem) use, and the risk of common cold is insufficient. The
present study investigated the potential effects of NSDs and hyp-
notic use on the risk of common cold in patients with NSDs.
Methods: This population‐based retrospective cohort study used
the data from the Taiwan National Health Insurance Research Data-
base on patients who received NSD treatment between 1998 and
2011. In total, 59,476 patients with NSDs were included in the
study cohort, and the reference cohort comprised 59,476 propensity
score‐matched patients. We conducted a Poisson regression analysis
to assess the risk of common cold.
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Results: The overall incidence of common cold in the NSD cohort
was significantly higher than that in the reference cohort (39.0 vs
21.9 per 10 person‐years). Overall, the NSD cohort exhibited a
higher risk of common cold than the reference cohort, with a consid-
erably increasing incidence rate ratio (IRR) (IRR = 1.78, 95% confi-
dence interval [CI] = 1.75–1.81). Compared with the patients of the
reference cohort without hypnotic use, those of the NSD cohort
with BZD and zolpidem use had 2.34 and 1.99‐fold risk of common
cold (95% CI = 2.30–2.38 and 1.95–2.03, respectively).
Conclusions: NSDs and hypnotic use were associated with a
higher risk of common cold.
Disclosure: Nothing to disclose.
P161 | Brain functional MRI (fMRI) study of
fragrance inhalation. Any impact on sleep/wake/
reward‐related brain areas?
G. Badre1; H. Olausson2; R. Ackerley3; I. Croy4
1SDS Kliniken, Gothenburg University, Gothenburg, 2Center for Social
and Affective Neuroscience, Linkoping University, Linkoping, Sweden,
3Laboratoire de Neurosciences Sensorielles et Cognitives UMR 7260,
CNRS ‐ Aix‐Marseille Université, Marseille, France, 4Dep of
Psychotherapy and Psychosomatic Medicine, Medical Faculty, Technical
University of Dresden, Dresden, Germany
Objectives/Instruction: The purpose of this study was to deter-
mine whether there is a neural system preferentially activated in
response to olfactory stimulation using fragrances claimed to have
an impact on well‐being and sleep. We selected for an fMRI investi-
gation two commercially available mixtures of fragrances (lavender,
chamomile, patchouli, vetiver etc…)(“Oriental” and “DeepSleep”) and
compared them to a control odor, which is often used in olfactory
research (Phenylethylalcohol ‐ PEA).
Methods: 30 normal‐weight healthy individuals (15 men, 15
women, 20‐35 years) having normal olfaction were recruited in a
randomized controlled study. Fragrances were presented via an expi-
ration‐triggered (computer‐controlled) olfactometer in a randomized
order to both nostrils. Each odor was presented in two runs (total 6
runs) with about 10 on‐off alternating blocks. After each odor pre-
sentation, the participants rated the respective odorant's intensity
and pleasantness.
Results: All fragrances resulted in a significant activation of olfac-
tory relevant areas, such as the orbitofrontal cortex, amygdala, insula
and piriform cortex. However, compared to control, “Oriental” was
related to enhanced BOLD signal change in the right and left cau-
date and a cluster which bordered the right thalamus. “Deepsleep”,
on the other hand, resulted in larger BOLD signal change in the tha-
lamus and middle frontal gyrus as compared to the control. Women
seemed especially reactive to “Deepsleep” as compared to men.
Additional connectivity analysis revealed that the primary olfactory
cortex (piriform cortex) was significantly positively connected to
other olfactory and emotionally relevant brain areas, such as the
hippocampus, anterior insula and amygdala. This was the case in
both fragrances and in the control odor. However, in “Deepsleep” a
positive connectivity was observed between the piriform cortex and
the frontal operculum and a negative connectivity to the superior
temporal sulcus. Those connectivities differed significantly from the
control condition. No differences were observed between “Oriental”
and control.
Conclusions: The fragrances selectively activated specific brain
areas which are related to reward processing in the case of “Orien-
tal” and socio‐emotional processing in the case of “Deepsleep”. The
results suggest that different odor mixtures may relate to specific
behavioral alterations. fMRI can provide a model of neuronal mecha-
nisms in response to fragrance stimulations.
Disclosure: Study funded by This Works.
P162 | A pilot study on a possible impact of
aromas on sleep quality in subjects with mild to
moderate insomnia
G. Badre1; I. Croy2; H. Olausson3; R. Ackerley4
1SDS Kliniken, Gothenburg University, Gothenburg, Sweden,
2Psychotherapy and Psychosomatic Medicine, Medical Faculty,
Technical University of Dresden, Dresden, Germany, 3Center for Social
and Affective Neuroscience, Linköping University, Linköping, Sweden,
4Laboratoire de Neurosciences Sensorielles et Cognitives UMR 7260,
CNRS ‐ Aix‐Marseille Université, Marseille, France
Objectives/Instruction: Pilot study aimed to test method and
investigate impact of fragrances claimed to improve sleep.
Methods: Twelve participants (Insomnia Severity Index 17+/‐ 2)
entered a double‐blind 3‐week period home study assessing efficacy
of two commercial mixed fragrances (lavender, chamomile, patchouli,
vetiver…) “Oriental” (“C”) and “ProSleep‐Deepsleep” (“F”) compared
to a “placebo” (“D” ‐ synthetic lavender fragrance). Subjects, contin-
uously monitored with actigraphy, filled daily a sleep diary, VAS
questionnaires (sleep quality), Karolinska Sleepiness Scale (KSS).
Aromas were randomly assigned (counter‐balanced order). Subjects
slept first 3 nights as usual. The next 4 nights, they sprayed the first
aroma on the pillowcase before bedtime, evaluating their experi-
ences at the end of the period. Following few “washing” nights they
slept 4 nights with a second aroma, the same procedure continued
with the 3d aroma, changing pillow for each aroma. Parametric
statistics were used for actigraphy, KSS, and sleep quality measures,
non‐parametric for questionnaire data.
Results: In subjective evaluation (obtained from 9 subjects) “C”
rated better than “F”, for measures of sleep quality (p < 0.001).
Reduced alertness (KSS) was found comparing the baseline sleep to
sleep with “F” (mean difference = 1.62, P = 0.029). In 50% of sub-
jects, impact of aromas lasted 1‐2 days. No clear preference for an
aroma. 80% preferred sleeping with an aroma rather than no aroma.
None of the aromas affected dreams. Occasional headache and dry
mouth were reported.
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For actigraphy, reliable data were obtained from 6 women and 2
men (41 ± 4 years). With the placebo there was a decrease in num-
ber of immobile phases (5.57; t = 3.78, df = 7, p = 0.007) and more
wake time (%) than “F” (mean difference = 158.8, p = 0.046).
With “F” there was less activity during sleep than with “D” (mean
difference = −6563, p < 0.001) and “C” (mean difference = 9556,
p = 0.030).
Conclusions: This pilot study showed validity of the methodology
and an impact of the aromas differing for each fragrance, but
decreasing after few days. There was discrepancy between subjec-
tive evaluation (“Oriental” rated significantly better than “Prosleep”)
and actigraphy (less time awake with “Prosleep”).
Disclosure: Study founded by This Works.
P163 | Comparison of lemborexant with
zolpidem extended release and placebo: topline
results from a phase 3 study in subjects 55 years
and older with insomnia
R. Rosenberg1; P. Murphy2; C. Chou2; S. Dhadda2;
G. Zammit3; M. Moline2
1Neurotrials Research Atlanta, Atlanta, GA, 2Eisai Inc., Woodcliff Lake,
NJ, 3Clinilabs Drug Development Corporation, New York, NY, United
States
Objectives/Introduction: We report results from a Phase 3 study
comparing the dual orexin receptor antagonist, lemborexant (LEM),
to zolpidem tartrate extended release (ZOL) and placebo (PBO) in
subjects ≥55 years with insomnia.
Methods: Randomized, double‐blind, double‐dummy, parallel‐group
design. Subjects received PBO, ZOL (6.25mg), or LEM (5 mg or
10 mg) for 1 month at bedtime. Eligible subjects were diagnosed as
having insomnia disorder (DSM‐5) confirmed by sleep history, sleep
diary, and polysomnography (PSG), including baseline wake after
sleep onset (WASO) ≥ 60 min. Paired PSGs at Baseline, the first 2
(Nights 1/2) and last 2 (Month 1) nights of treatment were analyzed
for latency to persistent sleep (LPS), WASO, and WASO in the sec-
ond half of the night (WASO2H).
Results: Of 3537 subjects screened, 1006 randomized (869F/
137M, mean 64 yrs) and 962 (96%) completed. Mean placebo‐cor-
rected change from baseline (minutes) at Nights 1/2 were: LPS:
LEM5 ‐10, LEM10 ‐13, ZOL ‐6; WASO: LEM5 ‐33, LEM10 ‐42, ZOL
‐27; WASO2H: LEM5 ‐22, LEM10 ‐28, ZOL ‐15. All comparisons of
LEM5 and LEM10 to both PBO and ZOL were statistically significant
at p < 0.01. Mean placebo‐corrected change from baseline (minutes)
at Month 1 were LPS: LEM5 ‐12, LEM10 ‐13, ZOL +1; WASO:
LEM5 ‐24, LEM10 ‐25, ZOL ‐16; WASO2H: LEM5 ‐16, LEM10 ‐18,
ZOL ‐10. All comparisons of LEM5 and LEM10 to both PBO and
ZOL were statistically significant at p < 0.01. There were 6 subjects
with serious adverse events (4 ZOL; 2 LEM5), none treatment‐
related. Non‐serious AEs were mostly mild or moderate in severity.
The most common AEs (>5% in any active treatment group and
>PBO) were headache and somnolence.
Conclusions: Lemborexant improved both sleep onset (LPS) and
sleep maintenance (WASO) compared to both PBO and ZOL, statisti-
cally significantly and with clinically meaningful benefit. Lemborexant
also improved sleep maintenance in the latter half of the night in
these older individuals with sleep maintenance difficulties. Results of
this Phase 3 pivotal trial are encouraging and support continued
development of lemborexant for the treatment of insomnia disorder.
Disclosure: This study was financially supported by Eisai, Inc. and
Purdue Pharma LP. RR has received grant/research support from
Actelion Pharmaceuticals, Eisai Inc., Flamel Pharmaceuticals, Jazz
Pharmaceuticals, Merck, and Philips Respironics, has investigational
device/drug interest with Eisai, Inc., Flamel Pharmaceuticals and Jazz
Pharmaceuticals, and has served on the speakers bureau for Merck.
PM, CC, SD, MM are employees of Eisai, Inc. GZ received grants/re-
search support from Actelion, Adare, Alder, Alkermes, Aptalis, Astel-
las, Astra‐Zeneca, Avadel, Balance Therapeutics, Biomarin, CHDI,
Corbus, Eisai, Flamel, Flex, Fresca, Idorsia, Janssen, Jazz, Johnson &
Johnson, Merck and Co., Neurocrine Biosciences, Novartis, Pfizer,
Purdue, Ritter, Sage Therapeutics, Sen‐Jam Pharmaceuticals, Sequen-
tial Medicine, Sunovion, Vanda; was a consultant for Actelion, Ava-
del, Eisai, Glaxo Smith Kline, Jazz, Idorsia, Purdue; received honoraria
from Guidepoint, Merck; had ownership interest in Clinilabs, Inc.,
Home Sleep and Respiratory Care, Nationwide Sleep Testing.
P164 | Activity tracker as a self‐help device in
insomnia − an intervention study
K.M.H. Tuisku; A. Alakuijala; S. Hällfors
Helsinki University Hospital, Helsinki, Finland
Objectives/Instruction: Negative self‐perceptions and adverse
behavioural coping are sustaining factors in chronic insomnia. Sleep
logs are used to support behavioural changes and awareness of sleep
patterns in patients with insomnia. Activity trackers, increasingly
popular as self‐help devices, produce more objective follow‐up data
about sleep for the patients.
Methods: Clinical sleep consultation patients (N = 81, mean age 39
years, 36 males and 45 females) suffering from persistent insomnia
were randomized to two groups. Cases wore activity trackers as
wristbands and simultaneously filled in sleep logs for two weeks,
while controls only filled in sleep logs. Insomnia symptoms (mea-
sured by Insomnia severity index) and life quality (measured by 15D
quality of life questionnaire) were assessed before and after the two
weeks of follow‐up. The patients’ experiences about activity tracking
were collected by a questionnaire.
Results: Insomnia symptoms were statistically highly significantly
reduced in the group wearing activity trackers (p < 0.0005) and their
life quality was statistically significantly increased (p = 0.014). There
were no statistically significant changes in the control group. Subjective
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benefits of the activity tracking were reported by 59% of the patients,
no effects by 26% and adverse effects by 8%. A change in health beha-
viour during activity tracking was reported by 34% of the patients.
Conclusions: Activity tracking can be useful for some patients with
chronic insomnia. It offers more objective information about one's
sleep pattern than sleep logs, and it seems to motivate patients to
behavioural changes, e.g. to increase daytime physical activity.
Relieving of insomnia symptoms is probably mediated by physical
exercise and new perceptions about sleep.
Disclosure: Nothing to disclose.
P165 | Altered wake resting‐state brain activity
in insomnia detected with high‐density EEG:
frequency‐ and time‐domain approaches
Y. Wei1; M.A. Colombo1,2,3; J.R. Ramautar1; Y.D. van der
Werf4; E.J.W. Van Someren1,5,6
1Department of Sleep and Cognition, Netherlands Institute for
Neuroscience, Amsterdam, The Netherlands, 2Bernstein Center Freiburg
and Faculty of Biology, University of Freiburg, Freiburg im Breisgau,
Germany, 3Centre for Chronobiology, Psychiatric Hospital of the
University of Basel, Basel, Switzerland, 4Department of Anatomy and
Neurosciences, 5Department of Psychiatry, VU University Medical
Center, 6Department of Integrative Neurophysiology, Center for
Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU
University, Amsterdam, The Netherlands
Objectives/Introduction: Insomnia Disorder (ID) is defined not
only by subjective sleep complaints, but also by accompanying com-
plaints about daytime functioning. Finding the neural correlates of
daytime complaints could thus be of value in understanding the
underlying pathophysiology of ID. In a series of wake resting‐state
studies, we aimed to utilize the high spatiotemporal resolution of
high density EEG (HD‐EEG) to detect neural correlates of daytime
complaints in ID, using both frequency‐ and time‐domain
approaches.
Methods: 256‐channel HD‐EEG with simultaneous lead II ECG was
recorded from 32 people with ID and 32 age‐ and sex‐matched con-
trols during evening wakeful rest of 5‐min duration with eyes closed.
Relative spectral power at each frequency from 0.5 to 45 Hz was esti-
mated with Welch's method. Two time‐domain analyses were carried
out: Heartbeat‐evoked potential (HEP) was obtained by averaging
EEG segments time‐locked to ECG R‐waves. Duration and occurrence
indices of 4 microstate classes were computed through k‐means clus-
tering of momentary EEG topographies. All derived measures were
compared between groups by means of nonparametric statistics.
Results: As compared to controls, people with ID showed spatially
widespread relative power increase within the beta frequency range,
centered at 19 Hz (cluster permutation test: p < 0.03). People with
ID, but not controls, showed a late positive component in their HEP,
occurring frontally 376–500 ms after the ECG R‐wave (cluster per-
mutation test: p < 0.02). Microstate class B, previously suggested to
be related to experiencing comfort, was deficiently expressed in peo-
ple with ID – the global explained variance and the mean duration of
class B microstates were lower as compared to controls (Wilcoxon
rank‐sum test: p = 0.001 and 0.006, respectively).
Conclusions: Frequency‐ and time‐domain analyses of HD‐EEG
have revealed multiple subtly altered spontaneous electrophysiologi-
cal processes in ID, which may involve heightened cortical arousal,
hypersensitivity to interoceptive inputs, and deficits in experiencing
comfort. The findings are in line with previous questionnaire, experi-
ence sampling, and task‐based studies.
Disclosure: Nothing to disclose.
P166 | Weekly changes in sleep and insomnia
symptoms during acute treatment of persistent
insomnia with behavioural or pharmacological
therapy
S. Beaulieu-Bonneau1; J.D. Edinger2; H. Ivers1; A.D. Krystal3;
C.M. Morin1
1École de Psychologie, Université Laval, Québec, QC, Canada,
2Department of Medicine, National Jewish Health, Denver, CO,
3Psychiatry and Behavioral Science, University of California San
Francisco, San Francisco, CA, United States
Objectives/Introduction: Cognitive‐behavioural therapy (CBT)
and medication are the main treatment options for persistent insom-
nia. The objective of this study was to explore weekly sleep changes
during acute treatment with behavioural therapy or medication.
Methods: This study reports secondary analyses from a two‐site
(Québec, Canada; Denver, USA) randomized controlled trial. Partici-
pants were adults with persistent insomnia who were randomized to
a 6‐week treatment involving behavioural therapy (BT) or zolpidem
(ZOL). Participants completed a daily sleep diary and the Insomnia
Severity Index (ISI) on a weekly basis. Linear mixed models were
computed to examine group (BT, ZOL) × time (baseline, six treat-
ment weeks) interactions on the ISI score and sleep diary parame-
ters: sleep onset latency (SOL), wake after sleep onset (WASO), total
wake time (TWT), total sleep time (TST), sleep efficiency (SE), and
sleep quality (SQ).
Results: The sample size was 211 participants (45.6 ± 14.9 years;
63% women). Significant group × time interactions were found for ISI
(p=.001), TWT (p < 0.001), TST (p < 0.001), SE (p = 0.003), and SQ
(p = 0.016), but not for SOL (p = 0.139) or WASO (p = 0.082). Con-
trasts revealed that: (1) the improvement on the ISI was greater for
ZOL vs. BT from week 1 to week 2 (‐4.4 vs. ‐2.1), with a lower ISI score
for ZOL in week 2 (12.2 vs. 14.0); (2) the improvement in TST and SQ
was greater in ZOL vs. BT from baseline to week 1 (+45.5 vs. ‐32.7
min; +0.5 vs. +0.2), with a longer TST for ZOL in weeks 1‐6 (410.9‐
423.4 min vs. 332.6‐368.5 min) and a better SQ in week 1 (3.2 vs. 2.9);
and (3) the improvement in TWT and SE was greater for BT vs. ZOL
from week 1 to week 2 (‐17.7 vs. +1.8 min; +4.1 vs. +0.1%), with a
shorter TWT for BT in weeks 2‐6 (67.6‐76.4 vs. 90.9‐104.0 min).
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Conclusions: Results suggest that throughout a six‐week treatment
regimen, ZOL was associated with increased TST, and BT with
reduced TWT. Other sleep parameters changed more rapidly with
ZOL or BT but the absolute differences tended to disappear toward
the end of treatment. Future studies should investigate how these
changes evolve over time.
Disclosure: C.M. Morin has received honorarium to serve as a con-
sultant on an advisory board for Philips and as speaker for Merck.
This study was supported by a National Institute of Mental Health
grant (MH91053).
P168 | Cognitive and behavioural therapies in
the treatment of insomnia: a systematic meta‐
analysis of all the literature
A. van Straten1; T. van der Zweerde1; C. Morin2; J. Lancee3
1Clinical Psychology, VU University Amsterdam, Amsterdam, The
Netherlands, 2Université Laval, Quebec, QC, Canada, 3University of
Amsterdam, Amsterdam, The Netherlands
Objectives/Instruction: Insomnia is a major public health problem
considering its high prevalence, impact on daily life, comorbidity with
other disorders and societal costs. Cognitive behavioral treatment
for insomnia (CBTI) is currently considered to be the preferred treat-
ment. However, no meta‐analysis exists of all studies using at least
one component of CBTI for insomnia, which also uses modern tech-
niques to pool data and to analyze subgroups of patients.
Methods: We carried out a comprehensive literature search and
combined terms indicative of insomnia (e.g., insomnia, sleep initiation
and maintenance disorders) with those of psychological treatment
(e.g., psychotherapy, behavior therapy). Studies were included if
1 they were a randomized controlled trial (RCT)
2 investigating CBTI or at least one component of it
3 among adults
4 with insomnia
5 in comparison with a non-active control group and
6 reporting on sleep diary outcomes.
We extracted data on patient‐, treatment‐ and study variables. Over-
all effects were calculated as well as univariate and multivariate
effects for different subgroups.
Results: We included 87 RCTs, comparing 118 treatments. Overall,
the interventions had significant effects on: insomnia severity index
(g=0.98), sleep efficiency (g=0.71), Pittsburgh sleep quality index
(g=0.65), wake after sleep onset (g=0.63), sleep onset latency
(g=0.57), number of awakenings (g=0.29) and sleep quality (g=0.40).
The smallest effect was on total sleep time (g=0.16). Face‐to‐ face
treatments of at least four sessions seem to be more effective than
self‐help interventions or face‐to‐face interventions with fewer ses-
sions. Otherwise the results seem to be quite robust (similar for
patients with or without comorbid disease, younger or older
patients, using or not using sleep medication).
Conclusions: We conclude that CBTI, either its components or the
full package, is effective in the treatment of insomnia.
Disclosure: Nothing to disclose.
P169 | Usage transitions between natural
products, over‐the‐counter and prescription
sleep aids: a longitudinal cross‐lagged analysis
J.M.Y. Cheung1,2; D.C. Jarrin2; S. Beaulieu-Bonneau2;
H. Ivers2; G. Morin2; C.M. Morin2
1The University of Sydney / Woolcock Institute of Medical Research,
Sydney, NSW, Australia, 2Centre d’Étude des Troubles du Sommeil,
School of Psychology, Laval University, Quebec, QC, Canada
Objectives/Introduction: Natural products (NP), over‐the‐counter
(OTC) and prescription (Rx) sleep aids are commonly used for
managing insomnia symptoms. However, little is known about the
transition patterns between different agents or how prior exposure
to one agent might influence subsequent sleep aid choice. Therefore,
the aim of this study was to map out the temporal patterns between
NP, OTC and Rx use in a Canadian population‐based sample.
Methods: Data were derived from a longitudinal study on the nat-
ural history of insomnia across seven time points, over five years.
Participants were 3416 adults (mean age = 49.7±14.7 years old;
62% women) who reported their NP, OTC and Rx use in the previ-
ous 12 months. Longitudinal cross‐lagged analyses were conducted
to explore sleep aid usage patterns at two consecutive time‐points
(i.e., T‐1 and T). Missing data from a total of 18515 observations
were excluded from analysis (T‐1 ≈ 20%, T ≈ 1%). Usage differences
were computed using the Χ2 test. The impact of prior exposure was
expressed as a relative risk (RR) with 95% confidence intervals (95%
CI). Sampling weights were applied to all analyses to adjust for par-
tial non‐response.
Results: Participants’ prior exposure to NP, OTC and Rx sleep aids
was associated with differences in their subsequent choice of agent
(p < 0.0001). Compared to non‐users, the RR (95% CI) for subse-
quent NP use was: 11.90 (10.87, 13.16) for NP users, 2.87 (2.54,
3.25) for OTC users and 1.75 (1.56, 1.96) for Rx users. Similarly, the
RR (95% CI) for subsequent OTC use was 14.08 (12.82, 15.87) for
OTC users, 2.88 (2.52, 3.30) for NP users and 1.65 (1.45, 1.91) for
Rx users. For subsequent Rx use, the RR (95% CI) was 16.67 (15.38,
18.18) for Rx users, 1.74 (1.52, 1.90) for OTC users and 1.58 (1.44,
1.75) for NP users.
Conclusions: Observed temporal patterns in sleep aid use defy
current assumptions of a step‐wise progression from NP/OTC to Rx
use. Findings further highlight a relatively stable usage trajectory
where the same agent is much more likely to be continued, suggest-
ing a role for mediating factors in the selection of sleep aids.
Disclosure: Research supported by the Canadian Institutes of
Health Research (MOP#115103) and FRQNT, Québec, Canada.
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P170 | Therapist‐guided Internet‐delivered
cognitive behavioral therapy for comorbid
insomnia and depression, compared to
depression treatment and placebo ‐ a
randomized trial
K. Blom; S. Jernelöv; E. Forsell; N. Lindefors; V. Kaldo
Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Objectives/Instruction: Comorbid insomnia and depression is
common, but seldom adequately treated. Cognitive behavioral ther-
apy (CBT) for depression is recommended for these patients in most
guidelines, but the most common treatment is antidepressants,
sometimes combined with sleep medication. Insomnia treatment only
(CBT‐i), seems more effective than CBT for depression only, in treat-
ing comorbid insomnia and depression, but effects might be
enhanced if the methods were combined. This trial tries a new com-
bination treatment, encompassing methods from both CBT‐i and
CBT for depression. The new treatment is compared to CBT for
depression with a placebo intervention for insomnia, representing
the best‐case treatment as usual. The hypothesis is that a combined
CBT for insomnia and depression is more effective than CBT for
depression with placebo.
Methods: The setting is the Internet Psychiatry Clinic, part of the
Stockholm County public health care, Sweden. Participants are 140
adults diagnosed by psychiatrists with insomnia and major depression,
randomized to either CBT for insomnia and depression, or CBT for
depression with placebo intervention for insomnia. The treatments are
12 weeks long, delivered via the Internet and psychologist‐guided.
Post‐treatment assessments are both self‐rated and performed face‐
to‐face by psychiatrists blind to treatment condition. Follow‐ups are
done after 6 months and 3 years. Primary outcome measures are
Insomnia Severity Index and Montgomery Åsberg Depression Rating
Scale ‐ Self rated. Secondary outcomes are diagnoses, clinical improve-
ment, sleep diary, objective sleep data (actigraphy), neurocognitive
functioning measured with computerized tests and other psychologi-
cal measures (behaviors, attitudes, stress, worry, anxiety).
Results: By the date of submission of this abstract, 136 partici-
pants have been included and treated, inclusion continues during the
spring of 2018. Primary outcome results pre‐post for 140 partici-
pants will be processed and presented at the conference. Analyses
will be done using hierarchical linear mixed effect modeling and a p‐
value of .05.
Conclusions: At the conference, preliminary conclusions will be
made about whether the hypothesis is confirmed or rejected, based
on short term data (pre‐post).
Disclosure: Nothing to disclose.
P171 | Evaluation of functional capacity
through the 6‐minute Walk Test in adults with
insomnia assisted in basic health units ‐
observational study
G.V. Rodrigues1; F.C.L. Mendes1; B.E.R.S. Batista1;
L.T. Pasqualotto1; L.V.F. Oliveira2; Y.R. Souza3; N.S. Faria
Júnior1
1University of the State of Minas Gerais, Divinópolis, 2University Center
UniEvangélica, Anápolis, 3University of the State of Rio de Janeiro, Rio
de Janeiro, Brazil
Objectives / Introduction: Insomnia is one of the most common
sleep disorders, characterized by difficulty in initiating and / or main-
taining sleep and by daytime symptoms that impair the occupational
functioning, interfering in the daily activities of the individuals, and
may even cause physical incapacity. Therefore, the need to evaluate
such repercussions becomes important in the search for further clari-
fication on the subject, and the 6‐Minute Walk Test (TC6M) is a
good evaluation tool.
The objective of this study was to evaluate functional capacity in
adult patients with insomnia assisted in Basic Health Units (BHUs) of
Divinópolis, Minas Gerais, Brazil.
Methods: The study was a cross‐sectional observational study, car-
ried out with a consecutive sample of convenience, recruited from
BHUs in the city of Divinópolis, being approved by the Ethics Com-
mittee in Research with Humans of the university, under protocol
number 1,475,521/2016. All patients underwent 6MWT after being
clinically evaluated and responding to the Insomnia Severity Index
(ISI) questionnaire, with the presence of insomnia being necessary to
perform the same.
Results: The sample consisted of 42 patients, 78.5% female, mean
age 55.7 ± 17.4 years and body mass index of 25.4 ± 4.7 kg / m². Of
these, 59.5% of the patients presented mild insomnia, 26.1% moder-
ate insomnia and 14.2% severe insomnia.
Regarding the distance covered in the 6MWT and the insomnia
severity, the average distance traveled was 422.5 ± 118.0 meters,
459.7 ± 123.2 meters, 345.9 ± 43.9 meters respectively of the
groups with mild, moderate and severe insomnia. Patients with sev-
ere insomnia had a shorter walking distance compared to patients
with mild insomnia (p = 0.030) and moderate insomnia (p = 0.007),
with a statistically significant difference.
In addition to being statistically significant, it can be stated that
there was a clinical difference between the distances traveled, as
suggested by the study by Bohannon and Crouch (2016), in which a
difference greater than 30.5 meters in the 6MWT is considered clini-
cally significant.
Conclusions: The severity of insomnia in this population interfered
directly with the distance covered in the 6MWT and, therefore, in
the functional capacity of these patients.
Disclosure: Nothing to disclose.
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P172 | Mismatch between subjective
perception and objective findings on sleep time
in insomnia patients
K. Bae
Chonnam National University Medical School, Gwangju, Republic of
Korea
Objectives/Instruction: Polysomnography in insomnia patients
has often revealed a mismatch between the subjective perception
and the objective findings of sleep time. We aimed to examine this
mismatch and investigate the characteristics associated with the mis-
match in insomnia patients.
Methods: In 121 insomnia patients, findings of nocturnal
polysomnography, responses to a subjective questionnaire after
sleep, and medical records were reviewed. The patients were classi-
fied into two groups‐total sleep time (TST) underestimation group
(N=56) and TST non‐underestimation group (N=65)‐depending on
the presence of a 2‐h difference between the subjective and the
objective TSTs. The demographic characteristics, type of insomnia,
use of sleep‐promoting medication, polysomnography findings, and
subjective reports were compared between the two groups.
Results: Nocturnal polysomnography showed significantly longer
TST(p<0.001) and shorter sleep latency (p< 0.001) than the subjec-
tively reported values. In comparison with the TST non‐underestima-
tion group, the TST underestimation group were significantly older
(p=0.043) more likely to have longer TST(p=0.012), shorter sleep
latency (p=0.002), and a smaller proportion of slow‐wave sleep
(p<0.001) in the polysomnographic analysis and more likely to show
shorter TST(p<0.001) and shallower sleep(p<0.001) in the subjec-
tively reported values.
Conclusions: We found a significant mismatch between the sub-
jective perception and the objective findings of sleep time as deter-
mined using polysomnography in insomnia patients. Underestimation
of sleep time may be more closely associated with the proportion of
slow‐wave sleep, which reflects sleep depth, than with objective
TST.
Disclosure: Nothing to disclose.
P173 | Associations of heart rate variability
with insomnia and the influence of sleep apnea
(SA)
R. Adams1; S. Appleton1; M. Baumert2; S. Immanuel2;
P. Catcheside3,4; A. Vakulin3,4; D. McEvoy3,4; S. Martin2;
G. Wittert2
1University of Adelaide, Woodville, 2The University of Adelaide,
Adelaide, 3Adelaide Institute of Sleep Health, Daw Park, 4Flinders
University, Bedford Park, SA, Australia
Objectives/Instruction: Insomnia is proposed to be a condition of
“hyperarousal”. However, a recent systematic review found little
evidence of autonomic dysfunction in insomnia (Dodds et al, 2017).
Population‐based studies determining the relationship of insomnia
with autonomic function, measured by heart rate variability (HRV)
are scarce. The aim of this study was to determine the relationship
of HRV with insomnia in a population‐based sample of men. We also
considered insomnia comorbid with sleep apnea (COMISA).
Methods: The Men Androgen Inflammation Lifestyle Environment
and Stress (MAILES) Study conducted home‐based full polysomnog-
raphy (PSG, Embletta X100) in 837 men aged ≥40y. Insomnia (ICSD‐
3 criteria) was assessed by questionnaire. Time domain HRV
measures (HR, average heart rate; SDNN, standard deviation of nor-
mal‐to‐normal RR‐intervals; RMSSD, root mean‐square of successive
differences of N‐N intervals) were calculated from the PSG ECG
channel (non‐rapid eye movement (N‐REM):n=761, REM sleep:
n=671). To compute respiratory sinus arrhythmia (RSA), inspiratory
onsets were automatically detected from RIP signals to obtain the
magnitude of phase‐averaged RR modulation. Linear regression mod-
els determined associations of HRV with 1) insomnia (dichotomous,
with/without SA) and 2) COMISA components (entered as dummy
variables) adjusted for age, smoking, body mass index, blood pres-
sure and apnea‐hypopnea index (models with overall insomnia only).
Unstandardised B coefficients (SE) are presented.
Results: Overall insomnia prevalence was 12.2% (n=93), insomnia
alone occurred in 5.5% (n=41) and COMISA in 6.7% (n=50). There
were no significant associations of insomnia or COMISA components
with HR, SDNN, or RMSSD. Compared to men without insomnia,
overall insomnia was associated with significant reductions in RSA
[NREM: ‐4.5 (1.8) p=0.014; REM: ‐4.8 (1.6), p=0.002]. COMISA was
associated with decreased RSA [NREM: ‐4.6 (2.5), p=0.067; REM:
‐4.8 (2.2) p=0.030] compared to men with neither insomnia nor SA,
whereas men with only insomnia showed non‐significant decreases
in RSA [NREM: ‐3.8 (2.8), p=0.17; REM: ‐4.2 (2.3), p=0.062].
Conclusions: In community‐dwelling men, insomnia showed incon-
sistent associations with HRV measures. However, insomnia, particu-
larly when comorbid with sleep apnea was associated with
reductions in HRV directly linked to respirations (RSA), consistent
with autonomic dysregulation potentially more reflective of OSA
than insomnia. Further work in larger samples is required.
Disclosure: Nothing to disclose.
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P174 | The significance of nocturnal blood
pressure change in insomnia patients
J.-W. Choi1; E.-J. Kim1; Y. Lee2
1Eulji University School of Medicine, 2Seoul National University College
of Medicine and Hospital, Seoul, Republic of Korea
Objectives/Instruction: Insomnia is a prevalent sleep disorder
that is associated with cardiovascular disease and its precursors,
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such as hypertension and blood pressure (BP) non‐dipping. Previous
studies have suggested that the underlying mechanism by which
insomnia is associated with hypertension is physiological hyper-
arousal. Several studies have suggested that insomnia is a state of
24‐hour hyperarousal and other studies have suggested night‐time
hypervigilance.
Methods: Polysomnographic findings, pre‐test (evening) BP values,
post‐test (morning) BP values and clinical data of 1185 subjects were
analyzed. Subjects were divided into six groups based on respiratory
disturbance index (RDI), periodic limb movements in sleep (PLMS)
and insomnia: reference (simple snoring, PLMS≤15 and RDI < 5),
insomnia (PLMS≤15, RDI < 5 and insomniac symptoms), high PLMS
(PLMS>15 and RDI < 5), mild (5≤RDI< 15), moderate (15≤RDI< 30)
and severe obstructive sleep apnea (OSA) (RDI≥30). Pre and post‐
test systolic blood pressure (SBP) and diastolic blood pressure were
compared among the six groups used repeated measure ANOVA.
We adjusted for age, gender, body mass index (BMI) and hyperten-
sion medication.
Results: There was significant difference between six groups in age
and BMI, not in gender. Insomnia group had lowest sleep efficiency
among six groups. (%, mean±SD; insomnia, 79.3±13.1 vs. reference,
85.2±12.5; mild OSA, 83.2±12.3; moderate OSA, 84.0±10.2; severe
OSA, 82.9±11.9; high PLMS, 80.3±12.0, p=0.008) Severe OSA group
had highest pre‐test (evening) SBP (mmHg, mean±SD; 143.7±17.8)
and insomnia group had lowest post‐test (morning) SBP. (mmHg,
mean ± SD; 125.7±17.8) Adjusting for age, gender, BMI and hyper-
tension medication, the mean decrease of SBP in insomnia group
was most prominent. (▵SBP, mmHg, mean±SD; insomnia, 14.1±14.5
vs. reference, 6.7±11.7; mild OSA, 9.3±16.6; moderate OSA,
7.8±15.4; severe OSA, 4.8±16.6; high PLMS, 7.3±19.3, p < 0.001).
Conclusions: SBP of insomnia group decreased most drastically
among the six groups. Although insomnia patients had the lowest
sleep efficiency, they slept almost 80% of the test time. These results
suggest that, insomnia is a state of night‐time hypervigilance and
improving night‐time sleep may reduce sympathetic hyperactivity.
Disclosure: Nothing to disclose.
P175 | Differences exist in metabolic rate in
insomnia compared to healthy sleepers: evidence
of physiological hyperarousal in insomnia
C. Gordon1,2; J. Chapman2; M. Comas2; C. Hoyos3;
D. Bartlett2,4; R. Grunstein2,4
1Sydney Nursing School, The University of Sydney, 2CIRUS Centre for
Sleep and Chronobiology, Woolcock Institute of Medical Research,
3Faculty of Science, The University of Sydney, 4Central Clinical School,
University of Sydney, Sydney, NSW, Australia
Objectives/Instruction: The hyperarousal concept of insomnia
has been proposed to be the cardinal feature of the disorder.
Research has shown increased cognitive and physiological activation
of body systems in insomnia patients during either the night or day
compared to healthy sleeping controls. However, findings are not
consistent and evidence of physiological dysfunction over 24 hours
is limited. We sought to determine if whole‐body metabolic rate is
increased in insomnia.
Methods: A systematic review was conducted. PubMed, Web of
Science, CINAHL, PsycINFO, EMBASE and Scopus databases were
searched for observational and interventional studies measuring
metabolic rate (oxygen consumption measured using calorimetry) in
insomnia. Metabolic rates in adults (18+years) were extracted for
insomnia and healthy‐sleeping controls for each study.
Results: The primary search identified 1506 records with 963
abstracts after duplicate removal. 35 full‐text articles meeting inclu-
sion criteria were reviewed. Four articles were included in the final
review. A total of 75 participants (n=44 insomnia; n=31 controls)
had metabolic measurements. One study reported increased oxygen
consumption (O2) across 24‐h in insomnia (300 ml/min) vs. healthy‐
sleeping controls (266 ml/min), and another revealing increased day-
time O2 in insomnia (266 vs 256 ml/min: controls). In contrast, when
determined at a single timepoint (~8am) there was no difference in
O2 between insomnia patients and controls. The fourth study
revealed lorazepam reduced O2 during the night compared to no
drug in insomnia patients only.
Conclusions: Overall it appears that metabolic rate is increased across
24 hours in insomnia. However, these increases in metabolic rate in
insomnia were minor compared to good‐sleeping controls and the clini-
cal significance is not clear. Larger, methodologically robust studies are
required to confirm these findings and the effect of any increase in
metabolic rate on sleep‐wake disturbances or pathophysiology.
Disclosure: Nothing to disclose.
P176 | Acceptability, tolerability, and potential
efficacy of cognitive behavioural therapy for
Insomnia Disorder subtypes defined by
polysomnography: a retrospective cohort study
C. Miller1; C. Espie1,2; D. Bartlett3; N. Marshall3; C. Gordon3;
R. Grunstein3
1Big Health Ltd, London, 2University of Oxford / Sleep and Circadian
Neuroscience Institute, Oxford, United Kingdom, 3CIRUS, Centre for
Sleep and Chronobiology, Woolcock Institute of Medical Research,
Sydney, NSW, Australia
Objectives/Introduction: In this retrospective cohort study, we
describe acceptability, tolerability and potential efficacy of cognitive
behavioural therapy (CBT) in Insomnia Disorder subtypes, derived
from polysomnography (PSG): insomnia with normal‐sleep duration
(I‐NSD) and insomnia with short‐sleep duration (I‐SSD).
Methods: All research volunteers were offered access to digital
CBT, single component sleep restriction therapy and face‐to‐face
group CBT. Follow‐up occurred at three months post‐treatment
using the insomnia severity index (ISI).
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Results: 96 participants (61 females, mean age of 41 years) were
grouped into either normal‐sleep (n=53) or short‐sleep (n=43). CBT
was acceptable to 63% of participants (normal‐sleep=31, short‐
sleep=29), with 28 completing therapy (tolerability: normal‐sleep=11,
short‐sleep=17). For potential efficacy, 39 (normal‐sleep=20, short‐
sleep=19) out of 96 participants (41%) completed a follow‐up ISI
assessment. In this reduced sample, mean (SD) ISI scores decreased
across both groups (normal‐sleep: 18.0 (4.0) to 10.7 (4.6); short‐
sleep: 16.5 (5.5) to 11.0 (6.3); both p < 0.01). Those with normal‐
sleep were more likely to respond (≥6‐point ISI reduction) to CBT
compared to short‐sleep (70%, n = 14/20 vs. 37%, n = 7/19 respec-
tively, p = 0.038). In this cohort, 60 (63%) of participants attempted
CBT and of those 28 (47%) completed therapy.
Conclusions: Results may be comparable to clinical participants
with implications for the successful translation of CBT for insomnia.
Disclosure: This was not an industry supported study. Sleepio®
provided digital cognitive behavioural therapy for insomnia to the
study without cost. The authors made all decisions regarding publica-
tion and reporting of these results: Sleepio® did not play any role in
these decisions. Dr. Miller receives a salary from Big Health (Big
Health Ltd., Sleepio®). Dr. Espie is the co‐founder and Clinical and
Scientific Director of the CBT programme (Big Health Ltd., Sleepio®).
All other authors report no conflicts of interest.
P177 | Feasibility and preliminary efficacy of
brief behavioural treatment for insomnia after
brain injury: a case series
V. Zouharova1; M. Gardani2
1Maastricht University, Maastricht, The Netherlands, 2University of
Glasgow, University of Glasgow, Glasgow, United Kingdom
Objectives/Introduction: Brain injury is one of the leading causes
of death and disability worldwide with sleep disturbances reported
to be part of the sequelae of symptoms following the injury. Specifi-
cally, insomnia symptoms, such as problems falling or staying asleep,
are reported by as many as 50% of individuals’ post‐brain‐injury
(Mazwi, Fusco, & Zafonte, 2015), with 30% meeting the diagnostic
criteria for an insomnia syndrome. This study investigated the feasi-
bility and preliminary efficacy of Brief Behavioural Treatment for
Insomnia (BBTI; Buysse et al, 2011) in a community sample of brain
injury patients.
Methods: Six participants (age range 49 to 70 years, males) were
recruited via Headway (Brain Injury Charity) to participate in a 4 ses-
sion BBT‐I intervention including a month and two month follow up.
Participants reported sleep disturbances and also screened with the
Sleep Condition Indicator (Espie et al, 2014). Participants responded
to a semi‐structured clinical interview in addition to measures of
depression and anxiety (HADS; Zigmond and Snaith 1983) and sleep
quality (PSQI; Buysse et al, 1989). A sleep diary was recorded
throughout the BBT‐I and at the 2 follow up points.
Results: Visual analyses of the sleep diary data were performed on
a case‐by‐case basis and statistically confirmed using Kendall's Tau‐b.
More specifically decreasing Total Wake Time (p < 0.001) and Sleep
Efficiency (p < 0.001) that were sustain at both follow ups. Addi-
tional changes in measures of insomnia symptoms and depression
were evident in the cases that exhibited response to the interven-
tion. Additionally, participants rated the intervention high on accept-
ability as a treatment.
Conclusions: Results from our study provide convincing prelimi-
nary evidence of Brief Behavioural Treatment for Insomnia (BBTI)
being not only feasible to use in individuals with brain injury but also
generally efficacious in alleviating both the post‐brain‐injury insomnia
symptoms and the coexisting mental health complaints.
Disclosure: Nothing to disclose.
P178 | Insomnia symptoms predicts
peri‐partum psychopathology, stress reactivity
and suicidality
L. Palagini; D. Caruso; M. Novi; I. Masci; B. Tripodi;
L. Paolilli; G. Cipollone; U. Moretto
Sleep Disorders Outpatients Clinic, Department of Clincal and
Experimental Medicine, Psichiatric Uniit, University of Pisa, Pisa, Italy
Objectives/Instruction: Depression and anxiety symptoms are
commonly experienced by women during the peri‐partum period and
may have negative consequences on mothers and newborns.
Changes in sleep quality and especially insomnia are also typical
throughout pregnancy and have been associated with adverse out-
comes including peri‐partum psychopathology. On this basis reason-
ing that identifying women at high risk of developing insomnia may
have important clinical implications on maternal‐fetal outcomes, we
aimed to study stress‐related sleep reactivity, as a risk factor to
developing insomnia, and its association with peri‐partum psy-
chopathology in pregnant women.
Methods: Sixty‐two pregnant women (mean age 33.6±3 years,
20.6±0.6 weeks of pregnancy) were evaluated during their routine
visit at the Gynecological Unit of the University of Pisa, Italy, using
the Insomnia Severity Index (ISI) for insomnia symptoms, the Ford
Insomnia Response to Stress Test for sleep‐reactivity (FIRST), the
Perceived Stress scale (PPS) for perceived stress, Edinburgh Postna-
tal Depression Scale (EPDS) for peri‐partum depressive symptoms,
Zung Self Rating Anxiety Scale (SAS) for anxiety symptoms.Item
number 10 of the EPDS was used to evaluate sucidality. T test was
used to calculate differences in means between women with insom-
nia symptoms vs non insomnia symtpoms. Unilinear/multiple and
logistic regressions have been performed to study correlations
between variables.
Results: Pregnant women with insomnia symptoms were the
27.8% and insomnia symptoms were correlated with greater per-
ceives stress and stress related sleep reactivity (respectively PSS:
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r=0.47, p < 0.001, FIRST r = 0.38, p = 0.002), greater depressive,
anxiety symptoms and suicidality (respectively EPDS: r=0.31, p=0.01,
SAS r=0.30 p=0.01, item 10 EPDS r: 0.2, p=0.03).
Conclusions: Pregnant women with greater insomnia symptoms
may suffer from greater psychopathology such as anxiety, depressive
symptoms and suicidality. They may also suffer from dysregulation in
perception and reactivity to stress. It should be of importance to
evaluate insomnia symptoms during pregnancy to prevent and treat
insomnia, psychopathology and their negative consequences on
maternal‐fetal outcomes.
Disclosure: Nothing to disclose.
P179 | A systematic review and network
meta‐analysis of complementary and alternative
interventions for insomnia
C. Baglioni1,2; E. Hertenstein1,3; Z. Bostanova1; G. Rücker4;
D. Riemann1; B. Feige1
1Department of Psychiatry and Psychotherapy, Medical Center,
University of Freiburg, Faculty of Medicine, Freiburg, Germany,
2Department TECOS, University G. Marconi of Rome ‐ Telematic, Rome,
Italy, 3Universitäre Psychiatrische Dienste Bern (UPD), AG
Universitätsklinik für Psychiatrie und Psychotherapie, Bern, Switzerland,
4Institute for Medical Biometry and Statistics, Medical Center,
University of Freiburg, Faculty of Medicine, Freiburg, Germany
Objectives/Introduction: Patients with insomnia disorder often
use Complementary and Alternative Interventions (CAI) as over‐the‐
counter (OTC) antihistamines, aromatherapy, foot reflexology, home-
opathy, meditative movement therapies, moxibustion, music therapy
and yoga. The National Institute of Health (NIH, 2005) convened
that there is insufficient evidence to support these interventions.
The aim of this study was to evaluate the efficacy of CAIs through a
systematic review and network meta‐analysis of randomized trials .
Methods: PubMed, CINHAL, PsycInfo, and PsycArticles were
searched from 1980 to End 2015. Twenty‐seven randomized control
trials were included evaluating CAI's efficacy in patients with insom-
nia disorder according to international diagnostic criteria. Six classes
of treatment (dietary supplements, exercise, light, melatonin, mindful-
ness, valerian) and two classes of control conditions (waiting list, pla-
cebo) were identified in the network. Risk of biases was assessed
through a checklist based on the Cochrane Collaboration′s tool. Out-
comes were grouped in two main concepts: subjective sleep quality
(based on sleep efficiency index reported in sleep diaries or, if this
was not available, questionnaires) and objective sleep quality (based
on sleep efficiency index obtained through polysomnography or, if
this was not available, actigraphy). Cohen′s d at 95% confidence
interval (CI) was calculated to assess the effect sizes of each treat-
ment class as compared with waiting list.
Results: Risk of bias assessment indicated a possible high risk of
selection bias in our sample of studies. No significant effect was
found for any of the six CAI treatment evaluated neither on
subjective nor objective sleep quality (for all comparisons in the net-
work p > 0.05).
Conclusions: We conclude that currently there is insufficient or
negative evidence to support CAI intervention for insomnia disorder.
There is a call for ameliorating the availability of evidence‐based
therapies, as cognitive‐behavior therapy for insomnia.
Disclosure: Nothing to disclose.
P180 | Does preoperative insomnia explain
persistent pain after breast cancer treatments?
E. Grén1,2; R. Sipilä2; P. Salo1,3
1Department of Psychology, University of Turku, Turku, 2Pain clinic,
Helsinki University Hospital, Helsinki, 3Finnish Institute of Occupational
Health, Turku, Finland
Objectives/Introduction: Persistent pain is a common ramifica-
tion of breast cancer treatments, especially breast surgery, that
impairs patients’ quality of life significantly. Several risk factors for
persistent postoperative pain in general have been identified, such
as previous pain and operation type, but these factors explain only a
small proportion of the development and maintenance of persistent
post‐treatment pain. In recent years, sleep has received growing
interest as a potential modifiable risk factor for pain for its diverse
effects on physical and mental health.
Methods: This study was part of a larger, prospective study con-
ducted at the Breast Surgery Unit, Helsinki University Hospital and
aimed to examine preoperative insomnia as a risk factor for persis-
tent post‐treatment pain 12 months after breast cancer surgery.
Insomnia was categorized as absence of insomnia, occasional insom-
nia, and nightly insomnia. Probability of moderate to severe pain (vs.
no or mild pain) was modeled using binary logistic regression. Poten-
tial confounders in the fully adjusted model were age, body mass
index, previous chronic pain, preoperative pain in the operative area,
axillary operation type, smoking, depressive symptoms, and meno-
pausal symptoms. Also, the relationship between preoperative
insomnia and preoperative pain was studied.
Results: According to logistic regression analysis on 698 women,
the risk of preoperative pain was 2.32‐fold [95% confidence interval
(CI) 1.02‐5.28, p=.045] after full adjustments among patients with
nightly insomnia compared with patients without insomnia. In the
crude model, nightly insomnia was associated with 2.26‐fold (95% CI
1.34–3.80, p = 0.002) risk of persistent post‐treatment pain. How-
ever, after full adjustments that association failed to reach statistical
significance and was largely explained by menopausal symptoms.
Conclusions: This study does not give support for preoperative
insomnia as an independent risk factor for persistent post‐treatment
pain in breast cancer patients. The findings suggest that preoperative
insomnia is tightly associated with preoperative pain, but other fac-
tors appear to play a more prominent role in the transition to persis-
tent pain. More longitudinal research is needed on the subject with
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validated insomnia questionnaires as well as on the role of menopau-
sal symptoms in pain persistence among breast cancer patients.
Disclosure: Nothing to disclose.
P181 | First Georgian digital cognitive
behavioral therapy (CBT) version for patients
with insomnia. Primary data on medical efficacy
and adherence
N. Okujava1; N. Malashkhia1; S. Shagidze1; A. Tsereteli1;
N. Chikhladze1; A. de Weerd2
1SEIN‐SKUH Epilepsy and Sleep Centre, Tbilisi State Medical University,
Tbilisi, Georgia, 2SEIN, Zwolle, The Netherlands
Objectives/Instruction: Up to 20000‐40000 people in Georgia
may need medical help for insomnia. Cognitive Behavioral Therapy
of insomnia (CBT‐i) currently is not implemented in Georgia. Aim of
our study was to evaluate innovative Georgian internet delivered
CBT version for insomnia (ICBT‐i) by means of therapeutic efficacy,
compliance and ease to handle.
Methods: Thirty six patients: 22 women and 14 men, aged from
19 to 64 years diagnosed with insomnia were enrolled into the pre-
liminary assessment of Georgian digital CBT program. Inclusion crite-
ria: age 18 >, access to the internet, enough experience in using
electronic devices. Each patient had face to face meeting with the
investigator, who explained how to use the program. All patients got
therapists support via e‐mail or telephone during the ICBT. Clinical
efficacy was evaluated by means of the Insomnia Severity Index (ISI)
before the ICBT and 1 month after completion. Compliance was
checked by number, dates and duration of visiting the web page and
completed modules. Ease to handle of the CBT program was rated
by patients in a special review field.
Results: Seventeen (47%) out of 36 patients accomplished full ICBT‐
i course. Mean ISI in this group dropped from 19.1 to 7.9 (p < 0.05),
showing significant therapeutic effect immediately after the CBT.
Twelve patients dropped out from the first module (33%). Reasons for
stopping the CBT‐i were: problems with using PC (4 patients older
than 50 years), bad compliance ‐ 7 patients. Seven more patients
(20%) stopped at the sleep restriction module, finding difficult accom-
plish sleep restriction related tasks. Feedback regarding ease to handle
the ICBT‐I showed that patients would prefer to have simpler explana-
tions and less text to read. In general, patients find it understandable
and simple to use. Majority of patients above 50 years (62%), regard-
less of adherence, would prefer face‐to face sessions to ICBT.
Conclusions: These data suggest that Georgian ICBT‐i version is a
promising therapeutic tool, comparable with international analogues
by means of efficacy and adherence. Further study involving high
amount of patients and long term follow up are required for final
assessment of therapeutic efficacy and sustainability of results.
Disclosure: Source of funding: Shota Rustaveli Georgian National
Science Foundaiton (SRNSF) Applied Research Grant
P182 | Sleep disturbance and the risk for
cognitive decline: assessment of visual attention
components in patients with insomnia
S. Rupprecht; T. Schultze; K. Finke; M. Schwab; O. Witte;
P. Bublak
Jena University Hospital, Jena, Germany
Objectives/Instruction: Chronic primary insomnia (CPI) is a highly
prevalent sleep disorder in subjects >50 years of age and related to psy-
chological distress. As both sleep deprivation and increased stress sus-
ceptibility have been shown to represent risk factors for
neurodegeneration, CPI patients may be subject to a higher probability
for developing progressive cognitive impairment. In fact, in patients with
CPI, lower sleep quality has been found to be associated with hippocam-
pal atrophy and cognitive decline. Similar brain and cognitive changes
prevail in patients with mild cognitive impairment (MCI), who bear an
increased risk for developing dementia. Our own previous work in MCI
patients, applying the conceptual framework of the ‘theory of visual
attention’ (TVA), has identified an elevated perceptual threshold in com-
parison to age‐matched healthy participants in a whole report task.
Methods: In the present study we assessed a sample of 16 CPI
patients and and sex matched controls with TVA‐based whole report
to test the hypothesis that CPI patients also show a significant
increase of the perceptual threshold.
Results: Compared to a healthy control group, we found no signifi-
cant differences with respect to TVA‐based parameters of processing
capacity. However, within the patient group, the perceptual thresh-
old values were significantly related to the subjective evaluation of
insomnia severity (ISI questionnaire). Also, higher threshold values in
CPI patients were significantly correlated to polysomnography
indices, i.e. sleep efficiency index, and arousal index.
Conclusions: TVA‐based assessment of visual processing capacity
may be able to identify CPI patients with an increased risk for cogni-
tive decline.
Disclosure: Nothing to disclose.
P184 | Residual symptoms after remission of
insomnia: associations with relapse over 4 years
X.W. Ji; H. Ivers; S. Beaulieu-Bonneau; J. Savard;
M. LeBlanc; C.M. Morin
Laval University, Quebec, QC, Canada
Objectives/Instruction: Chronic insomnia tends to “wax and
wane” over a lifetime. The presence of residual insomnia symptoms
is common, even among remitted individuals. Yet, little is known
about the nature of these residual symptoms and their association
with future relapse.
Methods: A population‐based dataset on the natural history of
insomnia (Canada, 2008‐2013) was used for this secondary analysis.
ABSTRACTS | 173 of 433
Residual insomnia symptoms were investigated in those who had
baseline insomnia symptoms/syndrome and achieved full remission
within one year. Then, cox regressions were used to determine the
hazard ratio (HR) of each residual symptom for relapse in the follow-
ing 4 years. Residual symptoms were examined with an extended
version of the Insomnia Severity Index (ISI), which incorporates
seven additional items on sleep quality and specific sleep‐related
daytime impairments. In addition, Beck Depression Inventory II (BDI‐
II) was controlled for in investigating risks of insomnia relapse.
Results: A total of 434 participants were included in this study
(mean age= 48.1 years old, range=18‐94; 65.9% female). The most
frequently reported residual nighttime symptoms (ISI item ≥ 2 on a 0‐
4 scale) at remission were “poor sleep quality” (SQ: 39.2%), followed
by “difficulty maintaining sleep” (DMS: 27%). The most common
residual daytime impairments were fatigue (24.7%), impaired mood
(23%) and impaired cognition (22.6%). After controlling for concurrent
depressive symptoms and physical diseases, women (95% CI HR:
1.07–1.58), those with residual DMS (95% CI HR: 1.07–1.58), poor SQ
(95% CI HR: 1.08–1.62) and impairments on cognitive functions (95%
CI HR: 1.06–1.62) were associated with significant risks for an insom-
nia relapse. Moreover, residual SQ and cognition impairment pre-
dicted relapse independently of DMS and depressive symptoms.
Conclusions: A wide range of residual symptoms exists in individu-
als with remitted insomnia. Notably, residual DMS is the most com-
mon nighttime symptom and it is also the only nighttime symptom
associated with insomnia relapse. Additionally, an emphasis on one's
perceived poor sleep quality and cognitive impairments attributed to
sleep is required, as they are also related to future relapse.
Disclosure: XWJ, HI, SBB, JS, ML and CMM do not have any con-
flict of interest to disclose. This study was supported by a Canadian
Institutes of Health Research grant (42504).
P186 | Associations between rumination about
insomnia and cognitive inhibition
A. Ballesio; C. Ottaviani; C. Lombardo
Department of Psychology, Sapienza University of Rome, Rome, Italy
Objectives/Instruction: According to cognitive models of insom-
nia disorder, rumination about lack of sleep and its diurnal conse-
quences plays a crucial role in maintaining insomnia. Meta‐analytic
evidence shows that general and depressive rumination is related to
poor cognitive inhibition. Interestingly, there is evidence of inhibitory
impairments in insomnia. Despite this evidence, no studies so far
investigated the relationship between cognitive inhibition and insom-
nia‐specific rumination. The aim of this study was to explore
whether poor cognitive inhibition is associated with symptom‐
focused rumination in a sample of individuals with a diagnosis of
insomnia disorder.
Methods: The study was approved by the Departmental Institu-
tional Review Board. Thirty young adults (22.67 ± 3.68 years, 73.3%
females) diagnosed with insomnia disorder signed an informed con-
sent and took part in the study. Insomnia condition was established
using clinical interview, standardized questionnaires and sleep diary.
Self‐reported measures of depression, emotion regulation, and rumi-
nation about the daytime consequences of insomnia were collected.
Cognitive inhibition was assessed using a Task Switching paradigm in
a laboratory setting. Time of assessment was always set in the morn-
ing to control for potential confounding role of circadian effects.
Hierarchical multiple regression analysis was computed with insom-
nia rumination as dependent variable and depression in the first step
and cognitive reappraisal in the second step as control variables and
reaction times (RTs) for the cognitive inhibition index of the Task
Switching in the third step.
Results: Hierarchical regression analysis revealed a significant equa-
tion model (F(1,28) = 14.660, p < 0.001; R
2 = 0.628, R2 change =
0.099) with higher depression (b = 0.781, p < 0.001), cognitive reap-
praisal (b = 0.329, p = 0.016), and poorer cognitive inhibition (b = ‐
0.334, p = 0.014) predicting higher rumination about daytime conse-
quences of insomnia.
Conclusions: Rumination about symptoms of insomnia in a clinical
sample is associated with impaired inhibitory capacities above and
beyond the role played by traditional predictors such as depression
and emotion regulation strategies. If replicated, present preliminary
results suggest the need to target cognitive inhibition deficits in
insomnia treatment.
Disclosure: Nothing to disclose.
P187 | The effect of cognitive behavioural
therapy for insomnia on quality of life outcomes:
a meta‐analysis of randomised controlled trials
X. Omlin1; A. Ballesio2; M.R.J. Aquino3; C.A. Espie1;
S.D. Kyle1
1Nuffield Department of Clinical Neurosciences, University of Oxford /
Sleep and Circadian Neuroscience Institute, Oxford, United Kingdom,
2Department of Psychology, Sapienza University of Rome, Rome, Italy,
3Department of Public Health and Primary Care, University of
Cambridge, Cambridge, United Kingdom
Objectives/Introduction: Insomnia is the most common sleep dis-
order, affecting 10–12% of the adult population. It profoundly
impairs daytime functioning and confers risk for the development
and exacerbation of mental and physical illness. The primary motiva-
tion to seek treatment among individuals with insomnia is the per-
ceived impact of sleep loss on daytime functioning and quality of
life. While cognitive behavioural therapy for insomnia (CBT‐I) has
been shown to engender long‐term sleep improvements little is
known about effects on quality of life (QoL). We conducted the first
systematic meta‐analysis to quantify the magnitude and reliability of
CBT‐I on QoL outcomes.
Methods: PubMed, EMBASE, Cochrane Library, MEDLINE, Psy-
cINFO and PsycARTICLES databases were searched for English‐
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language articles without restriction on publication period. We
included 15 randomised controlled trials comparing treatment for
insomnia (total of 655 patients) with a control arm (total of 591
patients) in adult samples. Studies were included if the treatment for
insomnia incorporated at least two of the five most widely accepted
components of CBT‐I (cognitive therapy, stimulus control, sleep
restriction, sleep hygiene, relaxation) and a standardised measure of
QoL or health‐related QoL. All CBT‐I delivery modalities (e.g. face‐to‐
face, web based) and treatment durations were considered. Hedges's
g at 95% confidence interval (CI) was calculated to assess effect size
of CBT‐I compared to the control arm. General QoL (n = 5 studies)
as well as mental QoL (n=10 studies) and physical QoL (n = 7 stud-
ies) were analysed respectively.
Results: Significant but small effect sizes were found for general
QoL (g = 0.353 (CI: 0.140–0.565; p = 0.001)) and mental QoL
(g = 0.238 (CI: 0.107–0.369; p < 0.001)) while there was no reliable
effect for physical QoL (g = 0.111 (CI: −0.050 to 0.273; p = 0.177)).
Conclusions: Meta‐analysis of randomised controlled trials
revealed an improvement with small effect size in general QoL and
mental QoL after CBT‐I compared to the control arm. However,
physical QoL appeared to demonstrate no significant benefit from
CBT‐I intervention.
Disclosure: Nothing to disclose.
P188 | Insomnia in the Baependi heart cohort
study
S.S. Ahmed1; T.P. Taporoski2; F. Beijamini3; A. Negrão2;
J.E. Krieger2; K.L. Knutson4; A.C. Pereira2; A. Sterr1; M. von
Schantz1
1University of Surrey, Faculty of Health and Medical Sciences, Guildford,
United Kingdom, 2Incor, University of São Paulo School of Medicine, São
Paulo, 3Federal University of Frontera Sul, Realeza, Brazil, 4Feinberg
School of Medicine, Northwestern University, Chicago, IL, United States
Objectives/Introduction: Insomnia is a common health problem,
contributing to behavioural and medical issues. Thus, it has significant
socioeconomic costs and impact on lifetime morbidity. However, it is
often overlooked despite its prevalence in developed countries where
sleep is impaired by technology and light pollution. Little is known
about insomnia in less urbanised populations. Baependi is a rural town
in the Brazilian heartland, which has been known to maintain day‐night
sleep cycles according to natural daylight availability, in spite of electri-
fication. We aim to investigate insomnia in the family‐based Baependi
population using the Brazilian Portuguese version of the Insomnia
Severity Index (ISI) questionnaire.
Methods: Statistical and descriptive regression analysis was done
on the Baependi dataset using R software. To fully take advantage
of this dataset, heritability analysis is being performed in this popula-
tion. Also, genome‐wide array data from the Baependi project will be
interrogated for associations with polymorphisms previously related
with insomnia symptoms.
Results: 662 eligible participants were identified. Regression analy-
sis indicates that 16% of the participants score can be categorised as
suffering from ‘clinical insomnia’ based on the ISI, with the average
total score of 9.4±4.8 (SD), a score corresponding ‘subthreshold
insomnia’ on the ISI scale. More females score above the threshold
clinical insomnia score (15/28), 19.4% of females in the dataset com-
pared to 11% of males. Overall 8.4% had severe problems falling
asleep, 5.7% had trouble waking up too early, and 6.2% found that
their sleep problem interferes in their daily functioning. Interestingly
25.7% of overall sample were dissatisfied with their current sleeping
pattern. Variables investigated in this dataset also showed a signifi-
cant positive correlation between ISI scores and Beck's Depression
Inventory (EDB) scores (p = 5.6 × 10−16), while showing a negative
correlation between the ISI scores and the Morningness‐Eveningness
Questionnaire (MEQ) scores (p = 8.3 × 10-3).
Conclusions: A distinctive aspect of this research is that there are
few other studies that have administered ISI in a population‐based
cohort. Therefore, prevalence of insomnia using ISI is not actually
known. Analysis using ISI in this dataset has laid some foundations
to understanding insomnia in a population that has maintained sleep
cycles according to natural daylight.
Disclosure: No conflicts of interest to disclose. The following
grants associated with this project are as follows: 1.) São Paulo
Research Foundation (Fundação de Amparo à Pesquisa do Estado de
São Paulo/FAPESP) to co‐author Alexandre C Pereira and José E
Krieger (grants 2007/58150‐7, 2010/51010‐8, 2011/05804‐5, 2013/
17368‐0) 2.) The Brazilian National Council for Scientific and Tech-
nological Development (Conselho Nacional de Desenvolvimento
Científico e Tecnológico/CNPq) to co‐author Alexandre C Pereira
and José E Krieger (grants 150653/2008‐5, 481304/2012‐6).
P189 | Trazodone lowers blood pressure levels
in patients with chronic insomnia: a longitudinal,
electronic health record study
A. Vgontzas1; J. Baker1; J. Fernandez-Mendoza1;
V. Krishnamurthy1; J. Gaines1; M. Basta2; C. Criley1;
E. Bixler1
1Penn State College of Medicine, Hershey, PA, United States, 2Heraklion
Medical Center, Heraklion, Greece
Objectives/Introduction: Insomnia has been associated with an
increased risk for hypertension, especially in those sleeping objec-
tively less than 6 hours. We sought to observe the effects of tra-
zodone on blood pressure (BP) over time independent of anti‐
hypertensive medication in a clinical sample.
Methods: The electronic medical record at Penn State Hershey
Sleep Research & Treatment Center was searched using i2b2, which
extracted 42 patients with a diagnosis of insomnia disorder pre-
scribed trazodone (47.6±12.8y, 57.1% female, 30.0±5.7 kg/m2 BMI).
Exclusion criteria included a diagnosis of sleep apnoea, CPAP use,
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and prescription of anti‐hypertensive medications after being pre-
scribed trazodone. Mean arterial blood pressure (MAP) was calcu-
lated from systolic and diastolic BP at pre‐treatment (MAP0) and at
three (MAP3) and six (MAP6) months of follow‐up. Data were anal-
ysed using repeated‐measures t‐test and ANCOVA, with sex, age,
BMI, and time‐to‐follow‐up as covariates.
Results: There were no significant changes in MAP (ΔMAP) in the
overall sample. However, unadjusted analyses showed that in
patients with normal BP levels (< 120/80 mmHg, n = 13) at pre‐
treatment MAP levels did not significantly change over time (3.0±1.7
mmHg in ΔMAP0‐MAP6 p = 0.113), while they did among patients
who had elevated BP (≥ 120/80 mmHg, n = 23) at pre‐treatment
(−5.8±1.9 mmHg in ΔMAP0‐MAP6, p = 0.006). Compared to those
with normal BP levels, patients who had elevated BP at pre‐treat-
ment had a significant decrease in multivariable‐adjusted MAP after
6 months of follow‐up (3.8±1.9 vs. −6.4±1.6 mmHg in ΔMAP0‐
MAP6, p < 0.001).
Conclusions: Our data suggest that trazodone has the potential to
lower BP levels in patients with chronic insomnia above and beyond
current treatment with anti‐hypertensive medication. Randomized
controlled trials should examine this question in patients with insom-
nia and objective short sleep duration, who are more likely to pre-
sent with comorbid hypertension.
Disclosure: Nothing to disclose.
P190 | Preventing cardiovascular diseases in
insomnia patients through CBT‐I?
A.F. Johann1,2; E. Hertenstein1; C. Baglioni1; K. Domschke1;
E. Schramm1; D. Riemann1; K. Spiegelhalder1
1Department of Psychiatry and Psychotherapy, Medical Center ‐
University of Freiburg, Faculty of Medicine, University of Freiburg,
2Medical Psychology and Medical Sociology, Faculty of Medicine,
University of Freiburg, Freiburg, Germany
Objectives/Instruction: Insomnia, cardiovascular disease (CVD)
and hypertension are linked with each other in various ways. Insom-
nia is a risk factor for CVD (Sofi et al. 2014), sleep continuity distur-
bances are associated with an increased risk for hypertension (Meng
et al. 2013), and hypertension is again a risk factor for CVD. So far,
no studies have investigated the preventive effect of insomnia treat-
ment on CVD. Thus, this study investigated the preventive effect of
cognitive behavioural therapy for insomnia (CBT‐I), the first‐line
treatment for insomnia, on hypertension. In detail, we investigated
whether CBT‐I reduces blood pressure in insomnia patients.
Methods: Forty‐six patients (17 males, 29 females; 41.0 ± 14.5
years) diagnosed with insomnia according to DSM‐5 criteria took
part in a clinical trial at the Clinic for Psychiatry and Psychotherapy
in Freiburg (Germany) between 2015 and 2017. After baseline mea-
surement patients were randomized into either the treatment group
or the waiting list control group. The intervention consisted of
weekly individual sessions of CBT‐I over 8 weeks. Baseline‐ and
post‐treatment measurement included 24h blood pressure measure-
ment and assessment of sleep using the Insomnia Severity Index.
Group differences were analysed using a two‐way ANOVA with the
between‐subject factor group (treatment vs. waiting list) and the
within‐subject factor time (baseline vs. post).
Results: The interaction effect group × time was neither significant
for systolic blood pressure (F(1,42) = 0.02, p = 0.901) nor for dias-
tolic blood pressure (F(1,42) = 2.27, p = 0.139) indicating that there
was no effect of CBT‐I on blood pressure. Regarding insomnia sever-
ity, we found that there was a significant group × time interaction in
so far as symptom improvement was larger in the treatment group
compared to the waiting list group (F = 31.34; p < 0.001).
Conclusions: Results indicate that CBT‐I, though improving the
severity of insomnia, does not have an effect on blood pressure.
Future studies should investigate if other treatments have an impact
on blood pressure to reduce the risk of CVD in insomnia patients.
Disclosure: Nothing to disclose.
P191 | Social rhythm regularity moderates the
relationship between sleep disruption and
depressive symptoms in individuals with post‐
traumatic stress disorder and major depression
E. Boland1,2; M. Kelly3; S. Perkins4; P. Gehrman2; P. Haynes5
1Behavioral Health, Cpl. Michael J. Crescenz VA Medical Center,
2Psychiatry, Perelman School of Medicine at the University of
Pennsylvania, Philadelphia, PA, 3University of Arizona, 4Southern
Arizona VA Healthcare System, 5University of Arizona, Health
Promotion Sciences, Tucson, AZ, United States
Objectives/Instruction: Approximately half of individuals with
post‐traumatic stress disorder (PTSD) are also diagnosed with major
depressive disorder (MDD), of which sleep disturbance is a frequent
symptom. Sleep disturbance is associated with increased likelihood of
depression relapse, poor depression treatment response, and suicidal-
ity. These negative associations highlight the need for a greater under-
standing of how sleep influences depression, particularly among
individuals also experiencing the symptoms of PTSD. Given the strong
evidence of circadian rhythm disturbance in MDD, there may be
chronobiological influences on the degree to which sleep disturbance
influences depression in those with PTSD and MDD. The present
study examined the relationship between social rhythm regularity, or
consistency of daily habitual behaviors, which is theoretically linked to
circadian rhythms, sleep disruption and depressive symptoms in a
sample of military Veterans with comorbid PTSD and MDD.
Methods: Cross‐sectional data were obtained from 58 male Veter-
ans who met DSM‐IV criteria for PTSD and MDD. Participants com-
pleted the Social Rhythm Metric (SRM), which assessed the degree
to which participants completed 17 different types of activities on a
regular basis (i.e., +/‐ 45 minutes of habitual time). Depression sever-
ity was measured with the Hamilton Depression Rating Scale with
176 of 433 | ABSTRACTS
the sleep items removed from analysis. Sleep disturbance was
reflected by minutes awake after sleep onset (WASO) via daily sleep
diary. Moderation analyses were conducted via linear regression.
Results: In the linear model, SRM scores did not significantly pre-
dict depressive symptoms. The interaction of WASO and SRM signif-
icantly predicted depressive symptoms (p = .03) and the main effect
of increased WASO was a significant predictor of increased depres-
sion (p = .01) Results demonstrated that WASO is a significant pre-
dictor of depression only at low levels of social rhythm regularity.
Conclusions: Social rhythm regularity may represent a risk/re-
silience factor for individuals with PTSD and comorbid depression.
Findings highlight the importance of exploring the intersection of
sleep and social/circadian rhythms in depression.
Disclosure: Funding for this research was supported by Depart-
ment of Defense #W81XWH‐08‐2‐0121 (PI: Haynes) and American
Sleep Medicine Foundation #37‐CA‐06 (PI: Haynes). Analysis and
presentation of this research supported by: Department of Veterans
Affairs IK2‐CX001501 (PI: Boland).
HYPERSOMNIA 1
P192 | Clinical autonomic dysfunctions in
narcolepsy type 1: a case‐control study
L. Barateau1,2,3; S. Beziat3; E. Evangelista1,2,3; R. Lopez1,2,3;
S. Chenini1,2; I. Jaussent3; Y. Dauvilliers1,2,3
1Neurology, National Reference Center for Narcolepsy and Central
Hypersomnias, 2Neurology, Sleep Disorder Unit, Gui de Chauliac
Hospital, 3Inserm U 1061, Montpellier, France
Objectives/Introduction: Narcolepsy type 1 (NT1) is a rare sleep
disease caused by the selective destruction of orexin neurons that
project to cerebral areas involved in central autonomic control. Clini-
cal autonomic abnormalities have been described in NT1, however,
large‐scale assessment of autonomic symptoms has never been sys-
tematically performed. Once being diagnosed, patients need life‐long
treatments (psychostimulants and anticataplectic drugs) known to
have an influence on autonomic regulation; as other potential con-
founders such as obesity. Our objectives are: (1) to compare auto-
nomic symptoms using the validated SCOPA‐AUT questionnaire in
untreated NT1 patients to healthy controls, taking into account
potential confounders (2) to study the effect of treatment intake on
SCOPA‐AUT results in NT1.
Methods: The SCOPA‐AUT questionnaire that evaluates gastroin-
testinal, urinary, cardiovascular, thermoregulatory, pupillomotor and
sexual dysfunction, was completed by 81 consecutive drug‐free NT1
patients (49 men, 39.3 ± 15.5y.o.) from the National Reference Cen-
tre for Narcolepsy, France, and 92 healthy controls (40 men,
42.6 ± 18.1y.o.). Body Mass Index (BMI), and clinical characteristics
were collected in all participants. Biological and neurophysiological
data were recorded in patients. A subgroup of 59 NT1 patients
completed the questionnaire a second time, after 3 months at least
of stable medication intake.
Results: Compared to controls, NT1 patients were more frequently
male (60% vs. 43%, p = 0.03) and obese (BMI=27.1 ± 4.8 vs.
23.6 ± 3.4, p < 0.001) with no difference for age. The total autonomic
SCOPA‐AUT score of NT1 was higher than controls (12.7 ± 6.7 vs
6.4 ± 5.9, p < 0.0001), even after adjustment for BMI and gender.
Patients experienced more problems than controls in every domains
of the scale, in crude and adjusted models (p < 0.001). The most strik-
ing differences emerged in the sexual and thermoregulatory domains
(p < 0.0001). Among patients evaluated twice, the total autonomic
SCOPA‐AUT score did not differ (12.6 ± 6.9 when untreated and
13.3 ± 7.7 when treated), neither did each subdomain of the scale.
Conclusions: The presence of autonomic nervous system impair-
ment in NT1 patients is confirmed by a validated scale assessment,
with sexual and thermoregulatory dysfunctions being severely
affected compared to controls, requiring further investigations. The
absence of effect of medications for NT1 is in favour of a trait (more
than a state) dysfunction.
Disclosure: Nothing to disclose.
P193 | The story continues: narcoplepsy
spectrum occurring several years post ASO3‐
adjuvanted H1N1 vaccination in young Irish
siblings
D. Ferguson1; L. Slattery2; B. Lynch3; S. O'Malley3;
C. Crowe2,4
1Department of Clinical Medicine, University of Dublin, Trinity College,
2Neurological Sleep Clinic, St. James's Hospital, 3Department of
Neurology, Temple Street Children's University Hospital, 4Sleep Clinic,
Mater Private Hospital, Dublin, Ireland
Objectives/Introduction: Genetic and environmental factors play
a role in the pathogenesis of narcolepsy. Recent studies highlight a
higher than previously reported risk of narcolepsy among first degree
relatives. The natural history of narcolepsy following administration
of the ASO3‐adjuvanted H1N1 pandemic influenza vaccine has been
well described.
Methods: We present the characteristics and clinical features of 3
families (A, B & C) with an evolving spectrum of sleep disorders fol-
lowing Pandemrix© vaccination.
Results: From approximately 100 cases of Pandemrix©‐related nar-
colepsy, 3 family clusters of sleep disorders were identified. Each
family's index patient presented with symptoms within weeks of vac-
cination and was diagnosed with narcolepsy type 1. It became appar-
ent that many of their siblings were developing symptoms of sleep
disorders several years later than the index cases. All siblings
received Pandemrix© in 2009‐2011. All siblings carried the HLA
DQB1*06:02 haplotype. Hypocretin levels were < 50pg/mL in the 3
index cases and in sibling 1 of Family A, corresponding with the
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presence of narcolepsy with cataplexy. Hypocretin was normal in
Family B & not yet tested in Family C.
Sleep studies in sibling 1 of Family A were diagnostic of narcolepsy
(nocturnal sleep onset rapid eye movement (SOREM); Mean Sleep
Latency Test (MSLT) mean sleep latency (MSL) 2 minutes, 4 SOR-
EMs). In sibling 1 of Family B, an equivocal study in 2015 (normal
MSL, 2 SOREMs) became diagnostic in 2017 (nocturnal SOREM;
MSLT MSL 6 minutes, 3 SOREMs). In sibling 2 of Family B an initial
study in 2017 showed MSL of 11.5 minutes and 2 SOREMs but on
follow‐up in 2018 showed a MSL of 11 minutes and no SOREMs. In
sibling 1 of family C, equivocal studies in 2014 showed normal MSL
with 3 SOREMs, but in 2017 showed MSL of 10.5 minutes and 2
SOREMs. Sibling 2 of Family C, also had an equivocal study in 2017
(MSL 14.5 minutes, 3 SOREMs).
Conclusions: A narcolepsy spectrum was found to cluster in multi-
ple siblings within Irish families. Parents are more likely to be aware
of sleep‐wake abnormalities in other siblings giving the opportunity
to study possible narcolepsy endophenotypes which may evolve into
the disorder.
Disclosure: Nothing to disclose.
P194 | Sodium oxybate treatment of
narcolepsy in pediatric patients: effects on sleep
architecture
Y. Dauvilliers1; R.K. Bogan2; J. Black3,4; R. Parvataneni3;
D.M. Richardson3; Y.G. Wang3; E. Mignot4
1Unité du Sommeil, CHRU Gui de Chauliac, INSERM U 1061,
Montpellier, France, 2School of Medicine, University of South Carolina,
Columbia, SC, 3Jazz Pharmaceuticals, 4Stanford Center for Sleep
Sciences and Medicine, Palo Alto, CA, United States
Objectives / Introduction: A double‐blind, placebo‐controlled,
randomized‐withdrawal study with extended open‐label evaluation
of sodium oxybate for treatment of pediatric narcolepsy was con-
ducted. This analysis evaluated the effects of sodium oxybate (SXB)
on sleep architecture in study participants.
Methods: Participants with narcolepsy with cataplexy, aged 7–16
who were on SXB or were SXB‐naïve were eligible. After screening,
SXB‐naïve participants were titrated on SXB to an optimal dose,
then entered a stable dose period (SD) for 2 weeks. Participants on
SXB treatment at screening entered the SD at their usual dose. SD
was followed by a 2‐week double‐blind, placebo‐controlled, random-
ized‐withdrawal period (DB); participants were randomized to either
placebo or to continued SXB. Following the DB, participants entered
an open‐label safety period (OL) for ≤48 weeks. For SXB‐naïve par-
ticipants, nocturnal polysomnography (PSG) was performed during
screening prior to initiating SXB, at the end of SD on their optimal
SXB dose, and at study end on their usual dose. For participants on
SXB treatment at study entry, PSG was performed at screening and
end of study, both on SXB. Safety evaluation included assessment of
treatment‐emergent adverse events (TEAEs).
Results: As 2/10/17: 106 participants were enrolled; 46 completed
1 year. In SXB‐naïve participants, PSG changes from screening (no
drug) to end of SD (optimal SXB dose) included decreased total num-
ber of arousals, (median [Q1,Q3] change = −36 [−53.0, −20.0]),
N1% (−3.1% [−8.0, −0.4]) and REM% (−7.2% [−12.3, −2.8]); and
increased N3% (10.6% [3.5,18.2]); N2% was unchanged. Further
decreases in arousals were seen from end of SD to the end of study
(−8.5 [−17.0, 5.0]) in SXB‐naive participants. In participants on SXB
at entry, sleep architecture generally did not change from screening
to the end of study. The most common TEAEs (> 10%) were enure-
sis, nausea, vomiting, headache, and decreased weight.
Conclusions: SXB treatment‐related changes in sleep architecture
(reduced arousals, REM and N1; increased N3; stable N2) in pediatric
narcolepsy patients were similar to changes previously observed in
adults with narcolepsy. The safety profile was consistent with adult
studies and no new safety concerns were identified.
Support: Jazz Pharmaceuticals:
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tors member, Chief Medical Officer, and an employee of SleepMed
Inc; is a Board of Directors member for First Community Corpora-
tion, SC, and National Sleep Foundation; has received consulting
fees from Aerial BioPharma, LLC, Jazz Pharmaceuticals, Inc., Apni-
Cure, UCB, and Teva; has received research support from Actelion,
Boehringer Ingelheim, GSK, Jazz Pharmaceuticals, Inc., Vanda, Merck,
Novo Nordisk, Pfizer, Schwarz, Sepracor, XenoPort, Eisai, Ventus,
Philips, ResMed, ApniCure, Sensory Medical, J&J, Apnex, and Fisher
Paykel; and has been a speakers’ bureau member for Teva, Jazz
Pharmaceuticals, Inc., UCB, Vanda, Merck, and XenoPort; JB is a
part‐time employee of Jazz Pharmaceuticals and shareholder of Jazz
Pharmaceuticals plc.; RP and GW are full‐time employees of Jazz
Pharmaceuticals, who, in the course of this employment, has
received stock options exercisable for, and other stock awards of,
ordinary shares of Jazz Pharmaceuticals, plc; EM has received
research support from Jazz Pharmaceuticals, Merck, and Glaxo Smith
Kline (GSK), has consulted for Novo Nordisk and Reset Pharmaceuti-
cals, and is on the speakers′ bureau for Vox Media.
P195 | Upper airway resistance syndrome with
a small mandible is not rare among Japanese
female
Y. Fuse-Nagase1; N. Doi2
1University Health Center, Ibaraki University, 2Ibaraki Prefectural
Medical Center of Psychiatry, Ibaraki, Japan
Objectives/Instruction: The authors report a case of a patient
with hypersomnia. She had a small face and a small mandible, which
narrowed her respiratory tract and caused upper airway resistance
syndrome.
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Methods: Case description: An 18‐year‐old female student was
seen by the presenter, the psychiatrist of the university health
administration facility, at the time of medical checkup for first‐year
students. She was a very pretty girl with a small face and a small
mandible. She complained that she felt sleepy all day long although
she slept about 7 hr every night. She fell asleep easily in the train
and in the bus every morning. She also fell asleep in class very often.
She was diagnosed with hypersomnia and was recommended to go
to see a specialist of sleep disorder. However, her mother disagreed
with the idea and she lost the chance of being treated. Three years
later, when she was a fourth‐year student, she came to the health
administration facility of her university to see the psychiatrist, again.
She said her hypersomnia was getting worse and she slept more
than 12 hr each night but fell asleep in every class.
Results: She was referred to a specialist of sleep disorder. Accord-
ing to the doctor, after being monitored by a portable device, she
was diagnosed with upper airway resistance syndrome. Her symp-
toms of hypersomnia slowly improved with using an oral application
and by orthodontics.
Conclusions: In Japan, women with a small face and a small mand-
ible are not rare. Medical doctors involved in primary care as to doc-
tors in health administration facilities need to have basic knowledge
of upper airway resistance syndrome so that they can find patients
with it and lead them to improve their quality of life by appropriate
treatment.
Disclosure: Nothing to disclose.
P196 | Detection of microsleep episodes with
machine learning tools
J. Skorucak1,2,3; D. Schreier4,5; A. Hertig-Godeschalk4,5;
A. Malafeev1,2,3; J. Mathis4; P. Achermann1,2,3
1Institute of Pharmacology and Toxicology, University of Zurich,
2Neuroscience Center Zurich, University of Zurich and ETH Zurich,
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Zurich, 4Sleep‐Wake‐Epilepsy Centre, Department of Neurology,
University Hospital Bern, 5Graduate School for Health Sciences,
University of Bern, Bern, Switzerland
Objectives / Introduction: Microsleep episodes (MSE) are brief
episodes of sleep, mostly defined to be shorter than 15s. MSE often
occur because of insufficient sleep in healthy individuals or due to
disease related excessive daytime sleepiness in patients. MSE lead to
lapses in consciousness during which individuals often fail to
respond to sensory stimuli. This may become dangerous, especially
in situations that demand high attention such as driving or monitor-
ing tasks. Thus, the identification of early signs of sleepiness and
sleep (i.e. MSE) is of considerable clinical and practical relevance.
Under laboratory condition, the maintenance of wakefulness test
(MWT) is the gold standard for assessing vigilance but MSE, charac-
terized by a slowing of EEG activity, are not analysed so far in most
sleep centres.
Methods: We analysed MWT recordings of 30 patients referred to
the Sleep‐Wake‐Epilepsy‐Centre. MSE were scored by experts rather
restrictively, defined by the occurrence of theta dominance on ≥1
occipital lead lasting 1‐15s, while the eyes were ≥ 80% closed. To
visualize oscillatory activity, we calculated spectrograms (autoregres-
sive model of order 16) of 1‐s epochs moved in 200‐ms steps
through the data and derived seven features: power in delta, theta,
alpha and beta bands, ratio theta/(alpha+beta), quantified eye move-
ments, and median frequency. Three algorithms were used for MSE
classification: support vector machine (SVM), random forest (RF), and
an artificial neural network (long short‐term memory [LSTM] net-
work). Data of 20 patients were used for the training of the classi-
fiers, and 10 for testing.
Results: MSE were successfully identified with a high sensitivity
(SVM 0.91, RF 0.90 and LSTM 0.82) and high specificity (0.96, 0.98
and 0.98). The RF classifier allowed to quantify the importance of
the features and revealed that median frequency was most relevant.
Conclusions: The automatic detection of MSE was successful for
our EEG‐based definition of MSE, with good performance of all
three algorithms applied. Inclusion of additional features and deriva-
tions may be beneficial, as well as a deep learning approach with
raw EEG data.
Supported by the Swiss National Science Foundation, nano‐tera.ch,
the Swiss Commission of Technology and Innovation, and the Clini-
cal Research Priority Program “Sleep and Health”.
Disclosure: Nothing to disclose.
P197 | Solriamfetol (JZP‐110) in the treatment
of excessive sleepiness in narcolepsy and
obstructive sleep apnoea: maintenance of
wakefulness test results across the day
P. Schweitzer1; K.P. Strohl2; A. Malhotra3; R. Rosenberg4;
R.B. Sangal5,6; P.C. Zee7; R. Thomas8; D. Chen9; J. Li9;
L.P. Carter9,10; L. Lee9; J. Black9,11; M.J. Thorpy12
1Sleep Medicine and Research Center, St. Luke's Hospital, Chesterfield,
MO, 2Case Western Reserve University, Cleveland, OH, 3Division of
Pulmonary, Critical Care and Sleep Medicine, University of California
San Diego, La Jolla, CA, 4Neurotrials Research Atlanta, Atlanta, GA,
5Sleep & Attention Disorders Institute, Sterling Heights, 6Oakland
University William Beaumont School of Medicine, Rochester, MI,
7Department of Neurology, Feinberg School of Medicine, Center for
Circadian and Sleep Medicine, Northwestern University, Chicago, IL,
8Department of Medicine, Division of Pulmonary, Critical Care and
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9Jazz Pharmaceuticals, Palo Alto, CA, 10University of Arkansas for
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Objectives/Introduction: Phase 3 trials in adults with narcolepsy
or obstructive sleep apnoea (OSA) demonstrated robust wake‐pro-
moting effects of solriamfetol on a 40‐min Maintenance of Wakeful-
ness Test (MWT). The subsequent analyses reported here were
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performed to evaluate the time course of solriamfetol on each MWT
trial after morning dosing.
Methods: Participants were randomised to receive placebo or solri-
amfetol 37.5 (OSA only), 75, 150, or 300mg. As pre‐specified, only
doses efficacious for both coprimary endpoints (MWT overall sleep
latency and Epworth Sleepiness Scale score at week 12) were fur-
ther tested at each MWT trial (MWT1: 1‐hr post‐dose, MWT2‐5: 2‐
hr consecutive intervals post‐dose; total time: ≈ 9 hr post‐dose). The
first trial with significant change (*p < 0.05) was identified and test-
ing to the next trial was performed until non‐significance or MWT5
was reached.
Results: In general, efficacious doses of solriamfetol showed a sig-
nificant change from baseline on each of the 5 individual MWT trials
at week 12, with the exception of 37.5 mg for OSA and 75 mg for
narcolepsy. In participants with narcolepsy, solriamfetol 150mg and
300mg demonstrated significant least squares (LS) mean change (s-
tandard error) from baseline to week 12 at each time trial from
MWT1 (150mg 9.9* [1.7], 300mg 9.9* [1.8], placebo ‐0.6 [1.7]) to
MWT5 (150mg 9.3* [1.9], 300mg 12.2* [2.0], placebo 3.1 [1.8]). In
participants with OSA, solriamfetol 75mg, 150mg, and 300mg
demonstrated significant LS mean change from baseline to week 12
at each time trial from MWT1 (75mg 5.8* [1.8], 150 mg 10.9* [1.3],
300mg 12.5* [1.4], placebo −0.4 [1.3]) to MWT5 (75 mg 7.8* [1.8],
150 mg 8.1* [1.3], 300 mg 7.6* [1.4], placebo 0.2 [1.4]). Common
treatment‐emergent adverse events in both narcolepsy and OSA
populations included headache, nausea, decreased appetite, anxiety,
and nasopharyngitis, and were mild to moderate.
Conclusions: Treatment with solriamfetol (75 mg in OSA, and 150
and 300 mg in OSA and narcolepsy) was associated with sustained
improvements in wakefulness, from 1 hr to 9 hr after morning dos-
ing. Safety and tolerability in both populations were consistent with
previous studies of solriamfetol.
Disclosure: PK Schweitzer: research funding from Jazz Pharmaceuti-
cals (Jazz), Philips Respironics, NightBalance. KP Strohl: site principal
investigator (PI) for Inspire Medical Systems; Jazz PI; received consul-
tancy fees from Sommetrics, GSK, and Seven Dreamers. A Malhotra:
officer of American Thoracic Society, relinquished outside personal
income since 2012; ResMed provided philanthropic donation to UC
San Diego to support sleep center. R Rosenberg: consultancy fees
from Eisai; honoraria/served on Merck speakers’ bureau; research
funding from Jazz, Merck, Actelion, Eisai, Philips Respironics; Jazz
advisory‐board member. RB Sangal: research grants from Shire, Jazz,
Eisai; served on Merck speakers’ bureau. PC Zee: research support
from Merck, Philips Respironics, Jazz, Eisai. R Thomas: holds patent
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P198 | A 5‐year post‐authorization safety
study (PASS) relative to Wakix® (pitolisant) use
and its long‐term safety in narcolepsy with or
without cataplexy in routine medical practice
G. Plazzi1; U. Kallweit2; C. Caussé3; Y. Joulin3; C. Scart-
Grès3; I. Lecomte3; J.-M. Lecomte3; J.-C. Schwartz3
1Dipartimento di Scienze Biomediche e Neuromotorie, Alma Mater
Studiorum, Bologna University, Bologna, Italy, 2Helios Klinik Hagen‐
Ambrock, Hagen, Germany, 3Bioprojet, Paris, France
Objectives/Instruction: Wakix®, the first histamine H3 receptor
inverse agonist obtained the European Marketing Authorization (MA)
in 2016 for the indication “In adults for the treatment of narcolepsy
with or without cataplexy” approved by the EMA/CHMP. The CHMP
requested a long‐term observational PASS to document the long‐
term safety of Wakix® in routine medical practice (RMP).
Methods: This international, non‐interventional, open‐label long‐
term PASS is planned to follow up 300 patients for 5 years. Pitoli-
sant is prescribed on RMP according to the MA before and indepen-
dently of the decision to enroll the patients in the countries where
Wakix® is commercialized. Investigators are sleep specialists in
charge of narcolepsy patients. Primary objectives are both safety (re-
port of adverse events (AEs)) and description of Wakix® use, nar-
colepsy management, patient characteristics. Among secondary
objectives: assessment of narcolepsy and depression with different
tools. A yearly report has to be done and here is the First Report
1 year after the first patient recruited.
Results: On 17 January 2018, 12 active investigators in 3 countries
recruited 98 patients (56 in Germany, 40 in Italy, 2 in France), 84 of
them have completed inclusion data, 56 have filled the self‐assess-
ment questionnaire at baseline. The main endpoint showed 6
adverse events (no serious) in 3 patients: 1 patient with arthralgia,
headache and nausea at day 17 after Wakix administration, 1 patient
with tiredness (day 87), 1 patient with arthralgia in both knees.
The baseline characteristics showed a mean age of 38.5 year‐old,
48.8% male, with a narcolepsy diagnosed 5.7 years before recruit-
ment, which was confirmed by Polysomnography and MSLT in
85.7%. 73.8% of patients present cataplexy, 63.1% hallucinations,
53.6% depression. Mean ESS was 15.4 and 82.1% was > 10. Con-
comitant narcoleptic treatment was prescribed for 52% of patients:
sleepiness treatments 22.6% of patients, cataplexy treatments
16.7%, sleepiness and cataplexy treatments 22.6%.
Conclusions: Because this is the beginning of the study with few
follow‐up visits, this first report showed essentially the first 98
patients baseline characteristics and a very few adverse events rate.
The follow‐up of these patients needs to be continued in order to
confirm the good safety profile of Wakix.
Disclosure: Giuseppe Plazzi, Ulf Kallweit are consultants of Biopro-
jet; Christian Caussé, Yves Joulin, Catherine Scart‐Grès, Isabelle
Lecomte are employees of Bioprojet. Jeanne‐Marie Lecomte and Jean‐
Charles Schwartz are founders of Bioprojet which sponsors this study.
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P199 | Effects of solriamfetol on primary OSA
therapy use in a 12‐week phase 3 trial
G. Mayer1; P.K. Schweitzer2; R. Rosenberg3; A. Malhotra4;
G.K. Zammit5,6; M. Gotfried7; P. Chandler8; M. Baladi8;
D. Menno8; K.P. Strohl9
1Hephata Hessisches Diakoniezentrum, Hephata‐Klinik, Schwalmstadt,
Germany, 2Sleep Medicine and Research Center, St. Luke's Hospital,
Chesterfield, MO, 3NeuroTrials Research and Atlanta School of Sleep
Medicine, Atlanta, GA, 4Univeristy of California San Diego, San Diego,
CA, 5Clinilabs Drug Development Corporation, 6Icahn School of
Medicine at Mount Sinai, New York, NY, 7Pulmonary Associates, PA,
Phoenix, AZ, 8Jazz Pharmaceuticals, Palo Alto, CA, 9Case Western
Reserve University, Cleveland, OH, United States
Objectives/Introduction: In obstructive sleep apnoea (OSA),
excessive sleepiness (ES) is common and is reported to persist in
13–65% of patients despite primary therapy use. Solriamfetol, a
selective dopamine/norepinephrine reuptake inhibitor, demonstrated
efficacy for the treatment of ES in OSA in a 12‐week, placebo‐con-
trolled phase 3 study. This analysis evaluated whether solriamfetol
treatment alters use of primary OSA therapy.
Methods: Participants with OSA and ES were randomised to pla-
cebo or solriamfetol 37.5, 75, 150, or 300mg once daily. Study
inclusion required current or prior use of primary OSA therapy,
including positive airway pressure (PAP) therapy, oral appliance, or
surgical intervention. Participants were only excluded based on pri-
mary therapy use if they had refused to try a primary therapy. Par-
ticipants using a device (e.g., PAP, oral appliance) were instructed
to maintain consistent use throughout the study. Use was recorded
by electronically downloadable data or by diary, and measured by
percentage of nights/week that participants used therapy (for
devices with or without downloadable data), percentage of nights/
week that participants used therapy ≥ 50%/night (no downloadable
data), and number of hours/night that participants used therapy
(downloadable data).
Results: The efficacy population comprised 459 participants (pla-
cebo, n = 114; solriamfetol combined, n = 345). Baseline mean per-
centage of nights, percentage of nights ≥ 50%/night, and number of
hours/night that participants used therapy was similar for the pla-
cebo (88.8% [n = 69], 93.2% [n = 24], and 6.6 hr/night [n = 43],
respectively) and all solriamfetol treatment groups (solriamfetol com-
bined: 89.9% [n = 218], 91.2% [n = 84], and 6.6 hr/night [n = 133],
respectively). There were clinically insignificant changes (mean [stan-
dard deviation]) from baseline to end of study (weeks 9–12) as mea-
sured by percentage of nights/week (placebo [n = 69], 0.8 [12.1];
solriamfetol [n=218], 1.1 [12.0]), percentage of nights/week with use
≥50%/night (placebo [n = 24], 2.7 [19.4]; solriamfetol [n = 84], 2.2
[13.7]), and hr/night (placebo [n = 43], −0.3 [0.9]; solriamfetol
[n = 133], −0.3 [1.2]). The most common treatment‐emergent
adverse events observed with solriamfetol were headache, nausea,
decreased appetite, anxiety, and nasopharyngitis.
Conclusions: These data support the finding that treatment of ES
with solriamfetol did not impact primary OSA therapy use in a
controlled setting. Safety and tolerability of solriamfetol were consis-
tent with previous studies.
Support: Jazz Pharmaceuticals.
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adi, and D Menno: employees of Jazz who receive stock options exer-
cisable for/other stock awards of ordinary shares Jazz Pharmaceuticals
plc during employment. KP Strohl: advisory board member, PI for Jazz;
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P200 | Uncontrollable cataplexies: have a look
to the cervical spine
D. Cugy
UHC, Bordeaux, France
Objectives/Instruction: Cataplexy is defined as episodes of sud-
den loss of voluntary muscle tone triggered by emotions generally
lasting < 2 min. Cataplexy is most commonly associated with and
considered pathognomonic for narcolepsy. The single pharmacother-
apy indicated and recommended in first‐line for cataplexy is sodium
oxybate. There is no consensus for second‐line treatment when cata-
plexies are not controlled.
Methods: Case report of two patients with uncontrolled cataplex-
ies related to narcolepsy.
Results: Patients are male, aged 62 and 68 years old. They both
have a HLA DR15 / DQ0602 phenotype. They have at least one epi-
sode of cataplexy per day. Both have benefited from a combination
of arousing and anti‐cataplectic treatment (SSRI, Sodium Oxybate)
but these treatments were not able to control cataplexies even after
a dose escalation.
Alternative causes of cataplexies or cataplexy‐like were searched.
Physical exam showed cervical stiffness. Cervical spine MRI revealed
inversion of cervical spine curvature and important staged
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discopathies with cervical canal stenosis. Specific management of
cervical pathology was proposed in addition to the treatment of nar-
colepsy and cataplexy. This was efficient and we observed a better
control of cataplexy.
In a very particular way, one patient described that he usually limited
cataplexies frequency by walking practice.
Conclusions: In patients with uncontrolled cataplexies under
Sodium Oxybate, cervical spine pathologies should be considered,
especially if cervical spine is stiff or patient reports an improvement





apparent relationship to atlantoaxial dislocation)
Disclosure: Nothing to disclose.
P201 | Test‐retest validity of the Epworth
Sleepiness Scale within a substantial short time
frame
B. Faludi; N. Kovács; J. Janszky; R. Rozgonyi
Dept. of Neurology, University of Pécs, Pécs, Hungary
Objectives/Instruction: The Epwoth Sleepiness Scale (ESS) is a
widely used, validated questionnaire towards effectively examining
the patients’ sleepiness in a range of different situations. Test‐retest
validity is an important aspect of a questionnaire of which, according
to only a few studies, was found to be low in the case of ESS. All
these studies applied long intervals between the tests thereby
increasing the possibility of fundamental change in circumstances
which in turn affect the reliability of the test.
The aim of the present study was to investigate the test‐retest valid-
ity of the ESS in a short time frame to provide stability of the test
circumstances. We also compared the originally used (Pearson's cor-
relation) and current, accepted (Lin's concordance coefficient) statis-
tical methods of test‐retest evaluation.
Methods: Using ESS questionarie we examined one‐hundred unse-
lected patients consecutively referred to the sleep lab. Test‐retest
paradigm was used with the interval of 1 hr between the tests. To
determine the validity of the ESS we used the Lin's concordance
coefficient and Pearson's correlation.
Results: The Lin's concordance coefficient was found to be low
(0.748) while the Pearson's correlation (0.76) revealed good reliability.
Conclusions: Our result provides a clear evidence about the poor
test‐retest validity of the ESS determined by the current statistical
method, despite the examination protocol excludes changes of test
circumstances. This result underlines the careful and cautious appli-
cation of the ESS in the routine clinical practice.
Disclosure: Nothing to disclose.
P202 | Predictors of daytime sleepiness
improvement in a population‐based 5‐year
longitudinal study
I. Jaussent1; C.M. Morin2; H. Ivers2; Y. Dauvilliers3
1U1061, INSERM, Montpellier, France, 2Department of Psychology,
Université Laval, Quebec, QC, Canada, 3Service de Neurologie, Unité
des Troubles du Sommeil, Hôpital Gui‐de‐Chauliac, CHU Montpellier,
Montpellier, France
Objectives/Instruction: Excessive daytime sleepiness (EDS) is
highly prevalent in the general population and preventive measures
are essential for health promotion. This study examined the predic-
tors of daytime sleepiness (DS) improvement in a longitudinal com-
munity study of 2167 adults over 5 years.
Methods: DS was assessed at baseline and at each follow‐up wave
(1, 2, 3, 4 and 5 years) by the Epworth Sleepiness Scale (ESS). Sus-
tained of DS improvement was defined as a 4‐point ESS decrease
without no further increase of more than 3 points in the subsequent
follow‐up. Transient DS reduction was defined as a fluctuation
between a 4‐point ESS decrease and an increase during the follow‐
up. Insomnia, sleep duration, sleep medication, and socio‐demo-
graphic, lifestyle, health and psychological measures were self‐rated
at each time point. Exposures that appeared or changed during the
follow‐up of subjects were taken into account as time‐dependent
covariates in the Cox proportional hazard models. The covariate was
valued the year prior to the DS decline and the relative change
between the year of the event and the year prior to the DS decline.
Significance level was set at p < 0.05.
Results: Overall, 184 (9%) participants reported a transient DS
improvement during the follow‐up and 587 (28%) a sustained DS
improvement till the end of the study. Compared to subjects without
DS reduction, an increase in sleep duration and a decrease in
depression severity were independently associated with a transient
DS improvement whereas living alone, a decrease in insomnia, in
depressive, in pain severity symptoms were independent predictors
of sustained DS improvement. Compared to subjects with a transient
DS, those with a sustained DS improvement were younger, living
alone, took one‐two coffee cups per day, reported less insomnia and
depressive symptoms, gained less weight and reported less endo-
crine and metabolic diseases.
Conclusions: The beneficial effects of sleep duration increase and
improved depressive symptoms on transient DS should be taken into
account in the prevention of DS because they are clearly identifiable
modifiable factors. Improvement of insomnia, depressive and pain
symptom severity on sustained DS should also be considered.
Disclosure: CM has served as speaker for Merck and consultant
on advisory board for Phillips. YD has received funds for speaking
and board engagements with UCB pharma, Jazz, and Bioprojet, with-
out competing financial interests related to the manuscript.
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P203 | Quality of life, functional evaluation,
and work productivity in patients with
narcolepsy: results from a phase 3 study of
solriamfetol (JZP‐110)
H. Emsellem1,2; M.J. Thorpy3; G.J. Lammers4,5; C. Shapiro6;
G. Mayer7,8; G. Plazzi9; D. Chen10; J. Li10; L.P. Carter10,11;
R. Ryan10; J. Black10,12; Y. Dauvilliers13
1Center for Sleep & Wake Disorders, Chevy Chase, MD, 2George
Washington University Medical Center, Washington, DC, 3Montefiore
Medical Center, Bronx, NY, United States, 4Department of Neurology,
Leiden University Medical Center, Leiden, 5Sleep‐Wake Center, Stichting
Epilepsie Instellingen Nederland SEIN, Heemstede, The Netherlands,
6University of Toronto, Toronto, ON, Canada, 7Hephata‐Klinik,
Schwalmstadt, 8Philipps University, Marburg, Germany, 9Department of
Biomedical and Neuromotor Sciences, University of Bologna, Bologna,
Italy, 10Jazz Pharmaceuticals, Palo Alto, CA, 11University of Arkansas
for Medical Sciences, Little Rock, AR, 12Stanford Center for Sleep
Sciences and Medicine, Palo Alto, CA, United States, 13Gui‐de‐Chauliac
Hospital, CHU Montpellier, INSERM U, France
Objectives / Introduction: Solriamfetol is a selective dopamine/
norepinephrine reuptake inhibitor with robust wake‐promoting
effects. In a phase 3 study, solriamfetol significantly improved wake-
fulness and decreased excessive sleepiness in adults with narcolepsy.
Health‐related quality of life (HRQoL) measures were assessed as
secondary endpoints.
Methods: Participants with narcolepsy were randomised to solri-
amfetol 75 mg, 150 mg, 300 mg, or placebo for 12 weeks. HRQoL
measures included the Functional Outcomes of Sleep Questionnaire
short version (FOSQ‐10), Work Productivity and Activity Impairment
questionnaire for Specific Health Problems (WPAI:SHP), and 36‐Item
Short Form Health Survey version 2 (SF‐36v2). Least squares mean
(standard error) (LS mean [SE]) changes from baseline to week 12
were calculated for each measure. Reported P values are nominal.
Safety and tolerability were also assessed.
Results: The modified‐intent‐to‐treat population was comprised of
231 participants (solriamfetol 75 mg, 150 mg, and 300 mg, n = 59, 55,
and 59, respectively; placebo, n = 58). Baseline demographics were
similar across treatment groups. Solriamfetol 300 mg improved the
FOSQ‐10 score (LS mean [SE]: 300 mg, 3.01 [0.42]; placebo, 1.56
[0.40]; p < 0.05). Solriamfetol 150 mg reduced percent overall work
impairment on the WPAI:SHP (LS mean [SE]: 150 mg, −19.77 [5.04];
placebo, −4.28 [5.00]; p< 0.05) and reduced percent activity impair-
ment at 150 and 300 mg (LS mean [SE]: 300 mg, ‐21.27 [3.55]; 150
mg, −17.84 [3.35]; placebo, −7.79 [3.42]; p< 0.05). Improvements in
SF‐36v2 domains were seen for role physical score (LS mean [SE]: 300
mg, 6.46 [1.21]; placebo, 2.38 [1.14]; p < 0.05), general health score
(LS mean [SE]: 75 mg, 2.42 [0.84]; placebo, ‐0.20 [0.81]; p < 0.05), and
vitality score (LS mean [SE]: 300 mg, 4.96 [1.19]; 150 mg, 5.83 [1.12];
75 mg, 4.68 [1.15]; placebo, 1.04 [1.12]; p < 0.05). The most common
treatment‐emergent adverse events were headache, nausea,
decreased appetite, nasopharyngitis, dry mouth, and anxiety.
Conclusions: Solriamfetol improved functioning and HRQoL at
300 mg, particularly on the SF‐36v2 vitality (all doses) and role
physical domains. Impairment at work was improved with solriamfe-
tol 150 mg. Activity impairment outside of work was improved with
solriamfetol 150 and 300 mg. Safety and tolerability were consistent
with previous solriamfetol studies.
Support: Jazz Pharmaceuticals.
Disclosure: H Emsellem: research funding from Jazz Pharmaceuti-
cals (Jazz), Flamel (Avadel), Balance Therapeutics,Harmony Bio-
sciences; advisory board member for Harmony. MJ Thorpy:
research/grant support and consultancy fees from Jazz, Merck &
Co, Inc., Teva Pharmaceutical Industries Ltd; speakers’ bureau
member for Jazz and Cephalon, Inc. (now Teva). GJ Lammers: con-
sultancy fees and/or honoraria; advisory board member for UCB
Pharma, Bioprojet, Theranexus, and Jazz. C Shapiro: research fund-
ing from National Institutes of Health, Canadian Institutes of
Health Research; speakers’ bureau for Jazz. G Mayer: honoraria
from Paul Ehrlich Institute, Germany; speakers’ bureau for UCB
Pharma, Sanofi; board member of European Narcolepsy Network.
G Plazzi: research support from UCB Pharma; consulted for UCB
Pharma, Jazz, Bioprojet. D Chen, J Li, LP Carter, R Ryan: employees
of Jazz who received stock options exercisable for/other stock
awards of ordinary shares of Jazz Pharmaceuticals plc during
employment. J Black: part‐time employee of Jazz and shareholder
of Jazz Pharmaceuticals plc. Y Dauvilliers: consultancy fees and/or
honoraria and speakers’ bureau member and/or advisory board par-
ticipant for UCB Pharma, Bioprojet, Theranexus, Flamel, Harmony
Biosciences, and Jazz.
P204 | A long‐term study of the safety and
maintenance of efficacy of solriamfetol (JZP‐110)
for treatment of excessive sleepiness associated
with narcolepsy or obstructive sleep apnoea
J.-L. Pepin1; R. Schwab2; C. Shapiro3; J. Hedner4;
M. Ahmed5; N. Foldvary-Schaefer6; P.J. Strollo7; G. Mayer8,9;
K. Sarmiento10; M. Baladi11; P. Chandler11; L. Lee11;
A. Malhotra12
1INSERM Unit 1042, Grenoble Alpes University Hospital, Grenoble,
France, 2University of Pennsylvania, Philadelphia, PA, United States,
3University of Toronto, Toronto, ON, Canada, 4Sahlgrenska University
Hospital, Gothenburg University, Gothenburg, Sweden, 5Cleveland Sleep
Research Center, 6Cleveland Clinic Lerner College of Medicine,
Cleveland, OH, 7University of Pittsburgh/Veterans Administration
Pittsburgh Health System, Pittsburgh, PA, United States, 8Hephata‐
Klinik, Schwalmstadt, 9Philipps University, Marburg, Germany, 10San
Francisco Veterans Administration Healthcare System, San Francisco,
11Jazz Pharmaceuticals, Palo Alto, 12Division of Pulmonary, Critical Care
and Sleep Medicine, University of California San Diego, La Jolla, CA,
United States
Objectives/Introduction: Narcolepsy and obstructive sleep
apnoea (OSA) share the common symptom of excessive sleepiness
(ES). Solriamfetol, a selective dopamine/norepinephrine reuptake inhi-
bitor, was efficacious for treatment of ES in participants with nar-
colepsy and OSA in several placebo‐controlled studies. This study
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evaluated the long‐term safety and maintenance of efficacy of solri-
amfetol.
Methods: Eligible participants had narcolepsy or OSA and had
completed a previous solriamfetol study. This study included a 2‐
week Titration phase followed by a Maintenance phase of up to 50
weeks. After 6 months of treatment, a subgroup of participants
entered a 2‐week placebo‐controlled Randomised Withdrawal (RW)
phase. Change in Epworth Sleepiness Scale (ESS) score from begin-
ning to end of the RW was the primary endpoint; Patient and Clini-
cian Global Impression of Change (PGI‐C and CGI‐C, respectively)
were secondary endpoints. For ESS score, an analysis of covariance
(ANCOVA) model was used with change from beginning to end of
the RW as the response variable. The model included fixed effects
of treatment group, efficacy baseline, and randomisation stratifica-
tion factor (narcolepsy and OSA).
Results: A total of 643 participants were included in the safety
population of the open‐label phase (226 narcolepsy; 417 OSA). Of
these, 280 participants (placebo, n = 141; solriamfetol, n = 139) com-
prised the efficacy population in the RW phase. At 6 months, partici-
pants randomised to placebo in the RW had an increase of 5.3 (least
squares [LS] mean) on the ESS compared with 1.6 in participants
randomised to continue solriamfetol (p < 0.0001). For both sec-
ondary endpoints, greater percentages of participants randomised to
placebo were reported as worse at the end of the RW versus the
solriamfetol group (both p < 0.0001). At 1 year, open‐label treatment
with solriamfetol demonstrated sustained reductions in mean ESS
scores and improvements on PGI‐C and CGI‐C. The most frequent
treatment‐emergent adverse events (AEs; ≥5%) with solriamfetol
were headache, nausea, nasopharyngitis, insomnia, dry mouth, anxi-
ety, and decreased appetite; 27 (4.2%) participants had ≥1 serious
AE.
Conclusions: These findings demonstrate long‐term maintenance
of efficacy with solriamfetol in the treatment of ES in subjects with
narcolepsy or OSA. The safety profile was consistent with prior pla-
cebo‐controlled studies of solriamfetol.
Support: Jazz Pharmaceuticals.
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P205 | Sodium oxybate treatment of
narcolepsy in pediatric patients: long‐term
efficacy and safety
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5Stanford Sleep Medicine Center, Redwood City, 6Jazz Pharmaceuticals,
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Objectives/Introduction: Narcolepsy symptom onset primarily
begins in childhood/adolescence. Sodium oxybate (SXB) was evalu-
ated as a treatment for narcolepsy in pediatric patients in a placebo‐
controlled, randomized‐withdrawal study with an open label exten-
sion. Efficacy was established during the double‐blind, randomized‐
withdrawal period. Results of the long‐term efficacy and safety
assessments are reported.
Methods: Children and adolescents with narcolepsy with cataplexy
who were on SXB treatment or were SXB‐naïve, aged 7‐16 were eli-
gible. After a two‐week double‐blind, placebo‐controlled withdrawal
period (DB), participants entered an open‐label safety period (OL) for
a total study duration of up to 1 year. Baseline efficacy assessments
occurred when participants were on a stable dose of SXB prior to
the DB. Change in weekly number of cataplexy attacks was calcu-
lated from daily cataplexy diaries. The Epworth Sleepiness Scale for
Children and Adolescents (ESS‐CHAD) was utilized to evaluate
sleepiness at each visit. Safety evaluations included anxiety, depres-
sion, and suicidality assessments, and treatment‐emergent adverse
events (TEAEs).
Results: As of the 10 February 2017 datacut: 106 were enrolled;
79 completed ≥6 months and 46 completed 1 year. Efficacy for cat-
aplexy and excessive daytime sleepiness (EDS) was maintained dur-
ing the OL. Median (Q1, Q3) change in weekly number of cataplexy
attacks from the stable‐dose period (SD) to the last week of OL was
0.0 (‐2.25, 4.17), with little change throughout. Similarly, the median
(Q1, Q3) change from SD to the last week of OL in ESS‐CHAD score
was 0.0 (‐3.0, 3.0). No increase in anxiety or depression was
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observed on the assessments. Two serious TEAEs occurred (acute
psychosis and suicidal ideation) with both participants endorsing pos-
itive responses on the suicidality assessment. Both events resolved
after discontinuing SXB; one participant withdrew from the study
(suicidal ideation) and the other resumed SXB at a lower dose with-
out recurrence of the event (psychosis). The most common TEAEs
(> 10%) were enuresis, nausea, vomiting, headache, and decreased
weight.
Conclusions: SXB demonstrated long‐term effectiveness (up to 1‐
year) in reducing and maintaining reductions in cataplexy and EDS in
pediatric patients with narcolepsy. The safety profile was consistent
with adult studies and no new safety concerns were identified.
Support: Jazz Pharmaceuticals
Disclosure: ML has received honoraria from Shire and grant sup-
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P206 | Polysomnographic evaluation of sleep
in Chiari type 1 malformation before surgical
decision and after surgery
D. Cugy1,2; J.R. Vignes3; M. Guibourd de Luzinais3
1UHC, 2CHU Bordeaux, EFSN ‐ Sleep Clinic, 3Neurochirurgie, CHU
Bordeaux, Bordeaux, France
Objectives/Instruction: Chiari malformation is known to be asso-
ciated with sleep apnea but others sleep disorders could be identi-
fied. We report here our experience of nocturnal polysomnographic
performed before surgical decision and after surgery of Chiari type 1
malformation
Methods: Retrospective analysis. Since 2010, we explored patients
with Chiari malformation during the pre‐operative assessment, and
when possible or indicated after surgery. Nocturnal video‐polysom-
nographic were performed in the sleep laboratory. Furthermore, at
each evaluation, patient completed Epworth Sleepiness Scale (ESS),
Pichot ADA asthenia scale, Pichot Q2DA depression scale and Modi-
fied Essay Questions (MEQ).
Results: Seventeen patients were recorded before surgical assess-
ment and 6 after surgery. Mean age was 43 ± 13 years old. All
patients have sleep fragmentation by arousals, due to Periodic Limb
Movements (PLM) for 11 patients, and significative sleep apneas
(mean 18/h) for 6 patients. Mean total sleep time (TST) was 405± 19
mn, under normal data from our sleep lab (mean = 415 ± 2 mn).
REM sleep represented only 13% of the TST.
After surgery, we observed an increase of mean TST to 432± 25 mn
(vs 385± 44 mn before) and of the REM sleep (17% of the TST vs
13%) for the 6 reevaluated patients. Sleep apnea index decreased
from 18 /h to 13/h and PLM appeared to be less frequent.
Considering self‐evaluation, only ESS has significative abnormal
results with a mean score at 11 ± 3 before surgery. For the 6
patients, all scores decreased after surgery: from 12 ± 2 to 6 ± 3 for
ESS, 16 ± 5 to 7 ± 2 for ADA, 8 ± 3 to 3 ± 2 for Q2DA and 4 ± 2
to 1 ± 1 for MEQ.
Conclusions: Our retrospective data showed a higher association
with PLM than to apneas in Chiari malformation. Furthermore, sleep
architecture parameters were altered. So polygraphy was insufficient
to explore sleep and a polysomnographic study has to be preferred.
Use of Epworth Sleepiness Scale questionnaire as a screening tool
appeared to be useful for sleepiness evaluation before surgery.
Disclosure: Nothing to disclose.
P207 | Central sleep apnoeas in a female
patient with pharmaco‐resistant epilepsy and
vagus nerve stimulation
N. Plos; I. Kušar Stojakovič; L. Dolenc Grošelj; M. Kirbiš
Clinical Institute of Clinical Neurophysiology, University Medical Center
Ljubljana, Ljubljana, Slovenia
Objectives/Instruction: While vagal nerve stimulation (VNS) can
reduce the frequency of seizures in patients with refractory epilepsy,
it can also cause side effects involving the upper and lower respira-
tory tract. VNS has been associated with obstructive apnoeas and
only in very few cases central sleep apnoeas (CSA) were found. The
pathophysiology of VNS mediated CSA has not been fully elucidated.
21 one‐year‐old female with mitochondrial cytopathy and pharmaco‐
resistant epilepsy was evaluated for suspected sleep disordered
breathing. Her tonic and sometimes clonic seizures started at the
age of 4. At first seizures were present during the day and night.
After VNS was implanted at the age of 7, daytime seizures ceased
to exist but the night time seizures still persisted. Over the years her
cognitive and motor skills have declined. Lately her parents have
noticed pauses in breathing during sleep and reported excessive day-
time sleepiness (EDS).
Methods: Night polysomnography (PSG) was performed in order to
provide detailed analysis of apnoeas and to investigate a suspected
ABSTRACTS | 185 of 433
correlation between apnoeas and vagus stimulation. VNS settings
during the recording were: an intensity of 2.25 mAmps, frequency of
30 HZ, pulse width 500 microseconds (ms), on‐time of 30 s and off‐
time of 180 s. A lot of epileptic activity on the electroencephalogra-
phy caused difficulties when defining sleep stages.
Results: PSG showed 22 central apnoeas and 36 central hypop-
neas. However the patient had additional central hypopneas consist-
ing of episodes of decreased airflow without desaturations. Average
SaO2 desaturation was 97% and the lowest SaO2 was 91%. AHI
was 11, but hypopneas without desaturation were not included.
Heart arrhythmias happened during breathing events.
Practically all of breathing events and heart arrhythmias were peri-
odic and corresponded to VNS stimulation (every 3 minutes). They
persisted for the duration of the stimulation (30 s) and came to an
end with VNS deactivation.
Conclusions: VNS may cause central apnoeas corresponding to
VNS stimulation. PSG should be considered in patients presenting
with apnoeas and EDS and adjustment of VNS settings is required.
Disclosure: Nothing to disclose.
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Objectives/Instruction: Shift work is associated with poor sleep,
and poor sleep may trigger headache. However, whether there is an
association between shift work and headache is unclear. The objec-
tive of this study was to investigate possible associations between
different types of headache and shift work.
Methods: 1585 nurses with different work schedules (day work, two‐
shift rotation, night work, three‐shift rotation) participated in a cohort
study with annual surveys that started in 2008/2009. A comprehensive
headache instrument was included in wave 6. Headaches were assessed
according to the International Classification of Headache Disorders IIIb.
Frequent headache (≥1 day per month), migraine, tension‐type head-
ache (TTH), chronic headache (headache > 14 days per month), and
medication‐overuse headache (MOH, chronic headache + acute head-
ache medication ≥10 days last month) comprised the dependent vari-
ables. Adjusted (for sex, age, percentage of full‐time equivalent, marital
status, children living at home) logistic regression analyses were con-
ducted with work schedule, number of night shifts worked last year,
number of quick returns (<11 hr in‐between shifts) last year, shift work
disorder (SWD), and insomnia disorder as predictors.
Results: Frequent headache, migraine, and chronic headache were
significantly associated with SWD (ORs 1.60 to 2.45) and insomnia
disorder (ORs 1.55 to 3.03), but not with work schedule, number of
night shifts or number of quick returns. TTH was only associated
with > 20 night shifts last year
(OR 1.41). MOH was only associated with insomnia disorder (OR
7.62).
Conclusions: We found no association between different types of
headache and work schedule. However, TTH was associated with
high number of night shifts. Nurses with insomnia disorder and
SWD reported higher prevalence of frequent headache, migraine,
chronic headache and MOH (only insomnia) compared to nurses not
having insomnia disorder and SWD, respectively.
Disclosure: Nothing to disclose.
P209 | Nocturnal eye movements in patients
with idiopathic rapid eye movement sleep
behaviour disorder and patients with Parkinson's
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Objectives/Introduction: Patients with idiopathic rapid eye move-
ment (REM) sleep behaviour disorder (iRBD) have a high risk of con-
verting into α‐synucleinopathies due to an early neurodegenerative
process involving lower brainstem areas. Eye movements (EMs) are
controlled by neurons located in the lower brainstem, midbrain, and
frontal areas, and are therefore vulnerable to be affected by an early
neurodegeneration. Several studies have reported impairment of the
oculomotor function in patients with Parkinson's disease (PD) during
wakefulness, but no studies have investigated how neurodegenera-
tion affects EMs during sleep. We aimed to evaluate nocturnal EMs
in iRBD and PD hypothesizing that these patients present abnormal
EMs during sleep.
Methods: A total of 28 patients with periodic leg movement disor-
der (PLMD; 15 males; 60.3 ± 11.9 years), 24 with iRBD (17 males;
63.0 ± 10.1 years), 23 with PD without RBD (PD‐RBD; 14 males;
61.4 ± 5.4 years), 29 with PD and RBD (PD+RBD; 19 males;
63.3 ± 5.1 years), and 24 controls (11 males; 56.7 ± 9.9 years) were
included. A previous validated EM detector was used to automati-
cally detect periods with any kind of EMs in artefact‐free epochs
between lights off and on. The EM coverage was computed as the
percentage of time containing EMs, during stages of wakefulness,
N1, N2, N3, and REM sleep. Between‐group comparisons were
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performed using Wilcoxon‐Ranksum tests, and the Benjamini‐Hoch-
berg procedure with a false discovery rate of 0.1 was used to con-
trol for multiple testing.
Results: We found that PD+RBD had significant less EM coverage
during wakefulness compared to controls (p < 0.001), and signifi-
cantly higher EM coverage during N2 compared to controls
(p = 0.003) and PLMD (p = 0.004). Furthermore, PD‐RBD showed
significantly higher EM coverage during N2 compared to controls
(p < 0.001) and PLMD (p = 0.001). Same trends were observed
between iRBD and controls in wakefulness and N2, but were not
significant after correction for multiple testing.
Conclusions: Patients with PD+/‐RBD reflect abnormal EM cover-
age during nocturnal wakefulness and N2, suggesting that the disor-
der is complex and affects various parts of the basal brain. The
different profiles of EM coverage in iRBD and PD+/‐RBD may mirror
different stages of central nervous system involvement across dis-
ease progression, a finding to be confirmed by future longitudinal
studies.
Disclosure: Nothing to disclose.
P210 | Apathy and depression in Parkinson's
disease with parasomnias: gender matters
M. Ntafouli; P. Bargiotas; C. Bassetti
Sleep-Wake-Epilepsy Center, Department of Neurology, University
Hospital Bern, Bern, Switzerland
Objectives/Instruction: Mood disturbances are common nonmo-
tor symptoms in patients with Parkinson's Disease (PD). However, it
remains unclear if these symptoms are related to the disease itself
or to disease comorbidities. The aim of the study was to investigate
whether the presence of parasomnias in patients with PD is associ-
ated with depression and apathy.
Methods: PD patients, who underwent subjective and objective
sleep‐wake assessments, were grouped according to the presence or
not of (any) parasomnia. The diagnosis of parasomnias was based on
clinical and polysomnographic data. Apathy was assessed using the
14‐item Starkstein Apathy Scale (cut‐off ≥14). Depression was
assessed using the Hamilton Depression Scale (cut‐off ≥9). The ESS,
PDQ39, and MMSE were used to evaluate sleepiness, quality of life
and cognitive impairment, respectively.
Results: The two groups were statistically comparable with respect
to age, gender, years of PD, severity of PD (H&Y), and motor score
(UPDRS‐III). Apathy prevalence in the group with parasomnias was
53.3% while in the control group without parasomnias was 33.3%.
PD patients with parasomnia had significantly higher apathy and
depression scores than PD patients without parasomnia, attributed
mainly to the differences in the female group. Among PD patients
with parasomnias, females had significantly higher apathy scores
than males but no other differences with respect to motor and non-
motor symptoms was found (data not shown). Gender was the only
independent predictor of apathy, with women presenting a higher
risk compared to men.
Conclusions: The presence of a parasomnia seems to increase the
risk of apathy and depression in PD patients and especially in female
individuals. Therefore, symptoms of apathy and depression should
be taken into consideration in those patients even if they do not
meet the diagnostic criteria for a mood disorder. Future studies
should focus further on the relationship between gender and other
mood features in PD patients with parasomnias.
Disclosure: Nothing to disclose.
P211 | Cheyne‐Stokes respiration and the
outcome of acute stroke
S.-Y. Lee1; Y. Kim1; S.H. Kim1; H.B. Shin2; E.Y. Roh3
1Kangwon National University School of Medicine, Chuncheon‐si,
2Kosleep Sleep Clinic, 3Seoul National University Boramae Hospital,
Seoul, Republic of Korea
Objectives/Instruction: Cheyne‐Stokes respiration (CSR) is fre-
quently observed in acute stroke patients. CSR has even been
reported to be a poor prognostic factor of cardiac failure. However,
the association between the presence of CSR and the outcome of
acute stroke is not well established. We aimed to assess whether
CSR has a predictive value in acute stroke.
Methods: We investigated the patients who were admitted with
acute ischemic stroke and received nocturnal polysomnography. We
collected data on demographics, risk factors, etiologic subtypes, and
stroke outcome and the parameters associated with respiratory
events in polysomnography. The stroke outcome was evaluated with
the occurrence of early neurological deterioration (END) and modi-
fied Rankin Scale (mRS) at one and three months. We assessed the
association between the presence of CSR and the stroke outcome
using multivariate logistic regression analysis.
Results: Among 182 patients, 35 (19.2%) showed CSR in
polysomnography. Incidence of END was not different between
groups according to CSR. MRS at one month and three months was
higher in CSR group than non‐CSR group. However, the association
between CSR and mRS disappeared after adjustment by risk factors,
severity and location of stroke using multivariate analysis, whereas
the association between obstructive sleep apnea and higher mRS/
END persisted after adjustment.
Conclusions: The presence of CSR in acute stroke was associated
with poor functional outcome. However, CSR was not an indepen-
dent factor predicting the outcome of stroke.
Disclosure: Nothing to disclose.
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P212 | Clinical utility and diagnostic
significance of hepcidin as a biomarker of
restless leg syndrome
H.-J. Im1; S.-H. Park2; D.W. Kim3
1Neurology, Hangang Sacred Heart Hospital, Hallym University Medical
Center, 2Neurology, Asan Medical Center, 3Neurology, Konkuk
University Medical Center, Seoul, Korea, Seoul, Republic of Korea
Objectives/Instruction: Restless legs syndrome (RLS) is a sensori-
motor disorder that often has a impact on sleep quality. However,
the etiology and pathophysiology is still unknown yet, albeit numer-
ous researches for the biological basis. Common consensus is its
association with iron supported as the following. Not only secondary
RLS is related under condition of lack of iron status, but also dopa-
mine agonist is still most effective agent for symptom relief even in
primary RLS. Serum ferritin levels, a marker of whole body iron used
to be a strong correlation with RLS, but low sensitivity is problematic
to diagnosis. Hepcidin is a regulatory hormone handling iron absorp-
tion, recycling, tissue storage. Deficit of hepcidin involves mishan-
dling iron metabolism and may lead to decreased availability of iron
even in brain. In the current case‐control study, we aim to investi-
gate clinical utility of hepcidin as a biomarker in RLS compared to
the healthy control.
Methods: We recruited 24 drug‐naïve patients who met criteria
for RLS using IRLSSSG and 16 healthy subjects since April 2017 ‐
November 2017. Using face‐to face interview, at the first visit, we
obtained sociodemographic characteristics, sleep profiles such as
habitual sleep duration, sleep quality, daytime sleepiness, and insom-
nia. We also obtained information about mood status and quality of
life questionnaire. Blood test and electrophysiologic test was per-
formed. Serum hapcidin was analyzed by ELISA kit at first visit in
both groups and 3month later during dopamine agnonist medication
in patients group. sleep factors, mood status and severity of symp-
tom was answered at 1 month, 3months later.
Results: RLS groups was older than the healthy group (49.4 ±15.3
vs 34.3 ± 4.9 years old) but proportion of gender was not different
between two group. Initial hepcidin level was comparable between
group (135.9pg/dL vs. 129.0pg/dL; p = 0.69) but hepcidin level was
significantly associated with disease severity by the negative direc-
tion. (beta=‐0.47, p = 0.03).
Conclusions: The pathophysiology of RLS is centered on dopamin-
ergic system dysfunction, altered iron hemostasis and decreased
CNS iron. However iron‐regulatory hormone. hepcidin can be useful
objective tracer for disease severity and effectiveness of pharmaco-
logic treatment even though not significant diagnostic marker.
Disclosure: Nothing to disclose.
P213 | Mild motor abnormalities in ‘idiopathic’
REM sleep behavior disorder: a diagnostic
window to early neurodegeneration
J. Nisser; S. Derlien; P. Bublak; M. Schwab; O. Witte;
U. Smolensky; T. Schultze; S. Rupprecht
Jena University Hospital, Jena, Germany
Objectives/Instruction: Mild motor abnormalities (MMA) can her-
ald the beginning of Parkinson′s disease (PD) but their diagnostic
value in identifing individuals at risk is limited by multifactorial age-
ing‐related influences on motor function.
Methods: By conducting a systematic assessment of motor func-
tion in 20 patients with ‘idiopathic’ REM sleep behavior disorder
(RBD) without parkinsonian motor signs and 20 healthy controls, we
characterized MMA in different motor domains, addressed further
determinants of motor function, and determined the diagnostic value
of new and established quantitative motor tests in prodromal PD‐
related disease.
Results: Patients with RBD showed MMA in perceptual motor
speed (falling stick test), trunk movement coordination (bend, twist
and touch test) and dynamic balance (straight line walk test) without
alterations in simple motor speed (alternate tap test), dexterity
(grooved pegboard), static balance (force plate) and gait (timed up
and go test). The fallings stick test showed the highest diagnostic
accuracy in identifying subjects with RBD [area under the receiver
operating characteristic curve (ROC‐AUC) 0.85, P≤0.001]. Multivari-
ate analysis revealed physical activity and age as additional determi-
nants of motor test performance.
Conclusions: RBD comprises a wide spectrum of MMA which can-
not be verified by established tests for motor speed, gait, and bal-
ance. The fallings stick test, a new screening test for perceptual
motor speed, provides high diagnostic potential to identify subjects
at neurodegenerative risk before parkinsonian motor signs become
apparent. Normative data for physical activity and age need to be
obtained to ensure correct interpretation of motor test results in
prodromal PD‐related disease.
Disclosure: Nothing to disclose.
P214 | Sleep disturbances, fatigue, anxiety and
depression in multiple sclerosis (MS): results of
the German SLEEP‐MS Survey
S. Rupprecht; S. Kluckow; O. Witte; M. Schwab; SLEEP-MS
Study Group
Jena University Hospital, Jena, Germany
Objectives/Instruction: Sleep disturbances, fatigue, anxiety and
depression are major determinants of quality of life in chronic dis-
ease. A systematic analysis of frequency and interrelated associa-
tions of these conditions in MS is lacking.
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Methods: German nationwide survey in 26 centerts o determine
prevalence of sleep disturbances, fatigue, anxiety and depression in
MS.
Results: Analysis included 2052 patients (616 males and 1436
females) with MS: RRMS>2y, n = 1279 (62%); RRMS< 2y, n=299
(15%); SPMS, n=356 (17%); PPMS, n=115 (5%). Prevalence of sleep
disturbances (Pittsburgh sleep quality questionnaire score ³5) in MS
in general was 73%, in RRMS< 2y 60%, RRMS>2y 54%, SPMS 54%
and PPMS 58%. Symptoms of fatigue (Modified Fatigue Impact Scale
Median‐Split³34) were reported by 45% of all MS patients. Anxiety
and depression (Hospital Anxiety and Depression Scale, HADS, anxi-
ety subscale³11, depression subscale³11) was present in 60% of all
MS patients. For comparison, in the German normal population,
prevalence of sleep disturbances is at 10%, anxiety at 7% and
depression at 18%. Only sleep disturbances (p= 0.08) and fatigue
(p=0.0001) but not age, gender duration, course and severity of MS
determined the mental quality of life (mental SF36 subscale) in the
multivariate analysis. Sleep quality was not influenced by different
kinds of MS‐medication.
Conclusions: Sleep disturbances, anxiety and depression are highly
prevalent in MS independent of disease stage and subtype. Since
impaired sleep quality and fatigue are the major determinants for
reduced quality of life special surveillance of these conditions and
psycho‐social care at early stages of disease is required.
Disclosure: The study was supported by Novartis.
P215 | Long sleep duration is associated with
cognitive decline in patients with multi domain
mild cognitive impairment
M. Basta1; P. Simos1; A. Vgontzas1; E. Koutentaki1;
S. Tziraki1; I. Zaganas2; S. Panagiotakis3; S. Kapetanaki2;
N. Fountoulakis3; C. Lionis4
1Psychiatry, 2Neurology, 3Medicine, University of Crete, School of
Medicine, VOUTES‐HERAKLION, 4Social and Family Medicine,
University of Crete, School of Medicine, Heraklion, Greece
Objectives/Instruction: The prevalence of Mild Cognitive Impair-
ment (MCI) increases among elderly and is associated with high risk
for dementia. Identifying factors that may contribute to the progress
of MCI to dementia is critical. The objective of this study was to
examine the association of objective sleep with cognitive perfor-
mance in MCI patients.
Methods: A subsample of 271 participants with a diagnosis of
probable Alzheimer's Disease (AD; N=50) or mild cognitive impair-
ment (MCI; N=121), and 100 cognitively intact persons (NI) were
recruited from a large population‐based cohort in the island of Crete,
Greece of 3140 older adults (> 60 years). All participants underwent
extensive neuropsychiatric/neuropsychological evaluation and a 3‐
day 24‐h actigraphy. Objective sleep variables and their association
with neuropsychological performance were examined across the 3
groups, controlling for demographics, BMI, depression, sleep apnea
symptoms, and psychotropic medications.
Results: AD patients had significantly longer night total sleep time
(TST) compared to MCI and NI groups. Long night and 24‐h TST was
associated with performance decrements in multiple neurocognitive
domains (sustained attention, visuoconstructive ability, executive
function, short‐term memory, verbal and visuospatial episodic mem-
ory) in the multi domain subtypes of MCI.
Conclusions: Elderly patients with MCI have similar objective sleep
duration with normal controls, while AD patients sleep longer. Addi-
tionally and interestingly, long sleep duration in patients with multi
domain subtypes of MCI is associated with decrements in episodic
memory and problem solving ability. It appears that long sleep dura-
tion may be an early biologic marker of accelerated cognitive decline
within these subtypes of MCI.
Disclosure: This study is supported by grant from the National
Strategic Reference Framework (ESPA) 2007‐2013, Program:
THALES, University of Crete, title:” A multi‐disciplinary network for
the study of Alzheimer's Disease” (Grant :MIS 377299). None of the
authors have any other conflict of interest to declare.
P216 | Sleep slow waves and spindles in the
acute stage of a moderate to severe traumatic
brain injury
S. Van der Maren1,2; C. Duclos2,3; C. Arbour2,4; H. Blais2;
H. El-Khatib1,2; E. Sanchez-Gonzalez2,5; F. Bernard2,6;
J. Carrier1,2; N. Gosselin1,2
1Psychology, University of Montreal, 2Centre d’Études Avancées en
Médecine du Sommeil (CÉAMS) Hôpital du Sacré‐Coeur de Montréal,
3School of Physical and Occupational Therapy, McGill University,
4Nursing Science, 5Neuroscience, 6Medecine, University of Montreal,
Montréal, QC, Canada
Objectives/Introduction: We have recently shown that sleep is
highly fragmented in hospitalized patients with acute moderate to
severe traumatic brain injury (TBI). However, whether these patients
have normal electroencephalographic oscillatory events during sleep
(i.e. sleep slow waves and spindles) is unknown. This study explores
whether sleep spindles and slow waves are altered in a group of
non‐sedated patients with acute moderate to severe TBI.
Methods: We tested 10 non‐sedated patients (age 25±12 yo, 6
males) hospitalized for a moderate to severe TBI. To control for the
environmental (e.g. noise, light, medical interventions) and traumatic
(e.g. pain, medication) factors, we compared them to a group of 8
patients (age 30±13 yo, 6 males) with orthopedic or spinal cord
injury (OSCI) who were hospitalized in the same environment. We
used an overnight ambulatory polysomnographic recording at the
bedside. Testing occurred 22±14 days post‐injury in TBI patients and
19±9 days post‐injury in patients with OSCI. After artefact rejection,
an automatic algorithm detected spindles and slow waves on C3
electrodes for N2 and N3 sleep, in the first three sleep cycles.
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T‐tests were used to compare groups for spindle and slow wave
characteristics (e.g. density, amplitude, slow wave slope, frequency,
slow wave duration).
Results: When inspected visually, no anomalies were found for
slow wave and spindle morphology in our sample. However, the TBI
group had a lower spindle density compared to OSCI patients for
the second sleep cycle (mean of TBI=2.35 ± 0.79 and mean of
OSCI=3.19 ± 0.69; t = 2.37; p = 0.031) and a similar trend was
found for the first sleep cycle (t = 1.74; p = 0.1). Also, the TBI group
had higher slow wave density in the third sleep cycle (mean of
TBI=7.62 ± 5.79 and mean of OSCI=2.77 ± 1.29; t = −2.31; p =
0.028). No group differences were found for other slow wave or
spindle characteristics.
Conclusions: This exploratory study suggests that subtle changes
in the sleep microarchitecture, and more specifically a decrease in
spindle density and an increase in slow wave density, could occur in
patients with acute moderate to severe TBI. Whether these differ-
ences are the reflect of the injury or the recovery process occurring
after a moderate to severe TBI will need to be further investigated.
Disclosure: Nothing to disclose.
P217 | Beyond actigraphy: towards a better
understanding of increased sleep duration
following traumatic brain injury
H. El-Khatib1,2; C. Arbour1,2; E. Sanchez-Gonzales1,2;
M. Dumont1,2; C. Duclos1,2; H. Blais1; J. Carrier1,2;
J. Paquet1; N. Gosselin1,2
1Center for Advanced Research in Sleep Medicine, Hôpital du Sacré‐
Coeur de Montréal, 2Université de Montréal, Montréal, QC, Canada
Objectives/Introduction: Sleep‐wake disturbances (SWD) are a
prevalent, disabling and persistent complaints following traumatic
brain injury (TBI). An excessive need for sleep and the inability to
maintain consolidated wakefulness during the daytime are an impor-
tant part of the reported SWD. However, due to heterogeneous and
complex clinical profiles of TBI survivors, the understanding of sleep
pattern changes remains a challenge that limits effective treatment.
The present study examined sleep‐wake patterns using actigraphy
and self‐reported questionnaires in adults with chronic TBI, focusing
on the influence of injuries severity, common comorbidities and
medication use.
Methods: Thirty‐four participants with moderate‐severe TBI (23M,
30.6±12.3yo) were compared to 34 controls (23M, 31.2±13.0yo) at
1‐3 years post‐injury. We used a 7‐day sleep diary and actigraphy to
document sleep‐wake patterns. Severity of overall injuries was evalu-
ated based on the Injury Severity Score. Subjective level of sleep
quality, sleepiness, fatigue, mood and pain were assessed with self‐
reported questionnaires. To test the influence of psychoactive medi-
cation on sleep‐wake pattern, group differences between medicated
TBI (n=13), non‐medicated TBI and controls were assessed.
Results: Overall, the TBI group reported poorer sleep quality, and
greater sleepiness, fatigue, anxiety, depression and pain than con-
trols. On actigraphy, the TBI group had earlier bedtime, more naps,
and slept an average of 0.5 ± 0.1 h more over the 24h period than
controls (p < 0.05). Sleep duration per 24h was more increased in
medicated TBI (8.0±0.8h) compared to non‐medicated TBI
(7.1 ± 0.8 h; p < 0.05) and controls (7.0 ± 0.8h; p < 0.01). The TBI
participants with longer sleep duration tended to report more fatigue
(r = 0.31; p = 0.06), but no association was found with comorbidities.
More severe injuries were associated with increased sleep duration
(r = 0.41;p < 0.05), sleepiness (r = 0.34; p < 0.05) and fatigue
(r = 0.44; p = 0.009). In TBI group, subjective fatigue was correlated
with anxiety (r = 0.41; p < 0.05) and depression (r = 0.47;
p = 0.005), while worse sleep quality was positively associated with
pain intensity (r = 0.67; p < 0.001).
Conclusions: Our results showed that adults with chronic TBI have
several complaints regarding their sleep and daytime functioning.
Increased sleep duration appears to be specific to a subgroup of TBI
patients who use psychoactive medication. Future studies should
aim at identifying patients at risk of persistent SWD in order to
develop efficient early interventions.
Disclosure: Nothing to disclose.
P218 | The sleep spindles in the middle
cerebral artery acute stroke
J. Isaac1; A.R. Peralta2; C. Bentes2
1Hospital José Joaquim Fernandes, Beja, 2Laboratório de EEG/Sono,
Departamento de Neurociências, Serviço de Neurologia, 3‐Unidade de
Acidentes Vasculares Cerebrais, Departamento de Neurociências, Serviço
de Neurologia, Hospital Santa Maria, Centro Hospitalar Lisboa Norte,
Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal
Objectives/Instruction: Sleep spindles are elements of sleep
microstructure characteristic of the N2 stage. These graphs depend
on the integrity of thalamocortical circuits. Studies evaluating sleep
spindles (SS) in hemispheric strokes are rare.
Objective: To identify the alterations in the frequency band of
sleep spindles in the acute phase of middle cerebral artery stroke
(MCA).
Methods: Successive sample of patients with MCA acute stroke,
NIHSS> 4 on admission, absence of benzodiazepines, EEG (system
10–10) ≥ 72h of stroke with ≥ 5 min sleep N2 and signed
informed consent. Variable studied: relative power of the slow (11‐
13Hz) and fast (13‐15Hz) spindles frequency bands in the two
cerebral hemispheres in frontal, fronto‐center and center‐parietal
leads (FFT of 10 samples of 30 seconds of phase N2 without arti-
facts or micro‐awakenings). We compared the two hemispheres
with T‐test for paired samples or Wilcoxon signed rank p > 0.05
(SPSS 20).
Results: 5 MCA acute stroke patients (2 left, 3 right), aged 69‐83
years. In the total sample, the relative power of the fast and slow
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spindle bands were significantly smaller in the injured hemisphere at
the three studied locations (slow spindles 0.0232 ± 0.01 - 0.0387 ±
0.019; fast spindles 0.0281 ± 002 - 0, 0358 ± 0.05) compared to the
uninjured (slow spindles 0.0369 ± 0.02 ‐ 0.0495 ± 0.02; fast spindles
0.0415 ± 0.02‐0.0544 ± 0.025) (p < 0.000).
Conclusions: The quantitative evaluation of N2 sleep EEG in the
MCA acute phase confirms a decrease in the frequency bands of fast
and slow spindles in the injured hemisphere. These frequency bands
are involved in the processing of declarative and motor memories
during sleep, so this data may be of prognostic importance. Future
developments of this work include the widening of the sample and
correlation of this change with the prognosis of patients with acute
stroke.
Disclosure: Nothing to disclose.
P219 | Alternations of sleep in patients with
severe disorders of consciousness
I. Nopper1,2; Y.G. Pavlov1,3; C. Barner1; F. Müller2;
S. Diekelmann1; B. Kotchoubey1
1University of Tübingen, Tübingen, 2Schön Klinik Bad Aibling, Bad
Aibling, Germany, 3Ural Federal University, Yekaterinburg, Russian
Federation
Objectives/Introduction: Patients with severe Disorder of Con-
sciousness (DOC) following brain injury show reflexive responses to
stimulation, eye movements and behavioural signs of sleep wake‐
cycles, with signs of purposeful or voluntary behaviour being weak
and inconsistent (Minimally Consciousness State (MCS)) or com-
pletely lacking (Unresponsive Wakefulness Syndrome (UWS)). The
challenges in differential diagnosis lead to a high number of misdiag-
nosis. By investigating the presence and distribution of sleep stages,
as an objective marker, the reliability of diagnostic evaluation might
be improved. Here we aimed at comparing sleep stage characteristics
between patients during a full 24h cycle.
Methods: We recorded 24‐h continuous polysomnographic record-
ings (PSG) in 32 DOC Patients (16 UWS, 16 MCS) and 10 fully con-
scious quadriplegic patients (Controls) in their usual hospital
environment. The recordings were sleep staged by three experienced
raters according to adapted Rechtschaffen & Kales (1968) criteria.
Comparisons between patient groups concerning sleep during day‐
time (8am‐8pm), night‐time (8pm‐8am), and the total recording per-
iod were calculated using univariate ANOVAs followed by post‐hoc
comparisons.
Results: Looking at overall sleep/wake states, patient groups differed
in their time spent awake during night‐time (F(2,39) = 6.50, p = .004),
with UWS patients spending more time awake (M = 538.85 min, SD =
162.89 min) than Controls (M = 346.70 min, SD = 92.50 min). How-
ever, over the total recording period no group differences in time
spent awake were found.
Looking at the distribution of single sleep stages, the time spent in
each sleep stage differed between the patient groups especially at
night‐time, revealing higher amounts of S1 sleep in MCS compared
to UWS patients (F(2,39)=3.93, p=.028), higher amounts of S2 sleep
in Controls compared to UWS patients (F(2,39)=4.09, p=.025) and
less REM sleep both in UWS and MCS patients compared to Con-
trols (F(2,39)=9.43, p< .001).
Over the total recording period, MCS patients (M=101.41min,
SD=67.23min) spent more time in S1 sleep compared to UWS
patients (M=51.97min, SD=42.50min; F(2,39)=3.36, p=.045) and
UWS patients (M=11.73min,SD=18.76min) spent less time in REM
sleep than Controls (M=55.95min, SD=28.67min); F(2,39)=7.41,
p=.002).
Conclusions: Differences between patients concerning sleep
stages and overall time spent awake/asleep occurred mainly at night‐
time. The findings demonstrate severe sleep disturbance in DOC and
support the necessity of long‐time PSG in patient evaluation.
Disclosure: Research was funded by the Deutsche Forschungsge-
meinschaft (DFG; Grant KO‐1735‐1).
P220 | Circadian distribution of behavioural
signs of sleep and wakefulness in patients with
disorders of consciousness
Y.G. Pavlov1,2; I. Nopper1,3; C. Barner1; F. Müller3;
S. Diekelmann1
1University of Tübingen, Tübingen, Germany, 2Ural Federal University,
Yekaterinburg, Russian Federation, 3Schön Klinik Bad Aibling, Bad
Aibling, Germany
Objectives/Introduction: The state of severe Disorder of Con-
sciousness (DOC) is distinguishable from coma by the appearance of
reflexive responses to stimulation, eye movements and behavioural
signs of sleep wake‐cycles (eyes open/closed). Signs of awareness
manifested in purposeful or voluntary behaviour are weak and incon-
sistent (Minimally Consciousness State (MCS)) or completely lacking
(Unresponsive Wakefulness Syndrome (UWS)). We aimed at assess-
ing circadian changes in the level of arousal on the behavioural and
electrophysiological level.
Methods: In the present study 42 patients (16 UWS, 16 MCS, 10
controls) were enrolled. A 24‐h EEG and video recording was per-
formed. Behavioural sleep was operationalized as the amount of
eyes closed and evaluated based on the video recordings (120 classi-
fications per hour). Comparisons between the amount of behavioural
sleep during day‐time (8 am ‐ 8 pm) and night‐time (8 pm ‐ 8am)
between groups were calculated by means of repeated measures
ANOVA followed by pairwise comparisons.
Results: The overall frequency of eyes‐closed and eyes‐open
epochs was close to 50/50% and was not significantly different
between groups (p > 0.99). However, the groups differed in the
presence of eyes‐closed epochs during the night‐time and day‐time,
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F (2, 39) = 4.24, p = .02. In the controls, eyes‐closed epochs were
more frequent during night‐time compared to day‐time (t (9) =
−3.11, p = 0.01), whereas in both groups of DOC patients, UWS (t
(15) = −1.30, p = 0.21) and MCS (t (15) = −1.55, p = 0.14), there
was no difference between night and day in the amount of beha-
vioural sleep.
Conclusions: These findings highlight differences between patients
with severe disorders of consciousness and conscious patients con-
cerning sleep‐wake cycle. As a next step in data processing, it is
planned to investigate changes in spectral power during day and
night as well as during periods of behavioural sleep and behavioural
wakefulness.
Disclosure: Research was funded by the Deutsche Forschungsge-
meinschaft DFG (project number: Grant KO‐1735‐1).
P222 | Prospective, home‐based assessment of
subjective sleep quality in Parkinson's disease
P.L. Ratti1; F. Faraci2; A. Mascheroni2; S. Hackethal3;
C. Ferlito1; S. Caverzasio1; E.K. Choe4; Y. Luo4; P.E. Nunes
Ferreira1; F. Mezzanotte1; A. Puiatti2; A. Kaelin-Lang1
1Neurocenter of Southern Switzerland, Regional Hospital of Lugano ‐
EOC, Lugano, 2Department of Innovative Technologies, University of
Science and Arts of Southern Switzerland SUPSI, Manno, 3Department
of Neurology, University Hospital Zürich, Zürich, Switzerland, 4College of
Information Studies iSchool, University of Maryland, College Park, MD,
United States
Objectives/Introduction: Insomnia is still an overlooked issue in
routine clinical management of patients with Parkinson's Disease (PD).
Prospective evaluation of insomnia symptoms by mean of sleep diaries
is a mainstay of insomnia assessment and management. In fact, retro-
spective information might be biased by subjects’ recall. This might be
essential in patients with PD, who might show subclinical cognitive
dysfunction. Our group has developed an app for tablets named Sleep
Fit. It allows ecological momentary assessment of sleep and motor
symptoms by mean of prospective, repeated sampling of patients’
symptoms, to minimize recall bias and maximize ecological validity.
We investigated the correspondence between subjective sleep quality
prospectively assessed by mean of Sleep Fit or retrospectively by
mean of a structured questionnaire, in PD patients.
Methods: Subjective sleep quality was assessed in 42 consecutive
patients (9 females, 67 ± 9.8 year‐old) with mild to moderate idio-
pathic PD prospectively, at home, on morning awakening for 2 weeks,
by mean of a Visual Analogue Scale assessing overall sleep quality of
the previous night (sq‐VAS) integrated into Sleep Fit. The Pittsburgh
Sleep Quality Index (PSQI) was then retrospectively administered at
day 14 at clinical consultation. The overall agreement between
prospectively and retrospectively collected information was calculated
for the PSQI total score and PSQI component 1 (“subjective sleep
quality”) as the normalized difference per patient. We also evaluated
this agreement for different temporal frames within the two weeks to
estimate potential recency effect of patients’ recall. The correlation
between agreement and demographics was also explored.
Results: Overall sleep quality estimated by the sq‐VAS scale
showed good agreement both with PSQI total score (20.9%) and
PSQI component 1 (22.9%). However, in single subjects this agree-
ment varied considerably, ranging from 0.5 to 52.4% for PSQI total
score and from 0.0 to 66.7% for PSQI component 1. No evidence of
recency effect was found.
Conclusions: Although the agreement between prospective and
retrospective assessments of subjective sleep quality was overall
good, a subgroup of PD patients seemed not to accurately report
their subjective sleep quality at retrospective evaluation. Sleep Fit
might be helpful to overcome this pitfall in clinical practice.
Disclosure: Nothing to disclose.
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P223 | Sleep disturbances associated with post
traumatic stress disorder: presentation and
polysomnographic features in a population of
patients admitted to a sleep laboratory
I. Valero-Sanchez; I. Smith
Respiratory Support and Sleep Centre, Royal Papworth Hospital,
Papworth Everard, United Kingdom
Objectives/Instruction: Post‐traumatic stress disorder (PTSD) is a
mental health condition that is triggered in some people by exposure
to a traumatic event. Sleep disturbance was identified as a core fea-
ture in recent research. In this study we assess sleep complaints and
objective sleep parameters in patients with PTSD admitted to a
sleep laboratory.
Methods: Retrospective study of patients with a diagnosis of PTSD
who were referred for full polysomnography (PSG) in a sleep service
as part of the investigation of a sleep disturbance. Demographic data,
presenting complaints, PSG parameters, subjective and objective levels
of sleepiness, sleep diary, medication and diagnoses were recorded.
Results: The studied sample included 30 patients, 46.7% female
53.3% male, mean age 45 years, (SD 15), mean BMI 28 (SD 4.7)
kg/m2.
13 patients presented with excess daytime sleepiness or fatigue, 11
with parasomnia, 5 with poor sleep and 1 patient with nightmare
disorder.
21 had a diagnosis of depression, 12 reported insomnia and 20
nightmares. 63.3% received antidepressants.
Mean total sleep time (TST) in sleep diary was 6.5 hr. Mean Epworth
score was 10 (SD 6.5).
PSG parameters expressed in mean, SD were: Sleep latency (SL)
26.3 (35.8) min, TST 390 (130) min, sleep efficiency (SE) for time in
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bed 77.6 (16.2)%, SE for sleep period of time 80.5 (16.7)%, stages 1
and 2: 48 (13.5)%, REM 17 (15.5)% slow wave sleep 13 (9.5)%,
apnoea hypopnea index 7.6 (9.2)/h, periodic limb movement (PLM)
index 19.5 (29.9)/h. Mean SL in multiple sleep latency test was 11.7
(4.6) min. Parasomnias were recorded in 7 cases.
After PSG, 8 patients were diagnosed with PLM disorder, 9 with
parasomnia, 6 with sleep apnoea, 3 with insomnia and 5 had no
sleep disorder identified. The presence of PLM during sleep did not
correlate with the usage of antidepressants.
Conclusions: Both sleep onset and sleep maintenance insomnia
were evidenced in objective and subjective tests. Nightmares were
frequent. Sleep apnoea was present in 50% (33.3% mild) and signifi-
cant PLM during sleep in 36.7%. Whether disturbed sleep is secondary
to, or a core feature of PTSD remains an area for further research.
Disclosure: Nothing to disclose.
P224 | The impact of sleep disturbances and
mental health outcomes on burnout in
firefighters and the mediating role of sleep
during overnight work: a cross‐sectional study
A.P. Wolkow1; L. Barger2,3; C. O'Brien2; J. Sullivan2;
S. Qadri2; S. Lockley1,2,3; C. Czeisler2,3; S. Rajaratnam1,2,3
1Monash Institute of Cognitive and Clinical Neuroscience, School of
Psychological Sciences, Monash University, Clayton, VIC, Australia,
2Division of Sleep and Circadian Disorders, Departments of Medicine
and Neurology, Brigham and Women's Hospital, 3Division of Sleep
Medicine, Harvard Medical School, Boston, MA, United States
Objectives/Introduction: Sleep and mental health disturbances
are prevalent among firefighters, but their association with burnout,
and the extent to which sleep attained during overnight work con-
tributes to these relationships is unknown. The current study investi-
gated whether firefighters’ sleep disorder risk and mental health
outcomes are associated with burnout, and explored the mediating
role of sleep at work in these relationships. A secondary aim was to
investigate associations between habitual sleep characteristics and
burnout.
Methods: Burnout levels were assessed in North American fire-
fighters (n = 6,307) using the Maslach Burnout Inventory (i.e., emo-
tional exhaustion, depersonalisation, personal accomplishment).
Firefighters also self‐reported mental health disorders (depression,
anxiety, post‐traumatic stress disorder; PTSD) and habitual sleep
characteristics (sleep duration, sleepiness, sleep deficit) and were
screened for common sleep disorders (insomnia, obstructive sleep
apnoea, shift work disorder, restless legs syndrome).
Results: Firefighters screening positive for a sleep disorder, particu-
larly insomnia, had an increased risk of emotional exhaustion (ad-
justed odds ratio 3.78, 95% CI 2.97–4.79, p < 0.0001),
depersonalisation (2.15, 1.71–2.71, p < 0.0001) and low personal
accomplishment (2.16, 1.75–2.66, p < 0.0001). Firefighters self‐
reporting a current diagnosis of PTSD, anxiety or depression were at
greater risk of emotional exhaustion (PTSD 4.88, 3.27–7.29; Anxiety
4.17, 3.11–5.60; Depression 3.61, 2.84–4.59; all p < 0.0001). Shorter
sleep during overnight work mediated the impact of having a sleep
disorder and mental health condition on high burnout (p < 0.0001).
Sleepiness and sleep deficit (difference between self‐reported
required and actual sleep), even in firefighters without sleep disorder
risk, were associated with emotional exhaustion (Sleepiness 2.32,
1.77–3.03; Sleep deficit 2.09, 1.59–2.74; both p < 0.0001), deper-
sonalisation (Sleepiness 1.65, 1.34–2.03, p < 0.0001; Sleep deficit
1.29, 1.06–1.57, p = 0.011) and low personal accomplishment
(Sleepiness 1.25, 1.07–1.47, p = 0.0006; Sleep deficit 1.17, 1.01–
1.35, p = 0.036).
Conclusions: Sleep disorders and mental health outcomes were
significantly associated with an increased risk of burnout in firefight-
ers, and these associations were mediated by short sleep during
overnight work. These results demonstrate how sleep and mental
health disturbances influence burnout in firefighters, and highlight
the need to examine the effectiveness of occupational interventions
that maximise sleep opportunities during overnight work to reduce
burnout risk in vulnerable personnel.
Disclosure: Alexander P. Wolkow, Laura K. Barger, Conor S. O′
Brien, Jason P. Sullivan, Salim Qadri, Steven W. Lockley, Charles A.
Czeisler and Shantha M.W. Rajaratnam report no conflicts of interest
directly related to the content reported in this abstract. Laura K. Bar-
ger reports research support from Cephalon, NFL charities, Sysco
and San Francisco Bar Pilots. Laura K. Barger has received consult-
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Ceridian, Davis Joint Unified School Board, San Jose State University
Foundation, Pugot Sound Pilots, Sygma and Torvec. Steven W. Lock-
ley holds a process patent for ‘Systems and methods for determining
and/or controlling sleep quality’, which is assigned to the Brigham
and Women′s Hospital per Hospital policy. Steven W. Lockley has
also served as a paid expert for legal proceedings related to light,
sleep and health. Steven W. Lockley is a Program Leader for the
CRC for Alertness, Safety and Productivity, Australia. Charles A.
Czeisler reports grants from Cephalon Inc., grants from Mary Ann &
Stanley Snider via Combined Jewish Philanthropies, grants from
National Football League Charities, grants from Optum, grants from
Philips Respironics, Inc., grants from ResMed Foundation, grants
from San Francisco Bar Pilots, grants from Schneider Inc., grants
from Sysco, grants from Cephalon, Inc, grants from Jazz Pharmaceu-
ticals, grants from Takeda Pharmaceuticals, grants from Teva Phar-
maceuticals Industries, Ltd, grants from Sanofi‐Aventis, Inc, grants
from Sepracor, Inc, grants from Wake Up Narcolepsy, personal fees
from Bose Corporation, personal fees from Boston Celtics, personal
fees from Boston Red Sox, personal fees from Columbia River Bar
Pilots, personal fees from Institute of Digital Media and Child Devel-
opment, personal fees from Klarman Family Foundation, personal
fees from Samsung Electronics, personal fees from Quest Diagnos-
tics, Inc, personal fees from Vanda Pharmaceuticals, personal fees
from American Academy of Sleep Medicine (AADSM), personal fees
from CurtCo Media Labs LLC, personal fees from Global Council on
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Wellness Foundation, personal fees from Harvard School of Public
Health (HSPH), personal fees from Maryland Sleep Society, personal
fees from National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK), personal fees from National Sleep Foundation
(NSF), personal fees from New England College of Optometry, per-
sonal fees from University of Michigan, personal fees from Univer-
sity of Washington, personal fees from Zurich Insurance Company,
Ltd, personal fees from Purdue Pharma, LP, personal fees from
McGraw Hill, personal fees from Houghton Mifflin Harcourt/Penguin,
personal fees from Koninklijke Philips Electronics, N.V., personal fees
from Cephalon, Inc, personal fees from State of Washington Board
of Pilotage Commissioners, personal fees from Ganesco Inc., holds
an equity interest in Vanda Pharmaceuticals, outside the submitted
work. In addition, Charles A. Czeisler holds a number of process
patents in the field of sleep/circadian rhythms (e.g., photic resetting
of the human circadian pacemaker). The research reported in this
abstract was supported by FEMA Assistance for Firefighters Grants
EMW‐2007‐FP‐02197 and EMW‐2008‐FP‐02566. The funders had
no role in the design, conduct or reporting of the study, or the deci-
sion to submit the abstract to this conference.
P225 | Sleep quality and its association with
dysfunctional beliefs and health outcome in a
sample of a Nigerian community
C. Seun-Fadipe1; K. Mosaku1; M. Komolafe2
1Department of Mental Health, 2Neurology Unit, Department of Internal
Medicine, Obafemi Awolowo University Teaching Hospital, Ile‐Ife,
Nigeria
Objectives/Instruction: Sleep‐related cognition has been consis-
tently reported to maintain insomnia, and this influence may be cul-
ture/context‐specific. This study aimed at evaluating sleep quality
and its association with dysfunctional beliefs and general health out-
come in a Nigerian community sample. It also assessed the correlates
of poor sleep quality among them.
Methods: It was a cross‐sectional study in which 267 respondents
were evaluated for sleep quality, dysfunctional beliefs/attitudes, day-
time sleepiness, sleep hygiene and general health outcome using the
Pittsburgh Sleep Quality Index (PSQI), 16‐ item Dysfunctional Beliefs
and Attitudes about Sleep (DBAS‐16) Scale, Epworth Sleepiness
Scale, Sleep Hygiene Index (SHI) and the 12‐ item Short‐Form Health
Survey (SF‐12) respectively.
Results: The mean age (SD) of the respondents was 46.2 (16.6)
years (Male = 41.6%). The prevalence of poor sleep quality was
41.2%. The gender (χ2 = 6.03, p = 0.01), relationship status
(χ2 = 11.434 p = 0.01) and type of relationship (χ2 = 8.64, p = 0.01)
had significant associations with sleep quality. The global PSQI score
had significant positive correlations with the respondents’ age
(r = 0.27, p < 0.01), number of children (r = 0.22, p < 0.01), ESS
score (0.34, p < 0.01), SHI score (r = 0.16, p < 0.01) and the DBAS
score (r = 0.46, p < 0.01) while it had significant negative correlation
with the SF‐12 score (r = −0.51, p < 0.01). Dysfunctional belief was
an independent predictor of poor sleep quality (p < 0.01).
Conclusions: This study showed that poor sleep quality had mod-
erately strong associations with dysfunctional beliefs/attitudes about
sleep and poor general health outcomes. It also suggests that explor-
ing critical beliefs about sleep may be an important step in formulat-
ing an effective sleep intervention programme in Nigeria.
Disclosure: Nothing to disclose.
P226 | Fear of sleep as perpetuating factor of
trauma‐related sleep disturbances
G. Werner
Clinical Psychology, LMU Munich, München, Germany
Objectives/Instruction: Research often shows clinically relevant,
residual sleep disturbances after trauma‐focused, sleep‐focused or
even combined treatments in patients with posttraumatic stress dis-
order (PTSD). Therefore, fear of sleep, has been suggested as addi-
tional perpetuating factor for trauma‐related sleep disturbances. Fear
of sleep is the fear of losing control or being particularly vulnerable
during sleep and seems to be specific for trauma‐related sleep dis-
turbances and not, for example, for people suffering only from
insomnia. However, studies investigating the role fear of sleep plays
for trauma‐related sleep disturbances and how it is linked to insom-
nia and nightmares are extremely scarce.
Methods: Therefore, a theoretical model on the links between sleep
disturbances, fear of sleep and PTSD will be presented together with
preliminary results from an online study (N = 759). In the current study,
we used self‐reported questionnaires and investigated fear of sleep in
relation to various aspects of trauma‐related sleep disturbances, using
correlational analyses as well as hierarchical cluster analyses.
Results: Besides high correlations between all measures in the
expected directions, the results indicated four clusters: (1) one
healthy group, (2) one group with only sleep disturbances such as
insomnia and nightmares, (3) one group with clinically relevant
PTSD‐symptoms as well as insomnia and nightmares, but low fear of
sleep and (4) one small, but very robust group, that is characterized
by clinically relevant PTSD‐symptoms, insomnia, nightmares and also
high levels of fear of sleep.
Conclusions: Altogether, the results emphasize the importance of
fear of sleep for trauma‐related sleep disturbances. However, it is
possible that fear of sleep specifically characterizes a subgroup of
people with PTSD, where it might be especially important to adapt
current treatment approaches to directly target fear of sleep and
associated aspects, such as the fear of loss of control related to fall-
ing asleep, in order to improve treatment outcomes.
Disclosure: Nothing to disclose.
194 of 433 | ABSTRACTS
P227 | Rapid eye movement sleep
abnormalities in female adolescents with
borderline personality
A. Saleh1; M. Nasredin1; M. Basheer2; E. Abd Al Raheem1;
M. Abd El Fatah1
1Psychiatry Department, 2Department of Clinical Neurophysiology,
Faculty of Medicine, Cairo University, Cairo, Egypt
Objectives/Instruction: Rapid Eye Movement (REM) Sleep is
hypothesized to play an important role in affective regulation and
processing of emotional stimuli. Core features of Borderline Personal-
ity (BP) include difficulties in emotional regulation and impulsivity that
usually present as early as the adolescence period. Previous studies
have shown that adult patients with BP have reduced REM latency,
increased REM percentage and density when compared to controls.
The study aimed at detection of sleep abnormalities particularly in
REM stage (Total REM duration, REM latency, REM density, and
REM distribution) in adolescent females suffering from BP.
Methods: The study was a case control study conducted in a uni-
versity psychiatry hospital. A convenient sample of 30 adolescent
females with BP were compared to 30 age matched healthy females.
The patients were diagnosed according to the Diagnostic and Statis-
tical Manual of Mental Disorders, Text Revised (DSM‐IV TR) criteria
for borderline personality disorder with the exception of the age cri-
terion, using the Structured Clinical Interview according to DSM‐IV
(SCID‐I & II). Pittsburgh Sleep Quality Index (PSQI) and an overnight
sleep lab polysomnographic study were applied to both groups.
Borderline Personality Questionnaire (BPQ) was used to measure the
severity of borderline personality.
Results: Patients with BP were subjectively dissatisfied with the qual-
ity of their sleep when compared to controls (p < 0.001). Abnormalities
in REM sleep in these patients when compared to controls were, higher
REM percent (18.96 ± 6.83 vs. 12.79 ± 4.97%, p < 0.001), shorter REM
latency (85.68 ± 30.42 min vs. 212.55 ± 60.70, p < 0.001), higher REM
density (7.67 ± 4.16 and 4.23 ± 2.90, p < 0.001) and higher number of
REM periods in the first half of the night (2.03 ± 0.89 vs. 0.43 ± 0.57,
p = 0.000). These changes in REM sleep were not associated with the
severity of the personality disorder.
Conclusions: Adolescent females with BP suffer from REM sleep
abnormalities suggested to be a trait marker for BP.
Disclosure: Nothing to disclose.
P229 | An experience sampling study
examining the link between sleep and paranoia
in patients with non‐affective psychosis
A. Rehman1; A. Gumley2; S. Biello1; A. Lee1
1Psychology, 2University of Glasgow, Glasgow, United Kingdom
Objectives/Introduction: Growing evidence suggests a relation-
ship between sleep disturbance and paranoid thinking, in both clini-
cal and non‐clinical populations. Research also suggests that this
relationship is mediated by levels of negative affect. The aims of this
study was to (1) examine whether sleep disturbance also predicts
the dimensions of paranoia, including distress, pre‐occupation and
conviction, (2) to test whether there is a time‐lagged, temporal rela-
tionship between sleep and paranoia, and whether this is mediated
by negative affect and (3) to use novel experience sampling methods
to test these relationships in people with non‐affective psychosis.
Methods: Momentary assessments of sleep, mood, and paranoia
were measured 8 times a day, for 8 days, at semi‐random intervals.
Multi‐level modelling was then used to assess relationships between
the variables.
Results: A sample of 20 patients were recruited. There was no
relationship between subjective sleep as measured by a sleep diary
and paranoia or its dimensions (all p => 0.05). There was no time‐
lagged, temporal relationship between sleep and paranoia (p = 0.67)
A sub‐set of individuals in the sample was identified who did not
report any variation or fluctuations in their measurements.
Conclusions: Sleep disturbances were common in people with
non‐affective psychosis; however there was no clear link between
sleep, and paranoia. Our findings support the treatment of sleep
problems in this sample, but not in relation to paranoia.
Disclosure: Nothing to disclose.
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P230 | Treating insomnia and depression: using
network analysis to explore working mechanisms
T.F. Blanken1,2; T. van der Zweerde3,4; A. van Straten3,4;
E.J.W. van Someren2,5; D. Borsboom1; J. Lancee6
1Psychological Methods, University of Amsterdam, 2Netherlands
Institute for Neuroscience, 3Clinical Psychology, 4EMGO Institute for
Health and Care Research, VU University Amsterdam, 5Departments of
Integrative Neurophysiology and Psychiatry, Centre for Neurogenomics
and Cognitive Research, VU University Medical Center, 6Clinical
Psychology, University of Amsterdam, Amsterdam, The Netherlands
Objectives/Introduction: Insomnia and depression often co‐occur.
Research shows that Cognitive Behavioral Therapy for Insomnia
(CBT‐I) not only improves insomnia complaints, but also depressive
symptoms. It remains unclear, however, whether the effect of CBT‐I
on depression occurs via improvements in insomnia, or whether
CBT‐I affects depression symptoms directly.
Methods: We performed a randomized controlled trial in patients
with insomnia (i.e. self‐reported fulfilling of DSM‐5 criteria) and (sub-
clinical) depression (Patient Health Questionnaire‐9 > 4). Participants
received guided web‐based CBT‐I or no treatment. We measured
insomnia (Insomnia Severity Index) and depression (Patient Health
Questionnaire) weekly for 10 weeks. We used network analyses,
including treatment allocation as a binary variable, to investigate
specific effects of CBT‐I on symptoms of insomnia and depression.
We evaluated effects of treatment (1) on its conditional dependence
relations between treatment and symptoms; (2) on individual symp-
tom severity; (3) on predictability of symptoms in the network (i.e.
proportions of variance explained by all other nodes in the net-
work).
Results: Network analysis suggests that in this sample (N = 104),
(1) CBT-I predominantly affects insomnia symptoms, particularly
difficulty maintaining sleep and early morning awakenings.
While depressive symptoms also decline, this seems to occur
via their relations to insomnia symptoms (specifically: sleep
complaints) rather than via direct associations to treatment;
(2) insomnia severity symptoms declined most, and
(3) predictability increases over time as a result of treatment,
especially in the insomnia symptoms: from on average 29%
at baseline to 62% at post-measurement.
Conclusions: This study has introduced the opportunity of using
network analysis to explore how CBT‐I improves depression and
suggests that CBT‐I effects insomnia symptoms first and depressive
symptoms via insomnia improvements, illustrated by direct condi-
tional dependencies between treatment and symptoms mostly with
insomnia symptoms. Adopting a network approach provides an
opportunity for the field to explore how treatments affect separate
symptoms of psychological disorders, in existing (trial) datasets and
future studies. More clinical research is needed in different and lar-
ger samples, and in samples with a clinical diagnosis of depression to
strengthen the current findings.
Disclosure: Nothing to disclose.
P232 | Sleep problems and daytime sleepiness
in adolescents with and without attention‐
deficit/hyperactivity disorder
S. Becker1,2; J. Langberg3
1Center for ADHD, Cincinnati Children's Hospital Medical Center,
2Department of Pediatrics, University of Cincinnati College of Medicine,
Cincinnati, OH, 3Department of Psychology, Virginia Commonwealth
University, Richmond, VA, United States
Objectives/Instruction: Most studies examining sleep and atten-
tion‐deficit/hyperactivity disorder (ADHD) have focused on school‐
aged children, with far fewer studies investigating sleep in adoles-
cents with ADHD. The objective of the present study was to exam-
ine whether adolescents with ADHD differ from adolescents without
ADHD in their sleep and daytime sleepiness as measured with par-
ent and adolescent ratings and actigraphy.
Methods: Participants were 302 young adolescents (ages 12–
14 years; 55.3% male; 81.8% White), with approximately half
(53.6%) diagnosed with ADHD based on a structured diagnostic
interview with the adolescent's parent. Adolescents completed the
Sleep Habits Survey (SHS) and Pediatric Daytime Sleepiness Scale
(PDSS). Parents completed the Sleep Disturbance Scale for Children
(SDSC) and a parent‐report version of the PDSS. Participants wore
actigraphs for approximately two weeks.
Results: Independent samples t-tests indicated that adolescents with
ADHD do not differ on their self‐reported weekday bedtime/wake
time or sleep duration (ps > 0.05) though adolescents with ADHD
reported a significantly later bedtime than adolescents without ADHD
on weekends (p = 0.03, d = 0.25). Adolescents with ADHD also
reported more sleep/wake problems than adolescents without ADHD
(p = 0.001, d = 0.43), and marginally greater eveningness circadian
preference (p = 0.07, d = 0.21). Parents also reported that adolescents
with ADHD have more total sleep disturbances than adolescents with-
out ADHD (p = 0.001, d = 0.76), with significant group differences
found for all SDSC subscales except sleep‐disordered breathing. Ado-
lescents with ADHD experience more daytime sleepiness than adoles-
cents without ADHD per both self (p = 0.002, d = 0.36) and parent
(p < 0.001, d = 0.71) report. All significant effects remained when
controlling for participant demographics, pubertal development,
comorbid psychiatric diagnoses, and ADHD/sleep medication use.
Actigraphy data are currently being processed and scored and will be
presented alongside the subjective data at the conference.
Conclusions: Adolescents with ADHD have more subjective sleep
problems and daytime sleepiness than their peers across both self
and parent ratings. However, adolescents with ADHD do not gener-
ally report shorter sleep duration or overall differences in bedtimes/
wake times than adolescents without ADHD. It will be important for
future research to identify whether predictors and consequences of
sleep problems differ for adolescents with and without ADHD.
Disclosure: Nothing to disclose.
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P233 | The impact of cytokines on sleep and
emotional risk improvement in adolescents with
an eveningness chronotype
M. Dolsen; A. Harvey
Department of Psychology, University of California, Berkeley, Berkeley,
CA, United States
Objectives/Instruction: Substantial sleep and wake changes occur
during adolescence, which are linked to worse mental health out-
comes. The immune system has emerged as a potential contributor to
the developmental changes that occur during the adolescent years.
This study examined if cytokines moderate the effects of a psychologi-
cal intervention targeting sleep, circadian dysfunction, and health.
Methods: Adolescents with an eveningness chronotype were ran-
domized to either the Transdiagnostic Sleep and Circadian Interven-
tion for Youth (TranS‐C; n = 83) or Psychoeducation (PE; n = 81).
Weekday total sleep time (TST), weekday bedtime, and the discrep-
ancy between weekday and weekend TST, bedtime, and waketime
were assessed via sleep diary. The circadian measure was the Chil-
dren's Morningness‐Eveningness Preferences scale. Emotional, cogni-
tive, behavioral, social, and physical health composite risk scores were
derived from self‐report measures. Oral mucosal transudate samples
were assayed for interleukin (IL)‐6 and tumor necrosis factor (TNF)‐α.
Results: From pre‐treatment to post‐treatment, adolescents with
higher TNF‐α exhibited reduced weeknight and weekend waketime
discrepancy compared to adolescents with lower TNF‐α controlling
for treatment condition (z = −1.99, p = 0.047). From pre‐treatment
to post‐treatment among participants with higher IL‐6, an earlier
bedtime was associated with reduced emotional risk controlling for
treatment condition (z = 2.23, p = 0.026). Similarly, an earlier bed-
time was marginally associated with reduced emotional risk during
treatment for participants with higher TNF‐α (z = 1.77, p = 0.077).
Conclusions: In this sample of adolescents with an eveningness
chronotype, higher TNF‐α was associated with less weekday to week-
end waketime variability. Furthermore, bedtime improvement was
associated with reduced emotional risk during treatment for partici-
pants with higher but not lower levels of cytokines. Although cytoki-
nes have been implicated in the pathogenesis of inflammatory
conditions and major depressive disorder, cytokines may also facilitate
neural development by promoting neuron survival and synaptic con-
nectivity. Future studies should further evaluate if cytokine levels
influence psychological treatment response among adolescents.
Disclosure: Nothing to disclose.
P234 | Transdiagnostic sleep and circadian
intervention for youth with eveningness: do
pubertal hormones have a moderating effect?
M. Dolsen; A. Harvey
Department of Psychology, University of California, Berkeley, Berkeley,
CA, United States
Objectives/Instruction: Puberty is a biological event characterized
by significant sleep, circadian, and psychological changes that can lead
to positive as well as negative developmental outcomes. This study
examined if pubertal hormones moderate the effects of a psychologi-
cal intervention targeting sleep, circadian dysfunction, and health.
Methods: Adolescents with an eveningness chronotype were ran-
domized to either the Transdiagnostic Sleep and Circadian Interven-
tion for Youth (TranS‐C; n = 80, 49 female) or Psychoeducation (PE;
n = 82, 46 female). Weekday total sleep time and bedtime were
assessed via sleep diary. The circadian outcome was the Children's
Morningness‐Eveningness Preferences scale (CMEP). Emotional, cog-
nitive, behavioral, social, and physical health composite risk scores
were derived from self‐report measures. Saliva samples were pro-
vided to assess testosterone, DHEA, and estradiol (females only).
Results: From pre‐treatment to post‐treatment, female adolescents
in TranS‐C with higher estradiol exhibited greater CMEP improvement
compared to participants with lower estradiol (z = 2.53, p = 0.011) or
participants in PE with higher estradiol (z = 3.64, p < 0.001). Male
adolescents in TranS‐C with higher DHEA exhibited reduced emo-
tional risk from pre‐treatment to post‐treatment compared to partici-
pants with lower DHEA (z = 2.19, p = 0.028) or participants in PE with
higher DHEA (z = −2.29, p = 0.022). Although DHEA did not moder-
ate the effect of TranS‐C on social risk, male adolescents in PE with
higher DHEA exhibited increased social risk during treatment com-
pared to participants with lower DHEA (z = −2.04, p = 0.042).
Conclusions: This study provides evidence that some benefits of
TranS‐C are greatest among female adolescents with higher levels of
estradiol. Higher levels of DHEA in males differentially moderated
the effect of TranS‐C and PE on health outcomes. Previous research
indicates that DHEA attenuates cortisol resulting in more externaliz-
ing problems but less internalizing problems, which may explain the
differential findings for males with higher DHEA.
Disclosure: Nothing to disclose.
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P235 | Proton magnetic resonance
spectroscopy of brain in obstructive sleep apnea
in Egyptian subjects
H. Gharraf
Chest Diseases and Sleep Medicine, Faculty of Medicine, Alexandria
Univrsity, Alexandria, Egypt
Objectives/Instruction: The overall objective of this work is to
study the cerebral metabolic changes in patients with OSA and to
determine the usefulness of MRS as an objective method for evalua-
tion of CNS impairment in these patients.
Methods: This study included two groups; group1 fifteen (15)
patients diagnosed with obstructive sleep apnea hypopnea syndrome,
and group 2 ten (10) healthy volunteers of comparable age. Magnetic
resonance spectra were obtained from frontal periventricular white
matter. For all subjects, height, body weight, and BMI were assessed.
Waist and hip circumference were measured and waist/hip ratio (W/H
ratio) was calculated. Overnight polysomnography (PSG) to identify
sleep apnea was done. Daytime sleepiness was evaluated by the
Epworth Sleepiness Scale. Symptoms of anxiety and depression were
measured with the Hospital Anxiety and Depression Scale (HADS).
Results: N‐acetylaspartate‐to‐creatine (NAA/Cr) and choline‐to‐
creatine (Cho/Cr) ratios were significantly lower in the frontal white
matter of obstructive sleep apnoea patients when compared to con-
trols. Absolute concentrations of N‐acetylaspartate (NAA) and cho-
line (Cho) were also significantly reduced in the frontal white matter
of patients with sleep apnoea. Statistically significantly negative cor-
relations existed between AHI and metabolites concentrations and
ratios in patients with OSAHS. Significant positive correlations
existed in patients with OSAHS between Hospital and depression
scale for depression (HAD‐D) and AHI (r = 0.764, p = 0.001), ODI
(r = 0.571, p = 0.026), and ESS (r = 0.644, p = 0.010) respectively.
Significant positive correlations existed in patients with OSAHS
between Hospital and depression scale for anxiety (HAD‐A) and AHI
(r = 0.753, p = 0.001), and ESS (r = 0.537, p = 0.039) respectively.
Multivariate Linear regression model of factors predictive showed
AHI as the main predictor factor for choline to creatine ratio in
patients with OSAHS with t = 5.180, at p < 0.001.
Conclusions: OSA patients show abnormal brain metabolites
related to neuronal damage due tointermittent chronic hypoxemia.
Anxious and depressive symptoms are highly prevalent in patients-
with severe untreated OSAS. The severity of depressive and anxious
symptoms may be related toexcessive daytime sleepiness and to
nocturnal hypoxemia both of which are strongly correlatedto brain
metabolites. AHI seems to be the main predictor factor for choline
to creatine ratio in patients with OSAHS.
Disclosure: Nothing to disclose.
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P236 | Sleep deprivation triggers shared
temporal dynamics of time and mood perception
in bipolar depression
T. Yoshiike1,2,3; S. Dallaspezia4; K. Kuriyama2,3; N. Yamada2;
C. Colombo1; F. Benedetti1
1Psychiatry and Clinical Psychobiology, Ospedale San Raffaele, University
Vita‐Salute San Raffaele, Milano, Italy, 2Department of Psychiatry, Shiga
University of Medical Science, Otsu, 3Department of Adult Mental
Health, National Institute of Mental Health, National Center of
Neurology and Psychiatry, Kodaira, Japan, 4Psychiatry and Clinical
Psychobiology, Ospedale San Raffaele, Milano, Italy
Objectives/Introduction: Time perception, which is mediated by
circadian and interval clocks, is essential for goal‐directed behaviors.
Despite the clock abnormalities implicated in bipolar disorder (BD), it
remains to be seen whether antidepressant treatments affect the
sense of time.
Methods: We studied the diurnal fluctuation of short‐term time
perception, as a possible marker of antidepressant response to
repeated sleep deprivation (SD), combined with light therapy, in 14
consecutively admitted depressed in patients with BD. Patients pro-
duced 10 s without clock signal, and rated their mood and alertness
using visual analogue scale every 4 hr, and activity changes were
measured during treatment.
Results: Over the first SD, produced time (PT) was shortened
(p = 0.020), while mood (p = 0.00011) and alertness (p = 0.048)
increased. Throughout the treatment, temporal changes in PT
showed a concurrent negative cross‐correlation with those in mood
(r = −0.72, p < 0.05), while no cross‐correlation was found between
PT and alertness, indicating that inner time accelerates simultane-
ously with mood improvement. In addition, temporal changes in PT
negatively predicted those in activity (r = −0.66, p < 0.05), indicating
that inner time acceleration precede an activity increase. Strong
opposite daily changes were observed for mood (positive change)
and PT (negative) at baseline, while after treatment both measures
showed a weak negative diurnal variation, as reported in healthy
humans (p = 0.0081). Nonetheless, depressive cognitive distortions
positively correlated with PT after treatment (r = 0.62, p = 0.033).
Conclusions: The results indicate close phenotypic properties of
time and mood perception dynamics, shedding new light on the role
of interval timing clock in antidepressant response in BD. Our find-
ings support the view that SD may restore the homeostatic drive,
while attenuating the prominent circadian representation of mood
which was seen before treatment.
Disclosure: Nothing to disclose.
P237 | Athens Insomnia Scale detects
depression with moderate accuracy in three
Japanese settings
H. Kadotani1,2; M. Takami1; Y. Sumi3; K. Nishikawa4;
M. Uetsu2; M. Matsuo3
1Department of Sleep and Behavioral Sciences, Shiga University of
Medical Science, Otsu, 2Sleep Out‐Patient Unit, Nagahama City Hospital,
Nagahama, 3Department of Psychiatry, Shiga University of Medical
Science, Otsu, 4Shiga CBT Center, Hikone, Japan
Objectives/Instruction: Patients with depression frequently com-
plain of insomnia. Here, we compared the performance of Athens
Insomnia Scale (AIS) in detecting depression in three Japanese set-
tings.
Methods: Subjects were from two clinical settings (first visits:
2015/4/1–2017/9/30) and one working population (analyzed in 2016)
from Shiga prefecture, Japan. The two clinical settings were attached
to the Department of Psychiatry of a university hospital (U)
(n = 392) and the Department of Otolaryngology of a city hospital
(C) (n = 325), respectively. We also analyzed city government
employees (W) (n = 1,852). We used AIS and Patient Health Ques-
tionnaire (PHQ‐9) to detect insomnia and depression, respectively.
Receiver operating characteristic (ROC) curve analysis was per-
formed to compare diagnostic performances of AIS in detecting
depression (PHQ‐9 ≥ 10) in these settings. The study was approved
by the Institutional Review Board.
Results: Areas under the ROC curve (AUC) for detecting depres-
sion using AIS were 0.81 (95% confidence interval [CI]: 0.77–0.85,
p < 0.0001), 0.88 (95% CI: 0.84–0.91, p < 0.0001), and 0.88 (95%
CI: 0.86–0.89, p < 0.0001) in U, C, and W settings, respectively.
Conclusions: The AIS detected depression with moderate accuracy
in the three settings. The AUCs were similar for both clinical and
working populations. Therefore, AIS may detect depression indepen-
dent of the settings.
Disclosure: MEXT/JSPS KAKENHI Grant Number: 17H00872;
MEXT Program for Building Regional Innovation Ecosystems. HK′s
laboratory is supported by a donation from Fukuda Lifetech Co.,
Ltd.; Fukuda Life Tech Keiji Co., Ltd.; Tanaka Sleep Clinic; Akita
Sleep Clinic; and Ai Ai Care Co., Ltd. to Shiga University of Medical
Science.
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P238 | Does sleep moderate the relationship
between work‐life balance and depression
differentially in men and women? Findings from
the North West Adelaide Health Study
L.J. Bunjo1; A.C. Reynolds2; S.L. Appleton3,4; T. Gill5;
S.A. Ferguson2; R.J. Adams3
1University of Adelaide, 2The Appleton Institute, CQUniversity Australia,
3The Health Observatory, University of Adelaide, 4Freemason's Centre
for Men's Health, University of Adelaide, 5Population Research and
Outcome Studies, University of Adelaide, Adelaide, SA, Australia
Objectives/Introduction: Work‐life balance is important for work-
ers’ mental health. Sleep also affects mental health, but its moderat-
ing effect on the relationship between work‐life balance and
depression has received little attention. Gender differences in this
relationship are rarely considered, limiting the specificity of manage-
ment advice. Our aim was to explore the relationship between work‐
life balance, job strain and job security, and depression in a sample
of Australian adults, and determine whether sleep duration moder-
ates this relationship differentially between genders.
Methods: Data were collected on self‐reported work characteris-
tics and sleep duration in 1,024 male and 618 female working adults
aged ≥18 years participating in the ongoing North West Adelaide
Health Study, a population‐based community‐dwelling cohort. Condi-
tional PROCESS models determined the moderating effect of sleep
duration on the relationship between work‐life balance (Australian
Work and Life Index) and depression scores (CES‐D), adjusted for
age and income, with the Johnson‐Neyman technique employed to
determine the point at which sleep duration significantly moderated
this relationship. Significance of p < 0.01 was selected due to multi-
ple comparisons.
Results: Reduced overall work‐life balance was positively associ-
ated with higher depression scores in females (B (CI): 17.1 (5.29,
29.0), p = 0.005) but not males (1.4 (−12.2, 9.4), p = 0.799). This
relationship for females was largely explained by overall work‐life
balance dissatisfaction (23.55 (10.23, 36.9), p = 0.001), which was
moderated by sleep duration (−3.0 (−4.9, −1.1) < 7.1 hr). In men,
the perception of work interfering with responsibilities outside work
was associated with depression (25.3 (11.1, 39.5) p = 0.001), moder-
ated by sleep duration (−3.0 (−5.0, −0.9) < 7.6 hr). Men perceived
work interfered with the ability to maintain connections and friend-
ships (25.0 (10.2, 39.8)), moderated by sleep duration (−2.8 (−5.0,
−0.7) < 7.8 hr); but sleep duration did not moderate overall work‐life
balance dissatisfaction.
Conclusions: The relationship between work‐life balance and
depression is expressed differentially in men and women with sleep
duration moderating some aspects of the relationship. This suggests
that while a global score of work‐life balance may be useful for iden-
tifying risk of depressive symptoms in females, it may not in males.
The benefits of sleep interventions may depend on which aspects of
work‐life balance are perceived to be affected by the worker.
Disclosure: Nothing to disclose.
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P239 | Sleep loss and circadian phase
modulate cortical connectivity but not neuronal
complexity in young and older individuals
G. Gaggioni; J. Ly; V. Muto; M. Jaspar; C. Meyer;
S. Chellappa; C. Schmidt; C. Phillips; G. Vandewalle
GIGA‐Institute, Cyclotron Research Center/In Vivo Imaging, University of
Liège, Liège, Belgium
Objectives/Introduction: How the ageing brain reacts to the fine‐
tuned regulation of sleep homeostasis and circadian processes
remains to be fully explored. It is unknown if cortical connectivity
and neuronal response complexity change with age, sleep loss and
across the circadian cycle. We addressed these issues by recording
neuronal response to a transcranial magnetic stimulation (TMS) dur-
ing 34‐hr of wakefulness extension in young and older individuals.
Methods: 13 healthy young (~23 years) and 13 elderly participants
(~63 years) followed a 34‐hr sleep deprivation protocol under con-
stant routine conditions. They underwent 9 EEG recordings of TMS‐
evoked potentials over the frontal cortex. After EEG pre‐processing
and source reconstruction, we determined spatio‐temporal distribu-
tion of significant sources. Cortical connectivity was inferred from
the geodesic sum of the causal interactions between the stimulated
area and the rest of the cortex. Neuronal response complexity was
derived by applying the Lempel‐Ziv compression algorithm on the
binary matrix of significant sources and then normalized.
Results: Increasing fatigue with time awake (p < 0.0001), and older
individuals feeling less sleepy than younger ones (p = 0.03) confirm
the effect of the sleep deprivation protocol. Mixed effects analyses
revealed a significant change in cortical connectivity with time spent
awake (p = 0.03): following an increase during daytime, a reduction
was perceivable from the beginning to the end of the biological night
(i.e. circadian phases 0°–165°). A weak tendency for a group effect
was detectable (p = 0.09). Analysis of the neuronal complexity
reveals a non‐linear profile, but neither an effect of time spent
awake (p = 0.25) nor group difference (p = 0.28).
Conclusions: These preliminary results confirmed our previous
finding that cortical connectivity decreases during the biological
night. A weak trait‐like effect might be visible with elderly having
dampened cortical connectivity than young. No effect of ageing and
time spent awake was found for the neuronal complexity.
Disclosure: Nothing to disclose.
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P240 | Sleep and circadian timing are
associated with subjective and objective memory
in older adults with subjective memory
impairment ‐ evidence for early targeted
interventions
J.E. Manousakis1; A.J. Scovelle1; S.L. Naismith2;
S.M.W. Rajaratnam1; C. Anderson1
1Monash Institute of Cognitive & Clinical Neurosciences, Monash
University, Melbourne, VIC, 2Charles Perkins Centre, School of
Psychology and the Brain & Mind Centre, University of Sydney, Sydney,
NSW, Australia
Objectives/Introduction: Poor sleep and disrupted circadian
rhythms are associated with poorer cognitive outcomes in older
adults, with and without dementia, suggesting sleep/circadian timing
may be modifiable risk factors for preserving cognitive function in
later life. Given neurobiological changes precede cognitive dysfunc-
tion by several years, early intervention is essential. While subjective
memory impairment (SMI) may be a prodromal stage of dementia, lit-
tle is known about the association between sleep and circadian tim-
ing and cognitive outcomes in this at risk group.
Methods: Twenty‐four older adults with SMI (Mage = 69.97, SD =
5.33) completed the Memory Functioning Questionnaire, underwent
a comprehensive neuropsychological assessment, and laboratory
based assessment of circadian phase (dim light melatonin onset) and
sleep (polysomnography).
Results: Advanced circadian timing was associated with increased
subjective memory complaints, specifically the ability to recall past
events throughout the lifespan (r = 0.69, p = 0.002), and increased
reliance on mnemonic tools in everyday life (r = 0.66, p = 0.004).
While circadian timing was not related to objective memory perfor-
mance on the California Verbal Learning test, minutes spent in slow
wave sleep was related to both total learning (r = 0.53, p = 0.009),
and the ability to use semantic clustering as a mnemonic device
(r = 0.54, p = 0.008).
Conclusions: Our data describe the first evidence for targeting the
sleep and circadian system for improved cognitive outcomes in older
adults reporting SMI, such that use of mnemonic strategies in SMI
was associated to both circadian timing and duration of slow wave
sleep. As strategy use decreases in MCI, interventions aimed at
improving sleep and circadian timing may be pivotal in delaying
objective memory deficits in this group.
Disclosure: Research was funded by the Mason Foundation, ANZ
Trustees. Authors report no conflicts of interest.
P242 | Postural stability upon being awakened
in the middle of the night and in the morning:
comparison of lemborexant versus zolpidem
extended release
P. Murphy1; D. Kumar1; G. Zammit2; R. Rosenberg3;
M. Moline1
1Eisai Inc., Woodcliff Lake, NJ, 2Clinilabs Drug Development Corporation,
New York, NY, 3Neurotrials Research Atlanta, Atlanta, GA, United States
Objectives/Introduction: Sleep‐promoting drugs should facilitate
sleep without interfering with postural stability upon awakening. We
present results of a study of the dual orexin receptor antagonist lem-
borexant (LEM) on a measure of postural stability.
Methods: Double‐blind, randomized, single‐dose, 4‐way crossover.
Eligible, healthy females (≥55 years) and males (≥ 65 years) had 8 hr
polysomnogram at baseline and at each single‐dose treatment at
bedtime with placebo (PBO), LEM 5 mg (LEM5), LEM 10 mg
(LEM10), or zolpidem tartrate extended release 6.25 mg (ZOL). If not
already awake, subjects were awakened, preferentially from stage
non‐REM 2, between 4–4.5 hrs post‐bedtime/post‐dose (middle of
the night; MOTN). At bedside, body sway was measured in units of
1/3° angle of arc using an ataxiameter device for 60 s. Increases
from baseline ≥7 were prespecified as clinically meaningful, bench-
marked to effects of alcohol at 0.5 g/kg. At 8 hr postdose, body
sway was reassessed.
Results: 120 subjects screened, 63 randomized, 56 completed all 4
treatment periods. For MOTN, mean change from baseline in body
sway was PBO: −1.8, LEM5: 5.0, LEM10: 7.5, ZOL: 19.6. All statisti-
cal comparisons vs. ZOL were p < 0.0001, while comparisons of
LEM vs. PBO were both p < 0.02. ZOL and LEM10 met the clinically
meaningful threshold for increase from baseline. At 8 hr, change
from baseline was PBO: −1.1, LEM5: 1.3, LEM10: 0.7, ZOL: 5.9. Sta-
tistical comparison of ZOL vs. PBO was p < 0.02. Neither LEM dose
was significantly different vs. PBO or ZOL. No 8 hr post‐dose value
met the threshold for clinically meaningful increase from baseline.
Conclusions: Postural stability, measured reliably by sensitive ataxi-
ameters, shows ZOL administered at bedtime increased body sway
upon a MOTN awakening substantively, almost 3 times above that
expected from blood alcohol content near the legal driving limit. In the
MOTN, LEM10 also increased body sway to just above this threshold,
while LEM5 did not result in clinically meaningful increases in body
sway. At approximately 8 hr postdose, neither dose of LEM nor ZOL
had meaningful residual next‐morning effects on this measure of pos-
tural stability. Lemborexant may become a useful alternative to drugs
like ZOL that suppress the central nervous system and are associated
with risk of falls, particularly in older individuals.
Disclosure: This study was financially supported by Eisai, Inc. and
Purdue Pharma LP. PM, DK, MM are employees of Eisai, Inc. RR has
received grant/research support from Actelion Pharmaceuticals, Eisai
Inc., Flamel Pharmaceuticals, Jazz Pharmaceuticals, Merck, and Phi-
lips Respironics, has investigational device/drug interest with Eisai,
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Inc., Flamel Pharmaceuticals and Jazz Pharmaceuticals, and has
served on the speakers bureau for Merck. GZ received grants/re-
search support from Actelion, Adare, Alder, Alkermes, Aptalis, Astel-
las, Astra‐Zeneca, Avadel, Balance Therapeutics, Biomarin, CHDI,
Corbus, Eisai, Flamel, Flex, Fresca, Idorsia, Janssen, Jazz, Johnson &
Johnson, Merck and Co., Neurocrine Biosciences, Novartis, Pfizer,
Purdue, Ritter, Sage Therapeutics, Sen‐Jam Pharmaceuticals, Sequen-
tial Medicine, Sunovion, Vanda; was a consultant for Actelion, Ava-
del, Eisai, Glaxo Smith Kline, Jazz, Idorsia, Purdue; received honoraria
from Guidepoint, Merck; had ownership interest in Clinilabs, Inc.,
Home Sleep and Respiratory Care, Nationwide Sleep Testing.
P243 | Effect of the “humming mask” on sleep
perception of healthy elderly
D.M. Kühn; R. Goeder; P.C. Baier
Center for Sleep Medicine, Psychiatriy and Psychotherapy, Christian‐
Albrechts University Kiel, Kiel, Germany
Objectives/Introduction: The humming mask is a massaging device
stimulating the paranasal sinuses through vibration. There were anec-
dotal reports that sleep benefits from the use of this device. Aim of
this open‐label pilot study was to investigate the effect of the hum-
ming mask on sleep perception in healthy elderly subjects without rel-
evant sleep disorders, but complaining about “bad sleep”.
Methods: Eighteen aged subjects (12 female, 6 male, mean age
67 years, 5 < PSQI < 11) were included in the study. As cover task
the subjects were instructed to keep dream diaries. After the screen-
ing visit the study consisted of two blocks of each one week, ended
by a visit. In a cross over design, subjects used the humming mask
for 20 min directly before lights of in one block and did not in the
other. Primary endpoint was change in the subjective sleep quality
as assessed with a modified version of the PSQI. The secondary end-
point was subjective sleep latency as assessed by a sleep diary.
Results: Despite being blind for the studies endpoints, subjects
reported improvements in subjective sleep quality (PSQI start:
8.4 ± 1.5, without mask: 7.3 ± 2.4, with mask: 6.4 ± 2.8, RM‐
ANOVA; F (2,53) = 3.185; p = 0.0070) and reduction in sleep latency
(without mask: 35 ± 33 min; with mask: 26 ± 24 min, t‐test
p = 0.08, tendency) by the use of the humming mask.
Conclusions: Our results support that use of the humming mask
improves sleep (perception). There are several limitations of this pilot
study. Firstly, only subjective measures were assessed. Secondly,
subjects were blinded for the study outcome, but not for the inter-
vention. However, the results of this pilot study encourage to fol-
low‐up with a sham controlled, double‐blind experiment, including
objective assessments. This would be a prerequisite to address the
potential mechanisms of action of the humming mask.
Disclosure: The Study was supported by “Nasivent”, the producer
of the “Humming mask”.
P244 | Younger patients are more obese and
have a more severe obstructive sleep apnea
syndrome
S. Mihaicuta1,2; R. Pleava3; A. Ciotlos Sinoi4; A. Rus4;
R. Dan5; D. Reisz6,7
1Pulmonology, University of Medicine and Pharmacy Dr. V. Babes,
2Pulmonology, 3Internal Medicine, Cardioprevent Foundation,
4Pulmonology, Victor Babes Hospital, 5Cardiology, 6Neurology, University
of Medicine and Pharmacy Dr. V. Babes, 7Neurology, Clinica de Medicina
a Capului, Timisoara, Romania
Objectives/Instruction: The prevalence of obstructive sleep
apnea syndrome (OSA) increases with age. We hypothesized that
the desaturation variables in patients (pts) below 65 years old (yo)
and over 65 yo would differ.
Methods: We analyzed 1,373 consecutive OSA patients
(59.13 ± 7.6 yo, 71% male) obtained during nocturnal polysomnogra-
phy. Data collected (May 2007–December 2017) included body‐mass
index (BMI), comorbidities, neck and abdominal circumference, as
well as polysomnographic data: apnea ‐ hypopnea index (AHI), oxy-
gen desaturation index (ODI) and mean oxygen desaturation (MOD).
Descriptive data is reported as mean values and standard deviations
(SD), or percentages. The Student's t‐test for independent samples
was performed. p‐values under 0.05 are regarded as statistically sig-
nificant. Continuous variables were analyzed by the Mann‐Whitney
U test. For categorical variables, the chi‐square test was performed.
Results: They were divided into two groups based on age as fol-
lowed: group 1, <65 yo (85.6%, 1,176 pts, 70.7% male) and group 2,
≥65 yo (14.4%, 197 pts, 68.5% male). When we compared the two
groups, we found significant differences regarding BMI (33.6 ± 7.34
vs. 31.63 ± 6.74, p < 0.001), neck circumference (43.74 ± 5.82 vs.
42.99 ± 4.38, p < 0.03), ODI (24.33 ± 22.54 vs. 28.28 ± 28.57,
p = 0.035) and AHI (41.21 ± 28.37 vs. 36.07 ± 21.02, p = 0.004).
Abdominal circumference (117.06 ± 16.89 vs. 115.57 ± 14.38,
p = 0.23) or MOD (92.20 ± 7.51 vs. 91.94 ± 7.88, p = 0.67) did not
differ significantly. Comorbidities such as systemic hypertension
(SHT), coronary artery disease (CAD) or stroke were increased in
elderly patients, respectively 65% vs. 80.7% (p < 0.01) for SHT,
17.8% vs. 37% (p < 0.001) for CAD and 2.8% vs. 9.6% (p < 0.01) for
stroke.
Conclusions: In the present study, younger patients are more
obese and have a severe OSA with a high desaturation index and
AHI as compared with older patients, who instead have a higher rate
of cardiovascular comorbidities.
Disclosure: Nothing to disclose.
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P245 | Sleep Disorders in an elderly population
and their relationship with cognitive symptoms:
an epidemiological survey
E. Di Coscio; U. Faraguna; M. Maestri; L. Carnicelli;
A. Schirru; G. Siciliano; U. Bonuccelli; E. Bonanni
University of Pisa, Pisa, Italy
Objectives/Introduction: Disturbed sleep is common in elderly
people and has been related to comorbidities. The aim of this study
was to evaluate the prevalence of sleep problems and their relation-
ship with chronic disease in an elderly population.
Methods: Subjects were participants of a population‐based study
of older adults for dementia and mild cognitive impairment screening
in Lunigiana. 2,137 subjects (age range 65–85 years, 961 males and
1,176 females) were identified as eligible. All patients underwent a
clinical interview and a questionnaire about insomnia, sleepiness,
snoring, sleep apnea, other sleep disturbances. In addition, subjects
were administered by trained physicians the Mini Mental State
Examination (MMSE), the Beck Depression Inventory, the Memory
Assessment Clinic‐Q (MAC‐Q).
Results: The participation rate was 83.5% and 1,784 subjects com-
pleted the study: 796 males and 988 females. The mean age of the
participating subjects was 70.5 years (SD 3.2). Insomnia symptoms
were reported in 63.8% of the population. The most common sleep
complaint was “early awakening” reported by nearly half of subjects
(46.6%), 200 patients presented an insomnia syndrome (11.2%).
Almost one quarter of the subjects (24.6%) presented excessive
sleepiness, while snoring affected the 20.5% of the population and
sleep apnoea the 3.4%. Legs jerk were reported in 21.2% of the sub-
jects. MMSE as a continuous variable correlated with maintenance
insomnia (p = 0.04), daytime consequences of insomnia (p = 0.04),
excessive daytime sleepiness (p = 0.03), legs jerks (p = 0.03). Univari-
ate analysis of insomnia syndrome with number of comorbidities
shows that having more comorbidities was related with an increased
incidence of insomnia syndrome that increase from 8% (no comor-
bidities) to 21% (3 or more comorbidities) with an OR of 1.25.
Conclusions: Our results confirm that sleep problems are very
common in elderly subjects and closely related to medical and psy-
chiatric illnesses. Since mutual influences of nocturnal sleep prob-
lems and medical disease have been proposed, comorbid sleep
disorders should be fully evaluated by the clinician and should not
be under diagnosed and under treated.
Disclosure: Nothing to disclose.
P246 | The effect of retirement on subjective
and objective sleep characteristics: the Finnish
Retirement and Aging study
S. Myllyntausta1; A. Pulakka1; P. Salo2,3; E. Kronholm3;
J. Pentti1,4; T. Oksanen3; M. Kivimäki3,4,5; J. Vahtera1;
S. Stenholm1,6; Finnish Retirement and Aging study
1Public Health, University of Turku and Turku University Hospital,
2Psychology and Speech‐Language Pathology, University of Turku, Turku,
3Finnish Institute of Occupational Health, 4Clinicum, University of
Helsinki, Helsinki, Finland, 5Epidemiology and Public Health, University
College London, London, United Kingdom, 6Faculty of Social Sciences
(Health Sciences), University of Tampere, Tampere, Finland
Objectives/Introduction: Previous studies have shown that self‐
reported sleep duration increases and sleep difficulties decrease after
retirement over several years. By using annually collected data, we
aimed at specifying the timing of changes in self‐reported sleep
duration and quality following retirement. Furthermore, this is the
first cohort study that examines objectively measured changes in
sleep during retirement transition.
Methods: Repeated survey and accelerometer data from the Fin-
nish Retirement and Aging study were used. The study population
consisted of 2,053 public sector employees who retired in 2014–
2017 and reported their usual sleep duration and quality in surveys.
From these participants, a sub‐population of those retiring in 2016–
2017 (n = 360) were included in the accelerometer measurements,
in which total sleep time, sleep efficiency and minutes awake during
the night were objectively assessed with a wrist‐worn accelerometer
(ActiGraph GT3X). Both the surveys and the accelerometer measure-
ment were repeated at least four times around retirement. The
changes in sleep around retirement were examined using linear and
logistic regression with generalized estimating equations. An alpha
level of 0.05 was used throughout the analyses.
Results: Self‐reported sleep duration increased by 19 min (95%
confidence interval 17–20 min) from the measurement immediately
prior to retirement to the measurement immediately after retire-
ment. When prevalence estimates in the measurement immediately
after retirement were compared to the measurement immediately
before retirement, we observed statistically significant decreases in
self‐reports on waking up too early in the morning, nonrestorative
sleep, sleep loss due to worry, and daytime tiredness. There were no
changes in difficulties falling asleep or difficulties maintaining sleep
following retirement. We are currently examining the sleep data
from 24‐hr measurements with wrist‐worn accelerometers, and the
results concerning the changes in objectively measured sleep follow-
ing retirement will be presented in the congress.
Conclusions: This longitudinal study suggests that various sleep
characteristics change immediately (in 0–3 months) following retire-
ment. Both the removal of work‐related stressor as well as the
increased leisure time immediately following retirement could
account for the changes in sleep, as work can no longer dominate
sleeping patterns after retirement.
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declare no conflicts of interest.
P247 | Associations of sleep and functioning
with the premature exit from the labour market:
repeated measures latent class analysis among
midlife and ageing public sector employees
E. Kronholm1; N. Marshall2; M. Mänty3,4; J. Lahti4;
E. Lahelma4; O. Rahkonen4; T. Lallukka1,4
1Finnish Institute of Occupational Health, Helsinki, Finland, 2University
of Sydney, Sydney, NSW, Australia, 3Department of Research,
Development and Innovation (RDI), Laurea University of Applied
Sciences, Vantaa, 4Department of Public Health, University of Helsinki,
Helsinki, Finland
Objectives/Instruction: To examine the associations between dif-
ferent patterns of categorical change of normal and problematic
sleep and health functioning with the risk of premature exit from the
labour market.
Methods: We examined participants of the Finnish Helsinki Health
Study, who responded to survey questionnaires in 2000–2, 2007
and 2012. At baseline, all were employed by the City of Helsinki.
The follow‐up surveys provided data about insomnia‐related symp-
toms, health functioning, exit from the labour market, and covariates.
Using a person oriented approach, patterns of categorical change of
normal and problematic sleep and health functioning were identified
by repeated measures latent class analyses (RMLCA). Time‐to‐event
analysis of premature exit between identified RMLCA groups was
performed by Cox proportional hazards modelling.
Results: We identified four latent groups of sleep and functioning
over time among 5,148 participants with complete data on the vari-
ables interest at three time points: (1) poor sleep and moderate func-
tioning (6.2%), (2) good sleep and poor functioning (24.6%), good
sleep and good functioning (64.0%, reference), and (3) poor sleep
and poor functioning (5.3%). Clear differences were found regarding
the risk of premature labour market exit. Members of the latent
group 2, had a notably increased risk (HR 4.38, 95% CI 3.44–5.57),
but the risk was highest for those belonging to the group 4 (HR
8.10, 95% CI 6.00–10.94). Covariates (sex, age, marital status, educa-
tion, body mass index, smoking, alcohol use, leisure‐time physical
activity, limiting long standing illness, and physician diagnosed
depression) only somewhat contributed to these associations. No
excess risk could be confirmed for people belonging to the group 1.
Conclusions: Poor sleep combined with poor functioning overt
time is associated with the highest risk of premature exit from the
labour market. However, also people with good sleep are at an
increased risk, if they have poor functioning. These results highlight
the advantages of person‐orientated methods to pinpoint risk groups
that can be missed in studies with variable orientated methods.
Thus, people with different risk factor combinations need to be con-
sidered in the efforts to prevent premature exit from paid employ-
ment.
Disclosure: Nothing to disclose.
P248 | Sleep apnea and hypogonadism in
Midle‐Aged Men: combined method of
treatment
I. Madaeva; O. Berdina; N. Semenova; L. Kolesnikova
Scientific Centre for Family Health and Human Reproduction Problems,
Irkutsk, Russian Federation
Objectives/Instruction: It is important sleep apnea is risk factor
of cardiovascular disease. Especially in Midle‐Aged men with hypog-
onadism.
Purpose: assessment of the effect combined use of CPAP (Con-
stant Positive Airway Pressure) and replacement testosterone ther-
apy on indicators of polysomnography monitoring (PSG) with
nocturnal penile tumescences (NPT) and serum testosterone level
before and after 3 month therapy.
Methods: We examined 28 men with SOAS and hypogonadism.
Mean age – 47.1 ± 7.4 years, BMI – 34.2 ± 3.5 kg/m2. The
polysomnography with nocturnal penile tumescence (NPT). were
recorded on a GRASS‐TELEFACTOR Twin PSG (Comet®) with ampli-
fier As 40 with integrated modul for sleep SPM‐1 (USA) with ampli-
fier for NPT‐sensor. NPT‐monitoring was carried out by implication
of mercuric NPT‐sensor. The total testosterone level was 8.5 ± 1.2
vs. 8.2 ± 0.2 nmol/l. All patients were divided into 2 groups: men
with therapy only CPAP (n = 14); men with combination therapy ‐
CPAP and Androgel (50 mg 1 times a day) (n = 12). Duration of ther-
apy in both groups was 3 months.
Results: After combination therapy regimen (CPAP and Androgel)
in men found increase of total testosterone levels 18.2 ± 3.4
(9.1 ± 1.2 ‐only CPAP), p < 0.05 and improvement in indicators of
altered nocturnal penile patternand improvement in indicators of
altered nocturnal penile erection episodes (Tup, Tmax, Tm/R, Tup/R,
the total number of NPT (p < 0.05)) compared with similar parame-
ters in men with only CPAP‐therapy. We had noted considerable
decrease in IMT at combination therapy regimen −29.2 ± 0.3 vs.
33.4 ± 1.8‐only CPAP.
Conclusions: CPAP ‐ therapy and testosterone replacement ther-
apy improves quality of a sleep and wakefulness in Midle‐Aged Men
with sleep apnea and hypogonadism. Substitution testosterone level
is required with CPAP for OSAS patients with aging hypogonadism.
CPAP ‐ therapy and testosterone replacement therapy as prevention
of cardiovascular diseases in Midle‐Aged Men with sleep apnea and
hypogonadism.
Disclosure: Nothing to disclose.
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P249 | The effects of APOE genotypes on the
longitudinal sleep behavior changes in non‐
demented general population: the Korean
Genome and Epidemiology Study
H.J. Kim1; S. Kim2; R.E. Kim2,3; S.A. Kim1; S.K. Lee2;
H.W. Lee1; C. Shin2,4
1Departments of Neurology and Medical Science, Ewha Womans
University School of Medicine and Ewha Medical Research Institute,
Seoul, 2Institute of Human Genomic Study, College of Medicine, Korea
University, Ansan, Republic of Korea, 3Psychiatry, University of Iowa,
Iowa, IA, United States, 4Department of Pulmonary, Sleep and Critical
Care Medicine, Korea University Ansan Hospital, Ansan, Republic of
Korea
Objectives/Introduction: Recently, evidence for causal and bidi-
rectional links between sleep disturbance and Alzheimer's disease
(AD) pathophysiology continues to grow along with the increasing
evidences of sleep‐stage dependent toxic metabolite clearance. As
the consequence, sleep modulation in elderly population is regarded
as one of the potential disease‐modifying intervention during the
long preclinical phase of AD.
Methods: We analyzed 1,787 subjects with apolipoprotein E (APOE)
genotype who scored at least 73 on the Korean Modified Mini‐Mental
State (K‐3MS) examination at the baseline regardless of education
level (mean 51.83 ± 6.95 years old, 47.7% female, mean follow up
duration 6.83 ± 1.05 years). For all analysis, we first compared partici-
pants at lower brain amyloid burden risk (ε2/ε2 or ε2/ε3 genotype,
n = 202, 11.3%) or greater risk (ε4 carriers, n = 326, 18.2%) with those
neutral for the amyloid burden (ε3/ε3, n = 1,259, 81.8%).
Results: There was no significant APOE group difference in mean
time in bed, subjective sleep duration, sleep efficiency in addition to
sleep latency both at the baseline and follow‐up visit. We assessed
their chronotye by MSFsc (Mid‐Sleep phase on Free days Corrected
for the Sleep deficits during weekdays) and the MSFsc of ε4 carriers
were significantly advanced than the other non‐carriers at the base-
line (p = 0.045). However, the difference become insignificant at the
follow‐up visit (p = 0.805). With respect to other sleep question-
naires including Epworth Sleepiness Scale (ESS), napping habits, snor-
ing and insomnia, there was no statistically significant difference
between groups. The mean value of Mini‐Mental State Examination
(MMSE) scores at the follow‐up visit was 27.75 ± 1.73 and there
was no significant APOE genotype group difference.
Conclusions: Our results demonstrated that aging process of circa-
dian rhythms could be different between APOE genotypes. To inves-
tigate the reciprocal link between sleep and Aβ pathology along with
aging process, not only sleep duration but also sleep pattern includ-
ing chronotype should be investigated in further studies.
Disclosure: This study was supported by a grant of Korean Cen-
ters for Disease Control and Prevention, Korean Ministry for Health
and Welfare [Grant 2005‐E71001‐00, 2006‐E71005‐00, 2011‐
E71004‐00, 2012‐E71005‐00, 2013‐E71005‐00, and 2014‐E71003‐
00]
P250 | Impact of age and napping on actimetry‐
derived sleep and 24‐hr rest‐activity indices
M. Reyt1; A. Latteur1; M. Maire2,3,4; C. Reichert2,3;
C. Cajochen2,3; C. Schmidt1,5; V. Muto1; G. Hammad1
1GIGA‐CRC in Vivo Imaging, University of Liège, Liège, Belgium, 2Centre
for Chronobiology, Psychiatric Hospital of the University of Basel,
3Transfaculty Research Platform Molecular and Cognitive Neurosciences,
University of Basel, Basel, 4Institute of Primary Health Care (BIHAM),
University of Bern, Bern, Switzerland, 5Psychology and Neuroscience of
Cognition (PsyNCog), University of Liège, Liège, Belgium
Objectives/Introduction: Sleep appears as a protective factor in
models of cognitive and brain aging. However, temporal organisation
of sleep and wakefulness over the 24‐hr cycle still remains underes-
timated in these models. Chronic napping is frequent in the older
population and might interfere with sleep‐wake regulation. Here, we
explored age‐related changes in actimetry‐derived indices of both
sleep and sleep‐wake fragmentation.
Methods: Actimetry data (Actiwatch plus device, Cambridge Neu-
rotechnology) were collected for 7 days in 24 younger (20–32 years,
16 women) and 21 older participants (58–85 years, 8 women, 9
chronic nappers [naps >20 min/day, >3*week, since >1 year]). Peri-
ods of complete inactivity >2 hr were excluded from analyses since
the latter presumably reflect actigraph removal. Sleep‐wake fragmen-
tation was explored by estimating transition probability to rest dur-
ing daytime (kAR), transition probability into activity during night‐
time (kRA), volume of sleep in the afternoon (fSOD), intra‐daily vari-
ability (IV) and inter‐daily stability (IS).
Results: Significant age‐related changes were observed for indices
measuring sleep‐wake cycle fragmentation (IV, t(43) = −3.79,
p < 0.001) and wake fragmentation (kAR, t(43) = −3.05, p < 0.01,
fSOD, t(43) = −3.60, p < 0.01). The younger presented lower wake
fragmentation compared to both older no‐nappers (kAR, t
(34) = −3.41, p < 0.01, fSOD, t(34) = −2.74, p < 0.05) and nappers
(fSOD, t(31) = −2.69, p < 0.05). Furthermore, sleep‐wake cycle frag-
mentation was lower in younger participants compared to older nap-
pers only (IV, t(31) = −5.10, p < 0.001). Finally, compared to older
no‐nappers, older nappers presented higher sleep‐wake cycle frag-
mentation (IV, t(19) = −3.64, p < 0.01) and lower inter‐daily stability
(IS, t(19) = 2.24, p < 0.05).
Conclusions: Overall, our data suggest that the impact of age is
more evident in actimetry‐derived indices taking into account wake
fragmentation during daytime. Nappers presented higher sleep‐wake
cycle fragmentation compared to no‐nappers, while sleep fragmenta-
tion did not significantly differ. Future analyses aim at taking into
account individually‐tailored rest‐activity profiles to estimate sleep‐
wake cycle fragmentation. Finally, whether these indices explain sig-
nificant part of variance in cognitive ageing remain to be assessed.
Disclosure: Disclosures of potential conflict of interest: The
authors do not disclose a potential conflict of interest. Sources of
funding: Swiss National Foundation (SNF), Belgian Fund for Scientific
Research (FNRS), European Research Council (ERC‐Starting Grant).
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P251 | Sleep, diet and physical activity are
associated with inflammation among non‐
demented community‐dwelling elderly
M. Basta1,2; P. Simos1; M. Yannakoulia3; I. Zaganas4;
E. Koutentaki1; G. Gouna4; M. Bourbouli4; S. Panagiotakis5;
M. Anastasaki1; S. Kapetanaki4; A. Vgontzas1,2
1Psychiatry, University of Crete, School of Medicine, Heraklion, Greece,
2Psychiatry, Penn State College of Medicine, Sleep Research and
Treatment Center, Hershey, PA, United States, 3Department of Nutrition
and Dietetics, Harokopio University, Athens, 4Neurology, 5Medicine,
University of Crete, School of Medicine, Heraklion, Greece
Objectives/Introduction: Inflammation in elderly is associated
with morbidity, including cognitive impairment, and mortality. The
aim of this study was to explore modifiable life‐style parameters in
predicting inflammation among non‐demented, community‐dwelling
elderly.
Methods: A sub‐sample of 117 patients with mild cognitive impair-
ment (MCI) and cognitively intact controls (NI) were recruited from a
large, population‐based cohort in the island of Crete, Greece of
3,140 older adults (>60 years). All participants underwent medical
history/physical examination, extensive neuropsychiatric and neu-
ropsychological evaluation, 3‐day 24‐hr actigraphy, subjective sleep
complains, physical activity, and diet patterns based on Principle
Component Analysis (PCA). Finally, all participants had a single morn-
ing IL‐6 and TNFα plasma levels measurement. Associations between
inflammatory markers and objective sleep duration (based on highest
or lowest 25th percentile), subjective poor sleep, diet patterns and
physical inactivity were assessed using multivariate linear regression
models, controlling for demographics, MCI diagnosis and depression.
Results: Mean age was 75.6 (SD = 6.9) yrs for MCI patients and
72.4 (SD = 7.6) for the NI group (p = 0.02). Peripheral levels of IL‐6
(mean ± SD) and TNFα were 1.27 ± 0.71 (pgr/ml) and 1.16 ± 0.53
(pgr/ml), respectively, in patients with MCI and 1.33 ± 1.04 (pgr/ml;
p > 0.7) and 1.01 ± 0.62 (pgr/ml; p > 0.2), respectively, in the NI
group. Regression analyses in the total group revealed significant
associations between TNFa (Model Adj. R2 = 0.136, p = 0.002) and
long objective night time sleep duration (B = 0.468, p = 0.004), con-
sumption of drinks/snacks (B = 0.139, p = 0.014) and marginally sig-
nificant for low consumption of vegetables/legumes/fish (B = −0.09,
p = 0.09). Also, IL‐6 (Model Adj. R2 = 0.112, p = 0.003) was associ-
ated with physical inactivity (B = −0.538, p = 0.001) and low con-
sumption of vegetables/legumes/fish (B = −0.190, p = 0.016).
Conclusions: These data indicate that TNFa and IL‐6 plasma levels
in non‐demented community‐dwelling elderly are associated with
long objective sleep duration, high carbohydrate and low vegetable/
legume/fish diet, and physical inactivity. Combined interventions tar-
geting several life‐style parameters, i.e. sleep hygiene, healthier diet
and physical activity, may decrease inflammation and improve or
delay cognitive decline among elderly.
Disclosure: This study is supported by grant from the National
Strategic Reference Framework (ESPA) 2007–2013, Program:
THALES, University of Crete, title:”A multi‐disciplinary network for
the study of Alzheimer's Disease” (Grant :MIS 377299). None of the
authors have any other conflict of interest to declare.
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P252 | Sleep disorders among hospital
employees
S. Wali; F. Alhejaili; N. Badgish; A. Alaama; A. Daghistani;
A. Turkistani; G. Sindi; H. Sabbahi; M. Basha; W. Al Qulayti;
W. Toffaha; Y. Simbawa; S. Sangoof; M. Alharbi
Sleep Medicine and Research Center, King Abdulaziz University Hospital,
Jeddah, Saudi Arabia
Objectives/Instruction: Sleep disorders are estimated to affect
millions of people worldwide, however, both healthcare personnel as
well as the general public overlook these sleep disorders. Daytime
sleepiness, tiredness, and cognitive impairment that are major conse-
quences of various sleep disorders, are under recognized as well.
These disorders would negatively affect the competence of employ-
ees that would have a drawback on the productivity of the institu-
tion. Hence, sleep disorders are indeed an important epidemiological
problem that needs to be addressed. Our aim was to screen Univer-
sity hospital employees for sleep disorders to estimate their preva-
lence and the size of the problem.
Methods: This was a cross sectional study that was conducted
from August till October 2016 at King Abdulaziz University Hospi-
tal (KAUH), Jeddah, KSA. Our target population was all KAUH
employees. A stratified random sample consisted of 100 of KAUH
staff were approached. All subjects were interviewed by trained
physicians using a questionnaire. The information collected
included socio‐demographic characteristics, the Berlin questionnaire
to assess the risk of obstructive sleep apnea (OSA), the Epworth
Sleepiness Scale to assess excessive daytime sleepiness (EDS), the
International RLS Study Group score to diagnose restless legs syn-
drome (RLS), The Pittsburgh Sleep Quality Index (PSQI) to assess
quality of sleep, and Sleep‐50 questionnaire designed to detect
sleep disorders.
Results: A hundred and sixteen employees were recruited, 56% of
them were males with a mean age of 30.9 years. The frequency of
sleep disorders in the study sample was as follows: RLS was seen in
6.9%; the risk of OSA was high in one fifth of subjects with male
predominance (p = 0.04); sleep quality was reported as poor in 93%
of subjects; and EDS was reported in 24% of the study population.
Interestingly, there was no significant difference between subjects
with sleep disorders and those without in terms of sleepiness. When
Sleep‐50 Subscales questionnaire was used, 32%, 5%, 28%, 71%,
and 55% of the study population reported symptoms of narcolepsy,
sleepwalking, nightmares, insomnia, and circadian rhythm disorder
respectively.
206 of 433 | ABSTRACTS
Conclusions: Sleep disorders are very common among employees
that would need to be explored to get the necessary healthcare
attention.
Disclosure: Nothing to disclose.
P253 | Sleep quality and quantity in Japanese
daytime workers in association with the duration
of the daily rest period
H. Ikeda1; T. Kubo1; T. Sasaki1; X. Liu1; T. Matsuo1; R. So1;
S. Matsumoto1; T. Yamauchi1,2; M. Takahashi1
1National Institute of Occupational Safety and Health, Japan
Organization of Occupational Health and Safety, Kawasaki, 2The Jikei
University School of Medicine, Tokyo, Japan
Objectives/Instruction: The daily rest period (DRP) is the interval
between the end of one workday and the beginning of the following.
A sufficient DRP may be necessary for a daytime worker to recover
from work. However, little is known about the association between
DRP, sleep duration, and sleep quality. This study aimed to examine
the correlation between DRP and sleep quantity and quality, in Japa-
nese permanent daytime workers.
Methods: An internet survey was conducted in Japan, in Novem-
ber 2016, and 3,867 permanent daytime workers (mean age
42.7 years, 35% females) were analyzed. The survey gathered infor-
mation about the usual DRP, the sleep duration on workdays, and
the sleep quality (Japanese version of the Pittsburgh Sleep Quality
Index; PSQI‐J). The participants were categorized into the eight fol-
lowing groups, according to their DRP duration, as follows: “less
than 10 hr”, “10 hr” (10 hr–10hr 59 min), “11 hr” (11 hr–11hr
59 min), “12 hr” (12 hr–12hr 59 min), “13 hr” (13 hr–13hr 59 min),
“14 hr” (14 hr–14hr 59 min), “15 hr” (15 hr–15hr 59 min), and
“equal or more than 16 hr”.
Results: The sleep duration for Japanese daytime workers in the
“less than 10 hr”, “10 hr”, “11 hr”, “12 hr”, “13 hr”, “14 hr”,
“15 hr”, and “equal or more than 16 hr” DRP groups were found to
be 5.3, 5.9, 6.1, 6.3, 6.5, 6.7, 6.7, and 6.9 hr, respectively. The trend
analysis revealed a significant linear trend indicating that the shorter
the DRP, the shorter the sleep duration (p < 0.05). Furthermore, the
PSQI‐J global scores for the above DRP groups were 7.1, 6.7, 6.7,
6.3, 6.0 (5.999), 5.6, 5.2, and 5.2, respectively. The trend analysis
revealed a significant linear trend indicating that the shorter the
DRP, the lower the sleep quality (p < 0.05), and mean PSQI‐J score
for workers with a DRP of less than 13 hr was above cutoff point
(=6) for the primary insomnia.
Conclusions: This study revealed that a longer DRP is associated
with longer sleep durations and better sleep quality in Japanese day-
time workers. Daytime workers may require a DRP longer than
11 hr to ensure more than 6 hr of sleep, and a DRP longer than
13 hr to ensure good sleep.
Disclosure: Nothing to disclose.
P254 | Effective intervention methods for
developing appropriate sleep habits in children
M. Furutani1; S. Utsumi2
1Graduate School of Human Development and Environment, Kobe
University, Kobe, 2Elementary School attached to Kobe University,
Akashi, Japan
Objectives/Instruction: Japanese children are known to have the
shortest sleep duration in the world and recently, certain schools
have introduced sleep education. However, children's lifestyle habits
including sleep are normally taught by parents. Therefore, the
delayed bedtime of elementary school children, their parents sleep
habits and sleep knowledge was investigated to identify appropriate
interventions for developing suitable sleep habits in children.
Methods: The parents of 406 children aged 5–12 years completed
a questionnaire distributed in their children′s schools. The question-
naire inquired children's and parent′s sleep habits and daytime
sleepiness, sleep‐related behaviors, and parent's sleep knowledge.
The children were classified into two groups based on their weekday
bedtime: Earlier than 21‐hr group (n = 230) and Later than 22‐hr
group (n = 175).
Results: The weekday sleep duration shortened (p < 0.01) as chil-
dren grow up. Moreover, the weekday sleep duration differed
between the two groups (p < 0.001): the earlier bedtime group had
9.35 hr of sleep, whereas the later bedtime group had only 8.18 hr
of sleep. The weekend sleep duration did not differ between the
ages. However, there were differences between the earlier (9.76 hr)
and the later bedtime group (9.07 hr), which were significant
(p < 0.001). The later bedtime group experienced more daytime
sleepiness (p < 0.001), lack of sleep (p < 0.001) and bad mood at
wake‐up time (p < 0.001) than in the earlier bedtime group. The rea-
son for going to bed or waking up in the later bedtime group was
intervention by their family (p < 0.001). Correlations between par-
ents and children on weekday and weekend bedtime, weekend rise
time, and time of finishing media tools was significant (p < 0.05). On
the other hand, there were no correlations with parent's knowledge
or their life habits and delayed bedtime of children. Approximately
90% of parents correctly understood sleep and sleep‐promoting
behavior.
Conclusions: Deciding a deadline to finish using media tools, and
deciding the bedtime of parents and children with bedtime delays is
important. These results also suggest that not only knowledge but
also providing motivation to parents is essential.
Disclosure: Nothing to disclose.
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P255 | Effects of work arrangement on sleep
regimen in creative R&D employees
E. Sõõru1,2; A. Hazak3; K. Männasoo3
1Department of Pulmonology, North Estonia Medical Centre Foundation,
2Institute of Clinical Medicine, 3Department of Economics and Finance,
Tallinn University of Technology, Tallinn, Estonia
Objectives/Instruction: Traditional “nine‐to‐five” working sched-
ules do not account for employees’ individual characteristics. We
seek to identify what type of creative R&D employees suffer from
the adverse effects of work arrangements on their sleep regimen.
Methods: We present ordinary least squares and ordered probit
regression estimates as well as recursive structural equation estimates
of the employees’ perceived level of sleep regimen distraction by
work. The study is based on data from a repeated survey among
Estonian creative R&D employees. The sample comprises 153 indi-
viduals from eleven entities.
Results: We find evening type people to be significantly more dis-
tracted by the adverse effects of work on their sleep regimen. Female
employees have a 6% higher probability of perceiving their work to
limit strongly their sleep schedule. Employees having flexibility in both
their working time and working place feel significantly less impacted
by the work driven constraints on their sleep regimen. Employees with
a higher creativity intensity of work appear less affected by the limita-
tions that work sets on their sleep, in comparison to employees with a
higher share of administrative and other non‐creative tasks.
Conclusions: The quality of sleep of evening type as well as female
employees being adversely impacted by their working arrangements
means potential underutilization of their creative abilities. Granting
working time and working place flexibility as well as avoiding alloca-
tion excessive administrative duties to creative R&D employees may
have a major positive impact on improving their sleep, thus expectedly
contributing to the improvement of their wellbeing and work results.
Disclosure: Nothing to disclose.
P256 | Daytime sleepiness: impacts of work
organisation
E. Sõõru1,2; A. Hazak3; M. Partinen4; M. Virkebau3
1Department of Pulmonology, North Estonia Medical Centre Foundation,
2Institute of Clinical Medicine, 3Department of Economics and Finance,
Tallinn University of Technology, Tallinn, Estonia, 4Department of Clinical
Neurosciences, University of Helsinki, Helsinki, Finland
Objectives/Instruction: The degree to which standard work
arrangements, rather than shift work, night work and other abnormal
work schedules, affect the daytime sleepiness of employees has
attracted limited attention in research. In this paper we investigate
how flexible working time, creative intensity of work and other work
arrangements affect daytime sleepiness in creative research and
development (R&D) employees.
Methods: We present fully observed recursive structural equa-
tion estimates and ordinary least squares and probit regression esti-
mates, using data from our original repeated survey of Estonian
creative R&D employees on a sample of 150 individuals from eleven
entities.
Results: Employees who can use flexible working time exhibited
significantly lower levels of daytime sleepiness. The higher their load
of administrative and other non‐creative work tasks was, the higher
the creative employee's daytime sleepiness was. Evening types were
significantly sleepier in the daytime than their morning type col-
leagues, possibly because the standard timing of working does not
match the time use preferences of the evening types. The probability
of women getting jobs with flexible working time was significantly
lower than the probability for men, and the probability they would
fall at or above the upper quartile on the daytime sleepiness scale
was 22.5 percentage points higher than in men.
Conclusions: Improvements and increased flexibility in work
arrangements may reduce daytime sleepiness considerably, and con-
tribute both to improved individual wellbeing and to better use of
the potential of employees.
Disclosure: Nothing to disclose.
P257 | The effect of self‐care interventions on
sleep quality in post coronary artery bypass graft
surgery patients
H. Ghavami; F. Safarzadeh; R. Ghare Aghaji
Nursing and Midwifery School, Urmia University of Medical Sciences,
Urmia, Islamic Republic of Iran
Objectives/Introduction: Adequate amount and good quality of
sleep are basic human needs. Studies in adults have shown that
inadequate sleep is associated with metabolic syndrome, diabetes
and with cardio‐metabolic risk factors,including weight status,
cholesterol, and blood pressure. Also, studies show that poor sleep
quality is common among patients after coronary artery bypass graft
surgery. So, the aim of the current study was to examine the effect
of self‐care interventions (based on sleep hygiene practices, nutrition
and physical activity) on sleep quality in post coronary artery bypass
graft surgery (CABG) patients.
Methods: This randomized controlled trial study included a total
of 160 post CABG patients. They were divided into two groups
randomly; 80 patients were randomized to the self‐care interven-
tions group, and 80 to the usual care group. Those in the self‐
care interventions group had 6 educative sessions on sleep
hygiene practice, aerobic exercises, and dietary training and then
they had individual consultant sessions about these self‐care items
monthly three times. Those in the usual care group were
instructed to continue their normal life. The patient characteristics
form and The Pittsburgh Sleep Quality Index (PSQI) were used for
data collection.
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Results: Based on Independent Samples T Test; the mean PSQI
score in the self‐care interventions group decreased to 7.13 ± 2.26
after the application of the self‐care intervention, while it increased
to 9.54 ± 2.14 in the control group. There were not any baseline dif-
ference between the two groups in terms of the mean PSQI score
p = 0.91 before the start of this study, but the difference between
the mean PSQI scores in the two groups was statistically high after
the application of the self‐care interventions (p =< 0.001).
Conclusions: Post CABG patients may benefit from participating in
self‐care interventions for improving their quality of sleep. Additional
research in self‐care interventions along with cognitive behavioral
therapy also may be beneficial.
Disclosure: Nothing to disclose.
P258 | Techniques of developing the
diagnostic and treatment skills in sleep apnea in
students/interns in Pulmonology Clinic Tirgu
Mures, Romania
G. Jimborean1; A. Csipor1; P. Postolache2; O. Arghir3;
E. Ianosi1
1Pulmonology, University of Medicine and Pharmacy, Tirgu Mures,
2Rehabilitation, University of Medicine and Pharmacy, Iasi,
3Pulmonology, University of Medicine and Pharmacy, Constanta,
Romania
Objectives/Instruction: Despite the wide expansion of sleep
apnea (SA) study during the faculty of medicine, the knowledges in
the field in students/interns are insufficient. At the same time the
disease is still late diagnosed or not at all. In Pulmonology Clinic we
developed several means to improve the knowledge about SA in stu-
dents and physicians and to promote an early diagnosis in respira-
tory sleep disorders (RSD).
Methods: Analyse of methods of achieving skills for correct
approach of SA in Pulmonology Clinic.
Results: We tested the knowledge about risk factors, instruments
for diagnosis, complications and treatment in RSD using a 20 items
questionnaires on 110 Vth‐year medicine‐students and 38 interns
(23 pulmonologists, 15 internal/cardiology specialty) before and after
a teaching‐session (2 hr course, 6 hr practice). Initially the knowledge
concerning SA was dramatic insufficient: 23.7% correct answers (stu-
dents), 65.7% in physicians (86% in pulmonologists, 33% in inter-
nists). We repeated the test after the teaching‐sessions and the
correct answers became 59% (students) and 92.1% (physicians). Tak-
ing into account the above we have emphasized the training in the
field. We included in the curriculum of pulmonology the course
“Physiological sleep and RSD” for the Vth‐year medicine‐students
with 2 days practical work. They study the sleep diary, the somno-
lence questionnaires, the risk factors and symptoms of the RSD, the
cardioventilatory polygraphy PG and polysomnography PSG (practice
and bulletins interpretation), treatment principles including CPAP
(Continuous Positive Airways Pressure). For the interns in pul-
monology we added weekly case‐based learning sessions and once‐
weekly “hands‐on” at the patient's bed (1 year); 50 PG/PSG valida-
tions. We organize twice a year post‐university workshops for physi-
cians/students (free of charge) in the frame of the “pulmonology
cercle”. At the same time we deepened relationships with internal
medicine, cardiology, diabetes and neurology specialties for an
improved SA diagnosis in patients with risk factors or complications.
Conclusions: The stage of pulmonology is the best location for
learning solid knowledge in RSD for students and interns of different
specialty. The competence in sleep disorders is a “must‐have” skill
especially for pulmonologist to enlarge the early diagnosis of RSD
and diminish the irreversible complications.
Disclosure: Nothing to disclose.
P259 | Parent‐based sleep education as a
possible intervention for sleep problem in school
aged children with autism spectrum disorder
F. Sun; M. Cao; L. Luo; J. Jing
Sun Yat‐Sen University, Guangzhou, China
Objectives/Instruction: Sleep problem is common among children
with autism spectrum disorder (ASD). However, few of intervention
studies tested the efficacy of sleep behavior intervention that carried
by parents. We aim to test the efficacy on the sleep quality of ASD
children by a Parent‐Based Sleep Education (PSE) program.
Methods: ASD children were recruited in a child development clini-
cal center. Sleep problems were addressed using Children's Sleep Habits
Questionnaire (CSHQ, full scale score >41). Forty two ASD children
(mean age: 7.36 ± 1.65) with sleep problems were randomly divided
into two groups (receiving PSE or non‐sleep related Psychological Edu-
cation, PE). Both of the education programs consisted of two 2‐hr ses-
sions (at the weekend). The main behavior strategies in the PSE were
Bedtime Routine, Extinction, Sleep Restriction, and Positive Reinforce-
ment, with PE only containing general knowledge about ASD. A 14‐
day Sleep diary and the CSHQ were used to assess sleep problems of
children with ASD before and after intervention. Two follow‐up phone
calls were also performed to ensure sleep diary record. All these ses-
sions and phone calls were at a one‐week interval.
Results: All 42 participants had completed the CSHQ,but sleep
diary data were available for 36 of them (PSE:19, PE:17). Compared
with PE, PSE had a positive effect to improve ASD children`s sleep
quality by increasing sleep efficiency (PSE: before 0.93 ± 0.004, after
0.95 ± 0.001, PE: before 0.93 ± 0.004, after 0.94 ± 0.002, Mean ±
SE, F = 12.709, p < 0.001) and reducing sleep latency (PSE: before
37.55 ± 2.098, after 25.13 ± 0.613, PE: before 33.62 ± 1.579, after
29.14 ± 0.916, min, Mean ± SE, F = 30.583, p < 0.001) and night
waking times (PSE: before 0.29 ± 0.032, after 0.21 ± 0.016, PE:
before 0.28 ± 0.039, after 0.34 ± 0.020, Mean ± SE, F = 5.856,
p = 0.016). As for the CSHQ, improvements after PSE treatment
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were seen in the scores of the total scale and subscales, including
Bedtime Resistance, Sleep Onset Delay and Sleep Anxiety.
Conclusions: Parent‐based sleep education with only two sessions
could be a potential effective treatment to improve sleep latency,
night waking and sleep efficiency in school aged children with ASD.
Disclosure: Nothing to disclose.
P260 | The impact of rotating work schedules
on sleep quality among hospital female nurses
and midwives
Y. Nagaura1; S. Uekata2; C. Kato2; H. Eto2; H. Kondo1,3,4;
T. Maeda5
1General Medicine, Nagasaki University Graduate School of Biomedical
Sciences, Ngasaki, 2Reproductive Health, Nagasaki University Graduate
School of Biomedical Sciences, 3Research and Clinical Center for Yusho
and Dioxin, Kyushu University Hospital, 4Center for Sleep Medicine,
Saiseikai Nagasaki Hospital, 5Community Medicine, Nagasaki University
Graduate School of Biomedical Sciences, Nagasaki, Japan
Objectives/Instruction: In Japan, shift work systems in nursing
jobs are undergoing a transition from a conventional three‐shift to a
two‐shift working system. The current cross‐sectional study was
designed to investigate the subjective sleep quality among nurses
and midwives working under these rotating work schedules.
Methods: In total, 2,154 female nurses and midwives working in
five hospitals were asked to participate in this study and subjective
sleep quality was assessed using the Japanese version of the Pitts-
burgh Sleep Quality Index (PSQI). Of the 1,580 effective responses,
we analyzed the data of 1,057 subjects engaged in four working
schedules as follows: day shift, rotating with a 12.5‐hr night shift,
rotating with a 16‐hr night shift, and a three‐shift work system.
Results: The percentage of poor sleepers with a total PSQI score
of 6 or more among day shift, 12.5‐hr night shift, 16‐hr night shift,
and three‐shift workers were 41.6%, 51.8%, 44.5%, and 59.8%,
respectively. The median (interquartile range) of the total PSQI score
in the three‐shift worker group was significantly higher than those in
the three other groups (6.0 [4.0–8.0], p < 0.001). In addition, 38.7%
of the three‐shift worker group had difficulty initiating sleep. The
influence of the shift work system on poor sleepers was further
assessed by logistic regression analysis adjusted by age, body mass
index, smoking, drinking, and presence of spouse and child. Using
the day shift as the reference group, the odds ratio (OR) for poor
sleep was 1.51 (95% CI; 0.98–2.33) in the 12.5‐hr night shift, 1.17
(95% CI; 0.79–1.71) in the 16‐hr night shift, and 2.01 (95% CI; 1.36–
2.96) in the three‐shift work system.
Conclusions: Regardless of the working schedules in our study,
poor sleep rates were high among hospital nurses and midwives.
Remarkably, subjective sleep quality of three‐shift workers was sig-
nificantly affected and resulted in insomnia, which was mainly due
to difficulties initiating sleep.
Disclosure: Nothing to disclose.
P261 | Primary care treatment of pain‐related
insomnia: a feasibility study of a hybrid cognitive
behavioural therapy approach
N. Tang1; C. Moore1; H. Parsons2; H. Sandhu2; S. Patel2;
D. Ellard2; V. Nichols2; J. Madan2; B. Parker2; U. Sharma3;
M. Underwood2
1Psychology, 2Clinical Trials Unit, Warwick Medical School, 3University/
User Teaching and Research Action Partnership, University of Warwick,
Coventry, United Kingdom
Objectives/Instruction: Hybrid cognitive‐behavioural therapy
(Hybrid CBT) is a new approach to tackling pain‐related insomnia.
The study tested the feasibility of adapting and implementing the
Hybrid CBT in primary care using a mixed‐method approach.
Methods: Twenty‐five patients with chronic pain and comorbid
insomnia were recruited from three local general practices and
randomly allocated to receive either the Hybrid CBT or a self‐help
control treatment, in addition to treatment as usual. The Hybrid
CBT involved four weekly one‐to‐one sessions of 2 hr delivered
by a trained Health Psychologist in the community. Participants in
the self‐help control group were sent four information booklets in
the post, one weekly, to mirror the dose and frequency of the
Hybrid CBT. All participants were assessed using questionnaires at
baseline, 12 and 24‐week post‐randomisation. Candidate primary
outcome measures for the definitive RCT were the Insomnia
Severity Index and Brief Pain Inventory. Secondary outcomes mea-
sures were the Multidimensional Fatigue Inventory, Hospital
Anxiety and Depression Scale and EQ5D‐5L. Five patients (20%)
were interviewed by an independent researcher pre‐ and post‐
treatment.
Results: Six health psychologists were offered intensive training to
deliver the Hybrid CBT; four were able to travel and provide their
service across sites. Fourteen participants were randomised to
receive Hybrid CBT, 11 to receive the self‐help control treatment.
Of the 14 in the Hybrid CBT group, 9 (64%) completed all treatment
sessions (4 discontinued due to poor health, 1 time constraints). The
total number of participants completing the 12‐ and 24‐week follow‐
up were 12 (6 per group; Hybrid CBT:43%; Self‐Help:55%) and 10 (5
per group; Hybrid CBT:36%; Self‐Help:45%). Candidate outcome
measures appeared to be sensitive to treatment effects. Thematic
analysis of pre‐post interview data revealed satisfaction with treat-
ment content among those who completed the Hybrid CBT, whereas
those in the self help group wanted therapist guidance on sleep
management.
Conclusions: The experience of delivering a complex psychological
intervention for the self‐management of both chronic pain and
insomnia in primary care has been challenging but informative.
Important lessons were learnt with regards to the infrastructure
required to achieve more efficient therapist recruitment/training and
better patient adherence and retention.
Disclosure: This abstract presents independent research funded by
the NIHR under its Research for Patient Benefit (RfPB) Programme
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(Grant Reference Number PB‐PG‐0213‐30121). The views expressed
are those of the author(s) and not necessarily those of the NHS, the
NIHR or the Department of Health.
P262 | Influence of regular physical exercise
on sleep quality and presence of sleep disorders
in patients assisted at the Basic Health Units of
Divinópolis, Brazil
K.N. Assunção1; D.A.G. Leal1; L.T. Pasqualotto1;
L.F. Martins1; J. Alves1; C.A. Santos1; W.D.M. Santos1;
R.L. Brandão1; L.V.F. Oliveira2; N.S. Faria Júnior1
1University of the State of Minas Gerais, Divinópolis, 2University Center
UniEvangélica, Anápolis, Brazil
Objectives/Introduction: In recent years the interest and studies
by the sleep disorders have increased. Research indicates a high
prevalence of these in adults, being considered a public health prob-
lem. Physical exercise, besides being considered a non‐pharmacologi-
cal intervention to improve sleep quality.
The objective of this study was to compare the quality of sleep and
the presence of sleep disorders in patients who practice regular
physical exercise (PRPE) and non‐regular exercise (NPRPE) patients,
assisted in Basic Health Units (BHUs) of Divinópolis, Brazil.
Methods: The cross‐sectional observational study was carried with
patients recruited from the BHUs. Sleep quality, presence of sleep
disturbances, excessive daytime sleepiness (EDS), risk for obstructive
sleep apnea and quality of life were assessed.
Results: The sample consisted of 64 patients, 32 patients in each
group. The mean age of the PRPE and NPRPE groups was
63.3 ± 8.6 years and 57.7 ± 13.2 years, respectively; 84.4% vs.
81.2% of the patients were female and the mean body mass index
was 26.6 ± 5.2 kg/m2 and 26.7 ± 5.3 kg/m2.
When comparing the groups, the PRPE group had a lower mean on
the ESS, but with no statistical significance. Regarding PSQI, there
was a statistically significant difference in the domains sleep disor-
ders (1.00 ± 0.76 vs. 0.69 ± 0.82 p = 0.025) and dysfunction during
the day (0.43 ± 0.53 vs. 1.00 ± 0.92 p = 0.033).
Regarding the domains of quality of life, there was a statistically sig-
nificant difference in the general state of health (63.54 ± 19.39 vs.
51.54 ± 20.01 p = 0.025), emotional aspects (76.17 ± 27.42 vs.
54.13 ± 26.33 p = 0.005) and mental health (67.50 ± 23.47 vs.
54.63 ± 24.23 p = 0.017).
The PRPE group did not present a history of work‐related accidents
while in the NPRPE group, 4 patients already presented.
Conclusions: PRPE patients assisted in BHUs presented lower
prevalence of poor sleep quality and EDS, although they were not
statistically significant, a greater presence of sleep disorders accord-
ing to PSQI, in addition to a better quality of life and a lower work
accident.
Disclosure: Nothing to disclose.
P264 | Sleep quality and risk for obstructive
sleep apnea in a sample of the Portuguese
population
A.M.C.d. Almendra1; M. Silveira2; V. Clérigo3; P. Pinto4;
H. Estrevão4; J. Moita4
1Centro Hospitalar de Lisboa Norte, Braga, 2Hospital Fernando Fonseca,
3Centro Hospitalar de Lisboa Norte, 4Associação Portuguesa do Sono,
Lisboa, Portugal
Objectives/Introduction: Sleep‐related disorders, particularly
Obstructive Sleep Apnea Syndrome (OSAS), influence the quality of
sleep and have increased in prevalence over the last years.
The aim of this study was to characterize the risk of OSAS and sleep
quality of a sample of the Portuguese population, as well as to verify
the existence of a correlation between the two variables.
Methods: Sleep quality and risk of OSAS were assessed using the
Pittsburgh Sleep Quality Index (PSQI) and the STOP BANG question-
naire respectively in 133 subjects.
Results: The median age was 56 ± 31 years, of which 63.2% were
female and the median body mass index was 25.28 ± 5.08.
Of the sample, 43.6% of the individuals presented a low risk for
OSAS and only 14.3% presented a high risk. In 67.7% the quality of
sleep was classified as poor.
The mean scores for STOP BANG and PSQI were 2.81 ± 1.64 and
8.63 ± 4.86, respectively.
The mean score for STOP BANG was significantly higher in subjects
with poor sleep quality (3.20 ± 1.47 vs. 2.35 ± 1.86, p = 0.025).
A positive correlation was found between STOP BANG and PSQI
(r = 0.20, p < 0.022).
Conclusions: This sample of the Portuguese population demon-
strates poor quality of sleep and a low‐moderate OSAS risk. It was also
found that the higher the STOP BANG score, the lower the quality of
sleep, confirming the negative influence of OSAS on sleep quality.
Disclosure: Nothing to disclose.
P265 | Sleep study for suspected sleep apnea ‐
are we overtesting?
M.A. Galego; A.L. Fernandes; B. Cabrita; C. Coelho;
M. Rodrigo; P. Simao; S. Correia; J. Ferreira
Hospital Pedro Hispano, Matosinhos, Portugal
Objectives/Introduction: Sleep apnea (SA) prevalence is increas-
ing and it is thought to remain underdiagnosed. Due to limited
capacity of sleep laboratories and the crescent testing demand, we
aimed to assess the prevalence of SA among sleep studies requested
to our sleep laboratory and which clinical features were more consis-
tent/predictive with SA diagnosis.
Methods: Retrospective analysis of all polysomnographies (PSG)
performed between March 2017 and February 2018 and type III
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home sleep apnea testing (HSAT) performed between September
2017 and February 2018. Patients’ clinical characteristics were col-
lected by chart review.
Results: A total of 316 exams were performed, 214 (67.7%) HSAT
and 102 (32.3%) PSG. Referral to outpatient consultation was mostly
made by Primary Care physicians (59.2%); 70.3% of sleep tests were
requested by Pulmonologists, followed by Otorhinolaryngologists
(21.2%). Patients were predominantly male (65.8%), median age of
55 ± 19 years and mean body mass index (BMI) of 29.9 ± 5.2 Kg/
m2. Arterial hypertension, dyslipidemia and diabetes were the most
frequent comorbidities with 48.5%, 38.1% and 17.2% respectivelly,
and snoring (89.2%), witnessed apneas (55.3%) and excessive day-
time sleepiness (EDS) (53.9%) the most common symptoms found.
Median Epworth Sleepiness Score was 9 ± 7 points.
Obstructive sleep apnea was the most prevalent disorder‐ 26.3%
mild, 21.8% moderate and 16.5% severe, followed by positional
sleep apnea (18%) and central apnea (2.9%). Autopositive airway
pressure (APAP) was the most frequent treatment option, 43.1%;
there was no indication for therapy in 25.1% (no symptoms or car-
diovascular disease) and 2.8% refused treatment.
Sleep apnea was excluded in 46 patients (14.6%) ‐ when compared
with the group with SA, patients with no SA were younger (48 ± 14
vs. 56 ± 12 years; p = 0.001), had superior female prevalence (45.5%
vs. 32.3%; p = NS), lower BMI (28 ± 5 vs. 30 ± 5Kg/m2; p = 0.007);
also more frequently gasping (25% vs. 18%; p = NS), EDS (50% vs.
45%; p =NS) and headache (22.7% vs. 13.9%; p = 0.012).
Conclusions: Our study revealed a low number of exams excluding
SA, meaning that there is a good efficacy between pre‐test patient
evaluation and the diagnosis of SA.
Disclosure: Nothing to disclose.
P266 | A curriculum for a two day PAP, oral
appliance and hypoglossal stimulator handling
expertise course for nursing staff in geriatric
medicine
N. Netzer1; P. Netzer1; H. Danker Hopfe2; H. Frohnhofen3;
R. Popp4; Network Geriatric Medicine, Standards and
Methods, Diagnostics of the German Sleep Society
1Hermann Buhl Institute University Innsbruck, Bad Aibling, 2Charité –
Universitätsmedizin Berlin, Berlin, 3Krupp Krankenhaus Essen, Universität
Witten‐Herdecke, Essen, 4Psychiatry Sleep Laboratory,
Universitätsklinkum Regensburg, Regensburg, Germany
Objectives/Introduction: The vaste majority of nursing staff in
nursing homes and geriatric acute and rehabilitation clinics worldwide
has no knowledge how to handle PAP, oral appliance, hypoglossal
stimulator devices and PAP masks of their elderly patients with diag-
nosed and PAP or otherwise treated sleep disordered breathing. We
aimed to develop a two day expertise seminar with course end exam
for nursing staff to learn how to handle PAP and other devices and
masks of stationary and ambulant elderly patients.
Methods: In order to develop a stringent feasible weekend course
we formed a consensus group of sleep physicians, geriatricians, sleep
psychologists and sleep technicians, all engaged in the specific work
groups of the German Sleep Society. The consensus group met for a
full weekend in Berlin to find consensus by voting on a practical cur-
riculum for nursing staff, which can be adopted by other sleep soci-
eties and health care providers.
Results: The curriculum spans over 14 full hours plus 1 hr coffee
brakes and 1 hr lunch break each day. The contents are as follows:
Part 1: Basic knowledge about all forms of sleep disordered breath-
ing; basic sleep physiology and sleep disordered breathing in the
elderly; the different forms of PAP treatment, hypoglossus stimula-
tion and oral appliance treatment. Part 2: Hands on training in small
groups in a rotation system: the different types of CPAP machines
how to be handled; the different types of ASV devices how to be
handled, the different types of PAP masks including chin strapes
how to be handled, put on and how to be cleaned; the different oral
appliances how to be handled and cleaned; how to control the
hypoglossal stimulator. Part 3:Theoretical presentations with practica
training: Control of breathing parameters via pulseoximetry; the diffi-
cult elderly patient ‐finding solutions; emergencies‐when to call the
physician. Part 4: Mediated role playing games: Training patient rela-
tives in handling PAP and other treatments; calming down the anx-
ious patient. Part 5: Written end course exam.
Conclusions: We conclude that we developed a feasible and prac-
tical weekend course for geriatric nursing staff in handling all forms
of treatment for sleep disordered breathing.
Disclosure: Nothing to disclose.
P267 | What makes doctors ask patients about
their sleep even if they do not consult for a
sleep complaint? A cross sectional study
M. Maalej1; K. Yaich1; W. Sellami2; R. Feki1; S. Omri1;
L. Zouari1; J. Ben Thabet1; N. Charfi1; M. Maalej1
1Psychiatry ‘C’ Department, Hedi Chaker University Hospital, 2Sfax
Medical School, Sfax, Tunisia
Objectives/Introduction: According to the French National
Authority for Health, because of the impact of insomnia and the fre-
quent absence of complaint from the patients, General Practitioners
(GPs) should have an “active” approach of the question of sleep dur-
ing the assessment of the global health of a patient.
The objective of our study was to identify the factors which allow
GPs to have such an active approach through asking their patients
about their sleep even if the latter do not consult for a sleep com-
plaint.
Methods: We carried out a cross‐sectional survey in May 2016 in
Sfax governorate, Tunisia. A representative sample of 193 GPs was
randomly selected. Among them, 127 accepted to participate in the
study.
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Results: The response rate to our survey was 65.8%. The sex ratio
(Men/Women) was 1.4. Twenty eight GPs (22%) declared they took
into account specific recommendations for the treatment of insom-
nia in their daily practice. Fifty nine GPs (46.5%) reported they often
asked their patients about their sleep when the latter did not consult
for a sleep complaint. Physical examination for insomniac patients
was systematically performed by 89.7% (N = 113) of the partici-
pants. Forty nine GPs (40.8%) esteemed they mastered hypnotic
drugs’ prescription. Seventy two participants (56.7%) thought that
sleep hygiene measures are efficient in insomniac patients. The stim-
ulus control technique was known and used by 9.2% (N = 11) and
5% (N = 6) of GPs respectively.
Often asking about the sleep of patients was correlated to making a
systematic physical examination for patients who consult for insom-
nia (p = 0.003), to mastering hypnotic drugs’ prescription (p = 0.019),
to believing in the efficacy of sleep hygiene measures (p = 0.016)
and to the knowledge and use of stimulus control technique
(p = 0.018 and p = 0.010 respectively).
Conclusions: Targeted continuous medical education on sleep
hygiene and the active approach doctors should have of the ques-
tion of sleep could help tunisian GPs promote good health as it is
defined by the World Health Organisation: a state of complete phys-
ical, mental and social well‐being and not merely the absence of dis-
ease or infirmity.
Disclosure: Nothing to disclose.
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P268 | Morning physiological changes after a
dawn simulation light
V. Gabel; J.M. Zeitzer
Department of Psychiatry and Behavioral Sciences, Stanford School of
Medicine, Palo Alto, CA, United States
Objectives/Instruction: When getting up in the morning, many
older people experience orthostatic hypotension, as the cardiovascu-
lar system is not able to compensate for the postural shift and main-
tain blood flow to the brain. In young individuals exposed to a dawn
simulation light, we found an increase in heart rate and sympathova-
gal tone prior to awakening and a decrease in sleepiness upon awak-
ening. In this study, we will determine whether a dawn simulation
light is able to decrease sleepiness in older adults and increase their
cardiovascular tone and blood pressure such that they would have
reduced postural hypotension when they get out of bed in the
morning.
Methods: 15 older participants (66.8 ± 9.36 years) had two over-
night stays in the laboratory, on one of which a dawn simulation
light was used for 30 min prior to scheduled wake time. Subjective
sleepiness (Stanford Sleepiness Scale), objective alertness (Psy-
chomotor Vigilance Test, PVT) and balance were tested before and
after the night of sleep; heart rate, EEG and blood pressure were
continuously recorded.
Results: Associated with the light exposure, we observed a smaller
increase in heart rate at wake time (5 ± 4%), and a greater increase
in pre‐wake blood pressure (59 ± 19 mmHg, p < 0.02, T‐test). We
found no significant effects of light exposure during sleep on subjec-
tive sleepiness upon awakening, in measures of standing or ambula-
tory balance, or in the median reaction time on the PVT and number
of PVT lapses.
Conclusions: Unlike healthy younger adults, we found no significant
effect on sleepiness after a dawn simulation light exposure in older
adults. We also did not observe an impact on measures of balance and
objective alertness. However, as shown in younger adults, the heart
rate transition appears less abrupt at wake time following the dawn
simulation and blood pressure starts to increase before wake time
under the light exposure. Dawn simulation light appears to prepare
the body in anticipation of a postural change before the awakening.
Disclosure: Nothing to disclose.
P269 | Sleep in Alzheimer's disease spectrum
disorders measured by WatchPAT, a home‐based
polysomnography
S. Park1; J.-E. Kim2; J.H. Roh1; J.-H. Lee1
1Asan Medical Center, Neurology, University of Ulsan College of
Medicine, Seoul, 2Asan Medical Center, Neurology, University of Ulsan
College of Medicine, Kang‐reung, Republic of Korea
Objectives/Introduction: There have been several human studies
regarding sleep parameters and their potential relationship with Alz-
heimer's disease (AD) pathogenesis. Previous studies were limited by
lack of in vivo pathology assessment or lack of intermediate groups
of subjects such as mild cognitive impairment (MCI). Furthermore,
AD patients potentially have more chances of poor sleep in unfamil-
iar environment like a polysomnography room in hospital.
In this pilot study we investigated sleep architecture in subjective
memory impairment (SMI), MCI, and AD patients who completed
amyloid PET scans prior to assessment of their sleep architecture
using WatchPAT® which enables measurements of sleep parameters
at home.
We hypothesized that patients with AD spectrum disorders or sub-
jects with amyloid pathology in the brain may have more sleep prob-
lems.
Methods: A total of 60 subjects (AD, 27; MCI 18; normal cognition
or SMI, 7; and other dementia, 8) were enrolled and completed
detailed neuropsychological tests, MRI, 18F‐Florbetaben PET, and
blood tests.
Unexpectedly, around 30% of AD subjects failed to complete the
WatchPAT monitoring and finally a total of 49 subjects (AD 19; MCI
18; normal cognition or SMI, 7; other dementia, 5) completed the
study. Quality and quantity of sleep and other sleep architectures
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were measured overnight by monitoring peripheral arterial tone sig-
nal reflecting the sympathetic nervous system activation.
All procedures were approved by the institutional review board at
Asan Medical center, Seoul, Korea.
Results: MCI patients showed significantly increase in light sleep
time and AD patients slept less on supine position compared to nor-
mal control/SMI subjects.
(Table 1, 2) When analyzed per amyloid imaging, subjects with amy-
loid positivity had a tendency to have delayed sleep latency com-
pared to the amyloid negative group. (Table 3, 4)
Conclusions: This pilot study results suggest poor sleep quality in
AD spectrum disorders or subjects with amyloid in the brain. Further
studies with increased number of subjects and longitudinal follow‐up
will provide more information of the causal relationship between the
sleep and AD pathogenesis.
Disclosure: Nothing to disclose.
P270 | Sleep disorders, age‐related estrogen
deficiency and melatonin in therapy
I. Madaeva; I. Danusevich; N. Semenova; L. Kolesnikova
Scientific Centre for Family Health and Human Reproduction Problems,
Irkutsk, Russian Federation
Objectives/Introduction: As is well‐known from SWAN study
(H.Kravitz et al., 2003), menopausal status was significantly associ-
ated with difficulty sleeping. It is also known that there is a relation-
ship between sleep disorders and decrease melatonin level.
To assess quantitative characteristics of sleep in perimenopausal
women treated with melatonin in a dose of 3 mg during 3 month.
Methods: A study included 21 perimenopausal women
(51.2 ± 4.7 year) with sleep disorders. IBM −27.09 ± 1.56. Seven-
teen women completed the study. Insomnia Severity Index (ISI)
21.3 ± 0.54. Anamnestic and gynecological examinations,
polysomnographic monitoring (PSM) were used. Polysomnography
(PSG) was performed applying system GRASS‐TELEFACTOR Twin
PSG (USA). All patients received melatonin 30 min before going to
sleep in a dose of 3 mg daily during 3 month.
Results: Insomnia was confirmed by PSM. The dynamics of PSM
demonstrated the improvement of the latency to sleep onset
(39.45 ± 6.71 vs. 23.25 ± 3.71), after 3 months melatonin therapy
(p < 0.05), total sleep efficiency (70.74 ± 9.43 vs. 95.7 ± 5.09) and
increase of REM‐sleep (94.72 ± 21.77 vs. 135.63 ± 22.76),
(p < 0.05). A significant number of EEG activation responses showed
a decrease in sleep fragmentation and improvement of the structure
of sleep segments.
Conclusions: The use of melatonin in a dose of 3 mg during
3 month, is one of the main methods of treatment of sleep disorders
in age‐related estrogen deficiency. The main clinical effect was due
to the elimination of pre‐ and intrasomnic disorders.
Disclosure: Nothing to disclose.
P271 | Sleep quality of older adults living in
different housing arrangements
A. Koscec Bjelajac1; J. Despot Lucanin2; D. Lucanin3;
E.A. Delale2; M. Stambuk4
1Occupational Health and Environmental Medicine Unit, Institute for
Medical Research and Occupational Health, 2Croatian Studies,
Psychology, University of Zagreb, 3University of Applied Health Sciences,
4Faculty of Agriculture, University of Zagreb, Zagreb, Croatia
Objectives/Introduction: Our previous study showed that sleep
quality (SQ) of 167 retirement home residents was impaired in
77.8% participants. Sleep efficiency, sleep latency, and use of sleep
medications were impaired the most, while subjective SQ and day-
time functioning were high. The aim of the present study was to
examine SQ of community‐dwelling (CD) older adults in Zagreb, and
to compare it with SQ of those residing in institutions. Life satisfac-
tion was the strongest predictor of SQ in our nursing home (NH)
study so we wanted to explore whether it would be significantly
related to SQ of CD older adults.
Methods: The results of 55 CD participants (80% females, 63–
86 years) were compared with the results of 60 NH participants
(85.5% females, 69–87 years). All were ambulatory, without diagno-
sis of dementia, and the data was collected individually by trained
interviewers in a local gerontology centre or in nursing homes. SQ
was assessed by the Pittsburgh Sleep Quality Index (PSQI). Two
questions were used to measure subjective health, and a standard-
ized scale to measure life satisfaction.
Results: The results showed that SQ of CD participants was signifi-
cantly better than SQ of NH residents when total PSQI scores were
compared (MCD = 5.6 vs. MNH = 8.2, p = 0.000). The differences in
the same direction were observed for sleep duration (p = 0.000),
sleep efficiency (p = 0.000) and use of sleep medication (p = 0.011).
The overall life satisfaction was of similar value in both groups
(p = 0.065) and it was relatively high, but the self‐rated health was
somewhat better in CD participants (p = 0.044). In CD participants
life satisfaction was associated only with shorter sleep latency
(p < 0.05). When housing arrangement was controlled for, life satis-
faction was significantly correlated to total PSQI score, subjective
sleep quality, sleep latency and sleep disturbances (r = −0.28 to
−0.53, p < 0.01) and to self‐rated health (r = 0.36, p < 0.01).
Conclusions: Our results show that the SQ of CD older adults is
expectedly better than SQ of NH residents, but the factors con-
tributing to SQ seem to differ depending on housing arrangement.
Disclosure: Nothing to disclose.
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P272 | From RBD to AD or mixed
neurodegeneration? A case report
A. Galbiati1,2; G. Carli1,3; F. Casoni1; S. Marelli1; A. Oldani1;
M. Zucconi1; D. Perani2,3,4; L. Ferini-Strambi1,2
1Department of Clinical Neurosciences, Neurology ‐ Sleep Disorders
Center, IRCCS San Raffaele Scientific Institute, 2Vita‐Salute San Raffaele
University, 3Division of Neuroscience, IRCCS San Raffaele Scientific
Institute, 4Nuclear Medicine Unit, San Raffaele Hospital, Milan, Italy
Objectives/Introduction: Rapid Eye Movement (REM) sleep
Behavior Disorder (RBD) is a REM sleep parasomnia that can be a
prodromal sign of neurodegenerative diseases, in particular alpha‐
synucleinopathies such as Parkinson's Disease and Lewy‐Body
Dementia (LBD). Only in a minority of cases a conversion of RBD in
Alzheimer's Disease (AD) has been reported.
Methods: We report the case of a 71‐year‐old patient who
referred in 2010 to our Sleep‐Clinic for a history of sleep‐related
behaviors characterized by motor agitation and aggressiveness,
screaming, crying and falling out of the bed with a daily frequency
from the age of 57.
Results: Habitual snoring, excessive daytime sleepiness and a
symptomatology of Restless Legs Syndrome were also reported.
Polysomnography (PSG) confirmed the suspect of RBD, furthermore
mild Obstructive Sleep Apnea (OSA) and Restless Legs Syndrome
with a Periodic Limb Movement Index (PLMI) of 57.1/hr were also
diagnosed. Neuropsychological evaluation showed a normal cognitive
functioning. The patient was treated with clonazepam and pramipex-
ole. A second PSG performed in 2013 showed no RBD episodes,
PLMI = 0 and Apnea‐Hypopnea Index (AHI) = 2.7. As in the first
assessment the patient exhibited a normal cognitive profile. In 2016,
PSG showed electromyographic phasic activities on submental mus-
cle during REM sleep and AHI = 13.4. Strikingly, the neuropsycho-
logical evaluation demonstrated the presence of multi‐domain
cognitive impairments affecting visuo‐spatial short‐term memory,
verbal long‐term memory, attention and visuo‐spatial abilities along
with complaint in episodic memory reported by the patient since
one year. Notably, Fluorodeoxyglucose Positron Emission Tomogra-
phy (FDG‐PET) image showed a widespread hypometabolism involv-
ing medium and inferior temporal gyrus, temporo‐parietal junction,
superior and inferior parietal lobule, posterior cingulum and pre-
cuneus. Further hypometabolism involved also medial frontal bilat-
eral and dorsolateral prefrontal cortex. This pattern was compatible
with AD.
Conclusions: The clinical course and the instrumental evaluations
confirm the development of a neurodegenerative disease from RBD.
Remarkably, neuropsychological impairments and FDG‐PET imaging
suggest a possible AD pathology that has to be confirmed with fur-
ther investigation. This finding should be cautiously interpreted,
especially from the neuropathological perspective, that will be exam-
ined in depth by means of an Amyloid PET.
Disclosure: Nothing to disclose.
P273 | Links between circadian rhythm
fragmentation, regular physical activity and
amyloid burden in healthy older adults
S. Rehel1; C. André1; E. Arenaza-Urquijo2; V. Ourry2;
F. Mézenge2; D. Vivien2; G. Chételat2; G. Rauchs1
1Normandie Univ, UNICAEN, EPHE, INSERM, U1077, CHU de Caen,
Neuropsychologie et Imagerie de la Mémoire Humaine, GIP Cyceron,
2Inserm, Inserm UMR‐S 1237, Normandie Univ, UNICAEN, GIP Cyceron,
Caen, France
Objectives/Introduction: Sleep‐wake disturbances are increas-
ingly considered as risk factors for Alzheimer's disease (AD) because
of their links with cognitive decline, brain atrophy and amyloid bur-
den. Conversely, studies have shown that lifestyle could have pro-
tective effects against AD, notably physical activity (PA) which has
been related to amyloid. The purpose of this study is to explore the
links between circadian rhythm quality, PA and amyloid burden in
ageing.
Methods: 85 healthy subjects (51 women, 34 men, mean age ±
SD: 69.5 ± 4.1 years), presenting risk factors for AD (memory com-
plaint, cardiovascular risk factors, apoE4), were included in this work.
Circadian rhythm was assessed using actigraphy to estimate sleep‐
wake cycle interdaily stability (IS, i.e., the stability of the rhythm over
days) and intradaily variability (IV, i.e., the fragmentation of the
rhythm relative to its 24‐hr amplitude) over a one‐week period.
Amyloid burden was measured with PET‐AV45, and PA was evalu-
ated with two questionnaires: the Physical Activity Scale for the
Elderly (PASE) and the Modifiable Activities Questionnaires (MAQ),
which respectively measure physical activity over a period of 7 days
and 12 months. To explore the links between circadian rhythm, PA
and amyloid burden in the whole brain or in regions of interest early
affected in AD (namely frontal regions and the precuneus), correla-
tion analysis were computed, with age, gender and Charlson's
Comorbidity Index as covariates.
Results: Circadian rhythm IV is negatively correlated with the level
of PA (r = −0.30; p = 0.007 for the PASE, r = −0.21; p = 0.061 for
the MAQ), and positively correlated with amyloid burden in the pre-
cuneus. Moreover, a lower level of PA (measured with the MAQ)
was associated with higher amyloid burden in the precuneus
(r = −0.26; p = 0.020).
Conclusions: Our results suggest an association between sleep‐
wake cycle quality, PA and amyloid burden in the precuneus, a
region known to be early affected in AD. This work supports the
idea that sleep‐wake disturbances may contribute to cognitive
decline and dementia. Although processes underlying these associa-
tions remain unclear, healthy sleep appears to play a role in main-
taining brain healthy, and our results highlight the potential effect of
physical exercise as a non‐pharmacological intervention for improv-
ing sleep and preventing AD.
Disclosure: Nothing to disclose.
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P274 | Sleep quality, excessive daytime
somnolence and quality of life of elderlies.
G.S. Brandão1; F.W.R. Camelier2; A.A.C. Sampaio1;
G.S. Brandão3; A.S. Silva4; G.S.B.F. Gomes1; L.D. Nogueira5;
L.T. Pasqualotto6; N.S. Faria Junior6; C.F. Donner7;
L.V.F. Oliveira5; A.A. Camelier2
1University of the State of Bahia ‐ UNEB, Department of Education
(DEDCVII.), Senhor do Bonfim, BA, Brazil., 2University of the State of
Bahia ‐ UNEB, Department of Life Sciences (DCV.), Salvador (BA),
3Diagnostic and specialty clinic (IMAIS.), Senhor do Bonfim (BA), 4Nove
de Julho University ‐ UNINOVE, São Paulo (SP), 5University Center
UniEvangélica, Anapolis (GO), 6University of the State of Minas Gerais ‐
Divinopolis Unit., Divinopolis, Brazil, 7Multidisciplinary & Rehabilitation
Outpatient Clinic., Borgomanero (NO), Italy
Objectives/Introduction: To characterize the profile of older peo-
ple with poor sleep quality and analyze possible associations with
excessive daytime somnolence, quality of life and functional mobility.
Methods: This is a cross‐sectional study, involving elderlies. Were
used Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale
(ESS), WHOQOL‐OLD and Timed Up and Go test ‐ TUG. The design
and conduct of this study followed the guidelines of the Reporting
of Observational Studies in Epidemiology (STROBE). The inclusion
criteria were 60 years older and score ≥5 in the PSQI. Participants
with a cognitive decline according to the Mental State Mini‐Exam
and those who were performing some treatment for sleep disorder
were excluded. The data were tested for normality (Kolmogorov-Smir-
nov test) were subjected to a descriptive analysis by the absolute fre-
quencies and percentages for categorical variables and measures of
central tendency and dispersion for numerical variables. Descriptive
statistics, Student′s t test for paired samples and Pearson′s correla-
tion coefficient were used. It was adopted the significance level of
5% (p ≤ 0.05) and statistical procedures were processed and ana-
lyzed in Statistical Package of the Social Sciences (SPSS).
Results: Were involved 131 elderly people, predominantly female
(87%); mean age 68 ± 7 years, low per capita income (84.8% ≤2
minimum wage), low education (86.3% ≤3 years of study), and
mostly staying with relatives (67.9%), married (39.7%) or amassed
(35.9%). Seventy one percent of the sample is above normal weight,
90.1% of women have an abdominal circumference ≥80 cm and a
high prevalence of chronic and psychosocial diseases was identified
in the self‐report, and the risk of obstructive apnea sleep in 38.2%.
The mean PSQI, ESS, WHOQOL‐OLD and TUG were equal to,
respectively, 11.2 ± 3.2; 8.32 ± 2.2; 84.8 ± 10.2 and 8.97 ± 2. It was
observed association of sleep quality with excessive daytime somno-
lence and quality of life, however it was not observed with func-
tional mobility.
Conclusion: The results of the present study allowed to identify a
sleep quality associated with excessive daytime somnolence and
quality of life and also to characterize the profile of elders with poor
sleep quality.
Disclosure: Nothing to disclose.
P275 | Sleep‐wake patterns in older adults
with mild cognitive impairment
T. Aedo1; C. Albala2; L. Lera2; P. Fuentes3; P. Peirano4
1University of Chile/Institute of Nutrition and Food Technology INTA,
2Public Health Nutrition Unit, University of Chile/Institute of Nutrition
and Food Technology INTA, 3University of Chile, 4Sleep and
Neurobiology Laboratory, University of Chile/Institute of Nutrition and
Food Technology INTA, Santiago, Chile
Objectives/Introduction: To establish the association between
Sleep/wake patterns (SWP) and mild cognitive impairment (MCI) in
Chilean elderly dwelling in the community.
Methods: Participants (n = 1,598) were part of the elderly cohorts
of the ALEXANDROS follow‐up study, and the data correspond to
their baseline assessment. A questionnaire was applied including
self‐report of chronic diseases, medication consumption, functional
limitations and, SWP, and an anthropometric evaluation was per-
formed. The nutritional status was categorized according to body‐
mass index (BMI) criteria established by the World Health Organiza-
tion. Cognitive status was assessed with the Mini Mental State
Examination (MMSE) and MCI was defined as having a score <22.
Logistic regression analyzes were performed to identify the associa-
tion between cognitive status and SWP.
Results: MCI showed a positive association with long sleep (≥9 hr;
OR 4.02; 95% CI 1.49–10.80) and a suggestive trend with short
sleep (OR 2.05; 95% CI 0.87–4.85) and daytime sleepiness. By
including nutritional status, the positive association with long sleep
remained apparent, the tendency with short sleep increased their
strength (OR 2.39; 95% CI 0.94–6.09) and with daytime sleepiness
reached significance (OR 2.55; 95% CI 1.04–6.22).
Conclusions: The results show altered SWP in older adults with
MCI. They also suggest that the early assessment of SWP in older
people may help identify those at‐risk for cognitive decline.
Support: FONDECYT (1130947; CONICYT, Chile) grant.
Disclosure: Nothing to disclose.
P276 | Subjective sleepiness and executive
functions over a 14‐hour wake period in elderly
subjects
B. Albinni1; F. Conte1; M. Cerasuolo1; F. Giganti2; G. Ficca1
1Department of Psychology, University of Campania, Caserta,
2NEUROFARBA, University of Florence, Florence, Italy
Objectives/Introduction: Although many clinical studies point to
excessive daytime sleepiness as a common complaint in aging (e.g.,
Ohayon and Vecchierini, 2002), systematic data on the time‐course
of elderlies’ vigilance levels over daytime wake period are surpris-
ingly sparse. A few data have been produced on elderly individuals’
subjective sleepiness and on its associations with objective beha-
vioural signals, such as yawning and blink rate (Zilli et al., 2008; De
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Padova et al., 2009) as well with simple reaction times (Hoch et al.,
1992), whereas the relationships between subjective sleepiness and
more complex performance measures have still to be clarified.
Therefore, the aim of this study is to trace the time‐course of sub-
jective sleepiness and of executive functioning (namely, the inhibi-
tion capacity) over a 14‐hr wake period in an aged population.
Methods: Fortysix elderly subjects (M = 18, F = 28, age
78.0 ± 7.6 years.) were monitored over a 14‐hr period for: (a) subjec-
tive daytime sleepiness, through a 5‐point Likert sleepiness scale
administered every hour from 8:30 to 22:30; (b) executive inhibition
function, by means of a Go‐noGo task that the subjects were
instructed to perform at four times (8:00, 11:30, 16:00 and 21:00),
with omissions (lapses at the Go stimuli) and false alarms (responses
to the noGo stimuli) as dependent variables.
Results: A significant effect of “time of day” was found for subjec-
tive sleepiness (F = 22.6, p < 0.0001), accounted for, as shown by
post‐hoc contrasts, by the higher values at the post‐prandial dip
(14:30 and 15:30 measurements) and in the evening hours (21:30
and 22:30 measurements) relative to all other times. The absolute
values of subjective sleepiness never exceeded the moderate score
of 3.1 on the Likert scale.Instead, no significant effect of “time of
the day” was found for objective measures, both for omission
(F = 1,18, ns) and inhibition capacity (F = 1,74, ns).
Conclusions: Repeatedly and systematically measured across the
whole wake period, our aged population's vigilance seems strikingly
preserved, showing an overall level and a diurnal time course compa-
rable to those described at previous ages. Interestingly, there is no
significant variation across daytime of complex performance, sug-
gesting that this variable is partly irrespective of vigilance levels’
fluctuations.
Disclosure: Nothing to disclose.
P277 | Home exercise improves the quality of
sleep and daytime sleepiness of elderlies
G.S. Brandão1; A.A.C. Sampaio1; G.S. Brandão2; A.S. Silva3;
G.S.B.F. Gomes1; M.S. Matias4; W.M. Santos5; N.S. Faria
Junior5; C.F. Donner6; L.V.F. Oliveira4; A.A. Camelier7
1University of the State of Bahia ‐ UNEB, Department of Education
(DEDCVII.), Senhor do Bonfim, BA, Brazil., 2Diagnostic and specialty
clinic (IMAIS.), Senhor do Bonfim (BA), 3Nove de Julho University ‐
UNINOVE, São Paulo (SP), 4University Center UniEvangélica, Anapolis
(GO), 5University of the State of Minas Gerais ‐ Divinopolis Unit.,
Divinopolis, Brazil, 6Multidisciplinary & Rehabilitation Outpatient Clinic.,
Borgomanero (NO), Italy, 7University of the State of Bahia ‐ UNEB,
Department of Life Sciences (DCV.), Salvador (BA), Brazil
Objectives/Introduction: Aging causes physiological changes which
affect the quality of sleep. Supervised physical exercise is an important
therapeutic resource to improve the sleep of the elderlies, however
there is a low adherence to those type of programs, which it is neces-
sary to implement an exercise program which is feasible and effective.
The study aimed to test the hypothesis that a semi‐supervised home
exercise program, improves sleep quality and daytime sleepiness of
elderlies of the community who present poor sleep quality.
Methods: This was a randomized controlled trial study, conducted
according to the CONSORT stands for Consolidated Standards of
Reporting Trials from May to September 2017, in Brazil, with elder-
lies of the community aging 60 years old or older, sedentary, with
lower scores or equal to 5 at the Pittsburgh Sleep Quality Index
(PSQI) and without cognitive decline. From one hundred ninety‐one
potential participants twenty‐eight refused to participate, therefore,
one hundred thirty‐one (mean age 68 ± 7 years), and 88% female,
were randomly assigned to an intervention group ‐ IG (home exer-
cise and sleep hygiene, n = 65) and a control group ‐ CG (sleep
hygiene only, n = 66). Sleep assessment tools were used: PSQI,
Epworth sleepiness scale (ESS) and clinical questionnaire of Berlin.
The level of physical activity has been assessed by means of Interna-
tional Physical Activity Questionnaire adapted for the elderly (IPAQ)
and Mini‐Mental State Examination for cognitive decline. All partici-
pants were assessed before and after the 12‐week intervention per-
iod and, also, the assessors were blind.
Results: The IG showed significant improvement in quality of sleep
with a mean reduction of 4.9 ± 2.7 points in the overall PSQI
(p < 0.01) and in all its 7 components of evaluation (p < 0.05), and
improvement of secondary endpoint, daytime sleepiness, a decline of
2.8 ± 2.2 points in the ESS (p < 0.01).
Conclusion: Our results suggest that semi‐supervised home exer-
cise is effective in improving the quality of sleep and self‐referred
daytime sleepiness of sedentary elderlies of the community who pre-
sented sleep disorders.
Disclosure: Nothing to disclose.
P278 | Age related sleep stage trends as
measured using remote sleep sensing hardware
B. Quinlivan1; A. Raj2; K. Santo-Domingo2; A. Zaffaroni1;
R.J.E.M. Raymann2
1ResMed Sensor Technologies, Dublin, Ireland, 2SleepScore Labs,
Carlsbad, CA, United States
Objectives/Introduction: With increasing age, an increase in
wake after sleep onset (WASO) and a decrease in deep and REM
sleep is generally observed and has been confirmed in a meta‐analy-
sis published by Oyahon et al in 2004. The Ohayon study provides
normative data for sleep in the sleeping environments included in
the meta‐analysis but is likely not representative of sleeping habits
in the home. The rise of consumer sleep trackers enables measure-
ment of sleep as experienced by people in daily life. Using an unique
set of sleep recordings collected with the S+ by ResMed (a non‐con-
tact bio‐motion sensor that enables home sleep staging estimation
(Schade et al, 2017)), we improved our sleep estimation model and
showed that the S+ technology is capable of capturing the age‐
related trends in sleep‐staging using data collected in real life.
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Methods: We analyzed the relationship between age and Time in
Bed from a subset of 27,098 recordings from the S+ dataset, with
the goal of creating a new model that takes into account both sleep
stage distribution as reported by Ohayon and Time in Bed in the
home environment as measured using S+. This updated set of nor-
mative data was then employed to train the S+ algorithm to more
accurately capture the age‐related trends.
Results: Between the ages of 15 and 75 the Ohayon normative
data shows a decrease in Deep (47.9 min) and REM (26.4 min),
accompanied with an increase in Light (13.7 min) and WASO
(63.3 min). The updated S+ algorithm, run on 27,098 nights of data
showed strong agreement with a decrease in Deep (48.3 min) and
REM (26.1 min), accompanied with an increase in Light (11.7 min)
and WASO (50.4 min) over the same age range.
Conclusions: Here we show for the first time that non‐contact
bio‐motion sleep sensing technology is capable of capturing the
well known age‐related sleep stage trends. As such, its validation
goes beyond the traditional sleep stage agreement statistics, com-
monly used to show validation. This work lays the foundations for
further improvement in the performance of sleep monitoring tech-
nologies and shows their validity for use beyond consumer sleep
tracking.
Disclosure: Brendan Quinlivan and Alberto Zaffaroni are employed
by ResMed. ResMed launched S+ by ResMed in 2014. Ansel Raj,
Kenny Santo‐Domingo and Roy J.E.M. Raymann are employed by
SleepScoreLab.
P279 | Sleep disorders and cognitive
impairement: a longitudinal study
C.A.M. Lo Iacono
Internal Medicine, Sapienza University of Rome, Rome, Italy
Objectives/Introduction:
1 About 50% of the elderly suffer from sleep disorders; in this
context it's important to study the correlation between sleep
and cognitive impairement.
2 to evaluate cognitive function assessed by the MMSE and
GDS in a homogenous population of elderly suffering from
sleep disorders but never been treated before.
3 to analyze the correlation between sleep disturbances (OSAS
and insomnia), sleep duration, snore, symptoms such as diffi-
culty to staying awake during the day and, both, cognitive
impairement and depression.
Methods: We selected 451 patients (247 Male, 204 Female), mean
age 71.50 ± 6.78. All patients were submitted to the anamnestic
evaluation of sleep quality and sleep duration keeping a daily sleep
diary and underwent to polygraphy; daytime sleepiness was assessed
through the Epworth Sleepiness Scale (ESS); the geriatric assessment
of mood and depression was performed using the GDS, the cogni-
tive performance status was assessed using the MMSE.
Inclusion criteria: Patient enrolled were >60 years old and received
first diagnosis of sleep disorders at observation.
Exclusion criteria: Inability to obtain Formal Informed Consent;
MMSE < 10; history of depression or sleep disorders.
Results: There is a statistically significant correlation between:
OSAS, rhoncopathy, daytime sleepiness, symptoms related to sleep
disturbances and mild cognitive impairement.Short sleep duration
(<6 hr) is not related to cognitive deterioration (IC 95%, p = 0.0532).
We didn't find any correlation between patients affected by primary
insomnia and cognitive impairement; it is possible that this result has
been influenced by the difficulty to detect a subject‐related symp-
tom without a standardized instrument in clinical practice to detect
insomnia except medical history.
As far as the evaluation of mood is concerned, we found statistically
significant correlation between: OSAS, short sleep duration (<6 hr),
daytime sleepiness and the possibility to develop depression. While
we didn't find a statistically significant results between insomnia,
symptoms related to sleep disturbances and depression.
Conclusions: Our findings confirm that there is a strong relation-
ship between sleep disorders, cognitive decline and depression. For
this reason, sleep disorders should be systematically evaluated and
searched in all elderly people to recognize and treat disease at an
early stage.
Disclosure: Nothing to disclose.
P280 | Nightly Hypoxemia in the elderly
inpatient population and its link to dementia
S. Wimmer; S. Pramsohler; L. Rausch; N. Netzer;
NiHyGerDem Study Group
Hermann Buhl Institute University Innsbruck, Bad Aibling, Germany
Objectives/Introduction: There is evidence from several studies
that hypoxemia can lead to cognitive impairment. A Norwegian
study showed that roughly 26% of the average elderly population
has nightly hypoxemia (Hjalmarsen and Hykkerud, 2008). There is
still a lack of epidemiological data referring to hypoxemia in the
elderly. The aim of our still ongoing study is to examine subjects
concerning nightly hypoxemia and its effect on cognitive impairment
and dementia. Furthermore this study investigates, if additional sup-
plied O2 for hypoxemic patients results in cognitive improvement.
Methods: n = 164 consecutive subjects (113 f, 51 m) of the inpa-
tient population of the geriatric rehabilitation clinic in Bad Aibling,
Germany, independent of referral reasons and diagnoses with a
mean age of 83.9 years were included. Cognitive functioning was
assessed first and after a period of ten days with the number con-
nection test (NCT), a concentration test (AKT) and the MMSE (de-
gree of dementia). The SaO2 during sleep was measured for at least
4 hr. T90 > 30% was used as a cutoff to distinguish between
hypoxic and non‐hypoxic patients. Data is expressed descriptively
and with Pearson correlation coefficient for correlations between
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cognitive function test and t90 results. Patients who fulfilled the t90
criteria were given a nightly 2 l/O2 supply over a period of 10 days.
Results: 33 of n = 164 patients (20.1%) had a t90 for more than 30%
of the time. There were no significant correlations between the t90
and the cognitive functional testing except the MMSE which correlated
with the t90 scores with r = −0.224. Sex correlates significantly with
t90 (p = 0.000), AKT (p = 0.033) and meanO2 (p = 0.000). 21 out of 33
Patients agreed to an additional O2 supply. We didn′t see significant
improvement of cognitive functioning due to oxygen supply.
Conclusions: We found similar epidemiologic data as the Norwe-
gian group. In this preliminary sample of our study we could see a
correlation between the MMSE and the t90 scores, but not for the
cognitive functioning tests. Additional oxygen provided for the
hypoxemic subgroup did not lead to an improvement in cognitive
functioning assessed by the mentioned tests. This might change with
a larger sample siz.
Disclosure: Nothing to disclose.
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P281 | Dynamic metabolic changes in the
waking and sleeping brain ‐ insights from MR
spectroscopy
M. Lehmann1,2; A. Hock3,4; N. Zölch4,5,6; H.-P. Landolt1,2;
E. Seifritz2,4
1Institute of Pharmacology and Toxicology, University of Zürich, 2Zürich
Center of interdisciplinary Sleep Research, University of Zürich, Zurich,
3Institute for Biomedical Engineering, University and ETH Zurich,
4Hospital of Psychiatry, Department of Psychiatry, Psychotherapy and
Psychosomatics, University of Zurich, Zürich, 5Institute for Biomedical
Engineering, University and ETH Zurich, Zurich, 6Institute of Forensic
Medicine, University of Zurich, Zürich, Switzerland
Objectives/Introduction: Sleep is important for health and cogni-
tive functioning, and dysregulated sleep‐wake processes are at the
core of sleep‐wake disorders. In humans, blood flow during sleep is
decreased compared to wakefulness in the thalamus and anterior
cingulate cortex (ACC). Studies in animals suggest that gamma‐ami-
nobutyric acid‐ergic (GABA) and glutamatergic (GLU) cells in thala-
mo‐cortical projections play an important role in the wake‐to‐sleep
changes in blood flow. Approaches examining the action of neuro-
transmitter systems in humans from the wake‐to‐sleep transition are
largely absent. Recent methodological advances allow for the non‐
invasive detection of naturally occurring metabolite concentrations
with high data quality in circumscribed areas of the human brain.
Methods: Here we aimed at unraveling the dynamic metabolite
changes in the thalamus from wakefulness to sleep onset, and inves-
tigating their possible association with increasing depth of sleep at a
high temporal resolution. We combined proton magnetic resonance
spectroscopy (1H‐MRS; metabolite cycling) for GABA and GLU quan-
tification with simultaneously recorded polysomnography (PSG) in 15
healthy, sleep‐restricted participants (8 females; 21–26 years) who
spent 2 hr during early night‐time (10–12 p.m.) in the MR scanner.
The measurement contained wake and sleep episodes and metabolic
changes in the thalamus were analyzed during wakefulness and sleep
according to a within‐subject design. An additional condition in
which participants stayed awake at the same time of the day was
used as a control for circadian changes in metabolites.
Results: In all participants, a decrease in thalamic GLU concentra-
tion from wakefulness to sleep was observed (p = 0.006). The
decrease correlated negatively with sleep duration in the 2‐hr
recording period (r = −0.84; p = 0.005). During the control wake epi-
sode, no changes in glutamate concentration were observed.
Conclusions: Our results suggest that combined MRS‐PSG allows
for the reliable detection of small metabolic changes between
wakefulness and sleep. Future studies will evaluate whether the
decrease in thalamic GLU reflects a global reduction in neuronal
activity, or whether it is restricted to central hubs subserving
sleep‐wake regulation.
Disclosure: Nothing to disclose.
P282 | Randomized, single dose, double‐blind,
4‐way crossover study determining the abuse
potential of pitolisant compared to phentermine
and placebo, in healthy, non‐dependent
recreational stimulant users
C. Scart-Grès1; B. Setnik2; J.-M. Lecomte1; J.-C. Schwartz1
1BIOPROJET, Paris, France, 2Syneos Health, Raleigh, NC, United States
Objectives/Instruction: A clinical Human Abuse Liability (HAL)
study was conducted to assess the abuse potential of pitolisant, the
first Histamine H3 receptor inverse agonist, a new treatment of nar-
colepsy with or without cataplexy.
Methods: The study was designed to determine the abuse poten-
tial of single doses of pitolisant (optimal therapeutic dose 40 mg
(P40) and supratherapeutic dose 240 mg (P240)) compared to phen-
termine 60 mg and to placebo, in 38 healthy, non‐dependent, recre-
ational stimulant users. The primary endpoint was the peak
maximum effect for Drug Liking (EmaxDL), and many secondary end-
points such Overall Drug Liking (ODL), Take Drug Again (TDA), posi-
tive and negative drug effects, ARCI stimulant scales, safety and PK
parameters were assessed.
Results: EmaxDL was significantly increased by phentermine com-
pared to placebo (p < 0.0001), confirming study validity, while both
doses of pitolisant demonstrated a statistically significant and clini-
cally relevant decrease compared to phentermine with overall profile
similar to placebo. Similarly for ODL and TDA, the difference
between phentermine and pitolisant was always significant
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(p < 0.0001) showing that subjects liked pitolisant less, and had
lower preference to take it again, even a trend toward not taking
drug again for P240, while comparisons between pitolisant and pla-
cebo indicated similar profiles. Moreover bad drug effects were sig-
nificantly higher with P240. Neither dose of pitolisant altered the
ARCI stimulants scales, indicating a dissimilarity to amphetamine and
morphine, inferentially producing no signal for euphoria. By contrast,
phentermine produced significant changes in all ARCI scales.
Pitolisant PK parameters and safety profile were consistent with pre-
vious known data. No serious adverse event and the most common
TEAE experienced was euphoric mood with phentermine, and head-
ache with P240.
Conclusions: Overall, this study indicates no evidence for abuse or
misuse of pitolisant either in patients or recreational abusers.
Disclosure: B Setnik is a consultant of Bioprojet, C Scart‐Grès is
an employee of Bioprojet and JM Lecomte and JC Schwartz are
founders of bioprojet company which sponsored this study.
P283 | Olanzapine influence on brain activity
shown in standardized low resolution brain
electromagnetic tomography and heart rate
variability during sleep in healthy subjects
Y. Abshir Ahmed
Max Planck Institute of Psychiatry, München, Germany
Objectives/Instruction: Several studies have shown in the past a
direct influence of olanzapine to prolong slow wave sleep (SWS)
duration as well as causing cardiac and metabolic side effects, which
has been detected in reduced heart rate variabilities (HRV), weight
gain and increased appetite. The subgenual anterior cingulate cortex
(sgACC) has been linked functionally and anatomically to the auto-
nomic nervous system (ANS). It has been described to relate more to
the parasympathetic system of the ANS. We hypothesized, olanzap-
ine's effect in the region of our interest (ROI) Brodmann area 25
(BA25) would be detectable in the standardized low resolution brain
electromagnetic tomography (sLORETA) neuroimaging method, HRV
and in increased appetite by using a self‐ rating questionnaire.
Methods: 10 healthy, young, male subjects underwent two 118
channel Sleep‐ EEG recordings
i) at baseline and
ii) after treatment with increasing olanzapine usage starting with
2.5 mg up to 10 mg for 7 days.
Artifact‐free 5 min EEG clips from the first N3‐sleep cycle were used
for the following frequency bands: δ, θ, α, β1 and β2. ROI BA25 was
analyzed with sLORETA neuroimaging. HRV was analyzed based on:
absolute very low frequency (0.003–0.04 Hz), low frequency (LF),
(0.04–0.15 Hz), high frequency (HF; 0.15–0.4 Hz), and similar relative
power HRV values as well as heart rate (HR).
Results: We observed an increase in the current source density in
α‐ frequency band (baseline 5.42 [SEM = 0.128] in contrast to
olanzapine intake 5.76 [SEM = 0.184]; p ≤ 0.01). In HRV, HR and
relative LF‐power increased (p ≤ 0.02). Positive correlation of HRV
parameters to sgACC alpha‐activity (HF relative) were weakened
after olanzapine intake. The self‐ rated questionnaire increased after
olanzapine intake significantly (p ≤ 0.016), from mean baseline appe-
tite 59.33% (SD ±18.46%) to 70% (SD ±17%).
Conclusions: Reported data suggests that changed activity in
sgACC BA25 participates in increased appetite. Olanzapine may have
a direct parasympathetic brain effect with increases in SWS duration
and α‐ frequency power of sgACC, but also to disturb the brain‐
heart axis due to its anticholinergic effect. Additionally, we've shown,
the possibility of sLORETA to detect pharmacological modulation
during sleep.
Disclosure: Nothing to disclose.
P284 | Relationship between early and late
components of the evoked response to two
different auditory stimuli applied during slow
wave sleep by means of closed‐loop technique
E. Krugliakova1; M. Rytz1; S. Fattinger1; R. Huber1,2
1University Children's Hospital Zürich, 2Department of Child and
Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, Zürich,
Switzerland
Objectives/Introduction: Closed‐loop auditory stimulation is a
promising, non‐invasive approach to boost slow waves during
sleep. The contribution of different features of the auditory
evoked response (event‐related potentials, ERPs) in the enhance-
ment of slow waves are unknown. The present study sought to
compare the ERPs to two auditory stimuli with different frequency
composition.
Methods: We collected high‐density sleep EEG (N = 6,
23.7 ± 1.3 years old) in two conditions carried out in different
nights: closed‐loop auditory stimulation in the up‐phase of slow
waves (STIM night) and non‐stimulation (BS night). Two types of
stimuli were used: 1/f pink noise (PN, ~50 dB, 100 ms) and a com-
plex tone (Chord, ~60 dB, 100 ms), composed of four sinusoidal
tones (352, 440, 528 and 704 Hz). We assessed the differences
between two stimuli types by comparing ERPs in 2.5 s epochs.
Results: There was no group‐level difference in the amplitude of
ERPs between PN and Chord. We assessed two features of the
ERPs: the P200 component of the ERP (at ~250 ms), reflecting initial
sound processing, and the amplitude of the evoked K‐complex (from
0.3 to 2 s), used as an individual marker of the efficacy of auditory
stimulation. To probe if processing of PN and Chord differs among
participants, we correlated the ratio of P200 (PN/Chord) and the
ratio of the evoked K‐complex (STIM/BS). We observed a significant
positive correlation (rs(6) = 0.943, p = 0.017), indicating that a large
difference in P200 between two stimuli types was associated with
bigger amplitude of the evoked K‐complex.
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Conclusions: The positive correlation of the ratio (PN/Chord) in
P200 and the amplitude of the evoked K‐complex (STIM/BS) indi-
cates that higher efficacy of auditory stimulation was associated with
more fine‐grained sensory processing. Source localization may help
us to understand where this effect originates from.
Disclosure: Nothing to disclose.
P285 | Differential regulation of theta and fast‐
gamma oscillations in the waking state of mice
disrupted in Hypocretin/Orexin Receptor‐1, or 2
selectively in noradrenergic, or dopaminergic
neurons
A. Vassalli; S. Li; P. Franken; M. Tafti
University of Lausanne, Lausanne, Switzerland
Objectives/Introduction: Neuromodulation of cortical and sub-
cortical circuits by the Hypocretin/Orexin (HCRT) neuropeptides is a
fundamental determinant in stability and EEG spectral quality of
behavioral states.
Methods: To investigate the specific roles of the Hypocretin‐to‐
Noradrenergic (HCRT‐to‐NA), and HCRT‐to Dopaminergic (HCRT‐to‐
DA) circuits in regulating brain's oscillatory rhythms, we created con-
ditional HcrtR1 and 2 KO (cKO) genetic alleles and selectively dis-
rupted the Hcrtr1 gene in NA neurons, and one or both genes in DA
neurons. Resulting mice were exposed to various behavioral para-
digms, as their EEG/EMG activity was recorded, and their behavior
was video‐taped.
Results: Disrupting the HCRT‐to‐NA connectivity (n = 9 mutant; 7
control mice) confirmed its importance in mounting a robust theta/
fast‐gamma oscillatory response in stressful conditions, but also
revealed conditions where it may, in contrast, curb hyperarousal.
Mice with DA‐selective HcrtR2 disruption (n = 9 mutant; 9 control),
but not inactivation in HcrtR1, or both receptors, were found to
exhibit a constitutive upregulation in theta frequencies while awake,
with a constitutive active‐waking state, which was uncoupled to
locomotor activity. Such EEG oscillatory profile of mice lacking
HCRTR2 in DA cells resembles, paradoxically, the one of mice in
which ventral tegmental area dopaminergic (VTA‐DA) neurons were
optogenetically stimulated. We aim to investigate at an electrophysi-
ological level how HCRTR2 signaling affects theta network activity.
We also found that alterations in the mice’ waking spectral profiles
were associated with specific alterations in the spectral quality of their
subsequent Slow‐Wave Sleep (SWS). In particular theta/fast‐gamma‐
enriched wakefulness was found to have a specific homeostatic impact
on a slow component of the delta oscillatory rebound in SWS.
Conclusions: HCRT signaling astutely regulates brain oscillatory
network activity, in manners that appear to widely diverge in differ-
ent behavioral contexts. Moreover, the HCRT circuit appears to use
distinct wake‐promoting monoaminergic cell groups to differentially
adapt and configure wake and sleep states to environmental contin-
gencies, using an array of codes we are just starting to uncover.
Supported by the Swiss National Science Foundation.
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P286 | Homer1a upregulation in the claustrum,
a neuronal super‐hub, may influence sleep/wake
behavior
J. Staib; J. Zhu; X. Guo; A. Pack; N. Naidoo
Center for Sleep and Circadian Neurobiology, University of Pennsylvania,
Philadelphia, PA, United States
Objectives/Instruction: Homer1a, an immediate early gene and
dominant negative member of the Homer family of synaptic signaling
proteins, is rapidly increased by neuronal activity and sleep loss.
Homer1a knockout mice have reduced ability to sustain wakefulness
and Homer1a is required for downscaling excitatory synapses during
sleep. The cellular basis of these effects are unknown. Using in situ
hybridization (ISH), we examined Homer1a expression in the mouse
brain following acute sleep deprivation (SD) to determine the spatial
localization of expression changes. Quantitative PCR (qPCR) was used
to confirm ISH results.
Methods: Brains were harvested for ISH from male C57BL/6 mice
(young, 2‐month; aged, 18‐month; n = 8/age) sleep deprived for 1 or
3 hr, undisturbed control mice (n = 8/age) sacrificed at the same
diurnal time‐point, and mice (n = 3/age) allowed recovery sleep for
3 hr. Brain regions identified by ISH were micro‐punched out from
3‐hr SD mice for qPCR. Relative gene expression was calculated
using the deltaCt method. Comparisons were performed using non‐
parametric Wilcoxon tests (2 groups) or Kruskal‐Wallis tests (multiple
groups) followed by pairwise Wilcoxon tests.
Results: Homer1a was upregulated in the claustrum, cingulate and
piriform cortices, but not in the classically studied sleep/wake regions
following acute SD. Claustrum localization was confirmed by
immunostaining with Gng2, a protein enriched in this region, and by
double RNAscope to Homer1a and Gng2. Homer1a levels were
reduced in all brain regions following recovery sleep. Homer1a is
also upregulated in the claustrum of aged mice following SD, but not
reduced after recovery. Using q‐PCR in the regions identified by ISH,
we confirmed that Homer1a was increased in the claustrum
(p = 0.0081) and piriform cortex (p = 0.0051), but not the locus
coeruleus (p = 0.69) or tuberomammillary nucleus (p = 0.066).
Conclusions: Homer1a shows early upregulation in response to SD
primarily in the claustrum and piriform cortex. The claustrum, the most
connected structure in the human brain per unit volume with reciprocal
connections to all regions of the cortex is a neuronal super‐hub. Upreg-
ulation of Homer1a in the claustrum suggests a role for this region in
sleep/wake behavior. Current studies are focused on investigating the
role of the claustrum in sleep/wake behavior using chemogenetics.
Disclosure: Nothing to disclose.
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P287 | Gray matter volume correlates of
sleepiness: a voxel‐based morphometry study in
younger and older adults
T. Åkerstedt1,2; M. Lekander1,2; G. Nilsonne1,2;
P. d'Onofrio1,2; G. Kecklund2; H. Fischer3; J. Schwarz2;
P. Petrovic1; K. Månsson1,3,4
1Clinical Neuroscience, Karolinska Institute, 2Stress Research Institute,
3Psychology, Stockholm University, Stockholm, 4Psychology, Uppsala
University, Uppsala, Sweden
Objectives/Instruction: Sleepiness is prevalent in society, often
linked to disturbed sleep, shift work, stress, or diseases. It is also
associated with an increased risk of accidents. Sleepiness may be
related to brain metabolism and, we hypothesize that it is associated
with brain gray matter (GM) volume. The present study investigated
the association between sleepiness and GM volume in thalamus and
insula, with a special focus on age, since both sleepiness and GM
volume change with age.
Methods: In all, 84 healthy individuals participated in the experi-
ment, of which 46 were in the age range 20–30 years and 38 rang-
ing between 65–75 years. Data was collected in a 3 T scanner
during a 5 min anatomical scan (first in a several sessions in the
scanner) in the evening after a full night of sleep. Momentary sleepi-
ness (Karolinska Sleepiness Scale) was rated 7 times during the time
in the scanner.
Results: iIn older, relative to younger adults, areas within bilateral
insular cortex and thalamus GM regions of interest were negatively
associated (FWE‐corrected) with sleepiness (Z = 4.02, p = 0.015 left
insula and Z = 4.42, p = 0.009 for right insula; Z = 3.75, p = 0.020
for left thalamus and Z = 4.60, p < 0.001 for right thalamus). Larger
volume was associated with low sleepiness in the older group, but
not in the older group. The effect in the insula was mainly present in
the mid‐anterior parts of the structure. In addition, after applying a
conservative small volume correction including all ROIs simultane-
ously, age‐interaction effects remained significant. TST the preceding
day eliminated effects.
Conclusions: eSlf‐rated momentary sleepiness in a monotonous
situation is negatively associated with GM volume in areas within
both thalamus and insula in older individuals. The results are in line
with notions of thalamus as a driver of arousal and of anterior insula
as a structure evaluating the state of the organism. Possibly, a larger
GM volume in these structures may be protective against sleepiness
in older individuals, a hypothesis that needs confirmation in further
studies. Possibly, TST plays a role in the observed associations.
Disclosure: Nothing to disclose.
P289 | Scale invariance attenuation and altered
sleep parameters following increasing dim‐light‐
at‐night duration periods
M. Panagiotou; J.H. Rohling; J.H. Meijer; T. DeBoer
Department of Cell and Chemical Biology, Leiden University Medical
Center, Leiden, The Netherlands
Objectives/Introduction: Artificial light has a widespread use
nowadays. However, light exposure at night has been associated
with various health disruptions including metabolic and immunologi-
cal disturbances, altered circadian timing and sleep disorders. In our
study, we investigated the effect of exposure to different dim‐light‐
at‐night [DLAN, 12:12 hr Light:DLAN (50–100:5 lux)] durations on
rest‐activity behavior, sleep architecture and sleep electroencephalo-
graphic (EEG) parameters in C57BL/6J mice. DLAN can be regarded
as a condition mimicking artificial light exposure at night.
Methods: EEG and the electromyogram was recorded in mice dur-
ing a control light‐dark baseline day (n = 5), following acute 12‐hr
DLAN exposure (n = 5) as well as after one week (n = 5), one month
(n = 5) and three months (n = 9) DLAN. For all the different DLAN
durations, a second day was recorded at the start of which 6 hr of
sleep‐deprivation (SD) were conducted by gentle handling. Addition-
ally, locomotor activity for the control light‐dark (LD), the one‐month
and three‐month DLAN conditions was monitored by passive infra-
red detectors.
Results: Prolonged DLAN exposure led to circadian rhythm disrup-
tion and sleep quality degradation. We applied detrended fluctuation
analysis (DFA) on the behavioral data and found a significantly lower
scaling component α in animals exposed to the 3‐month DLAN condi-
tion compared to control conditions (p < 0.01), while following 1‐
month of DLAN exposure showed intermediate α values between con-
trol LD and 3 months DLAN. Additionally vigilance state distribution
was altered, showing a gradual delay in the waking peak in the dim
light (active) period as a function of DLAN exposure duration (1 day–
1 month) compared to control LD. Following 3 months DLAN expo-
sure, mice showed less non‐rapid‐eye‐movement (NREM) sleep during
the light period (p < 0.05), while waking and NREM sleep levels did
not differ from control dark period, particularly in the first half of the
dim‐light period. Interestingly, a diminished response to sleep depriva-
tion as well as a general attenuation of EEG power density across vigi-
lance states was noted in the 3‐month DLAN condition (p < 0.05).
Conclusions: Our data show that prolonged exposure to DLAN
induces a diminished integrity of the neurophysiological system,
impacting sleep, and sleep regulation as well as the underlying brain
network.
Disclosure: Nothing to disclose.
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P290 | Individual waking alpha EEG power
correlates negatively with adenosine receptor
density measured with PET
D. Elmenhorst1,2; E. Hennecke3; E.-M. Elmenhorst3; T. Kroll1;
D. Aeschbach3,4; A. Bauer1,5
1Forschungszentrum Jülich | INM‐2, Forschungszentrum Jülich, Jülich,
2Department of Psychiatry, Rheinische Friedrich‐Wilhelms‐University
Bonn, Bonn, 3German Aerospace Center, Cologne, Germany, 4Sleep
Division, Harvard Medical School, Boston, MA, United States,
5Department of Neurology, Heinrich‐Heine‐University, Düsseldorf,
Germany
Objectives/Introduction: The spectral components of quantitative
human wake EEG are highly genetically determined which has been
demonstrated in twin and test‐retest studies. The alpha range (8–
12 Hz) dominates the wake EEG. Its occurrence was found to be
related to cerebral energy metabolism by an inverse relation in e.g.
cortical fMRI BOLD and thalamic FDG PET studies. Adenosine is a
neuromodulator directly linked to the energy metabolism by ATP
breakdown and a potential mediator of sleep homeostasis. Individual
differences in alpha rhythm occurrence might be based on adenosine
receptors availability.
The objective of the current study was to investigate whether A1
adenosine receptor density is related to the alpha component of the
wake EEG.
Methods: 14 healthy male volunteers (mean age ± SD
27.7 ± 5.4 years) participated in a dynamic 18F CPFPX bolus/infu-
sions‐PET study with blood sampling and metabolite analyses. Regio-
nal distribution volumes (VT) were determined by calculating the
tissue‐to‐plasma ratio during the steady state phase. Wake EEG was
acquired repeatedly over two days of sustained wakefulness and
after recovery sleep and the alpha power determined by fast Fourier
transformation (μV2) averaged over the sessions and in the respec-
tive range. Adenosine receptor availability in atlas based brain
regions in proximity to the EEG derivations and known to be rele-
vant in sleep wake regulation were correlated with the alpha power
(Pearson's product moment correlational analyses).
Results: Significant negative correlations were found between the
alpha power in the occipital recording (O2 electrode) and striatal
(r = −0.59; p = 0.025) as well as thalamic (r = −0.60; p = 0.02) ade-
nosine receptor availability. Comparable associations were found for
the central recordings (C4) and the anterior cingulate cortex
(r = −0.64; p = 0.013), occipital cortex (r = −0.59; p = 0.03), and the
thalamus (r = −0.6; p = 0.038).
Conclusions: Our findings suggest an individual functional relation-
ship between A1 adenosine receptor availability and EEG alpha
power density.
Disclosure: Nothing to disclose.
P291 | Ambient temperature warming and the
role of the lateral hypothalamus in REM sleep
expression
N. Komagata1; B. Latifi1; D. Hausmann1; M. Schmidt2,3
1University of Bern, 2Centre for Experimental Neurology, Department of
Neurology, Inselspital University Hospital, University of Bern, Bern,
Switzerland, 3Ohio Sleep Medicine Institute, Dublin, OH, United States
Objectives/Introduction: Ambient temperature (Ta) warming
toward the high end of the thermoneutral zone (TNZ) preferentially
increases REM sleep over NREM sleep across species. Although the
role of the anterior hypothalamus in thermoregulation and NREM
sleep expression are well documented, the hypothalamic control of
REM sleep during ambient temperature manipulation remains to be
determined. We examined the potential role of the posterior lateral
hypothalamus (LH) melanin concentrating hormone (MCH) system in
the modulation of REM sleep during Ta manipulation.
Methods: Genetically engineered MCH‐R1‐knockout (KO) mice or
MCH::cre mice implanted with chronic cortical EEG and neck EMG
electrodes were used for experimentation. Mice were housed at
23.0 ± 1.0°C in their home cages in a temperature‐controlled cabi-
net. During the light period at 2 hr intervals, four bouts of rapid Ta
warming to a maximum of 31.7°C were achieved for 30 min with a
thermostatically controlled combination of convection heater and
indirect infrared lamp. To optogenetically manipulate MCH neuronal
activity, we stereotactically injected AAV2‐EF1a‐DIO‐ChR2‐eYFP,
AAV2‐EF1a‐DIO‐ArchT3.0‐eYFP, or AAV2‐EF1a‐DIO‐eYFP (controls)
in the LH of MCH::Cre mice.
Results: In wild type controls (n = 4), REM sleep durations were
significantly increased in the warm TNZ high (27.5–31°C) compared
to the cool TNZ low (24.0–27.5°C) condition (p < 0.05). However,
MCH‐R1‐KO mice (n = 7) showed no significant changes in REM
sleep as a function of Ta. We found that random semi‐chronic optical
activation (ChR2, n = 7, 473 nm) of LH MCH neurons at 20 Hz sig-
nificantly increased REM sleep durations compared to YFP controls
(n = 5, p < 0.05) and compared to the baseline condition, but did
not affect NREM sleep. Optical activation in combination with the Ta
manipulation protocol had an additive effect on increasing REM
sleep (gain of function), beyond what optical stimulation or Ta warm-
ing alone was able to achieve. Finally, optical MCH inhibition (ArchT,
n = 5, 532 nm) appeared to block the expected increase in REM
sleep during Ta warming.
Conclusions: Taken together, these data support a key role for the
MCH system in the output expression of REM sleep during Ta
manipulation, and that concomitant MCH activation with Ta warming
can over‐express this effect.
Disclosure: Nothing to disclose.
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P292 | Caring for those with brain injury:
investigating sleep disturbances and fatigue
N. Grant1; S. Biello1; M. Gardani2
1University of Glasgow, 2School of Psychology, University of Glasgow,
Glasgow, United Kingdom
Objectives/Introduction: Family members such as spouses or
partners often provide long‐term continuous support and care for
individuals with brain injury (BI). Despite this, limited research has
investigated how caregiving impacts carer sleep quality, wellbeing
and fatigue symptomology. This study aimed to investigate the pos-
sible mediating factors that contribute to poor sleep quality in carers
for those with brain injury. More specifically, whether fatigue, anxi-
ety, depression and perceived burden were associated with and/or
predicted poor sleep in carers of those with brain injury.
Methods: A cross‐sectional correlational design was utilised with
237 carers of people with BI completing a battery of measurement
including the Pittsburgh Sleep Quality Index (PSQI; Buyssee et al,
1989), Hospital Anxiety Depression Scale (Zigmond and Snaith
1983), Fatigue Severity Scale (Krupp et al, 1989) and Zarit Caregiver
Burden Interview Short Form (Zarit et al, 1985). Measurements
assessed sleep quality, psychological wellbeing and fatigue.
Results: Study participants (n = 237, 226 female) with mean age of
47.08 (±10.72). Poor subjective sleep (PSQI > 5) was a common
complaint with 94.09% of carers being classified as poor sleepers
(mean score 10.70 ± 3.336). Self‐reported characteristics demon-
strated high instances of fatigue (4.94 ± 1.33), burden (ZBI‐12;
26.27 ± 9.16), anxiety (12.42 ± 4.39) and depression (9.30 ± 3.75) in
carers. Analysis show a significant relationship between anxiety
(r = 0.403, p < 0.001), depression (r = 0.484, p < 0.001) perceived
burden (r = 0.335, p < 0.001) fatigue severity (r = 0.468, p < 0.001)
and sleep quality. Multiple regression analysis revealed a significant
model F (4,237) = 11.67, p < 0.001, R2 = 31.8, with the model
explaining 31.8% of variances in sleep quality. Depression and fati-
gue were significant predictors of sleep quality with fatigue sympto-
mology being the strongest predictor of poor sleep amongst carers
(β2 = 0.760).
Conclusions: Carers demonstrated elevated levels of poor sleep
quality, fatigue and poor psychological wellbeing. Anxiety, depres-
sion, perceived burden and fatigue were associated with sleep dis-
turbances in carers with fatigue and depression predicting poor
sleep. These results provide further emphasis on the necessity for
support provisions which aim to improve sleep hygiene practices,
improve psychological wellbeing and address fatigue symptomology
for carers.
Disclosure: Nothing to disclose.
P293 | Habitual daily caffeine consumption
and its cessation changes human grey matter
density independent from the effect of cerebral
blood flow: a multimodal study
Y.-S. Lin1,2,3; J. Weibel1,2; H.-P. Landolt4,5; F. Müller3;
F. Santini6,7; C. Garbazza1,2; M. Meyer1,2,8; H. Slawik1,2,8;
S. Borgwardt3; C. Cajochen1,2; C. Reichert1,2
1Centre for Chronobiology, 2Transfaculty Research Platform Molecular
and Cognitive Neurosciences, University of Basel, 3Neuropsychiatry and
Brain Imaging, Psychiatirc Hospital of the University of Basel, Basel,
4Institute of Pharmacology and Toxicology, 5Zürich Center for
Interdisciplinary Sleep Research, University of Zürich, Zürich,
6Radiological Physics, University Hospital Basel, 7Department of
Biomedical Engineering, University of Basel, 8Clinical Sleep Laboratory,
Psychiatric Hospital of the University of Basel, Basel, Switzerland
Objectives/Introduction: Grey matter density (GMD), a structural
brain measure associated with sleep slow wave activity (SWA), is
acutely decreased after caffeine consumption in low consumers. This
effect can be explained by decreases in cerebral blood flow (CBF).
Here, we investigate the effect of long‐term high caffeine consump-
tion and its withdrawal on GMD and its association with CBF.
Methods: Twenty male habitual caffeine consumers (26.4 ± 4.1 y/o,
daily caffeine consumption 472.5 ± 106.6 mg) were recruited in a
double‐blind, crossover design. Each volunteer underwent caffeine
(10 days, 3 × 150 mg), withdrawal (placebo after 9‐day caffeine), and
placebo (10 days) conditions. Sleep electroencephalography was
assessed on day 9 and 10. T1‐weighted MPRAGE (1 × 1 × 1 mm3,
TR = 2,000 ms, TE = 3.37 ms) and 2D‐EPI arterial spin labeling
sequence (4 × 4 × 4 mm3, TR = 3,000 ms, TE = 12 ms) were
acquired in a 3T scanner after 12.5 hr of controlled wakefulness on
day 10. Voxel‐wise multimodal linear mixed‐effect model was per-
formed through VoxelStats toolbox. CBF and condition effects as
two hypothetical factors of the GMD variable were included into the
model step‐wisely. Cluster threshold was set at p < 0.001. All
reported regions were pFWE < 0.05.
Results: Compared to placebo, decreases in GMD were evident in
both caffeine and the withdrawal conditions in mainly frontal, pari-
etal, superior temporal, and subcortical regions. GMD increase was
observed in withdrawal only in inferior frontal gyrus, insula, middle
temporal, superior occipital, and caudates. Independent of condi-
tions, CBF was positively correlated with GMD. The interaction anal-
ysis (CBF × condition) indicated that the correlation in GMD‐
decreased regions in caffeine and withdrawal conditions was particu-
larly evident but diminished in the GMD‐increased regions (observed
only in withdrawal).
Conclusions: Our study corroborates the association between CBF
reduction and an apparent decrease in GMD in both cortical and
subcortical regions after long‐term daily caffeine consumption, this
effect lasts at least 36 hr after withdrawal. The data thus strongly
suggest to carefully control for caffeine‐intake in GMD analyses. Our
data further indicate that the withdrawal‐induced short‐term changes
in the adenosinergic system can affect GMD independent of CBF. It
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remains to be investigated whether this effect can be linked to other
markers of neuronal changes such as sleep slow wave activity.
Disclosure: Nothing to disclose.
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P294 | Measures of interoception during
changes in conscious state from wakefulness to
sleep and their potential significance for altered
awareness in psychiatric conditions
J. Lechinger1; D.P.J. Heib2; W.R. Gruber3; M. Schabus2;
S.-L. Weinhold1; R. Göder1; W. Klimesch3
1Centre for Psychiatry and Psychotherapy, Sleep Medicine, University
Hospital of Schleswig‐Holstein, Kiel, Germany, 2Laboratory for Sleep &
Consciousness Research, 3Psychology, University of Salzburg, Salzburg,
Austria
Objectives/Introduction: In order to create a holistic conscious
percept, the perceiver′s brain needs to form a subject as reference
for this percept. During altered states of awareness such as sleep,
measures of interoception should therefore change. Interestingly,
also psychiatric conditions with altered subjective awareness such as
psychotic or dissociative symptoms exist. Our aim is to detect mea-
sures of interoceptive awareness in healthy and to later on test
these measures in psychiatric conditions with altered awareness.
Methods: So far, we've studied 24 healthy sleepers (mean age =
24.42 years, SD = 2.59, 12 females). 8 hr PSG was recorded using a
32‐channel Synamps amplifier (NeuroScan Inc., Texas). Preprocessing
and R‐peak detection was done in Brain Vision Analyzer 2
(BrainProducts, Germany). Spindle/slow oscillation detection was
done using Matlab routines. Heartbeat evoked potentials (HEP) were
calculating by averaging 1,000 random segments per subject per
sleep stage. HEP amplitudes were detected around 250–400 ms post
R‐peak according to prior literature. ANOVAs and bootstrapping
statistics were calculated. To determine the spectral peak frequency
per sleep stage at Oz, the signal was segmented into 6 s epochs,
Fast Fourier transformed, and averaged over segments.
Results: Frontocentral HEP amplitude decreased from wake to
deep sleep, with a renewed increase during REM (ANOVA sleep
stage × laterality, sleep stage: F (5,110) = 3.74, p < 0.01, ɛ = 0.76).
Interestingly, heartrate and spectral peak frequency significantly cor-
related during wakefulness (r = 0.48, p < 0.05). With increasing sleep
depth this correlation faded (S2: r = 0.40, p = 0.056; S3: r = 0.34,
p = n.s.; S4: r = 0.26, p = n.s.). Heartbeats appearing during a sleep
spindle did not produce a detectable response. Furthermore, during
SWS we found a temporal coupling of heartbeats and slow oscilla-
tions with a significant R‐peak grouping during the up‐state
(Z = 23.19, p < 0.001).
Conclusions: Our results strongly indicate a coupling between car-
diac and central nervous activity which changed with conscious state
from wakefulness through sleep. Our aim is to now investigate
whether these potential measures of interoception vary with patho-
logical alterations of conscious perception in patients with
schizophrenia and dissociative symptoms.
Disclosure: Nothing to disclose.
P295 | Genetic contribution to slow wave
energy in adolescents
A. Markovic1; P. Achermann2; L. Tarokh1
1University of Bern, Bern, 2University of Zurich, Zurich, Switzerland
Objectives/Introduction: The sleep homeostatic process in adults
has been shown to be moderately stable over time and unique to an
individual. Work in transgenic mice has suggested a role of genes in
sleep homeostasis. The aim of the current study was to quantify the
genetic contribution to sleep homeostasis in adolescence. We use
slow wave energy (SWE) as a metric for the amount of dissipated
sleep pressure. This measure reflects both the magnitude of slow
wave activity and sleep duration.
Methods: High‐density (58 derivations) sleep EEG was recorded in
14 monozygotic (MZ) and 12 dizygotic (DZ) adolescent twin pairs
(mean age = 13.2; SD = 1.1; 20 females). Slow wave energy (SWE)
was quantified as the cumulative sum of slow wave activity (1–
4.6 Hz) over the night. Structural equation modelling was used to
quantify the amount of variance in SWE due to genes.
Results: On average we found that 74% of the variance in SWE
across scalp derivations was due to genes. The genetic contribution
to SWE was consistently high across all derivations.
Conclusions: Our results show that the amount of sleep pressure
dissipated is largely under genetic control. Given the importance of
adequate sleep for optimal functioning our findings have broad impli-
cations.
Disclosure: Nothing to disclose.
P296 | Slow‐wave enhancement reduces
trauma‐induced APP overexpression in novel
mouse model of traumatic brain injury
compatible with EEG/EMG headset
M.M. Morawska1,2; D. Noain1; T. Scammell2; C.R. Baumann1
1Neurology, University Hospital Zurich, Zurich, Switzerland, 2Beth Israel
Deaconess Medical Center, Neurology, Harvard Medical School, Boston,
MA, United States
Objectives/Introduction: Traumatic brain injury (TBI) is one of
the leading causes of death and disability worldwide, with cognitive
impairment being the most prevalent symptom. We recently showed
that slow‐wave modulation could be used as a potential therapeutic
option for protein overexpression/accumulation in TBI. Here, we
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present further evidence supporting the role of slow‐wave oscilla-
tions in the delta frequency band in decreasing protein burden fol-
lowing TBI in mice.
Methods: We adapted a classical weight‐drop diffuse mouse TBI
model for use in animals preinstrumented with EEG/EMG headset by
applying a 70° angle for a 115 g impactor falling from 1 m distance.
We then characterized posttraumatic cognition and assessed overex-
pression of amyloid precursor protein (APP) as a histological trauma
indicator. We tested the effect of 3 doses of sodium oxybate (per
os; 100, 200, and 400 mg/kg) on NREM duration and EEG spectral
power during NREM sleep. Finally, we tested the effect of 3 day, 2×
day 400 mg/kg sodium oxybate treatment regime on trauma‐induced
APP overexpression.
Results: Our results show that our mild TBI model results in APP
overexpression in perikarya, dendrites and axons (two‐way ANOVA,
p < 0.01, n = 4/group). The TBI animals showed impaired object
recognition 5 days after trauma (t‐test, compared to chance level
(0.5), SHAM: p < 0.05, TBI: ns, n = 8/group). Sodium oxybate had
dose‐dependent effect on the NREM duration (dark phase: repeated
measures ANOVA, p < 0.01, light phase: repeated measures
ANOVA, p < 0.05, n = 5/group) and increased EEG power in the
delta band (Dunett's multiple comparisons (compared to vehicle):
100 mg/kg: 1.5 Hz p < 0.05, 2–2.5 Hz p < 0.001; 200 mg/kg: 0.5–
3 Hz p < 0.001; 400 mg/kg: 0.5–2.5 Hz p < 0.001, 3.5 Hz p < 0.05,
4 Hz: p < 0.01; n = 4) in the first 2 hr post‐injection. Twice daily
administration of sodium oxybate during 3 days after trauma signifi-
cantly reduced trauma‐induced APP overexpression in the cortex
(two‐way ANOVA, p < 0.01, n = 4/group).
Conclusions: In summary, our murine model shows high degree of
construct, face and predictive validity, reflected by replicability of
histological trauma marker and cognitive impairment, compared to
other rodent models. Further experiments aimed at decreasing delta
power following TBI are needed to fully establish the role of slow‐
wave oscillatory activity in posttraumatic recovery.
Disclosure: Nothing to disclose.
P297 | The 0.02 Hz‐oscillation in sigma power
times spontaneous transitions from non‐REM
sleep
R. Cardis; S. Lecci; A. Lüthi
DNF, Unil, Lausanne, Switzerland
Objectives/Introduction: The mechanisms regulating the microar-
chitecture of non‐REM sleep (NREMS), in particular fluctuations in
arousability levels, are critical for sleep pathophysiology. Optogenetic
manipulations of specific neuronal populations trigger shifts in arou-
sal probability, yet correlates in undisturbed NREMS are unclear. We
investigated spontaneous exits from NREMS with respect to the
infra‐slow 0.02 Hz‐oscillation in sigma power (10–15 Hz), which cor-
relates with permissive windows for auditory stimulus‐induced
NREMS‐wake transitions (Lecci et al., Science Adv., 2017). An addi-
tional ongoing experiment using optogenetic technique is aimed at
understanding the behavior of the infra‐slow 0.02 Hz‐oscillation in
bouts of NREMS uninterrupted by microarousals.
Methods: We performed 48 hr of polysomnographic recording
(EEG/EMG) in freely‐moving mice sleeping in undisturbed conditions.
The behavioral state was scored with a 4‐s resolution and the tem-
poral dynamics of specific frequency bands were analyzed with
respect to beginnings or ends of NREMS bouts.
Results: Spontaneous exits from NREMS to both wake and REMS
occurred during the fragility period defined by the descending phase
of the 0.02 Hz‐oscillation in sigma power. Moreover, the sigma
power surge preceding NREM‐REM transitions arose from the
0.02 Hz‐oscillation. Microarousals occurred in 25% of fragility peri-
ods, after which the 0.02 Hz‐oscillation continued undisturbed.
Before a transition to REMS, the 0.02 Hz‐oscillation seemed
strengthened, whereas after prolonged wakefulness or REMS, the
oscillation is weakened.
Conclusions: We propose a biological correlate for the microarchi-
tecture of sleep, the 0.02 Hz‐oscillation in sigma power. Sponta-
neous exits from NREMS occur preferentially during permissive
windows defined by the phase of the 0.02 Hz oscillation. To better
discriminate the role of microarousals in the course of the 0.02 Hz‐
oscillation, we planned a new experiment using optogenetic to sup-
press microarousals and characterize the behavior of the uninter-
rupted 0.02‐Hz oscillation.
Disclosure: Nothing to disclose.
P298 | Sleep under cold pressure: rats vs.
hamsters
O. Shylo; V. Lomako; G. Babiychuk
Institute for Problems of Cryobiology and Cryomedicine National
Academy of Sciences of Ukraine, Kharkiv, Ukraine
Objectives/Introduction: It is believed that to cope with cold
environment the hibernators and non‐hibernators use the same
adaptive adjustments but in a different extent. To what degree they
involve sleep in the adaptation to cold have been still poorly under-
stood. The research aim was to compare the effect of rhythmic cold
exposures (RCE) with different intensity of the cold stimulus, increas-
ing cold tolerance, on sleep‐wakefulness pattern in rats and ham-
sters.
Methods: Both males of white breedless rats (Rattus norvegicus)
(250–300 g) and golden hamsters (Mesocricetus auratus) (85–95 g)
were cold exposed over two days to −12°C or 10°C in the light per-
iod for 15 min hourly, for a total of nine exposures per day. Continu-
ous EEG, EMG registration and animals’ locomotor activity video
recording were performed.
Results: Rhythmic cold exposures (−12°C) nearly inverted the daily
rhythms of vigilance states distribution both in rats and hamsters.
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The significant decrease in REMS (7.9 ± 1.03 vs. 4.55 ± 1.41, n = 5,
p = 0.02, rats, control vs. RCE, respectively, 12.46 ± 1.03 vs.
8.32 ± 1.82, n = 6, p = 0.014, hamsters, control vs. RCE respectively)
and SWS (62.51 ± 2.65 vs. 43.97 ± 1.84, n = 5, p = 0.01, rats, con-
trol vs. RCE, respectively, 51.94 ± 6.94 vs. 40.31 ± 7.4, n = 6,
p = 0.01, hamsters, control vs. RCE respectively) amount in the light
phase of the day with subsequent their rebound at night were found
during the first day of the exposure. Hamsters were less susceptible
to RCE (10°C). The only decrease in REMS (12.46 ± 1.07 vs.
10.15 ± 0.06, n = 6, p = 0.01, control vs. RCE respectively) in light
phase during the first day of exposures was found. On the contrary
in rats there was an increase in SWS amount during the light phase
of the day in both days of cold applications (62.51 ± 7.16 vs.
81.11 ± 5.02, n = 5, p = 0.03, 62.51 ± 7.16 vs. 84.55 ± 5.18, n = 5,
p = 0.04, control vs. RCE, the first and the second day respectively).
Conclusions: Despite the ability to hibernate hamsters responded
to the studied cold exposures nearly in the same manner as the rats
were. The only differences were found under the milder temperature
load (10°C). Whether no differences found are accounted to the lost
of hibernation phenotype due to the long selection of laboratory
Syrian hamsters is to be the topic of future research.
Disclosure: Travel grant received from ESRS.
P299 | Sigma power topography maturation
across the first two decades of life
S. Kurth1; R. Huber2; M. Le Bourgeois3
1University Hospital Zurich, 2University Children's Hospital Zurich,
Zurich, Switzerland, 3University of Colorado Boulder, Boulder, CO, United
States
Objectives/Introduction: Sigma power has been associated with
cognitive skills and memory function. However, a data basis is lack-
ing for defining sigma sub‐frequency cut‐offs and differences in
regional occurrence of sigma power. This is particularly important
considering the developmental and age‐related changes in this fre-
quency.
Methods: 83 high‐density sleep EEG (128 channels) recordings
from healthy subjects age 2.4–25.9 years were analyzed (12 subjects
twice, at 2.4–7.9 and 6.6–12.2 years). Standard EEG preprocessing
was applied (artifact rejection, average reference). Topographical dis-
tribution of EEG power was investigated in the slow (10–12 Hz) and
fast (12.25–16 Hz) sigma frequency range (N2, N3). Normalized data
(within‐subject, across topography) were used for linear correlation
with age and nonparametric statistical mapping with supra‐threshold
cluster analysis (p < 0.05). Clusters of electrodes exceeding the 95th
percentile were considered significant.
Results: Age‐related changes became apparent in the topographical
distribution of sigma power: slow sigma revealed a nearly global
decrease with age (104 electrodes, r = −0.59 to −0.28). In the fast
sigma frequency an age‐related decrease was observed in 38
electrodes arranged in a circular manner over centro‐temporal
regions (r = −0.38 to −0.22).
Conclusions: Subdivision into prefrontal‐central and centro‐tem-
poral sigma power maxima was also visually verified (with 7 age
groups) and became most apparent approaching the end of the second
decade. Topographical distribution of sigma power thus emerges into
two different primary locations across maturation. Findings suggest
that in later adolescence two regionally differing network refinements
occur in the thalamocortical system. This marker may facilitate the
localization of maturational processes in neuronal networks underlying
thalamocortical connectivity and associated cognitive abilities.
Disclosure: Nothing to disclose.
P300 | Cortical perturbations reveal local
sleep‐like down states in cortical perilesional
area
S. D'Ambrosio1; M. Fecchio1; S. Casarotto1; A. Pigorini1;
C. Landi2; M. Rosanova1; M. Massimini1; S. Sarasso1
1University of Milan, 2European Foundation for Biomedical Research
FERB Onlus, Milan, Italy
Objectives/Introduction: The electrical properties of the portions
close to cortical lesions are still poorly defined and we are left to the
notion that slow waves can be detected in the wake EEG of those
areas. In this work we investigated the occurrence of a general sleep
related neurophysiological mechanism over the perilesional areas of
unilateral cortical ischemic stroke patients.
Methods: Here we assessed local cortical excitability in unilateral
stroke patients using a combination of navigated transcranial mag-
netic stimulation and high‐density electroencephalography (TMS‐
EEG).
We performed TMS‐EEG measurements in a group of ten
chronic stroke patients, with unilateral, focal cortical lesions (4 F; age
[y ± SEM]: 68 ± 4). Each patient underwent at least to 2 TMS‐EEG
measurements (one over the perilesional area of the affected hemi-
sphere and one over the homologue contralateral cortical site over
the healthy hemisphere, allowing a direct intra‐subject comparison).
For each cortical site we collected about 200 single‐trials for subse-
quent analysis and averaging.
Results: In unilateral cortical lesions, TMS‐evoked EEG potentials
(TEPs) recorded over perilesional areas were characterized by the
occurrence of a pronounced slow wave (<4 Hz) associated with a
suppression in the high‐frequencies range (>20 Hz). Statistical analy-
sis between the two conditions were performed across subjects,
resulting as follows: amplitude of slow waves comparison, t = 3.3
and p = 0.0076; high frequencies suppression comparison, t = 4.2
and p = 0.0017.
Conclusions: In all patients, the stimulation of the healthy hemi-
sphere was characterized by a complex, long‐lasting EEG response
similar to those obtained in healthy control subjects. On the other
ABSTRACTS | 227 of 433
hand, when applied over the affected hemisphere within the same
patient, TMS invariably evoked a high‐amplitude, positive‐negative
EEG response closely resembling those obtained during NREM sleep
and general anaesthesia in healthy subjects.
The comparisons were significant for all the subjects, suggesting the
occurrence of local cortical down state confined to intact portions of
the cortical mantle surrounding the ischemic damage.
These results show the occurrence of a general sleep related neuro-
physiological mechanism over the perilesional cortical areas. This is
relevant since while anatomical lesions and disconnections cannot be
reversed, it may still be possible to modulate intrinsic neuronal/net-
work properties thus promoting functional recovery.
Disclosure: Nothing to disclose.
P301 | Peripheral sympathetic activations
underlying PWA drops induce significant
changes in EEG activity in a sleep‐stage‐specific
manner
M. Betta1; G. Bernardi1,2; G. Handjaras1; A. Leo1; P. Papale1;
E. Ricciardi1; P. Pietrini1; J. Haba-Rubio2; R. Heinzer2,3;
F. Siclari2
1MoMiLab Research Unit, IMT School for Advanced Studies Lucca, Lucca,
Italy, 2Centre d'Investigation et de Recherche sur le Sommeil (CIRS),
3Pulmonary Department, Lausanne University Hospital, Lausanne,
Switzerland
Objectives/Introduction: EEG‐microarousals during sleep are asso-
ciated with surges in sympathetic activity and represent the hallmark
of pathological sleep fragmentation common to many sleep‐related
disorders. However, little is known about their time‐frequency compo-
sition and its modulation by the magnitude of concomitant sympa-
thetic activity. Here we used drops in pulse wave amplitude (PWA)
measured by photoplethysmography (PPG) as a marker of peripheral
sympathetic activation [1]–[4] to investigate associated EEG changes.
Methods: PWA‐drop detection [5] was performed on the overnight
PPG of 16 subjects of the HypnoLaus Cohort [6]. EEG‐activity was
analyzed in six channels: F3/4‐C3/4‐O1/2. For each sleep stage, a
regression analysis was performed on the time‐varying root‐mean‐
square of band‐pass‐filtered EEG‐signals (delta: 0.5–4 Hz, theta: 4–
8 Hz, alpha: 8–12 Hz, sigma: 12–16 Hz, beta: 16–25 Hz, gamma:
25–45 Hz), using as regressor the PWA‐drop timing (40% amplitude‐
threshold). A permutation test was performed by randomly shuffling
events within the regressor. Then, we explored drop‐induced EEG
changes and their correlation with the PWA area under the curve
(AUC). For each PWA‐drop (10% amplitude‐threshold), a time‐fre-
quency representation of EEG changes (1s time‐windows; 75% over-
lap; 1 Hz frequency‐bin; 0–35 Hz) was computed in a 14s‐window
centered on the PWA‐drop beginning. Power values were z‐scored
using EEG‐activity ‘background’ values estimated from a 60 s time‐
window centered on each drop (drop‐associated periods were dis-
carded).
Results: EEG‐activity was significantly modulated by PWA‐drops in
all sleep stages, with the most consistent effect within delta and
beta/gamma bands (p < 0.05 in >80% of subjects). In all sleep stages,
PWA‐drops were preceded by sharp significant increases in delta
power and followed by significant high‐frequency increases (alpha/
beta/gamma). In light NREM sleep, relative high‐frequency increases
were evident even for small PWA‐drops, while this was not the case
for slow‐wave sleep.
Conclusions: Our results demonstrate that sympathetic activations
are associated with quantitative and qualitative EEG changes that
depend both on the magnitude of the autonomic activation and the
sleep stage. This time‐frequency characterization of EEG changes
may be employed to define new automatic algorithms to detect
sleep‐stage‐specific micro‐arousals. This will be helpful in order to
understand arousal‐related pathological mechanisms involved in
many sleep disorders.
Disclosure: Nothing to disclose.
P302 | Sleep orchestrates input‐specific
plasticity and global stability of neural assemblies
in the human cortex
J.G. Maier1,2; M. Kuhn2; F. Mainberger2; K. Nachtsheim2;
S. Guo2; U. Bucsenez2; B. Feige2; C. Mikutta1; S. Klöppel2,3;
C. Normann2; D. Riemann2; C. Nissen1,2,4
1University Hospital of Psychiatry and Psychotherapy, Bern, Switzerland,
2Department of Psychiatry and Psychotherapy, Medical Center ‐
University of Freiburg, Faculty of Medicine, University of Freiburg,
Freiburg, Germany, 3University Hospital of Old Age Psychiatry and
Psychotherapy, 4Sleep Center, Department of Neurology, University
Hospital, Bern, Switzerland
Objectives/Introduction: Distinct lines of research propose that
sleep promotes input‐specific plasticity after learning (active consoli-
dation hypothesis) and homeostatic scaling to ensure global stability
in neural networks (synaptic homeostasis hypothesis) ‐ a basic chal-
lenge for adaptive functioning in a changing environment (plasticity‐
stability dilemma). However, integrative evidence, particularly in
humans, is absent.
Methods: We tested a total of 30 healthy university students (14
females, 16 males, age 24.0 ± 2.1 years, age range 19–28 years) to
investigate the effect of a short period of NREM daytime sleep
(45 min) on non‐invasive indices of input‐specific specific long‐term
potentiation (LTP)‐like plasticity (paired associative stimulation, PAS)
induced change in motor‐evoked potential) and global stability (wake
EEG theta activity) of human cortex functioning.
Results: We demonstrate a significant increase in MEP amplitudes
(p = 0.022) and stabilization of EEG theta activity (p = 0.049) in the
human cortex after sleep compared with an equal period of wakeful-
ness (repeated‐measures design; PAS experimental group: n = 14).
LTP‐like plasticity correlated with local sleep slow wave and spindle
activity. The observed increase in MEPs after sleep in the PAS
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experimental group, was not caused by sleep itself, but required
prior induction of input‐specific plasticity, as demonstrated by com-
parison with a sham stimulation control condition (Sham control
group; n = 16; p = 0.003).
Conclusions: We provide first evidence for concurrent promotion
of prior induced input‐specific LTP‐like plasticity and homeostatic
global stabilization of neural assemblies in the human cortex after
short periods of NREM sleep compared to wakefulness. Our findings
indicate that sleep reduces the plasticity‐stability dilemma by orches-
trating local plasticity and global stability of neural assemblies in the
human cortex.
Disclosure: Nothing to disclose.
P303 | Bidirectional and context‐dependent
changes in theta and gamma oscillatory brain
activity in noradrenergic cell‐specific Hcrtr1 KO
mice
S. Li1; P. Franken2; A. Vassalli1
1Department of Physiology, 2Center for Integrative Genomics, University
of Lausanne, Lausanne, Switzerland
Objectives/Introduction: Noradrenaline (NA) and hypocretins/
orexins (HCRT), and their receptors, dynamically modulate the cir-
cuits that configure behavioral states, and their associated oscillatory
activities. Salient stimuli activate spiking of locus coeruleus noradren-
ergic (NALC) cells, inducing NA release and brain‐wide noradrenergic
signaling, thus resetting network activity, and mediating an orienting
response. Hypothalamic HCRT neurons provide one of the densest
input to NALC cells.
Methods: To functionally address the HCRT‐to‐NA connection, we
selectively inactivated the Hcrtr1 gene in NA neurons (Hcrtr1Dbh-CKO)
mice, and their control littermates (CTR), electrocortical response
(ECoG) in several contexts of enhanced arousal.
Results: Under enforced wakefulness (EW: CKO n = 9; CTR n = 7),
or after cage change (CC: CKO n = 8; CTR n = 6), Hcrtr1Dbh‐CKO
mice exhibited a weakened ability to lower infra‐theta frequencies
(1–7 Hz), and mount a robust, narrow‐bandwidth, high‐frequency
theta rhythm (~8.5 Hz). A fast‐gamma (55–80 Hz) response, whose
dynamics closely paralleled gamma, also diminished, while beta/slow‐
gamma activity (15–45 Hz) increased. EW‐associated locomotion
was lower. Surprisingly, nocturnal nestbuilding‐associated wakeful-
ness (CKO n = 5; CTR n = 5), inversely, featured enhanced theta and
fast‐gamma activity. Lastly, slow‐wave‐sleep following EW and CC
featured a profound deficit in slow‐delta waves (0.75–2.25 Hz).
Conclusions: HCRT‐to‐NA signaling may fine‐tune arousal, up in
alarming conditions, and down during self‐motivated, goal‐driven
behaviors and is critical to induce the homeostatic slow‐delta
rebound characteristic of post‐stress sleep.
Disclosure: Nothing to disclose.
P304 | Is the sleep structure vulnerable to
microbiological indoor air contaminants?
M. Meira e Cruz1,2; J. Belo3,4; N. Canha5,6; J. Lage5;
M. Picado3; C. Viegas3,7; T. Faria3,7; P. Macedo3; S. Cabo
Verde5; C. Alves8; M. Almeida5
1Sleep Unit, Cardiovascular Center of University of Lisbon, Lisbon Faculty
of Medicine, 2Portuguese Association of Chronobiology and Sleep
Medicine, 3Lisbon School of Health Technology, Polytechnic Institute of
Lisbon, 4Health and Technology Research Center ‐ ESTeSL‐IPL, 5Center
for Nuclear Sciences and Technologies, Instituto Superior Técnico,
University of Lisbon, 6Portugal Center of Environmental and Marine
Studies, Environmental Department, University of Aveiro, 7Environment
and Health Research Group (GIAS), Lisbon, 8Portugal Center of
Environmental and Marine Studies, Environmental Department,
University of Aveiro, Aveiro, Portugal
Objectives/Introduction: The present study aims to assess the
indoor air microbiological concentrations and evaluate the existence
of associations with sleep parameters.
Methods: A total of nine men following specific inclusion criteria:
age between 25 and 40 years old, healthy individuals, non‐smoking,
without children below five years and without sleeping problems
and whose households are within Grande Lisbon area, were
recruited. An unattended polysomnography (PSG) was performed
during 2 weeknights in a row. The second night PSG′s results were
used in order to minimize the first night effect. IAQ monitoring was
based on a comprehensive multi‐pollutant assessment where micro-
biological (fungi and bacteria) parameters were quantified.
Results: The mean age was 31.9 ± 5.80 years. The increase of
fungi concentration was associated to lower percentages of stage 2
of NREM (N2) sleep; this correlation was observed in the fungal con-
centration at the beginning of the night (rs = −0.650; p = 0.058) and
in the morning (rs = −0.763; p = 0.017). Both bacteria (rs = 0.732;
p < 0.050) and fungi (rs = 0.733; p < 0.05) were related to higher
rates of K‐complex during the NREM sleep.
Conclusions: The exposure to microorganisms has been demon-
strated to have an adverse effect in health with documented allergy
reactions, infections, toxic and inflammatory reactions. The results of
the present study also indicate a potencial possible existence of a
pathway that interfere also with the sleep structure. During the con-
tinuous sleep cycles throughout the night, people should spend
about half of their sleep time in stage N2 and a decrease in this
stage may interfere on the body repair and restauration. The func-
tional role of K‐complex is still a matter of debate, although many
authors consider it to be an arousal reaction because it can be trig-
gered by external and possibly internal stimuli. In any case, it is well
documented that K‐complexes are associated with autonomous acti-
vation. The environmental characterization enables to understand
the factors that may contribute to the degradation of sleep's quality.
Deeper studies in a large sample will allow to better understanding
the occupants’ exposure during this representative period.
Disclosure: Nothing to disclose.
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P305 | Sleep quality and daytime sleepiness
among primary care physicians
A. Wichniak1; K. Sroslak2; A. Wierzbicka2; M. Matuszczyk3;
M. Matuszczyk4
1Third Department of Psychiatry and Sleep Disorders Center, 2Sleep
Disorders Center, Department of Clinical Neurophysiology, Institute of
Psychiatry and Neurology, Warsaw, 3Medforum, Katowice, 4Mental
Health Center, Tychy, Poland
Objectives/Introduction: Irregular sleep pattern and inadequate
sleep duration affect emotions regulation, judgment and increase the
risk of accidents. It is also a threat to people whose safety depends
on the cognitive functioning of a poorly sleeping person. The aim of
the study was to assess the sleep quality of Primary Care Physicians
in Poland.
Methods: This questionnaire‐based research and was divided into
three phases. Here we focus on first two phases in which 3,362
(63% response rate) and 2,564 (43% response rate) physicians partic-
ipated, out of which 64.5–65.5% were females, mean age was 51.7–
51.9 years.
Results: 7.1% of physicians reported totally or clearly unsatisfac-
tory sleep quality. The total number of physician dissatisfied with
various aspects of their sleep was 42.5%. In the case of poor sleep
quality 47% of physicians did not take any action. 23% of them used
hypnotics or sleep‐promoting drugs. Only 20% of poorly‐sleeping
physicians used the sleep hygiene, and 11% regularly exercised phys-
ically to improve their sleep. Only 0.6% of the physicians with poor
sleep quality have used a specialist's consultation. The average sleep
time on working days was 6:45 hr. One third of physicians regularly
slept below 7 hr, and as many as 60% of them considered their
length of sleep to be adequate. 78.4% physicians answered never or
rarely when asked about experiencing daytime sleepiness, which
interferes with work and other daily activities. At the same time
within this group 41.5% reported they needed 5 min of less to fall
asleep and 42.6% reported having fallen asleep during monotonous
activities.
Conclusions: The quality of sleep of primary care physicians is sim-
ilar to that found in epidemiological studies for the general popula-
tion. An obvious problem is the frequent sleep deprivation.
Significant proportion of physicians does not pay enough attention
to the quality of their sleep and is not aware about increased sleepi-
ness.
Disclosure: This study was supported by an unrestricted educa-
tional grant by Polfarmex. The funding source had no role in the
design and conduct of the study; collection, management, and analy-
sis of the data; or preparation the abstract. The authors declare no
other conflicts of interest.
P306 | Night‐shift work and work hours
among primary care physicians ‐ consequences
for sleep quality, body weight and risk of
primary sleep disorders
K. Sroślak1; A. Wichniak2; A. Wierzbicka1; M. Matuszczyk3;
M. Matuszczyk4
1Sleep Disorders Center, Department of Clinical Neurophysiology, 2Third
Department of Psychiatry and Sleep Disorders Center, Institute of
Psychiatry and Neurology, Warszawa, 3Medforum, Katowice, 4Mental
Health Center, Tychy, Poland
Objectives/Introduction: Adequate sleep is important in jobs in
which proper performance of duties influences the safety of other
people. Night work and long work hours are common among medical
professionals and influence occurrence of sleep disorders. The aim
of the study was to assess sleep quality, daytime sleepiness and risk
of primary sleep disorders among primary care physicians in Poland ‐
including restless leg syndrome (RLS), sleep‐disordered breathing
based on NoSAS rating and shift work sleep disorder (SWSD).
Methods: This questionnaire‐based research was divided into three
phases. We focused on third phase of the study in which 2,384
physicians participated, out of which 1,555 (65.2%) participated in all
three study phases.
Results: Physicians working different numbers of hours varied on
subjective sleep quality (p = 0.02), average sleep length (p = 0.041),
daytime sleepiness (p = 0.003), frequency of overweight (p = 0.001)
and RLS (p = 0.001). Number of work hours explained 12.6% of vari-
ance in NoSAS (p < 0.001). There were significant differences
between physicians working shifts and those who do not work
nights in subjective sleep quality (p = 0.042), average sleep length
(p = 0.028), frequency of overweight (p = 0.023), RLS (p = 0.003)
and NoSAS (p = 0.008). We did not find significant differences in
daytime sleepiness (p = 0.522), however, there were significant dif-
ferences in frequency of physicians falling asleep during monotonous
activities (p = 0.011) and in sleep latency (p = 0.012) ‐ physicians
who work at night more frequently reported falling asleep during
monotonous activities, but also had longer sleep latency. We further
verified frequency of risk factors for SWSD and found 14% of our
sample of night working physicians (N = 496) meeting two or more
criteria for SWSD.
Conclusions: Physicians often work extended work hours and
night shifts, which disrupt sleep and are linked to heightened risk of
sleep disorders. Risk of sleep‐disordered breathing is more closely
linked to average work hours than night work itself. Risk of RLS is
more frequent among night working physicians. Prevalence of SWSD
in our sample showed to be higher than previously reported in other
studies.
Disclosure: This study was supported by an unrestricted educa-
tional grant by Polfarmex. The funding source had no role in the
design and conduct of the study; collection, management, and analy-
sis of the data; or preparation the abstract. The authors declare no
other conflicts of interest.
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P307 | A case study: increased spectral power
and correlations of multimodal neuroimaging
data during N1 sleep as a link to glymphatic
mechanism
H. Helakari1,2; N. Huotari1,3; V. Borchardt1,3; L. Raitamaa1,3;
M. Kallio4; T. Myllylä1,3,5; T. Keinänen4; V. Korhonen1,3;
V. Kiviniemi1,3
1Medical Imaging, Physics and Technology (MIPT), University of Oulu,
2Diagnostic Radiology, 3Department of Diagnostic Radiology, 4Unit of
Clinical Neurophysiology, Oulu University Hospital, 5Optoelectronics and
Measurement Techniques Unit, University of Oulu, Oulu, Finland
Objectives/Introduction: Recently found glymphatic system
works as clearing system of the brain, and it doubles the removal of
waste metabolites during sleep. Multimodal neuroimaging research
shows that cardio‐ respiratory and low frequency pulsations drive
the glymphatic clearance. The role of these physiological glymphatic
pulsations is still unknown during sleep.
Methods: Healthy control was scanned after normal night (9 hr
sleep) awake and after 21 hr sleep deprivation with 10 Hz whole
brain magnetic‐resonance‐encephalography (MREG, fast fMRI)
sequence with Siemens 3T Skyra in combination with 256‐channel
direct current electroencephalography (DC‐EEG), near‐infrared spec-
troscopy (NIRS), and cardiorespiratory signals. Standard sleep staging
was performed for EEG, observing non‐REM stage1 (N1) through all
8 min signal. After standard preprocessing, MREG average signal of
gray matter was calculated, and EEG and water NIRS (NIRSFH, fore-
head and NIRSOP, occipital) were downsampled to 10 Hz. Power
spectrum was calculated for MREG, EEG (Fp1 and Pz) and NIRS.
EEG channels were correlated with MREG and NIRS in all chosen
frequency bands (fullband, FB (0–5) Hz; very‐low frequency, VLF
(0.01–0.1) Hz; respiration, resp (0.2–0.35)Hz, cardiac, card (0.85–
1.05) Hz. EEG channels were separated into frontal, temporal, pari-
etal and occipital lobe, and average negative and positive correla-
tions to MREG and NIRS were calculated.
Results: EEG (Fp1 and Pz), MREG and NIRS showed higher spectral
power in VLF and resp in N1. Especially in MREG, power increased
3× higher in N1. Cardiac power was higher in NIRSOP and MREG
awake compared to N1. EEG‐NIRSFH in FB, VLF (parietal and occipi-
tal) and resp (frontal, parietal and occipital) and EEG‐NIRSOP in VLF
and resp (frontal, parietal and occipital) had higher correlations in N1
compared awake. EEG‐MREG and EEG‐NIRSOP correlated better
awake in cardiac frequency (temporal).
Conclusions: We found increased spectral power in all modalities
and higher correlation between EEG and NIRS in VLF and resp in
N1. Despite respiratory motion, physiological difference in respira-
tion between sleep and awake is known, and this needs to be dis-
covered in terms of brain pulsations. Findings in VLF support recent
literature that global fMRI (MREG) reflects vigilance level. Together
our results may be a link to glymphatic pulsation mechanisms by
showing the difference of signals between awake and N1.
Disclosure: Nothing to disclose.
P308 | Nonparametric approach for sleep stage
classification using cardiorespiratory and
movement features
S. Kumar1; S.S. Dash1,2
1Sleepiz AG, 2ETH Zurich, Zurich, Switzerland
Objectives/Introduction: Sleep is a naturally recurring process
which virtually all higher animals experience and its function is not
clearly known. The accepted way to analyze sleep is through its seg-
mentation in four different stages; wake (W), light (N1, N2), deep
(N3) and rapid eye‐movement (R); as defined by the American Acad-
emy of Sleep Medicine by the appearance of brain activity patterns
and other physiological signs. The most accurate way to measure
the sleep stages is polysomnography (PSG) which is expensive and
uncomfortable for a test subject. On the other side of the spectrum
lies actigraphy that is used to monitor body movement, but it is not
enough to assess sleep stages with high accuracy. In this study, we
evaluated the importance of cardiorespiratory features such as heart
rate and breathing rate to assess the models for sleep stage classifi-
cation.
Methods: We have explored cardiorespiratory and movement fea-
tures from 13 nights’ healthy adults’ data from CAP and ISRUC
database and analyzed their sleep stages with a suite of classification
algorithms, such as linear discriminant analysis (LDA), support vector
classification (SVM) and random forest.
Results: The non‐linear variant of random forests was the algorithm
with the best performance, obtaining 85.79 ± 1.6% accuracy for
sleep‐wake classification using the cardiorespiratory and movement
features compared to 67.29 ± 1.29% accuracy using only features
derived from body movement. We improved the accuracy to
87.08 ± 1.38% for sleep‐wake classification by considering additional
features from previous and next two epochs. We have also applied
the classification algorithm to classify different sleep stages (W, light,
deep, R). We obtained the accuracy 74.97 ± 0.78% using the vital
signs compared to 50.16 ± 1.01% accuracy using only features
derived from body movement.
Conclusions: The features from respiration and heart rate help in
further increasing the accuracy for sleep stage classification com-
pared to movement features only.
Disclosure: The authors Sunil Kumar and Soumya Dash are co‐
founders by Sleepiz AG, Zürich.
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P310 | Does Light with variation in spectrum
and intensity during night shift prevent delay of
circadian rhythm and sleepiness?
S. Higuchi1; T. Tsuyama1; A. Noguchi1; S.-I. Lee2; K. Maeda3;
Y. Awata3
1Kyushu University, Fukuoka, 2Hokkaido University, Sapporo, 3Japan
Aerospace Exploration Agency (JAXA), Tsukuba, Japan
Objectives/Instruction: Delay of circadian rhythm induced by
light exposure at night is one of the causes of circadian misalignment
in shift workers. According to the phase response curve, it is
expected that combination of low melanopic illuminance light in the
early night and high melanopic illuminance light in the late night can
prevent the delay of circadian rhythm.
Methods: Eleven young male adults participated in this study. On
the second night, the subjects engaged in simulated night work for
12 hr from 21:00 to 09:00. The variable light condition consisted of
three types of light. A low melanopic illuminance light (430 lx–
3,000 K) was used from 21:00 to 03:00, a middle one (540 lx–
4,500 K) was used from 03:00 to 06:00, and then finally a high mela-
nopic one (720 lx–5,900 K) was used from 06:00 to 9:00. A constant
light condition as a control was middle melanopic illuminance. Dim
light melatonin onset (DLMO) of the first night and third night was
measured as an index of the circadian phase. The Karolinska sleepiness
scale (KSS) and performance of a psychomotor vigilance task (PVT)
were also assessed every hour during the simulated night work. This
study was approved by the Ethical Committee of Kyushu University.
Results: DLMO by night shift was significantly delayed in both the
constant light and variable light conditions. However, the delay of
DLMO in the variable light condition (0.9 hr) was significantly smaller
than that in the constant light condition (1.7 hr). Although there
were significant increases in subjective sleepiness scale and number
of laps of PVT during night work, the differences between the two
lighting conditions were not significant.
Conclusions: Variable light during night shift is effective for pre-
venting delay of circadian rhythm but is not effective for preventing
sleepiness.
Disclosure: Nothing to disclose.
P311 | Larks, owls, swifts and woodcocks
among fruit flies: maladaptive responses of the
sleep‐wake cycle to hot and/or long summer
days are modified by heritable chronotype
L. Zakharenko1; D. Petrovskii1; A. Putilov2
1Department of Insect Genetics, Institute of Cytology and Genetics of
the Siberian Branch, Russian Academy of Sciences, Novosibirsk,
2Research Group for Math‐Modeling of Biomedical Systems, Research
Institute for Molecular Biology and Biophysics, Novosibirak, Russian
Federation
Objectives/Introduction: Drosophila melanogaster and our own
species have many things in common including history of relatively
rapid out‐of‐Africa dispersal. In Eurasia, we are facing the problem of
adjustment of the circadian rhythms and night sleep episode to sea-
sonal variation in day length and air temperature, and we are usually
responding to reduction of night sleep by prolongation of siesta. To
further explore similarity between two species, we examined possi-
bility to distinguish 4 extreme chronotypes among fruit flies.
Methods: Circadian rhythms of locomotor activity and sleep‐wake
pattern were tested in constant darkness and 4 strains originating
from three wild populations of Africa, Europe and the USA were
selected to represent 4 distinct chronotypes: “larks” (early morning
and evening activity peaks), “owls” (late morning and evening peaks),
“swifts” (early morning and late evening peaks) and “woodcocks”
(late morning and early evening peaks). The circadian rhythms and
sleep efficiency of the selected chronotypes were further tested
under either long day condition (LD20:4 at 20°C) or combination of
LD20:4 with hot temperature (29°C). In total, the rhythms of 176
flies were recorded.
Results: Despite identity of such experimental conditions for 4
chronotypes, their circadian rhythms and sleep timing showed signifi-
cantly distinct patterns of maladaptive response to exposure to heat
and/or short days. All two‐way rANOVAs yielded significant interac-
tion between chronotype and clock time (p < 0.001).
Conclusions: An experimental study of heritable chronotypes in
the fruit fly can facilitate a search for genetic underpinnings of indi-
vidual variation in vulnerability to circadian misalignment, maladap-
tive sleep‐wake behavior, and sleep disorders.
Disclosure: Nothing to disclose.
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P312 | Sleep homeostasis during daytime food
entrainment in mice
R.C. Northeast1,2; Y. Huang1; L.E. McKillop1; D.A. Bechtold2;
S.N. Peirson3; H.D. Piggins2; V.V. Vyazovskiy1,3
1University of Oxford, Department of Physiology, Anatomy and Genetics,
Oxford, 2University of Manchester, Faculty of Biology, Medicine and
Health, Manchester, 3University of Oxford/Sleep and Circadian
Neuroscience Institute, Oxford, United Kingdom
Objectives/Introduction: 24 hr rhythms of physiology and beha-
viour are driven by both the environment and the internal endoge-
nous clock. Daily restricted feeding (RF) in nocturnal rodents during
their inactive phase initiates food entrainment as activity in anticipa-
tion of food (FAA), resulting in reorganisation of the typical 24 hr
sleep‐wake structure. Here, we investigate the effects of RF on
sleep‐wake architecture and sleep homeostasis in mice.
Methods: Adult male C57Bl/6J mice (n = 7) were implanted with
frontal and occipital EEG and EMG electrodes for chronic recording
during a standard RF paradigm, where food access was restricted for
4 hr during the light period (Zeitgeber time; ZT4‐8) for 12 days.
After the animals were returned to an ad libitum food schedule, 3‐hr
sleep deprivation (SD) was performed between ZT3‐6 by providing
novel objects to mimic the episode of spontaneous wakefulness
associated with FAA and eating. Results were statistically assessed
as baseline vs. RF (Wilcoxon signed‐rank test).
Results: We compared sleep characteristics between baseline and
one representative day of RF once stable entrainment to feeding
time was achieved. Although the amount of wake was increased dur-
ing FAA and subsequent feeding, the total 24 hr amount of wake
remained stable (661.4 ± 7.1 vs. 685.7 ± 36.1 mins; n.s.), and the
loss of sleep during the light period was compensated by its increase
during the dark phase. This was achieved by a lower number of con-
solidated spontaneous wake episodes (>10 min) during the dark per-
iod under RF (9.8 ± 0.5 vs. 6.7 ± 0.6; p = 0.016). Interestingly, while
the mean duration of wake episodes during the dark period
remained unchanged (45.8 ± 3.1 vs. 50.6 ± 8.5 min; n.s), the initial
levels of non‐REM EEG slow‐wave activity (SWA) during subsequent
sleep were significantly lower during RF compared to baseline (fron-
tal: 108.6 ± 1.1 vs. 98.6 ± 1.4; p = 0.016). Consistently, a higher
rebound of SWA was also observed during sleep following enforced
SD as compared to spontaneous sleep after a similar duration of
waking associated with FAA. However, the total amount of SWA
accumulated during the 24 hr (slow‐wave energy) was similar
between baseline and RF.
Conclusions: In conclusion, our study suggests that despite the
substantial changes in wake and sleep distribution induced by RF,
sleep homeostasis is generally maintained.
Disclosure: Nothing to disclose.
P313 | Melatonin circadian rhythms in
menopausal women with insomnia: ethnic aspect
N. Semenova; I. Madaeva; L. Sholokhov; L. Kolesnikova
Federal State Public Scientific Institution, Scientific Centre for Family
Health and Human Reproduction Problems, Irkutsk, Russian Federation
Objectives/Introduction: The hormone melatonin is one of the
elements of the circadian mechanism. The studies carried out so far
have shown that people with sleep disorders have a lower melatonin
level. The aim of study is an assessment of the melatonin circadian
rhythms in menopausal women of different ethnic groups with
insomnia.
Methods: 250 menopausal women divided into Caucasian
(n = 160) and Asian (n = 90) groups were examined. All women
underwent clinico‐anamnestic examination. Each ethnic group was
divided into perimenopause and postmenopause. After polysomnog-
raphy and specialized questionnaires for the assessment of sleep dis-
orders groups were divided into control (without insomnia) and main
group (with insomnia). Mixed non‐stimulated saliva was used as a
material to determine the melatonin level; it was sampled at strictly
fixed hours four times a day (6:00–7:00, 12:00–13:00, 18:00–19:00,
23:00–00:00 hr). The melatonin content by an immunoenzymometric
assay was determined. Statistical analysis was performed by non‐
parametric tests.
Results: In Caucasian postmenopausal women without insomnia
melatonin levels in 12:00–13:00 hr, 18:00–19:00 hr and 23:00–
00:00 hr are lower by 1.94 times, 3.22 times and 1.54 times respec-
tively (p < 0.05), and in 6:00–7:00 hr are higher by 1.43 times
(p < 0.05) compared to perimenopausal ones. Statistically significant
differences in the melatonin levels between perimenopausal and
postmenopausal Asian women without insomnia were not found.
There were not ethnic differences between control groups. Insomnia
in Caucasian women in perimenopause is associated with a decreas-
ing of melatonin levels in 12:00–13:00 hr, 18:00–19:00 hr and
23:00–00:00 hr by 1.58 times, 1.96 times and 1.54 times respec-
tively (p < 0.05), and an increasing in 6:00–7:00 hr by 2.09 times
(p < 0.05). In Asian perimenopausal women with insomnia compared
to control the melatonin level is lower in 18:00–19:00 hr and 23:00–
00:00 hr by 1.97 times and 1.71 times respectively (p < 0.05); in
postmenopausal ones ‐ is lower in 12:00–13:00 hr, 18:00–19:00 hr
and 23:00–00:00 hr by 2.41 times, 1.48 times and 1.87 times
respectively (p < 0.05).
Conclusions: Insomnia in Caucasian perimenopausal women is
associated with a shift in the peak of melatonin secretion in the
early morning hours while in Asian women both in perimenopause
and postmenopause insomnia is associated with a decrease in mela-
tonin level in the evening and night hours.
Disclosure: Nothing to disclose.
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P314 | Evening and bedtime use of electronical
devices and its effects on subjective sleep
characteristics. Are blue light filters effective?
M. Šmotek1,2; E. Fárková1,2; D. Manková1; J. Kopřivová1,2
1Sleep Medicine and Chronobiology, National Institute of Mental health,
Klecany, 23rd Faculty of Medicine, Charles University in Prague, Prague,
Czech Republic
Objectives/Introduction: Light is considered one of the most
important factors influencing circadian system in humans. Inadequate
light signal can cause desynchronization of circadian rhythms and
serious health problems, disrupted sleep or impaired cognitive func-
tioning. Particularly blue end of light spectrum with wavelengths
between 460 and 480 nm, also emitted from all kinds of electronical
devices, has an important role in influencing our circadian system. Its
use in the evening and night hours can significantly suppress mela-
tonin levels and lead to the disruption of sleep and circadian func-
tioning. The objectives of the study are to map “light hygiene” in
the population of healthy volunteers and to compare reports of sub-
jective sleep quality in groups divided by the length of evening and
night exposure and by the use of filters blocking blue light spectrum.
Methods: 866 participants in total completed a questionnaire bat-
tery consisting of Pittsburgh Sleep Quality Index (PSQI), Fatigue
Severity Scale (FSS), Epworth Sleepiness Scale (ESS), The Munich
Chronotype Questionnaire (MCTQ), Morningness‐Eveningness Ques-
tionnaire (MEQ) and added questions mapping the length of the eve-
ning exposure to electronical devices (TV, PC, tablets and phones),
the timing of this exposition, the length of exposition during night
awakenings and the use of various filters blocking short‐wavelength
light.
Results: Statistical analyses (Independent‐samples t ‐tests and Krus-
kal‐Wallis tests) show that people using blue‐light filters have less
sleep disturbances (p = 0.047), people that are exposed to light
1.5 hr before sleep and those that who tend to expose themselves
to screens during night have more daytime dysfunction (p = 0.011
and p = 0.003 resp.) the following day. Also those who are exposed
to light 1.5 hr before sleep feel less alert (p = 0.008) and less
refreshed (p = 0.007) the next morning.
Conclusions: Our results are in line with other studies that con-
verge to show the negative impact of evening and night light expo-
sure to short‐wavelength spectrum on subjective and objective sleep
parameters.
Acknowledgments: This study is a result of the research funded
by the project Nr. LO1611 with a financial support from the MEYS
under the NPU I program. Further supported by MH CZ ‐ DRO
(“National Institute of Mental Health ‐ NUDZ, IN: 00023752”), pro-
ject “PROGRES Q35” and 260388/SVV/2018.
Disclosure: Nothing to disclose.
P315 | Effects of lighting with continuously
changing color temperature and illuminance on
subjective sleepiness and melatonin profiles
S. Veitz1,2; O. Stefani1,2; M. Freyburger1,2; M. Meyer1,2,3;
J. Weibel1,2; F. Rudzik1,2; T. Bashishvilli1,2; C. Cajochen1,2
1Centre for Chronobiology, Psychiatric Hospital of the University of
Basel, 2Transfaculty Research Platform Molecular and Cognitive
Neurosciences, University of Basel, 3Clinical Sleep Laboratory, Psychiatric
Hospital of the University of Basel, Basel, Switzerland
Objectives/Introduction: Current understanding of the term
“Human Centric Lighting (HCL)” is the change of correlated color
temperature and illuminance across the day. Here we tested the
repercussions of a HCL solution on subjective sleepiness and
melatonin secretion during two 16:8 hr light:dark cycles in healthy
men.
Methods: Fourteen male healthy sleepers spent twice 48 hr in the
laboratory once under a fixed light condition (fixedLED) and once
under dynamically changing light (dynLED) in a balanced crossover
design. After a 13‐hr baseline phase (5 hr preparation under 2,800K/
100lux followed by 8 hr sleep), a 35‐hr phase followed (16 hr of
scheduled wakefulness ‐ 8 hr of scheduled sleep ‐ 11 hr scheduled
wakefulness). During wakefulness light exposure in the fixed condi-
tion was set to 4,000K and 95lux (at the eye level). The dynamic
condition was defined as a light change starting in the morning with
3,500K/<1lux incrementally increasing until reaching a 5,000K/
100lux during the day until 5 p.m. Correlated color temperature and
illuminance continuously decreased afterwards finally reaching
2,700K/<1lux at bedtime.
Results: The diurnal profile of subjective sleepiness did not signifi-
cantly change between fixedLED and dynLED (factor “light condi-
tion”: p = 0.43, “time of day”: p < 0.001, interaction “light
condition” × “time of day”: p = 0.37), while the diurnal melatonin
profile yielded an almost significant (p = 0.056) interaction between
“light condition” and “time of day”. Post‐hoc comparisons revealed
significantly higher melatonin values under dynLED compared to
fixLED 1 hr prior bedtime (p at least <0.004).
Conclusions: Melatonin being important for many physiological
processes in the human body should not be suppressed in the eve-
ning and night by light. Our results foster the common recommenda-
tion of using warmer color temperature light in the evening. Since
subjective sleepiness did not change under the HCL condition com-
pared to the standard lighting condition, we can now extend this
recommendation for night shift workers.
Disclosure: Nothing to disclose.
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P316 | The impact of shift‐work on human
energy intake: a systematic review
E. Cayanan1,2; N. Eyre1; V. Lao1; M. Comas3,4; C. Hoyos3,5;
N. Marshall1,3; C. Phillips2,6,7; C. Gordon1,3
1Sydney Nursing School, The University of Sydney, Camperdown, 2The
University of Sydney/Woolcock Institute of Medical Research, 3CIRUS
Centre for Sleep and Chronobiology, Woolcock Institute of Medical
Research, University of Sydney, Glebe, 4Central Clinical School, 5School
of Psychology, The University of Sydney, Camperdown, 6Royal North
Shore Hospital, St Leonards, 7Sydney Medical School, The University of
Sydney, Camperdown, NSW, Australia
Objectives/Introduction: Epidemiological studies show that shift‐
work impacts negatively on cardiovascular and metabolic health.
Shift‐workers are particularly susceptible to obesity and associated
co‐morbidities such as diabetes, which may potentiate adverse
health consequences.
This systematic review investigated whether the energy intake of
night shift‐workers differed from that of other shift schedules as
determined by food diary or food recall over a 24‐hr period.
Methods: A systematic review was conducted. CINAHL, MEDLINE,
Web of Science, Embase and PsycINFO databases were searched for
observational and interventional studies measuring energy intake in
real or simulated shift‐work amongst healthy shift‐workers. Search
terms related to shift‐work, food and energy intake. Energy intake in
kilojoules was extracted for each work schedule to compare
between and within night, day, afternoon and rotating shift work
cases.
Results: The primary search identified 1,366 records. There were
1,056 abstracts after duplicate removal, 67 full‐text articles were
assessed for eligibility and 16 studies met the criteria for inclusion in
the qualitative analysis. These studies were mostly case control stud-
ies in healthy middle‐aged shift‐workers. There was no definitive
indication that night shift‐work impacted upon energy intake com-
pared to a regular shift pattern. There appeared to be a lack of con-
gruency in the macronutrient distribution consumed by each shift
schedule category. Risk of bias assessment showed a low to moder-
ate risk of bias in the majority of studies with the major issues aris-
ing from variable shift classification. There is an inherent challenge in
the assessment of shift‐work due to heterogeneity in the patterns of
shifts and timing of dietary assessment that precluded formal meta‐
analysis.
Conclusions: There was no clear impact of night shift on energy
intake and nor did any particular macronutrient seem to be
favoured amongst shift‐workers. The broad variability in shift‐work
schedules and lack of clarity around the timing of dietary assess-
ment resulted in misclassification bias that potentially favoured a
null hypothesis. Future studies should clearly describe shift sched-
ules and consider the timing of dietary assessment to capture a
more reliable and realistic summary of dietary choices to allow fair
comparison.
Disclosure: Nothing to disclose.
P317 | The effects of a split‐sleep schedule on
vigilance and sleep in nurses working night shifts
T. Weysen; T. Leufkens; A. Van der Lans; L. Van den Heuvel
Philips Research, Eindhoven, Eindhoven, The Netherlands
Objectives/Introduction: Shift workers need to be alert during
the night and sleep during the day. Due to this circadian misalign-
ment, shift workers often report shorter and disturbed sleep. As a
consequence, cognitive performance is affected resulting in an
increased chance of errors and accidents during work at night. A
possible solution to counteract sleep deprivation and its associated
impaired performance in shift workers is to adhere to a split‐sleep
schedule, i.e. having two or more sleep bouts in a period of 24 hr. In
this current real‐life study, the effects of a split‐sleep schedule were
investigated in a group of nurses.
Methods: Over a period of a month, 50 nurses working in night
shifts were randomly assigned to either a control group or an inter-
vention group. In the latter group, participants were instructed to
sleep in two bouts over a period of 24 hr: 5–6 hr after their night
shift and 2–3 hr right before the next night shift. A 10‐min psy-
chomotor vigilance test (PVT) was completed at the beginning, in
the middle and towards the end of each night shift. Subsequently,
the Karolinska Sleepiness Scale (KSS) was completed to assess sub-
jective sleepiness. During the whole month, sleep was assessed via a
sleep wake diary and an Actiwatch.
Results: During the nightshifts and especially towards the end of
the night, participants in the intervention group showed less decline
in PVT reaction time and number of lapses (both p < 0.05) as com-
pared to the control group. Furthermore, participants in the inter-
vention group reported that they slept significantly more in a period
of 24 hr (p < 0.05). Sleeping in two bouts did not influence subjec-
tive sleepiness as measured with the KSS.
Conclusions: Sleeping according to a split‐sleep schedule
improved nocturnal performance and increases self‐reported total
sleep time in nurses that worked in nightshifts. To our knowledge,
this was the first study in a real‐life setting showing the effects
and practicability of a split sleep schedule. More research is needed
to investigate whether sleeping in a split‐sleep schedule is capable
of preventing the longer‐term risks that are associated to working
in night shifts.
Disclosure: Nothing to disclose.
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P318 | Interaction of chronotype subscales and
their association with single nucleotide
polymorphisms in shift‐working drivers
A. Puchkova1; A. Putilov2; V. Dorokhov1
1Laboratory of Sleep and Wakefulness Neurobiology, Institute of Higher
Nervous Activity and Neurophysiology of the Russian Academy of
Sciences, Moscow, 2Research Group for Math‐Modeling of Biomedical
Systems, Research Institute for Molecular Biology and Biophysics,
Novosibirsk, Russian Federation
Objectives/Introduction: Chronotype is a complex of traits and
preferences in sleep and activity timing. People demonstrate a wide
range of characteristics that cannot be described by a simple
“early‐late type” scale. The interaction of chronotype components
may be the most prominent when the organism has to adapt such
conditions as shift work. Genetic factors also play an important role
in chronotype formation. The aim of this study was to examine the
interaction of various chronotype parameters and associations with
single nucleotide polymorphisms (SNPs) in drivers working on roll-
ing shifts.
Methods: 303 professional bus drivers (all male, age 21 to
68 years, average 45.7) took part in the study. All of them worked
on rolling 8–10 hr shifts starting at 3:30–17:30. To assess chrono-
type we have used a Russian version of Munich Chronotype Ques-
tionnaire (MCTQ) and a part of a Sleep‐Wake Pattern Assessment
Questionnaire (SWPAQ) for morning and evening activation assess-
ment. Candidate SNPs were: RORA (rs1159814), CLOCK
(rs12649507), PER3 (rs2640909), NPSR1 (rs324981), NPAS2
(rs4851377), DRD3 (rs6280), SLC6A3 (rs6347), DBH (rs1611125).
Results: Chronotype parameters in our sample were correlated:
people with later midsleep time suffered from stronger social jetlag;
both of these parameters were also associated with lower morning
activation (correlation analysis, p < 0.01). Overall drivers had a
prominent social jetlag (1.6 ± 1.6 hr). Subscales of morning and eve-
ning activation were highly correlated (p < 0.001). The drivers mostly
demonstrated a mixed “owlark” type, likely due to professional
selection. Minor allele frequencies of SLC6A3 and NPSR1 SNPs
were correlated with midsleep time (r = 0.36; p < 0.001 and
r = 0.21; p < 0.01). Major allele homozygotes in CLOCK SNP had
higher social jetlag (one‐way ANOVA, F (2;173)=3.9489; p < 0.05).
PER3 and RORA polymorphisms were associated only with morning
activation subscale. Minor allele homozygotes in PER3 had later
morning activation, in case of RORA they had an earlier type
(ANOVA and pairwise comparison with other genotypes, p < 0.05
and p < 0.001 respectively).
Conclusions: In the studied sample morning activation plays a sig-
nificant role in chronotype formation, and PER3 and RORA SNPs
influence it. SNPs in CLOCK, NPSR1 and SLC6A3 genes are also
associated with chronotype parameters.
Disclosure: Nothing to disclose.
P319 | No circadian activity rhythm in single‐
handed racing sailors
R.V. Rial1; A. Gamundí1; F. Canellas2; M. Akaarir1;
N. Molina1; M.C. Nicolau1; Grup de Recerca Neurofisiologia
del son i Dels Ritmes Biològics
1Universitat Illes Balears (UIB), IUNICS/IDISBA, 2Universitat de les Illes
Balears (UIB), IUNICS/IDISBA, UIB, Palma de Mallorca, Spain
Objectives/Introduction: The report aims to know whether the
high stress suffered by single handed sailors during a transatlantic
race could distort their circadian activity rest‐cycles.
Methods: From the official page of the “Mini Transat Illes de
Guadeloupe, 2015” race, we downloaded, every 6 hr, the successive
geographic coordinates of a sample of single‐handed sailors partici-
pating in the race. Although a total of 81 sailors participated, we
only studied a sample of 15 sailors, comprising the first 5 ones arriv-
ing to destiny, the 5 last ones, and a third group of 5 sailors arriving
in intermediate places. The ships′ coordinates were used to calculate
the distance run every 6 hr, from the departure (Lanzarote, Canary
Islands) to the arrival to Guadeloupe 14–20 days later.
We assumed that the oscillations in the displacements of ships every
6 hr would be a proxy of the general activity of the sailors governing
the helm and the sails. To validate this assumption, we provided
three sailors with wrist activity meters. However, only one of the
meters provided data on the real activity rhythms of the wearer.
The distances run every 6 hr by the sailors and the activity data
recorded with the wrist activity meter were submitted to cosinor
analysis.
Results: The Cosinor analysis revealed that, by far, no sailor
showed significant circadian activity at all, despite of being exposed
to one of the strongest Zeitgebers known for humans, the L/D cycles
of tropical seas. Further, the data recovered from the single activity
meter also showed total absence of significant circadian activity
rhythm.
To our knowledge, this is the first report of total absence of overt
circadian activity rhythm in humans, with absolute independence of
being exposed to a powerful Zeitgeber. These results extend to pre-
viously unsuspected limits the flexibility of the human circadian sys-
tem responsible of regulating the activity‐rest and wake‐sleep cycles.
Conclusions: The human circadian rhythms of rest‐activity disap-
pear under highly stressful situations.
Disclosure: Nothing to disclose.
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P320 | Effects of short exposure to different
light illuminance in regular rest breaks on
melatonin suppression and sleepiness during
simulated night work
S.-I. Lee1; S. Kinoshita2; A. Noguchi2; T. Eto2; K. Maeda3;
Y. Awata3; S. Higuchi2
1Hokkaido University, Sapporo, 2Kyushu University, Fukuoka, 3Japan
Aerospace Exploration Agency (JAXA), Tsukuba, Japan
Objectives/Introduction: Exposure to bright light during night
work can suppress melatonin and disrupt circadian clock but it could
be effective in maintaining wakefulness and/or visibility. Towards
reaching a compromise between the opposite effects of lights, in the
present study, we investigated the effects of regular short exposure
to different illuminance of lights on melatonin and sleepiness during
simulated night work under constant light exposure.
Methods: In the first experiment, the effects of brighter light expo-
sure in regular short breaks during night work on melatonin and
sleepiness were investigated. Twelve healthy male subjects
(21.3 ± 2.5 years old) participated in two break conditions, including
constant lights (same illuminance with that in the night work: 550 lx)
and brighter lights (4,700 lx) during break period (10 min). Each con-
dition conducted at random with an interval of two weeks. From a
week before the experiment, subjects were scheduled to sleep
between 24:00 and 01:00 and wake between 07:00 and 08:00. Sub-
jects spent time under dim lights (<30 lx) between 21:00 and 1:00
and then executed simulated night work under constant lights
(550 lx) between 1:00 and 6:00. Subjects took breaks every hour
from 02:00 to 06:00. Salivary melatonin and subjective sleepiness
(Karolinska sleepiness scale: KSS) were measured every hour. In the
second experiment consisted of twelve healthy male subjects
(20.0 ± 0.9 years old), the effects of taking a short break under dim
lights (<1 lx) were examined using the identical protocol in the first
experiment.
Results: Melatonin suppressions at 04:00, 05:00, and 06:00 were
significantly lower when subjects took breaks under brighter lights
than when they did under constant lights (p < 0.05, respectively).
Conversely, melatonin suppressions at 04:00, 05:00, and 06:00 were
significantly greater when subjects took breaks under dim lights than
when they did under constant light condition (p < 0.05, respectively).
However, there were no such significant difference in subjective
sleepiness in both experiments.
Conclusions: Our findings suggest that regular short exposure to
brighter lights can diminish melatonin suppression by constant lights
during night work whereas regular short exposure to dim lights can
promote melatonin suppression. Unexpectedly, however, subjective
sleepiness was barely affected.
Disclosure: Nothing to disclose.
P321 | Social jetlag in Chinese assessed with
wearable devices
Z. Zhang1; G. Guo2; C. Cajochen3; S. Hermann1; M. Qi1;
J. Li2; W. Chen2; R. Khatami1,4
1Center for Sleep Research and Sleep Medicine, Clinic Barmelweid AG,
Barmelweid, Switzerland, 2Huawei Device (Dongguan) Co., Ltd, Shenzhen,
China, 3University of Basel, Basel, 4University of Bern and University
Hospital Bern, Inselspital, Bern, Switzerland
Objectives/Introduction: Social jetlag (SJ) is highly prevalent in
modern societies and associated with many health problems. SJ has
never been assessed in China, a rapidly developing country. Thus,
we recorded sleep‐wake behavior in a large cohort of the Chinese
population and objectively derived SJ for each volunteer.
Methods: 71,176 anonymous Chinese volunteers wore HUAWEI
wearable devices continuously for at least 7 days and their sleep
data were recorded in 2017. Changes of the adjusted midpoint of
sleep on free‐days (MSFsc) and SJ (the difference between midpoints
of sleep on free‐days and weekdays) with age, the gender differ-
ences of MSFsc and SJ, the relationship between SJ and daytime‐
nap (DN)/nocturnal sleep duration (NSD) and BMI, were analyzed.
Subgroup comparisons between people with DN (average DN
>30 min, n = 29,917) and without DN (average DN = 0, n = 4,223)
were done to test whether DN influenced SJ.
Results: The peak of MSFsc in our Chinese cohort was at 4‐am at
an age of 22‐years. No statistical differences were found between
22‐years and the age range 16–26 years (p > 0.001), and between
males and females. The mean SJ was 0.3(1.23)‐hr [mean(std)] and
only 17.1% Chinese had more than 1‐hr SJ. SJ significantly corre-
lated with age (r = −0.03, p < 0.0001), MSFsc (r = 0.54, p < 0.0001)
and NSD (r = 0.014, p = 0.0002), but did not correlate with BMI
(p = 0.297). No gender difference were found in SJ (p = 0.06).The
comparisons between DN and non‐DN groups showed no differ-
ences in MSFsc (3.69(1.62) vs. 3.66(1.41), p = 0.31) and SJ (0.3(1.41)
vs. 0.26(1.16), p = 0.11). There was no correlation between SJ and
the DN duration (p = 0.25). In each group SJ did not correlate with
BMI (p = 0.30 and 0.34, respectively); SJ yielded no gender differ-
ence in the two subgroups (p = 0.77 and 0.86, respectively) either.
Age correlated to SJ only in the DN group (r = −0.03, p < 0.0001).
Conclusions: SJ was smaller in China compared to Europe (17.1%
vs. 69% population with SJ > 1‐hr). It negatively correlated with age,
without gender differences and correlation with BMI, which is in
conflict with European results. Subgroup comparisons suggest that
very common napping was less influential to SJ in Chinese, but
whether this is due to a ceiling effect needs further studies.
Disclosure: Nothing to disclose.
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P322 | Is sleepiness in shift work different
according to work schedule?
S.D.B. Garnier1; A. Pappathomas2; M. Roy3; C. Mérette4;
C. Bastien2; A. Vallières1
1Psychology, Laval University, Quebec, 2Psychology, Laval University,
3Q‐CROC, 4Medicine, Laval University, Québec, QC, Canada
Objectives/Instruction: Excessive sleepiness is a main symptom
of shift work disorder (SWD). However, little is known on the sleepi-
ness course on 24‐hr that is specific to shift workers with SWD. This
study aims at identifying sleepiness under two different shift work
schedules for workers with SWD in comparison to good sleepers.
Methods: 80 night shift workers of which 43 met SWD criteria
were recruited. They work 6 to 10 nights out of 14. Night shifts are
either consecutive (CNS) or fragmented (FNS), for which nights are
intervened with free days. Participants without SWD and satisfied
with their sleep were good sleepers (GS). Four groups were created:
(1) CNS‐SWD; (2) CNS‐GS; (3) FNS‐SWD; and (4) FNS‐GS. Sleepi-
ness was assessed in three ways: (1) participants were asked if they
experience excessive sleepiness (yes/no); (2) based on the Stanford
sleepiness scale (SSS) they rated their sleepiness level before day
sleep, after day sleep, before night work, during night work, after
night work, before night sleep and after night sleep; (3) they com-
pleted the Epworth sleepiness scale.
Results: There is no significant difference between shift workers
with SWD and GS on the Epworth and the proportion of “yes”.
CNS‐SWD present a significant higher total score on the SSS
(p = 0.046) and a significant higher sleepiness level when they wake
up after day sleep (p = 0.033) than CNS‐GS. FNS‐SWD present sig-
nificant higher sleepiness level during night work than FNS‐GS
(p = 0.026). CNS‐GS present significant higher sleepiness level than
FNS‐GS before going to bed in the morning (p = 0.040).
Conclusions: The moment sleepiness is excessive varies according
to the work schedule. A high sleepiness after day sleep seems to be
specific to CNS with SWD. When the work schedule is fragmented,
the sleepiness seems to be more problematic during night work. The
study also show that only asking to shift workers if they experience
excessive sleepiness do not allow to identify those with this diffi-
culty. Similar findings are obtained with the Epworth sleepiness
scale. More thorough evaluation of sleepiness in shift workers is
warranted with paying attention to work schedule and the presence
or not of SWD.
Disclosure: Acknowledgement: The study was supported by a
CIHR funding 191771 awarded to the last author.
P323 | The relationship between vitamin D
deficiency and daytime sleepiness in workers of
a general hospital
H.J. Lee1; H. Choi1; C. Sohn2; T. Kim3; I.-Y. Yoon1
1Seoul National University Bundang Hospital, Seongnam‐si, 2Nanum
Psychiatry Clinic, Seoul, 3Gwangju Institute of Science and Technology,
Gwangju, Republic of Korea
Objectives/Instruction: Several previous studies have demon-
strated that decrease in serum vitamin D level can lead to sleep dis-
turbances, and shift workers might be more vulnerable to vitamin D
insufficiency. The present study investigated the relationship
between serum vitamin D levels and sleep problems in shift workers
and non‐shift workers.
Methods: Data were obtained from 134 shift workers with night
time hours and 260 non‐shift workers at Seoul National University
Bundang Hospital in Seongnam, Korea. All the participants under-
went blood tests for vitamin D and completed self‐reported ques-
tionnaires regarding demographic information, sleep quality, daytime
sleepiness and fatigue. Vitamin D deficiency was defined as a serum
25‐hydroxyvitamin D concentrations <20 ng/mL.
Results: Among the 394 workers, 322 were diagnosed as vitamin
D deficiency representing a prevalence of 81.7%.
There was no substantial difference in serum vitamin D levels
between shift workers and non‐shift workers after controlling for
possible confounding factors. However, the prevalence of vitamin D
deficiency was higher in shift workers (p = 0.004). In the whole par-
ticipants, vitamin D‐deficient group suffered from more severe day-
time sleepiness (p = 0.045). We also found that serum vitamin D
levels were negatively correlated with daytime sleepiness (p = 0.018)
in shift workers while there was no significant correlation was found
in non‐shift workers after adjusted analysis.
Conclusions: The prevalence of vitamin D deficiency was high in
both shift workers and non‐shift workers. In particular, vitamin D
deficiency was associated with severe daytime sleepiness in shift
workers. Therefore, physicians need to recognize and modify vitamin
D deficiency for alleviating shift work‐related daytime functioning
impairment.
Disclosure: The source of funding: Ministry of Science and Infor-
matiin and Communication Technology
P324 | Pilot study to investigate sleep
disorders in blind and severe visual impairment
C. Dirks; P. Young; A. Heidbreder
Institute of Sleep Medicine and Neuromuscular Diseases, University
Hospital Muenster, Muenster, Germany
Objectives/Introduction: Sleep disorders are associated with seri-
ous health problem in blind and visual impaired people. The loss of
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light perception may result in a shift of sleep‐wake‐pattern, which
may lead to significant impediments in daily life due to problems fall-
ing asleep, maintaining sleep and daytime sleepiness ‐ so called Non‐
24‐sleep‐wake‐rhythm‐disorder. Up to date epidemiological data
about Non24 only exist for the USA. This pilotstudy was conducted
to provide first epidemiological data for Germany for the prevalence
of Non24 and other sleep disorders.
Methods: 111 blind and visual impaired subjects (36 subjects with-
out light perception; m = 56, 27–85 years, Mx = 59.53, SD = 14.69)
and 111 sighted controls (m = 41, 27–88 years, Mx = 58.32, SD =
14.21) were recruited to answer a set of validated questionnaires
referring to general health status (SF‐36), sleep characteristics (PSQI)
and daytime sleepiness (ESS). In addition a questionnaire to predict
Non24‐sleep‐wake‐disorder, which is not validated in German yet,
was provided.
Results: Results show a prevalence of 72.2% for the Non24‐sleep‐
wake‐disorder in blind people, which is in accordance to results of
the US‐study. In contrast, our results indicated Non24 in only 21.3%
of the subjects with residual light perception. Furthermore, we found
that for both blind and people with visual impairments other sleep
disorder like problems falling asleep (100% vs. 79.9%), maintaining
sleep (90% vs. 88.1%), breathing disorders (19.4% vs. 32%) or sleep
related moving disorders (28.1% vs. 32.9%) were common in our
study collective.
Conclusions: The Non24‐sleep‐wake‐disorder is a frequent prob-
lem among people with no light perception. The perception of light,
functioning as an extern cue for our endogenous circadian sleep‐
wake‐rhythm, plays therefore a key role. But sleep disruption is not
fully explained by Non24, making a detailed sleep history essential.
Disclosure: Nothing to disclose.
P325 | Daytime siesta is associated with
increased HbA1c community cross‐sectional
study
M. Al-Abri1; I. Al-lawati2; F. Al-Zedjali1
1Sultan Qaboos University, 2Ministry of Health, Muscat, Oman
Objectives/Introduction: Sleep timing has different patterns
worldwide and it can be influenced by social, cultural and environ-
mental factors. Daytime siesta is commonly practiced in different
parts of the world with controversial results of its effect on glucose
metabolism. The aim of the study is to examine the association of
afternoon siesta and glycated hemoglobin.
Methods: This is a cross sectional study conducted between June
2015 and February 2017. Young adults and middle‐aged local sub-
jects were randomly selected and enrolled in the study. Anthropo-
metric measurements were taken for height and weight and hip and
waist ratio. Consented subjects were asked to wear actigraphy for
one week and run their usual daily activities. They had been asked
to come fasting on day seven for blood collection to test for fasting
glucose, glycated hemoglobin (HbA1c), lipid profile and insulin.
Results: Four hundred subjects agreed to participate in the study
(52% male, 48% female). The mean age of participants was
32.8 ± 11.5 years. The study indicated that duration of afternoon
siesta was significantly associated with HbA1c in non‐diabetic sub-
jects (HbA1c< 7%) (p = 0.001, B coefficient 0.123) independent of
age and gender and nocturnal sleep duration, but it was not associ-
ated significantly with fasting glucose and fasting insulin levels.
Siesta duration was not associated with traits of obesity (BMI, waist
circumference), dyslipidemia (Total cholesterol, triglycerides, LDL)
and increase in blood pressure (p > 0.05).
Conclusions: Afternoon siesta is associated with increased level of
glycated hemoglobin and that may predispose to the development of
type 2 diabetes mellitus.
Disclosure: The study is funded by the research council of Oman
P326 | Variability of total sleep time in
patients with delayed sleep‐wake phase disorder
C. Arakawa; A. Watanabe; M. Hirose; Y. Esaki; R. Kawai;
R. Kumagai; S. Yamamoto; Y. Ono; H. Morishita; N. Iwata;
T. Kitajima
Department of Psychiatry, School of Medicine, Fujita Health University,
Toyoake, Japan
Objectives/Introduction: The patients with delayed sleep‐wake
phase disorder (DSWPD) often exhibit prolonged sleep time. Our
goal was to clarify whether the quantity of sleep in patients with
DSWPD would substantially vary during the course, and this had
association with the clinical status (remission or non‐remission).
Methods: Study subjects were the patients diagnosed with
DSWPD according to International Classification of Sleep Disorders,
third edition (ICSD‐3). Data were retrospectively collected from med-
ical records and sleep diaries of the patients. The weekly averages of
the total sleep time (TST) and the length of main sleep phase (LMSP)
were determined based on the sleep diary. The distributions of TST
and LMSP for each patient were examined, and their association
with remission/non‐remission were statistically tested. Clinical factors
such as social adaptation, medication and comorbid psychiatric or
sleep disorders were also examined for each patient with regards to
the influence on TST or LMSP based on the medical record.
Results: Among 24 patients enrolled, 19 patients [13 males and 6
females; mean age, 24.8 ± 8.9 (SD, 12–42) years] could be analyzed,
and the durations of analyzed sleep diary were 6–48 weeks (mean
25.7 ± 11.1 weeks). The width of TST's variation had a range of 1.2–
5.9 hr, and that of LMSP had a range of 1.0–6.8. Seven patients
(36.8%) exhibited ≥10 hr TST. There was a tendency that both of
TST and LMSP were longer when the patients were in non‐remission
than in remission, although these differences did not reach statistical
significance (TST: p = 0.2055, LMSP: p = 0.0699). Direct effects of
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above clinical factors on TST or LMSP were identified only in a few
patients according to the medical record.
Conclusions: In most of patients with DSWPD, the duration of
sleep time changed markedly during the treatment course; however,
we could not clarify whether this had association with the clinical
status. The possibility that various clinical factors had effects could
also be considerable. For further discussion, well‐designed prospec-
tive studies including control subjects are needed in the future.
Disclosure: This is not an industry‐sponsored study. Dr. Arakawa,
Dr. Watanabe, Dr. Hirose, Dr. Esaki, Dr. Kawai, Dr. Kumagai, Dr.
Yamamoto, Dr. Ono, and Dr. Morishita declares that there is no con-
flict of interest. Dr. Iwata has received research grants from Otsuka,
GSK, Tanabe‐Mitsubishi, Dainippon‐Sumitomo, Eizai, Daiichisankyo,
and has received personal fees from Eli Lilly, Janssen, Otsuka, Shio-
nogi, GSK, Dainippon‐Sumitomo, Astellas, Yoshitomi, Meiji, Novartis,
and Pfizer. Dr. Kitajima has received research grants from Eizai,
Takeda, MSD, and has received personal fees from Eizai, Tanabe‐
Mitsubishi, Otsuka, Takeda, Eli Lilly, MSD, Meiji, Yoshitomiyakuhin,
Dainippon‐Suimitomo, Fukuda, Shionogi, and Novo Nordisk.
P327 | Sleep coaching in a population‐based
RCT improves adolescent sleep
A.-K. Pesonen; L. Kuula
University of Helsinki, Helsinki, Finland
Objectives/Introduction: Efficient measures to help adolescents
in their circadian regulation are scarce. Instead of authoritarian bed-
time regulations, more emphasis should be placed on adolescent
self‐regulation and motivation building. The current study tested the
efficiency of a new 4‐week sleep coaching protocol, basing on moti-
vational interview, reflective listening, and individualized solutions
for better sleep rhythm. The individual meetings were organized
through Skype.
Methods: 1,374 adolescents (16–17 years olds) selected from the
population register responded to a screening questionnaire. Those
with markedly late sleep rhythm were selected to a randomized
intervention. 109 completed the intervention. The change in sleep
was measured with actigraphy before and after the intervention.
Results: Those in the sleep coaching group increased their sleep
time significantly (p < 0.05) compared to the control and bright light
treatment conditions. However, the timing of the sleep did not
change significantly.
Conclusions: This study shows that personalized support and
coaching is a feasible method to improve sleep in adolescents. Still
the timing of the sleep did not change significantly. This probably
reflects the fact that their late sleep rhythm was not truly extreme
at the baseline.
Disclosure: Nothing to disclose.
P328 | Tasimelteon for jet lag disorder: results
of the JET8 study, a randomized placebo
controlled phase 3 trial
C. Polymeropoulos; J. Brzezynski; L. Prokosch; M. Keefe;
M. Mohrman; M. Polymeropoulos
Vanda Pharmaceuticals Inc., Washington, DC, United States
Objectives/Introduction: The JET8 study measured the effects of
tasimelteon on objective and subjective sleep parameters during an
8 hr phase advance simulating jet lag disorder. Jet lag disorder is a
circadian rhythm disorder that commonly affects millions of travellers
per year who cross multiple time zones. Tasimelteon, a MT1 and
MT2 melatonin receptor agonist, demonstrated significant and clini-
cally meaningful benefits in nighttime and daytime sleep parameters
in the JET8 8 hr phase advance study. The JET8 study design
induced the circadian challenge experienced by travellers who cross
8 times zones. The JET8 study was a randomized, double‐blind, pla-
cebo‐controlled, multicentre phase III study.
Methods: Subjects received 20 mg of tasimelteon or placebo orally
prior to an 8 hr phase advance and were assessed by PSG for
effects on night‐time sleep parameters including total sleep time
(TST), latency to persistent sleep (LPS), and wake after sleep onset
(WASO). Next Day Alertness was determined from the Karolinska
Sleepiness Scale (KSS) and the Visual Analog Scale (VAS).
Results: Subjects receiving tasimelteon compared to placebo had a
significant improvement in sleep parameters including TST in the
first two thirds of the night (tasimelteon = 216.4 min., placebo =
156.1 min., p < 0.0001), TST in the full night (tasimelteon = 315.8
min., placebo = 230.3 min., p < 0.0001), LPS (tasimelteon = 21.8
min., placebo = 36.8 min., p < 0.01), and WASO (tasimelteon =
144.6 min., placebo = 219.1 min., p < 0.0001). The study also
demonstrated improvement in Next Day Alertness as measured by
average KSS (tasimelteon = 4.0, placebo = 4.5, p < 0.01) and average
VAS (tasimelteon = 60.8, placebo = 54.2, p < 0.01). The JET8 study
randomized 318 healthy subjects.
Conclusions: The JET8 study demonstrated clinically meaningful
and statistically significant improvement in both night‐time sleep and
next day alertness in patients affected by jet lag disorder. These
results suggest that tasimelteon can be an effective therapeutic tool
in the treatment of individuals that experience symptoms of jet lag
disorder.
Disclosure: Nothing to disclose.
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P329 | Quantifying the risk of poor sleep
outcomes for high and very high adolescent
social media users: findings from the nationally
representative UK Millennium Cohort Study
H. Scott; H.C. Woods; S.M. Biello
University of Glasgow, Glasgow, United Kingdom
Objectives/Instruction: The impact of adolescents’ social media
use on sleep has become a topic of concern for parents, teachers
and practitioners, with recent evidence indicating that heavier users
tend to report poorer sleep. However, there remains a need to
establish a baseline of typical daily social media use in today's ado-
lescent population, with prevalence rates for comparatively high and
very high users; and to quantify their associated risk of poor sleep
outcomes. This study aims to address these gaps in current evidence
using data from the nationally representative UK Millennium Cohort
Study.
Methods: 11,714 adolescents (aged 13–15) reported their social
media and sleep habits in Sweep 5 of the UK Millennium Cohort
Study. Odds Ratios from binomial logistic regression models were
used to calculate the adjusted Relative Risk of various sleep out-
comes for high (3–5 hr; 14% of adolescents) and very high (5+ hr;
21% of adolescents) daily social media users, compared to average
users (1–3 hr), controlling for demographics, household characteris-
tics, health, wellbeing and physical activity.
Results: Compared to average users, on school days comparable
high and very high social media users were 17% and 67% more likely
(respectively) to have later than average sleep onset (after 11 p.m.),
and 58% and 83% more likely to have later than average wake times
(after 8 a.m.). In basic models, controlling only for age and sex, high
and very high users were more likely to have long sleep onset
latency (over 30 min) and frequent nighttime awakenings. However,
these effects were non‐significant or notably reduced in comprehen-
sively controlled models, with only very high users 27% more likely
to have frequent nighttime awakenings than comparable average
users. Reported effects are significant at p < 0.05.
Conclusions: This study establishes typical levels of daily social
media use ‐ and prevalence rates of comparatively high and very
high use ‐ in the UK adolescent population. It quantifies the associ-
ated risk of poor sleep outcomes for each group, controlling for a
comprehensive range of demographic and health measures. It high-
lights a dose‐response relationship whereby the heaviest social
media users are most likely to have later sleep onset, wake times
and nighttime awakenings.
Disclosure: Nothing to disclose.
P330 | Effects of bright light on sleepiness and
cognitive performance during simulated night
shift work
J. Mrdalj1; E. Sunde2; T. Pedersen1; E. Thun3; J. Grønli1;
A. Harris2; B. Bjorvatn4; S. Waage4; S. Pallesen2
1Department of Biological and Medical Psychology, 2Department of
Psychosocial Science, 3Department of Clinical Psychology, 4Global Public
Health and Primary Care, University of Bergen, Bergen, Norway
Objectives/Introduction: Bright light has been suggested as a
countermeasure to sleepiness and cognitive impairment during night
shifts. We aimed to investigate how different intensities of full‐spec-
trum white light (4,000K), administered through ceiling mounted
Light Emitting Diode (LED) room lighting, affected subjective sleepi-
ness and cognitive performance during simulated night shifts.
Methods: We conducted a randomized controlled study employing
a counterbalanced, repeated‐measurements design. To simulate night
shift work, 25 participants (5 males), aged 19–27 years, performed a
battery of cognitive tasks in the laboratory between 11 p.m. and
7 a.m. for three consecutive nights, in two light conditions: bright
light (mean illuminance: 890.2 lx, SD = 85.9) and dim light (mean illu-
minance: 88.5 lx, SD = 8.3). Between the light conditions there was
a four week washout period. A 10‐min psychomotor vigilance task
(PVT) and the Karolinska sleepiness scale (KSS) was completed five
times (11:40 p.m., 1:10 a.m., 2:40 a.m., 4:10 a.m. and 5:40 a.m.).
Results: Preliminary analysis indicates that the number of PVT per-
formance lapses and KSS‐scores increased during each night shift, in
both light conditions. However, in the bright light condition the
increase in PVT‐lapses and KSS‐score was substantially lower than in
the dim light condition in the later hours of the night shifts. The
mean number of PVT‐lapses during the first night shift was signifi-
cantly lower in bright light compared to dim light condition at
2:40 a.m. (7.7 ± 7.9 vs. 14.6 ± 16.1; p < 0.05) and 4:10 a.m.
(9.5 ± 7.7 vs. 17.4 ± 14.3; p < 0.05). During the third night shift, the
mean number of PVT‐lapses was lower in bright light compared to
dim light condition at 4:10 a.m. (11.0 ± 10.9 vs.19.1 ± 16.9;
p < 0.05) and 5:40 a.m. (12.6 ± 12.3 vs. 19.6 ± 15.3; p < 0.05).
Conclusions: Exposure to full spectrum bright light (890 lx) seems
to improve cognitive performance and reduce sleepiness as com-
pared to dim light (89 lx) during simulated night shift work.
Disclosure: The authors disclose no conflict of interest. Authors
Mrdalj and Sunde contributed equally to this work.
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P331 | Daytime sleep following bright light
exposure during simulated night shifts
J. Mrdalj1; T. Pedersen1; S. Pallesen2; E. Sunde2; E. Thun2;
T. Henriksen3,4; D. Skene5; J. Grønli1
1Department of Biological and Medical Psychology, 2Department of
Psychosocial Science, 3Department of Clinical Medicine, Section for
Psychiatry, University of Bergen, Bergen, 4Valen Hospital, Fonna Local
Health Authority, Division of Mental Health Care, Valen, Norway,
5University of Surrey, Surrey, United Kingdom
Objectives/Introduction: Bright light has been suggested as a
countermeasure to sleepiness and cognitive impairment during night
shifts, and to lessen negative effects on subsequent sleep. We aimed
to investigate the effect of light intensity during simulated night
shifts on daytime sleep following the shifts.
Methods: We conducted a study employing a randomized counter-
balanced, controlled, repeated‐measurements design. To simulate
night shift work, participants performed a battery of cognitive tasks in
the laboratory from 11 p.m. to 7 a.m. for three consecutive nights in
two different light conditions: full spectrum bright light (mean illumi-
nance: 890.2 lx, SD = 85.9) and dim light (mean illuminance: 88.5 lx,
SD = 8.3). Daytime sleep following each night shift was monitored at
home by the use of polysomnography. Here we report preliminary
data on 10 out of 13 participants. Mean ± SEM and Cohen's d are
used to estimate differences and effects sizes between conditions.
Results: Following the third night shift in bright light, participants
exhibited longer total daytime sleep (421.9 ± 30.9 min vs.
324.5 ± 25.2 min, d = 1.6), shorter sleep onset latency (5.1 ± 2.0 min
vs. 8.9 ± 1.5 min, d = −1.0) and higher percentage time spent in stage
N2 (44.2 ± 5.7% vs. 32.1 ± 4.3%, d = 1.1) compared to the dim light
condition. Percentage time spent in stage N3 and REM sleep indicated
smaller differences in the bright light condition compared to the dim
light condition (21.5 ± 9.1% vs. 32.6 ± 6.8%, d = −0.6, and
25.0 ± 3.87% vs. 26.0 ± 3.1%, d = −0.1, respectively).
Conclusions: Total daytime sleep was increased after exposure to
bright light during simulated night shifts compared to lower intensity
light.
Disclosure: The authors disclose no conflict of interest. The
authors Jelena Mrdalj and Torhild Pedersen have contributed equally
to this work.
P332 | Social media use and sleep in adults: a
vulnerability perspective
L. Exelmans1; H. Scott2
1School for Mass Communication Research, KU Leuven, Leuven, Belgium,
2School of Psychology, University of Glasgow, Glasgow, United Kingdom
Objectives/Introduction: This study expands knowledge on the
effects of technology use on sleep by
(1) looking at social media use in an adult sample,
(2) considering the difference between overall and night-time
specific social media use, and
(3) exploring a vulnerability perspective.
For the latter, the moderating roles of gender, age, and habitual
checking behaviour were examined.
Methods: A representative quota sample of 584 adults (51.2%
women, Mage = 48.5 years old) participated in an online survey. Par-
ticipants reported their overall and night‐time social media use based
on Woods & Scott (2016). Nighttime checking habit was assessed
with the Self‐Report Habit Index (Verplanken & Orbell, 2006). They
co23mpleted the Pittsburgh Sleep Quality Index. Moderation analy-
ses were computed with Hayes’ PROCESS macro.
Results: Almost 40% indicated they used social media on a daily
basis, and 44.3% used social media multiple times per day. For night‐
time use, 60% of respondents used social media shortly before bed-
time, 28.9% used them in bed, before going to sleep. Only night‐time
social media use predicted poorer sleep quality (β = 0.206, p < 0.01).
This association was moderated by age (B = −0.005, 95% CI
[−0.009; −0.001]), and was thus stronger among younger partici-
pants. Gender was not a significant moderator. Regarding nighttime
checking habit, overall social media use predicted better sleep quality
only among those with a with a low tendency to check social media
at night (B = 0.020, 95% CI [0.004; 0.035]). Contrarily, night time
social media use was associated with a better sleep quality only
among those with a strong evening checking habit (B = 0.014, 95%
CI[0.007; 0.021]).
Conclusions: Nighttime social media use seems detrimental for
sleep quality, in particular for younger adults. For the puzzling find-
ings regarding habit strength, we hypothesize that a strong tendency
to check social media at night may be indicative of compulsive social
media use. Nighttime social media use may gratify the need to check
social media accounts, lowering potential mental arousal and benefit-
ting sleep. Prior research already signaled that, compared to children
and adolescents, adults may use media as a coping strategy for sleep
problems.
Disclosure: Nothing to disclose.
P333 | Bedtime and behavioral problems in
Finnish students
L. Kortesoja1; R. Hotulainen1; A. Rimpelä2; S. Karvonen3;
P. Lindfors2; M.-P. Vainikainen4
1Faculty of Educational Sciences, University of Helsinki, Helsinki, 2School
of Health Sciences, University of Tampere, Tampere, 3National Institute
for Health and Welfare, Helsinki, 4Faculty of Education, University of
Tampere, Tampere, Finland
Objectives/Introduction: Adolescent sleep is essential not only
for well‐being but also for learning. Previous research on Finnish
adolescence revealed that those who have later bedtime are at risk
for health problems. The present longitudinal study explores if late
bedtime at the beginning of the seventh grade (12–13 years)
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predicts behavioral problems at the end of the ninth grade and in
the second year of upper secondary school.
Methods: The data were collected from the metropolitan area of
Helsinki in 2011, 2014 and 2016. Only the data that consisted of
the students who provided data in all three collections were included
in this study. Hence, the data comprises 3,513 students. Strengths
and difficulties questionnaire (SDQ) was used to measure behavioral
problems. The SDQ comprises five subscales; emotional symptoms,
conduct problems, hyperactivity, peer problems and prosocial behav-
ior. The total difficulties score includes the first four subscales
excluding the prosocial subscale. The bedtime was measured with
the question “What time do you usually go to bed during school
week?”
Results: All of the SDQ subscales (prosocial scale excluded) used to
assess behavior problems suggested that bedtimes after 11:00 p.m.
at the seventh grade predict the self‐reported difficulties. In addition,
later bedtimes increased the odds ratio (OR) for behavior problems
in adolescents.
Conclusions: Bedtime after 11:00 p.m. at the seventh grade pre-
dicted the behavioral problems in each subscale as well as a higher
score in total difficulties. This study implies that adolescent sleep
should be taken more closely into account in health education and
planning of school schedules.
Disclosure: Nothing to disclose.
P334 | The pleasure of sleeping
R.V. Rial1; D. Salinero2; M. Akaarir1; J.A. Rubiño1;
A. Gamundí1; M.C. Nicolau1; Grup de Recerca
Neurofisiologia del son i Dels Ritmes Biològics
1Universitat Illes Balears (UIB), IUNICS/IDISBA, 2Universitat de les Illes
Balears (UIB), IUNICS/IDISBA, UIB, Palma de Mallorca, Spain
Objectives/Introduction: For most people, sleeping is a pleasure.
Conversely, sleep deprivation is an excruciating torture. In addition,
it is known that dopamine, the neurotransmitter responsible of the
wanting for pleasant stimuli, plays a pivotal role in the regulation of
wake and sleep, being necessary for maintaining wakefulness, irre-
spective of the actual sleep propensity. Moreover, the inhibition of
ventral tegmental dopaminergic neurons promote, before inducing
sleep, sleep‐related nesting behaviour, a direct proof of the causal
relation between Dopamine levels and sleep propensity. Despite of
these evidences, the pleasant properties of sleep remain largely
unrecognized. This report aims to fill the gap: sleep, like food, water
and sex, is a primary reinforcer.
Methods: We developed a questionnaire searching for factors
eventually related to the main question, the degree of agreement
with the sentence “For me, sleeping is a pleasure”. The sub-







Under the hypothetic assumption that evening types would show
higher affect to sleep, we also provided the responders with the
Horne and Östberg morningness‐eveningness questionnaire.
Results: Only two subjects out of 217 respondents (0.9%) marked
1, (never felt pelasure in sleeeping) while 77% marked 4–5 and over
99% recognized having enjoyed sleep always, or, at least, on some
occasion.
In addition, 0.46% of the respondents were definitely morning type,
11.52% moderately morning, 66.82% neither type, 19.35% moder-
ately evening and 2.3% definitely evening, i.e. the chronotype of the
studied population remained within the known normal limits. The
Pearson index for the correlation between love for sleep and
chronotype was small (r = −0.17, p < 0.012) which means that the
love for sleep is greater in evening types, but the differences only
explains less than a 3% of the variance.
Conclusions:
1 Sleeping is a pleasant state for an ample majority of humans
2 Although evening chronotypes appreciate sleeping more than
morning chronotypes, the difference is quite small.
Disclosure: Nothing to disclose.
P335 | No effect by daily coffee consumption
on the association between a common gene
variant of the melatonin receptor 1B and fasting
blood glucose
X. Tan1; O.E. Titova2; D.-M. Ciuculete2; E. Lindberg2;
S. Elmståhl3; L. Lind2; H.B. Schiöth2; C. Benedict2
1Department of Neuroscience, 2Uppsala University, Uppsala, 3Lund
University, Lund, Sweden
Objectives/Introduction: The association between genetic variant
in the melatonin receptor 1B(MTNR1B) and type 2 diabetes mellitus
(T2DM) can be moderated by chronotype (i.e. timing of sleep and
wake‐up), thus behavioral factors related to circadian rhythm might
be involved in this interaction. Caffeine has been shown to delay
melatonin‐induced circadian rhythm. Since caffeine‐enriched coffee
is a common diet in Western societies, we sought to investigate
whether the association between MTNR1Band T2DM (defined by
morning fasting glucose level or use of antidiabetics) varies by daily
coffee consumption.
Methods: This cross‐sectional investigation utilized a subsample of
2,389 individuals from the EpiHealth study. Participants were Swed-
ish adults aged 61.4 ± 8.4 years (50.3% female). T2DM was found in
8.4% of the participants. Genotyping of theMTNR1Brs10830963 sin-
gle‐nucleotide polymorphism was done by a custom Illumina iSelect
array. Daily coffee consumption, habitual sleep duration, chronotype,
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and level of leisure time physical activity were assessed by question-
naire. Logistic regression models were used to calculate odds ratios
(ORs) and 95% confidence intervals (CIs).
Results: An association was shown between rs10830963 genotype
in the MTNR1Band T2DM (OR = 1.60, 95% CI: 1.18–2.17,
p = 0.002). However, no connection was found between daily coffee
consumption and T2DM (OR = 0.96, 95% CI: 0.86–1.07, p = 0.456).
Finally, no interaction between coffee consumption and rs10830963
genotype in the MTNR1Bwas found (OR = 1.01, 95% CI: 0.82–1.25,
p = 0.932).
Conclusions: Our study does not indicate a role of daily coffee
consumption in the association between the MTNR1Brs10830963
polymorphism and T2DM.
Disclosure: Nothing to disclose.
P336 | Which characteristics predict the
preference for later school start times in Zurich
adolescents?
H. Werner1; D. Janisch2; N. Widmer2; M.L. Yaw2; R. Huber1;
O. Jenni1
1University Children's Hospital, 2University of Zurich, Zurich, Switzerland
Objectives/Introduction: Empirical studies have shown that ado-
lescents suffer from a sleep deficit and significantly sleep longer on
weekend than on school days. In fact, associated daytime sleepiness
has negative effects on adolescents’ health, well‐being and school
performance. Chronic sleep deficits in adolescents are seen as a pub-
lic health issue. Thus, later school start times in the morning were
recommended for adolescents by the American Academy of Pedi-
atrics in 2014. In Switzerland, however, such advances are not yet
established. The aim of the present online survey was to define
whether adolescents in the greater Zurich area prefer to go later to
school and which socio‐demographic, school‐ and sleep‐related vari-
ables are associated.
Methods: Cross‐sectional study of 5,310 high school students, age
10–22 years (65% females). Preference for later school‐start times,
school characteristics (time table, public transportation, duration of
way to school), sleep‐scheduled times (school‐ and weekend‐days),
daytime sleepiness, and health‐related quality of life were assessed
by standardized questionnaires (MCTQ, KIDSCREEN) and integrated
in the online survey.
Results: The majority of the adolescents (72%) wish to have later
school start times in the morning. They indicated that their preferred
average school start time would be at 8:36 a.m. (SD = 0:42). In addi-
tion, they indicated that lunch time could be shortened in order not
to have to stay longer at school in the afternoon. Multivariate analy-
ses showed that later school start times are preferred by boys more
than girls, by students with longer commute to school than with
shorter way to school, using public transportation compared to pri-
vate transportation, with lower school marks compared to students
with higher marks, with later chronotypes than with earlier chrono-
types, with greater sleep deficit than less sleep deficit, and with
greater daytime sleepiness than with lower daytime sleepiness
(p < 0.001).
Conclusions: Our study shows that Zurich adolescents are ready
for later school start times in the morning. Especially boys, those
students with longer commute to school, using public transportation,
lower school marks, later chronotypes, greater sleep deficit and day-
time sleepiness support later school start times in the morning.
Disclosure: Nothing to disclose.
P337 | Young children′s sleep and maternal
sleep‐related cognitions: a comparison between
three different Arab societies in Israel
I. Haimov1; G. Zreik1; L. Tikotzky2
1Psychology, The Max Stern Yezreel Valley College, Emek Yezreel,
2Psychology, Ben‐Gurion University of the Negev, Beer Sheva, Israel
Objectives/Introduction: Cultural and parental sleep‐related
behaviors and cognitions have an important role in the development
of children′s sleep. However, to the best of our knowledge, no study
has yet investigated parental factors in relation to children′s sleep
among Arab families in Israel. There are three Arab ethnocultural
groups living in Israel, namely Christian, Muslim and Bedouin. The
three groups differ from each other culturally, residentially, and in
their social and economic characteristics. Thus, this study examine
similarities and differences between Arab families in Israel regarding
maternal sleep‐related cognitions and children′s sleep.
Methods: Mothers of 120 young children from three different
Arab Societies in Israel participated in this study. The average age of
the children was 18.2 months (range: birth to three years; SD =
10.36). Mothers completed the Brief Infant Sleep Questionnaire
(BISQ), and the Infant Sleep Vignettes Interpretation Scale (ISVIS).
Results: Analysis revealed significant group differences on two
ISVIS subscales: Distress and Temperament (F (2,117) = 8.82,
p < 0.002; F (2,117) = 3.72, p < 0.018). On the ISVIS Distress sub-
scale, Christian mothers scored significantly higher than did Muslim
and Bedouin mothers, indicating that they were more likely to inter-
pret infant night‐wakings as a sign of distress and need for help. On
the other hand, Christian mothers scored significantly lower on the
ISVIS Temperament subscale compared to Muslim and Bedouin
mothers, indicating that they were less likely to attribute infant
night‐wakings to infant nature. Likewise, significant group differ-
ences were found with regard to children′s sleep (F (2,117) = 3.93,
p < 0.023). Post‐hoc analysis indicated that Christian mothers
reported more children′s night‐wakings than did mothers of Muslim
and Bedouin children.
Significant Pearson correlations were found between the Maternal
Distress, Limits subscales and child sleep. These findings demon-
strated that mothers who were more likely to attribute infant‐night‐
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wakings to infant distress and who were less likely to emphasize the
importance of limiting parental nighttime involvement, reported that
their children had more fragmented sleep.
Conclusions: The findings of this study support the literature on
the importance of cross‐cultural factors in the development of sleep
in early childhood and demonstrate for the first time cross‐cultural
differences in young children′s sleep and in maternal sleep‐related
cognitions in Israeli Arabs.
Disclosure: Nothing to disclose.
P338 | Equality of sleep disturbances in
parents is associated with reduced stress
G. Hardelin1; B.C. Holding1; J. Axelsson1,2
1Department of Clinical Neuroscience, Karolinska Institutet, 2Stress
Research Institute, Stockholm University, Stockholm, Sweden
Objectives/Introduction: Mothers generally take a greater
responsibility for childcare during the night than fathers, and reports
support that mothers get up more times during the night and there-
fore have more disrupted sleep. We propose that an imbalance in
sleep between parents can affects parental stress and relationship
satisfaction. The aim of this study was to determine whether there
is any objective and/or subjective support for a sleep imbalance
between mothers and fathers, unfavorable for women, and whether
such an imbalance predicts more parental stress and worse relation-
ship satisfaction.
Methods: Sleep and daytime functioning will be measured with
actigraphy and questionnaires for 7 days in 80 parent couples (48
couples have gone through the protocol so far and tentative analy-
ses are presented below). An inclusion criteria was having a child
with sleep problems. The parental stress scale consists of items mea-
suring both positive and negative aspects of parenting that are likely
to change on a daily basis.
Results: Mothers reported being awake more often during sleep
than fathers (p < 0.01), something that was also supported by more
time awake objectively (p < 0.05). There was a trend for a larger
sleep imbalance to predict greater parental stress (p < 0.1). Parental
stress increased for women but decreased for men as a function of
minutes awake during the night (p < 0.001). We found no associa-
tion between sleep imbalance and relationship satisfaction (p > 0.1).
Conclusions: We suggest that being awake during the night
(amount of minutes) cause more stress amongst women the follow-
ing day, but less stress in men, which in turn suggests that if men
take more responsibility of the child during the night, parental stress
may be reduced for both women and men. The analyses will be
done with the larger population to conclude direction and strengths
of possible relationships.
Disclosure: Nothing to disclose.
P339 | Romantic love ‐ another reason to sleep
less during adolescence
L. Kuula-Paavola; I. Merikanto; A.-K. Pesonen
University of Helsinki, Helsinki, Finland
Objectives/Introduction: Early‐stage romantic involvement may
resemble hypomania in its manifestation on behavioural, physiologi-
cal and psychological levels. Previous research suggests that self‐
reported sleep may diminish as a result of falling in love during ado-
lescence.
Methods: 1374 adolescents (66% girls; mean age 16.9, SD = 0.6
years) selected from the population register responded to a battery
of questionnaires before an invited subsample (resulting n = 309)
underwent a week‐long actigraphy measurement period (GeneActiv
Original). The adolescents responded to questions about their sleep
behaviour and also a question regarding romantic love. In this study,
we compared those who reported being in the early stages of love
to those who were not regarding self‐reports of sleep duration as
well as objectively measured sleep. Girls and boys were analysed
separately.
Results: 11% of all participants reported being in the early stages
of romantic love. Girls who were in love, had shorter self‐reported
sleep duration both on weekdays (mean difference 31 min,
p ≤ 0.001) and at weekends (15 min, p = 0.037) than those who
were not in love. During the actigraphy measurement period the
mean difference in sleep duration was 24 min (p = 0.041). Boys’
sleep did not differ significantly according to self‐report about being
in love (all p‐values >0.42).
Conclusions: During adolescence, romantic love may be one fur-
ther cause for shorter sleep duration, especially in girls. While the
mechanism remains unclear, feelings of romantic love contain impor-
tant lessons in a developmental context, and may require processing
time in the evening. There are several potential confounders which
need to be further investigated.
Disclosure: Nothing to disclose.
P340 | To snooze or not to snooze: effects of
intermittent morning awakenings 30 minutes
before final awakening
T. Sundelin1,2; S. Landry3,4; J. Axelsson1,5
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm,
Sweden, 2Department of Social Psychology, New York University, New
York, NY, United States, 3Monash Institute of Cognitive and Clinical
Neurosciences, School of Psychological Sciences, 4Department of
Physiology, School of Biomedical Sciences, Monash University,
Melbourne, VIC, Australia, 5Stress Research Institute, Stockholm
University, Stockholm, Sweden
Objectives/Introduction: Hitting snooze on one′s alarm repeat-
edly before getting up (“snoozing”) is a common practice. Although
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there is much research on sleep restriction, sleep fragmentation, and
sleep inertia, little is known about the effects of snoozing per se.
Here, we wanted to study whether snoozing has effects similar to
those of sleep fragmentation and/or if it may alleviate sleep inertia.
Methods: Following a habituation night, 23 habitual snoozers
(mean age 26.3 years) were measured with polysomnography during
two nights in the lab: one snooze night and one non‐snooze night.
In the snooze condition, participants set their alarm 30 min before
their preferred wake time and hit the snooze button four times
before performing cognitive tests (addition and short‐term memory).
In the non‐snooze condition, participants set their alarm to their pre-
ferred wake time and immediately performed the cognitive tests
when the alarm went off. The tests were also performed 45 min
after waking and twice in the afternoon.
Results: There were no differences in whole night sleep between
the two conditions (p′s ranging from 0.063 to 0.862 for all
polysomnography measures, N = 23). During the last 30 min of the
night, there was a significant decrease in total sleep time, N3, and
REM, and increase in wakefulness, N1, and number of arousals (p′s
between 0.037 and <0.001) in the snooze condition. In the snooze
condition, participants were faster at adding numbers during the first
test of the day (p = 0.013), but not at later times. Furthermore, there
was no difference in percentage of correct additions (p = 0.779), nor
for short‐term memory ability (p = 0.115) at any point. There was
also no difference in self‐reported sleepiness or effort at any test
session (p′s > 0.572)
Conclusions: Although snoozing the last half hour of the night
resulted in 8.5 min less sleep during that time, it did not cause a sig-
nificant difference in sleep over the full night. There were no differ-
ences in the measured cognitive abilities, nor self‐rated sleepiness,
during the day following snooze or non‐snooze, but snoozing made
participants faster at an addition task performed right upon waking,
suggesting that this waking style may help curtail sleep inertia.
Disclosure: Nothing to disclose.
P341 | Sleep complaints and well‐being in
shiftworkers of different occupational groups
V. Chernyuk1; N. Bobko2; V. Mazur3; T. Martynovska4;
D. Gadayeva1; R. Yabchanka3; I. Hrytsyuk5
1Kundiiev Institute of Occupational Health of the National Academy of
Medical Sciences of Ukraine’, Kiev, 2Kundiiev Institute of Occupational
Health of the National Academy of Medical Sciences of Ukraine’,, Київ,
3Lviv National Medical University named after Danylo Halytsky, Lviv,
4Kundiiev Institute of Occupational Health of the National Academy of
Medical Sciences of Ukraine’, 5Kundiiev Institute of Occupational Health
of the National Academy of Medical Sciences of Ukraine, Kiev, Ukraine
Objectives/Introduction: Sleep problems are the most often com-
plaints of night‐ and shiftworkers. The purpose was to compare
sleep related complaints in shiftworkers of different occupational
groups.
Methods: Blood pressure (BP), heart rate (HR), calculated hemody-
namic parameters, breath holding, balance keeping and responses to
the questionnaire to evaluate the biological age by Voitenko (1991)
were studied in shiftworkers: 59 telephonists (30–55 years old,
women), 62 truck drivers (28–65 years old, men), 67 surgeons (23–
74 years old, men) and 31 miners (32–58 years old, men). Surgeons
and miners worked regular night hours under harmful environment,
truck drivers and surgeons ‐ long work hours. Two sleep related
complaints in connection with other studied parameters were inves-
tigated:
(1) sensitive sleep and
(2) sleep loss due to excitement.
TTEST at p < 0.05 was used to compare shiftworkers of 2 groups
within each occupation: those who complained, and those who did
not complain.
Results: Sensitive sleep reported 57% of telephonists, 55% of truck
drivers, 42% of surgeons and 29% of miners. This complaint was
accompanied also by worse (p < 0.05) balance keeping and breath
holding (in surgeons and miners); lower HR and older biological age
(in surgeons); higher pace of aging, high BP (143/92 vs. 133/
83 mmHg), HR (83 vs. 79 bit/min) and worse hemodynamic parame-
ters (in miners); worse subjective health evaluation (in the each occu-
pation but in telephonists ‐ at p < 0.07). More frequently
encountered (p < 0.05) concomitant complaints were found by 1
question in truck drivers and surgeons, by 4 questions ‐ in telephon-
ists, by 13 questions ‐ in miners.
Sleep loss due to excitement reported 55% of telephonists, 49% of
truck drivers, 58% of surgeons and each miner. This complaint was
accompanied by worse subjective health evaluation (in the each
occupation), older biological age (in drivers and surgeons), higher
pace of aging (in telephonists) and also other complaints due to 3
indices in drivers, by 10 indices ‐ in telephonists and surgeons.
Conclusions: Sensitive sleep is accompanied rather by worsening
in objective parameters of body functioning while sleep loss due to
excitement ‐ by subjective complaints. Unfavourable work place fac-
tors promote sleep complaint concomitant unfavourable changes in
workers well‐being.
Disclosure: Nothing to disclose.
P342 | Reactivation of hypothalamic inhibitory
neurons during REM sleep maintains appetite
L. Oesch1; M. Gazea2; C. Gutierrez Herrera2;
A. Adamantidis2
1Center for Experimental Neurology, 2University of Bern and University
Hospital Bern, Inselspital, Bern, Switzerland
Objectives/Introduction: Sleep has been linked to the consolida-
tion of memories related to spatial encoding, reward and emotion.
Reactivation of neural sequences in the hippocampus and neocortex
during sleep reflects transfer and storage of information acquired
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during awake behavioral conditioning. However, whether sleep reac-
tivation within homeostatic circuits strengthens innate behaviors is
unknown.
Methods: We use in vivo calcium imaging (GCaMP6s) in freely‐
moving mice to longitudinally record activity dynamics from single
glutamatergic or GABAergic neurons in the lateral hypothalamus
(LHvglut2 and LHvgat, 153 cells from 4 animals and 151 neurons from
6 animals, respectively) across sleep and feeding behaviors. Further-
more, we applied optogenetic tools to silence LHvgat neurons selec-
tively during REM sleep or wakefulness prior to a goal‐oriented task
(8 test animals, 8 controls).
Results: We showed that the cellular activity of LHvgat and LHvglut2
neurons clusters into ‘food‐directed’ and ‘food‐avoidance’ behaviors,
respectively, while both populations show strong cellular activities
during REM sleep. Importantly, LHvgat neurons active during food‐
directed behavior are reactivated during rapid eye movement (REM),
but not non‐REM, sleep, whereas no sleep‐state specific reactivation
was observed for LHvglut2 neurons. The reactivation of LHvgat neu-
rons across REM sleep episodes occurred in parallel, rather than
sequential patterns. Finally, REM sleep‐, but not wake‐specific opto-
genetic silencing of LHvgat neurons decreased food intake during
subsequent wakefulness.
Conclusions: Collectively, these results demonstrate that reactiva-
tion of food‐directed neurons during REM sleep is essential to main-
tain feeding and expand the role of REM sleep to the stability of
innate behavior.
Disclosure: Nothing to disclose.
P343 | Benefits of a short afternoon nap:
Investigating the parallel effects on physiological
arousal and cognitive performance
T. Ru1,2; Q. Chen2; L. Liu3; G. Zhou1
1National Center for International Research on Green Optoelectronics,
2School of Psychology, South China Normal University, 3Oversea Testing
VIP, New Oriental Education & Technology Group, Guangzhou, China
Objectives/Introduction: Previous studies have demonstrated
that the benefits of short afternoon nap on habitual nappers’ task
performance would be moderated by the cognitive complexity and
task difficulty (Ru, Chen, You & Zhou, 2017, in press).The current
study aims to further investigating the effects of afternoon nap on
physiological arousal in parallel to its effects on task performance
and testing the possibility of physiological arousal as underlying
mechanism of napping effects on mental performance.
Methods: A 2 (Nap intervention: nap/no nap) × 2 Task difficulty:
easy/difficult) within‐subject design was employed in the current
study, in which seventeen university students with the long‐term
habit of an afternoon nap participated in all three conditions (includ-
ing an adaption condition) on three inconsecutive days. Polysomnog-
raphy was used to record EEG during nap intervention and task
session for measuring physiological arousal. During the task session,
participants performed both an easy and a difficult measurement
block each including a sustained attention (auditory PVT—easy:
1~5 s ISI; difficult: 1~9 s ISI) and a working memory (N‐back task—
easy: 2back; difficult: 3back) task. Adaption condition always came
first; the order of nap vs. no nap condition and the easy vs. difficult
block was randomized across the participants.
Results: Linerar mixed model was employed for data analysis.
Results showed that (1) a habitual midday nap improved perfor-
mance on sustained attention (p < 0.05) but not on working mem-
ory; (2) for the EEG power ratio, nap condition elicited higher θ than
no nap did while this is only the case for δ and reverse for β on diffi-
cult PVT trails (ps < 0.05); higher δ and lower β than no nap did
while higher α was found only on 2‐back trials (ps < 0.05); (3) the
lapse in easy PVT was marginally correlated with δ component
(r2 = 0.18, p = 0.07), the response speed in 2‐back task was margin-
ally related with θ component (r2 = −0.18, p = 0.08) and the
response speed in 3‐back task was significantly related with θ com-
ponent (r2 = −0.21, p < 0.05).
Conclusions: Physiological arousal as mechanism underlying nap-
ping effects on task performance was only partially supported.
Disclosure: Nothing to disclose.
P344 | Glucose tolerance following a 6‐week
sleep extension protocol in overweight short
sleepers
I. Hartescu; K. Morgan; D.J. Stensel; J.A. King; A.E. Thackray
School of Sport, Exercise and Health Sciences, Loughborough University,
Loughborough, United Kingdom
Objectives/Introduction: The evidence suggests that weight gain
can, in part, be mediated by impaired glucose tolerance resulting
from chronically restricted sleep. Less experimental attention has
been paid to the hypothesis that sleep extension, by positively
impacting glucose handling, could provide a pathway to improved
metabolic health and weight loss. We examined the feasibility of
delivering a practical sleep extension protocol which significantly
increased sleep duration, and impacted glucose tolerance among
overweight ‘short sleepers’ at increased risk of diabetes. Following
screening, 22 men (mean age = 42.2, SD = 8.8; BMI = 29.65, SD =
2.93) were randomised to an intervention sleep extension condition,
or the control condition.
Methods: Following baseline assessment, intervention participants
were provided with personalised guidance in a 1‐to‐1 session.
Opportunities for extending the sleep period were identified and
agreed. Access to online resources (specifically addressing sleep
hygiene, relaxation procedures, and cognitive strategies) was pro-
vided. The 6‐week sleep extension period which followed aimed to
increase total sleep time from baseline by 1 hr. A helpline number/
email was provided for this period.
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For both groups a 3‐hr meal tolerance/insulin sensitivity test proce-
dure was employed at baseline and 6 weeks. Total sleep time (TST)
was recorded daily on a personal sleep diary. Actigraphic sleep mea-
sures continued for both groups throughout the trial.
Results: At baseline, there was no difference in TST between the
intervention and control group (Control 5.62 hr; intervention
5.64 hr). After 6 weeks of sleep extension, the intervention group
reported a total sleep time of 7.05 hr, compared to the control
group who reported total sleep time of 5.83 hr. These differences
were corroborated by actigraphy.
There was no difference in insulin response between the two groups
at baseline (t(10) = 0.98, two‐tailed). However, when the test was
repeated at 6 weeks, the intervention group showed significantly
lower insulin concentrations (mU/L) relative both to the control
group (t(10) = 0.03, two‐tailed), and their own baseline (t(10) = 0.05,
two‐tailed).
Conclusions: These findings are consistent with improved glucose
tolerance following the implementation of a successful sleep exten-
sion protocol in overweight habitually short sleepers.
Disclosure: Nothing to disclose.
P345 | Is it possible to adjust the driving and
resting times when operating highly autonomous
trucks?
M. Axelson1; C. Ahlström2; S. Krupenia3; A. Anund2;
W. Leeuwen4; G. Kecklund4
1Department of Biomedical Engineering, Linkoping University, 2Swedish
National Road and Transport Research Institute (VTI), Linköping, 3Scania,
Södertälje, 4Stress Research Institute, Stockholm University, Stockholm,
Sweden
Objectives/Introduction: The ADAS&ME project seeks to create
driver monitoring systems facilitating safer and more efficient use of
highly autonomous vehicle functionality. One application is to adapt
the driving and resting times by continually adjusting the tachograph
mode from driving to resting during autonomous driving at times when
the driver is genuinely resting. The goal of this exploratory pilot study was
to investigate the effect of a mid‐shift rest period on driver sleepiness.
Methods: Ten professional truck drivers (3 female, age:
45 ± 17 years) participated in this within‐subject design study. Two
counterbalanced conditions (Drive/Rest) were driven on a motorway
during daytime, each lasting about 6 hr including breaks. In Rest, a
confederate driver drove the truck for about 2 hr mid‐drive while
the participants could do as they wished from the passenger seat.
Drive was a baseline condition with ordinary driving. Before and
after the driving session, the TAP‐M, Lane Change Task (LCT) and
N‐back tests were performed. During driving, ECG, EOG, KSS and
stress ratings were acquired every fifth minute.
Results: A 2 (Drive/Rest) by 2 (Before/After) repeated measures
ANOVA showed no significant differences for any of the cognitive
tests or for the measures acquired while driving. There was a trend
towards higher KSS ratings after driving in the Drive condition, F
(1,25) = 3.91, p = 0.06, which stemmed from markedly higher KSS
ratings in three individuals (KSS 3–6, 2–5 and 3–7).
Conclusions: The driving and resting times should prevent drivers
from becoming too fatigued, something which explains the non‐sig-
nificant results. However, one third of the drivers had markedly
higher KSS ratings after the Drive condition, whereas none of them
showed any signs of sleepiness after the resting period. The low
number of participants makes it difficult to draw any conclusions
and further investigations are needed, especially since the rather
high KSS values that were reached are known from other studies to
be associated with an increased risk for involuntary lane crossings.
Disclosure: Nothing to disclose.
P346 | Excessive daytime sleepiness and traffic
accidents among taxi drivers: a cross‐sectional
survey in Izmit
Ç. Çaglayan1; B. Mercimek1; U. Urgan1; S. Kıran2
1Department of Public Health, Kocaeli University, Kocaeli, 2Department
of Occupational Health and Medicine, Hacettepe University, Institute of
Public Health, Ankara, Turkey
Objectives/Introduction: Sleepiness is a condition that has a neg-
ative effect on motor and cognitive performance. It is one of the
individual risk taking behaviour as excessive speed and alcohol use
for traffic accidents. The aim of this study is to investigate that
potential relationship between sociodemographic characteristics, per-
sonalbehaviours, excessive daytime sleepiness conditions and traffic
accidents among taxi drivers.
Methods: The survey was conducted between June and August
2016 using a face‐to‐face interview technique at the taxi stand. The
sample size was calculated as 190 and 160 of them participated in
the survey. The questionnaire that used was including the sociode-
mographic characteristics, working conditions, healthy lifestyle
behaviors, body mass index (BMI), previous traffic accidents, per-
ceived health status of the participants, Eppworth Sleepiness Scale
(ESS) and General Health Questionnaire (GHQ‐12). Descriptive, uni-
variate and Pearson correlation analyzes were performed. Signifi-
cance level of alpha was accepted 0,05.
Results: The participation rate of taxi drivers was 84%. All drivers
are male and average age is 44.9 ± 10.9. 82.5% of the participants
were married and 56.3% were high school graduates. 66.9% of par-
ticipants stated that they use cigarette, 30.9% said they use alcohol.
88% of drivers rated their perceived health as good ‐very good. The
frequency of those who have traffic accidents is 66.2% and the fre-
quency of EDSS was found 2%. The mean of the ESS scores is
2.7 ± 2.4. There was a significant difference between the frequency
of accident those whom has higher ESS scores than lower ESS
scores (p:0.007). There were statistically significant positive
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correlations between ESS scores, alcohol consumption amounts, traf-
fic accidents, number of work accidents, number of night work, BMI
and GHQ‐12 scores in the correlation (p < 0.01).
Conclusions: Even though assessment of sleep disorders is a pre-
requisity for fitness to work, it might be other reasons as like lack of
healthy life behaviours for EDSS among taxi drivers. It need to be con-
sidered to promotion of healthy life behaviors and wareness of sleep
hygiene to prevent excessive daytime sleepiness while working.
Disclosure: Nothing to disclose.
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P347 | Neural correlates of autobiographical
memory and self in patients of stroke and head
injury
P. Taylor1; M. Sandhya2; V.V. Binoy1; S. Menon1;
A.S. Hegde3; R. Srinivasa4
1Humanities, National Institute of Advanced Studies (NIAS), IISC
Campus, 2Radiology and Intervention, National Institute of Mental
Health and Neuroscience (NIMHANS), 3Institute of Neuroscience,
4Neurology, M S Ramaiah Memorial Hospital, Bangalore, India
Objectives/Introduction: Autobiographical memories (AMs) are
significant in maintaining a sense of self. AM is a multifaceted
higher‐order cognitive process which involves recollection of specific
personal events. It is mainly categorized into Semantic AM and Epi-
sodic AM. Studies evaluating AM separately in stroke and head
injury patients have shown that AM is affected in them.
Methods: In this study we are comparing the effects of mild stroke
in PCA (Posterior Cerebral Artery) and in MCA territory (Middle
Cerebral Artery) and in mild head injury on episodic and semantic
AM at two different time points that is in the acute phase (approx.
10 days) and at 3 months. 15 patients and 10 healthy subjects were
examined on Autobiographical Incidents Schedule (AIS), Personal
Semantic Memory Schedule (PSMS) and Self test.
Results: All patients group were impaired on both tests relative to
controls (p < 0.001). Episodic memories was most affected in MCA
stroke (p < 0.001) and personal semantic memories most affected in
PCA stroke (p < 0.005). We found that when both episodic and
semantic AM was considered PCA stroke affected the most. Further,
on hemispheric comparison AM was most affected in patients of
right MCA stroke than left MCA stroke and contrastingly, left PCA
stroke than right PCA stroke. Childhood episodic AM was most
affected in MCA stroke whereas early adult and recent event memo-
ries was most affected in head injury than in stroke.
Conclusions: Critical areas of the brain are important for AM and
self and injury to these specific areas by stroke or head injury dictate
the outcome and recovery.
Disclosure: Nothing to disclose.
P348 | Sleeping after an emotional event leads
to long‐term decreases in visceral and subjective
emotional responses associated with memory
E. Bolinger1; T.J. Cunningham2; J.D. Payne2; K. Zinke1;
M.A. Bowman3; J. Born1
1Institute for Medical Psychology and Behavioural Neurobiology,
University of Tübingen, Tübingen, Germany, 2Department of Psychology,
University of Notre Dame, Notre Dame, IN, 3Department of Psychology,
University of Pittsburgh, Pittsburgh, PA, United States
Objectives/Introduction: How does sleep influence the emotional
tone associated with memories? Recently, we demonstrated that
cognitively influenced aspects of emotional tone, i.e. those which are
subject to top‐down control mechanisms (measured by subjective
valence and arousal ratings), decreased after a 10‐hr interval filled
with nocturnal sleep compared to a day of wake. In contrast, sleep
compared to wake increased more automatic aspects of emotion
(heart rate deceleration, HRD) after a short delay. Here, we exam-
ined whether these short‐term influences (i.e. after 10 hr) persist
after an extended delay (i.e. one week).
Methods: During the encoding session, participants viewed nega-
tive and neutral pictures either in the morning before a day of wake-
fulness (Wake group, n = 16) or the evening before a night of sleep
(Sleep group, n = 16). Participants returned one week later for a
recognition session. While viewing the images at each session, sub-
jective ratings (i.e. valence and arousal) and HRD responses were
measured. Emotional response was calculated as the response to
negative images minus the response to neutral images. During the
recognition session, the emotional response measure was limited to
pictures that were correctly recognized (hits).
Results: After one week, the valence rating emotional response
was lower (less negative) in the Sleep than the Wake group (F
(1,26) = 5.24, ηp2 = 0.17, p = 0.03) when controlling for encoding
emotional response (which was significantly related to the emotional
response after one week: F (1,26) = 36.12, ηp2 = 0.58, p < 0.001).
The HRD emotional response was also lower in the Sleep group
compared to the Wake group (F (1,26) = 6.97, ηp2 = 0.21,
p = 0.014). Sleep did not influence arousal ratings.
Conclusions: Our results suggest that sleeping after a negative
event might beneficially decrease the emotional response associated
with the memory for that event in the long‐term. After one week,
both automatic (HRD) and cognitively controlled (subjective valence
ratings) emotional responses decreased if participants slept directly
after encoding. These results build on our previous findings showing
that the HRD emotional response is increased in the short‐term by
sleep, suggesting sleep's influences on the emotional tone of memo-
ries may exhibit complex dynamics that evolve over time.
Disclosure: Nothing to disclose.
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P349 | A daytime nap facilitates the
consolidation of and modulates the autonomic
response to emotional memories
N. Cellini1; M. Mercurio1; M. Sarlo1,2
1Department of General Psychology, 2Padova Neuroscience Center,
University of Padova, Padova, Italy
Objectives/Introduction: Notwithstanding compelling evidence
supports the role of sleep in consolidating neutral information, how
sleep processes emotional memories remains controversial. Here we
tested whether and how a daytime nap, containing no REM sleep,
modulates emotional memories processing both at the behavioral
and at the autonomic level.
Methods: Thirty‐nine (19 F) healthy students were exposed to 24
highly‐arousal unpleasant and 24 neutral pictures at 1:00PM. After
each image, participants rated their subjective valence and arousal.
Then participants were split into the Nap group (N = 19), who took
a 60‐min nap in the lab, and the No‐Nap group (N = 20), who con-
tinued with their daytime activities. At 5:00PM all participants per-
formed a recognition test during which they saw half of the previous
pictures intermixed with 24 novel stimuli. They had to decide
whether they had seen the picture before. During both sessions,
electrocardiogram and electrodermal activity were recorded to assess
autonomic reactivity to the stimuli.
Results: The Nap group showed higher memory discrimination than
the No‐Nap group for unpleasant pictures (p = 0.034). This effect
was mainly driven by the higher false alarm rate observed in the No‐
Nap group (p = 0.030). Memory discrimination in the Nap group was
positively associated with delta and spindle activity during slow
wave sleep (SWS; r = 0.60, p = 0.025 and r = 0.49, p = 0.073,
respectively). Subjective arousal decreased in both group for both
stimuli type. Both groups showed a skin conductance response
habituation in the recognition session. However, the Nap group
showed a reduction in cardiac deceleration after the nap for both
unpleasant and neutral stimuli, whereas the No‐Nap increased the
deceleration for the unpleasant stimuli (p's < 0.05).
Conclusions: Our results confirmed our previous results that a
nap, even without REM sleep, can facilitate the consolidation of
emotional memories compared to a similar period of wakefulness.
This process seems modulated by SWS activity. Moreover, we
observed that after a period of sleep participants reduced their ori-
enting responses to the unpleasant stimuli (i.e., reduced cardiac
deceleration), whereas participants who did not sleep increased their
orienting responses. We suggest that sleep may help to preserve the
adequate autonomic response to emotional events.
Disclosure: Nothing to disclose.
P350 | Assessing the sequential hypothesis for
memory consolidation in narcoleptic patients
M. Strauss1,2; L. Griffon2; P. Van Beers2; M. Chenaoui2;
D. Léger2; P. Peigneux1
1Neuropsychology and Functional Imaging Research Group (UR2NF)
Center for Research in Cognition and Neurosciences (CRCN), Université
Libre de Bruxelles, Brussels, Belgium, 2Sleep and Vigilance Department,
EA 7330 VIFASOM Sommeil‐Vigilance‐Fatigue et Santé Publique,
Université Paris Descartes, Sorbonne Paris Cité, APHP, Hôtel‐Dieu de
Paris, Paris, France
Objectives/Introduction: How sleep architecture plays a role in
memory consolidation is still debated: does each stage of sleep ben-
efit independently to memory, or is the non‐rapid‐eye‐movement
(NREM) ‐ rapid‐eye‐movement (REM) sleep sequence more efficient
for memory consolidation (sequential hypothesis)? We aimed to
answer this question in studying a group of narcoleptic patients,
who offer the unique opportunity to manipulate the order of sleep
stages, as these patients can sometimes fall asleep in REM sleep
before entering NREM sleep.
Methods: 54 patients with central hypersomnia, between 18 and
45 years old, were included in the analysis. They were tested for
declarative (word pairs) and perceptual (visual texture discrimination
task) memory before and after a nap, repeated 3 times during the
day. 50 patients were kept for analysis with a total of 149 naps.
Naps/patients were assigned to one group or the other depending
on the sleep sequence during the nap (NREM‐REM or REM‐NREM
sleep). Naps/patients without a complete sequence were assigned to
the No‐Sequence group.
Results: In the declarative task, all groups showed equally
decreased performances after sleep. The time spent asleep or in a
specific sleep stage was not correlated with performances.
In the perceptual task, patients who slept with a complete sequence
(NREM‐REM or REM‐NREM) tended to increase their performances,
while patient napping without a complete sequence tended to
decrease their performances after sleep. However, there was no sig-
nificant interaction. Taken all naps together, better performances
were correlated with more time spent in NREM sleep (p < 0.05).
Conclusions: No effect of the sleep sequence could be demon-
strated in this study. Only a positive effect of the time spent in
NREM sleep was shown on performances in the perceptual task.
Then, our results do not support the sequential hypothesis, and the
NREM‐REM sequence may not be necessary for an optimal memory
consolidation. Alternatively, the sleep sequence may not be neces-
sary in the specific tasks tested, or we cannot exclude a negative
effect specific to the patient population. This study is one of the first
to test experimentally the sequential hypothesis in humans.
Disclosure: Nothing to disclose.
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P351 | Lack of frequency‐tagged magnetic
responses suggests statistical regularities remain
undetected during NREM sleep
J. Farthouat1; A. Atas2; V. Wens3; X. De Tiege3; P. Peigneux1
1UR2NF ‐ Neuropsychology and Functional Neuroimaging Research Unit
at CRCN, 2CO3 ‐ Consciousness, Cognition, and Computation Group at
CRCN, 3LCFC ‐ Laboratoire de Cartographie Fonctionnelle du Cerveau,
Université Libre de Bruxelles (ULB), Bruxelles, Belgium
Objectives/Introduction: Hypnopedia, or the capacity to learn
during sleep, is debatable. Although convincing evidence was pro-
vided for the creation of elementary conditioning during human
sleep, it remains unclear whether more sophisticated learning is
possible. We tested using magnetoencephalographic (MEG)
frequency‐tagged recordings whether high‐order associations
embedded in statistical regularities can be detected during NREM
sleep.
Methods: Young adults (N = 21; 23.7 ± 2.7 years) participated in 2
MEG sessions. In the Sleep (90 min nap) MEG session, they heard
habituation auditory streams (HAB; ascending/descending half‐tone
scales) while falling asleep. While in stable NREM2/NREM3 sleep,
stimulation switched to statistical (STAT) and random (RDM) 5‐min
auditory streams (counterbalanced). Participants not reaching NREM
sleep were assigned to the NoNREM_NoExposure group (N = 10);
others belonged to the NREM_Exposure group (N = 11). In the sub-
sequent MEG session at Wake, both groups were delivered 5‐min
STAT and RDM streams 2 times each (counterbalanced). Auditory
streams material: STAT streams featured non‐melodious successions
of 12 pure tones statistically grouped into four randomly alternating
tritones (G#CD, AC#G, FA#D# and EF#B in musical notation,
A = 440 Hz). Transitional succession probability between two tones
within a tritone was 1.0, and between two tritones 0.33, creating
statistical grouping regularities. In RDM streams, the 12 tones were
randomly presented (transitional probability = 0.09). Tones were
delivered at a 5.505 Hz presentation rate, thus tritone presentation
rate was 1/3 = 1.835 Hz.
Results: During sleep (NREM_Exposure), strong tone‐related
(5.505 Hz) signal‐to‐noise ratio (SNR >10) was present in bilateral
temporal sensors, reflecting successful perception of auditory stimu-
lations both in STAT and RDM streams (p > 0.1). However, no tri-
tone frequency (1.835 Hz)‐tagged response was evidenced in STAT
or RDM streams (SNRs = ±1). During subsequent wakefulness, both
NREM_Exposure and NoNREM_NoExposure groups exhibited unam-
biguous tritone‐frequency tagged responses during STAT but not
RDM streams (cluster‐based permutation test p < 0.05) in left and
right temporal sensor, reflecting successful detection of statistical
auditory regularities.
Conclusions: We show using MEG frequency‐tagged recordings
that associations embedded in statistical regularities remain unde-
tected during NREM sleep whereas learned during subsequent
wakefulness. These results suggest that the brain′s learning capabili-
ties during NREM sleep restrict to elementary associations.
Disclosure: The Belgian National Fund for Scientific Research
(FRS‐FNRS) funded in full or part JF, AA, VW and XdT during the
time of the study. Experimental costs were supported by FRS‐FNRS
grant T.109.13 to PP. The author(s) declare no competing financial
interests.
P352 | Perinatal memory and the influence of
prenatal stimulation on newborns sleep
A. Lang1; R. del Giudice1; S. Scholle2; M. Schabus1
1University of Salzburg, Salzburg, Austria, 2Robert‐Koch‐Krankenhaus
Apolda GmbH, Apolda, Germany
Objectives/Introduction: Newborns are reported to recognize
their mother's voice after birth, suggesting that a fetus has in princi-
pal the ability to learn. The aim of our study was to examine overt
signs of recognition in newborns to a more complex stimulus, namely
a prenatally repeatedly presented nursery rhyme. Given that sleep is
prominent in third term fetuses and newborns, we were additionally
interested if and how prenatal stimulation influences the distribution
of sleep/wake states in newborns during periods of renewed stimula-
tion and non‐stimulation (silence) after birth.
Methods: Pregnant women (n = 30) either replayed a taped nurs-
ery rhyme from week 34 of gestation until birth, twice a day, to the
unborn (experimental group; EG) or did not (control group; CG). Two
and five weeks after birth, infants’ electrocardiogram (ECG) was col-
lected while playing the same (familiar) rhyme and a newly presented
(unfamiliar) rhyme back over speakers, each with the maternal (famil-
iar) and a strange female (unfamiliar) voice. Randomized stimulation
periods were alternating with non‐stimulation (silence) periods. Every
stimulation and non‐stimulation block lasted 180 seconds, resulting
in a total recording time of 27 min per recording.
Results: After calculating differences in mean heart rates (HR)
between stimulation and preceding non‐stimulation blocks, repeated
measures ANOVA revealed no significant main effects for rhymes or
voices at both recordings. In a next step mean HR and heart rate
variability (HRV) for summed up (i) stimulation and (ii) non‐stimula-
tion periods was calculated. Independent Samples T‐Test has shown,
that infants unfamiliar with prenatal stimulation (CG) had higher
mean HR (p = 0.004) and lower parasympathetic activity (mean high‐
frequency power of HRV; p = 0.001) during stimulus presentation
times at week 2. Furthermore, despite active (“REM”) sleep was
prominent at both recordings, infants unfamiliar with prenatal stimu-
lation (CG) have shown higher amount of wake states during stimu-
lation periods (42% vs. 20%) at week 2.
Conclusions: Our findings suggest no signs of perinatal memory for
more complex prenatal stimulation material like nursery rhymes. Nev-
ertheless, newborns familiar with prenatal stimulation appear less
stressed and less disturbed in their sleep behavior during re‐stimula-
tion after birth, indicating prenatal habituation to auditory stimulation.
Disclosure: Nothing to disclose.
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P353 | Brain connectivity during the
consolidation of procedural learning in quiet rest
versus sleep
Z. Zavecz1,2; P. Simor1; K. Janacsek1,2; D. Nemeth1,2
1Eötvös Loránd University, 2Hungarian Academy of Sciences, Budapest,
Hungary
Objectives/Introduction: Post‐learning sleep and sleep‐specific
neural oscillations can facilitate off‐line memory consolidation. Some
of these oscillatory patterns might also be functional during a wake-
ful quiet rest state, however, the influence of wakeful rest on mem-
ory consolidation was only scarcely investigated. Furthermore, the
beneficial impact of sleep on non‐declarative, procedural skills, espe-
cially sequence learning is less conclusive. The aim of our study was
to explore the functional connectivity (FC) during memory consolida-
tion of subprocesses of procedural learning in quiet rest vs. sleep.
Methods: Here, we applied a complex perceptual‐motor procedural
learning task (namely the Alternating Serial Reaction Time Task) in
order to investigate the consolidation of two learning processes: (1)
implicit statistical learning, a fundamental mechanism of the brain,
which extracts and represents regularities, and (2) explicit sequence
learning which is a higher‐order type of learning with explicit access
to the represented regularities. Young adults (N = 72) after perform-
ing the task were randomly allocated into one of two different
groups to spend a one‐hour off‐line period in a relaxed resting state
(quiet rest, N = 34), or asleep (N = 38). EEG connectivity was ana-
lyzed throughout the off‐line period.
Results: On a behavioral level, we have found no differences
between these groups (F (2,75) = 1.10, p = 0.34): statistical learning
and explicit sequence learning was preserved in all groups after the
off‐line period. However, we investigated the individual differences
within the groups, so we calculated correlations between different
types of learning indices and brain connectivity of the consolidation
both in the sleep group and the quiet rest group. FC was calculated
by WPLI (Weighted Phase‐Lag Index) after Laplace transformation.
To study the relationship between individual FC and overall learning
score indices, permutation‐based correlation analysis was conducted
(all ps < 0.05).
Conclusions: Our findings indicate, that the beneficial long‐range
connections during the consolidation in different states (i.e. sleeping
vs. quiet rest) could predict individual differences in different sub-
types of procedural learning.
Disclosure: Nothing to disclose.
P354 | Reinstatement of emotional
associations during human sleep: an intracranial
EEG study
G. Legendre1; M. Seeck2; L. Spinelli2; S. Schwartz1;
V. Sterpenich1
1Basic Neuroscience, University of Geneva, 2Neurology, Geneva
University Hospitals, Genève, Switzerland
Objectives/Introduction: Memory replay occurs spontaneously
during sleep and promotes consolidation. Such replay can be experi-
mentally triggered by presenting sensory cues that had previously
been paired with recently encoded information. Whether this same
procedure may allow the reactivation and consolidation of associated
emotional states is still unknown.
Methods: Here we recorded intracranial EEG signal in 7 epileptic
patients (undergoing presurgical investigation; N = 7). Six patient had
an electrode implanted in the amygdala (N = 6), six in the hippocam-
pus (N = 6) and five in the orbitofrontal cortex (N = 5). They heard
two different sounds presented together with either funny or neutral
pictures. After this conditioning phase, both sounds were played
while patients had a nap, and after the nap. We analyzed the EEG
response to both sounds of the amygdala, hippocampus and orbito-
frontal cortex across different frequency bands. We compared the
conditions with two‐tailed paired t‐test.
Results: We first controlled that participants found the funny pic-
tures more emotional. Patients all rated funny pictures as more emo-
tional on average (p < 0.001). We then investigated how the
amygdala and the orbitofrontal cortex react to the two types of con-
ditioned sounds. During sleep, the emotionally conditioned sound
increased oscillations implicated in memory in the amygdala (theta
range; p < 0.01) and orbitofrontal cortex (beta range; p < 0.05).
Together with this effect, a stronger connectivity between the orbi-
tofrontal cortex and the hippocampus was observed in the theta fre-
quency range (p < 0.01).
Conclusions: We showed that, during sleep, the emotional compo-
nents of memories are replayed in limbic circuits when cued. More-
over, we showed that this process implicate an increase in
oscillations and connectivity typically involved in memory encoding
and retrieval (theta and beta frequency range). The predominance of
these oscillations in contrast with more classical sleep oscillations
(like spindles or slow‐oscillations) suggest a complex interplay across
frequencies and regions. We hope these clues will provide new
insights into the involvement of the different frequency bands in
shaping memories during sleep.
Disclosure: Nothing to disclose.
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P355 | Pre‐attentive auditory perception
during slow‐wave sleep: a study of event‐related
potentials in response to violation of global and
local regularity in the sound sequence
K. Liaukovich1,2; Y. Ukraintseva1; K. Sake2; O. Martynova1,3
1Human Higher Nervous Activity Lab, Institute of Higher Nervous
Activity and Neurophysiology of Russian Academy of Sciences, 2School of
Psychology, 3Centre for Cognition and Decision Making, National
Research University Higher School of Economics, Moscow, Russian
Federation
Objectives/Introduction: Data on auditory event‐related poten-
tials (ERPs) prove that sound detection is altered but remains during
slow‐wave sleep (SWS), however novelty detection may be absent.
To test this we aimed to compare patterns of mismatch negativity
(MMN), index of pre‐attentive discrimination evoked on global (GV)
and local violations (LV) of auditory sequence regularity during SWS
and waking state (WS).
Methods: Auditory ERPs were recorded from 14 healthy volun-
teers during a daytime nap. Passive odd‐ball paradigm with LV and
GV was presented during SWS and after sleep during WS. Both
irregular sequences consisted of trials where the first four sounds
were the same (standards), but the fifth sound differed. In the LV
sequence 80% trials ended with the standard sound (composed of
500, 1,000, and 1,500 Hz harmonic sinusoidal waves) and 20% trials
ended with the deviant sound (505, 1,010, and 1,515 Hz). In the GV
sequence 80% trials ended with the deviant sound and 20% with
the standard sound. We detected negative peaks of averaged ERPs
difference waveforms (Deviant ‐ Standards) in several time windows:
60–160 ms, MMN 160–260 ms, 280–380 ms, 360–500 ms. Using
repeated measures ANOVA we compared the peak latencies and
amplitudes at frontal F (Fz, F3, F4) and central C (Cz, C3, C4) elec-
trode clusters in LV and GV sequences during SWS and WS.
Results: The latency of early negative peaks in LV was longer in
SWS than WS for (60–160 ms: F electrodes, p = 0.031; MMN 160–
260 ms: p = 0.049). The late negative peak latency was also longer
in LV than in GV (360–500 ms: C electrodes, p = 0.039) during SWS.
The MMN amplitude increased during SWS for MMN 160–260 ms
in LV at F electrodes (p = 0.027). As we observed an incomplete
structure of ERPs in GV we expectedly found no significant differ-
ences for global MMN between SWS and WS.
Conclusions: The ERPs results suggest that discrimination of LV in
auditory sequences remains even in SWS, but with increased latency
and amplitude of MMN. An absence of clear MMN or other compo-
nents of sound novelty detection in passive GV paradigm in SWS
supports previous data on disrupted high‐level discrimination in
sleep.
Disclosure: Nothing to disclose.
P356 | The impact of sleep on complex gross‐
motor adaptation in adolescents
K. Bothe1; J. Birklbauer2; F. Hirschauer1; H.-P. Wiesinger2;
J. Edfelder2; G. Gruber3; K. Hoedlmoser1
1Laboratory for Sleep, Cognition and Consciousness Research, Centre for
Cognitive Neuroscience, 2Department of Sport Science and Kinesiology,
University of Salzburg, Salzburg, 3Department of Psychiatry and
Psychotherapy, Medical University of Vienna, Vienna, Austria
Objectives/Introduction: Sleep has been shown to facilitate the
consolidation of newly acquired motor memories in adults. However,
the role of sleep in motor memory consolidation is less clear in ado-
lescents, especially concerning real‐life gross‐motor skills. Therefore,
we investigated the effects of sleep and wakefulness on a complex
gross‐motor adaptation task by using a bicycle with an inverse steer-
ing device.
Methods: 29 healthy adolescents aged between 11 and 14 years
(5 female) were either trained to ride an inverse steering bicycle with
supporting wheels (learning condition) or a stationary bicycle (control
condition). Training took place in the morning (WAKE, n = 14) or in
the evening (SLEEP, n = 15) followed by a 9 hr retention interval
and a subsequent re‐test session. Slalom cycling performance was
assessed by speed (riding time) and accuracy (standard deviation of
steering angle, SDSA) measures.
Results: Behavioral results indicated that both groups showed simi-
lar speed and task accuracy throughout training and retrieval regard-
less of spending the retention interval asleep or awake (SDSAGROUP:
F (1,27) = 0.326, p = 0.573, η2 = 0.012; riding timeGROUP: F
(1,27) = 1.863, p = 0.184, η2 = 0.065). However, overnight perfor-
mance gains in accuracy were associated with an increase in left
hemispheric N2 slow sleep spindle activity (SpA) from control to
learning night (r15 = −0.522, p = 0.046). Furthermore, decreases in
REM (r15 = 0.581, p = 0.023) and tonic REM (r15 = 0.550, p = 0.034)
duration were related to higher overnight accuracy improvements.
Regarding speed, an increase in tonic REM duration was especially
favorable for higher overnight performance gains in riding time
(r15 = −0.533, p = 0.041).
Conclusions: Thus, although not yet detectable on a behavioral
level, sleep seemed to play a role in the acquisition of gross‐motor
skills. A promising direction for future research is to focus on the
possibility of delayed performance gains in adolescent populations.
Disclosure: Nothing to disclose.
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P357 | Does sleep benefit prospective
intention realization: comparing valence and
neutral cues
N. Kashyap1; S. Dhaka2; K. Verma3; J. Kushwah4
1Department of Humanities and Social Sciences | Indian Institute of
Technology Guwahati, IIT Guwahati, Guwahati, 2Humanities and Social
Sciences, NIT Rouerkela, Rouerkela, 3HSS, IIT Guwahati, Guwahati, India,
4TU Dortmund, Dortmund, Germany
Objectives/Introduction: Several studies evidence retrospective
memory facilitation following nights of sleep when compared with
wakefulness. The same results do not hold for prospective memory
as few studies have attempted to investigate the relationship. Within
the event cued prospective memory system cue characteristics play
a central role in the success of its detection and further retrieval of
intention. Emotions salience is an important cue characteristic that
facilitates cue detection and intention realization. The present study
explores the role of sleep in stabilizing and consolidating valence and
neutral cues traces and its effect on prospective memory perfor-
mance
Methods: A repeated measure design was used on twenty paid
volunteers (mean age: 21 ± 1.5) with no prior history of sleep distur-
bances and psychiatric conditions. Subjects learnt prospective cues
on experimental nights prior to sleep/deprivation and performed on
prospective intention realization task after one night of recovery
sleep
Results: Behavioral Analysis: Data for accuracy of intention realiza-
tion was subjected to 2 retention (sleep, deprivation) × 2 affect (va-
lence, neutral) repeated analysis of variance. The results suggest that
sleep following cue learning leads to more successes in prospective
intention realization as compared to deprivation (F (1,19) = 8.23,
p < 0.05). Similarly, valence cue resulted in more number of prospec-
tive intention realization at retrieval (F (1,19) = 5.61, p < 0.05). Post‐
hoc analysis on retention x affect interaction suggests sleep benefits
valence cue dependent intention realization more than neutral cues.
ERP Analysis: Mean amplitudes between 160–210 ms (prospective
monitoring) and 600–900 ms (retrospective remembering) from 9
electrodes (F7, Fz, F8, T7, Cz, T8, P7, Pz, P8) site following cue
onset at retrieval were subjected to repeated measure ANOVA [re-
tention (sleep, sleep deprivation), Affect (valence, neutral) & LCR (lat-
eral, central, right)]. None of the main variables reported significant
main effects. Only partial interaction effects were reported.
Conclusions: The result suggests that both sleep and cue valence
individually facilitates the accuracy of prospective intention realiza-
tion.
Disclosure: No conflict of interest among authors.
P358 | Well done! Effects of post‐learning
positive reinforcement on motor memory recall
performance 12 hours and 1 month after
learning
F. Rångtell; L. van Egmond; S. Karamchedu; A. Moulis;
M. Ilemosoglou; F. Schmidt; X. Tan; C. Benedict
Neuroscience, Uppsala University, Uppsala, Sweden
Objectives/Introduction: Procedural memory is an implicit type
of memory, and includes learning of complex motor skills (e.g. a new
dance move). The extent by which newly acquired motor skills are
consolidated is driven by various factors, including sleep and
whether the memory is expected to be of future relevance. Whether
positive reinforcement on learning performance, irrespective of the
person's actual performance, improves the ability to recall motor
memory both in the short and the long‐term has not yet been inves-
tigated.
Methods: To test this hypothesis, we compared effects of positive
reinforcement vs. no reinforcement on consolidation of procedural
(finger sequence tapping) memory in 68 male and female students.
In the reinforcement group (N = 34), positive feedback was provided
by the computer after cessation of the learning session (“That was
one of the best performances we have had”). The positive feedback
was given irrespective of the participant's actual performance. Learn-
ing took place in the evening before in‐home sleep (measured by
actigraphy). Two recalls were scheduled after learning: 12 hr and
about one month later. No additional reinforcement was given at
any of the recalls
Results: Positive reinforcement immediately following learning
improved consolidation of the newly acquired motor memory
(p < 0.05), as indicated by the gain in finger tapping performance
across the post‐learning night. Strikingly, the difference in the gain in
procedural memory between the reinforcement and control group
was still seen after one month. Sleep parameters collected during
and after the post‐learning night, such as total sleep time and subjec-
tive sleep quality, did not correlate with overnight consolidation of
the motor memory.
Conclusions: Our findings suggest that positive reinforcement dur-
ing learning of a motor task is a simple intervention to boost motor
memory recall performance in students, both in the short and in the
long term.
Disclosure: Nothing to disclose.
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P359 | The effect of sleep deprivation on
recognition of ambiguous emotional facial
expressions in individuals with ADHD
O. Dan; A. Cohen; K. Asraf; K. Nachum; I. Haimov
Psycholoy, Max Stern Academic College of Emek Yezreel, Shimshit, Israel
Objectives/Introduction: The present study sought to investigate
whether young adults with ADHD have more difficulty recognizing
emotional facial expressions compared with young adults without
ADHD, and whether such a difference worsens following sleep
deprivation.
Methods: Thirty‐one young men (M = 25.6) with (n = 15) or with-
out (n = 16) a diagnosis of ADHD were included in this study. The
participants were instructed to sleep 7 hr or more each night for
one week, and their sleep quality was monitored via actigraph. Sub-
sequently, the participants were kept awake in a controlled environ-
ment for 30 hr. The participants completed a visual emotional morph
task twice—at the beginning and at the end of this period. The task
included presentation of interpolated face stimuli ranging from neu-
tral facial expressions to fully emotional facial expressions of anger,
sadness or happiness, allowing for assessment of the intensity
threshold for recognizing these facial emotional expressions.
Results: At the onset of the experiment there were no differences
in recognition thresholds between the participants with ADHD and
those without ADHD. Following sleep deprivation, however, the
ADHD group required clearer facial expressions to recognize the
presence of angry, sad, and, to a lesser extent, happy faces.
A significant Time × ADHD interaction was found for angry emo-
tional recognition threshold (ERT) [F (1,27) = 21.55, p < 0.01, eta =
0.44]. Similarly, a significant Time × ADHD interaction was found
for sad ERT [F (1,27) = 11.75, p < .01, eta = 0.30]. Finally, a signifi-
cant Time × ADHD interaction was found for happy ERT [F
(1,27) = 7.49, p < 0.05, eta = 0.22].
Conclusions: Among young adults with ADHD, sleep deprivation
may hinder the processing of emotional facial stimuli.
Disclosure: Nothing to disclose.
P360 | The sleepiness curve of young men
with and without Attention Deficit Hyperactivity
Disorder (ADHD)
A. Cohen; K. Asraf; I. Haimov; O. Dan
Psychology, Max Stern Academic College of Emek Yezreel, Yezreel Valley,
Israel
Objectives/Instruction: The present study aimed at comparing
the sleepiness curve of young men with ADHD to that of young
men without ADHD, and to examine whether ADHD is associated
with heightened sleepiness in general, and during and after a night
of sleep deprivation in particular.
Methods: Thirty young men (M = 25.5) with (n = 14) or without
(n = 16) a diagnosis of ADHD were included in this study. Five days
prior to the experimental session, participants were instructed to
sleep at least 6 hr each night and their sleep quality was monitored
via actigraph. During the experimental session, participants were
kept continuously awake in a controlled environment for 25 hr
(8 a.m.–9 p.m.). Every hour the level of sleepiness of the participants
was assessed by the Karolinska Sleepiness Scale (KSS) in order to
obtain the sleepiness curve of both study groups.
Results: Actigraphy data demonstrated that sleep duration of the
participants with ADHD was similar to that of participants without
ADHD but their sleep efficiency was poorer. Moreover, during the
experimental session the ADHD group demonstrated higher levels of
sleepiness at all time points, with the difference reaching statistical
significance during afternoon (1–5 p.m.) and following 2 p.m. Specifi-
cally, both groups demonstrated a steady increase in sleepiness from
midnight to 9 a.m. but the increase was significantly greater among
the ADHD participants.
Conclusions: Young men with ADHD suffer from sleepiness more
than their counterparts from the general population, and the magni-
tude of this difference depends on the time of day and is severely
aggravated by sleep deprivation.
Disclosure: Nothing to disclose.
P361 | The effect of short sleep on lipid
metabolism in Japanese university students
S. Miyata1; A. Noda2; K. Iwamoto1; H. Fujishiro1;
R. Taguchi2; N. Ozaki1
1Department of Psychiatry, Nagoya University Graduate School of
Medicine, Nagoya, 2Department of Biomedical Sciences, Chubu
University Graduate School of Life and Health Sciences, Kasugai, Japan
Objectives/Instruction: Sleep deprivation is common among the
current society and has several adverse effects, such as changes in
metabolism and inflammatory response, dyslipidemia, and cardiovas-
cular disease. The recent development of mass‐spectrometry‐based
methods to resolve complex lipid components is having a profound
effect on current approaches to analyzing the pathophysiological role
of lipid species. In this study, we investigated the effect of short
sleep on lipid metabolism in healthy university students.
Methods: Sixteen healthy university students enrolled in this study.
We selected participants who usually sleep between 6 and 8 hr
nightly according to sleep logs. We obtained informed consent in
writing from each participant after the nature of the procedures had
been fully explained. On natural‐sleep nights, subjects were in bed
for 8 hr (natural sleep), and on controlled‐sleep nights, they were
allowed to be in bed between only between 3 a.m. and 7 a.m.,
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limiting their total sleep time to less than 4 hr (short sleep). Lipid
from plasma was evaluated using liquid extraction surface analysis
with nanoelectrospray ionization mass spectrometry (LESA‐MS). Data
were analysed with a chi‐square test using statistical software (SPSS
ver. 25, IBM). Probability (p) values of <0.05 were considered statis-
tically significant.
Results: LESA‐MS detected more than 700 lipid molecule species
from seven lipid classes, including phosphatidylcholines (PC), phos-
phatidylethanolamines (PE), phosphatidylserine (PS), sphingomyelin
(SM), triacylglyceride (TAG), phosphatidylinositols (PI), phosphatidyl-
glycerols (PG), and sphingomyelins (SM). We identified 20 signifi-
cantly different lipid species in five classes including PC, PE, PS, SM
and TAG between natural sleep and short sleep.
Conclusions: The association of short sleep duration with molecu-
lar lipid species reflects the importance of changes in lipid homeosta-
sis in the pathogenesis of sleep deprivation.
Disclosure: Nothing to disclose.
P362 | Homeostatic response to sleep
restriction in adolescents
J. Skorucak1,2,3; N. Weber4; C. Reynolds5; S. Coussens4;
M. Carskadon6; P. Achermann1,2,3; M. Short4,5
1Institute of Pharmacology and Toxicology, University of Zurich,
2Neuroscience Center Zurich, University of Zurich and ETH Zurich,
3Zurich Center for Interdisciplinary Sleep Research, University of Zurich,
Zurich, Switzerland, 4Cognitive Neuroscience Laboratory, University of
South Australia, 5School of Psychology, Flinders University, Adelaide, SA,
Australia, 6Alpert Medical School, Brown University, Providence, RI,
United States
Objectives/Introduction: As chronic sleep restriction is highly
prevalent in adolescents, it is important to understand how adolescent
sleep is regulated under such conditions. In adults, sleep intensity is
homeostatically regulated: if sleep is restricted, then sleep intensity
increases. Our knowledge of this process is primarily informed by total
sleep deprivation studies and has been incorporated in mathematical
models of human sleep regulation. Some animal studies, however, sug-
gest that adaptation occurs in chronic sleep restriction conditions. Our
goal was to investigate sleep regulation in adolescents undergoing dif-
ferent durations of sleep opportunities.
Methods: 34 subjects were divided into three groups: 5, 7.5 and
10 hr of sleep opportunity. Each group underwent a protocol of 9
nights mimicking a school week between 2 weekends: 2 baseline
nights (10 hr sleep opportunity), 5 condition nights (5, 7.5 or 10 hr),
followed by two recovery nights (10 hr). Markers of sleep homeosta-
sis, slow‐wave activity (SWA; EEG power in 0.75–4.5 Hz range) and
slow‐wave energy (SWE; cumulative SWA) were calculated for fron-
tal and central EEG derivations and compared to predictions of the
two‐process model of sleep regulation.
Results: The protocol was effective in restricting sleep, with
decreased TST and sleep latency, and increased sleep efficiency in
all nights in the 5‐hr and 7.5‐hr conditions. Time in REM sleep was
decreased in all restriction nights in the 5‐hr condition and most
nights in the 7.5‐hr condition. Frontal SWA was increased compared
to baseline in the 5‐hr condition during the first 3 restriction nights
(p = 0.001). In central derivations, SWE was significantly below base-
line in restriction nights 1 and 5 in the 5‐hr (p = 0.013) and 7.5‐hr
condition (p = 0.033). Predictions of the two‐process model were
accurate, with only minor differences (frontal derivations) compared
to empirical homeostatic markers.
Conclusions: Sleep homeostasis is preserved under chronic sleep
restriction in adolescents. These findings improve our understanding
of effects of repetitive short sleep in adolescents.
Supported by the Swiss National Science Foundation, Clinical
Research Priority Program “Sleep and Health” of the University of
Zurich, Australasian Sleep Association Rob Pierce Grant in Aid and
Helen Bearpark Memorial Scholarship.
Disclosure: Nothing to disclose.
P363 | Intrinsic nonlinearity of psychomotor
vigilance test metrics as a function of hours
awake during sleep deprivation
S. Riedy1,2; H. Van Dongen1,2
1Sleep and Performance Research Center, 2Elson S. Floyd College of
Medicine, Washington State University, Spokane, WA, United States
Objectives/Instruction: The Psychomotor Vigilance Test (PVT)
measures sustained attention through speeded responses to visual
stimuli (rolling millisecond counter), which appear at random 2–10 s
intervals across a 10 min test period. Performance impairment on the
PVT during sleep loss can be quantified with a variety of outcome
metrics, which describe different aspects of the response time (RT) dis-
tribution. We investigated the psychometric properties of previously
published PVT outcome metrics. Here we focus on the extent to
which they show linear change as a function of time awake.
Methods: N = 23 healthy subjects (ages 22–37 years, 12 females)
completed one of two in‐laboratory studies with a sleep opportunity
(10 hr time‐in‐bed) followed by 62 hr of total sleep deprivation
(TSD). The PVT was administered every 2 hr during TSD. Thirty‐six
outcome metrics were calculated for each PVT bout. Analyses
focused on daytime test bouts that occurred at 3 time points during
TSD on the same time of day (i.e., at 24 hr intervals, keeping time of
day constant). Data were analyzed with nonlinear mixed‐effects
regression against time awake and time awake squared, controlling
for study and time of day, and including a random intercept over
subjects. Curvature was calculated as the metric deviation from lin-
earity from time point 2 to time point 3 divided by the linear slope
from time point 1 to time point 2, where zero curvature indicates
perfect linearity across time awake.
Results: In total, 23 subjects completed 267 test bouts. The small-
est curvatures (i.e., greatest linearity across time awake) were found
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for a likelihood ratio metric for relative RT frequency in three por-
tions of the RT distribution (curvature ± SE: 0.01 ± 0.22; t = 0.03,
p = 0.97), the log of the SD of RTs (0.01 ± 0.18; t = 0.05, p = 0.96),
and six metrics based on the number of lapses (RTs >500 ms)
(t ≤ 0.25, p ≥ 0.80).
Conclusions: The degree of linearity across time awake varied
greatly among the 36 PVT outcome metrics investigated. Metrics
based on the number of lapses were among the most linear, indicating
that performance impairment observed on these types of PVT metrics
is robustly proportional to the amount of sleep deprivation incurred.
Disclosure: Nothing to disclose.
P365 | Cognitive performance and
self‐reported sleepiness are modulated by
time‐of‐day during a mountain ultramarathon
R. Hurdiel1; S.M. Riedy2; G.P. Millet3; B. Mauvieux4;
C. Elsworth-Edelsten5; M. Dudoignon6; G. Zunquin1;
G. Dupont7
1University of the Littoral Opale Coast, Unité de Recherche
Pluridisciplinaire Sport, Santé, Société ‐ EA 7369, Dunkerque, France,
2Sleep and Performance Research Center, Elson S. Floyd College of
Medicine, Washington State University, Spokane, WA, United States,
3ISSUL, Institute of Sport Sciences, Faculty of Biology and Medicine,
University of Lausanne, Lausanne, Switzerland, 4INSERM, U 1075
Comete, Normandy University, Caen, France, 5Experimental Sport and
Exercise Science, School of Human and Life Sciences, Canterbury Christ
Church University, Canterbury, United Kingdom, 6Henri Warembourg
Medicine University, Lille 2 University, Lille, 7University of Artois, Unité
de Recherche Pluridisciplinaire Sport, Santé, Société ‐ EA 7369, Lievin,
France
Objectives/Instruction: Studies examining performance during an
ultramarathon have primarily used race time or ranking as dependent
variables. Few studies have examined cognitive performance or
sleepiness during an ultramarathon. Ultramarathon studies with mea-
sures of cognitive performance or sleepiness have largely been lim-
ited to pre‐race and/or post‐race assessments. We examined
cognitive performance and self‐reported sleepiness throughout a
mountain ultramarathon (MUM).
Methods: Ninety‐two runners completed the study during a
168 km MUM. Sleepiness and cognitive performance were assessed
at up to eight checkpoints during the race using the Karolinska
Sleepiness Scale (KSS) and correct responses on the Digital Symbol
Substitution Task (DSST), respectively. Runners also reported any
sleep obtained on the course at the checkpoints. Hours of sleep
obtained the night before the race were also reported. KSS and
DSST data were analyzed with nonlinear mixed‐effect regression
models with a sinusoidal function to model the circadian rhythm,
time‐into‐race and cumulative on‐course nap duration as main
effects, and a random intercept over subjects.
Results: Runners reported 7.24 ± 0.92 hr (mean ± SD) of sleep the
night before the race, and 14.40 ± 9.60 min of sleep during the race
(77% of runners reported a nap). Average KSS and DSST scores at
the start line were 1.89 ± 0.97 and 39.30 ± 7.40, respectively. Aver-
age KSS and DSST scores at the finish line were 2.78 ± 2.10 and
34.12 ± 8.69, respectively. KSS ratings peaked at 03:15, and DSST
scores peaked at 15:15. KSS scores increased significantly and DSST
scores decreased significantly across the course of the race (t > 2.94
p < 0.01). Amount of sleep obtained on the course was not a signifi-
cant predictor of KSS scores (t91 = 1.53, p = 0.13), but the amount
of sleep obtained on the course was significantly and negatively
associated with DSST scores (t87 = −2.32, p = 0.02).
Conclusions: Sleepiness and performance decrements increased
across the course of the race and were modulated by time‐of‐day.
Amount of sleep obtained on the course was not related to sleepi-
ness levels. Runners who slept on the course prior to testing, how-
ever, had poorer cognitive performance, which may suggest that
naps were not a fatigue mitigation strategy but a result of physical
exertion.
Disclosure: Nothing to disclose.
P366 | Chronic sleep restriction only reduces
performance when it accrues rapidly
T.L. Signal; J.L. Zaslona; M.J. van den Berg; L.J. Wu
Sleep/Wake Research Centre, Massey University, Wellington, New
Zealand
Objectives/Introduction: Laboratory research shows a strong
relationship between chronic sleep restriction (CSR, where sleep is
curtailed night after night) and reaction time performance. There has,
however, been limited research investigating the extent of CSR in
occupational settings and the consequences for workers’ function-
ing.
Methods: Air traffic controllers (ATCs) worked a schedule that
included two sets of backward rapidly rotating shifts (afternoon, day,
morning, night shift beginning the day the morning shift ends, ×2),
and a second schedule that included a longer forward rotating work
pattern (2 morning, 2 afternoon, 2 night shifts). Sleep was measured
via actigraphy and reaction time performance at the end of each
night shift with a 10‐min Psychomotor Vigilance Task test (PVT).
CSR was determined by comparing sleep per 24‐hr on work days to
non‐work days. Sleep lost or gained each 24‐hr was summed to pro-
duce a CSR value at the end of the work period, which could not be
greater than zero (assuming that sleep cannot be stored). Mixed
model ANCOVAs investigated whether the level of CSR, sleep in the
last 24‐hr, workload, schedule worked, or the interaction of factors
affected performance at the end of the night shift.
Results: ATCs (n = 13, mean age = 48, 11 males) obtained 7.6 hr
sleep on average on non‐work days. CSR averaged 4.4 hr (SD 1.5 hr)
and 4.5 hr (SD 1.6 hr) across the two backward rotating work peri-
ods, and 7.4 hr (SD 3.2 hr) across the forward rotating work period.
A significant interaction was found between the schedule worked
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and CSR for response speed (p = 0.0021) and fastest 10% of
responses (p = 0.0061), with greater CSR associated with slower per-
formance in the backward rotating schedule but not in the forward
rotating schedule.
Conclusions: These findings suggest that the way in which sleep
loss accumulates may be more important than the actual amount of
sleep loss accrued across a work pattern. In the backward rotating
schedule CSR builds more rapidly compared to the forward rotating
pattern, which may allow some opportunity for partial adaptation to
the effects of CSR.
Disclosure: Support: This study was industry funded. T. Leigh Sig-
nal declares no conflict of interest. Jennifer Zaslona declares no con-
flict of interest. Margo van den Berg declares no conflict of interest.
Lora Wu declares no conflict of interest.
P367 | The alerting effects during the wake
maintenance zone vary with prior duration of
wakefulness
J. de Zeeuw1,2; S. Wisniewski1,3; A. Papakonstantinou1,3;
F. Bes1,3; A. Wahnschaffe1,3; M. Zaleska2; D. Kunz1,2,3;
M. Münch1,3,4
1Institute of Physiology, Sleep Research & Clinical Chronobiology, Charité
‐ Universitätsmedizin Berlin, Corporate Member of Freie Universität
Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health,
2Intellux GmbH, 3Clinic for Sleep & Chronomedicine, St. Hedwig‐
Krankenhaus, 4Institute of Medical Immunology, Charité ‐
Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,
Humboldt‐Universität zu Berlin, and Berlin Institute of Health, Berlin,
Germany
Objectives/Instruction: Sleepiness does not simply increase the
longer one stays awake, instead it is regulated by a homeostatic and
a circadian process. In the evening, prior to the dim light melatonin
onset, there is a strong circadian arousal signal that opposes the
homeostatic build‐up of sleepiness, called the Wake Maintenance
Zone (WMZ). The aim of this study was to investigate how the
WMZ affects different cognitive performance tests, as well as sub-
jective and objective sleepiness after different durations of prior
wakefulness.
Methods: Twelve young male participants (25.3 ± 2.6 yrs; mean ±
SD) completed a constant routine protocol with 40 hr of extended
wakefulness in dim light, including two WMZs. A range of cognitive
performance tests were assessed, including sustained attention,
response inhibition, working memory and executive functioning. The
cognitive tests were divided in two parts which alternated every
hour so that each cognitive performance tests was carried out every
2 hr. Subjective sleepiness, salivary samples for melatonin concentra-
tions and the Karolinska Drowsiness Test (3 min; open eyes) in the
electroencephalogram (EEG) were assessed hourly.
Results: Cognitive response inhibition was improved during WMZ1
(13.5 hr awake) and sustained attention was improved during WMZ2
(37.5 hr awake), while higher executive function tests showed no
significant improvements. The EEG power density showed significant
reductions in the delta/theta frequency range during WMZ1 and in
the delta/theta, alpha, and sigma/beta ranges during WMZ2, with a
greater change in the sigma/beta range during WMZ2 compared to
WMZ1. During WMZ1 the EEG power reductions coincided with
stable subjective sleepiness and sustained attention. During WMZ2,
the EEG power reductions were more pronounced and coincided
with improved sustained attention.
Conclusions: Our results show that the circadian arousal signal in
the evening differently modulates cognitive functions and EEG
power, depending on the duration of prior wakefulness.
Disclosure: Funding: This study was funded by the German Fed-
eral Ministry of Education and Research (OLIVE project) and Intellux
GmbH (Berlin), Germany Disclosures: None
P368 | Effect of a single night of total sleep
deprivation and a night of recovery sleep on
plasma melatonin and cortisol profiles and the
metabolome
A. Homma1; V. Revell2; P. Gunn1; C. Mitchell1; S. Davies1;
B. Middleton1; F. Raynaud3; D. Skene1
1Chronobiology, Faculty of Health and Medical Sciences, 2Surrey Clinical
Research Centre, University of Surrey, Guildford, 3Cancer Research UK
Cancer Therapeutics Unit, Division of Cancer Therapeutics, Institute of
Cancer Research, Sutton, United Kingdom
Objectives/Introduction: Disruption to sleep and the circadian
timing system can impact metabolism. The aim of this study was to
investigate the effect of a single night of sleep deprivation and a
subsequent recovery night on melatonin, cortisol and the metabo-
lome in young females to increase understanding of metabolic path-
ways involved in sleep/wake regulation.
Methods: Healthy young female subjects (n = 12, 24.8 ± 1.3 years
(mean ± SEM)) maintained a regular sleep/wake schedule for 10 days
prior to an in‐laboratory session, comprising a 24‐hr period (day 1)
incorporating a sleep opportunity (23:00–07:00 hr), followed by
24 hr during which subjects remained continually awake (day 2) and
another 24‐hr period (day 3) which incorporated a recovery sleep
opportunity. Blood samples were collected for 72 hr at 1–2 hr inter-
vals for measurement of plasma melatonin, cortisol, and targeted liq-
uid chromatography‐mass spectrometry (LC/MS) metabolomics
analysis. Night timepoints between 00:00 and 06:00 hr for day 1
(baseline sleep), day 2 (no sleep) and day 3 (recovery sleep) were
analysed using repeated one‐way ANOVA.
Results: The dim light melatonin onset time on day 1 was
21:56 ± 0:14 hr and this did not significantly change between study
days (22:02 ± 0:14 hr; day 2, 21:54 ± 0:11 hr; day 3). Mean night‐
time melatonin levels showed a trend to increase during sleep depri-
vation (19.0 ± 6.9%, p = 0.07) relative to baseline sleep, these levels
declining back to baseline during recovery sleep. No significant
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differences were observed in cortisol levels. Using targeted LC/MS
metabolomics, 130 plasma metabolites were quantified. Of these, 6
(4.6%) metabolites were significantly changed between baseline
sleep and sleep deprivation, 5 (histidine, butyrylcarnitine, symmetric
dimethylarginine, alpha‐aminoadipic acid, lysoPC a C18:0) decreasing
and 1 (tetradecenoylcarnitine) increasing. These levels returned to
baseline during recovery sleep. Some metabolites were significantly
altered during recovery sleep compared to baseline sleep (n = 22,
16.9%).
Conclusions: Melatonin and metabolites that were altered during
acute sleep deprivation returned to baseline levels during a subse-
quent night of recovery sleep.
Disclosure: Nothing to disclose.
P369 | Sleep deprivation alters affective and
neural responses to erotic stimuli in heterosexual
males
L. Riontino; F. Dupraz; M. Moyne; S. Schwartz
University of Geneva, Genève, Switzerland
Objectives/Introduction: Based on recent data evidencing the
impact of sleep loss on reward brain functions, here we hypothe-
sized that sleep deprivation may alter behavioral and neural
responses to primary rewards, here specifically sexual stimuli.
Methods: Seventeen healthy young heterosexual men underwent
functional neuroimaging (fMRI) while they were exposed to five cat-
egories of pictures: erotic pictures of only women, only men, hetero-
sexual couples, non‐erotic pictures of people, and landscapes. For
each picture, participants judged the level of emotional arousal eli-
cited and perceived emotional valence. Each participant was tested
after a night of normal sleep (baseline) and following 24 hr of total
sleep deprivation.
Results: Arousal judgments were affected by sleep deprivation
(main effect of Sleep, F (1,16) = 5.34, p < 0.05), and stimulus type
(main effect of Stimulus Category, F (4,64) = 86.75, p < 0.05), with a
tendency for an interaction between both factors (F (4,64) = 1.85,
p = 0.13). Post‐hoc analyses showed that arousal for pictures of men
was significantly reduced after sleep deprivation compared to base-
line (p = 0.01), with a tendency for a similar effect for pictures of
women (p = 0.09). For valence, there was a tendency for main effect
of Sleep (F (1,16) = 3.73, p = 0.07), a significant main effect of Stim-
ulus Category (F (4,64) = 112.34, p < 0.05), and no interaction (F
(4,64) = 0.77, ns). At the brain level, sleep deprivation reduced brain
responses to erotic pictures of women in the ventromedial prefrontal
cortex, implicated in computing the hedonic value of rewards. Criti-
cally, sleep deprivation increased amygdala activation when individu-
als rated the erotic pictures as more arousing, and decreased left
prefrontal cortex activity for pictures judged as more positive (i.e.
erotic pictures of women).
Conclusions: While sleep deprivation did not affect judgments for
highly salient stimuli, such as erotic pictures of women, it did affect
reward and executive brain functions. Indeed, sleep deprivation
increased amygdala reactivity to arousing stimuli and limited the
recruitment of prefrontal regions involved in behavioral inhibition
when facing erotic pictures of women. Whether this pattern of acti-
vation may facilitate the enactment of inappropriate sexual behaviors
after sleep deprivation remains speculative.
Disclosure: Nothing to disclose.
P370 | Work organization reduces sleep
quality among airline pilots
P. Pellegrino1; C.R.d.C. Moreno2,3; E.C. Marqueze1,2
1Epidemiology, Catholic University of Santos, Santos, 2School of Public
Health, University of São Paulo, São Paulo, Brazil, 3Stress Research
Institute, Stockholm University, Stockholm, Sweden
Objectives/Instruction: To estimate the prevalence and risk fac-
tors of work organization associated with bad sleep quality among
pilots.
Methods: 1,234 airline pilots filled in an online questionnaire. Inde-
pendent variables included demographic data, working organization
aspects, health, and sleep information. A question derived from the
Karolinska Sleep Questionnaire was used to obtain the subjective
quality of sleep. Poisson regression with robust variance was per-
formed, adjusted by gender, age, having children under 12 years of
age, education, BMI and marital status.
Results: The prevalence of bad sleep quality was 48.2%. Bad sleep
quality was associated with the high frequency of technical delays
(PR 1.14, CI 95% 1.01–1.28), five or more consecutively night shifts
(PR 1.33, CI 95% 1.09–1.62), moderate and great need for recovery
after work (PR 1.96, CI 95% 1.60–2.41, and PR 2.38, CI 95% 1.94–
2.91, respectively), difficulty to commute to work (PR 1.19, CI 95%
1.04–1.38), being insufficiently physically active (PR 1.17, CI 95%
1.05–1.32) and sleeping 6–8 hr and less than 6 hr on days off (PR
1.16, CI 95% 1.03–1.13, and PR 1.59, CI 95% 1.31–1.93, respec-
tively) (Area ROC = 0.73).
Conclusions: Pilots′ daily work, consisting of frequent delays, long
working hours and the perception of unsuficient work demand
recovery has a negative impact on the quality of sleep of these pro-
fessionals. The high prevalence of bad sleep quality is worrying as it
can lead to poor health conditions, as well as decreased performance
and compromised flight safety.
Disclosure: Nothing to disclose.
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P371 | Decreased inhibitory control after
partial sleep deprivation in individuals reporting
binge eating
S. Cerolini; A. Ballesio; F. Ferlazzo; C. Lombardo
Department of Psychology, Sapienza University of Rome, Rome, Italy
Objectives/Instruction: Impairments in executive functions (EFs)
have been shown to be associated with dysregulated eating, such as
binge eating. Poor EFs have been linked to greater caloric intake in
both healthy children and adults. In parallel, experimental findings
suggested that sleep deprivation markedly impairs EFs. The aim of
this study was to evaluate if partial sleep deprivation may impair EFs
in a group of individuals reporting binge eating (BE) and in a group
of healthy controls (C).
Methods: EFs (switch cost and backward inhibition) were mea-
sured in the laboratory using the Task Switching Paradigm after a
habitual night of sleep and after a night of partial sleep deprivation.
Sleep was ecologically measured trough an electronic portable device
and sleep diaries. Depression was measured by a self‐report ques-
tionnaire.
Results: The total sample consisted of 27 participants divided in
two groups (BE, N = 14; C, N = 13). Results showed a significant
interaction Night × Group (F (1,25) = 4.68, p = 0.04) even after con-
trolling for depression (F (1,24) = 6.96, p = 0.014) on the backward
inhibition score. First, LSD post hoc tests showed that the two
groups differed in the habitual night (F (1,24) = 6.32, p = 0.019), evi-
dencing higher inhibitory control in BE group compared to C group.
Second, LSD post hoc tests showed that after partial sleep depriva-
tion, compared to the habitual night, backward inhibition was
decreased in BE group (F (1,24) = 4.69, p = 0.04), while in the C
group it was higher (F (1,24) = 3.60, p = 0.07).
Conclusions: This preliminary study was the first to explore the
impact of sleep deprivation on executive functions in participants
reporting binge eating symptoms and healthy controls. It demon-
strated that sleep deprivation may affect inhibitory control in partici-
pants reporting binge eating symptoms, thus highlighting their
potential mediating role in influencing eating behavior.
Disclosure: Nothing to disclose.
P372 | State anxiety over 62 hours of sleep
deprivation and recovery
T.J. Doty; A. Bessey; N. Prindle; M. Powers Armstrong;
T. Burke; V.F. Capaldi; T.J. Balkin
Center for Military Psychiatry and Neuroscience, Behavioral Biology
Branch, Walter Reed Army Institute of Research, Silver Spring, MD,
United States
Objectives/Instruction: Previous work has indicated increases in
self‐reported anxiety following one night of total sleep deprivation
(TSD). This study extends previous work by assessing the effects of
two nights of sleep deprivation on state anxiety as well as the effect
of a single night of recovery sleep.
Methods: Seventeen healthy adults (7 females) ranging from 18 to
33 years of age participated. Self‐reported state anxiety was
assessed using the Spielberger State Trait Anxiety Inventory (STAI‐S).
The STAI‐S was administered at 10 a.m., 1 p.m., and 4 p.m. under
four sleep conditions
(1) Baseline: day following one night of 8 hr time-in-bed (TIB),
(2) TSD1: day following one night of TSD,
(3) TSD2: day following two nights of TSD,
(4) Recovery: day following 12 hr TIB after 62 hr of TSD.
The data were analyzed with a 4 (Sleep Condition) × 3 (Time of
Day) mixed linear model.
Results: There was a significant main effect of Sleep Condition, F
(3,192) = 15.94, p = 2.70 × 10−9. Post‐hoc tests revealed that anxi-
ety was significantly increased after one night of TSD compared to
baseline (p = 0.009). Additionally, anxiety reported following two
nights of TSD was further increased compared to one night of TSD
(p = 0.0008). This increase in self‐reported anxiety was reversed
after one night of recovery sleep (decreased compared to TSD2,
p = 2.50 × 10−9; no difference compared to baseline, p = 0.37).
There was no main effect of Time of Day nor was there a significant
interaction between Sleep Condition × Time of Day.
Conclusions: The present findings suggest that state anxiety levels,
as measured by the STAI‐S, increase across two nights of TSD and
return to baseline following a single night of recovery sleep. These
preliminary findings suggest that a single 12‐hr period of sleep is suf-
ficient for restoring baseline levels of state anxiety ‐ a finding that
has implications for determining appropriate ‘recycle rates’ (duration
between mission) for Soldiers and others involved in continuous
operations.
Disclosure: Nothing to disclose.
P373 | Specified brain states determined by
dynamic functional connectivity occur with
higher frequencies after 52 hours sleep
deprivation compared to recovery
C. Li1; E.-M. Elmenhorst2; T. Kroll1; A. Matusch1;
D. Aeschbach2,3; A. Bauer1,4; D. Elmenhorst1,5
1Institute of Neuroscience and Medicine (INM‐2), Forschungszentrum
Jülich, Jülich, 2Institute of Aerospace Medicine, German Aerospace
Center, Cologne, Germany, 3Division of Sleep Medicine, Harvard Medical
School, Sleep Division, Boston, MA, United States, 4Department of
Neurology, Medical Faculty, Heinrich‐Heine‐University Düsseldorf,
Düsseldorf, 5Department of Psychiatry and Psychotherapy, Rheinische
Friedrich‐Wilhelms‐University Bonn, Bonn, Germany
Objectives/Introduction: Resting‐state fMRI (rs‐fMRI) studies
demonstrated sleepiness could induce brain functional dysconnectivity
associated with the cognitive abnormalities. Currently, a dynamic
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functional connectivity (FC) approach allows us to estimate the covari-
ances across a series of short sliding windows and generate correspond-
ing brain states using k‐means clustering. In this way, the dynamic FC
differences during rs‐fMRI scanning can be well characterized. The aim
of this study is to investigate how the brain states are dynamically
altered by sleep deprivation in comparison to sleep recovery.
Methods: We recruited 14 right‐handed males (Age:
28.21 ± 5.21 years) with sleep durations ranging from 7 to 8.5 hr.
MRI datasets and sleepiness severity were acquired after 52 hr sleep
deprivation and 14 hr of recovery sleep. We preprocessed the rs‐
fMRI data with first 5 volumes deletion, realignment, slice‐timing and
motion correction, normalization with DARTEL and spatial smooth-
ing. Using the Group ICA Of fMRI Toolbox (GIFT), 34 components
were identified. We then applied a sliding window of 22 images
(TRs) with a step of 1 TR to calculate the covariances. Number of
clusters was determined using the elbow criteria and brain states
were estimated with k‐means algorithm. Then, we statistically com-
pared the group‐differences on the mean dwell time, fraction of
states and number of transitions.
Results: We observed four brain states and a significantly higher
number of transitions (p = 0.017) after sleep deprivation. Interest-
ingly, state 4 was present only after sleep deprivation. However, the
mean dwell time and fraction of state 2 were significantly increased
after recovery sleep (p = 0.026; p = 0.034). Correlational analysis fur-
ther revealed sleepiness was negatively correlated with mean dwell
time and fraction of state 1 (p = 0.003, r = −0.727; p = 0.002,
r = −0.744) but positively associated with fraction of state 4
(p = 0.038, r = 0.558). At last, we replicated our brain states across
different windows size and numbers of clusters.
Conclusions: These results suggest 52 hr sleep deprivation leads
to a higher number of transitions of FC brain states compared to
rested wakefulness which might be caused by a specific state associ-
ated with drowsiness or light sleep.
Disclosure: Nothing to disclose.
METHODOLOGY & COMPUTATION 2
P374 | Comparison between the use of APAP
and manual titration during split night
polysomnography for diagnosis and treatment of
OSA
H. Gharraf1; H. Shaarawy2
1Chest Dseases Departmnet, Faculty of Medicine, 2Chest Diseases and
Sleep Medicine, Faculty of Medicine, Alexandria Univrsity, Alexandria,
Egypt
Objectives/Instruction: Is to compare between the use of APAP
and manual titration to determine the needed CPAP pressure during
split night polysomnography for diagnosis and treatment of OSA.
Methods: 100 patients with severe OSA were enrolled after exclu-
sion of patients with heart failure or respiratory failure. After diag-
nostic polysomnography, patients were divided into 2 groups:
group1 offered manual CPAP titration and Group2 offered APAP
titration, the time for CPAP titration was at least 4 hr in both
groups.
Results: Both groups were matched as regard age, gender, BMI,
sleep parameters and AHI (44.52 ± 7.81/hr in group1 and
42.66 ± 9.68/hr in group2 with no statistical significance, after CPAP
titration AHI was significantly improved in both groups, the time
needed to reach the therapeutic pressure was significantly lower in
group2 than in group1, attended technician was needed only in
group1.
Conclusions: Use of APAP was equal to manual titration in this
group of patients with severe OSA, with decreased cost and lesser
time to reach the therapeutic pressure, large multicenter trials are
needed to update the guidelines in view of using APAP in split night
protocol for diagnosis and treatment of severe uncomplicated cases
of OSA.
Disclosure: Nothing to disclose.
P375 | Outcomes of TORS as part of multilevel
surgery in select OSA patients
K. Nagpal
Ent and Head and Neck Surgery, Indraprastha Apollo Hospitals, New
Delhi, India
Objectives/Instruction: TORS has found to be the best sleep sur-
gery procedure so far. It is a novel technique involving surgical
resection of base of tongue. TORS for base of tongue resection with
or without epiglottoplasty and palatoplasty or septoplasty depending
upon the need has changed the overall outlook and outcome of
sleep apnea surgeries.
Methods: Surgical outcomes of 50 patients have been studied at
our centre post TORS procedure. Inclusion criteria begin all patients
aged above 18 years, with mild, moderate or sever OSA but with
AHI levels not exceeding 45/hr and BMI less than 35 and with CPAP
intolerance or non ‐acceptance. All underwent PSL and DISE prior to
surgery. All were primary cases for TORS. Oher than AHI, Oxygen
desaturation index, ESS, pre and post treatment for blood pressure,
pre and post treatment sugar control, reduced or absent snoring and
overall improvement in Quality of life were analyzed for outcomes.
Results: Almost all patients post surgery had no snoring or dimin-
ished snoring. 18 patients were on anti hypertensives prior to surgery
out of which 16 patients did not require the drugs post surgery. 15
patients were diabetic and all of them had better sugar control post
operatively except one. Quality of life improved significantly in 60%
cases. Improvement in AHI were noticed in 50% of patients.
Conclusions: TORS is an effective modality in non CPAP compliant
patients with acceptable outcomes and in some significant
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improvement in quality of life. However meticulous attention is paid
to selection of cases.
Disclosure: Nothing to disclose.
P376 | Agreement of mobile app with
SleepSense and polysomnography in patients
with sleep‐disordered breathing
P. Song1; S.J. Choi2,3; A.-R. Jung1,2; E.Y. Joo4
1Department of Neurology, Ilsan Paik Hospital, Inje University College of
Medicine, Gyeonggi‐do, 2Department of Neurology, Samsung Medical
Center, Sungkyunkwan University School of Medicine, 3Samsung Medical
Center, Department of Clinical Nursing Science, Sungkyunkwan
University School of Medicine, 4Department of Neurology, Neuroscience
Center, Samsung Biomedical Research Institute, Samsung Medical
Center, Sungkyunkwan University School of Medicine, Seoul, Republic of
Korea
Objectives/Introduction: SleepSense is a recently developed non‐
contact home sleep monitoring device using mobile application. It
detects the heartbeat, respiration rate and accelerates motions, then
it estimates sleep‐wake pattern as well as sleep structure by their
algorithm. To validate the reliability of this SleepSense, we con-
ducted the comparison and agreement analyses between SleepSense
and PSG for various sleep parameters.
Methods: 36 participants who are complaining of sleep distur-
bances for more than 3 months underwent one‐day full night PSG
with mobile app and SleepSense on the mattress. Sleep parameters
(time in bed [TIB], total sleep time [TST], sleep onset latency [SOL],
sleep efficiency [SE], wakefulness after sleep onset [WASO min] and
sleep structure [% NREM, REM sleep]) were compared. Wilcoxon
Signed‐Rank test was used for the intergroup comparisons of param-
eters. Agreements among parameters were assessed with intraclass
correlation coefficient (ICC) and 95% confidence interval.
Results: Mean age of participants were 46.5 ± 14.8 y. Mean
apnea‐hypopnea index (AHI) was 22.7 ± 17.8/h. Mean values of TIB,
TST, SE and WASO between PSG and SleepSense were not statisti-
cally different. Sleepsense overrated SOL (24.8 ± 21.25 min
vs.15.5 ± 29.40 min, p < 0.001) and N3 sleep (17.9 ± 13.04%
vs.5.1 ± 5.52%, p < 0.001) while it underestimated REM sleep
(12.8 ± 7.58% vs.19.4 ± 6.36%, p < 0.001) and light sleep (N1 + N2
sleep) (52.2 ± 15.60% vs.73.6 ± 14.73%, p < 0.001) than PSG. In the
correlation analyses, TIB showed a good agreement (ICC 0.964)
between two devices. However, other parameters did not show
good agreement (ICC < 0.700). According to the severity of sleep‐
disordered breathing (SDB), two groups (AHI ³ 15/h, n = 22 & AHI <
15/h, n = 14) were assessed. Both groups showed a satisfactory
agreement in the estimation of TIB (ICC > 0.930). In addition, in
group of AHI < 15 demonstrated the significant agreement in the
TST (ICC 0.925) and WASO (ICC 0.847) between two devices.
Conclusions: Agreement of mobile app with SleepSense is useful
to that of PSG for differentiating sleep status from wakefulness.
Estimation of sleep stage by SleepSense is limited yet. The presence
of SDB may affect the assessment of sleep‐wake and sleep struc-
tures with this contactless sleep monitoring device.
Disclosure: Nothing to disclose.
P377 | Methods for detecting abnormal
ventilation in children with snoring and with
different genetic features
P. Nokelainen1; S.-L. Himanen1; U. Sompa1; A. Hakala2;
M. Tenhunen3
1Department of Clinical Neurophysiology, University of Tampere,
2NeuroEvent Labs, 3Department of Medical Physics, Tampere University
Hospital, Tampere, Finland
Objectives/Introduction: Detecting respiratory effort and
hypoventilation in children is demanding. In polysomnography record-
ings (PSG) respiratory effort is assessed with esophageal pressure
measurement (pESO), but requires use of uncomfortable trans‐nasal
pressure sensor catheter. Indirect methods such as inductive abdomi-
nal/thoracic belt sensors and surface electromyography (EMG) of res-
piratory muscles can be used, but tend to interfere with subject's sleep
and normal activity during the test. Neither the belts nor EMG pro-
vides qutitative measure for respiratory effort. In this study we tested
noninvasive sensors, which were compared to traditional ones.
Methods: We made PSG for 12 children with snoring, including
one with Pitt‐Hopkins (PHS), and another with Russel‐Silver syn-
drome (RSS). PHS is known to alter the neural structure of respira-
tory centers and cause a unique type of hyperventilation. RSS
causes growth reduction thus potentially affecting the diameters of
respiratory structures. These syndromes challenge the recording sys-
tems in very different ways. The acquisitions made include conven-
tional PSG channels with simultaneous etCO2 measurement and
video monitoring (Embla, Natus Medical Inc., USA). Some subjects
had video recording with depth sensor (Neuro Event Labs, Finland),
tracheal microphone (PneaVox, Cidelec, France) for detection of
breathing sounds. All recordings include electromechanical film trans-
ducer (Emfit, Finland) mattress for movement and sleep‐disordered
breathing estimation. Mattress signal, which isvalidated against
pESO, provides information of increased respiratory effort and pro-
longed partial obstruction.
Results: The PSG results were analysed and snoring was estimated
in relation to tracheal microphone analysis and increased respiratory
effort in mattress signal. The depth sensor analysis was done off‐line,
from intervals of interest to develop analysis methods for online
monitoring. The PHS patient had hyperventilation during wake,
which was detectable with the standard instrumentation. The analy-
sis showed that our depth sensor instrumentation needs modifica-
tion. Belts can detect respiratory movements and frequency easily,
as in RSS patient, but continuous movement artifacts as in PHS
patient represent serious challenge for effective monitoring.
262 of 433 | ABSTRACTS
Conclusions: Video recordings with depth sensors can be used for
real‐time monitoring of breathing parameters like frequency and
amplitude. It will however continue to be challenging to develop
wearble probes for children in particular, that can measure breathing
parameters during wake and sleep.
Disclosure: Nothing to disclose.
P378 | Evaluation of home polysomnography
for making a sleep diagnosis
L.C. Rohling; R. Tijdens; K.W. van Kralingen
Sleep Medicine, Stichting Epilepsie Instellingen Nederland (SEIN), Zwolle,
The Netherlands
Objectives/Introduction: Clinical polysomnography (C‐PSG, type
1) is the golden standard for investigating sleep disorders. The disad-
vantages of a C‐PSG are a possible first night effect and high costs.
An alternative for a C‐PSG is the home polysomnography (H‐PSG,
type 2). By performing two consecutive 24 h H‐PSG we investigated
if the first night effect occurs and if a second consecutive H‐PSG is
necessary to come to a correct sleep diagnosis. We also investigated
if possible sensor loss influences the diagnostic process using H‐
PSG.
Methods: A retrospective study was performed on the data of
patients visiting our tertiary sleep center. Analysis was performed on
the sleep parameters of the first and second night for the total
group of patients who underwent this investigation between January
and December 2013. Statistical analysis was performed by paired‐
samples T‐Test. The sensor loss preventing the interpretation of the
signals parameters were documented.
Results: A total of 262 patients (47.3% male, 46.1 ± 14.7 yrs) were
identified and all were included. The results of the total group show
significant differences in the following sleep variables, when compar-
ing night 2 with night 1: a decrease of Time in Bed (Δ‐
17,4 ± 72,1 min; p = < 0,0001), Total Sleep Time (Δ‐10,8 ± 86,6 min;
p = 0,04), Awakenings (Δ‐1,6 ± 11,6 per h; p = 0,02), REM onset
latency (Δ‐7,4 ± 55,9 min; p = 0.03), Sleep Stage NREM 2 (Δ‐
10,3 ± 54,3 min; p = 0,002), and increase of Sleep Stage NREM 3
(Δ+3,7 ± 29,2 min; p = 0.04). The results did not show a significant
difference for Apnea Hypopnea Index, Oxygen Desaturation Index,
and PLMI. Ninety‐six percent of the H‐PSG was of good quality to use
for clinical purpose. In the 4% of H‐PSGs with a technical problem, the
most frequent problem was loss of the saturation signal, 21% of all,
and the least frequent loss of the EEG signal, only 3%.
Conclusions: We conclude that when using H‐PSG the first night
effect does not occur. The small differences in sleep parameters do
not influence the diagnostic process. Therefore, a 24 h H‐PSG has
an advantage when compared to C‐PSG. Moreover, this study found
that there is a low risk of sensor failure of the H‐PSG within a clini-
cal population, which makes it a good alternative for clinical PSG.
Disclosure: Nothing to disclose.
P379 | A novel home‐based strategy for
obstructive sleep apnoea detection in paediatrics
C.A. Macleod1; S. Dacombe1; R. Sayer1; R. Hamilton2;
H. Kubba2; A. Morley2; J.H. Williamson3; K. Thushitha2;
E. Tanner3
1Medical Devices Unit, 2Royal Hospital for Children, NHS Greater
Glasgow & Clyde, 3School of Engineering, University of Glasgow,
Glasgow, United Kingdom
Objectives/Introduction: Obstructive sleep apnoea (OSA) in chil-
dren is a respiratory disorder caused by an obstruction in the upper
airway leading to disrupted breathing during sleep. The gold standard
for diagnosis is polysomnography (PSG) conducted overnight in a
sleep lab. However, the cost, availability and the equipment neces-
sary can be restrictive and the method is not ideally suited to young
children. The aim of this project is the development of a simple mul-
ti‐sensor system for OSA detection which can be used easily in the
patient's home yet provide useful physiological information to clini-
cians to assist in their clinical assessment.
Methods: To simplify the system from the comprehensive
approach used in PSG, sensors have been selected which could
easily be integrated into a wearable garment, such as a t‐shirt, reduc-
ing the need for expert‐setup. The sensors were selected to be
unobtrusive to movement and be discreet for wear by young chil-
dren. The proposed system incorporates microphones positioned
over the trachea to monitor airflow while stretch sensors around the
chest and abdomen identify respiratory effort. Accelerometers are
integrated to identify sleep position and movement for artefact
rejection and pulse oximetry will be included to detect periods of
oxygen desaturation and pulse.
Results: Initial bench testing of the prototype system found a posi-
tive correlation between airflow information recorded via the micro-
phones and respiratory related movement from the stretch sensors
in 10‐min recordings from a single individual repeated 10 times, r
(Mean (SD)) = 0.997 (0.002). The calculated respiration rate mea-
sured by both methods also showed a positive correlation to the
actual rate (metronome used to instruct inhalation and exhalation),
(stretch sensors) r = 1, n = 10, p < 0.01 (microphone) r = 0.919,
n = 10, p = 0.03.
Conclusions: Early work demonstrates the potential of a simple
but novel multi‐sensor platform designed for home use in detecting
OSA events. The next stages of this study will involve testing the
prototype sensor system with a population of non‐symptomatic indi-
viduals and in parallel with an established sleep lab PSG system and
development of a suite of suitable algorithms for automatic OSA
event detection.
Disclosure: This project is funded by Glasgow Children′s Hospital
Charity.
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P380 | Psychometric properties of the Chinese
Epworth Sleepiness Scale among individuals with
depressive symptoms: a confirmatory factor
analysis
Y.C. Lam1,2; S.-H. Cheung3; C.H. Hui3; S.F. Cheung4;
J. Lam3,5; E.Y.Y. Lau1,2
1Department of Psychology, The Education University of Hong Kong,
2Centre for Psychosocial Health, The Education University of Hong Kong,
3Department of Psychology, The University of Hong Kong, Hong Kong,
Hong Kong, 4Department of Psychology, University of Macau, Macau,
Macao, 5Department of Psychology, Temple University, Philadelphia, PA,
United States
Objectives/Introduction: The Epworth Sleepiness Scale (ESS)
evaluates individuals′ daytime sleepiness across situations through
their responses to 8 items on a 4‐point Likert scale. An aggregate
score of the ESS has been widely used to assess daytime sleepiness
in healthy and clinical populations, assuming a single‐factor structure.
However, recent research suggested that the ESS could be measur-
ing multiple dimensions of sleepiness. While excessive daytime
sleepiness has been found to associate with depressive symptoms,
no studies have evaluated the factor structure of ESS in samples
with depression. In view of the above, this study aimed to examine
the psychometric properties and the single‐factor structure of the
ESS among individuals with depressive symptoms.
Methods: This study is part of a longitudinal project titled “Emo-
tional Stability, Positive Worldview, Forgivingness, and Sleep Quality:
A Search for Causal Pathways”. Participants completed an online
survey including the validated Chinese version of the ESS and the
depression subscale of the Depression Anxiety Stress Scales‐21
(DASS‐Depression) measuring depressive symptoms. We selected a
sub‐sample of the participants (n = 601, mean age=27.45, SD=6.66,
59.4% female, DASS‐Depression>9) with depressive symptoms for
our current analyses. Among these participants, 41.0% were mildly
depressed, 37.5% were moderately depressed, 13.6% were severely
depressed, and 8.0% were extremely severely depressed.
Results: Confirmatory factor analysis results supported a single‐fac-
tor model of ESS (χ2=75.120, df=17, p < .001; CFI=.950; TLI=.918;
RMSEA=.075, 90% CI=.058‐.093; SRMR=.039). In addition, the Chi-
nese ESS had good reliability, Cronbach′s alpha=.80. Daytime sleepi-
ness was positively correlated with log‐transformed score on DASS‐
Depression, r(601)=.082, p = .043.
Conclusions: A single‐factor model of the Chinese ESS is validated
with good psychometric properties as a reliable measure of daytime
sleepiness in adults with depressive symptoms. Our data also corrob-
orated previous studies on the association between daytime sleepi-
ness and depressive symptoms. Future studies are warranted to
uncover the mechanisms underlying this association, and whether
the presence of excessive daytime sleepiness may be indicative of
depression of a different etiology, form or severity.
Disclosure: This study is funded by the General Research Fund
(#17403014), Research Grant Council, HKSAR.
P381 | Impact of weak extremely low
frequency pulsed electromagnetic field on
subjective assessment of sleep quality
I. Blokhin1; G. Arsen'ev2; V. Dorokhov2
1P.N. Lebedev Physical Institute of the Russian Academy of Sciences,
2Institute of Higher Nervous Activity and Neurophysiology of the Russian
Academy of Sciences, Moscow, Russian Federation
Objectives/Introduction: It seems promising to use the non‐phar-
macological distant physiotherapy exposure of ELFMF for the cor-
rection of sleep disorders and the normalization of circadian rhythms
of sleep. The aim of our study was to assess the impact of weak
ELFMF on different characteristics of night sleep, the estimation of
using subjective assessment of sleep quality.
Methods: In our experiments the device ‐ ELFMF generator “Smart
Sleep” was used forming rectangular current pulses supplied to the
magnetic field emitter. At a distance of 70‐200 cm in the experimen-
tal zone field intensity was less than 0.2 μT, which is significantly
less than the permissible hygienic standards. The device has 7 modes
of pulse frequency: 2, 4, 8, 16, 20, 32, 40 Hz.
The experiment involved 20 healthy volunteers (both sexes, aged
20‐30). The operating mode of the ELFMF generator got out arbi-
trarily. The duration of the night exposition by ELFMF depended on
the sleep duration (6‐8 h). Time intervals between the experimental
nights with and without ELFMF exposure were at least 3‐5 days. All
the subjects in the morning after awakening filled out the question-
naires on various indicators of the quality of sleep. The average
number for each subject: no exposed ‐ 12, with exposed ‐ 12. Total
‐ 480 nights.
Results: The Kruskall‐Wallis single‐factor rank analysis was used to
assess the differences between the results of the questionnaires in
the background nights and under the influence of different frequen-
cies of the ELFMF:
p < 0,05 for the: health improvement in the awakening (4 Hz,
20 Hz), reducing the fragmentation (8 Hz) and shortening the dura-
tion of sleep (20 Hz), the dreams memorizing (4 Hz), quality (2 Hz,
16 Hz), emotions (8 Hz) and awareness (20 Hz).
p < 0,01 for the: shortening sleep duration (32 Hz), the dreams mem-
orizing (2 Hz), quality (4 Hz) and emotions (2 Hz).
Conclusions: Thus, the obtained results give a reason to believe
that ELFMF (2‐40 Hz) have a positive impact on the studied indica-
tors quality of sleep and dreams. Further we plan to conduct the
polysomnographic studies using the portable EEG system.
This work was supported by the grants from the Russian Foundation
for Basic Research (grant numbers 17‐36‐00025/17‐OGON).
Disclosure: Nothing to disclose.
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P382 | Inter‐ and intra‐expert variability in
sleep scoring: comparison between visual and
automatic analysis
V. Muto1; C. Berthomier2; C. Schmidt1,3; G. Vandewalle1;
J. Devillers1; S.L. Chellappa1; C. Meyer1; C. Phillips1,4;
P. Berthomier2; J.P. Prado2; O. Benoit2; M. Brandewinder2;
J. Mattout5; P. Maquet1,6
1GIGA‐Cyclotron Research Centre‐In vivo Imaging, Sleep Research Group,
University of Liège, Liège, Belgium, 2PHYSIP SA, Paris, France,
3Psychology and Neuroscience of Cognition (PsyNCog), University of
Liège, 4Department of Electrical Engineering and Computer Science,
University of Liège, Liège, Belgium, 5Lyon Neuroscience Research Center,
INSERM U 1028, CNRS UMR 5292, University of Lyon 1, Lyon, France,
6Department of Neurology, CHU Liège, Liège, Belgium
Objectives/Introduction: Visual sleep scoring (VS) is affected by
inter‐expert (difference in scoring between experts working on the
same polysomnographic recordings) and intra‐expert variability (evo-
lution in the way to score of a given sleep scorer when compared
with a reference). Here our aim was to quantify inter and intra‐
expert sleep scoring variability in a group of 6 experts (working at
the same sleep center and trained to homogenize their sleep scoring)
by using the automatic scoring algorithm Aseega (AS) as a reference.
Methods: Polysomnographic data were collected in 24 healthy
young male participants (mean age 21.6 ± 2.5 years) and scored
according to the AASM criteria. The first data set (DS1) was com-
posed of 4 recordings, each one scored by 6 experts and AS (28
scorings). Other 88 recordings (DS2) were scored few weeks later by
the same experts and AS (176 scorings). The epoch‐by‐epoch agree-
ment (concordance and Cohen kappa coefficient) was computed
between VS and AS.
Results: Inter‐expert agreement on DS1 decreased as the number of
experts increased, from 86% for mean pairwise agreement down to
69% for all 6 experts. Adding AS to the pool of experts narrowly chan-
ged the kappa value, from 0.81 to 0.79. Intra‐expert variability was
highlighted by the systematic decrease of the agreement between AS
and each single expert across datasets (‐3.7% on average).
Conclusions: Whatever the approach used, visual scoring induces
inter‐ and intra‐expert variability. Even if autoscoring neither pro-
vides any ground truth, nor can improve the inter‐scorer agreement
(as several automated methods exist), it can efficiently cope with the
intra‐scorer variability, since the AS used is perfectly reproducible
and largely insensitive to experimental conditions. These properties
are mandatory when dealing with large dataset, making autoscoring
methods a sensible option. A number of automatic methods are cur-
rently available; however precise assessment and comparison on
common datasets using common metrics remain an open question.
Disclosure: C. Berthomier, P. Berthomier and M. Brandewinder
have ownership and directorship in Physip, and are employees of
Physip. This study was funded by Fonds National de la Recherche
Scientifique (Belgium), University of Liège research funds, Swiss
National Science Foundation (# 310030_130689) and the European
Research Council (ERC).
P383 | Guidelines for the application of the
objective sleepiness scale for drowsiness
assessment
J. Taillard1; P. Berthomier2; M. Brandewinder2;
C. Berthomier2
1USR 3413 SANPSY, CNRS/Université de Bordeaux, Bordeaux, 2PHYSIP
SA, Paris, France
Objectives/Introduction: Electroencephalography (EEG) remains
the reference method to study drowsiness, but only few objective
methods have been proposed based on the visual analysis of wake
EEG. Muzet proposed the Objective Sleepiness Score (OSS) [1]. For
each 20s‐epoch this scale defines 5 states of drowsiness based on the
visual analysis of EEGs (C3, O1, P3, Fz) and EOGs. An automatic algo-
rithm (AA) following a single‐EEG approach was developed and vali-
dated using a database visually scored by Muzet (VA1) using OSS [2].
The objective of this study was to improve and facilitate the use of the
OSS by proposing guidelines that explicit the visual scoring criteria.
Methods: 19 volunteers (30 ± 6 years, 12 women) were recorded
during 2 h of driving in a simulator, with a Cortical Brain State (CBS)
test as a biocalibration at the beginning and end of the session. All
recordings (8192 scoring decision epochs) were scored by VA1,
which stands as the reference, and by AA. Two sample recordings of
422 and 438 epochs were randomly chosen and visually scored by
another expert (VA2).
VA2 applied two scoring procedures: first, literal OSS scoring rules
as stated in [1], then adapted the scoring criteria of EEG by taking
into account the individual characteristics deriving from the biocali-
bration. The epoch‐by‐epoch agreement (concordance, C, and kappa
coefficient, K) was calculated.
Results: The agreement between AV1 and AV2 increased from
15% (K = ‐.40) when applying literal rules to 83% (K = .60) when
applying adapted rules. When including AA, the overall agreement
variated from K = ‐.12 to K = .53.
Conclusions: Taking into account the CBS observed during the
biocalibration phase is key to enable the scoring of drowsiness using
OSS. Alpha and theta rhythms used to determine drowsiness states
must be defined by their characteristics as they appear during the
CBS test.
[1] Muzet et al. Preventing driver drowsiness at the wheel: can
steering grip sensor measurement contribute to its prediction? Proc.
of 4th Eur. Congress and Exhibition on Intelligent Transport Systems
and Services, Budapest,24‐26 May 04.
[2] Berthomier et al., Real‐Time Automatic Measure of Drowsiness
based on a Single EEG Channel. J. Sleep Res., 17:P434, 2008.
Disclosure: Nothing to disclose.
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P384 | High‐throughput sleep phenotyping
establishes heritability and identifies a novel
linkage peak in diversity outbred mice
B. Keenan1; R. Galante1; J. Lian1; P. Simecek2; D. Gatti2;
L. Zhang1; D. Lim1; K. Svenson2; G. Churchill2; A. Pack1
1Center for Sleep and Circadian Neurobiology, University of
Pennsylvania, Philadelphia, PA, 2The Jackson Laboratory, Bar Harbor,
ME, United States
Objectives/Introduction: Genetic association studies in outbred
mouse populations, such as the Diversity Outbred (DO), required
high‐throughput phenotyping strategies. We describe a strategy uti-
lizing activity‐based measures of sleep and circadian traits, which are
then leveraged to identify a novel genetic linkage peak in DO mice.
Methods: Phenotypes were measured in age‐matched male DO
mice (n = 338) and their 8 common or wild‐derived inbred founders
[A/J (n = 6), C57BL/6J (n = 14), 129S1/SvlmJ (n = 6), NOD/LtJ
(n = 6), NZO/H1LtJ (n = 6), CAST/EIJ (n = 8), PWK/PHJ (n = 8),
WSB/EIJ (n = 6)]. Sleep/wake amounts and bout characteristics were
quantified, with sleep defined as ≥40 s of continuous inactivity
based on infrared beams; latency to sleep (vigilance), multiple sleep
latency test (MSLT) and circadian period (using wheel running) were
also characterized. Intraclass Correlation Coefficients (ICCs) were cal-
culated from repeated assessments to assess reproducibility. Nar-
row‐sense heritability (h2; proportion of variability explained by
additive genetic effects) was quantified in DO mice and broad‐sense
heritability (H2; proportion of variability explained by strain) esti-
mated in founders. Genome‐wide quantitative trait analyses were
performed on these high‐throughput phenotypes in DO mice using a
mixed model analysis evaluating the effects of the eight founder
genotype probabilities at each locus.
Results: Most phenotypes showed ICC≥0.60, indicating good
reproducibility, and there was high correlation (rho>0.85) between
sleep/wake traits using the primary sleep definition (≥40 s of inactiv-
ity) and alternative definitions of ≥20, ≥60 or ≥80 s. All traits dif-
fered among founder strains and there was moderate‐high
heritability for most phenotypes; sleep/wake characteristics during
lights‐off and circadian period were most heritable (H2=54‐60%).
There was large phenotypic variability in DO mice, with values cov-
ering observed ranges in founders. Heritability estimates were lower
in DO mice, with circadian period the most heritable (h2=36%), pos-
sibly reflecting unmeasured non‐additive genetic effects. Genome‐
wide analyses identified a novel linkage association with sleep dura-
tion in lights‐off on chromosome 3 (LOD score ~7.5), encompassing
two candidate genes.
Conclusions: A high‐throughput phenotyping strategy using activ-
ity patterns provides reproducible estimates of heritable sleep and
circadian phenotypes. This paradigm was used to identify a novel
linkage peak related to sleep duration in DO mice. Follow‐up analy-
ses are underway to validate this association and determine the cau-
sal gene and variant.
Disclosure: Authors from the University of Pennsylvania (B.
Keenan, R. Galante, J. Lian, L. Zhang, D. Lim, A. Pack) declare no
conflicts. Authors from Jackson Laboratory (P. Simecek, D. Gatti, K.
Svenson, G. Churchill) note that Jackson Laboratory produces and
sells Diversity Outbred Mice.
P385 | Pilot assessments of mobile and
automated sleep recording and auditory slow‐
wave stimulation for in‐home studies
C. Lustenberger; M.L. Ferster; R. Büchi; N. Demarmels;
S. Huwiler; J. Kurz; W. Karlen
Department of Health Sciences and Technology, ETH Zurich/Institute of
Robotics and Intelligent Systems, Zurich, Switzerland
Objectives/Introduction: Non‐invasive sleep stimulation methods
to promote restorative processes of sleep have recently gained con-
siderable interest. Single‐night, in‐lab studies show that precisely
timed tones played during deep sleep can enhance slow wave activ-
ity and improve declarative memory. Whether such methods proof
transformative to real‐life settings remains to be investigated. We
developed a portable device that allows for in‐home sleep monitor-
ing and individualized auditory stimulation. We report preliminary
results on biosignal data quality obtained with this novel device and
the achieved effect of auditory stimulation on slow waves.
Methods: We evaluated biosignal quality and stimulation effect of
the device in two participants (32 and 26 y.) by measuring one night
with (verum) and one without tone application (sham) at participants’
home. The device featured one prefrontal EEG (electroencephalogra-
phy), EOG (electrooculography) and EMG (electromyography) record-
ing channels from which non‐rapid eye movement sleep was
automatically detected and auditory stimulation triggered. Tones were
precisely timed to the up‐phase of slow waves using a phase‐locked
loop and a slow wave amplitude criterion. We visually assessed biosig-
nal quality and evaluated the effect of stimulation on slow waves by
investigating the time‐locked response of the EEG to the first 200
auditory stimuli using a single‐subject statistical approach (unpaired t‐
test of trials between sham and verum night for each subject).
Results: Recording set‐up time for the device (around 5‐10 min)
was very low compared to in‐lab methodologies and was easy to
apply for the subjects themselves. The quality and resolution of the
obtained biosignals was comparable to lab‐based systems. In both
subjects, auditory stimuli significantly enhanced amplitude of slow
waves, either of the stimulated wave (n = 1, p < 0.05) or of a subse-
quent slow wave (n = 1, p < 0.05). None of the subjects reported to
hear tones during the night.
Conclusions: Our mobile sleep stimulation device enabled high‐
quality sleep research outside the sleep lab. Future studies using our
device are needed to evaluate the efficacy of slow wave enhance-
ment over longer application periods and in larger populations.
Disclosure: Nothing to disclose.
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P386 | Dissecting local sleep spindles in the
thalamocortical system
M. Bandarabadi1,2; C.G. Herrera1; T.C. Gent1; C. Bassetti1;
K. Schindler1; A.R. Adamantidis1
1Department of Neurology, Inselspital University Hospital, University of
Bern, Bern, 2Department of Physiology, University of Lausanne,
Lausanne, Switzerland
Objectives/Introduction: Sleep spindles are electroencephalo-
graphic (EEG) oscillatory events (9‐16 Hz) that are hypothesized to
stabilize sleep, gate sensory processing and consolidate memory.
Spindle generation relies on transient electrical activity within the
reticular nuclei of thalamic neurons that resonate in thalamo‐cortical
(TC) circuits. Despite considerable characterization of both global
and local spindles in the human brain, their occurrence and role in
mice remains unclear.
Methods: We developed an optimized spindle detection algorithm
to detect spindles in 14 mice and investigated their region‐specific
correlation with neuronal firing, slow waves, and vigilance state tran-
sition using simultaneous thalamic and cortical LFP/unit recordings in
freely‐moving mice.
Results: We found a strong spike‐field coupling during spindles
within thalamic reticular nucleus (TRN), anterodorsal (AD) and cen-
tromedian (CMT) thalami, and to a lesser extent within ventrobasal
complex (VB), cingulate (CING) and somatosensory barrel (BARR)
cortices. We further found a strong coupling between slow waves
and spindles within the CMT, AD, CING, and visual cortex, but a
weaker coupling in the TRN, VB, and the BARR. Thalamo‐cortical
network analysis showed a high co‐occurrence ratio of spindles
within the thalamus (82 ± 7%), with fewer spindles propagating to
the neocortex (60 ± 11%). Co‐occurrence at the cortical level was
low (50 ± 16%), indicating a localized control of sleep‐spindles in the
neocortex. Spindle rate prior to REM sleep onset, but not wakeful-
ness, was significantly increased with maximum probability within a
window of 25 s prior transition to REM sleep (~3 times higher than
baseline). Finally, optogenetically driving the TRN GABAergic cells
using stabilized step‐function opsin significantly increased bursting
activity in TRN neurons resulted in a significant increase in spindle
rate and sleep stabilization.
Conclusions: These results provides a new and improved toolbox
for spindle detection and characterization in mice and further indi-
cates a local mechanism for spindle generation in thalamocortical cir-
cuits and their role in the sleep‐wake state control.
Disclosure: Nothing to disclose.
P387 | Heart rate variability‐based sleep
staging in healthy subjects and patients with
sleep disorders
P. Fonseca1,2; M. Radha1,2; M. Ross3; A. Moreau3; A. Cerny3;
S. Overeem2,4; P. Anderer3
1Philips Research, 2Dept. of Electrical Engineering, Eindhoven University
of Technology, Eindhoven, The Netherlands, 3Sleep and Respiratory Care,
Home Healthcare Solutions, Philips Austria GmbH, Vienna, Austria,
4Sleep Medicine Centre, Kempenhaeghe, Heeze, The Netherlands
Objectives/Introduction: The last few years have seen an increase
in publications on sleep staging using cardiac and respiratory features.
Some of the best recent algorithms achieved Cohen's kappa coeffi-
cients of agreement up to 0.50 in comparison with polysomnography
(PSG). However, most studies have focused on the analysis of healthy
participants, and the question of how well these algorithms generalize
to sleep disordered patients remains unanswered.
The objective of this study is to evaluate and compare the 4‐class
sleep stage classification (Wake, N1 + N2, N3 and REM) perfor-
mance of a long short term memory (LSTM) classifier using heart
rate variability (HRV) features in healthy subjects as well as sleep
disorders patients.
Methods: A total of 136 features describing HRV computed from
ECG were used to train an LSTM model for sleep stage classification.
The analysis was done in the PSG recordings of the SIESTA dataset,
using the manual annotations of 3 experts as ground‐truth. The
model was trained and evaluated in 4‐fold cross‐validation with two
recordings of each of 195 healthy participants, 51 patients diag-
nosed with sleep apnea, and 26 with insomnia, all based on the ICD‐
10 criteria. The performance between different groups and, for the
healthy controls, between sexes was compared with a Mann‐Whit-
ney U test. Pearson's correlation was used to test correlation with
age for the healthy control group.
Results: The overall validation kappa was 0.64. The performance
for healthy participants (0.64) was not significantly different than for
insomnia (0.66, p = .18), but was significantly higher than for sleep
apnea (0.60, p < .001). Kappa decreased significantly with age (‐0.41,
p < .001) and a significant difference was found between healthy
males and females (0.62 vs 0.66, p < .01).
Conclusions: With an overall kappa of 0.64 our classifier achieves
better performance than recently published algorithms, for healthy
and for sleep disordered patients. The slightly lower performance for
sleep apnea can be explained by changes in the characteristics of the
HRV features which, in the presence of disordered breathing events,
fail to completely characterize the differences between sleep stages.
Disclosure: At the time of writing, P. Fonseca, M. Radha, M. Ross,
A. Moreau, A. Cerny and P. Anderer were employed by Philips Elec-
tronics Nederland B.V. and Philips Austria GmbH. Philips is a manu-
facturer of consumer and medical electronic devices, and
commercializes products in the area of sleep monitoring, diagnosis
and therapy.
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P388 | Development of predictive models of
obstructive sleep apnea by using decision tree
A. Masoumeh1; S. Eslami2,3,4; K. Etminani2; F. Rezaeitalab5;
H. Asadpour6; M. Amini7
1Student Research Committee, Department of Medical Informatics,
2Department of Medical Informatics, Faculty of Medicine, Mashhad
University of Medical Sciences, Mashhad, Islamic Republic of Iran,
3Department of Medical Informatics, Faculty of Medicine, University of
Amsterdam, Amsterdam, The Netherlands, 4Pharmaceutical Research
Center, Faculty of Medicine, Mashhad University of Medical Sciences, m,
5Department of Neurology, School of Medicine, Mashhad University of
Medical Sciences, 6Sleep Laboratory of Ibn‐e‐Sina Hospital, Faculty of
Medicine, Mashhad University of Medical Sciences, 7Lung
DiseasesResearch Center, Faculty of Medicine, Mashhad University of
Medical Sciences, Mashhad, Islamic Republic of Iran
Objectives/Introduction: Polysomnography as the gold standard
diagnostic technique in obstructive sleep apnea (OSA) is cumber-
some and costly. Multiple trials in prediction of OSA by clinical and
laboratory variables have been done in different data sets. We
planned this study to develop predictive models of OSA in our data-
set.
Methods: This is a retrospective cross‐sectional study on 376
patients suspected to OSA in Ibn‐e‐Sina and Emam Reza university
sleep clinics, Mashhad, Iran. Data mining has been done by decision
tree method with algorithms of C5.0, CHAID, C&R in IBM SPSS
MODELER14.2. Maximum of 5 depths was considered for all trees.
Variables selected by C5.0 tree were: STOP‐BANG score, age, and
history of depression, cognitive problem and restless leg syndrome.
Variables selected by CHAID were: age, neck circumference, sex,
Epworth sleepiness scale (ESS) score, STOP‐BANG, body mass index,
history of restless leg syndrome and cognitive dysfunction. Variables
selected by C&R were: age, neck circumference, STOP‐BANG score,
ESS score, cognitive dysfunction and depression.
Results: CHAID and C 5.0 showed the highest accuracy in predict-
ing OSA, with C 5.0 revealed the highest sensitivity and specificity.
According to 97% sensitivity of C5.0 it was the best model in our
dataset.
Conclusions: Although our study showed a high performance for
some models selecting a model for prediction of OSA should be
done with caution.
Disclosure: Nothing to disclose.
P389 | Developing minimum data set for
information management systems of obstructive
sleep apnea
M. Akbari1; S. Eslami2,3,4; F. Rezaeitalab5; H. Asadpour6;
K. Etminani2; M. Ebrahimi1; F. Pourtaghi7; M. Amini8
1Student Research Committee, Department of Medical Informatics,
2Department of Medical Informatics, Faculty of Medicine, Mashhad
University of Medical Sciences, Mashhad, Islamic Republic of Iran,
3Department of Medical Informatics, Faculty of Medicine, University of
Amsterdam, Amsterdam, The Netherlands, 4Pharmaceutical Research
Center, Faculty of Medicine, Mashhad University of Medical Sciences,
5Department of Neurology, Faculty of Medicine, Mashhad University of
Medical Sciences, 6Sleep Laboratory of Ibn‐e‐Sina Hospital, Faculty of
Medicine, Mashhad University of Medical Sciences, 7Faculty of Nursing
and Midwifery, Mashhad University of Medical Sciences, 8Lung Diseases
Research Center, Faculty of Medicine, Mashhad University of Medical
Sciences, Mashhad, Islamic Republic of Iran
Objectives/Introduction: Information systems are an important
potential source for gathering knowledge in the field of sleep medi-
cine. In obstructive sleep apnea (OSA) as in other domains, there is a
need to define a Minimum dataset (MDS) to fix the meaning of
essential domain data and allow sharing data across institutes. The
purpose of this study was to design a national MDS underlying
information management systems regarding sleep apnea in Iran.
Methods: A descriptive cross‐sectional study had been done
between May 2014 and 2015, Mashhad, Iran. An item list was
extracted by comprehensive literature review, seeking experts’ con-
sensus, searching valid websites related to sleep disorders, and
defining patient records. A sample of 30 sleep experts were invited
to ascertain variables of minimum dataset in two round Delphi
method. Variable was accepted based on the level of agreement
among experts. Specifically, variables with a median of 4 out of 5 or
more were included in the dataset, while those with median 3
and less than 3 were forwarded to the nest stepand excluded,
respectively.
Results: Maximum list of data items included 153 variables with 73
variables final MDS categorized into 4 groups. Four groups included
diagnosis data elements, global data elements, follow up data ele-
ments and treatment data elements. The global data elements cate-
gory includes two subcategories as administrative and demographic
elements. The diagnosis data elements category consists of 4 sub-
groups including data on history, physical exam, laboratory tests, and
polysomnography results. The medical history subgroup consists of
smaller subgroups including history of previous diseases, sleep ques-
tionnaire, career information, day and night symptoms, smoking and
medication history. The physical examination subgroup also consists
of 4 subgroups including otorinopharyngology, heart and lung, neu-
rology, and upper airway exams. The treatment data elements cate-
gory consists of several subgroups including therapy devices,
medications, referrals, and lifestyle modification advices.
Conclusions: MDS may be a valuable and organized source of
information for assessment, planning, treatment and research in
OSA. It also have the potential to prevent a variety of misleading
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errors such as inappropriate recording, lack of quick access to medi-
cal records, various formats used in recording and lack of standard
dataset.
Disclosure: Nothing to disclose.
P390 | Extracting association rules from
polysomnographic data of obstructive sleep
apnea subjects
S. Eslami1,2,3; M. Akbari4; K. Etminani1; H. Asadpour5;
F. Rezaeitalab6; M. Amini7
1Department of Medical Informatics, Faculty of Medicine, Mashhad
University of Medical Sciences, Mashhad, Islamic Republic of Iran,
2Department of Medical Informatics, Faculty of Medicine, University of
Amsterdam, Amsterdam, The Netherlands, 3Pharmaceutical Research
Center, Faculty of Medicine, Mashhad University of Medical Sciences,
4Student Research Committee, Department of Medical Informatics,
5Sleep Laboratory of Ibn‐e‐Sina Hospital, Faculty of Medicine, Mashhad
University of Medical Sciences, 6Department of Neurology, Faculty of
Medicine, Mashhad University of Medical Sciences, 7Lung Diseases
Research Center, Faculty of Medicine, Mashhad University of Medical
Sciences, Mashhad, Islamic Republic of Iran
Objectives/Introduction: Under‐diagnosis of obstructive sleep
apnea (OSA) is quite common. Data mining by association rules can
help in early diagnosis of OSA.
Methods: This is a retrospective cross‐sectional study on 376 indi-
viduals suspected to OSA in Ibn‐e‐Sina and Emam Reza university
sleep clinics, Mashhad, Iran. Date on demographic variables and
questionnaire scores (STOP‐BANG and Epworth sleepiness scale
(ESS)) were gathered. Using WEKA3.7.6 and APRIORI algorithm with
min support=0.2 and min confidence =0.9 data divided in 2 main
(male, female) groups. For each group 4000 rules extracted. After
omitting repeated and inappropriate ones, 50 rules for men and 50
rules for women selected and disposed for experts. In order to
extract rules related to apnea severity, target variable evaluated in 4
classes (normal, mild, moderate, severe apnea). A total number of
8000 rules were assigned which severe apnea in the right side of all
extracted rules. Mild and moderate apnea had not noticed.
Results: After evaluating rules by experts 4 rules accepted for men
and 7 rules for women (min confidence= 0.92 and 0.95, respec-
tively). In all rules STOP‐BANG score more than 3 and ESS score
more than 8 were from the selected rules.
Conclusions: Association rules are helpful in early diagnosis of
OSA.
Disclosure: Nothing to disclose.
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P391 | The predictive risk factors of
cardiovascular events in patients with
obstructive sleep aponea and hypopnea
syndrome
R. Chen
Department of Respiratory Medicine | Sleeping Center, Second Affiliated
Hospital of Soochow University, Suzhou, China
Objectives/Instruction: Obstructive sleep apnea hypopnea syn-
drome (OSAHS) is known to be associated with cardiovascular
events. In this study, we use the INTERHEART Risk Score (IHRS) to
assess prevalence of cardiovascular risk factors in the OSAHS
patients, and to develop valuable factors for routine screening of
cardiovascular events in these patients.
Methods: Overnight polysomnography (PSG) was performed to a
total of 219 patients in the sleep center of the Second Affiliated
Hospital of Soochow University. Based on the results of the AHI,
these patients were divided into four groups: primary snoring group,
mild, moderate and severe OSAHS groups. INTERHEART Risk Score
were caluculated from these aspects: age&sex, diabetes, hyperten-
sion, family history, smoking, second hand smoke, psychosocial fac-
tors, dietary factors, physical activity, abdominal obesity. Based on
IHRS, 219 patients were divided into low risk group, moderate risk
group and high risk group for a heart attack. The differences and
correlation analysis between the clinical parameters and PSG data of
the groups were evaluated.
Results: The severe OSAHS group had significantly higher IHRS,
waist hip ratio (WHR), body mass index (BMI), neck circumference
than primary snoring group group: [(15.11 ± 6.50) vs(10.54 ± 4.31),
(0.950 ± 0.058)vs (0.899 ± 0.088), (27.90 ± 3.23) Kg/m2 vs
(24.86 ± 3.35) Kg/m2,(40.47 ± 2.51) cm vs (37.06 ± 2.93) cm, all
p < 0.05),OSAHS severity had positive correlation with the IHRS
parameters in smoking, diabetes, and WHR, (all p < 0.01).
The subjects with high IHRS were found with higher AHI, ODI,
TS90% and lower LSaO2, MSaO2 than the low IHRS group (all
p < 0.05). There were positive correlation between IHRS and AHI
(r = 0.245, p < 0.001), ODI (r = 0.255, p < 0.001), T90% (r = 0.254,
p < 0.001),and negative correlation between IHRS and MSaO2
(r = ‐0.218, p = 0.001), LSaO2 (r = ‐0.225, p = 0.001), total sleep
time (TST) (r = ‐0.149, p = 0.027).
Conclusions: Cardiovascular events in patients with OSAHS is cor-
related with recurrent nocturnal apnea and hypoxia. Severe OSAHS
patients had higher IHRS, they may had high risk for heart attack in
the future. AHI, ODI and TS90% are important PSG parameters to
predict the risk of cardiovascular events.
Disclosure: Nothing to disclose.
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P392 | Estimation of obstructive sleep apnea
severity using additive Bayesian networks
S. Bozkurt1; A. Bostanci2; M. Turhan2
1Biostatistics and Medical Informatics, 2Otolaryngology, Head and Neck
Surgery, Akdeniz Univesity School of Medicine, Antalya, Turkey
Objectives/Instruction: Machine learning‐based prediction models
are widely used in many different areas, recently. The goal of this
study is to develop an additive bayesian network model and to eval-
uate its results for the classification of obstructive sleep apnea (OSA)
severity of patients with suspected sleep disordered breathing as
normal, mild, moderate and severe based on non‐polysomnographic
variables.
Methods: This retrospective cohort study enrolled 338 consecutive
patients, who underwent complete polysomnographic evaluation due
to suspected sleep disordered breathing at our accredited sleep dis-
orders center between January 2014 and August 2015. The inde-
pendent variables related to OSA severity were analyzed using
additive Bayesian networks model.
Results: The analyses revealed that the size of soft palate and
uvula (OR:10.94 [1.87‐64.11]) and mallampati score (OR: 4.5 [1.46‐
43.22]) were the most significant predictor variables in the final
model. In addition, results of 10‐fold cross‐validated tests indicated
that the severity of suspected OSA patients can be classified, using
additive Bayesian networks, with 0.632 sensitivity and, 0.529 speci-
ficity. In addition, the model has 0.777 sensitivity and 0.646 speci-
ficity to classify severe OSA patients.
Conclusions: While machine learning methods might be used to
improve accurate OSA screening and help to refer only the sus-
pected OSA patients to sleep laboratories for the expensive tests,
sensitivity and specificity of the additive Bayesian networks were
low. However, this model can be the basis for modeling the relation-
ship of all variables to each other.
Disclosure: Nothing to disclose.
P393 | The effectiveness of remote monitoring
in improving CPAP compliance: a randomised,
controlled study
S. van der Kleij1; B. Hanraets2; I. de Backer1; J. Asin1
1Department of Pulmonary Medicine and Center for Sleep Medicine,
Amphia Hospital, Breda, 2Center for Homeventilation, UMC Utrecht,
Utrecht, The Netherlands
Objectives/Introduction: Adherence to continuous positive air-
way pressure (CPAP) in obstructive sleepapneu (OSA) is generally
60‐70%. Short‐term adherence and early perceived benefits are the
best predictors of long‐term adherence. Former studies of remote
monitoring were influenced by a postponed start until after CPAP
titration, or a control group without sham. Other studies do not
mention the effectiveness of therapy and were only focussed on
compliance. This study measures the effect of remote monitoring on
compliance and effectiveness of CPAP in the short and long term.
Methods: A single blind, randomised controlled trial, comparing
remote monitoring and adjustment using AirView™ versus placebo
was performed. AirView™ connects wireless to the Resmed CPAP.
Study‐parameters were compliance after 10 weeks and 1 year (CPAP
use in mean hours/night), number of patients lost and interventions.
Results: A total of 115 patients with newly diagnosed OSA were
enrolled in each group (power 80%, α=0.05, β=0.2) with balanced
baseline characteristics of mean age (intervention vs control resp.
54;54 yrs), apneu‐hypopneu‐index (AHI, 47;48/hr), BMI (33;31 kg/m2),
sex (man 75;74%), ESS (12;14) and FSS (37;37). Compliance after
10 weeks was equal in mean hours of CPAP use per night as mea-
sured during the last week (6:27; 6:35 h, p = 0.569), AHI (2.4; 2.3/hr,
p = 0.886), ESS (5.7; 4.9, p = 0.222), FSS (28.2; 28.7, p = 0.804). The
number of contacts per patient with a healthcare professional was sig-
nificantly different during the follow‐up from week 3 untill week num-
ber 10 (0.25; 0.13, p = 0.025). In the remote monitoring group
contacts could be initiated by the healthcare professional or the
patient. In the placebo‐group all contacts were initiated by the patient.
Number of drop‐outs after 1 year were equal (12;11, p = 0.827), with
compliance equal in mean hours of CPAP use during the last week
(6:49; 6:43 h, p = 0.59) and residual AHI (1.9; 2.2/h p = 0.41).
Conclusions: Remote monitoring in CPAP has no additional effect
on compliance in our patient group with a high‐adherence and inten-
sive support rate from the start. However remote monitoring can
simplify and improve teleconsultation and when teleconsultation is
as good as regular consultation under certain circumstances this
might be more convenient for the patient.
Disclosure: Resmed and VitalAire provided the remote monitoring
equipment.
P394 | Home sleep apnea testing with
Polywatch® ‐ comparison with polysomnography
M. Ferreira1; L. Batata1; C. Santos1; J. Moita1; M.F. Teixeira1;
T. Pereira2
1Centro de Medicina do Sono do Hospital Geral, Centro Hospitalar e
Universitário de Coimbra, 2Escola Superior de Tecnologia da Saúde de
Coimbra, Coimbra, Portugal
Objectives/Instruction: Home sleep apnea testing (HSAT) is an
easier, more convenient method for the diagnosis of obstructive
sleep apnea syndrome (OSAS) with lower costs in comparison with
in‐lab polysomnography (PSG) if used properly.
Many devices are currently available for this type of testing. The
purpose of our study was to evaluate the specific performance of
Polywatch®‐BMC Medical (PolylogicAnalysis software Version
2.984.0) in our sleep lab, in a group of patients with suspected
OSAS.
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Methods: Fifty patients with clinical indication for PSG agreed to
simultaneous HSAT, adapted by a trained sleep technologist. Techni-
cal procedures and scoring of sleep events followed the recommen-
dations of American Academy of Sleep Medicine, version 2.3. For
diagnosis of OSAS we considered an apnea hypopnea index (AHI)
greater than 15/h or greater than 5/h with daytime symptoms or car-
dio‐vascular risk. A paired t‐test was performed, p value of 0.05.
Results: Fourty‐seven subjects were included, 31 men and 16
women, age 51.15 ± 10.72 years and body mass index (BMI) of
29.22 ± 5.04Kg/m2. We found lower number of hypopneas
(p = 0.000), higher number of obstructive apneas (p = 0.013), higher
average (p = 0.000) and minimum oxyhemoglobin saturation
(p = 0.008) and lower time spent with oxyhemoglobin saturation bel-
low 90% (p = 0.001) in HSAT. This device revealed sensitivity of
66.7% and specificity of 45.5% for the diagnosis of SAOS.
Conclusions: Polywatch® showed good diagnostic performance for
severe SAOS and in the overall, similar sensitivity and specificity as
other studies for the same cut‐off values.
The main limitation relates to the device algorithms that do not
allow for manual scoring or editing of oxyhemoglobin dessaturation
events and failed to identify some measurements.
Disclosure: Nothing to disclose.
P395 | Comparing electrocardiographic
differences in patients with complex sleep apnea
using four different adaptive servo‐ventilation
devices
J. Knitter1; S. Parthasarathy2
1College of Medicine, 2UAHS Center for Sleep & Circadian Sciences,
Tucson, AZ, United States
Objectives/Introduction: Treatment with adaptive servo‐ventila-
tion (ASV) was reported to increase the risk of mortality in the
SERVE‐HF trial, although the causative mechanism remains unclear.
One possible explanation involves device‐specific performance char-
acteristics (“device‐effect”), as opposed to characteristics common
among all ASV devices (“class‐effect”). Differences in QTc and mean
heart rate across devices due to differences in minute ventilation
may be a potential mechanism. This study investigated differences in
QTc and ECG‐derived heart rate across four different ASV devices
administered to the same subjects.
Methods: We performed a randomized controlled cross‐over trial of
fourteen patients (age 69.1 ± 14.9 yr) with complex sleep apnea and
preserved cardiac contractility who were adherent to ASV therapy.
Patients underwent four nights of laboratory‐based polysomnography,
randomized to a different ASV device each night, using Philips ASV
device (System One), updated Philips ASV device (Dreamstation),
ResMed S7 VPAP Adapt (used in the SERVE‐HF trial), and ResMed S9
VPAP Adapt. Whole‐night ECG analysis was performed using a wave-
let‐transform‐based ECG delineator which output beat‐by‐beat
parameters, including QT interval corrected for heart rate (QTc) using
Bazett's formula. Analysis was performed using linear mixed models
with repeated measures after adjusting for sleep stage.
Results: Fifty‐four device‐nights comprising 680,116 heart beats
were included in the study. During polysomnography, mean heart
rate was significantly greater during therapy with S7 device
(66.1 bpm [95% CI 60.6, 71.5]) than S9 device (63.1 bpm [95% CI
57.6, 68.6], Philips ASV (63.7 bpm [95% CI 58.2, 69.2]), and Modi-
fied Philips ASV (65.7 bpm [95% CI 60.2, 71.1], all p values <
0.0001). Mean QTc was significantly greater during therapy with S7
device (399 ms [95% CI 398, 399]) than S9 device (397 ms [95% CI
397, 397], and Modified Philips ASV (396 ms [95% CI 396, 396], all
p values < 0.0001). Mean QTc during S7 device use was not signifi-
cantly different than during Philips ASV device therapy (p = 0.074).
Conclusions: Significant differences in heart rate and QTc exist
between various ASV devices. While the absolute differences in QTc
appear small in magnitude, such differences need to be explored in
individuals with systolic heart failure.
Disclosure: This work was funded in part by Philips‐Respironics,
Inc.
P396 | Effect of gender on obstructive sleep
apnea severity change according to age‐group
Y.-Y. Shin1; S. Byun2; J.-I. Byun1; W.C. Shin1
1Kyung Hee University Hospital at Gangdong, Seoul, 2Icheon Hospital,
Icheon, Republic of Korea
Objectives/Instruction: Severity of obstructive sleep apnea (OSA)
is known to be greater in men compared to women. However, the
gender differences in apnea‐hypopnea index tends to decrease with
increaging age. This may be due to hormonal changes associated with
menopause, because reduced levels of estrogen/progesterone is
reported to be associated with increased prevalence of sleep disor-
dered breathing. However, whether the change also occur similary in
male has not been fully evaluated. Moreover, the changes in individual
breathing sessation characteristics have not been evaluated in detail.
In this study we aimed to evaluate whether the severity change of
obstruction events according to age differ between genders.
Methods: Polysomnogrphic recordings of consecutive patients who
was diagnosed for obstructive sleep apnea in KyungHee University
Hospital at Gangdong between Dec 2010 ~ Dec 2017 were
included. The patients were divided into two groups according to
menopausal status (< 55 years old and 55 years old or more). Differ-
ence in demographic, clinical, and polysomnographic parameter
between gender, and age were compared.
Results: Total 568 patients were analyzed, which included 467 male
patients (age< 55, n = 324, age>55, n = 143) and 101 female patients
(age< 55, n = 36, age>55, n = 65). As expected, there were significant
effect of gender on body‐mass index (F = 23.8, p < 0.001), BDI
(F = 29.0, p < 0.001), apnea (F = 43.1, p < 0.001), hypopnea
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(F = 12.7, p < 0.001), apnea‐hypopnea index (AHI, F = 51.3,
p < 0.001), and respiratory disturbance index (RDI, F = 61.7,
p < 0.001). Effect of age was found only in BMI (F = 4.4, p = 0.036),
but not in AHI or RDI. However, age x gender interaction was signifi-
cant in hypopnea index, AHI, and RDI, which showed tendency of
increase in female, but tendency of decrease in male patients.
Conclusions: This study shows that the age difference in severity
of hypopnea, but not apnea is affected by gender.
Disclosure: Nothing to disclose.
P397 | Distinct EEG‐EMG‐coherence patterns
associated with sleep‐disordered breathing
severity grade
H. Gouveris1; A. Abriani1,2; K. Bahr1; P. Boekstegers1,2;
T. Huppertz1; E. Martin1; C. Matthias1; S. Groppa2;
M. Muthuraman2
1Dept. Otorhinolaryngology, 2Section of Movement Disorders and
Neurostimulation, Biomedical Statistics and Multimodal Signal Processing
Unit, Dept. of Neurology, Medical Centre of the University of Mainz,
Mainz, Germany
Objectives/Instruction: We investigated whether using EEG‐
EMG‐coherence (EEC) as a feature fed to a support vector machine
(SVM) algorithm may allow staging of disease severity among sleep‐
disordered‐breathing (SDB) patients.
Methods: EEG‐EMG‐coherence data resulted by applying a multita-
per processing for estimating the power spectrums separately and
calculating the coherence on raw C3‐/C4‐EEG‐ and EMG‐ chin data
of polysomnographic (PSG) recordings of 102 SDB patients (33
female; age: 53, ± 12,4 yrs) acquired on the second of two consecu-
tive PSG nights in each patient. Four epochs (30 s each, classified
manually by AASM 2012‐ criteria) of each sleep stage (N1, N2, N3,
REM) were marked (in total 1632 epochs/night) and were included in
the analysis. After multitaper processing, EEC values were fed to a
SVM algorithm to classify SDB disease severity based on respiratory
disturbance index (RDI). Twenty patients had a mild (RDI ≥ 10/h and
< 15/h), 30 patients had a moderate (RDI ≥ 15/h and < 30/h) and 27
patients had a severe OSA (RDI ≥ 30/h). Twenty five patients had a
RDI < 10/h. The AUC (area under the curve) value was calculated
for each receiver operator characteristic (ROC) curve.
Results: EEG‐EMG coherence values could distinguish between
SDB‐patients without OSA and OSA patients of the above three
severity groups using an SVM algorithm. Using PSG data of the sec-
ond night, in mild OSA the AUC was 0.616 (p = 0.024), in moderate
OSA the AUC was 0.659 (p = 0.003), and in severe OSA the AUC
was 0.823 (p < 0.001).
Conclusions: Grading disease severity in SDB patients can be per-
formed using PSG‐based multitaper‐processed EEC values processed
with a SVM algorithm.
Disclosure: Nothing to disclose.
P398 | Imaging of obstructive sleep apnoea
anatomic risk factors after bariatric surgery
weight loss: a pilot study
K. Sutherland1,2; N. Sarkissian1,2; A. Lowth1,2; S. Grieve1;
S. Liebman3; G. Smith3; P. Cistulli1,2
1Charles Perkins Centre, University of Sydney, 2Respiratory Medicine,
3Upper Gastrointestinal & Hepatobiliary Surgery Unit, Royal North Shore
Hospital, Sydney, NSW, Australia
Objectives/Introduction: Obesity is a strong, and potentially
reversible, risk factor for Obstructive Sleep Apnoea (OSA). However,
weight loss results in variable Apnoea Hypopnea Index (AHI)
improvement. This is not explained by the magnitude of weight loss
and surgical weight loss resolves OSA in only a minority of cases.
Specific anatomical factors may explain weight loss effects better
than total body weight. These include regional fat, upper airway soft
tissues or airway space volume, with mediation by craniofacial skele-
tal structure. Recently, fat inside the tongue has been specifically
implicated in OSA. The aim of this pilot imaging study is to concur-
rently assess anatomical factors which may relate to OSA improve-
ment following surgical weight loss.
Methods: Participants on the waiting list for bariatric surgery were
invited to undergo an in‐laboratory polysomnography and a Mag-
netic Resonance Imaging (MRI) scan (within one week of each other)
before surgery. After 6 months of weight loss, both assessments
were repeated. The MRI consisted of both abdominal and head
regions with two sequences (T1 for visualisation of soft tissue
boundaries and Dixon for fat visualisation). Segmentation of the
upper airway soft tissue borders and fat were performed using
image analysis software (3D slicer). Soft tissue and fat segmentations
are overlayed to determine the tongue fat volume. Preliminary
descriptive data are presented.
Results: Fifteen participants have been recruited to date, and post‐
surgery imaging and analysis is complete in N = 5. Of these 5 partici-
pants the majority are female (N = 4), 46.8 ± 8.3 (mean ± SD) years,
pre‐surgery BMI 43.4 ± 6.7 kgm2, with baseline AHI 25.34 ± 11.4
events/hour. Post‐surgery weight loss was 33.5 ± 5.9 kg and total
AHI reduced to 9.1 ± 5.0 events/hour. Preliminary data suggest
reduction in total tongue volume (‐19.8 ± 9.5 cm3) and tongue fat
volume (‐13.1 ± 12.1 cm3) and increase in total upper airway space
volume (+3.2 ± 5.1 cm3).
Conclusions: This preliminary data demonstrates the feasibility of
detailed imaging of obese OSA patients pre‐ and post‐ bariatric sur-
gery. Work is ongoing to complete analysis of the dataset and assess
relationships to OSA improvement following weight loss.
Disclosure: Nothing to disclose.
272 of 433 | ABSTRACTS
P399 | Craniofacial photography for
assessment of obstructive sleep apnoea risk in
an Icelandic general population sample
K. Sutherland1,2; A. Bamagoos1,2; B. Benediktsdottir3;
S. Gudmundsdottir4; T. Gislason3,4; P. Cistulli1,2
1Charles Perkins Centre, University of Sydney, 2Respiratory Medicine,
Royal North Shore Hospital, Sydney, NSW, Australia, 3Medical Faculty,
University of Iceland, 4Department of Sleep, Landspitali University
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Objectives/Introduction: Craniofacial structure can predispose to
Obstructive Sleep Apnoea (OSA). However, assessment of craniofa-
cial risk factors for OSA is largely limited to small clinical samples
due to specialised imaging requirements. Quantitative facial surface
measurements, acquired by photography, predict OSA in sleep clinic
populations. However, sleep clinic patients have high suspicion of
OSA. It is unknown whether this facial phenotyping method reflects
OSA risk in the general population. The aim of this study was to use
quantitative facial photography to assess OSA risk in a general popu-
lation sample.
Methods: Subjects were Icelandic participants in the European
Community Respiratory Health Survey (ECRHS), selected from the
general population and first studied in 1990. In 2012, they were
invited for a sleep assessment (Type 3 ambulatory study) and cranio-
facial photography (87% of those invited completed these assess-
ments). Facial photographs (front and profile) were analysed using
facial landmark coordinates. Eleven linear and angular measurements
relating to the face, including eyes, nose, and mandible were anal-
ysed. OSA was defined as Apnoea‐Hypopnea Index (AHI) ≥15
events/hour (moderate‐severe disease). Logistic regression (backward
likelihood ratio) was used to assess the relationship of craniofacial
measurements (adjusted for age, gender, height, weight) to OSA.
Model performance was assessed by the area under the receiver
operating characteristic curve (AUC). Statistical significance was
accepted at p < 0.05.
Results: AHI and photographs were available in 400 subjects
(48.3% male), N = 63 (15.8%) had OSA. Compared to controls, OSA
subjects were more male (70% vs. 44.2%, p < 0.001), obese (BMI
30.5 ± 5.6 vs. 27.5 ± 4.5 kgm2, p < 0.001) and older (56.8 ± 5.9 vs.
53.6 ± 6.9 years, p < 0.001). Four facial measurements contributed
to the model to classify those with OSA. OSA was related to
reduced facial index (wider face for facial height, p = 0.04), reduced
eye width (p = 0.025), increased nose height (p = 0.001), and
increased maxillary‐mandibular relationship angle (suggestive of
mandibular retrusion, p = 0.064). The model AUC (95% confidence
interval) was 0.8 (0.7, 0.9).
Conclusions: Craniofacial measurements obtained by facial pho-
tography related to the presence of OSA. This study supports this
simple photographic technique as having utility in capturing pheno-
typic information related to OSA risk in large epidemiological sam-
ples.
Disclosure: Nothing to disclose.
P400 | Sleepiness, fatigue, anxiety and
depression in overlap syndrome
N.-T. Economou1; L. Velentza2; Y. Papachatzakis2;
D. Koutsompolis2; P. Zarogoulidis3; G. Trakada2
1Psychiatry, Athens Medical School, 2Division of Pulmonology,
Department of Clinical Therapeutics‐Alexandra Hospital, University of
Athens School of Medicine, Athens, 3Pulmonary Department‐Oncology
Unit, ‘Theageneio’ Cancer Hospital., Thessaloniki, Greece
Objectives/Introduction: Patients with Chronic Obstructive Pul-
monary Disease (COPD) and/or Obstructive Sleep Apnea (OSA) often
complain about sleepiness, fatigue, anxiety and depression. However,
common screening questionnaires, like Epworth Sleepiness Scale
(ESS), Fatigue Severity Scale (FSS) and Hospital Anxiety and Depres-
sion Scale (HADS) have not been evaluated in patients with overlap
‐ coexisting COPD and OSA ‐ syndrome versus patients with OSA
alone Our study compared ESS, FSS and HADS between patients
with overlap syndrome and patients with OSA, before and after
treatment with Continuous Positive Airways Pressure (CPAP).
Methods: We examined thirty‐eight (38) patients with coexisting
COPD and OSA (Group A) versus 38 patients with OSA alone
(Group B), in a case‐control study (27 men, 11 women). All patients
underwent pulmonary function tests (PFTs), oximetry and overnight
polysomnography and completed the questionnaires, before and
after 3 months of CPAP therapy.
Results: The two groups did not differ significantly in terms of age,
Body Mass Index (BMI), neck, waist and hip circumferences, and
arterial blood pressure values. They also had similar comorbidities.
They differed significantly, as expected, in PFTs (Forced Vital Capac-
ity ‐ FVC, 2.53 ± 0.73 vs 3.08 ± 0.85 lt, p = 0.005, Forced Expiratory
Volume in 1sec ‐ FEV1, 1.78 ± 0.53 vs 2.60 ± 0.73 lt/min,
p < 0.001) and in daytime oximetry (94.75 ± 2.37 vs 96.13 ± 1.56%,
p = 0.007). ESS, HADS ‐ Anxiety and HADS ‐ Depression scores did
not differ statistically significant between the two groups (p = 0.27,
p = 0.44, and p = 0.67, respectively), whereas overlap syndrome
patients expressed significantly more fatigue than OSA patients
(p = 0.02), that remained even after 3 months of CPAP therapy
(p = 0.015).
Conclusions: We conclude that sleepiness, anxiety and depression
were similar in both groups, whereas fatigue was more prominent in
patients with overlap syndrome than in sleep apneic patients and did
not ameliorate after treatment.
Disclosure: Nothing to disclose.
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P401 | Investigation of the relationship
between neutrophil‐to‐lymphocyte ratio, platelet‐
to‐lymphocyte ratio and obstructive sleep apnea
syndrome
J.S. Lee1; H. Kim2
1Hallym University College of Medicine/Hallym University Sacred Heart
Hospital, Anyang, 2Hallym University College of Medicine/Dongtan
Sacred Heart Hospital, Hwaseong, Republic of Korea
Objectives/Introduction: Previous studies reported the relation-
ship between systemic inflammation and obstructive sleep apnea
syndrome (OSAS). The neutrophil‐to‐lymphocyte ratio (NLR) and pla-
telet‐to‐lymphocyte ratio (PLR) have been widely used and recog-
nized reliable inflammatory markers in the clinical area. This study is
aimed to determine the relationship between the OSAS and clinical
inflammatory markers (NLR and PLR).
Methods: We performed a retrospective analysis of 103 patients
who demonstrated apnea‐hypopnea index (AHI) more than 5 in the
polysomnography. The control was selected from 6,017 healthy indi-
viduals who had visited our health promotion center. The individuals
who had history of cancer, chronic inflammatory disorder, acute
infection, and cardiac diseases were excluded. By using propensity
score, the age‐, sex‐ and body mass index (BMI) matched 103
obstructive sleep apnea (OSA) patients and 206 healthy controls
were finally analyzed. The OSA and control groups were compared
by NLR, PLR and other complete blood cell count profiles. We also
investigated the correlation between inflammatory markers (NLR and
PLR) and sleep disorder related parameters (AHI, arousal index, snor-
ing index, and Epworth sleepiness scale).
Results: Although the white blood cell count, neutrophil, and lym-
phocyte counts were significantly increased, the NLR was not signifi-
cantly increased in the OSA group (p = 0.649). The PLR was
significantly decreased in the OSA group (p = 0.022). The mean pla-
telet volume (MPV) was significantly decreased in the OSA group
(p < 0.001). In the correlation analysis, there was no significant cor-
relation between NLR and sleep disorder related parameters. There
was a negative correlation between PLR and AHI (r = ‐0.229,
p = 0.020).
Conclusions: The PLR value can give us valuable information
about the severity of OSAS. Further researches may be required to
elucidate the role of platelet in inflammation in patients with OSAS.
Disclosure: Nothing to disclose.
P402 | Estimating obstructive sleep apnea in
cyprus: a randomized stratified epidemiological
study using STOP‐BANG questionnaire
F. Frangopoulos1; S. Zannetos2; I. Nicolaou1; T. Adamidi1;
T. Zachariadou3; N.T. Oikonomou4; E. Manios4;
A. Georgiou1; G. Trakada4
1Respiratory Department, Nicosia General Hospital, 2DG European
Programmes, Coordination and Development, 3Engomi Primary Heath
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Clinical Therapeutics, National and Kapodistrian University of Athens
School of Medicine, Alexandra Hospital, Athens, Greece
Objectives/Introduction: Obstructive Sleep Apnoea (OSA) syn-
drome is a highly prevalent disorder. Recent epidemiologic data in
Northern Europe estimate the prevalence of moderate and severe
OSA to 23,4% in women and 49,7% in men[i].
Estimates of OSA prevalence in Southern Europe are lacking. The
aim of the study was to predict the prevalence of OSA in Cyprus.
Prevalence of sleep‐disordered breathing in the general population:
the HypnoLaus study, R Heinzer et al., Lancet Respir Med. 2015
April; 3(4): 310‐318.
Methods: The survey was contacted by CATI method (Computed
Aided Telephone Interviewing) using STOP‐BANG questionnaire.
Participants were all adults residing in Cyprus. The randomly
selected sample was stratified according to the last demographic
report. The estimated sample size needed was less than 2000 but
5000 sample housing units were screened and 4118 eligible respon-
ders completed the survey.
The question about Neck Circumference was removed from the final
evaluation due to the uncertainty of most of the participants and
the risk of bias.
Results: From a total of 4118 participants (2252 males, 1862
females) 46.6% were over 50 years old. Participants responded posi-
tively for snoring 29.9%, for feeling tired or sleepy during the day
39.3%, for observed apnoea during sleep 12.3%, and for hyperten-
sion 24.6%. BMI index was calculated and 4.7% were found obese
class II and III.
From the statistical analysis 2640 participants (64.1%) were at low
risk for OSA, 1200 participants (29.1%) at intermediate risk (3‐4 pos-
itive answers‐demographics) and 277(6.7%) at high risk for moder-
ate‐severe OSA.
Conclusions: The finding of 50% of male at intermediate to high
risk of OSA and 18% of women is similar to the estimation of Hyp-
nolaus study.
Nevertheless, this unrealistically high prevalence in the general popu-
lation reported in the last epidemiological reports shows that the
present sleep apnoea syndrome definition, screening and diagnostic
tools are too inclusive and should be revised.
Disclosure: Nothing to disclose.
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P403 | Decreased thickness of peripapillary
retinal nerve fibre layer and macular layer in
patients with moderate and severe obstructive
sleep apnoea syndrome
P.-W. Lin1; H.-C. Lin2
1Department of Ophthalmology, Division of Glaucoma, Sleep Center,
2Department of Otolaryngology, Sleep Center, Robotic Surgery Center,
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Objectives/Introduction: Early signs of glaucoma usually manifest
as thinning of the peripapillary retinal nerve fibre layer (pRNFL) and
macular layer. In this study, we evaluate the thickness of pRNFL and
macular layer in patients with obstructive sleep apnoea syndrome
(OSA) and further investigate the relationship between the ophthal-
mologic and polysomnographic variables in patients with different
severities of OSA.
Methods: All subjects underwent a full‐night a polysomnography
(PSG) and then completed ophthalmologic evaluation, including best‐
corrected visual acuity, intraocular pressure, slit lamp biomicroscopy,
gonioscopy, ophthalmoscopy, standard automatic perimetry (SAP)
and optical coherence tomography (OCT) exam. Continuous data
between two groups were compared using Kruskal‐Wallis Test, while
categorical data were compared using chi‐square test. Correlation
between PSG variables and ophthalmologic variables in OSA patients
were assessed using Pearson's correlation coefficient. All statistical
tests were two‐sided. A p value < 0.05 was considered significant.
Results: A total of 135 subjects were enrolled in the study (125
patients with OSA, 10 subjects with simple snorer/normal group).
The pRNFL thickness was significantly lower for the severe OSA
group than for the normal group in the inferior quadrant (p = 0.031)
and in the nasal‐inferior sector (p = 0.036).
When normal subjects and mild OSA patients were grouped together
and compared with patients with moderate/severe OSA, pRNFL
thickness measurements for the latter group were significantly lower
in the inferior quadrant (p = 0.013) and temporal‐inferior sector
(p = 0.040). Macular layer thickness in the superior and inferior
hemispheres, in the superior‐outer sector, and in the inferior‐outer
sector was also significantly thinner in the moderate/severe OSA
group than in the normal/mild OSA group (all p values < 0.05). The
AHI negatively correlated with the thickness of total macular layer
(r = ‐0.140, p = 0.028) and the inferior hemisphere of macular layer
thickness (r = ‐0.137, p = 0.031).
Conclusions: Patients with moderate/severe OSA had lower
pRNFL thickness and macular thickness as compared to the normal/
mild OSA group. The severity of OSA inversely correlated with total
macular layer thickness, and the lowest saturation of oxygen posi-
tively correlated with the total macular layer thickness in OSA
patients. Clinicians need to consider the possibility of glaucoma in
patients with moderate/severe OSA.
Disclosure: Nothing to disclose.
P404 | Improvement of visual sensitivity and
retinal thickness after continuous positive airway
pressure in patients with obstructive sleep
apnoea syndrome
H.-C. Lin1; P.-W. Lin2
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Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Objectives/Introduction: Early signs of glaucoma usually manifest
as thinning of the peripapillary retinal nerve fibre layer (pRNFL) and
macular layer. In this study, we assess whether treatment with con-
tinuous positive airway pressure (CPAP) might improve visual sensi-
tivity and pRNFL thickness in patients with obstructive sleep apnoea
syndrome (OSA).
Methods: Patients presenting with snoring and daytime sleepiness
who underwent overnight polysomnography (PSG) to determine
OSA severity were recruited and subsequently referred for ophthal-
mologic evaluation at baseline and 3 months after CPAP treatment.
Each patient underwent visual acuity measurement, Perkins applana-
tion tonometry, slit‐lamp biomicroscopy, ophthalmoscopy, and stan-
dard automated perimetry (SAP) exam. pRNFL thickness and macular
thickness (MT) parameters were measured by spectral‐domain optical
coherence tomography (OCT). The SAP, pRNFL and MT thickness
parameters before and after treatment were compared. Continuous
variables were analyzed using Wilcoxon's rank sum test, and categor-
ical Fisher's exact test. Further statistical analysis were performed by
Wilcoxon signed rank test for paired data and Spearman's rank cor-
relation. A p value < 0.05 was considered significant.
Results: A total of 44 subjects were recruited, including 32 patients
with OSA and 12 control subjects. At baseline, the mean deviation
(MD) of SAP was ‐2.15 ± 1.91 dB in the OSA group. After CPAP
treatment for 3 months, the MD was improved to ‐1.38 ± 1.37 dB
(p = 0.014). As regard the OCT parameters, the inferior quadrant
and nasal‐inferior sector of pRNFL thickness significantly improved
after CPAP treatment for 3 months (p = 0.019 and 0.002, respec-
tively). The macular layer thickness in the superior‐inner sector, infe-
rior‐outer sector, superior hemisphere, inferior hemisphere and the
thickness of total macular layer were also significantly improved
after CPAP treatment. Improvement of MT in the superior‐inner sec-
tor positively correlated with apnea/hyponea index (r = 0.405,
p = 0.021) and desaturation index (r = 0.473, p = 0.006) on pre‐
treatment PSG.
Conclusions: The treatment of CPAP can improve visual sensitivity
and increased retinal thickness in patients with OSA.
Disclosure: Nothing to disclose.
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P405 | Does CPAP treatment lead to increased
light and moderate‐vigorous physical activity in
OSA patients with cardiac or cerebrovascular
events?
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A. Vakulin1,5; P. Catcheside1; R.D. McEvoy1,6
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Objectives/Introduction: OSA is the partial, or complete, closure
of the airway during sleep. Gold‐standard treatment for OSA is con-
tinuous positive airway pressure (CPAP) that keeps the airway open.
Unfortunately, compliance to CPAP is low. Numerous small studies
have shown moderate‐vigorous physical activity as an effective
treatment for OSA, whilst only one small study has shown that
CPAP lead to a spontaneous increase in physical activity, as mea-
sured subjectively by the International Physical Activity Question-
naire, and objectively by pedometers. This study sought to expand
on this topic using data collected in a larger randomised control trial
(RCT).
Methods: Data were collected as part of the Sleep Apnea Cardio-
vascular Endpoints RCT (the ‘SAVE Trial’).
2687 participants had experienced a prior cardio‐ or cerebrovascular
event and had untreated OSA. Patients were randomly allocated to
receive usual cardiovascular care alone (n = 1341), or with addition
of CPAP (n = 1346).
Light and moderate‐vigorous physical activity were self‐
reported at baseline, 6 months, 24 months 36 months, and
end of study. Three questions asked “(vigorous/moderate/mild)
exercise for more than 15 min (number of times in the past
week)?”, with examples of activities in each category given. Min
of light and moderate‐vigorous physical activity per week were
calculated.
Mixed models examined whether CPAP led to differences in light
and moderate‐vigorous physical activity during follow‐up, adjusted
for baseline confounders, being country region, diabetes status, car-
diovascular event type, age, daytime sleepiness, body mass index,
apnea‐hypopnea index, smoking status and baseline physical activity.
A secondary analysis compared compliant CPAP users.
(≥4 h/night), with propensity‐matched usual care participants.
Results: Participants allocated to CPAP reported significantly more
moderate‐vigorous physical activity compared to usual care partici-
pants (33.8 min vs 28.4 min, p < .001). There was no difference in
light physical activity (80.4 min vs 79.9 min, p = .748).
In the sub‐analysis, compliant CPAP users reported more moderate‐
vigorous physical activity (33.8 min vs 25.4 min, p < .001) and light
physical activity (80.3 min vs 75.7 min, p = .044), compared to
propensity matched controls.
Conclusions: These results indicate that CPAP users, particularly
those with good adherence, report increases in physical activity com-
pared to controls.
Disclosure: The SAVE (Sleep Apnea Cardiovascular Endpoints) trial
was funded by project grants 1006501 and 1060078 from the
National Health and Medical Research Council (NHMRC) of Australia
as well as by the Respironics Sleep and Respiratory Research Foun-
dation and Philips Respironics. Supplementary trial funding was pro-
vided by Fisher & Paykel Healthcare and the Australasian Sleep
Trials Network (enabling grant 343020 from the NHMRC). In‐kind
donations were provided by Philips Respironics for continuous posi-
tive airway pressure equipment and by ResMed for sleep apnea
diagnostic devices.
P406 | Prevalence of parasomnias in relation
to presence and severity of obstructive sleep
apnea. A registry‐based cross‐sectional study
R.S. Lundetræ1; I.W. Saxvig2; S. Pallesen2,3; H. Aurlien4,5;
S. Lehmann2,6; B. Bjorvatn1,2
1Department of Global Public Health and Primary Care, University of
Bergen, 2Norwegian Competence Center for Sleep Disorders, Haukeland
University Hospital, 3Department of Psychosocial Science, University of
Bergen, 4Department of Neurology, Haukeland University Hospital,
5Department of Clinical Medicine, 6Department of Clinical Science,
University of Bergen, Bergen, Norway
Objectives/Introduction: Previous research suggests a positive
association between parasomnias and obstructive sleep apnea (OSA).
In the present study, we aimed to further assess the prevalence of
parasomnias in relation to presence and severity of OSA. We hypothe-
sized higher parasomnia prevalence with higher OSA severity.
Methods: The sample comprised 4,372 patients referred to a Nor-
wegian university hospital with suspicion of OSA (mean age
49.1 years, 69.8% males). OSA was diagnosed and categorized by
standard respiratory polygraphy (type 3 portable monitor). The
patients completed a comprehensive questionnaire prior to the sleep
study, including questions about different parasomnias during the
last 3 months. Pearson chi‐square tests explored differences accord-
ing to the presence and severity of OSA. Furthermore, logistic
regression analyses with the parasomnias as dependent variables and
OSA severity as predictor were conducted (adjusted for sex, age,
marital status, smoking, and alcohol consumption).
Results: In all, 34.7% had apnea‐hypopnea index (AHI) < 5 (no
OSA), 32.5% had AHI 5‐14.9 (mild OSA), 17.4% had AHI 15‐29.9
(moderate OSA), and 15.3% had AHI ≥30 (severe OSA). The overall
prevalence of parasomnias was 3.3% (sleepwalking), 2.5% (sleep‐
related violence), 3.1% (sexual acts during sleep), 1.7% (sleep‐related
eating), and 43.8% (nightmares). The overall parasomnia prevalence
was highest in the no OSA group. In the chi‐square analyses,
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including all OSA groups, the prevalence of sleep‐related violence
and nightmares were inversely associated with OSA severity
(p = 0.02 and p < 0.001, respectively), whereas none of the other
parasomnias were significantly associated with OSA severity. When
adjusting for multiple confounders in the logistic regression analyses
the odds of sleepwalking was significantly higher in severe compared
to mild OSA (OR=2.0, 95% CI= 1.12‐3.55). The other parasomnias
were not associated with OSA presence or severity.
Conclusions: We did not find higher parasomnia prevalences in
patients with OSA compared to those not having OSA. With the
exception of sleepwalking, the parasomnias were not associated with
OSA severity.
Disclosure: Nothing to disclose.
P407 | Positional dependency in mild
obstructive sleep apnoea in the European Sleep
Apnoea Database (ESADA) study
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Objectives/Introduction: Positional obstructive sleep apnoea
(pOSA) is an important sleep apnoea phenotype and seems to be
more prevalent in mild OSA patients. The aim of our study was to
estimate the prevalence, clinical characteristics and risk factors for
pOSA in a group of mild OSA patients of the European Sleep
Apnoea Database (ESADA) cohort.
Methods: A multi‐centric subsample of 452 mild OSA patients
from the ESADA cohort was evaluated. Positional OSA was defined
as an overall apnoea‐hypopnea index (AHI) ≥5, supine AHI to non‐
supine AHI ratio of ≥2 and an AHI that normalizes (AHI < 5) in the
non‐supine posture. We compared clinical and polysomnographic
variables between patients with and without pOSA and investigated
predictive factors for pOSA using binary logistic regression analysis.
Results: Two hundred twenty (49%) of 452 patients fulfilled the
pOSA criteria. These patients were significantly younger (46 vs 51,
p < 0.001) and leaner (BMI 28 vs 30, p = 0.006). Comorbid hyper-
tension (24 vs 33%, p = 0.033) and Type 2 diabetes (6 vs 13%
p = 0.004) were less prevalent in pOSA compared to non‐pOSA
patients. AHI (8.5 vs 10.4), nadir oxygen saturation (87 vs 88%,
p = 0.02) and sleep time spent with SaO2 < 90% (0.2 vs 0.8%,
p = 0.004) were lower in pOSA. Negative independent predictors of
pOSA in a mild sleep apnoea population were age [odds ratio (95%
CI) 0.98 (0.96‐0.99), p = 0.006] and lower AHI [odds ratio (95% CI)
0.88 (0.82‐0.94), p < 0.001]. Daytime sleepiness reflected by
Epworth sleepiness scale score (ESS) did not differ between groups
(9.1 vs 9, p = 0.87).
Conclusions: Positional OSA is highly prevalent and noted in
almost half of our mild OSA patients. Since patients with mild OSA
are the prevailing group of OSA patients, positional OSA potentially
comprises the vast majority of OSA patients. Furthermore, this pOSA
phenotype may reflect the milder form of OSA disease spectrum,
including younger patients with a low degree of comorbidities.
Disclosure: Nothing to disclose.
P408 | Clinical judgement in mild OSA ‐ data
from the European Sleep Apnoea Database
(ESADA) study
I. Bouloukaki1; M. Dieltjens2; J. Verbraecken2; L. Grote3;
J. Hedner3; M.R. Bonsignore4; O. Marrone5;
W.T. McNicholas6; A. Pataka7; P. Steiropoulos8;
T. Saaresranta9; U. Anttalainen9; S. Schiza1
1Sleep Disorders Center, Medical School, University of Crete, Heraklion,
Greece, 2Multidisciplinary Sleep Disorders Centre, Antwerp University
Hospital and University of Antwerp Edegem, Antwerp, Belgium, 3Sleep
Laboratory, Pulmonary Medicine, Sahlgrenska University Hospital,
Gothenburg, Sweden, 4DiBiMIS, University of Palermo, 5National
Research Council, Institute of Biomedicine and Molecular Immunology,
Palermo, Palermo, Italy, 6Department of Respiratory and Sleep Medicine,
St. Vincent's University Hospital, School of Medicine, University College,
Dublin, Dublin., Ireland, 7Department of Respiratory Medicine,
Respiratory Failure Unit, G.Papanikolaou Hospital, Medical School,
Aristotle University of Thessaloniki, Thessaloniki, 8Department of
Pneumonology, Democritus University of Thrace, Alexandroupolis,
Greece, 9Turku University Hospital, Division of Medicine, Department of
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Objectives/Introduction: Mild obstructive sleep apnoea (OSA) is
highly frequent but the clinical significance is under debate. The
Clinical Global Impression Severity (CGI‐S) Scale is used to reflect
the clinician's overall rating of the condition after consideration of
event frequency, symptoms, anthropometrics and comorbidities. Our
study aimed to evaluate the usefulness of the CGI‐S for evaluation
of mild OSA.
Methods: A multi‐centric subsample of non‐apneic snorers
(n = 1969) and mild OSA patients (n = 1986) from the European
Sleep Apnoea Database (ESADA) cohort was evaluated. The Clinical
Global Impression Severity (CGI‐S) Scale is a 7‐point scale ranging
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from 1 (normal) to 7 (extremely ill). The CGI‐S scale was transformed
to four severity categories: Normal (score=1), mild (score=2‐3), mod-
erate (score=4) and severe (score=5‐7). Non‐apneic snorers and
patients with mild OSA were compared with respect to CGI‐S score.
We also evaluated the capacity of the CGI‐S scale to predict treat-
ment recommendation for positive airway pressure (PAP) or oral
devices in mild sleep apnea.
Results: The CGI‐S score was significantly higher in mild OSA
patients compared with non‐apneic snorers (21% vs 12% were
scored ≥4, p < 0.001). Moreover, non‐apneic snorers were more fre-
quently rated in the “normal” category compared to mild OSA
patients (57% vs 15%, p < 0.001). Independent predictors for a
higher CGI‐S score were age (β=0.05, p = 0.001), ESS score (β=0.46,
p < 0.001), coronary artery disease (β=0.40, p < 0.001), cerebrovas-
cular disease (β=0.33, p = 0.006), chronic obstructive pulmonary dis-
ease (β=0.53, p < 0.001), type‐2 diabetes (β=0.32, p < 0.001) and
AHI (β=0.11, p < 0.001). A high CGI‐S score (≥4) strongly predicted
a treatment recommendation with PAP (odds ratio (95% CI) 2.19
(1.50‐3.19), p < 0.001).
Conclusions: The CGI‐S may be a useful tool for assessment not
only of OSA event frequency but also to integrate comorbidities and
daytime function. CGI‐S might provide a better assessment of dis-
ease severity in patients with mild OSA.
Disclosure: Nothing to disclose.
P409 | Effect of oxygen supplementation on
sleep and nocturnal breathing in patients with
chronic obstructive pulmonary disease travelling
to high altitude: randomized cross‐over trial
L. Tan1,2; M. Furian1; T.D. Latshang1; S.S. Aeschbacher1;
F. Huber1; D. Flueck1; M. Lichtblau1; S. Ulrich1; E.D. Hasler1;
P.M. Scheiwiller1; S. Usenbaeva3; S. Ulrich1; M. Kohler1;
K.E. Bloch1
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Zurich, Switzerland, 2Sleep Medicine Center, West China Hospital,
Sichuan University, Chengdu, China, 3Department of Respiratory
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Objectives/Introduction: The current study evaluates whether
nocturnal supplemental oxygen therapy improves sleep and breath-
ing disturbances in lowlanders with chronic obstructive pulmonary
disease (COPD) staying for 2 nights in a mountain resort at 2048 m.
Methods: 21 patients with COPD GOLD grade 2/3, median(quar-
tiles) age 68(64;70)y, forced expiratory volume in 1s (FEV1) 55
(48;60)% predicted, living below 800 m were studied at 490 m (Zur-
ich) and during 2 altitude sojourns of 2 days each at 2048 m (St.
Moritz), separated by a wash‐out period >2 weeks below 800 m.
During altitude sojourns nocturnal oxygen (3 L/min) (or ambient air,
sham oxygen) was administered by nasal cannula according to a dou-
ble‐blinded, randomized, cross‐over design. Questionnaire
evaluations and nocturnal polysomnography were performed during
nights at 490 and 2048 m. Co‐primary outcomes were the mean
nocturnal oxygen saturation (SpO2) and the apnea/hypopnea index
(AHI).
Results: Polysomnography at 490 m revealed median (quartiles)
SpO2 92%(91;94), total AHI 16.3/h(9.8;26.0), obstructive AHI 13.5/h
(9.8;22.6), central AHI 1.2/h(0.2;3.5), sleep efficiency 83%(69;89). In
the night at 2048 m, using sham oxygen, SpO2 was 86%(84;88), total
AHI 27.5/h(13.6;55.4), obstructive AHI 5.6/h(2.2;9.2), central AHI
16.6/h(9.9;41.6), sleep efficiency 70%(64;83), p < 0.01 all corre-
sponding comparisons. Compared to sham oxygen, mean changes
(95% confidence intervals) induced by oxygen at 2048 m were SpO2
+9%(+8;+10), total AHI ‐20.6/h(‐28.3;‐13.0), obstructive AHI ‐0.3/h(‐
3.6;2.9), central AHI ‐21.4/h(‐28.6;‐14.2), sleep efficiency +6%
(+1;+12). Oxygen therapy tended to improve subjective sleep quality
by 8% (‐0 to 17), p = 0.06 but had no effect on cognitive perfor-
mance the day after.
Conclusions: Lowlanders with COPD experience pronounced
hypoxemia, sleep apnea and sleep fragmentation when spending a
night at 2048 m. Since nocturnal oxygen supplementation improves
these changes, it may be useful to prevent severe hypoxemia,
breathing and sleep disturbances in mountain tourists with COPD
staying overnight at high altitude.
Disclosure: Nothing to disclose.
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P410 | Mild cognitive impairment and its risk
factors in Chinese patients with obstructive
sleep apnea
R. Chen
Department of Respiratory Medicine, Sleeping Center, Second Affiliated
Hospital of Soochow University, Suzhou, China
Objectives/Introduction: Obstructive sleep apnoea (OSA) is
known to be associated with impairment in cognitive function.The
aim of this study was to characterize neurocognitive impairment in a
cohort of Chinese patients with varying severities of OSA, and to
investigate the risk factors of mild cognitive impairment (MCI) in
patients with OSA.
Methods: Eligible male OSA patients (n = 2101) were categorized
into a MCI group and a non‐MCI group, based on the Montreal Cog-
nitive Assessment (MoCA). Characteristics of participants between
the groups were compared with Mann‐Whitney U‐test. Additionally,
we constructed a multivariable logistic regression model to identify
risk factors associated with MCI in OSA patients.
Results: Group differences in age (45 years versus 38 years,
P = 0.000), levels of education (12 years versus 14 years, P = 0.000)
and the Epworth Sleepiness Scale (ESS) score (10 versus 9,
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P = 0.033) were found between the subjects with and without MCI.
Concerning polysomnography variables, the subjects with MCI had a
poor sleep efficiency (87.40% versus 89.85%, P = 0.000), spent more
time in light sleep (76.20% versus 73.60%, P = 0.000) and less time
in slow wave sleep (SWS) (8.30% versus 9.65%, P = 0.006) compared
to the control group. Furthermore, in multivariate logistic regression
model, aging was associated with an increased odds of MCI in OSA
patients (45 ≤ age ≤59 years versus age ≤ 44 years: OR = 2.43,
95% CI 1.92‐3.06; age ≥ 60 years versus age ≤ 44 years: OR = 3.21,
95% CI 2.25‐4.58), higher education status protected the patients
cognitive function (OR = 0.46, 95% CI 0.37‐0.56), and severe exces-
sive daytime sleepiness (EDS) was indicated as the risk factor of MCI
in patients with OSA (ESS ≥ 16 versus ESS ≤ 10: OR = 1.37, 95% CI
1.05‐1.79).
Conclusions: Our results demonstrate that MCI in patients with
OSA may be depend on the increasing age, educational level and
EDS. It remains unclear that the relationship of MCI to sleep frag-
mentation, intermittent hypoxia and sleep architecture.
Disclosure: Nothing to disclose.
P411 | Characterization and severity
assessment of patients with obstructive sleep
apnea
N. Kyuchukov1; I. Krachunov1; Z. Ivanova1; T. Popova2;
P. Pavlov1; P. Glogovska1; Y. Ivanov1; P. Hristova3
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Objectives/Introduction: Obstructive sleep apnea (OSA) is
increasingly prevalent. Most patients remain undiagnosed until the
disease progresses. Early detection plays an important role in man-
agement and treatment.
To characterize patients with OSA and reveal distinctive features in
their profile which will help to predict the diagnosis and disease
severity.
Methods: Patients conducted sleep study for detection of OSA.
They were added to a registry and statistical analysis was performed.
Results: A total of 255 patients took part in the study ‐ 26 of them
performed polysomnography and other 229 were evaluated using
polygraphy. Men prevailed with 81.6%. In only 12 (4.7%) of patients
the preliminary diagnosis was not confirmed. Smokers were 84.1%.
Patients with comorbidities prevailed ‐ 88.2% had arterial hyperten-
sion, 23.1% had COPD, 33.4% had diabetes, 13.3% were with thy-
roid disorders.
Patients’ most frequent symptoms were ‐ snoring in 95.1%, exces-
sive daytime sleepiness 71.0%, restless sleep in 70.6%, awakenings
in 70.2%, nocturnal dyspnea 68.2%.
Significant correlation (p < 0.05) was found between AHI and weight
(r = 0.25), neck circumference (r = 0.38), waist circumference
(r = 0.32), Mallampati score (r = 0.30), Epworth score (r = 0.34), time
with nocturnal SpO2 below 90% (r = 0.41). The patients with cardiac
arrhythmias, excessive daytime sleepiness and nicturia had higher
AHI (p < 0.05).
Conclusions: Patients with OSA had high percentage of comorbidi-
ties and most often complained of snoring, daytime sleepiness, rest-
less sleep, awakenings and nocturnal dyspnea. Disease severity
correlated with body weight, neck circumference, Epworth and Mal-
lampati scores. Waist circumference correlated well with disease
severity and could be useful if no data for neck circumference is
available. Cardiac arrhythmias, daytime sleepiness and nicturia could
also predict higher severity of the disease.
Disclosure: Nothing to disclose.
P412 | Comparison of apnea detection using
nasal pressure transducer, oronasal thermal
airflow sensor, and tracheal sound sensor
M. Glos1; A. Sabil2; A. Günther1; C. Veauthier1; C. Schöbel1;
I. Fietze1; T. Penzel1,3
1Charité‐Universitätsmedizin Berlin, Berlin, Germany, 2Research and
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Republic
Objectives/Introduction: Our study aimed to investigate flow
estimation by a tracheal sound (TS) sensor during sleep in patients
with sleep related breathing disorders (SRBD). TS signal was used
for apnea detection and results were compared to those obtained by
oronasal thermal airflow sensor (Therm) and by nasal pressure trans-
ducer (NP) signals.
Methods: In addition to in lab polysomnographic recordings, TS
were recorded using the PneaVoX technology (CIDELEC, France).
Data from 32 SRBD patients (25 males, mean age 67 ± 15 years,
and mean BMI 30 ± 4 kg/m²) were used to compare the detection of
apneas by the three independent methods TS, Therm, and NP. Sig-
nals were scored visually according to AASM rules by two indepen-
dent scorers (S1, S2) in random order.
Results: Both scorers detected more apneas with NP and TS than
with Therm (S1: NP=4508, TS=4243, Therm=3766 and S2:
NP=4717, TS=4279, Therm= 3884). A total of 3508 apneas for S1
and 3402 for S2 were detected simultaneously with all three sen-
sors. TS and NP had the most apneas in common (4057 for S1 and
3824 for S2), followed by NP and Therm (3860 for S1 and 3792 for
S2). TS and Therm had least number of apneas in common (3535 for
S1 and 3453 for S2). Finally, apnea duration was slightly longer for
NP than for the TS and the Therm.
Conclusions: With the sensor placed properly on the suprasternal
notch, it seems that tracheal sound flow analysis is on the one hand
capable to detect apneas otherwise missed by oronasal thermal air-
flow sensor and on the other hand disregards apneas that are
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overestimated by nasal pressure. Stud results suggest that tracheal
sound sensors can be used for apnea detection.
Disclosure: This study was supported by an unrestricted grant
from CIDELEC, France.
P413 | Age‐related differences in the ability of
c‐reactive protein to detect cardiometabolic risk
in mild‐to‐moderate obstructive sleep apnoea
A. Vgontzas1; J. Baker1; J. Gaines1; J. Fernandez-Mendoza1;
F. He1; Y. Li1; C. Criley1; M. Basta2; E. Bixler1
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Objectives/Introduction: Mild‐to‐moderate obstructive sleep
apnoea (OSA) affects 15‐40% of the adult general population. How-
ever, it remains unclear when and how to best treat mild‐to‐moder-
ate OSA, given that in most cases the disorder is asymptomatic. It
has been shown that CRP in young and middle‐aged adults with
OSA improves the prognostic value of AHI to assess individual risk
for cardiovascular and metabolic aberrations associated with mild‐to‐
moderate OSA. In this study we examine whether age modifies the
association of CRP with cardiometabolic aberrations in patients with
mild‐to‐moderate OSA.
Methods: A sample of 103 adults 28‐84 years old
(54.39 ± 11.96 years) with mild‐to‐moderate OSA (AHI between 5
and 29 events per hour) underwent 8‐h polysomnography, a clinical
history and physical examination, including measures of blood pres-
sure and body mass index, and a fasting morning blood draw to
assessed HbA1C and CRP levels.
Results: CRP was associated with greater odds for hypertension
(OR = 2.48, 95% CI = 1.41‐4.38, p = 0.002) compared to AHI (OR =
1.02, 95% CI = 0.94‐1.12, p = 0.599) in adults 28‐59 years old. In
contrast, neither CRP nor AHI were associated with hypertension in
adults 60‐84 years old (OR = 1.51, 95% CI = 0.72‐3.17, p = 0.282
and OR = 1.07, 95% CI = 0.96‐1.19, p = 0.205, respectively). CRP
was also associated with greater Hb1AC levels (β = 0.39, p = 0.002)
compared to AHI (β = 0.01, p = 0.932) in adults 28‐59 years old,
while in adults 60‐84 years old there was no significant association
for either CRP or AHI (β = 0.17, p = 0.350 and β = 0.12, p = 0.527,
respectively). All results remained significant after adjusting for gen-
der and BMI.
Conclusions: Our data suggest that including a measure of CRP
improves the ability for clinicians to detect cases of mild‐to‐moder-
ate OSA with true cardiometabolic risk. Importantly, the utility of
this measure is strongest in young and middle‐aged adults. These
results also suggest a different phenotype in older adults with mild‐
to‐moderate OSA compared to young and middle‐aged adults.
Disclosure: Nothing to disclose.
P414 | Is the stop‐bang questionnaire a good
clinical predictor for sleep‐disordered breathing
in the general population?
S. Loof1; E.R. Rietzschel2; K.B. Hertegonne1;
M.L. De Buyzere2; F. Bauters1
1Department of Pneumology, 2Department of Cardiology, Ghent
University Hospital, Ghent, Belgium
Objectives/Introduction: To identify patients at high risk for
sleep‐disordered breathing (SDB), various screening tools have been
tested, among which the STOP‐BANG questionnaire (SBQ). How-
ever, this questionnaire has been mainly evaluated in clinical popula-
tions and small sample sizes.
We aimed to validate the STOP‐BANG questionnaire as a screening
tool for SDB in a large general population cohort.
Methods: Our study population consists of 2252 participants of
the Asklepios cohort, a prospective general population study, of
which the second measurement round was conducted between
2011 and 2016. All subjects were submitted to extended clinical
assessment, a home polygraphy (HP) and self‐administered sleep
questionnaires. Diagnostic accuracy of the STOP‐BANG question-
naire as well as other SDB screening tools was assessed.
Results: The diagnostic accuracy of the SBQ was suboptimal, with
an area under the curve (AUC) of 0.67 (95% CI 0.63‐0.72) for mod-
erate and 0.71 (95% CI 0.64‐0.78) for severe sleep apnea (SA) in the
male population. At the pre‐set SBQ cut‐off of ≥ 3 the sensitivity
was 86.7% and the specificity was 30.5% for moderate to severe SA
in men. As sex is an inherent part of the questionnaire, selecting a
different cut‐off in total score for both sexes increased both sensitiv-
ity and specificity. Neck circumference was also reevaluated, as the
mean neck circumference was 40.4 cm in men and 34.7 cm in
women. At the currently used cut‐off of 40 cm, 97.4% of our female
population has a negative score.
Conclusions: A validation study of the STOP‐BANG questionnaire
showed poor diagnostic accuracy to detect patients at high risk for
moderate to severe sleep apnea. Adding a sex‐specific cut‐off for
neck circumference increased the diagnostic accuracy. As the impact
of age and body mass index (BMI) on SDB were also dependent of
sex, a sex‐specific screening tool is desirable and should be further
investigated.
Disclosure: Nothing to disclose.
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P415 | Severe obstructive sleep apnea:
positional patients (PP) vs. non‐positional
patients (NPP)
A. Oksenberg1; N. Gadoth1; J. Töyräs2; T. Leppänen2
1Sleep Disorders Unit, Loewenstein Hospital Rehabilitation Center,
Raanana, Israel, 2Department of Applied Physics and Department of
Clinical Neurophysiology, Diagnostic Imaging Center, University of
Eastern Finland and Kuopio University Hospital, Kuopio, Finland
Objectives/Introduction: In sleep clinic populations, the preva-
lence of Positional Patients (PP) is about 60% and this prevalence
decreases with increasing severity of obstructive sleep apnea (OSA).
However, it is not fully understood which characteristics determine
positional dependency in severe OSA (apnea‐hypopnea index,
AHI≥30) patients. We aimed to investigate the prevalence of PP in
severe OSA, to assess the differences between PP and Non‐Positional
Patients (NPP) and to examine the main predictors of positional
dependency in those patients. We hypothesize that the OSA pheno-
type is clinically different between PP and NPP with severe OSA.
Methods: Polysomnographic recordings of 309 consecutive
patients with severe OSA were analyzed. Positional OSA was
defined according to a common classification (i.e. PP: supine‐AHI/lat-
eral‐AHI≥2 and NPP: supine‐AHI/lateral‐AHI< 2).
Results: 35.0% of the patients were classified as PP. NPP were
more obese (p < 0.001) and had a more severe OSA disease com-
pared to PP (AHI 61.0 vs. 41.1, respectively, p < 0.001). Further-
more, obstructive apneas were slightly longer (25.6s vs. 24.4s,
p = 0.024) and the percentage of total apnea/hypopnea time from
total sleep time (AHT%) was higher in NPP compared to PP (45.5%
vs. 28.7%, respectively, p < 0.001).Based on stepwise binomial logis-
tic regression model, the most significant predictor for positional
dependency was AHT% (β=‐0.147, p < 0.001) followed by BMI (β=‐
0.093, p < 0.001) and total apnea time (β=0.011, p = 0.021). This
indicates that when AHT% and BMI increases (ORs 0.911 and 0.863,
respectively), the probability to be PP decreases. In contrast, when
total apnea time increases (OR=1.011), the probability to be PP also
increases. The model classified correctly 75.6% of the patients to be
either NPP or PP with a sensitivity of 82.0% and specificity of
63.9%. The area under ROC curve was 0.842 (95% CI: 0.799‐0.885,
p < 0.001) indicating good predictive accuracy of the model.
Conclusions: More than a third of the patients with severe OSA were
PP. They were leaner and had a less severe disease compared to NPP.
These PP could achieve a significant decrease in the amount and sever-
ity of apneas/hypopneas when adopting the lateral posture suggesting
that positional therapy may be beneficial also for these patients.
Disclosure: Study was financially supported by the Academy of
Finland (decision number 313697), the Research Foundation of the
Pulmonary Diseases, Kuopio University Hospital, the Research Com-
mittee of the Kuopio University Hospital Catchment Area for the
State Research Funding (projects 5041767 and 5041768), and the
Respiratory Foundation of Kuopio Region. The authors declare that
they have no other conflicts of interest.
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Objectives/Introduction: The aim of this study was to assess asthma
control among asthmatic outpatients with sleep disturbances (SD).
Methods: A questionnaire was filled in by 334 outpatients with
bronchial asthma. Sleep disturbances (snoring, daily sleepiness and
apneas) were self reported by 174 patients. One hundred and one
patients with sleep disturbances (SD group) and 101 patients with-
out sleep disturbances (non‐SD group) matched for age, BMI (body
mass index), asthma severity and smoking status were followed‐up.
Asthma control was assessed by ACT (asthma control test) and ACQ
(asthma control questionnaire). Data was statistically processed.
Values for p < 0.05 were considered significant.
Results: The median age of the studied patients was 60.0 (18‐ 87) yrs,
median value for BMI was 27.5 (18.7‐ 51.1) kg/m2. Non‐smokers were
77 (76.24%) in each of the studied groups. In the SD group 3 (2.97%)
patients were with mild asthma, 77 (76.24%) with moderate, 21 (20.79%)
with severe. In the non‐SD group mild asthma was found in 5 patients
(4.95%), 77 (76.24%) had moderate asthma, 19 (18.81%) ‐ severe.
The most common sleep disturbances were: snoring (36.6% of the
patients); daily sleepiness (26.7%), respiratory pauses and apnea
(12.9%) and other (23.8%).
In the SD group the ACT score was 16 (5‐ 25) which was signifi-
cantly lower compared to ACT score of the non‐SD group‐ 23 (5‐
25) (KW= 46.02; p < 0.001).
In the SD group the ACQ score was 2.29 (0.14‐ 5.29) which was sig-
nificantly higher compared to ACQ score of the non‐SD group‐ 0.86
(0.14‐ 4.86) (KW= 48.01; p < 0.001).
Conclusions: Sleep disturbances were an additional factor for poor
asthma control. Asthmatic outpatients may require more careful clin-
ical assessment for sleep disturbances as comorbidity.
Disclosure: Nothing to disclose.
P417 | Cerebral white matter and cognitive
decline in middle‐aged and older adults with
obstructive sleep apnea
M.-È. Martineau-Dussault1,2; A.-A. Baril1,3; S. Chami1,3;
K. Gagnon1,4; N. Gosselin1,2
1Center for Advanced Research in Sleep Medicine, Hôpital du Sacré‐
Coeur de Montréal, 2Department of Psychology, 3Faculty of Medicine,
Université de Montréal, 4Department of Psychology, Université du
Québec à Montréal, Montreal, QC, Canada
Objectives/Introduction: Recent studies have linked obstructive
sleep apnea (OSA) to an increased risk of developing dementia,
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leading to a growing interest in studying early cerebral changes in
older adults with OSA. Our preliminary data demonstrates that white
matter (WM) characteristics are associated with OSA severity in the
elderly, suggesting brain oedema, i.e. increased fractional anisotropy
and decreased diffusivities on diffusion tensor imaging. However,
whether these WM characteristics predict cognitive decline over
time remains unknown. The aim of this study was to explore
whether WM characteristics are associated with cognitive decline
over an 18‐month period in non‐treated middle‐aged and older
adults with OSA.
Methods: 16 adults (mean age: 63.2 ± 4.5 years, 12 men) with an
apnea‐hypopnea index >5 events/h and who refuse the treatment
were included at baseline and at 18‐month follow‐up.
At baseline, subjects were evaluated with overnight polysomno-
graphic recording, comprehensive neuropsychological assessment
and magnetic resonance imaging session, including diffusion
weighted imaging sequence. Using Tract‐Based Spatial Statistics
within FSL, diffusion tensor image metrics were extracted and
included whole white matter fractional anisotropy, axial diffusivity,
radial diffusivity, and mean diffusivity. Subjects were evaluated again
at 18‐month follow‐up with a neuropsychological assessment. The
cognitive decline was measured by the difference between the raw
scores at follow‐up and baseline for the different tests representing
attention, executive functions, working memory, learning and mem-
ory, language, and visuo‐spatial functions. Correlations were per-
formed between WM characteristics and changes in cognitive
performance.
Results: White matter characteristics showed significant correla-
tions with the cognitive decline on the Digit Span, a test involving
attention and working memory. More specifically, more severe decli-
nes on the Digit Span total score were correlated with lower radial
and mean diffusivities (r values between 0.548 and 0.554, p values
between 0.026 and 0.028) and with higher fractional anisotropy.
(r = ‐0.512, p = 0.043) at baseline.
Conclusions: Our results suggest that white matter characteristics
generally linked to brain oedema predict cognitive decline on an
attention and working memory task in adults with non‐treated OSA.
Disclosure: Nothing to disclose.
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Objectives/Introduction: Poor adherence to CPAP as the gold
standard treatment of OSA is reported from 45 to 75%. In this study
we evaluated CPAP adherence in an Iranian adult OSA population
and assessed barriers to CPAP use in non‐adherent group.
Methods: This is a mixed method study (quantitative and qualita-
tive) on adult OSA subjects who had used CPAP device. Adherence
rate was evaluated by a retrospective cross‐sectional method on
available data of CPAP memory card analysis of Emam Reza and Ibn‐
e‐Sina university sleep clinics, Mashhad, Iran. Data on CPAP adher-
ence were assessed in short‐term (previous 14 days), long‐term
(90 days) and total usage periods. Poor‐adherence was defined as
less than 4 h per night, less than 70% of the nights of each period.
Descriptive statistics, independent t‐test, and chi‐square test were
used with p‐values of < 0.05 considered as statistically significant. A
qualitative content analysis with data collected by in‐depth inter-
views by telephone call in order to find barriers of CPAP usage.
Results: Quantitative part: CPAP usage records of 81 patients (with
mean ± SD age 56.1 ± 11.4 years, AHI 30.5 ± 7.5, minimum oxygen
saturation during sleep study 74.6 ± 13.8%) were included in the
study. Totally 41(50.6%) patients were defined as poor‐adherent;
with 42.5% and 67.7% poor‐adherence in short and long‐term peri-
ods, respectively. Poor‐adherent group were younger (53.6 ± 12.6
vs. 58 ± 9.2 years) and less hypoxic than good‐adherent subjects
(minimum saturation 78.6 ± 10.2% vs. 70.5 ± 15.8%) (p = 0.044 and
0.008, respectively). Qualitative part: 17 accessible patients from
poor‐adherent group were interviewed. Barriers to CPAP usage
extracted in 3 main themes: knowledge (concerns about disease
cure, optimum usage, time to change mask), side effects (discomfort
with mask, problems when travelling) and cost of care.
Conclusions: A high percentage of our OSA patients had poor
short‐term and long‐term adherence to CPAP. Most of the barriers
for CPAP usage rate are from those aspects of patient education
which can simply be overcome by giving complementary information
in follow‐up visits.
Disclosure: Nothing to disclose.
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P419 | Patient barriers in acceptance of
polysomnography ordered by doctor ‐ a
qualitative study
S. Alaei1; S. Eslami2,3,4; F. Rezaeitalab5; L. Afshari Slaeh6;
H. Tabesh2; H. Asadpour7; F. Pourtaghi8; M. Amini9
1Student Research Committee, Department of Medical Informatics,
2Department of Medical Informatics, Faculty of Medicine, Mashhad
University of Medical Sciences, Mashhad, Islamic Republic of Iran,
3Department of Medical Informatics, Faculty of Medicine, University of
Amsterdam, Amsterdam, The Netherlands, 4Pharmaceutical Research
Center, Faculty of Medicine, Mashhad University of Medical Sciences,
5Department of Neurology, School of Medicine, Mashhad University of
Medical Sciences, 6Department of Occupational Medicine, Faculty of
Medicine, Mashhad University of Medical Sciences, 7Sleep Laboratory of
Ibn‐e‐Sina Hospital, Faculty of Medicine, Mashhad University of Medical
Sciences, 8Faculty of Nursing and Midwifery, Mashhad University of
Medical Sciences, 9Lung DiseasesResearch Center, Faculty of Medicine,
Mashhad University of Medical Sciences, Mashhad, Islamic Republic of
Iran
Objectives/Introduction: Undiagnosed obstructive sleep apnea
(OSA) has been well known for its significant neurocognitive and
cardiovascular morbidity. A relatively high rate (7 to 62%) of disobe-
dience from doctor's order suggests that simply advising
polysomnography is not enough. This is a qualitative study on
patients’ barriers to perform polysomnography ordered by sleep spe-
cialists.
Methods: A qualitative content analysis was done. Data were col-
lected by in‐depth interviews with 12 purposively selected patients.
After detailed explanation of methods, benefits, possible complica-
tions and cost of polysomnography to individuals referred by sleep
specialists, they were asked whether they will come for test or not.
Those who refused polysomnography were interviewed about rea-
sons of refusal of sleep study.
Results: Barriers for performing sleep study were categorized in 5
groups: risk perception (neglecting OSA significance, not admitting
having OSA), knowledge (treatment length, linking OSA symptoms to
other disorders, dreams visible during study), cost (study and treat-
ment), environmental factors (unfamiliar environment, unwilling to be
tested in clinic or hospital, unable to sleep with wires, unawareness
about treatment outcomes, being distressed by device).
Conclusions: Even after detailed explanation of polysomnography,
individuals highly suspected to OSA report multifaceted barriers to
acceptance of PSG ordered by physicians. Knowledge about differ-
ent patients concerns can help to improve rate of test performance.
Disclosure: Nothing to disclose.
P420 | Obstructive sleep apnoea syndrome
with cranio facial abnormalities:case report and
review of literature
B. Omarjee1; K. Serge2; J.-F. Vellin3; A. Omarjee4
1Consultation des Pathologies Respiratoires de l'Allergie et du Sommeil,
Saint Denis, 2Cabinet de Pédiatrie, Sainte Clotilde, 3Service d'Oto‐Rhino‐
Laryngologie et de Chirurgie Cervico‐Faciale, CHU Félix Guyon, Saint
Denis, Réunion, 4Service de Neurologie, CHU Maison Blanche, Reims,
France
Objectives/Introduction: Obstructive sleep disordered breathing
(SBD) includes a spectrum of clinical entities with variable severity
of intermittent upper airway obstruction. The term “obstructive
SDB” is used when symptoms of intermittent upper airway obstruc-
tion during sleep are present and can be defined by objective mea-
sures such as polysomnography (PSG).
Methods: This case is about a 4‐year‐old male child who since he
was 3 years old presented asthma with at least four hospitalization
and chronic snoring with prolonged periods of sleepleeness and
sleeping upright. On exam, he was obese with audible snoring even
upright. A lateral neck X‐ray demonstrated massive adenoid hyper-
trophy with only a thread of air nasopharynx with tonsillar hypertro-
phy partially obstructing the oropharynx. He was referred to ENT
and following a tonsillectomy and adenoidectomy 1 month later, he
desaturated to 75‐80% on room air, but apparently recovered and
was sent home after monitoring in 24 h. Ten days later the child
arrested at home and was resuscitated and transferred to hospital
where he was intubated. His prognosis was poor and ventilator sup-
port was withdrawn per the parents’ desires. The autopsy revealed
enlarged right ventricle consistent with corpulmonale. Preoperative
monitoring of pulse oximetry and pre and postoperative PSG is rec-
ommended to avoid complications of surgery.
Results: The prevalence of OSAS is between 1 and 4% but most
studies demonstrated a high frequency in children with achondropla-
sia. Apnoea‐Hypopnoea Index (AHI) is the most commonly reported
PSG parameter describing SDB severity in the literature and recom-
mended to avoid complications of surgery. Therapy may necessitate
uvulopalatoplasty and continuous positive airway pressure. There are
no high‐quality studies supporting the validity of OSAS definition in
children with craniofacial abnormalities.
Conclusions: In the present case PSG‐is highly recommended to
avoid complications of surgery. OSAS treatment is a priority in the
presence of major craniofacial abnormalities.
Disclosure: Nothing to disclose.
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P421 | Psychometric properties of the 9‐item
Ethos brief among obstructive sleep apnea
patients
M. Ulander1; A. Broström2; A. Pakpour3; P. Nilsen4
1Department of Clinical and Experimental Medicine, Linkoping University,
2Department of Clinical Neurophysiology, Linkoping University hospital,
Jonkoping University, Linkoping, 3Department of Nursing, Jonkoping
University, Jonkoping, 4Department of Health and Society, Linkoping
University, Linkoping, Sweden
Objectives/Introduction: Continuous positive airway treatment
(CPAP) is the recommended treatment for patients with obstructive
sleep apnea (OSA). Outcome measure often focus clinical and/or
self‐rated variables related to medical condition. However, a brief
validated instrument focusing the whole life situation (i.e., ethos)
suitable for clinical practice is missing. The aim was to investigate
factorial structure, categorical functioning of the response scale and
differential item functioning (DIF) across sub‐populations of the
Ethos brief scale among patients with OSA before and after treat-
ment with CPAP is initiated.
Methods: Prospective design, 180 OSA patients (68% men,
59,66 years, sd 11,51) from CPAP clinics at two hospitals, one uni-
versity and one county hospital. A clinical assessment and overnight
polysomnography scored by a sleep physician was used to diagnose
patients. Questionnaires used before treatment initiation, after
6 months and 12 months CPAP treatment were; Ethos brief (9
items), Epworth sleepiness scale (ESS, 8 items), Hospital anxiety and
depression scale (HADS, 14 items), and short form‐12 (SF‐12, 12
items). Validity and reliability of the Ethos was investigated using
Rasch and confirmatory factor analysis (CFA) models. In addition
measurement invariance, unidimensionality and differential item
functioning (DIF) across gender groups, Apnea hypopnea index (AHI)
groups and ESS were performed. The reliability of the Ethos was
confirmed using both Composite reliability (0.90) and Cronbach′s
Alpha (0.90).
Results: The results supported unidimensionalily of the Ethos in
both CFA and the Rasch model. Moreover, no DIF was found across
gender, AHI and ESS groups. The results of the DIF were conformed
in multigroup CFA. Finally, a latent profile analysis (LPA) was per-
formed to examine the profiles of patients based on their scores in
the Ethos. The LPA yielded 2 profiles of the patients with low
(n = 42) and high (n = 151) Ethos. Patients in the low profile group
were younger, had higher depression scores, lower perceived health,
poorer adherence after 6 month and higher BMI.
Conclusions: The Ethos brief scale seems to be a valid tool with
robust psychometric properties suitable for use among patients with
OSA before and after treatment with CPAP is initiated. Future stud-
ies should focus on its predictive validity.
Disclosure: None.
P422 | A patient with concomitant catathrenia,
snoring and central sleep apnea events. The
polysomnographic differences between them
S. Delis Gómez; E. Rocío Martín; R. Wix Ramos
Neurophysiology Department, Hospital ‘La Princesa’, Madrid, Spain
Objectives/Introduction: Catathrenia (nocturnal groaning) is a
rare condition characterized by monotonous irregular sounds that
occur during sleep. Not infrequently, catathrenia has been confused
with snoring and central sleep apnea.
Methods: Case report.
Results: A healthy 33 year‐old man presented with the chief con-
cern of “abnormal breath sounds” that occur during sleep for the
past two decades, unaware for the patient, but especially disturbing
for his family and current partner. He has good sleep hygiene, but
reports some sleepiness with an Epworth sleepiness scale score of
11/24. There was no past medical history of note and he was on no
regular medications. His partner reports two different types of
sounds, one compatible with mild regular snoring, and another differ-
ent “funny noise” while exhaling, no witnessed apneas were noted.
Overnight Polysomnography (PSG) with sound and video recorded,
was performed. PSG findings showed normal apnea/hipopnea index
(4.1/h), 4 central sleep apnea events were registered, with normal
sleep efficiency and well‐preserved sleep architecture. Light inspira-
tory snoring was recorded during NREM sleep, mainly within the
first half of the study. Expiratory groaning sounds were noted mainly
during REM sleep predominantly during second half of the study (8
events were recorded, ranging from 15 to 170 s of duration), begin-
ning with deep inspiration followed by protracted expiration during
which a monotonous vocalization of groaning was produced, associ-
ated with an arousal 80% of the times. The PSG findings closely
resembled central apneas, but the abnormal respiratory pattern of
bradypnea, with preceding deep inspiration and subsequent vocaliza-
tions during the prolonged expiratory phase, without oxygen desatu-
ration, differentiate catathrenia from true central apnea (also
documented during the study with characteristic graphic distinction
on PSG, same consideration as with inspiratory snoring).
Conclusions: We recommend video‐audio PSG as the investigation
of choice to diagnose catathrenia, having special caution in order to
differentiate the PSG findings associated with these three different
entities, which could be confused and let us to misdiagnosis, espe-
cially when they coexist in the same patient.
Disclosure: Nothing to disclose.
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P423 | Obstructive sleep apnea‐hypopnea
syndrome and comorbidities: a retrospective
Moroccan study
J. Achrane1; A. Jniene1,2; L. Harrak1; L. Achachi1; M. El Ftouh1
1Department of Pulmonology, Mohammed V University/Ibn Sina
University Hospital Center, Ibn Sina Hospital, 2Mohammed V University/
Laboratory of Physiology, Faculty of Medicine and Pharmacy, Rabat,
Morocco
Objectives/Introduction: In the general population, Obstructive
sleep apnea‐hypopnea syndrome (OSAHS) is by far the commonest
form of sleep apnea. It's considered as a public health concern
because of its high prevalence and its association with numerous
comorbidities causing a high morbidity and mortality risk which
impose their assessment. The disease is characterized by periodic
partial or complete recurrent upper airway obstruction during sleep
despite ongoing respiratory effort leading to micro‐arousals and/or
desaturation.
The objective of this study is to assess the prevalence of comorbidi-
ties in a group of Moroccan patients diagnosed clinically and
polysomnographically with OSAHS and its association with Apnea‐
Hypopnea Index (AHI).
Methods: This is a retrospective study of 53 charts from patients
diagnosed with OSAHS in the pulmonology department of Ibn Sina
Hospital between October 2016 and December 2017.
Results: We evaluated 53 patients with OSAHS (38 men and 15
women) with a mean age of 47.8 ± 12,9 years. The prevalence of
comorbidities was 71,7%. Cardiovascular comorbidities were present
in 41,5% (from whom hypertension in 39,6%), obesity in 48,1%, ENT
comorbidities in 20,8%, diabetes mellitus in 15,1%, depression under
medical supervision in 5,7% and asthma in 3,8%. Comorbidities
occurred in 29,4% of patients with AHI lower than 30/h (mild to
moderate OSAHS), and in 70,6% of patients with AHI upper or equal
to 30/h (severe OSAHS) (p: 0,04).
Conclusions: As for Caucasian studies, we showed high prevalence
of comorbidities in a Moroccan sample of patients diagnosed with
OSAHS and the presence of these comorbidities was significantly
associated to severity of OSAHS. Larger studies are necessary to
comfort these findings.
Disclosure: Nothing to disclose.
P424 | Vitamin D deficiency by obstructive
sleep apnea (OSA) severity: the importance of an
adequate supplementation.
R. Silvestri; I. Aricò; A. Brigandì; M. Cafarelli; M.G. Restuccia
Sleep Center Dep of Clinical and Experimental Medicine Messina
University, Messina, Italy
Objectives/Introduction: Recent studies report a link between
obstructive sleep apnea (OSA) syndrome and vitamin D levels.
Methods: We enrolled all new OSA patients referred to our Sleep
Centre in the last three years. All selected patients had a clinical/in-
strumental evaluation including polysomnography, anthropometric
values (Body mass index, BMI), daytime somnolence by Epworth
Sleepiness Scale (ESS), vitamin D assessment, comorbidity, therapy.
Results: Three hundred twenty patients (215 M,105 F) were
enrolled. Mean age 61 ± 11.5, range 16‐86, mean BMI 31.6 ± 6.3.
Comorbidities were hypertension in 58.1%, diabetes in 23.7%, thy-
roid disease in 12.9%, migraine in 3.1%, COPD in 28%. All patients
have been diagnosed for OSA by means of cardiorespiratory ambula-
tory monitoring. Mean ESS score were 8.4 ± 4.9 and mean AHI
32.5 ± 20.2. We divided all sample in three subgroups by severity:
sixty patients had mild OSA, 69 moderate OSA and 191 severe OSA.
Serum vitamin D mean values were 23.2 ± 13.9, no differences
among the three subgroups. Vitamin D supplementation was pre-
scribed in 164 patients and CPAP therapy in 32 patients.
Multivariate analysis showed an inverse correlation between vitamin
D and AHI (p = 0.04, r = 0.8, CI 5%), both in all sample and in each
subgroup. A trend of inverse correlation was also found among vita-
min D and BMI, AHI and ESS (r = 0.005, 0.07, 0.006, respectively).
Re‐evaluation of all patients after 6‐month supplementation therapy
is currently on going.
Conclusions: Vitamin D deficiency seems to increase by apnea
severity and may play a role on co‐morbid symptoms such as obesity
and excessive daytime somnolence. An adequate supplementation
could play a valid role in a multi approach treatment of OSA patients.
Disclosure: Nothing to disclose.
P425 | Central sleep apnea and cardiovascular
burden: sex differences in a retrospective
romanian population
C.I. Borcea1; O. Vlaicu1; R.E. Nedelcu2; F.D. Mihaltan1;
O.C. Deleanu1
1University of Medicine and Pharmacy Carol Davila, Bucharest, Romania,
2Institute of Pneumophtisiology Marius Nasta, Bucharest, Romania,
Bucuresti, Romania
Objectives/Introduction: Sleep‐related breathing disorders are
highly prevalent in patients with established cardiovascular disease.
Central sleep apnea (CSA) shares several pathophysiological features
of obstructive sleep apnea (OSA) and good working knowledge
about these association is important for optimal clinical care.
Methods: We retrospectively (2009‐2016) examined association
between CSA and self‐reported CVD in 19 individuals who under-
went overnight, unattended polysomnography at home. After exclu-
sion of other sleep pathologies (insomnia, circadian rhythm,
hypoventilation syndromes, obstructive and mixed sleep apnea,
upper airway resistance syndrome), other respiratory, metabolic
acute/uncontrolled pathologies, or chronic prescription opioid use,
we compared male vs female patients regarding demographics, OSA
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symptoms, heart ration (HR), blood pressure (BP), comorbidities and
sleep studies. SPSS 20 (Chi test, T‐test).
Results: 829 patients screened; 19 patients (13 male, 68%) with
CSA analyzed. Mean parametres: age 60.5 ± 32.52, Epworth sleepi-
ness score (ESS) 7.05 ± 3.75, BMI 30.43 ± 7.56 kg/m2, diagnostic
AHI 43.32 ± 25.53/h. They were properly PAP titrated and medical
treated. The most frequent cardiovascular comorbid diseases were
hypertension (74%), ischemic coronary artery disease (42%) and
chronic heart failure (32%). There were no significant differences
between genders regarding age, ESS, symptoms, CSA severity or
comorbidities. The male group differs only by mean DBP pressure
(87 ± 7.07 vs 67.5 ± 7.07 mmHg, p = 0.002), although normal and
similar mean DBP pressure (130 ± 14.14 vs 122.5 ± 21.21, p=NS),
suggesting proper control of hypertension. This data are more or less
similar with some other literature findings.
Conclusions: Knowledge about these distinct gender‐related differ-
ences in features of a Romanian sleep cohort must draw attention
to the differences between the various parameters specific to the
CSA pathology according to the type of patients, pertinent interpre-
tations even if the differences between the two populations were
not statistically significant, leaving considerable room for improve-
ment for future investigators to target.
Disclosure: Nothing to disclose.
P426 | Hypertension in obstructive sleep
apnea is associated with increased carbonic
anhydrase activity
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Ş. Beydemir4; J. Hedner1
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Medicine and Clinical Nutrition, Sahlgrenska Academy, University of
Gothenburg, Gothenburg, Sweden, 2Department of Thoracic Medicine,
Sleep Disorders Center, University of Crete, Heraklion, Greece,
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Objectives/Introduction: The catalytic function of the enzyme
carbonic anhydrase (CA) plays a fundamental role in carbon dioxide,
proton, and bicarbonate homeostasis. Increased blood CA activity
has been associated with obstructive sleep apnea (OSA). In the cur-
rent study, we investigated the influence of comorbid hypertension
on CA activity in patients with OSA. The effect of positive airway
pressure (PAP) therapy on CA activity was also studied.
Methods: 20 hypertensive patients and 12 normotensives controls
were recruited from a sleep clinic OSA cohort (27 males, age
52 ± 10 years, body mass index 37.3 ± 6.7 kg/m2, apnea‐hypopnea
index 48 ± 31 events/h) and followed up after PAP treatment (dura-
tion 9 ± 18 months). Patients treated with diuretics were excluded.
Blood CA activity was assessed at baseline and PAP therapy follow‐
up by an in vitro colorimetric method.
Results: At baseline, hypertensive OSA patients, compared with
normotensive controls, had a higher CA activity (1033 ± 204 vs.
862 ± 201 units, p = 0.028). In a generalized linear regression model
adjusting for gender, age, smoking, body mass index and apnea‐
hypopnea index, hypertension status was significantly associated
with CA activity (β= 198, 95%CI 82‐1475, p = 0.014). PAP treatment
did not significantly change CA activity over time (976 ± 216 vs.
956 ± 199 units for the whole patient group, p = 0.39).
Conclusions: CA activity was higher in OSA patients with comor-
bid hypertension compared with normotensives. PAP was not found
to modify CA activity in OSA suggesting that increased CA activity
constitutes a physiological trait for hypertension development in
OSA. Future larger scale studies are needed to better map the
potential influence of CA on respiratory and hemodynamic function
in OSA.
Disclosure: Nothing to disclose.
P427 | Association between sleep disordered
breathing symptoms, sleep apnea and socio‐
economic status: a systematic review of the
literature
O. Guglielmi1; P. Lanteri2; S. Garbarino1
1Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics
and Maternal/Child Sciences (DINOGMI), University of Genoa, Genova,
2Neurophysiology Center, Dipartimento Integrato Neuroscienze Mediche
e Chirurgiche e Riabilitazione ‐ Continuità Cure, ‘G. Gaslini’ Institute,
Genoa, Italy
Objectives/Introduction: Socioeconomic health disparities persist
despite improvements in health and health care in the last decades.
Low socio‐economic status (SES) is associated with worse health
outcomes, such as obesity, diabetes, metabolic syndrome and cardio‐
cerebrovascular disease and greater mortality. The aim of this sys-
tematic review is to summarize previous studies obtained in litera-
ture about the association between SES and obstructive sleep apnea
(OSA)/sleep disordered breathing (SBD) symptoms risk.
Methods: The review was realized following the PRISMA state-
ment. A literature search in Medline, PubMed, PsycInfo, Scopus,
Web of Science and Google Scholar was conducted. Articles pub-
lished in English, without time publication limits, aimed to analyze
the association between SDB symptoms or OSA diagnosis and SES,
were selected.
Results: Of 156 abstracts identified, 21 met inclusion criteria, of
which only one was longitudinal study and the remainder part was
cross‐sectional research. In 6 (28,6%) articles the sample was com-
posed by children. In 15 studies (71,4%) OSA was diagnosed by
polysomnography. Low SES are indicate as risk factor for the pres-
ence of SDB symptoms in 13 (61,9%) of the articles. With respect to
pediatric population, subjects from low SES presented an increased
risk of OSA respect to higher SES ones in all the research selected.
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In adults subgroups studies nevertheless, the association between
SDB and socio‐economics aspects is more controversial.
Conclusions: The results of this systematic review point out that
low SES could be a risk factors for OSA, especially in pediatric popu-
lation. Physical activity and others health behaviors could mediate
the association between low SES and SBD symptoms. Socioeco-
nomic circumstance should receive more attention in research of the
sleep medicine area.
Disclosure: Nothing to disclose.
P428 | Daytime dyspnea is a strong predictor
of sleep apnea in an unselected population of
COPD patients
D. Hansson; A. Andersson; K. Andelid; A. Nordensson;
A. Ullman; L. Fabbri; J. Hedner; L. Grote
Sahlgrenska University Hospital, Gothenburg, Sweden
Objectives/Introduction: Sleep disordered breathing (SDB) is a
prevalent but frequently overseen condition in patients with Chronic
Obstructive Pulmonary Disease (COPD) and may have detrimental
effects on outcome. However, the best way to recognize this condi-
tion is yet not established. We therefore studied the prevalence of
SDB in stable COPD by means of an overnight tonometry. We
hypothesized that COPD severity, anthropometric measures, and
daytime sleepiness predict SDB.
Methods: Patients (n = 32, mean age 70 ± 6 y, BMI 27 ± 7 kg/
m2, FEV1% 44 ± 14) were studied with overnight arterial tonome-
try (Watch‐PAT 200, Itamar Medical, Israel). Phenotyping including
pulmonary function test (body plethysmography), arterial blood
gases, and anthropometric data was performed. Daytime symptoms
were evaluated with the COPD Assessment Test (CAT), the Medi-
cal Research Council (MRC) Breathlessness Scale (COPD symptoms)
and the Epworth Sleepiness Scale (ESS, daytime sleepiness). Inde-
pendent predictive factors for significant SDB (defined as Apnea
Hypopnea Index (AHI) ≥15n/h) were assessed by General Linear
Modelling.
Results: Mean AHI, Rapid Eye Movement sleep (REM)‐AHI, ODI,
REM‐ODI were 14.1 ± 9, 23.7 ± 12, 5.9 ± 5, and 11.7 ± 8 n/h,
respectively. Mean saturation was 91.9 ± 3%. SDB prevalence was
29% in female (n = 20) and 44% in male (n = 12) COPD patients and
increased from 18% to 40% in patients with mild compared to sev-
ere airway obstruction (FEV1 class 70‐50% versus < 30%). Arterial
PO2 correlated with REM‐ODI (r = ‐0.45, p = 0.018) and REM‐AHI
(r = ‐0.36, p = 0.06). Daytime sleepiness correlated with the number
of nocturnal awakenings (r = 0.48, p = 0.044). In the adjusted model,
daytime dyspnea (MRC score) was the only predictor of significant
SDB in COPD patients (Odds ratio 3.2, CI 1.04‐9.9, p = 0.04) inde-
pendent of age, gender, BMI, FEV%, CAT, and ESS. One patient
failed to perform the sleep test, no device‐related technical drop‐out
occurred.
Conclusions: Daytime dyspnea, but not increased sleepiness or
obesity, predicted moderate to severe SDB in this clinical cohort of
patients with COPD. We identified significant SDB in almost one‐
third of the cohort and the prevalence progressed with COPD sever-
ity. Arterial tonometry proved to be a reliable and user‐friendly sleep
diagnostic tool. Our data demonstrates that novel diagnostic algo-
rithms which integrate sleep in the routine phenotyping of COPD
patients need to be developed.
Disclosure: Nothing to disclose.
INSOMNIA 3
P429 | Time estimation following a nap
condition in good sleepers
M. Salanitro1; E. Norris1; A. Vallières2; M. Carr1;
C. Bradshaw1; M. Blagrove1; M. Crawford1
1Swansea University, Swansea, United Kingdom, 2Laval University,
Quebec City, QC, Canada
Objectives/Introduction: The quarter‐of‐an‐hour rule (QHR) is an
effective component of stimulus control; however it requires
patients to be able to accurately determine the passage of time. Bel-
leville (2001) found that insomnia patients misperceived a time inter-
val of 12.5 min after a nap. Misperception of time intervals may
mean that patients stay in bed longer than the recommended QH,
potentially negating the therapeutic effects of stimulus control. We
propose that sleep inertia is the reason individuals misperceive the
time interval. The study aimed to manipulate the levels of sleep iner-
tia to measure the effects thereof on time estimation.
Methods: In a randomized, cross‐over design, twelve good sleepers
underwent both a nap condition (slept until reaching stage 3 sleep,
or asleep for 60 min) and a wake condition (laid awake for 30 min)
in a bedroom in a laboratory setting. Following each condition, par-
ticipants were required to estimate when 15 min had elapsed. The
co‐variate sleepiness was assessed with the Stanford Sleepiness
Scale before and after each condition.
Results: In the nap condition, five participants reached stage 3
sleep, six reached stage 2 sleep, and one participant did not fall
asleep and was removed from the analyses. Our manipulation check
confirmed that sleepiness after the nap condition was higher than
before the nap (3.8 vs. 5.3), whereas in the wake condition sleepi-
ness remained unchanged (3.3 vs. 4). The difference between the
post‐nap sleepiness and post‐wake sleepiness was significant
(p < .05). Participants in the nap condition produced a time estima-
tion (mean=10.2 min, SD=4.6) which was significantly different to
the estimation after the wake condition (mean=16.5 min, SD=5.8, t
(10)=2.9, p < .05).
Conclusions: Unexpectedly, individuals underestimated the pas-
sage of time after the nap condition compared to the wake condi-
tion, presumably because of increased sleep inertia. The results need
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to be replicated with insomnia patients to determine the implications
for adherence to the QHR in patients.
Disclosure: Nothing to disclose.
P430 | Modelling sleep state misperception at
sleep onset
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M. Ross4; P. Anderer4; S. Overeem1,3; A. Vermeeren5
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Objectives/Introduction: Insomnia patients often overestimate
their sleep onset latency (SOL). The mechanism underlying this type
of sleep state misperception is not fully understood. We hypothesize
that the length of uninterrupted sleep fragments after sleep onset
influences the perception of the SOL because too short sleep frag-
ments might be overlooked. We attempt to make a model of the
minimum length that a sleep fragment should have in order to be
perceived as sleep, and we fit the model to subjective data of insom-
niacs and healthy controls.
Methods: Standard in‐lab polysomnographic recordings were per-
formed in 20 elderly, untreated insomniacs and 21 age‐matched self‐
defined good sleepers. Recordings were visually scored according to
R&K criteria. In the model sleep onset was defined as the first epoch
of the first sleep fragment longer than L minutes, with L varying
from 0.5 to 40. We selected the length L that resulted in the small-
est Mean Square Error (MSE) of the difference between modelled
SOL and SOL perceived by the subject. This was done for both sub-
ject groups separately.
Results: For insomniacs, the lowest MSE was found for a length L
of 30 min (MSE without model: 7195 vs. L = 30: 3927). In the
healthy subjects, applying the model only resulted in small improve-
ments of the MSE. The lowest MSE was found for L = 10 (MSE
without model: 1185 vs. L = 10: 969), although the results for all
model parameters L below 20 were very similar.
Conclusions: The aim of this study was to investigate the mecha-
nisms underlying sleep onset misperception, by modelling the influ-
ence of sleep interruption on subjective SOL. The results indicate
that in insomnia patients the perception of sleep onset can be influ-
enced if a sleep fragment is interrupted after less than 30 min. The
different results for the two groups suggest that, for the perception
of sleep onset, insomniacs are more sensitive to sleep interruption
than healthy subjects. In order to extend our findings to the general
population, the analysis should be repeated in different age groups.
Additionally, other parameters could be added to the model, for
instance sleep depth and the duration of the sleep disruption.
Disclosure: Nothing to disclose.
P431 | Sleep quality related with exercise
duration and timing in community dwelling
adults
J. Lee1,2; S. Lee1; S. Kim3; J. Bang1
1Department of Psychiatry, Kangwon National University Hospital,
2Department of Psychiatry, Kangwon National University School of
Medicine, Chunchon, 3Department of Psychiatry, Doeun Hospital,
Jincheon, Republic of Korea
Objectives/Introduction: Epidemiological studies have indicated
physical exercise improved the sleep quality and quality of life. Phys-
ical exercise has been proposed as a non‐photic zeitgeber with a
positive impact on sleep and mood through its circadian effect. Some
studies suggest the effect of exercise on sleep can vary depending
on the intensity and timing of exercise, and light exposure. We
investigated whether the subjective and objective sleep quality dif-
fers according to the duration and timing of exercise in community
dwelling adults.
Methods: Participants were recruited from 3 Public Health Centers
in a rural area of Korea. The Beck depression inventory (BDI), Kor-
ean version of Morningness‐Eveningness Questionnaire (MEQ‐K),
Pittsburgh Sleep Quality Index (PSQI) and Short Form‐12 (SF‐12)
were administered. The exercise group (EG) was divided into EG ≤
1 h (one hour or less) and EG > 1 h (more than one hour) by its
duration, and into morning EG and afternoon EG by its timing. The
actigraphy (Actiwatch 2; Philips Respironics, Murrysville, USA)
recording was conducted at home for 7 days. Eighty five subjects in
the non‐exercise group (NEG) (60.0 ± 13.1 years), 69 in EG ≤ 1 h
(60.3 ± 11.3 years) and 30 in EG > 1 h (61.3 ± 14.7 years) were ana-
lyzed. The data were compared between the groups by ANCOVA
controlling for BDI scores. The p < 0.05 was defined as significant.
Results: Among the NEG, EG ≤ 1 h and EG > 1 h, there was no
difference in MEQ‐K and PSQI scores. The EG > 1 h had higher
physical component summary (PCS) scores from SF‐12 than the
NEG. There was no difference in sleep parameters among three
groups. The afternoon EG had no difference in PSQI and PCS/MCS
scores, and sleep parameters compared to the morning EG. Com-
pared to the morning outdoor EG, the afternoon outdoor EG
showed no difference in sleep parameters, but lower MEQ‐K and
PSQI scores.
Conclusions: The subjective and objective sleep quality was not
different according to the exercise duration in our study. However,
our finding suggests the exercise of longer duration would improve
the physical health‐related quality of life. And doing exercise in the
afternoon rather than morning could bring a better subjective sleep
quality.
Disclosure: Nothing to disclose.
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P432 | Patient's perception of comorbid
anxiety and insomnia: a qualitative approach
S.-E. Nadeau; A. Vallières; Y. Leanza
Université Laval, Québec, QC, Canada
Objectives/Introduction: Insomnia and anxiety are common
comorbid psychological disorders. Most of research and etiologic
models address them independently and do not discuss about the
context of the comorbidity. This qualitative study explores the per-
ception of patients who suffer from insomnia and anxiety.
Methods: Thirteen individual interviews (7 women, 6 men; mean
age 45) were conducted with patients after their psychological
assessment in a sleep clinic. The participants were diagnosed with an
insomnia disorder [ID] and had anxiety [A] causing significant clinical
distress or impairment functioning. Participants were asked to
describe their experience of the symptoms of ID and A (apparition,
course, maintenance, consequences, and help‐seeking). Interviews
were digitally recorded and transcribed. Interviews were analyzed
using thematic analysis with an interrater agreement procedure.
Results: Three salient themes emerged from this analysis: ‘ID and
A: a vicious circle’, ‘ID a fertile ground for A’, and ‘worrying instead
of sleeping’. First, participants reported that the disorders enable
each other's in a vicious circle. They explained that a lack of sleep
makes it harder to stay alert during the day. They added that the
stress from the extra effort needed to stay alert prevents them from
sleeping. Secondly, patients said they must cure their ID to have the
energy to solve their anxiety. Furthermore, patients observed that
fatigue caused by ID makes them more sensitive to external events
which enables their A. In all cases, the patients felt that their ID pre-
vents them to reach their personal goals and it makes them feel anx-
ious. Finally, patient reported having thought they developed an ID
because they were already A. They explained that trying to solve
problems, having thoughts racing through their mind, and question-
ing themselves at night prevent them to sleep well.
Conclusions: The results highlight the complexity of the relations
between ID and A. According to participants, these comorbid disor-
ders seem to be interrelated as they provoke, enhance or maintain
each other. Integrating results in further research could improve clin-
ical etiology models and favor a transdiagnostic approach to treat ID
and A.
Disclosure: Nothing to disclose.
P433 | The efficacy of cognitive and behavior
therapies for insomnia on daytime symptoms: a
systematic review and network meta‐analysis
F. Benz1; T. Knoop1; A. Ballesio2; V. Bacaro3; A. Johann1,4;
G. Rücker5; B. Feige1; D. Riemann1; C. Baglioni1,3
1Department of Psychiatry and Psychotherapy Medical Center,
University of Freiburg, Faculty of Medicine, Freiburg, Germany,
2Department of Psychology, Sapienza University of Rome, 3Department
TECOS, University G. Marconi of Rome ‐ Telematic, Rome, Italy, 4Medical
Psychology and Medical Sociology, University of Freiburg, Faculty of
Medicine, 5Institute for Medical Biometry and Statistics, Medical Centre,
University of Freiburg, Freiburg, Germany
Objectives/Introduction: Insomnia is a highly prevalent disorder
worldwide. Besides nocturnal symptoms, insomnia patients also
experience diurnal symptoms. In fact, diurnal symptoms are often
the reason insomnia patients seek help. Nevertheless, it is not clear
whether standard treatments for insomnia are effective on daytime
symptoms. The aim of this systematic review and network meta‐ana-
lysis is to provide evidence on the efficacy of cognitive and behavior
therapies for insomnia for daytime symptoms of insomnia.
Methods: PubMed, PsycINFO, PsycARTICLES, MEDLINE, CINAHL
and Web of Science were searched from 1987 (data of publication
of DSM‐III‐R) to March 2017 to identify randomized controlled trials
investigating the effect of cognitive and behavior therapies for
insomnia on daytime symptoms such as fatigue, sleepiness, quality of
life, mood disturbance and reduced cognitive functions. Eight classes
of treatments (behavioral or cognitive‐behavioral therapy for insom-
nia administered either face‐to‐face individually or in group setting
or through self‐help/internet) and 8 classes of control interventions
(waiting list, treatment as usual, active contact control, sleep hygiene
education, pharmacological interventions for insomnia or other con-
dition, pharmacological placebo, psychological placebo, behavioral
and psychological interventions) were identified in the network. Risk
of bias was assessed through the Cochrane Collaboration's Tool.
Cohen′s d at 95% confidence interval (CI) was calculated to assess
the effect sizes of each class as compared with waiting list.
Results: Fifty‐eight studies met inclusion criteria. Risk of bias
assessment indicated a possible high risk of attrition bias in our sam-
ple of studies. For fatigue as outcome, no significant effect was
found (for all comparisons in the network p > 0.05). Results showed
significant effects for self‐help cognitive‐behavioral therapy for
insomnia on quality of life (d = 0.25, 95% CI: 0.07; 0.42) and depres-
sive symptoms (d = ‐0.24, 95% CI: ‐0.45; ‐0.02) and individual face‐
to‐face behavioral therapy for insomnia on depressive symptoms
(d = ‐0.73, 95% CI: ‐1.45; ‐0.02).
Conclusions: Preliminary findings suggest potential effects of indi-
vidual face‐to‐face behavioral therapy on depressive symptoms and
potential effects of self‐help cognitive‐behavioral therapy on depres-
sive symptoms and quality of life.
Disclosure: Nothing to disclose.
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P434 | Neural correlates of cognitive control
functioning in individuals with insomnia disorder
C. Muscarella1; O. Mairesse1,2,3; G. Hughes4; D. Neu2; E. Van
den Bussche1
1Vrije Universiteit Brussel, 2Brugmann University Hospital, 3Royal
Military Academy (R.M.A.), Brussels, Belgium, 4University of Essex,
Colchester, United Kingdom
Objectives/Introduction: Individuals with insomnia disorder (ID)
commonly report associated complaints of cognitive functioning.
Conversely, both behavioral and neurological evidence supporting
subjective cognitive impairments in ID remain remarkably scarce and
inconclusive. To investigate this discrepancy, the present study used
next to behavioral measures, event‐related potentials (ERPs) to
assess proactive control (i.e., maintenance and updating of task‐rele-
vant information) and reactive control (i.e., interference monitoring
and resolution) in individuals with ID. ERPs will allow for a more sen-
sitive investigation of these proactive and reactive control processes,
which may be difficult to fully understand using only behavioral
measures.
Methods: Eighteen individuals with ID (mean age: 32 ± 11.36y,
83% women) and 15 good sleeper controls (GSC; mean age:
32 ± 10.94y, 87% women) completed the AX‐Continuous Perfor-
mance Task. This task required participants to maintain specific cue‐
information active in order to prepare an adequate response to a
subsequent probe.
Results: The results indicate that, although ID show a comparable
level of performance as GSC, they show a reduced proactive
engagement of cue‐induced maintenance and response preparation
processes (as reflected by the P3b (p < .05) and the contingent neg-
ative variation (p < .05) components. Moreover, in contrast to GSC,
ID fail to engage reactive control (as indexed by the N2 component
(p < .05)) in order to overcome invalid response tendencies.
Conclusions: As such, these findings advocate for neurological
impairments in cognitive control functioning in ID. Our study con-
tributes to a better understanding of the discrepancy between the
commonly reported cognitive impairments in ID and the scarce
objective evidence for these cognitive complaints.
Disclosure: Nothing to disclose.
P435 | Tracking nightly changes in pre‐sleep
cognitive arousal during sleep restriction therapy
L.F. Maurer; C.A. Espie; X. Omlin; S.D. Kyle
Nuffield Department of Clinical Neurosciences, University of Oxford/
Sleep and Circadian Neuroscience Institute, Oxford, United Kingdom
Objectives/Introduction: Although cognitive arousal before bed-
time is believed to account for the maintenance of insomnia, we
know little about how it is modified by the key components of cog-
nitive‐behavioral treatment for insomnia. Here, we profile nightly
changes in self‐reported pre‐sleep arousal during sleep restriction
therapy (SRT) for insomnia.
Methods: As part of an ongoing study, ten participants (5 male,
mean age = 38.1 ± 7.67) with insomnia disorder completed 5 cogni-
tive items from the pre sleep arousal scale (PSAS) every morning for
2 weeks before and 4 weeks during SRT. A linear mixed‐model anal-
ysis was conducted on the sum score of all 5 arousal items. Fixed
effects included time of the intervention (baseline = week 1‐2; early
treatment = week 3‐4; late treatment = week 5‐6) and random
effects were run to account for between‐subject variation.
Results: The completion rate for all arousal items was highly sat-
isfactory at 95.3%, yielding 428 data points (of a possible 449).
Linear mixed‐model analysis revealed significant results for the
time of the intervention on arousal (F (2, 416) = 5.13, p = .006).
Pairwise comparisons between time points yielded a significant
decrease in arousal from baseline (mean arousal = 10.72 ± 3.86)
to late treatment (mean arousal = 9.35 ± 3.88; p = .002), while
there was no significant decrease from baseline to early treatment
(mean arousal = 9.96 ± 3.92, p = .067) or from early to late treat-
ment (p = .197).
Conclusions: Our preliminary findings show that cognitive pre‐
sleep arousal diminishes during the course of SRT, and therefore,
reveals a potential mechanism of action for the treatment of insom-
nia by restricting time in bed.
Disclosure: Nothing to disclose.
P436 | Internet‐based CBT for insomnia in the
general population ‐ a description of design,
measurements and interventions in recent RCT
studies
S. Siebmanns1; M. Ulander2; J. Sandberg1; L. Johansson1;
P. Johansson3; A. Broström1
1Jönköping University, Jönköping, 2Department of Clinical
Neurophysiology, Linkoping University Hospital, 3Department of
Cardiology and Department of Medical and Health Sciences, Linkoping
University, Linköping, Sweden
Objectives/Introduction: Internet‐based cognitive behavioural
therapy for insomnia (ICBTi) has been proposed as an effective,
accessible, non‐pharmacologic treatment for insomnia disorder. The
objective was to perform a literature review of published random-
ized controlled trials (RCT).
Methods: Literature review. PubMed was used to identify RCTs of
ICBTi published since 2013. Keywords were insomnia, ICBT and
RCT. The search resulted in 40 hits. Papers with study designs and
methods not relevant to the objective were removed (n = 29). Rea-
sons for exclusion were: only study protocol, not internet‐based, and
results based on old data.
Results: Design: Recruitment were done via e‐mail, from websites,
online ads, and advertisements in local newspapers.
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Inclusion criteria: Six studies based their inclusion only on ISI score
(from >7 to >=15). 3 studies used a combination of ISI and DSM‐IV.
Two studies used DSM‐IV only.
Sample sizes: 4 studies had less than 100 participants, and 2 studies
over 200, the mean number was 139 participants (48‐303). The
mean age varied from 15 to 52 years. Significantly more female par-
ticipants in all studies.
Data collection: ISI combined with sleep diary was the most commonly
used primary or secondary outcome measurements (n = 7), 2 used ISI
only, and 2 used sleep diary only. Other common instruments were,
PSQI, HADS, DBAS‐16 and CES‐D. All studies had pre‐ and post‐treat-
ment measurements, but none during the intervention. The follow‐up
period varied between 8 weeks and 3 years. The most common follow‐
up time was 6 months (n = 4), with a range from 4 weeks‐3 years.
Intervention: Most of the studies (n = 10) used traditional ICBTi‐treat-
ments (i.e., stimulus control, sleep restriction, relaxation, sleep hygiene).
One study did not include stimulus control. The treatment duration
were six weeks (n = 8), eight weeks (n = 2) and nine weeks (n = 1). All
except one used therapist guided support.
Results: All studies showed significant post treatment improve-
ments on sleep outcomes.
Conclusions: All studies showed significant improvement with
regard to sleep. The total number of participants in the studies was
relatively low. Most studies are not based on clinical samples, which
may affect the generalizability of the findings.
Disclosure: Nothing to disclose.
P437 | “You can′t always get what you want”
‐ methodological challenges with an internet‐
based CBT intervention for insomnia among
patients with cardiovascular disease
S. Siebmanns1; M. Ulander2; J. Sandberg1; L. Johansson1;
P. Johansson3; A. Broström1
1Jönköping University, Jönköping, 2Department of Clinical
Neurophysiology, Linkoping University Hospital, 3Department of
Cardiology and Department of Medical and Health Sciences, Linkoping
University, Linköping, Sweden
Objectives/Introduction: Internet‐based cognitive behavioural
therapy for insomnia (ICBTi) is a frequently used intervention. Pub-
lished studies are promising, but methodological limitations (e.g.,
heterogeneity, low number of participants, unclear adherence to the
intervention) have been reported. The aim was to describe method-
ological challenges perceived in the Hit‐IT study, an ongoing ICBTi
study for patients with insomnia and cardiovascular disease (CVD).
The Hit‐IT study: Design: RCT with 1‐year follow‐up. All patients
with CVD (i.e., myocardial infarction, heart failure, atrial fibrillation
and angina) from 6 primary care centers are screened for insomnia
and during a clinical examination diagnosed according to DSM‐V cri-
teria.
Intervention: 9 weeks I‐CBTi (1‐week introduction, 2 weeks psy-
choeducation on CVD/insomnia, 6 weeks of sleep hygiene, stimulus
control and sleep restriction) vs 3 weeks internet‐based sleep
hygiene education.
Questionnnaires: Sleep (Pittsburg Sleep Quality Index, Insomnia
Severity Index, sleep diary), depressive‐ and cardiac symptoms
(Patient Health Qurestionnaire‐9, Cardiac Anxiety Questionnaire) and
Quality of Life (SF‐12) at baseline, during and after intervention
(after 6 and 12 months).
Methods: Interim analysis with descriptive statistics.
Results: Out of 2170 approached patients with diagnosed CVD
1508 (70%) responded (No=1330/Yes=178). Of the 178 approvals
(124 men/54 women), 54 did not complete internet‐based screening
(no e‐mail, declined participation and for unknown reasons). Of the
124 participants who completed screening, 40 (34 men/6 women,
age range 42‐84 years) were excluded (ISI < 8). In addition, 32 were
excluded after telephone contact and clinical examination (declined
participation n = 10, no clinical insomnia n = 14, sleep apnea n = 4,
restless legs n = 2, epilepsy n = 1, pharmacological side effect n = 1).
Currently 46 participants have been randomized in the Hit‐IT study
(15 females, 31 males, mean age 71 years/Range 41‐92 years). 19
participants have completed control group (1 dropout related to
technical problems, 3 in treatment). In the intervention group, 6 have
completed, 4 intentions to treat, 3 dropouts (n = 2 unknown reason,
n = 1 technical problems), 10 participants in treatment.
Conclusions: Clear methodological challenges with regard to the
strenuous patient inclusion process are identified. The current study
has a higher mean age and higher number of participating men than
current ICBTi studies in general population.
Disclosure: Nothing to disclose.
P438 | The association between insomnia,
stress reactivity and hyperarousal in women in
menopausal transition
O. Ballot; H. Ivers; C.M. Morin
Psychology, Laval University, Quebec, QC, Canada
Objectives/Introduction: Sleep difficulties are common during
the menopausal transition. Among the many biological and psycho-
logical factors contributing to sleep difficulties, stress reactivity and
hyperarousal are important risk factors in the general population.
This study examines the role of stress reactivity and arousal predis-
position as moderators of insomnia during the menopausal
transition.
Methods: Data for this study were derived from a longitudinal
study on insomnia. Participants for this study were 475 women aged
40 to 60 years who were divided into three age‐matched groups:
pre‐menopausal (n = 119) or post‐menopausal (n = 154) throughout
the five‐year follow up period, or in menopausal transition during
ABSTRACTS | 291 of 433
that same period (n = 202). Annual follow up were conducted over a
five‐year period, with participants completing questionnaires assess-
ing the quality of sleep (Pittsburgh Sleep Quality Index, PSQI), the
severity of insomnia (Insomnia Severity Index, ISI), the probability of
experiencing sleep difficulties in response to stress (Ford Insomnia
Response To Stress Test, FIRST) and predisposition to activation
(Arousal Predisposition Scale, APS). Linear mixed models using a con-
dition (3) x time (5) design were performed on the sleep variables.
To investigate moderation, a median score of 30 for APS or of 20
for FIRST at baseline was used to create APS and FIRST moderating
factors (low vs. high).
Results: A significant group (menopausal status) X time interaction
was found on the PSQI (p = .028) and ISI (p = .014). Simple effects
of menopausal status revealed that insomnia severity increased and
sleep quality decreased in the two years before and during the
menopausal transition (p < .05). In addition, no significant differences
of the moderator X group X time interaction were observed for the
ISI (p = .489 and p = .781, respectively) or the PSQI (p = .962 and
p = .313, respectively) according to APS or FIRST clinical levels at
baseline.
Conclusions: These results suggest that sleep disturbances and
insomnia severity increase during the menopausal transition and
become more important during menopause. However, stress reactiv-
ity or arousal predisposition do not seem to moderate the relation-
ships between menopause status, time and these sleep disturbances.
Disclosure: This study was supported by Canadian Institutes of
Health Research grant (MOP42504 and B0512201). It was not an
industry supported study. OB and HI have no conflict of interest to
disclose. C.M. Morin has received honorarium to serve as a consul-
tant on an advisory board for Philips and as speaker for Merck.
P439 | Racing thoughts in insomnia are
associated with insomnia severity and mood
instability: towards a better characterisation of a
key clinical symptom
L. Weiner1; N. Ramos-Siegel2; G. Gurcai3; P. Ossola4;
S. Weibel1; G. Bertschy1; P. Bourgin2; Ü. Kilic-Huck2
1University Hospital of Strasbourg, INSERM 1114, 2University Hospital
of Strasbourg, Neurology Department, CNRS ‐ UPR 3212, 3Psychology
Department, University of Strasbourg, Strasbourg, France, 4University of
Parma, Parma, Italy
Objectives/Introduction: To our knowledge, racing thoughts, usu-
ally described in manic episodes of bipolar disorder (BD), have never
been specifically assessed in patients with primary insomnia, despite
being a common hyperarousal symptom reported by patients, espe-
cially at bedtime. We investigated racing thoughts in patients with
insomnia compared to healthy controls and manic patients with BD,
and assessed the relationship between racing thoughts, affective
temperaments, and insomnia severity.
Methods: 62 patients with primary insomnia, 119 controls, and 53
manic BD patients filled out the Racing and Crowded Thought Ques-
tionnaire (RCTQ; Weiner et al., 2018), a 34 item self‐report scale
(range 0 to 136). Circadian variability of racing thoughts was
assessed via a Likert scale. Insomnia severity was assessed via the
Insomnia Severity Index (ISI; Bastien et al., 2001), and affective tem-
peraments, including cyclothymia, dysthymia, and anxiety, were
investigated via the TEMPS‐A (Akiskal et al., 2005).
Results: RCTQ score was higher in patients with insomnia com-
pared to controls (48.21 vs. 12.00; p < .001), and similar that of
manic patients (49.92, ns). Patients with insomnia reported that rac-
ing thoughts were more severe in the evening and at bedtime
(p < .001). Moreover, in insomnia, RCTQ score was positively corre-
lated with ISI scores (r = .34, p < .05), and cyclothymic temperament
scores of the TEMPS‐A (r = .34, p < .05).
Conclusions: Self‐reported racing thoughts are an important clini-
cal feature of primary insomnia, higher than in controls, and similar
to those reported by manic patients with BD. Yet most studies
focusing on the thinking patterns involved in insomnia have only
considered rumination and worry, linked to depressive and anxious
mood, which are respectively more prominent in daytime and in the
evening (Carney et al., 2010). Our results are the first to suggest that
racing thoughts are part of the clinical picture of insomnia, and that
they are associated with mood instability of the cyclothymic kind in
these patients. Future studies should further address racing thoughts
in patients with insomnia to determine whether they are related to a
specific phenotype linking insomnia and BD vulnerability.
Disclosure: Nothing to disclose.
P440 | Evaluation of Insomnia among workers
of a cast iron factory
M. Saraei1,2; A. Najafi2; H. Masoudi2
1Center for Research on Occupational Diseases (CROD), 2Occupational
Sleep Research Center, Baharloo Hospital, Tehran University of Medical
Sciences, Tehran, Islamic Republic of Iran
Objectives/Introduction: Integrating sleep medicine in occupa-
tional settings and further attention towards this important issue is
required in different industries, especially those with various occupa-
tional exposures. Sleep problems such as insomnia lead to decreased
performance and productivity and increased workplace accidents.
However, limited studies are conducted to evaluate sleep problems
among industries with multiple hazardous occupational exposures.
This study aimed to assess insomnia among workers of a smelting
factory.
Methods: All workers of a smelting factory, producing cast iron,
were recruited in this cross‐sectional study. After obtaining consent
form, participants completed a questionnaire including demographic
information and a validated Insomnia Severity Index (ISI) question-
naire. Insomnia was categorized to subthreshold, moderate, and
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severe based on ISI score. Data analysis was performed by using
descriptive statistics.
Results: A total of 200 participants were evaluated. All workers
were male and mean (SD) of age was 39.1 (8.9) years. Smoking was
reported by 72 (36%) of workers. Workers’ shift was from 6AM to
5PM. Ninety (45%), 15 (7%), and 3 (1%) of workers had subthresh-
old, moderate, and severe insomnia, respectively. Married workers
and the ones with higher education (diploma and upper) were more
likely to have subthreshold and moderate insomnia, 69 (76.7%) and
10 (66.7%) vs. 26 (28.9%) and 3 (20%), respectively. Sixty three
(31%) of participants had early morning awakening and maintenance
insomnia and 15% reported initial insomnia.
Conclusions: High proportion of workers in studied smelting fac-
tory had insomnia. Further evaluation of associated sleep disorders
and comprehensive assessment of hazardous occupational exposures
including metal fumes, solvents, and shift work schedules with
appropriate interventions seem warranted.
Disclosure: Nothing to disclose.
P441 | Searching for paradoxical insomnia
D. Neutel1; C. Reis1,2; T. Alvarenga1; T. Paiva1
1CENC ‐ Sleep Medicine Center, 2ISAMB ‐ Medical Faculty of Lisbon,
Lisbon, Portugal
Objectives/Introduction: To compare the polysomnographic
macrostructure data in insomnia and paradoxical insomnia patients
and to evaluate their misperception/Among insomnia patients there
is a group characterized by all the clinical complaints of insomnia,
although without objective changes in the polysomnography parame-
ters called paradoxical insomnia. Sleep misperception (SM), a key
feature of insomniacs with particular dimension in paradoxical insom-
nia, remains quite unexplained.
Methods: The retrospective cohort study (n = 332) included: 276
patients (65.9% of women; mean of 47.3 ± 14.8 years age) with the
clinical diagnosis of insomnia and 56 patients (75.4% of women;
mean of 40.9 ± 13.2 years age) with paradoxical insomnia. All
patients performed a polysomnographic (PSG) study type I. The ana-
lyzed variables were the PSG data. To evaluate SM three formulas
were used based on objective and subjective total sleep time
(Δdelta=objectiveTST‐subjectiveTST; index=objectiveTST‐subjecti-
veTST/objectiveTST and coefficient=objectiveTST/subjectiveTST).
Student t‐test or Mann‐Whitney, was used according to data distri-
bution; significance was settled at p ≤ 0.05. Variables presenting sta-
tistical differences in both groups, logistic regression models were
tested in order to determine if some of these parameters could be
associated to the different misperception indexes used.
Results: Most of the PSG parameters were different between
groups (p < 0.05) (exception of N3, N2 percentages and mean heart
rate). The subjectiveTST was 228.56 ± 105.61 min for insomnia and
326.86 ± 118.36 min for paradoxical insomnia (p = 0.003).
Concerning the three formulas analyzed for SM no differences were
found between groups. For all variables presenting statistically signif-
icant difference a regression model was performed. In the Insomnia
group Δdelta was explained by the TST (p < 0.001) and by sleep
efficiency (p < 0.05); there was no association with the index; the
coefficient was explained by sleep efficiency (p < 0.003). In paradox-
ical insomnia group there was no association between any misper-
ception measures and PSG parameters.
Conclusions: Sleep misperception does not influence the diagnosis
of insomnia and paradoxical insomnia. In spite of similar measures of
misperception in both groups, paradoxical insomnia demonstrated
higher subjective sleep time. For insomniacs associations between
misperception and PSG were found; this was not the case for para-
doxical insomnia, what implies the need of future research. From our
data paradoxical insomnia is a clear‐cut entity.
Disclosure: Nothing to disclose.
P442 | Sleep quality in shift workers of
offshore petroleum industry
K. Sadeghniiat Haghighi1; O. Aminian2; A. Zahabi1; A. Najafi1;
A. Rahimi-Golkhandan1
1Occupational Sleep Research Center, Baharloo Hospital, 2Occupational
Medicine Department, Tehran University of Medical Sciences, Tehran,
Islamic Republic of Iran
Objectives/Introduction: Shift work especially night work has
negative outcomes for workers, their families, and relevant organiza-
tions. Working at night is associated with shortened and disturbed
sleep, daytime sleepiness, fatigue, impaired performance, and
increased risk of accidents. In this study we aimed to evaluate sleep
quality in Iranian workers of offshore drilling rigs.
Methods: One hundred and ninety‐two offshore workers of two
oil rigs were enrolled in this cross sectional study. They were asked
to fill out the validated and reliable Persian version of Pittsburg sleep
quality index (PSQI). Data regarding age, marital status, and educa-
tion level, smoking, the shift work schedule, and BMI (Body Mass
Index) were recorded.
Results: The Mean age and mean work experience of the partici-
pants were 37 ± 9.3 and 10 ± 8.6 years, respectively. Fifty‐six
(29.2%) of participants were fixed day shift workers, 111 (57.8%)
were swing shift workers (7 days/7nights), 6 (3.1%) were fixed night
shift workers and 19 (9.9%) were standby shift workers. Mean PSQI
score of all workers was 6.73 ± 3.61. In 69% of subjects, total score
of PSQI was ≥ 5. Night shift workers had greater score of PSQI than
other three groups of shift workers.
Conclusions: This study showed that more than half of oil rig
workers had poor sleep quality and the mean PSQI score was higher
in fixed night shift workers. This warrants comprehensive evaluation
of studied participants in sleep clinic setting.
Disclosure: Nothing to disclose.
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P443 | Insomnia and cognitive function in
older adults: a cross‐sectional analysis of the
Canadian Longitudinal Study on Aging
N. Cross1,2; F. Chouchou1,2; N. Gosselin1,3; J. Carrier1,3;
C. Thompson3; R. Postuma4; T.T. Dang-Vu1,2,5
1Institut Universitaire de Gériatrie de Montréal et CRIUGM, 2PERFORM
Centre, Concordia University, 3Center for Advanced Research in Sleep
Medicine, Hospital du Sacre‐Coeur, 4Division of Neurology, McGill
University, 5Département de Neurosciences, Université de Montréal,
Montreal, QC, Canada
Objectives/Introduction: Mounting evidence suggests that dis-
turbed sleep in later life may contribute to cognitive decline and
dementia. While insomnia has been associated with deficits in mem-
ory and executive function, these relationships in older adults are
still unclear as previous research has been mainly conducted in small
samples, have not accounted for medical comorbidities associated
with insomnia, or have not assessed insomnia symptoms specifically.
This study aimed to examine the association between insomnia and
cognitive function in a large nationally representative dataset of
older adults. We hypothesised that insomnia shares unique relation-
ships with memory and executive function independent of other
health and lifestyle factors.
Methods: 28,612 participants >45 years completed the baseline
assessments of the Canadian Longitudinal Study on Aging. These
assessments included health questionnaires, physical examinations,
and neuropsychological testing by a trained interviewer. An 8‐ques-
tion instrument was administered to assess participants’ sleep habits
and detect insomnia symptoms. Insomnia was defined as sleep onset
>30 min (early insomnia) and/or waking during the night or early
morning (late insomnia) for more than 3 times per week, in concur-
rence with interference in daily functioning. The associations
between insomnia and cognitive performance (across declarative
memory, executive function and psychomotor speed) were examined
with general linear regression models to obtain adjusted means and
95% confidence intervals. Bonferonni adjustment for multiple com-
parisons was applied to all models.
Results: Insomnia was identified in 1,202 subjects (4.2% of the
whole sample). Analyses adjusting for age, sex, education, body mass
index, as well as lifestyle factors and comorbidities associated with
insomnia (e.g. hypertension, depression) demonstrated that those with
insomnia performed worse on tests of memory (Rey Auditory Verbal
Learning Test, 3.6 vs 3.9 words, p < 0.001) and executive function
(Mental Alternation Test, 25.9 vs 24.6 s, p = 0.001). These remained
significant even when adjusting for sleep duration. There were no dif-
ferences in cognitive performance across insomnia subtypes.
Conclusions: These findings indicate that insomnia in older adults
is associated with worse cognitive functioning, even when account-
ing for comorbidities and sleep duration. Future longitudinal analyses
are warranted to assess whether insomnia is associated with
prospective changes in cognitive function.
Disclosure: Nothing to disclose.
P444 | Chronic insomnia in morning and
evening persons, and short and long‐term effects
of unguided internet‐based cognitive behavior
therapy for insomnia
M. Lien1; E. Bredeli1; B. Sivertsen2; H. Kallestad3;
S. Pallesen1; Ø. Vedaa2,3
1University of Bergen, 2Norwegian Institute of Public Health, Bergen,
3Norwegian University of Science and Technology, Trondheim, Norway
Objectives/Introduction: Internet‐delivered Cognitive Behavior
Therapy for Insomnia (CBT‐I) has shown promising effects for people
in need of treatment for insomnia, albeit more research is needed to
identify those who might not benefit from such treatment. The aim
of the present study was to investigate if morning and evening per-
sons with chronic insomnia responded differently to internet CBT‐I.
Methods: Adult patients (N = 95; mean age=45.0 [SD=12.4],
64.2% female) with insomnia were offered internet CBT‐I lasting for
9 weeks (Sleep Healthy Using the Internet [SHUTi]), and were
assessed with sleep diaries, the Insomnia Severity Index (ISI), the
Bergen Insomnia Scale (BIS) and the Dysfunctional Beliefs and Atti-
tudes about Sleep Scale (DBAS‐16), the Hospital Anxiety and
Depression Scale (HADS) and Chalder Fatigue Questionnaire (CFQ).
Patients were characterized as morning or evening persons based on
a median split of the Horne‐Östberg Morningness Eveningness
Questionnaire. Short (9 weeks) and long‐term (18 months) effects of
treatment were examined with mixed model repeated‐measures
analyses.
Results: The two groups did not differ in terms of age, gender or
educational status. At baseline, morning persons had more wake
time after sleep onset (WASO, d = 0.62, p < .01), and evening per-
sons had longer sleep onset latency (SOL, d = 0.60, p < .01), com-
pared to each other. Results showed a significant group × time
effect of WASO to posttreatment, whereas no effects were
observed on any of the other outcomes. ISI scores were reduced
from 17.4/17.3 (morning/evening persons) at baseline to 9.1/8.5
(Cohen dpre-post=2.33, p < .001/dpre-post=2.47, p < .001) for post, and
remained relatively stable at 10.7/8.5 at 18‐month follow up (dpre-
post18 m=1.88, p < .001/dpre-post18 m=2.45, p < .001). Similar results
were found on the BIS, DBAS, HADS, CFQ and sleep diary data.
Conclusions: Despite different insomnia symptomatology across
the two groups at baseline, the current study suggests that internet
CBT‐I is an effective treatment irrespective of a persons placement
along the morningness‐eveningness dimension.
Disclosure: Nothing to disclose.
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P445 | Smartphones may serve as efficient
sleep therapists
A. Baharav1,2; S. Eyal1; K. Niejadlik3
1HypnoCore, Petach Tiqva, 2Wingate Institute, Netania, Israel, 3Aetna,
Hartford, CT, United States
Objectives/Introduction: Insomnia is highly prevalent and is asso-
ciated with daytime impairment and secondary morbidities. The
widely recommended and efficient Cognitive Behavioral Therapy for
Insomnia remains inaccessible to most sufferers. We present a
mobile application solution that provides digital e‐coaching for
insomniacs who seek self‐help solutions.
Methods: 250 subjects with Insomnia complaints and a PSQI over
8 were offered the SleepRate app that consists of a first week of
information gathering to allow for evaluation, including sleep ques-
tionnaires, nightly sleep diary providing subjective data, objective
measures derived from a wearable device, and reported sleep related
habits. This week is followed by weekly cycles of e‐coaching that
implement standard protocols of cognitive behavioral therapy aiming
to realign sleep drive and biological clock, reduce hyperarousal,
improve sleep related habits, and provide sleep education.169 sub-
jects completed the first assessment week. All complained of difficul-
ties falling asleep, or being awake at night, early awakenings, or non‐
refreshing sleep. 96 of those met the criteria of having longer than
30 min average Sleep Onset (SO, N = 36), Wake After Sleep Onset
(WASO, N = 26), or both long SO and long WASO (N = 17). 32 sub-
jects had also Sleep Efficiency (SE) lower than 85%; 90 had normal
average SO, WASO and SE, with several abnormal nights.
Results: 69% of the 169 who completed the first week, completed
therapy and got their end of therapy report. Statistical analysis was
performed using paired t‐test between first week, and end of ther-
apy. Average SO decreased significantly in all (p < 0.01) from
28.16 min to 21.12 min, more if initial SO was high, from 60.66 to
30.91. Same findings for WASO: decreased from 21.16 min to
17.41 min in all, and from 47.77 to 24.70 in those with initial high
average WASO. SE improved more in those with abnormal SE.
Conclusions: Digital CBTi using a mobile application proved to be
an efficient aid for people affected by Insomnia, and the improve-
ment is larger when the initial complaints are worse. The main chal-
lenge remains engagement and compliance with the guidance
provided by an e‐coach.
Disclosure: A Baharav, S Eyal work at HypnoCore, a company that
has developed the SleepRate solution.
P446 | The genetic liability for insomnia is
associated with the number of awakenings
during sleep in young and healthy individuals
P. Ghaemmaghami1; V. Muto1,2; M. Jaspar1,2,3; C. Meyer1,2;
M. Elansary4; M. Van Egroo1; C. Berthomier5; E. Lambot1,2;
M. Brandewinder5; A. Luxen1; C. Degueldre1; E. Salmon1,3,6;
S. Archer7; C. Phillips1,8; D.-J. Dijk7; P. Visscher9;
D. Posthuma10; E. Van Someren10; F. Collette1,3;
M. Georges4; P. Maquet1,2,6; G. Vandewalle1,2
1GIGA‐Cyclotron Research Centre‐In Vivo Imaging, University of Liege,
2Walloon Excellence in Life Sciences and Biotechnology (WELBIO),
3Psychology and Cognitive Neuroscience Research Unit, 4GIGA‐Medical
Genomics, University of Liege, Liege, Belgium, 5PHYSIP SA, Paris, France,
6Department of Neurology, University Hospital of Liège, Liege, Belgium,
7Surrey Sleep Research Centre, University of Surrey, Guildford, United
Kingdom, 8GIGA‐In Silico Medicine, University of Liege, Liege, Belgium,
9Institute for Molecular Bioscience, University of Queensland, Brisbane,
QLD, Australia, 10Netherlands Institute for Neurosciences, Amsterdam,
the Netherlands
Objectives/Introduction: Identifying risk factors for insomnia in
individuals that are likely to develop insomnia is needed to develop
prevention strategies. Novel genetic tools using results of large case‐
control genome wide association studies (GWAS) allow to predict the
liability for complex diseases based on full‐genome common genetic
variations. Here, we applied such tools to assess the link between the
genetic liability of developing insomnia and sleep phenotypes in
young and healthy adults not reporting any sleep complain.
Methods: Electroencephalography was recording during 8 hr base-
line sleep in 200 healthy young male volunteers with normal sleep
(aged 22.07 years ± 2.71). Sleep architecture, the percentage and
latency of each sleep stage, and the total number, hourly rate and
mean duration of awakenings were extracted from automatic sleep
scoring (Aseega, Physip). Blood samples were collected in all partici-
pants to assess common Single Nucleotide Polymorphisms (SNPs)
over the entire genome. Individual liability for insomnia was com-
puted based on whole genome SNPs using the summary‐statistics of
a case‐control GWAS seeking for genetic determinants of insomnia
(Hammerschlag et al. Nat Genet 2017;49:1584‐1592, https://ctg.cnc
r.nl/software/summary_statistics).
Results: Generalized linear mixed model reveal significant associa-
tions of one′s genetic risk score for insomnia with the total number
(r = −0.23, p = 0.004) and hourly rate (r = −0.25, p = 0.002) of
awakenings: higher liability for insomnia was associated with less
awakenings. Although not significantly, increased liability for insom-
nia was positively associated with mean duration of awakening
(r = 0.13, p = 0.06), suggesting insomnia liability is associated with
less awakenings of longer duration. The associations remain signifi-
cant after adjusting for age. In fact, the genetic liability for insomnia
was also significantly associated with age despite the limited age‐
range of our young sample (r = −0.18, p = 0.008). Association with
other sleep metrics were not significant.
Conclusions: These results show that individual genetic liability for
insomnia is linked to macroscopic sleep fragmentation as indexed by
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awakenings during sleep in young and healthy individuals. Further
analyses will consider other aspects of sleep in a larger sample. Iden-
tification prior to disease onset could help identifying novel preven-
tion targets for insomnia.
Disclosure: FNRS, ULiège, ARC, FEDER, Welbio, FMRE, Clerdent
Foundation.
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P447 | Serum of narcolepsy type 1 patients
does not decrease hypocretin receptor 2
function
M. Schinkelshoek1,2; R. Fronczek1,2; Y. Kooy-Winkelaar3;
J. Hamberg1; K. Kamstra1; N. Struckman1; S. Michel4;
G.J. Lammers1,2
1Neurology, Leiden University Medical Center, Leiden, 2Sleep‐Wake
Centre, Stichting Epilepsie Instellingen Nederland, Heemstede,
3Immunohematology and Blood Transfusions, 4Cell and Chemical Biology,
Leiden University Medical Center, Leiden, the Netherlands
Objectives/Introduction: The loss of hypocretin‐producing neu-
rons leading to narcolepsy type 1 is suggested to be caused by an
immune response. Even though several studies in narcolepsy type 1
patients found autoantibodies targeting molecules that are moder-
ately specific for hypocretin‐producing neurons, such as Tribbles
homolog 2, or the hypocretin receptor 2, the functional effect of
these antibodies is not clear. Therefore, we assessed the effect of
narcolepsy type 1 patient serum on hypocretin receptor 2 function-
ing.
Methods: Chinese hamster ovary cells transfected with a human
hypocretin receptor 2 were incubated with serum from narcolepsy
type 1 patients and healthy controls. Hypocretin‐1 was subsequently
administered to the incubated cells and intracellular Ca2+ concentra-
tion was measured using flurorescence microscopy and dedicated
imaging software. Administration of ATP was used as a positive con-
trol. Ratios of Ca2+ concentration upon hypocretin‐1 and ATP admin-
istration was used for standardisation of the results.
Results: 9 narcolepsy type 1 patients and 9 sex‐ and age‐matched
healthy controls were included in this study. Mean hypocretin‐1/ATP
ratios were 1.47 ± 0.76 in experiments with narcolepsy type 1 serum
and 1.05 ± 0.56 in those with healthy control serum. Mann‐Whitney
U‐tests showed no significant differences between both groups.
Conclusions: An effect of narcolepsy type 1 patient serum on
hypocretin receptor 2 functioning could not be demonstrated. These
results do not support the hypothesis that hypocretin receptor 2‐
specific antibody‐mediated auto‐reactivity is present in narcolepsy
type 1 patients. Future research on the possible role of autoantibod-
ies to hypocretin receptor 2 in the development of narcolepsy type
1 is warranted.
Disclosure: Nothing to disclose.
P448 | Sleep‐state and dream perception in
sleep disorders
M. Schinkelshoek1,2; K. de Wit1; V. Bruggink1;
R. Fronczek1,2; G.J. Lammers1,2
1Neurology, Leiden University Medical Center, Leiden, 2Sleep‐Wake
Centre, Stichting Epilepsie Instellingen Nederland, Heemstede, the
Netherlands
Objectives/Introduction: Sleep‐state misperception is a common
phenomenon among primary insomnia patients with a prevalence
ranging between 9.2 and 50%. In obstructive sleep apnea, inverse
sleep‐state misperception has been reported. These studies depend
on polysomnography measures for the identification of sleep‐state
misperception and predicting patient‐related factors. We assessed
factors influencing sleep‐state perception during the 20‐min naps of
a multiple sleep latency test.
Methods: In this prospective observational study, 247 consecutive
patients undergoing a routine multiple sleep latency test between
March 2014 and October 2017 in SEIN Heemstede, a tertiary sleep‐
wake centre in the Netherlands, were included. Sleep and dream
perception was assessed by questionnaires after each nap. Mixed
models were applied to assess the influence of patients’ clinical data
on sleep‐state and dream perception.
Results: Patients fell asleep in 82.3% of nap opportunities. Patients
reported to have slept in 72.8%. A lower age (β = −0.042/years ±
0.017; p = 0.014), the occurrence of N2 stage sleep
(β = 2.106 ± 0.842; p = 0.012) and a shorter sleep onset latency
(β = −0.225/min ± 0.052; p < 0.001) were significant predictors for
correct sleep‐state perception. Sleep diagnosis did not predict cor-
rect sleep‐state perception (p = 0.575). In 28.0% of naps in which
patients did not reach REM sleep, patients reported to have
dreamed. On the contrary, patients reported not to have dreamed in
26.4% of naps in which REM sleep did occur. Dream perception per-
centage was not significantly different between diagnosis categories.
Conclusions: Sleep‐state perception is better in younger patients
with shorter sleep onset latencies during a nap in which N2 sleep
occurred. Sleep‐state perception does not differ between sleep diag-
nosis categories during the short naps of the multiple sleep latency
test. Notably, the perception of dreaming is influenced by, but defi-
nitely not limited to the occurrence of REM sleep.
Disclosure: Nothing to disclose.
P449 | Personality traits in subjective
perception of hypersomnolence
E. Miletinova1; J. Kostalova1,2; M. Bergerova1; J. Buskova1,2
1National Institute of Mental Health, Klecany, 2Third Faculty of
Medicine, Charles University in Prague, Prague, Czech Republic
Objectives/Introduction: In hypersomnia patients, many factors
seem to contribute to their subjective perception of daytime
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sleepiness. Our aim was to investigate potential effect of specific
personality traits, assessed by Temperament and Character Inventory
(TCI), in particular novelty seeking (NS), harm avoidance (HA) and
persistence (PS) on subjective perception of daytime sleepiness,
assessed by Epworth sleepiness scale (ESS) in hypersomnia patients.
Methods: Our exclusion criteria included all sleep comorbidities
that could contribute to daytime sleepiness, such as sleep apnea or
periodic leg movements in sleep. We also excluded all narcolepsy
type 1 patients or severely depressed participants (assessed by Beck
Depression Inventory; BDI). After applying these criteria, we investi-
gated 21 hypersomnia patients (14 females, mean age = 35.8 years,
SD = 11.4; BMI = 24.3, SD = 4.5; mean ESS score = 16.14, SD =
4.3). In order to objectively assess sleepiness, we performed Multi-
ple sleep latency test, which revealed mean sleep latency of 7.2 min
(SD = 4.3). Mean BDI score was 11.5 points (SD = 9.0). We firstly
calculated frequencies of scores in TCI domains that fell within the
normal limits (15–85th percentile). Secondly, we analysed the corre-
lations between these traits and BDI and ESS scores, adjusted for
age.
Results: From our participants, NS fell within the normal limits in
61.9%, HA in 52.4% and PS in 66.7% of cases. We found only a
negligible relationship between ESS and NS (Pearson's r = −0.097;
p = 0.683) and weak negative relationship between ESS and HA
(Pearson's r = −0.279, p = 0.234) and ESS and PS (Pearson's
r = −0.284, p = 0.224), all of which were non‐significant. However,
we found statistically significant strong negative relationship
between ESS and BDI (Pearson's r = −0.479, p = 0.033). Further-
more, we found statistically significant strong positive relationship
between BDI and HA (Pearson's r = 0.0.445, p = 0.0.043).
Conclusions: We conclude, that specific temperament dispositions,
such as novelty seeking, harm avoidance or persistence do not have
a major impact on perception of daytime sleepiness in hypersomnia
patients. However, temperament might contribute to other aspects
of psychological well‐being, such as subjective perception of depres-
sion in this cohort. Thus, considering particular personality traits
could be useful in adjusting specific personally‐tailored psychothera-
peutic forms of treatment.
Disclosure: Nothing to disclose.
P450 | Disturbed nighttime sleep in patients
with central disorders of hypersomnolence
R. Wix Ramos1,2,3; M. Macario Argueta1; S. Delis Gómez1;
E. Rocio Martinez1
1Clinical Neurophysiology, Hospital ‘La Princesa’, 2Neurology, HM
‘Puerta del Sur’, 3Neurology, HM ‘Sanchinarro’, Madrid, Spain
Objectives/Introduction: Narcolepsy type 1 (NT1), narcolepsy
type 2 (NT2) and idiopathic hypersomnia (IH) are central disorders of
hypersomnolence where the main complaint is the inability to stay
awake and alert, are not better explained by others causes.
Describe demographic data and compare the clinical spectrum,
including psychological tests and PSG‐MSLT parameters of patients
diagnosed as NT1, NT2 or IH in our center.
Methods: 40 consecutive patients diagnosed with NT1, NT2 or IH.
Demographic and anthropometric data [body mass index (BMI) non‐
obese <30 kg/m2, obese ≥30 kg/m2]; scores on sleep‐questionnaires
[Epworth Sleepiness Scale (ESS) {no EDS ≤10, mild (11–15), severe
(≥16)}; positive Ullanlinna Narcolepsy Scale (UNS) (≥14); Insomnia
Severity Index (ISI) to evaluate the presence of disturbed nighttime
sleep (DNS) {no insomnia/subthreshold (0–14), moderate‐severe
(≥15)}]; psychological tests [Beck depression inventory (BDI‐II) {no‐
mild ≤19, moderate‐severe (20–63)}; the state‐trait anxiety inventory
(STAI) considered positive above 50th percentile]. We also looked
HLA results. Parameters were obtained from a diagnostic nocturnal
PSG‐MSLT reports recorded in drug‐free patients.
Results: From our cohort, 8 were diagnosed as NT1, 17 as NT2
and 15 as IH. Sex distribution was 25 females and 15 males. Obesity
was present in 12.5% of NT1 category, 0% NT2 and 20% IH. About
sleep questionnaires, 100% of the patients reported EDS as mild to
severe (ESS: 18.8, 15.5, 16.6). UNS was higher in NT1 (p < 0.001).
DNS measure trough ISI show moderate‐severe insomnia in 88% of
NT1 group, 33% NT2 and 60% IH. In terms of psychological tests,
38% of the cohort who score for moderate‐severe depression was
from NT1 group and 12% from NT2 and 13% IH. Anxiety state/trait
in NT1 was (25 and 25%), NT2 (28 and 14%) and IH (20 and 50%).
The percent of positive HLA was higher in NT1 (100, 33, 33%).
Wake after sleep onset was higher in NT1 (p = 0.043). No statisti-
cally significant differences were observed in others parameters as
sleep efficacy, sleep latency, change of phases or proportion of dif-
ferent stages of sleep. 25% of NT1 had severe obstructive sleep
apnea.
Conclusions: Disturbed nighttime sleep is common in patients with
central disorders of hypersomnolence.
Disclosure: Nothing to disclose.
P451 | The role of emotion regulation in
narcolepsy with cataplexy
M. Opwis1; U. Kallweit2,3; A. Triller3; M. Dohr1;
W. Pollmann1; C. Salewski1
1Department of Psychology, FernUniversität Hagen, 2Institute for Sleep
Medicine, Universität Witten‐Herdecke, 3Neurology, Helios Klinik Hagen‐
Ambrock, Hagen, Germany
Objectives/Introduction: Narcolepsy with cataplexy (NC) is a
neurological sleep disorder characterized by irresistible daytime
sleepiness and a sudden loss of muscle tone triggered by strong
emotions (cataplexy). Psychiatric disorders such as depression are
frequent comorbidities. While this makes the role of emotion regula-
tion (ER) essential in this clinical condition, surprisingly little is known
about ER in patients with NC. The purpose of this study is to
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explore the use of different ER strategies in NC‐patients and their
associations with mental health.
Methods: Forty‐one NC‐patients (31f, age: 35.4), 42 patients with
stress‐related sleep disorders, mainly insomnia (37f, age: 37.1), and
48 healthy controls (37f, age: 36.6) completed questionnaires on ER
strategies and mental health outcomes. ANOVAs with Bonferroni
corrected post‐hoc tests were performed.
Results: In contrast to the other groups, NC‐patients showed sig-
nificantly impaired mental health (p < 0.001). At the same time, NC‐
patients reported some enhanced ER skills, like significantly less self‐
blame (p = 0.045), more acceptance (p = 0.003) and by trend less
rumination (p < 0.084). In contrast to the two control groups, some
maladaptive strategies, like emotional suppression, were not related
to negative mental health outcomes in NC‐patients.
Conclusions: NC‐patients may improve their ER‐skills to cope with
the disease. However, this does not protect them against depression
or decreased quality of life. Moreover, the associations between mal-
adaptive ER strategies and mental health seem to have some unique
variations in NC, probably due to the functionality of suppressing
emotions. As adaptive ER is a core feature for coping with chronic
diseases, disease‐specific patterns should be further explored and
considered in psychological NC treatments.
Disclosure: Nothing to disclose.
P452 | Anterior hippocampus volume loss in
narcolepsy with cataplexy
V. Nemcova1; M. Křečková1; D. Kemlink2; K. Šonka2;
J. Krásenský3; J. Buskova2,4; M. Vaněčková3
1Institute of Anatomy, 1st Medical Faculty, Charles University in Prague,
Praha, 2Department of Neurology and Centre of Clinical Neuroscience,
Charles University in Prague, First Faculty of Medicine Dep. of
Neurology, 3Department of Radiology, Charles University, First Faculty of
Medicine and General, Prague, 4National Institute of Mental Health,
Klecany, Czech Republic
Objectives/Introduction: Narcolepsy with cataplexy (NC) is a life-
long disease due to the loss of hypocretin neurons in the hypothala-
mus but the structural changes are not limited to the hypothalamus.
We previously revealed an overall hippocampal volume loss in NC.
The aim of this study is to measaure the volume loss of the anterior
and posterior part of the hippocampus in NC patients.
Methods: In total 48 patients with NC and in 37 controls were
examined on the same 1.5 T MR scanner, the measurement was car-
ried out as T1W 3D image with the slice thickness of 1.0/0 mm.
Manual MRI hippocampal volumetry was performed using manual
delineation in ScanView programme. Only subjects with HLA
DQB1*06:02 allele positivity were included. Subjects with brain
morphological abnormaities and with any severe neurological or psy-
chiatric comorbidities were excluded.
Results: There was a significant absolute loss of the total volume
of the anterior hippocampus (sum of left and right) in NC patients as
compared to the controls (10.5%, p = 0.03 ANCOVA after correction
for total brain volume and multiple testing). Related to the total brain
volume: right anterior hippocampus was 6.2% smaller in NC patients
(p = 0.09), left anterior hippocampus was 6.8% smaller (p = 0.04).
We found a negative correlation between the total anterior hip-
pocampus volume and the duration of the disease (R = −0.4036,
p = 0.016 ‐ corrected for multiple testing).
Conclusions: The anterior hippocampal volume loss was found in
NC. This volume loss positively correlates with duration of disease.
Disclosure: Nothing to disclose.
P453 | Relationship between efficacy
endpoints and measures of functional status and
health‐related quality of life (HRQoL) in
narcolepsy patients treated for excessive
sleepiness
T.E. Weaver1; S.D. Mathias2; R.D. Crosby2,3; M. Bron4;
S. Bujanover4; D. Menno5; K.F. Villa4
1University of Illinois at Chicago, Chicago, IL, 2Health Outcomes
Solutions, Winter Park, FL, 3Neuropsychiatric Research Institute, Fargo,
ND, 4Jazz Pharmaceuticals, Palo Alto, CA, 5Jazz Pharmaceuticals,
Philadelphia, PA, United States
Objectives/Introduction: A 12‐week, double‐blind, randomized,
placebo‐controlled Phase 3 trial in patients with narcolepsy associ-
ated with excessive sleepiness showed that solriamfetol at doses of
150 and 300 mg resulted in statistically significant, clinically mean-
ingful improvements on Epworth Sleepiness Scale (ESS), Mainte-
nance of Wakefulness Test (MWT) and Patient Global Impression of
Change (PGI‐C). Significant improvements in some functional status
and health‐related quality of life (HRQoL) measures were also
observed with the 150 and 300 mg doses. Because significant
improvements in efficacy endpoints do not always translate into
improvements in functional/ HRQoL outcomes, the relationship
between efficacy and functional/HRQoL outcomes was examined.
Methods: In all participants, the ESS, MWT, Functional Outcomes
of Sleep Questionnaire‐short version (FOSQ‐10), Work Productivity
and Activity Impairment Questionnaire (WPAI), EuroQoL 5‐Dimen-
sion (EQ‐5D‐5L), Short‐Form (SF)‐36v2 and PGI‐C were administered
at baseline (except PGI‐C), Weeks 4, 8 and 12. Pearson correlation
coefficients were calculated, pooling across all treatment groups, to
assess the relationship between changes in efficacy and functional/
HRQoL outcomes between baseline and Week 12 (change scores).
Correlations were reported for functional/HRQoL outcomes with sig-
nificant improvements (nominal) at any dose at Week 12. Values of
0.10 to <0.30, 0.30 to 0.50, and >0.50 reflect low, moderate, and
high correlations, respectively.
Results: Data from the modified intent to treat population were
analyzed (n = 231). Correlations (rho) for change scores were high
between ESS and FOSQ‐10 (−0.703), SF‐36v2‐Vitality (−0.559), and
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work productivity loss (WPL) measured by WPAI (0.503), and moder-
ate between ESS and SF‐36v2‐Role‐Physical (RP) (−0.484), activity
impairment (AI) measured by WPAI (0.436), and SF‐36v2 Physical
Component Score (PCS) (−0.352). Correlations were low between
MWT and SF‐36v2 Vitality (0.291), WPL (−0.249), FOSQ‐10 (0.242),
RP (0.239), and AI (−0.215). PGI‐C correlations were high with
FOSQ‐10 (−0.504), and moderate with SF‐36v2 Vitality (−0.499), AI
(0.477), WPL (0.417), and RP (−0.405), and low for PCS (−0.297).
Conclusions: Changes in efficacy endpoints for ESS, MWT and
PGI‐C from baseline to Week 12 were associated with changes in
several functional and HRQoL outcomes for solriamfetol‐treated nar-
colepsy patients. Associations between self‐reported efficacy end-
points (ESS and PGI‐C) and measures of functional/HRQoL status
were stronger than associations with the objective efficacy endpoint
(MWT).
Disclosure: TE Weaver received research support as a site for
the clinical trial of solriamfetol. She also received royalty fees for
use of the Functional Outcomes of Sleep Questionnaire from Phi-
lips Respironics, Nyxoah, ResMed, Jazz Pharmaceuticals, Bayer AG,
Night Balance, and Cook Medical. S Mathias is employed by Health
Outcomes Solutions which received compensation from Jazz Phar-
maceuticals for conducting these analyses. R Crosby serves as a
paid Statistical Consultant to Health Outcomes Solutions. M Bron
is an employee of Jazz Pharmaceuticals who, in the course of this
employment, has received stock options exercisable for, and other
stock awards of, ordinary shares of Jazz Pharmaceuticals plc. S
Bujanover is an employee of Jazz Pharmaceuticals who, in the
course of this employment, has received stock options exercisable
for, and other stock awards of, ordinary shares of Jazz Pharmaceu-
ticals plc. D Menno is an employee of Jazz Pharmaceuticals who,
in the course of this employment, has received stock options exer-
cisable for, and other stock awards of, ordinary shares of Jazz
Pharmaceuticals plc. KF Villa is an employee of Jazz Pharmaceuti-
cals who, in the course of this employment, has received stock
options exercisable for, and other stock awards of, ordinary shares
of Jazz Pharmaceuticals plc.
P454 | Delayed diagnosis and burden of
excessive sleepiness associated with obstructive
sleep apnea
L. Tesler Waldman1; S. Parthasarathy2; K.F. Villa3; M. Bron3;
S. Bujanover3; M. Brod1
1The Brod Group, Mill Valley, CA, 2University of Arizona, Tucson, AZ,
3Jazz Pharmaceuticals, Palo Alto, CA, United States
Objectives/Introduction: Obstructive sleep apnoea (OSA) is asso-
ciated with excessive sleepiness (ES), which may go undiagnosed and
can significantly impair a patient's quality of life (QOL). This research
examined timing and reasons patients sought medical care for their
ES and OSA symptoms, and the impact of ES on QOL.
Methods: Semi‐structured 2‐hr focus groups, segmented by gen-
der, were conducted in 3 US cities with a total of 42 participants
who were currently experiencing ES with OSA. Transcripts were
coded using qualitative analysis software and analysed for content
by theme using an adapted grounded theory approach common to
qualitative research. An Independent Review Board approved the
study.
Results: Over half of the sample (n = 23, 55%) reported sleeping
≥7 hr a night on average, and 74% (n = 31) were currently receiving
treatment for OSA. Twenty‐two participants (52%) reported experi-
encing OSA symptoms for ≥1 year, with an average duration of 11.4
(median 8.0, range 1–37) years before seeking medical attention.
During this period, those participants reported snoring (n = 20, 91%)
and ES (n = 13, 59%) as the most frequent symptoms. Several partic-
ipants (n = 7, 32%) considered their symptoms to be “normal,” rather
than a sign of a serious medical condition. For all 42 participants,
the primary reasons for ultimately seeking medical attention were:
input from their spouse/partner, another family member, or friend
(n = 21, 50%); their own concern about particular symptoms (n = 7,
17%); and/or falling asleep while driving (n = 5, 12%). Four partici-
pants (10%) reported being misdiagnosed prior to receiving their
OSA diagnosis. QOL domains impacted by ES included: physical
health and functioning (n = 40, 95%); daily life functioning (n = 39,
93%); cognition (n = 38, 90%); social life/relationships (n = 37, 88%);
and emotions (n = 30, 71%).
Conclusions: These findings suggest that patients may be unaware
that their symptoms could indicate OSA requiring evaluation and
treatment. Among these patients, there was an average of over
11 years between symptom onset and seeking medical attention.
Even following diagnosis, ES associated with OSA can continue to
substantially affect both the range and seriousness of QOL and daily
functioning. Further research is needed to address diagnostic delays
and unmet treatment needs for patients with ES associated with
OSA.
Disclosure: LT Waldman has received research funding from Jazz
Pharmaceuticals. M Brod has received research funding from Jazz
Pharmaceuticals. KF Villa is an employee of Jazz Pharmaceuticals
who, in the course of this employment, has received stock options
exercisable for, and other stock awards of, ordinary shares of Jazz
Pharmaceuticals plc. M Bron is an employee of Jazz Pharmaceuticals
who, in the course of this employment, has received stock options
exercisable for, and other stock awards of, ordinary shares of Jazz
Pharmaceuticals plc. S Bujanover is an employee of Jazz Pharmaceu-
ticals who, in the course of this employment, has received stock
options exercisable for, and other stock awards of, ordinary shares
of Jazz Pharmaceuticals plc. S Parthasarathy has received consul-
tancy fees from Philips, Nightbalance, Vapotherm, Bayer, and Merck;
and research funding from Phillips.
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P455 | Impact of narcolepsy on educational
skills in young Polish patients
A. Wierzbicka1; A. Wichniak2; L. Wolkow1; W. Jernajczyk1
1Sleep Disorders Center, Department of Clinical Neurophysiology, 2Third
Department of Psychiatry and Sleep Disorders Center, Institute of
Psychiatry and Neurology, Warsaw, Poland
Objectives/Introduction: Narcolepsy is a rare hypersomnia of
central origin with the symptoms onset usually in the second and
third decade of life. In many cases the proper diagnosis is delayed
by years. Despite of therapeutical interventions, the disorder affects
daily‐life activity. Aim of the study was to assess the influence of
narcolepsy symptoms on the educational performance in Polish pop-
ulation of teenagers and young adults.
Methods: Thirty consecutive patients (13 females) aged 13–
25 years (mean 19.3 ± 3.6) diagnosed with narcolepsy type 1
(n = 26) and type 2 (n = 4) during last 3 years in Sleep Disorders
Center in Warsaw were surveyed for their educational performance,
revision of future plans, getting social services.
Results: The group consisted of 12 school teenagers, 11 university
students, 6 workers and one patient on disablement pension. Mean
age at diagnosis was 14.4 ± 2.5 years and mean time from the disor-
der onset to the diagnosis was 5.3 ± 3.0 years. Twenty‐three
patients (76.6%) declared learning difficulties, in 7 (58.3%) teenagers
leading to one‐to‐one tuition. University students had also many
problems with education and 6 of them (54.5%) paused or termi-
nated the studies or changed the field of study. Six patients who
didn't continue education after primary or secondary school had to
choose physical work. Eight patients (26.6%) received various kinds
of social benefits because of the disorder. According to Sheehan Dis-
ability Scale narcolepsy had the most negative impact on education/
work (mean value = 6.8), less effect on social life and domestic
duties (mean values: 5.4 and 4.3). More than half narcoleptic sub-
jects presented mild or moderate depressive symptoms assessed by
Beck Depression Inventory.
Conclusions: Narcolepsy has a marked negative impact on all
aspects of daily‐life, especially on education performance, resulting
in tutorial support, changing of future plans, getting social services.
Disclosure: Nothing to disclose.
P456 | Relationship between efficacy
endpoints and measures of functional status and
health‐related quality of life (HRQoL) in
obstructive sleep apnea patients treated for
excessive sleepiness
S.D. Mathias1; R.D. Crosby1,2; C. Drake3; M. Bron4;
S. Bujanover4; D. Menno4; K.F. Villa4
1Health Outcomes Solutions, Winter Park, FL, FL, 2Neuropsychiatric
Research Institute, Fargo, ND, ND, 3Henry Ford Health System, Novi, MI,
MI, 4Jazz Pharmaceuticals, Palo Alto, CA, CA, United States
Objectives/Introduction: A 12‐week, double‐blind, randomized,
placebo‐controlled Phase 3 trial in patients with obstructive sleep
apnea associated with excessive sleepiness showed that solriamfetol
doses 37.5, 75, 150 and 300 mg resulted in statistically significant,
clinically meaningful improvements on the Epworth Sleepiness Scale
(ESS), Maintenance of Wakefulness Test (MWT), and Patient Global
Impression of Change (PGI‐C) (except 37.5 mg PGI‐C). In addition,
significant improvements in functional status and health‐related qual-
ity of life (HRQoL) were observed with the 150 and 300 mg doses.
Given that significant improvements in efficacy endpoints do not
always translate into improvements in functional/HRQoL outcomes,
the relationship between efficacy and functional/HRQoL outcomes
was examined.
Methods: In all participants, the ESS, MWT, Functional Outcomes
of Sleep Questionnaire‐short version (FOSQ‐10), Work Productivity
and Activity Impairment Questionnaire (WPAI), EuroQoL 5‐Dimen-
sion (EQ‐5D 5L), Short‐Form (SF)‐36v2 (SF36‐v2) and PGI‐C were
administered at baseline (except PGI‐C), Weeks 4, 8 and 12. Pearson
correlation coefficients were calculated, pooling across all treatment
groups, to assess the relationship between changes in efficacy and
functional/HRQoL outcomes between baseline and Week 12 (change
scores). Correlations were reported for those functional/HRQoL out-
comes with significant (nominal) improvements at Week 12. Values
of 0.10 to <0.30, 0.30 to 0.50, and >0.50 reflect low, moderate, and
high correlations, respectively.
Results: Data from the modified intent to treat (mITT) population
were analyzed (n = 459). Correlations (rho) for change scores were
high between ESS and FOSQ‐10 (−0.541), and moderate between
ESS and SF‐36v2 Vitality (−0.489), activity impairment (AI) measured
by WPAI (0.441), work productivity loss (WPL) measured by WPAI
(0.334) and SF‐36v2 Role‐Physical (−0.332). Correlations were low
between MWT and SF‐36v2 Vitality (0.273), SF‐36v2 Role‐Physical
(0.184), FOSQ‐10 (0.163), AI (−0.136) and WPL (−0.091). PGI‐C cor-
relations were high with SF‐36v2‐Vitality (−0.581) and FOSQ‐10
(−0.529), and moderate between PGI‐C and AI (0.476) and WPL
(0.398) and SF‐36v2 Role‐Physical (−0.371).
Conclusions: Changes in the efficacy endpoints for ESS, MWT and
PGI‐C from baseline to Week 12 were associated with changes in
several functional and HRQoL outcomes for solriamfetol‐treated
OSA patients. Associations between self‐reported efficacy endpoints
300 of 433 | ABSTRACTS
(ESS and PGI‐C) and measures of functional/HRQoL status were
stronger than associations with the objective efficacy endpoint
(MWT).
Disclosure: S Mathias is employed by Health Outcomes Solutions
which received compensation from Jazz Pharmaceuticals for con-
ducting these analyses. R Crosby serves as a paid Statistical Consul-
tant to Health Outcomes Solutions. C Drake has received grant
support and consulting fees from Jazz, Merck, Pernix and Eisai. KF
Villa is an employee of Jazz Pharmaceuticals who, in the course of
this employment, has received stock options exercisable for, and
other stock awards of, ordinary shares of Jazz Pharmaceuticals plc.
M Bron is an employee of Jazz Pharmaceuticals who, in the course
of this employment, has received stock options exercisable for, and
other stock awards of, ordinary shares of Jazz Pharmaceuticals plc. S
Bujanover is an employee of Jazz Pharmaceuticals who, in the
course of this employment, has received stock options exercisable
for, and other stock awards of, ordinary shares of Jazz Pharmaceuti-
cals plc. D Menno is an employee of Jazz Pharmaceuticals who, in
the course of this employment, has received stock options exercis-
able for, and other stock awards of, ordinary shares of Jazz Pharma-
ceuticals plc.
P457 | Motor vehicle accidents in patients
with excessive daytime sleepiness
K. Sadeghniiat-Haghighi1; A. Najafi1; A. Khajeh-Mehrizi1;
A. Rahimi-Golkhandan2
1Tehran University of Medical Sciences/Occupational Sleep Research
Center, 2Occupational Sleep Research Center, Tehran, Islamic Republic of
Iran
Objectives/Introduction: Excessive daytime sleepiness (EDS) is a
common problem in patients referred to sleep clinics which could
result in adverse consequences in their personal and social activities
including Motor vehicle accidents (MVAs). Epworth Sleepiness Scale
(ESS) and Multiple Sleep Latency Test (MSLT) are known subjective
and objective methods for measuring EDS, respectively. In this study,
we aimed to evaluate the relationship between EDS and MVAs.
Methods: Medical records of 144 patients (106 male) with EDS
referred to Baharloo sleep clinic, Tehran, Iran were assessed in this
cross‐sectional study. All participants filled out a questionnaire
including demographic characteristics, ESS and history of MVAs due
to sleepiness in last 5 years and underwent full night polysomnogra-
phy and MSLT. Sleepiness was categorized to normal, moderate, and
severe according to Mean sleep latency (MSL) in MSLT.
Results: Patients with history of MVAs had a significantly lesser
MSL and higher ESS score than those without MVAs (6.6 ± 3.9 vs.
9.3 ± 6.5, p value = 0.038 and 17.9 ± 4.4 vs. 15.6 ± 5.5, p value =
0.030, respectively). MVAs were reported in 41.9%, 31%, and
16.1% of patients with severe, moderate, and normal sleepiness,
respectively. There was a significant relationship between severity of
sleepiness and history of MVAs (p value = 0.02). Regression analysis
showed that after adjustment for age and sex, ESS and MSL remains
significantly different between patients with and without MVAs.
Conclusions: ESS score and MSL would help sleep clinicians to
find high risk patients for safety sensitive jobs, the issue which
should not be overlooked by them during visits in sleep clinic.
Disclosure: Nothing to disclose.
P458 | Suboptimal adherence to treatment is
common in patients with narcolepsy
L. Pérez-Carbonell; E. Lyons; G. d'Ancona; G. Leschziner;
P. Drakatos; B. Kent
Sleep Disorders Centre. Guy's and St Thomas’ NHS Trust, London,
United Kingdom
Objectives/Introduction: Narcolepsy is a chronic neurological dis-
order, which usually requires lifelong therapy. Adherence to treat-
ment is a critical factor in the management of chronic disease,
however, we know little about adherence in narcolepsy. We aimed
to assess adherence, and predictors of adherence, in narcolepsy
patients attending a tertiary sleep centre.
Methods: We retrospectively assessed patients undergoing treat-
ment for type 1 (NT1) and type 2 (NT2) narcolepsy, obtaining demo-
graphic and clinical information from their electronic files. Adherence
was assessed by comparing prescription collection rates with pre-
scribed therapy in the last year. Three levels of adherence were
defined: poor (≤50%), intermediate (49–79%), and good (≥80%).
Refractory daytime sleepiness was defined as persistent Epworth
score >12 despite trials of at least three wakefulness‐promoting
agents, in monotherapy or combined. Exclusion criteria were uncon-
trolled sleep comorbidity and changes of medication within
6 months prior to last consultation. Regression analyses were per-
formed to identify predictors of poor adherence, and to examine the
relationship of adherence with symptom control.
Results: A total of 90 patients with narcolepsy were included,
56.7% females, with a mean age of 39.21(±13.88) years. 72 patients
(80%) had a diagnosis of NT1 and 18 of NT2. Cataplexy was persis-
tent in 48.6% of NT1 patients. Psychiatric comorbidities were pre-
sent in 24.4% of patients, and 43.3% had refractory sleepiness.
Good adherence was seen in 55.6% of patients, whilst 13.13% were
intermediately and 31.1% poorly adherent. No difference was seen
in likelihood of good adherence between patients with refractory
and non‐refractory symptoms (56.2 vs. 54.9%; p > 0.05). In multi-
variate regression, NT2 diagnosis was an independent predictor of
poor adherence (adjusted OR 3.23; 95% CI 1.04–10.1; p = 0.042),
but no relationship was seen with gender, age, refractory sleepiness,
or psychiatric history. Refractory sleepiness was present in 28.6% of
poorly adherent patients, compared to 44% of those with good
adherence. Regression analysis identified NT1, but not poor adher-
ence, as a predictor of refractory symptoms (AOR 5.64; 95% CI
1.40–3.14; p = 0.015).
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Conclusions: Suboptimal adherence to prescribed therapy is com-
mon in narcolepsy patients, including those with apparent refractory
symptoms, and particularly in subjects with NT2. Adherence to treat-
ment should be routinely assessed in narcolepsy prior to any step‐up
in therapy.
Disclosure: Nothing to disclose.
P459 | Kleine‐Levin syndrome or migraine with
brainstem aura?
C. Gutierrez Muñoz1; M. Martinez Martinez1; V. Gonzalez
Quintanilla2; A. Paramio Paz1; T. Diaz de Teran1; D. Herrero
Navarro1; A. Lopez Delgado1; J. Romero Esteban1; D. Tovar
Echevarri3; J. Banzo Marraco3; R. Carpizo Alfayate1
1Unidad Multidisciplinar Trastornos del Sueño y Ventilación, 2Neurología,
3Medicina Nuclear, Hospital Universitario Marqués de Valdecilla,
Santander, Spain
Objectives/Introduction: Kleine‐Levin Syndrome (KLS) is a rare
entity included within Central Hypersomnia in the International
Classification of Sleep Disorders (ICSD‐3). Historically, it has been
defined as a severe recurrent hypersomnia with hyperphagia/
hypersexuality, however, these symptoms aren′t considered essen-
tial nowadays. Migraine with brainstem aura (MBA) may share
clinical features with KLS, so the differential diagnosis should
be considered in a patient with recurrent headache and
hypersomnia.
Methods: 16‐year‐old right‐handed girl with a history of biparietal
oppressive headache and family history of migraine. Since
18 months, she reported changes in her headache associating irre-
sistible drowsiness and sleeping more than 20 hr/day. These epi-
sodes lasted 6–8 days every 3–4 weeks being asymptomatic
between episodes. Amitriptyline had decreased headache intensity
and episodes were more spaced over time. During episodes, she was
confused and apathic but she didn′t present hyperphagia. Headache
usually associated tinnitus and slight hearing loss. Weight 59.7 kg
and size 161 cm. Mallampati I. Evening chronotype. Psychopatholog-
ical exploration normal.
Results: Supplementary tests: ‐Blood tests including thyroid hor-
mones and autoimmune tests were normal. ‐ HLA‐I A*02,B*07,*15;
C*02,*07 were negative. ‐HLA‐II DRB1*07, *15;DQA1*01, *02;
DQB1*02, *06; DQ2 (2.2), DQ6 were negative.
- Auditory evoked potentials normal.
- Brain MRI normal.
- Brain SPECT showed right temporal hypoperfusion.
- Genetic study of ATP1A2 and CACNA1A negative.
- Intercritical PSG showed high-amplitude low-frequency waves
in bilateral frontal and frontotemporal areas. No other remark-
able findings.
- PSG+MSLT at the end of an episode showed night with sleep
onset in REM and MSLT with average sleep latency>8′ and 1
SOREM.
Conclusions: This case raises the differential diagnosis between
KLS (supporting by recurrent hypersomnia, PSG and SPECT) and
MBA (headache with tinnitus, hearing loss and the improvement
after migraine treatment although it′s true that diplopia, dysarthria
or ataxia were absent). Headache is described in many patients with
SKL and drowsiness can appear as a migraine aura. It has been
recently described that the common mechanism could be the
hypothalamic modulation present in both pathologies. In our case,
patient′s symptoms, PSG findings and the rest of the tests were
decisive to support the diagnosis of KLS. We believe that it′s essen-
tial to carry out sleep studies to guide the diagnosis in these
patients.
Disclosure: Nothing to disclose.
P460 | Polysomnographic features related to
REM sleep of patients with narcolepsy
T. Yagi1; S. Chiba1; H. Itoh2; K. Nishimura-Kato1
1Ota Memorial Sleep Center, Kawasaki, 2Jikei University School of
Medicine, Tokyo, Japan
Objectives/Introduction: REM sleep behavior disorder (RBD),
REM without atonia (RWA) and periodic limb movements in sleep
(PLMS) are known as symptoms of Narcolepsy. The purpose of this
study is to summarize polysomnographic features related to REM
sleep of patients with Narcolepsy diagnosed in our sleep clinic.
Methods: We enrolled 139 patients (80 male, 59 female patients,
9 to 72 years, an average of 24.4 ± 10.8 years) are diagnosed with
Narcolepsy who undergone polysomnography and multiple sleep
latency test (MSLT) from the period of 2011 to 2016. They are clas-
sified into the group with symptom of cataplexy and the group with-
out cataplexy. The group with cataplexy is 48 patients (22 male, 26
female patients, 9 to 72 years, an average 26.6 ± 14.9 years). The
group without cataplexy is 91 patients (58 male, 33 female patients,
12 to 56 years, an average of 23.6 ± 7.7 years). We compared it
about a difference of PSG and MSLT features, %RWA, PLMS, mean
sleep latency (mSL), number of sleep onset REM period (SOREMP)
between Narcolepsy with cataplexy group and Narcolepsy without
cataplexy group. In addition, we compared presence of abnormal
behavior between these two groups.
Results: It was found in group with cataplexy that they have a
higher %RWA, and they display symptom of REM sleep behavior dis-
order. They have disruption of nocturnal sleep, and PLMSI is
increased on PSG and increased SOREMP in MSLT findings.
Conclusions: Our study showed that was evident Narcolepsy with
cataplexy group having more REM related findings in PSG and
MSLT.
Disclosure: Nothing to disclose.
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P461 | Sleep disorders in patients with Leber
hereditary optic neuropathy
I. Příhodová1; H. Kolářová2; K. Šonka1; D. Kemlink1;
T. Honzík2
1Department of Neurology and Center of Clinical Neuroscience,
2Department of Pediatrics and Adolescent Medicine, First Faculty of
Medicine, Charles University and General University Hospital in Prague,
Praha, Czech Republic
Objectives/Introduction: Sleep disturbances associated with pri-
mary mitochondrial disorders were described but limited data are still
available. The aim of the study was to evaluate sleep disorders and
sleep structure in patients with Leber hereditary optic neuropathy
(LHON).
Methods: 17 patients (8 male, mean age 32.4 ± 17.4, age range 7–
60 years) with a diagnosis of LHON genetically confirmed were
included (10 LHON‐affected patients, 7 asymptomatic LHON carri-
ers). A detailed interview, the Pittsburgh Sleep Quality Index, the
Epworth Sleepiness Scale, the Horne and Ostberg Morningness/
Eveningness Questionnaire and nocturnal polysomnography were
used to assess sleep problems and sleep quality.
Results: 10 patients (59%) reported chronic insomnia, 5 patients
(29%) excessive daytime sleepiness. Nocturnal polysomnography
revealed sleep disruption (arousal index >15) in 5 cases (29%), sleep
related breathing disorder in 4 (24%), parasomnia in 3 cases (18%)
and periodic limb movements in 1 patient (6%). Statistically signifi-
cant reduction of NREM 3 sleep was found in symptomatic patients
compared with carriers (17.6 ± 6.7 vs. 23 ± 7.4, p = 0.02).
Conclusions: Sleep disturbances (chronic insomnia, subjective
excessive daytime sleepiness, nocturnal sleep disruption) were found
in symptomatic/asymptomatic LHON. Reduction of NREM 3 sleep
was present in symptomatic patients.
Disclosure: Supported by Czech Ministry of Health, AZV 16‐
32341A and by the grant Progres Q27/LF1.
P462 | Does the excessive daytime sleepiness
in advanced Parkinson`s disease depend on the
quality of night time sleep?
K. Shevtsova; M. Nodel; G. Kovrov
Sechenov University, Moscow, Russian Federation
Objectives/Introduction: 40–50% of patients with Parkinson′s
disease (PD) have excessive daytime sleepiness (EDS). One of the
controversial issues of the pathophysiology of EDS in PD is its con-
nection with night`s sleep disorders.
Objective: to assessment the connections of the EDS with the
clinic and polysomnographic characteristics of night`s sleep.
Methods: 19 patients (7 men and 12 women) with PD disease
without dementia (mean age‐ 65.9 ± 8.1 years; duration of disease:
10.8 ± 4.4 years, stage – 2.5 ± 0.4 on Hoehn ‐Yahr) with the subjec-
tive feeling of sleepiness were enrolled in the study. 17 patients
received dopamine agonists (DA) and levodopa (LD) treatment (mean
daily dose −628.9 ± 122.8 mg), 2 received LD with no DA treat-
ment. UPDRS (parts 2–3), Parkinson Disease Sleep Scale (PDSS),
Epworth Sleepiness Scale (ESS), the over night polysomnography
(PSG) and Multiple Sleep Latency Test (MSLT) were performed in all
patients. Mann‐Whitney U‐test, unpaired Student's t‐criteria were
used to assessment of significance of inter‐groups differences.
Assessment of interconnections between indices wasprovided by
Spearman's correlation matrix.
Results: The prevalence of significant subjective sleepiness level
(ESS > 10) was 10 (53%).8 (47%) patients have mild subjective sleepi-
ness (EDS ≤ 10). The low mean value of sleep efficiency
−63.5 ± 13.6%, high mean value of the sleep fragmentation
(17 ± 11.4 awakenings) at the night was observed. 8 patients with the
greater degree of daytime sleepiness (the mean value of MSLT
<5 min) had a higher ESS score (16 ± 5.7 compared 9.4 ± 5.2 in
patients with mean value of MSLT >5 min (p = 0.01). Patients with
ESS > 10 differed from the patients with mild sleepiness (EDS ≤ 10)
by the smaller representation of the sleep stage 3 (9.7 ± 11.3% as
compared with 17 ± 2.3% in patients with EDS > 10, p < 0.05). The
prevalence of REM sleep behavior disorder (RBD) was 7 (37%). The
mean MSLT sleep latency in patients with RBD was 8.8 ± 2.4 min as
compared with 16 ± 4.2 min in patients without parasomnia
(p < 0.05).
Conclusions: The connections of EDS with some night`s sleep dis-
orders, the smaller representation of deep sleep, RBD in patients
with advanced PD without dementia were found.
Disclosure: Nothing to disclose.
P463 | Insomnia, nightmares and daytime
sleepiness in university students with ADHD
A. Schlarb1; J. Grünwald2
1Bielefeld University, Bielefeld, 2University of Tuebingen, Tuebingen,
Germany
Objectives/Introduction: This study examined associations
between ADHD in university students and sleep disturbances,
namely insomnia, daytime sleepiness and nightmares as well as diur-
nal preference.
Methods: 70 university students took part in the study. All partici-
pants completed standardized questionnaires with regard to ADHD,
sleep disturbances and diurnal preference. Furthermore, they took
part in certain attention related subtests of the Testbatterie zur
Aufmerksamkeitsprüfung (TAP).
Results: 32.9% of all participants exhibited symptoms of ADHD.
Furthermore, on average, insomnia symptomology was clinically
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significant elevated (p = 0.007). Associations between ADHD, insom-
nia and nightmares were significant based on questionnaires (all
p < 0.001). Beyond, students showed significant rates of impaired
attention (p = 0.045).
Conclusions: Insomnia and nightmares as well as daytime sleepi-
ness were enhanced in participants with ADHD symptomatology.
This association was strong in students suffering from ADHD symp-
tomatology in childhood and nowadays. Further investigations
should deepen insight in this field of research and introduce the
findings into treatment and therapy.
Disclosure: Nothing to disclose.
P464 | Alteration of cyclic alternating pattern
correlates with impairment of heart rate
variability in patients affected by amyotrophic
lateral sclerosis
P. Congiu1; G. Milioli2; G. Borghero3; L. Tamburrino1;
M.L. Fantini4; M.M.F. Puligheddu1
1University of Cagliari, Sleep Center, Monserrato, 2University of Parma,
Parma, 3Neurology UOC, University of Cagliari, Monserrato, Italy,
4Universitè d'Auveragne, Clermont‐Ferrand, France
Objectives/Introduction: Amyotrophic lateral sclerosis (ALS) is a
progressive and fatal neurodegenerative disease characterized by
an almost exclusive impairment of motor neurons, although
involvement of other systems, such as autonomic nervous system,
cognitive function and sleep, has been described. The main aim of
this study was to evaluate sleep quality/quantity, sleep stability by
means of CAP assessment, and cardiac autonomic control by
means of heart rate variability assessment. Moreover, we evalu-
ated the correlation between CAP and autonomic function during
sleep.
Methods: 49 consecutive ALS patients (33 M; 15 F) referred to
our sleep disorders center were enrolled. All subjects underwent a
complete history with sleep questionnaire, neurological and general
examination, and a full‐night video‐PSG assisted in lab. 31 subjects
were selected for CAP analysis and HRV assessment, basing on
exclusion criteria (EEG/ECG artifacts, concomitant therapies with car-
dio‐active drugs or BDZ, diagnosis of sleep‐disordered breathing).
Control group consisted of 26 sex and age‐matched healthy subjects.
The study has been approved by local ethic committee, and all the
subjects enrolled signed the written informed consent.
Results: Compared to controls, ALS subjects had an altered sleep
structure with reduction of TST (p < 0.0001), increased WASO
(p < 0.0001), and reduced N2 (p = 0.0217), N3 (p = 0.0181) and
REM (p = 0.04) phases. Regarding CAP patients showed reduction of
A phases (p < 0.0001) mostly due to reduction of A1 phases
(p < 0.0001). HRV assessment showed a significant reduction of tot-
power, SDNN, pNN50, pNN20, LF and HF both in NREM and in
REM sleep. Correlation analysis of CAP and HRV of patients showed
a linear positive correlation between A1, A2 and A3 indexes and
SDNN, RMSSD and pNN50, which are influenced by vagal activity.
Conclusions: Sleep in ALS patients is altered both in stability and
structure. Moreover, ALS patients present an impaired cardiac auto-
nomic function mostly due to vagal components, that positively cor-
relates with reduction of A components of CAP, indicating a rigidity
of both autonomic and cerebral function during sleep in ALS
patients. PSG study of ALS patients should be performed early in
order to identify and treat any sleep disorders, and subclinical disau-
tonomia.
Disclosure: This research was supported by the Regional Council
of Sardinia Grant (2015) (M. Puligheddu, P. Congiu) and by Fon-
dazione Banco di Sardegna (2016) (M. Puligheddu, P.Congiu).
P465 | Sleep fit: a new app to assess sleep
symptoms in Parkinson's disease
A. Mascheroni1; C. Ferlito2; S. Hackethal3; S. Caverzasio2;
E.K. Choe4; Y. Luo4; M. Marazza5; A. Kaelin-Lang6;
F. Faraci1,7; A. Puiatti1; P.L. Ratti2
1SUPSI – DTI, ISIN – Institute for Information Systems and Networking,
Manno, 2Neurocenter of Southern Switzerland, Regional Civic Hospital of
Lugano, EOC, Lugano, 3Department of Neurology, University Hospital of
Zürich, Zurich, Switzerland, 4College of Information Studies, University of
Maryland, Maryland, MD, United States, 5Infornation & Communication
Technology, Regional Civic Hospital of Lugano, EOC, Bellinzona, 6Faculty
of Biomedical Sciences, University of Southern Switzerland, Lugano,
7SUPSI – DTI, Laboratory of Mathematics & Physics for Engineering,
Manno, Switzerland
Objectives/Introduction: Sleep and wakefulness complaints are
extremely common in patients with Parkinson's Disease (PD) and
show high day‐by‐day variability. Ecological momentary assessment
of sleep‐related symptoms by mean of prospective, repeated home‐
based measures is crucial to better characterize and understand
these phenomena. To assess current subjective symptoms, techno-
logical interfaces are required to exactly record the timestamps in
which information is collected. However, new technologies might
not be easy to use by patients with PD.
Methods: Sleep Fit is an app for tablets especially conceived for
patients with PD. Sleep Fit core structure consists in a PD‐oriented
sleep diary, an electronic finger tapping test and subjective scales
on sleepiness, emotional state and motor symptoms. In its latest
version, SleepFit provides enhanced ergonomics for patients with
reduced hand dexterity, enriched graphics, automated flows that
guide the patients in performing tasks throughout the 24 hr,
secured real‐time data collection and possibility of consultation by
the researchers. We tested Sleep Fit asking a group of PD
patients to perform multiple assessments four times a day and
also after each nap, for 2 weeks, at their home. A sleep diary was
included within these tasks, and had to be completed once daily.
Patients’ adherence was computed as the percentage of com-
pleted tasks on the total of expected tasks. We also evaluated the
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satisfaction in a subgroup of patients having used the final version
of the app.
Results: Sleep Fit was tested by 43 PD patients (10 females, mean
age 67.7 ± 9.8). Of them, 19 used the alpha version, 7 an intermedi-
ate version and 17 the final v1.1.4 version. Patients’ adherence was
90% on all the proposed tasks. It increased from 88% (alpha) to 94%
(v1.1.4) with the final version. Sleep diary was completed in 96.5%
of the cases. Ninety‐four percent of the patients having used the
final version of Sleep Fit declared they would use it again for the
same period (76.5%) or longer (17.7%).
Conclusions: Sleep Fit is a well‐accepted, easy‐to‐use tool to accu-
rately assess sleep symptoms in PD that can be employed for both
research and clinical purposes.
Disclosure: Nothing to disclose.
P466 | Nocturnal stridor treated with
continuous positive airway pressure in a patient
with multiple system atrophy: a case study
P. Peřinová1; J. Rusz1,2; S. Dostálová1; J. Klempíř1; K. Šonka1
1Department of Neurology and Center of Clinical Neuroscience, First
Faculty of Medicine, Charles University and General University Hospital,
2Department of Circuit Theory, Faculty of Electrical Engineering, Czech
Technical University in Prague, Prague, Czech Republic
Objectives/Introduction: Patients with multiple system atrophy
(MSA), additionally to autonomic failure and waking motor symp-
toms, often present with numerous sleep disorders. Sleep‐related
breathing disorders including nocturnal stridor belong to the most
common. According to some studies, stridor has been considered a
poor prognostic factor. There are two main options to treat stridor
in MSA patients: tracheostomy and continuous positive airway pres-
sure (CPAP). There are limited data on CPAP treatment in MSA
patients with nocturnal stridor, herein we discuss our experience
with an MSA patient suffering from nocturnal stridor.
Methods: We present the case of a 71‐years old woman who was
diagnosed with MSA at 61 years of age. Stridor was present only
during nights and was classified as late onset (i.e. emerging more
than 3 years after waking motor symptoms). Stridor, as well as, other
sleep disorders (REM sleep behaviour disorder, NREM parasomnia,
periodic limb movement syndrome, mild obstructive sleep apnea)
were confirmed by videopolysomnography. Moreover, the occurence
and features of stridor were detected by the presence of fundamen-
tal frequency in signal, using post hoc computer assisted acoustic
analysis with software PRAAT.
Results: CPAP pressure was titrated during night polysomnography.
The pressure was set by the technician according to visual and
acoustic on‐line observations with the best efficacy achieved at the
pressure setting of 14 mbar. The stridor nearly disappeared accord-
ing to this clinical observation. In the 2 hr analyzed section of both
initial and under CPAP polysomnography, the stridor percentage
time decreased with CPAP treatment from 11.5% to 4.1%, the stri-
dor rate from 21.7 to 14.8 stridors/min and the stridor regularity
changed from 0.022 to 0.080 min. The patient referred a better
sleep quality and lower daytime sleepiness at clinical follow‐up
6 months after treatment initiation with adequate compliance.
Conclusions: In our report, we demonstrate that CPAP can be
used as an effective method of nocturnal stridor treatment in
patients with MSA. Furthemore, we recommend to evaluate the
presence of stridor by objective acoustic analysis as milder forms
under CPAP appear to be neglected by human hearing alone.
Supported by Czech Ministry of Health, AZV 16-28914A.
Disclosure: Nothing to disclose.
P467 | A young man with multiple system
atrophy – how does polysomnography help?
D.R. Carneiro; M. Sousa; I. Luzeiro; A. Morgadinho;
C. Januário
Serviço de Neurologia, Centro Hospitalar e Universitário de Coimbra,
Coimbra, Portugal
Objectives/Introduction: To describe the case of a young man
with an important dysautonomic profile and how the whole investi-
gation leaded to a supported diagnosis of probable Multiple System
Atrophy(MSA).
Methods: MSA is a complex neurodegenerative disorder. Its diag-
nostic requires association of dysautonomic phenomena to a cerebel-
lar or a parkinsonian syndrome. The prognosis is poor, with a fast
progression to disability and reduced potential of therapeutic
response. Besides criteria limits its onset at 30 years old, there are few
cases before 40 years old. REM‐Sleep Behaviour Disorder(RSBD) is a
characteristic feature of MSA and other synucleinopathies.
Results: A 36 year‐old man with a progressive slowness of the
right hemibody for 8 months, beginning in the post‐op of a ureteral
stenosis dilatation. The urinary urgency leaded to the urodynamic
study which revealed bladder hyperactivity with ureteral stenosis.
He refers an occasional left limb resting tremor, hypophonia without
dysphagia. He also concerned about fatigue, sleep pattern dysfunc-
tion with abnormal movements of sleep, erectile dysfunction and
subjective memory complaints. On neurological examination we
observe an asymmetric akinetic‐rigid parkinsonian syndrome
(mUPDRS‐29), generalized hyperreflexia without any other pyramidal
or cerebellar signs. Genetic and secondary causes of Parkinsonism
where excluded. However, Polysomnography revealed RSBD and
Periodic Movements of Sleep and we proceeded with the study
approach to synucleinopathies. In fact, Brain MRI revealed MSA
characteristics ‐ the linear hyperintense signal laterally to the lenticu-
lar nuclei and in the transverse pontocerebellar fibers in T2 scan,
putaminal hypointense signal in SWI scan and diffuse cerebellar atro-
phy. DATSCAN showed a highly reduced dopamine pre‐synaptic
transporters mainly in right nuclei. Cardiac Scintigraphy with 123I‐
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MIBG did not evidence cardiac sympathetic denervation. Response
to Levodopa was poor, even with increasing dosage.
Conclusions: This is an interesting documentation of a man with
probable MSA‐P, because of its age of onset associated to a charac-
teristic brain image and richness of non‐motor symptoms which
lasted the diagnosis until the emergence of the parkinsonian syn-
drome. RSBD is not included yet in diagnostic criteria of MSA, but
we believe that the path is through it, as it is a relevant marker of
synucleinopathies.
Disclosure: Nothing to disclose.
P468 | Brain white matter damage and its
association with neuronal synchrony during sleep
E. Sanchez1,2; H. El-Khatib1,2; C. Arbour1,2; C. Bedetti3;
H. Blais2; K. Marcotte1,2; A.-A. Baril1,2; M. Descoteaux4;
D. Gilbert2; J. Carrier1,2; N. Gosselin1,2
1Université de Montréal, 2Hôpital du Sacré‐Coeur de Montréal, 3Institut
Universitaire de Gériatrie de Montréal et CRIUGM, Montreal, 4Université
de Sherbrooke, Sherbrooke, QC, Canada
Objectives/Introduction: The restorative function of sleep partly
relies on its ability to deeply synchronize cerebral networks to create
large slow oscillations observable with electroencephalography.
These are notably essential to synaptic plasticity underlying learning
and memory consolidation. However, whether a brain can properly
synchronize and produce a restorative sleep when it underwent mas-
sive and widespread white matter damage is unknown.
Methods: Here, we answered this question by testing 23 patients
with extensive white matter damage secondary to traumatic brain
injuries (TBI) and compared them to 27 healthy subjects using diffu-
sion tensor imaging and electroencephalographic analyses of full‐
night polysomnography. All four diffusion metrics were used to infer
whole‐brain voxel‐wise white matter structure. Slow waves morphol-
ogy and slow‐wave activity were analyzed to infer on neuronal syn-
chrony during stages N2 and N3 of sleep.
Results: We showed that greater white matter damage over large
frontal and temporal brain regions correlated with a pattern of
higher neuronal synchrony characterized by slow waves of larger
amplitudes (r = 0.32–0.64, p < 0.05 FWE‐corrected) and steeper
slopes (r = 0.42, p < 0.05 FWE‐corrected) during non‐rapid eye
movement sleep. In the first sleep cycle of the night, a significant
positive correlation was also found between white matter damage
and slow‐wave activity power (r = 0.39–0.42, p < 0.05 FWE‐cor-
rected). All associations were only ever found for the TBI group, and
not for the control group. TBI patients consistently scored higher in
self‐reported measures of fatigue (t = 2.4, p = 0.02), which were also
significantly correlated with greater white matter damage (r = 0.42,
p < 0.05 FWE‐corrected).
Conclusions: This study reveals that more damaged brains are
associated with accentuated neuronal synchrony during sleep and
more severe fatigue during the day. This could be caused by cerebral
disconnection or by elevated homeostatic sleep pressure in TBI
patients. These results challenge the idea that large slow waves are
the reflection of a healthy brain and the current hypotheses regard-
ing the role of white matter structure on the brain's ability to syn-
chronize its cortical regions during sleep and produce restorative
sleep.
Disclosure: Nothing to disclose.
P469 | Visual dysfunction and
neurodegeneration in Rem sleep behavior
disorder and Parkinson's disease: a visual evoked
potentials study
R. Cremascoli1; R. De Icco2; G. Toscano2; M. Versino2;
M. Ranzani2; L. Bianchi2; B. Minafra2; R. Zangaglia2;
C. Pacchetti2; A. Romani2; M. Terzaghi2; R. Manni2
1University of Pavia/IRCCS C. Mondino National Neurological Institute,
Pavia, Italy, porto Valtravaglia, 2IRCCS C. Mondino National Neurological
Institute, Pavia, Italy, Pavia, Italy
Objectives/Introduction: Visual dysfunction, covering a multilevel
involvement of different structures, is often reported in patients with
Idiopathic Rem Behavior Disorder (IRBD) and Parkinson's disease
(PD), and it proves to occur at an early stage of PD and be associ-
ated to a more pronounced cognitive deficits at follow up. We inves-
tigated visual evoked potentials (VEPs) as a possible marker of
neurodegeneration in IRBD and PD patients.
Methods: Fifty‐nine Parkinson's Disease (IPD) patients, divided in
32 patients at onset (IPD‐onset) and 27 IPD‐advanced and 46
IRBD patients were submitted to Luminance‐contrast VEPs, to
red‐green color VEPs and to motion‐onset VEPS. For the IRBD
patient group follow‐up data were available in order to assess
overtime conversion to PD or dementia (range 1–6 years; mean
follow‐up duration 4.2 years). The mean age of the 3 groups of
patients (IPD‐advanced 71.3 years; IRBD 68.3 years; IPD‐onset
63.4 years) were significantly different (p = 0.002) and the age fac-
tor as a covariate proved to be statistically significant for all the
latencies but for none of the amplitude of the N70‐P100 and the
N1 and N2 components.
Results: Concerning VEPs as a whole, IPD‐advanced group showed
a higher occurrence of P100 latency and N1 latency abnormalities
than the other two‐groups. In the IPD‐advanced group, not signifi-
cant differences were detected according to the presence of halluci-
nations, whereas the P100 latency with 15’ check was longer in
patients with than in those without cognitive dysfunction
(p = 0.033). The same held true for the latency of N1 chromatic
component (p = 0.036). Ten IRBD patients converted to IPD and/or
to cognitive dysfunction showed P100 latency with 15’ check
(p = 0.025) and of N1 latency of chromatic component (p = 0.011)
longer than those found in non‐converted RBD.
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Conclusions: VEPs alterations proved to be present in IRBD
patients and PD patients at an early stage of the disease with the
rate of dysfunction correlating with overtime conversion to PD in
IRBD groups and the rate of cognitive dysfunction in IPD‐advanced
group.
Disclosure: Nothing to disclose.
P470 | Total sleep deprivation unmasks
subjective daytime sleepiness and impairments in
alertness unique to mild traumatic brain injury
A. McKeon; M. St. Pierre; J. Choynowski; C. Courtney;
A. Grillakis; V. Capaldi; A. Yarnell; A. Brager
Military Psychiatry & Neuroscience, Walter Reed Army Institute of
Research, Silver Spring, MD, United States
Objectives/Introduction: Mild traumatic brain injury (mTBI) has
been extensively linked to self‐reported sleepiness and poor cogni-
tive performance. However, post‐mTBI sleep profiles and the effect
of total sleep deprivation (TSD) on sleepiness and performance
remained unstudied.
Methods: Thirteen participants, with (n = 7) and without (n = 6)
mTBI underwent 40 hr of total sleep deprivation (TSD) anchored by
baseline and recovery 8‐hr sleep opportunities with polysomnography.
Objective and subjective sleepiness was assessed by the maintenance
of wakefulness test (MWT) and Stanford Sleepiness Scale (SSS) and
performance was measured using the psychomotor vigilance test
(PVT) across the daily rhythm. Group differences were assessed using
t‐tests, analysis of variance, and hierarchical linear modeling.
Results: At baseline, those with mTBI experienced significantly less
total sleep time (TST), t (6.43) = −3.804, p = 0.008, greater waking
after sleep onset (WASO), t (6.41) = 2.78, p = 0.03, shorter rapid eye
movement (REM) latency, t (11) = −2.239, p = 0.047, and less slow
wave sleep (SWS), t (11) = −2.524, p = 0.028, compared to controls.
We report a lack of significant differences between groups during
recovery sleep. This may be due to a reduced homeostatic response
to sleep deprivation. Overall, there was no significant group differ-
ences in objective sleepiness during TSD. Few time points reached
statistical significance, with controls having a longer sleep latency
compared to those with mTBI ([25 hr: MC = 1.92, SDC = 0.48; MT =
0.79, SDT = 0.16], [29 hr: MC = 2.25, SDC = 0.46; MT = 1.21, SDT =
0.26], [33 hr: MC = 2.25, SDC = 0.54; MT = 1.07, SDT = 0.27]); how-
ever, these findings were not clinically meaningful. The mTBI group
experienced greater subjective sleepiness, F (2, 47.20) = 4.22,
p = 0.020, during TSD than controls. Further, the mTBI group experi-
enced significantly more false starts, F (2, 43.29) = 4.58, p = 0.016,
and minor lapses, F (2, 35.12) = 3.47, p = 0.042, during TSD com-
pared to controls.
Conclusions: TSD unmasked greater subjective daytime sleepiness
and impaired vigilance after mTBI compared to non‐mTBI counter-
parts. No change in the daily rhythm of objective sleepiness was
observed between groups. However, those with mTBI may still have
lower level compensation of sleep and circadian processes, which
will be the focus of our future work.
Disclosure: The opinions and assertions contained herein are the
private views of the authors and are not to be construed as official
or as reflecting the views of the US Army or of the US Department
of Defense. This abstract has been approved for public release with
unlimited distribution.
P471 | Daytime sleepiness in patients with
chronic fatigue syndrome
I. Bileviciute-Ljungar1,2
1Clinical Sciences, Karolinska Institutet, Stockholm, 2ME/CFS unit, Pain
and Rehabilitation Center, Anaesthetics, Operations and Specialty
Surgery Center, Linköping, Sweden
Objectives/Introduction: One of disabling symptoms in daily life
of patients with chronic fatigue syndrome (CFS) is daytime sleepi-
ness. The night sleep is non‐restorative and many patients sleep day-
time. However, they still feel an excessive fatigue. The aim of this
study was to find parameters correlating with daytime sleepiness.
Methods: The main variables describing daytime sleepiness were
Epworth Sleepiness Scale (EES) and appreciated time of daytime
sleep per week in minutes (ATDSW). Karolinska Sleep Questionnaire
(KSQ), Insomnia Severity index (ISS), mood (Hospital and Depression
Scale, HADS), CFS symptom questionnaire and objective measure-
ments of temperature, saturation and pulse during rest or physical
activity were studied using correlation analysis. Results were consid-
ered as significant if both EES and ATDSW showed significant
(p < 0.05) correlations with chosen parameters.
Results: 92 patients with CFS (43 ± 2 years old, 84% women, BMI
26 ± 0.5) fulfilled a battery of questionnaires and underwent clinical
investigation with measure of mouth temperature, pulse and satura-
tion during rest and short physical activity. EES (median 11) and
ATDSW (377 ± 33) were pathological for the group. EES and
ATDSW correlated positively with self‐rated CFS symptoms: head-
ache, sensitivity to light, orthostatic intolerance and breathing diffi-
culties during physical activity; with depression scores (HADS) and
with indexes of fatigue/sleepiness and awakening nighttime in KSQ.
No associations were found between ESS/ATDSW and insomnia as
well as objective measures of physiological parameters.
Conclusions: Results indicate that excessive daytime sleepiness in
CFS is a severe sleep disturbance and maybe is not dependent on
insomnia. Daytime sleepiness is associated with severe CFS symp-
toms and need further investigation.
Disclosure: Nothing to disclose.
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P472 | Positional difference between patients
with obstructive sleep apnea with and without
Parkinsonism
D.L. Koo1; K.-A. Woo2; H. Nam2
1Department of Neurology, 2Boramae Medical Center, Seoul National
University College of Medicine, Seoul, Republic of Korea
Objectives/Introduction: Obstructive sleep apnea (OSA) is com-
mon sleep disturbances in patients with Parkinsonism. We aimed to
estimate nocturnal positional differences between OSA patients with
and without Parkinsonism.
Methods: Fifty three patients, who met the criteria for idiopathic
Parkinson's disease or atypical Parkinsonism as well as diagnosed to
OSA by polysmonography, were included. Fifty one OSA patients
without Parkinsonism (age, sex, apnea‐hypopnea index were matched)
were also enrolled as controls. Various clinical and polysomnographic
parameters were evaluated. Positional difference and success rate of
CPAP titration were compared between two groups.
Results: Patients with OSA and Parkinsonism (OSA+P) were mean
67.8 ± 8.6 years (men, 49.1%), and OSA without Parkinsonism (OSA‐
P) were 68.6 ± 6.8 years (men, 47.1%). Body mass index was not dif-
ferent between OSA+P and OSA‐P groups (23.9 ± 3.2 and
24.5 ± 3.5, respectively). AHI was 19.4 ± 14.6/hr in OSA+P group
and 19.7 ± 17.2/hr in OSA‐P group. OSA+P group revealed signifi-
cantly lower proportion of patients with positional change during
sleep, compared to OSA‐P group (64% and 82%, p = 0.047). The
proportion of 100% supinal position during sleep was 36% in OSA+P
group and 18% in OSA‐P group (p = 0.047). The success rate of con-
tinuous positive airway pressure titration was lower in OSA+P group
than that of OSA‐P group (43% and 88%, p = 0.119).
Conclusions: Patients with OSA+P showed decreased positional
change and higher proportion of 100% supinal position during sleep,
compared with OSA‐P patients. The severity of OSA increases dur-
ing supine position than lateral or prone positions. We have sug-
gested the impaired positional change and supinal sleeping tendency
from nocturnal akinesia or dyskinesia may play a role in the develop-
ment of OSA in Parkinsonism.
Disclosure: Nothing to disclose.
P473 | Effects of ischemic stroke on sleep
architecture: a retrospective study
G. Dorffner1,2; L. Pichler1; G. Gruber2; Z. Rošt’áková3;
R. Rosipal3
1Medical University of Vienna, Center for Medical Statistics, Informatics
and Intelligent Systems, Section for Artificial Intelligence and Decision
Support, Medical University of Vienna, 2The SIesta Group GmbH, Vienna,
Austria, 3Institute of Measurement Science, Slovak Academy of Sciences,
Bratislava, Slovakia
Objectives/Introduction: Sleep in patients after suffering from a
stroke is a topic of high interest, which has not been widely studied
yet. In this retrospective study we compared the sleep architecture,
as measured by AASM 2007 criteria, of 95 stroke patients with that
of age and sex matched controls, in order to quantify such an influ-
ence.
Methods: Polysomnographic (PSG) data from 95 patients in the
acute phase of an ischemic stroke (1 to 10 days after a stroke
occurred), acquired at the 1st Department of the Neurology, Come-
nius University, Bratislava between the years 2014 and 2016, was
available for this study. The PSG montages did not perfectly match
the requirements by the AASM (American Academy of Sleep Medi-
cine) manual. In particular, there were no frontal electrode signals in
the recordings. Scoring was performed with the computer‐supported
system Somnolyzer, after substituting frontal channels with copies of
corresponding central electrode channels. For comparison, PSG data
from 95 healthy controls from the SIESTA database, matched to the
stroke population in sex and age, was scored in exactly the same
way. From two consecutive nights available for each SIESTA subject,
the first night was chosen, to match the assumption that stroke
patients were PSG‐naïve at the time of recording. 12 major sleep
variables (including sleep efficiency, sleep stage latencies and per-
centage in each sleep stage) were analyzed. To test mean differences
between the two groups a t‐test for independent samples was used
and p‐values were corrected according to the Bonferroni method
before comparing them to the significance level of 0.05.
Results: Besides having a lower sleep efficiency (68.5% vs. 76.7%,
p = 0.028) the main difference in the sleep of stroke patients was a
strongly reduced REM sleep (7.2% vs. 18.4%, p < 0.001) and
increased NREM‐stages N1 (27% vs. 21.1%, n.s.) and N2 (50.1% vs
44.6%, p = 0.035).
Conclusions: Ischemic stroke was shown to have an effect on
average sleep architecture in terms of less sleep. Percentage‐wise,
REM sleep was significantly reduced following the stroke, balanced
by an increase of the light sleep stages N1 and N2. Deep sleep N3
was unaffected.
Disclosure: Georg Dorffner and Georg Gruber are employees of
The Siesta Group, a service provider for sleep scoring in clinical tri-
als, and also hold shares in the company. The other authors do not
have anything to disclose.
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P474 | Regular exercise program impacts
positively on sleep disturbances, depression and
fatigue in female patients with multiple sclerosis
D. Sadeghi Bahmani1,2; N. Razazian3; M. Alikhani3;
V. Farnia3; E. Holsboer-Trachsler1; S. Brand1
1University of Basel, Basel, Switzerland, 2Sleep Research Centre,
3Kermanshah University of Medical Sciences, Kermanshah, Islamic
Republic of Iran
Objectives/Introduction: Multiple Sclerosis (MS) is a chronic pro-
gressive autoimmune disease impacting both body and mind. Sleep
disturbances, fatigue, depression and paresthesia are typical com-
plains in patients with MS. Beside growing evidence that exercise
programs have a positive influence on sleep disturbances, there is
lack of evidence about the impact of an exercise program on sleep
in patients with MS. We tested the hypothesis that, as in addition to
the standard immune regulatory medication, either a workout or a
coordinative exercise can improve sleep disturbances in patients
with MS compared to a control group.
Methods: Fifty‐two women with MS (mean age: M = 38.48 years,
SD = 4.63) were randomly assigned to one of the following condi-
tions: workout; coordinative exercise; control condition. Their exist-
ing immune modulatory therapy remained unchanged. Participants
completed questionnaires covering sleep disturbances, symptoms of
fatigue, depression, and paresthesia, both at baseline and at the end
of the study 8 weeks later.
Results: Compared to the control group and over time, sleep dis-
turbances, fatigue, depression, and paresthesia decreased signifi-
cantly in the workout and coordinative exercise groups (p's < .001;
N = 52). At the end of the study, compared to the control group, the
reported depression symptoms decreased in the intervention condi-
tions (p's < 0.001).
Conclusions: The pattern of results suggests that for females with
MS and treated with standard immune regulatory medication, exer-
cise training programs such as workout and coordinative exercise
positively impacts on sleep disturbances, core symptoms of MS,
namely fatigue, depression, and paresthesia. Exercise training pro-
grams should be considered in the future as possible complements
to standard treatments.
Disclosure: Nothing to disclose.
P475 | Among patients with multiple sclerosis
(MS) both objective and subjective sleep,
depression, fatigue and paresthesia improved
after 3 weeks of intense rehabilitation
D. Sadeghi Bahmani1; J. Kesselring2; M. Papadimitriu2;
J. Bansi2; M. Gerber1; U. Pühse1; U.E. Lang1; E. Holsboer-
Trachsler1; S. Brand1
1University of Basel, Basel, 2Kliniken Valens, Valens, Switzerland
Objectives/Introduction: There is growing evidence that regular
physical activity has a favorable effect on psychological functioning
and sleep. However, as regards patients with MS, evidence is still
scarce. The aim of the present study was therefore to investigate
the impact of a regular physical activity program on psychological
functioning and subjective and objective sleep in patients with MS.
Methods: A total of 46 patients (mean age about 51 years; EDSS:
5.3, 78.4% females) took part in this longitudinal and 4 weeks lasting
intervention study. At baseline and 4 weeks later, patients com-
pleted self‐rating questionnaires covering depression, mental tough-
ness, subjective sleep, and subjective physical activity. Further, sleep
was assessed via sleep‐EEG‐recordings at both time points. Patients
had physical activity programs every weekday for 1 to 4 hr.
Results: Compared to baseline (BL), at the end of the study (SE),
subjective sleep complaints decreased (BL: M = 15.17, SD = 5.70;
SE: 14.00 (SD = 4.58); t(45) = 2.03, p = 0.048). Over time, depres-
sion (BL: M = 2.8, SD = 2.6; SE: 1.8 (SD = 2.04); t(45) = 3.48,
p = 0.001), fatigue (BL: M = 42.18, SD = 14.34; SE: 36.11 (SD =
14.91); t(45) = 3.21, p = 0.002), and paresthesia scores (BL:
M = 4.15, SD = 2.89; SE: 3.26 (SD = 2.50); t(45) = 2.75, p = 0.009)
improved. Over time, subjective vigorous physical activity (min)
increased (BL: M = 90.00, SD = 31.26; SE: 507.14 (SD = 161.09); t
(45) = 2.64, p = 0.011). Descriptively, (N = 18) sleep onset latency
decreased, light sleep decreased, and deep sleep increased.
Conclusions: In patients with MS, regular physical activity has the
potential to impact positively on psychological functioning and both
subjective and objective sleep.
Disclosure: Nothing to disclose.
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P476 | SLOW wave activity (SWA) under
conditions of microgravity: the effects of 7 days
of whole body unloading using a hyperbuoyancy
floatation (HBF) bed
V. Gnoni1,2; S. Higgins1,2; J. Rosenzweig3; C.-C. Tsai1;
H. Hasegawa1,4; T.E. Morris-Paterson5; D.A. Green6;
A.D. Nesbitt1,2,7; T. Ball8; Z. Cvetkovic3; G.D. Leschziner1,2,7;
S.D.R. Harridge5; I. Rosenzweig1,2
1Sleep and Brain Plasticity Centre, Department of Neuroimaging, King's
College London,, 2Sleep Disorders Centre, Guy's and St Thomas’ Hospital,
London, UK, London, United Kingdom,, 3Department of Informatics,
King's College London, 4Department of Neurosurgery, King's College
Hospital, 5Centre for Human and Applied Physiological Sciences, King's
College London, London, United Kingdom, 6KBRwyle, European Astronaut
Centre, Cologne, Germany, 7GSTT Neurology and Basic and Clinical
Neuroscience, KCL, London, United Kingdom, London, United Kingdom,
8Medical Center, University of Freiburg, Freiburg, Germany
Objectives/Introduction: The effects of microgravity during
spaceflight, or with prolonged bed rest, on the brain have received
attention in relation to a visual impairment and intracranial pressure
syndrome in astronauts returning from the International Space Sta-
tion. However, the associated changes in neuroanatomy, cognition,
neuroelectrical activity and connectivity during wake and sleep have
not been studied extensively. In addition, significantly shortened and
disrupted sleep has also been consistently reported in space mis-
sions. The aim of the present study was to determine the effects of
7 days of supine unloading on a hyper‐saline filled water bed (hyper
buoyancy floatation, HBF), an Earth‐based novel analogue of micro-
gravity, on the topography of slow wave activity (SWA) (1–4 Hz).
Methods: Twelve healthy male subjects, aged (27.2 ± 4.2 years),
with no previous neuro/psychiatric history, underwent overnight in‐
laboratory polysomnography (PSG/EEG) recordings during 7 days of
an unloading period, collected with CPz referencing (64‐EEG‐chan-
nels; Ant Neuro, Germany). Sleep staging was performed according
to standard criteria. For the duration of the intervention period, the
subjects remained supine, followed set sleep/wake schedules, and
received a controlled diet. They were allowed a maximum of 15 min
per day off the HBF (for personal hygiene etc).
Results: The unloading period of 7 days resulted in a significant
(p < 0.05) change in SWA over centro‐frontal regions relative to the
rest of the brain. Global EEG power spectra (power spectral density
averaged across all scalp channels) did not differ between the first
and last night recording, for any of the sleep stages (N1, N2, N3,
REM sleep, Wake). The significant decrease in SWA power spanning
the frequency range 0.5–2.5 Hz was most prominent during N3 and
REM. However, during REM, a wider fronto‐occipital region was
affected.
Conclusions: Overall, results suggest the presence of local SWA
power differences induced by an intervention period of only 7 days
on HBF, a novel Earth‐based analogue of microgravity. Further stud-
ies are required to investigate potential mechanisms underlying the
observed SWA changes and their possible role in previously reported
cognitive changes under microgravity conditions.
Disclosure: Acknowledgements: Wellcome Trust [103952/Z/14/Z].
P477 | Which patients have abnormal spindles
and K complexes on routine PSGs?
S. Parreira; C. Bentes; A.R. Peralta
Serviço de Neurologia, Hospital de Santa Maria, CHLN, Lisboa, Portugal
Objectives/Introduction: Neurological disorders, namely Parkin-
son's disease (PD), REM sleep behaviour disorder (RBD), dementia,
psychiatric disorders, and stroke, may lead to changes in NREM
sleep microstructure. Previous studies have mostly analysed subtle
quantitative changes in sleep spindles and K‐complexes morphology
in each of these disorders. There are, however, PSGs where NREM
sleep microstrutucture is visually altered. The clinical significance of
this finding has not been systematically evaluated. Our aim was to
characterize a group of patients with clear morphological changes in
spindles and K‐complexes according to demographic characteristics,
neurological comorbidities and sleep macrostructure.
Methods: From 736 polysomnography's (PSG) performed in 2010–
2017 in a sleep lab from a university hospital neurological depart-
ment, we selected those with sleep spindles and K‐complexes abnor-
malities either in quantity and/or morphology based on the visual
analysis of the PSG by certified technicians and somnologists. We
performed a descriptive analysis of this group, including sex, age,
neurological disorders, other sleep disorders, and sleep macrostruc-
ture.
Results: We identified a total of 76 PSG with clear visually identi-
fied changes in sleep spindles and K‐complexes. Twenty‐one (28%)
were women, and mean age was 62.1 ± 18.2 years. Mean BMI was
27.8 ± 4.8 kg/m2. Mean sleep duration was 7 hr 07 ± 2 hr 03, wake-
fulness corresponded to 29% ± 17%. REM sleep was 6 ± 5% and
Non‐REM sleep corresponded to 65%±16%; with N1 24 ± 19%, N2
31 ± 19%, and N3 11 ± 11%. Neurological comorbidities were pre-
sent in 55 patients (72%): 15 DP, 7 multi system atrophy, 5 progres-
sive supranuclear palsy; 8 patients were diagnosed with dementia, 8
with epilepsy, and 3 with ischemic stroke; 9 patients had other neu-
rological diagnoses (3 restless legs syndrome, 2 Guillain‐Barré syn-
drome, 2 intracranial tumours, 1 vascular parkinsonism, 1 head
trauma). RBD was diagnosed in 14 patients (18%).
Conclusions: Poorly formed sleep spindles and K‐complexes occur
mostly in patients with previous neurological disorders, mainly PD or
atypical parkinsonism. Sleep in these patients is fragmented and
superficial, which may be related to the possible sleep protecting
functions of K complexes and spindles. These N2 changes may also
lead to difficulties classifying sleep, reinforcing the need for video‐
PSG in patients with significant neurological comorbidities.
Disclosure: Nothing to disclose.
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P478 | Poor sleep quality in patients with type
2 diabetes in association with melatonin and
other factors
P. Tretjakovs1; I. Konrade2; G. Krievina1; I. Kalere2;
N. Limba1
1Department of Human Physiology and Biochemistry, 2Department of
Internal Diseases, Riga Stradins University, Riga, Latvia
Objectives/Instruction: Of the present study was to evaluate the
serum levels of melatonin in type‐2 diabetic patients and to clarify
whether there is an influence of adiposity and smoking.
Methods: 26 type‐2 diabetic (T2D) patients were recruited in the
pilot study and 12 healthy subjects (non‐smokers) were selected as
controls (C). The study groups were matched for age and sex. Mela-
tonin was measured in saliva by ELISA. Statistical analyses were per-
formed using SPSS Statistic software.
Results: Patients with T2D had significantly lower melatonin level
than healthy control subjects (p < 0.003), besides T2D patients with
adiposity (BMI > 30 kg/m2) had significantly lower melatonin level
than patients without adiposity (p < 0.035), as well as T2D smokers
had significantly lower melatonin level than T2D non‐smokers.
Conclusions: T2D patients are associated with decreased mela-
tonin level in saliva. Adiposity and smoking have influence on the
decrease of melatonin concentration of T2D patients.
Disclosure: Nothing to disclose.1
P480 | The comparison of dexmedetomidine
and midazolam for sleep in critically ill patients
S.J. Kim1; Y.J. Lee2; J.S. Park2; Y.-J. Cho2; H.I. Yoon2;
C.-T. Lee2; J.H. Lee2
1Pulmonology, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, United
Arab Emirates, 2Pulmonology, Seoul National University Bundang
Hospital, Seongnam, Republic of Korea
Objectives/Instruction: Many critically ill patients treated in the
intensive care unit (ICU) experience sleep disruption. For the seda-
tion of critically ill patients, dexmedetomidine and midazolam are
commonly used. This study was undertaken to compare dexmedeto-
midine and midazolam for sleep in critically ill patients.
Methods: This prospective study was conducted in medical ICU of
a tertiary referral hospital. Polysomnography recording was per-
formed over 24 hr to assess the quantity and quality of sleep in
patients who sedated with dexmedetomidine and midazolam.
Results: Total 19 patients were enrolled. Even though Richmond
Agitation‐Sedation Scale was not different (p = 0.099), total sleep
time was longer in midazolam group (418.0 [286.3] min) than
dexmedetomidine group (210.1 [146.0] min, p = 0.050). Midazolam
group showed longer sleep duration compared with dexmedeto-
midine group during stage 2 (194.3 [201.1] min vs. 48.3 [68.0] min,
p = 0.034) and REM (28.0 [40.6] min vs. 1.3 [3.6] min, p = 0.032)
sleep.
Conclusions: The duration of sleep in sedated critically ill patients
was longer with midazolam than dexemedetomidine. Especially,
midazolam group showed longer sleep in stage 2 and REM sleep.
Disclosure: Nothing to disclose.2
P482 | Hypopharyngeal surgery for OSAS –
side effects
A. Katbeh; N.N. Carmel Neiderman; E. Rosenzweig
Department of Otolaryngology Head and Neck Surgery and Maxillofacial
Surgery, Tel Aviv Sourasky Medical Center, Sackler School of Medicine,
Tel Aviv University, Tel Aviv, Israel
Objectives/Instruction: Hypopharyngeal collapse during sleep
prevails in as much as 70% of OSAS patients. The commonest inter-
ventions targeting hypopharyngeal aerodynamics are lingual tonsil-
lectomy with tongue base(T.B) ablation and hyoid suspension(H.S)
applied alone or as part of multilevel approach. These procedures
might be associated with several side effects (SE) affecting long term
quality of life. We hereby present the incidence of dysgeusia, hypos-
mia, oral sensation and dysphagia in our cohort.
Methods: This is a retrospective study. 41 patients that underwent
H.S, T.B coblation ablation, T.B transoral robotic surgery (T.O.R.S), T.B
channeling between 82,014–12,017 where identified. Patients were
asked to complete the eat 10 questioner. They were further interro-
gated regarding changes of smell, taste and oral sensation. Scoring
was 0–4 regarding disturbance severity. Patients were grouped in
accordance to the surgical procedure performed. Significance of inci-
dence or severity difference of SE were checked by chi square test.
Results: 27 patients completed the questioner. 20 reported at least
one S.E. Mean eat 10 score was 3. S.E incidence ratio and mean
eat10S.E severity were: 55 and 1.6 respectively for T.O.R.S patients,
57 and 6.28 for B.T coblation, 36 and 1.5 for H.S., 23 and 1.3 for
B.T channeling and 36 and 2.5 for the combined group. Differences
between groups were statistically insignificant. Difference between
combined group and all other groups together was insignificant as
well (p = 0.75).
Conclusions: The risk for persistent SE in patients undergoing
hypopharyngeal surgery for O.S.A.S is high regardless of the proce-
dure elected. Larger cohort is needed for SE intervention specific
risk determination. Multistage approach should be considered.
Disclosure: None.3
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P483 | Sleep in ATR‐X
P. van Mierlo1,2; H. Braakman2; H.J. Schelhaas2; S. Pillen1
1Sleep Medicine Center, Kempenhaeghe, 2Department of Neurology,
Academic Center for Epileptology Kempenhaeghe & Maastricht UMC+,
Heeze, the Netherlands
Objectives/Instruction: X‐linked alpha thalassemia mental retar-
dation (ATR‐X) syndrome is characterized by four main symptoms:
severe mental retardation, alpha thalassaemia, facial dysmorphisms
and genital abnormalities, occurring exclusively in males. Sleep disor-
ders are commonly reported in clinic, but their frequency and nature
have not been studied.
Aim: In this cross‐sectional study we explored sleep rhythm, and
the prevalence and treatment of sleep disorders in ATR‐X syndrome.
Methods: All members of the Dutch and international ATR‐X foun-
dation were asked to participate in this study. If they were willing,
parents received the sleep questionnaire of Simonds and Parraga
and kept a graphical sleep diary for 2 weeks.
Results: Thirty‐seven participants joined the study with mean age
of 12.9 years (range 1.8–43.5 years). Twenty six out of 37 (70%)
reported sleep problems (62% current, 8% in the past). The most fre-
quent occurring sleep problems were difficulty falling asleep (41%)
and maintaining sleep (51%). The sleep diary (N = 17) showed a total
mean sleep time of 10.4 hr, total bed time of 12.3 hr (daytime naps
included), sleep efficiency 85% and sleep onset of 0.96 hr. There
was no decrease in sleep time or total bed time with increasing age.
Individuals with sleep problems went to bed earlier (p = 0.03) and
had a lower sleep efficiency (p < 0.01) than individuals without self‐
reported sleep problems. Parents mentioned gastro‐intestinal prob-
lems, jerky movements and hyperactivity as possible sleep disturbers.
Sixteen out of 37 participants (43%) used medication (predominantly
melatonin N = 10) to improve sleep which gave improvement in only
two (melatonin together with temazepam; alimimazin).
Conclusions: Seventy per cent of individuals with ATR‐X syndrome
experienced sleep problems, although total sleep time was normal in
most patients. Physical discomfort and hyperactivity were mentioned
by parents as a possible cause of sleep problems. However, long
bedtimes might also have a negative influence on sleep efficiency.
Sleep medication is usually not effective, urging the need for new
treatment programs in these patients.
Disclosure: This research was funded with an unrestricted grant
from the Dutch ATR‐X syndrome Foundation.
P484 | Non‐apnoea sleep disorder increases
the risk of incident heart failure‐a nationwide
population‐based cohort study
I.-D. Wang1; C.-K. Peng2
1Division of Pulmonary and Critical Care Medicine, Department of
Internal Medicine, Tri‐Service General Hospital, 2Division of Pulmonary
and Critical Care Medicine, Department of Internal Medicine, Tri‐Service
General Hospital, National Defense Medical Center, Taipei, Taiwan
Objectives/Instruction: Non‐apnoea sleep disorder (NASD)
increases the risk of cardiovascular events, such as hypertension
and ischemic heart disease (IHD). Patients with heart failure (HF)
are at higher risk for sleep disorder; however, there is no docu-
mentation on NASD's association with HF to date. Therefore, our
study aimed to determine whether NASD increases the risk of
incident HF.
Methods: Using the outpatient and inpatient data from Taiwan's
Longitudinal Health Insurance Database, we conducted a nation-
wide cohort study of patients with a first‐time diagnosis of NASD
in the year 2000 and followed up the risk of incident heart failure
until December 31, 2013. We calculated risks and incidence ratios
of HF for patients with NASD compared with the general popula-
tion. The cumulative incidence of NASD and the subsequent risk
of HF are assessed by the Kaplan‐Meier method and Cox regres-
sion using a matched comparison cohort of HF patients without
NASD.
Results: The NASD cohort had an adjusted hazard ratio (HR) of
incident HF 23.6% higher than that of the cohort without NASD
(95% CI = 1.164–1.308; p < 0.001). In the NASD population, the
mean interval to HF in males and females were 5.02 ± 3.65 years
and 5.02 ± 3.70 years, respectively. The Kaplan‐Meier analysis indi-
cated that after the seventh year, the incidence of HF was higher in
the NASD cohort than in the control cohort till the end of the follow
up.
Conclusions: Our study demonstrates that NASD patients are at a
higher risk of incident HF.
Disclosure: Nothing to disclose.
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P485 | Opioid use in adults referred for sleep
disorder assessment and associated long‐term
consequences: a population‐based study
T. Kendzerska1,2,3; T. Gomes4,5; A. Gershon4,5; M.-E. Hogan4;
D. McIsaac1,2,3; R. Talarico2; D. McKim6; J. Sandoz6;
R. Dales6; P. Tanuseputro1,2,3
1Ottawa Hospital Research Institute, 2Institute for Clinical Evaluative
Sciences, 3University of Ottawa, Ottawa, 4University of Toronto,
5Institute for Clinical Evaluative Sciences, Toronto, 6Ottawa Hospital,
Ottawa, ON, Canada
Objectives/Instruction: Opioid use is associated with impaired
breathing in sleep and impaired sleep architecture. Despite these
risks, there are no large‐scale population studies investigating the
long‐term consequences of this relationship. We conducted a popu-
lation‐based cohort study using provincial health administrative data
in Ontario (Canada) to (i) investigate the prevalence of opioid use
among adults who underwent an initial diagnostic overnight sleep
study, and (ii) assess the relationship between opioid use, positive
airway pressure (PAP) treatment, and long‐term outcomes in this
population.
Methods: We included all adults who underwent an initial diagnos-
tic sleep study in Ontario between 2013 and 2016, and followed
them until March 2017, excluding individuals who received palliative
care or resided in a long‐term care facility prior to the sleep study.
Our exposure, opioid use at the date of the sleep study, was identi-
fied from the Narcotics Monitoring System. PAP therapy initiation
was defined through the Ontario Assistive Devices Program data-
base. Our composite outcome was time from sleep study to the first
of emergency department visit, hospital admission, or all‐cause
death. We used Cox models to investigate the relationship between
opioid exposure, PAP initiation and the outcome, controlling for
income status, comorbidities, primary care exposure and use of con-
trolled substances at baseline.
Results: A total of 267,461 adults (median age 51 years; 57%
men), were included in our analyses of whom 12,205 (5%) were on
opioids at the time of the sleep study. Over a median follow‐up of
24.5 months, 103,398 (39%) initiated PAP and 140,080 (52%) devel-
oped a composite outcome. Controlling for confounders, opioid use
was significantly associated with an increase hazard of the compos-
ite outcome (HR = 1.21, CI: 1.19–1.24), but not with PAP prescrip-
tion (HR = 1.03, CI: 0.99–1.06). The results were driven by all‐cause
death: HR = 1.52, CI: 1.39–1.66.
Conclusions: In a large population‐based study, we found that
among adults referred for a sleep disorder assessment, opioid expo-
sure was associated with a 21% increased hazard of hospital visits
or death from any cause. These findings suggest the need for better
management in these individuals and can be used to identify those
at the most risk, ultimately improving clinical outcomes.
Disclosure: Bruyere Research Institute ‐ Big Data Research Fund.
P486 | Analysis of tissue metalloproteinase
inhibitor‐1 gene polymorphism (C536T) in non‐
valvular atrial fibrillation patients with
concomitant obstructive sleep apnea‐hypopnea
syndrome
T. Balabanovich1; V. Shyshko1; T. Stepuro2
1Internal Diseases, 2Grodno State Medical University, Grodno, Belarus
Objectives/Instruction: The events in obstructive sleep apnea/hy-
popnea (OSAHS) result in an arrhythmogenic structural substrate for
atrial fibrillation (AF) characterized by atrial fibrosis formation. Both
in AF patients and in subjects with OSAHS an altered expression of
some matrix metalloproteases and their tissue inhibitors has been
described, which may influence the extracellular matrix remodeling.
Aim of the study was to explore if tissue metalloproteinase inhibitor‐
1 (TIMP‐1) gene polymorphism (C536T) could be found in patients
with non‐valvular AF and co‐existing OSAHS and be related to
OSAHS severity and various stages of AF.
Methods: 78 patients with non‐valvular AF (50 (64.1%) men) were
recruited into this study (mean age 54.04 ± 8.15 years) and classified
into one of 3 groups: paroxysmal, persistent and permanent AF. A
24‐hr multifunctional study with cardiorespiratory monitoring was
conducted in the study subjects and they were divided into 2 groups
according to the presence of OSAHS. DNA was extracted from
peripheral venous blood leukocytes by commercial kits. Genotyping
of TIMP‐1 (C536T) was carried out using real‐time polymerase chain
reaction method. All statistical analyses were performed using STA-
TISTICA 10.0 (Start Soft Inc., USA)
Results: There were 55 (70.51%) confirmed OSAHS patients (34
(61.82%) men) among the study subjects. OSAHS group demon-
strated AHI level of 25 (LQ14; UQ34) and non‐OSAHS patients have
AHI level of 4 (LQ2; UQ4) (p < 0.001). 32.73% patients had severe
OSAHS, 41.82% patients had moderate OSAHS and 25.45% patients
were with mild OSAHS. Patients with persistent/permanent AF had
higher level of AHI than patients with paroxysmal AF (18 (LQ4;
UQ30)/28.5 (LQ23.5; UQ35.5) vs. 9 (LQ4; UQ20, p = 0.002). Moder-
ate/severe OSAH patients were more likely than mild OSAHS
patients to have permanent AF (38.89%/17.39% vs. 0%, p = 0.013).
The analysis of TIMP‐1 (C536T) polymorphism revealed the follow-
ing distribution of CC, CT, and TT genotypes between the study
groups: in all subjects the frequency of CC genotype was 100%, CT
genotype – 0%, TT genotype – 0%. The allele frequency of the C
allele was 100%.
Conclusions: The results showed absence of association between
TIMP‐1(C536T) gene polymorphism and the stage of AF progression
or presence of OSAHS in the study cohort.The prevalence of perma-
nent AF rises with the disease severity of OSAHS and level of AHI.
Disclosure: Nothing to disclose.
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P487 | Effects of sleep extension on glucose
metabolism in chronically sleep‐deprived
individuals
A. So-Ngern1; N. Chirakalwasan2,3; S. Saetung4;
A. Thakkinstian5; S. Reutrakul6
1Division of Sleep Medicine, Department of Medicine, Faculty of
Medicine, Khon Kaen University, Khon Kaen, 2Division of Pulmonary and
Critical Care Medicine, Department of Medicine, Faculty of Medicine,
Chulalongkorn University, 3Excellence Center for Sleep Disorders, King
Chulalongkorn Memorial Hospital, Thai Red Cross Society, 4Division of
Endocrinology and Metabolism, Faculty of Medicine, Ramathibodi
Hospital, Mahidol University, 5Section for Clinical Epidemiology and
Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol
University, Bangkok, Thailand, 6Division of Endocrinology, Diabetes and
Metabolism, Department of Medicine, University of Illinois at Chicago,
Chicago, IL, United States
Objectives/Introduction: Sleep deprivation is common in general
population and shown to be associated with increased insulin resis-
tance which may pose the risk of diabetes development. This study
investigated whether 2‐week sleep extension in chronically sleep‐
deprived individuals would improve glucose metabolism.
Methods: A randomized‐crossover trial was conducted in non‐dia-
betic volunteers who reported habitual sleep time <6 hr/night during
the week days. The participants were randomized to maintain their
habitual sleep or extend their sleep time for 2 weeks (with a goal of
1 hr extension), then crossed over after a washout period. Sleep was
monitored by actigraphy recordings. A 75‐g oral glucose tolerance
was performed at the end of each period with glucose and insulin
levels, along with weight and caloric intake recordings. Mixed effect
linear regression analysis adjusting for sequence and period effects
was applied.
Results: Twenty‐one subjects (19 females) with mean age of
33.1 ± 6.1 years completed the protocol. Mean sleep duration during
habitual sleep was 318.7 ± 44.3 min. The average washout period
was 21 ± 11 days. The participants extended their sleep by
36.0 ± 45.2 min. There were no significant effects of sleep extension
on any metabolic parameters. Two additional per protocol analyses
were performed. Seventeen participants did extend their sleep dur-
ing the sleep extension period, with a mean sleep duration of
361 ± 42 min (average extension 51.2 ± 33.8 min). The analysis in
this group did not reveal significant effects of sleep extension on
metabolic parameters. The second per‐protocol analysis included
eight participants who could sleep more than six hours during sleep
extension (mean sleep duration 396 ± 25 min, extended by
60.1 ± 28.5 min). The analysis revealed that sleep extension resulted
in improved fasting insulin resistance (HOMA‐IR) (adjusted mean dif-
ference −0.50 (95% CI −0.90, −0.11, p = 0.013)), increased early
insulin response to glucose (insulinogenic index) (mean difference
0.39 (95% CI 0.15, 0.63, p = 0.001)), and improved β‐cell function
(disposition index) (mean difference 1.07 (95% CI 0.17, 1.97,
p = 0.02)).
Conclusions: Sleep extension in chronically sleep‐deprived individ-
uals resulted in improved glucose metabolism but only among those
who could sleep >6 hr/night. Our findings suggest that a critical
amount of sleep is needed to benefit metabolic outcomes.
Disclosure: Nothing to disclose.
P488 | Respiratory events, heart rate and
oxygen parameters in obstructive sleep apnea ‐
chronic obstructive pulmonary disease patients
S. Mihaicuta1,2; P. Schonner1; A. Rus3; A. Ciotlos Sinoi3;
D. Reisz4,5
1Pulmonology, University of Medicine and Pharmacy Dr. V. Babes,
2Pulmonology, Cardioprevent Foundation, 3Victor Babes Hospital,
4Neurology, University of Medicine and Pharmacy Dr. V. Babes, 5Clinica
de Medicina a Capului, Timisoara, Romania
Objectives/Instruction: It is expected that the patient having the
overlap syndrome of obstructive sleep apnea (OSA)‐ chronic obstruc-
tive pulmonary disease (COPD) will show overall higher impact on
different physiological parameters.
Methods: 1,865 consecutive patients from 2007 to 2017 from
Timisoara Sleep Lad were analyzed: 1,536 (82.4%) in group OSA
without COPD and 329 (17.6%) in group OSA ‐COPD. The groups
were compared regarding central, mixed and obstructive apnea
index, hypopnea index, apnea‐hypopnea index (AHI), mean duration
of central, mixed and obstructive apnea, mean duration of hypopnea
and apnea, mean heart rate during sleep, mean blood oxygen satura-
tion, lowest desaturation, desaturation index. The p‐values under
0.05 are regarded as statistically significant.Descriptive data is
reported as mean values and standard deviations (SD), medians, or
percentages.The Student's t‐test for independent samples was per-
formed. Continuous variables were analyzed by the Mann‐Whitney
U test. For categorical variables, the chi‐square test was performed.
Results: central apnea index 3.1 ± 5.4/hr vs. 3.3 ± 5.3/hr (p = 0.980),
mixed apnea index 3.5 ± 5.9/hr vs. 3.7 ± 6.8/hr (p = 0.663), obstruc-
tive apnea index 24.6 ± 21.9/hr vs. 25.2 ± 20.1/hr (p = 0.157), hypop-
nea index 13.4 ± 9.3/hr vs. 15.7 ± 10.7/hr (p < 0.001), apnea
hypopnea index 44.8 ± 24.8/hr vs. 47.3 ± 25.3/hr (p = 0.090), central
apnea duration 17.3 ± 6.3 s vs. 16.7 ± 5.1 s (p = 0.211), mixed apnea
duration 20.5 ± 7.1 s vs. 19.8 ± 6.3 s (p = 0.443), obstructive apnea
duration 20.4 ± 5.5 s vs. 20.2 ± 5.3 s (p = 0.904), hypopnea duration
21.6 ± 3.8 s vs. 21.3 ± 3.7 s (p = 0.202), apnea duration 21.5 ± 4.7 s
vs. 20.9 ± 4.1 s (p = 0.112), heart rate during sleep 68.0 ± 12.1 beats
per min vs. 69.1 12.9 (p = 0.235), mean O2 saturation 92.4 ± 4.1% vs.
90.1 ± 5.7% (p < 0.001), lowest desaturation 77.0 ± 12.7% vs.
73.5 ± 14.3% (p < 0.001), desaturation index 30.5 ± 26.9/hr vs.
36.0 ± 27.5/hr (p < 0.001).
Conclusions: COPD makes OSA patients significantly more desatu-
rated during sleep regarding mean O2 saturation, lowest desatura-
tion, and desaturation index with no significantly differences
regarding the type and duration of respiratory events and heart rate,
with the exception of hypopnea index.
Disclosure: Nothing to disclose.
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P489 | Anthropometric and comorbidity
differences in patient with obstructive sleep
apnea and chronic obstructive pulmonary
disease
S. Mihaicuta1,2; P. Schonherr3; D. Reisz4,5; A. Ciotlos-Sinoi6;
A. Rus6; R. Dan7
1Pulmonology, University of Medicine and Pharmacy Dr. V. Babes,
2Pulmonology, Cardioprevent Foundation, 3University of Medicine and
Pharmacy Dr. V. Babes, 4Neurology, University of Medicine and
Pharmacy Dr. V. Babes, 5Clinica de Medicina a Capului, 6Victor Babes
Hospital, 7Cardiology, University of Medicine and Pharmacy
Dr. V. Babes, Timisoara, Romania
Objectives/Instruction: In the overlap syndrome of obstructive
sleep apnea (OSA) – chronic obstructive pulmonary disease (COPD)
it is expected that the patients will show overall poorer results and a
higher prevalence of health consequences.
Methods: 1865 consecutive patients from 2007 to 2017 from
Timisoara Sleep Lab were analyzed with data regarding patients’ his-
tory, gender, age, body mass index (BMI) kg/weight2), apnea‐hypop-
nea index (AHI), pack‐years of smoking, Epworth sleepiness scale
(ESS), comorbidities such as diabetes mellitus (DM), systemic hyper-
tension (SHT), coronary artery disease (CAD), heart failure (HF),
arrhythmias, stroke. Descriptive data is reported as mean values and
standard deviations (SD), or percentages. The Student's t‐test for
independent samples was performed. Continuous variables were
analyzed by the Mann‐Whitney U test. For categorical variables, the
chi‐square test was performed.
Results: 1536 (82.4%) patients in group OSA without COPD vs.
329 (17.6%) patients in group OSA ‐COPD, 483 (31.4%) female vs.
53 (16.1%) (p < 0.001), 1053 (68.6%) male vs. 276 (83.9%)
(p < 0.001), age 52.2 ± 12.2 years vs. 58.2 ± 9.0 years (p < 0.001),
BMI 33.5 ± 6.6 kg/m2 vs. 36.0 ± 6.9 kg/m2 (p < 0.001), AHI
44.8 ± 24.8/hr vs. 47.3 ± 25.3/hr (p = 0.090), smoking 664 (44.1%)
patients vs. 244(77.0%) (p < 0.001), pack‐years 21.1 ± 14.1 vs.
32.3 ± 17.5 (p < 0.001), ESS 11.1 ± 5.2 vs. 12.2 ± 5.4 (p < 0.001),
DM 99 (17.6%) vs. 45 (37.5%) (p < 0.001, SHT 1027 (67.6%) vs. 254
(77.4%)( p < 0.001), CAD 438 (29.4%) vs. 153 (48.3%) (p < 0.001),
HF 332 (22.4%) vs. 144 (45.1%) (p < 0.001), arrhythmias 348
(23.3%) vs. 93 (30.4%) (p = 0.008), stroke 62 (4.3%) vs. 17 (5.7%)
(p = 0.287).
Conclusions: COPD ‐OSA is common. Patients are more males,
heavier, older, sleepier, and more smokers. Cardiovascular comorbidi-
ties are significantly higher, with the exception of stroke. However,
COPD does not seem to significantly affect apnea hypopnea index.
Disclosure: Nothing to disclose.
P490 | Sleep bruxism, low back pain and
quality of life
M. Lima1; B. Silva1; D. Sanz2; J. Silva3; I. Luzeiro1
1Serviço de Neurologia, 2Serviço de Maxilofacial, 3Serviço de
Reumatologia, Centro Hospitalar e Universitário de Coimbra, Coimbra,
Portugal
Objectives/Instruction: Sleep bruxism (SB) is a sleep‐related
movement disorder. The repercussions in the patients’ quality of life
(QoL) are scarcely studied. Chronic low back pain (LBP) is one of the
main and most studied causes of chronic pain and dysfunctions in
the QoL. Main: determine the patients’ with the diagnosis of SB,
QoL, comparing with the QoL of patients with LBP. Secondary:
determine, in the group with SB, how the QoL of those with isolated
SB and those with SB associated with migraine is.
Methods: Clinical, observational and transversal, non‐randomized
study performed at Centro Hospitalar e Universitário de Coimbra
(CHUC) which included 38 patients, of both genders, in adulthood;
18 with SB and 20 with LBP. The instruments applied were surveys
that assessed characteristics of pain, daytime sleepiness scale
(Epworth), QoL survey (SF‐36v2) and anxiety and depression scale
(HADS). The statistical analysis was performed in SPSSv24 with stan-
dard p < 0.05 cutoff.
Results: The sample (n = 38) is mostly female and presents a high
BMI. In both diseases the pain's intensity is similar. There is less
inability (p < 0.05) in SB. The QoL is similar; except in physical per-
formance (p < 0.05) that is lesser in LBP. HADS did not reveal signif-
icant differences between both. There is no relationship between
Epworth scale and the diseases, presenting both low daytime sleepi-
ness levels. Between isolated SB (n = 7) and SB associated with
migraine (n = 11) the significant differences (p < 0.05) found in QoL
are in bodily pain and social function. In HADS, SB associated with
migraine presents more anxiety. HADS and SF‐36v2 show good cor-
relation between them (p < 0.05), regardless of the disease. Pain
intensity relates to anxiety, bodily pain and social function (p < 0.05
and p < 0.01), and inability relates to bodily pain, role‐physical and
general health (p < 0.05 and p > 0.01), regardless of the disease.
Conclusions: Patients with LBP present worse physical perfor-
mance and greater inability than BN, the remaining parameters of
QoL present overlapping results. SB associated with migraine pre-
sents more bodily pain, worse social function, greater intensity and
inability, and more anxiety than isolated, the remaining parameters
present overlapping results.
Disclosure: Nothing to disclose.
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P492 | The role of chronotype and sleep
hygiene in the treatment of obesity
E. Fárková1,2; M. Šmotek1,2; J. Herlesová3; J. Schneider1,4;
E. Bakštein1,4; J. Kopřivová1,2
1National Institute of Mental Health, Klecany, 23rd Faculty of Medicine,
Charles University, 3OB Clinic, 4Czech Technical University in Prague,
Faculty of Electrical Engineering, Prague, Czech Republic
Objectives/Introduction: Physiological changes related to
reduced sleep quality/duration and circadian rhythmicity are risk fac-
tors for increased apetite, body weight, blood pressure and for
reduced glucose tolerance and immune response. These and other
factors contribute to the emergence of metabolic and cardiovascular
disorders. Due to many contributing factors, there is a vast space for
improvement, especially through chronotype identification, sleep
hygiene adjustment and control of light environment. These inter-
ventions can be used to current obesity treatment methods and
increase the effectiveness of programs aimed at reducing body
weight values.
Methods: 92 women (18–50 years) in conservative obesity treat-
ment (BMI > 25 kg/m2) using 3‐months actigraphy, sleep diaries,
MEQ, MCTQ. Therefore the length and quality of sleep, the individ-
ual setting of circadian rhythms and the rate of social jet‐lag were
validated.
Results: There is a negative correlation between BMI and sleep
duration (−1.2, p = 0.026), so we can say that women with higher
BMI have a shorter sleep duration. The distribution of chronotypes
in the set indicates the Gaussian distribution, as well as in the
healthy population. Chronotype is closely related to individual rate
of social jet‐lag. We found a positive correlation between the BMI
and the social jet‐lag (0.03, p = 0.03), which suggests that women
who have a higher BMI have a greater discontinuity between their
internal biological clocks and the outside social time.
Conclusions: The results of the study show that BMI or body
weight changes the quality and length of sleep. With increasing BMI,
the amount of sleep decreases and the rate of social jet‐lag rises.
Perhaps because of the massive weight, the patient suffers from
orthopedic and respiratory difficulties, which may wake them up and
prolong sleep latency. If this scenario repeats, the sleep deficit grows
and the freshness does not come. The disruption of the sleep‐wake
cycle can lead to extensive changes in the body, for example leading
to a disruption of the metabolic system. Previous studies have
shown that metabolic and circadian system interacts bilaterally and
that short and poor sleep can contribute to weight gain and obesity.
We consider to expand the obese population′s research and use the
knowledge in clinical practice.
Disclosure: This study is a result of the research funded by the
project GA UK (1096216), project Nr. LO1611 with a financial sup-
port from the MEYS under the NPU I program. Further supported
by project “PROGRES Q35” and 260388/SVV/2018.
P493 | Are subjective measurements of
insomnia sufficient in chronic pain?
K. Abeler; O. Friborg; S. Bergvik
Institute of Psychology, UiT‐ The Arctic University of Norway, Tromsø,
Norway
Objectives/Introduction: Insomnia is prevalent among patients
with chronic pain and may contribute to aggravation and persistence
of pain. Among key features of insomnia are increased sleep onset
latency, periods of wake after sleep onset and early morning awak-
ening, which all contribute to reduced sleep efficiency (SE). In a clini-
cal setting insomnia is often assessed by subjective measures such
as the insomnia severity index (ISI). How well does ISI reflect SE as
measured by polysomnography (PSG) and actigraphy in pain patients
and healthy controls?
Methods: 56 patients with chronic musculoskeletal pain and 53 age
and gender matched healthy controls participated. Symptoms of
insomnia were measured by ISI. A cut off score of 15 was used to indi-
cate clinical insomnia. SE was measured by one night of PSG and
7 days of actigraphy. Pain was assessed by Brief Pain Inventory (BPI),
symptoms of anxiety and depression by Hopkins Symptoms Check List
25 (HSCL 25) and fatigue by Chalder fatigue scale. Group differences
were analyzed by Students t‐tests and Fisher`s exact test for continu-
ous and dichotomous variables, respectively. Pearson correlation coef-
ficients were estimated for associations between variables.
Results: Clinical insomnia (ISI > 15), was more prevalent among
pain patients than controls (30.4% vs. 3.8%, p < 0.001). Actigraphy
showed significantly lower SE among pain patients (M = 86.5, SD =
5.0) than controls (M = 89.2, SD = 4.1), p = 0.002. There was no
significant difference in SE as measured by PSG. Among pain
patients, the correlation between ISI score and SE (either actigraphy
or PSG) was non‐significant. However, ISI correlated significantly
with BPI (r = 0.37, p = 0.006), HSCL (r = 0.77, p < 0.001) and
Chalder fatigue (r = 0.75, p < 0.001).
Conclusions: Subjectively measured insomnia was more prevalent
among patients with chronic pain compared to healthy controls, but
did not reflect objectively measured indicators of insomnia. How-
ever, subjective insomnia was related with measures of pain, mental
distress and fatigue. In comorbid insomnia and pain, assessment of
depression, fatigue and objective measures of sleep may be war-
ranted in order to address sleep disturbance adequately.
Disclosure: Nothing to disclose.
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P494 | Insomnia disorder as a predictor of
mental disorders and pain: a systematic review
and meta analysis
E. Hertenstein1; B. Feige2; T. Gmeiner2; C. Kienzler2;
K. Spiegelhalder2; A. Johann2; M. Jansson-Fröjmark3;
L. Palagini4; G. Ruecker5; D. Riemann2; C. Baglioni2
1Psychiatrie und Psychotherapie, Universitäre Psychiatrische Dienste
Bern (UPD), Bern, Switzerland, 2Freiburg University Medical Center,
Freiburg, Germany, 3Department of Psychology, Stockholm University,
Stockholm, Sweden, 4University of Pisa, Pisa, Italy, 5University of
Freiburg, Freiburg, Germany
Objectives/Instruction: Previous research has identified insomnia
as a predictor for the onset of major depression. The aim of this
meta‐analysis is to investigate whether insomnia also predicts the
onset of other mental disorders and pain.
Methods: The databases PubMed, Medline, PsycInfo, and PsycArti-
cles were searched for longitudinal studies investigating the predic-
tive value of the presence of insomnia at baseline for the presence
of psychopathology or pain at follow‐up. Primary studies were eligi-
ble if they included insomnia diagnosed based on DSM criteria and
no mental comorbidity/pain at baseline or a statistical control for
baseline psychopathology/pain.
Results: Fourteen primary studies were included in the meta‐analy-
sis. Across all studies, the model found an odds ratio of 2.43 (confi-
dence interval: 1.67–3.54), indicating that insomnia disorder is a
significant predictor for later onset of psychopathology/pain. Sub-
group analyses showed similar results, i.e. insomnia was identified as
a predictor of depression, anxiety disorders, alcohol abuse, and pain.
One study suggested that insomnia is also a predictor of psychotic
disorders. The overall risk of bias in the primary studies was rated as
moderate, whereby most problems arose from insufficient documen-
tation of attrition and reasons for dropout.
Conclusions: This meta‐analysis provides evidence that insomnia
increases the risk for future onset of psychopathology and pain in
general. A future research agenda should include more prospective
studies evaluating insomnia diagnosis at baseline and long‐term fol-
low‐up intervals assessing a wide range of mental disorders. In addi-
tion, prospective long‐term interventional studies investigating the
efficacy of insomnia treatment for the prevention of mental disor-
ders and pain are called for.
Disclosure: Nothing to disclose.
P495 | Sleep in individuals at risk of bipolar
disorder
P. Jawinski1,2; C. Sander2,3,4; U. Hegerl2,3,4; T. Hensch2,3
1Department of Psychology, Humboldt‐Universität zu Berlin, Berlin, 2LIFE
‐ Leipzig Research Center for Civilization Diseases, 3Department of
Psychiatry and Psychotherapy, University of Leipzig, 4Depression
Research Centre, German Depression Foundation, Leipzig, Germany
Objectives/Instruction: Individuals with hypomanic personality
are extraverted, impulsive, energetic, overconfident, and intensely
emotional. Beyond that, they are at an increased risk of bipolar dis-
order (BD, ‘manic‐depressive illness’). Given the pathogenic role of
disturbed sleep in BD, we investigated whether sleep alterations
may also be related to hypomanic personality.
Methods: Participants filled in the Hypomanic Personality Scale
(HPS; N = 1,890) and either underwent a 7‐day actigraphy assess-
ment (n = 771) or completed the Pittsburgh Sleep Quality Index
(PSQI; n = 1,766), or both. We analyzed whether the HPS total score
and the three HPS facets ‘hypomanic core’, ‘sociability’, and ‘ordi-
nariness’ (as derived from factor analyses) are associated with the
fourteen objective and seven subjective sleep variables.
Results: In total, 40 out of 84 correlations were significant after
multiple testing correction (False Discovery Rate <0.05). HPS was
associated with shorter, less efficient and a particularly higher vari-
ability of objectively assessed sleep. Likewise, HPS was associated
with the questionnaire data, i.e. with shorter and less efficient sleep,
higher daytime sleepiness, and lower sleep quality. The most signifi-
cant associations were obtained between the PSQI total score (indi-
cator for poor subjective sleep quality) and HPS facet hypomanic
core (rho = 0.158, p = 3E‐11) as well as facet ordinariness (rho =
−0.165, p = 3E‐12).
Conclusions: The current study reveals compelling evidence for
sleep alterations in individuals at risk of BD. Similar to relapse pre-
vention strategies in BD, the modification of sleep habits might be a
valuable approach to avert mood episodes in individuals with hypo-
manic personality.
Disclosure: Nothing to disclose.
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P496 | Family irregularity disturbs the
development of sleep in children
M.E. Koopman-Verhoeff1; F. Serdarevic1; D. Kocevska1;
H. Tiemeier1,2; C.A.M. Cecil1,3; F.C. Verhulst1;
M.P.C.M. Luijk1,4
1Child and Adolescent Psychiatry, Erasmus Medical Center, Rotterdam,
the Netherlands, 2Social and Behavioral Science, Harvard TH Chan
School of Public Health, Boston, MA, United States, 3Institute of
Psychiatry, Psychology and Neuroscience, Kings College London, London,
United Kingdom, 4Psychology, Erasmus University Rotterdam, Rotterdam,
the Netherlands
Objectives/Instruction: Previous studies have shown that poor
family environments are related to more sleep problems; however,
little is known about how family irregularity in early life affects the
development of sleep problems over childhood using objective sleep
measures. The current study tests the hypothesis that early family
irregularity contributes to the development of sleep problems.
Methods: This population‐based study comprises 5,443 children
from the Generation R Study. Family irregularity was measured with
seven maternal reported questions on family routines when children
were 2 and 4 years old. Mothers reported on sleep problems at child
age 3, 6, and 10 years, children completed questionnaires at age 10.
Additionally, we used tri‐axial wrist accelerometers for five nights in
851 children (mean age 11.7 years) to assess sleep measures objec-
tively.
Results: Family irregularity was associated with more mother‐
reported sleep problems at ages 3, 6, and 10 years (respectively,
β = 0.13, 95%CI: 0.10–0.16, p < 0.01; β = 0.11, 95% CI: 0.08–0.14,
p < 0.01; β = 0.06, 95% CI: 0.03–0.09, p < 0.01) and with child‐
reported sleep problems at 10 years (β = 0.08, 95% CI: 0.04–0.13,
p < 0.01). Also, family irregularity predicted a later objective sleep
onset and waking time at age 11 (respectively, β = 0.11, 95% CI:
0.04–0.17, p < 0.01; β = 0 .09, 95% CI: 0.02–0.16, p < 0.01), but not
sleep duration or efficiency. The association of family irregularity
and multi‐rated subjective sleep problems at age 10 years was medi-
ated by mother‐reported child psychopathology at age 6 years
(mother-reported sleep problems: β = 0.14; 95% CI: 0.04–0.33 for
[Ratio of indirect to direct effect 40%]; child-reported sleep problems:
β = 0.05; 95% CI: 0.00–0.16 [Ratio of indirect to direct effect 13%]).
Conclusions: Our findings show that pre‐school family irregularity
is prospectively associated with more sleep problems during child-
hood, and with a later objective sleep onset and a later waking time.
In part, these sleep problems were associated with family irregularity
by way of child psychopathology. This study is unique in the exami-
nation of both subjective and objective sleep data in the context of
family irregularity. These findings suggest that interventions improv-
ing pre‐school family irregularity, which are targeted to reduce child
psychopathology, may also impact the development of sleep prob-
lems beneficially.
Disclosure: The funders had no role in the study design, data col-
lection, analysis, interpretation of the data, or writing of the report.
F.C.V. is the contributing editor of the Achenbach System of
Empirically Based Assessment, from which he receives remuneration.
For the other authors, no competing financial interest were
reported.
P497 | Sleep quality during pregnancy and at
postpartum is associated with delusional ideation
E. Solomonova1,2; A. Mackinnon2,3; B. Hayton4; N. Feeley5;
S. Robins2; I. Gold1,6; E. Libman1,2; P. Zelkowitz1,2
1Psychiatry, McGill University Montreal, 2Lady Davis Institute for
Medical Research, Jewish General Hospital, 3Psychology, 4McGill
University Montreal, 5Ingram School of Nursing, 6Philosophy, McGill
University Montreal, Montreal, QC, Canada
Objectives/Instruction: Delusional ideation (DI) is relatively
prevalent in non‐clinical populations, including pregnant women. DI
may be a precursor of psychiatric conditions, such as depression,
schizophrenia and postpartum psychosis. Disordered sleep during
pregnancy and in the postpartum is well‐documented, and includes
insomnia, fragmented sleep, daytime fatigue, sleep apnea and peri-
odic limb movement. Poor sleep during pregnancy has been associ-
ated with a number of adverse outcomes including mood disorders
and postpartum psychosis. Thus, both disordered sleep and DI may
be related to postpartum psychosis and to development of psy-
chopathology. The present study investigated the relationship
between sleep quality and DI during pregnancy and in the
postpartum.
Methods: A community sample of 300 women pregnant expecting
a singleton birth (mean age = 31.92 ± 4.55 y.o.) participated in a lon-
gitudinal study of perinatal mental health in Montreal, Canada. Par-
ticipants were assessed during the third trimester of pregnancy (32–
34 weeks gestation, PN, N = 300) and at 2 months postpartum (PP,
N = 287). Sleep quality was measured by the Sleep Symptom Check-
list (SSC) self‐report questionnaire, and DI was measured by a total
score on the Peters Delusional Ideation scale (PDI). Four sleep scores
were calculated: SSC total score and three subscales: insomnia, day-
time symptoms, and sleep disorders.
Results: Stepwise regressions were performed with SSC subscales
as predictors and PDI scores at PN and at PP as outcome. PDI at
PN was positively associated with daytime symptoms (F(1,
246) = 21.779, p < 0.001, adjusted R2 = 0.081); and at PP, PDI score
was positively associated with the severity of scores on insomnia
and sleep disorder subscales (F(2, 269) = 17.921, p < 0.001, adjusted
R2 = 0.111). Total SSC score at PN predicted PDI symptoms at PP
(F(3, 259) = 9.234, p < 0.001, adjusted R2 = 0.086)
Conclusions: Severity of delusional ideation was associated with
sleep disturbances in women both during pregnancy and in the post-
partum. Different aspects of disordered sleep predicted DI during
pregnancy and at postpartum. These differences may reflect specific
qualities of sleep disorders and of sleep‐associated distress at each
time point. These results suggest that sleep quality may exacerbate
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delusional ideation during pregnancy and in the postpartum, which,
in turn may contribute to increased risk of psychopathology.
Disclosure: Nothing to disclose.
P498 | Bi‐directional relationship between
sleep and psychiatry illness
J. Isaac1; A. Matos-Pires2
1Hospital José Joaquim Fernandes, 2Psychiatry Department, Hospital
José Joaquim Fernandes, Beja, Portugal
Objectives/Instruction: In recent years evidence of a two‐way
relationship between sleep and psychiatric illness emerges, in con-
trast to the idea that sleep disorders are only symptoms of mental
illness. It is known today that sleep disturbances represent an inde-
pendent risk factor for mental illness. Sleep functions can influence
the course and outcome of psychiatric illness.
Objective: Summarize the relationship between sleep disorders
and psychiatry illness, with focus on bipolar disorder.
Methods: A systematic literature review was performed. We used
standard search strategies involving the querying of two online data-
bases (MEDLINE® and EMBASE), between January 2014 to Septem-
ber 2017, for English language articles using the key words: sleep
and mental health; sleep and bipolar disorder. Data from citations
included in the articles of the initial research were also used, if these
were shown as a good value for the explanation of the problematic
in question. We selected 25 studies from 59 articles.
Results: Sleep disorders are highly prevalent among individuals
with bipolar disorder. There appears to be a certain genetic predis-
position to sleep problems with a dysregulation of their circadian
rhythm, which leads some authors to consider that sleep disorders
may be an early marker for this condition. Sleep disorders occur at
all stages of the disease. Most of the sleep architecture findings are
concentrated in the REM sleep phase, with a decreased latency and
increased REM density. In several publications it is suggested that
sleep disorders are associated with the worst course of the disease,
and may induce acute phases in bipolar disorder.
Conclusions: Sleep disturbances are very common and often the
first or the main complaint underlying psychiatric conditions. How-
ever, the reverse is also common, with a gap in the diagnosis and
appreciation of the risks of psychiatric illness in people with sleep
disorders. Evidence that sleep disturbances are associated with an
increased risk of developing psychiatric illness has existed since the
1980s. It is necessary to sensitize the population and physicians who
diagnose and treat sleep issues for effective intervention in the man-
agement of these health patients.
Disclosure: Nothing to disclose.
P499 | Which daytime impairments are specific
to insomnia and which overlap with depression:
a case‐control study
X.W. Ji1; H. Ivers1; J. Savard1; M. LeBlanc1; C.M. Morin1
1Laval University, Quebec, QC, Canada
Objectives/Instruction: It is often difficult to determine to what
extent the daytime symptoms are specific to insomnia or suggestive
of another condition (i.e., depression), a confusion that may hinder
optimal care. This study aims to describe insomnia‐related daytime
symptoms and examine their overlap with depression‐related symp-
toms.
Methods: Data were derived from a population‐based epidemiolog-
ical study in Canada (Quebec, 2008). Participants were selected
based on the presence of insomnia syndrome and significant depres-
sive symptoms. They were categorized into four groups: Pure Insom-
nia, Pure Depression, Comorbid Insomnia and Depression, and
Neither insomnia nor depression, which were matched on age and
gender. Analyses of covariance (ANCOVAs), adjusting for nighttime
insomnia symptoms, were conducted to compare the four groups on
the following variables: Multidimensional Fatigue Inventory (MFI),
Epworth Sleepiness Scale (ESS), State‐Trait Anxiety Inventory – Trait
(STAI‐Trait), Extended Insomnia Severity Index (ISI‐daytime symp-
toms), and Dysfunctional Beliefs and Attitudes about Sleep Scale
(DBAS).
Results: A total of 228 participants were selected. The ANCOVAs
revealed a significant group effect for all targeted symptoms (all ps <
0.001). Post hoc tests further showed that when compared to con-
trol (Neither group), the three other groups had higher scores on
most of the variables except for the ESS and DBAS. The Insomnia
group presented more severe ISI daytime symptoms (on energy,
p < 0.001 and on interpersonal relationship, p < 0.05) than the
Depression group. Further, there were no added effects from
depression on any of ISI daytime items, as indicated by the absence
of significant differences on those items between the Insomnia and
Comorbid groups. However, the STAI‐Trait scores (p < 0.001) were
higher in the Depression than in the Insomnia group, while the MFI
scores were comparable between the two groups. The Comorbid
group reported higher STAI‐trait and MFI scores relative to the
Insomnia and Depression groups (p < 0.05).
Conclusions: The findings indicate that daytime impairments
related to decreased energy and interpersonal relationship, as mea-
sured by the ISI, are specific to Insomnia while daytime symptoms of
anxiety and fatigue appeared to exist in both Insomnia and Depres-
sion. Specific attention should be devoted to those daytime dysfunc-
tions when treating insomnia and comorbid conditions.
Disclosure: XWJ, HI, JS, ML, and CMM do not have any conflict
of interest to disclose. This study was supported by a Canadian Insti-
tutes of Health Research grant (42504).
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P500 | Impact of sleep restriction on mood
and emotion regulation in adolescents with
attention‐deficit/hyperactivity disorder
S. Becker1,2
1Center for ADHD, Cincinnati Children's Hospital Medical Center,
2Department of Pediatrics, University of Cincinnati College of Medicine,
Cincinnati, OH, United States
Objectives/Instruction: Adolescents with attention‐deficit/hyper-
activity disorder (ADHD) frequently experience emotion dysregula-
tion and co‐occurring internalizing symptoms (anxiety/depression).
This study used an experimental sleep restriction/extension protocol
to examine whether shortened sleep duration is causally linked to
affect, emotion dysregulation, and internalizing symptoms in adoles-
cents diagnosed with ADHD.
Methods: Forty‐eight adolescents with ADHD (ages 14–17 years;
75% male) successfully completed a 3‐week summer sleep manipula-
tion protocol using a cross‐over experimental design. The protocol
included a phase stabilization week, followed in counterbalanced
order by a sleep restriction week and a sleep extension week.
Throughout the protocol, adolescents and parents completed a brief
measure of negative and positive affect. At the end of each week,
parents and adolescents completed measures of positive and nega-
tive affect, emotion regulation, and internalizing symptoms.
Results: Compared to the restricted sleep week, parents reported
more positive affect (p = 0.001, d = 0.52), less negative affect
(p = 0.02, d = 0.35), less emotion dysregulation (p < 0.001, d = 0.56),
and fewer depressive symptoms (p < 0.001, d = 0.82) during the
extended sleep week. Effects were not found for adolescent‐
reported internalizing symptoms, emotion regulation, or mood with
the exceptions of significantly greater depressed mood on one mea-
sure of internalizing difficulties (p < 0.001, d = 0.33) and marginally
less positive affect reported during the restricted sleep week com-
pared to the extended sleep week (p = 0.09, d = 0.25).
Conclusions: This study provides the first evidence that sleep
duration causally contributes to mood difficulties and internalizing
symptoms in adolescents with ADHD, though effects were clearer
parent report than adolescent self report measures. This study pro-
vides initial evidence that sleep contributes to emotion difficulties in
adolescents with ADHD, though more studies are needed to under-
stand specificity of effects and reasons for apparent informant dif-
ferences.
Disclosure: Nothing to disclose.
P501 | Therapeutic auditory stimulation during
sleep in depression: preliminary findings
E. Kobelev1; K.V. Danilenko1; S.V. Yarosh1;
G.R. Khazankin1,2; L.I. Aftanas1,2
1Institute of Physiology and Basic Medicine, 2Novosibirsk State
University, Novosibirsk, Russian Federation
Objectives/Introduction: A previous study of audio stimuli during
sleep in depression found that decreased slow‐wave sleep correlated
with depression improvement the next morning (Landsness et al.,
2011). However, the goal of the stimulation may be not deprivation
but rather improvement of slow‐wave sleep.
Methods: Seven patients with melancholic depression underwent
three polysomnographic trials ‐ one adaptation and two experimental
(“active” and “placebo”, counter‐balanced). EEG electrodes were
positioned at Fz‐Cz (bipolar derivation). Auditory paired (with interval
of 1 s) 50‐ms signals were automatically presented via miniaturised
headphones. The stimuli onset was anchored to the moment when
the program detected a decline of EEG waves below an amplitude
threshold, with the elapsed time 0.5 s to fall at peak to increase
amplitude of brain electrical oscillations (closed‐loop in‐phase stimu-
lation as per Ngo et al., 2013). For the “placebo” night, the elapsed
time for the stimuli varied randomly from 0 to 1 s. The 30‐s epochs
with stimuli were preceded and followed by 30‐s epochs without
stimulation, and these 1.5‐min cycles were presented throughout the
stage N2/N3 sleep. The number of cycles taken in the analysis was
such that the cycles with in‐phase and non‐in‐phase stimuli were
matched by number of stimuli presented. Patients scored their
depression and sleep quality by the abbreviated Hamilton scale
HDRS‐7‐SR (before and after sleep) and by the Leeds Sleep Evalua-
tion Questionnaire (LSEQ, in the morning), respectively.
Results: Compared to the pre‐ and post‐stimuli epochs, acoustic
stimuli significantly increased EEG power density in the frequency
bands 0.5–2.5 Hz (delta waves), 16–25 Hz and decreased at 12.5–
14.5 Hz. However, there was no difference in this effect between
in‐phase and non‐in‐phase stimulation. Greater overnight power den-
sity was associated with the greater decrease of HDRS‐7‐SR score
(N = 14, p < 0.02) and better score on the wakening subscale of
LSEQ.
Conclusions: Acoustic stimuli during sleep in depressed patients
presented in a closed‐loop fashion increase EEG delta sleep power
density. Higher power density was associated with improve of
depression state in the morning. Continuation of the study with
proper placebo is warranted to prove or disprove the practical utility
of the method.
Disclosure: Funding: The Russian Foundation for Basic Research
grant #15‐04‐09349 (2015‐2017).
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P502 | The effect of sleep deprivation, daily
life stress and happiness on academic
performance in Korean adolescent students
G. Ju1; H.-S. Yoon1; S.I. Lee2; C.-J. Shin2; J.-W. Son2; S. Kim2
1Psychiatry, Chungbuk National University Hospital, 2Medicine,
Chungbuk National University, Cheongju‐si, Republic of Korea
Objectives/Introduction: Sleep deprived on weekdays compared
with weekends in adolescents have been shown to be associated
with a wide variety of adverse effects on their lives, for example,
academic performance. However, few epidemiological studies have
specifically investigated this phenomenon. The present study exam-
ined the concurrent associations between sleep deprivation in week-
days, academic performance and other mental health factor in
Korean adolescent students.
Methods: Analyses are based on data from the 2013–2016 Korean
Youth Risk Behavior Web‐based Survey (KYRBWS‐V). The survey
used a cross‐sectional, national and representative sample consisting
of 204,033 students (grades 7–12) who were selected using a strati-
fied, clustered, multistage sampling method. Participants who
reported “feeling depressed” were excluded. Multiple regression
analysis was conducted to test the associations between academic
performance, sleep deprivation (weekday and weekend sleep time
difference), daily life stress, and feeling of happiness. Then the hypo-
thetical path model was analyzed by path analysis.
Results: Greater daily life stress and more sleep deprivation in
weekdays were correlated with better academic performance and
less feeling of happiness degree were correlated with poor academic
performance. Happiness, and sleep deprivation were potential influ-
encing factors for academic performance (p < 0.05). In the path anal-
ysis, significant the factors influencing academic performance were
sleep deprivation, happiness, stress, and fatigue recovery degree
(p < 0.05). Sleep deprivation and happiness showed direct effects on
academic performance in adolescents, while daily life stress showed
indirect effects on academic performance in adolescents. Sleep
deprivation was found to mediate the relationship between happi-
ness and academic performance.
Conclusions: The findings of the study reveal that sleep depriva-
tion, happiness, daily life stress can predict adolescents′ school per-
formance. Our analyses of the relevant data from the KYRBWS‐V
suggested that the results will influence on future education strate-
gies in school and on potential factors contributing to academic
achievement.
Disclosure: Nothing to disclose.
P503 | Digital media use before bedtime and
sleep quality among Finnish adolescents
N. Sandman1; T. Turunen1; P. Salo1,2; C. Salmivalli1
1Department of Psychology and Speech‐Language Pathology, University
of Turku, 2Finnish Institute of Occupational Health, Turku, Finland
Objectives/Introduction: Use of digital media before bedtime,
especially with portable devices like smartphones, has a potential to
disturb sleep. In the current study we investigated sleep quality and
usage of various forms of digital media with different devices before
bedtime among Finnish adolescents. Our aim was to explore how
adolescents used digital media before bedtime and did heavy usage
negatively affect sleep.
Methods: The sample consist of 2,967 Finnish upper secondary
education students (52.1% girl, 46.4% boy and 1.5% other). Majority
of the participants (86.2%) were 16 years old. Use of digital media
before bedtime was investigated with a question “How often have
you done following things during the last hour before going to
sleep?” with 12 different categories of digital media use with various
devices to choose from (such as “Used social media on mobile
phone”). Sleep related questions included self‐assessment of subjec-
tive sleep satisfaction, sleep duration during weekdays and week-
ends, insomnia symptoms, daytime tiredness and short Morningness‐
Eveningness questionnaire (MEQ).
Results: 96.2% of participants reported to use digital media every
night during the last hour before falling asleep. Since almost all par-
ticipants used digital media every night, it was not possible to com-
pare light and heavy users in this population. However, 8.9% of the
participants self‐assessed that use of digital media disturbs their
sleep every night and 41.3% reported digital media to disturb their
sleep at least once a week. Participants who reported that digital
media disturbs their sleep were more often evening chorotypes, had
shorter sleep duration, more social jet lag and more daytime tired-
ness than participants who did not feel that digital media disturbed
sleep (p < 0.001 for all).
Conclusions: Use of digital media before bedtime every night is
the norm among 16‐year‐old Finnish students. This leads to a lack of
variance in the data, making it challenging to study possible negative
impact of digital media usage to sleep. Regardless, there is a clear
association between self‐reports of digital media disturbing sleep
and low sleep quality. In this population, everyone is using smart
devices before bedtime but this only leads to sleep problems among
minority of users.
Disclosure: Nothing to disclose.
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P504 | Daylight exposure, depression and
sleep in adolescents
C. Moreno1,2; G. Öztürk2; A. Lowden2
1School of Public Health, University of Sao Paulo, Sao Paulo, Brazil,
2Stress Research Institute, Stockholm University, Stockholm, Sweden
Objectives/Introduction: Sleep complaints and lowered mood
states are frequently reported among in adolescence, especially dur-
ing the dark season of the year. Autumn (Sep‐Nov) in Sweden pro-
vides 14% of global yearly radiation, in winter 5%, markedly less
than in spring (38%) and summer (43%). The aim of this study was
to explore associations between daylight exposure, depressive symp-
toms, sleep and physical activity in adolescents during Scandinavian
dark winter periods.
Methods: Data from 1,242 high school students (15–20 years;
52% boys) were obtained through a questionnaire on demographics
(height, weight, age and gender), estimated hours of time spent out-
doors in daylight, sleep problems, night‐time technology use and
physical activity. Indices were built for hours of daylight exposure
(combined school days and weekends), depression (HAM‐D6, 6‐
items), sleep disturbances (Karolinska Sleep Questionnaire, KSQ ‐ 4‐
items), nighttime technology use (3‐items) and excessive sleepiness
(Epworth Sleepiness Scale, ESS). Depression was predicted using lin-
ear and logistic regression analysis. Symptom of depression was
defined by cut‐off score >22 (18% of sample) on the HAM‐D6. Stu-
dents lived in the Stockholm area at latitude 59.3°N.
Results: Linear regression showed that symptoms of depression
was predicted by hours of daylight exposure (p < 0.000), sleep dis-
turbances (KSQ, p < 0.000), physical exercise (p < 0.000), night‐time
technology use (p < 0.000) and excessive sleepiness (ESS, p < 0.000)
but not age. Logistic regression predictors for symptoms of depres-
sion was gender (female), hours of daylight exposure (low), physical
activity (low) and sleep disturbances (high). Social jetlag showed an
association with depression (p = 0.001) and with sleep length
(p < 0.000).
Conclusions: The study demonstrated that both daylight exposure
and disturbed sleep was associated with symptoms of depression. It
remains to be determined how much outdoor daylight exposure
should be recommended to prevent health problems in adolescence.
Disclosure: Nothing to disclose.
P505 | Auditory closed‐loop stimulation of the
sleep slow oscillations in patients with
schizophrenia
R. Göder1; A. Hansen2; N. Wesselkamp2; H. Drews2;
J. Lechinger2; P.C. Baier2; S. Weinhold2
1Psychiatry and Psychotherapy, 2University Hospital Schleswig‐Holstein,
Kiel, Germany
Objectives/Introduction: Slow oscillations hallmark the electroen-
cephalogram during slow‐wave sleep and are critical to memory con-
solidation. In a recent study it was shown, that auditory stimulation in
phase with the ongoing rhythmic occurrence of slow oscillation up
states enhances the slow oscillation rhythm and the consolidation of
declarative memory (Ngo et al., Neuron 78, 2013). Deficits in memory
performance are among the most severe neuropsychological impair-
ments in schizophrenia and contribute to poor functional outcome.
Treatment options to improve these memory deficits are highly needed.
Methods: In the present study 20 patients with schizophrenia were
included with a mean age of 41 years (range from 23 to 53 years).
All patients were on stable antipsychotic medication. We conducted
a randomized experimental design with repeated measures. An adap-
tation night preceded each of the two experimental sessions, the
stimulation and shame condition in the sleep lab. Auditory closed‐
loop stimulation was applied in accordance to Ngo et al., 2013. To
test declarative memory we used a verbal learning test of 15 words.
Learning was conducted at 9 pm prior to polysomnography and
recall at 7:30 am on the morning thereafter.
Results: After stimulation memory performance was higher as after
sham stimulation, but this difference was not significant. Patients
recalled 12.9 ± 1.9 words after stimulation and 12.1 ± 2.7 words
after sham stimulation (p > 0.1; paired t‐test).
Conclusions: Our results are promising, but further research is
needed to improve sleep‐related memory processes and thereby
functional outcome in patients with schizophrenia.
Disclosure: Nothing to disclose.
P506 | High risk of OSA increases affect
dysregulation among patients with schizophrenia
spectrum disorder: an effect mitigated by the
presence of a concurrent substance use disorder
C. Geck1,2; E. Lee2,3; A. Douglass2,3; J. De Koninck2,4;
A. Smith1; A. Gosselin1,2
1Forensic Treatment Unit, Royal Ottawa Health Care Group, 2University
of Ottawa Institute of Mental Health Research, 3Sleep Disorders Clinic,
Royal Ottawa Health Care Group, 4University of Ottawa, Ottawa, ON,
Canada
Objectives/Introduction: It is well‐known that obstructive sleep
apnea (OSA) leads to multiple adverse outcomes, including affect
dysregulation. Existing literature demonstrates high comorbidity
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between: 1) OSA and schizophrenia‐spectrum disorders (SSD); and 2)
SSD and substance use disorder (SUD). However, no studies have
compared the impact of OSA on affect regulation in patients with
SSD versus patients with SSD+SUD, so we compared both sub-
groups on different subjective measures of affect regulation. We
hypothesized that:
(1) higher OSA risk would correlate with higher impulsivity
among patients with SSD+SUD only, due to the additional
complexity of concurrent disorders and because patients with
SUD typically tend to display poorer impulse control; and
(2) for both groups, higher risk of OSA would correlate with all
other measures of affect regulation.
Methods: Ten SSD and 31 SSD+SUD patients completed the Sleep
Disorders Questionnaire 2‐Sleep Apnea subscale to estimate the risk
of OSA, and the Pittsburgh Sleep Quality Inventory (PSQI). Self‐report
measures were administered to examine different aspects of affect
regulation: the Depression Anxiety and Stress Scale (DASS), the Diffi-
culties in Emotion Regulation Scale (DERS), the Barratt Impulsiveness
Scale (BIS) and the Buss‐Perry Aggression Questionnaire (BPAQ).
Results: Among patients with SSD+SUD, higher risk of OSA was
correlated with poorer impulse control (BIS, r = 0.46, p = 0.006) and
poorer quality of sleep (PSQI, r = 0.31, p = 0.047). Among patients
with SSD, higher risk of OSA was linked with poorer emotional regu-
lation (DERS, r = 0.58, p = 0.040). For both subgroups, higher risk of
OSA was associated with lower mood (SSD: DASS, r = 0.87,
p = 0.001; SSD+SUD: DASS, r = 0.36, p = 0.028).
Conclusions: As predicted, higher risk of OSA was correlated with
poorer impulse control among patients with SSD+SUD only. Higher
risk of OSA was correlated with poorer emotion regulation among
patients with SSD only. For both groups, higher risk of OSA was cor-
related with lower mood. No correlation was found between higher
risk of OSA and aggression. These findings present novel insights
into the potentially differential impacts of OSA on affect regulation,
which appears to vary depending on the clinical picture. Using
polysomnography to confirm the presence of OSA will help improve
our understanding of the present findings.
Disclosure: Nothing to disclose.
P507 | Severity of paranoid thoughts in a non‐
clinical sample moderates the relationship
between previous night sleep and next‐day
paranoia: a prospective study using experience
sampling methodology
J. Barton1; F. Varese1; S. Kyle2; S. Jones3; G. Haddock1
1University of Manchester, Faculty of Biology, Medicine and Health,
Manchester, 2University of Oxford/Sleep and Circadian Neuroscience
Institute, Oxford, 3Lancaster University, Lancaster, United Kingdom
Objectives/Introduction: Sleep disturbances such as insomnia
and nightmares have been shown to be linked to the increased
severity of paranoia in healthy and clinical samples. However, it is
not clear whether increased severity of paranoid moderates an ele-
vated vulnerability to the effects of sleep disturbance. Therefore,
objective and subjective measurements of sleep were assessed in a
low and high non‐clinical paranoia group, and both were assessed on
daily paranoia, mood and mood regulation in an experience sampling
methodology design (ESM). The study was designed to understand
whether nightly measured sleep predicted next day paranoia across
a single week, and to test potential mediators of this relationship
using a prospective ESM design.
Methods: Two groups were recruited based on a sample from a
previous study (Barton et al., in submission) to form a lower quartile
(n = 24) and upper quartile (n = 21) paranoia group. Both were
screened for clinical diagnoses and sleep disorders other than insom-
nia. All participants completed baseline questionnaires and were then
provided with a Pro Diary actigraphy watch which allowed for the
integrated day by day collection of paranoia, mood, mood regulation
and putative cognitive mediators. All participants completed entries
via the watch 5 times a day over 7 days and the data was analysed
using multi‐level modelling.
Results: Previous night objective (p < 0.001) and subjective
(p = 0.004) total sleep time was associated with increased next day
paranoia scores in the whole sample (n = 45). No other sleep vari-
ables were associated with next day mean paranoia scores
(p > 0.05). In the moderation analysis, it was shown that the associa-
tion between total sleep time and paranoia was stronger in the high
compared to low trait paranoia group (p = 0.018). It was shown that
negative affect, threat anticipation and dissociation mediated 49, 37,
and 42% of the association between previous night total sleep time
and next day paranoia respectively.
Conclusions: Previous night total sleep is associated with next day
paranoia and this is moderated by severity of paranoid thoughts.
Mediation analysis suggested that negative affect, threat anticipation
and dissociation were important mediators.
Disclosure: Nothing to disclose.
P508 | Daily activity levels, sleep quality and
chronotypes in the early phase of psychosis
J.-M. Petit1,2; R. Jenni2,3; M. Cleusix2,3; P.S. Baumann2,3;
M. Fournier2; P. Klauser2,3; P.J. Magistretti1,2,4;
K.Q. Do-Cuenod2; P. Conus3
1School of Life Science, BMI, EPFL, Lausanne, 2Department of Psychiatry,
CHUV/Center for Psychiatric Neuroscience, 3Department of Psychiatry,
CHUV/Service of General Psychiatry, Prilly, Switzerland, 4Department of
Biological and Environmental Sciences and Engineering, KAUST, Thuwal,
Saudi Arabia
Objectives/Introduction: Recent evidence suggest that sleep and
circadian disturbances may play a role in the early stages of the psy-
chosis and be related to symptoms severity. In order to assess sleep
and circadian impairments in a cohort of early psychosis (EP) patients
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treated in the TIPP program (Lausanne University Hospital, Switzer-
land), we evaluated sleep quality and chronotype and we measured
the daily activity levels in EP and in healthy control (CTL) subjects.
We also tested correlations between these data and clinical
evaluation.
Methods: Study included 18 EP and 9 CTL subjects (mean age ±
SD: 26 ± 3.8 years; 2 females). Sleep quality and chronotype were
determined using the “Pittsburg Sleep Quality Index” (PSQI) and the
“Morningness‐Eveningness Questionnaire” (MEQ) respectively. In
addition, subjects wore an actigraphic wrist over 21 days. Activity
levels were calculated from activity counts recorded during 1 min
epochs by a GeneActiv “Original” tri‐axis accelerometer and divided
in “Sedentary/Light Activity” (SLA) or “Moderate/Vigourous Activity”
(MVA). Following elimination of days with incomplete recording, data
were separated in “Week Days” (WD) and “Week‐End Days” (WED).
Statistical comparison of PSQI, MEQ and activity in both groups
were performed using a Mann‐Whitney test. Correlations of sleep/
circadian parameters with scores from clinical symptoms scales
(MADRS, PANSS, SOFAS, GAF) and medication (CPZ equivalent)
were evaluated using a nonparametric Spearman correlation test.
Results: The EP subjects displayed a higher PSQI global score
(p < 0.005) than CTL subjects. Among the PSQI components, the
sleep latency score was the most increased. In EP group, PSQI was
positively correlated (r = 0.536; p = 0.0392) with mean MADRS
score. Chronotype between both groups was not different. Due to a
significant decrease in SLA (p < 0.05), total activity during WD was
lower in EP subjects (p = 0.0027). No difference was observed for
WED.
Conclusions: The EP subjects reported a poorer subjective sleep
quality that, in line with other studies, is mainly due to an increase
in sleep latency. In EP, PSQI was positively correlated with MADRS
scores suggesting that depressed patients have poorer sleep quality.
The decrease in activity during WD is likely to be related to the lim-
ited access of EP subjects to social synchronizers rather than to
medication.
Disclosure: This work was supported by grants from Swiss
National Science Foundation (NCCR “SYNAPSY, The Synaptic Bases
of Mental Disease”).
P509 | Sleep as a moderator of the
relationship between child maltreatment and
romantic relationship patterns
A. Pfaff; A. Schlarb
Bielefeld University, Bielefeld, Germany
Objectives/Introduction: Previous research shows that adverse
childhood experiences (ACEs) can lead to a worse sleep quality and
have an impact on social behavior and relationships. This study aims
to examine the role of sleep on the association between ACEs and
romantic relationship quality. Additionally, the relationship between
ACEs and romantic relationship patterns (RRQ) and nightmares is
investigated.
Methods: A sample of 377 participants aged 18–53 years was
examined. A self‐assessment questionnaire survey was conducted to
interview the participants about their ACEs, romantic relationship
patterns (quality, history, orientation) as well as about their sleep
patterns (quality, nightmares).
Results: Sleep quality was found to be a significant mediator of the
relationship between child maltreatment and RRQ (β = −0.362, 95%
CI [−0.630, −0.134]). Neither a general history of ACEs (p = 0.480)
nor single types of ACEs (p = 0.080 – p = 0.998) predict short‐term
romantic relationship orientation. Overall childhood maltreatment
(CM) (p ≤ 0.000), history of sexual abuse (p = 0.010), separation of
parents (p = 0.003), violence against the mother (p = 0.026), sub-
stance abuse of a household member (p = 0.005), and psychic disor-
der of a household member (p = 0.000) predict more romantic
relationships in the participants’ histories. A heightened nightmare
frequency is predicted by emotional neglect (p = 0.044) and sub-
stance abuse of a household member (p = 0.046). More nightmare
daytime effects were as well predicted by overall CM (p ≤ 0.000).
Conclusions: This study underlines the influence of childhood
experiences on the adult life. As sleep was found to moderate the
relationship between ACEs and RRQ, therapeutic treatments for
childhood maltreated individuals should take sleep quality improve-
ment as an important goal into consideration.
Disclosure: Nothing to disclose.
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P512 | Association between REM sleep EEG
connectivity and daytime core symptoms in
children with Autism Spectrum Disorder
K. Gagnon1,2; A. Lambert1; S. Tessier1; A.-C. Rochette1;
R. Godbout1,3
1Sleep Laboratory & Clinic, Hôpital Rivière‐des‐Prairies, 2Université du
Québec à Montréal, 3Université de Montréal, Montréal, QC, Canada
Objectives/Instruction: The Autism Spectrum Disorder (ASD) is a
neurodevelopmental condition characterized by atypical connectivity
between brain regions. We have previously found a lower intrahemi-
spheric EEG coherence within the right frontal area in adults with
ASD during REM sleep.We verified whether frontal REM sleep con-
nectivity was also atypical in ASD children and if it was associated
with daytime functioning.
Methods: The sleep of 11 children with ASD (10.5 ± 1.2 years)
and 13 typically developing (TD) children (10.2 ± 2.0 years) was
recorded for 2 consecutive nights with a full EEG montage; EEG
data from night 2 was used. Participants with a full‐scale IQ below
80 or taking medication were excluded. Parents filled the Autism
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Diagnostic Interview‐Revised (ADI‐R). EEG coherence values for
Delta, Theta, Alpha, Sigma and Beta frequency bands were calcu-
lated for intrahemispheric frontal pairs of electrodes on artifact‐free
samplesof REM sleep. Group differences on EEG coherence were
assessed with repeated‐measured ANOVA on each electrode pair for
all frequency bands. The associations between ADI‐R subscales
scores and EEG coherence was tested with Pearson's r.
Results: Compared to TD children, ASD children displayed signifi-
cantly greater coherence values between frontal intrahemispheric
pairs of electrodes: FP1‐F7 (F(3;54) = 9.2, p < 0.001), FP1‐F3 (F
(4;80) = 5.7, p < 0.001), F3‐F7 (F(4,84) = 8.6, p < 0.001), FP2‐F8 (F
(2;30) = 5.5, p < 0.05), FP2‐F4 (F(3;59) = 4.5, p < 0.01), and F4‐F8 (F
(2;45) = 4.6, p < 0.05). The social ADI‐R subscale score was posi-
tively correlated with frontal left hemisphere (FP1‐F3) sigma coher-
ence in ASD children (r = 0.74, p = 0.02).
Conclusions: Opposite frontal EEG coherence values in ASD chil-
dren and adults suggest an atypical developmental pattern of brain
organization in ASD. The positive correlation between left frontal
coherence and social deficits on the ADI‐R points toward a common
neuronal substrate.
Disclosure: Nothing to disclose.
P513 | The relationship between sleep and
temperament in early childhood
I. Morales Muñoz1; S. Nolvi2; H. Karlsson2,3; J. Paavonen1,4;
L. Karlsson2,5
1Mental Health Unit, National Institute for Health and Welfare, Helsinki,
2FinnBrain Birth Cohort Study, Institute of Clinical Medicine, University
of Turku, Turku Brain and Mind Center, 3Department of Psychiatry,
Turku University Hospital and University of Turku, Turku, 4Child
Psychiatry, University of Helsinki and Helsinki University Hospital,
Helsinki, 5Department of Child Psychiatry, Turku University Hospital and
University of Turku, Turku, Finland
Objectives/Introduction: Sleep patterns and temperament in the
first year of life are closely related, and have important developmen-
tal implications (Ednick et al., 2009). However, despite the growing
understanding of the role of sleep in preschool children's develop-
ment, scarce research has been conducted in earlier ages, i.e. impor-
tant developmental periods. Temperament is conceptualized as a
construct with two systems: reactivity and regulation. Nevertheless,
many studies have been focused on reactivity as a key component
of temperament, whereas less research has been conducted on regu-
lation (de Marcas et al., 2015). We aimed to examine the relationship
between sleep and temperament during infancy.
Methods: This study was derived from the FinnBrain Birth Cohort
Study. The variables of interest were sleep and temperament at 6
and 12 months. A total of 1,990 subjects at 6 months, and 1,684 at
12 months had data available for the analyses. Sleep functioning was
assessed using the Brief Infant Sleep Questionnaire (BISQ) and tem-
perament with the Infant Behavior Questionnaire‐Revised (IBQ‐R).
The association between several sleep variables (short sleep, delayed
circadian rhythm, night‐time awakenings, late settling‐time, and sleep
difficulties) and the three IBQ‐R dimensions (Surgency‐SUR, Negative
Affectivity‐NEG and Regulation‐REG) was studied.
Results: Sleep difficulties at 6 months were negatively associated
with SUR (p = 0.003), while other sleep variables were unrelated.
Regarding NEG, we obtained significant positive associations at both
6 and 12 months, with short sleep (p < 0.001; p < 0.001), frequent
night‐time awakenings (p < 0.001; p < 0.001), late settling‐time
(p < 0.001; p < 0.001), and sleep difficulties (p < 0.001; p < 0.001).
Sleep quality problems were also negatively related to REG at both
time‐points: short sleep (p = 0.065; p = 0.010), late settling‐time
(p = 0.010; p = 0.014), sleep difficulties (p < 0.001; p = 0.004); and
frequent night‐time awakenings, only at 6 months (p < 0.001).
Conclusions: Sleep characteristics, such as short sleep, nigh‐time
awakenings, late settling‐time and sleep difficulties are positively
associated with Negative Affectivity and negatively with Regulation
among infants. The interrelations of child emotional reactivity and
self‐regulation and sleep require further attention. Follow‐up is
needed to understand the potential bidirectional contributions
between sleep and temperament and also to identify possibilities for
tailored interventions for pediatric sleep problems.
Disclosure: Nothing to disclose.
P514 | A full sleep assessment in children with
attention deficit hyperactivity disorders (ADHD)
S. Miano; N. Amato; C. Garbazza; M. Manconi
Sleep and Epilepsy Center, Neurocenter of Southern Switzerland, Lugano,
Switzerland
Objectives/Instruction: We present the results of a prospective
case‐control sleep study in children with attention deficit hyperactiv-
ity disorder (ADHD), aimed to identify one of the following 5 sleep
phenotypes: (1)narcolepsy‐like; (2) sleep onset insomnia (SOI); (3)ob-
structive sleep apnea syndrome (OSA); (4) periodic limb movements
(PLMs); and (5) sleep epilepsy, and to explore differences in sleep
slow wave activity (SWA) distribution and sources, as compared to
normal controls, by high density electroencephalography (HD‐EEG).
Methods: Thirty consecutive outpatients with ADHD (9 females,
mean age 10.1 ± 2.1 years), were recruited, and underwent the full
sleep assessment. Twenty five controls, sex‐ and age‐matched con-
trol subjects (12 females, mean age 10.34 ± 1.54) only underwent
the PSG‐HD EEG. The scalp topography, the SWA sources’ distribu-
tion were calculated in children with ADHD and compared to normal
controls. In addition, the differences of SWA, comparing the first
and last part of the night, were calculated.
Results: The narcoleptic‐like phenotype was found in 4 children,
SOI in 5 children, OSA in 7 children, PLMs in 8 children, while sleep
epilepsy in 5. All patients slept less 9 hr at actigrapy, confirmed by
PSG, and had a higher apnea hypopnea index than controls. At scalp
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topography, both groups showed a similar distribution of SWA, but
in ADHD subjects, the focus of SWA was over centro‐parietal
regions, whereas in control subjects it was prominent over frontal
regions (p < 0.05). The statistical non parametric comparison of
localized sources showed a greater delta power over the posterior
cingulates in ADHD group compared to controls (p < 0.05). The
overnight physiological decrease in SWA, diffused over the whole
scalp, was more evident in control subjects. To account for this dis-
crepancy between groups, late sleep from early sleep delta power
values were subtracted and the obtained distributions compared. A
significant increase of delta power was found over central regions in
ADHD (p < 0.05).
Conclusions: The study confirms the relevant association between
ADHD and defined sleep disorders, inducing a chronic sleep depriva-
tion. The HD‐EEG analysis confirms a maturation delay of SWA,
which may also reflect a state of sleep deprivation, and a reduced
downscaling process.
Disclosure: Nothing to disclose.
P515 | Clinical and patient global impression in
a study of sodium oxybate in children and
adolescents with narcolepsy with cataplexy
G. Plazzi1; C. Ruoff2; F. Hassan3; M. Chen4; T. Swick5;
J. Black6,7; Y.G. Wang6; R. Parvataneni6; N. Simakajornboon8
1Department of Neurological Sciences, University of Bologna, Bologna,
Italy, 2Stanford University Sleep Medicine Center, Redwood City, CA,
3C. S. Mott Children's Hospital, Ann Arbor, MI, 4Seattle Children's
Hospital, Seattle, WA, 5Neurology and Sleep Medicine Consultants,
Houston, TX, 6Jazz Pharmaceuticals, 7Stanford Center for Sleep Sciences
and Medicine, Palo Alto, CA, 8Cincinnati Children's Hospital Medical
Center, Cincinnati, OH, United States
Objectives/Instruction: Clinical and Patient Global Impression of
Change (CGIc, PGIc, respectively) for cataplexy severity and nar-
colepsy overall were assessed as secondary/exploratory endpoints in
a study of sodium oxybate (SXB) in paediatric patients with nar-
colepsy with cataplexy.
Methods: Children and adolescents (7–17 years) diagnosed with
narcolepsy with cataplexy either on SXB treatment or SXB‐naïve were
enrolled. SXB‐naïve participants were titrated to a stable dose (SD) of
SXB and those on SXB remained on their current SD. After the SD
period, participants were randomised to continue SXB (SD) or receive
placebo in a 2‐week, double‐blind withdrawal period (DB). CGIc for
cataplexy severity and narcolepsy overall, and PGIc for narcolepsy
overall were assessed at the end of the DB period with respect to the
end of the SD period. Responses (+3 [Very Much Improved] to −3
[Very Much Worse]) were compared between placebo and SXB
groups using the Cochran‐Mantel‐Haenszel row mean difference test.
Treatment emergent adverse events (TEAEs) were also assessed.
Results: Sixty‐three participants were randomised (7–11 years:
41%; female: 44%; SXB naïve: 62%). Prior to receiving any
treatment, the mean CGI scores for cataplexy and narcolepsy overall
indicated markedly ill disease severity. Compared to subjects ran-
domised to SXB, the placebo group demonstrated lower mean
(standard deviation [SD]) CGIc and PGIc scores with a greater per-
centage of patients being “much worse” and “very much worse,”
regardless of age group or SXB entry status: CGIc cataplexy severity,
placebo −1.5 (1.2) vs. SXB −0.4 (1.1)* and 65.6% vs. 17.2%; CGIc
narcolepsy overall, placebo −1.4 (1.1) vs. SXB −0.4 (1.0)* and 59.4%
vs. 10.3%*; PGIc narcolepsy overall, placebo −1.3 (1.0) vs. SXB 0.0
(1.3)* and 48.3% vs. 16.7%. In the safety population, the most fre-
quently reported TEAEs (>5%) included enuresis, nausea, vomiting,
headache, and weight decrease. (*p < 0.001).
Conclusions: In participants on SD SXB, randomisation to placebo
resulted in significant worsening of cataplexy and narcolepsy symp-
tom severity as rated by clinicians and participants, supporting the
efficacy of SXB on cataplexy and overall narcolepsy symptoms in
paediatric patients with narcolepsy with cataplexy. Safety and tolera-
bility were consistent with previous studies in adult and paediatric
populations.
Disclosure: C Ruoff has served as an advisory board member and
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Multicenter Retrospective and Prospective Follow‐up Study of Early
Onset Childhood Narcolepsy: Recent Cases and Post Infection.” F
Hassan has received research funding from Jazz Pharmaceuticals and
has participated on a scientific advisory board for Spinraza (Biogen).
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and/or honoraria from Jazz Pharmaceuticals, Vanda Pharmaceuticals,
XenoPort Pharmaceuticals, UCB Pharma, Merck Pharma, Aerial Bio-
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Pharmaceuticals, Aerial BioPharma, LLC, GSK Pharmaceuticals,
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Pharmaceuticals, and Bioprojet.
P516 | The impact of experimental sleep
restriction on adolescent mood
M. Short1; S. Booth2
1School of Psychology, Flinders University, Adelaide, SA, 2Central
Queensland University, Rockhampton, QLD, Australia
Objectives/Instruction: Adolescence is a critical developmental
period when the onset of mood disorders is prevalent. Limited
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studies have examined the relationship between sleep duration and
mood experimentally using chronic sleep restriction paradigms that
are consistent with adolescents’ normative sleep. Further, studies
tend to measure positive or negative mood rather than discrete
mood states. The present study examines the relationship between
sleep duration and mood states in adolescents using a dose‐response
study including measures of sadness, anger, depressed mood, confu-
sion and happiness.
Methods: Thirty‐four adolescents (20 male), aged 15–17 years spent
ten days and nine nights in a temperature‐ and light‐controlled sleep
laboratory. In between two baseline nights and two recovery nights
with 10 hr time in bed (TIB) per night, participants experienced either
severe (5 hr TIB, N = 12), or moderate (7.5 hr TIB, N = 10) sleep
restriction for five consecutive nights, while the control group
(N = 12) had 10 hr TIB each night. Mood was measured every three
hours during wake using unipolar visual analogue scales measuring
mood states of “sad”, “depressed”, “angry”, “confused”, “happy.”
Results: Linear mixed models analyses revealed that participants in
the 5 hr group, but not the 7.5 or 10 hr groups, reported being sig-
nificantly more sad (F (4,1314) = .57, p < 0.001), depressed (F
(4,1314) = 7.48, p < 0.001), and angry (F (4,1314) = 3.00, p = 0.018)
during sleep restriction than at baseline and significantly less happy
(F (4,1314) = 12.72, p < 0.001). The effect of sleep restricted to 5 hr
on confusion varied according to sex (F (4,1313) = 7.01, p < 0.001),
with males reporting increased confusion from baseline to sleep
restriction, while females did not. Two nights of recovery sleep was
not sufficient to recover from increased negative mood states for
the 5 hr group, although recovery occurred for happiness.
Conclusions: Given the prevalence of insufficient sleep and the
prevalence of mood disorders and dysregulation across adolescence,
these findings highlight the importance of sufficient sleep to help
mitigate these risks.
Disclosure: Nothing to disclose.
P517 | The predictive value of
polysomnography combined with quality of life
for treatment decision of children with habitual
snoring related to adenotonsillar hypertrophy
G. Zhao; Y. Li; X. Wang; Q. Yang; X. Ding; C. Wang; W. Xu;
D. Han
Department of Otorhinolaryngology Head and Neck Surgery, Beijing
Tongren Hospital, Capital Medical University, Beijing, China
Objectives/Instruction: Both surgical treatment and non‐surgical
treatment are suggested by clinicians for children with habitual snor-
ing related to adenotonsillar hypertrophy; However, how should the
decision be made remains unclear. The objective of this study was
to investigate potential predictors for the treatment decision, i.e. sur-
gical treatment vs wait and see in children with habitual snoring
related to adenoidal and/or tonsillar hypertrophy.
Methods: Children with complaints of snoring and/or apnea associ-
ated with adenotonsillar hypertrophy who received polysomnogra-
phy (PSG) monitoring at our Hospital were recruited. After at least
6 months, the subjects were followed up and grouped according to
whether or not they had received adenoidectomy and/or tonsillec-
tomy (AT) execution. The heights, weights, as well as quality of life
(assessed using the OSA‐18 quality of life questionnaire) and base-
line PSG of the subjects were recorded and compared. Two logistic
regressions were performed to reveal the factors influencing deci-
sion‐making on conducting AT.
Results: A total of 509 children were finally included (345 males
and 164 females). Among these children, 287 eventually received
AT. Significant differences in age, scores for item 1 and 5 of the
OSA‐18, apnea‐hypopnea index, obstructive apnea index, obstructive
apnea‐hypopnea index (OAHI), and Lowest arterial oxygen saturation
(p < 0.05) were observed between groups. By multivariate logistic
regression, the factors that influenced the surgical decision were
identified as follows: age <7 years (p = 0.008: odds ratio [OR] =
1.667, 95% confidence interval [CI]: 1.140–2.438), score for item 5
of OSA‐18 > 4 points (p = 0.042: OR = 1.489, 95% CI: 1.014–2.212)
and OAHI > 1/hr (p = 0.044: OR = 1.579, 95% CI: 1.013–2.463).
Conclusions: School age children aged <7 years, with OAHI > 1/hr
and mouth breathing scored >4 points were more likely to receive
AT during the disease process and thus require increased attention.
Disclosure: The research was supported by National Key Research
& Development Program of China (2017YFC0112500) and Beijing
Municipal Administration of Hospitals’ Mission Plan (SML20150201).
P518 | Adenotonsillectomy improved quality of
life better versus nonsurgical management for
children with controversial diagnoses of
obstructive sleep apnea: a prospective cohort
study
G. Zhao; Y. Li; X. Wang; Q. Yang; X. Ding; C. Wang; W. Xu;
D. Han
Department of Otorhinolaryngology Head and Neck Surgery, Beijing
Tongren Hospital, Capital Medical University, Beijing, China
Objectives/Introduction: To investigate the effect of adenotonsil-
lectomy versus nonsurgical management on quality of life (QoL) in
children with controversial obstructive sleep apnea (OSA) diagnoses
by American Thoracic Society (ATS) and International Classification
of Sleep Disorders (ICSD‐3).
Methods: Children complaining of snoring who received PSG mon-
itoring in Capital Medical University Beijing Tongren Hospital were
recruited. Subjects with controversial OSA diagnoses according to
ATS and ICSD‐3 were enrolled and assigned to 2 groups: Group 1,
adenotonsillectomy (adenoidectomy with or without tonsillectomy);
Group 2, nonsurgical management. Gender, age, height, weight and
BMI were matched and baseline QoL was recorded. After at least
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6 months, subjects were followed up by phone and final QoL was
obtained.
Results: A total of 63 subjects were finally included. 39 of them
received adenotonsillectomy and 24 received nonsurgical manage-
ment. Baseline characteristics, PSG parameters and OSA‐18 showed
no difference between groups. And both groups had improved QoL
at follow‐up: sleep disturbance (group 1: weighted mean difference
(WMD) [95% confidence interval CI], −7.97 [−9.09, −6.86]; group 2:
−3.92 [−4.97, −2.86]), physical symptoms (group 1: −7.9 [−8.92,
−6.87]; group 2: −4.08 [−5.3, −2.86]), emotional distress (group 1:
−1.95 [−2.86, −1.04]; group 2: −1.38 [−2.7, −0.05]), daytime func-
tion (group 1: −2.28 [−3.09, −1.47]; group 2: −2.63 [−3.75, −1.5]),
caregiver concerns (group 1: −12.36 [−14.2, −10.52]; group 2:
−5.38 [−7.55, −3.2]), and total score (group 1: −32.46 [−36.53,
−28.39]; group 2: −17.38 [−22.04, −12.71]). However, the improve-
ment was significantly greater in group 1 than that in group 2 in the
domains sleep disturbance, physical symptoms, caregiver concerns
and total score (p < 0.05).
Conclusions: Adenotonsillectomy can improve caregiver‐reported
QoL better versus nonsurgical management for children with contro-
versial OSA diagnoses.
Disclosure: This research was supported by National Key
Research & Development Program of China (2017YFC0112500)
and Beijing Municipal Administration of Hospitals’ Mission Plan
(SML20150201).
P519 | Sleep onset latency and psychologic
problems in Siberian adolescents: the school‐
based study
S. Tereshchenko; M. Shubina
Department of Child's Physical and Mental Health, Scientific Research
Institute of Medical Problems of the North, Krasnoyarsk, Russian
Federation
Objectives/Instruction: The Strengths and Difficulties Question-
naire (SDQ) was developed by R. Goodman [J Child Psychol Psychia-
try. 1997 Jul;38(5):581–6] as a brief psychopathological screening
tool that has been recommended for the detection and classification
of psychosocial problems in adolescents. Data regarding the SDQ
assessment in adolescents with sleep disturbances are limited. To
evaluate the association of sleep onset latency with psychologic
problems according to Strengths and Difficulties Questionnaire in
Siberian adolescents.
Methods: 481 urban Siberian (Krasnoyarsk) adolescents (aged 12–
18; boys/girl ratio 213/268) were tested with self‐report version of
SDQ questionnaire and sleep characteristics. Adolescents were asked
“During the past month, how long (in minutes) has it usually taken
you to fall asleep each night?” to estimate sleep onset latency. Bed-
time and wake‐up time on school days were assessed with the ques-
tion: “At what times (hours: minutes) do you usually go to bed and
wake up on school days?” Data are shown as median (25–75% quar-
tiles). Kruskal‐Wallis test was used.
Results: Significant positive associations were detected between
sleep onset latency and SDQ total difficulties score with more
remarkable progressive increasing in adolescents with emotional
problems. Sleep onset latency were 16.5 (15.5–17.6) min in group
with emotional symptoms score = 0–3 (n = 314), 21.3 (16.3–26.3)
min in group with emotional symptoms score = 4 (n = 114), and 24.2
(20.9–27.4) min in group with emotional symptoms score = 4
(n = 53), Kruskal‐Wallis test p = 0.022.
Conclusions: Sleep onset latency increasing may be used as a sur-
rogate marker of psychosocial problems in adolescents, especially
those with emotional problems.
Disclosure: Nothing to disclose.
P520 | Sleep spindles features in obesity
obstructive sleep apnea adolescents
I. Madaeva; O. Berdina; O. Bugun; L. Rychkova;
N. Semenova
Scientific Centre for Family Health and Human Reproduction Problems,
Irkutsk, Russian Federation
Objectives/Instruction: Sleep spindles (SS) are the EEG‐hallmarks
of stage 2 non‐rapid eye movement sleep. SS may indicate on dis-
turbed sleep. Limited studies have examined the SS patterns in
obstructive sleep apnea (OSA), and no studies have evaluated those
in obesity adolescents with OSA. The aim of this study was to evalu-
ate SS characteristics in obesity adolescents according to absence or
presence of OSA.
Methods: We examined 30 male obesity adolescents (mean age
16.5 ± 0.3 years). Obesity was diagnostic if body mass index Z‐score
(BMI Z‐score) >2 for age and sex. Polysomnography (PSG) was per-
formed applying system GRASS‐TELEFACTOR Twin PSG (USA). All
patients were divided into 2 groups in accordance with the PSG
results (18 obesity OSA patients ‐ the 1st group, 12 obesity non‐
OSA patients ‐ the 2‐nd group). Adolescents were included in the 1‐
th group if apnea/hypopnea index ≥1.4 episodes in hour. SS were
scored visually from C4‐A1 EEG derivation after PSG analysis. SS
were defined as a waveform with frequency between 11.0–15.9 Hz,
at least 0.5 s in length. All differences were considered significant at
p < 0.05 (Mann‐Whitney test).
Results: The Mann‐Whitney test showed that number of sleep
spindle density was significantly higher in obesity OSA adolescents
than in obesity non‐OSA group (767 ± 235 n versus 275 ± 82 n,
p < 0.0001, and 4.3 ± 1.5 n/30 s epoch versus 1.2 ± 0.3 n/30 s
epoch, p < 0.0001, respectively). However, maximum spindle ampli-
tude and spindle frequency were significantly lower in the 1st group
than in the 2nd group (20.8 ± 0.3 μV versus 28.2 ± 0.4 μV,
p < 0.0001, and 11.7 ± 0.6 Hz versus 13.5 ± 0.4, p = 0.008
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respectively). There was no significant change in spindle duration
between the three groups.
Conclusions: SS characteristics related to OSA presence in obesity
adolescents. We suggested that, the slow and low amplitude spindles
in the OSA group might indicate long hyperpolarization rebound
sequences with low hyperpolarization level, possibly indicating altered
neural mechanisms in the structures regulating spindle activity in OSA.
While the increased spindle number and spindle density in obesity
OSA adolescents might were the EEG responses to multiple brief
occlusions in impaired sleep, an adaptive response to hypoxia.
Disclosure: Nothing to disclose.
P521 | The relationship between sleep habits
and positive and negative emotions in infants
and toddlers: a preliminary study
V. Bacaro1; S. Nesi1; A.F. Johann2,3; B. Feige2; A. Devoto4;
C. Lombardo5; D. Riemann2; P. De Bartolo1,6; C. Baglioni1,2
1Department TECOS, University of Rome ‘G. Marconi’ ‐ Telematic,
Rome, Italy, 2Department of Psychiatry and Psychotherapy, Medical
Center, 3Medical Psychology and Medical Sociology, University of
Freiburg, Faculty of Medicine, Freiburg, Germany, 4Centre for Sleep
Medicine, 5Department of Psychology, Sapienza University of Rome,
6Laboratory of Experimental Neurophysiology, IRCCS Santa Lucia
Foundation, Rome, Italy
Objectives/Introduction: Sleep is fundamental for emotional
development especially in early infancy. Children with sleep distur-
bance tend to have problems in self‐regulation, and specifically in
managing their emotions. This study aimed to investigate the rela-
tionship between sleep habits and emotions in nursery setting using
an ecological momentary assessment.
Methods: Preliminary data on 24 children (12 F, 12 M) aged 6–
35 months (17.8 ± 9.6) were obtained. Sleep habits and emotion
were monitored by educators during nursery times through a sleep
and emotion diary (based on Positive and Negative Affect Scale for
Children questionnaire) for 10 days. Sociodemographic, family orga-
nization, nighttime sleep habits at home and emotional and beha-
vioural assessment questionnaire were administered to children
families and educators.
Results: Based on questionnaires, we divided children in 2 groups:
children without sleep problems (N = 13) and children with sleep
problems (N = 11). Daily sleep time of children without sleep prob-
lems was significantly higher compared to children with sleep prob-
lem during both the first (F(1,22) = 6.29, p = 0.02) and the second
week (F(1,22) = 7.61, p = 0.01). A significant correlation between daily
sleep time during the first week and positive emotions in general
(r = 0.47, p = 0.02), happiness (r = 0.63, p = 0.01), cheerfulness
(r = 0.76, p < 0.01), dynamism (r = 0.78, p < 0.01), joy (r = 0.70,
p < 0.01), was found. Daily sleep time during the second week
resulted moderately correlated with energy (r = 0.45, p = 0.03)
cheerfulness (r = 0.43, p = 0.03), dynamism (r = 0.43, p = 0.04), fear
(r = −0.41, p = 0.04), loneliness (r = −0.41, p = 0.05).
Conclusions: Preliminary analyses indicated that good sleep seems
to be associated with high positive emotions, but not necessarily
with low negative emotions. Future studies conducted in larger sam-
ples are warranted to replicate these results.
Disclosure: Nothing to disclose.
P522 | Polysomnographic study in primary‐
school children with Attention Deficit
Hyperactivity Disorder
R. Carcangiu1; L. Staner1; F. Sellal2; F. Duval3
1Centre Hospitalier Rouffach, Unité D'Explorations Fonctionnelles du
Rythme Veille‐Sommeil, Rouffach, 2Department of Neurology, Hopitaux
Civils Colmar, Colmar, 3Department of Psychiatry, Centre Hospitalier
Rouffach, Rouffach, France
Objectives/Introduction: 10% of children with Attention Deficit
Hyperactivity Disorder (ADHD) present persistent sleep disorders.
Sleep has a role in cerebral plasticity. Poor sleep may worsen the
attentional dysfunction in ADHD. Comorbidity diagnosis (ADHD +
sleep disorder) is complex. This retrospective study investigates sub-
jective and objective sleep quality in a group of 22 ADHD children.
Methods: Aged from 6 to 10 years (mean age 7.5), 18 boys and 4
girls, they were referred to our Sleep Unit for poor sleep and poor
attention. They had not yet a conclusive diagnosis of ADHD and
they were all stimulant drug‐naïve. They underwent a sleep‐expert
interview and one‐night PSG. After PSG, diagnosis of ADHD was
made by an expert in this field: clinical features of all children met
the DSM‐V diagnostic criteria for ADHD (14 combined and 8 inat-
tentive presentation). A neurocognitive evaluation (Kitap battery)
confirmed attention deficit.
Results: The children's families reported: snoring (77%), tiredness
(68%), insomnia (41%) and parasomnia (41%). No one complained
about clear Restless Legs Syndrome, but 14% reported “restless
sleep”. 86% complained about at least two sleep symptoms. 50% of
families considered sleep problems more important than attention
deficit and consulted first for sleep problems. PSG showed a mean
sleep latency of 21 min ± 22; a mean sleep efficiency of 89% ± 8
and total sleep time of 553 min ± 61. 23% of children had a bad
night at Sleep Unit with sleep latency >30 min or sleep efficiency
<80%, with total sleep time <420 min. PSG showed periodic limb
movement disorder during wakefulness in 23% of children and an
Apnea‐Hypopnea Index (AHI) between 3–4.9/hr in 36%. No one had
a AHI ≥ 5/hR. Parasomnia episodes were not recorded.
Conclusions: The present results show that 50% of school‐aged
drug‐naïve ADHD children arriving at our sleep consultation had a
priority complaint of poor sleep rather than attention. PSG showed
comorbid sleep disorders: parasomnia in 41%, mild OSAS in 36%,
restless legs syndrome in 23%, insomnia in 23%. These results
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reinforce the idea that ADHD children complaining about sleep dis-
orders may consult first sleep‐expert. They should undergo a cogni-
tive and PSG analysis.
Disclosure: Nothing to disclose.
P523 | Night‐to‐night sleep variability and
objective short sleep duration are associated
with impaired sympathetic‐parasympathetic
balance in adolescents
J. Fernandez-Mendoza; F. He; S. Calhoun; A. Vgontzas;
D. Liao; E. Bixler
Penn State College of Medicine, Penn State College of Medicine, Hershey,
PA, United States
Objectives/Introduction: Impaired sympathetic‐parasympathetic
balance, as measured by heart rate variability (HRV), has been asso-
ciated with increased risk of cardiovascular morbidity. Inadequate
sleep has been shown to contribute to impaired HRV, however, it is
not clear what sleep problems are independently associated with
impaired HRV in adolescents, a population in which insomnia symp-
toms, short sleep duration and night‐to‐night sleep variability are
highly prevalent. We examined whether polysomnography (PSG) and
actigraphy (ACT) measured sleep duration and its night‐to‐night vari-
ability were independently associated with worse HRV indices, as
measured by 24‐hr EKG, in adolescents.
Methods: We examined this question in the Penn State Child
Cohort, a randomly‐selected sample of 421 adolescents (12–
23 years). All subjects underwent 9‐hr, in‐lab PSG, wore an ACT
monitor in the non‐dominant wrist for 7 days, and an ambulatory
EKG for 24 hr. Mixed‐effect regression models predicting HRV
indices included PSG sleep duration and ACT sleep duration and its
variability (standard deviation) adjusted for each other as well as for
sex, race, age, body mass index, insomnia symptoms, and apnoea/hy-
popnoea index.
Results: Shorter PSG sleep duration and higher ACT sleep variabil-
ity were independently associated with worse HRV indices [e.g.,
SDNN: 2.05 ± 0.70, p < 0.01 and −4.50 ± 1.14, p < 0.01 and Log‐
HF: 0.10 ± 0.03, p < 0.01 and −0.10 ± 0.05, p = 0.05, respectively],
while ACT sleep duration was not [e.g., SDNN: −0.57 ± 0.84,
p = 0.49 and Log‐HF: −0.06 ± 0.04, p = 0.12, p = 0.37, respectively].
Conclusions: Short PSG sleep duration and high ACT sleep vari-
ability are independently associated with impaired sympathetic‐para-
sympathetic balance, which indicates that these two objective
measures may help identify distinct sleep phenotypes associated
with increased cardiovascular risk in adolescence.
Disclosure: This study was funded by the National Heart Lung and
Blood Institute (R01 HL63772, PI: Bixler; R01 HL97165, MPI: Bixler,
Liao; UL1 TR000127, C06 RR16499, CTSI) and, in part, by the
American Heart Association (14SDG19830018).
P524 | Self‐assessed sleep quality and it
influencing factors in Latvian adolescents
E. Mičule1; M. Celmina2; A. Romanova1; J. Wojdyla1;
I. Daugule1
1Pediatric Department, University of Latvia, Faculty of Medicine, Rīga,
2Epilepsy and Sleep Medicine Clinic, Childrens’ Clinical University
Hospital, Riga, Latvia
Objectives/Introduction: Good sleep quality (SQ) is important for
physical and mental health of the individual, and is a positive indica-
tor of well‐being. However, in adolescents SQ decreases noticeably
due to different reasons. The objective of the study was to analyse
the SQ and it influencing factors in Latvian adolescents.
Methods: Prospective study was performed at different schools in
Latvia including adolescents attending 7th–12th grade. Adolescents
were asked to assess their sleep quality and adequacy and to men-
tion reasons of bad SQ and inadequate sleep amount using a ques-
tionnaire. Sleep hygiene index (SHI; range 14–65) was calculated.
Statistical analysis: ANOVA, Chi‐squared test.
Results: Final sample consisted of 973 respondents (female/male
ratio: 571/402) aged 12 – 19 years (mean – 15.4 ± 1.7; median –
15). In total, 21% (197/956) of adolescents assessed their SQ as bad,
55% (526/955) reported they have inadequate sleep amount. How-
ever significantly more girls assessed their SQ as bad compared to
boys (65% (128/571) vs. 35% (69/402) (p = 0.04)). In the total patient
sample the mean SHI score was 32.9 ± 6.0; range: 14–53. Higher
SHI was among adolescents, who assessed their SQ as bad com-
pared to individuals with good SQ (mean values: 36,048 ± 5,603 vs.
32,113 ± 5,832 (p < 0.001)), and among adolsecents, who reported
inadequate sleep amount compared to adolescents with enough
sleep (34,221 ± 6,061 vs. 31,335 ± 5,566 respectively (p < 0.001)),
moreover girls had higher SHI than boys (33,731 ± 6,171 vs.
31,750 ± 5,662 (p < 0.001)). In both sexes SQ decreased with age:
in 13‐years‐olds 45.8%, in 18‐years‐olds 57% reported inadequate
sleep amount (p = 0.03) and 14% in 13‐years‐olds, 21% in 18‐years‐
olds reported sleeping not well (p = 0.02). Reasons for bad SQ were
mentioned by 26%(259/571) girls, 17% (169/402) boys: significantly
more often girls compared to boys mentioned: homework (19%(49/
259) vs. 13%(22/402) (p = 0.002)); not having a time for sleep (52%
(134/259) vs 21%(85/402) (p = 0.001)), emotional conditions (32%
(83/259) vs 14%(57/402) (p = 0.03)) as causes for inadequate sleep
amount.
Conclusions: Self‐assessed SQ in Latvian adolescents decreases
with age. Females have worse SQ due to load of school homework,
emotional conditions and not having enough time for sleeping. Rea-
sons for differnce in SQ between sexes should be studied more
detailed taking into accout psychological factors.
Disclosure: Nothing to disclose.
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P525 | Infants′ sleep development during the
1 year after birth under nocturnal co‐sleep
conditions
H. Eto1; Y. Manago2; C. Kato1; K. Nishihara3
1Reproductive Health, Nagasaki University Graduate School of
Biomedical Sciences, Nagasaki, 2NHO Ureshino Medical Center,
Ureshino, 3Department of Sleep Disorders Research, Tokyo Metropolitan
Institute of Medical Science, Institute for Science of Labo, Tokyo, Japan
Objectives/Introduction: The 10% birth rate of preterm infant in
Japan is increasing. This study examined preterm infants′ sleep
development under nocturnal co‐sleeping conditions. We examine
quiet sleep, active sleep, and wakefulness during their first 1 year.
Methods: Subjects were 4 first‐born preterm‐infant without compli-
cations with a gestation period greater than or equal to 32 weeks, and
had been admitted to the neonatal intensive care unit. The caregivers
gave verbal and signed informed consent before participating in the
study. Videosomnographic recordings were made on 2 consecutive
nights, and Actigraphic recordings were made using Actiwatch®
(Respironics, Inc.) for 5 consecutive days, at home under co‐sleep condi-
tions, at 4‐weeks, 7‐weeks, 12‐weeks, and 25 weeks. The sleep parame-
ters were analyzed by video data, and the circadian rhythm of rest‐
activity for the mothers and the infants was examined by autocorrelo-
grams for 5 continuous days during each week. (Nishihara, et al., 2002).
Results: Quiet sleep increased 7% at 4 weeks and 20–30% in
25 weeks. Active sleep decreased 0–3% in 25 weeks. By 25 weeks
the longest sleep period was 400–500 min. Nocturnal waking
decreased during the same period. Typical self‐soothing behavior
was observed. Actiwatch data of each infant during the four obser-
vation periods was calculated. The autocorrelation function indicated
a 24‐hr amplitude peak at 12 and 25 weeks (p < 0.001).
Conclusions: We observed the transitioning of preterm infants
nocturnal sleep over 25 weeks. Quiet sleep was increasing and
active sleep was decreasing, and self‐soothing occurred early simi-
larly to term infants. Development of circadian rhythm was delayed
compared to term birth infants, however, if calculated from the time
of fertilization the timing was similar.
Disclosure: Nothing to disclose.
P526 | The association of sleep disturbances
and gastroesophageal reflux in adolescents
S. Tereshchenko; M. Shubina
Department of Child's Physical Health, Scientific Research Institute of
Medical Problems of the North, Krasnoyarsk, Russian Federation
Objectives/Instruction: Many clinical studies have shown a rela-
tionship between gastroesophageal reflux disease (GERD) and sleep
disturbances in adult patients. Data about this relation in children
and adolescents are limited, especially in studies based on the school
samples.
Objective: To evaluate the association of sleep disturbances and
gastroesophageal reflux in urban Siberian adolescents.
Methods: 465 urban Siberian (Krasnoyarsk) adolescents aged 12–18
were asked for belching and/or heartburn presence in the past month
and screened with the Russian version of Gastroesophageal Reflux
Disease Questionnaire (GerdQ). The sum of the scores for the six
GerdQ questions ranged from 0 to 18 and was defined as the GerdQ
score, with a score ≥ eight indicative of high probability for GERD.
Additionally, adolescents were tested for sleep quality with Pittsburgh
Sleep Quality Index (PSQI), nine questions from section #5. Answers
were pointed from “0” (“not during the past month”) to “3” (“three or
more times a week”). “Sleep disturbance score” was calculated as the
sum of points for all nine questions. Data are shown as median (25–
75% quartiles). Kruskal‐Wallis test was used.
Results: Progressive positive associations were detected between
“Sleep disturbance score” and selected adolescents groups with an
increase in the level of upper GI motility disturbance: no belching
and/or heartburn presence group (n = 330) – 4.87 (4.66–5.09), belch-
ing and/or heartburn complaints but no GERD group (n = 110) –
6.24 (5.88–6.59) and GERD high probability group (n = 25) – 7.95
(6.89–9.02), Kruskal‐Wallis test p < 0.001).
Conclusions: In this school‐based sample of urban adolescents we
observed a strong association between GERD and sleep distur-
bances, that may reflect the effect of nighttime symptoms on sleep
quality. On the other hand, sleep disorders may be caused by anxi-
ety and depression associated with GERD.
Disclosure: Nothing to disclose.
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P527 | A simple measurement of cardiac
output using blood circulating time can faithfully
reflect changes in cardiac condition in patients
with sleep apnea and cardiac diseases
T. Tobushi1; S.-I. Ando2; K. Tanaka3; S. Kon-No1; M. Sato3;
A. Hayashi3; T. Kadokami1
1Department of Cardiovascular Medicine, Saiseikai Futsukaichi Hospital,
Chikushino, 2Sleep Apnea Center, Kyushu University Hospital, Fukuoka,
3Saiseikai Futsukaichi Hospital, Chikushino, Japan
Objectives/Introduction: Patients with cardiac diseases are highly
comorbid with sleep disordered breathing (SDB). We previously
reported that the lung‐to‐finger circulating time (LFCT) calculated
automatically from polygraph data of cardiac patients with SDB
could indicate cardiac output (CO). In this study, we tried to access
the ability of this method to indicate the changes in CO and SDB
parameters as well through the treatment.
Methods: We enrolled 84 patients and finally 69 patients com-
pleted SDB study before and after treatment (median age 77 years,
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36 men). We divided them into heart failure group (HF: n = 43) and
non‐HF group (NHF: n = 26). SDB indexes were evaluated using a
portable polygraph (SAS‐2100) and LFCTs were calculated using cus-
tom made algorithm.
Results: Overall prevalence of SDB (respiratory disturbance index
(RDI) > 15/hr) before treatment was 66.6%. RDI significantly
improved through treatment from 25.3 ± 18.2 to 18.7 ± 14.0/hr
(p < 0.01). Mean SpO2 and minimum SpO2 values also improved
from 93.8 ± 2.8 to 95.2 ± 2.2% (p < 0.05) and 80.5 ± 9.4 to
84.1 ± 8.3% (p < 0.01), respectively. In HF group, ejection fractions
of left ventricle was significantly lower than non‐HF group
(51.9 ± 18.7 and 63.5 ± 12.4%, p < 0.01) and B‐type natriuretic
peptide was higher in HF group than non‐HF group (558.6 ± 477.2
and 159.4 ± 164.2%, p < 0.01). RDI improved significantly only in
HF group from 29.0 ± 17.9 to 19.9 ± 14.9/hr (p < 0.01) in HF
group and 19.2 ± 17.3 to 16.7 ± 12.5/hr (p = 0.2) in non‐HF group.
CO measured by LFCT were significantly improved only in HF
group from 26.5 ± 7.2 to 24.8 ± 6.8 L/min (p = 0.03), whereas no
significant change in non‐HF group 20.5 ± 6.0 to 22.3 ± 6.2 L/min
(p = 0.07).
Conclusions: LFCT measurement using the data of polygraph could
simply evaluate the changes in CO along with the changes in usual
SDB parameters. This method could be useful tool for screening and
management of cardiac patients with SDB.
Disclosure: The resource of the study was funded by Teijin
Pharma Ltd.
P528 | Assessment of sleep quality in patients
with Idiopathic pulmonary fibrosis
E. Nena1; M. Karailidou2; T. Karampitsakos2; E. Manoloudi2;
A. Voulgaris2; M. Froudarakis2; P. Steiropoulos2
1Laboratory of Hygiene and Environmental Protection, Medical School,
Democritus University of Thrace, 2Department of Pneumonology,
Medical School, Democritus University of Thrace, University Hospital of
Alexandroupolis, Alexandroupolis, Greece
Objectives/Introduction: Idiopathic Pulmonary Fibrosis (IPF) is a
progressive and ultimately lethal pulmonary disease of unknown
pathogenesis which can be also associated with sleep disturbances.
Aim of the study was to explore possible associations between sleep
quality and
a) pulmonary function tests (PFTs),




f) daytime sleepiness in a line of consecutive patients with IPF.
Methods: Included were 39 newly‐diagnosed patients, who under-
went PFTs and completed the following questionnaires: Pittsburgh
Sleep Quality Index (PSQI), Saint George Respiratory Questionnaire
(SGRQ), International Physical Activity Questionnaire (IPAQ), Zung
Self‐Rating Anxiety Scale (SAS), Zung Self‐Rating Depression Scale
(SDS) and Epworth Sleepiness Scale (ESS).
Results: Mean age of IPF patients was 69.6 ± 6.2 years, the major-
ity (n = 36, 92.3%) were males. Their mean BMI was 28.2 ± 3 kg/m2
while the total SGRQ score was 41 ± 22.1 (symptoms score and
activity score were respectively 41.4 ± 21.7 and 62.6 ± 29.6). Eleven
patients (30.6%) had a PSQI ≥ 5, indicative of poor sleep quality.
Compared with those with good sleep quality (PSQI < 5) they did
not differ in terms of age (69.79 ± 6.9 vs. 69.57 ± 5.1 years,
p = 0.921) or BMI (27.82 ± 3.2 vs. 28.36 ± 2.78 kg/m2, p = 0.613).
No difference was found in scores of total SGRQ (47.06 ± 19.95 vs.
48.16 ± 22.92, p = 0.886), IPAQ (404.25 ± 711.63 vs.
497.84 ± 624.19, p = 0.691), SDS (43.57 ± 5.4 vs. 41.78 ± 8.82,
p = 0.485) and ESS (5.36 ± 3.73 vs. 6 ± 5.42, p = 0.705). Likewise,
PFTs revealed no difference. A significant difference was only
observed in SAS score (34.79 ± 4.87 vs. 40.16 ± 7.81, p = 0.021).
Conclusions: Poor sleep quality can be detected in IPF patients,
which is not associated with lung function, physical activity or over-
all health related QoL, a fact that highlights the need of use of speci-
fic questionnaires.
Disclosure: Nothing to disclose.
P529 | Nearly 1 in 5 patients with stroke could
have undiagnosed OSA that could impact their
recovery
S. Sultan Khawaja1; S. Kalsoom1; A. Goudaman1;
S.-H. Haider-Zaidi1; S. Munshi1; M. Sovani1
1Nottingham University Hospitals NHS Trust, Nottingham, United
Kingdom
Objectives/Introduction: Obstructive sleep apnoea (OSA) is asso-
ciated with increased cardiovascular morbidity and mortality. Previ-
ous work shows strong association between OSA and stroke. AF is
associated with OSA as well as being a causal factor in stroke. OSA
could potentially decline the recovery phase in Stroke and cause AF
recurrence. Prediction tools assessing OSA risk are not routinely uti-
lised in stroke patients. We reviewed the potential incidence of OSA
in stroke patients, investigated the proportion with AF and their
length of inpatient stay (LOS).
Methods: 295 consecutive patients presenting to acute stroke ser-
vices were reviewed. 113 patients excluded due to stroke‐mimics or
data discrepancies. Study period from November 2015 to January
2017. Pre‐stroke symptoms and co‐morbidities reviewed and
patients were assessed for risk of OSA using STOP BANG score
(SBS) questionnaire within 30 days of presentation .In non‐communi-
cative patients, questionnaires were given to relatives.
Results: 182 patients’ data analysed. 98 females (53.84%) and 84
(46.15%) male patients. Median patient age was 77 years, with range
of 28 to 96 years. 13 patients (7.14%) patients died during in‐patient
stay, with 92.85% (169 patients) surviving to discharge. Of 182
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patients, 31 patients (17.03%) had high SBS (≥5). 78 (42.85%) had
intermediate SBS (3–4) and 65 (35.71%) had low SBS (0–2). In
patients with high SBS, 16.2% (5 patients) had AF; with intermediate
SBS, 24% (19 patients) had AF and in patients with low SBS, 21%
(14 patients) had AF. Mean LOS in patients with high SBS was
43.3 days. In intermediate SBS, mean LOS was 52.9 days and in low
SBS was 30.72 days. Mortality during in‐patient stay in high SBS
was 1 (7.69%), intermediate SBS was 7 (53.84%) and in low SBS
patients was 5 (38.46%)
Conclusions: Stroke patients with intermediate‐high SBS (>3) have
greater incidence of AF, longer LOS and worse survival compared to
low SBS. We recommend early recognition of potential OSA by util-
ising SBS and performing sleep studies in patients with intermediate‐
high SBS. Identifying and treating OSA could impact recovery from
stroke and hence LOS.
Disclosure: Nothing to disclose.
P530 | Sleep during naturally occurring acute
respiratory infections (ARIs)
J. Axelsson1,2; M. Ingre2; C. Regenbogen3; M.J. Olsson2;
M. Garke2; M. Lekander1,2; J. Lasselin1
1Stockholm University, 2Karolinska Instititutet, Stockholm, Sweden,
3RWTH Aachen University, Aachen, Germany
Objectives/Introduction: There is strong experimental support for
infections to increase the drive for sleep in animals, and it is widely
believed that more sleep is part of an adaptive immune response. The
objective was to determine how people sleep while suffering from an
acute respiratory infection (ARI) in normal daily life.
Methods: We recruited 100 people, of which 30 became acutely
sick in a ARI during the study period, and measured their sleep, both
objectively (actigraphy) and subjectively (diary ratings), sickness
symptoms and body temperature for one week when sick, and again
4 weeks later when healthy.
Results: During the ARI, people spent objectively longer time in
bed, but they also had longer wake bouts and less total sleep time
(p < 0.05). During the week with ARI, people also experienced more
difficulties falling asleep, more restless sleep, and more shallow sleep
(p < 0.05), although they did not report sleep to be less sufficient.
Most sleep disturbances occurred at the beginning of the week with
ARI, when symptoms were strong, and showed signs of recovery
thereafter (as indicated by interactions between condition and day
with sickness for 9 out of the 10 outcomes, p < 0.05). The degree
of symptoms was related to worse sleep quality and more restless
sleep (p < 0.05), but not to any of the objective sleep outcomes or
the other subjective sleep variables. Having a higher body tempera-
ture was related to less actual sleep (p < 0.05), but not to any of the
other outcomes.
Conclusions: This study, carried out in people's own homes, shows
that having an acute respiratory infection is related to a longer sleep
duration but also more disturbed sleep, both objectively and subjec-
tively, rendering people sleep less and worse than normal. To under-
stand whether the sleep alterations seen during infections are
adaptive and whether sleep could be used as a means to facilitate
recovery there is a need for future larger studies that classify the
exact pathogen type, and also manipulate sleep duration.
Disclosure: Nothing to disclose.
P531 | Obstructive sleep apnea (OSA) and
rhinitis: literature review and personal
experience
A. Bucci
ENT ‐ Head and Neck Surgery, ASUR Marche ‐ AV2, Senigallia (AN), Italy
Objectives/Introduction: Sleep disordered breathing (SDB) have
been reported to be associated with rhinitis as a potential etiologic
factor. Even if the consequences of nasal obstruction on sleep qual-
ity have been well demonstrated, the relationship between the two
disorders remains controversial.
Methods: We performed an analysis of medical literature perform-
ing a systematic review with the purpose to highlight fundamental
aspects of OSA and rhinitis.
Results: The mechanism of OSA is still not well understood. Sub-
jects with chronic nasal obstruction reported significantly higher ESS
(Epworth Sleepiness Scale). The high nasal resistance leads to a more
negative intraluminal pressure in the lower airways that may pro-
mote partial or intermittent collapse of the pharynx, increasing the
risk of OSA. The link between OSA and rhinitis has been discussed
in the literature.
Conclusions: Multilevel anatomic obstruction is often present in
snoring and OSA. As the nose is the first anatomical boundary of
the upper airway nasal obstruction may contribute to SDB. The role
of nasal obstruction in OSA remains controversial: there isn't a linear
correlation between the degree of nasal obstruction and the severity
of SDB. Rhinitis is a risk factor for OSA. Decreasing nasal congestion
with nasal steroids may improve sleep, daytime fatigue, and the qual-
ity of life of patients with rhinitis. Many pathophysiological mecha-
nisms can potentially explain the role of nasal pathology in SDB: the
Starling resistor model, the unstable oral airway, the nasal ventilatory
reflex and the role of nitric oxide. Physicians should always be aware
of the high risk of sleep disorders in patients with rhinitis.
Disclosure: Nothing to disclose.
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P532 | Agreement study of general sleep
quality within infertile couples
A. Najafi1; A.A. Akhlaghi2; E. Khatooni3
1Occupational Sleep Research Center, Baharloo Hospital, Tehran
University of Medical Sciences, 2Department of Epidemiology and
Reproductive Health, Reproductive Epidemiology Research Center, Royan
Institute For Reproductive Biomedicine, 3Department of Epidemiology
and Biostatistics, School of Public Health, Tehran University of Medical
Sciences, Tehran, Islamic Republic of Iran
Objectives/Introduction: Sleep hygiene and sleep related disor-
ders are emerging field in the field of infertility. Limited evidence is
available regarding sleep quality and its related problems among
infertile couples. This study aimed to assess sleep quality among
infertile couples and estimate agreement of sleep quality between
couples.
Methods: This was a cross‐sectional study. A total of 153 infertile
couples (306 participants) referred to Royan Institute for Reproduc-
tive Biomedicine were recruited in the study. Participants completed
an informed consent form, a demographic characteristics ‘question-
naire and Pittsburgh sleep Quality Index (PSQI). PSQI score >5 was
defined as bad sleeper.
Results: The Mean age and mean work experience of the partici-
pants were 37 ± 9.3 and 10 ± 8.6 years, respectively. Fifty‐six
(29.2%) of participants were fixed day shift workers, 111 (57.8%)
were swing shift workers (7 days/7 nights), 6 (3.1%) were fixed night
shift workers and 19 (9.9%) were standby shift workers. Mean PSQI
score of all workers was 6.73 ± 3.61. In 69% of subjects, total score
of PSQI was ≥5. Night shift workers had greater score of PSQI than
other three groups of shift workers.
Conclusions: Current findings indicated significant agreement
between sleep quality of infertile couples. Further investigation of
common risk factors for poor sleep quality among infertile couples
and early therapeutic interventions are recommended.
Disclosure: Nothing to disclose.
P534 | Self‐reported insomnia and subclinical
carotid atherosclerosis: is there a relation?
L. Korostovtseva1; A. Alieva1; O. Rotar1; M. Bochkarev1;
M. Boyarinova1; I. Filchenko1,2,3; Y. Sviryaev1,3; A. Konradi1,4;
E. Shlyakhto1,2
1Almazov National Medical Research Centre, 2First Pavlov State Medical
University of St. Petersburg, 3Sechenov Institute of Evolutionary
Physiology and Biochemistry of RAS, 4ITMO University, St Petersburg,
Russian Federation
Objectives/Introduction: Based on the recent studies, insomnia is
assumed to be an additional cardiovascular (CV) risk factor, however,
its association with arterial atherosclerotic damage is unclear. We
assessed the relation between self‐reported insomnia and
asymptomatic atherosclerosis evaluated by carotid intima‐media
thickness (IMT).
Methods: In this analysis, we included 861 (321 males, 37%; mean
age 44.9 ± 11.9 years old) out of 1,600 participants of the St Peters-
burg population‐based sample (within the epidemiological study
ESSE‐RF) without previously known CV events. All subjects under-
went a structured interview (lifestyle, medical history, complaints),
blood pressure (BP) and total cholesterol (TChol) level assessment.
Insomnia was evaluated based on the answers “≥3 times per week”
to at least one of the questions: “How often did you have difficulties
in falling asleep for longer than 30 min after going to bed in the last
month?”, “How often did you have difficulties in falling asleep after
midnight awakening in the last month?”. We also asked about snor-
ing (yes/no). Subclinical atherosclerosis was assessed by carotid IMT
(ultrasound device «My Sono U6», Samsung, Korea) qualified as fol-
lowing: normal ≤0.9 mm, abnormal >0.9 mm. We applied parametric
statistics (t‐Student, chi‐square tests, two‐sided criteria), Spearman
correlation analysis.
Results: At least one insomnia complaint was reported by 176 sub-
jects (20%), while 65 participants (8%) reported both difficulties in fall-
ing asleep and midnight awakenings. IMT thickening was found in 122
subjects (14.2%). IMT values were greater in subjects with insomnia
complaints (0.71 ± 0.16 vs. 0.76 ± 0.18 in insomniacs vs. non‐insom-
niacs p < 0.001), in particular, in those with frequent nocturnal awak-
enings (p = 0.004) but not in subjects complaining of sleep onset
difficulties (p = 0.06). Only subjects with nocturnal prolonged awaken-
ings showed higher prevalence of increased IMT (chi‐square 5.3,
p = 0.025) compared to those with difficulties falling asleep (p = 0.20).
Correlation analysis demonstrated a weak association between mean
IMT and insomnia complaints (ρ = 0.14, p < 0.001), mean IMT and
snoring (ρ = 0.21, p < 0.001). However, they were no longer signifi-
cant after adjustment for age, BP and TChol.
Conclusions: Our results from the epidemiology cohort confirm an
association between insomnia complaints and subclinical carotid
atherosclerosis, although it appears to be weak compared to the
common CV risk factors.
Disclosure: The work was partly supported by the grant of the
Russian Scientific Foundation, project # 17‐75‐10099, and by the
Grant of the President of Russian Federation for the Leading Scien-
tific Schools of Russia NSH‐5508.2018.7 (agreement
№14.W02.18.5508‐NSH, 17.01.2018)
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P535 | Sleep/wake cycle patterns in
adolescence relate to alterations in
cardiovascular and metabolic health in early
adulthood
C. Algarin1; S. Reyes1; R. Burrows2; B. Lozoff3; P. Peirano1;
S. Gahagan4
1Sleep and Neurobiology Laboratory, 2University of Chile / Institute of
Nutrition and Food Technology INTA, Santiago, Chile, 3Center for Human
Growth & Development, University of Michigan, Ann Arbor, MI,
4Department of Pediatrics, University of California San Diego, San Diego,
CA, United States
Objectives/Introduction: Sleep/wake cycle patterns (SWP) are
relevant to healthy functioning of cardiovascular and metabolic sys-
tems. Adolescent lifestyles are characterized by disrupted SWP that
interfere with several processes. The objective of this study was to
assess whether SWP in adolescence (17‐year‐olds) might influence
cardiovascular and metabolic variables 5 y later (22‐year‐olds).
Methods: Participants were part of an infancy cohort and follow‐
up study. Motor activity was recorded for 1 week using actigraphs
(Actiwatch‐16/64) worn on the nondominant wrist, yielding SWP
through an automated method (Actiware®). SWP for the diurnal per-
iod included: wake‐up time, daytime sleep amount (DSA) and number
of naps. SWP for the nocturnal period included: sleep onset time,
nighttime waking amount (NWA) and number of episodes (WEN).
Nutritional and cardiovascular variables of interest were body mass
index, waist circumference, systemic blood pressure (BP), and plasma
glucose, cholesterol and triglycerides. We used linear regression and
univariate GLM for data analysis. Statistical models included sex as a
covariate.
Results: Participants (n = 402) were 50.2% male with mean ages of
17.5 ± 0.3 and 22.5 ± 0.4 years at the two assessments. Results
showed that NWA (F = 1.82, p < 0.01) and nocturnal WEN
(F = 1.47, p < 0.04) at 17 were positively related to BP at 22 years.
WEN at 17 years was also positively associated with plasma choles-
terol at 22 years (β = 0.099, p < 0.05). DSA at 17 years was related
to plasma cholesterol (F = 1.43, p < 0.01) and triglycerides concen-
trations (F = 1.79, p < 0.01) at 22 years.
Conclusions: Fragmented nighttime sleep in adolescence appears
to influence cardiovascular and metabolic variables in early adult-
hood, including higher systemic BP and increased plasma triglyc-
erides and cholesterol concentrations. These results support the
hypothesis that SWP in adolescence influence the functioning of
cardiovascular and metabolic systems in young adulthood.
Support: NIH HD33487 and NIH HL088530 grants.
Disclosure: Nothing to disclose.
P536 | Examining the relationship between
sleep disturbance and daytime variables in
psoriasis using actigraphy and experience
sampling methodology
A. Henry1,2; A. Chisholm3; C. Bundy4; L.A. Carter5;
C. Griffiths6; S. Kyle7
1Manchester Centre for Health Psychology, University of Manchester,
Manchester, 2Big Health Ltd, London, 3School of Psychological Sciences,
University of Liverpool, Liverpool, 4School of Healthcare Sciences, Cardiff
University, Cardiff, 5Centre for Biostatistics, University of Manchester,
6Salford Royal NHS Foundation Trust, Manchester, 7Sleep and Circadian
Neuroscience Institute, University of Oxford, Oxford, United Kingdom
Objectives/Introduction: Psoriasis, an inflammatory skin condi-
tion, is associated with sleep disturbance but few studies have exam-
ined sleep and its relationship to daytime variables prospectively.
We examined whether
(1) psoriasis symptoms, night-time arousal and low mood pre-
dicted subsequent objective and/or subjective sleep; and
(2) whether objective and subjective sleep predicted next-day
psoriasis symptoms and day-time functioning.
Methods: Momentary assessments of psoriasis symptoms, mood
and daytime functioning were completed at five pseudo‐random
intervals daily for 15 days using time‐stamped digital diary entry.
Objective sleep was estimated using actigraphy while subjective
reports of sleep and night‐time arousal were assessed upon waking
each morning. Multi‐level models were computed to test relation-
ships.
Results: Nineteen individuals (Female: 11 [59.7%], median age:
39 years) with psoriasis reporting poor sleep quality were recruited
for a prospective experience sampling study. Increased night‐time
arousal was associated with poorer subjective sleep (p < 0.05). Nei-
ther subjective nor objective sleep parameters were associated with
day‐time psoriasis symptoms in bi‐directional analyses. However,
both objective and subjective sleep predicted impairments in next‐
day fatigue (Objective and subjective total sleep time [TST], subjec-
tive sleep quality), sleepiness (Subjective TST, sleep efficiency and
sleep quality) and concentration (Sleep quality) (p < 0.05).
Conclusions: We showed night‐time arousal predicted subjective
sleep parameters in people with psoriasis, and that sleep was a pre-
dictor of next‐day functioning. Current sleep treatments that target
cognitive factors and arousal (e.g., cognitive behavioural therapy)
should be trialled in psoriasis.
Disclosure: Nothing to disclose.
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P537 | Cardiorespiratory effects of indoor air
quality during sleep
M. Meira e Cruz1,2; J. Belo3,4; N. Canha5,6; J. Lage5;
M. Picado3; C. Viegas3,7; T. Faria3,7; P. Macedo3; S. Cabo
Verde5; C. Alves3,7; M. Almeida3
1Sleep Unit, Cardiovascular Center of University of Lisbon, Lisbon Faculty
of Medicine, 2Portuguese Association of Chronobiology and Sleep
Medicine, 3Lisbon School of Health Technology, Polytechnic Institute of
Lisbon, 4Health and Technology Research Center, 5Center for Nuclear
Sciences and Technologies, Instituto Superior Técnico, University of
Lisbon, Lisbon, 6Portugal Center of Environmental and Marine Studies,
Environmental Department, University of Aveiro, Aveiro, 7Environment
and Health Research Group (GIAS), Lisbon, Portugal
Objectives/Introduction: The impact of environmental pollution
in health is globally documented, with long and short‐term effects
related to higher rates in mortality and morbidity, namely cardiovas-
cular and respiratory causes. The present study aims to assess IAQ
and evaluate the existence of correlations between cardiorespiratory
outcomes during the sleep.
Methods: A total of nine men following specific inclusion criteria
(age between 25 and 40 years old, healthy individuals, non‐smoking,
without children below 5 years and without sleeping problems), whose
households are within Grande Lisbon area, were recruited. An unt-
tended polyssomnography (PSG) was performed during 2 weeknights
in a row. The second night PSG′s results were used in order to mini-
mize the first night effect. IAQ monitoring was based on a comprehen-
sive multi‐pollutant assessment where physical (temperature and
relative humidity) and chemical (carbon dioxide, carbon monoxide,
formaldehyde, volatile organic compounds, particulate matter – PM10
and PM2.5) were assessed through real time instruments.
Results: The mean age was 31.9 ± 5.80 years. The results related
to the heart rate (HR) showed that the standard deviation from the
mean value increased in those participants that were exposed to
higher levels of PM10 (rs = 0.583; p = 0.099) and PM2.5 (rs = 0.600;
p = 0.088). During REM sleep, the HR acceleration and deceleration
index increased with higher CO concentrations (r = 0.643; p = 0.085
and r = 0.627; p = 0.096). During the NREM sleep, a decrease in the
pulse transit time was related to higher concentrations of CO2 (rs =
−0.650; p = 0.058). The respiratory rate was lower in those subjects
that were exposed to higher levels of relative humidity, in both
NREM (rs = −0.678; p < 0.05) and REM (rs = −0.816; p < 0.05)
sleep. In opposition, during the REM sleep the respiratory rate
increased when the temperature was higher (rs = 0.680; p = 0.093).
Conclusions: In this study, the increase in some parameters of
indoor air quality (PM, CO and CO2) and thermal comfort was asso-
ciated to mild, but rather significant, changes on cardiovascular and
respiratory indicators of autonomic response meaning sympathetic
activation thus making plausible to hypothesise a conection between
disturbed air quality and cardiovascular risk.
Disclosure: Nothing to disclose.
P538 | Increased risk of sleep disorder in burn
patients: a nationwide, population‐based cohort
study
C.-Y. Liang1; K.-Y. Wang1; W.-C. Chien2,3
1School of Nursing, National Defense Medical Center, 2Department of
Medical Research, National Defense Medical Center, Tri‐Service General
Hospital, 3School of Public Health, National Defense Medical Center,
Taipei, Taiwan
Objectives/Introduction: Burn is a major event which can cause
physical and psychological impairments for those affected. Previous
studies indicated that sleep disturbance was a major problem after
burn. However, the literature was limited. There were no study iden-
tified the risk and types of sleep disorder in burn patients. The goal
of this study was using a population‐based case‐control study to
assess the risk of sleep disorder among burn patients.
Methods: We used data from Taiwan's National Health Insurance
Research Dataset to investigate the risk of having sleep disorder in
burn patient from 2000‐2013 which is a valid representative sample
of the total population in Taiwan. The case group was diagnosed as
burn (ICD‐9 CM: N‐code 940‐949 and E‐code 890‐899) prior to the
index date. The control group was diagnosed without burn in study
period, and then we took 4 times matched by index year, gender
and age. The tracking continued until December 31, 2013. The event
of tracking definite is the occurrence of sleep disorder (ICD‐9‐CM
307.4, 780.5×). Cox proportional hazard regression analysis was used
to evaluate the effects of burn injury on the risk of sleep disorder.
Results: There were 10,653 individuals diagnosed as burn. The
results showed burn injury significantly increased the risk of total
sleep disorder (adjusted HR = 1.36; 95% CI, 1.048–2.864, p = 0.044),
insomnia (adjusted HR = 1.41; 95% CI, 1.083–2.960, p = 0.036),
sleep disturbance (adjusted HR = 2.40; 95% CI, 1.840–5.029,
p = 0.005) and sleep apnea (adjusted HR = 1.38; 95% CI, 1.063–
2.906, p = 0.029). In the subgroups stratified analysis, comparing to
without burn patients, the risk of sleep disorder was increased in
burn patients aged 13–18 (5.45‐fold, 95% CI, 4.109–11.450,
p < 0.001) and with monthly income less than18,000 NTD(2.13‐fold,
95% CI, 1.641–4.484, p = 0.001). Cox regression analysis showed
that the risk of sleep disorder was increased to 3.211‐fold (95% CI,
1.390–7.419, p = 0.006) in burn patients with mental disorders.
Conclusions: Among burn population, cases with mental disorders
carried a higher risk of developing sleep disorder.
Disclosure: Nothing to disclose.
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P539 | Self‐reported and actigraphic sleep
quality in female patients with fibromyalgia and
healthy controls
M. Fernandes1; M.P. Guzzo2; C. Iannuccelli2; C. De
Vincenzo1; L. Mallia3; F. Lucidi4; M. Di Franco2; C. Violani1
1Department of Psychology, 2Department of Internal Medicine and
Medical Specialties, Sapienza University of Rome, 3Department of
Movement, Human and Health Sciences, University of Rome ‘Foro
Italico’, 4Department of Social and Developmental Psychology, Sapienza
University of Rome, Rome, Italy
Objectives/Introduction: Sleep disturbances are a relevant and
frequent feature (74–90%) in Fibromyalgia (FM) (Bigatti et al., 2008;
Choy, 2015). Sleep quality in FM patients is commonly assessed
through self‐reports (SR), however studies with actigraphy (AG) gave
unclear results (Diaz‐Piedra et al. 2015) and found that the agreements
between AG and SR sleep latencies and Total Sleep Time (TST) were
poor, with high discrepancies associated to high FM impact scores
(Segura‐Jiménez et al., 2015). We compared the SR and AG sleep qual-
ity measures of FM patients with those of age‐matched healthy con-
trols (HC); and examined the concordance between subjective and
objective (AG) measures of sleep in both groups.
Methods: Patients were recruited at the FM unit of the university
hospital. After a medical visit, physicians invited female outpatients
who fulfilled both ACR/EULAR 1990 and 2010 diagnostic criteria to
participate in the study. HC were enrolled in the Sapienza university
community. All participants wore a wrist actigraph (AMI Motionlog-
ger Watch) and completed a sleep diary for seven consecutive days.
When returning the actigraph, they completed questionnaires mea-
suring sleep quality (Sleep Disorder Questionnaire), fatigue severity
(Checklist Individual Strength), and fibromyalgia impact (FIQ).
Results: 30 FM patients and 23 HC were included for data analy-
sis. The sleep questionnaire showed poorer sleep quality in several
variables considered in FM patients compared to HC (all p < 0.001).
FM patients and HC did not differ in any of the actigraphy measures
of sleep efficiency or continuity (e.g. Sleep Efficiency p = 0.40,
WASO p = 0.45, Sleep Fragmentation Index p = 0.75). The inter‐
method agreement for TST and Sleep Efficiency was low in FM
patients, while it was good for TST among HC. Hierarchical regres-
sions considering fatigue severity and sleep measures showed that
fatigue gave a unique significant contribution to the FM impact.
Conclusions: Although FM patients and HC have similar objective
AG sleep patterns, the subjective experience of sleep quantity and
quality is poorer among FM patients, suggesting that they might
underestimate TST. These findings support the view that fatigue is a
crucial feature and the importance of assessing both objective and
subjective measures of sleep quality in FM patients.
Disclosure: None to declare.
P540 | Independent association between
severe obstructive sleep apnea and liver stiffness
W. Trzepizur1; J. Boursier2; M. Le Vaillant3;
P.-H. Ducluzeau4; S. Dubois5; S. Henni6; P. Abraham6;
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1Département de Pneumologie, 2Département d'Hépato‐
Gastroentérologie, Centre Hospitalier Universitaire, 3Institut de
Recherche en Santé Respiratoire des Pays de la Loire, Angers, 4Unité
d'Endocrinologie‐Diabétologie‐Nutrition, Pole de Médecine, Centre
Hospitalier Universitaire, Tours, 5Département d'Endocrinologie,
Diabétologie et Nutrition, 6Département de Médecine du Sport et
Explorations Fonctionnelles Vasculaires, 7Département de Radiologie,
8Département d'Hépato‐Gastroentérologie, Centre Hospitalier
Universitaire, Angers, France
Objectives/Introduction: The goal of this study was to assess the
relationship between the severity of obstructive sleep apnoea (OSA)
and liver stiffness measurement (LSM) by transient elastography, an
accurate method for evaluation of NAFLD severity in patients inves-
tigated for suspected OSA.
Methods: One hundred forty‐seven patients assessed by overnight
polysomnography for clinical suspicion of OSA were included in the
study. LSM was performed using FibroScan®. Significant liver disease
and advanced liver fibrosis were defined as LSM≥7.3 kPa and
LSM ≥ 9.6 kPa, respectively.
Results: Twenty‐three of the 147 patients included were secondar-
ily excluded because of unreliable LSM. OSA was confirmed in all
patients, including 34 (27.4%) patients with mild OSA, 38 (30.6%)
with moderate OSA and 52 (42.0%) with severe OSA. LSM values
ranged between 7.3 and <9.6 kPa in 18 (14.5%) patients and
≥9.6 kPa in 15 (12.1%) patients. A dose‐response relationship was
observed between OSA severity and LSM values (p = 0.004). After
adjustment for age, gender, MS and insulin resistance, severe OSA
was associated with an increased risk of LSM ≥ 7.3 kPa (odds ratios
[95% confidence interval]): 7.17 [2.51–20.50]) and LSM ≥ 9.6 kPa
(4.73 [1.25–17.88]).
Conclusions: Severe OSA is independently associated with
increased liver stiffness, which may predispose OSA patients to a
higher risk of significant liver disease.
Disclosure: Nothing to disclose.
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P541 | The impact of obesity on morning
headaches in OSAS patients
D. Spînu1; V. Vovc2; A. Lupușor1
1State University of Medicine and Pharmacy ‘N. Testemițeanu’, Chișinău,
2Institute of Neurology and Neurosurgery, Chisinau, Republic of Moldova
Objectives/Introduction: According to international data, 45% of
patients with Obstructive sleep apnea syndrome (OSAS) present obe-
sity and 20% present morning headache (MH). Also, it is known that
the prevalence of headaches episodes is higher in overweight patients
then in those with normal weight. The goal of our study is to evaluate
the relationship between weight and MH in OSAS patients.
Methods: The study sample included 18 patients (12 women, mean
age – 60.84 ± 7.5 years) diagnosed with OSAS (mean AHI –
37.36 ± 33.09) through ambulatory cardiorespiratory monitoring dur-
ing sleep. MH was established according to ICHD‐3 beta criteria. For
all patients was calculated BMI (=weight [kg]/height[m]2).
Results: MH was present in 12 of OSAS patients (66.7%) (8
women, mean age – 60.62 ± 6.5 years; mean AHI – 28.3 ± 33.38)
and 6 patients (33.3%) were without MH (4 women, mean age –
61.25 ± 10.34 years; mean AHI – 31.1 ± 14.6). The OSAS patients
with MH presented an higher BMI (mean BIM = 33.58 ± 9.78) then
patients without MH (mean BMI = 30.86 ± 5.47). 50% (BMI > 30) of
OSAS patients with MH, were obese, while only 33.3% of OSAS
patients without MH.
Conclusions: MH occurs more frequently in OSAS patients with
higher BMI. We can suppose that a higher BMI represents a risk fac-
tor for MH in OSAS patients.
Disclosure: Nothing to disclose.
P542 | The antihypertensive effect of
continuous positive airway pressure therapy for
patients with obstructive sleep apnea and
resistant hypertension: telephone survey
E. Paulauskaitė1; G. Vaitukaitienė1; S. Miliauskas1
1Pulmonology Department, Lithuanian University of Health Sciences,
Kaunas, Lithuania
Objectives/Introduction: Obstructive sleep apnea (OSA) is associ-
ated with drug‐ resistant hypertension (RH). Our aim was to see
weather continuous positive airway pressure (CPAP) therapy
effected RH treatment.
Methods: This study was comprised of a retrospective chart
review and a telephone survey. This was a pilot study. Medical
records were reviewed of all patients, who underwent diagnostic
polisomnografy for OSA at Pulmonology department of Lithuanian
University of Health Sciences Hospital in 2015. Study subjects were
patients with RH and moderate or severe OSA (apnea‐ hypopnea
index (AHI) > 15 per hr).
Results: A total of 28 patients met the criteria and agreed to com-
plete brief telephone survey regarding RH treatment. All patients
with moderate/severe OSA and RH were using CPAP therapy more
than 5 hr during night for about 1 year. The antihypertensive drug
regimen was unaltered in 9 patients (32.1%), modified in 19 patients
(67.9%) by either dose reduction (n = 8) or by discontinuing 1 anti-
hypertensive drug (n = 11). The survey showed that patients whose
antihypertensive treatment was modified by discontinuing 1 drug,
had higher AHI compared with patients whose treatment was
unchanged or was reduced the drug dose (p = 0.013).
Conclusions: According to this telephone survey CPAP therapy
was associated with better blood pressure control for the patients
with moderate/severe OMA and RH that let to reduce the number
or the dose of antihypertensive drugs.
Disclosure: The authors declared no conflict of interest.
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P543 | The influence of anticipatory stress on
sleep ‐ preliminary results from an experience
sampling method study
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C. Imboden5; K. Bader6; M. Hatzinger7,8; A.T. Gloster9
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Psychology and Epidemiology, University of Basel, Basel, 3Centre for
Affective, Stress, and Sleep Disorders, University Psychiatric Clinic
Basel, Base, Switzerland, 4Institute for Clinical Psychology and
Psychotherapy, Technical University of Dresden, Dresden, Germany,
5Private Clinic Wyss, Münchenbuchsee, 6Centre for Specialized
Psychotherapy, University Psychiatric Clinic Basel, Basel, 7Psychiatric
Services Solothurn, Solothurn, 8Psychiatric Services Basel, 9Clinical
Psychology and Intervention Science, University of Basel, Basel,
Switzerland
Objectives/Introduction: In research about non‐normative sleep
behaviour, the various effects of sleep deprivation and sleep distur-
bances on affect have been focused on. However, comparatively lit-
tle research on how stress immediately influences sleep quality has
been conducted. In this study, the direct influence of evening antici-
patory stress for the next day on the subjective appraisal of sleep
quality the next morning was examined using data from Experience
Sampling Method (ESM). To further differentiate the results, the
moderating effect of state emotion regulation on the effect of proxi-
mate stressors on sleep quality is analysed.
Methods: In a quasi‐experimental longitudinal design, clinical and
healthy control participants completed questionnaires 6 times a day
over 1 week, using the Experience Sampling Method (ESM) para-
digm. In addition, they filled out a questionnaire battery at baseline,
including the Insomnia Severity Index and questionnaires regarding
emotion regulation. The hypotheses were tested on a day‐to‐day
level, using evening and morning ESM data, as well as baseline data.
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Results: 284 participants with Major Depressive Disorder
(n = 118), Social Anxiety Disorder (n = 47), and healthy controls
(n = 119) were included in the study. The mean age was 31.75 years
(SD = 11.52) and 189 (66.55%) were female. 93.16% of the prompts
in the morning or evening have been completed (n = 3,704 prompts).
Anticipatory stress correlated negatively with subjective sleep quality
(r = −0.228, p < 0.001). Groups differed both in sleep quality ratings
(F(1,1823) = 152.2, p < 0.001) and anticipatory stress appraisals (F
(1,1807) = 59.03, p < 0.001). A time‐dependent multi‐level model
using appraisal of sleep, emotion regulation, anticipatory stress, and
the baseline scores of insomnia and emotion regulation will be anal-
ysed. Differences in emotion regulation as a moderator of antici-
pated stress and its impact on sleep quality will be examined.
Conclusions: This study shows how anticipatory stress can have
an immediate effect on subsequent sleep and how the ability to reg-
ulate emotions can moderate this effect. The findings implicate a
susceptible process in nocturne events and can be utilized for the
development of improved treatment for populations suffering from
insomnia or sleep disturbances. As the study shows results from
both psychiatric patients and healthy controls, generalizability vs.
specificity will be directly tested.
Disclosure: Nothing to disclose.
P544 | Misperception of sleep patterns and
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major depressive disorders, and social anxiety,
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Objectives/Introduction: While it is a very common finding that
patients with clinical symptoms of insomnia present with normal
objective measures of sleep continuity, the psychological factors
contributing to this misperception of sleep are rather unclear. Here
we compared subjective, objective and retrospective sleep quality
ratings among patients with major depressive disorders (MDD), social
anxiety (SAD) and healthy controls (HC). We hypothesized that,
compared to controls, patients will show (1) stronger misperception
of sleep (difference between objective sleep continuity measures
and subjective sleep evaluation immediately after sleep) and (2) a lar-
ger memory experience gap (MeG, i.e. disagreement between the
insomnia rating of the previous week, compared to the promptly
subjective and objective assessments).
Methods: Age and gender matched groups of 56 patients with
MDD, 14 patients with SAD and 58 HC took part in the present study.
Sleep was assessed by actimetry over seven consecutive nights. Sub-
jective sleep was assessed (1) each morning immediately after awak-
ening with the question “How do you rate your sleep quality” on a
metric scale from 0 (best sleep quality) to 100 (worst sleep quality),
and (2) retrospectively, after the week of actimetry, with the Insomnia
Severity Index (ISI; with higher scores indicating worse sleep quality)
referring to overall sleep quality of the past seven nights.
Results: Neither retrospective sleep assessment nor immediate
sleep morning assessment correlated with objective sleep measure-
ments in any of the three groups (p's > 0.15), except for a positive
correlation with SOL in SAD subjects (r = 0.59, p < 0.05). By trend
of significance (p < 0.10), retrospective ISI ratings of MDD subjects
were worse and ISI ratings of SAD patients better than immediate
sleep morning ratings, while there was no MeG in healthy controls.
Conclusions: The results of our study confirm previous observa-
tions of misperception of sleep, even when sleep evaluation was
performed immediately in the morning. In addition, in patients with
depression or anxiety, retrospective sleep assessments by question-
naires may be confounded by a MeG.
Disclosure: This study was supported by the Swiss National
Science Foundation (SNF Grant # 100014_149524/1 and
PP00P1_163716/1). No conflicts of interests to disclose.
P545 | Poor sleep quality and depressive
symptoms in young adults
M. Gonçalves1,2; A. Henriques1; E. Ramos1,3; A.R. Costa1;
C. Guilleminault4; H. Barros1,3
1EPIUnit ‐ Instituto de Saúde Pública, Universidade do Porto, 2Centro de
Medicina do Sono, Hospital CUF Porto, 3Departamento de Ciências da
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Objectives/Introduction: The association between poor sleep and
affective disorders is well established, but it remains unknown which
specific sleep dimensions are associated with depressive symptoms.
We characterized sleep quality and estimated the association
between dimensions of poor sleep quality and depressive symptoms
in a sample of 21‐year‐old young adults.
Methods: A cross‐sectional study was conducted comprising 1459
21‐year old participants (52% women) from the EPITeen Cohort,
Porto, Portugal. The Pittsburgh Sleep Quality Index was used to
assess sleep quality. Besides an overall score (>5: poor quality; ≤5:
good quality), this scale measures sleep quality along 7 dimensions:
subjective sleep quality, sleep latency, sleep duration, habitual sleep
efficiency, sleep disturbances, use of sleep medication, and daytime
dysfunction (higher scores, worse sleep quality). The Portuguese ver-
sion of the Beck Depression Inventory‐II was applied to assess the
severity of depressive symptoms (scores>13 meaning presence of
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depressive symptoms). Odds ratios (OR) and 95% confidence inter-
vals (95% CI) between sleep quality (global and for each dimension)
and depressive symptoms were computed using logistic regression
models, adjusting for sex, education, body mass index and smoking
status.
Results: At 21 years of age, 30.0% of young adults presented poor
sleep quality, being higher among women (33.2 vs. 26.6%,
p = 0.006). Moreover, 15.6% presented depressive symptoms, being
higher among women (20.1% vs. 10.8%, p < 0.001). Poor sleep qual-
ity was associated with a higher prevalence of depressive symptoms
(adjusted OR = 4.66, 95% CI: 3.43–6.33). Considering each sleep
dimension separately, stronger associations were observed for sleep
disturbance (adjusted OR = 9.08, 95% CI: 3.70–22.27), daytime dys-
function (adjusted OR = 8.04, 95% CI: 5.28–12.23) and subjective
sleep quality (adjusted OR = 8.84, 95% CI: 4.80–16.24).
Conclusions: Overall, poor sleep quality is associated with
increased frequency of depressive symptoms among young adults,
but special attention should be paid to the presence of sleep distur-
bance, daytime dysfunction and subject's opinion regarding their
sleep quality. Future longitudinal studies should better clarify this
association, in order to assess the relevance of considering different
dimensions of sleep quality when delineating strategies to prevent
depression in this specific population.
Disclosure: Nothing to disclose.
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Objectives/Introduction: Depression is associated with decreased
heart rate variability (HRV) during sleep, which reflects abnormal
autonomic regulation of the sinoatrial node, but this has not been
assessed across the entire sleep period. While studies investigating
depression biomarkers in sleep physiology have focused on elec-
troencephalographic features, heart rate abnormalities may provide
new information about the sleep signature of depression. The cur-
rent study investigated changes in heart rate across sleep in people
with depression, and assessed the validity of a classification algo-
rithm using sleep‐derived heart rate patterns to identify depression
status.
Methods: A retrospective database containing sleep electroen-
cephalograms and electrocardiograms was used to derive heart rate
and HRV in the very low frequency (VLF), low frequency (LF), and
high frequency (HF) ranges. These parameters were compared across
sleep stages in 279 individuals with depression (69% female,
46 ± 17 years old) and 374 healthy controls (55% female,
40 ± 19 years old). This dataset was integrated in a larger sample of
1193 recordings to train a heart rate profiling algorithm developed
by a biomedical company to discriminate between individuals with
depression and healthy controls. This algorithm was then tested in a
distinct sample of 174 individuals: 87 with depression (59% female,
44 ± 11 years) and 87 healthy controls (55% female, 43 ± 11 years).
Results: The depression group had significantly higher heart rate
and lower VLF, LF, HF HRV than the controls (n = 543, all
p < 0.050). A significant interaction between depression status and
sleep stages [n = 543, F(3, 1617) = 6.0, p < 0.001] indicated that, for
VLF, this group difference was at least 2.8 times more pronounced
during stage 1 sleep than in other sleep stages. The algorithm had
an overall classification accuracy of 79.0% [n = 174, sensitivity:
82.8%, 95% CI( 0.73–0.89), specificity: 77.0%, 95% CI (0.67–0.85)].
Conclusions: These findings confirm that depression is character-
ized by elevated heart rate and low HRV during sleep, a phe-
nomenon suggestive of autonomic deregulation. For VLF, this was
especially marked during “light” sleep. The accuracy by which the
algorithm was able to detect depression suggests it may be a
promising biomarker of depression and highlights the extent to
which autonomic dysfunctions may relate to sleep abnormalities in
people with depression.
Disclosure: This study is part of a wider investigator‐led project
based on a retrospective polysomnographic database at the Royal
Ottawa Mental Health Centre (ROMHC). Medibio Limited, a medical
technology company, has led the heart rate algorithm development
and provided partial funding for the salaries of research assistants
working on collating diagnostic information from ROMHC medical
records. The senior author did not receive a salary from Medibio.
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hospitalized during a suicidal crisis
A. Boafo1; R. Armitage2; S. Greenham1,3; A. Dale3;
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Objectives/Introduction: Adolescence is a sensitive period for
the emergence of both sleep and mood problems, two major risk
factors for suicidality. While the effects of depression on sleep are
less consistent in adolescents than in adults, some studies suggested
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that young people with depression have poor sleep consolidation,
shortened REM latency, and abnormal amounts of N3 sleep. Yet,
very little is known about sleep in depressed adolescents undergoing
acute suicidal crisis.
Methods: This study included 17 adolescents (15.0 ± 1.2 years old,
82% females) with major depression admitted to a pedopsychiatric
unit for acute risk of suicide who endorsed significant suicidal idea-
tion and behaviors (Suicide Behaviors Questionnaire‐Revised ≥7).
Sixteen of them were taking antidepressants. None was taking ben-
zodiazepines, sedatives or hypnotics. An sample of 18 non‐depressed
adolescents was retrospectively collated from another database
(15.0 ± 1.1 years old, 83% females). Across both groups, none of the
participants had a history of sleep disorder or significant medical
condition. All participants underwent a polysomnography adaptation
night before the polysomnography recording used for analyses.
Results: On average, compared to the control group, suicidal ado-
lescents took 46 min longer to fall asleep (n = 35, Z = −4.5,
p < 0.001) and 70 min longer to reach REM sleep (n = 35, Z = −3.2,
p = 0.001). Suicidal adolescents also had a slightly but significantly
higher percentage of N1 sleep than the control group (3.5% versus
2.0%; n = 35, t(33) = −2.6, p = 0.020). A significant interaction indi-
cated that group differences in N3 changed across the progression
of the sleep episode (n = 35, F(2,66) = 3.4, p = 0.041): in the first
two thirds of the night, the two groups had similar N3 percentage
(p ≥ 0.411), but in the last third of the night, the suicidal group had
significantly lower N3 percentage than the control group (p = 0.008).
Conclusions: Significant sleep abnormalities were observed during
a suicidal crisis in a sample of mostly medicated depressed adoles-
cents. This included sleep and REM sleep initiation difficulties and
shallower sleep especially at the end of the night. Future studies
should decipher the relative effects of depression, suicidality and
medication on sleep. These findings stress the need to address sleep
disturbances in the management of suicidality in adolescents.
Disclosure: Nothing to disclose.
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and General University Hospital, Charles University in Prague, Praha,
Czech Republic
Objectives/Introduction: Cognitive dysfunction and higher
degree of anxiety and depressive symptoms are the main neuropsy-
chiatric OSA consequences. The aim of this study was to character-
ize the neuropsychiatric clinical picture of OSA patients and to
determine the CPAP effect on adherent and non‐adherent patient to
neuropsychiatric functioning after 3 months of CPAP usage.
Methods: 126 OSA patients were involved into the study, 43 of
them were indicated to CPAP treatment and were retested by neu-
ropsychological test battery. The following tests were performed:
Montreal Cognitive Assessment (MoCA) for the evaluation of cogni-
tive impairment, Beck Depression Inventory (BDI‐II) and the State‐
Trait Anxiety Inventory (STAI) together with the Epworth Sleepiness
Scale (ESS) for the evaluation of neuropsychiatric symptoms and a
person's general level of daytime sleepiness.
Results: OSA patients with the CPAP showed significantly less day-
time sleepiness, anxiety and depressive symptoms (all p < 0.001) and
no cognitive dysfunction (p = 0.213) after 3 months of CPAP usage
than before the treatment start. The study found significant differ-
ence between adherent and non‐adherent retested OSA patients in
CPAP effect regarding the psychomotor speed (p = 0.012).
Conclusions: 3‐months CPAP treatment have significant effect on
affectivity and on excessive daytime sleepiness in OSA patients.
Adherent patients had faster psychomotor speed in MoCA test than
less adherent patients.
Disclosure: Nothing to disclose.
P549 | Investigation of sleep structure with
polysomnograhy in the patients with first
episode psychosis
E. Kızılay; S. Yetkin
Gulhane Medicine Faculty, Ankara, Turkey
Objectives/Introduction: Sleep researches allow the structure of
sleep to be analyzed at macro and micro levels of sleep changes. These
researches reveal a different perspective on the understanding of the
pathophysiology of schizophrenia. Sleep disturbance in schizophrenic
individuals is common among healthy individuals. These disturbances
usually occur before the symptoms of the disease and are considered
as an important risk factor. In this study, sleep architecture of drug‐
naive non‐affective first episode psychosis patients and healthy con-
trols was investigated, and the relationship between the sleep struc-
ture and clinical features of the patients during the active psychotic
period and after the active psychotic period was investigated.
Methods: Twenty‐one non‐affective drug‐naive first‐episode psy-
chotic patients and 11 of these patients that had been followed for
at least 6 months (with one psychotic episode) and 18 healthy vol-
unteers matched for age and education. Two consecutive night
polysomnography (PSG) studies were conducted in all sample. Posi-
tive and Negative Syndrome Scale (PANSS) was administered during
the onset of the psychotic episode and ongoing. Sleep consistency
and sleep structure variables were compared between patients and
healthy groups. Correlation analyzes were performed between
patients′ sleep continuity and changes in sleep structure and their
clinical characteristics.
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Results: Compared to healthy controls, there was an increase in
sleep latency and a decrease in sleep efficacy in patients with non‐
affective first‐episode psychosis. Patients showed a significant
decrease in slow wave sleep (p < 0.001). In the 6th month follow‐up
of the patients after active psychotic episodes, the variables related
to sleep continuity and sleep structure were not different from
healthy controls. There was a positive correlation between PANSS
positive subscale scores and sleep latency in first‐episode psychosis
patients, and a negative correlation between PANSS negative sub-
scale scores and slow‐wave sleep.
Conclusions: The findings indicate that the decrease in slow‐wave
sleep in patients with non‐affective drug‐naive first‐episode psy-
chotic patients is significant. The fact that reduced slow wave sleep
is associated with negative symptoms in first‐episode psychosis
patients and that sleep structure returns to normal after a psychotic
episode suggests that it may be related to underlying physiopathol-
ogy of the disease.
Disclosure: Nothing to disclose.
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Objectives/Introduction: Sleep problems are not only key symp-
toms of many mental and physical health conditions, but can also
influence the development of psychopathology, such as depression
and posttraumatic stress disorder (PTSD). Here we investigate sleep
as an outcome as well as a potential mechanism influencing the rela-
tionship between exposure to traumatic experiences during child‐
and adulthood and later perceived anxiety, stress and intrusion
development.
Methods: We examined a sample of 50 medical students prior to
and during their first internship representing a well described real‐
world stressor. Data on sleep and heartrate were continuously col-
lected over a time frame of 12 weeks non‐invasively by a wrist‐worn
activity monitor. Prior to starting the internship, i.e., at baseline par-
ticipants reported early critical life events and traumatic experiences.
At mid‐ internship, and after the internship, participants filled in a
questionnaire battery on stress, sleep and intrusive memories about
stressful incidents during the internship.
Results: Half of the examined population has been exposed to
trauma during child‐ and adulthood. An independent T‐Test showed a
significant better subjective sleep quality for individuals who have not
been exposed to trauma before the start of the internship (T
(48) = 2.25, p = 0.029). Linear regression analyses revealed that per-
ceived stress after 3 months in the hospital predicted wake after sleep
onset time (F(1,23) = 6.89, p = 0.015, R2 = 0.48) in both groups.
Conclusions: Trauma during child‐ and adulthood may affect sleep
quality years later and may also change stress perception and intru-
sive memory formation during a prolonged phase of acute stress
exposure.
Disclosure: Nothing to disclose.
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Objectives/Introduction: Post‐Traumatic Stress Disorder (PTSD)
is characterized by recurring intrusive memories of past traumas.
Sleep disturbances are also very common. In healthy people,
increased intrusive memories after seeing traumatic stimuli have
been associated with lower sleep spindle density. However, surpris-
ingly little is known about spindles in people with PTSD. Depression,
which commonly co‐occurs with PTSD, has been linked to reduced
spindles. This study evaluated spindles occurrence and morphometry
in people with PTSD and their possible association with depressive
symptoms. We hypothesized that spindles density would be low in
individuals with PTSD and that this would be worse in those with
more severe depressive symptoms.
Methods: Polysomnographic data was retrospectively collated for
60 individuals referred to a sleep clinic: 32 people diagnosed with
PTSD (47.1 ± 9.9 years old, 13% females) and 28 people without
any documented history of mental disorders (46.4 ± 9.6 years old,
14% females). Twenty‐seven participants from the PTSD group were
taking psychotropic medication. Depressive symptoms were assessed
using the Beck Depression Inventory (BDI‐II). Fast (13.5–16 Hz) and
slow (11–13.5 Hz) spindle detection was conducted on C3 during
NREM2 and NREM3 sleep.
Results: Spindle density did not significantly differ between the
two groups. Compared to the control group, people with PTSD had
significantly lower slow spindle amplitudes during NREM2 (n = 60,
Z = −2.2, p = 0.026), with a similar trend for fast spindles (n = 60,
Z = −1.8, p = 0.071). NREM3 fast spindles had a significantly faster
frequency in the PTSD group than in the control group (n = 53,
Z = −2.3, p = 0.019). Within the PTSD group, depressive symptoms
were negatively correlated with the frequency of slow spindles dur-
ing NREM3 (n = 27, r = −0.44, p = 0.021).
Conclusions: Significant morphometric abnormalities were
observed in people with PTSD and sleep complaints. This seems to
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be influenced by the severity of comorbid depressive symptoms.
Given the importance of spindles for sleep maintenance, these
abnormalities could possibly play a role in poor sleep quality,
increased awakenings and atypical sleep architecture in PTSD. Fur-
ther work is required to assess the potential effects of psychotropic
medication on sleep spindles to better decipher the effects of PTSD
pathophysiology and related pharmacological manipulations on spin-
dle generation.
Disclosure: Nothing to disclose.
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Objectives/Introduction: Depression in youth is often accompa-
nied by sleep and circadian rhythms disruptions, which are partly
regulated by our daily behaviors and social rhythms. It has previously
been proposed that irregular social rhythms could generate or wor-
sen a depressive episode. Accordingly, some previous studies
showed unstable social rhythms in people with bipolar disorder or
unipolar depression, but this was mostly studied in middle aged and
older adults. The purpose of this study was to characterize social
rhythms in adolescents and young adults with depression and to
determine how social rhythms relate to age, sleep and depressive
symptoms.
Methods: The Social Rhythm Metric (SRM‐5), a validated diary
documenting the timing of daily behaviors and social activities, was
completed during 14 days by 51 participants with unipolar depres-
sion (22.1 ± 0.8 years old; 27.5% males) and 50 healthy controls
(24.5 ± 0.4 years old; 41.2% males). In the depression group, the
sleep‐wake cycle was monitored with actigraphy during the period
when the SRM‐5 was completed, and the severity of depressive
symptoms was assessed using the Hamilton Depression Rating Scale.
Results: After controlling for age, sex, and occupational status, par-
ticipants with depression had significantly less regular social rhythms
than controls (n = 101, F(1) = 8.8, p = 0.004). Within the depression
group, younger age correlated with more unstable social rhythms
(n = 51, r = 0.31, p = 0.026). Also, irregular social rhythms correlated
with later sleep onset times (n = 50, r = −0.33, p = 0.021), as well as
with a greater variability in the timing of sleep onset (r = −0.40
p = 0.004), sleep offset (n = 50, r = −0.45 p = 0.001), and total time
spent in bed (n = 50, r = −0.28, p = 0.047). In contrast, social
rhythms were not significantly correlated with the severity of
depressive symptoms.
Conclusions: These results suggest that youth with depression
have irregular social rhythms, and that this may be independent from
the degree of depressive symptoms severity. Irregular social rhythms
were found to be most pronounced in those with younger age, as
well as in those with more delayed and unstable sleep schedules.
Considering the promising outcomes of psychotherapies directly tar-
geting social rhythms in adolescents with bipolar disorders, further
work should determine whether this may also be a useful clinical
tool for young people with unipolar depression.
Disclosure: Nothing to disclose.
P553 | Temperament, character and
personality in patients with panic disorder and
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Objectives/Introduction: This study is aimed at assessing temper-
ament, character and personality features in patients with Panic
Disorder and Sleep Disorder (group PS) compared with those with-
out sleep disorder (group P).
Methods: Personality measurements were taken using the Struc-
tured Interview for DSM‐IV Personality Disorders (SIDP‐IV) and the
Temperament and Character Inventory (TCI). Fourty‐seven patients
(male = 29, female = 18) with a DSM‐IV diagnosis of PS with (n° 39,
83%) or without (n° 8, 17%) sleep disorder were enrolled in the
study. Axis I diagnoses were made using the SCID‐IV. A sample of
45 age‐matched (mean age = PS: 34.8 ± 9.1, P: 32.6 ± 8.8, n.s.).
Results: Patients (PS) showed a greater prevalence of Personality
Disorders (PD) than group P (PS: 38.6% vs. P: 5.4%; p < 0.001), par-
ticularly Cluster B (PS: 19.0% vs. P: 2.1%; p < 0.005) and Cluster C
PD (PS: 22.4% vs. P: 4.3%; p < 0.005). Regarding TCI dimensions,
patients showed higher Harm Avoidance (PS 21.6 ± 6.8 vs. P
17.7 ± 6.6; p ≤ 0.001), and lower scores in the trhee character
dimensions: Self Directedness (PS 25.5 ± 7.1 vs. P 30.3 ± 6.1;
p ≤ 0.001), Cooperativeness (PS 27.3 ± 5.6 vs. P 31.3 ± 5.1;
p ≤ 0.001), Self Trascendence (PS 12.4 ± 5.9 vs. P 20.7 ± 4.7;
p ≤ 0.001).
Conclusions: The study confirms that patients with Panic Disorder
associated sleep disorder have a greater prevalence of DSM‐IV Axis‐
II PD, particularly those of the Cluster B and C, that probably arose
from abnormalities in both temperament (HA) and character (SD, C,
ST) dimensions in panic disorder with sleep disorder.
Disclosure: Nothing to disclose.
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Objectives/Introduction: The impairment of sleep quality is a fre-
quent problem among students. This is particularly true for medical
students, especially during exams. The objectives of our work were
to assess the quality of sleep of medical students during exams per-
iod and to study the impact of anxiety and depression levels on
sleep.
Methods: We carried out a cross‐sectional study among 184 stu-
dents of Sfax Medical School in Tunisia during the period of final
exams of the academic year 2015/2016. Each participant filled in the
following questionnaires: Pittsburg Sleep Quality Index (PSQI) and
Hospital Anxiety and Depression Scale (HAD).
Results: The average age of students was 21.4 years. Among the
participants, 71.7% (N = 123) were women. Fifty nine students had
a common housing among whom 37 shared their bedrooms with
others. Coffee and hypnotic drugs were consumed by 152 (82.6%)
and 40 (21.7%) students respectively. The mean PSQI score was 8.2.
Among the participants, 80.4% (N = 148) had a poor quality of sleep.
As for anxiety and depression, the mean scores were 10.1 and 8.5
respectively. Anxiety and depression levels were abnormal in 47.8%
(N = 88) and 31.5% (N = 58) of the cases respectively. The PSQI
score was significantly higher for women than for men (p = 0.02)
and for those who shared their bedrooms (p = 0.03). Students who
consumed coffee and hypnotic drugs had a significantly poorer qual-
ity of sleep (p = 0.02 in both cases). Women had a significantly
higher level of anxiety (p = 0.01). The PSQI score was correlated to
anxiety and depression scores (r = 0.4 and p < 0.01 in both cases).
Conclusions: Our study showed that medical students struggle
with sleep problems and emotional distress during exams period. A
specific training on stress management, such as mindfulness based
stress reduction, could be added to the academic program. It is likely
to improve the quality of sleep and relieve the emotional distress of
these students.
Disclosure: Nothing to disclose.
P555 | The influence of depressive symptoms
and physical illness on sleep disturbance in
elderly people
B. Nam
1Psychiatry, Konkuk University/Konkuk University Hospital, Chungju,
Republic of Korea
Objectives/Introduction: This study was conducted to collect
basic data for the elderly mental health by identifying the influence
of depressive symptoms and physical illness on sleep disturbance.
Methods: Among 1,535 Medicaid people at least 60 years of age
residing in Chungju, 1,262 people were examined. We investigated
the general characteristics of the patients and the history of physical
illness. Also we did screening test for depression and sleep quality.
Data analysis was done by t‐test, Pearson′s correlation, step by step
regression analysis with SPSS/PC WIN 19 version.
Results: Among the 1,262 survey personnel, 520 (41%) people had
depressive symptoms and 718 (57%) people had sleep disturbance.
Also, 140 (11%) people had been diagnosed as stroke, 712 (56%)
people had hypertension, and 279 (22%) people had diabetes melli-
tus. There was no significant difference in physical illness, age,
height, weight between the sleep disorder group and the normal
group, but in the sleep disorder group, the depression symptom was
significantly larger (p < 0.001) and also in female group than male
group respectively (p = 0.006). It was found that there was a static
correlation between depression symptoms and the quality of sleep
(correlation coefficient of Pearson 0.360). Among stroke, hyperten-
sion, diabetes and other physical disorders, stroke and diabetes did
not significantly correlate with sleep quality. However, hypertension
was found that it had static relationship with sleep quality (Pearson′s
correlation coefficient 0.057). As a result of carrying out the step-
wise regression analysis to investigate the description amount of the
change, statistically significant results were not found for other
causes such as stroke and diabetes. Depression symptoms and high
blood pressure showed the greatest explanation (13.2%).
Conclusions: The study showed that depressive symptoms are sig-
nificant associated with sleep quality in elderly over 60 years old. So
we suggest that elderly people with sleep disturbance need care for
depression and hypertension.
Disclosure: Nothing to disclose.
P556 | The relationship between obstructive
sleep apnea and depression
M. Li
First Affiliated Hospital of Jilin University, Changchun, China
Objectives/Introduction: Obstructive sleep apnea (OSA) patients
may exhibit symptoms that overlap with depression, such as sleep
problems, fatigue, difficulty concentrating, and irritability.
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Methods: Eighty‐eight patients who suffered from OSA were
divided into mild, moderate, and severe according to the Apnea‐
Hypopnea Index (AHI) and lowest oxygen saturation at night. The
Zung Self‐rating Depression Scale (SDS) was used to assess depres-
sive symptoms and severity in all subjects. The standard score was
determined by multiplying the SDS score by 1.25. A standard score
≥50 indicated depression compared the morbidity of depression
across the three OSA subgroups and investigated the relationship
between OSA and depression.
Results: The prevalence of depression was significantly increased
in the OSA group (47.7%). The incidence of depression in the mild,
moderate, and severe OSA groups was 11.9%, 38.1%, and 50.0%,
respectively (p < 0.05). In the 42 patients who presented with
comorbid OSA and depression, increased SDS scores were associ-
ated with an increased body mass index (BMI), AHI, and SaO2 min
at night. The prevalence of depression increased with OSA severity.
In patients with comorbid OSA and depression, depression severity
was positively correlated with the BMI, AHI, and ESS and negatively
correlated with the SaO2 min at night.
Conclusions: The current findings indicate that clinicians who treat
patients with OSA should be aware of the potential occurrence of
depression and should routinely assess depression in this patient
population. The central nervous system may be involved in the
pathogenesis of OSA in patients with depression and should be fur-
ther investigated to identify novel treatments.
Disclosure: Nothing to disclose.
P557 | Social responsiveness in pediatric
narcolepsy patients
L. Quaedackers1,2; M. Van Gilst1,3; P. van Mierlo1;
G.J. Lammers4; K. Dhondt5; E. Peeters6; D. Hendriks7;
N. Vandenbussche1; S. Pillen1; S. Overeem1,2,3
1Center for Sleep Medicine, Kempenhaeghe, Heeze, 2Department of
Industrial Design, 3Department of Electrical Engineering, Eindhoven
University of Technology, Eindhoven, 4Sleep Wake Center, SEIN,
Heemstede, the Netherlands, 5Department of Psychiatry, Child &
Adolescent Psychiatry, Pediatric Sleep Center, Ghent University Hospital,
Ghent, Belgium, 6Department of Child Neurology, Juliana Children's
Hospital‐Haga Teaching Hospital, 7Sleep Center, Medical Center
Haaglanden, The Hague, the Netherlands
Objectives/Introduction: This study aims to explore the impair-
ments in social functioning in pediatric narcolepsy patients compared
to healthy children.
Methods: The parents of 53 pediatric narcolepsy patients and 64
age‐ and sex matched healthy children completed the Social Respon-
siveness Scale (SRS) and the Child Behavior Checklist (CBCL).
Results: Pediatric narcolepsy patients scored significantly higher on
both the total score of the SRS (median = 56, IQR = 23.5), compared
to the healthy control group (median = 44.5 IQR = 8.5, U = 797.0,
p < 0.000). Twenty four out of 53 (45.3%) narcolepsy patients
reported at least mild to moderate difficulties in social functioning
compared to seven out of 64 (10.9%) healthy controls (χ2 = 17.165,
p =< 0.000). Eleven narcolepsy patients (20.8%) and only one
healthy control (1.6%) had T‐scores above 76 (χ2 = 11.602,
p = 0.001), which is considered severe and strongly associated with
a clinical diagnosis of an autism spectrum disorder. Pediatric nar-
colepsy patients also scored higher on the sum of the CBCL sub-
scales Withdrawn/ depressed, Social problems and thought problems
(further referred to as CBCL WST) (median = 183, IQR = 30.5) com-
pared to the healthy controls (median = 155 IQR = 13 U = 500.0,
p < 0.000). CBCL WST is presumed to be indicative of autism spec-
trum problems. There was a high correlation (r = 0.745, p < 0.000)
between the SRS score and the combined CBCL scale. Within the
patient group, girls reported significantly more often mild to moder-
ate difficulties in social functioning on the SRS (77.8%) compared to
boys (28.6%, χ2 = 17.560, p < 0.000).
Conclusions: Problems in social responsiveness are common in
children with narcolepsy, especially in girls. There should be more
attention for screening for of these symptoms in pediatric narcolepsy
patients. Instead of a using a dedicated screening tool such as the
SRS, assessing the described subscales of the more commonly used
CBCL can also provide a valid reason to consider further psychiatric
evaluation.
Disclosure: Nothing to disclose.
P558 | A novel home video behaviour analysis
algorithm to diagnose childhood chronic
insomnia
L. Galbraith1; K. Bull2; C. Hill2
1Faculty of Medicine, University of Southampton, 2Division of Clinical
Experimental Sciences, University Hospital Southampton, Southampton,
United Kingdom
Objectives/Introduction: Chronic insomnia (CI) is the most com-
mon sleep disorder in childhood, categorised as limit setting or
sleep onset association type. In both, parent‐child interaction is sig-
nificant in the development and persistence of the problem. CI is
currently diagnosed by clinical interview with the parent, however
parental recall of their own behaviour may be inaccurate. Objective
observation may aid diagnosis and treatment. We aimed to trial
home video technology in childhood brain tumour survivors who
have a high prevalence of CI. Specifically, we aimed to develop a
novel scoring algorithm of behavioural observations for future clini-
cal applications.
Methods: Participants were recruited from neuro‐oncology clinics
at Southampton Children's Hospital, UK. Inclusion criteria were: aged
3–12 years, completed brain tumour treatment at least 6 months
previously, and at risk of CI according to a screening questionnaire
(Sleep Disturbance Scale for Children: Disorders of Initiating and
Maintaining Sleep subscale). Families completed a home video sleep
study using an infra‐red camera with actigraphy (SOMNOmedics),
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followed by a clinical sleep history taken from the parent (audio
recorded to allow peer review). Video analysis was undertaken using
BORIS v6.1, a software programme designed by researchers at
University of Turin for animal behaviour observation. An analysis
algorithm was designed and iteratively developed which categorised
behaviours into the following domains: sleep schedule, bedtime rou-
tine, lights out, night wakings, parent and child speech and behaviour
(sleep promoting and sleep inhibiting). These domains could both be
visually plotted and quantitatively computed (e.g. total and mean
duration of activities) to aid interpretation by the clinician.
Results: Five children have been recruited. Inter‐rater reliability for
scoring of sleep‐related behaviours will be presented. Preliminary
video analysis has indicated that parents of childhood brain tumour
survivors commonly demonstrate overly soothing behaviour at bed-
time and night wakings (e.g. co‐sleeping and extended close physical
contact), which is likely to contribute to CI in the child.
Conclusions: Video behavioural analysis has the potential to be a
useful tool in aiding diagnosis of CI and, particularly with the further
development of our scoring algorithm, could be used to give parents
specific feedback regarding their overnight interactions.
Disclosure: Nothing to disclose.
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P559 | Sleep and daytime functioning in
children with autism
A. Geranmayeh1; B.C. Holding1; I. Lundmark1; R. Fondberg1;
J. Axelsson1,2
1Clinical Neuroscience, Karolinska Instititutet, 2Stress Research Institute,
Stockholm University, Stockholm, Sweden
Objectives/Introduction: Autism spectrum disorder (ASD) is a
neurodevelopmental condition associated with a high prevalence of
sleep disturbances. It is well established that sleep problems affect
several aspects of cognition and has also been shown to predict
internalizing/externalizing behavioural problems. Previous studies
suggest that the relationship between sleep problems and daytime
behaviour may be correlated with the manifestations of autism. Our
aims were to investigate
(1) the association between sleep problems and degree of ASD
severity and how this relates to daytime behaviour in chil-
dren with ASD, and
(2) how sleep disturbances relate to prosocial behavior.
Methods: We conducted a cross‐sectional study where parents
reported their children's sleep problems (Children's Sleep Habits
Questionnaire), symptoms of ASD (Autism Quotient‐Children's Ver-
sion) and daily behaviour problems (Strengths and difficulties ques-
tionnaire). We here report interim analysis of the first 39 children
with Autism (4–11 years old) in this ongoing study, the majority boys
(85%). Data were analysed using multiple regression models.
Results: Sleep problems were associated with more problems with
daytime behaviour (p = 0.001). Higher severity of ASD was related
to more problems with daytime behaviour, (p = 0.04). When adjust-
ing for the effect of sleep problems, the significant association
between severity of ASD and daytime behavior disappeared
(p = 0.35). The positive relationship between sleep problems and
behavioural problems remained significant (p = 0.004) after adjusting
for the severity of autism. Additionally, sleep problems were related
to less prosocial behaviour, (p = 0.002) but the association between
degree of autism and prosocial behaviour was not significant.
Conclusions: Our interim results support a relationship between
sleep problems and impaired daytime behavior in children with ASD.
We also observe a significant association between the severity of
autism and daytime behavioural problems, but this relationship was
no longer significant after adjusting for sleep problems. This indi-
cates that daytime functioning may be more related to sleep distur-
bances rather than severity of ASD. Further research should
examine causality by determining whether improvement in sleep
leads to improvements in daytime functioning.
Disclosure: The study has been supported by a grant from Wolff
Memory fund. None of the authors have a conflict of interest.
P560 | Weekday‐weekend sleep variations in
young children and the associated family factors
L. Xiu1; M. Hagströmer2; L. Bergqvist1; E. Johansson2;
K. Ekbom1; V. Svensson1; C. Marcus1; M. Ekstedt3,4
1Division of Pediatrics, Department of Clinical Science, Intervention and
Technology, 2Division of Physiotherapy, Department of Neurobiology,
Care Sciences and Society, 3Department of Learning, Informatics,
Management and Ethics, Medical Management Centre, Karolinska
Instititute, Stockholm, 4Faculty of Health and Life Sciences, Linnaeus
University, Kalmar, Sweden
Objectives/Introduction: The great weekday‐weekend variations
in sleep schedules have been reported to be associated with chronic
sleep loss and increased health risk. However, this variation is less
understood in young population. The aim of this study was to inves-
tigate the weekday‐weekend sleep variations in young children, as
well as to identify the associated family risk factors.
Methods: Children participating in a longitudinal obesity preven-
tion project in Stockholm was used. In total, 137 children aged
2 years were included and were classified into three groups based
on two family risk factors, parental low education and unhealthy
weight:
(1) “high risk” (parents with both low education and obesity),
(2) “medium risk” (parents with either low education or obesity),
(3) “low risk” (parents with neither low education nor obe-
sity).Children's sleep was assessed using wrist‐worn
accelerometer for 7 days. The analysis of variance for
repeated measures was adopted to examine the weekday and
weekend sleep among groups. Further, the weekday‐weekend
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variations among groups were explored with adjustment for
confounders.
Results: There were 27 children in the high risk group, 79 in the
medium risk group and 31 in the low risk group. There was no dif-
ference in the average sleep patterns across the week among
groups. Children showed later sleep onset (p < 0.001), later sleep
offset (p < 0.001), delayed midpoint of sleep (p < 0.001) and longer
sleep duration (p = 0.01) on weekends than weekdays. Children in
the high risk group showed more delayed sleep during weekends
than children in both low and medium risk groups, with later sleep
offset (p = 0.005) and midpoint of sleep (p = 0.03). After adjustment
for confounders, the group differences in weekday‐weekend sleep
variations can only be detected between the low and high risk
groups, with more delayed sleep offset (p = 0.02) and midpoint of
sleep (p = 0.04) on weekends in children in the high risk group than
children in the low risk group.
Conclusions: The weekday‐weekend sleep variations can be identi-
fied in children at aged 2 years. Compared to children of parents
with high education and normal weight, children of parents with low
education and unhealthy weight had greater delayed sleep timing on
weekends.
Disclosure: Nothing to disclose.
P561 | Sleep duration and socio‐economic
status in pediatric population: a systematic
review of the literature
O. Guglielmi1; P. Lanteri2; S. Garbarino1
1Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics
and Maternal/Child Sciences (DINOGMI), University of Genoa,
2Neurophysiology Center, Dipartimento Integrato Neuroscienze Mediche
e Chirurgiche e Riabilitazione ‐ Continuità Cure, ‘G. Gaslini’ Institute,
Genoa, Italy
Objectives/Introduction: Insufficient sleep is a primary public
health problem. Low sleep quantity in pediatric population is associ-
ated with weight gain and obesity, cognitive impairment, low aca-
demic performance and behavioral disorders. Some research have
observed that socioeconomic status (SES) and neighborhoods charac-
teristics could be predictors of sleep disparities in pediatric popula-
tion.
Methods: This systematic review have been realized according to
the PRISMA statement. A bibliography search in the main database
(PubMed, Web of Science, Scopus, PsycInfo, Cochrane Library), with-
out publication time limits, was realized. All the articles published in
English focusing on the association between sleep duration and SES
in pediatric population were included.
Results: From 106 articles analyzed, 25 studies investigated the
association between sleep duration and SES. Most of the articles
selected employed a cross‐sectional methodology and only 2 publi-
cation were longitudinal studies. In 7 (28%) pre‐adolescent and 5
(20%) adolescent sample were involved. Only 2 studies (%) focused
on sleep duration in infant from 0 to 3 years old. In the majority
of the studies low SES was associated with short sleep duration,
while in 2 (8%) studies the association was inverse. Only in 7
(28%) studies no relation between sleep quantity and SES was
obtained.
Conclusions: The results obtained indicate that inadequate sleep
duration positively correlate with low SES. Prevention of chronic dis-
eases of the child and the adult cannot ignore the promotion of the
correct lifestyles and sleep hygiene from the pediatric age, particu-
larly involving parents with low SES.
Disclosure: Nothing to disclose.
P562 | Treatment of symtoms of depression
with light goggles in adolescents
A. Lowden1; G. Öztürk1; C. Moreno1,2
1Stress Research Institute, Stockholm University, Stockholm, Sweden,
2School of Public Health, University of Sao Paulo, Sao Paulo, Brazil
Objectives/Introduction: Sleep complaints and lowered mood
states are frequently reported in adolescence, November was
marked as the worst month for mood and fatigue in a previous ques-
tionnaire study. The aim of this study was to treat depressive symp-
toms by use of light goggles during the Scandinavian dark winter
period.
Methods: In an intervention study, high school students (15–
20 years; 52% boys) answered a question on willingness to try light
goggles (Luminette®) in the morning to improve health. For 2 weeks
60 invited students with moderate or high depression scores on the
depression scale (HAD‐D6) wore glasses during 20 min in the morn-
ing before going to school and at weekends. Subjects were random-
ized to either a white light condition (≈1,000 lux) or red light
condition. Subjects were questioned before and after treatment and
a repeated mixed model analysis was performed using condition (be-
fore/after) and light (white/red) as factors.
Results: Compliance to treatment was very good according to daily
logs. In total 50 students fulfilled the protocol. Effects of white and
red light did not yield significant differences. General improvement
on the depression scale (HAD‐D6) was 26% (p < 0.001), 7.3% on
the Epworth Sleepiness Scale (p < 0.006), insomnia index 16%
(Karolinska Sleep Questionnaire, p < 0.013) and increased morning-
ness (Diurnal Type Scale) 5.5%. After treatment 42% of the students
would recommend use of light goggles to peers and 37% would
partly do so, 2% disagreed with goggle use. The lack of difference
between white and red diods might be explained by placebo induced
effects or by the strength of direct lighting effects on pathways sig-
naling to mood regulating brain areas.
Conclusions: The study demonstrated that at a season were very
little daylight is obtained traveling to school, use of goggles reduces
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symptoms of depression and has mild positive effects on insomnia
symptoms, daytime sleepiness and promotes morningness.
Disclosure: Nothing to disclose.
P563 | When the children don't sleep: the
impact on paternal mental health
M. Gardani1; L. Bisdounis2; V. Zouharova3; R. Hatton1
1University of Glasgow, Glasgow, United Kingdom, 2University of
Amsterdam, Amsterdam, 3Maastricht University, Maastricht, the
Netherlands
Objectives/Introduction: While a considerable amount of
research has been conducted investigating the relationship between
children′s poor sleep and maternal mental health and general well‐
being (Lam, Hiscock & Wake, 2003 and others), studies exploring
this link in fathers are limited.The aim of this study was to address
the scarcity of existing research in this area by investigating the
association between children's sleep quality and several paternal
mental health outcomes, such as stress, anxiety and depression.
Methods: Using a cross sectional design we have recruited 308
dyads of fathers and children (mean age 39.51 ± 6.41 and 7 ± 2.1
respectively) that responded to a number of measures for sleep
(child), anxiety, depression, stress and involvement in childcare.
Results: Highly significant associations were found between mea-
sures of paternal mental health and sleep in children, which mea-
sured with the Children's Sleep Habits Questionnaire (Owens et al,
2000). More specifically, paternal stress (r = 0.243, p < 0.001; Per-
ceived Stress Scale), depression (r = 0.219, p < 0.001; Patient Health
Questionnaire Depression Scale), anxiety (r = 0.220, p < 0.001;
State‐Trait Anxiety Inventory) were found to be significantly associ-
ated with child's sleep as reported by the fathers. No significant
associations with parental involvement were found (Paternal Involve-
ment in Child Care Index) despite that 87.8% of the fathers were liv-
ing in the same household as the children.
Conclusions: This study adds to the existing literature that chil-
dren's sleep difficulties have an impact on paternal mental health
with higher instances of stress, anxiety and depression without the
mediation of parental involvement.
Disclosure: Nothing to disclose.
P564 | Moderate impact of prone positioning
in Robin infants: a polysomnography study
L. Coutier1,2; A. Guyon1; P. Reix1; P. Franco1
1Lyon Neuroscience Research Center, INSERM U 1028, CNRS UMR
5292, University of Lyon 1, Lyon, 2Service de Pneumologie, Hopital
Femme‐Mère‐Enfant, Bron, France
Objectives/Introduction: Obstructive sleep apnea syndrome
(OSA) is very frequent in infants with Pierre Robin Sequence (PRS).
Its management is not consensual but the prone positioning (PP) is
commonly recommended. However, its effect has never been stud-
ied by polysomnography (PSG). The aim of the study was to evaluate
the impact of the PP on sleep and breathing outcome measures.
Methods: This retrospective study was conducted between 2015
and 2017 in a tertiary care hospital. For each incidental PRS infant, a
nocturnal PSG with pulse oximetry and transcutaneous carbon diox-
ide was performed in the supine position (SP) and in the PP. Sleep
and breath outcomes measures, expressed as median [Q1–Q3], were
compared between SP and PP.
Results: PSG outcomes of 18 PRS infants, aged of 61 ± 50 days at
evaluation, were analyzed. Among the 18 infants, 11 had clinical
manifestations of OSA. All had OSA diagnosed on PSG. In the PP,
13 infants among 18 had a better night quality than in the SP with a
significantly higher sleep efficiency (83 [69–90] vs. 70 [55–77],
p = 0.04). In PP, there was a trend towards a lower obstructive
apnea hypopnea index in rapid eye movement stage (50 [28–82] vs.
61 [40–103], p = 0.05). The PP was sufficient alone to decrease
OSA index below 10 events/hr in 3 infants; otherwise a respiratory
support was required for 13. The SP was maintained for 2 infants.
Conclusions: In PRS infants, PP improves sleep quality but was
found to be frequently insufficient to correct OSAS. We recommend
a nocturnal sleep and breathing study to be systematically performed
in those babies
Disclosure: Nothing to disclose.
P565 | Sleep habits in a western
Mediterranean population from 0 to 30 months:
a cohort study
A. Gamundí1; M. Mora2; R.V. Rial1; M.C. Nicolau1;
M. Akaârir1
1Laboratory of Sleep and Biological Rhythms, University of the Balearic
Islands, 2CS. S'Escorxador, IB‐Salut, Palma de Mallorca, Spain
Objectives/Introduction: There are few studies on sleep habits
and sleep quality in paediatric population in our sociodemographic
environment (Island of Mallorca), despite the fact that sleep disor-
ders have a high prevalence in childhood. The objective of this study
was to describe the patterns and sleep habits of children from 0 to
30 months of age and the factors that modify them.
Methods: Descriptive, observational and cross‐sectional study. The
parents were asked to fill a survey that included the Brief Infant
Sleep Questionnaire (BISQ) as well as other sociodemographic vari-
ables, medical history, physical examination and sleep habits of their
child.
Results: 200 children (97 males) were studied. Total sleep hours
decreased from 14.07 ± 2.58 in children under 6 months of age to
11.73 ± 1.26 at 24–30 months after birth (p < 0.05), mainly by
decreasing daytime sleep from 4.46 ± 2.02 to 1.82 ± 1.26 (p < 0.05)
hours. In addition, the number of awakenings decreased
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progressively with age from 1.90 ± 1.22 to 0.69 ± 0.97 (p < 0.05)
per night. Aged mothers, low socioeconomic status, breastfeeding,
bed‐sharing, and supine positioning have been associated with
increased sleep fragmentation. However, using pacifier and sleeping
outside the parents′ room reduced the number of awakenings.
Conclusions: It is confirmed that in the Western Mediterranean
environment, children population from 0 to 30 months of age pre-
sents important sleep disturbances, reason why the health profes-
sionals must know this situation to advise families properly.
Disclosure: Nothing to disclose.
P567 | The role of polysomnography in
respiratory management of obstructive sleep
apnea in infants with Pierre Robin sequence:
essential or not?
P. Biermé1,2; L. Coutier1,2; P. Franco1,2
1Hopital Femme‐Mère‐Enfant, Bron, 2Claude Bernard University Lyon 1,
Lyon, France
Objectives/Introduction: Currently, polysomnography (PSG) is
the gold standard for the diagnosis of obstructive sleep apnea syn-
drome (OSAS), but its access is still difficult. A polygraphy (PG) com-
bined with oximetry and transcutaneous PCO2 (TcPCO2) allows the
diagnosis of OSAS. Until this day, the management of infants with
Pierre Robin Sequence (PRS) and OSAS is not standardized. The aim
of this study is to compare the OSAS therapeutic decision in infants
with PRS depending on PSG versus PG combined to oximetry and
TcPCO2.
Methods: This study was conducted in infants with PRS in the
sleep unit of the pediatric university hospital of Lyon, France, from
2015 to 2017. A nocturnal PSG with measurement of gas exchange
was performed for each infant during their routine follow‐up. Each
anonymized PSG were analyzed by a single reviewer. After suppres-
sion of sleep data, 1 month after, anonymized raw data were ana-
lyzed by the same single reviewer in order to obtain only PG data.
The first OSAS therapeutic option selected with PSG by 3 pediatri-
cians was notified. The new OSAS therapeutic option selected with
PG by the same 3 pediatricians was notified. Respiratory index [ob-
structive apnea index (OAI), obstructive hypopnea index (OHI),
obstructive apnea hypopnea index (OAHI)] were compared between
PSG and PG. Data were presented as median and interquartile range
25% and interquartile range 75% [Q1–Q3].
Results: PSG was performed in 20 infants at a median of 43 [24.5–
113.5] days. 15 patients had isolated PRS, 5 patients had associated
or syndromic PRS. All patients had confirmed OSAS with PSG. Ther-
apeutic option selected after PG combined to oximetry and TcPCO2
and compared to decision after PSG recording was identical for 18
infants and different for 2 infants. No significant difference was
observed between OAHI measured by PG and PSG (23 [16.3–43.5]/
hr, vs. 29 [13.3–48]/hr, p = 0.458). OHI was under‐estimated in PG
versus PSG (2 [0–3]/hr vs. 8.5 [5.3–25]/hr, p < 0.0001).
Conclusions: An overnight PG recording in a sleep unit, combined
to oximetry and TcPCO2, lead to select the adequate therapeutic
option to treat OSAS in PRS infants in the 8 first months of life.
Disclosure: Nothing to disclose.
P568 | Psychological factors of sleep disorders
in school‐age children: the role of parent′s
subjective sleep problems and dysfunctional
beliefs about their child′s sleep
D. Kudryashov1; A. Tkhostov1; E. Rasskazova1; T. Botasheva2
1Psychology, Moscow State University, Moscow, 2The Rostov State
Medical University, Rostov‐on‐Don, Russian Federation
Objectives/Introduction: Sleep disorders are a sensitive criterion
of adaptation problems in children and adults, and they are associ-
ated with various psychological factors such as beliefs about sleep.
Since the impact of sleep problems in children is more expressed
than in adults, it is important to explore ways to treat and prevent
them. One of these targets are parents’ unrealistic and dysfunctional
beliefs. The aim of the study is to reveal a relationship between the
parental sleep and beliefs about their own sleep and their children's
sleep.
Methods: 100 children ages 5–13 (45 females, mean age
8.21 ± 2.13 years) and their parents (100 females, ages 26–56 years)
participated in the study. Children were interviewed about their sleep
quality using Sleep Self‐Report (SSR; Owens et al., 2000) while their
parents complete Insomnia Severity Index (ISI, Morin, 1993), Dysfunc-
tional Beliefs About Sleep Scale (DBAS; Morin, 1993), Dysfunctional
Beliefs About Children's Sleep Scale (DBACS; Ng et. al. 2012), Chil-
dren's Sleep Habits Questionnaire (CSHQ; Owens et. al. 2000).
Results: The parental appraisal of quality of the child′s sleep corre-
lated with the children's assessment of their own sleep (r = 0.53,
p < 0.05), as well as with parental complaints about their own sleep
(r = 0.36, p < 0.05) and their dysfunctional beliefs about their sleep
(r = 0.36, p < 0.1) and sleep of their children (r = 0.36, p < 0.05).
After adjusting for parent′s dysfunctional beliefs about their own
sleep parent′s subjective sleep problems and dysfunctional beliefs
about children's sleep were independent significant predictors of
children's subjective sleep quality (R‐square change 22.8%, beta =
0.36 and 0.37, p < 0.001).
Conclusions: Both parental sleep disorders and parental dysfunc-
tional beliefs predicts poorer subjective sleep in children thus sup-
porting the hypothesis that sleep regulation is developing in the
parent‐child interaction.
Acknowledgements: Research is supported by the Russian Founda-
tion for Basic Research, project No. 17‐06‐00363.
Disclosure: Nothing to disclose.
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P569 | Cataplexy and sleep disorders in
Niemann‐Pick type C disease – a case study
B. Gnidovec Strazisar1; N. Krajnc2; L. Kopac1
1Department of Paediatrics, General Hospital Celje, Celje, 2Department
of Paediatrics, General Hospital Slovenj Gradec, Slovenj Gradec, Slovenia
Objectives/Introduction: Niemann‐Pick disease type C (NP‐C) is
a rare and progressive autosomal recessive lysosomal lipid storage
disorder leading to disabling neurological manifestation and prema-
ture death. One of its characteristic symptoms is cataplexy that is
found in 5–30% of the NP‐C patient. However, sleep disturbances
are described only exceptionally. Children with type 1 narcolepsy at
disease onset often display complex abnormal motor behaviours that
do not meet the classical definition of cataplexy. However in pedi-
atric NP‐C patients no such »unconscious« active motor behaviours
were discribed. We present a child with juvenile form of NP‐C in
whom dyskinetic‐dystonic movements and stereotypies were
observed intermingled with cataplectic attack.
Methods: 13‐years‐old boy that was diagnosed with NP‐C at the
age of 7 years by molecular genetic testing of NPC1 gene. He was
put on miglustat treatment and fluoxetine was introduced. Video
recording of paroxysmal events was followed with nocturnal
polysomnography recording (PSG) and 3‐day videoEEGtelemetry.
Results: On video recording clear gelastic cataplectic attacks with
loss of facial and neck tone were recorded. Other type of paroxys-
mal events included atonic head drops followed by with asymmetric
tonic posturing and unilateral dystonia/dyskinesia with grabbing hand
automatisms, sometimes followed by left hand nose wipping. PSG
revealed distrupted sleep with sleep efficiency of 54% and sleep
onset REM despite fluoxetine treatment. Altered sleep patters
included sudden increases in muscle tone during slow wave sleep,
atypical K‐complexes and spindle activity and increased amount of
REM sleep (39% of TST). EEG recording showed no epileptiform dis-
charges, however long‐term video‐EEG during the latter paroxysm
disclosed attenuation of the activity over left frontal leads and ver-
tex, followed by spread over left hemisphere and rhythmic sharp
theta activity over left frontocentral leads, suggesting epileptic sei-
zures.
Conclusions: Classical cataplexy, typically provoked with strong
emotions, is a characteristic symptom of Niemann‐Pick disease type
C that can be accompanied also by important sleep disruption. In
case of associated complex movement disorder that often co‐occur
in pediatric narcolepsy with cataplexy extensive neurophysiological
evaluation should be performed to exclude epileptic events and
guide pharmacological treatment in NP‐C.
Disclosure: Nothing to disclose.
P570 | Effect of parental group sleep
education in young children with Down
syndrome: the REST‐Ed study
E.A. Hill1,2; J. Street3; P. Jackson4
1Department of Paediatric Cardiac, Respiratory & Sleep Physiology, NHS
Lothian, 2Centre for Clinical Brain Sciences, The University of Edinburgh,
3Department of Community Child Health, NHS Lothian, 4Department of
Child Life and Health, University of Edinburgh, Edinburgh, United
Kingdom
Objectives/Introduction: Children with Down syndrome (DS)
experience a higher incidence of sleep problems than their typically‐
developing peers. Untreated, this can lead to sleepiness, behavioural/
emotional problems, cognitive impairment and reduced quality of life.
Children's sleep problems affect parental wellbeing, and parents car-
ing for a child with a developmental disability may also experience
poor sleep. This study (ISRCTN no. TBC) aims to evaluate the effect
of a sleep education package on the sleep and quality of life of
young children (aged 6 months–5 years) with DS and their parents/
carers living in Scotland.
Methods: Families with children aged 6 months‐5 years with DS
will be identified anonymously on behalf of the investigators by a
national charity, Down's Syndrome Scotland. The package, based on
an intervention evaluated by Stores and Stores in 2004, includes a
short film, colour booklet and instructional talk, delivered in a small
group setting. Effectiveness of the intervention will be evaluated
using a randomised, parallel groups design, with a 12 m post‐inter-
vention follow‐up period. All study participants will be screened for
sleep‐disordered breathing (SDB) using home‐based level III cardio‐
respiratory polygraphy; children with significant SDB are ineligible
and will be signposted for clinical assessment and treatment locally.
The remaining children will be randomised by balanced‐block to
receive either the intervention or a control group session on a topic
unrelated to sleep. Subjective and objective measures will be made
at baseline and at 1 m, 3 m, 6 m and 12 m follow‐up visits. Subjec-
tive sleepiness, behaviour and quality of life of children and parents/
carers will be assessed using standardised questionnaires, including
Epworth Sleepiness Scale, Infant and Toddler Quality of Life scale,
Child Behavior Checklist, and General Health Questionnaire. Objec-
tive sleep quality/duration will be assessed using actigraphy. Stan-
dard statistical analyses will be undertaken, with significance set at
p < 0.05.
Results: Recruitment will commence upon receipt of ethical
approval, with a minimum sample size of 50 participants (25 per
group). Preliminary study results will be available for presentation by
the time of the conference.
Conclusions: If effective, this early sleep education intervention
package may reduce the incidence of sleep problems in young chil-
dren with DS, improving quality of life for the children and their par-
ents.
Disclosure: Nothing to disclose.
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P571 | Temperament and sleep in children:
investigation of the direction of the association
L. Bastien; É. Tétreault; A. Bernier
Université de Montréal, Montréal, QC, Canada
Objectives/Introduction: Although many are interested in the
nature and direction of the link between sleep and temperament,
they are still unclear (Sorondo and Reeb‐Sutherland, 2015). The aim
of this study was to investigate the reciprocal relationship between
sleep and temperament in children.
Methods: The study was conducted with 82 children studied longi-
tudinally. At age 2 and 3, children′s sleep was assessed using acti-
graphs and temperament was assessed using the Toddler Behavior
Assessment Questionnaire (Goldsmith, 1996).
Results: The results indicated that sleep at 2 years was associated
with prone to anger dimension of the 3‐year temperament, while the
2‐year social fear dimension was associated with sleep at 3 years.
Finally, the level of activity (3rd dimension of temperament) and
sleep were not associated at any measurement time.
Conclusions: These results suggest that the direction of the rela-
tionship between sleep and temperament varies with the observed
dimension of the temperament.
Disclosure: Nothing to disclose.
P573 | Relationship between sleep and health‐
related factor in adolescents
K.J. Hwang1; Y.J. Jung2; W.C. Shin1
1School of Medicine, Kyung Hee University, Seoul, 2Catholic University of
Korea, Daejeon St. Mary's Hospital, Daejeon, Republic of Korea
Objectives/Introduction: Insufficient sleep among adolescents is
common and has adverse health and behavior consequences. The
purpose of this study is to determine whether physical activity,
afterschool behavior, and nutrition are associated with sleep.
Methods: A total of 1,864 students, 8 middle schools (7–9th grade)
were recruited. All students conducted self‐reported questionnaires
assessing regarding usual sleep/wake patterns over the previous
2 weeks, daytime function, physical activity, afterschool behavior
and dietary factor. Students were divided by gender.
Results: A total of 1,634 students (53.3% male, mean age
13.36 ± 1.03) completed the survey. For both gender, the shorter
sleep duration on school days (SD), the later bedtime was found to
be on both school days and weekends. Shorter sleeper also reported
more daytime sleepiness. Among boy, SD was positively associated
with frequency and duration of both moderate and vigorous physical
activity, but not significant. For both gender, SD was negatively
associated with weekly internet use, but not significant. There are
no association between SD and dietary factor.
Conclusions: These findings suggest that sleep duration of adoles-
cent is positively related to physical activity, especially in boys. Suffi-
cient sleep is recommended to adolescent for health benefits, yet
more research is needed to understand if sufficient sleep should be
recommended for improving health‐related factor.
Disclosure: Nothing to disclose.
P574 | Our experience in treatment sleep
apnea in children
M. Milkov1; M. Bliznakova1; P. Petrov2; M. Petrova2;
H. Madjova1
1Medical University, Prof. P. Stojanov, Varna, 22 MBAL, Sofia, Bulgaria
Objectives/Introduction: The abstracts′ purpose is to provide
information about Obstructive Sleep Apnea (OSA) and its treatment
in children (1–4% of OSA cases.) al.
Methods: OSA is a disorder of breathing during sleep, character-
ized by prolonged partial upper airway obstruction, which disrupts
normal ventilation leading to many complications (neurobehavioral,
cardiovascular, endocrine etc). The main symptom, reported by par-
ents is snoring ‐ harsh, snorting noises caused by vibration of the
soft palate in 7.45% (meta‐analysis).
Results: The results are based on literature for etiology and treat-
ment of OSA in children. There is no specific age in which the dis-
ease occurs but there is a higher risk for boys aged 11–13 compared
to 5–10 aged boys and girls. Each case is different that is why it is
really important to make the needed testing (polysomnography –
PSG is the gold standard) and analysis of the full health status of
each patient. The PSG diagnosis is defined as apnea‐hypopnea index
(AHI)>1/hr or AHI ≥1.5 hr. Other methods are cardio‐respiratory
monitoring, electromyography, and electroencephalography. The
main choice of treatment for children is surgical – Adenoidectomy
and/or Tonsillectomy (A&T). Another commonly used treatment for
children is orthodontic. Medical treatment is helpful for the postop-
erative period: anti‐inflammatory therapies with intranasal steroids
and leukotriene modifiers for 12 weeks help in the postoperative
period and Continuous positive airway pressure ventilation (CPAP) –
for persisting OSA after A&T.
Conclusions: The main aim of the Ear Nose Throat (ENT) specialist
for OSA during childhood is to prevent the side effects as well as
the development of the disease during adulthood. A&T with the fol-
lowing medical treatment lead to significant improvements in OSA in
children. PSG and CPAP are the key for diagnostics and management
of the disease.
Disclosure: Nothing to disclose.
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P575 | Effect of gender, obesity and neck
circumference on the severity of obstructive
sleep apnea in Egyptian patients
A. Gharib1,2; A.A. Saleh2,3; A.-A. Elbalsha2,4; I.O. Elfaky
Abdalwahab2; S. Loza2
1Pulmonary Research Unit, Department of Internal Medicine, National
Research Center, 2Cairo Center for Sleep Disorders, 3Psychiatry and
Addiction Medicine Hospital, Faculty of Medicine, Cairo University,
4Department of Chest Diseases, Faculty of Medicine, Al‐Azhar University,
Cairo, Egypt
Objectives/Instruction: Obstructive Sleep Apnea (OSA) is a com-
mon disease due to risk factors such as obesity, upper airway
anatomical abnormalities or hormonal influences. Previous studies
assessed the gender related differences in patients with OSA and
showed discrepancies between men and women. Thus, our aim was
to compare the clinical and polysomnographic features between
Egyptian men and women diagnosed with OSA and to determine the
factors affecting the severity of their Apnea Hypoapnea Index (AHI).
Methods: This retrospective study was conducted on 1012
patients who underwent polysomnography at the Cairo Center for
Sleep disorders, Cairo, Egypt, between January 2012 and December
2016. Their medical data were reviewed and statistically analyzed.
Patients were classified into mild (AHI 5–15), moderate (AHI 15–30)
and severe (AHI > 30) OSA. Males and females were compared and
the correlation between Age, Gender, Body Mass Index (BMI), Neck
Circumference (NC) and the Epworth Sleepiness Scores (ESS) with
the AHI and other sleep parameters was explored.
Results: A total of 838 patients (678 males, 160 females) were diag-
nosed with OSA. Patients with mild, moderate and severe OSA were
24.3% (204), 17.4% (146) and 58.2% (488) respectively. BMI was
insignificant between men and women (34.18 ± 13.53 vs.
36.73 ± 23.25, p = 0.07). Females were older than males
(58.87 ± 10.25 vs. 54.39 ± 22.96, p = 0.001). NC was higher in men
than women (43.56 ± 5.3 vs. 39.34 ± 4.41, p = 0.001). ESS were simi-
lar between men and women (10.23 ± 6.48 vs. 10.82 ± 6.11,
p = 0.304). Men exhibited more arousals than women (37.92 ± 24.81
vs. 26.5 ± 22.85, p = 0.001). AHI was higher in men than women
(47.97 ± 31.22 vs. 37.95 ± 31.72, p = 0.001) with severe OSA found
more in men than women (61.5% vs. 44.4%, p = 0.001). No significant
difference was found between pre and post menopausal women. A
positive significant correlation was found between BMI, NC, ESS with
the AHI, Arousal index, Average SpO2 and Desaturation index
(p = 0.0001). BMI and NC were the only independent factors affecting
the severity of the AHI (p = 0.002 and 0.0001 respectively).
Conclusions: Our results suggest that the prevalence of severe
OSA in Egyptian patients is more common in men than women. Lin-
ear regression analysis showed that BMI and NC but not gender
independently affected the severity of the disease.
Disclosure: Nothing to disclose.
P576 | A study of physical activity, sleep and
mood in Finnish adolescents
M. Heath1; S. Virtanen2; L. Kuula-Paavola2; M. Gradisar1;
A.-K. Pesonen2
1Flinders University, Adelaide, SA, Australia, 2University of Helsinki,
Helsinki, Finland
Objectives/Introduction: To assess whether the impact of physi-
cal activity on mood is mediated by sleep in adolescents.
Methods: All adolescents with a home address in Helsinki, Finland,
born between 1/1/1999 and 31/12/2000, with Finnish registered as
their native language (N = 7,539, 50% males), were invited to partici-
pate in a 30 min online survey. 1,367 valid responses were received
(18% of invited cohort; 33% males). Of interest to this study was
the physical activity, sleep, and mood data. Physical activity ques-
tions included; how often they participated in physical activity after
6 pm, how often they were very active in the hour before bedtime,
how often they participated in exercise in their free time, and on
average how long they exercised in one session. Sleep variables
were measured by The Munich Chronotype Questionnaire; total
sleep time (TST), sleep onset latency (SOL), and chronotype. Mood
was measured by the Beck Depression Inventory (item 16 refers to
sleep difficulty and was omitted from analyses).
Results: Bootstrapping analysis found the three proposed media-
tion models were significant for girls, but not for boys. For girls more
physical activity in free time was a significant predictor of longer
TST, b = 0.01, SE = 0.002, p = <0.001, and longer TST was a signifi-
cant predictor of better mood, b = −0.24, SE = 0.03, p = <0.001.
Similarly, more physical activity after 6 pm was a significant predic-
tor of later chronotype, b = −0.10, SE = 0.03, p = 0.001, and later
chronotype was a significant predictor of better mood, b = 0.20,
SE = 0.02, p = <0.001. Lastly, more physical activity after 6 pm was
a significant predictor of shorter SOL, b = −1.05, SE = 0.44,
p = 0.02, and shorter SOL was a significant predictor of better
mood, b = 0.01, SE = 0.002, p = <0.001.
Conclusions: Evidence was found for the mediating relationship of
sleep between physical activity and mood with notable gender dif-
ferences. Although the three proposed mediation models were sup-
ported for adolescent girls, there were no significant results for
boys. More research is needed to replicate and test these relation-
ships longitudinally.
Disclosure: Nothing to disclose.
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P577 | Sleep related symptoms and gender in
France: an analysis of the Reseau Morphee
database
S. Royant-Parola1; S. Hartley1,2; P. Levy3; S. Dagneaux1;
F. Aussert1; C. Martinot1; V. Londe1; A. Brion1; I. Poirot4;
C. Colas des Francs1,5; P. Escourrou5
1Réseau Morphée, 2APHP Hopital Poincaré, Garches, 3APHP Hôpital
Tenon, Paris, 4CHRU de Lille, Lille, 5APHP Hôpital Antoine Béclère,
Clamart, France
Objectives/Introduction: Description of sleep related symptoms
among responders to an online sleep questionnaire.
Methods: Observational study of responses to an online question-
naire developed by a consensus of sleep experts.
Results: 15,596 participants completed the questionnaire and all
responses were included. 69% were women, mean age was
42.37 ± 14.94. Participants were mainly white‐collar workers 4,376
(28%) and professionals 3,978 (26%). 10% were students, 9% unem-
ployed and 11% retired. Mean IMC was 24.59 ± 5.02. Responses
were evenly distributed across France.
The most common complaint was insomnia: 82% sleep maintenance
insomnia, 59% sleep onset insomnia, and 71% early morning waking.
Apart from early morning waking, all insomnia complaints were sig-
nificantly more frequent in women (p < 0.0001). Sleep onset insom-
nia and non‐restorative sleep were more common in younger
patients while sleep maintenance and early morning waking
increased with age. Sleep onset insomnia was not affected by meno-
pause, but all other complaints were more prevalent in women over
55 compared to women under 45 (p < 0.0001).
Respiratory problems were common: snoring in 30% and respiratory
pauses in 9%. Symptoms were significantly more frequent in men
and increased with age. The combination of snoring and pauses was
seen in 7% and was more common in men (14% vs. 5%,
p < 0.0001). Morning headaches affected 36% and were more fre-
quent in women and younger patients whereas nycturia was slightly
more frequent in men and increased with age.
While the presence of pain in the legs in the evening was reported
by 30%, possible restless legs (evening pain increased by rest and
reduced by movement) was more common in women (13% vs. 10%
p < 0.0001) of whom 16% also had leg movements at night.
The mean ESS was 9.48 ± 4.9 with a significant difference between
men and women (9.02 ± 4.9 vs. 9.68 ± 4.92 p < 0.0001). Women
were more likely to have a score >10 (43% vs. 36% p < 0.0001)
27% reported falling asleep at the wheel: this was more frequent in
men than in women (32% vs. 24% p < 0.0001).
Conclusions: Sleep problems are frequent in the French population
with 82% reporting insomnia, 7% symptoms compatible with sleep
apnea and 12% possible restless legs syndrome.
Disclosure: Nothing to disclose.
P578 | Gender differences in aging process of
sleep behavior: the Korean Genome and
Epidemiology Study
H.J. Kim1; S. Kim2; R.E. Kim2,3; S.A. Kim1; S.K. Lee2;
H.W. Lee1; C. Shin2,4
1Departments of Neurology and Medical Science, Ewha Womans
University School of Medicine and Ewha Medical Research Institute,
Seoul, 2Institute of Human Genomic Study, College of Medicine, Korea
University, Ansan, Republic of Korea, 3Psychiatry, University of Iowa,
Iowa, IA, United States, 4Department of Pulmonary, Sleep and Critical
Care Medicine, Korea University Ansan Hospital, Ansan, Republic of
Korea
Objectives/Introduction: Age‐related changes in sleep are often
accompanied by gradual increase of sleep complaints. We investi-
gated the effects of gender on the aging process of sleep behavior
in the Korean general population.
Methods: We analyzed 2,351 subjects (mean 52.02 ± 6.97 years
old, 51.2% female) of the Korean Genome and Epidemiology Study
(KoGES) participants, who completed two‐time‐point sleep behavior
questionnaires in 2005–2006 and in follow up visit (mean follow up
duration 6.83 ± 1.05 years). We also assessed their sleep quality
objectively by ambulatory polysomnography at the follow‐up visit.
Results: The mean time in bed (TIB, p = 0.030) and sleep latency
(SL, p = 0.001) were longer in the advanced age group. As the con-
sequence, the habitual sleep efficiency (SE = SD/TIB) was decreased
with age (p < 0.001) even though subjectively reported sleep dura-
tion (SD) did not significantly different between age group
(p = 0.360). The Mid‐Sleep on Free days Corrected for Sleep deficits
during weekdays (MSFsc) was advanced (p < 0.001), and the social
jet lag was decreased (p < 0.001) with age. Women reported signifi-
cantly poorer sleep quality in all sleep behavior measure, however,
age group stratification revealed most of the gender differences
became insignificant after 65 years old. The difference of longitudi-
nal change between sex was significant in TIB (p = 0.002), SD
(p = 0.001) and MSFsc (p < 0.001). And the change of MSFsc was
also significantly different between age groups (p = 0.024). Objec-
tively measured sleep latency was increased in women (p < 0.001)
as subjective measure, however, the other sleep quality related met-
rics including sleep efficiency (p < 0.001) and arousal index
(p < 0.001) were significantly poorer in the men as well as sleep dis-
ordered breathing parameters.
Conclusions: In both genders, increasing age was associated with
poorer sleep quality on a range of both subjectively and objectively
measured sleep parameters. Our study demonstrated substantial evi-
dence of gender differences in sleep evolution across the senes-
cence, which is fundamental to provide the extent to which sleep
changes in each gender require particular attention for further inves-
tigation and proper intervention.
Disclosure: This study was supported by a grant of Korean Centers
for Disease Control and Prevention, Korean Ministry for Health and
Welfare [Grant 2005‐E71001‐00, 2006‐E71005‐00, 2011‐E71004‐00,
2012‐E71005‐00, 2013‐E71005‐00, and 2014‐E71003‐00].
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P579 | Subjective sleep quality, fatigue and
depressive symptoms during and after pregnancy
D. Vogelaers; L. Delesie; I. Hanoulle; S.-J. Maertens;
A. Mariman; E. Tobback
University Hospital Ghent, Gent, Belgium
Objectives/Instruction: Future and new mothers experience sleep
changes during pregnancy and after childbirth. These are important
to manage as they can affect women's physical, mental and emo-
tional well‐being, including the development of depressive symptoms
and postpartum depression. We aimed at gaining more insight in
sleep parameters, fatigue and depressive symptoms during late preg-
nancy and in postpartum. Additionally, differences in breast‐ and
bottle feeding mothers are investigated.
Methods: At 35–37 weeks gestation, 2 and 8 weeks postpartum,
women filled out a socio‐demographic questionnaire, the Pittsburgh
Sleep Quality Index (PSQI), the Insomnia Severity Index (ISI), the
Fatigue Severity Scale (FSS) and the Center for Epidemiological Stud-
ies Depression Scale (CES‐D). Women without exclusive breast‐ or
bottle feeding at the time of measurement were excluded from anal-
yses.
Results: One hundred fifteen woman were included at the first, 61
at the second and 35 at the third time point. During late pregnancy,
the whole sample showed a mean global PSQI score of 7.4 (SD 3.20,
range 1–15), with 79.8% scoring above the cut‐off value for poor
sleep (PSQI 5). The sample showed a mean ISI score of 8.82 (SD
4.21, range 0–21), with 56.5% showing subclinical (ISI 8–14) and
8.7% moderately/severe (ISI 15–22) insomnia. Mean FSS and CES‐D
scores fell within the normal range. Mean PSQI and FSS further
increased at 2 weeks postpartum, mean ISI remained unchanged and
mean CES‐D decreased in the whole sample. At 8 weeks postpar-
tum, all mean global scores decreased as compared to the first time
point, with only mean PSQI (5.46, SD 2.68, range 1–12) exceeding
the cut‐off value. Sixty percent of the women still experienced poor
sleep. At 2 and 8 weeks postpartum, there were no significant differ-
ences (p = 0.05) in any global score between breast‐ and bottle feed-
ing mothers.
Conclusions: Mean global PSQI, ISI and FSS of the whole sample
were highest at 2 weeks postpartum and lowest at 8 weeks postpar-
tum as compared to late pregnancy. Mean CES‐D scores decreased
over time from pregnancy till 8 weeks postpartum. No significant
differences were observed between breast‐feeding and bottle feed-
ing mothers.
Disclosure: Nothing to disclose.
P580 | Breastfeeding, prolactin release and
sleep
J. Isaac1; A. Matos-Pires2
1Psychiatry Department, 2Hospital José Joaquim Fernandes, Beja,
Portugal
Objectives/Introduction: Becoming a mother is a major life‐chan-
ging event for any woman. Much needed restorative sleep during
this time is often interrupted with night wakening, mainly for infant
care and feeding. Despite the need for mothers to obtain adequate
sleep, the association between maternal sleep and breastfeeding
behaviors is rarely examined.
Objective: The aim of the present study was to explore the rela-
tion between breastfeeding and prolactin release with sleep.
Methods: A systematic literature review was performed. We used
standard search strategies involving the querying of two online data-
bases (MEDLINE® and EMBASE), for English language articles using
the key words (breastfeeding + prolactin + sleep) followed by evalu-
ation of the bibliographies of relevant articles.
Results: The principal lactogenic hormone is prolactin (PRL). Pro-
lactin′s primary role is to help stimulate milk production after child-
birth. PRL secreted by the anterior pituitary is critical to the
establishment of lactation and breastfeeding. Pituitary PRL secretion
seems to be, at least in part, sleep‐dependent. PRL secretion is
enhanced during the whole sleep period, as inferred from plasma
levels. Some studies reveal that women who breastfed exclusively
(B/F) seems to have more nocturnal sleep than women who used
formula at night and demonstrated a marked increase in slow wave
sleep. The most likely explanation for the altered sleep architecture
noted to occur in women who are fully breastfeeding their infants is
an increase in circulating PRL, which occurs in lactating women.
Conclusions: Breastfeeding may promote sleep during postpartum
recovery. Enhanced Slow Wave Sleep may be an important factor to
support breastfeeding in the postnatal period.
Disclosure: Nothing to disclose.
P581 | Relation between menstrual cycle, sleep
and daytime sleepiness
J. Miura1; I. Kumakawa1; F. Sato1; K. Yama1; M. Machida1
1Pharmacy, Hokkaido University of Science, Sapporo, Japan
Objectives/Introduction: Premenstrual syndrome (PMS) is com-
mon in young women. Premenstrual dysphoric disorder (PMDD) is a
subtype of PMS with severe mental symptoms. Women often expe-
rience insomnia and/or daytime sleepiness before menstruation. This
study, therefore, aimed to investigate disturbance in sleep and wake-
fulness in young women with PMS/PMDD.
Methods: Thirty‐six healthy Japanese women, aged 19–24 years,
participated in the study. PMDD, moderate to severe PMS, or no or
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mild PMS were judged using the PMDD scale (Miyaoka, et al.,
2011). Insomnia and daytime sleepiness after the menstruation
ended (after menstruation) and before the next menstruation started
(before menstruation) were assessed using Athens Insomnia Scale
(AIS) and Epworth Sleepiness Scale (JESS), respectively. Five‐minute
psychomotor vigilance task (PVT) was administered after and before
menstruation, and reaction time and number of errors were ana-
lyzed. Activity during sleep was monitored using wActisleep+ Moni-
tor (ActiGraph, Pensacola, FL). The averages of sleep efficiency for
the seven nights after and before menstruation were calculated. Sta-
tistical analyses were performed using non‐parametric tests. This
study was approved by the ethics committee of the Hokkaido Phar-
maceutical University.
Results: Four women were judged to have PMDD, nine women
moderate to severe PMS, (PMS (+)), and twenty‐three women no or
mild PMS (PMS (−)). The JESS score was significantly higher in the
PMS (+) group than in the PMS (−) group before menstruation
(p = 0.010). The AIS score was significantly higher in the PMS (+)
group than in the PMS (−) group both after and before menstruation
(p = 0.013 and 0.000, respectively). Neither the reaction time nor
the number of errors was different between the PMS (+) and PMS
(−) groups. The sleep efficiency was significantly lower in the PMS
(+) group than in the PMS (−) group after menstruation (p = 0.043),
and the similar tendency was observed before menstruation
(p = 0.053). In addition, the sleep efficiency was lower before men-
struation than after menstruation in the whole subjects (p = 0.016).
AIS and JESS scores before menstruation were positively correlated
in the whole subjects (p = 0.014).
Conclusions: Young women with premenstrual symptoms experi-
ence insomnia and daytime sleepiness before menstruation more
strongly than those without. This might be related with lower sleep
efficiency.
Disclosure: Nothing to disclose.
P582 | Gender differences of cardiovascular
risk in population with sleep disturbance in
Russia/Siberia: WHO program MONICA‐
psychosocial
I. Gagulin; E. Gromova; A. Gafarova; D. Panov; E. Krymov;
V. Gafarov
Collaborative Laboratory of Cardiovascular Diseases Epidemiology,
Institute of Internal and Preventive Medicine ‐ Branch of Institute of
Cytology and Genetics, Novosibirsk, Russian Federation
Objectives/Introduction: To determine the gender differences in
the effect of sleep disorders on risk of myocardial infarction (MI) and
stroke in an open population 25–64 years in Russia/Siberia over
16 years of follow‐up.
Methods: Under the third screening of WHO program MONICA ‐
Psychosocial a random representative sample of both gender aged
25–64 years in Novosibirsk was examined in 1994 (men: n = 657,
44.3 ± 0.4 years; women: n = 689, 45.4 ± 0.4 years). The sleep
assessment was performed using the Jenkins Sleep Questionnaire.
There were 15 cases of new onset MI in women and 30 in men, as
well as new‐onset stroke 35 cases in women and 22 in men from
1994 to 2010. Univariate and multivariate regression model of Cox
proportional hazards (Cox‐regression) was used for risk assessments.
Results: In an open population aged 25–64 years 48.6% of men
and 65.9% of women had sleep disorders (p < 0.001). Univariate
Cox regression analysis showed 2.4‐fold risk of MI in those males
with SD over 16‐year of follow‐up (95% CI 1.1–5.3; p < 0.05) but
not for women. In multivariate Cox regression model we also did not
get to influence the risk of CVD in women (p > 0.05). The risk of MI
in men who was never married was 3‐fold higher (95% CI 1.9–9;
p < 0.0001). In divorced persons HR = 4.3 (95% CI 2.1–8.9) and in
widowed men HR = 7.5 (95% CI 2.5–22; p < 0.0001) compared to
married ones. In univariate analysis risk of stroke was higher in men
HR = 3 (95% CI 1.2–7.6; p < 0.05) than in women HR = 1.9 (95% CI
1.03–3.7; p < 0.05). Multivariate analysis revealed in men with SD
2.8‐fold risk of stroke (95% CI 1.1–7.1; p < 0.05) and women HR =
2.7 (95% CI 1.4–5.42; p < 0.01). Stroke risk was higher in men with
lower educational level and SD. There was an increase in the risk of
stroke in women with a college education and SD HR = 3.7 (95% CI
1.1–11.9; p < 0.05).
Conclusions: Our results demonstrated sleep disorders as a risk
factor of MI in men only and stroke for both gender. Negative social
gradient increases cardiovascular risk in urban inhabitants with sleep
disorders.
Disclosure: Nothing to disclose.
P583 | Is use of systemic hormone therapy
associated with better sleep? A large, registry‐
based study of pre‐, peri‐ and post‐menopausal
women in Norway
R. Andenæs; L. Ribu; N. Misvær; S. Helseth; M.C. Småstuen
1Health Sciences, OsloMet ‐ Oslo Metropolitan University, Oslo, Norway
Objectives/Introduction: Good sleep is a key factor for the main-
tenance of quality of life. Sleep quality changes during life, influ-
enced by various factors such as level of hormones, life style, and
age. The menopause, with declining estrogen levels is considered to
represent a particularly vulnerable period of life with regard to
threatened sleep quality. Objectives were to examine possible asso-
ciations between use of systemic hormone therapy (HT) and sleep
quality in a large population sample adjusted for possible con-
founders.
Methods: Female participants aged 45–75 years without any
report of heart disease or previous radiation therapy for gynecologi-
cal cancer were selected from the Norwegian Health Study in Nord‐
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Trøndelag (HUNT3, 2006–2008) (N = 14,278). Data from HUNT3
were linked to the Norwegian Prescription Database, to identify indi-
viduals who collected prescriptions of systemic HT (Estogen, Proges-
terone and Estrogen in combination), and sleep medication. Sleep
quality was dichotomized: good sleep quality was defined as report-
ing insomnia symptoms never/rarely or sometimes versus reporting
such symptoms several times a week. Data were analyzed using mul-
tiple logistic regression.
Results: Of the 14,278 analysed women a majority reported good
sleep, 93.8% (n = 13,398) while 6.2% (n = 880) reported not having
good sleep. In total, 998 women used HT, with the highest preva-
lence of 10.5% reported in women from 55 to 64 years. After
adjusting for relevant covariates, using HT was associated with
higher odds for better sleep, however this association was not statis-
tically significant (OR = 1.23, 95% CI [0.95–1.59], p = 0.12). Being a
HT user did not seem to sufficiently alleviate the problems regarding
having hot flashes, as 62.5% of HT users reported being bothered
with hot flashes both during day and/or night. Perceived good
health, aged between 65 and 75, not using sleep medication and
being satisfied with life, were factors showing the strongest associa-
tions with good sleep quality.
Conclusions: The low use of HT and high prevalence of hot
flashes, both in non‐users and users of HT, might indicate that many
women remain untreated despite climacteric symptoms, and that
many women were not using a sufficient dose of HT to alleviate
their symptoms and likely improve their sleep.
Disclosure: Nothing to disclose.
P584 | “What about us?” Men in the face of
childbirth ‐ their sleep and experiences of stress
around the time of birth
B.G. Cattarius; A.A. Schlarb
1Faculty of Psychology and Sports Science, University of Bielefeld,
Bielefeld, Germany
Objectives/Introduction: While many studies deal with the sleep-
ing problems of pregnant women and mothers, few studies have
focused on the sleep of fathers and fathers‐to be. Although fathers
in many countries accomplish their role differently than they used
to, it is known that men also suffer from sleep difficulties around
the time of birth although not as frequently as women. The goal of
this study is to evaluate male sleep difficulties and experiences of
stress around the time of birth.
Methods: 69 fathers‐to be were included in the study. In a longitu-
dinal study (T1 in the last trimester of pregnancy and T2 3 month's
postpartum) sleep difficulties based on PSQI and sleep diaries were
assessed. Beyond that the perceived stress scale (PSS) was calcu-
lated. In addition to that other factors as age, parity, parental leave,
participation in prenatal classes, their baby's frequency of night wak-
ing, and cognitions of their baby's sleeping habits were inquired.
Results: A paired‐sample t‐test was conducted to compare fathers
in parental leave (A) (n = 36) with fathers without parental leave (B)
for all relevant variables. A significant difference for PSQI(A) and (B);
t(67) = −1.98, p = 0.05, in frequency of night waking(A), (B);
t(67) = −3.64, p = 0.001 and in how recovered fathers feel after
sleeping (A), (B); t(67) = −2.69, p = 0.009. Furthermore, 26 fathers
rate the sleeping habits of the baby as a problem. Beyond, significant
higher stress scores according to the PSS was measured for first
time fathers; t(67) = 3.93, p = 0.000.
Conclusions: With constantly changing division of tasks between
partners and new expectations concerning fathers, men should be
prepared during pregnancy for the changes which occur postpartum,
particularly relating to sleep habits and coping with stress. Since the
study hints at potential insomnia among fathers on parental leave, a
case that is often only discussed in regard to mothers on parental
leave, men planning to go on parental leave should take this step
cautiously. Routine check‐ups for sleep difficulties during pregnancy
and the time after could avoid health issues and provide a function-
ing transition into parenthood.
Disclosure: Nothing to disclose.
P587 | A big data approach to objective
measurement of sex differences in sleep
schedules
K. Martinmäki1; L. Leinonen1; T. Korhonen1
1Polar Electro Oy, Kempele, Finland
Objectives/Introduction: Consumer‐targeted wearables enable
objective measurement of sleep in a large group of people over a
prolonged period of time. Fitness trackers with a Polar Sleep Plus™
feature utilise data from an in‐built accelerometer to determine sleep
parameters using a proprietary algorithm. A comparison against
polysomnography suggests that the algorithm is suitable for research
use with children, adolescents (1) and adults (unpublished data). Our
aim was to study sex differences in sleep schedules among users of
Polar fitness trackers.
Methods: We selected a sample of anonymised measurements
with Polar Sleep Plus™ from the Polar Flow database. Users with
less than five measurements were excluded. The measurements
came from 121,223 users aged 18 to 64. The measurements were
synched to the database during a 6‐month period, totalling over six
million nights. We compared differences in Fell asleep time (sleep
onset), Woke up time (sleep offset), and Sleep time (time elapsed
from sleep onset to offset) between women and men in four differ-
ent age groups (18–29, 30–39, 40–49, 50–64).
Results: On average, women slept for 7 hr 32 min and men for
7 hr 10 min (p < 0.0001). In all age groups, women slept longer than
men (p < 0.0001). An average Fell asleep time was 23:34 for women
and 23:55 for men indicating an earlier circadian timing of sleep for
women (p < 0.0001). Similar differences in Fell asleep time between
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the sexes were found in all age groups (p < 0.0001). An average
Woke up time was 07:10 for women and 07:10 for men.
Conclusions: This big data approach using wearable technology
confirmed sex differences in sleep schedules. A trend of longer sleep
duration and the earlier circadian timing for women was consistent
across age groups.
References: 1. Pesonen AK and Kuula L. The Validity of a New Con-
sumer‐Targeted Wrist Device in Sleep Measurement: An Overnight
Comparison Against Polysomnography in Children and Adolescents. J
Clin Sleep Med. 2018 Mar 30. pii: jc‐17‐00529. [Epub ahead of print].
Disclosure: K Martinmäki, L Leinonen and T Korhonen work as
researchers in Polar Electro Oy.
P588 | Sex differences in the circadian and
sleep dependent regulation of sleep spindles in
humans
A. Lazar1; Z.I. Lazar2; D.-J. Dijk3
1Faculty of Medicine and Health Sciences, University of East Anglia,
Norwich, United Kingdom, 2Faculty of Physics, Babes‐Bolyai University,
Cluj‐Napoca, Romania, 3Faculty of Health and Medical Sciences,
University of Surrey, Guildford, United Kingdom
Objectives/Introduction: Sleep spindles (SP) are closely associ-
ated with both the physiological and cognitive aspects of sleep and
have been shown to be modulated by homeostatic and circadian
effects. A sexual dimorphism has been demonstrated for the associa-
tion of sleep spindles with cognition as well as in the circadian and
sleep dependent regulation of cognitive performance. However, it is
not known whether the circadian and sleep dependent modulation
of sleep spindles is modulated by sex.
Methods: 34 young (18 females, age: 25.1 ± 3.4) healthy subjects
completed a 10‐day forced desynchrony protocol, in which a 28‐hr
sleep‐wake cycle was imposed while living in a dim light environ-
ment (<5 Lx). Sleep EEG was recorded throughout the protocol (231
sleep episodes) from 12 electrodes. Slow sleep spindles (SSP) (11–
13 Hz) and fast sleep spindles (FSS) (13–15 Hz) were detected based
on a fully automatic approach. Detailed topographical analysis of
multiple sleep spindle parameters was undertaken. Circadian phase
was derived from the assessment of the Dim Light Melatonin Onset
based on blood samples collected during the protocol.
Results: There was a main effect of sex on FSP density and fre-
quency with women presenting higher values compared to men
(p < 0.005). The density effect was greatest over the frontal region
whereas the frequency effect was most pronounced over the poste-
rior region. Men presented higher SSP density over the frontal
region only (p < 0.05). There was no effect of sex on spindle dura-
tion. Both FSP density and frequency showed a marked sleep depen-
dent increase across all major brain regions (p < 0.001). This
increase was greater in women than men over the frontal region
(p < 0.005) for FSP density and over all brain regions for FSP
frequency (p < 0.01 all regions). There was a circadian modulation of
both SSP and FSP density and frequency (p < 0.05) with an interac-
tion with sex (p < 0.05). Sex differences emerged during the circa-
dian night only when melatonin was highest.
Conclusions: There is a marked sexual dimorphism in the circadian
and sleep dependent modulation of sleep spindles across the differ-
ent brain regions. This has implications for understanding the sexual
dimorphism in the cognitive and psychiatric correlates of sleep.
Disclosure: The authors report no conflict of interest.
P589 | What are the characteristics associated
with increased slow wave sleep?
A.R. Peralta1,2; I. Amorim1; A. Franco1,2; C. Bentes1,2
1Hospital Santa Maria, Neurosciences, Centro Hospitalar Lisboa Norte,
Lisboa, 2Faculdade de Medicina da Universidade de Lisboa, Lisbon,
Portugal
Objectives/Introduction: Slow Wave Sleep is associated with var-
ious sleep related functions, including cognitive functions and
removal of noxious substances. Decreased slow wave sleep occurs
in different sleep disorders. There is few data analysing factors asso-
ciated with increased SWS. The objective if this study was to evalu-
ate demographic, clinical and polisomnographic features associated
with increased SWS on routine PSGs.
Methods: Clinical case series. The percentage of SWS was evalu-
ated from a database of full polysomnographies (PSGs) performed in
a university hospital sleep lab, from a neurology department. Exclu-
sion criteria included total sleep time (TTS) less than 4 hr and PSGs
with EEG artefacts. SWS was classified as decreased (<10%); normal
(10–25%); increased (>25%) of TTS. The group of patients with
increased SWS was compared with the reference (normal) group for
demographic, clinical and PSG variables with T test for quantitative
variables or Qui2 for categorical variables. Significance value was
0,05.
Results: From 719 PSG, there were 75 (10.4%) patients with
increased SWS percentage. Decreased SWS occurred in 43.5% and
normal SWS percentage in 46.0%. Compared to patients with normal
SWS percentage patients with increased SWS were more frequently
females (70%), had less wakefulness after sleep onset, increased
sleep efficiency and lower percentages of N1 and N2 sleep. Age,
BMI, RDI, PLM index and other sleep macrostrutural measures were
similar.
Conclusions: A low albeit significant proportion of patients show
increased SWS on routine PSGs. These patients have more consoli-
dated sleep, despite similar percentages of sleep related pathologies
including obstructive sleep apnea and periodic limb movements. Other
mechanisms are possibly involved in enhancement of SWS, namely
factor associated with female gender. Further studies are necessary to
evaluate its associations and possible clinical consequences.
Disclosure: Nothing to disclose.
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P590 | The possible role of P2X7 receptors of
ATP in the induction of recovery sleep following
sleep deprivation
Z. Lelkes1; H.-K. Wigren2; S. Soini2; H. Ikonen2; T. Salminen2;
O. Santangeli2; T. Porkka-Heiskanen2
1Department of Physiology, Faculty of Medicine, University of Szeged,
Szeged, Hungary, 2Department of Physiology, University of Helsinki,
Helsinki, Finland
Objectives/Introduction: The basal forebrain (BF) is a key area in
sleep regulation and implicated in the induction of recovery sleep
(RS). ATP, as a neurotransmitter, enhances the release of cytokines
via type 2 purinergic receptors and may be involved in sleep regula-
tion. It is speculated that ATP, as a neurotransmitter, might also be
involved in the induction of RS. To test this hypothesis, we studied
how the local BF administration of A438079, a P2X7 receptor antag-
onist of ATP, during sleep deprivation (SD) influences the subse-
quent RS.
Methods: In 7 male Han‐Wistar rats with implanted EEG/EMG
electrodes and guide cannulae for microdialysis probes, the probe
targeted into the BF was perfused (1 μl/min) with artificial cere-
brospinal fluid (CSF) on the baseline day. Then, on the subsequent
SD days, the rats were sleep deprived for 12 hr in the light period,
and during SD, the microdialysis probe was perfused with CSF
(SD+CSF) or 5 mM A438079 (SD+A). Sleep was recorded for 24 hr
on the baseline and SD days and also on the days immedeiately fol-
lowing the SD days.
Results: SD+CSF enhanced NREMS during the subsequent RS
(ANOVA followed by Tukey‐test, p < 0.05), SD+A resulted only in a
tendency to increase NREMS. NREMS following SD+CSF and SD+A
did not differ significantly from each other, blocking of P2X7 recep-
tors during SD by A438079 resulted only in a tendency to supress
the following NREMS rebound (baseline night: 25.7 ± 2.0%; postde-
privation nights: 35.2 ± 2.2 and 32.0 ± 1.5% following SD+CSF and
DS+A respectively). Both SD+CSF and SD+A enhanced REMS dur-
ing the subsequent RS (ANOVA followed by Tukey‐test, p < 0.05),
REMS following SD+CSF and SD+A did not differ from each other
(baseline night: 6.5 ± 0.9%; postdeprivation nights: 15.2 ± 0.8 and
15.7 ± 1.1% following SD+CSF and SD+A respectively).
Conclusions: Our present findings give only very little support to the
hypothesis that ATP and its P2X7 receptors might be involved in the
induction of RS, the application of a stronger P2X7 antagonist is needed
to clarify this question. Such experiments are planned in the future.
Disclosure: This work was supported by the Academy of Finland.
P591 | Elevated glutamate levels in the
anterior cingulate cortex after a sleep‐inducing
dose of gamma‐hydroxybutyrate in humans: a
magnetic resonance spectroscopy study
D.A. Dornbierer1,2; D.M. Baur1; N. Zölch2; B. Quednow2;
T. Krämer3; E. Seifritz2; O. Bosch2; H. Landolt1
1Institute of Pharmacology and Toxicology, Human Sleep
Psychopharmacology, 2Department of Psychiatry, Psychotherapy and
Psychosomatics, Psychiatric Hospital, 3Department of Forensic
Pharmacology and Toxicology, Zurich Institute of Forensic Medicine,
University of Zurich, Zurich, Switzerland
Objectives/Introduction: Gamma‐hydroxybutyrate (GHB) is a
GABAB‐/GHB receptor agonist that is medically used as anesthetic
and for the treatment of narcolepsy and alcohol withdrawal.
Recently, GHB was proposed as repurposing candidate for the treat-
ment of neuropsychiatric disorders such as Parkinson's and Alzhei-
mer's disease, fibromyalgia and major depressive disorder. Insomnia
is a common comorbidity of these pathologies and GHB's ability to
enhance slow‐wave activity (SWA) might be a hallmark of its benefi-
cial effects on above disease courses. Despite its clinical relevance,
no study has investigated the impact of GHB‐facilitated NREM sleep
on metabolite levels in disease relevant brain regions such as the
anterior cingulate cortex (ACC) in humans.
Methods: A single oral dose of GHB (50 mg/kg body weight) or
placebo were administered to 16 healthy male volunteers at
2:30 am, in the middle of a sleep episode from 11 pm–7 am, to
specifically increase SWA in the second half of the night. Current
source density analyses of EEG data were performed with low‐reso-
lution electromagnetic tomography. Levels of disease relevant
metabolites, including glutamate and GABA, were quantified in the
ACC upon awakening (8:30–9:00 am) with J‐resolved magnetic reso-
nance spectroscopy (JPRESS‐MRS).
Results: In the second half of the night, GHB prolonged NREM and
reduced REM sleep compared to placebo (pall < 0.05). Furthermore,
power in delta and theta (1–8 Hz) frequencies was increased
(p < 0.05). This increase in oscillatory power was most pronounced
bilaterally over prefrontal cortices (p < 0.05). Interestingly, JPRESS‐
MRS analyses revealed increased glutamate levels in the ACC in all
subjects after GHB compared to placebo (p < 0.001). By contrast,
GABA levels remained unaffected.
Conclusions: This study indicates that intra‐night GHB administra-
tion increases ACC glutamate levels on the next morning. These
metabolic alterations may result from increased SWA in the ACC
during the night, because due to GHB's short half‐life time (t1/2 ~
30–60 min), no acute drug effects may be expected at the time of
MRS assessment. The ACC plays a critical role for cognitive perfor-
mance, including attention and cognitive control. The elevated con-
centration of glutamate may thus provide a neurochemical
explanation for GHB's ability to reduce symptoms of fatigue and
impaired cognitive performance in neuropsychiatric disorders.
Disclosure: Nothing to disclose.
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P592 | Preclinical evaluation of the potential
use of Pitolisant as new intervention for sleep
abnormalities in Prader‐Willi syndrome
M. Pace1; M. Falappa1; E. Balzani1; H. Stark2; V. Tucci1
1Istituto Italiano di Tecnologia, Genova, Italy, 2Heinrich‐Heine‐
Universitaet Duesseldorf, Institut fuer Pharmazeutische and Medizinische
Chemie, Duesseldorf, Germany
Objectives/Introduction: Prader‐Willi syndrome (PWS) is a rare
neurodevelopmental disorder that is linked to genomic imprinting
abnormalities. PWS patients suffer from sleep disturbances such as
excessive daytime sleepiness (EDS), rapid eye movement (REM) sleep
alterations and, in some cases, cataplexy. Here we present a pre‐clin-
ical study in which we tested the effects of Pitolisantin a mouse
model of PWS, carrying a deletion of Snord116, which presents
sleep, feeding and metabolic abnormalities. Pitolisant is an inverse
agonist of histamine 3 receptor (H3R) and, recently, has been pro-
posed as new therapeutic intervention for EDS and narcolepsy.
Methods: We characterized sleep architecture in PWS (PWScrm+/p−)
mutant mice compared to wild‐type littermate controls (PWScrm+/p+).
In particular, we recorded EEG/EMG and temperature profiles before
and after injection of Pitolisantor placebo in both groups. Mice were
constantly monitored for a total of 48 hr, starting at the beginning of
light‐off phase (active phase). Pitolisant (20 mg/kg) placebo was
injected after 24 hr of baseline profiling, and mice were monitored for
additional 24 hr.
Results: The profile of sleep in mutant PWScrm+/p− mice recapitu-
lated our previous discovery that REM sleep is significantly increased
in this mutant line.However, in this new study, mutants treated with
Pitolisant presented a reduction of REM sleep during the active
phase (i.e. dark phase, the 12 hr immediately following the injection,
p = 0.001). This latter effect on REM sleep was present also in
PWScrm+/p+ mice, in whichREM sleep was almost suppressed during
active phase. On the other hand, sleep during inactive phase (i.e.
light phase, from 12 to 24 hr after pitolisant/placebo injection) was
unaffected in both genotypes. The effects of Pitolisanton REM sleep
were accompanied by a dramatic decrease in body temperature in all
mice.
Conclusions: Our preliminary results demonstrate that Pitolisanten-
hances wakefulness and reduces EDS during the day in PWS mice.
Moreover, the effects on REM sleep may be mediated by alteration
of the core body temperature. Therefore, further investigation is
necessary to clarify the direct or indirect control of sleep by Pitoli-
salnt, as well as its clinical use to ameliorate the quality of sleep in
PWS patients.
Disclosure: Nothing to disclose.
P593 | Optogenetic control of sleep slow
waves to improve recovery after ischemic stroke
L. Facchin1; C. Schöne1; A. Mensen2; M. Bandarabadi1,2;
K. Schindler2; A. Adamantidis1,2; B. Claudio1,2
1Experimental Neurology, 2Neurology Department, University Hospital
Inselspital, Bern, Switzerland
Objectives/Introduction: Sleep‐wake disturbances are frequent
after stroke and are associated with poorer rehabilitation and long‐
term outcomes. Clinical and experimental studies suggest a favour-
able effect of sleep on post‐stroke neuroplasticity and functional
recovery. Here, we investigate the role of sleep Slow Wave (SW)‐like
oscillations on motor recovery following ischemic stroke using opto-
genetic and in vivo electrophysiology techniques in mice.
Methods: Ischemic stroke was induced in wild type mice via mid-
dle cerebral artery occlusion (MCAO). Different optogenetic opsins
were targeted to pyramidal neurons using local infusion of CamkII‐
ChR2‐EYFP (ChR2) CamkII‐ArchT‐EYFP (ArchT) and CamkII‐mCherry
(control) adeno‐associated viruses (AAV) within the peri‐lesional pri-
mary somatosensory forelimb (S1FL) cortex. Optical stimulations
were designed to mimic SW‐like bistability during sleep during the
recovery period. Optogenetic SW‐like were delivered daily (2 hr/day,
at ZT 09:00) starting on post‐stroke day 5 until day 15. Behavioural
tests were conducted on post‐stroke days 4, 7, 10 and 15 to assess
the effect of optogenetically‐evoked SW on motor outcomes.
Results: We showed that MCAO induced an increased amount of
NREM sleep (n = 5, t‐test, p < 0.05) following ischemic stroke,
where ipsilesional SW where longer in duration compared to control
animals (n = 5, t‐test, p < 0.05) We showed that both optogenetic
activation (ChR2, n = 7) and silencing (ArchT, n = 7) of pyramidal
neurons within the per‐lesional S1FL cortex successfully induced
SW‐like bistability in ipsilesional and contralesional cortical elec-
troencephalography (EEG) recordings. Next, we showed that chronic
optogenetic induction of SW‐like bistability, predominantly during
NREM sleep, significantly improved the recovery of fine motor
movements (two‐way ANOVA, p < 0.05) as compared to control
mice (n = 7). Interestingly, the induction of SW‐like bistability post‐
stroke did not affect strength or symmetry of movements.
Conclusions: Our findings showed that optogenetically‐induced
SW‐like bistability through manipulation of peri‐lesional pyramidal
neurons activity significantly improves functional outcomes after
stroke. In line with the literature, our results suggest a positive role
of sleep in motor recovery following ischemic stroke.
Disclosure: Nothing to disclose.
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P594 | Functional consequences of brain
glycogen deficiency on the sleep‐wake cycle
regulation in PTG‐KO mice
S. Burlet-Godinot1,2; I. Allaman2; G. Grenningloh2;
P.J. Roach3; A. Depaoli-Roach3; P.J. Magistretti1,2,4;
J.-M. Petit1,2
1Psychiatry, CHUV‐CNP, Prilly, 2School of Life Science, BMI, EPFL,
Lausanne, Switzerland, 3Department of Biochemistry and Molecular
Biology, Indiana University School of Medicine, Indianapolis, IN, United
States, 4Biological and Environmental Sciences and Engineering, KAUST,
Thuwal, Saudi Arabia
Objectives/Introduction: In the brain, glycogen is localized in
astrocytes where its levels are linked to neuronal activity. Astrocytic
glycogen synthesis is regulated by glycogen synthase activity (GSa)
that is positively controlled by the protein targeting to glycogen
(PTG) expression levels. We previously demonstrated that a 6 hr
gentle sleep deprivation (GSD) increased PTG mRNA expression and
GSa in mice brain. Glycogen levels were also paradoxically main-
tained following GSD. In order to gain further insight on the role of
PTG in this process, we studied the sleep/wake cycle in basal and
GSD conditions in homozygous PTG knockout mice (PTG‐KO).
Methods: We used 10 C57BL/6J mice (WT) and 10 PTG‐KO main-
tained in standard conditions (22 ± 1°C; L:D 12:12). Vigilance states
were recorded and visually scored during 24 hr of baseline and dur-
ing 6 hr of GSD (ZT0‐ZT6) followed by 6 hr of recovery. The spec-
tral analysis of sleep EEG was performed. Glycogen was
biochemically assayed in different brain regions in baseline condi-
tions and following GSD.
Results: Cortical and hippocampal glycogen levels were extremely
reduced (−77 ± 1.5%; −75.7 ± 2.3% respectively) in PTG‐KO. During
the dark period of baseline, PTG‐KO displayed a more fragmented
wakefulness with a significant increase in the number of slow wave
sleep episodes (+26.1 ± 8%; p < 0.05) and a shortening of waking
episodes duration (−21.6 ± 7.2%; p < 0.01). While no quantitative
change of paradoxical sleep (PS) was observed, a significant increase
in the power of the theta band (7–8.5 Hz) was present in PTG‐KO
during this state. Following GSD, PTG‐KO did not display significant
PS rebound despite maintaining of glycogen levels in brain.
Conclusions: The drastic decrease of glycogen content induced by
the blockade of PTG synthesis affected the maintenance of wakeful-
ness during the active period. Together with the impaired homeo-
static regulation of PS following GSD, these results might indicate an
involvement of glycogen metabolism for sustained cortical activation.
Interestingly, the increase in theta power in baseline PS observed in
PTG‐KO also underlines a link between glycogen and PS regulation
that warrants further investigation.
Disclosure: This work was supported by grants from Swiss
National Science Foundation (FNRS#31003A_130821 and
310030B_148169) to PJM, (NCCR “SYNAPSY”) to JMP and SBG;
NIH grants DK27221 and NS056454 to PJR.
P595 | Acoustic modulation of slow‐wave
sleep in rats: effect of boosting or inhibiting
delta activity in SWS on motor learning
C. Gonçalves Moreira1; M.L. Ferster2; D. Noain1;
C. Baumann1
1Neurology Department, University Hospital Zürich, Zurich, 2Department
of Health Sciences and Technology, ETH Zurich, Zürich, Switzerland
Objectives/Introduction: Slow oscillations (SOs), the hallmark of
slow‐save sleep (SWS), play a major role in sleep‐dependent memory
formation, including learned motor tasks. SOs consist of an upstate
where neurons have an increased excitability, followed by a down-
state where neurons are silenced. Previous studies in humans estab-
lished that targeting auditory pulses to SOs’ upstate ‐ in‐phase
modulation ‐ constitutes a privileged time window for improvement
in memory reactivation, whereas intervening SOs’ downstate ‐ out‐
of‐phase modulation ‐ seems to disrupt slow oscillatory patterns and
diminish recall performance. We hypothesize that in‐phase acoustic
stimulation in healthy rats during motor training by pellet reaching
task can increase SWS activity, which translates into enhanced learn-
ing of motor skills, whereas out‐of‐phase stimulation offers the
opposite effect.
Methods: A newly auditory closed‐loop protocol for rodents was
established to target SOs’ upstate or downstate phases and deliver
clicks of pink‐noise (25 ms, 35 dB) with 8 ms jitter. In our model,
sleep is recorded by electroencephalography/electromyography while
acoustic stimulation is applied in two conditions: to enhance or dis-
rupt SOs and ultimately modulate deep sleep. No noise is presented
in a third condition as control. For that, a real‐time NREM detection
feature (RMS [δ (0.1–2 Hz)/β(20–30 Hz)] ∧ RMS [EMG (10–
1,000 Hz)]) runs alongside a predictive phase‐locked loop (1 Hz band
target) as a derivative function of endogenous signal individually.
Results: Closed‐loop acoustic stimulation is fully established in rats.
In‐phase closed‐loop acoustic stimulation can increase delta‐power
up to a median of 15% (IQR = −5.8% to 18.4%, p = 0.07, n = 5)
without altering sleep amount (two‐way ANOVA, p > 0.05, n = 5).
Primary data comparison shows increases up to 79% (paired t‐test,
p < 0.001, n = 5). In & out‐of‐phase acoustic stimulation can be used
to modulate memory consolidation in the single‐pellet reaching task.
Animal experiments are ongoing.
Conclusions: In‐phase acoustic stimulation can increase slow wave
activity while out‐of‐phase hasthe opposite effect in rats. These con-
ditions can be used to modulate memory consolidation in rats on
the single pellet reaching task.
Disclosure: Nothing to disclose.
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P596 | Extended photoperiod alters sleep,
circadian rhythmicity and expression of synaptic
pasticity‐associated genes. The impact of blue‐
enriched light
J. Grønli1; L.H. Bjerrum1; J. Mrdalj1; S. Skrede1,2; J.P. Wisor3;
T.T. Pedersen1; J. Waslander1,4; M. Rempe3,5; K. Ersland1,6;
C. Bramham1; T.E.G. Henriksen1,7; A.R. Marti1
1University of Bergen, 2Bergen Clinics Foundation, Bergen, Norway,
3Washington State University, Spokane, WA, United States, 4University
of Groningen, Groningen, The Netherlands, 5Whitworth University,
Spokane, WA, United States, 6Haukeland University Hospital, Bergen,
7Valen Hospital, Kvinnherad, Norway
Objectives/Introduction: Light can have complex effects on the
brain. It has been suggested that blue‐enriched light promotes alert-
ness in both humans and rodents through signaling via intrinsic pho-
tosensitive retinal ganglion cells. The brain's ability to maintain
cognitive alertness depends on sleep, circadian rhythmicity and
synaptic plasticity ‐ an increase or decrease in synaptic strength in
response to neural activity patterns. Here we use a model of pro-
longed photoperiod (20 hr light, 4 hr dark; 20:4 LD) of two different
light spectra (white and blue‐enriched) to characterize the effects of
an extended photoperiod on sleep, circadian rhythmicity and synap-
tic plasticity‐associated genes important for mood and cognition in
rats.
Methods: For telemetric recording of the circadian rhythm (body
temperature, BT) and sleep (electroencephalogram and electromyo-
gram), rats (n = 6/group) were housed in standard 12:12 LD condi-
tion, followed by exposure to 7 days (E7) of extended photoperiod
(20:4 LD) in either white or blue‐enriched light conditions. Tissue
from a separate set of animals (n = 10/group) was collected on E7 at
ZT12, from anterior cingulate cortex (ACC; implicated in mood regu-
lation) and prefrontal cortex (PFC; implicated in mood and cognitive
performance). Tissue samples were analyzed with qPCR for expres-
sion of immediate early response genes implicated in synaptic plas-
ticity (Arc, KLF10 and NPAS4), and compared to time‐matched
12:12 LD controls.
Results: At E7, the circadian rhythm of BT remained at 24 hr, but
the acrophase was shifted to co‐occur with the dark phase. Only
white light increased total sleep time (white: 8.9 ± 3.6%, p = 0.004
vs. blue: 3.6 ± 1.5%, p = 0.155) and time in slow‐wave sleep (SWS)
(white: 8.9 ± 3.7%, p = 0.014 vs. blue: 4.1 ± 1.7%, p = 0.193) com-
pared to baseline. Independently of spectral qualities, expression of
Arc (ACC and PFC; t's(15–18) > −3.74, p's < 0.002) and KLF10 (ACC;
t's(17–18) > −2.51, p's < 0.02) was decreased. NPAS4 was decreased
in the blue‐enriched condition only (PFC; t(15) = −3.53, p = 0.003).
Conclusions: Extended photoperiod disrupted the acrophase of
body temperature. Blue‐enriched light inhibited an increase in sleep
parameters observed in white light condition. Furthermore, the
effect on synaptic plasticity markers depends on the spectral quality
and brain regions central for mood‐regulation and cognition.
Disclosure: Nothing to disclose.
P597 | Variability in habitual nighttime sleep
predicts white matter integrity of neural
impulsivity network
S. Reyes1; C. Algarin1; B. Lozoff2; S. Gahagan3; B.B. Biswal4;
P. Peirano1
1Sleep and Neurobiology Laboratory, University of Chile/Institute of
Nutrition and Food Technology INTA, Santiago, Chile, 2Center for Human
Growth & Development, University of Michigan, Ann Arbor, MI,
3Department of Pediatrics, University of California San Diego, San Diego,
CA, 4Department of Biomedical Engineering, New Jersey Institute of
Technology, New Ark, NJ, United States
Objectives/Introduction: We examined whether habitual sleep
time differences between weekdays and weekends were associated
with white matter integrity in tracts connecting ventral striatum
(vSTR) and ventromedial prefrontal cortex (vmPFC), which relate
with impulsive behavior.
Methods: Participants were part of a cohort follow‐up study since
infancy. Bedtime (BT) and wake‐up time (WT) for weekdays and
weekends were detected by an automated method applied to acti-
graphic data recorded for a week. Differences in BT and WT
between weekend and week days were categorized based on the
median of their distribution. Through diffusion tensor imaging stud-
ies, tracts connecting vSTR‐vmPFC were identified by FSL (FMRIB
Software Library) probabilistic tractography to estimate white matter
integrity parameter [fractional anisotropy, mean (MD), axial and
radial diffusivities]. Linear Regression and univariate GLM including
sex as covariate were used for data analysis.
Results: Thirty‐two participants were included, 41% were female
and mean age was 21.7 ± 1.9 years. Mean BT and WT were: (a)
weekdays: 1:06 am ± 1.3 hr and 09:25 am ± 1.7 hr and (b) weekend:
2:05 am ± 1.9 hr and 10:23 am ± 2.1 hr. Median BT and WT differ-
ence between weekend and week days were: 0.8 ± 2.4 hr and
0.5 ± 2.4 hr. Significant results were found for MD, later WT on
weekends was related with decreased MD (β = −0.374, p < 0.05)
values in vSTR‐vmPFC tracts. Compared to WT on weekdays, partic-
ipants who delayed ≥0.8 hr their WT on weekends (F(1,30) = 3.8;
p = 0.05) showed lower MD values relative to those who delayed
<0.8 hr or even wake‐up earlier on weekends (0.723 vs.
0.745 × 103; p = 0.05).
Conclusions: This study shows a relationship between difference
in nighttime sleep length during weekdays and weekends and white
matter integrity in young adults. Participants who extend their sleep
on weekends presented greater white matter integrity (lower MD
values) in vSTR‐vmPFC tracts. Since this neural network relate to
impulsivity, our results may help understand the link between sleep
and impulsive behavior.
Support: Fondecyt (CONICYT, Chile) 11160671 and NIH HD33487
and NIH HL088530 grants.
Disclosure: Nothing to disclose.
ABSTRACTS | 361 of 433
P598 | Local non‐REM sleep enabled through
heterogeneous thalamic burst propensity
L.M.J. Fernandez; G. Vantomme; A. Osorio Forero; E. Béard;
A. Lüthi
University of Lausanne, Lausanne, Switzerland
Objectives/Introduction: Sleep is a global vigilance state, yet its
cerebral correlates are locally heterogeneous. We explore the
expression of locally different sleep features and investigate their
underlying cellular and circuit mechanisms, as well as their relevance
for local circuit function.
Methods: We record in mice (n = 22) the palette of regional activi-
ties in‐vitro within the major thalamic rhythm pacemaker (the thala-
mic reticular nucleus TRN), and the local variations of sleep
oscillations in multiple cortical areas in‐vivo.
Results: We identify TRN CaV3.3 calcium channels as a molecular
source for cortical heterogeneity in mouse non‐REM sleep. CaV3.3‐
channels enabled a graded form of repetitive burst discharge: stron-
gest in somatosensory, intermediate in auditory, and weak in non‐
sensory sectors of the TRN. In undisturbed sleep, the corresponding
somatosensory (but not auditory and prefrontal) cortices, showed
fast, strong and locally synchronous sleep spindles. Without CaV3.3
channels, somatosensory areas expression in delta waves was
enriched, and spindles became homogenous across sensory and non‐
sensory cortices. Furthermore, the tight locking of fast spindles to
the upstate of cortical slow‐oscillation was disrupted. Finally, we
recently obtained evidence that the effects of Cav3.3 gene deletion
can be reproduced by pharmacogenetic inhibition of TRN cells.
Conclusions: Here, we unravel the critical role of the thalamus in
shaping local heterogeneities of non‐REM sleep and in imposing forms
of spindle‐enriched sleep in the major sensory modality of mouse.
Disclosure: Nothing to disclose.
P599 | Thalamic dual‐control of sleep and
wakefulness
T. Gent; M. Bandarabadi; C. Gutierrez Herrera;
A. Adamantidis
Centre for Experimental Neurology, Inselspital University Hospital,
University of Bern, Bern, Switzerland
Objectives/Introduction: Slow‐waves (0.5–4 Hz) predominate in
the cortical electroencephalogram during non‐rapid eye movement
sleep (NREM) in mammals. They reflect the synchronisation of large
neuronal ensembles alternating between active (UP) and quiescent
(DOWN) states and propagate along the neocortex. However, the
thalamic contribution to cortical UP‐states and sleep modulation
remains unclear.
Methods: We used wild‐type freely bahaving mice chronically
implanted with multisite optrodes in thalamus and cortex. Sleep was
recorded during the dark period.
Results: Using multisite tetrode recordings in freely behaving mice,
we show that spontaneous centromedial thalamus (CMT) neuronal
firing is phase advanced to global cortical UP‐states, as well as
NREM‐to‐Wake transitions but not temporally‐locked to sensory tha-
lamic neuronal firing. Optogenetic tonic activation of CMT neurones
induces rapid NREM‐to‐Wake transitions, whereas burst activation
mimics UP‐states in the cingulate cortex (CING) and enhances brain‐
wide synchrony of cortical slow‐waves during sleep, through a thala-
mic relay located in the antero‐dorsal thalamus (AD). Finally, we
demonstrate that both CMT and AD relay neurones are critical for
the traveling of slow‐waves and recovery of sleep.
Conclusions: These findings suggest that tuning of CMT neuronal
firing alone can modulate brain‐wide cortical activity during sleep
and provides dual control of sleep‐wake states.
Disclosure: Nothing to disclose.
P600 | Volume of subcortical brain areas is
associated with sleep macrostructure in healthy
young individuals
P. Ghaemmaghami1; V. Muto1,2; M. Jaspar1,2,3; C. Meyer1,2;
M. Elansary4; M. Van Egroo1; C. Berthomier5; E. Lambot1,2;
M. Brandewinder5; A. Luxen1; C. Degueldre1; E. Salmon1,3,6;
S. Archer7; C. Phillips1,8; D.-J. Dijk7; M. Georges4;
P. Maquet1,2,6; G. Vandewalle1,2
1GIGA‐Cyclotron Research Centre‐In Vivo Imaging, University of Liege,
2Walloon Excellence in Life Sciences and Biotechnology (WELBIO),
3Psychology and Cognitive Neuroscience Research Unit, 4GIGA‐Medical
Genomics, University of Liege, Liege, Belgium, 5PHYSIP SA, Paris, France,
6Department of Neurology, University Hospital of Liège, Liege, Belgium,
7Surrey Sleep Research Centre, University of Surrey, Guildford, United
Kingdom, 8GIGA‐In Silico Medicine, University of Liege, Liege, Belgium
Objectives/Introduction: Human sleep is highly dependent on
subcortical areas. How difference in the structural characteristics of
these areas affect sleep is not established. These types of issues are
difficult to address with standard neuroimaging neuroimaging tech-
niques. Here, we employed a tool that allows to predict brain vol-
umes of different brain subcortical regions based on full genome
genetic variations and we assessed the associations between these
predicted brain regional volumes and sleep architecture in young
individuals.
Methods: Electroencephalography of 200 healthy young male vol-
unteers (aged 18–31 years, mean = 22.07 ± 2.71) was recorded dur-
ing an 8 hr baseline sleep. Sleep architecture was extracted from
automatic sleep scoring (Aseega, Physip). Blood sample were col-
lected in all participants to assess common Single Nucleotides Poly-
morphisms (SNPs) over the entire genome. ENIGMA's genome‐wide
association meta‐analyses (http://enigma.ini.usc.edu/research/down
load-enigma-gwas-results/) was employed to predict the intracranial
volumes and volume of 7 different subcortical brain regions.
Results: Linear correlations reveal significant associations between
sleep metrics and 2 predicted feature of brain volume. Predicted
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intracranial volume was significantly linked to the sleep efficiency
(r = −0.16, p = 0.027) and the percentage of REM sleep (r = −0.15,
p = 0.035). Furthermore, the predicted volume of the nucleus
accumbens was significantly associated with the percentage of the
N2 sleep (r = −0.18, p = 0.014) and the percentage of the REM
sleep (r = 0.14, p = 0.044).
Conclusions: Our preliminary results show that one can predict
unassessed brain volume feature and relate then to measure sleep
phenotypes. They suggest that predictions of entire brain volume
and nucleus accumbens volume are linked to sleep architecture.
Disclosure: FNRS, ULiège, ARC, FEDER, Welbio, FMRE, Clerdent
Foundation.
P601 | IL‐1β, IL‐6 and TNF‐α, induced by
upper airway resistive breathing, downregulates
respiratory controller response to hypercapnic
stimuli
F. Perlikos1; I. Koutsourelakis2; A. Papalois3; A. Sotiriou4;
C.E. Giannakopoulou5; M. Dettoraki6; T. Vassilakopoulos1
1Pulmonary Medicine Department, Laiko General Hospital, 2Sleep
Medicine Unit, Evangelismos General Hospital, 3Elpen Experimantal
Surgery Unit, 4Critical Care Department, Evangelismos General Hospital,
5Pulmonary Medicine Department, Sotiria General Hospital, 6Elpis
General Hospital, Athens, Greece
Objectives/Introduction: Upper airway resistive breathing
remains a hallmark of Obstructive Sleep Apnea Syndrome. Upper air-
way resistive breathing induces IL‐1β, IL‐6 and TNF‐α in the dia-
phragm, the lung and plasma. Our aim is to investigate the role of
these cytokines, induced by resistive breathing, on the respiratory
controller output.
Methods: 8 IL‐1β deficient mice (IL‐1β−/−), 8 IL‐6 deficient mice
(IL‐6−/−), deficient mice (TNF‐α−/−) where used, together with 8
appropriate wild type (WT) controls (C57/BL6), all males 8 to
10 weeks old. All mice were subjected to whole body plethysmogra-
phy (WBP) to assess ventilatory responses during exposure to the
following mixtures: 21% O2–79% N2, 100% O2, 7% CO2–93% O2,
7% CO2–21% O2–72% N2, 7% CO2–10% O2–83% N2, 3% CO2–10%
O2–87% N2 και 10% O2–90% N2. After all mice underwent tracheal
banding (TB), a procedure to reduce their trachea surface by 50%
and thus to induce upper airway resistive breathing. A final WBP fol-
lowed after 24 hr.
Results: The WT control mice that underwent TB presented lower
Minute Ventilation responses by 71.8% and 73.2% at gas mixtures
7% CO2–10% O2–83% N2 and 3% CO2–10% O2–87% N2 respec-
tively. The TNF‐α-/- mice presented lower Minute Ventilation (MV)
responses by 50.6% and 45.5% for the same gas mixtures (p = 0.043
and p = 0.044 respectevly, compared to WT controls). The IL‐6−/−
mice presented lower MV responses by 40.6% and 25.2% for the
same gas mixtures (p > 0.008 and p > 0.001 respectevly, compared
to WT controls). The IL‐1β−/− mice presented lower MV responses
by 46.8% and 46.9% for the same gas mixtures (p = 0.022 and
p = 0.022 respectevly, compared to WT controls).
Conclusions: IL‐1β, IL‐6, TNF‐a induced by upper airway resistive
breathing, due to tracheal banding, downregulate the Minute Venti-
lation respiratory controller response for hypercapnic stimuli.
Disclosure: Nothing to disclose.
P602 | Carotid Body Deafferentiation in mice
with upper airway resistive breathing
downregulates respiratory controller response to
hypoxic stimuli
F. Perlikos1; I. Koutsourelakis2; K. Loverdos3; M. Dettoraki4;
A. Sotiriou5; C.E. Giannakopoulou3; T. Vassilakopoulos6
1Laiko General Hospital, 2Sleep Medicine Unit, Evangelismos General
Hospital, 3Pulmonary Medicine Department, Sotiria General Hospital,
4Elpis General Hospital, 5Critical Care Department, Evangelismos General
Hospital, 6Pulmonary Medicine Department, Laiko General Hospital,
Athens, Greece
Objectives/Introduction: The carotid body, a well‐recognized
peripheral chemoreceptor, is one of the three main afferent neural
pathways which contribute to the control of breathing (together
with the phrenic nerve and the vagus nerve). Our aim is to investi-
gate the role of resistive breathing, on the respiratory controller out-
put, via the carotid body.
Methods: 16 appropriate wild type mice (WT, C57/BL6), all males
8 to 10 weeks old, divided in two groups each (n = 8). All mice were
subjected to whole body plethysmography (WBP) to assess ventila-
tory responses during exposure to the following mixtures: 21% O2–
79% N2, 100% O2, 7% CO2–21% O2–72% N2, 7% CO2–10% O2–
83% N2 and 10% O2–90% N2. After 24 hr each of the two groups
underwent one of two following operations: Carotid Body Deaffer-
entiation (CBD, bilateral dissection of the carotid sinus nerve) or a
sham operation. After 48 hr all mice underwent tracheal banding, a
procedure to reduce their trachea surface by 50% and thus induce
resistive breathing. A final WBP followed after 24 hr.
Results: WT mice that underwent the sham operation exhibit sta-
tistical significantly higher minute ventilation (MV) responses (pre-
sented as % change compared to the MV response to the to 21%
O2–79% N2 roomair gas mixture) for the 7% CO2–10% O2–83% N2
and 10%O2–90% N2 gas mixtures, compared to the WT mice that
underwent CBD (p = 0.007 and p = 0.008 respectively). Gas mix-
tures 100% O2 and 7% CO2–21% O2–72% N2 didn't show statisti-
cal significant differences between MV responses of the group that
underwent CBD compared to the sham operation (p = 0.56 and
p = 0.36 respectively).
Conclusions: Resistive breathing, due to tracheal banding, down-
regulates the respiratory controller MV response for hypoxic stimuli,
via the carotid body.
Disclosure: Nothing to disclose.
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P603 | Diurnal changes in Glutamate levels
from childhood to adulthood assessed by
Magnetic Resonance Spectroscopy
C. Volk1; V. Jaramillo1; R. Merki1; M. Furrer1; R. O'Gorman1;
R. Huber1,2
1University Children's Hospital Zurich, 2Psychiatric Hospital University of
Zurich, Zurich, Switzerland
Objectives/Introduction: In healthy young adults, we recently
demonstrated that 1H‐MR spectroscopy is a sensitive tool to mea-
sure diurnal changes in Glutamate + Glutamine (GLX) levels. More
specifically, GLX showed a decrease from evening to morning and
this decrease was correlated with the decrease in EEG slow wave
activity (SWA), suggesting a relationship between GLX and the
recovery function of sleep. Because sleep undergoes maturational
changes during development, we examined the changes in GLX in
children and adolescents.
Methods: In an ongoing study, MR spectra of 14 healthy children/
adolescents (4 female, 12.4 ± 1.7 years) were measured in the left
parietal lobe in the evening around two hours before a night of sleep
and in the subsequent morning around two hours after lights on
using a 3 T MRI scanner. GLX concentrations were quantified as
ratios to Creatine with LC Model and compared to GLX levels of 16
healthy adults (6 female, 21.3 ± 2.2 years) who were measured using
the same protocol.
Results: Our preliminary analyses show that compared to adults,
children did not show a significant change in GLX levels from eve-
ning to morning (p = 0.3). Pooling all data (n = 30), we found a posi-
tive association between age and the diurnal changes in GLX
(p = 0.001, r = 0.56). Between group analysis revealed that evening
GLX levels did not differ (p = 0.1), but morning levels differed signifi-
cantly (p = 0.003).
Conclusions: These preliminary results indicate that an overnight
reduction in GLX might be age dependent and may suggest that
there is a developmental change in the regulation of GLX during
sleep.
Disclosure: Nothing to disclose.
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P604 | Heart rate variability and its circadian
variation in patients with disorders of
consciousness: a diagnostic tool?
M. Angerer1; C. Blume1,2; M. Raml1; M. Wislowska1,2;
A. Kunz3; E. Trinka3; G. Pichler4; M. Schabus1,2
1Lab for Sleep, Cognition and Consciousness Research; Department of
Psychology; University of Salzburg, 2Centre for Cognitive Neuroscience
Salzburg (CCNS), 3Christian‐Doppler‐Hospital; University Hospital of
Paracelsus Medical Private University, Salzburg, 4Geriatric Health
Centres of the City of Graz; Albert Schweitzer Clinic; Apallic Care Unit,
Graz, Austria
Objectives/Introduction: Current research suggests that the
integrity of circadian temperature or activity rhythms is related to
consciousness levels in patients with disorders of consciousness
(DOC). Until now however, little attention has been paid to circadian
variations of cardiac activity in DOC patients. In healthy individuals,
heart rate variability (HRV) changes across the sleep‐wake cycle and
has been suggested to reflect the ability of individuals to react ade-
quately to changes in the environment. We thus investigated day‐to‐
night variations in HRV and how they relate to the diagnosis of
DOC patients as assessed with the Coma Recovery Scale‐Revised
(CRS‐R).
Methods: Long‐term (24–48 hr) polysomnography including 3‐lead
electrocardiography was recorded in 11 DOC patients (6 in vegeta-
tive state/unresponsive wakefulness syndrome [VS/UWS], 5 in a min-
imally conscious state [MCS]) and in 3 healthy controls. Light levels
in the patient rooms were <500 lux during day (7 am–9 pm) and
<10 lux during night (9 pm–7 am). We computed non‐parametric
rank‐based tests to identify group differences (VS/UWS, MCS, con-
trols) in HRV as well as correlations between CRS‐R scores and HRV
parameters. Results with p < 0.05 were considered significant,
p < 0.1 denoted a trend.
Results: Results indicate that the interbeat variability during day
differentiated between diagnoses (i.e. VS/UWS, MCS, controls)
(p = 0.016). Specifically, VS/UWS patients had a significantly lower
interbeat variability than MCS patients (p = 0.035) and controls
(p = 0.035). MCS patients showed by trend a lower interbeat vari-
ability than controls (p = 0.090). Moreover, higher CRS‐R arousal
scores were associated with higher sympathetic activity during the
day as measured by very low frequency power (VLF, 0.003–0.04 Hz;
p = 0.026). Interestingly, MCS but not VS/UWS patients presented
by trend an increase in parasympathetic activity during the night as
measured by high frequency power (HF, 0.15–0.4 Hz; p = 0.068).
Conclusions: The results suggest that patients with higher con-
sciousness levels generally have a higher HRV and more pronounced
circadian differences. They thus seem to be able to better adapt to
environmental changes and their autonomic nervous system appears
to follow the circadian cycle more adequately.
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Our findings render HRV parameters an interesting tool to learn
more about the state of severely brain‐injured patients.
Funding: FWF Y‐777.
Disclosure: Nothing to disclose.
P605 | Sleep, chronotype and social jet lag in a
sample of Portuguese college students
M. Gonçalves1; A. Pinheiro2; M. Oliveira1; D. Vieira3;
D.J. Skene4
1Centro de Medicina do Sono, Hospital CUF Porto, Porto, 2Faculdade de
Psicologia, Universidade de Lisboa, Lisboa, 3CEOS.PP, ISCAP, Politécnico
do Porto, Porto, Portugal, 4Chronobiology, University of Surrey, UK,
Surrey, United Kingdom
Objectives/Introduction: Sleep plays a critical role in health and
psychosocial functioning. A decrease in sleep quality and quantity
has been associated with worse health outcomes. The current study
probed the relationship between sleep, chronotype and health status
in a Portuguese sample of college students.
Methods: 396 young adults (24.65 ± 5.67 years (mean ± SD), age
range 18–35 years; 57.6% females) completed an online question-
naire including sociodemographics(age, body mass index (BMI)),
behavioral characteristics (use of caffeine, alcohol, cigarettes), and
questionnaires/scales to assess chronotype and sleep quality: the
Morningness and Eveningness Questionnaire (MEQ), the Munich
ChronoType Questionnaire (MCTQ), the Pittsburgh Sleep Quality
Index (PSQI) and the Epworth Sleepiness Scale (ESS). Means and
standard deviations were calculated for continuous variables, fre-
quencies and percentages were calculated for categorical variables.
Bivariate correlations between the independent variables (e.g., social
jet lag ‐ the difference in the midpoint of sleep between work days
and free days) and dependent variables of interest (e.g., BMI) were
examined
Results: Sleep duration was 7:55 ± 1:26 hr:min and 8:53 ± 1:39 hr:
min during work days and free days, respectively, with 11.4% of par-
ticipants sleeping 6 hr or less on work days. MEQ‐based chronotype
distribution was 2.8% for extreme eveningness, 23% for moderate
eveningness, 63.1% for intermediate, 5.8% for moderate morning-
ness, and 5.3% for extreme morningness. The averaged daytime
sleepiness was 7.87 (±4.57) (34.3% of participants with excessive
daytime sleepiness, i.e. ESS³10), mean social jet lag was
1.04 ± 1.13 hr:min. BMI was negatively associated with sleep dura-
tion (r = −0.112, p = 0.026). Cigarettes consumed was negatively
associated with sleep duration (r = −0.301, p = 0.032) and with day-
time sleepiness (r = 0.310, p = 0.027). Caffeine intake was negatively
associated with sleep duration (r = −0.151, p = 0.010) and positively
associated with BMI (r = 0.188, p = 0.001). Eveningness was posi-
tively associated with caffeine intake (r = 0.123, p = 0.042). Further-
more, social jet lag was positively associated with daytime sleepiness
(ESS; r = 0.14, p = 0.005) and with evenigness scores (MEQ;
r = 0.125, p = 0.016).
Conclusions: These findings confirm the impact of sleep duration
and quality on behavioral measures associated with health and qual-
ity of life in college students. Future studies should test the impact
of sleep duration and quality in academic achievement and psy-
chosocial adjustment in this population.
Disclosure: Nothing to disclose.
P606 | Daytime sleepiness, salivary cortisol
and melatonin levels during 4‐week blue light
blockade. Do we adapt?
H. Oginska1; A. Domagalik2; M. Pokrywka3; T. Marek1
1Institute of Applied Psychology | Department of Cognitive Neuroscience,
Jagiellonian University, 2Neurobiology Department, Jagiellonian
University/Malopolska Centre of Biotechnology, 3Clinical Biochemistry,
Jagiellonian University, Krakow, Poland
Objectives/Introduction: Blue light (BL, short wavelength, ca.
480 nm) is known to influence circadian rhythm system, alertness,
cognitive and affective functioning of humans. In this experiment we
limited the BL exposure to approximately 10%, by providing the par-
ticipants with amber contact lenses ‐ to be used continuously during
4 weeks. It may be hypothesised that reduced BL stimulation would
result in lowered general alertness and weaker suppression of mela-
tonin (its higher levels) and its earlier onset time.
Methods: The participants were 19 healthy volunteers (11 women),
aged 23.58 ± 2.76 years; extreme chronotypes excluded. Their
declared sleep was longer than 6.5 hr and PSQI (Pittsburgh Sleep
Quality Index) lower than 5 pts. (mean 3.00 ± 1.16). Here we report
observations of their daytime sleepiness assessments (Epworth Sleepi-
ness Scale) as well as salivary cortisol and melatonin levels. Addition-
ally, actigraphy recordings (MotionWatch8) were analysed.
Results: There were no differences in dim light melatonin onset,
but a slight increase in the mean evening level of saliva melatonin
appeared after 4 weeks of BL blockade: from 13.76 to 15.80 pg/ml
(t = 2.023, p = 0.059). Cortisol pattern (mean morning level, CAR,
evening level) did not show any alterations. Total ESS score did not
differ significantly between baseline and BL blockade conditions
(although item 1 of ESS, i.e. chance of dozing while “sitting and
reading” exhibited significant increase during BL blockade; p < 0.03).
No difference was observed in timing and length of sleep (7 hr
27 min vs. 7 hr 21 min).
Conclusions: There are two possible interpretations of our results:
‐ people adapt quickly to lowered levels of BL and even low expo-
sure (10% of the regular level) to BL may regulate circadian rhyth-
micity of sleep and hormones’ secretion; ‐ the impact of social
zeitgebers is so strong (in everyday life) that sleep‐wake timing stays
constant and this regulates an overall rhythm. Those results relate
only to alertness indices; cognitive and affective aspects of human
functioning in BL blockade require further exploration.
Disclosure: Nothing to disclose.
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P607 | Two dimensions of chronotype ‐ some
personality, mood, and behavioural correlates of
subjective circadian phase and amplitude
H. Ogińska1
1Institute of Applied Psychology | Department of Cognitive Neuroscience,
Jagiellonian University, Kraków, Poland
Objectives/Introduction: Chronotypes is usually defined with
preferred sleep timing and ‘feeling best time’, i.e. morning‐evening
orientation, or ‘subjective phase’. Chronotype Questionnaire pro-
poses to supplement the picture with self‐assessment of circadian
amplitude. This scale relates to stability of sleep‐wake pattern, ability
to overcome drowsiness or to take a nap at a given moment of the
day, diurnal variability of mood, sensitivity to external synchronisers
(zeitgebers), and time awareness. Eveningness has been identified as
a risk factor for some problematic behaviours and vulnerability to
various psychopathologies (like seasonal, unipolar and bipolar affec-
tive disorders). Does the distinctness of the rhythm also play role?
Methods: Here we set up together three independent studies
which linked morningness‐eveningness and amplitude dimensions
with personality, affective and behavioural issues, analysed in various
age‐social groups. The methods included Positive and Negative
Affect Schedule, Ten Item Personality Inventory, General Procrasti-
nation Scale, Coping Inventory for Stressful Situations.
Results: Study I: 334 graduates and undergraduates, aged 21–
30 years (mean 24.86, SD 2.56). Larger subjective amplitude was
associated with lower positive affectivity and higher negative affec-
tivity (PANAS); the correlations were much stronger (p < 0.001) than
those of eveningness and affectivity (p < 0.06). Study II: 179 corpo-
rate workers (118 females; mean age 25.66, SD 6.61). Both evening-
ness and large amplitude correlated significantly (p < 0.03) with
procrastination (GPS), emotional instability and low consciousness
(TIPI). Study III: 143 young adults (119 females; mean age 23.15, SD
3.69); analysis of strategies of coping with stress (CISS). Subjective
amplitude correlated negatively with strategy focused on problem
solving, and positively with emotion regulation and avoidance strat-
egy (p < 0.04).
Conclusions: It seems that subjective amplitude is a valuable sup-
plementation of chronotype description, as its scores correlate signif-
icantly with personality factors, mood, and behavioural tendencies
(procrastination, coping). The links are at least as strong as those,
widely described in the literature, consequences of morningness‐
eveningness.
Disclosure: Nothing to disclose.
P608 | Human iPSC‐derived fibroblasts as a
model to investigate genetic and epigenetic
contributions to regulation of circadian rhythms
N.-H. Du1; S. Cowley2; Z. Cader3; S. Brown1
1Institute of Pharmacology and Toxicology, University of Zurich, Zurich,
Switzerland, 2Sir William Dunn School of Pathology, 3Nuffield
Department of Clinical Neurosciences, University of Oxford, Oxford,
United Kingdom
Objectives/Introduction: Circadian rhythms are expressed at dif-
ferent levels, from behavioural to cellular rhythms. Across tissues,
these rhythms are related. For example, cellular rhythms measured in
human primary skin fibroblasts correlate with human behavioral
chrononotype: people whose cellular oscillations have longer period
length have significantly later chronotypes. In healthy subjects,
genetic variations partially explain these differences in the speed of
cellular oscillations. However, in animal models environmentally dri-
ven epigenetic modifications also play a strong role, and it is reason-
able to assume that the same might be true in humans. A growing
body of evidence shows that circadian dysfunctions are related to
many diseases, from diabetes to neurodegenerative disorders. We
hypothesize that disease‐related epigenetic modifications have
important influence upon circadian rhythms. The aim of this study is
to assess the contribution of genetic vs. epigenetic variations to
clock function in human cells.
Methods: Induced pluripotent stem cells (iPSCs) provide a unique
system to distinguish genetic vs. epigenetic effects, since epigenetic
changes (as well as clock function) are erased in iPSCs. By comparing
clock properties between fully genotyped skin fibroblasts and iPSC‐
derived fibroblasts from the same subject, we were therefore able to
quantify genetic and epigenetic influence upon circadian rhythms.
Cellular oscillations re measured by transducing the cells with len-
tivirus carrying a circadian reporter.
Results: In collaboration with the StemBANCC consortium, we first
characterised rhythms in primary skin fibroblasts collected from dif-
ferent patients: diabetes (71 patients), Alzheimer′s disease (22),
Parkinson disease (147), bipolar disorder (39), neuropathy (44), and
control (33). We found that especially in the neuropathy group,
many lines of primary skin fibroblasts had very low amplitude
rhythms and in some cases even lost the rhythms. Rhythms were
then compared with those of iPSC‐derived fibroblasts from the same
subjects, and significant variance was detected in the circadian prop-
erties of primary and iPSC‐derived fibroblasts. High‐throughput char-
acterization of genetic and epigenetic differences correlated across
cell lines from different individuals will be used to identify possible
sources of this variance.
Conclusions: Our results suggest that cellular circadian oscillations
are affected by disease state. iPSC‐derived fibroblasts point to both
cell‐intrinsic (i.e. genetic) and acquired (i.e. epigenetic) characteristics
explaining these differences.
Disclosure: Nothing to disclose.
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P609 | Validation of the French version of
Children's Chronotype Questionnaire in school‐
aged children: a study in Luxembourgish
population
S. Figueiredo; A. Gomes; C. Rocha; J. Hipólito; O. Nunes
Department of Psychology, Universidade Autónoma de Lisboa, Lisbon,
Portugal
Objectives/Introduction: Human behaviour diferences are deter-
mined by factors such as the circadian phase preference. Adults have
been well examined concerning performance variation during the
work schedules depending on chronotype. However there is a seri-
ous gap on research of children respecting the evaluation and under-
standing of their sleep patterns, specifically referring the chronotype
variability. The main goal was to validate the Children's Chronotype
Questionnaire (CCTQ, Werner, LeBourgeois, Geiger et al., 2009) for
French language and to identify chronotype and specific sleep habits
differences of young children of Luxembourgish schools, according
to age and different school schedules.
Methods: After completing the procedure for the adapation of the
CCTQ to the French Language, the instrument was administrated,
during a 2 month‐period, to the parents of 173 children, aged
between four and 11 years old, in Luxembourg. The CCTQ measures
the sleep and wake behaviours in three specific levels/scales with a
total of 27 items: midsleep phase (duration of sleep time) for free
days and school days (1), morningness and eveningness (M/E) (2),
and chronotype (3).
Results: The CCTQ presented good internal consistency (α 0.70)
but lower compared to the original version (0.81). Correlation coeffi-
cients were positively high (r = 0.91). Children showed different
punctuations considering the M/E (58 morning type, 66 evening
type, the other subjects were identified as intermediate type) being
that the morning type demonstrated lower midsleep phase (a differ-
ence of 23 min) with statistical significance compared to the evening
type subjects (n = 173, p = 0.017, η2 0.06). Their sleep habits signifi-
cantly differ (p < 0.05) regarding awake and sleep behaviors and
schedule preferences considering age (p = 0.000, η2 0.83) ‐ mostly
between four and 10 yr old ‐ and considering school timetables
(p = 0.009, η2 0.136) ‐ mostly between children attending to the full
day school timetable (that includes classes during both morning and
afternoon, differently from the other two timetables: only morning
or only afternoon).
Conclusions: This study presents the first validated French version
of the CCTQ and highlights that chronotype of children should be
strongly considered by valid measures such as the CCTQ to under-
stand how to implement more adequate timetables for testing in
specific academic areas.
Disclosure: Nothing to disclose.
P610 | Not all circadian disruption protocols
are created equal
A. Fisk; L. Brown; S. Peirson; V. Vyazovskiy; Vyazovskiy
University of Oxford, Oxford, United Kingdom
Objectives/Introduction: Light is the primary entraining cue for
the circadian system, adjusting biological time to the external envi-
ronment, however it also has direct effects on arousal and sleep.
The demands of our modern 24/7 society, with increasing exposure
to artificial light at inappropriate times of day, is widely considered
to be detrimental to our physiology. Evidence comes from studies
using aberrant light/dark (LD) cycles to produce circadian disruption
in mouse models. A range of different protocols have been used,
including constant light (LL), jet‐lag (JL), dim light at night (DLAN),
and non‐24 hr LD cycles (T‐cycles). To date, no detailed comparison
of the effects of these different protocols has been conducted.
Methods: We used passive infra‐red (PIR) sensors to simultane-
ously measure activity and immobility‐defined sleep in wild‐type
C57BL/6J mice under different protocols, including LL, JL, DLAN and
T20 (10 hr light: 10 hr dark). We compared the effects of these dif-
ferent protocols on commonly used measures of circadian disruption
including periodogram power (Qp), intradaily variability (IV) and inter-
daily stability (IS), as well on the architecture of immobility‐defined
sleep.
Results: Different LD conditions produced different effects on cir-
cadian activity. Whilst IV is increased and IS were decreased under
all conditions (n = 24, IV ANOVA F(1,20) = 28.8 p < 0.0001, IS
ANOVA F(1,20) = 295.6, p < 0.0001) decreases in Qp were only
observed under LL and T20 (LL p < 0.0001, T20 p = 0.0053). All
conditions change the distribution of immobility‐defined sleep.
Moreover, the effects of some protocols persisted after animals
were returned to normal LD conditions.
Conclusions: Our data suggests that commonly used protocols
exert different effects on sleep and circadian rhythms. These data
provide a framework to understand the effects of these protocols on
other biological processes such as cognition.
Disclosure: Nothing to disclose.
P611 | Chronotypes differ influence in the
weekday/weekend variability of pain in patients
with fibromyalgia
S.-C. Fang1; Y.-L. Wu2; P.-S. Tsai2
1School of Nursing, College of Nursing, 2Nursing, Taipei Medical
University, Taipei, Taiwan
Objectives/Introduction: Chronotypes have been associated with
pain. Pain is dynamic and change day to day by individual difference.
However, little is known about the pain lever between weekday/
weekend in patients with fibromyalgia among difference chronotype.
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Therefore, the aim of this study was to investigate the relative con-
tributions of chronotypes and weekday‐to‐weekend differences to
the variability of pain in patients with fibromyalgia.
Methods: We constructed a cross‐sectional study and recurred
patients with fibromyalgia according to the 2010 American College
of Rheumatology criteria and Polysymptomatic Distress Scale (PDS)
score ≥13. Participants’ will be excluded if they have any of the fol-
lowing: (1) age ≤18 years old; (2) shift work; Pain was assessed by
the Visual Analogue Scale (VAS) and participants recorded pain
scores seven consecutive days at same time (before sleep). Week-
days were defined from Sunday to Thursday and weekends was
from Friday to Saturday. Participants’ chronotypes were determined
using the Morningness/Eveningness Questionnaire (MEQ). Demo-
graphic data and health‐related factors were also assessed as poten-
tial confounding factors. A generalized estimating equations (GEE)
will be used to test the whether MEQ score had a significant effect
on the pain between weekdays and weekends.
Results: Among 80 patients with fibromyalgia included in the
study, 11 (13.75%) were classified into a morning type (M‐type)
group, 25 (31.25%) were classified into a nither type (N‐type) group,
and 44 (55%) were classified into an evening type (E‐type) group.
The median age M‐type group higher than E‐type. The sex, employ-
ment status, FIQR, CPSQI, exercise habits, and analgesics use were
not sing significantly difference among in those chronotypes groups.
The mean of pain score were 4.9, 5.0, and 5.6 in M‐type, N‐type,
and E‐type groups, respectively, on weekdays, and the mean of pain
score were 4.6, 5.3, and 5.7 in M‐type, N‐type, and E‐type groups,
respectively, on weekends. The interaction effect between difference
chronotypes and weekdays/weekends for pain was significantly dif-
ference β = 0.52; SE = 0.26 (p = 0.04) after adjusting for age and
employment status.
Conclusions: Chronotype could be influence variability of pain in
patients with fibromyalgia, regardless of weekday/weekend.
Disclosure: Nothing to disclose.
P612 | Chronotypes differ influence in the
weekday/weekend variability of pain in patients
with fibromyalgia
S.-C. Fang; Y.-L. Wu; P.-S. Tsai
Nursing, Taipei Medical University, Taipei, Taiwan
Objectives/Introduction: Chronotypes have been associated with
pain. Pain is dynamic and change day to day by individual difference.
However, little is known about the pain lever between weekday/
weekend in patients with fibromyalgia among difference chronotype.
Therefore, the aim of this study was to investigate the relative con-
tributions of chronotypes and weekday‐to‐weekend differences to
the variability of pain in patients with fibromyalgia.
Methods: We constructed a cross‐sectional study and recurred
patients with fibromyalgia according to the 2010 American College
of Rheumatology criteria and Polysymptomatic Distress Scale (PDS)
score ≥13. Participants’ will be excluded if they have any of the fol-
lowing: (1) age ≤18 years old; (2) shift work; Pain was assessed by
the Visual Analogue Scale (VAS) and participants recorded pain
scores seven consecutive days at same time (before sleep). Week-
days were defined from Sunday to Thursday and weekends was
from Friday to Saturday. Participants’ chronotypes were determined
using the Morningness/Eveningness Questionnaire (MEQ). Demo-
graphic data and health‐related factors were also assessed as poten-
tial confounding factors. A generalized estimating equations (GEE)
will be used to test the whether MEQ score had a significant effect
on the pain between weekdays and weekends.
Results: Among 80 patients with fibromyalgia included in the
study, 11 (13.75%) were classified into a morning type (M‐type)
group, 25 (31.25%) were classified into a nither type (N‐type) group,
and 44 (55%) were classified into an evening type (E‐type) group.
The median age M‐type group higher than E‐type. The sex, employ-
ment status, FIQR, CPSQI, exercise habits, and analgesics use were
not sing significantly difference among in those chronotypes groups.
The mean of pain score were 4.9, 5.0, and 5.6 in M‐type, N‐type,
and E‐type groups, respectively, on weekdays, and the mean of pain
score were 4.6, 5.3, and 5.7 in M‐type, N‐type, and E‐type groups,
respectively, on weekends. The interaction effect between difference
chronotypes and weekdays/weekends for pain was significantly dif-
ference β = 0.52; SE = 0.26 (p = 0.04) after adjusting for age and
employment status.
Conclusions: Chronotype could be influence variability of pain in
patients with fibromyalgia, regardless of weekday/weekend.
Disclosure: Nothing to disclose.
P614 | Investigation of sleep structure with
polysomnograhy in the patients with first
episode psychosis
E. Kizilay1; S. Yetkin2
1Psychiatrie, 2Gulhane Medicine Faculty, Ankara, Turkey
Objectives/Introduction: Sleep researches allow the structure of
sleep to be analyzed at macro and micro levels of sleep changes.
These researches reveal a different perspective on the understanding
of the pathophysiology of schizophrenia. Sleep disturbance in schizo-
phrenic individuals is common among healthy individuals. These dis-
turbances usually occur before the symptoms of the disease and are
considered as an important risk factor. In this study, sleep architec-
ture of drug‐naive non‐affective first episode psychosis patients and
healthy controls was investigated, and the relationship between the
sleep structure and clinical features of the patients during the active
psychotic period and after the active psychotic period was investi-
gated.
Methods: Twenty‐one non‐affective drug‐naive first‐episode psy-
chotic patients and 11 of these patients that had been followed for
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at least 6 months (with one psychotic episode) and 18 healthy vol-
unteers matched for age and education. Two consecutive night
polysomnography studies were conducted in all sample. Positive and
Negative Syndrome Scale (PANSS) was administered during the
onset of the psychotic episode and ongoing. Sleep consistency and
sleep structure variables were compared between patients and
healthy groups. Correlation analyzes were performed between
patients′ sleep continuity and changes in sleep structure and their
clinical characteristics.
Results: Compared to healthy controls, there was an increase in
sleep latency (p < 0.022) and a decrease in sleep efficacy
(p < 0.004) in patients with non‐affective first‐episode psychosis.
Patients showed a significant decrease in slow wave sleep
(p < 0.001). 6th month follow‐up of the patients after active psy-
chotic episodes, the variables related to sleep continuity and sleep
structure were not different from healthy controls. There was a posi-
tive correlation between PANSS positive subscale scores and sleep
latency in first‐episode psychosis patients, and a negative correlation
between PANSS negative subscale scores and slow‐wave sleep.
Conclusions: The findings indicate that the decrease in slow‐wave
sleep in patients with non‐affective drug‐naive first‐episode psy-
chotic patients is significant. The fact that reduced slow wave sleep
is associated with negative symptoms in first‐episode psychosis
patients and that sleep structure returns to normal after a psychotic
episode suggests that it may be related to underlying physiopathol-
ogy of the disease.
Disclosure: Nothing to disclose.
P615 | Phase advance jet lag disorder: results
of the JET study
C.M. Polymeropoulos; E.L. Czeisler; M.A. Fisher;
M.H. Polymeropoulos
Vanda Pharmaceuticals Inc., Washington, DC, United States
Objectives/Introduction: The JET study measured the effects of
a 5‐hr and 8‐hr phase advance on nighttime sleep as a model of Jet
Lag. Jet Lag Disorder occurs when an individual's circadian rhythms
become misaligned due to rapid change in time zone that occurs
after rapid transmeridian travel. By simulating such a time zone
change in a lab setting, the effects of phase shifting can be studied
in the absence of confounders that occur during travel including
variable sleep deprivation and light exposure.
Methods: This study investigated multiple interval phase advances
in 319 patients (Intervals: 5‐hr: n = 86; 8‐hr: n = 233). The phase
advance was determined by the patient's usual bedtime and then
put to bed either 5 or 8 hr ahead of that bedtime. Sleep was mea-
sured by polysomnography (PSG).
Results: A significant difference was demonstrated between the
5 and 8‐hr phase advance in SE during each of the three thirds
of the night: first third of the night SE (5‐hr: 45.5%; 8‐hr: 54.1%,
p = 0.02), second third of the night SE (5‐hr: 53.4%; 8‐hr: 24.8%;
p < 0.0001), and third of the night SE (5‐hr: 76.8%; 8‐hr: 33.3%;
p < 0.0001).
Conclusions: This study demonstrates that in‐lab phase advance
can be used to study 5‐ to 8‐hr phase advance Jet Lag as the model
was able to show significant differences in PSG‐measured sleep effi-
ciency between a 5‐hr phase advance and an 8‐hr phase advance
during each third of the night. These results also support this study
design as a model to be used in developing therapeutics for the
treatment of phase advance disorders including Jet Lag Disorder.
Disclosure: Nothing to disclose.
P616 | A proposal of circadian markers and
indexes for the study of chronodisruption in
sleep and circadian pathologies
B. Rodríguez-Morilla1; E. Estivill2; C. Estivill-Domènech2;
J. Albares3; F. Segarra2; M. Campos1; J.A. Madrid1,4
1Chronolab, University of Murcia, Murcia, 2Clínica del Sueño Dr. Estivill,
3Medicina del Sueño Dr. Albares. Centro Médico Teknon, Barcelona,
4Ciber Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain
Objectives/Introduction: In developed societies, sleep disorders
are frequently due to circadian alterations. In turn, sleep alteration
commonly leads to chronodisruption. Thus, diagnosis and treatment
of circadian and sleep disorders should be jointly addressed. This
work proposes several indexes for quantifying the quality of circa-
dian rhythms in different sleep and circadian disorders and in healthy
subjects.
Methods: The study included 20 healthy control volunteers (C) and
254 patients: Obstructive Sleep Apnoea (OSA), n = 12; Delayed
Sleep Phase Disorder (DSPD), n = 58 and primary insomnia (PI),
n = 184. Their rhythms of wrist temperature (T), motor activity (A),
body position (P) and light exposure (L) were assessed during one
week through Ambulatory Circadian Monitoring (ACM) using a multi-
chanel device (Kronowise®, Chronolab, University of Murcia).
Sleep‐wake states were inferred from the integrated variable TAP,
(obtained from T, A and P) which expresses general activation. TAP
was subsequently analysed by non‐parametric analysis to calculate
indexes of interdaily stability (IS), intradaily variability (IV) and rela-
tive amplitude (RA). From those, a Circadian Function Index (CFI)
was obtained to assess circadian robustness. Midsleep time was esti-
mated from the central time of TAP‐L5 (5 consecutive hours of low-
est values). Environmental synchronization, ES, (synchronization
between TAP‐L5 and the central time of the environmental dark
phase) and internal synchronization among variables (ISync) were
also calculated. All these indexes were subject to one‐way ANOVAs
with between‐groups factor pathology (PI, OSA, DSPD and C).
Results: Significant differences between PI, OSA, DSPD and C
were found in all the indexes (all ps < 0.05). C showed greater CFI
than the other three groups, while DSPD and OSA exhibited lower
ABSTRACTS | 369 of 433
ES than PI and C. DSPD showed the latest TAP‐L5, the lowest
amount of light exposure during the day and the highest during the
night. Finally, the lowest ISync was observed in OSA.
Conclusions: ACM allowed a reliable assessment of circadian dis-
ruption in different sleep and circadian pathologies. Our results
revealed significant chronodisruption in OSA and DSPD, and con-
firmed a relationship between circadian desynchronization and an
abnormal rhythm of light exposure. As a conclusion, these findings
highlight the importance of circadian assessment in sleep medicine.
Disclosure: Nothing to disclose.
P617 | Sleep structure and awakening
threshold in delayed sleep‐wake phase disorder
(DSWPD)
B. Solheim1; K. Langsrud2; H. Kallestad2; B. Bjorvatn3,4;
T. Sand1,5
1INB, NTNU, 2Psychiatry, St.Olavs Hospital, Trondheim, 3Department of
Global Public Health and Primary Care, University of Bergen, 4Norwegian
Competence Center for Sleep Disorders, Haukeland University Hospital,
Bergen, 5Neurology and Clinical Neurophysiology, St.Olavs Hospital,
Trondheim, Norway
Objectives/Introduction: We aimed to quantify the awakening
threshold (AT) in DSWPD‐patients and healthy controls and investi-
gate a possible relationship with sleep stage. A secondary objective
was to study habitual sleep structure by polysomnography (PSG) in
DSWPD.
Methods: Twenty DSWPD patients (mean age 24.8 years) and 16
controls (mean age 24.4 years) had two nights with PSG in a sleep
laboratory. Participants followed their habitual sleep‐wake schedule
on the first night and a forced sleep‐wake schedule (00:00–07:00 hr)
on the second night. A custom‐made alarm clock was used to mea-
sure AT the second morning.
Results: AT was higher in patients than controls; 75.5 dB vs.
72.6 dB, Mann‐Whitney p = 0.01, and the difference could not be
explained by sleep‐time differences (ANCOVA). Patients who were
in REM sleep upon attempted awakening had a higher AT compared
to patients who were in NREM sleep; 80.0 dB vs. 74.7 dB, ANOVA
F = 6.4, p = 0.02. Patients had increased sleep onset latency by PSG
during the first laboratory night (20.6 vs. 12.1 min, p = 0.004), but
no differences were observed for other sleep structure variables.
Conclusions: Difficult early‐morning awakening was related to
REM sleep in DSWPD‐patients, confirming our previously published
results from another patient group. Sleep onset problems, even with
habitual bedtimes, does also seem be a feature of DSWPD.
Disclosure: Nothing to disclose.
P618 | Comparisons of subjective and
actigraphic measurements of sleep between
shift‐working and daytime psychiatric nurses
B.-H. Yoon; J. Kwak; H. Kang
Naju National Hospital, Naju, Republic of Korea
Objectives/Introduction: Shiftwork is known to be one of the
common causes of sleep and health problems and finally causes the
decreased quality of life. The purpose of this study was to investi-
gate the sleep patterns of shift‐working and daytime psychiatric
nurses using actigraphy and compare it with subjective assessment
for sleep.
Methods: Twenty‐three shift‐working and 25 daytime nurses were
enrolled. They rated their sleep quality using Pittsburgh Sleep Qual-
ity Index (PSQI) and other self‐rating scales were measured for psy-
chosocial aspects. Actigraphy was applied to the subjects for a total
of 7 days to measure the sleep parameters. They also wrote sleep
diaries during the period of wearing actigraphy. Sleep‐related param-
eters of actigraphy, global score and components of PSQI, and the
results of other self‐rating scales were compared between shift‐
working and daytime nurses.
Results: Although the global score of PSQI did not show significant
difference, the PSQI components showed significant differences
between two groups: the shift‐working nurses showed lower sleep
quality, more sleep disturbance and hypnotic medication use, and
worsened daytime dysfunction than daytime nurses (p < 0.01,
respectively). The shift‐working nurses showed significantly shorter
total time in bed and total sleep time, lower sleep efficiency, and
longer average awakening time than those of daytime nurses in
actigraphy (p < 0.05, respectively).
Conclusions: The results showed that shift‐working nurses experi-
enced more sleep disturbances in both subjective and objective
aspects of sleep than daytime nurses. This study also suggests that
actigraphy may be useful to measure the objective aspects of sleep
that are difficult to assess with subjective questionnaires alone.
Disclosure: Nothing to disclose.
P619 | A new monitoring tool for detecting
human circadian rhythms: a mathematical
approach using a thoracic temperature sensor
M. Abdallah1,2; A. Chkeir1; M. Nassereddine2; R. Soubra1;
F. Chehade1; J. Duchêne1
1University of Technology of Troyes, Troyes, France, 2Lebanese
University ‐ Faculty of Sciences, Hadath, Lebanon
Objectives/Introduction: The 24‐hr biological rhythms known as
circadian rhythms have been a fast‐growing field of research for dec-
ades. Recently, the study of circadian rhythms has become important
and promising in medical research especially in the field of cancer
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treatment. This is due to the fact that perturbations in circadian
rhythms have been associated with the progression of cancer and
wrongly timed chemotherapy sessions. Nevertheless, the study of
the myriad circadian rhythms can be implicative in many areas of
research in both biology and medicine. Yet many researchers in biol-
ogy and medicine are not experts with the implementation and com-
puterization of these mathematical approaches. In this context, this
study aims at developing graphical user interface software that com-
prises Fourier analysis and Cosinor analysis in a clear and systematic
manner that aids researchers in studying a set of rhythms including
biological rhythms readily with a click of a button.
Methods: We have developed a graphical user interface where it
combines two of the powerful tools in analyzing biological rhythms;
Fourier analysis and Cosinor analysis. This software is intended for
researchers that are acquainted with the concepts of signal process-
ing and mathematical modeling by necessarily experts.
Results: The unprecedented advantage of the developed software
is that it computes and displays the results of the two methods side
by side allowing the user to decide upon which method is optimal
depending on the outcome and error. In this pretext, the monitoring
tool includes the calculation of the root mean square error, in addi-
tion to residual sum of square RSS, between the data and models,
thus giving even more information regarding the comparison
between the two analysis method.
Conclusions: The rhythm parameters estimated by both methods
can provide useful information to researchers in the field of chrono-
biology and other field of research involving data series to be ana-
lyze.
Disclosure: Nothing to disclose.
P620 | A new monitoring tool to detect an
irregular Sleep‐Wake circadian rhythm based on
the automatic dichotomy index computation
R. Soubra1; A. Chkeir1; M. Diab2; M. Abdallah1; J. Duchene1
1Université de Technologie de Troyes, Troyes, France, 2Rafik Hariri
University, Beirut, Lebanon
Objectives/Introduction: The success of chemotherapy treatment
is achieved based on “Chronotherapy”: the concept of administering
the correct drug at the accurate time based on the circadian rhythm
study. The objectives of this study were to detect the rest/activity
cycle and calculate automatically the dichotomy index (I < O), as
both parameters are proved to be reliable indices of the circadian
rhythm.
Methods: To achieve our purposes, this study was performed in
three phases. Firstly, DARC “Détection Automatique du Rythme Cir-
cadien” algorithm was used to segment automatically the rest‐activ-
ity phases. Then, a Graphical User Interface (GUI) was implemented
to provide an automatic I < O calculation across several days of
records and smooth the analysis. Lastly, an experimental study was
conducted based on 9 control subjects in order to validate the auto-
matic method.
Results: The student‐test results and mean squared error measure-
ments show no significant difference between I < O outcomes cal-
culated automatically and manually (p‐value = 0.718, MSE = 0.022).
Additionally, the outcomes of this study minimize patients’ interven-
tion, facilitate user involvement and reduce the required time for
data analysis.
Conclusions: This work affords an easy‐to‐use graphical user inter-
face. It incorporates our listed purposes with several analysis options
that vary according to the user requirements for an enhanced I < O
study such as an improved chronotherapy. Moreover, it provides an
enhanced analysis for several illnesses treated through the circadian
rhythm interpretation and I < O examination such as insomnia, sleep
apnea and others.
Disclosure: Nothing to disclose.
LEARNING, MEMORY AND COGNITION 3
P621 | The relationship of stimulus
emotionality to sleep‐dependent memory
consolidation: Testing contrasting theories using
memory for negative, neutral and positive
emotionally‐toned photographs and stories
A.M. Reid1; M. Carr2; A. Bloxham3; N. Basoudan4;
E. van Rijn5; M. Blagrove2
1Psychology, University of York, York, 2Psychology, Sleep Laboratory,
Swansea University, Swansea, 3Bishop Grosseteste University, Lincoln,
4Psychology, Swansea University, Swansea, United Kingdom, 5Duke‐NUS
Medical School, Singapore, Singapore
Objectives/Introduction: This study compares the sleep‐depen-
dent memory effects for negative, positive, and neutral stimuli using
two tasks, photograph recognition and story recall. The relative ben-
efit of sleep for positive versus negative emotional stimuli was used
to test between theories that predict that emotionally negative stim-
uli are preferentially consolidated during sleep, versus theories that
emotional stimuli in general, whether negative or positive, are priori-
tized over neutral stimuli.
Methods: Participants were randomly allocated to either the sleep
(n = 31; 17 females, 14 males; mean age = 21, SD = 1.77) or wake
conditions (n = 30; 13 females, 17 males; mean age = 21.23, SD =
1.74). 120 images taken from the Nencki Affective Picture System
(NAPS) database were presented, each consisting of photographs
rated as positive (n = 40), neutral (n = 40), or negative (n = 40).
Memory for these was tested by eliciting ′new′ or ′old′ responses
from participants to 60 of the presented photographs and 60
matched photographs that had not been presented. The three stories
were also learned prior to the nap/wake period, all three texts were
closely matched for total number of nouns, verbs and adjectives
ABSTRACTS | 371 of 433
(~62), word count (~162), and number of sentences (n = 11). All par-
ticipants arrived at the sleep laboratory at 10:00 to 10:30. Training
on the two learning tasks was immediately followed by testing (T1).
A two hour nap opportunity, or control wake period, then occurred.
Testing at time point two (T2) commenced at approximately 14:00
to 14:30.
Results: The Sleep condition had better retention of the pho-
tographs than did the Wake condition, F(1,53) = 5.196, p = 0.027,
there was no Emotion x Condition interaction, F(2,106) = 1.028,
p = 0.361, nor a main effect of emotion, F(2,106) = 1.336, p = 0.267.
Story memory was also better retained by the Sleep condition than
by the Wake condition, F(1,54) = 9.796, p = 0.003. Independent t‐
tests revealed that emotional story recall was higher in the Sleep
condition relative to Wake for both negative (t(54) = 2.35,
p = 0.023) and positive texts (t(54) = 3.09, p = 0.003); there was no
difference between conditions on neutral text recall (t(54) = 1.36,
p = 0.180).
Conclusions: The results show that sleep benefits memory consoli-
dation of positive and negative emotional stimuli. For story recall
emotional stimuli were prioritized over neutral stimuli during sleep.
Disclosure: Nothing to disclose.
P622 | The impact of memory strength for
sleep‐dependent memory consolidation
D.P.J. Heib1; K.-H. Bäuml2; M. Schabus1
1Centre for Cognitive Neuroscience, University of Salzburg, Salzburg,
Austria, 2Psychology, University of Regensburg, Regensburg, Germany
Objectives/Introduction: Memory consolidation during sleep is
highly selective in nature. That is, sleep does not equally consoli-
date all memories formed throughout wakefulness, but rather
favours the consolidation of certain memories over others. Besides
other factors, memories’ initial strength has been discussed as
making a difference when it comes to sleep‐dependent consolida-
tion. Problematically, previous studies intermixed different ways to
strengthen memories, namely restudy and retrieval‐practice. These
two processes are, however, non‐equivalent and can induce very
different memorial effects. In this study, we examined whether
sleep‐associated memory consolidation depend on items’ initial
strength, when strength is manipulated solely by varying the num-
ber of study trials.
Methods: 90 healthy subjects (M = 22.9, SD = 2.59 years) partici-
pated in a 3x2 mixed‐factorial design with the between‐subject fac-
tor DELAY (9 hr‐sleep, 9 hr‐wake, short‐delay; n = 30) and the
within‐subject factor memory STRENGTH (weak [S−], high [S+]). All
subjects studied a list of 80 word‐pairs. One half of the word‐pairs
was presented twice (S−), the other half thrice (S+). The 9 hr‐sleep‐
group studied the word‐pairs in the evening and performed a cued‐
recall test on the subsequent morning. The 9 hr‐wake‐group studied
the word‐pairs in the morning and performed the test in the evening
of the same day. Subjects in the short‐delay‐group studied the word‐
pairs either in the morning or in the evening and performed the
memory test after a retention period of 40 min. Test performance
was quantified by recall‐rates and reaction‐times.
Results: Results revealed significant main effects for DELAY and
STRENGTH (p < 0.001). Post‐hoc comparisons indicated poorer
recall‐rates and prolonged reaction‐times for subjects in the 9 hr‐
wake‐group compared to both the 9 hr‐sleep‐group and the short‐
delay‐group (p < 0.001). In contrast, no performance difference was
found between the 9 hr‐sleep‐group and the short‐delay‐group
(p > 0.49). In addition, superior recall‐rates and shortened reaction‐
times were found for S+ compared to S− in all three groups
(p < 0.01). A DELAYxSTRENGTH interaction was only found for the
dependent variable recall‐rate (p < 0.05). This interaction revealed
that, compared to the short‐delay‐group, the 9 hr‐wake‐group
showed slightly pronounced forgetting‐rates for S− compared to S+
(S−: ΔM = −30.44; S+: ΔM = −21.56), which was not present in the
9 hr‐sleep‐group.
Conclusions: Sleep‐associated memory consolidation does not
depend on the amount of item re‐exposure before sleep.
Disclosure: Nothing to disclose.
P623 | Academic performance, sleep duration
and chronotype in Korean adolescents
J.H. Kim1; S.J. Han2; K.I. Yang3; S.B. Hong4
1Department of Neurology, Dankook University College of Medicine,
Dankook University Hospital, Cheonan, 2Department of Neurology,
Wonkwang University College of Medicine, Sanbon Hospital, Sanbon,
3Department of Neurology, Suncheonhyang University College of
Medicine Cheonan Hospital, Cheonan, 4Department of Neurology,
Sungkyunkwan School of Medicine, Samsung Medical center, Seoul,
Republic of Korea
Objectives/Introduction: The aim of this study was to investigate
the relationship between sleep‐related factors and the academic per-
formance in Korean adolescents
Methods: The computer‐assisted online survey was performed in
July 2011. 150 schools were selected nationwide including junior
high and high schools in Korea. Questions included sleep duration
on schooldays and weekend, Beck depression (BDI), Epworth sleepi-
ness scale (ESS) and superscience morningness‐eveningness scale
(MEs). Academic performance was measured by self‐reported grades
at the school (1–5 scale, from top 20%, 20–40%, 40–60%, 60–80%,
80–100%). They also reported their ranks for Korean, Mathematics
and English subjects.
Results: A total of 25,940 students aged 13 to 18 years (male,
51.4%) participated in the survey. Senior high school students had
lower MEs than younger high school students and middle school stu-
dents suggesting older adolescents had more delayed circadian type
24.7 ± 4.4 vs. 27.1 ± 4.3, p < 0.001). The students with better
school grades slept less on school days than those with the lowest
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grades (389.3 ± 74.4 vs. 408.2 ± 90.5, p < 0.001) as well as on
weekends. MEs was higher in the students with better school grades
than those with lower grades (25.8 ± 4.5 vs. 24.8 ± 4.6, p < 0.001).
This pattern was similar in the analysis of their ranks in the class for
each subject (English, math and Korean)
Conclusions: Korean adolescents with better academic perfor-
mance had shorter sleep duration and more morning chronotype
than those with worse performance. Although sleep is known to be
crucial for better cognition, the factors influencing academic perfor-
mance in adolescents seem to require more factors beyond sleep
duration.
Disclosure: Nothing to disclose.
P624 | Are prenatally learned nursery rhymes
recognized at birth? A high‐density EEG study
M. Schabus1; A. Lang1; R. del Giudice1; S. Wegenkittl2;
P. Ott2
1Center for Cognitive Neuroscience & Dept. Psychology, University of
Salzburg, 2Fachhochschule Salzburg ‐ University of Applied Sciences,
Salzburg, Austria
Objectives/Introduction: Research on prenatal learning indicates
that already fetuses are capable of learning and remembering speech
as early as 34 weeks of gestational age with this fetal voice process-
ing being highly influenced by the maternal voice. Exciting new
research has also shown that human speech rhythms are capable of
entraining the amplitude and phase of MEG oscillations in the adult
auditory cortex. To date it is however not clear if the same holds
true for sleeping babies in the first weeks of life and whether prena-
tal exposure to these speech rhythms makes a difference. We there-
fore investigated the role of maternal speech processing in the brain
of 2 to 5 weeks old babys.
Methods: 28 pregnant women participated in our study. All moth-
ers were asked to present a previously recorded (familiar) nursery
rhyme (FR) (in their own familiar maternal voice, FV) twice daily to
the unborn fetus at about 80 dB from 34 weeks gestational age
onwards. Two and five weeks after birth the same familiar rhyme as
well as an unfamiliar new rhyme was presented to the newborn in
the familiar mother's voice (FV), as well as another unfamiliar female
voice (UV).
Results: We then analyzed speech envelope coupling with the
babies brain responses as recorded by 128 high‐density EEG. Mutual
information was used as the coupling metric on the Hilbert trans-
formed amplitude data. A non‐parametric single‐sided Kolmogorov‐
Smirnov Test with a 5% significance level is used to determine the
differences between the groups. Preliminary results show a signifi-
cant difference between maternal and non‐maternal voice at 1 Hz
(p < 0.001) and at 4 Hz (p < 0.05), while at 2 and 4 Hz no signifi-
cant differences were observed (p > 0.72). For familiar vs. unfamiliar
rhyme contrasts no significant differences were observed.
Conclusions: Results indicate that even sleeping baby brains (days
after birth) couple more strongly to the familiar maternal voice, yet
seem to be unable to recognize prenatally replayed rhymes.
Disclosure: Nothing to disclose.
P625 | Gross motor adaptation benefits from
NREM2 sleep and fast spindle activity during
nocturnal sleep after training
F. Hirschauer1; J. Birklbauer2; K. Bothe1; H.-P. Wiesinger2;
J. Edfelder2; K. Hoedlmoser1
1Laboratory for Sleep, Cognition and Consciousness Research, Centre for
Cognitive Neuroscience, University of Salzburg, Salzburg, Austria,
University of Salzburg, Salzburg, 2Department of Sport Science and
Kinesiology, University of Salzburg, Hallein, Austria
Objectives/Introduction: This study tested the impact of noctur-
nal sleep versus diurnal wakefulness on the performance of a gross
motor adaptation task (i.e., riding an inverse steering bicycle).
Methods: 44 healthy male students (M = 24.84, SD = 4.01 years)
were randomly assigned either to a sleep or a wake group. 26 of
these participants were included in the analyses as they sufficiently
mastered to cope with the motor adaptation task. This was impor-
tant to ensure that the subjects are able to complete the test where
performance was quantified by the steering angle (accuracy) and the
riding time (speed) during riding the inverse steering bicycle for
5x30 m straight line. A 16‐channel EEG system was used for
polysomnography during sleep. Sleep was scored visually according
to AASM criteria and sleep spindles were detected automatically
(The Siesta Group, Vienna, Austria).
Results: While subjects who slept during the retention interval
maintained their performance levels over night, subjects who spent
the retention interval awake became significantly less accurately
(t12 = −3.688, p = 0.003) and more slowly (t12 = −3.071,
p = 0.010). At re‐test, both groups still performed similarly accu-
rately, but the sleep group performed significantly faster than the
wake group (t22 = −2.316, p = 0.030). After training subjects spent
more time in stage N2 sleep (t10 = 2.257, p = 0.048) and showed
higher activity of fast sleep spindles (t10 = 2.753; p = 0.005) com-
pared to the adaptation night without preceding gross motor adapta-
tion training. The higher the fast spindle activity after training, the
faster subjects performed after sleep (t11 = 0.673, p = 0.023).
Conclusions: Sleep helps to keep motor adaptation stable, whereas
wakefulness not only led to more inaccurate but also slower perfor-
mance. Among those subjects who slept during retention, N2 sleep
duration as well as activity of fast sleep spindles (13–15 Hz)
increased after motor adaptation. Furthermore, post‐training high
activity of fast sleep spindles was related to faster performance at
re‐test in the morning. This link between sleep‐related motor adapta-
tion and fast spindle activity is well in line with results from fine‐
motor tasks (e.g. motor sequence learning, mirror tracing) and
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provides evidence that a retention interval containing nocturnal
sleep helps to maintain the adaptation of a real‐life, gross‐motor
task.
*This study was funded by the Austrian Science Fund (P25000‐B24).
Disclosure: Nothing to disclose.
P626 | Subjectively defined optimal/non‐
optimal time of day modulates controlled but
not automatic retrieval processes in verbal
memory
D. Puttaert1,2; S. Adam3; P. Peigneux1
1UR2NF ‐ Neuropsychology and Functional Neuroimaging Research at
CRCN, 2Laboratoire de Cartographie Fonctionnelle du Cerveau,
Université Libre de Bruxelles, Bruxelles, 3Psychology of Aging Unit,
Université de Liège, Liège, Belgium
Objectives/Introduction: We investigated the impact of subjec-
tively defined optimal/non‐optimal time of day on verbal memory
retrieval, using an adaptation of the Jacoby 1991 Process‐Dissocia-
tion Procedure (PDP) that allows estimating the respective contribu-
tions of automatic and controlled memory retrieval processes within
a same memory task.
Methods: Participants (N = 40; 23.35 ± 1.76 years) were tested at
the time of day they individually defined as most optimal (n = 20) or
worst (n = 20) for cognitive performance, between 7:00 and 19:00.
Neutral to moderate chronotype, habitual sleep quality and preced-
ing night duration/ quality were similar between conditions (ps >
0.26). Participants were instructed to memorize successively pre-
sented French words (e.g., “chacal”). For each word, a stem to com-
plete (e.g., cha—) was proposed after a variable lag (0, 3, 12
intermediate words), under two counterbalanced conditions. In the
Inclusion condition, they must complete the stem with the previously
presented word (e.g., cha‐cal), alternatively with the first word com-
ing to their mind, i.e., successful performance could be supported by
explicit recollection or familiarity processes. In the Exclusion condi-
tion, they must provide a word different than the previously pre-
sented to complete the stem (e.g., cha‐que), i.e., performance above
chance level requires explicit recollection of the word to avoid. In
the PDP procedure, computations based on Inclusion and Exclusion
scores generate estimates of the respective contributions of auto-
matic and controlled processes in verbal memory.
Results: As expected, sleepiness was higher in Non‐Optimal (KSS
mean/SD: 4.3 ± 2.11) than Optimal (mean and SD: 3.125 ± 1.24;
p < 0.05) conditions. In the word‐completion task, estimates of con-
trolled processes were higher for participants evaluated at Optimal
than Non‐optimal moment (0.71 ± 0.13 vs. 0.57 ± 0.22; p < 0.01).
For automatic processes, no moment effect was found (0.28 ± 0.25
vs. 0.34 ± 0.23; p > 0.05).
Conclusions: Our results are in line with the hypothesis that sub-
jective time of day optimality impacts cognitively demanding
controlled but not automatic processes, underlying the individual
specificity of biological, social and cognitive factors on diurnal varia-
tions in performance.
Disclosure: The authors are not aware of any affiliation, funding or
financial holdings that might be perceived as affecting the objectivity
of this study. The authors declare that there is no biomedical finan-
cial interest or potential conflict of interest.
P627 | Obstructive sleep apnea and non‐
invasive ventilation treatment‐related effects on
semantic memory integration in a false memory
generation paradigm
O. Benkirane1; O. Mairesse2; R. Schmitz1; D. Neu2;
P. Peigneux1
1UR2NF ‐ Neuropsychology and Functional Neuroimaging Research Unit
at CRCN, Université Libre de Bruxelles (ULB), 2Sleep Laboratory & Unit
for Chronobiology U 78, Brugmann University Hospital, Bruxelles,
Belgium
Objectives/Introduction: Generation of false memories at recall
may reflect the normal processes by which new verbal material is
integrated and associated into preexisting long‐term memory sys-
tems. For instance, after learning new words, healthy participants
presented later on with never learned but conceptually related ele-
ments erroneously recognize it as previously learned due to semantic
contamination. Obstructive sleep apnea (OSA) is know to exert a
deleterious impact on cognitive functioning, in particular attention
and vigilance, but its effects on verbal learning are unclear, as well
as beneficial effects of compliant continuous positive airway pres-
sure (CPAP) treatment. We investigated here OSA and CPAP treat-
ment‐related effects on verbal memory integration.
Methods: 22 patients with OSA (35–73 years; AHI > 15) were
tested at three time points:
(1) after diagnosis polysomnography (PSG) (no treatment),
(2) after a first night with CPAP and PSG, and
(3) after 3-months of compliant ambulatory CPAP treatment.
At each time point, they had to learn 10 lists; each list comprised 15
semantically related words. Afterward, they had to recognize learned
words in a list comprising 20 really studied words, 20 lures (new
words semantically related to the learned lists), and 20 distractors.
For each item, they specified whether recognition was based on
controlled recall (R), item familiarity (K) or guess (G).
Results: CPAP treatment decreased AHI/hour (pre 39 ± 19 vs. post
9.9 ± 8) and increased REM sleep and perceived sleep quality (ps <
0.001), persisting 3 months later. Recognition of studied and lure
words increased after CPAP initiation, both after 1 night and
3 months of treatment (ps < 0.005). R responses for studied words
also increased after 1 night and 3 months of CPAP (ps < 0.05).
Conclusions: CPAP effects on sleep quality were effective from
the 1st night and persisted on the long term, as expected.
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Furthermore; our results evidence unambiguous CPAP treatment‐
related effects on verbal learning abilities (learning and semantic
memory generalization) and cognitive functioning in treated OSA
patients, suggesting the reinstatement of normal memory mecha-
nisms while sleep quality is restored.
Disclosure: Nothing to disclose.
P628 | Clustered and temporally organised
occurrence of NREM‐stage2 sleep spindles
mediates motor memory consolidation
A. Boutin1; E. Gabitov1; B. Pinsard2; J. Doyon1
1McConnell Brain Imaging Centre, Montreal Neurological Institute and
Hospital ‐ McGill University, 2Centre de Recherche de l'Institut
Universitaire de Gériatrie de Montréal ‐ Université de Montréal,
Montreal, QC, Canada
Objectives/Introduction: Sleep benefits motor memory consolida-
tion. This mnemonic process is thought to be mediated by thalamo‐
cortical spindle activity and associated reactivations of task‐related
neural patterns during non‐rapid‐eye‐movement (NREM) sleep. How-
ever, the particular role of NREM‐stage 2 and NREM‐stage 3 sleep
spindle activity upon this mnemonic process still remains controver-
sial. Hence, using novel metrics sensitive to the clustering and tem-
poral organisation of spindle events, we sought to identified stage‐
specific sleep spindle patterns underlying motor memory consolida-
tion.
Methods: Twenty right‐handed young adults were required to per-
form a 5‐element motor sequence learning (MSL) task, as rapidly and
accurately as possible, and to rehearse practice over 14 training
blocks. MSL consolidation was assessed by computing the difference
(%) in performance between immediate and delayed 24‐hr post‐train-
ing testing sessions. EEG sleep data were then recorded the night
following training. Spindle detection was applied to all artefact‐free
NREM2 and NREM3 epochs at the Pz derivation. Sleep spindles
were considered if events lasted 0.3–2 s, occurred within the 11–
16 Hz frequency range and with an onset within NREM2 and
NREM3 sleep periods.
Results: Results revealed that NREM2 spindle local density (SLD;
spindle‐centred 60‐s window) positively correlated with the degree
of overnight performance gains (r = 0.64, p < 0.01), while no correla-
tion was evident between NREM3 SLD and overnight MSL gains
(r = 0.27, p = 0.23). In addition, we assessed sleep spindle temporal
organisation (i.e., inter‐spindle interval [ISI]) and showed a negative
correlation between NREM2 ISI and overnight performance gains
(r = −0.62, p < 0.01), while no correlation was observed between
NREM3 ISI and MSL gains (r = −0.21, p = 0.43).
Conclusions: The present findings strengthen the critical role of
NREM2 sleep, over NREM3 sleep, upon MSL consolidation. Our
results also show spindle patterns that may reflect information‐pro-
cessing mechanisms required for overnight consolidation. Specifically,
they reveal that both SLD and ISI during NREM2 sleep, but not
NREM3 sleep, relate to MSL consolidation. Hence, despite the
apparent erratic occurrence of spindles during NREM sleep, we pro-
vide here the first‐time evidence that NREM2 sleep spindles may
iteratively occur within clustered and temporally organised patterns
in order to efficiently reactivate and further consolidate specific
motor memories.
Disclosure: Nothing to disclose.
P629 | Split sleep is superior to consolidated
nocturnal sleep for memory retention in sleep
restricted adolescents
J. Cousins; E. van Rijn; K. Wong; T.B. Teo; M. Chee
Duke‐NUS Medical School, Singapore, Singapore
Objectives/Introduction: The question of whether sleep in
humans should be obtained in a single bout of nocturnal sleep or
split between nocturnal and daytime sleep periods is hotly debated.
Daytime naps provide consistent benefits to post‐nap memory, but it
remains unclear how both pre and post‐nap learning are affected
under a split sleep schedule when adolescents undergo sleep restric-
tion.
Methods: We compared long‐term memory in 58 participants who
learned across 3 consecutive days with consolidated (6.5‐hr noctur-
nal sleep opportunity) or split sleep (5 hr nocturnal sleep +1.5 hr
daytime nap opportunities). On each day, participants spent one‐
hour learning detailed facts about six species of amphibian in the
morning (11:00), and six different species of amphibian after the nap
period in the afternoon (17:00).
Results: Participants were tested the following evening after a noc-
turnal recovery sleep opportunity (9‐hr), via 360 two‐alternative
forced choice questions. A mixed ANOVA with group (5 hr + Nap/
6.5 hr) and learning‐time (morning/afternoon) showed a significant
main effect of group (p = 0.046) and a group*learning‐time interac-
tion (p = 0.021). The 5 hr + Nap group remembered significantly
more about species learned in the afternoon (p = 0.01), while groups
did not differ for species learned prior to the nap in the morning
(p = 0.23).
Conclusions: This suggests that when available nocturnal sleep is
curtailed to suboptimal levels, a split sleep schedule enhances learn-
ing after a nap opportunity, but critically this schedule does not
impair morning learning, where less preceding nocturnal sleep was
obtained. A split sleep schedule is therefore superior for the learning
and retention of educationally relevant factual information if avail-
able nocturnal sleep is limited.
Disclosure: Nothing to disclose.
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P630 | Phase amplitude coupling facilitates
pre‐post‐sleep consolidation of declarative and
but not of procedural memories
C. Mikutta1,2; J. Maier3; B. Feige3; D. Riemann3; C. Nissen1,3
1University Hospital of Psychiatry, Translational Research Center,
University of Berne, Bern, 2Privat Klinik Meiringen, Meiringen,
Switzerland, 3Department of Psychiatry and Psychotherapy, University of
Freiburg, Freiburg, Germany
Objectives/Introduction: The interaction between slow wave
oscillations (SWO) and sleep spindles is believed to facilitate memory
consolidation and underlying synaptic refinements. More specifically,
only specific SWO‐phase‐spindle‐amplitude configurations appear to
support memory consolidation. However, it remains largely unknown
if SWO coupling with spindles is specific for either declarative or
procedural memories.
Methods: To address this question, we associated the phase ampli-
tude coupling (modulation index, Tort, 2010) between SWO and
spindles in NREM sleep in 20 young healthy adults (10 females, 10
males, mean age 27.1 ± 4.6 years) with declarative (word list task,
WLT) and procedural (mirror tracing task, MTT) memory testing.
Results: We found that the modulation index, against our expecta-
tion, did not significantly correlate with neither declarative nor pro-
cedural over night memory consolidation (p > 0.05 for both).
However, the precise temporal interaction of SWO and spindle
activity was significantly associated with declarative but not proce-
dural memory consolidation (circular‐linear correlation, WLT:
r = 0.64, p < 0.01; MTT: r = 0.09, p > 0.05).
Conclusions: We therefore speculate that specifically the temporal
organization of phase amplitude coupling is a key player in sleep‐
related declarative memory consolidation.
Disclosure: Nothing to disclose.
P631 | Sleep and memory consolidation of
reward‐motivated encoding
E. van Rijn; S. Koh; K. Vinogradova; J. Cousins; M. Chee
Centre for Cognitive Neuroscience, Duke‐NUS Medical School, Singapore,
Singapore
Objectives/Introduction: Sleep plays an active role in memory
consolidation. It has been suggested that memories with increased
salience, such as through reward, are processed preferentially during
sleep. Furthermore, when seemingly trivial events are in temporal
proximity to related salient events, these initially weak memories can
be tagged for later consolidation. The present study investigated
whether sleep preferentially consolidates rewarded memories, and
facilitates consolidation of conceptually‐related items through behav-
ioral tagging.
Methods: Participants encoded pictures of animals and objects in
two phases, immediately following one another. Different pictures
from the same categories were encoded in each phase. During the
second encoding phase, participants received a monetary reward for
correct recognition of pictures from the two categories. Following a
12‐hr delay including daytime wakefulness (n = 29) or nocturnal
sleep (n = 29), participants completed a surprise recognition test for
their memory of pictures from both encoding phases.
Results: Repeated Measures ANOVA indicated a significant main
effect of Group (p < 0.05) and a significant Group*Phase interaction
(p < 0.01). Participant in the sleep group remembered significantly
more pictures than participants in the wake group. Specifically, the
sleep group remembered significantly more pictures encoded during
the reward phase compared to the wake group (p < 0.01, mean ±
SD sleep group: 21.76 ± 9.02, wake group: 13.31 ± 9.23), but not
during the pre‐reward phase (mean ± SD sleep group:
20.55 ± 10.83, wake group: 17.21 ± 9.13).
Conclusions: Recognition memory was better following a period of
sleep compared to wake. This benefit of sleep for memory was only
found for pictures from the reward phase. Reward may have tagged
pictures encoded during the reward phase for subsequent sleep‐
dependent memory consolidation. Alternatively, the reward phase
may have been consolidated preferentially during sleep as it was
encoded closest to the retention interval. More research is needed
to disentangle the relationship between sleep, memory and reward.
Disclosure: Nothing to disclose.
P632 | The effect of sex hormones on sleep
and cognitive performance
K. Hoedlmoser1; S. Herzog1; G. Gruber2; H. Kerschbaum3
1Laboratory for Sleep, Cognition and Consciousness Research, Centre for
Cognitive Neuroscience, University of Salzburg, Salzburg, Austria,
University of Salzburg, Salzburg, 2Medical University of Vienna, Vienna,
3Department of Cell Biology, Centre of Cognitive Neuroscience,
University of Salzburg, Salzburg, Austria
Objectives/Introduction: Sex hormones fluctuate across a
monthly cycle:
(I) follicular phase (days 1–14), and
(II) luteal phase (days 15–28).
Whereas estrogen shows a dominance and a peak during the
follicular phase, progesterone is more pronounced in the
luteal phase. There is growing evidence that these fluctua-
tions in sex hormones may influence sleep and cognitive per-
formance. Therefore the presented study investigated the
interactions of sex hormones, sleep and cognitive perfor-
mance (i.e., declarative memory, intelligence).
Methods: 58 healthy women (age: 22.31 ± 3.19) spent two nights
(baseline, experimental) in the sleep laboratory. Polysomnography
was recorded during the nights. Before and after sleep saliva sam-
ples were collected. Preceding the experimental night subjects
encoded 160 word‐pairs. Retrieval of these word‐pairs was assessed
before (RET1) and after sleep (RET2). Furthermore subjects
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performed the Raven′s Advanced Progressive Matrices to examine
intelligence. Sleep was scored visually according to AASM criteria
and sleep spindles were detected automatically (The Siesta Group,
Vienna, Austria). Progesteron and estragen were analysed by using
an ELISA kit according to the recommendations of Demeditec Diag-
nostics. Because of problems with the saliva samples 12 subjects
had to be excluded from the analyses.
Results: Memory performance was significantly improved after
sleep (t = −4.874, p < 0.001; RET1: 70.09 ± 18.85%; RET2:
72.41 ± 19.46%). However, we did not find any relation between
memory consolidation and sleep architecture or sleep microstructure
(i.e. sleep spindles, slow oscillations). Women showing stronger fast
(13–15 Hz) sleep spindles during both nights performed better in the
intelligence task (r = 0.376, p = 0.012). Analyses of the sex hor-
mones revealed a relationship between fast sleep spindles and pro-
gesterone level: the higher the progesterone level, the higher the
sleep spindle density (r = 0.384; p = 0.017).
Conclusions: Our dataset replicates earlier findings, that sleep
spindles serve as a biological marker for general cognitive abilities.
While we did not find any changes in sleep macro‐ or microstructure
after declarative learning, our data revealed that women with ele-
vated endogenous progesterone levels show increased fast sleep
spindles. Our results support prior findings suggesting a role of
endogenous progesterone in the production of sleep spindles. The
menstrual cycle seems to moderate thalamo‐cortical communication,
which has to be considered when exploring the role of sleep fea-
tures in sleep‐related memory consolidation.
Disclosure: Nothing to disclose.
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P633 | Poor housing quality is associated with
short sleep duration in New Zealand
T.L. Signal1; J. McCarthy2
1Sleep/Wake Research Centre, Massey University, 2Strategy and Policy
Unit, Ministry of Health, Wellington, New Zealand
Objectives/Introduction: Housing quality and household over-
crowding have been associated with a range of adverse health out-
comes but very few studies have investigated the influence of
physical aspects of a home on sleep health.
Methods: The present study is secondary analysis of adult data
(≥15 years) from the New Zealand Health Survey (2013/2014).
Respondents were asked “How many hours of sleep do you usually
get in a 24‐hr period, including all naps and sleeps?” which was cate-
gorised according to National Sleep Foundation recommendations
for each age category as appropriate/may be appropriate versus
short or long. Housing quality was based on responses to items on
household temperature and the presence of household dampness,
mould and smell which were aggregated into a single housing quality
scale that ranged from 1 (highest quality) to 5 (lowest quality).
Household overcrowding was a binary variable determined using the
Canadian National Occupancy Standard. Logistic regression analyses
were undertaken, controlling for gender, age, socioeconomic status
and ethnicity.
Results: Data were analysed from 13,309 respondents (43.5%
male, age range 15 ‐ >75 years). Approximately 90–95% of respon-
dents in each age category (10 years bins) reported their sleep dura-
tion as appropriate/may be appropriate, with the exception of those
≥75 years (84.4%). Between 2.7–8.8% of respondents in each age
category reported short sleep. Housing quality was associated with
an increased odds of short but not long sleep durations. A housing
quality score of 3 and 4 increased the odds of short sleep 1.48 times
(95% CIs 1.0–2.2) and a housing quality score of 5 increased the
odds of short sleep 1.69 times (95% CIs 1.1–2.7). Household over-
crowding was not independently associated with either short or long
sleep duration.
Conclusions: The quality of the home environment is indepen-
dently associated with the occurrence of short sleep. Improving the
quality of the home environment by ensuring homes are warm and
dry is a potential public health approach that warrants further inves-
tigation. This could decrease the occurrence of short sleep and
reduce inequities in sleep health in the wider population.
Disclosure: Nothing to disclose.
P634 | Sleep‐wake dependent changes in
molecular markers of synaptic plasticity in
humans: a PET/MRS study
S. Weigend1; S.C. Holst2; V. Treyer3; R.L. O'Gorman Tuura4;
J. Meier1; S.M. Ametamey5; A. Buck3; H.-P. Landolt1
1Institute of Pharmacology and Toxicology, University of Zürich, Zürich,
Switzerland, 2Neurobiology Research Unit, Copenhagen University
Hospital Rigshospitalet, Copenhagen, Denmark, 3Department of Nuclear
Medicine, University Hospital Zurich, 4Center of MR Research, Children's
University Hospital, 5Institute of Pharmaceutical Sciences, Department of
Chemistry and Applied Biosciences, ETH Zurich, Zürich, Switzerland
Objectives/Introduction: We recently found that sleep depriva-
tion increased the availability of metabotropic glutamate receptors
of subtype 5 (mGluR5) in the human brain. The effect of recovery
sleep was not investigated and the repercussions of prolonged wak-
ing and sleep on the mGluR5‐regulated molecular markers of synap-
tic plasticity, brain‐derived neurotrophic factor (BDNF) and fragile X
mental retardation protein (FMRP), are unknown. To investigate a
role of mGluR5 in sleep homeostasis, we simultaneously quantified
mGluR5 availability and dynamic changes in brain metabolites, as
well as BDNF and FMRP levels in plasma, after prolonged waking
and recovery sleep.
Methods: Thirty‐one healthy men completed a controlled in‐lab
study, in which 3‐Tesla PET/MR‐Spectroscopy scanning and blood
sampling were conducted at the same circadian time in baseline,
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after 40 hr prolonged waking and recovery sleep. mGluR5 availability
was quantified with the novel PET radioligand 18F‐PSS232, whereas
concentrations of glutamate, the glutamate/glutamine (GLX) ratio and
GABA in basal ganglia (BG) and dorsolateral prefrontal cortex (dlPFC)
were measured with dedicated PRESS/MEGAPRESS MRS sequences.
The levels of BDNF and FMRP were quantified with ELISA. Statisti-
cal analyses included mixed‐model ANOVAs and least significant dif-
ferences (LSD) where appropriate.
Results: Prolonged waking induced an increase in whole‐brain and
striatal mGluR5 availability, which normalized after one night of
recovery sleep (pall < 0.05). Glutamate and GLX in BG (pall < 0.01)
and blood FMRP levels (p < 0.02) were higher after sleep loss than
in baseline and tended to normalize after recovery sleep (pall > 0.05
compared to baseline). By contrast, GABA levels in BG, metabolite
concentrations in dlPFC, and blood BDNF levels were unaffected by
changes in sleep history (pall > 0.1).
Conclusions: Sleep‐wake dependent changes in mGluR5 availabil-
ity, glutamate/GLX dynamics, and blood FMRP concentration suggest
a role of the BG glutamatergic system in the homeostatic regulation
of sleep in humans. Research supported by SNSF (grant # 320030‐
163439) and CRPP “Sleep & Health”.
Disclosure: Nothing to disclose.
P635 | On the high levels of delta power after
prolonged wakefulness: reflection of a
continuous process or a discrete NREM sleep
sub‐state?
J. Hubbard1; T. Gent2; M. Hoekstra1; Y. Emmenegger1;
V. Mongrain3; A. Adamantidis2; P. Franken1
1Centre for Integrative Genomics, Université de Lausanne, Lausanne,
2Department of Neurology, Inselspital, Universität Bern, Bern,
Switzerland, 3Unviersité de Montreal, Montreal, QC, Canada
Objectives/Introduction: During NREM sleep, increased cortical
synchrony of slow‐waves is observed in frontal cortical areas. The
most widely used method for quantifying this process is through
power spectrum analysis of the EEG delta‐band (0.75–4 Hz). How-
ever, recent evidence has suggested that the slope of NREM slow‐
waves may also provide a window into the kinetics of sleep‐wake
driven processes. This study sought to determine whether a combi-
nation of slope and spectral analysis could yield previously unknown
slow‐wave properties, following spontaneous or enforced waking.
Methods: Male C57BL/6 mice were implanted with EEG/EMG, and
exposed to 48‐hr of baseline (12 hr Light: 12‐hr Dark) conditions,
followed by a 6‐hr sleep deprivation (SD). A subset of mice were
implanted with thermistors to record cortical temperature (n = 8) or
tetrodes for local activity (n = 4).
Results: Slope analysis of NREM sleep revealed a rapid decrease in
the period (or increase in speed) of the slow‐wave, following sus-
tained bouts of enforced and spontaneous waking. This was
followed by a more in‐depth analysis of the power spectrum during
the first 6‐hr of recovery after SD. Remarkably, a discrete NREM
sub‐state emerged, dominated by significantly increased power in
the fast delta range (delta‐2, 2–4 Hz), dissipating within the first hour
of recovery, subsequently decaying at the same rate as slower delta
(delta‐1, 0.75–1.75 Hz; n = 38, p < 0.0001). Further analysis indi-
cated a strong correlation between these dynamics and other physi-
ological changes in muscle tone, neuronal spiking rate, and brain
temperature, and were present under baseline where extended
bouts of wake took place.
Conclusions: Sleep homeostasis is assumed to be a process that is
in a continuous and quantitative relationship with prior sleep‐wake
distribution. Detailed dissection of the time‐course of EEG delta
power during recovery sleep, revealed high and steeply decaying val-
ues in EEG delta power are specific to a narrow range (delta‐2) and
are discontinuous. As delta‐2 dynamics were paralleled by dynamic
changes in EMG, cortical firing, and brain temperature, we interpret
these three variables to reflect a transient and discrete sub‐state of
NREM sleep. It is during this time in which the animal's physiology
quickly recalibrates from an aroused and active state, to one typical
of the >95% remaining NREM sleep.
Disclosure: Nothing to disclose.
P636 | Working memory performance is better
maintained in older compared with young adults
after sleep deprivation
A. Gerhardsson1,2; T. Åkerstedt2,3; J. Axelsson2,3;
M. Lekander2,3; G. Kecklund2; H. Fischer1; J. Schwarz2
1Department of Psychology, 2Stress Research Institute, Stockholm
University, 3Department of Clinical Neuroscience, Karolinska Institute,
Stockholm, Sweden
Objectives/Introduction: The prefrontal hypothesis suggest that
sleep deprivation worsens executive components of working mem-
ory and is therefore comparable to normal aging. In contrast,
others argue that sleep deprivation mainly impairs non‐executive
components. However, only a few studies have focused on the
combined effect of aging and sleep deprivation on working mem-
ory. Thus, we investigated the effect of sleep deprivation on work-
ing memory performance in young (18–30 years) and older adults
(60–72 years).
Methods: Subjects were allocated into a young control (n = 63),
young sleep deprived (n = 61), old control (n = 47) and an old sleep
deprived (n = 47) condition. They performed a Sternberg working
memory task, where they were to answer if a probe letter matched
any of the previous letters presented in groups of 4 or 6 letters, tar-
geting low and high executive load. We used generalized linear
mixed‐models for the analyses. In addition, half of the subjects per-
formed a stress test ~1 hr before the test, which was controlled for
in the analysis.
378 of 433 | ABSTRACTS
Results: Overall, sleep deprivation impaired accuracy (d’: Mdiff =
0.43, 95% CI [0.27, 0.59], p < 0.001), but not response times (Mdiff =
−25.12 ms, 95% CI [−83.26, 33.01], p = 0.86). Sleep deprivation had
a significantly larger impact on young compared with older adults in
terms of accuracy (d’: Mdiff = 0.57, 95% CI [0.25, 0.89], p < 0.001).
Older adults were on average slower than young in both sleep condi-
tions (Mdiff = −206.81 ms, 95% CI [−264.95, −148.68], p < 0.001).
Performance was worse in the 6‐letter condition, but there were no
interactions of sleep and age condition with executive load. Omission
rate was higher after sleep deprivation (Mdiff = −0.05, 95% CI [−0.08,
−0.02], p < 0.001), especially for low compared with high executive
load (Mdiff = −0.06%, 95% CI [−0.10, −0.02], p = 0.002).
Conclusions: Our data support an impairment of mainly non‐execu-
tive components of working memory after sleep deprivation for
younger adults, while older adults’ performance is better maintained.
Response times were affected by age but not sleep deprivation.
Together, these findings indicate that sleep deprivation is not directly
comparable to normal aging and that the effects of sleep deprivation
on working memory is different in young and older adults.
Disclosure: This study is funded through a grant from the Bank of
Sweden Tercentenary Foundation.
P637 | Mood impairment is less strong in older
than in young adults after sleep deprivation
J. Schwarz1; A. Gerhardsson2; G. Kecklund1; M. Lekander1,3;
H. Fischer2; J. Axelsson1,3; T. Åkerstedt1,3
1Stress Research Institute, 2Department of Psychology, Stockholm
University, 3Department of Clinical Neuroscience, Karolinska Institute,
Stockholm, Sweden
Objectives/Introduction: Sleep deprivation commonly impairs
affective regulation and causes worse mood. However, previous
research mainly studied young adults. Since sleep, susceptibility to
sleep deprivation and emotion regulation change profoundly across
the adult life span, we investigated whether the effect of sleep depri-
vation on mood is less pronounced in older than in young adults.
Methods: In an experimental design, young (18–30 years) and
older adults (60–72 years) participated in either a sleep control
(NSD) (young: n = 63, older: n = 47) or a total sleep deprivation con-
dition (SD) (young: n = 61, older: n = 47). Sleepiness, mood and com-
mon symptoms of sleep deprivation were measured using
established questionnaires and rating scales (Karolinska Sleepiness
Scale, Positive and Negative Affect Schedule (PANAS), Profile of
Mood States (POMS), CHICa scale).
Results: Sleep deprivation was associated with a significant
increase in sleepiness (p < 0.05) and deterioration in mood in both
young and older adults (Total Mood Disturbance Mean ± SD: young
NSD: 1.0 ± 17.1, young SD: 36.3 ± 28.8; older NSD: −4.8 ± 13.4,
older SD: 9.2 ± 16.4). However, older adults mood was significantly
less affected for the majority of outcome measures as indicated by
age*sleep deprivation interactions (p < 0.05).
Conclusions: The results show that older adults are emotionally
less affected by sleep deprivation than young adults. This could pos-
sibly be related to the well‐known positivity effect in older age, which
suggests that older adults may prioritize regulating their emotions to
optimize well‐being. The results also highlight that caution needs to
be warranted when generalizing results across the adult life span.
Disclosure: This study is funded through a grant from the Bank of
Sweden Tercentenary Foundation.
P638 | Oculomotoric evidence for a speed‐
accuracy trade‐off in selective attention tasks
during sleep deprivation
C. Mühl; S. Benderoth; D. Aeschbach
Institute of Aerospace Medicine, Sleep and Human Factors, DLR,
Cologne, Germany
Objectives/Introduction: The effects of sleep deprivation (SD) on
selective attention can be studied by visual search tasks, such as
conjunction (CST) and spatial configuration (SST) search. As in other
task domains, SD leads to a cognitive slowing and a decrease in
accuracy, but also to a deficiency in adjusting response time to an
increase in the number of items in the search display. It is currently
unclear what mechanism underlies the decrease in accuracy in selec-
tive attention under sleep loss. Here we used gaze tracking in visual
search tasks, hypothesizing cognitive slowing to result in longer fixa-
tion durations and slower saccades.
Methods: Visual search performance (response time, accuracy as
sensitivity d’) and associated gaze behavior were recorded in sleep
deprived participants (N = 24, age: 25 ± 5 STD; 12 women), kept
awake during a 24 hr period, and in a control group (N = 24, age:
26 ± 4 STD; 10 women) with a time‐in‐bed of 8 hr.
Results: We were able to replicate the increase of response time
under SD compared to the control group (CST: p = 0.019; SST:
p < 0.001) and a decrease in sensitivity d’ (CST: p = 0.03; SST:
p < 0.001).The oculomotoric measures provided indications of a cog-
nitive slowing in slower saccade velocities for the SD group com-
pared to the control group (CST: p < 0.001; SST: p < 0.001). In
contrast, fixation durations decreased in the SD group relative to the
control group (CST: p = 0.018; SST: p = 0.008). Moreover, the
change in fixation duration due to sleep deprivation (i.e. difference
from baseline) was positively correlated with the change in task
accuracy (CST: ρ = 0.29, p = 0.048; SST: ρ = 0.33, p = 0.022).
Conclusions: The oculomotoric changes under sleep deprivation
suggest that tasks requiring selective attention may suffer not only
due to general cognitive slowing, but also from an unfavorable
speed‐accuracy trade‐off: decision speed per item ‐ as derived from
fixation durations ‐ increases, while accuracy decreases in turn.
Disclosure: Nothing to disclose.
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P639 | Exploring the effect of 24‐hr sleep
deprivation on social decision‐making
C. Li1; J. Zhang2; L.T.S. Yee1; J.H. Hsiao3; Y. Hong2; T. Li1;
J. Zhang4; E.Y.Y. Lau1
1Department of Psychology, Education University of Hong Kong, Hong
Kong, Hong Kong, 2Business School, Chinese University of Hong Kong,
3Department of Psychology, University of Hong Kong, 4Department of
Psychiatry, Chinese University of Hong Kong, Hong Kong, China
Objectives/Introduction: Sleep deprivation (SD) is known to have
a negative effect on cognitive functions. However, the impact of SD
on social functions remains unclear with limited research on the rela-
tionship between sleep loss and social decision‐making. The current
study aimed to investigate the effect of 24‐hr of sleep deprivation
on social decision‐making.
Methods: Thirty‐five healthy young adults (mean age = 20.5, 23
females) were recruited to the study and randomly assigned to either
SD or control group. Following a week of habitual sleep with acti‐
graph and sleep diary, participants went through a 3‐day experimen-
tal protocol. On Day 1, participants completed questionnaires on
personal characteristics (e.g. chronotypes, personality, emotion intel-
ligence) during daytime and had a polysomnography (PSG)‐monitored
night of normal sleep at home. On Day 2, the SD group stayed
awake at the lab for the whole night while control group had normal
sleep at home. On the last day, measures of sleepiness, vigilance,
and social decision‐making were administered. Participants were
asked to distribute $100 between himself/herself and the next par-
ticipant on the Trust Game and accept or reject 10 offers of a split
of $10 each (unfair offers: $1, $2, $3; fair offer: $5) by previous par-
ticipants on the Ultimatum Game, which measures rational decision‐
making.
Results: Participants in the SD group were sleepier (t(33) = 5.10,
p < 0.001) and less vigilant (t(33) = 3.99, p < 0.001) than the control
group on Day 3. However, there was no significant difference
between the amount of money offered in the Trust Game and the
accepting rate in the Ultimatum Game.
Conclusions: To our knowledge, only one study has investigated
the impact of total sleep deprivation on social decision‐making using
Trust Game and Ultimatum Game, and that study adopted 36 hr of
SD. The current study with 24‐hr of SD did not show an effect of
sleep loss on social decision‐making. Future research is warranted to
elucidate the precise relationship between SD and social decision‐
making as well as the potential roles of factors such as individual dif-
ferences in cognitive affective resources and parameters of study
paradigm.
Disclosure: Nothing to disclose.
P640 | Theta and alpha oscillatory activity
changes during visual and auditory cognitive
tasks after sleep deprivation
S. Montamat1; A.S. Karunajeewa1; M.L. Navarrete2;
B.P. Lamprev1; J. Haba-Rubio3; V. Ibanez1
1Sleep Laboratory, Division of Pneumology, Geneva University Hospitals
(HUG), Geneva, Switzerland, 2Otorrinolaringología, Universidad
Autónoma de Barcelona/Hospital Valle de Hebron, Barcelona, Spain,
3Centre d'Investigation et de Recherche sur le Sommeil, Lausanne
University Hospital, Lausanne, Switzerland
Objectives/Introduction: During sleep deprivation (SD), attention
and alertness are reduced. Under SD, spontaneous EEG activity fol-
lows well known changes. However little is known about the dynam-
ics of the theta and alpha oscillatory activity during cognitive tasks.
The goal of the present study was to determine the impact of SD on
visual and auditory attention networks by studying alpha and theta
oscillatory activity during attentional tasks.
Methods: Twenty healthy participants performed an auditory and
a visual cued attentional task before and after a night of SD. Each
day, participants had five sessions separated by intervals of 2 hr.
Recorded continuous EEG was segmented into epochs target‐locked.
Reaction time (RT) and accuracy of the responses were also mea-
sured. Frequency bands were selected per each individual alpha fre-
quency (IAF). Alpha was determined as IAF at baseline ±2 Hz and
theta as IAF at baseline −4/−6 Hz. SD effects on performance and
frequency amplitude were assessed with parametric and non‐para-
metric statistics.
Results: For both tasks, alpha activity had a decrease in amplitude
(desynchronization), followed by an increase in amplitude (synchro-
nization). After SD, alpha synchronization was higher in frontal areas
(t‐test, p < 0.03) for both tasks. For the auditory task, alpha desyn-
chronization was reduced (p < 0.02) and alpha synchronization
increased (p < 0.01) in parietal areas, after SD. A theta synchroniza-
tion was observed in frontal areas, and was significantly reduced in
amplitude after SD (p < 0.003) for visual task. For the auditory task,
theta activity did not show significant differences between sleep
conditions. SD produced, a decrease of performance and an increase
of RT (p < 0.001).
Conclusions: Alpha inhibition theory says that alpha desynchro-
nization is related to neuronal activation and alpha synchronization
is related to an inhibitory activity. SD interferes similarly for auditory
and visual attentional tasks during de resetting of neuronal activity
(alpha synchronization). Theta oscillatory activity in frontal areas is
probably related to integration and processing of target stimulus dur-
ing attentional tasks and is impaired during SD, as seen with the
visual stimulus. For the auditory stimulus, a strong theta evoked
response could entangle the theta induced activity in the frontal
areas.
Disclosure: Nothing to disclose.
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P641 | Sleep deprivation impairs social
memory
T. Sundelin1,2; J. Axelsson1,3
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm,
Sweden, 2Department of Social Psychology, New York University, New
York, NY, United States, 3Stress Research Institute, Stockholm University,
Stockholm, Sweden
Objectives/Introduction: Several studies have found that sleep
deprivation has a negative effect on memory and learning. However,
most of these studies have been performed using actual memory
tasks, and few, if any, have looked at memory of a social setting. In
this study we wanted to see whether people′s memory from a social
situation, not prompted by a memory task, would be affected by
sleep deprivation.
Methods: 182 participants (mean age 25.3 years, 103 women) were
randomized into a sleep condition (3 nights of 8–9 hr in bed) or a sleep
deprivation condition (2 nights of 8–9 hr in bed followed by 31 hr of
wakefulness). They spent the day following the last night with an
experimenter, performing several different tasks. The experimenter
was blind to the condition of the participant. One week later, the par-
ticipants filled out a follow‐up questionnaire, where they were asked
to provide the name and hair colour of the experimenter.
Results: Participants who were sleep restricted (N = 91) were sig-
nificantly less likely to remember the experimenter′s name than
those who had slept (N = 91) (40% vs. 57% correct, p = 0.026).
However, there was no difference regarding memory of the experi-
menter′s hair colour (79% vs. 81% correct, p = 0.853)
Conclusions: In line with previous findings, showing that sleep loss
impairs encoding, sleep deprivation affected participants′ ability to
remember details from a social situation when they were unaware
they would be asked to do so. However, some aspects of such mem-
ory seem to remain intact, such as remembering someone′s appear-
ance. This may be indicative of a difference in effects on episodic
and semantic memory, although it may also be due to the smaller
range of possible options for hair colour vs. names.
Disclosure: Nothing to disclose.
P642 | Investigation of the possible effects of
the BDNF Val66Met polymorphism on the sleep
EEG in a large, homogenous sample
D.M. Baur1; N. Moser1; L. van Bommel1; S.C. Holst1;
B. Stucky1; W. Berger2; P. Achermann1; M. Cohen-Zion3;
H.-P. Landolt1
1Institute of Pharmacology and Toxicology, University of Zurich,
2Institute of Medical Molecular Genetics, University of Zürich, Zürich,
Switzerland, 3School of Behavioral Sciences, Academic College of Tel
Aviv‐Jaffa, Tel Aviv‐Jaffa, Israel
Objectives/Introduction: Animal studies indicated a causal link
between brain‐derived neurotrophic factor (BDNF) and sleep
homeostasis. Investigation in a small human sample of the impact of
the functional Val66Met polymorphism of BDNF (rs6265) suggested
that the sleep EEG in Val/Val homozygotes differed from Met‐allele
carriers, and that the differences resembled the effects of sleep
deprivation. Here we aimed at corroborating these earlier findings in
a larger sample.
Methods: All‐night sleep EEG recordings in baseline and recovery
nights after 40 hr prolonged wakefulness were collected in 118
healthy young men (18–34 years; 78 Val/Val and 40 Met‐allele carri-
ers). Sleep stage scoring was performed by multiple trained scorers.
Sleep variables and EEG power spectra of entire nights and consecu-
tive NREM‐REM sleep cycles were analyzed. Statistical analyses
were conducted with PERMANOVA, linear mixed‐effects, and gener-
alized additive models.
Results: Prolonged wakefulness reliably increased slow wave sleep
and NREM sleep EEG power in the ~ 0.5–11 Hz range, and reduced
power in the ~ 13.75–15 Hz band. By contrast, in baseline and
recovery nights, sleep architecture and EEG spectra in NREM and
REM sleep were strikingly similar in Val/Val and Met‐allele carriers.
In addition, the response to sleep deprivation did not differ between
the genotypes.
Conclusions: More robust inferential statistics may disclose subtle
differences between the genotypes. Nevertheless, the ongoing anal-
yses indicate that the impact of rs6265 of BDNF on sleep and the
sleep EEG may be less pronounced than previously suggested.
Disclosure: Nothing to disclose.
P643 | Excessive daytime sleepiness and
occupational accidents among resident doctors
in Kocaeli city
U. Urgan; Çiğdem Çağlayan
Kocaeli University, Kocaeli, Turkey
Objectives/Introduction: Extended working hours, high number
of night shifts and sleep deprivation are part of the work life of resi-
dent physicians. İn general, there is a view that long working hours
support better education for these physicians. Excessive daytime
sleepiness (EDS) resulting from these conditions can prepare the
ground for work accidents such as needlestick‐sharps injuries (NSİ)
and work related traffic accidents (WRTA).
This study aimed to evaluate the EDS status of resident doctors and
reveal the relationship between EDS and occupational accidents
among resident doctors.
Methods: This cross‐sectional study was conducted in 2017. The
studied universe constitutes of 350 resident physicians who work in
two hospitals providing postgraduate medical education in Kocaeli.
The participation rate for this study was 83% (n = 289) of the uni-
verse.
Socio‐demographic characteristics, working conditions, occupational
accidents belonging to the participants were questioned by using a
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data collection form. Epworth Sleep Scale (ESS) was used. The data
were collected by the researcher, face to face with the residents.
Descriptive analysis was performed. Factors related to EDS (ESS ≥
10) were assessed by chi‐square test. Additionally, ESS scores were
assessed by NSI and WRTA relationship, which revealed with using
Mann‐Whitney U test.
Results: The average age of the participants was 28.7 ± 2.4 years.
The mean of sleep duration was 6.4 ± 1.0 hr. Among the residents,
the EDS frequency was 36.6% for married persons (p = 0.047);
34.4% for non‐child owners (p = 0.050); 37.4% for sleeping less
than 7 hr in a day, 25.4% for sleeping 7 hr or more in a day
(p = 0.029); 43.2% for working in surgical branches and 24.0% for
those working in other branches (p = 0.001). Statistically, no signifi-
cant relation found between EDS and other socio‐demographic
characteristics and working conditions. The mean of the ESS was
found to be 9.22 ± 4.26 for residents who experienced NSI,
6.62 ± 3.94 for others (p = 0.000). Also, the mean of the ESS score
was found to be 10.29 ± 4.64 for residents who experienced
WRTA (p = 0.010).
Conclusions: We found a relationship between sleepiness level
and the number of NSI and WRTA. It should be ensured that the
their daily sleeping time is over 7 hr and the occuptional factors
should be improved in surgical branches.
Disclosure: Nothing to disclose.
P644 | Sleep loss in shift‐working long‐haul
truck drivers
J. Onninen1,2; M. Sallinen1,2; M. Sihvola2; J. Virkkala2;
A. Tolvanen1; M. Pylkkönen2
1Department of Psychology, University of Jyväskylä, Jyväskylä, 2Finnish
Institute of Occupational Health, Helsinki, Finland
Objectives/Introduction: Sleep loss is implicated in road traffic
accidents. Long‐haul truck drivers are at risk for sleepiness and cur-
tailment of sleep due to long driving bouts and circadian misalign-
ment. More information is needed about the dynamics of sleep loss
build‐up in irregular shift systems.
Methods: We recorded the sleep and working hours of 48 truck
drivers during a 2‐week period. The drivers were 22 to 58 years old
and had an average of 15 years of trucking experience. Sleep was
verified with wrist‐worn actigraphy and sleep logs. Daily sleep was
compared to individual self‐estimated sleep need (SN). Our outcome
measure were the sleep compared to SN in 72 hr prior to shift end,
and the accumulating sleep compared to SN during the study period,
using midnights as checkpoints.
Results: Mean daily sleep was 7:46 (SD 2:02) hours, an average of
2 min (SD 2:06 hr) less than SN. Sleep 72 hr prior to shift end aver-
aged −0:37 (SD 4:10) hours less than SN. Less than 4 hr of sleep
compared to SN was observed in over one fourth of night shifts,
29% of morning shifts, and 11% of day/evening shifts using the
72 hr time span. 60% of drivers had at least once accumulated less
than four hours of sleep compared to SN.
Conclusions: Truck drivers working irregular shifts have marked
variance in the sleep they obtain daily, but on average sleep close to
what their sleep need is. Sleep loss is more pronounced in associa-
tion with night and morning shifts than with day or evening shifts.
Future studies should examine the shift combinations that are con-
nected to sleep loss build‐up.
Disclosure: Nothing to disclose.
P645 | A questionnaire study on sleep‐wake
pattern and sleep quality in TMJ & orofacial pain
clinic
H. Lee1; K. Park1; B. Kim1; S. Kim1; I. Park1; S.T. Kim1
1Department of Orofacial Pain & Oral Medicine, College of Dentistry,
Yonsei University, Seoul, Republic of Korea
Objectives/Introduction: Patients with temporomandibular disor-
der (TMD), especially those with a chronic pain condition, also com-
plain of sleep disturbances frequently. The sleep‐wake pattern and
sleep quality could effect on orofacial pain condition in several way.
Therefore, this study tried to investigate the sleep‐wake pattern and
sleep quality in TMD & orofacial pain patients and evaluate the asso-
ciation between the sleep‐wake pattern and sleep quality and pain
condition via questionnaire.
Methods: We examined 3,279 patients with TMD, who visited the
Orofacial Pain Clinic at Yonsei University College of Dentistry during
January 1, 2015 to August 31, 2016. We conducted a survey using
the Pittsburgh Sleep Quality Index (PSQI) questionnaire and classi-
fied TMD patients into two groups based on Diagnostic Criteria for
Temporomandibular Disorders (DC/TMD). For statistical analysis, we
calculate the correlations between pain intensity, measured by
Numeric Rating Scale (NRS), and various factors such as sex, age,
total sleep time, sleep efficiency, awaken time, hypnotic medications.
Results: The result from statistical analysis showed correlations
between pain intensity (NRS) and some factors in sleep question-
naires. As age increases, the pain tends to be more severe
(p < 0.05). The lower sleep efficiency, the patients report their pain
more severe (p < 0.05). However, no significant correlations was
showed for other factors such as sex, total sleep time, awaken time
and whether the patient taking hypnotic medications or not.
Conclusions: The sleep‐wake pattern and sleep quality are highly
associated with TMD & orofacial pain. Therefore, a sleep deprivation
can cause chronic pain in the orofacial area. We found statistically
significant associations between sleep deprivation and orofacial pain.
TMD patients with chronic pain suffer from sleep deprivation similar
to other chronic pain patients. These results imply that clinicians
treating patients with orofacial pain should examine sleep‐wake pat-
tern and sleep quality.
Disclosure: Nothing to disclose.
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P646 | Neural network recognition of
drowsiness using EEG
O. Tkachenko1; V. Dorokhov1; S. Rivera2
1Institute of Higher Nervous Activity and Neurophysiology of RAS,
2Intego Press, Moscow, Russian Federation
Objectives/Introduction: Drivers, aerodrome controllers and
other operators doing monotonous work are susceptible to drowsi-
ness which often leads to tragic accidents. Some authors believe that
up to 30% of traffic accidents were caused by sleepy drivers. Wire-
less dry electroencephalographic (EEG) electrodes developed recently
could be used to signal them about being in dangerous state immedi-
ately. The aim of the study was to develop and test simple algorithm
of real‐time EEG analysis.
Methods: 30 healthy subjects (14 females and 16 males, 18–
35 years old, average 22 years) participated in the study. After sleep
deprivation (no more than 4 hr of sleep during previous night) they
performed monotonous driving task using simple driving simulator in
the darkened isolated room. Experiment duration was 1.5 hr. EEG
from 6 electrodes (Fp1, Fp2, C3, C4, O1, O2) was recorded along
with car trajectory and video of subject's face. Latter two were then
used to define subject's state (awake, drowsy or sleepy). Neural net-
work with two hidden layers (1,024 and 64 neurons, respectively)
was trained to recognize whether subject was sleepy or not using
EEG spectral characteristics, i.e. theta, lower alpha, upper alpha and
beta relative spectral powers. 2‐s fragments of EEG were used for
the analysis. Cross‐validation using 80–20% data split was per-
formed.
Results: We obtained type I error (sleepy subject classified as
awake) for 20% cases and type II error (awake subject classified as
sleepy) for 19%% cases.
Conclusions: Classification base level is acceptable, but moderate
at the time. We plan to improve it further using more complex EEG
features and recurrent neural networks. This work was supported by
the Russian Academy of Sciences and Russian Foundation for Basic
Research (grant № 17‐36‐00025/2017‐OGON).
Disclosure: Nothing to disclose.
P647 | Sleep quality of first year vs. sixth year
medical students from the State University of
Medicine and Pharmacy of the Republic of
Moldova
A. Lupușor1,2; S. Zubco2; V. Vovc1,2
1Laboratory of Functional Neurology, Sleep Medicine Center, Institute of
Neurology and Neurosurgery, 2Human Physiology and Biophysics,
‘Nicolae Testemitanu’ State University of Medicine and Pharmacy of the
Republic of Moldova, Chisinau, Republic of Moldova
Objectives/Introduction: To assess sleep quality (SQ) of first year
medical students (1YS) vs. sixth year medical students (6YS).
Methods: In the study were included 102 students (73 females),
1YS ‐ 50 (mean age 19 years), 6YS ‐ 52, (mean age 25 years) from the
State University of Medicine and Pharmacy of the Republic of Mol-
dova. Sleep quality assessment was based on self‐report using The
Pittsburgh Sleep Quality Index (PSQI). Anxiety was assessed by Spiel-
berger‐Hanini inventory, depression by Beck depression inventory.
Results: In both groups, tendencies towards low quality sleep was
observed, although the quality of sleep in 1YS is lower than in 6YS
(8.96 vs. 7.28, p = 0.0072). This finding is due to the fact that 1YS
showed a voluntary sleep deprivation (PSQI sleep duration scale
2.32 vs. 1.28, p = 0.0067), sleeping 2 hr less as 6YS (average sleep
duration 4.6 hr vs. 6.7 hr, p < 0.001), this reduction being based on
late bedtime. Withal, 1YS showed worse results on the PSQI day-
time dysfunction scale (1.86 vs. 1.08, p < 0.0001). Also, 1YS com-
pared to 6YS presented: very high personality anxiety vs. high,
(p = 0.0141), increased reactive anxiety vs. normal (p < 0.001) and
moderate vs. mild depression (p = 0.0002).
Conclusions: Medical students have a low quality of sleep. In spe-
cial, the 1YS reported a worse subjective quality of sleep because of
voluntary sleep deprivation. Also, 1YS showed an increased anxiety
and higher depression level. All together generate daytime dysfunc-
tion and probably have a negative effect on students’ performance.
Disclosure: Nothing to disclose.
P648 | Selective slow‐wave sleep suppression
affects glucose tolerance and melatonin
secretion
A. Polishchuk1,2,3; K.M. Liaukovich2; M. Meira e Cruz3;
K.A. Saltykov2; A.N. Nizhnik2; Y.V. Ukraintseva2
1Lomonosov Moscow State University, 2Institute of Higher Nervous
Activity and Neurophysiology of RAS, Moscow, Russian Federation,
3Cardiovascular Center of University of Lisbon, Lisbon Faculty of
Medicine, Lisbon, Portugal
Objectives/Introduction: As reported earlier, slow‐wave sleep
(SWS) suppression impairs morning glucose tolerance [Tasali et al.,
2008; Herzog et al, 2013], but exact mechanisms that underlie this
effect remains unclear. Among the candidates are changes in mela-
tonin secretion which are closely related to sleep quality [Rao et al.,
1996] and influences synthesis, secretion and action of insulin
[Cipolla‐Neto et al., 2014]. The present study aimed to explore a
possible role of melatonin in glucose tolerance impairment after
SWS suppression.
Methods: Healthy male volunteers (N = 14) with a regular sleep‐
wake cycle participated in two experimental sessions: a session with
selective SWS suppression during night sleep and a session with reg-
ular night sleep (control). SWS suppression was achieved by present-
ing an acoustic tone with gradually rising sound intensity until the
occurrence in polysomnogram signs of lighter sleep stages. Salivary
samples were collected seven times: three times in the evening
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(during dim light melatonin onset); twice in the night; and twice in
the morning (immediately after awakening and again 40 min later).
The samples were analysed by liquid chromatography‐tandem mass
spectrometry for melatonin. In the morning an oral glucose tolerance
test was performed and blood glucose was measured.
Results: The SWS suppression resulted in a reduction of its overall
duration by 58%. Morning glucose tolerance was significantly
impaired after selective SWS suppression (p = 0.023). Additionally,
SWS suppression led to marginally significant decrease of night
melatonin level (p = 0,076) and to the significant increase of mela-
tonin in the moment of awakening (p = 0.010).
Conclusions: Thus, the present study's findings indicate that SWS
plays an essential role in the regulation of melatonin production, and
a certain amount of undisturbed deep sleep is necessary for its nor-
mal secretion. Considering the influence of melatonin on the circa-
dian profile of insulin secretion and action, we may assume that
changes of its secretion as a result of disturbed sleep could led to
impairment of glucose tolerance.
This study was supported by the Russian Foundation for Basic
Research (RFBR grant number 18‐013‐01187 A).
Disclosure: Nothing to disclose.
METHODOLOGY & COMPUTATION 3
P649 | Validation of the sleep assessment
algorithm in the medical application Nightly and
comparing it to polysomnography in 30 healthy
individuals
A. Wichniak1; A. Wierzbicka2; A. Gaczkowska3; K. Rostek4;
W. Jernajczyk2
1Third Department of Psychiatry and Sleep Disorders Center, 2Sleep
Disorders Center, Department of Clinical Neurophysiology, Institute of
Psychiatry and Neurology, Warsaw, Poland, 3DreamJay Inc., San
Francisco, CA, United States, 4Institute of Automatic Control and
Robotics, Warsaw University of Technology, Warsaw, Poland
Objectives/Introduction: The most accurate way to objectively
measure sleep is polysomnography (PSG). Unfortunately, it is not
practical and too costly to be used in the majority of patients. These
problems led to the development of a medical application ‐ Nightly.
The application has the potential to combine both diagnostic and
therapeutic procedures for patients suffering from insomnia or night-
mares. Nightly measures with the use of smartphone sensors the
user′s motions during sleep and then computes the sleep pattern
from the received data. The objective of this study was to evaluate
the accuracy of sleep‐wake phase (WAKE, NREM and REM) recogni-
tion using the Nightly application comparing it to polysomnographic
recordings.
Methods: Thirty healthy volunteers (15/15 M/F; mean age
24.2 ± 4.9) were recruited. The subjects spent three consecutive
nights at a sleep laboratory. Sleep architecture was assessed using
polysomnography, non‐dominant wrist actigraphy (CamNTech,
Motionwatch 8) and Nightly application installed on iPhone model
SE. Sleep stages were scored visually according to AASM manual
version 2.4. Bland‐Altman plots were used to examine the degree of
agreement between PSG, Nightly and actigraphy for sleep latency
(SOL), total sleep time (TST), wake after sleep onset (WASO), and
sleep efficiency (SE).
Results: Nightly underestimated SOL (9.0 min vs. 15.3 min in PSG,
p < 0.05), showed good agreement for TST (444.5 min vs. 442.6 min
in PSG, not‐significant), not‐significantly overestimated WASO
(30.4 min vs. 24.1 in PSG) and showed very good agreement for SE
(91.9% vs. 91.9% in PSG). Actigraphy indicated mean SOL to be
6.0 min (p < 0.05 vs. PSG and p < 0.05 vs. Nightly), TST 449.8 min
(p < 0.05 vs. PSG), WASO 22.2 min (not‐significant), and SE to be
93.9% (p < 0.05 vs. PSG). The mean accuracy of Nightly to detect
sleep and wake phases as compared to PSG was 88.3 ± 5.2% (range
69.6% to 96.7%).
Conclusions: Nightly application is an effective tool for assessing
sleep and wake phase in healthy subjects as compared to standard
assessment methods in sleep medicine. The obtained data encourage
further development of this smartphone based application to evalu-
ate and treat sleep disorders.
Disclosure: Agnieszka Gaczkowska and Kornel Rostek are employ-
ees and shareholders of DreamJay Inc. that develops Nightly applica-
tion.
P650 | Gender differences in PSQI according
to the main sleep disorders groups
C. Reis1,2; L. Pilz3,4,5; L. Keller3,6; T. Alvarenga1;
T. Roenneberg3; T. Paiva1
1CENC ‐ Sleep Medicine Center, 2ISAMB ‐ Medical Faculty of Lisbon,
Lisbon, Portugal, 3Institute for Medical Psychology, Center for
Chronobiology, Medical Faculty, LMU, Munich, Germany, Munich,
Germany, 4Laboratório de Cronobiologia e Sono, HCPA/UFRGS, 5PPG em
Psiquiatria e Ciências do Comportamento, UFRGS, Porto Alegre, RS,
Brazil, 6Department of Child and Adolescent Psychiatry, University
Hospital Munich, Munich, Germany
Objectives/Introduction: The Pittsburgh Sleep Quality Index
(PSQI) is a widely used measure of sleep quality in research and clin-
ical settings. The aim of this study was to compare the PSQI scores
of the main sleep disorders groups with a sample from the general
population as well as to find scores gender differences.
Methods: The total sample was composed by 787 individuals. 341
individuals (mean age 35 ± 12 years old; 69% female) from the gen-
eral population (GP); 144 from insomnia (IN) (mean age
42.37 ± 12 years old; 67.4% female); 181 from sleep related breath-
ing disorders (SRBD) (mean age 51.51 ± 12 years old; 37.0% female);
35 from central disorders of hypersomnolence (CDH) (mean age
34.14 ± 12 years old; 60.0% female); 41 from circadian rhythms
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sleep‐wake disorders (CRSWD) (mean age 33.61 ± 12 years old;
30.8% female) and 55 from sleep related movement disorders
(SRMD) (mean age 43.25 ± 12 years old; 31.7% female). ANOVA
test was used to compare groups and logistic regression was used to
test if sex was associated to PSQI score, adjusting for age for each
group.
Statistical differences were considered for p value ≤0.05.
Results: The PSQI scores were: GP (5.75 ± 2.91), IN (11.53 ± 3.76),
SRBD (9.97 ± 4.78), CDH (9.53 ± 4.68), CRSWD (9.83 ± 4.60) and
SRMD (10.79 ± 4.65). The PSQI general score for the GP group was
different from all the clinical groups (p < 0.0001) as expected. In the
clinical groups differences were found between IN and SRBD
(p = 0.006) with the SRBR presenting the lowest mean value. Evalu-
ating gender differences in the groups they were found in: the GP
(OR = 1.15; 95% CI 1.05–1.26; p = 0.003); SRBD (OR = 1.13; 95%
CI 1.05–1.22; p = 0.001) and SRMD (OR = 1.58; 95% CI 1.22–2.04;
p = 0.001) presenting women the higher risk of have higher scores.
No differences were found for the other clinical groups.
Conclusions: Insomnia has the worst sleep quality among sleep
disorder groups followed by SRMD. Inside these groups there are
some presenting different scores between genders, suggesting that
we may have to interpret the PSQI scores taking it into account the
patient's sleep disorder.
Disclosure: Nothing to disclose.
P651 | Comparison between polysomnography
scoring of auto‐analyzing software with trained
technician
R. Heidari1; N. Nikoee2; M. Seyed Hoseini3,4; A. Najafi5;
A. Amali6; B. Amirzargar7
1Otorhinolaryngology/Sleep Medicine, Tehran University of Medical
Sciences/Occupational Sleep Research Center, 2Managment, Humanities
Electronic Unit Branch, Islamic Azad University, 3Managment, University
of Science and Technology, 4Managment, Iran University of Science and
Technology, 5Occupational Sleep Research Center, 6Otorhinolaryngology/
Occupational Sleep Research, 7Otolrhinoaryngology, Tehran University of
Medical Sciences, Tehran, Islamic Republic of Iran
Objectives/Introduction: Nowadays sleep disease is known as an
independent risk factor for many disease, and for diagnosis this dis-
order, polysomnography is gold standard, there are many software
which design in this field to decrease the time and cost of use the
trained technicians, in this study we want to comparison the param-
eters of automated analyzer software with a trained technician to
know which of them maybe reliable and can assist.
Methods: 20 patients who undergone full night polysomnography
class 1 randomly selected[A1] at sleep clinic of Baharloo hospital. A
sleep technologist who were blind to study, scored epoch by epoch
sleep stages and respiratory events according to recommended crite-
ria of AASM 2013 then an auto analysis was done using auto analy-
sis of N‐7000 amplifier. Results of auto analysis and the ones scored
by trained sleep technologist compared with SPSS software, descrip-
tive statistics were used for data analysis.
Results: Mean age and BMI was 40.85 (9.33) years and 29.9 (6.1)
Kg/ M2. total sleep time and sleep efficiency by A (auto analysis) was
significant more than M (manual scoring),(511.82 (35.34) VS 396.85
(75.97) for TST and 95.47 (3.74) VS. 74.14 (35.34) p value <0.01),
also, there were no concordance for Sum of apneas, hypopneas dur-
ing total sleep time which was much higher by A(Median 150 for A
vs. 43 by M p value <0.01). However, calculated number of hypop-
neas (in Non‐REM stage) in A and M analysis was quite similar with
no statistical significant difference. the least precision was observed
in scoring of stages 3 and REM stage for A scoring and the most
similarity between the two approaches for scoring stage N2.
Conclusions: Detecting hypopnea in non‐REM stage by auto ana-
lyzing software maybe the parameters that help the technicians to
use for scoring respiratory events, but there wasn't any similarity
between these two techniques for scoring polysomnography.
Disclosure: Nothing to disclose.
P652 | Improved actigraphy‐based sleep
monitoring through optimal parameter tuning
F. Ryser1,2; C. Baumann2; E. Montvai2; R. Gassert1; E. Werth2
1Rehabilitation Engineering Lab, Department of Health Sciences and
Technology, ETH Zurich, 2Department of Neurology, University Hospital
Zurich, Zurich, Switzerland
Objectives/Introduction: Wearable movement sensors have been
used for years as cost‐efficient and patient‐friendly alternative to
polysomnographic (PSG) measurements. For different wrist‐worn
devices, linear functions have been developed to quantify overnight
sleep when lights on and off times are known. However, these algo-
rithms show decreased performance when sleep efficiency is low,
which limits their field of application to non‐fragmented overnight
sleep. In order to make movement‐based sleep trackers applicable to
patient populations with unconsolidated sleep and daytime naps, we
aim to optimize the established linear sleep detection algorithms for
detecting sleep in longer activity recordings.
Methods: To model daytime activity including naps, we collected
data in a sleep laboratory setting where subjects performed alternat-
ing cycles of 160 min of wakefulness followed by 80 min of sleep
opportunity. They were equipped with an actimeter (Actiwatch Spec-
trum, Philipps Respironics) and a wearable inertial measurement unit
(JUMP, www.zurichmove.com) on their non‐dominant wrist. Naps
were recorded by PSG measurements. The dataset included in total
58 hr (7054 epochs of 30 s) of recording from two healthy subjects,
including 1651 epochs of sleep (23.3%) and 5421 epochs of wake
(76.7%), respectively. To score the data of the JUMP sensors, an
unconstrained genetic algorithm was used to optimize the eight
parameters of the linear algorithm presented by Cole et al. (Sleep,
1992). Two‐thirds of the dataset were used for training, one third
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for evaluation. The results were validated against PSG ground truth
and compared to the Actiwatch results.
Results: With our algorithm, an accuracy of 90.2% was achieved
(sensitivity: 88.5%, specificity: 90.8%). Compared to the Actiwatch
algorithm (accuracy: 59.6%, sensitivity: 98.3%, specificity: 44.9%),
the overall performance given by the accuracy has been considerably
increased from below 60% to above 90% while maintaining high
sensitivity and improving specificity.
Conclusions: We show that by optimizing the linear sleep detec-
tion algorithm for real‐world datasets containing more wake than
sleep phases, an algorithm initially biased towards sleep can be
tuned to favour wake detection. Our movement‐based sleep‐wake
detectors can more reliably classify daytime naps compared to an
Actiwatch, which extends the use of sleep trackers to patient popu-
lations with fragmented night sleep and daytime naps.
Disclosure: Nothing to disclose.
P653 | A smartphone based machine learning
method for the fine characterization of snoring
M. Holzwarth1; A. Bricout1,2; D. Colas1
1HOLI, Lyon, 2TIMC‐IMAG, CNRS, La Tronche, France
Objectives/Introduction: The large scale screening of sleep apnea
is limited by the complexity of currently available means of study.
Snoring is a cardinal sign of obstructive sleep apnea. However, its
subjective evaluation is random and its objective evaluation is done
within medical settings that go beyond the purpose of screening.
Automatic methods for analyzing snoring have been proposed. These
methods are based on either insufficient or unrealistic modeling
(specific microphones). Our goal was to build a model of detection,
and thus characterization, of snoring by the use of standard smart-
phones in real life conditions.
Methods: We used a machine learning approach in R: – Construc-
tion of a heterogeneous database of nocturnal audio recordings in
50 healthy volunteers (30–60 years old, ~50% males/females) using
their personal smartphone at home. ‐ Manual annotation of 10,000
snoring events were done – Spectral / temporal characteristics
according to PLoS ONE 8 (12) e84139 were extracted ‐ Those fea-
tures were used to feed a supervised learning Support Vector
Machine algorithm. Performance was evaluated using a Leave‐One‐
Out‐Cross Record procedure on the recordings.
Results: This approach yielded a statistical performance as follow:
success rate = 80% specificity = 84% sensitivity = 74% Cohen′s
kappa = 0.52 with F1Score = 0.73.
Conclusions: Using a machine learning method allowed us to imple-
ment a powerful acoustic snoring detection model into a standard
smartphone environment. This application can be deployed in clinical
studies for finely characterizing snoring or to asses positional snoring.
Disclosure: Funding was provided in part by BPI Excellence.
P654 | If you′re sleepy and you know it, …
B. Delwiche1; D. Neu2; N. Pattyn1; O. Mairesse2,3
1Vrije Universiteit Brussel, 2CHU Brugmann, 3Experimental and Applied
Psychology, Vrije Universiteit Brussel, Brussels, Belgium
Objectives/Introduction: The prevalence of sleepiness‐related
road, work and domestic accidents, suggests that humans may often
fail to correctly determine how sleepy they are. Although discrepan-
cies between subjective and objective sleepiness have repeatedly
been examined earlier, only very few studies have addressed these
inconsistencies using an adequate methodology. The purpose of this
study is to evaluate the potential overlap between objective and
subjective sleepiness levels, within an Item‐Response Theory frame-
work.
Methods: Twenty‐two healthy participants aged between 18 and
47 years, enrolled in a 36‐hr constant routine protocol. Every two
hours, participants reported their subjective level of sleepiness by
means of the Karolinska Sleepiness Scale (KSS) before performing a
20‐min multiple sleep latency test (MSLT) session. Raw KSS scores
and sleep latencies were calibrated into linear subjective and objec-
tive measures of sleepiness according to the Andrich Rating Scale
Model. Subsequently, measures were equated through Common Per-
son Linking (CPL), allowing to determine ‐within error‐ whether par-
ticipants subjectively over‐ or underestimate objective sleepiness
levels.
Results: Our results show that a 5‐category KSS presents with
improved measurement properties (rating scale functioning, item fit,
reliability/validity testing, measurement invariance). In addition, our
findings indicate that after calibration, usual MSLT‐thresholds may
require optimization, and that four unequally spaced categories bet-
ter reflect increasing levels of sleep propensity. CPL revealed a gen-
eral estimation bias for about 64% of the sample. Similar proportions
of subjects present with respective over‐ or underestimation of
sleepiness levels. Regarding time‐dependent biases, most estimation
errors tended to occur within the so‐called post‐lunch dip (day 1:
14:00; underestimation); during early morning hours (day 2: 4:00;
overestimation) and at the final trial (day 2: 20:00; overestimation).
Conclusions: Taken together, our findings suggest that in general,
most individuals make estimation errors, with around one third of
participants underestimating sleepiness levels. Moreover, these types
of errors more frequently occur when homeostatic pressure is high
and circadian wake drive is still low.
Disclosure: Nothing to disclose.
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P655 | Cardiac activity and wrist movements:
SomnoArt a new technology to assess sleep
architecture in healthy, depressed and insomniac
patients
A. Viola1; G. Fuchs1; J.Y. Schaffhauser2; J. Saoud2;
R. Luthringer3
1MDIS, 2PPRS, Colmar, France, 3Index Ventures, Geneva, Switzerland
Objectives/Introduction: Previously we showed how the inte-
grated analyses of heart rate and body movements during sleep can
lead to an equivalent evaluation of sleep architecture and continuity
to the one obtained from polysomnographic recordings (Muzet et al.
2016). These data were based on 60 nights records from healthy
subjects. The aim of the current study was to confirm that this new
approach of sleep stage scoring can also be applied to patients. Fur-
thermore, a larger pool of healthy control subjects has also been
assessed.
Methods: The results presented here are based on 590 sleep
nights (333 healthy, 55 insomniacs and 202 depressed patients) that
have been recorded in 76 healthy volunteers and 151 patients. The
recordings combined standard PSG and recording heart rate and
body movements. The data were processed for PSG scoring accord-
ing to the AASM's rules and for heart rate and body movement
using the Somno‐Art software. A comparison of the extracted sleep
architecture and continuity parameters was performed.
Results: Based on the statistical analyses as intra‐class correlation
coefficient, the band Altman and the box‐plot comparisons, shown a
good and excellent agreement between the PSG scoring and the
Somno‐Art analyses for the various sleep parameters.
Conclusions: In conclusion, SomnoArt new sleep scoring approach
represents a valid alternative to the cumbersome PSG recordings and
brings a valuable advantage over PSG given the fact that of the easy
to use recording system which can be carried out repeatedly in ambu-
latory settings in both healthy subjects and pathological patients.
Disclosure: Nothing to disclose.
P656 | Correlation between the score of
“STOP BANG” questionnaire and the severity of
the OSA
S. Arbutina; J. Stojkovic; G. Breskovska; M. Zdraveska;
D. Dokic; C. Trajkovska
PHI Clinic of Pulmoallergology, Skopje, The former Yugoslav Republic of
Macedomia
Objectives/Introduction: Obstructive sleep apnea (OSA) is the
most prevalent sleep‐breathing disturbance, affecting 24% of men
and 9% of women in the general population.Studies have shown that
patients with OSA will have an increased incidence of: coronary
artery diseases, hypertension,congestive heart failure,
cerebrovascular accidents, gastroesophageal reflux disease, etc…
The “STOP BANG” questionnaire has been developed to be screen-
ing tool for obstructive sleep apnea. STOP BANG consists of 8 yes
or no questions based upon snoring, tiredness/sleepiness, observed
apneas, high blood preasure, BMI > 35 kg/m2, age >50 years, neck
circumference >40 cm, and male gender.
Aim: Of our studuy was to determinate a correlation between the
score of “STOP BANG” questionnaire and the severity of the OSA.
Methods: We included 70 pts who were highly suspected for
OSA. All of them were given a questionnaire STOP BANG. Patients
who had a score of more than 4 were included in study.For assess-
ment of severity of the desease it was performed home sleep study
.The severity of sleep apnea based upon the AHI and categorized
into 4 groups: none (AHI < 5/hr), mild (AHI ≥ 5 to <15/hr), moderate
(AHI ≥ 15 to <30/hr), and severe (AHI ≥ 30/hr).
Results: We found that with the score 4, only one patient had >5
AHI, 2 pts had 5–15 AHI, no one had 15–30 AHI, and 1 had more
than 30 AHI. With score 5: no one has <5 AHI, 2 pts had 5–15 AHI,
1 had 15–30 AHI, 3 had <30 AHI. With sore 6 no one had AHI <5.3
of ptshad 5–15, 3 had 15–30, and 7 had more than 30 AHI. With
score 7, no one had <5 AHI, 3 pts had 5–15, 5 has 15–30 and 10
had <30 AHI. With score 8 No one had <5 AHI, 4 had 5–15, 10 had
15–30 and 15 pts had more than 30 AHI.
Conclusions: High STOP BANG score indicated a higher probabil-
ity of heavier disease. The probability to have more severe OSA
increases with high scores of STOP BANG more sever.
Disclosure: Nothing to disclose.
P657 | Can smartphone sleep applications
reliably assess sleep‐wake cycle? Preliminary
findings from a PSG study
M. Mazzetti1; E. Fino1; F. Pizza2; S. Vandi3; G. Plazzi2
1Department of Experimental, Diagnostic and Specialty Medicine
(DIMES), 2Department of Biomedical and Neuromotor Sciences
(DIBINEM), University of Bologna, 3IRCCS, Istituto delle Scienze
Neurologiche, AUSL di Bologna, Bologna, Italy
Objectives/Introduction: Smartphone applications are considered
as the prime candidate for the purposes of large scale, low cost and
long term sleep monitoring. How reliable is smartphone assessment
of sleep remains a key issue and more validation studies with both
healthy and patient populations are needed. In this study we com-
pared the performance of four smartphone applications (Sleep Cycle‐
accelerometer; Sleep Cycle‐microphone; Smart Alarm; Sense) with
polysomnography (PSG). Our main objective was evaluating whether
sleep reports provided by applications offer reliable assessment of
standard sleep parameters and establishing which of the application
features result more promising for personal home use.
Methods: 20 healthy participants were recorded at home, for two
consecutive nights. Four iPhone applications (two per each night)
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designed for sleep‐wake detection were used simultaneously with
continuous PSG.
Results: Pearson's correlation coefficients between PSG parameters
(Time in bed, TIB; Total Sleep Time, TST; Wake After Sleep Onset,
WASO; Sleep Efficiency, SE; Sleep Latency, SL; NREM Sleep Stages
1–4, N1, N2, N3, N4; Slow Wave Sleep, SWS; Rapid Eye Movement
Sleep, REM) and app reports were calculated. Significant correlations
are reported below. Sense: TIB (app) and TIB (PSG): r = 0.713,
p = 0.003; TST (app) and TST (PSG): r = 0.777, p = 0.001; Sleep
Score (app) and SE (PSG): r = 0.482, p = 0.069; Light Sleep (app) and
N1 + N2 + REM (PSG): r = 0.424, p = 0.062; Sleeping Soundly (app)
and N3: r = 0.596, p = 0.019; Sleeping Soundly(app) and N4 (PSG):
r = 0.520, p = 0.047. Smart Alarm: TIB (app) and TIB (PSG):
r = 0.944, p < 0.001; Time Awake (app) and WASO (PSG): r = 0.473,
p = 0.035; Sleep Quality (app) and SE (PSG): r = 0.431, p = 0.057.
Sleep Cycle-accelerometer: TIB (app) and TIB (PSG): r = 0.672,
p = 0.002; Sleep quality (app) and SE (PSG): r = −0.480, p = 0.038.
Sleep Cycle-microphone: TIB (app) and TIB (PSG): r = 0.492,
p = 0.045; Sleep quality (app) and TIB (PSG): r = −0.522, p = 0.032.
Conclusions: Two apps provided partially reliable estimates of SE
and showed significant correlations with TST and WASO measured
by PSG. Only one app showed significant correlations with SWS
parameters. In general, the examined apps do not offer reliable sleep
stage data, not discriminating light sleep from deep sleep and espe-
cially not providing any estimate of REM.
Disclosure: This work was partially supported by a research grant
from Fondazione Altroconsumo.
P658 | Does mattress zoning affect the
biomechanics of sleep?
A. Chohan; H. Shore; L. Smith; J. Richards
Health Sciences, University of Central Lancashire, Preston, United
Kingdom
Objectives/Introduction: A sleep system should provide enough
support to keep spinal alignment close to neutral throughout the
night minimising muscle activity. Mattress zoning is one of the latest
developments in pocket sprung mattress design aiming to improving
sleep quality by improving spinal alignment.
Methods: Ten Qualisys™ cameras recorded movement of the spine
in 6 degrees of freedom using a multisegment spine model during
side lying on two aesthetically identical mattresses, internally one
mattress included a zoned area. Subjective measures of perceived
mattress comfort and perceived firmness were taken, whilst peak
pressure was measured at the hip and shoulder.
Results: On a sample size of 20 healthy participants, there were no
significant differences in the peak pressure at the shoulder. How-
ever, there was at the hip (p = 0.004) with the non‐zoned mattress
having lower pressures (2.63 kPa) than the zoned (2.92 kPa). There
was no significance relating to perceived mattress firmness or
comfort though it should be noted that 65% of participants pre-
ferred the zoned.
Spinal posture was measured in terms of how far posture varied
from a neutral position. Within the sagittal plane there were signifi-
cant differences between the zoned and non‐zoned mattresses at
the upper lumbar to lower lumbar region (p = 0.046) with the Zoned
mattress deviating the least. The coronal plane showed significant
differences in the upper thoracic to mid thoracic (p = 0.038) and
lower thoracic to upper lumber (p = 0.024) with Zoned deviating the
least. The Zoned mattress demonstrated less rotation within the
lower lumber to pelvis segment (p = 0.012).
Conclusions: This study suggests that whilst zoned mattresses do
not disperse pressure as effectively at the hip, it is in fact more sup-
portive to compensate as it reduces “hammocking” and improves
overall spinal alignment. The zoned mattress outperformed the non‐
zoned mattress in key areas around the lower lumbar to pelvic
region suggesting that it may help to reduce torsional strains, poten-
tially helping individuals with LBP. The findings of this study show a
multi‐factorial approach is beneficial in understanding our interaction
with sleep surfaces.
Disclosure: Staff time was funded by a University Investment Vou-
cher, match‐funded by Silentnight Group Ltd.
P659 | Automatic human sleep stage scoring
using Deep Neural Networks
A. Malafeev1,2,3; D. Laptev4; S. Bauer4; X. Omlin2,5;
A. Wierzbicka6; A. Wichniak6,7; W. Jernajczyk6; R. Riener2,3,5;
J. Buhmann4; P. Achermann1,2,3
1Institute of Pharmacology and Toxicology, University of Zurich,
2Neuroscience Center Zurich, University of Zurich and ETH Zurich,
Zurich, 3Center for Interdisciplinary Sleep Research, University of Zurich,
Center for Interdisciplinary Sleep Research, 4Institute for Machine
Learning, Information Science and Engineering, 5Sensory‐Motor Systems
Lab, ETH Zurich, Zurich, Switzerland, 6Sleep Disorders Center,
Department of Clinical Neurophysiology, 7Third Department of
Psychiatry, Department of Clinical Neurophysiology, Institute of
Psychiatry and Neurology, Warsaw, Poland
Objectives/Introduction: Sleep research and medicine require the
analysis of polysomnography (PSG). According to the current stan-
dard sleep stages shall be visually scored by an expert. Scoring is
time consuming and to some degree subjective. It is important to
develop tools for automatic sleep stage detection. Artificial neural
networks are used to classify data. Particularly, Deep Neuronal Net-
works (DNNs) perform better than other machine learning (ML)
methods for various problems and types of data, including pattern
recognition in images and time‐series. Convolutional Neural Net-
works (CNNs) are the best for images and Recurrent Neural Net-
works (RNNs), especially the Long‐Short Term Memory (LSTM)
networks are suited for time‐series analyses.
Methods: Data were recorded in two laboratories:
(1) 18 healthy young males (3 nights each);
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(2) patients suffering from narcolepsy (n = 23) or hypersomnia
(n = 5).
Sleep at night and a Multiple Sleep Latency Test (MSLT; approx.
9 hr continuous recording). We developed networks which included
CNN and LSTM modules. The networks worked with raw data. We
trained these networks using a subset of the data (healthy subjects
only; mixed data) and validated them on the remaining data which
were not used for training. We also used classical ML methods for
comparison.
Results: All our methods trained on healthy participants performed
very well on the data of healthy subjects for all sleep stages (F1
scores 0.85–0.95) except stage 1 (F1 score ~0.4) and slightly worth
on patients (0.6–0.8). LSTM networks showed better performance
for stage 1 than other methods. Deep learning methods showed bet-
ter performance than classical ML methods on the patient data, i.e.
they generalize better. All methods improved when we included
patient data into the training dataset.
Conclusions: We demonstrated that DNNs performance on sleep
scoring is close to human expert scoring in both healthy adults and
patients. The detection of stage 1 was also similar to experts. Taking
the temporal structure of sleep into account was important. DNNs
generalized better than other methods. Our algorithms could benefit
from larger and more diverse training datasets. Supported by nano‐
tera.ch and the Swiss National Science Foundation.
Disclosure: Nothing to disclose.
P660 | Finding the ideal sleep solution: are you
sleeping comfortably?
A. Chohan1; H. Shore1; J. Richards1
1Health Sciences, University of Central Lancashire, Preston, United
Kingdom
Objectives/Introduction: Humans spend around a third of a life-
time in bed. There are a variety of mechanisms that reduce back
pain and improve quality of sleep by decreasing spinal muscle activ-
ity, improved spinal alignment, and reducing pressure at main con-
tact areas between the body and the sleep surface; one of which
involves mattress comfort layers.
Methods: Ten Qualisys™ cameras recorded movement of the spine
using a multisegment spine model during side‐lying on three visually
identical mattresses. Internally mattresses contained a zoned 1,000‐
count spring configuration, each had a different comfort layer of
equal depth (Geltex, Latex and Memory Foam). Peak pressure distri-
bution was measured at the hip and shoulder. Additional comfort
and firmness ratings were recorded.
Results: Twenty healthy participants showed a statistically signifi-
cance difference in the peak pressure of the shoulder (p < 0.001).
Pairwise comparisons showed that Geltex was significantly different
to Latex (p < 0.001; 2.36 kPa) and Memory Foam (p < 0.05;
2.41 kPa). Mattress peak pressure at the shoulder changed
significantly over time (p < 0.01) for Geltex (p < 0.05) and Latex
(p < 0.05) but not Memory Foam. Lower peak pressures were shown
at the hip for Geltex (2.17 kPa) when compared to Latex (p = 0.013;
2.39 kPa) and Memory Foam (p < 0.001; 2.51 kPa). Though Geltex
was perceived the most firm, hip peak pressure changes significantly
over time in Latex (p < 0.001) and Memory Foam (p = 0.004) but
not Geltex. The coronal plane showed statistically significant differ-
ences between mattresses (p = 0.016) within the lumbar region with
differences shown between: Geltex and Latex (p = 0.011), Geltex
and Memory Foam (p < 0.05) and Latex and Memory Foam
(p = 0.002). The lower lumbar to pelvis segment also showed signifi-
cant difference (p = 0.046) between: Geltex and Memory Foam
(p < 0.05) and Latex and Memory Foam (p < 0.05). The sagittal
plane showed statistically significant differences (p = 0.041) the
lower thoracic and lumbar segment between Geltex and Latex
(p = 0.012) and Geltex and Memory foam (p = 0.005).
Conclusions: Evidence suggests that a Geltex comfort layer dis-
perses pressure at the hip and shoulder more effectively than Latex
or Memory Foam. Geltex showed significantly less deviation from
the spinal neutral position in key areas around the lower lumber sug-
gesting a more neutral spinal posture improving spinal health.
Disclosure: Staff time was funded by The Silentnight Group Ltd.
P661 | Validation of Russian version of the
dysfunctional beliefs about children′s sleep scale
D. Kudryashov1; A. Tkhostov1; E. Rasskazova1;
T. Botasheva2; V. Vasil'eva2; O. Zavodnov2
1Psychology, Moscow State University, Moscow, 2The Rostov State
Medical University, Rostov‐on‐Don, Russian Federation
Objectives/Introduction: The influence of dysfunctional beliefs of
a person on assessment of his own activity has been confirmed in
studies of cognitive psychologists. Moreover, a special group of dys-
functional beliefs about sleep that lead to chronic insomnia was identi-
fied. It can be argued that understanding the psychological factors of
sleep disorders in children and adults is important for the research,
treatment and prevention of a large class of sleep disorders. The aim
of this study was to validate the Russian version of the Dysfumctional
Beliefs About Children Sleep Scale (DBACS; Ng et. al., 2012).
Methods: 101 children, ages 5–13 years old (44 females, mean age
8.36 ± 2.41 years) and their parents participated in the study. Chil-
dren were interviewed about their sleep quality using Sleep Self‐
Report (SSR; Owens et al., 2000) and checklist measuring their sleep
vulnerability (12 reasons for their disturbances: “To what degree
your sleep is disturbed by … stress, strong emotions etc.”) while
their parents (93 females, age 24–52) completed Children Sleep
Habits Questionnaire (CSHQ; Owens et. al. 2000), DBACS and the
same checklist about their child′s sleep vulnerability. Cronbach′s
alpha for children's checklist was 0.68 and for parents’ checklist was
0.82. All questionnaires were translated and back‐translated.
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Results: Russian version of DBACS demonstrated good reliability
(Cronbach′s alpha was 0.83). Cronbach′s alpha for SSR was 0.83.
DBACS total score correlated with children′s sleep vulnerability both
appraised by parents and children (r = 0.35 and r = 0.38, p < 0.01),
CSHQ total score(r = 0.38, p < 0.01), SSR total score and its Day-
time sleepiness subscale (r = 0.20 and r = 0.32, p < 0.01) that fur-
ther supported validity of DBACS. No gender differences or age
effects were found.
Conclusions: Results support the reliability and validity of Russian
version of the DBACS and support the importance of psychological
factors of sleep disorders studying. Further research is needed to
explore psychological factors of sleep problems across the various
clinical groups and the ways of psychological treatment and preven-
tion of that problems in Russia.
Acknowledgements: Research is supported by the Russian Foun-
dation for Basic Research, project No. 17‐06‐00363.
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P662 | Classification of obstructive sleep
apnea with and without REM sleep behavior
disorder based on convolutional neural network
using cardiopulmonary coupling spectrogram
J.-U. Park1; E. Urtnasan1; E.-Y. Joo2; K.-J. Lee1
1Department of Biomedical Engineering, Yonsei University, Wonju,
2Department of Neurology, Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul, Republic of Korea
Objectives/Introduction: This study proposes a method of
automatically classifying pateints of Obstructive Sleep Apnea
(OSA) with and without REM sleep behavior disorder (RBD) based
on convolutional neural network (CNN) using cardiopulmonary
coupling (CPC) spectrum induced from a single‐channel electrocar-
diogram (ECG).
Methods: Nocturnal polysomnography (PSG) recordings were
obtained during the sleep of 62 subjects (with RBD group: 33,
without RBD group: 29) at Samsung Medical Center (Seoul,
Republic of Korea). Data were divied into training set of 49 sub-
jects and test set of 13 subjects in order to train and test CNN
structure. ECG‐based CPC analysis was conducted using Embla
CPC (Embla systems LLC, USA). And, CPC spectograms were used
as input data of CNN to classify OSA with and without RBD
group. CNN has three layer structure (first layer: filter N. (80), fil-
ter size (2 × 3), activation function (rectified linear unit, RELU),
pooling size (1 × 4); second layer: 40, 2 × 3, RELU, 1 × 4; and
third layer: 16, 2 × 3, RELU, 1 × 4). Finally, all neurons are fully
connectd and learning process is performed through feedforward
and back propagation algorithms.
Results: The classification performance showed accuracy, sensitiv-
ity and specificity of 84.6%, 88.0% and 80.0% for test set (positive:
with RBD, negative: without RBD, respectively.
Conclusions: The CPC‐based method has the potential for auto-
matically classifying OSA with and without RBD patients in a home
environment without any other physiological signals.
Disclosure: All authors declares that he or she has no conflict of
interest.
P663 | Activity monitor setup with two
sensors
J. Virkkala1,2
1Sleep Laboratory, Finnish Institute of Occupational Health, 2Clinical
Neurophysiology, University of Helsinki and Helsinki University Hospital,
Helsinki, Finland
Objectives/Introduction: Actigraphy is a common technique for
sleep‐wake classification and for activity monitoring. Usually for
sleep‐wake classification, a monitor is placed on the non‐dominant
wrist. It would be beneficial to have an additional sensor on e.g. the
trunk, indicating body position and movement. Using two standard
activity monitors results in a problem of synchronizing the signals in
long recordings. Use of two devices also doubles the cost of the
setup. We combined a standard clinical actigraph monitor and a low‐
cost movement sensor in a wireless setup.
Methods: ActiGraph GT9X and wGT3X devices (ActiGraph, LLC)
have the possibility to store heart rate (HR) from heart rate monitors
over Bluetooth. We custom programmed a low‐cost, general‐pur-
pose, coin‐size movement sensor Movesense (Suunto Oy, a sub-
sidiary of Amer Sports Corporation) to transmit position information
encoded as HR information. Movesense integrates 9‐DOF move-
ment, temperature, heart rate, and ExG sensors with a built‐in mem-
ory. In this study, the Movesense device single axis acceleration
values −1.27 to 1.27 g were transformed and transmitted as 1–
255 bpm HR to the ActiGraph monitor and stored synchronously
with monitor activity once per second.
Results: We evaluated the setup by connecting the two sensors
together and recorded for a period of 2 weeks. The sensors’ corre-
sponding acceleration values were identical to resolution of sensor.
Conclusions: With the simple addition of a low‐cost movement
sensor we created an activity monitor setup with two synchronized
signals from different body locations. One sensor provides standard
activity monitor data and the other low‐cost sensor provides addi-
tional information about body position. Instead of body position sen-
sor, the sensor can be programmed to provide e.g. activity counts
when placed on the waist, information about standing when placed
on the thigh, periodic leg movements when placed on the ankle, or
possibly even breathing movement when placed over the thorax.
Disclosure: Nothing to disclose.
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P664 | The influence of between shift
recovery duration and time of day on sleep: an
analysis of 14 field actigraphy studies
R. Matthews1; M. Ingre2; S. Salminen3; A. Fletcher4;
G. Kecklund5; J. Axelsson5
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Sweden, 3Finnish Institute of Occupational Health, Helsinki, Finland,
4Integrated Safety Support, Melbourne, SA, Australia, 5Stockholm
University, Stress Research Institute, Stockholm, Sweden
Objectives/Introduction: Shiftwork and flexible working hours
are common in modern society. Across shiftwork industries, an
immeasurable number of roster combinations of work and rest are
used. Sleep duration prior to shift is an important factor in fatigue
risk management. While it is clear that shorter recovery times curtail
the opportunity to sleep, questions remain on how time of day
affects this relationship. Hence, this study used sleep diary and activ-
ity data from multiple worksites, to investigate how rest duration
and timing between shifts affects sleep duration and sleepiness.
Methods: The analyses were based on diary and actigraphy data
from 328 subjects in 14 data collections at 11 work sites in Sweden,
Finland and Australia, totally rendering data on 4,000 sleep episodes.
The recovery times between shifts were used to predict sleep dura-
tion before morning, evening and night shifts using multilevel mixed
effects modeling.
Results: Sleep duration was strongly associated to recovery times
between shifts, particularly before evening and night shifts
(b = +0.31 hr of total sleep time for each hour of recovery time,
p = 0.012; and b = +0.34 hr, p < 0.001, respectively). More recovery
time before morning shifts was also a significant predictor of sleep
duration (b = +0.12 hr, p < 0.001), but this amount of sleep seemed
more affected by schedule specific factors, e.g. the starting time of
the morning shift. In addition, sleep duration was strongly affected
by work site and individual differences.
Conclusions: Sleep duration prior shifts are curtailed by a number
of factors including (1) short recovery times between shifts, (2) circa-
dian influences (most dramatically shortened prior evening and night
shifts), (3) shift specific aspects (e.g. change‐over times), and (4) indi-
vidual differences. It is recommended to avoid recovery times
shorter than 12 hr off between shifts, since it drastically increase
the amount of workers having curtailed sleep.
Disclosure: Nothing to disclose.
P665 | A new tool for automatic detection of
microsleeps during sleep restriction: validation in
healthy volunteers
S. Takillah1,2; M. Guillard1,2; P. Van Beers1,2;
M. Quiquempoix1; A. Rabat1,2; M. Chennaoui1,2
1Fatigue and Vigilance Team, French Armed Forces Biomedical Research
Institute, Brétigny‐sur‐Orge, 2EA 7330 VIFASOM, Université Paris
Descartes, Paris, France
Objectives/Introduction: Hypovigilange is characterized by symp-
toms which are itchy eyes, slow eyes blink movements, incorrect
decision making and microsleeps. Therefore, there is a need for a
new tool providing automatic detection at least for microsleeps
when people fells drowsiness. Our approach consists to provide a
new algorithm based on multisensor electroencephalogram (EEG)
measurements.
Methods: 12 healthy males volunteered (20–36 years old, height
(mean ± SD): 1.78 ± 0.08 m, weight: 75.1 ± 7.1 kg, body mass index
(BMI): 23.8 ± 2.1) were included in this laboratory‐controlled proto-
col. Polysomnographic recording devices were used continuously to
collect six channels: frontal (F3‐M2, F4‐M1), central (C3‐M2, C4‐M1)
and occipital (O1‐M2, O2‐M1) EEG derivations on MWT. In order to
assess the performance of automatic microsleeps detection compara-
tively with a manual scoring (2 experts of conventional polysomno-
grams), maintenance of wakefulness test (MWT‐40 min) was
performed in a previous sleep restriction protocol (Bougard et al
2018). The MWT was conducted in the sleep laboratory, in a dark-
ened bedroom according to the AASM recommendations (Littner
et al., 2005).
Results: For all signal considered, the features are extracted in the
spectral domain. Traditionally and according to the AASM recom-
mendations, microsleeps were defined as the time sleep episodes
between 3–15 s during which 4–7 Hz (theta) activity replaced the
waking 8–13 Hz (alpha) background rhythm. Microsleeps episodes
were extracted by: (i) smoothing the filtered power of 4–7 Hz Morlet
wavelet transform with a Kalman filter and (ii) using a double thresh-
old and persistence greater than 3 s and less than 15 s. The area
under the curve of the ROC (Receiver Operating Characteristic)
curve was used to characterize performance of the automatic detec-
tion comparatively with the traditional visual detection (TPR = 0.76;
FPR = 0.12; PPV = 0.86; F1 = 0.81; ACC = 0.82).
Conclusions: Our results establish the validity of our algorithm
which appears as a good candidate for automatic microsleeps detec-
tion during sleep restriction. Therefore, our algorithm has an obvious
potential for reducing the cost and increasing the efficiency of
microsleeps scoring.
Disclosure: Nothing to disclose.
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P666 | Level of consciousness during
anesthesia and sleep is indexed by the spectral
scaling exponent of resting EEG
M. Colombo1; M. Napolitani2; O. Gosseries3,4; S. Casarotto2;
M. Boly5; M. Rosanova2; S. Laureys4; B. Riedner3; F. Siclari6;
M. Massimini2,7; A. Chieregato1; S. Sarasso2
1Neurosurgical Intensive Care, ASST Grande Ospedale Metropolitano
Niguarda, 2Dipartimento di Scienze Biomediche e Cliniche ‘L. Sacco’,
Università degli Studi di Milano, Milan, Italy, 3Department of Psychiatry,
University of Wisconsin‐Madison, Madison, WI, United States, 4Coma
Science Group, University and University Hospital of Liège, GIGA‐
Research B34, Liège, Belgium, 5Department of Neurology and
Department of Psychiatry, University of Wisconsin‐Madison, Madison,
WI, United States, 6Centre d'Investigation et de Recherche sur le
Sommeil, Lausanne University Hospital and University of Lausanne,
Lausanne, Switzerland, 7Istituto Di Ricovero e Cura a Carattere
Scientifico, Fondazione Don Carlo Gnocchi, Milan, Italy
Objectives/Introduction: The presence of consciousness cannot
be reliably inferred from behavioural responsiveness. Indeed, anes-
thetic agents cause behavioural unresponsiveness; while some
(xenon, propofol) promote unconsciousness, others (ketamine) pro-
mote dream‐like consciousness. This is paralleled by sleep states that
promote unconsciousness (N3) and by others that preserve it, with
the presence of dreams (REM). It is important for a robust and reli-
able marker of consciousness to separate unconsciousness beyond
behavioural unresponsiveness.
Methods: The decay of the power spectral density (PSD) of resting
electroencephalography (EEG) was evaluated as a marker of con-
scious experience during anesthesia, and validated during sleep loss
of consciousness.
The spectral scaling exponent of the PSD was obtained, after de‐
biasing for oscillatory peaks, over a broad band (1–40 Hz) and in two
sub‐bands. In the anesthesia dataset, three groups of five healthy
subjects were measured during and before the anesthesia with either
Propofol, Xenon or Ketamine. In the sleep dataset, five healthy sub-
jects were awakened multiple times through the night, resulting in
short recordings in different sleep stages.
Results: States supporting consciousness (wakefulness, ketamine‐
anesthesia) were clearly separated from states of unconsciousness
(Propofol, Xenon) by considering the spectral exponent of the PSD,
in particular when jointly considering the two sub‐bands. The spec-
tral exponent greatly decreased within each subject due to loss of
consciousness. Similarly, the exponent was lower in unconscious
deep sleep (N3) than in wakefulness and REM sleep.
Conclusions: Unsconsciousness could be reliably discriminated
from behavioural unresponsiveness, by a steeper decay of the PSD
of resting EEG. In the future, the measure could help to assess intra-
operative awareness during anesthesia, to monitor patients with dis-
orders of consciousness and to perform automatic sleep staging.
Disclosure: Nothing to disclose.
P667 | Representation of polysomnography
recordings as low dimensional trajectories in
latent space
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1EA 7330 VIFASOM, Université Paris Descartes, 2Centre du Sommeil et
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Appliquées, Ecole Polytechnique, Palaiseau, 4Institut de recherche
biomédicale des armées, Paris, 5Service de Neurophysiologie Clinique,
Hôpital Timone, Marseille, France
Objectives/Introduction: Polysomnography (PSG) recordings are
the gold standard in the study of sleep, where multiple biophysiolog-
ical signals are recorded from subjects, such as electroencephalogram
(EEG), electrooculogram (EOG), electromyogram (EMG) and respira-
tory activity (nasal flux and oxygen saturation). The qualitative evalu-
ation of sleep sessions (sleep scoring) is based on the visual
identification of sleep stages by experts according to the traditional
Rechtschaffen and Kales (R&K) standard and the more recent stan-
dard by the American academy of sleep medicine (AASM). The suc-
cession of sleep stages results in the hypnogram of the PSG
recording. However, recent studies have shown that inter‐expert
agreement in sleep scoring is variable and in the order of 85%. In
addition, hypnograms may not be discriminating enough to identify
certain sleep disorders, such as paradoxical insomnia. Our aim is to
use modern methods of machine learning in order to obtain an alter-
native, and hopefully more discriminative description of sleep, that
lies between the explicit biophysiological signals of the PSG and the
succinct representation of the hypnogram.
Methods: We use autoencoders to project the multi‐channel repre-
sentation of PSG recordings into trajectories in a latent space of 2
or 3 dimensions. Autoencoders are unsupervised machine learning
models that learn to compress information into representations of
lower dimension (latent space). Importantly, this compression forces
the model to represent similar signals into the same regions of the
latent space.
Results: A preliminary analysis with a small cohort of healthy sub-
jects enabled to distinguish between successful nights of sleep from
more atypical ones by visual inspection of latent space trajectory.
Conclusions: The representation of sleep sessions as trajectories in
low dimensional latent space provides an intermediate description of
sleep between the highly complex and explicit signals of PSG record-
ings and the succinct representation of hypnograms. These latent
space trajectories are promising tools to complement the standard
hypnogram and may enable better identification of sleep disorders.
Disclosure: Nothing to disclose.
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P668 | Prevalence of reported excessive
daytime sleepiness among Moroccan patients
diagnosed with Obstructive sleep apnea‐
hypopnea syndrome and it's correlation with
Epworth sleepiness scale
A. Jniene1,2; J. Achrane1; L. Harrak1; L. Achachi1;
M. El Ftouh1
1Department of Pulmonology, Mohammed V University / Ibn Sina
University Hospital Center, Ibn Sina Hospital, 2Mohammed V University /
Laboratory of Physiology, Faculty of Medicine and Pharmacy, Rabat,
Morocco
Objectives/Introduction: A large proportion of adult patients
who presents to sleep disorder centers have disorders associated
with excessive daytime sleepiness (EDS). These include Obstructive
sleep apnea‐hypopnea syndrome (OSAHS) which is a common global
health disorder characterized by periodic complete or partial upper
airway obstruction during sleep despite ongoing respiratory effort. It
is associated with sleep disorder symptoms including loud snoring,
disturbed and frequent wake‐up during sleep and EDS. Because EDS
is a subjective symptom that is often confused with chronic fatigue,
the Epworth Sleepiness Scale (ESS) has been developped as a simple
self‐administered questionnaire with less subjectivity. The objective
of this study is to assess the prevalence of EDS in a group of
Moroccan patients diagnosed clinically and polysomnographically
with OSAHS and its correlation with the ESS.
Methods: This is a retrospective study of 53 charts from patients
diagnosed with OSAHS in the pulmonology department of Ibn Sina
Hospital between October 2016 and December 2017.
Results: We evaluated 53 patients with OSAHS (38 men and 15
women) with a mean age of 47.8 ± 12.9 years. The prevalence of
EDS was 98.1% and the ESS was greater than 10 in favor of an EDS
in 58.5%. There was no statistically significant relationship between
reported EDS and the ESS (p: 0.2).
Conclusions: The high prevalence of EDS reported by patients is
probably due to the confusion with other conditions essentially
chronic fatigue. Although these semiological concepts present funda-
mental differences from physiological and pathological points of
view, general medical literature still often confuses both symptoms
because of the lack of distinction in the clinical use of terms. ESS is
considered as part of clinical questionnaires and indices that may
lead to suspicion of sleep apnea in a person. However, it's interest-
ing to consider new non‐invasive, easily realizable and more objec-
tive clinical tools.
Disclosure: Nothing to disclose.
P669 | Hypertension control in OSA ‐ data
from the European Sleep Apnea Database
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Objectives/Introduction: Obstructive sleep apnea (OSA) is a rec-
ognized risk factor for hypertension. The effectiveness of various anti-
hypertensive drugs in OSA is limited and only few small size controlled
trials have been published on this topic. We analyzed blood pressure
(BP) status and medication in the large European Sleep Apnea Data-
base (ESADA) cohort. We hypothesized that drugs that limit sympa-
thetic nerve traffic may have advantageous hemodynamic effects in
OSA.
Methods: 5,568 patients from 33 European centers within the
ESADA network were recruited. Office BP was assessed in hyper-
tensive OSA patients receiving monotherapy (n = 3,375, mean age
52.2 ± 10 years, BMI 32.7 ± 7 kg/m2, apnea‐hypopnea index (AHI)
33.5 ± 26 n/hr) or dual therapy (n = 2,193, mean age
59.3 ± 10 years, BMI 33.5 ± 7 kg/m2, AHI 33.8 ± 26 n/hr). The fol-
lowing antihypertensive drugs were evaluated; betablockers (BB),
diuretics (DIU), renin‐angiotensin blockers (RAB), calcium channel
blockers (CCB), and centrally acting antihypertensives (CAH). Hemo-
dynamic data were analyzed for any single or combination of drug
class by means of generalized linear models. Confounders like age,
BMI, gender, AHI and comorbidities including ischemic heart disease,
cardiac failure, and diabetes were addressed. Metabolic parameters
(HbA1c, cholesterol) were analyzed for each treatment.
Results: In monotherapy, systolic BP in hypertensive OSA patients
on BB (n = 587) was 2.1 ± 0.8 mmHg and 2.9 ± 1.2 mmHg lower
compared with patients on RAB (n = 1,895) or CCB (n = 339) (fully
adjusted model, p = 0.011 and 0.017, respectively). In combination
therapy, systolic BP in hypertensive OSA patients on BB/DIU
(n = 180) was 7.8 ± 2.9 mmHg, 6.3 ± 1.6 mmHg and 4.9 ± 1.5
mmHg lower compared with patients on CAH/DIU (n = 50), CCB/
RAB (n = 449), or BB/RAB (n = 716) (fully adjusted model, p = 0.007,
<0.001 and 0.001, respectively). BB/DIU treatment was associated
with lower diastolic BP and pulse pressure. No unfavorable meta-
bolic effects of BB treatment alone or in combination with other
antihypertensive treatments were detected.
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Conclusions: Patients treated with beta blockade alone or in com-
bination with diuretics, had lower office BP independent of impor-
tant confounders for BP control. RAB antihypertensives were by far
the most frequently used, but did not associate with favorable BP or
metabolic parameters. A prospective evaluation of optimal BP treat-
ment in OSA, in particular for combination therapies, is warranted.
Disclosure: Nothing to disclose.
P670 | Napping in patients with OSAHS is
associated to diurnal fatigue
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Objectives/Introduction: Napping is a cross‐cultural phenomenon
which occurs across the lifespan and which procures benefits on
health. In general, people vary widely in the frequency and the dura-
tion with which they nap as well as the improvements in alertness
and reduction of fatigue, but it's widely admitted to nap between 10
and 30 min per day. In patients with sleep disturbances, napping
tend to be long because of the night sleep quality deficit, moreover
some studies showed that the health benefits do not necessarily
extend to these patients and could even worsen their condition.
The objective of this study is to assess the prevalence of reported
napping in a group of Moroccan patients diagnosed clinically and
polysomnographically with OSAHS and its association with diurnal
fatigue.
Methods: This is a retrospective study of 53 charts from patients
diagnosed with OSAHS in the pulmonology department of Ibn Sina
Hospital between October 2016 and December 2017.
Results: We evaluated 53 patients with OSAHS (38 men and 15
women) with a mean age of 47.8 ± 12.9 years. The prevalence of
napping was 49.1% with a median duration of 78 min [55;133]. In
this group of patients, diurnal fatigue was experienced in 57.7% of
cases (p: 0.01).
Conclusions: In patients with OSAHS, it appears that napping is
long and contradictorily associated with diurnal fatigue. Indeed, any
sleep, including napping, is likely to result in apneas and/or hypop-
neas and so to a fragmented and non‐restorative sleep. This finding
could constitute an advice to patients to put the instrumental treat-
ment also when napping. In this context, larger studies would be
interesting to conduct.
Disclosure: Nothing to disclose.
P671 | Discrimination of hypopnea in everyday
practice: is it worthwhile?
S. Correia; M. Rodrigo; G. Luis; Z. Camilo; B. Cabrita;
C.P. Coelho; A.L. Fernandes; D. Rodrigues; A. Galego;
P. Simão; J. Ferreira
Hospital Pedro Hispano, Porto, Portugal
Objectives/Introduction: Discrimination of hypopneas as obstruc-
tive or central is recommended for the correct diagnosis of Sleep
Apnea. The proportion of patients at risk of central disturbances is
increasing (e.g., patients with cardiovascular diseases) so we have to
be sure that we are correctly identifying central hypopneas. The aim
of this study was to evaluate if discrimination of hypopneas in
everyday practice is worthwhile.
Methods: We conducted a retrospective observational study. All
the in‐laboratory polysomnography (PSG) of the last 12 months and
type III home sleep apnea testing (HSAT) of the last 6 months, real-
ized for suspected sleep apnea, were analyzed.
The noninvasive algorithm proposed by Randerath and the recom-
mendations of the AASM were used for differencing central of
obstructive hypopnea. Sleep apnea (AHI > or= 5) was classified as
obstructive (OSA) if <20% of central apnea/hypopnea (A/H) events;
central (CSA) if > or = 50% and mixed if 20–49%.
Results: 316 sleep study were analyzed: 214 (HSAT) and 102
(PSG). The mean age was 55 ± 13 with a predominance of males
(66%). Most patients had comorbidity associated: 49% HTA; 38%
Dyslipidemia; 17% Diabetes Mellitus; 6% Coronary disease; 4%
stroke history and 4% Atrial Fibrillation.
Sleep apnea was present in 86% patients, most of them had OSA:
95% without hypopnea classification and 84% with hypopnea classi-
fication (p < 0.001). Regarding severity of sleep apnea, 49% had mild
SA, 30% moderate SA and 21% severe sleep apnea. The median pro-
portion of central events with and without hypopnea classification
was 4% vs. 0.0% (p < 0.001). The prevalence of mixed sleep apnea
and CSA was higher with hypopnea classification when compared
without hypopnea classification (11% vs. 2%, and 5% vs. 2% respec-
tively, p < 0.001).
33 (12%) patients had wrong diagnosis when hypopneas were not
discriminated: 27 had diagnosis of OSA instead of mixed sleep
apnea; 4 patients OSA instead of CSA and 2 patient mixed sleep
apnea instead of CSA.
Conclusions: The clear discrimination of central and obstructive
hypopneas is necessary in order to avoid misinterpretation and inap-
propriate treatment of complicated breathing patterns.
Disclosure: Nothing to disclose.
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P672 | Contactless monitoring of breathing
rate improves measurement robustness
M. Rullan1,2; S.S. Dash2,3; E. Wilhelm4; R. Riener4
1ETH Zurich, Basel, 2Sleepiz AG, 3ETH Zurich, 4ETH Zurich/ Institute of
Robotics and Intelligent Systems, Zurich, Switzerland
Objectives/Introduction: Sleep apnea, manifested by periods of
paused or shallow breathing during sleep, is suffered by every tenth
person. However, most of the affected population is unaware of the
disorder. Current diagnosis methods include polysomnography and
polygraphy. The obstructive sensors used in these two methods affect
sleep quality, and they cannot be used for long‐term monitoring due
to significant costs and lack of convenience. Here, addressing the need
for less intrusive diagnostic procedures, we present a contactless
device to measure breathing during sleep. Furthermore, we assess its
performance and robustness compared to the nasal cannula and
chest‐band respiratory effort sensors used in polygraphy.
Methods: Two patients with self‐reported snoring underwent 7
full‐night recordings using ApneaLink and a K‐band Doppler radar‐
based contactless monitoring device. Breathing‐rate estimates per
30 s epochs were determined from the different measurement chan-
nels (e.g. nasal cannula, chest‐band respiratory effort, radar device).
The results were cross‐compared to obtain the measurement correla-
tion and biases between the different sensors. Finally, the accuracy
of each measurement throughout the night was evaluated.
Results: The three modalities used to measure breathing achieved
a good correlation with each other, and had no consistent biases.
The nasal cannula however stopped to produce measurements mid‐
recording in 2 out of the 7 nights, due to the sensor shifting position
when the patient moved.
Conclusions: Non‐contact breathing rate measurements based on
radar are shown to correlate well with state‐of‐the‐art solutions
requiring patient contact. Radar measurements also showed superior
robustness to patient shifting positions during the night, when com-
pared to the polygraphy sensors, which were more prone to losing
contact with the patient throughout the night.
Disclosure: Marc Rullan and Soumya Sunder Dash are co‐founders
of Sleepiz AG, Zurich, Switzerland
P673 | Catestatin serum levels in male patients
with obstructive sleep apnea
J. Bozic1,2; J.A. Borovac1; D. Supe-Domic3; T. Galic2;
Z. Dogas2
1Department of Pathophysiology, 2Department of Neuroscience,
University of Split School of Medicine, 3Department of Medical
Laboratory Diagnostics, University Hospital of Split, Split, Croatia
Objectives/Introduction: Catestatin is a neuroendocrine multi-
functional peptide involved in regulation of arterial blood pressure
and inhibition of catecholamine secretion and sympathetic activity.
Concordantly, obstructive sleep apnea (OSA) is marked by auto-
nomic, cardiometabolic and inflammatory dysregulation thus affect-
ing multiple organ systems. The goal of the present study was to
determine and compare catestatin serum levels between male OSA
patients and healthy control subjects. Additionally, we aimed to
investigate the potential discriminatory role of catestatin as a bio-
marker of positive OSA status.
Methods: In this cross‐sectional study, 40 OSA patients and 40
age/sex/BMI‐matched control subjects were consecutively enrolled.
Each subject underwent anthropometric measuring and peripheral
blood sampling while OSA patients also underwent a full‐night
polysomnography. Catestatin serum levels were determined by the
enzyme‐linked immunosorbent assay (ELISA). The area under the
curve (AUC) was determined by the receiver operating characteris-
tics (ROC) analysis.
Results: A total of 80 male subjects were enrolled in the study,
with no significant differences between OSA and control group in
respect to age (50.6 ± 10.4 vs. 50.9 ± 7.7 years, p = 0.903) and BMI
(30.4 ± 2.9 vs. 29.8 ± 2.9 kg/m2, p = 0.356). Both groups did not dif-
fer in any anthropometric measures, except that OSA group had sig-
nificantly higher neck circumference compared to control group
(42.0 ± 3.6 vs. 38.9 ± 2.3 cm, p < 0.001). Regarding the baseline
polysomnographic parameters of OSA population, mean apnea‐
hypopnea index (AHI) was 42.8 ± 17.4 events/hr with mean oxygen
desaturation index (ODI) of 38.9 ± 18.4 events/hr. Catestatin serum
levels were significantly higher in OSA group compared to controls
(3.1 ± 1.5 vs. 1.3 ± 0.8 ng/mL, p < 0.001). The obtained AUC value
for serum catestatin as a predictor for positive OSA status was 0.88
(±SE 0.037, 95% CI 0.81–0.96, p < 0.001) with a cut‐off value of
2.0 ng/mL providing 80% sensitivity and 80% specificity in detection
of OSA status.
Conclusions: Serum catestatin levels were significantly higher in
OSA patients than matched control subjects and were a robust indica-
tive of OSA status. However, further studies are required to elucidate
the mechanistic role of catestatin in complex pathophysiology of OSA
and its suppressive role in sympathetic system overactivity.
Disclosure: Nothing to disclose.
P674 | Depression associated to cardiovascular
and/or metabolic comorbidities in Patients with
obstructive sleep apnea‐hypopnea syndrome
J. Achrane1; A. Jniene1,2; L. Achachi1; L. Harrak1;
M. El Ftouh1
1Department of Pulmonology, Mohammed V University/Ibn Sina
University Hospital Center, Ibn Sina Hospital, 2Mohammed V University/
Laboratory of Physiology, Faculty of Medicine and Pharmacy, Rabat,
Morocco
Objectives/Introduction: OSAHS is a public health concern
because of its high prevalence and its association with numerous
comorbidities causing a high morbidity and mortality risk. Among
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these comorbidities psychological disorders are common in patients
with Obstructive Sleep Apnea‐hypopnea syndrome (OSAHS) and
especially depression as suggested with multiple clinical studies.
In our context, symptoms of depression are under‐evaluated and
under‐diagnosed unlike other comorbidities namely cardiovascular
and metabolic.
The objective of this study is to assess the prevalence of depression
in a group of Moroccan patients diagnosed clinically and polysomno-
graphically with OSAHS and its association with cardiovascular and/
or metabolic comorbidities (diabetes mellitus, obesity).
Methods: This is a retrospective study of 53 charts from patients
diagnosed with OSAHS in the pulmonology department of Ibn Sina
Hospital between October 2016 and December 2017.
Results: We evaluated 53 patients with OSAHS (38 men and 15
women) with a mean age of 47.8 ± 12.9 years. The prevalence of
depression was 49.1%. The association with cardiovascular comor-
bidities namely hypertension and/or diabetes mellitus and/or obesity
was found in 57.9% (p: 0.04).
Conclusions: The association of depression and cardiovascular
and/or metabolic comorbidities in patients with OSAHS appears to
be common. It seems interesting to conduct larger studies for better
management of this multidisciplinary and transversal disease.
Disclosure: Nothing to disclose.
P675 | Prevalence of sleep apnea syndrome in
a cohort of acromegalic patients
S. Correia; J. Lima Ferreira; M. Rodrigo; B. Cabrita;
A. Marques; P. Melo; P. Simão; J. Ferreira
Hospital Pedro Hispano, Porto, Portugal
Objectives/Introduction: Acromegaly is a rare disease, with an
estimated prevalence around 2.8–13.7 cases per 100,000 patients.
The disease is characterized by an excess secretion of growth hor-
mone with raised Insulin‐like growth factor I (IGF‐I). On the other
hand, Sleep Apnea Syndrome (SAS) affects 67–75% of acromegalic
patients.
In acromegaly, Obstructive Sleep Apnea (OSA) is more frequent than
Central Sleep Apnea (CSA) due to craniofacial deformations, over-
growth of soft tissues such as the tongue (macroglossia), pharynx or
larynx, inducing thickening of the airway.
Methods: We conducted a prospective observational descriptive
study including all acromegalic patients treated at Pedro Hispano
Hospital. All the patients were submitted to a complete polysomnog-
raphy at our Sleep Unit, blood gases evaluation and echocardiogra-
phy.
Results: Of the 23 patients, only 16 accepted to be included in the
study. The median age was 63 ± 16 years with a majority of females
(69%). Mean BMI was 29 ± 4 and neck circumference 39 (±3.9) cm.
The median Epworth was 7 ± 9 and the Stop‐Bang Questionnaire
4 ± 3. Only 13 patients had Beck Depression Inventory, with a
median score of 6 ± 13. The median fold change referred to stan-
dard deviation score for IGF1 at the time of the study was
0.63 ± 0.30. Arterial hypertension, dyslipidemia and diabetes were
the most frequent comorbidities with 44%, 25% and 31% respec-
tively.
When the diagnostic of acromegaly was performed, 87% present a
macroadenoma and at the time of the sleep study, 81% had con-
trolled acromegaly. In terms of acromegaly treatment, 94% were
submitted to surgery, 43% to radiotherapy and 81% to pharmalogical
treatment. Left ventricular hypertrophy was found in 25% patients.
The median Respiratory Disturbance Index (RDI) was 19 ± 52 with a
median arousal index of 40.95 ± 26. SAS was diagnosed in 87.5% of
patients: 23.1% mild SAS, moderate in 38.5%, severe in 38.5%. Nine
patients had OSA (7 on Auto‐CPAP), 2 CSA (both on servoventila-
tion), 1 with one Obesity Hipoventilation syndrome and one on posi-
tional treatment for Positional Sleep apnea.
Conclusions: SAS is highly prevalent in patients with acromegaly.
Most present obstructive sleep apnea.
Disclosure: Nothing to disclose.
P676 | The best formula for predicting cpap
pressure? We have any?
D. Rocha
CHTMAD ‐ Vila Real, Vila Real, Portugal
Objectives/Introduction: The use of Cpap for the treatment of
sleep apnea is consensual, however it is necessary reach the ideal
pressure, for the optimization of the treatment. The titration in labo-
ratory would be the ideal method, however its slowness and his cost
makes it impractical. Thus, more and more the search for mathemati-
cal formulas are real, which may replace this titration in the labora-
tory, or the use of Auto‐cpap, which also increases the treatment
cost for this disease and which may also raise doubts in cardiac ben-
efit
The objective of this work is to compare the predictive equations of
Cpap, with the pressure of p90 of Auto‐cpap in our patients, in the
district of Vila Real.
Methods: Based on a review article by Macário Camacho et al.,
which carried out a systematic review of the international literature,
that worked with mathematical equations used to predict the effec-
tive pressure of Cpap, we selected 8 formulas, that best represent
our population and also those, that better results had, when com-
pared with patients auto‐cpap. Then, we compared that formulas,
with the P90 values determined by the Auto‐cpap of 72 patients, in
the readings between the 1st month and the year of use. Only
patients meeting the minimum criteria for CPAP were evaluated
(4 hr per night for at least 70% of the nights of the month).
Results: The differences of values for Cpap obtained for each for-
mulas are notorious, as well as the results obtained by them in com-
paration to the P90 of the Auto‐cpap.
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The variables most used in the predictive formulas were neck cir-
cumference, AHI and BMI, present in 5, 5 and 6 formulas respec-
tively.
Conclusions: The differences between the formulas analyzed and
the P95 of the Auto‐cpap, leads us to admit the need of develop, a
new representative formula for our population and also works for an
alert, regarding the use of these formulas, that must be cautious and
that their effectiveness, should always be checked periodically.
Disclosure: Nothing to disclose.
P677 | Sleep apnea: before and after heart
transplant
E. Matos; T. Calvo; D. Rocha; A. Ferreira; H. Moreira;
A. Mendes; I. Ferradosa; A. Fernandes
Pulmonology, CHTMAD ‐ Vila Real, Vila Real, Portugal
Objectives/Introduction: 66‐year old man, non‐smoker and nor-
mal body mass index.
Methods: Cardiac history: Followed in another institution cardiol-
ogy consultation since 1994 by congenital atrio‐ventricular block and
aortic disease. Has been submitted to definitive pacemaker (DDD)
implantation in april 2002, with preserved left ventricular (LV) sys-
tolic function at that time. In august 2008 LVEF (LV ejection frac-
tion) was estimated at 25%. Until september 2010 does not meet
conditions for classic aortic valve replacement surgery. April 2011
cardiac catheterization revealed severely depressed LV systolic func-
tion. July 2011 echocardiogram showed dilated cardiomyopathy with
severely compromised systolic function (23% LVEF) and in septem-
ber 2011 starts the pre‐transplantation cardiac study. LVEF in
november 2011 was 18%. Underwent heart transplantation in
september 2015.
Results: Pneumology/ sleep history: First evaluation and study for
persistent cough in 2003. Between may and july 2007, for suspected
respiratory pauses a sleep polygraphy was made revealing an apnea/
hypopnea index (AHI) of 22.3/hr; due to the presence of heart failure
and central apneas with suggestive cheyne‐stokes respiration, adap-
tive servo‐ventilation (ASV) therapy was instituted. Between 2007
and 2008 always well adapted to ASV, but presented some disadap-
tation in july 2009. Reassessment by polissomnography (PSG) was
made in february 2011 showing 14.2/hr of RDI. All the evaluations
made between 2011 and 2014, with approximately 100% of ASV
utilization, and residual AHI <5/hr. After cardiac transplant continues
with ASV by stating not being able to sleep without it. A new sleep
assessment was requested and PSG was performed in october 2017
(respiratory disturbance index (RDI) 16.9/hr; central apnea index
(CAI): 0/hr). In march 2018, despite excellent adhesion, ASV therapy
was suspended and automatically‐adjusting positive airway pressure
(APAP) prescribed. April 2018 card reading showed AHI <5/hr, 73%
use >4 hr and P95% of 11.6 cmH2O; a change to continuous posi-
tive airway pressure (CPAP) mode was programmed.
Conclusions: Few cases are known where sleep apnea diagnosis
was made several years before heart transplant. To better under-
stand how does sleep apnea can evolve and to ponder about what is
the best treatment approach in this context is the objective with this
case presentation.
Disclosure: Nothing to disclose.
P678 | Association of respiratory mechanic
instability and respiratory parameters in adults
with obstructive sleep apnea
J.H. Choi1; B. Lee2; S.-H. Hwang3
1Otorhinolaryngology‐Head and Neck Surgery, Soonchunhyang
University Bucheon Hospital, Bucheon, 2Biostatistics, Graduate School of
Chung‐Ang University, Seoul, 3Otolaryngology‐Head and Neck Surgery,
Bucheon St. Mary's Hospital, College of Medicine, The Catholic
University of Korea, Bucheon, Republic of Korea
Objectives/Introduction: Respiratory mechanic instability (RMI) is
derived from the analysis of the paradoxical thoracoabdominal
movements during airway obstruction. This study aimed to evaluate
the RMI parameters in obstructive sleep apnea (OSA) patients and
the correlation between RMI parameters and other parameters in
polysomnography.
Methods: One hundred thirty nine adult patients who attended
our clinic during 10 months were enrolled retrospectively, under-
went clinical examinations and in‐lab polysomnographys. The RMI
parameters were measured from thoracoabdominal band during
polysomnography.
Results: Subjects were divided into control (n = 17, apnea‐hypop-
nea index [AHI] <5) and OSA (n = 122, AHI ≥5) groups. The OSA
group was subdivided into three subgroups according to the AHI
(mild, 5 ≤ AHI < 15; moderate, 15 ≤ AHI < 30; severe, AHI ≥30). As
AHI increased, all RMI parameters showed the significant rising pat-
tern and difference among control and subgroups. Arousal index
(Arl), lowest oxygen saturation (lowest O2), and oxygen desaturation
index ≥3% (ODI3) were significantly associated with all RMI parame-
ters. Using a cutoff values, the areas under the curve of all RMI
parameters for predicting mild, moderate, and severe OSAS were
approximately larger than 0.85.
Conclusions: All RMI parameters were well related to respiratory
parameters of polysomnography, like Arl, lowest O2, and ODI3. The
areas under the curve of all RMI parameters for predicting OSA and
subgroups showed the significant diagnostic performance. These
parameters may help to identify OSA patients from control.
Disclosure: Nothing to disclose.
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P679 | Investigation of KL‐6, ET‐1 and S100A9
levels in idiopathic pulmonary fibrosis (IPF)
patients with Obstructive sleep apnea (OSA)
S. Michelakis; I. Bouloukaki; E. Tsitoura; C. Mermigkis;
K.M. Antoniou; N. Tzanakis; V. Moniaki; E. Mauroudi;
S. Schiza
Sleep Disorders Center, Medical School, University of Crete, Heraklion,
Greece
Objectives/Introduction: Obstructive sleep apnea (OSA) and idio-
pathic pulmonary fibrosis (IPF) often coexist and IPF guidelines
recently recognize OSA as a serious problem affecting survival.
Krebs von den Lungen‐6 (KL‐6), Endothelin‐1 (ET‐1) and S100A9
have been found to be elevated in patients with IPF, potentially rep-
resenting biomarkers of subclinical lung injury. Yet, these biomarkers
have not been fully assessed in OSA patients with IPF. The aim of
this study was to investigate potential additive effects of OSA in IPF
patients in serum and BALF KL6 levels and serum ET‐1 and S100A9
levels.
Methods: Seventy nine patients (age 72.5 ± 6.6 years) with newly
diagnosed IPF were included. In addition to overnight attended
polysomnography and pulmonary function tests, we also measured
serum and BAL levels of KL‐6, serum levels of ET‐1 and S100A9.
The relationship of the above biomarkers with indices of OSA sever-
ity and pulmonary function was examined.
Results: Twenty four patients with IPF and 40 patients with IPF‐
OSA were included in the study. Fifteen patients served as controls.
There were no differences in gender, age, BMI or comorbidities
among the three groups. Serum KL‐6 levels were significantly
increased in IPF patients compared to IPF‐OSA patients (1,420 vs.
1,023U/ml, p = 0.04). Furthermore, a negative correlation was found
between serum KL‐6 and severity of IPF, assessed by DLCO
(r = −0.64, p = 0.003) and KCO (r = −0.54, p = 0.015), only in IPF
group. Serum KL‐6 was also associated with TLC (%) (r = −0.48,
p = 0.012) only in the IPF‐OSA group. However ET‐1 levels were
correlated with KCO in both IPF and IPF‐OSA groups (r = −0.54,
p = 0.006 and r = −0.47, p = 0.002, respectively) but with DLCO
(r = −0.5, p = 0.001) only in IPF‐OSA group.
Conclusions: Our findings showed negative associations of serum
KL‐6 and ED‐1 with specific lung diffusion parameters only in IPF‐
OSA subgroup of patients. This evidence could support the hypothe-
sis that specific biomarkers levels probably reflect the additional
oxidative stress OSA provides in IPF patients. Further studies are
needed to clarify this observation.
Disclosure: Nothing to disclose.
P680 | Hypoglossal nerve stimulation for
obstructive sleep apnea
S. Gradanska1; M. Milkov2; H. Madjova1; A. Tzvetkova1;
M. Bliznakova2; J. Kostadinov1; P. Petrov3; M. Petrova3
1Prof. Paraskev Stoyanov Medical University of Varna Faculty of Dental
Medicine, 2Prof. Paraskev Stoyanov, Varna, 32 MBAL Sofia, Sofia,
Bulgaria
Objectives/Introduction: Traditionally, obstructive sleep apnea
has been defined by anatomical compromise in which soft tissues
and craniofacial structures around the pharyngeal airway lead to
increased airway collapsibility.4 Because of protective reflexes, the
pharyngeal airway maintains patency during wakefulness, but, during
sleep, loss of these reflexes reduces the activity of the pharyngeal
dilator muscle, causing collapse of the susceptible airway.1 The
hypoglossal nerve is a motor nerve that controls the pharyngeal
dilatator muscle and movements of the tongue
Methods: Mild stimulation of the distal hypoglossal nerve restores
the tone of the pharyngeal dilatator muscle. Increase of muscle tone
can prevent the tongue and other soft tissues from collapsing and
obstructing the airway during sleep. Inspire Upper Airway Stimula-
tion (UAS) is based on unilateral inspiratory stimulation to the medial
branch of the hypoglossal nerve. Inspire Upper Airway Stimulation
(UAS) is used to treat a subset of patients with moderate to severe
Obstructive Sleep Apnea (OSA) (apnea‐hypopnea index [AHI] of
greater than or equal to 15 and less than or equal to 65).
Results: Inspire UAS is used in adult patients 22 years of age and
older who have been confirmed to fail or cannot tolerate positive
airway pressure (PAP) treatments (such as continuous positive air-
way pressure [CPAP] or bi‐level positive airway pressure [BPAP]
machines) and who do not have a complete concentric collapse at
the soft palate level.
Conclusions: <ul type=“disc”> <li class=“MsoNormal” style=“co-
lor: rgb (51, 51, 51); margin‐bottom: 3.75pt; line‐height: normal;
background‐image: initial; background‐position: initial; background‐
size: initial; background‐repeat: initial; background‐attachment: initial;
background‐origin: initial; background‐clip: initial;”>. Patients with
obstructive sleep apnea due primarily to velopharyngeal compromise
may have a good response to palatal surgery, whereas those with
unstable ventilatory control may improve with agents such as oxy-
gen or acetazolamide, which can stabilize the breathing pattern. In
theory, strategies that increase activity in the pharyngeal dilator
muscles should be effective for patients who have dysfunction in
these muscles.8
Disclosure: Nothing to disclose.
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P681 | Comparison between auto‐trilevel and
bilevel positive airway pressure ventilation for
treatment of obesity hypoventilation syndrome
patients
X. Zhang
Respirology, The First Affiliated Hospital with Nanjing Medical University,
Nanjing, China
Objectives/Introduction: To observe the efficacy of auto‐trilevel
positive airway pressure (Auto‐trilevel PAP) ventilation for obesity
hypoventilation syndrome (OHS) by comparison of bilevel positive
airway pressure (BiPAP) ventilation.
Methods: Twenty‐three patients with both OHS and OSAS were
recruited. Three different positive airway pressure (PAP) modes
issued by the ventilators were used for 8 hr per night with each
mode at each night and two nights’ interval without any treatment
among different modes. In mode 1 the EPAP issued by BiPAP was
titrated as the minimal positive pressure for disappearance of snor-
ing. The same inspiratory positive airway pressure (IPAP) titrated by
PaCO2 in mode 1 was used in mode 2 and 3 as well. However, the
EPAP issued by BiPAP in mode 2 was 3 cmH2O higher than that in
mode 1. In mode 3 with autotrilevel PAP, the beginning of EPAP
was set the same as that in mode 1 while the end of EPAP (EEPAP)
was automatically adjusted to elevate based on upper airway
patency condition. The following parameters were compared such as
nocturnal apnea hypopnea index (AHI), minimal SpO2 (miniSpO2),
arousal index, morning PaCO2 and daytime ESS.
Results: Compared with before ventilation therapies, there was a
significant decrease in nocturnal AHI, arousal index, morning PaCO2
and daytime ESS, but a significant increase in miniSpO2 and sleep
efficiency caused by all three modes of ventilation (all p < 0.01).
Comparison among three modes demonstrated that with the same
IPAP, the mode 3 could result in the lowest arousal index and day-
time ESS. Compared with mode 1, in mode 2 there was a statistically
lower AHI, higher miniSpO2 and morning PaCO2 (all p < 0.05), but in
mode 3 there was a lower AHI, higher miniSpO2 (all p < 0.05), with
no significant difference in PaCO2 at the end of therapy (p > 0.05).
Compared with mode 2, in mode 3 there was a significant lower
PaCO2 (p < 0.05), but no significant difference in AHI and miniSpO2
(all p > 0.05).
Conclusions: Auto‐trilevel PAP ventilation had a higher efficacy in
simultaneous removal of apnea hypopnea events and correction of
hypercapnia and was superior over BiPAP ventilaiton for treatment
of OHS.
Disclosure: Nothing to disclose.
P682 | Snoring causes OSA: sensory nervous
lesions in the palate worsen over time in
untreated snorers but not in CPAP‐treated
patients
E. Svanborg1; O. Sunnergren2; M. Ulander3; A. Broström4
1IKE, Clinical Neurosciences, Linkoping University, Linköping, 2ENT,
Ryhov County Hospital, Jönköping, 3Clinical Neurophysiology, Linkoping
University Hospital, Linköping, 4Department of Nursing Science, School
of Health Science, Jönköping University, Jönköping, Sweden
Objectives/Introduction: Previous studies have shown that there
are signs of both motor and sensory nervous lesions in the upper
airway of patients with obstructive apnea (OSA) and, to a lesser
extent, of habitual snorers.
Hypothesis: snoring per se may damage upper airway neurons over
time, thereby causing the progression to manifest sleep apnea. To
prove this, non‐snoring subjects, untreated snorers and CPAP‐treated
OSA‐patients underwent repeated sensory testing in the upper air-
way in a long‐time study.
Methods: Cold detection threshold (CDT) testing, a routine neuro-
physiological method to study sensory function, was performed at
the soft palate and the lip. 64 subjects were initially tested in 2008
for their ability to perceive the sensation of cold and retested 6 ‐
7 years later. 20 were non‐snoring controls, 24 untreated snorers
and 20 had received CPAP. CDT‐testing was performed using the
method of limits by a Medoc TSA 2001 equipment with an intra‐oral
thermod.
Results: In untreated snorers AHI increased from average 9–12.
Eight previously normal subjects had developed OSA (AHI/ODI >5).
CDT:s worsened from 5.0°C to 14.5°C (p = 0.001). Three subjects
had completely lost their cold sensitivity in the palate, whereas it
was normal and unchanged on their lips. In non‐snorers there were
no significant changes in AHI (mean values 2.0). Cold detection
thresholds increased slightly from average 3.1°C to 6.0°C
(p = 0.003). In the CPAP‐treated patients the CDT:s did not signifi-
cantly change (from 5.1°C 2008 to 7.1°C in 2015).
Conclusions: CDT:s worsened much more in the untreated snorers
than in the other two groups (p = 0.03). This group therefore risks
developing poor sensitivity in the upper airway in a couple of years
of habitual snoring. This could contribute to sleep apnea, since also
the snorers′respiratory disturbance had increased. In contrast, it
seems that efficient treatment of OSA protects the sensory innerva-
tion, since the CPAP‐treated group maintained their sensitivity to
cold.
Disclosure: Nothing to disclose.
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P683 | First successful mechanical splint for
OSA with an orally administrable pharyngeal
stenting device
D. Neu1,2,3; G. Nawara4; J. Newell5; D. Styczen5;
D. Bouchez6; O. Mairesse5,7
1Sleep Laboratory and Unit for Chronobiology U 78, Brugmann
University Hospital, Université Libre de Bruxelles (U.L.B.), 2ULB 312
Faculty of Medicine and ULB 388 Faculty of Motor Sciences, ULB
Neuroscience Institute (UNI), 3Center for the Study of Sleep Disorders
(CETS), DELTA Hospital (CHIREC) ‐ Neuroscience Pole, 4Department of
Otorhinolaryngology, DELTA Hospital (CHIREC) ‐ Head and Neck Pole,
5Sleep Laboratory and Unit for Chronobiology U78, Brugmann University
Hospital, Université Libre de Bruxelles (U.L.B.), Brussels, 6Polytechnical
School ‐ Independent Researcher (Engineering), Université Catholique de
Louvain‐La‐Neuve (UCL), Louvain‐La‐Neuve, 7EXTO, Vrije Universiteit
Brussel (V.U.B.), Brussels, Belgium
Objectives/Introduction: We report the case of obstructive sleep
apnea (OSA) in a 19‐year old, otherwise healthy and drug‐free, male
patient with a BMI of 23 kg/m2, presenting with persistent daytime
sleepiness and non‐restorative sleep sensations after velo‐ and uvu-
loplasty. Clinical evaluation also reported moderate macroglossia and
loud snoring at anamnesis. Given persistent daytime symptoms and
the patient′s prior explicit refusal of CPAP‐treatment, mandibular
advancement device or additional surgery, an individually tailored
prototype of a pharyngeal stenting device was proposed in the
framework of a first feasibility trial (′PHASTENTOSA′).
Methods: In contrast to former mechanical stenting attempts by
means of nasally inserted trumpets, the studied device here com-
prises a mouth‐administered, completely removable functional pha-
ryngeal stent mounted on a simple inferior dental guard. The stent
aims at providing a mechanical upper airway splint by limiting retro‐
lingual collapse between the tongue and the posterior pharynx wall.
For the study purpose, the patient underwent two consecutive
polysomnographic recordings (PSG) in an academic Sleep Unit of a
general University Hospital. The clinical assessment was completed
with the Pittsburgh Sleep Quality Index (PSQI) and the Epworth
Sleepiness Scale (ESS).
Results: Symptom‐scales confirmed excessive daytime sleepiness
(15/24 on the ESS) and non‐restorative sleep sensations with a PSQI
level of 7. At baseline, PSG showed a total apnea‐hypopnea index
(AHI) of 15.5 and of 24.4 per hour of rapid eye movement (REM)
sleep, but no nocturnal hypoxemia. During consecutive PSG, with
the treatment device in place, residual AHI dropped to 6.7 (56.8%
reduction) and to 1.4 per hour of REM sleep (94.3% reduction)
respectively. The device was well tolerated and kept in situ during
PSG without any interruptions or complications. Sensation at morn-
ing arousal was reportedly refreshing. Recorded sleep efficiency
under active treatment, with respect to sleep maintenance, was
excellent at 96.5%. Sleep architecture, with respect to sleep stage
proportions and sleep fragmentation appeared to be numerically sim-
ilar between both nights.
Conclusions: Hence, our report shows for the first time, the
achievability of a successful mechanical splint with an easy‐to‐
administer orally inserted, pharyngeal stenting device, which may
represent a novel treatment option for OSA in the future.
Disclosure: Nothing to disclose.
P684 | Is speech frequency hearing loss
associated with STOP‐BANG score in
commercial drivers?
A. Najafi1; N. Naeemabadi1; M. Saraie2; K. Sadeghniiat
Haghighi1; M. Mahmoodi-Afsah1; A. Rahimi-Golkhandan1
1Occupational Sleep Research Center, Baharloo Hospital, 2Center for
Research on Occupational Diseases (CROD), Tehran University of
Medical Sciences, Tehran, Islamic Republic of Iran
Objectives/Introduction: Obstructive sleep apnea (OSA) is a com-
mon sleep‐disordered breathing. OSA and intermittent hypoxia may
be a risk factor for hearing loss. The main purpose of this study was
to assess the association between speech frequency threshold and
STOP‐BANG score as a validated questionnaire for screening of OSA
in commercial drivers.
Methods: This cross‐sectional study was performed on 1,000 com-
mercial drivers. All the participants were asked to fill out the vali-
dated Persian version of Epworth sleepiness scale (ESS) and STOP‐
BANG questionnaire. A blood sample was collected from all drivers.
Pure tone audiometry (PTA) was performed by an expert audiologist
and hearing threshold levels of all subjects were measured in fre-
quencies of (500–1,000–2,000–3,000 Hz) for each ear in dB.
Results: The mean age of all drivers was 43 ± 9.9 years. The mean
ESS and STOP‐BANG score of the participants was 3.1 ± 2.8 and
1.8 ± 0.8, respectively. Drivers were classified in high and low risk
for OSA according to the STOP‐BANG score. There was a significant
difference between speech frequency thresholds (500–1,000–2,000–
3,000 Hz) in high risk subjects and low risk for OSA (p value
<0.001).
Conclusions: Patients who were high risk for OSA may be prone
to hearing loss. More investigation is needed.
Disclosure: Nothing to disclose.
P685 | Using prediction formulas for
continuous positive airway pressure in
obstructive sleep apnea syndrome
A. Najafi1; K. Sadeghniiat-Haghighi2; S. Arshi2; S. Jamshidi2;
A. Rahimi-Golkhandan2
1Occupational Sleep Research Center, 2Tehran University of Medical
Sciences/Occupational Sleep Research Center, Tehran, Islamic Republic of
Iran
Objectives/Introduction: Continuous positive airway pressure
(CPAP) is the most effective therapy for patients with moderate to
severe Obstructive Sleep Apnea (OSA). Increased demand for sleep
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lab tests (diagnostic Polysomnography (PSG) and CPAP titration) has
led to long waiting lists and high cost. Therefore, CPAP prediction
formulas derived from anthropometric and PSG recorded parameters
are used to determine CPAP pressure. In this study, we aimed to
compare the prediction formulas derived CPAP pressure with the
pressure obtained from manual titration among patients referred to
a sleep clinic.
Methods: In this cross‐sectional study, 90 subjects with confirmed
OSA who underwent CPAP titration in Baharloo sleep clinic, Tehran,
Iran during 2017 were enrolled. All of the participants had Respira-
tory Disturbance Index (RDI) ≥15/hr in their overnight PSG and
underwent manual CPAP titration study. Then, the pressure obtained
from manual titration was compared with the calculated pressure
using available prediction formulas for each patient. Hoffstein, Lin,
Hukins, and Loredo prediction formulas were used.
Results: The mean CPAP pressure resulted from manual titration
was greater that pressures calculated by four prediction formulas.
The difference between mean CPAP pressure obtained by manual
titration and pressures calculated by Hoffstein, Lin and Hukins for-
mulas were statistically significant. However, mean CPAP pressure
obtained by manual titration was not statistically different from
Loredo formula (11.7 ± 2.6 vs. 11 ± 2.3, respectively; p value =
0.11).
Conclusions: CPAP pressure prediction formula developed by Lor-
edo et al provided the most similar result with CPAP pressures
obtained from manual titration. This formula can be used as a guide
for the optimum pressure needed during manual titration and for
selected patients who are candidates for auto‐titration.
Disclosure: Nothing to disclose.
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P686 | Characterization of patients with OSAS
and nocturnal dessaturation
D. Machado; C. Marques; I. Sanches; D. Ferreira
Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia,
Portugal
Objectives/Introduction: Obstructive sleep apnea syndrome
(OSAS) is associated with variable degrees of nocturnal dessatura-
tion. Besides the obstructive events of the upper airways there are
other factors that may contribute for dessaturation in these patients.
The aim is to describe the characteristics of patients with OSAS and
nocturnal dessaturation.
Methods: Retrospective analysis of patients diagnosed with OSAS
and a percentage of recording time with SpO2 < 90% equal or supe-
rior to 30% (T90 ≥ 30%), from 2014 to 2016 at our hospital.
Results: Identified 68 patients: 11 with mild OSAS, 10 with mod-
erate and 47 with severe. The mean age was 66 ± 12 years‐old
and 63% were male. T90 was not significantly different between
the 3 groups of severity (60%, 63% and 56% respectively,
p = 0.711). The remaining characteristics were also not significantly
different, with the exception of BMI (31, 33 and 36 kg/m2 for
mild, moderate and severe OSAS respectively, p = 0.034). Although
not achieving statistically significance there was a tendency in mild
OSAS, comparing with moderate and severe, for more non‐smokers
(73%, 34% and 53%, respectively), more female (64%, 50% and
28%) and higher values of pCO2 (46 mmHg, 43 mmHg and
43 mmHg). The 68 patients had a mean pO2 of 71 mmHg and
various comorbidities: hypertension (69%), heart failure (27%), neu-
romuscular diseases (3%) and COPD (17%), with a tendency for a
higher incidence of COPD in mild OSAS (27%, 20% and 14%).
CNS depressant drugs were used in 27% of patients. Regarding
the pulmonary function testing 50% of patients had normal tests,
16% had obstructive, 15% restrictive and 19% mixed ventilatory
patterns.
Conclusions: Most the patients with significantly nocturnal dessat-
uration had severe OSAS; however, these patients did not have
higher T90 compared to mild or moderate OSAS. There was a ten-
dency for higher values of pCO2 in mild OSAS, and in this group
may had been included patients with obesity‐hypoventilation syn-
drome, factor that may contribute to nocturnal dessaturation. There
was also more COPD in patients with mild disease, factor that may
also contribute to dessaturation, which was slightly higher in mild
than severe OSAS.
It would be interesting evaluate in which of these patients CPAP
treatment would correct nocturnal dessaturation.
Disclosure: Nothing to disclose.
P687 | Rapid Eye Movement‐related
obstructive sleep apnea: comparison between
two definitions
C. Marques; D. Machado; I. Franco; I. Sanches; R. Monteiro;
C. Nogueira; D. Ferreira
Centro Hospitar Vila Nova de Gaia‐Espinho, Vila Nova de Gaia, Portugal
Objectives/Introduction: Compare the prevalence and clinical
characteristics between two different definitions of Rapid Eye Move-
ment related obstructive sleep apnea (REM‐related OSA).
Methods: A retrospective review of all patients that performed
polysomnography during 2017 in a Terciary Portuguese Hospital was
made and were included all patients with apnea‐hypopnea index
(AHI) ≥5 events/hr.
In this sample, it was applied two different definitions of REM‐
related OSA and compared their characteristics.
REM‐related OSA was defined as:
1 Definition 1: ratio AHI REM/AHI NREM > 2
2 Definition 2: AHI NREM < 5 and AHI REM ≥ 5 and at least
30 min of REM sleep.
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Results: Identified 221 patients, mostly male (n = 135; 61.1%),
mean age 57 ± 11. Mean AHI was 22.0 ± 18.5 with 101 patients
(45.7%) with mild OAS, 70 (31.7%) with moderate OAS and 50
(22.6%) with severe OSA.
When definition 1 was applied it was identified 84 patients with
REM‐related OSA (38.1%). The REM‐related OSA group had a higher
percentage of females (47.1% vs. 33.8%; p = 0.049), a lower score in
Epworth Sleepiness Scale (9 vs. 6; p = 0.012) and a lower median
AHI (11.4 vs. 19.4; p =< 0.001). REM sleep time, percentage of sleep
time with SatO2 < 90%, body mass index (BMI), age, symptoms and
comorbidities (including cardiovascular and pulmonary diseases, anxi-
ety and depression) were not statistically different.
When definition 2 was applied it was identified 25 patients with
REM‐related OSA (11.3%). The REM‐related OSA group had a higher
percentage of females (76% vs. 34.2%; p < 0.001), lower median
AHI (5.9 vs. 17.9; p < 0.001), lower percentage of sleep time with
SatO2 < 90%, (3.%1 vs. 6%; p = 0.038), higher BMI (33 vs. 28.5;
p = 0.012), higher prevalence of depression (32% vs. 13.3%;
p = 0.014) and use of two or more antihypertensive drugs (44% vs.
24.5%; p = 0.038). REM sleep time, Epworth Sleepiness Scale score,
age, symptoms and comorbidities as pulmonary and cardiovasculary
disease and anxiety were not statistically different.
Conclusions: REM related OAS was more prevalent in females and
had lower AIH regardless the definition used.
The use of more restrictive definition for REM‐related OSA, like defi-
nition 2, defines a group with higher BMI and an arterial hyperten-
sion more difficult to treat, which can help in the therapeutic
decisions.
Disclosure: Nothing to disclose.
P688 | Outcomes in home sleep testing in
patients with high pre‐test probability for
obstructive sleep apnoea
K. Ziherl; M. Podlipnik; I. Gramc; I. Sarc
University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia
Objectives/Introduction: Home sleep testing (HST) is a diagnostic
method used to diagnose obstructive sleep apnoea (OSA) in patients
with high pre‐test probability. We aimed to compare two screening
questionnaires regarding outcomes measured by positive HST study
and diagnostic polysomnography (PSG) in negative HST.
Methods: We performed 338 HST studies from 2016–2017 in
patients with high pre‐test probability (Berlin questionnaire ≥2 posi-
tive categories or STOPBANG ≥5) for OSA, 35 were excluded from
analysis due to insufficient data. All patients underwent HST, and
those who were negative underwent diagnostic PSG. Study was pos-
itive if respiratory event index (REI) or apnoea hypopnea index (AHI)
was higher than 15/hr.
Results: 303 patients were included in analysis, 219 (72%) men,
age 54 ± 10.3 years, Epworth sleepiness scale 11 ± 7.7, body mass
index 34.9 ± 6.5 kg/m2. 22 (7%) had high pre‐test probability only on
STOPBANG, 48 (16%) only on Berlin questionnaire, and 233 (77%)
on both. 225 (74%) patients had REI ≥15/hr. Of those with REI ≤15/
hr, 31 (40%) had AHI ≥15/hr on diagnostic PSG. Patients were more
often positive on HST study if both screening questionnaires were
positive than if only one was (78% vs. 61%, p = 0.007), but there
was no difference in outcomes in diagnostic PSG between these
two groups (35% vs. 46% positive, p = 0.41). No difference in out-
comes was observed between Berlin and STOPBANG questionnaire
if only one was positive (HST positive in 56% and72%, respectively,
p = 0.66).
Conclusions: Patients with high pre‐test probability for OSA were
diagnosed with HST in 74%. In those who were negative, 40% were
later positive on diagnostic PSG. The diagnostic yield of HST was
higher if both screening questionnaires were positive.
Disclosure: Nothing to disclose.
P689 | SPECT study in different subgoups of
sleep related breathing disorders
I. Bernath; Z. Szakacs; D. Nagy
Military Hospital, Budapest, Budapest, Hungary
Objectives/Introduction: Prospective, nonrandomized, cross sec-
tional study was organized to investigate the impact of different sub-
types of sleep related breathing disorders (SRBD) on regional cerebral
blood flow and the integrity of the cerebrovascular reserve capacity.
Methods: Study participants were recruited from cases of consecu-
tive diagnostic polysomnography performed on patients, referred to
our laboratory suspected of having SRBD, based on high question-
naires scores. Sixty eligible patients were candidates for further
SPECT investigation, in order to create the one by one twenty‐per-
son subgroups.
Group 1. IHR. // N:20, male, age:45ys avg.BMI:28 avg.//
Group 2. OSAS(n) // N:20, male, age:40ys avg.BMI:27 avg.//
Group 3. UARS// N:20, male, age:41ys avg.BMI:30 avg.//
Eligible patients (those with history of cerebro‐cardio vascular
events, with positive head MRI, or taking medicines having influence
on regional cerebral blood flow were excluded) the next morning
after polysomnography underwent Tc99 m‐HMPAO‐ SPECT study,
followed by Acetazolamide challenge. SPECT scans were visually
analysed by two independent specialists.
Results: Finally 40 patients /18/IHR‐8/OSAS(n)‐14/UARS/completed
the SPECT study.
Except four cases /2 UARS and 2 IHR/ positive results, extensive
areas of hypofixation, were gained. Left and right side were almost
equally affected, except for the frontal regions with dominant right
sided involvement.
Areas affected by localization were the follows.
402 of 433 | ABSTRACTS
In group 1: 5 temporal and 11 fronto-parietal
In group 2: 3 fronto-temporo-parietal and 5 temporo-parietal
In group 3: 3 frontopolar and 9 temporo-parietal
Acetazolamide challenge revealed compromised autoregulatory
vasodilation in 14 cases.
In almost all instances the IHR group (12 positive results of 16
patients) was affected.
Conclusions: ll subtypes of SRBD, regardless of the presence of
hypoxia or apnea compromised regional cerebral blood flow by
SPECT. Contrary, the localization of SPECT hypofixaiton was highly
dependent on hypoxia. Majority of cases with normoxemia affected
the temporo‐parietal lobe, while those with IHR mostly altered the
function of the frontal lobe. In fact, our work is the first one to rea-
lise that sleep fragmentation or desaturation are not sufficient con-
tributors, but hypoxia is responsible for impaired cerebrovascular
reserve capacity, often encountered in SRBD cases.
Disclosure: Nothing to disclose.
P690 | Prevalence of sleep apnea syndrome in
patients with stroke history
P. Caseiro; M. Lopes; D. Borges; H. Silva; P. Coelho;
T. Pereira
IPC, Clinical Physiology, ESTeS Coimbra, Coimbra, Portugal
Objectives/Introduction: Evaluate the prevalence of SAS in
patients with stroke history, the relationship with associated risk fac-
tors, as well as a possible relationship between the location of the
ischemic stroke and the prevalence of SAS.
Stroke and sleep apnea syndrome (SAS) have both high incidence,
with significant impact on the world′s population. There are several
studies that link the major cardiovascular changes resulting from
SAS, including the occurrence of stroke. However, the presence of
SAS as a result of stroke is increasingly more frequent, being also
important to study the stroke changes that determine the appear-
ance of SAS and affects the recovery of these patients.
Methods: The present retrospective study data was obtained from
the analysis of the clinical process of patients who take a
polysomnographic in the laboratory, between July 2011 and July
2016, at the Unidade Local de Saúde de Matosinhos ‐ Hospital
Pedro Hispano, neurology service. A total of 472 clinical cases were
analyzed whence 14 patients had a stroke history.
Results: The study sample was constituted with 13 male (92.9%) and
one female patients, with a mean of age 67.8 years. SAS diagnosis was
confirmed in 12 patients (85.7%), mostly severe (58.3%) and mild
(33.3%). 92.9% of the sample revealed risk factors where patients with
severe SAS presented more. Association between smoking habits and
SAS severity was significant (p = 0.05). Regarding the occurrence of
stroke in SAS patients, it was possible to verify a higher incidence of
subcortical strokes (6 patients). It is also important to highlight the 2
cases of brainstem stroke, both associated with severe SAS.
Conclusions: Our results confirmed that SAS is present in the
majority of patients with stroke history. It was proved that patients
with previous stroke have higher risk of SAS, given the high preva-
lence relatively to general population. Early identification and treat-
ment are essential in order to prevent the clinical worsening of
patients with previous stroke or stroke risk, once the improvement
in these patients is demonstrated after therapy.
Disclosure: Nothing to disclose.
P691 | Obstructive sleep apnea yndrome and
type II diabetes: effects of non‐invasive
ventilation in Hemoglobin A1c values
P. Caseiro; A. Ribeiro; C. Sousa; T. Pereira
IPC, Clinical Physiology, ESTeS Coimbra, Coimbra, Portugal
Objectives/Introduction: The aim of the present study was to
evaluate Hba1C index, before and after treatment with NIV, in dia-
betic patients with obstructive sleep apnea.
Pathologies such as Obstructive Sleep Apnea Syndrome (OSAS) and
Type II Diabetes Melittus (T2DM) have a very significant prevalence
and impact in the population. There are several studies reporting
important metabolic changes in patients with OSAS and Diabetes.
The relation between NIV treatment and Hemoglobin A1c (HbA1c)
values is an important indicator to evaluate the disese.
Methods: This sample was composed by 31 individuals with T2DM
and OSAS, who started NIV, and were followed in the Sleep and
Ventilation Unit of the Tondela‐Viseu Hospital. The value of HbA1c
prior of the NIV theraphy was collected and, after about 6 months
of NIV therapy we collected the new data, also including NIV data
and NIV adherence (Controlled T2DM patients with HbA1c <7%;
Uncontrolled T2DM with HbA1c ≥7%; Adherent patient with use
average >4 hr/night and >70% of effective therapy days).The used
significance level was 5%.
Results: The sample was composed by 31 patients, male majority
(58.1%) with an average age of 56.7 ± 12.5 years. It was found that a
large part of the sample was obese with a Body Mass Index average of
32.5 ± 5 kg/m2. The NIV average daily used was 6.14 ± 1.64 hr/night.
Automatic Positive Airway Pressure (APAP) was the NIV therapy most
used. Concerning HbA1c values, the mean value before therapy intro-
duction was 8.25 ± 1.30% and, after about 6 months of NIV treat-
ment, the mean value decreased to 7.79 ± 1.33%, with a significance
level of p = 0.026%. Initially only 19% of patients had T2DM con-
trolled and, after therapy, the number increased to 32%. There was
also an improvement in HbA1c values in patients that used Automatic
PAP compared to Continuous PAP therapy.
Conclusions: Appropriate therapy of Obstructive Sleep Apnea Syn-
drome seemed to induce a better control of Diabetes disease, with
an improvement of HbA1c values, in patients with Obstructive Sleep
Apnea Syndrome and Type II Diabetes Melittus.
Disclosure: Nothing to disclose.
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P692 | Comparison of sleep instability indices
in normal individuals and patients with severe
obstructive sleep apnea
P. Petrov1; M. Popovska-Petrova2; R. Petrov3,4; M. Milkov5
1Cardiology, 2Second MHAT, 3Sleep & Health Medical Centre, 4Sleep &
Health, Sofia, 5Varna Medical University, Varna, Bulgaria
Objectives/Introduction: Obstructive sleep apnea (OSA) is one of
the most prevalent diseases with socio‐economic significance. One
of the major consequences of this sleep disordered breathing is the
decrease of sleep quality. Different measures for sleep impairment
have been proposed and cyclic alternating pattern (CAP) is probably
the most important.
Methods: Fourty consecutive male patients of our sleep laboratory
(mean age 47.5 ± 11.0 years) were included in the present study.
Each of them underwent a full‐night polysomnography study and the
recordings were scored by an experienced and certified scorer. CAP
parameters were determined according to the established rules.
Based on the apnea hypopnea index (AHI), the patients were dev-
ided into two groups: severe obstructive sleep apnea (AHI >30.0/hr)
and healthy individuals (AHI ≤5.0/hr). Student′s T‐test for indepen-
dent variables was used for comparison of different CAP indices
between the two groups.
Results: Thirty‐two patients were with severe OSA (mean AHI =
71.6 ± 23.9/hr) and 8 did not show signs of sleep disordered
breathing (mean AHI = 1.85 ± 1.5/hr). CAP ratio, A3 index, A2 and
A3 mean durations showed significant differences between the two
groups (80.6 vs. 38.3, p < 0.001; 54.8/hr vs. 18.9/hr, p < 0.001;
12.7 s vs. 7.9 s, p < 0.005; 13.7 s vs. 9.7 s, p < 0.05 respectively).
On the other hand, A1 and A2 index, A1 and mean duration did not
show any statistically significant difference.
Conclusions: In OSA patients analysis of CAP ratio, A3 index, A2
mean duration and A3 mean duration may prove useful for evalua-
tion of sleep quality.
Disclosure: Nothing to disclose.
P693 | Persistence of periodic breathing/
Cheyne‐Stokes respiration after tilt table test
during short term respiratory monitoring in
patients with systolic heart failure
C. Borrelli1; F. Gentile2; F. Rossari2; P. Sciarrone2;
C. Passino3; G. Mirizzi3; F. Bramanti3; G. Iudice3; M. Emdin3;
A. Giannoni3
1Sant'Anna School of Advanced Studies, 2University of Pisa, 3Fondazione
Toscana Gabriele Monasterio, Pisa, Italy
Objectives/Introduction: Periodic breathing (PB: hyperventilation/
hypopneas) and Cheyne‐Stokes respiration (CSR: hyperventilation/ap-
neas) are usually considered to occur in lying and sleeping conditions
in patients with heart failure (HF).
However, recent evidences suggest that both phenomena may
spread throughout the 24‐hr. The aim of this study is to evaluate
whether PB/CSR may be observed in awake and orthostatic condi-
tions in patients with systolic HF.
Methods: A total of 202 chronic systolic HF patients on optimal
guideline‐recommended treatment (left ventricular ejection fraction
of 33 ± 9%; 66 ± 12 years of age; 79% males) underwent beyond
echocardiography, pulmonary function test, 24‐hr electrocardio-
graphic and respiratory recording and neurohormonal evaluation (na-
triuretic peptides, plasma norepinephrine, renin activity and
aldosterone levels), a short term attended respiratory monitoring
(SRM) during tilt table testing (10 min in clinostatism and 5 min in
orthostatism).
A short term scoring from 0 to 2 was created, with 0 being normal
respiration, 1 being PB/CSR disappearing in orthostatism and 2 being
PB/CSR persisting in orthostatism.
Results: The prevalence of scores 0–1–2 were 54%, 34% and 11%,
respectively.
The score was predictive of apnea‐hypopnea index severity at the
24‐hr recording (all p < 0.001), both during daytime (from 0 to 2: 7
IR 2–15, 12 IR 6–20, 26 IR 12–33, events/hr), nighttime (20 IR 6–29,
23 IR 16–34, 37 IR 24–48 events/hr) and the 24‐hr (13 IR 5–21, 18
IR 11–26, 32 IR 20–36 events/hr).
At univariate, logistic multinomial analysis predictors of persistence
of PB/CSR in orthostatism were moderate to severe mitral regurgita-
tion (MR), left atrial volume and baseline atrial fibrillation (AF), while
at multivariate analysis only MR (OR 3.55, CI 1.05–12.01, p = 0.04)
and AF (OR 5.37; CI 11.74–16.61; p = 0.004) resulted as indepen-
dent predictors.
Conclusions: In HF patients, a short term recording performed
during tilt testing is able to stratify the severity of PB/CSR both dur-
ing daytime, nighttime and the 24‐hr, with MR and AF being inde-
pendently associated with persistence of PB/CSR in awake/
orthostatic conditions.
Disclosure: Nothing to disclose.
P694 | Prevalence of signs and symptoms of
sleep apnea in Portuguese adult population
P. Caseiro; D. Araujo; C. Narciso; C. Gil; O. Sousa;
J. Figueiredo
IPC, Clinical Physiology, ESTeS Coimbra, Coimbra, Portugal
Objectives/Introduction: Our aim was to analyse the prevalence
of signs and symptoms of sleep apnea, in the Portuguese population
aged over 30 years, having used validated questionnaires.
Despite of the high prevalence of obstructive sleep apnea (OSA) it
remains an underdiagnosed clinical condition. The diagnosis involves,
in the majority of the cases, a full PSG. However, other screening
tools may be used, like questionnaires, to estimate the presence or
absence of the pathology.
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Methods: An observational and cross‐sectional study was made.
We used the data collected by Coimbra Health School (surveys that
assessed sleep quality indirectly and anthropometric data obtained in
different regions of the country). The sample was composed by
2,146 individuals.
In order to estimate OSA prevalence, it was considered that the indi-
vidual may suffer OSA if the criterion A (BQ‐Berlin Questionnaire
with an indicative risk score for OSA + ESS‐Epworth Sleepiness
Scale with provisional score of excessive daytime sleepiness) and/or
B (PSQI‐Pittsburgh Questionnaire with a score indicative of sleep
disorder + ESS with provisional score of excessive daytime sleepi-
ness) occurred.
Results: In our total sample of 2,146 individuals, 45.2% were male
and 54.8% were female with a global age average of 48.92 years.
The most common signs described were nocturia (63.2%), morning
tiredness (59.5%). The presence of both signs was significantly
higher in the female group compared to male group (p < 0.05). Also
snoring (53.4%) and apnea (16.2%) were frequently reported, but
without gender differences.
Berlin Questionnaire (BQ) score reported that 31% of the individuals
had high risk for OSA (p < 0.05). Excessive daytime sleepiness,
obtained by Epworth Sleepiness Scale (ESS) score, was observed in
26.1% of the individuals and 8.7% showed a positive result accord-
ing to the Pittsburgh Sleep Quality Index (p < 0.05).
The global prevalence of OSA in Portuguese population, obtained
with our methodology, was about 13.42%. By gender, a significant
difference (p < 0.05) comparing males (17.5%) and females (10%).
Conclusions: The prevalence of OSA in the Portuguese population,
obtained in our sample and using the proposed methodology, was
estimated 13.42%.
Disclosure: Nothing to disclose.
P695 | Prevalence of sleep apnea syndrome
(SAS) in patients with implantable cardiac
electronic devices
M.J. Guimarães1; S. Ribeiro2; M. Guimarães1; D. Ferreira1;
V. Sanfins2
1Pulmonology, 2Cardiology, Hospital de Guimarães, Guimarães, Portugal
Objectives/Introduction: To evaluate the value of electronic car-
diac devices in the diagnosis of SAS among patients with DECI.
Methods: We included 29 patients with cardiac electronic devices
implanted with sleep apnea/hypopnea event detection algorithm
(Kano™ 100DR, Reply™ 200DR from Livanova, Vitalio™, Incepta™
CRTD, Incepta™ CDI and Invive™ from Boston Scientific). Livanova
devices have the SAM algorithm (sleep apnea monitoring) validated
in the Dream study.
The Boston Scientific devices detect apnea and hypopnea events
through ApneaScan™ Patients performed polygraphy with the
ApneaLink plus™ equipment by Resmed™
All patients in whom SAS was detected were confirmed by level 1
or 2 polysomnography.
After confirmation of the diagnosis the patients were monitored by
the DECI, to evaluate the adherence to the therapy.
Results: 21 men and 8 women, with a mean age of 76.1 years
(±9.8). BMI 26.8 kg/m2 (±4.2). HBPwas the most frequent pathology
(74.2%). In the echocardiography 63.3% of the patients had normal
left ventricular systolic function. The implanted device was a defini-
tive pacemaker in 23 patients (sinus node dysfunction in 13 patients,
and in the remaining eight atrioventricular conduction disorders), all
dual‐chamber programmed in DDDR mode, cardiac resynchronization
system with implantable cardioverter‐defibrillator in five patients,
and a dual‐chamber implantable cardioverter‐defibrillator in one
patient. In 15 patients the device was Livanova and in 14 Boston
Scientific patients.
The agreement between the polysomnography and the Pacemaker
was Kappa = 0.54 (p = 0.001), 95%. Of the 20 cases with AHI >15/
hr, 18 have pacemaker values ≥20/30.
When we correlated the values ofthe device with PGS values, we
verified values >15/hr: sensitivity of 90%, specificity of 83%, values
predictive positive of 90% and negative of 87.5%, with diagnostic
accuracy of 87.5%.
Conclusions: The prevalence of SAS is high in patients with car-
diac electronic devices. There are devices with algorithms capable of
recording events that should signal patients to perform polysomno-
grams to confirm the diagnosis. This study demonstrated a signifi-
cant correlation between the values recorded in the devices and in
the polysomnography.
Disclosure: Nothing to disclose.
P696 | Comparison of performance of four
adaptive servo ventilation devices in patients
with complex sleep apnea
J. Knitter1; S. Patel2; O. Bailey2; C. Poongkunran2; A. Flores2;
L. Martinez2; U. Kobayashi2; D. Combs3; S. Parthasarathy3
1University of Arizona College of Medicine, 2UAHS Center for Sleep &
Circadian Sciences, 3Department of Pediatrics, UAHS Center for Sleep &
Circadian Sciences, Tucson, AZ, United States
Objectives/Introduction: Adaptive Servo Ventilation (ASV)
increased the risk for mortality in the SERVE‐HF trial. The mecha-
nisms for such a finding remain unclear. Conceivably, device algo-
rithms that control respiratory rate and pressure support may have
led to high minute ventilation, which, in turn, may have contributed
to hypocapnia and life‐threatening arrhythmias. Whether such a find-
ing was due to a device algorithm‐based effect (“device‐effect”) or
applies to all devices with servo‐algorithm (“class‐effect”) is uncer-
tain. The objective of this study was to compare the performance of
various ASV devices on indices of sleep‐disordered breathing and
minute ventilation.
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Methods: We performed a randomized controlled cross‐over trial
of patients with complex sleep apnea with preserved cardiac con-
tractility who were adherent with ASV therapy. Patients underwent
four nights of laboratory‐based polysomnography while receiving
therapy from a Philips ASV device (System One), updated Philips
ASV device (Dreamstation), ResMed S7 VPAP Adapt (used in the
SERVE‐HF trial), and ResMed S9 VPAP Adapt.
Results: During polysomnography, apnea‐hypopnea index was not
different across the different devices (p = 0.9). Minute ventilation
(VE) was greater during S7 device (9.8 ± 0.4 Lpm) when compared to
all other devices for wakefulness state: S9 (4.9 ± 1.0 Lpm), Dream
Station (8.4 ± 0.2 Lpm), and System One (8.6 ± 0.3 Lpm;
p < 0.0001). VE was greater during S7 therapy when compared to
both Philips devices for stage N1 and REM sleep (p < 0.01). Respira-
tory rate was greater during S7 therapy when compared to other
devices for all sleep‐wakefulness states (p < 0.0001). Pressure sup-
port level was greater during S7 therapy when compared to all other
devices during wakefulness (p < 0.0001).
Conclusions: There were significant differences in minute ventila-
tion delivered by various ASV devices. We speculate that the mecha-
nisms underlying the adverse effects of ASV in previous trials could
be secondary to excessive ventilation due to device‐effect and not
due to class‐effect.
Disclosure: This work was funded in part by Philips‐Respironics.
P698 | Gender differences in obstructive sleep
apnea patients
C. Marques; D. Machado; I. Franco; I. Sanches; R. Monteiro;
C. Nogueira; D. Ferreira
Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia,
Portugal
Objectives/Introduction: The aim of this study is to evaluate if
there are any differences between female and male patients with
obstructive sleep apnea (OSA) in terms of symptoms, comorbidities
and polysomnographic parameters.
Methods: It was included all patients that performed polysomnog-
raphy during 2017 in a Terciary Portuguese Hospital and had an
apnea‐hypopnea index (AHI) ≥5 events/hr. Sociodemographic and
polysomnographic data, symptoms and comorbidities was retrospec-
tive review. A level of significance of 0.05 was assumed.
Results: We included 220 patients, 85 (38.6%) female and 135
(61.4%) male. The median age was 61 in females and 56 in males.
The female patients had, with statistical significance, lower median
AHI (11.8 vs. 17.9; p = 0.002), with higher prevalence of mild OSA
(57.6% vs. 37.8%; p = 0.004) and a lower prevalence of severe OSA
(15.3% vs. 27.4%; p = 0.037). There were no statistically significant
differences in sleep efficiency, percentage of time with SatO2 under
90% or snoring episodes.
Female patients had more non‐restful sleep (69.2% vs. 37.8%;
p < 0.001). Snoring, witnessed apnea and sleepiness (according
epworth sleepiness scale) were not statistically different. Although
there was no statistical difference, in females appeared to be a ten-
dency for a higher frequency of insomnia (29.5% vs. 21.3%;
p = 0.183) and nocturnal awakenings with sensation of choking
(44.3% vs. 32.8%; p = 0.097).
Regarding comorbidities, female patients had more arterial hyperten-
sion (62.4% vs. 43%; p = 0.005), anxiety (11.8% vs. 3.7%; p = 0.021)
and depression (35.3% vs. 3%; p < 0.001).
It was initiated positive airway pressure therapy in 47 (55.3%)
females and 72 (53.3%) males.
Conclusions: Female patients appear to have a different clinical
spectrum. In terms of symptoms they had a higher prevalence of non‐
restful sleep, despite having similar sleep efficacy when compare to
male patients. Female patients had a lower median AHI, with a higher
prevalence of mild OSA. Despite that they had a similar prevalence of
initiation positive airway pressure therapy, which may be justified by a
higher prevalence of arterial hypertension in females.
Disclosure: Nothing to disclose.
P699 | Montreal cognitive assessment versus
mini‐mental state examination scales for
cognitive impairments in obstructive sleep
apnea‐hypopnea syndrome patients with and
without morning headache
A. Lupușor1,2; A. Diaconu2; V. Vovc1,2; I. Moldovanu1,2
1Laboratory of Functional Neurology, Sleep Medicine Center, Institute of
Neurology and Neurosurgery, 2Human Physiology and Biophysics,
‘Nicolae Testemitanu’ State University of Medicine and Pharmacy of the
Republic of Moldova, Chisinau, Republic of Moldova
Objectives/Introduction: Cognitive impairments (CI) and morning
headache (MH) frequently occur in obstructive sleep apnea syn-
drome (OSAS) patients. In the same time, both OSAS and MH are
risk factors for developing CI. The aim of the study was to compare
which test ‐ Montreal Cognitive Assessment (MoCA) or Mini Mental
State Examination (MMSE) ‐ has a higher sensibility for CI in OSAS
patients and also to establish the relationship between MH and CI in
OSAS patients.
Methods: The sample included 17 patients (11 females, mean age
57.8 years, SD ± 8.6), diagnosed with OSAS (mean AHI 50, SD ± 30)
through cardiorespiratory monitoring during sleep (SleepDocPorti
“Dr. Fenyves und Gut”). MH was established according to ICHD‐3.
Cognitive function was assessed with MoCA and MMSE.
Results: All patients fulfilled the MMSE (mean score ‐ 26.58 ± SD
3.36 (>25 considered normal) ‐ 2 patients (12%) presented results
below 25) and MoCA (mean score ‐ 22.05 ± SD 4.05 (≥26 consid-
ered normal) ‐ 14 patients (82%) had a total score below 26 and 3
patients above 26). Afterwards the sample was divided into two
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subgroups: with MH (11 patients) and without MH (6 patients) and
the mean MoCA total score was compared: for the MH group was
21.36 vs. 23.33 for the group without MH, p > 0.05. We also com-
pared the MoCA result by domains: the abstraction ability in OSAS
patients with MH was 0.8 vs. 1.6 in those without MH, p < 0.05.
Conclusions: In the studied sample the MoCA questionnaire
revealed CI in 82% of patients vs. only 12% revealed by MMSE. As
a result, we can suppose that MMSE has a lower sensibility for CI
disturbances in OSAS patients, and using MMSE for CI assessment
in OSAS patients can underestimate this phenomenon.
On the other hand, there is no relationship between MH and CI in
OSAS patients ‐ both subgroups with and without MH presented CI,
only the abstraction ability being significant diminished in patients
with MH.
Disclosure: Nothing to disclose.
P700 | Sleep apnea syndrome screening and
diagnosis among public transport (bus) drivers in
Hungary
A. Terray-Horváth; Z. Szakacs; M. Simon; I. Bernath
Neurology, Sleep Disorders Center, Hungarian Defences Forces, Medical
Center, Budapest, Hungary
Objectives/Introduction: Obstructive sleep apnea is the most fre-
quent sleep disordered breathing associated with daytime sleepiness,
cognitive impairment and daytime dysfunction.
Methods: The relevant factors of sleep apnea syndrome were com-
pered in bus drivers who underwent polysomnography (Alice 6, Phi-
lips, Respironics) test. The objective of the present study was to
determine the prevalence of sleep apnea among consecutive bus-
drivers (age: 49 ± 9). The survey comprised Epworth Sleepiness
Scale (ESS) for daytime sleepiness assessment, body mass index, cof-
fee consumption and smoke habit as well.
Results: Accordig to the polysomnography results 40 (54.1%) bus
drivers were diagnosed with sleep apnea (13.5% moderate, 12.2%
severe). BMI correlated positively with RDI, AHI, ODI results, but no
correlation was found with sleep apnea and ESS.
Conclusions: Moderate and severe OSA is a high risk among bus
drivers. The obesity is good marker to identify the potential sleep
apnea patients, thus polysomnography procedure is necessary in
obes patients.
Disclosure: Nothing to disclose.
P701 | Obstructive sleep apnoea as a risk
factor for incident metabolic syndrome: a
multicentric prospective epidemiological study
C. Hirotsu1,2; J. Haba-Rubio1; S. Togeiro2; P. Marques-Vidal3;
L. Drager4; P. Vollenweider3; G. Waeber5; M. Preisig6;
L. Bittencourt2; S. Tufik2; R. Heinzer1
1University Hospital of Lausanne, Center for Investigation and Research
in Sleep, Lausanne, Switzerland, 2Department of Psychobiology,
Universidade Federal de São Paulo (UNIFESP), Brazil, Sao Paulo, Brazil,
3Internal Medicine, University Hopital of Lausanne CHUV, Lausanne,
Switzerland, 4Hypertension Unit, Heart Institute (InCor) and Renal
Division, University of São Paulo Medical School, Sao Paulo, Brazil,
5CHUV ‐ Centre Hospitalier Universitaire, Lausanne University Hospital,
6Psychiatry, University Hopital of Lausanne CHUV, Lausanne, Switzerland
Objectives/Introduction: Cross‐sectional studies have demon-
strated that obstructive sleep apnoea (OSA) and metabolic syndrome
(MetS) are often associated. We aimed to investigate the effect of
OSA on the risk of developing MetS in a general population sample.
Methods: Prospective study combining two population‐based sam-
ples (Episono in Brazil and HypnoLaus in Switzerland). MetS was
assessed according to the Joint Interim Statement. Polysomnography
(PSG) was performed at baseline and follow‐up in Episono, and at
baseline in HypnoLaus. OSA was defined according to apnoea‐
hypopnoea index as mild (5·0–14·9/hr) and moderate‐to‐severe
(≥15·0/hr).
Results: 1,853 participants (52 ± 13 years, 56% female) without
MetS at baseline were included. After a 6‐year mean follow‐up, 318
(17·2%) developed MetS. Multivariable analysis adjusted for baseline
confounders showed that moderate‐to‐severe OSA was indepen-
dently associated with incident MetS (OR = 2·33 [1·50–3·61]). Medi-
ation analysis revealed that moderate‐to‐severe OSA increased the
number of MetS components (mainly abdominal obesity and
impaired glucose/insulin homeostasis) from baseline to follow‐up
through partial mediation of time with oxygen saturation (SpO2)
<90%. Subset analysis in Episono confirmed that the increase in the
percentage of time with SpO2 <90% between baseline and follow‐
up PSG represents a risk factor for MetS (OR = 1·36 [1·04–1·69] for
each 10% increase).
Conclusions: Baseline OSA is independently associated with
increased risk of developing MetS through mediation of nocturnal
hypoxaemia in the general population.
Disclosure: Nothing to disclose.
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P702 | A clinical portrait of patients treated at
the Université Laval Sleep Clinic
A. Vallières1; T. Araújo1; A. Pappathomas1; M.R. Crawford2;
S.D.B. Garnier1
1École de Psychologie, Université Laval, Québec, QC, Canada,
2Department of Psychology, Swansea University, Swansea, United
Kingdom
Objectives/Introduction: At the Sleep Clinic of Université Laval,
established in 2015, we are referred individuals with any sleep disor-
ders associated or not with psychopathologies. Since its opening,
more than 240 patients complaining of sleep difficulties have been
treated. This study aims to describe a clinical portrait of an ecologi-
cally valid population consulting for sleep difficulties.
Methods: Patients self‐reported to the Sleep Clinic, or were
referred by general practitioner or pulmonologist. After a phone
screening interview, patients came to the clinic for a semi‐structured
clinical interview on sleep and psychopathology. During this evalua-
tion period, patients completed sleep diaries and self‐reported ques-
tionnaires assessing sleep, sleepiness, anxiety, and depression. The
sleep diary was completed throughout psychotherapy. A descriptive
analysis of 207 patients’ records (57% female, Mage = 42.5 years)
was performed to assess patients’ sleep disorders, mental disorders,
medical conditions, and treatment length.Psychologists or doctorate
students in psychology conducted therapy sessions. The study was
approved by the Université Laval ethical committee.
Results: Results reveal a high level of comorbities with an average
of 2.86 diagnoses per patient (SD = 1.64) and more than 4 diagnoses
for 27.5% of the patients. More precisely, 141 out of 207 (68.1%)
patients presented with at least one other mental comorbidity; 73
(35.3%) with a medical comorbidity; and 67 (32.4%), with another
sleep disorder alongside their primary sleep concern. Insomnia was
the main sleep disorder (74.4%, 154/207) followed by fatigue
(17.4%, 36/207), sleep apnea (10.1%, 21/207), and hypersomnia
(0.05%, 10/207). Anxiety (51.7%, 107/207) and depressive (30.9%,
64/207) disorders were the predominant patients’ psychopatholo-
gies, while fibromyalgia (2.9%, 6/207), hypertension (2.9%, 6/207),
and head trauma (2.42%, 5/207) were the main medical conditions.
The mean length of treatmentfor sleep disorders was of 9.4 therapy
sessions (SD = 8.0).
Conclusions: The clinical portrait illustrates the reality of multiple
morbidities, with more than 14 of the sample reporting at least 4
separate diagnoses. Having multiple morbidities may have implica-
tions for our clinical decisions such as the use of a more transdiag-
nostic approach, as opposed to sequential applications of distinct
treatments for each disorder. Future research is needed to evaluate
such transdiagnostic treatment approaches for the sleep disorder
patient with multiple morbidities.
Disclosure: T.A. and S.deB.G. salaries were partially paid by
patients’ psychotherapy fees while others authors have nothing to
disclose.
P703 | Polysomnographical effects of on‐line
cognitive behavioral therapy for insomnia
P. D′Onofrio1; S. Jernelöv2; A. Rosén2; V. Kaldo2;
T. Åkerstedt2
1Stockholm University, 2Karolinska Instititute, Stockholm, Sweden
Objectives/Introduction: Insomnia is a serious public health prob-
lem worldwide. Cognitive Behavioral Therapy (CBT) is proven effec-
tive in treating insomnia. Sleep Restriction (Rest) is a central
treatment component in CBT for insomnia (CBT‐i), and Sleep Com-
pression (Comp) is sometimes put forward as a less burdening alter-
native. However, there is a lack of information on their effects on
polysomnographic (PSG) measures, and beyond post‐treatment
assessments such evaluations are virtually non‐existing. The primary
purpose of the present study was therefore to evaluate the effect of
restricting time in bed, and compare the effects of Comp v/s Rest on
polysomnographic measures at post treatment and at follow up.
Methods: Twenty six patients (mean age 46.4 ± 14.4 years, 80%
women) with Insomnia Disorder were randomly assigned to the
sleep restriction group (Rest = 16n) or to the sleep compression
group (Comp = 10n). All participants underwent four polysomno-
graphic ambulatory nights during a period of ten weeks; before the
beginning of treatment (pre‐treatment), after the first week of treat-
ment (mid‐treatment), after five weeks of treatment (post‐treatment)
and after ten weeks (follow up). The Karolinska Sleep Diary (KSD)
was completed on the morning after each PSG night, one day before
and two days after.
Results: For PSG measures, all patients (regardless of group) showed
a significant increase in SleepEfficiency (Pre = 82.8 ± 9.8%, mid‐
treat = 89.9 ± 6.8, Post = 89.5 ± 6.8%, p < 0.01), shorter TIB (Pre =
469.2 ± 52 min, mid‐treat = 393.6 ± 59 min, Post = 404.3 ± 50 min,
p < 0.01), shorter Wake Time after Sleep Onset (Pre = 64.6 ± 38.9
min, mid‐treat = 34 ± 29 min, Post = 34.9 ± 26.6 min, p < 0.01),
shorter Sleep Onset Latency (Pre = 15.3 ± 16.8 min, mid‐treat = 6.4
± 5.8 min, Post = 8.1 ± 5.8 min, p < 0.05), fewer nighttime awaken-
ings/hr (Pre = 5.2 ± 3.7, Post = 3.5 ± 1.8, p < 0.05), and higher per-
centage of REM‐sleep (Pre = 21.3 ± 5.5%, mid‐treat = 23.59 ± 6.4,
Post = 24.5 ± 6.4%, p < 0.01). A Statistically significant interaction
between group and condition was found only for TIB measurement
(F = 3,347, p < 0.05) and for REM% (F = 3,072, p < 0.05). For KSD,
at post‐treatment all participants showed a significant increase in feel-
ing well rested in the morning (F = 4,488, p < 0.05), and a significant
decrease in morning sleepiness (F = 2,881, p < 0.05). No interaction
between groups and conditions was found.
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Conclusions: Five weeks of online CBT‐I improves sleep continuity
and clinical ratings of sleep quality regardless of the type of sleep
reduction strategy, compression or restriction.
Disclosure: Nothing to disclose.
P704 | Cognitive behavior therapy for
insomnia ‐ is sleep compression an equally
effective and less difficult alternative compared
to sleep restriction?
A. Rosén1; S. Jernelöv1; V. Kaldo1,2; E. Forsell1;
T. Åkerstedt1; P. D′onofrio3
1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm,
2Department of Psychology, Linneaus University, Växjö, 3Stress Research
Institute, Stockholm University, Stockholm, Sweden
Objectives/Introduction: One of the main components of Cogni-
tive Behavior Therapy for insomnia (CBT‐i) is Sleep Restriction (SR).
SR abruptly restricts time in bed to the average time the patient
actually slept the previous week, to produce higher sleep efficiency
and establish a robust sleeping pattern. However, SR is also related
to adverse events such as sleep deprivation and fatigue. Sleep Com-
pression (SC) is a possible alternative treatment component, which
decreases time in bed more gradually. By doing so, SC is proposed
to produce less adverse effects than SR, but this proposition has not
been empirically tested.
The aim of this study is to therefore to compare SC to SR, with the
ultimate goal to improve treatment outcome of CBT‐i. Focus for the
comparison is improvement of insomnia symptoms and participants
perceived negative effects of the treatments.
Methods: This is a randomized controlled trial with 5 weeks of
Internet delivered treatment with therapist support, followed by a
5 weeks self‐care period. Interventions consist of 5 + 5 weeks of SR
[SJ1] or SC. Follow‐up is conducted at 5 and 10 weeks after treat-
ment start. Participants (n = 188) are adults with insomnia recruited
nationally in Sweden. Primary outcome is insomnia severity, mea-
sured with the Insomnia Severity Index (ISI). The most important sec-
ondary outcome is Adverse Events (AE).
Results: Preliminary data (n = 94) suggests that both treatment
groups improve in insomnia severity from pre measurements to fol-
low up (p =< 0.001, ηp2 = 0.503), but that there is no significant dif-
ference between the both groups with regards to improvement in
insomnia severity (ISI change score pre‐10 weeks: SR = 8 v/s SC =
5.6; p = 0.079), and no significant difference in number of reported
adverse events between the groups (SR = 14.1 v/s SC = 12.5;
p = 0.377).
Conclusions: Preliminary data from this study suggests that both
interventions are equally effective in treating insomnia, and at this
point no statistically significant difference can be seen in number of
adverse events. This brings up the question of sleep compression
could be put forward as a less difficult alternative for treating
insomnia.
Disclosure: Nothing to disclose.
P705 | One and ten‐year follow‐up of insomnia
severity after a randomized trial of behavioral
self‐help treatment for insomnia with or without
therapist guidance
S. Jernelöv1; M. Lekander1,2; K. Blom1; V. Kaldo1,3
1Clinical Neuroscience, Karolinska Instititutet, Solna, 2Stockholm
University, Stockholm, 3Linnaeus University, Växjö, Sweden
Objectives/Introduction: Cognitive behavioral therapy (CBT) is
treatment of choice for insomnia, but availability is scarce. Having
CBT for insomnia (CBT‐i) delivered as self‐help can increase availabil-
ity at low cost, but evidence for its long‐term efficacy is limited. We
will present data from one‐year and ten‐year follow‐up of a behav-
ioral self‐help treatment ‐ the longest follow‐up of CBT‐i known to
us. We hypothesize that the previously reported positive effects of a
cognitive behaviorally based self‐help book on insomnia severity in
individuals also with co‐morbid problems, would prove maintained
also at one and ten‐year follow‐up.
Methods: After a parallel randomized (block randomization, n ≥ 21)
controlled “open label” trial where volunteer, media recruited partici-
pants with insomnia (n = 133) were randomized to three groups ‐
bibliotherapy with (n = 44) and without (n = 45) therapist support,
and waiting list control (n = 44), with assessments pre‐ post and
three‐month follow‐up, long‐term follow‐up assessments were con-
ducted at 1 and 10 years. Intervention was six weeks of bibliothera-
peutic self‐help, with established cognitive behavioral methods
including sleep restriction, stimulus control, and cognitive restructur-
ing. Therapist support was a 15‐min structured telephone call sched-
uled weekly. Main outcome measure at one and ten‐year follow‐up
was the Insomnia Severity Index (ISI).
Results: We have previously reported significant improvements in
insomnia severity in both self‐help groups from pre to post treat-
ment, and maintainted at three‐months (Jernelöv et al 2012*). Fol-
low‐up data shows that these improvements were maintained also at
one year (p < 0.001), with ISI‐scores having decreased from pre‐
treatment, with 6.8 points for the group receiving self‐help without
suport and 10 points for the group receiving self‐help with therapist
support (interaction p < 0.001). Preliminary data from the first 53
participants at ten‐year follow up suggests that treatment gains may
be largely maintained, with a mean decrease of 6.2 and 6.3 points
respectively (p < 0.01).
*Jernelöv, S., et al. (2012). BMC Psychiatry 12(5): 1–13.
Conclusions: These findings suggest that a time‐limited behavioral
self‐help intervention for individuals with insomnia produces long‐
lasting effects on insomnia severity.
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Disclosure: SJ is the author of the commercially available self‐help
book used in the study.
P706 | Chronotype and psychiatric comorbidity
in patients with insomnia referred to sleep
disorders center
E. Poradowska1; A. Ślusarz1; A. Wierzbicka2; J. Salbert1;
A. Wichniak1; W. Jernajczyk2; M. Jarkiewicz1
1III Departament of Psychiatry and Sleep Disorders Center, 2Department
of Clinical Neurophysiology and Sleep Disorders Center, Institute of
Psychiatry and Neurology, Warsaw, Poland
Objectives/Introduction: Mental health and chronotype play and
importnant role in sleep regulation and should be routinely assessed
in patients with sleep disorders. The aim of the study was to (1)
assess chronotype, severity of insomnia, level of sleepiness and
depressive symptoms among patients referred to our center by pri-
mary care physicians due to various sleep disorders, mostly because
of insomnia, (2) compare patients with and without comorbid psychi-
atric condition, (3) compare patients with morning, evening and
intermediate chronotype.
Methods: We examined 170 consecutive patients (99 women,
mean age 46.5 ± 15.1 years and 74 men, mean age
39.9 ± 16.4 years), who were administered the Morningness ‐ Even-
ingness Questionnaire (MEQ), Athens Insomnia Scale (AIS), Epworth
Sleepiness Scale (ESS) and Beck Depression Inventory (BDI). The
group differences were tested for significance using Student's T‐Test
and ANOVA.
Results: There was a significant difference between patients with
and without comorbid psychiatric condition in AIS (13.90 ± 3.79 vs.
15.6 ± 5.2; p < 0.001) and BDI (12.71 ± 8.53 vs. 27.57 ± 13.59;
p < 0.001). Additionally, the AIS scores in patients with intermediate
(15.2 ± 4.1) and morning (15.1 ± 4.3) chronotype were higher than
in patients with evening chronotype (12.7 ± 5.0) (p < 0.05), what
was primary related to the younger age of patients with lower MEQ
scores. After adjusting age factor the effect was no longer observed.
Conclusions: The obtained data confirm higher intensity of sleep
difficulties in patients with comorbid psychiatric condition, as well as
greater depressive complaints. The outcome of the study showing
that morningness might be associated with poor sleep was due to
age factor and was not confirmed.
Disclosure: Nothing to disclose.
P707 | Mediating effects of somatic symptoms
in the association between sleep disturbance
and mental health following Qigong exercise in a
RCT
J.S.M. Chan1,2; S.M. Ng2; L.P. Yuen3; K.F. Chung4;
T.M.C. Lee1; C.L.W. Chan2; BMS; Qigong group
1Psychology, 2Social Work and Social Administration, The University of
Hong Kong, 3International Association for Health and Yangsheng, Hong
Kong, 4Psychiatry, The University of Hong Kong, Hongkong, China
Objectives/Introduction: Sleep disturbance has a close relation-
ship with mental health and is positively related to greater somatic
symptoms. However, the effects of Qigong on somatic symptoms
and the role of somatic symptoms in the relationship between sleep
quality and metal health following Qigong exercise remain unclear.
Methods: A randomized waitlist‐controlled trial was conducted to
assess efficacy of Qigong exercise and investigate the mediating
effects of somatic symptoms in the relationship between sleep dis-
turbance and mental health among persons with sleep disturbance.
189 participants with sleep disturbance were screened and recruited
from the community and randomly assigned to Qigong (n = 96) and
control (n = 93) groups. Intervention was eight 3‐hr weekly sessions
of Qigong training plus 30‐min self‐practice at least 3 times per
week. Self‐reported questionnaires, including Pittsburgh Sleep Qual-
ity Index (PSQI) and somatic symptom inventory (SSI) and Hospital
Anxiety and Depression (HADS) were assessed at baseline (T0),
immediate post‐intervention (T1) and 3‐month post‐intervention (T2).
Results: At baseline, two groups were comparable except for more
painful somatic symptoms (SSI‐pain: 49.55 vs. 44.02, p = 0.010) and
depressive symptom (HADS‐depression: 7.79 vs. 6.83, p = 0.036) in
Qigong group. Repeated measure ANCOVA controlling for baseline
depressive and painful somatic symptoms showed compared with
control group, Qigong exercise significantly improved sleep quality
(F = 5.77, p = 0.030) and reduced somatic symptoms (SSI‐painful:
F = 9.31, p < 0.001; SSI‐painless: F = 15.45, p < 0.001), anxiety
(HADS‐anxiety: F = 3.89, p = 0.002) and depressive (HADS‐depres-
sion: F = 7.35, p = 0.001) symptoms. Significant associations were
found between PSQI change score and reduction in anxiety
(r = 0.228, p = 0.002 at T1 and r = 0.166, p = 0.022 at T2) and
depression (r = 0.254, p < 0.001 and r = 0.228, p = 0.020) at both
T1 and T2 following Qigong exercise using the linear regression;
while controlling for painful or painless somatic symptoms, associa-
tion between PSQI change score and reduction in anxiety and
depression were fully mediated by somatic symptoms.
Conclusions: Qigong exercise alleviated sleep disturbance and
somatic symptoms, and improved mental health. Significant mediating
effect of reduction of somatic symptom in the associations between
sleep improvement and mental health following Qigong exercise were
found. This study sheds light on possible role of reduction of somatic
symptoms in enhancing sleep quality and mental health.
Disclosure: Nothing to disclose.
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P708 | Do really chronic sleeping pills users
develop tolerance to the drugs?
M. Bensky; A. Green; Y. Dagan
Sleep and Fatigue Institute, Assuta Medical Center, Tel‐Aviv, Tel Aviv,
Israel
Objectives/Introduction: Chronic Insomnia is a common sleep
problem with prevalence of 10–30% of total population; It is defined
as subjective experience of an inadequate quantity or quality of
sleep that has persisted for at least one month. Medical therapy is
an acceptable therapy for insomnia, at least for a fixed period. There
are inconsistent evidences for the development of tolerance to the
sedative effect of benzodiazepines; however, there is almost no evi-
dence in the literature to tolerance for Z drugs. The aims of our
study were: (1) To Identify and characterize the usage of sleeping
drugs among chronic users. (2) To find whether there is an evidence
to tolerance among chronic hypnotic users, which expressed by
increase in average number of “usage days”.
Methods: Retrospective analysis from computerized pharmacy
record of “Maccabi health service” with total of 1.2 million patients.
The data was collected for all patients above the age of 18 between
the years 2011–2015. Occasional users were defined as those who
dispensed at least one monthly prescription of sleeping drugs
(30 days) while chronic user were defined as those who dispensed
at least 9 prescriptions (270 days) per year for at least 2 years.
Results: Only 1% of the adult populations were defined as chronic
users. 66% of chronic hypnotics consumers were females, and 34%
males. Age was positively associated with higher rate of chronic
usage. Benzodiazepines therapy was more prevalent compare to Z
drugs in the total population while there was no difference in the
chronic patients. We observed no change in the total average num-
ber of “usage days” between the years 2011–2015 in the chronic
patient group. Moreover, only 5% of the occasional users became
chronic users every year, while 15% of the chronic users did the
opposite and turn to be occasional ones. Of note, 50–58% of the
chronic users has actually decreased their “usage days” per year over
the long term, while only 36–47% increased.
Conclusions: Insomnia symptoms can have adverse implications on
emotional, mental health and quality of life. Our results suggest that
chronic patients did not develop tolerance to sleeping drugs.
Disclosure: Nothing to disclose.
P709 | The relationship between anxiety,
chronotype, melatonin onset and sleep on
depression symptoms in insomnia
C. Gordon1,2; M. Comas2,3; J. Chapman2; A. Solis Flores2;
N. Lovato4; C. Miller5; D. Bartlett2,3; R. Grunstein2,3,6
1Sydney Nursing School, The University of Sydney, 2CIRUS Centre for
Sleep and Chronobiology, Woolcock Institute of Medical Research,
3Central Clinical School, University of Sydney, Sydney, NSW, 4Flinders
University, Adelaide, SA, Australia, 5Big Health Ltd., London, United
Kingdom, 6Department of Respiratory and Sleep Medicine, Royal Prince
Alfred Hospital, Sydney, NSW, Australia
Objectives/Introduction: Insomnia has been shown to have a bi‐
directional association with depression. Insomnia patients with eve-
ning chronotype are more likely to be depressed. The influence of
the circadian system may influence these associations. Therefore,
the aim of this study was to investigate subjective (anxiety, chrono-
type and sleep diary), and objective (polysomnography and melatonin
onset) variables in people with insomnia disorder and depression
symptoms.
Methods: Participants were recruited from the community and
insomnia clinics and were screened at a sleep clinic by a physician
for the diagnosis of Insomnia Disorder (DSM‐5). Eligible participants
completed baseline questionnaires (General Anxiety Disorder (GAD‐
7); Composite Morningness Questionnaire (CMQ); Depression Anxi-
ety Stress Scale (DASS‐21)) and a 14‐day sleep diary before two
consecutive nights in a sleep laboratory (1st night with a full sleep
opportunity and PSG; 2nd night dim light melatonin onset (DLMO)
was assessed). Correlations and multiple regression were used to
test subjective and objective predictors of depression symptoms in
insomnia.
Results: Participants (n = 87; mean age 46.4 [15.0] y; 70% female)
were predominately intermediate chronotypes (CMQ: 34.6), with
mild anxiety (GAD‐7: 6.9), and moderate depression scores (DASS‐
21: 9.7). Objective and subjective sleep metrics (PSG TST, SOL,
WASO: 355.6, 23.0, 75.6 min vs. diary TST, SOL, WASO: 333.1,
47.0, 61.8 min) were not different. DLMO clock time averaged
21:08 (range: 17:45–00:53) with a mean phase angle of 1.64 hr. The
correlation between DLMO and chronotype was modest (r = −0.22;
p = 0.035), whilst anxiety was shown to be the strongest predictor
of depression (r2 = 0.340; p < 0.001).
Conclusions: To the best of our knowledge this is the first study
to examine anxiety, chronotype, depression symptoms, objective and
subjective sleep, and circadian measures in Insomnia disorder. Anxi-
ety scores were highly predictive of depression. The inclusion of cir-
cadian measures did not add to the prediction of depression
symptoms in this cross‐sectional sample of Insomnia disorder.
Disclosure: Nothing to disclose.
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P710 | Insomnia in primary care: a survey
conducted on the Italian population older than
50 years. Results from the “Sonno e Salute”
study
P. Proserpio1; D. Arnaldi2; G. Biggio3; R. Ferri4; P. Girardi5;
R. Manni6; A. Minervino7; L. Palagini8; L. Nobili9,10
1Department of Neuroscience (DINOGMI), Clinical Neurology, Niguarda
Hospital, Milano, 2Department of Neuroscience (DINOGMI), Clinical
Neurology, University of Genoa and Ospedale Policlinico San Martino,
Genoa, 3Department of Life Sciences, University of Cagliari, Sleep Center,
Cagliari, 4Oasi Research Insitute IRCCS, Troina, 5Sant'Andrea Hospital,
Sapienza University of Rome, Rome, 6Sleep Medicine and Epilepsy Unit,
IRCCS, C. Mondino National Neurological Institute, Pavia, Pavia,
7Department of Mental Health, Hospital of Cremona, Cremona,
8Department of Neuroscience, University of Pisa, Pisa, 9Department of
Neuroscience, Niguarda Hospital, Center of Sleep Medicine, Milano,
10Department of Neuroscience (DINOGMI), University of Genoa, Gaslini
Institute, Genoa, Italy
Objectives/Introduction: Insomnia affects one‐third of the adult
population and is associated with poor quality of life and multiple
psychiatric and medical conditions, notably depression and cardio-
vascular disease. We conducted an observational epidemiological
survey to assess:
(1) the prevalence of insomnia in an Italian population (aged over
50 years) presenting directly to the general physician (GP);
(2) the association of insomnia with sleepiness and comorbidities
and
(3) the pharmacological treatment.
Methods: The study was carried out by GPs. Each GP was asked
to enroll the first patient over 50 years old spontaneously presenting
for any medical problems for five consecutive days. The Italian ver-
sion of the Sleep Condition Indicator (SCI) was administered; day-
time sleepiness was evaluated by a visual analogic scale (VAS). For
every patient, GP collected information regarding comorbidities and
pharmacological treatment for insomnia and evaluated the severity
of insomnia using the Clinical Global Impression Severity Scale
(CGISS).
Results: A total of 748 patients (mean age 65, SD 9.45) were
enrolled by 149 GPs. Prevalence of insomnia was 55.3%. Linear
regression shows a significant correlation between SCI score and
CGISS score (p < 0.001) and VAS sleepiness score (p < 0.001). The
presence of insomnia was found to be associated with the following
medical conditions: anxiety and depressive disorders (p < 0.001),
other psychiatric disorders (p = 0.05), cardiovascular disease
(p < 0.001), chronic pain (p = 0.002). A statistical significant correla-
tion was found between SCI score and the use of: benzodiazepines
(p < 0.001), z‐drugs (p < 0.001), antidepressants (p < 0.001) and
melatonin prolonged release (p < 0.001).
Conclusions: Insomnia affects half of Italian primary care popula-
tion over 50 years and is frequently associated with different psychi-
atric and medical conditions, sleepiness and usage of different drugs.
Disclosure: Lino Nobili has received honoraria from Fidia Farma-
ceutici (for consulting activities).
P711 | Risk of herpes simplex virus infection
among patients with insomnia: a retrospective
cohort study
H.-C. Wu1; C.-L. Lin2; C.-H. Chung3; W.-C. Chien4,5
1Department of Nursing, Hsin Sheng Junior College of Medical Care and
Management, 2Department of Nursing, Chang Gung University of
Science and Technology, Taoyuan, 3Taiwanese Injury Prevention and
Safety Promotion Association, 4Department of Medical Research, Tri‐
Service General Hospital and National Defense Medical Center, 5School
of Public Health, National Defense Medical Center, Taipei, Taiwan
Objectives/Introduction: This study explored the risk of develop-
ing Herpes simplex virus (HSV) infection in patients with insomnia.
Methods: This study applied a population‐based retrospective
cohort design. A total of 8,425 patients aged ≥20 years who had
received a diagnosis of insomnia between 2000 and 2005. They
were identified according to the corresponding ICD‐9 code (780.52;
insomnia, unspecified). The reference cohort comprised 16,850 age‐
and sex‐matched patients. Data from the Taiwan National Health
Insurance Research Database were employed from 2000 to 2013.
Results: Patients with insomnia had a higher risk of HSV infection,
compared with the reference group (hazard ratio (HR) = 2.19, 95%
confidence interval (CI) 1.73–2.79). For individuals divided into three
age groups (≤40, 41–65, and >65 years old), the HSV infection risk
of the insomnia cohort was significantly greater than that of the ref-
erence cohort (HR = 4.08, 95% CI 1.98–8.42; HR = 1.61, 95% CI
1.04–2.48; HR = 2.25, 95% CI 1.64–3.09, respectively). For male or
female, the HSV infection risk of the insomnia cohort was signifi-
cantly greater than that of the reference cohort (HR = 2.31, 95% CI
1.69–3.14; HR = 1.97, 95% CI 1.35–2.88, respectively).
Conclusions: Compared with without insomnia cohort, patients
with insomnia had a higher risk of developing HSV infection.
Disclosure: Nothing to disclose.
P712 | A phase 1/2 double‐blind, placebo‐
controlled study of SAGE‐217 in an insomnia
model
A. Bullock1; H. Gunduz-Bruce1; G. Zammit2; A. Sankoh1;
H. Li1; M. Qin1; C. Silber1; S. Kanes1; J. Jonas1; J. Doherty1
1Sage Therapeutics, Inc., Cambridge, MA, 2Clinilabs Drug Development
Corporation, New York, NY, United States
Objectives/Introduction: SAGE‐217 is a novel, orally‐bioavailable,
positive allosteric modulator (PAM) of synaptic and extrasynaptic
GABAA receptors (GABAAR) being investigated in clinical studies in
multiple indications, including sleep disorders. This Phase 1/2, dou-
ble‐blind, placebo‐controlled study evaluated the safety and efficacy
of 30 mg and 45 mg SAGE‐217 doses in a 5‐hr phase advance
model of insomnia.
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Methods: Randomized healthy volunteers (n = 45) received 30 mg
SAGE‐217, 45 mg SAGE‐217, or placebo once each on three sepa-
rate visits in a double‐blind, crossover study using a 5‐hr phase
advance model of insomnia, with lights‐out and polysomnography
recording beginning 5 hr prior to habitual bedtimes. Blinded study
drug was administered 30 min before lights‐out. Participants
remained in bed for 8 hr. Treatment periods were followed by 7‐day
washouts. Sleep Efficiency (SE; percentage of time in bed spent
asleep), measured by polysomnography, was the primary endpoint.
Secondary endpoints included Wake After Sleep Onset (WASO), and
Total Sleep Time (TST). Safety and tolerability were assessed by
standard safety parameters, including adverse events (AEs).
Results: SAGE‐217 at 30 mg or 45 mg achieved the primary end-
point by significantly improving SE to medians of 85% and 88%,
respectively, compared to 73% for placebo (both doses p < 0.0001).
Median TST increased significantly from 350.0 min in the placebo
group to 406.3 and 420.3 min in the SAGE‐217 30 mg and 45 mg
groups, respectively (both doses p < 0.0001). SAGE‐217 30 mg and
45 mg groups also showed significant decreases in median WASO
compared to placebo (55.0 min for 30 mg; 42.5 min for 45 mg;
113.0 min for placebo; p < 0.0001). SAGE‐217 was generally well
tolerated, with low AE rates across all treatment groups (11.4%
30 mg; 4.8% 45 mg; and 9.8% placebo). No serious AEs were
reported. Most common AEs across all periods and groups were
headache (4/127, 3.1%) and fatigue (3/127, 2.4%).
Conclusions: In this first randomized, placebo‐controlled insomnia
model trial of this GABAAR PAM, SAGE‐217 met the primary end-
point of improved sleep efficiency, demonstrated improvements in
total sleep time and maintaining sleep, and was generally well toler-
ated.
Disclosure: This study was funded by Sage Therapeutics, Inc. Amy
Bullock, Handan Gunduz‐Bruce, Abdul J. Sankoh, Haihong Li, Min
Qin, Christopher Silber, Stephen Kanes, Jeffrey Jonas, and James
Doherty are employees of Sage Therapeutics with stock/stock
options. GKZ has: ownership interest in Clinilabs, Inc., Home Sleep
and Respiratory Care, and Nationwide Sleep Testing; consulting fees
from Acetlion, Avadel, Eisai, Glaxo Smith Kline, Jazz, Idorsia, and Pur-
due; honoraria from Guidepoint and Merck; and research support
from Actelion, Adare, Alder, Alkermes, Aptalis, Astellas, Astra‐Zeneca,
Avadel, Balance Therapeutics, Biomarin, CHDI, Corbus, Eisai, Flamel,
Flex, Fresca, Idorsia, Janssen, Jazz, Johnson & Johnson, Merck and
Co., Neurocrine Biosciences, Novartis, Pfizer, Purdue, Ritter, Sage
Therapuetics, Inc., Sen‐Jam Pharmaceuticals, Sequential Medicine,
Sunovion, and Vanda.
P713 | Physical activity and insomnia: an
international perspective
I. Hartescu; K. Morgan
School of Sport, Exercise and Health Sciences, Loughborough University,
Loughborough, United Kingdom
Objectives/Introduction: Physical activity shows a ‘U’ shaped
relationship with sleep quality, with very low levels, and very high
levels associated with increased insomnia risk. Physical inactivity
continues to rise internationally, though showing considerable cross‐
national variability (WHO, 2010). Multi‐centre epidemiological com-
parisons also indicate substantial cross‐national variations in insom-
nia symptoms. The present study was designed to assess the extent
to which higher and lower moderate intensity physical activity levels
contribute to insomnia risk in 5 countries.
Methods: Sleep, demographic, health and physical activity profiles
were obtained from an online survey of 9238 participants (age range
18–75; 76% female) drawn from five countries: South Africa, Aus-
tralia, China, South Korea and the UK. Those reporting sleep onset
or maintenance problems, or unrestorative sleep (all with daytime
consequences) on ≥3 nights/week for the previous ≥3 months were
categized as insomnia cases. Continuous, moderate intensity physical
activity l was divided into 5 categories: <10 min/week; 10–75 min/
week; 76–149 min week; 150–300 min/week; and >300 min/week.
Risk was assessed in partially adjusted (age, gender) and fully
adjusted (+health, sleep medication, smoking status, alcohol con-
sumption, caffeinated consumption, educational level and employ-
ment status) logistic regression models.
Results: In partially adjusted models, the lowest level of physical
activity was associated with significant insomnia risk (OR = 1.37
(95% CI = 1.05–1.79; p < 0.05). In the fully adjusted model, how-
ever, only the highest level of physical activity significantly elevated
insomnia risk (OR = 1.30 (95% CI = 1.03–2.51; p < 0.05). Risk asso-
ciated with high activity remained after the addition of ‘country’ to
the model (OR = 1.31 (95% CI = 1.02–1.69; p < 0.05). The coun-
try × physical activity level interaction term was non‐significant
(p = 0.266). Across all models, female gender, low rated health, low
education, and older age consistently increased insomnia risk.
Conclusions: Extremes of inactivity/activity are significantly associ-
ated with insomnia risk. While low activity appears to be a proxy for
poorer health, high activity increases risk independent of health and
demographic factors.
Disclosure: The 5‐Nation Sleep Survey, from which these data are
taken, was supported by Sealy (UK) Ltd. Kevin Morgan was paid as a
consultant to this firm in 2016.
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P714 | Can flavour influence sleep
disturbance? An experimental research with hop
S. Becker-Klunder
Research and Development, Luck GmbH & Co KG, Bocholt, Germany
Objectives/Introduction: To initial experience in using flavoured
bed equipment's to influence insomnia. The measured and self‐rated
sleep quality and efficiency shall be better with this treatment of fla-
vour.
Methods: The study was based on two phases and started with 6
healthy people. The participants were put in a controlled trial in a
double cross over design to sleep with a pillow treated with and
without a flavour of hop. The application of the equipment's with
the treatment hop was double blinded so that the study participants
and the assistants of the sleep laboratory didn′t know whether they
had the treatment or not. The sleep was controlled in an accredited
sleep lap standardized and the evaluation was done following the
AASM manual. In a second step 3 participants with a diagnosed
sleep disorder were recruited from the laboratory. They slept for
four nights on a pillow with and without treatment without knowing,
when the treatment was, evaluation as named.
Results: After the first trial with healthy participants there were no
clear relationship between the treatment and the sleep of the partic-
ipants. But no participant had any dysfunction or side effect. So the
second step started with affected people. In this step all three par-
ticipants showed a small improvement of the insomnia in the deep
sleep phase and also the sleep efficiency and they reported by them-
self a better sleep. One participant could reduce his medication.
Conclusions: In this research it is showed that the treatment with
a hop flavour in a pillow could cause a small positive effect to
Insomnia patients. The affected participants were enthusiast but
regarding the size of the study participants the reported results are
only an indication and further research is needed.
Disclosure: I am Scientist in Public Health and work for the com-
pany Lück GmbH & Co KG, Bocholt Germany. This company makes
the products. The research and the results are based on the experi-
ence of a accredited sleep laboratory in Velen Germany and inde-
pendent from the company., Aalten 15.04.18
P715 | The comparison research of effects of
neurofeedback and cognitive behavior treatment
for insomnia patients
C. Sungwon
Duksung Women's University, Seoul, Republic of Korea
Objectives/Introduction: Insomnia refer to difficulty of in initiat-
ing sleep, maintaining it, or a relaxing sleep despite the opportunity
to get plenty of sleep. CBT‐I is evidence‐based therapy for insomnia,
proven to be effective in ameliorating insomnia by non‐medication
that corrects sleep related misbehavior and distorted thinking. How-
ever, exisiting treatment is an approach that does not consider the
main physiological characteristic of insomnia which is arousal phe-
nomenon. Additionally it has a problem of confirming only the
patient′s subjective report about the therapeutic effect. Therefore,
this study proposes a beta‐decrease neurofeedback training for the
reduction of hyperactivity which is physiological characteristic of
insomnia and confirms whether the new therapeutic approach is as
effective as the existing evidence‐based therapy.
Methods: 14 participants who showed a score suggestive of
insomnia in the sleep disorder test were randomly assigned to the
Neurofeedback training group and the CBT‐I group and received the
corresponding treatment. Resting brain wave were measured for
comparing therapeutic effect when before and after treatment.
Results: According to Wilcoxon's signed‐ranks test, both groups
showed statistically significant change about ISI(NF: 0.005, CBT‐I:
0.027), PSQI(NF: 0.017, CBT‐I: 0.027), PSAS(NF: 0.008, CBT‐I:
0.028) and GSES(NF: 0.005, CBT‐I: 0.046). But only the CBT‐I group
showed significant decline in DBAS (p = 0.028) and the neurofeed-
back training group significantly decreased beta power related to
hyperarousal (beta‐3, p = 0.046).
Conclusions: All treatments were effective in improving insomnia,
but neurofeedback was more effective on ameliorating hyperarousal
symptoms and CBT‐I was more effective in decreased dysfunctional
thinking about sleep.
Disclosure: Nothing to disclose.
P716 | The effects of neurofeedback in
fibromyalgia: a randomized controlled study
Y.L. Wu; S.C. Fang; P.S. Tsai
Nursing, Taipei Medical University, Taipei, Taiwan
Objectives/Introduction: Poor sleep is reported by nearly 80% to
90% of the individuals with fibromyalgia. poor sleep quality is a risk
factor for the development of fibromyalgia; Poor sleep may have a
strong dose‐dependent association with symptom severity. Previ-
ously RCT trails showed that SMR training significantly improves
sleep. This randomized controlled study examined whether the
improvements of the sleep quality following neurofeedback
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(sensorimotor rhythm, SMR) training correlate with the reduction of
pain intensity after neurofeedback training in fibromyalgia.
Methods: Participants in the SMR group (n = 60) were trained in 8
weekly laboratory sessions, whereas participants in the control group
(CG) were accepted telephone education (n = 20). A total of
600 min SMR enhancement training will be provided to participants
during an 8‐week training period. During the first 4 weeks, they will
be trained 3 sessions per week. For the second 4 weeks, the partici-
pants will be trained 2 sessions per week. Sleep quality (Pittsburgh
Sleep Quality Index, PSQI), pain (Brief Pain Inventory, BPI) and
fibromyalgia symptom severity (Revised Fibromyalgia Impact Ques-
tionnaire, FIQR) were assessed before and after training.
Results: The changes in SMRG and CG from pre and post test
were analysis. After 8 weeks, the decreased PSQI score (mean
change −2.17 vs. −1.28, p = 0.373), decreased BPI (mean change
−1.55 vs. −0.07, p < 0.001) and FIQR (mean change −15.33 vs.
0.05, p = 0.004) were found. And improved day time dysfunction
(PSQI) in SMRG than CG (mean change −0.45 vs. 0.05, p = 0.04).
Conclusions: SMR neurofeedback training in fibromyalgia
improved sleep quality, pain and fibromyalgia symptoms.
Disclosure: Nothing to disclose.
P717 | Comparison of sleep related factors in
clinic clients with and without sleep difficulty
complaints
W.-C. Liao1; C.-F. Lai2; H. Din2
1China Medical University Hospital, 2Chun Shan Medical University,
Taichung, Taiwan
Objectives/Introduction: Sleep is affected by multiple factors.
However, majority of patients get medical treatments without a
comprehensive sleep assessment. This study tries to implement com-
prehensive sleep assessment scales in a medical center and to
explore differences of sleep‐related factors between clinic clients
with and without sleep difficulty complaints.
Methods: Five dimensions of comprehensive sleep assessment
(CSA) scales including personal, physiological, psychological, social,
and environmental factors were used to assess clients’ status. Cli-
ents who visited sleep clinic due to sleep difficulties (n = 32, 16
males and 16 females, ages 43.7 ± 14.2 years) and gender‐and age‐
matched healthy subjects without sleep difficulties (n = 96, 47 males
and 49 females, ages 42.0 ± 13.7 years) were randomly recruited at
a ratio of 1:3 (with sleep complaints vs. without sleep complaints) to
compare their sleep and the CSA factors.
Results: Results show that all clinic clients with sleep complaints
did have poor sleep quality (PSQI >5) and mild to moderate daytime
sleepiness (ESS >11). Personal factors of long working hours
(χ2 = 10.315, p = 0.001), shift workers (χ2 = 8.964, p = 0.003), night
shift (χ2 = 9.395, p = 0.004) and perceived stress (χ2 = 9.503,
p = 0.002) were disruptors of sleep quality. Physiological factors
from physical examination including breathing by mouth, low soft
palate, high narrow palate, Edward Angle, tongue hypertrophy, and
occlusion of the worn surface were observed in clinic clients. Psy-
chological factors including higher perceived stress (χ2 = 32.542,
p = 0.000), anxiety and depression (χ2 = 32.868, p = 0.000); social
factors including lack of leisure activities (χ2 = 39.857, p = 0.000),
more drinking habits (χ2 = 1.798, p = 0.018), irregular amount and
frequency in meals (χ2 = 5.086, p = 0.024), excessive dinner
(χ2 = 21.511, p = 0.000), being incapable of getting up on time due
to previous poor night sleep (χ2 = 4.444, p = 0.035); and environ-
mental factors including light disruption (χ2 = 7.683, p = 0.006),
noise disruption (χ2 = 5.086, p = 0.024), low or high bedroom tem-
perature (χ2 = 4.595, p = 0.032) were existed in clients.
Conclusions: Many sleep related factors including personal, physi-
ological, psychological, social, and environmental dimensions existed
in sleep complainers. Findings of this study provide important refer-
ence for assessing and intervening clinic clients with sleep difficul-
ties.
Disclosure: Nothing to disclose.
P718 | Association of chronotype with sleep
and alertness in nurses under fixed shift
C.-P. Kuo1; H.-C. Chang2; S.-C. Chung3; W.-C. Liao4
1Chun Shan Medical University, 2Chun Shan Medical University Hospital,
Taichung, 3Chang Gung University, Tauyuan, 4China Medical University,
Taichung, Taiwan
Objectives/Introduction: Shift nurses often suffer from disruption
of the circadian rhythm resulting in sleep disorder as well as physio-
logical and psychological health issues. Individual's chronotype may
play a role influencing the alertness and fatigue level of a shift
worker while taking different shifts.This study focused on the influ-
ence of the chronotype on sleep pattern and health in nurses with
fixed shifts.
Methods: A purposive sampling method was used to recruit nurses
from two medical centers with fixed day (n = 37), evening (n = 37),
and night (n = 35) shifts. Data including personal information,
chronotype (Morning‐Evening Questionnaire), sleep pattern (Acti-
watch worn 24 hr a day, together with a sleep diary for 6 days),
sleep quality (Pittsburg Sleep Quality Index, PSQI), fatigue (Standard
Shiftwork Index Chronic Fatigue Scale, SSICFS), and alertness (Visual
Alertness Scale, VAS) were collected in the middle weeks of a
monthly shift schedule.
Results: Result show that the majority of nurses’ chronotype were
intermediate (60.6%) or evening (32.1%) type. More nurses under
night shift slept less than 7 hr than those under day or evening
shifts. Nurses with evening type took significantly longer sleep
latency than nurses with intermediate or morning type while worked
in day shifts (F = 0.187, p = .026). Nurses with evening type had
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higher alertness level while worked in evening shifts (F = 1.187,
p = 0.055).
Conclusions: Nurses with evening type may be more suitable for
evening shifts. Managers can take nurses’ chronotype into consider-
ation while arrange their shifts as an option for better performance
and sleep quality.
Disclosure: Nothing to disclose.
P719 | The paradoxes of sleep state
misperception and of paradoxical insomnia: a
search for an evidence‐based definition
A. Castelnovo1; R. Ferri2; N. Punjabi3; V. Castronovo4;
C. Garbazza1; M. Zucconi4; L. Ferini-Strambi4; M. Manconi1
1Ospedale Regionale di Lugano (EOC), Lugano, Switzerland, 2Sleep
Research Centre, Department of Neurology I.C., Oasi Institute for
Research on Mental Retardation and Brain Aging (IRCCS), Troina, Italy,
3Department of Epidemiology, Johns Hopkins University, Baltimore, MD,
United States, 4Ospedale San Raffaele; University Vita‐Salute San
Raffaele, Milan, Italy
Objectives/Introduction: Misperception is definitively the most
intriguing yet challenging feature of insomnia. After decades of
debate, the scientific sleep community is still critically divided
between who considers the underestimation of sleep duration a typ-
ical feature of all insomniacs, with some extreme cases being part of
a clinical continuum, and who supports the existence of a separate
diagnostic category, namely “subjective insomnia”, otherwise known
as “paradoxical insomnia” (PI). Most of the debate is fuelled by the
lack of a consensus on which should be a quantitative definition of
sleep state misperception and by the absence of evidence‐based
strategies to study and define paradoxical insomnia.
Methods: We conducted a systematic review of the literature and
extracted 20 different quantitative definitions of PI. We then applied
these definitions to two real‐world datasets. The first consisted of
200 chronic primary insomnia patients, diagnosed according to
DSM‐IV‐TR criteria, the second of 200 age‐ and gender matched
healthy controls without insomnia. For each dataset, available data
from the objective sleep parameters and their subjective estimation
were imported and analysed in MATLAB using custom algorithms.
Finally, we identified some basic, fundamental features a quantitative
definition of PI must respect and applied them to our 20 definitions.
Results: Prevalence of PI according to the 20 selected definitions
ranged from 8 to 66% in insomnia patients, and from 0 to 89% in
healthy controls. Overlap between definitions ranged from 3 to 84%.
We ranked classworthy the available definitions. Only three fulfilled
our new proposed quantitative criteria for PI, and several open
issues remains, like whether there is a minimum number of hours an
insomnia patient should sleep in order to be defined as paradoxical,
and whether SOL can be used in the definition of paradoxical insom-
nia together with TST.
Conclusions: Given the high heterogeneity of quantitative defini-
tions of paradoxical insomnia, the scarce literature on the topic is of
little use. We suggest to adopt only the definitions that survived a
rigorous methodological evaluation and use them when studying the
phenomenon until a consensus is reached. A research agenda is pro-
posed at the end of the paper.
Disclosure: Nothing to disclose.
PARASOMNIAS
P720 | Screening for idiopathic REM sleep
behavior disorder: usefulness of actigraphy
A. Stefani1; A. Heidbreder2; E. Brandauer2; M. Guaita2;
L.-M. Naier1; T. Mitterling2; J. Santamaria3; A. Iranzo3;
A. Videnovic4; C. Trenkwalder5; F. Sixel-Döring5;
G. Wenning2; A. Chade6; W. Poewe2; O. Gerschanik6;
B. Högl2
1Neurology, 2Medical University of Innsbruck, Innsbruck, Austria,
3Hospital Clinic de Barcelona, Barcelona, Spain, 4Harvard Medical
School, Boston, Massachusetts, Boston, MA, United States, 5Paracelsus‐
Elena Klinik, Kassel, Germany, 6Favaloro Foundation University Hospital,
Buenos Aires, Argentina
Objectives/Instruction: To evaluate the utility of multimodal low‐
cost approaches including actigraphy, a wrist‐worn device monitoring
rest/activity cycles, in identifying patients with idiopathic REM sleep
behavior disorder (iRBD).
Methods: Seventy patients diagnosed with sleep disorders causing
different motor manifestations during sleep (iRBD, sleep apnea, rest-
less legs syndrome) and 20 subjects without any relevant motor
manifestation during sleep, underwent video‐polysomnography
(vPSG) and two‐week actigraphy, completed six validated RBD
screening questionnaires, and sleep apps use was assessed. Actigra-
phy was analyzed automatically, and visually by seven blinded sleep
medicine experts who rated as “no”, “possible” and “probable” RBD.
Results: Quantitative actigraphy analysis distinguished patients
from controls, but not between patients with different types of
motor activity during sleep. Visual actigraphy rating by blinded
experts in sleep medicine using pattern recognition identified vPSG
confirmed iRBD with 85–95% sensitivity, 79–91% specificity, 81–
91% accuracy, 57.7 ± 11.3% positive predictive value, 95.1 ± 3.3%
negative predictive value, 6.8 ± 2.2 positive likelihood ratio,
0.14 ± 0.05 negative likelihood ratio and 0.874–0.933 AUC. AUC of
the best performing questionnaire was 0.868. Few patients used
sleep apps, therefore their potential utility in the evaluated patients’
groups is limited.
Conclusions: Visual analysis of actigraphy using pattern recogni-
tion can identify subjects with iRBD, is able to distinguish iRBD from
other motor activity during sleep, even when patients are not aware
of the disease in contrast to questionnaires. Therefore, actigraphy
can be a reliable screening instrument for RBD potentially useful in
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the general population. Therefore, actigraphy can be a reliable
screening instrument for RBD potentially useful in the general popu-
lation.
Disclosure: This study was supported by the FWF Austrian
Science Fund, project number I 2120‐B27. Ambra Stefani and Marc
Guaita report support from the Austrian Science Fund, project num-
ber I 2120‐B27.
P721 | Altered heartbeat‐evoked potential
amplitude in nightmare disorder
L. Perogamvros1,2; H. Park3; L. Bayer1; A. Perrault2;
O. Blanke3; S. Schwartz2
1Sleep Laboratory, Division of Pneumology, Geneva University Hospitals,
Chêne‐Bourg, 2Department of Neuroscience, Faculty of Medicine,
University of Geneva, 3Laboratory of Cognitive Neuroscience, Center for
Neuroprosthetics and Brain Mind Institute, Ecole Polytechnique Fédérale
de Lausanne, Geneva, Switzerland
Objectives/Instruction: The pathophysiology of nightmare disor-
der is not well known. According to some studies, nightmares reflect
an increased emotional arousal during sleep. At the same time, the
brain response to the heartbeat or heartbeat‐evoked potential (HEP),
which relates to interoceptive processing, is increased when intrinsic
levels of arousal are elevated, such as in high emotional arousal,
stress and insomnia. Here we asked whether HEP during sleep might
differ in nightmare patients as compared to healthy volunteers.
Methods: We measured HEP amplitude across wakefulness, NREM
and REM sleep in 11 patients with nightmare disorder and 11
healthy controls using 21‐channel EEG.
Results: We found that nightmare patients had altered HEP ampli-
tude compared to healthy controls in a frontal cluster (cluster‐level
p = 0.032, corrected for multiple comparisons in space and time).
This HEP effect was specific for REM sleep. In the nightmare group,
there was also a negative correlation between HEP amplitude in the
frontal cluster and the Beck depression scale (r = −0.68, p = 0.02).
Conclusions: These findings support higher emotional arousal and
interoceptive processing during REM sleep of nightmare patients,
which may favor the emergence of emotional dreams.
Disclosure: Nothing to disclose.
P722 | Imagery rescripting and imaginal
exposure for nightmares: efficacy and
mechanisms of change
A.E. Kunze1; A. Arntz2; N. Morina3; M. Kindt2; J. Lancee2
1LMU Munich, Munich, Germany, 2University of Amsterdam, Amsterdam,
The Netherlands, 3University of Münster, Münster, Germany
Objectives/Instruction: Nightmares can be effectively treated with
cognitive‐behavioral therapies. It remains elusive which therapeutic
elements are responsible for the beneficial effects on nightmare symp-
toms. Imagery rescripting (IR) and imaginal exposure (IE) are commonly
identified as active treatment components of nightmare therapies.
With this randomized controlled trial, we compared IR and IE as indi-
vidual treatments to a wait‐list (WL) condition to determine whether
these particular therapeutic elements ameliorate nightmare symptoms
and whether mastery and tolerability mediated the effects.
Methods: In this trial we randomized 104 patients with a primary
DSM‐5 diagnosis of nightmare disorder into an IR, IE, or wait‐list
control group. In the intervention conditions all participants received
three weekly 60 min individual treatment sessions. The treatment
conditions only consisted of IR or IE and did not both comprise of
treatment elements such as extensive psycho‐education, relaxation
and safe‐place exercises, or nightmare journals. Nightmare distress
was assessed with the Nightmare Distress and Impact Questionnaire
(NDIQ; range 0–36). Mediators were assessed weekly with VAS
scales. Tolerability (0–100): “I think that I can tolerate the emotions
elicited by my nightmares.” Mastery (0–100): “I think that I am in con-
trol of the content of my nightmares.”
Results: Results showed that compared to WL, both interventions
effectively reduced nightmare frequency, dir-wl = 74; die-wl = 0.70 and
distress dir-wl = 0.98; die-wl = 1.35 in a sample that predominantly con-
sisted of idiopathic nightmare sufferers. The effects of IR and IE were
comparable to those observed for other psychological nightmare
treatments. Initial effects at post‐treatment were sustained at 3‐ and
6‐months follow‐up. Distress was mediated by mastery in the rescript-
ing condition (but not by tolerability). Distress was mediated by toler-
ability in the exposure condition (but not by mastery).
Conclusions: IR and IE both seem to be efficacious treatment
components of nightmare therapies. Additional research is needed to
directly compare IR and IE among both idiographic and posttrau-
matic nightmare sufferers with respect to treatment expectancy,
acceptability, and effectiveness. Even though IR and IE for night-
mares seem to produce similar therapeutic effects, the results of this
study suggest that IR and IE tap into different underlying processes.
Disclosure: Nothing to disclose.
P723 | Validation of the Dutch translation of
the Paris Arousal Disorder Severity Scale in a
one‐year and one‐month version
P. van Mierlo1; M. van Gilst2; I. Arnulf3; S. Overeem2,4;
A. Pijpers5
1Sleep Medicine Center Kempenhaeghe, Heeze, 2Department of Electrical
Engineering, Eindhoven University of Technology, Eindhoven, The
Netherlands, 3Sleep Disorder Unit, Pitie‐Salpetriere Hospital, AP‐HP,
Paris, France1; Sorbonne University, Paris, France, 4Department of
Industrial Design, Eindhoven University of Technology, Eindhoven, 5Sleep
Medicine Center, Kempenhaeghe, Heeze, The Netherlands
Objectives/Instruction: The Paris Arousal Disorders Severity
Scale (PADSS) was developed to evaluate clinical symptoms and
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severity of sleep walking and sleep terrors. The original PADSS is
used as a screening tool to assess nighttime behavior, its frequency
and consequences over the past year. However, to monitor treat-
ment effects, evaluation over a shorter time frame would be prefer-
able. The aim of this study was to test the psychometric properties
of the Dutch version of the PADSS and to develop and validate a
one month version.
Methods: The Dutch PADSS was obtained by forward‐backward
translation of the original French questionnaire. A second version
was created evaluating symptoms over the past month, instead of
the past year. Both versions were completed by patients with sleep
walking and/or sleep terrors; and healthy control subjects.
Results: The PADSS was completed by 46 consecutive patients
(age 27.0 ± 6.0 years) with sleep walking/sleep terrors and 34
healthy controls (age 27.7 ± 5.6 years). The PADSS showed a good
internal consistency in both the one‐year version (Cronbach′s
alpha = 0.727) and the one‐month version (Cronbach's alpha =
0.790). Factor analysis using a 2‐factor model, yielded factors repre-
senting wandering and violence, comparable to the French version.
Patients had higher scores than healthy controls on both the one‐
year version (16.4 ± 4.6 vs. 1.6 ± 3.4, p < 0.001 and the one‐month
version (14.5 ± 5.1 vs. 2.0 ± 3.5, p < 0.001). Dutch patients had
lower (total) scores on the PADSS one‐year version than the previ-
ously published French cohort (16.4 ± 4.6 vs. 19.4 ± 6.3, t = 2.797,
p < 0.01). A lower cut‐off score to discriminate between patients
and healthy controls yielded better results The best Dutch cut‐off
score was 11.5 (sensitivity 81.8%, specificity 97.1%, ROC‐AUC
0.988), whereas the optimal cut‐off in the French cohort was 13.5.
Conclusions: Both versions of the Dutch‐PADSS are scales with good
internal consistency. Although a lower cutoff score was preferred, the
PADSS one‐year version can be used as a screening tool for non‐REM
parasomnias. The PADSS one‐month version could be used to evaluate
current symptoms and potentially to monitor treatment effects. There-
fore, its responsiveness to changes should be validated next.
Disclosure: Nothing to disclose.
P724 | Idiopathic REM sleep behavior disorder
‐ symptoms of prodromal synucleinopathy and
their relation to the degeneration of nigrostriatal
pathway
K. Šonka1; S. Dostálová1; J. Nepožitek1; P. Peřinová1;
V. Ibarburu1; I. Dall Antonia1; I. Příhodová1; O. Bezdíček1;
T. Nikolai1; J. Trnka2; Z. Mecková2; K. Kupka2; E. Růžička1;
P. Dušek1
1Department of Neurology, 2Institute of Nuclear Medicine, First Faculty
of Medicine, Charles University and General University Hospital, Prague,
Czech Republic
Objectives/Instruction: Idiopathic REM sleep behavior disorder
(iRBD) is considered as the prodromal synucleinopathy. It is
frequently associated with several motor and non‐motor symptoms
such as hyposmia, constipation, and orthostasis along with gradual
loss of dopaminergic neurons in substantia nigra. Our aim was to
compare prevalence and severity of degenerative symptoms in iRBD
and control group. Additionally, we investigated whether these
symptoms are associated with the degree of nigrostriatal degenera-
tion.
Methods: 75 RBD (5f, mean age 67.5 ± SD = 6.2 years) and 41
control subjects (4f, mean age 65.3 ± 8.4) years) were examined
using Movement Disorders Society‐Unified Parkinson′s Disease Rat-
ing Scale (MDS‐UPDRS‐III), Montreal Cognitive Assessment (MoCA),
University of Pennsylvania Smell Identification Test (UPSIT), Scales
for Outcomes in PD‐Autonomic (SCOPA‐AUT), and orthostatic test.
In 62 iRBD patients, 123I‐Ioflupane (DaTscan) SPECT was per-
formed, putaminal indices were calculated using the BASGAN_V2
software and subsequently classified as normal, borderline, or abnor-
mal.
Results: iRBD patients had significantly more severe mean scores
in MDS‐UPDRS‐III (p = 0.01), MoCA (p = 0.001), UPSIT (p = 0.0001),
and SCOPA‐AUT (p = 0001) compared to controls. Orthostatic test
was positive in 33% iRBD patients vs. 0% controls (p = 0.05). iRBD
patients with abnormal DaTscan had significantly higher MDS‐
UPDRS‐III (p = 0.01) and lower UPSIT (p = 0.03) scores compared to
patients with borderline/normal DaTscan result while no differences
were found for age, symptom duration, MoCA, and SCOPA‐AUT
scores.
Conclusions: iRBD is associated with autonomic dysfunction,
hyposmia,cognitive decline, and motor impairment suggesting synu-
cleinopathy. Minor motor symptoms and hyposmia along with abnor-
mal DaTscan are likely markers of imminent conversion to manifest
neurodegeneration.
Disclosure: Supported by Czech Science Foundation (GACR 16‐
07879S), and Czech Ministry of Health (AZV 16‐28914A).
P725 | Influence of NREM parasomnia on
daytime functioning, sleep quality, psychological
health and quality of life in patients and bed
partners
M. Docksey1; G. Leschziner2; K.N. Anderson3; S.H. Eriksson1
1Department of Clinical and Experimental Epilepsy, National Hospital for
Neurology and Neurosurgery, Institute of Neurology, University College
London, 2Sleep, Guy's and St Thomas’ NHS Foundation Trust, London,
3Regional Sleep Service, Newcastle upon Tyne NHS Foundation Trust,
Newcastle, United Kingdom
Objectives/Introduction: Complaints of tiredness and poor sleep
quality are frequently reported in patients with NREM parasomnia.
Despite this, formal assessments of these functions in patients have
been limited and bed partners have never been included in analyses.
The aim of this study was to determine daytime functioning, sleep
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quality, psychological health and quality of life (QoL) in adults with
NREM parasomnia and their bed partners.
Methods: 32 patients (14 male, mean age 41) diagnosed with
NREM parasomnia (sleepwalking, night terrors or sexsomnia) and 14
bed partners (6 male, mean age 35.75) were included in the study.
All participants completed questionnaires assessing daytime somno-
lence, insomnia, sleep quality, depression and anxiety symptoms and
QoL. Patients completed an additional questionnaire assessing
NREM parasomnia characteristics.
Results: Questionnaire scores revealed patients (n = 32) to have
poor sleep quality (cut‐ off score >5; mean score 7.66) and insomnia
symptoms (cut‐off score >7; mean score 10.56), which was also
found in bed partners (n = 14; mean score 5.71 and 7.71, respec-
tively). Daytime somnolence was in normal range for both groups.
Anxiety scores were significantly greater than the standard cut‐off
(>45) for patients (mean score 77.53) and bed partners (mean score
67.86), and depression scores were on the borderline (>10) for
patients (mean score 10.34). QoL scores were compared to healthy
control data (Lopez et al, 2013, n = 100), which indicated both
groups had reduced QoL (mean cut‐off score 87.13; patient mean
scores 73.84; bed partners mean score 78.87). Statistical analysis
revealed significant associations between effects of episodes and
decreased sleep quality in patients (p < 0.05), and greater frequency
of episodes with insomnia (p < 0.005). Furthermore, increased sever-
ity of episodes was significantly associated with poorer sleep quality
in bed partners (p > 0.001), insomnia (p < 0.05) and reduced QoL
(p < 0.05).
Conclusions: Our study confirms that adult NREM parasomnia is a
condition that negatively affects sleep quality, anxiety and QoL in
patients and for the first time also shows an impact on their bed
partners. Additionally, increased frequency of episodes is potentially
damaging to sleep quality in patients and overall QoL for their bed
partners.
Disclosure: Nothing to disclose.
P726 | Impaired visuo‐spatial abilities in REM
sleep behaviour disorder are detected by the
qualitative scoring of the Mini‐Mental State
Examination Pentagon Test
A. Galbiati1,2; G. Carli1; C. Pagnini1; A. Dodich3; C. Cerami3;
S. Marelli1; C. Passera3; M. Zucconi1; S. Iannaccone3;
L. Ferini-Strambi1,2
1Department of Clinical Neurosciences, Neurology ‐ Sleep Disorders
Center, IRCCS San Raffaele Scientific Institute, 2Vita‐Salute San Raffaele
University, 3Division of Neuroscience, IRCCS San Raffaele Scientific
Institute, Milan, Italy
Objectives/Instruction: Rapid Eye Movement (REM) sleep Behav-
ior Disorder (RBD) is a REM sleep parasomnia characterised by the
loss of REM physiological atonia that enables patients to act out
their dreams. RBD is frequently associated with the development of
neurodegeneration and cognitive impairments, in particular in the
visuo‐spatial domain. However, due to the possible subtle nature of
these deficits, they might go unnoticed at the standard neuropsycho-
logical assessment. In the light of these evidences, the aim of this
study was to compare the performance of RBD patients and Healthy
Controls (HC) at the Qualitative Scoring of the Mini‐Mental State
Examination Pentagon Test (QSPT), also exploring the relationship
with polysomnographic (PSG) parameters.
Methods: 90 RBD patients (68.82 ± 7.11) and 110 HC
(62.68 ± 7.39) were retrospectively evaluated. RBD was diagnosed
accordingly to current criteria. Both RBD patients and HC under-
went a comprehensive neuropsychological evaluation, comprising the
Mini‐Mental State Examination (MMSE). Two independent raters,
blind to the status of the subjects (RBD or HC), performed the
QSPT. Comparisons between RBD and HC regarding the overall
score of QSPT as well as all the subscales of the test were investi-
gated. Defining a cut‐off as two deviation standard below the mean
score of HC (cut‐off: 10) we determined the frequency of RBD
patients and HC with impaired performance, and compared patients’
PSG features.
Results: RBD performed significantly worse in comparison to HC in
the QSPT total score (RBD 11.12 ± 1.92; HC 12.07 ± 0.89,
p = 0.032) controlling for age and educational level. 16 out of 90
(15%) RBD patients and 2 out of 110 (1%) HC exhibited a total
score <10 (χ2(1) = 15.39, p < 0.001). RBD patients who performed
below the cut‐off showed lower percentage of REM sleep
(p < 0.014) and slow wave sleep (p < 0.020).
Conclusions: We found a worse performance at the Mini‐mental
pentagon test from a qualitative prospective in RBD patients com-
pared to HC. This finding is in line with the notion that RBD patients
show a visuo‐spatial impairment and suggests that QSPT may be a
useful tool in the early detection of this aspect.
Disclosure: Nothing to disclose.
P727 | A visual search task reveals an impaired
visual processing in RBD patients
E. Giora1; A. Galbiati1,2; M. Zucconi2; L. Ferini-Strambi1,2
1Vita‐Salute San Raffaele University, 2Department of Clinical
Neurosciences, Neurology ‐ Sleep Disorders Center, IRCCS San Raffaele
Scientific Institute, Milan, Italy
Objectives/Instruction: Cognitive impairments, in particular
related to visuo‐spatial abilities, are recognized as a frequent daytime
concern in Rapid Eye Movement (REM) sleep Behavior Disorder
(RBD), a REM parasomnia frequently associated with the develop-
ment of alpha‐synucleinopathies over time. Despite this evidence,
the effect of RBD on visual processing has been poorly investigated.
The aim of this study is to assess the basic mechanisms of stimulus
analysis in RBD patients by means of a visual search paradigm.
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Methods: 18 RBD patients (mean age: 68.38 ± 8.18, 15 males) and
12 age‐matched healthy controls (HC) were enrolled in the study.
After a nocturnal video‐polysomnographic recording patients per-
formed a visual search task in which they had to detect the pres-
ence/absence of a target (letter T) embedded in the 50% of trials
into a set of distractors (letters Os, Xs, or Ls). Target's salience and
distractors’ numerosity were manipulated as independent variables,
whereas accuracy and reaction times (RT) were recorded as depen-
dent variables.
Results: Confirming the classical effects of a visual search task, RT
increased with the number of distractors (p < 0.001), the absence of
the target (p < 0.001) and decreased with the salience of the target
(p < 0.001). Slower RT were generally observed in patients with
RBD in comparison to HC (p < 0.05). However, considering RT of
stimuli with target present in comparison to RT of stimuli without
the target, the two groups showed a significant difference only in
the condition of target absent (p < 0.05).
Conclusions: RBD patients exhibit an overall impairment in visual
processing highlighted by the more demanding conditions of the
task. This main deficit is magnified in the analysis of patterns with-
out the target, which require an exhaustive analysis of the entire
stimulus. These results are in line with previous literature that
reported visuo‐spatial impairments in RBD.
Disclosure: Nothing to disclose.
P728 | Disease duration rather than aging is a
key predicting factor for covert progress of
neurodegeneration in patients with rapid eye
movement sleep behavior disorder
Y. Sumi1; M. Matsuo1; K. Kuriyama1; H. Kadotani2
1Psychiatry, 2Sleep and Behavioral Sciences, Shiga University of Medical
Science, Otsu, Japan
Objectives/Introduction: Although progression to severe neu-
rodegenerative diseases is the prominent problem in rapid eye
movement sleep behavior disorder (RBD) patients, predictive factors
for such progress are yet to be determined, especially in patients
without clear motor symptom or cognitive decline. RBD patients are
reported to have high converting rate to neurodegenerative diseases
as a function of RBD disease duration. But simple effect of aging is
not negligible. We investigated influence of aging and disease dura-
tion against cognitive decline and dopaminergic denervation.
Methods: Medical records of RBD patients, who visited the Sleep
Clinic in Shiga University of Medical Science during April 1, 2016 to
April 1, 2018, were reviewed and 21 patient records fulfilling follow-
ing assessments were included in this study.
For cognitive assessment, MoCA‐J was used to better detect slight
cognitive decline such that cannot be measured by conventional
dementia scale.
Dopaminergic denervation was semi‐quantified by DAT 123I‐FP‐CIT
SPECT, followed by calculation of specific 123I‐FP‐CIT tracer binding
ratio (SBR) by DAT VIEW software (Nihon Medi‐Physics, Tokyo,
Japan).
A stepwise multiple regression analysis was conducted with MoCA‐J
score, and SBR as dependent variables, and age, sex, disease dura-
tion, BMI, years of education were used as independent variables.
Results: All patients were male, with a mean (SD) age of 73.2 (5.9)
years, disease duration of 9.4 (5.4) years, BMI of 24.4 (2.9) kg/m2,
and education of 13.2 (2.9) years. MoCA‐J score was 23.7 (3.2), and
SBR was 4.00 (1.29).
Multiple regression analysis equation: MoCA‐J score = 26.962 ‐
0.352 * disease duration (R2 = 0.356, F = 10, 488, p = 0.04).
However, no significant relation was found between SBR and inde-
pendent variables.
Conclusions: Disease duration significantly correlated with the
score of MoCA‐J but did not correlate DAT uptake; age did not cor-
relate with either MoCA‐J or DAT uptake.
This research suggested two possibilities. First, disease duration of
RBD may be more closely related to the progression of neurodegen-
erative diseases rather than aging. Second, MoCA‐J can capture the
sign of neurodegeneration earlier than DAT‐SPECT.
Disclosure: This study protocol was approved by the ethics com-
mittee of the Shiga University of Medical Science. There are no con-
flicts of interest. This study was supported by JSPS KAKENHI Grant
Numbers 17H00872, 16K20817.
P729 | The utility of polysomnography in
NREM parasomnias: a large cohort retrospective
study
V. Gnoni1; P. Drakatos1; L. Marples1; R. Muza1; S. Haggis1;
A. Nesbitt1; R. Macavei1; L. Perez Carbonell1; I. Duncan1;
A. Birdseye1; S. Dastagir1; I. Rosenzweig1,2; D. O'Regan1;
A.J. Williams1,3; G.D. Leschziner1,4; B.D. Kent1,3
1Sleep Disorders Centre, Guy's Hospital, 2Department of Neuroimaging
King's College, Sleep and Brain Plasticity Centre, 3King's College,
4Department of Clinical Neurosciences, King's College, London, United
Kingdom
Objectives/Introduction: Although video polysomnography
(vPSG) is not routinely indicated for the evaluation of typical cases
of non‐REM (NREM) parasomnias, it can aid diagnosis of unusual
cases, other sleep disorders, complicated cases with REM behavior
disorder (RBD), and in differentiating parasomnias from epilepsy. In
this study we aimed to assess the utility of vPSG in consecutive
patients with a clinical diagnosis of NREM‐parasomnias covering the
whole phenotypic spectrum.
Methods: 512 patients with a final diagnosis of NREM parasom-
nias who had undergone vPSG were retrospectively identified.
Potential priming factors for parasomnias events were extracted
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from medical records. vPSGs were analysed for features of NREM
parasomnias and for the presence of other sleep disorders.
Results: 206 (40.0%) patients were diagnosed with sleepwalking,
72 (14.1%) with sleep terrors, 39 (7.6%) with confusional arousals,
15 (2.9%) with sexsomnia, 7 (1.4%) with sleep‐related eating disor-
der, 122 (23.8%) with mixed phenotype and 51 (10.0%) with para-
somnia overlap disorder (POD). Priming factors were identified in
35.9% of patients; the most common were stress (52%) sleep depri-
vation (29.3%), and insomnia (13%). The vPSG supported the diagno-
sis of NREM parasomnias in 64.4% of the patients, and of POD in
9.8%. In 28.9% of the patients, obstructive sleep apnea (OSA) or/and
periodic limb movements during sleep (PLMS) were identified: 22%
of patients had OSA (AHI: 18.6 ± 15.5 events/hr), and 11% PLMS
(PLMI: 33.2 ± 23.6 events/hr), but no significant differences were
found between parasomnias phenotypes. Age >50 years, obesity,
male sex, and subjective daytime sleepiness were identified as inde-
pendent predictors of concomitant OSA and/or PLMS.
Conclusions: vPSG has a high diagnostic yield in patients with
NREM parasomnias and should be routinely performed when there
is diagnostic doubt. A high index of suspicion for OSA and PLMS is
also recommended, particularly in older, overweight, male patients.
Disclosure: Nothing to disclose.
P730 | Treatment approach in patients with
NREM parasomnias: a large cohort retrospective
study of 512 patients
P. Drakatos1; L. Marples1; R. Muza1; S. Higgins1; N. Gildeh1;
R. Macavei1; E. Dongol1; A. Nesbitt1; I. Rosenzweig1,2;
E. Lyons1; G. d'Ancona1; J. Steier1,3; A. Williams1; B. Kent1;
G. Leschziner1,4,5
1Sleep Disorders Centre, Guy's and St. Thomas NHS, 2Sleep and Brain
Plasticity Centre, Department of Neuroimaging, IoPPN, 3Faculty of Life
Sciences and Medicine, 4and Brain Plasticity Centre, Department of
Neuroimaging, IoPPN, 5Department of Basic and Clinical Neurosciences,
IoPPN, King's College, London, United Kingdom
Objectives/Introduction: Non‐REM parasomnias are not uncom-
mon conditions in the general population. Current treatment options
are based on small case series and reports. In this study we aimed to
present the clinical experience from a large cohort of patients.
Methods: 512 patients with Non‐REM parasomnia or parasomnia
overlap disorder (POD), who had undergone a video polysomnogra-
phy and were exposed to treatment with adequate follow up (FU)
time of at least 6 months, were retrospectively identified over a per-
iod of 7.5 years (between June 2008 and December 2015). Treat-
ment outcome was assessed based on patients’ reports, and
treatment approach on a locally accepted hierarchy of interventions.
Results: The age of the patients ranged from 19 to 88 years old
with a mean of 39.3 ± 12.1 years, 265 were males (51.8%), and the
median FU time was 8.0 months (interquartile range 7.0–11.0) of FU
time. 40% of the patients were diagnosed with sleepwalking, 23.8%
with mixed‐phenotype and 10% with POD. 97.2% ultimately
reported adequate control of their symptoms. 60.1% were treated
with pharmacotherapy and 32.0% without, consistent across all phe-
notypes (p = 0.09). Benzodiazepines were the commonest drugs pre-
scribed (47.1%, p < 0.05). Ultimately 37.7% of our patients were
receiving a benzodiazepine (clonazepam, 95.8%) as part of their suc-
cessful treatment, 11.7% an antidepressant (fluoxetine, 31.6%), 9.2%
a z‐drug (zopiclone, 100%), and 10.7% melatonin. 13.2%, 12.1% and
5.8% of our patients reported good control of their symptoms with
sleep hygiene, management of sleep‐disordered breathing, and psy-
chological interventions (cognitive behavioral therapy (CBT) or mind-
fulness‐based stress reduction (MBSR)), as monotherapy respectively.
Conclusions: The treatment approach to effective treatment of
the patients with Non‐REM parasomnias or POD offering first sleep
hygiene advice, next treatment of concurrent sleep disorders and
management of other priming factors like stress and anxiety, and
lastly pharmacotherapy for Non‐REM parasomnia is supported by
our results. Non pharmacological interventions were effective in one
third of our patients, and CBT/MBSR and melatonin appeared
promising new treatments.
Disclosure: Nothing to disclose.
P731 | The “RBD Rating Scale” (RBD‐RS):
description and validation of a new instrument
to measure manifestation and change of RBD
symptoms over time
S. Wisniewski1,2; F. Bes1,2; D. Kunz1,2
1Clinic for Sleep & Chronomedicine, St. Hedwig‐Krankenhaus, 2Institute
of Physiology, Charité – Universitätsmedizin Berlin, Berlin, Germany
Objectives/Introduction: The intake of melatonin not only has
slowly evolving acute effects on symptoms of REM sleep behavior
disorder (RBD), but ‐ in contrast to clonazepam ‐ also a remitting
influence after discontinuation. Until now, just one polysomno-
graphic (PSG) based instrument to assess the severity of RBD at the
time of diagnosis exists (RBDSS; Sixel‐Döring et al., 2011). In order
to document the initial state before the beginning of treatment and
also specific symptom changes in the course of the disease, an
external evaluation form has been developed.
Methods: The “RBD Rating Scale” (RBD‐RS) is completed by a clin-
ician based on interviews with patients and their bed partners with
regard to the last 6 months.
Severity of RBD symptoms is evaluated on two dimensions: On the
first scale (“frequency”)the occurrence of symptoms can be esti-
mated from never (=0), less than monthly (=1), monthly (=2), 1–2
times a week (=3), 3–5 times a week (=4) and daily (=5).The second
scale (“expression”) describes the form of the most severe manifes-
tation of RBD symptoms from no movement (=0), to speech or slight
distal movements (=1), screaming or complex, non‐aggressive move-
ments (=2), complex movements with risk of injury (=3) and leaving
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the bed (=4). Both ratings are summarized to a total score (with a
range from 0 to 9).
Results: In a cohort of iRBD patients (N = 100) who were all trea-
ted with melatonin, clinicians filled out the RBD‐RS at baseline (PSG)
and at every check up in further treatment (at least once, at most
three times a year). Within a validation study, in particular the test‐
retest‐ and interrater reliability, objectivity and external validity of
this newly developed instrument are to be tested, by evaluating
videometric data of RBD patients in PSG at baseline, focusing on
frequency and expression of symptoms.
Conclusions: The RBD‐RS is expected to prove an easy‐to‐use
instrument to document RBD symptom changes over time. It should
do so in an objective, reliable, valid and economical way via clinical
interview, adding to existing instruments that need PSG based evalu-
ation of RBD symptoms severity.
Disclosure: Nothing to disclose.
P732 | Somnambulism and environmental
factors
W. Jernajczyk1; A. Wierzbicka-Wichniak1; A. Wichniak2;
K. Skwarło-Sońta3
1Clinical Neurophysiology, 2Third Department of Psychiatry, Institute of
Psychiatry and Neurology, 3Department of Animal Physiology, Faculty of
Biology, University of Warsaw, Warsaw, Poland
Objectives/Introduction: Activity of humans, like that of other
living organisms, exhibits a circadian rhythm, generated by endoge-
nous biological clock. Periodic variations in ambient light intensity is
the most important external cue (zeitgeber) that synchronizes rhyth-
mical functions with the environmental conditions. Growing usage of
the mobile devices (cell phones, tablets), laptops and/or watching TV
around bedtime may increase an exposure to the blue component of
visible light spectrum and contribute to the sleep disorders. In the
Sleep Disorder Center of the Institute of Psychiatry and Neurology
in Warsaw, Poland, only 3 adult patients were diagnosed with som-
nambulism between 2000 and 2012 while between 2013 and 2017
the number of such adults increased to 52. It is worth to emphasize
that while somnambulism i.e. sleepwalking episodesaffects up to
15% of children, in most cases it recedes around puberty.
Hypothesis: Refraining from using devices emitting blue light will
help to recede or significantly reduce the severity of sleepwalking
episodes.
Methods: All patients were asked not to watch TV and to stop
using mobile devices and/or laptops minimum 1 hr prior to entrance
to bed. After six weeks of treatment the patients who did not report
the improvement were additionally prescribed with low dose of SSRI
(escitalopram, paroxetine).
Results: Change in the pre‐bedtime behavior eliminated episodes
of somnambulism in 21 of 48 patients (44%) while 19 other (40%)
achieved a marked improvement after the introduction of
antidepressant pharmacotherapy. The therapy was not effective in
two patients (4%) and 6 persons did not attend the follow‐up visit.
Conclusions: The growing number of episodes of somnambulism
in adults may originate from an excessive exposure to the blue light
around bedtime. Successful treatment comprises the change in sleep
hygiene supplemented in some cases with an antidepressant given in
a low dose.
Disclosure: Nothing to disclose.
P733 | Effects of melatonin in idiopathic REM‐
sleep behavior disorder develop over time and
are outlasting
D. Kunz1,2; S. Wisniewski1; F. Bes1,2
1Institute of Physiology, Charitè ‐ Universitätsmedizin Berlin, 2Clinic for
Sleep & Chronomedicine, St. Hedwig‐Krankenhaus, Berlin, Germany
Objectives/Introduction: Idiopathic REM sleep behaviour disor-
der (iRBD) is considered to represent a prodromal state in develop-
ing clinical synucleinopathy (e. g. Parkinson's Disease). The two
treatments of choice ‐ clonazepam and melatonin ‐ differ with
respect to side effects and treatment response timing. Even though
melatonin is considered to have considerably lower side effects,
clonazepam is much more often used, most likely because of its very
rapid acute effect. Effects of melatonin in RBD develop gradually
over weeks, but persist even after treatment discontinuation. Here
we report on a large group of iRBD patients treated with melatonin
over varying times.
Methods: 100 consecutive iRBD patients (mean age at RBD‐diag-
nosis: 69.37 ± 7.53; mean age at first RBD‐symptoms: 64.04 ± 8.63;
82 males; diagnosed by three night video polysomnography) were
treated with 2 mg slow‐release melatonin. Patients were instructed
to administer melatonin, A: 30 min prior to habitual bedtime, and B:
always at the same clock‐time ± 30 min. Melatonin treatment dura-
tion differed: Group 1 (n = 79): continuously ongoing; Group 2
(n = 21): stopped until six months after treatment initiation. Severity
of RBD symptoms was repeatedly determined by two dimensions
(RBD‐rating scale; see presentation this conference): frequency
(range 0–5), expression (range 0–4).
Results: 95/100 of iRBD patients reported an improvement of
symptoms during melatonin treatment. All five non‐responders were
later determined non‐compliant to instruction B. RBD‐ratings of
patients Group 1 improved from baseline 8.0 ± 1.10 to 4.31 ± 1.74
after four weeks, to 4.45 ± 1.37 after eight weeks, to 4.36 ± 2.61
after 12 months, to 3.77 ± 2.11 after 24 months and to 3.33 ± 2.11
after 36 months. RBD‐ratings of patients Group 2 improved to
2.92 ± 2.19 5.01 years after discontinuation of melatonin.
Conclusions: To the best of our knowledge, this sample is the lar-
gest group of iRBD patients ever reported to be treated with mela-
tonin. Our observations underline that melatonin is effective and
safe in RBD. Effects develop gradually, remain stable during years of
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treatment and outlast discontinuation after at least six months of
treatment. The horizon for effective RBD treatment may be to pre-
vent conversion to full blown synucleinopathy. Future follow‐up of
our patients will have to evaluate that aspect.
Disclosure: Nothing to disclose.
P734 | A simplified efficient scoring method to
quantify REM sleep without atonia
J. Klemming1; A. Papakonstantinou1,2; F.W. Bes1,2;
D. Kunz1,2
1Institute of Physiology, Charitè ‐ Universitätsmedizin Berlin, 2Clinic for
Sleep & Chronomedicine, St. Hedwig‐Krankenhaus, Berlin, Germany
Objectives/Introduction: REM sleep without atonia (RSWA) is a
hallmark of REM sleep behaviour disorder (RBD) and one of the
required diagnostic criteria. Current methods to quantify RSWA may
include the EMG of several muscles, as well as evaluation of
phasic ‐, tonic ‐, and “any” muscle activity, are however laborious
and time consuming. Our goal was to develop a scoring method to
quantify RSWA (manually or automatically) in a simple, straightfor-
ward and time‐efficient way, based on chin EMG only, that never-
theless provides a reliable estimate about the extent of muscle
activation during REM sleep.
Methods: Our definition of muscle activation during REM sleep
was adapted from the original description given by Lapierre and
Montplaisir (1992), later adapted and validated by Consens et al
(2005). We define muscle activation in a REM‐episode as muscle
activity longer than 1 s, with amplitude of more than 4 times the
lowest background EMG activity of that REM‐episode. Interruptions
with less activity up to 1 s are included. Lowest background EMG
activity is visually evaluated for each REM episode. The exact dura-
tion of the muscle activation is calculated, without dividing the EMG
signal in mini epochs, and expressed as percentage of time spent in
REM sleep. Muscle activity of 20 RBD patients was visually scored
for RSWA and compared with 20 healthy controls and 20 PLMS
patients matched for age and gender.
Results: With our scoring method, we could differentiate well
between RBD and non‐RBD subjects. Best Cut‐off value showed
high sensitivity (90.0%) and specificity (92.5%). ROC analysis demon-
strated AUC values of 0.96 (p < 0.05). In the non‐RBD groups, as
expected, no significant differences could be demonstrated.
Conclusions: AUC values are in line with published results from
the SINBAR group. The results indicate that our scoring method is a
reliable and efficient tool for detecting RSWA in RBD patients. The
method represents an attractive alternative to the laborious gold
standard, especially in situations when RSWA needs to be repeatedly
quantified, e.g. within the framework of a progressing neurodegener-
ation.
Disclosure: Nothing to disclose.
P735 | Sleep stage and time of occurrence of
minor and major motor episodes differentiate
disorders of arousal from Sleep‐Related
Hypermotor Epilepsy
P. Proserpio1; G. Loddo2; F. Zubler3; L. Ferini-Strambi4;
L. Licchetta2,5; F. Bisulli2,5; P. Tinuper2,5; L. Tassi1;
V. Menghi5; F. Provini2,5; L. Nobili1,6
1Center of Sleep Medicine, Center of Epilepsy Surgery, Niguarda Hospital,
Milano, 2Department of Biomedical and Neuromotor Sciences, University
of Bologna, Bologna, Italy, 3Department of Neurology, Inselspital,
University Hospital Bern, University of Bern, Bern, Switzerland,
4Department of Clinical Neurosciences, Sleep Disorders Center,
University Vita‐Salute San Raffaele, Milan, 5IRCCS Institute of
Neurological Sciences, Bologna, 6Department of Neuroscience
(DINOGMI), Gaslini Institute, University of Genoa, Genoa, Italy
Objectives/Introduction: Differential diagnosis between Sleep‐
Related Hypermotor Epilepsy (SHE) and Disorder of Arousal (DOA)
can be challenging. Generally DOA arise more frequently from deep
NREM sleep, in the first third of the night while sleep‐related sei-
zures occur mostly during light NREM sleep anytime during the sleep
period. However, systematic studies analyzing and comparing these
aspects in parasomnic and epileptic patients are scanty and their
results are discordant. Aim of this study is to evaluate the stage and
the relative time of occurrence of minor and major DOA and epilep-
tic events.
Methods: Video‐polysomnography recordings of 89 patients with a
definite diagnosis of DOA (59) or SHE (30) were retrospectively
selected and reviewed by experts to define major or minor events.
For every major or minor event, we analyzed the stage and the rela-
tive time of occurrence. The “event distribution index” was defined
on the basis of the occurrence of the event during the first vs. the
second part of sleep period time. A group analysis was performed
between subjects with DOA or SHE in order to identify candidate
predictors. The discriminative performance of each continuous dis-
crete predictors was quantified (AUC or specificity/sensitivity).
Results: Significantly less total events were observed in patients
with DOA (3.2 ± 2.4) than in patients with SHE (6.9 ± 8.3; p = 0.03).
Episodes occurred mostly during N3 and N2 in DOA and SHE
patients respectively. Indeed, the occurrence of at least one major
event outside N3 was highly suggestive for SHE (p = 2*e‐13; accu-
racy = 0.898, sensitivity = 0.793, specificity = 0.949). The occurrence
of at least one minor event during N3 was highly suggestive for
DOA (p = 4*e‐5; accuracy = 0.73, sensitivity = 0.733, speci-
ficity = 0.723). The “event distribution index” was statistically higher
in DOA for total events (p = 0.012) and for major events
(p = 0.0026).
Conclusions: Our work confirms that the stage and the relative
time of occurrence of minor and major complex motor manifestation
during sleep represent a useful tool to discriminate DOA from SHE
episodes.
Disclosure: Nothing to disclose.
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P736 | REM sleep behavior disorder and other
sleep disturbances in dementia with Lewy bodies
J. Santamaria1; A. Fernández-Arcos2; E. Morenas-Rodríguez3;
R. Sánchez-Valle4; A. Lladó2; C. Gaig2; A. Iranzo2; A. Lleó3
1Neurologys Service and Multidisciplinary Sleep Disorders Unit, Hospital
Clinic de Barcelona, 2Neurology Service and Multidisciplinary Sleep
Disoders Unit, 3Neurology Service, Hospital de la Santa Creu i Sant Pau,
4Neurology Service, Barcelona, Spain
Objectives/Introduction: Sleep disturbances may occur in
patients with dementia with Lewy bodies (DLB), especially REM
sleep behavior disorder (RBD). A correct identification of sleep disor-
ders in DLB is important to increase diagnostic accuracy and imple-
ment appropriate treatment.
Methods: We evaluated the frequency and characteristics of RBD
and other sleep disturbances in a series of consecutive patients with
DLB through a clinical interview, validated sleep questionnaires and
video‐polysomnography (V‐PSG).
Results: Thirty‐five patients, 65.7% men, mean age
77.7 ± 6.1 years were included. Poor sleep quality (67.9%), snoring
(60%) and abnormal movements/behaviors during sleep (60%) were
the most common sleep‐related complaints. V‐PSG showed posterior
background awake with EEG frequencies slower than 8 Hz in 11
patients (34.3%). Abnormal sleep architecture was found in 24
(75.0%) patients, including absence of sleep spindles or K complexes
(12.9%), slow frequency spindles (25.8%) or posterior delta slowing
in REM sleep (16.1%). Ten (31.2%) patients showed abnormal behav-
iors during arousals. Nineteen out of 35 (54.2%) patients had a sug-
gestive history of RBD. In 26 in whom REM sleep was recorded,
RBD was diagnosed in 13 (50.0%), 11 out of 15 with a suggestive
clinical history (4 false positives) and 2 out of 11 with a negative his-
tory (two false negatives). Three of the four false positives had other
sleep abnormalities causing behaviors mimicking RBD (obstructive
sleep apnea in one, periodic leg movement disorder in one and com-
plex visual and auditory hallucinations in one). Posterior background
EEG frequency awake was negatively correlated with the percentage
of “any” EMG activity during REM sleep in the mentalis (p = 0.004).
Wake/sleep architecture abnormalities ‐other than lack of REM sleep
atonia‐ were more frequent in patients with RBD (p = 0.02).
Conclusions: Wake/sleep abnormalities are common in DLB and
impair wakefulness, NREM, REM sleep and arousals from sleep. This
complexity hinders the correct identification of RBD, which occurs in
half the patients. The correlation between posterior EEG background
activity awake and abnormal EMG activity in REM sleep suggests
that both findings have a subcortical origin.
Disclosure: Nothing to disclose.
P737 | Nightmares and stress: a longitudinal
study
M. Schredl1; M. Gilles1; I. Wolf1; V. Peus1; B. Scharnholz1;
M. Sütterlin2; S. Bardtke3; T. Send3; A. Samaras3;
M. Deuschle4
1Sleep Laboratory, Central Institute of Mental Health, 2Department of
Gynecology and Obstetrics, University Medical Center Mannheim,
University of Heidelberg, 3Central Institute of Mental Health,
4Department of Psychiatry and Psychotherapy, Central Institute of
Mental Health, Mannheim, Germany
Objectives/Introduction: In nightmare etiology, trait and state
factors play important roles. However, the interaction of state and
trait factors has never been studied in a longitudinal design.
Methods: The present sample included 406 pregnant women who
were followed‐up about six months after giving birth (N = 375) and
four years later (N = 302). A nightmare frequency scale and several
stress‐related questionnaires were presented at the three measure-
ment points.
Results: The nightmare frequencies decreased slightly over this
time period (p < 0.0001 but were very stable (correlation: r = 531,
p < 0.0001, N = 279). In line with previous findings, current stres-
sors were associated with nightmare frequency in the cross‐sectional
analysis (p < 0.0001; N = 394 (t1) to N = 294 (t4)) but longitudinal
analyses also indicated that previously measured nightmare fre-
quency showed even stronger effects (p < 0.0001, N = 267–339).
Conclusions: Since the nightmare frequencies were very stable, it
would be very desirable to carry out intervention studies treating
nightmares as early as possible ‐ even in childhood ‐ and investigate
how the nightmare frequencies are affected in the following years.
Disclosure: Nothing to disclose.
P738 | Do patients affected by isolated REM
sleep behavior disorder present a specific brain
[18F]FDG PET pattern?
C. Liguori; R. Ruffini; E. Olivola; A. Chiaravalloti; A. Stefani;
N.B. Mercuri; O. Schillaci; F. Placidi
University of Rome ‘Tor Vergata’, Rome, Italy
Objectives/Introduction: REM behavior disorders (RBD) is a sleep
parasomnia, characterized by the pathological lack of atonia during
REM sleep associated with enacting dreams. Several longitudinal
studies revealed that patients affected by isolated RBD (iRBD) trend
to convert to α‐synucleinopathies at follow‐up.
This study aimed at evaluating brain glucose metabolism, measured
by [18F]FDG‐PET, in patients affected by iRBD compared to Parkin-
son's Disease (PD), Lewy Body Dementia (LBD), Alzheimer's Disease
(AD) and elderly controls (EC).
Methods: Differences in brain [18F]FDG uptake were analyzed
using statistical parametric mapping (SPM8) implemented in Matlab
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R2012b. The following voxel‐based comparisons were performed
using a ‘two‐sample t test’ design model: iRBD vs. PD; iRBD vs.
LBD; iRBD vs. AD; iRBD vs. EC.
Results: 54 iRBD, 28 PD, 10 LBD, 55 AD, and 35 EC were
included in this study. iRBD patients showed brain glucose hypome-
tabolism in the precuneus, middle temporal gyrus, parietal and occip-
ital lobes compared to EC (p < 0.05). Considering the other
comparisons, iRBD patients mainly showed: cerebral glucose hypo-
metabolism in frontal areas compared to AD patients (p < 0.05);
temporal glucose hypometabolism compared to LBD (p < 0.05); and
frontal, cerebellar, and brainstem brain glucose hypometabolism
compared to PD patients (p < 0.05).
Conclusions: This study documented the alteration of brain [18F]
FDG uptake in iRBD patients, as expected in a preclinical neurode-
generative process. Moreover, iRBD patients showed a distinctive
pattern of cerebral [18F]FDG uptake, which is different from AD,
LBD or PD. These findings further support the hypothesis that iRBD
may represent a preclinical stage of neurodegeneration in which
biomarkers changes already occur.
Disclosure: Nothing to disclose.
MOVEMENT DISORDERS
P739 | REM sleep‐related neck myoclonus,
physiological phenomenon or parasomnia?
R. Lopez1,2; J. Fanielle3; N. Vitello4; S. Chenini1;
E. Evangelista1,2; L. Barateau1,2; F. Pizza5; Y. Dauvilliers1,2
1Centre de Référence National Narcolepsie et Hypersomnies, 2Inserm U
1061, Montpellier, France, 3Centre d’Étude des Troubles de l’Éveil et du
Sommeil, Liege, Belgium, 4Unité du Sommeil, Vichy, France, 5Department
of Neurological Sciences, University of Bologna, Bologna, Italy
Objectives/Instruction: Neck myoclonus during sleep (NM) is
characterized by sudden flexion or version of the head that occurs
typically during rapid eye movement (REM), with unknown etio-
pathogenic mechanisms. We report here a series of five non‐medi-
cated patients with a primary clinical complaint of abnormal motor
behaviors during sleep potentially related to excessive NM. We also
identified 25 other patients with incidental findings of excessive
NM.
Methods: From 2014 à 2017, 30 unmedicated patients (20 males,
median age 27 years range 16–51) with excessive NM (defined by a
REM NM index above the 95th percentile of the normative values
obtained in a previous study, i.e. 14.3/hr) took part of the study. We
described the clinical and polysomnographic characteristics of these
subjects and compared them to those of 30 healthy controls (17
males, 30 years range 20–30) and 23 patients with REM sleep Beha-
viour disorder ‐ RBD (20 males, 69 range 44–80).
Results: The median NM index was 41.4/hr of REM sleep (from
20.3 to 134.5/hr), and 0.8/hr (from 0.0 to 23.8/hr) of non‐REM sleep.
Patients with clinical complaint of NM had a higher REM NM index
than patients with incidental findings of NM (80.3/hr, range 56.9–
134.5 vs. 39.0/hr, range 20.3–86.5). The test‐retest variability of the
REM NM index was low in 8 patients having at least two recordings
(from 0.3 to 23.4%). Compared to controls, patients with NM dis-
played higher levels of subjective and objective sleepiness and REM
sleep deregulation, without difference for phasic or tonic muscular
activities during REM sleep. There was no difference for REM NM
index in patients with RBD and controls.
Conclusions: Excessive NM is rarely associated with clinical com-
plaints of nighttime movements and sleep fragmentation, and could
be related to functional impairment. The absence of association
between NM index and REM sleep without atonia indexes may sug-
gest that NM results from a unique pathophysiological mechanism
responsible for REM sleep deregulation, rather than a variant of
RBD.
Disclosure: Nothing to disclose.
P740 | The Grand Total EEG score changes
with the course of idiopathic REM sleep
behavior disorder
K. Tanioka1,2; K. Taniguchi2,3; T. Hamano4,5; N. Tachibana2,3
1Department of Neurology, Graduate School of Medicine and Faculty of
Medicine Kyoto University, Kyoto, 2Center for Sleep‐related Disorders,
Department of Neurology, Kansai Electric Power Hospital, 3Division of
Sleep Medicine, Kansai Electric Power Medical Research Institute,
4Department of Neurology, Kansai Electric Power Hospital, 5Division of
Neurology, Kansai Electric Power Medical Research Institute, Osaka,
Japan
Objectives/Instruction: Idiopathic REM sleep behavior disorder
(iRBD) is well known as a prodromal symptom of dementia with
Lewy bodies (DLB). Recently, it was reported that the Grand Total
EEG (GTE) score had a sensitivity of 79% and a specificity of 76% in
differentiating patients with DLB from those with Alzheimer's dis-
ease (AD) when using cut‐off score of 6.5 by H. Lee, et al (2015).
There have been no studies that investigated how GTE score chan-
ged with the course of iRBD. We, therefore, studied the GTE scores
of iRBD patients with long follow‐up.
Methods: The study is retrospective assessment of daytime EEG
of iRBD patients (N = 17) with follow‐up durations of longer than
24 months (range 24–120 months) at one urban sleep center in
Osaka, Japan from December 2006 to December 2016. GTE score
was calculated according to the EEG assessments by G.Roks, et al
(2008).
Results: The mean age of first visit to our hospital was
69.6 ± 6.1 years old, and estimated age of iRBD on set
was 62.9 ± 6.4 years old. The mean duration of iRBD at first visit
was 6.7 ± 6.8 years. Two (11.8%) out of 17 patients were female.
The last GTE scores of 12 (70.6%) out of 17 patients were higher
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than or equal to the first GTE scores (at first visit GTE: 4.0 ± 2.2,
range 1–8, at last visit GTE score: 6.9 ± 2.2, range 3–10).
Conclusions: The GTE score tends to be higher as iRBD pro-
gresses. There is, however, great individual difference. Some patients
showed no change in GTE scores despite long intervals, while others
abrupt increase in their scores. Long term follow‐up is warranted
whether GTE score could be helpful to expect the future possibility
to develop full‐blown DLB.
Disclosure: Nothing to disclose.
P741 | Periodic limb movements during sleep
in stroke/transient ischemic attack: prevalence,
course and cardiovascular burden
M. Manconi1; F. Fanfulla2; R. Ferri3; S. Miano1; J. Haba-
Rubio4; R. Heinzer4; T. Horvath5; P. Proserpio6; P. Young7;
G. Moschovitis8; A. Seiler5; C. Cereda1; L. Nobili6; R. Wiest9;
S.R. Ott10; C.L. Bassetti5
1Sleep and Epilepsy Center, Neurocenter of the Southern Switzerland,
Lugano, Switzerland, 2Sleep Medicine Unit, Istituti Clinici Scientifici
Maugeri, Scientific Institute of Pavia, Pavia, 3Department of Neurology,
Oasi Institute for Research on Mental Retardation and Brain Aging, Sleep
Research Centre, Troina, Italy, 4Center for Investigation and Research in
Sleep, Lausanne University Hospital, Lausanne, 5Neurology Department
Inselspital,, Bern University Hospital, Bern, Switzerland, 6C. Munari
Center of Epilepsy Surgery,, Niguarda Hospital, Milano, Italy, 7Klinik für
Schlafmedizin und Neuromuskuläre Erkrankungen,, Universitätsklinikum
Münster, Münster, Germany, 8Department of Cardiology, Regional
Hospital of Lugano, Lugano, 9University Institute of Diagnostic and
Interventional Neuroradiology, 10Department of Pulmonary Medicine and
University of Bern, Bern University Hospital, Bern, Switzerland
Objectives/Instruction: To define prevalence, time course and
associated factors of periodic limb movements during sleep (PLMS)
in patients with ischemic stroke or transient ischemic attack (TIA).
Methods: Patients enrolled in the prospective SAS‐CARE study
underwent a double polysomnographic investigation in the acute
and chronic phases after stroke/TIA, together with a MRI brain scan
and a 24‐hr blood pressure evaluation. The prevalence of PLMS in
patients was compared with that in a matched sample of randomly
selected healthy controls from the HypnoLaus cohort. One‐hundred‐
and‐sixty‐nine recordings were performed in the acute phase and
191 after 3 months (210 recordings were obtained from the same
105 patients in both phases), and were compared to those of 162
controls.
Results: The mean number of PLMS per hour, as well as the per-
centage of participants with a PLMS index >10 and >15/hr, were
similar between patients and controls. PLMS remained stable from
the acute to the chronic phase after stroke. Factors positively associ-
ated with PLMS were: age, BMI, history of hypertension. Blood pres-
sure over 24 hr and the burden of cerebro‐vascular damage was
similar between the PLMS and non‐PLMS groups.
Conclusions: PLMS are equally frequent in patients with stroke/
TIA and the general population. The absence of higher blood
pressure values and of a greater vascular brain damage found in
patients with PLMS compared to non‐PLMS patients might be due
to a larger use of antihypertensive medication among patients with
PLMS, which corresponds to a higher prevalence of previous diagno-
sis of hypertension in patients with PLMS.
Disclosure: Nothing to disclose.
P742 | Restless legs syndrome is associated
with arterial stiffness and clinical outcomes in
acute stroke patients
S.-H. Han
Neurology, Chung‐Ang University College of Medicine, Seoul, Republic of
Korea
Objectives/Instruction: Restless legs syndrome (RLS) has been
associated with vascular diseases, including cardiovascular and cere-
brovascular diseases. However, the exact relationship between those
diseases and RLS has to be yet clarified. This study investigated the
clinical significance of RLS and the factors related to this disorder in
patients with acute ischemic stroke patients.
Methods: The presence of RLS was assessed based on the four
essential criteria of the International Restless Legs Syndrome Study
Group in 2003 in patients with acute ischemic stroke. Their clinical
and laboratory characteristics, small vessel disease (SVD) burden on
brain magnetic resonance imaging (MRI), and arterial stiffness, as
determined by brachial arterial pulse wave velocity (baPWV), were
recorded.
Results: Stroke severity using the National Institute of Health
Stroke Scale (NIHSS) and the clinical outcomes using modified Rak-
ing Scale (mRS) were measured. Of 296 patients with acute ischemic
stroke, 16 (5.4%) were diagnosed with RLS. All clinical and laboratory
findings were not different between patients with and without RLS.
Logistic regression analysis showed that a 1 m/s increase in baPWV
was associated with the presence of RLS. The diagnosis of RLS was
associated with poor clinical outcome, as were age and NIHSS at
admission.
Conclusions: RLS is associated with baPWV and predicts poor clin-
ical outcome in patients with acute ischemic stroke. Additional stud-
ies are needed to evaluate whether management of RLS improves
outcomes in patients with ischemic stroke.
Disclosure: Nothing to disclose.
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P743 | Correlations of use of antidepressants,
hypnotics and anti‐histaminics with occurrence
of clinically significant periodic limb movement
in polysomnographically assessed abnormal
fatigue and insomnia
A. Mariman; E. Tobback; L. Delesie; O. Desmet; I. Hanoulle;
D. Vogelaers
University Hospital Ghent, Gent, Belgium
Objectives/Instruction: Periodic Limb Movements during Sleep
(PLMS) are characterized by rhythmic extensions of the big toe and
dorsiflexions of the ankle with occasional flexions of the knee and
hip. PLMS may lead to microarousals and sleep fragmentation and
consequently to complaints including non‐restorative sleep, fatigue
and excessive daytime sleepiness. PLMS are commonly observed
on polysomnography (PSG) in patients with restless legs syndrome
(RLS) but also occur in subjects without RLS. In a recent review
article, Kolla et al. (2018) suggest that some antidepressants may
be associated with slightly higher rates of RLS and/or PLMS. The
aim of the present study is to further investigate correlations
between the use of antidepressants, hypnotics and anti‐histaminics
and PLMs.
Methods: A retrospective study was undertaken on patients
referred to a tertiary care diagnostic center for abnormal fatigue or
insomnia and assessed by PSG between January and December
2016. Demographics, objective sleep variables, use of medication,
caffeine, alcohol and nicotine were registered. Descriptive statistics
were computed and correlations were calculated using the method
of Spearman.
Results: Out of 832 included subjects (mean age 41.6 years, SD
12.9, 70.6% female), 204 (24.5%) showed PLMS of clinical signifi-
cance (defined as an arousal index of >30/hr in the absence of other
significant primary sleep disorder). Within this group, PLMS were sig-
nificantly correlated (p = 0.05) with selective serotonin reuptake inhi-
bitors (SSRI; N = 107, r = 0.159), in particular escitalopram (N = 53,
r = 0.147), serotonin‐norepinephrine reuptake inhibitor (SNRI;
N = 120, r = 0.083) and non‐sedating antihistaminics (N = 66,
r = 0.076). PLMS were not significantly correlated (p = 0.05) with
hypnotics (benzodiazepines: N = 120, r = −0.069; Z‐drugs: N = 37,
r = −0.017), use of caffeine (r = 0.039), alcohol (r = 0.044) and nico-
tine (r = −0.001).
Conclusions: In the present study, the use of SSRIs, SNRIs and
non‐sedating anti‐histaminics were significantly correlated with
PLMS of clinical significance, as registered by PSG. Within the group
of SSRIs, this was most evident for escitalopram. However, classi-
cally presumed risk factors such as alcohol, caffeine and nicotine use
were not associated with an increased risk for PLMS.
Disclosure: Nothing to disclose.
P744 | 3D detection of leg movements
associated with arousals
M. Gall1; H. Garn1; B. Kohn1; C. Wiesmeyer1; G. Kloesch2;
A. Stefanic2; M. Boeck2; M. Wimmer3; M. Mandl3; S. Seidel2
1AIT Austrian Institute of Technology GmbH, 2Medical University of
Vienna, Vienna, 3Kepler University Clinic, Linz, Austria
Objectives/Introduction: Periodic leg movements during sleep
(PLMS) are currently diagnosed based on electromyography (EMG)
of the tibialis anterior muscles. We used automatic 3D video analysis
to detect leg movements and compared the results to conventional
polysomnographic recordings.
Methods: Using a novel 3D near‐infrared sensor, our video analysis
software measures the height profile of the body at high spatial and
temporal resolution. Motor events are characterized by changes in
this profile. Using a region of interest including the legs, the soft-
ware assigns these events to the limbs and computes selected fea-
tures in the spatial, temporal and frequency domain. Time
synchronized video‐PSG and 3D‐video sleep data of 71 patients pre-
senting with nocturnal leg movements were recorded in a multi‐cen-
tric clinical study in Austria. Polysomnographic (PSG) recordings
were annotated by visual inspection by two experienced somnolo-
gists using the WASM 2016 standards. Results were compared to
leg movements automatically detected in 3D.
Results: 5,652 candidate leg movements (CLM) were detected by
3D, of which 1,988 (35.2%) were not detected by EMG. Of those
not detected by EMG, 476 (23.9%) were associated with an arousal.
3,745 CLM were detected by both methods, with 888 (23.7%) being
associated with an arousal. EMG detected 4133 CLM, of which 388
(9.38%) were not detected by 3D. 388 (17.8%) of those not
detected by 3D were associated with arousals.
Conclusions: CLM derived from EMG can indicate either actual
movements or muscle contractions without visible movements. On
the other hand, movements not caused by the tibialis anterior mus-
cles are missed in the standard PSG recordings but are clearly visible
in 3D. Thus, 3D video somnography provides additional and more
complete diagnostic data than conventional EMG in such cases. The
fraction of movements initiated by tibialis and by other muscles var-
ied substantially between patients. Therefore, CLM detection with
tibialis anterior muscle EMG clearly depends on movement patterns.
Intriguingly, CLM detected by 3D and EMG showed comparable
rates of associated arousals. Moreover, the contactless approach of
the 3D technology provides substantial advantages by avoiding elec-
trode contact problems, enabling undisturbed sleep and facilitating
the procedure of electrode handling.
Disclosure: This study was sponsored in parts by the Austrian
Research Promotion Agency, FFG project no. 860159.
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P745 | Soluble transferrin receptor blood test
as a measure of iron status in the study of
restless legs syndrome in blood donors
L. Lillo Triguero1; A. Guillem2; A. Del Castillo3; L.A. Álvarez
Sala-Walther3; R. Peraita- Adrados4
1Sleep Unit, La Luz Hospital Quironsalud, 2Neurology, 3Internal Medicine,
Gregorio Marañón University Hospital, Complutense University of
Madrid, 4Sleept & Epilepsy Unit ‐ Clinical Neurophysiology, Gregorio
Marañón Universiy Hospital, Complutense University of Madrid, Madrid,
Spain
Objectives/Introduction: Ferritin is the accepted measurement to
study the iron status of patients with RLS. However, as an acute
phase reactant is highly variable. Transferrin receptor maintains cel-
lular iron homeostasis. Soluble Transferrin Receptor (sTfR) may be a
better indicator of iron status. Our aim was to compare the sensitiv-
ity of serum ferritin and sTfR in the study of systemic iron status, in
a population of blood donors, and the relationship between sTfR and
the presence of RLS symptoms.
Methods: We recruited 129 participants (45.7% women, 54.3%
men), mean age 43.8 years ± 10.9. Before blood donation, written
inform consent was obtained. Serum ferritin levels and sTfRt were
determined from blood tests. Four screening questions, based on
International Restless Legs Syndrome Study Group (IRLSSG) diagnos-
tic criteria, were used to asses RLS symptoms: (1) unpleasant sensa-
tions in the legs during rest; (2) an urge to move the legs; (3)
worsening in the evening or night; (4) the unpleasant sensations pre-
vent from sleeping. We define iron deficiency as ferritin <50 mcg/dl,
or sTfR > 1.86.
Results: Ferritin mean value was 48.69 mcg/dl ± 44.32 among
women, and 131.81 mcg/dl ± 97.99 among men, which was statis-
tically significant (p = 0.00), whereas the mean sTfR value was
3.22 ± 1.01 among women, and 3.03 ± SD 0.89 among men, with-
out statistical significance (p = 0.22). The 55.8% of the sample
showed ferritin <50 mcg/dl, and 93% showed sTfR > 1.86, reflect-
ing an iron deficiency. Twenty three participants (17.8%) out of
129, had at least one positive answer for the RLS screening ques-
tions [3 (1.7%) 1 positive answer, 8 (4.5%) 2 positive answers, 11
(6.2%) 3 positive answers, 1 (0.6%) 4 positive answers]. We did
not find any relation between blood donation and RLS symptoms
(p = 0.5), neither ferritin (p = 0.6) nor sTfR (p = 0.4) levels and
RLS.
Conclusions:
1 Soluble Transferrin Receptor blood test was more sensitive
than ferritin to detect iron deficiency in our sample.
2 sTfR measurements were not influenced by gender.
3 No significant association was found between blood donation
and the presence of RLS symptoms, neither ferritin nor sTfR
and RLS symptoms.
Disclosure: Nothing to disclose.
P746 | Comparing objective and subjective
measurements of excessive daytime sleepiness
in patients with significant periodic limb
movements of sleep (PLMS)
S. Delis Gómez; E. Rocío Martín; R. Wix Ramos
Neurophysiology Department, Hospital ‘La Princesa’, Madrid, Spain
Objectives/Introduction: The purpose of this clinical series of 10
patients with hypersomnia is to assess the possible clinical associa-
tion between the rate of periodic limb movements of sleep (PLMS)
and the severity of daytime sleepiness.
Methods: In order to test this hypothesis, we compared objective
sleepiness, assessed by the multiple sleep latency test (MSLT) and
subjective sleep propensity by the Epworth sleepiness scale (ESS) in
a clinical retrospective series of 10 patients with a significant PLMS
index (>15 PLM/hr), comparing the group with higher PLM index
(>25 PLM/hr) with the group with a lower one rate (15–25 PLM/h).
The MSLT was preceded by a nocturnal polysomnography (PSG)
with an apnea‐hypopnea index (AHI) <5/hr in all cases (subjects with
previous diagnose of obstructive sleep apnea syndrome (OSAS) used
CPAP with their usual pressure). Parameters were obtained from a
diagnostic nocturnal PSG‐MSLT reports recorded in drug‐free
patients, documenting MSLT in minutes (min) and number of sleep
onset REM periods (SOREMPs). We made the analyses through
Sigma‐plot 10.0 with Anova Test (parametric).
Results: Ages of the 10 subjects ranged from 42 to 71 years
(56.4 ± 10), and 6 were male and 4 female. 8 subjects (80%) were
previously diagnosed with OSAS with good adherence to treatment
in absence of significant apneas (with CPAP), and 2 (20%) were pre-
viously diagnosed with intermittent restless legs syndrome (RLS) with
symptoms controlled under treatment. Patients with the highest
PLMS index (PLMS > 25/hr, n = 4, 40%) had a mean sleep latency of
2.98 min with a mean of 0.66 SOREMPs on MSLT, and a mean ESS
score of 19, whereas those with lower PLMS index (PLMS 15–25/hr,
n = 6, 60%) had a mean sleep latency of 4.57 min with 0.16 SOR-
EMPs on MSLT, and a mean ESS score of 16.
Conclusions: In this study, we find a link between PLMS and
increased subjective sleepiness by ESS (p = 0.033), but no for objec-
tive sleepiness by MSLT (p = 0.375). This data points to the impor-
tance of routine scoring and consideration of PLMS during the
preceding nocturnal PSG, in the evaluation of MSLT results, in
patients with otherwise unexplained excessive daytime sleepiness.
Disclosure: Nothing to disclose.
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P747 | The role of vitamin D supplementation
in Willis/Ekbom, Restless Leg Syndrome (WES/
RLS). A new therapeutic option to improve
symptoms and augmentation
R. Silvestri; I. Aricò; A. Brigandì; M. Cafarelli; L. Mirci
Sleep Center, Department of Clinical and Experimental Medicine Messina
University, Messina, Italy
Objectives/Introduction: Vitamin D deficiency has been noticed
to correlate with the occurrence and severity of RLS/WED both in
children and in adults.
Methods: We enrolled all new adult RLS patients referred to our
Sleep Centre in the last 3 years. All selected patients had a clinical
evaluation including anthropometric values (Body mass index, BMI),
iron and vitamin D assessment, RLS severity score, neuropsychologi-
cal assessment, comorbidity, therapy, augmentation. Patients were
all re‐assessed after a 6 months interval for reassessment of symp-
toms and therapy.
Results: Twenty‐six consecutive RLS patients (mean age
59.03 ± 8.6, range 45–79 years), (5M, 21 F), mean BMI 30.43 ± 5.3,
mean IRLS‐RS 19.6 ± 6.4, mean ESS 8.7 ± 5.2 were enrolled. Neu-
ropsychological assessment showed mean scores on BDI and HAM‐
A compatible with mild depressive anxiety syndrome (mean BDI and
HAM‐A scores 16.3 and 21.9, respectively). PSQI showed a poor
sleep quality (Mean score 10.1 ± 4.3). Comorbidities were: hyperten-
sion in 50%, diabetes in 19.2%, osteoporosis in 11.5%, sleep apnea
in 53.8%, migraine in 11.5%, thyroid disease in 30.8%. At first visit,
twelve patients were already on Dopa‐agonists (four of which also
on pregabalin). Mean vitamin D value was 26.3 ng/ml. Vitamin D
supplementation were prescribed in all patients with insufficient val-
ues with improvement of RLS symptoms after 6 months of therapy
(IRLS‐RS score 6.7 ± 6.1, p = 0.0002). Augmentation was reported
by eight patients with lower vitamin D values than patients without
augmentation (16.04 ng/ml versus 24.8 ng/ml, with statistical signifi-
cance p = 0.001). Augmentation symptoms improved after supple-
mentation of vitamin D. No results were found for ESS, BDI and
HAM‐A scores. Multivariate regression analysis showed an inverse
correlation between vitamin D and IRLS‐RS score, BDI score and
PSQI (r = 0.8, IC 5%).
Conclusions: Vitamin D deficit plays a role on the expression of
symptoms severity in RLS; higher D3 values by adequate supplemen-
tation may improve symptoms and reduce augmentation.
Disclosure: Nothing to disclose.
P748 | Autonomic nervous system dysfunction
during the suggested immobilization test in
restless legs syndrome
A. Rassu1,2; S. Chenini1,2; E. Evangelista1,2,3; L. Barateau1,2,3;
R. Lopez1,2,3; I. Jaussent2,3; Y. Dauvilliers1,2,3
1Department of Neurology, Gui‐de‐Chauliac Hospital, CHU Montpellier,
Sleep Disorders Centre, 2National Reference Network for Narcolepsy,
3Inserm U 1061, Montpellier, France
Objectives/Introduction: To investigate the relationships
between cardiovascular autonomic function and sensory discomfort/
periodic limb movements (PLM) through a continuous beat‐to‐beat
blood pressure monitoring (CBPM) during the suggested immobiliza-
tion test (SIT) in patients with restless legs syndrome (RLS).
Methods: Thirty‐two patients with drug‐free primary RLS (10 men,
median age 62.0 years) and 17 controls (3 men, median age
60.4 years) underwent the one hour SIT during waketime, starting at
8:00 pm, with a concomitant CBPM (Nexfin™). All subjects reported
the degree of sensory discomfort through a Visual Analogue Scale
(VAS) administered every 10 min. PLM were recorded on surface
limb electromyography. The presence of sensory symptoms during
the SIT (S‐SIT+) was defined by a score ≥4/10 at the VAS (last tertile
of the distribution). A positive motor SIT (M‐SIT+) was defined by
PLM ≥15/hr (last tertile of the distribution). Mixed models regression
were performed to study the evolution of CBPM measures. The p‐
value was set at p < 0.05.
Results: Seventeen patients (53.1%) had S‐SIT+; none of the con-
trols reported S‐SIT+. Changes on systolic blood pressure (BP) were
found in all groups (p < 0.0001); the S‐SIT+ group had the higher
systolic BP. No significant changes were found on diastolic blood
pressure (DBP) (p = 0.09) and heart rate (HR) (p = 0.78), but interac-
tion between groups and periods revealed that both DBP and HR
were higher in patients with S‐SIT+. Seventeen patients (53.1%) had
M‐SIT+, and all the controls M‐SIT−. No between‐group and along
the SIT changes were found on DBP (p = 0.08) and HR (p = 0.78);
SBP increased during the SIT (p < 0.0001), without any difference
between groups. Combining sensory and motor SIT components,
patients were classified in four groups: S‐SIT−/M‐SIT− (n = 8); S‐
SIT+/M‐SIT− (n = 7); S‐SIT−/M‐SIT+ (n = 7); S‐SIT+/M‐SIT+ (n = 10).
Both SBP and DBP increased in S‐SIT+/M‐SIT− group (p < 0.0001)
and in S‐SIT+/M‐SIT+ group (p = 0.0008; p = 0.01). HR remained
stable in all groups.
Conclusions: Patients with RLS presenting sensory discomfort dur-
ing the SIT, with or without PLM, displayed a concomitant increasing
of systolic and diastolic BP. These results highlighted the links
between the sensory symptoms and the cardiovascular autonomic
nervous system dysfunction during waketime in patients with RLS,
suggesting an increased long‐term risk of cardiovascular diseases.
Disclosure: Nothing to disclose.
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P749 | Frequent association of central nervous
system disorders in patients with periodic limb
movements during rapid eye movement sleep
A. Barros1; R. Peralta2,3; C. Bentes2,3
1Centro Hospitalar de Lisboa Central, 2Centro Hospitalar de Lisboa
Norte, 3Faculdade de Medicina da Universidade de Lisboa, Lisboa,
Portugal
Objectives/Introduction: Periodic limb movements (PLM) occur
mostly during non‐rapid eye movement sleep and rarely during rapid
eye movement (REM) sleep. Few studies have shown that in patients
with neurological disorders, namely REM sleep behaviour disorder
(RBD), narcolepsy, Parkinson Disease and spinal cord injury, PLM
may occur in REM sleep. Given the active inhibition of somatic
motoneurons during REM, the appearance of PLM in REM sleep
(PLM‐REM) could indicate overt or subclinical injury of central ner-
vous system (CNS) in this pathway. The aim of this work is to assess
neurological comorbidities associated with PLM‐REM.
Methods: Retrospective study, from a University‐hospital neurolog-
ical department. Inclusion criteria were: (1) age >=18 years; (2) PLM‐
REM >4 and PLM‐REM index >=5/hr; (3) REM sleep time >=10 min
and (4) clinical follow‐up >=1 year. Demographic, clinical (including
neurological comorbidities and concomitant medication use) and
polysomnographic characteristics were analysed. Follow‐up data on
the novo neurological diagnosis was obtained from clinical files. Idio-
pathic PLM‐REM was defined when PLM‐REM index >=5/hr and
there was no known neurological or iatrogenic association.
Results: 102 patients were included (64.7% males). Mean age was
58.2 ± 16.6 years. Twenty‐five out of 102 patients had only PLM
during REM sleep, 37 patients had PLM‐REM more than twice than
PLM in non‐REM sleep. Most patients (82.3%) had PLM sleep index
>=5/hr and only 8.8% patients had restless leg syndrome. The med-
ian PLM index was 15.1/hour in sleep and 16.1/hr during REM sleep.
Comorbidities occurred in 59 patients [29.4% RBD, 4.9% narcolepsy,
41.2% CNS disorders (including 30.4% neurodegenerative disorders)].
Thirty‐four patients were on antidepressants, neuroleptics and/or
antiepileptic drugs. Thirty‐two patients showed idiopathic PLM‐REM.
From the 43 patients without previous neurological disorders (includ-
ing RBD) there were 3 patients (7.0%) with newly diagnosed CNS
disorders (median follow‐up period was 36 months).
Conclusions: This study confirms PLM‐REM occurs more fre-
quently in patients with other CNS disorders but may also be
described as idiopathic. Despite the low frequency of de novo neuro-
logical diagnosis on follow‐up, that may be chance related, our
results raise the possibility that idiopathic PLM‐REM may be a pre-
clinical biomarker of CNS disorders. Further long term prospective
and case‐control studies are recommended to confirm these findings.
Disclosure: Nothing to disclose.
P750 | Restless leg syndrome effect on heart
rate variability, is it real?
E. Dongol1; M. Ezzeldin1; R. Muza2; A. Williams2
1Qena Faculty of Medicine, South Valley University, Qena, Egypt, 2Sleep
Disorders Center, Guy's and St. Thomas NHS, London, United Kingdom
Objectives/Introduction: There are conflicting data about the
impact of restless leg syndrome on heart rate variability and auto-
nomic function. Some studies suggested that RLS affects the HRV
which may directly lead to the higher prevalence of cardiovascular
disease. Other studies found that primary restless legs syndrome
(RLS) was not associated with new‐onset cardiovascular disease
(CVD) or coronary artery disease (CAD). We aimed to assess the
change of the HRV parameters in the patients who develop restless
leg syndrome in 5 years follow up.
Methods: National sleep research resource database contains data
of the sleep heart health study dataset. It contains the baseline mea-
sures including overnight polysomnography and follow up of the
patients after 5 years. All the patients, who had two polysomnogra-
phy, at the base line and on the follow up and developed the symp-
toms consistent with restless leg syndrome were included in the
analysis. Patients were excluded if they already had RLS at the base-
line or had any factor known to affect the HRV such as D.M, hyper-
tension, myocardial infarction, drugs or sleep apnea. HRV analysis
was done in patients who fulfilled the selection criteria.
Results: Of the 5804 subjects included in the study and after
applying the exclusion criteria, we ended with 11 patients with
newly developed RLS and age and gender 25 matched subjects who
did not have RLS. No significant difference regarding the parameters
of age, BMI and ESS. In the normal sujects group, there was no sig-
nificant difference regarding the HRV parameters values except for
the NNRR variable with p‐value of 0.006. In the RLS group, a signifi-
cant difference in the pNN20, 30, 40 with p‐value less than 0.05 as
well as a significant difference regarding the NNRR parameter of p‐
value of 0.026.
Conclusions: It can be concluded that RLS development may really
affect the HRV. A study with larger number of patients is needed to
confirm this finding.
Disclosure: Nothing to disclose.
P751 | On the restless legs syndrome and
insomnia symptoms in Georgian pregnant
women ‐ preliminary findings
L. Maisuradze1,2; S. Kasradze3
1Ivane Beritahvili Center of Experimental Biomedicine, 2Ilia State
University, 3Institute of Neurology and Neuropsychology, Tbilisi, Georgia
Objectives/Introduction: Restless legs syndrome (RLS) is a com-
mon sleep disorder that increases in prevalence during pregnancy. It
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is estimated to affect approximately 25% of all pregnancies with a
peak in the third trimester. However, less attention has been
focused on the RLS diagnostic testing or therapy in Georgia; accord-
ingly, the relationship of RLS to history of pregnancy remains unex-
plored. The current study was aimed to identify RLS and insomnia
symptoms in the Georgian pregnant women.
Methods: A total of 43 pregnant women (age range: 21–38, preg-
nancy: second and third trimester) selected from two Tbilisi ambula-
tory care centers participated in the study and answered four
questions to detect RLS as proposed by the International Restless
Legs Syndrome Study Group (IRLSSG). Subjects who answered posi-
tively the four questions were asked to complete two question-
naires: Sleep Impairment Index and Epworth Sleepiness Scale.
Results: A total of 9 subjects (20.9%) met the four criteria for
RLS (33.3% with symptoms once/month, 22.2% with symptoms ≥3
times/month, 33.3% with symptoms ≥3 times/week, and 11.1%
with symptoms once/year). Of these, 4 subjects (44.4%) were in
the second trimester (age: 24–37) and 5 subjects (55.6%) were in
the third trimester (age: 24–34). Family history was positive in 5
participants (55.6%). 4 subjects (44.4%) reported the onset of
symptoms of RLS at the given pregnancy. 5 women (55.6%) had
experienced symptoms of RLS more early than the onset of preg-
nancy; however, no one has been applied to doctor before to tell
this problem. Of the 9 pregnant subjects having RLS, main insom-
nia symptoms were detected in 6 subjects (66.7%); of these, four
women had sleep onset insomnia and two subjects had excessive
daytime sleepiness.
Conclusions: Although the pathophysiology of RLS in pregnancy is
still under investigation in the general population, the findings point
out the relationship of RLS to sleep deterioration and history of
pregnancy. The results show: (a) pregnancy affects the development
of RLS and (b) sleep difficulties are common in pregnant women
who experience the symptoms of RLS. It is needed to implement
Clinical guidelines for the diagnosis and treatment of RLS in Geor-
gian Healthcare Settings.
Disclosure: Nothing to disclose.
P752 | Head jerk during REM sleep: healthy
motor event or movement disorder?
M. Kohsaka1; Y. Syoji1; N. Fukuda1; M. Mizui1; T. Ishikane1;
S. Kohsaka2
1Department of Psychiatry, Ishikane Hospital, 2Department of Pediatrics,
Hokkaido University School of Medicine, Sapporo, Japan
Objectives/Introduction: Head jerks are defined by sudden
movements of the head with the intense turning to one side.
Although these head jerks are considered to affect the quality of
sleep, previous studies showed that these phenomena were often
recognized in healthy subjects. We investigated the head jerks in
sleep disorders, and reevaluated the quality of sleep.
Methods: We obtained video‐polysomnography (v‐PSG) data from
185 patients with sleep disorders in our hospital from January 2016
to March 2018. REM sleep behavioral disorder and epilepsy were
excluded from the study. They underwent PSG for consecutive two
nights. The sleep stages were visually scored by 20‐s epochs accord-
ing to the criteria of Rechtschaffen and Kales, and the respiratory
and motor events were scored according to AASM criteria. The
movement‐induced artifacts defined as head jerks were short‐lived
phenomena on PSG (EEG, EOG and chin‐EMG) with the duration of
0.2 to 0.4 s. On video recordings, these head jerks exhibited a brief
version of the head to one side or ventral flexion.
Results: Thirty‐eight patients (20.5%) showed at least one head jerk
during REM sleep. Eight patients (4.3%) showed head jerks during
REM sleep in every four sleep cycles. They consisted of 5 women
and 3 men aged from 15 to 33 years. We calculated total number of
events of head jerk per hour of REM sleep as event index. Such
event indices in eight patients were 3.8–50.2 (23.4 ± 14.4, mean ±
SD). More than 50% of events were followed by arousals. Epileptic
discharge related to head jerk was not recognized in all patients.
Conclusions: Frauscher et al. reported that neck myoclonus was
observed in 35% of healthy subjects with variable frequency, sug-
gesting that it constitutes physiologic phenomena. In our study,
younger patients tended to show head jerks, which were accompa-
nied by frequent arousals. These arousals induced the fragmentation
of REM sleep, and are considered to be responsible for sleep impair-
ment. An establishment of guideline will be necessary to evaluate
this movement disorder like the treatment of periodic limb move-
ment disorder.
Disclosure: Nothing to disclose.
P753 | Rocking bed therapy for sleep related
rhythmic movement disorder: movement
preference and acceptability in six children
R.M. van Sluijs1; Q.J. Rondei1; E. Wilhelm1; L. Jäger1;
M. Schnauss1; M. Gall2; H. Garn2; V. Hewertson3;
P. Achermann4; H.-P. Landolt4; O. Jenni5; R. Riener1;
C.M. Hill3
1Sensory‐Motor Systems Lab, ETH Zürich, Zürich, Switzerland, 2Austrian
Institute of Technology, Vienna, Austria, 3University of Southampton,
Southampton, United Kingdom, 4University of Zurich, 5University
Children's Hospital Zurich, Zurich, Switzerland
Objectives/Introduction: Sleep related rhythmic movement disor-
der (RMD) is characterized by episodes of rhythmic movement
involving large muscle groups that occur related to sleep onset and
during sleep. Clinical consequences include injury and impaired day-
time functioning. Rhythmic sensory stimulation is known to be
soothing. Furthermore, it might be able to substitute the sensory
experience of RMD episodes. The Somnomat is an automated bed,
designed to provide rocking movements in two directions with fre-
quencies up to 2.0 Hz. We hypothesize that the bed movement
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frequency preferred by subjects resembles their habitual movement
frequency.
Methods: During an afternoon protocol, children with RMD (n = 6;
4 male) aged 5 to 14 years (M: 9.0y, SD: 4.1y) were presented with
different movement frequencies up to 2.0 Hz. After the bed rocked
for one minute, participants were asked to indicate if the bed should
move faster or slower to promote sleep. Additionally, the level of
comfort and sleepiness were assessed using a five‐point visual rating
scale. Habitual movement frequency was determined, for the five
subjects with symptoms in the lab, as the average movement fre-
quency of three RMD episodes scored manually based on video
recorded.
Results: The average habitual movement frequency was 0.97 Hz
(SD: 0.31 Hz). Three participants preferred stimulation at 0.25 Hz,
which was slower than typical rhythmic movements. The other three
participants chose frequencies within the range characteristic of
rhythmic movement disorder (0.5, 1.0 and 2.0 Hz). Levels of comfort
and sleepiness at the preferred frequency were 4.33 (SD: 0.82) and
4.00 (SD: 0.89) out of 5 respectively, with 5 indicating optimal com-
fort and maximal sleepiness. All participants indicated liking the
movement and were willing to try out the bed overnight. Parents
reported having no safety concerns.
Conclusions: Three participants chose faster movement frequen-
cies resembling their habitual movements. The other three partici-
pants chose the slowest frequency provided, which in previous
studies was reported to be most comfortable and sleep‐inducing in
healthy adults. As a next step, the effect of rocking bed therapy on
symptoms will be determined by comparing a night without move-
ment with a night where the bed moves using the subjects preferred
frequency.
Disclosure: Nothing to disclose.
P754 | Multisensor data fusion algorithm for
sleep quality estimation using multiple
measurements
T. Guettari; D. Voilmy; A. Chkeir; P. Hovan
UTT, Troyes, France
Objectives/Introduction: Sleep monitoring represents an interest
field in medical word. We spend a part of our life in bed, then an
analyzing of our sleep represents a part of our medical consultation.
Therefore, the supervision of the evolution of our sleep quality is
primordial thing. A lot of systems have been implemented, tested
and commercialized. Each system has a specified properties and
characteristics. In our living lab, We study the correlation between
the sleep quality and balance stability measured at wake up. In this
study we use the withing system which is based on movement
counted when the person was in the bed at night in order to mea-
sure sleep quality and for the balance stability is measured by scale
which uses the movement counted when the person is on the scale.
The balance stability is used to enhance the sleep quality score
therefore the data fusion algorithms are tested on recorded data-
base. The database is recorded by students in internship and phd
students. In this work, the data base is described, the correlation
study is presented and the fusion data algorithms are detailed. Esti-
mation methods of the weight for each modality (scale and withing
system) are prospected.
Methods: Scores fusion algorithm which represents a third layer of
data fusion algorithm.
Results: The correlation between measurment of balance stability
and sleep qulaity has been verified (98% of test step).
Conclusions: The multimodal fusion data algorithm is able to
enhance the estimation of sleep quality.
Disclosure: Nothing to disclose.
P755 | A randomized controlled trial of
botulinum toxin for treating sleep bruxism: a
polysomnographic evaluation
K.J. Park1; Y.J. Shim2; H.J. Lee1; B.E. Kim1; J.E. Lee1;
I.H. Park1; S.R. Kim1; I.H. Hong1; S.T. Kim1
1Orofacial Pain and Oral Medicine, Yonsei University Dental Hospital,
Seoul, 2Wonkwang University Daejeon Dental Hospital, Daejeon,
Republic of Korea
Objectives/Introduction: To investigate the effects of botulinum
toxin type A (BoNT‐A) injection on sleep bruxism(SB) episodes during
sleep in SB patients who did not respond to oral splint treatment.
Methods: Twenty three subjects with a clinical diagnosis of SB
completed this study. Twelve subjects received bilateral BoNT‐A
injections (25 U per muscle) into the masseter muscles (experimental
group), and the other 11 received bilateral saline injections into the
masseter muscles (control group). Videopolysomnographic (vPSG)
recordings were made before, at 4 weeks and at 12 weeks after
injection. SB episodes and Rhythmic masticatory muscle activity
(RMMA) were scored and analyzed for several parameters (e.g., fre-
quency of episodes, bursts per episode, episode duration). The peak
amplitude of electromyographic (EMG) activity in the two muscles
was also measured.
Results: In BoNT group, the injection reduced the frequency of SB
episode, number of bursts, or duration for RMMA episodes. It differed
significantly before and 4, 12 weeks after the injection (p < 0.001,
repeated measure ANOVA). At 4 weeks after injection, the greatest
changes occurred. However there was no significant differences
between before and at any time period in saline injection group.
Conclusions: BoNT‐A injection is an effective strategy for control-
ling SB for at 4 weeks and at 12 weeks after injection. It reduces
the frequency of SB episode, number of bursts, or duration for
RMMA episodes. Future investigations on the efficacy in larger sam-
ples over a longer follow‐up period are needed.
Disclosure: Nothing to disclose.
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P756 | Prevalence of restless legs syndrome
(RLS) in the general population
T. Sand1,2; P. Omland2; K. Hagen1,2; K. Langsrud3;
E. Brenner2; M. Engstrøm1,2
1INB, NTNU, 2Neurology and Clinical Neurophysiology, 3Psychiatry,
St.Olavs Hospital, Trondheim, Norway
Objectives/Introduction: Estimated prevalence of RLS varies with
the method applied. Our aim was to compare prevalence with ICSD‐
3 and IRLSSG criteria in the elderly adult general population.
Methods: We invited 1,200 subjects selected at random from the
population in Nord‐Trøndelag, Norway, participating in the large epi-
demiological HUNT‐4 study. N = 232 subjects (152 women and 80
men) mean age 58.4 (range 22–89 years). Subjects completed the
Cambridge‐Hopkins questionnaire (CHq) and were later interviewed
face‐to‐face by a medical doctor for the final RLS diagnosis.
Results: Thirty‐two subjects (14%) were diagnosed with RLS with
ICSD‐3 criteria. Sixty‐two subjects had RLS according to IRLSSG, 31
(13%) of whom had chronic and 31 (13%) had intermittent forms.
With the two initial screening questions in CHq (leg symptoms
relieved by movement), only one false negative subject was observed.
However, the number of false positives (n = 85) was very high.
Conclusions: The prevalence of RLS depends critically on the crite-
ria as the IRLSSG‐based estimate was twice the ICSD‐ 3 estimate.
Simple questions can be used as screening, because the number of
false negatives was very low, but the number of false positives was
very high. RLS‐population prevalence estimated by one or two sim-
ple questions may accordingly not be valid.
Disclosure: Nothing to disclose.
P757 | Asymmetry of periodic leg movements
in sleep (PLMS) in Parkinson's disease
W. Hermann1,2; T. Spitzer3; H. Reichmann1; A. Storch3,4
1Department of Neurology, 2Interdisciplinary Sleep Laboratory,
Departments of Neurology and Internal Medicine I, Technische
Universität Dresden, Dresden, 3Department of Neurology, University of
Rostock, 4German Center for Neurodegenerative Diseases (DZNE)
Rostock, Rostock, Germany
Objectives/Introduction: To study whether periodic limb move-
ments in sleep (PLMS) appear asymmetric in Parkinson's disease (PD)
compared to Restless‐legs‐Syndrome (RLS) and obstructive sleep
apnoea (OSA) and whether asymmetry of PLMS corresponds to asym-
metry of motor symptoms in PD. PLMS were first described in the
1960s by Lugaresi and colleagues. PLMS are repetitive movements
occurring during sleep. The pathophysiology of PLMS is still unclear.
PLMS are often associated with RLS but also occur in other conditions
like sleep disordered breathing (e.g., OSA), spinal cord lesions and also
PD. PLMS were already described as sometimes alternating between
sides, but in PD, where asymmetry of motor symptoms as well as
pathology is a hallmark, no detailed data exist on asymmetry of PLMS.
Methods: Cross‐sectional, monocentric, retrospective analysis of
polysomnography recordings using slightly modified American Academy
of Sleep Medicine (AASM) criteria for PLMS. Exclusion criteria for con-
trol groups comprised all other general or neurological diseases that
may cause periodic leg movements in sleep (e.g., spinal cord lesions).
Results: Until now, we included 29 patients with idiopathic PD (mean
age 69.9 ± 6.9 years) and sex‐ and age‐matched controls with OSA
(n = 27, age 70.6 ± 6.6 years) and RLS (n = 11, age 67.9 ± 8.1 years;
Kruskal‐Wallis‐test, p = 0.600). Of all patients we analyzed two or more
PSG recordings. Overall PLM‐Index (PLM‐I) was significantly higher in
OSA compared to PD (65.8 ± 61.8 vs. 15.7 ± 26.3; p = 0.005) and also
RLS compared to PD (40.3 ± 33.1 vs. 15.7 ± 26.3; p = 0.009). PLMS
were asymmetrical regardless disease entities or PAP treatment when
we analyzed more affected vs. less affected side (PLMS‐I: PD
9.4 ± 16.4 vs. 4.6 ± 10.7, p = 0.001; OSA 23.0 ± 23.3 vs. 15.1 ± 19.8;
p < 0.0001; RLS 17.9 ± 13.8 vs. 9.5 ± 8.7, p = 0.004). We did not find
any correlations between the asymmetry of PLMS with handedness or
dominant side of PD motor symptoms.
Conclusions: Periodic leg movements in sleep (PLMS) show asymme-
try in patients with PD, RLS and OSA. There is no association between
the occurrence of asymmetric PLMS and the asymmetry of motor symp-
toms in PD. This seems to underline that motor symptoms of PD and
PLMS have a different pathophysiological background. Further studies
are needed to elucidate whether PLMS are asymmetrical in general.
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